2016”N“x –k—˘‘ĺŠwˆăŠw•”E‘ĺŠw•a‰@Œ¤‹†‹ĆŃW(HTML”Ĺ)


i’FŒ´–{‚ĹŒäŠm”F‰ş‚ł‚˘j



‰đ–UŠw (Źě’PˆĘ)


[Šwp˜_•ś]

110001. [Œ´’˜] In vivo 3D analysis of systemic effects after local heavy-ion beam irradiation in an animal model. Nagata K, Hashimoto C, Watanabe-Asaka T, Itoh K, Yasuda T, Ohta K, Oonishi H, Igarashi K, Suzuki M, Funayama T, Kobayashi Y, Nishimaki T1, Katsumura T2, Oota H2, Ogawa M2, Oga A, Ikemoto K, Itoh H, Kutsuna N, Oda S, Mitani H: Sci Rep 2016/6; 6: 28691. (ź–Šr”V1, Ÿ‘şŒ[Žj2, ‘ž“c”ŽŽ÷2, ŹěŒł”V2: 1Œ`‘ÔŒn, 2‰đ–U)

110002. [Œ´’˜] A comparative study on the regulatory region of the PERIOD1 gene among diurnal/nocturnal primates. Katsumura T1, Fukuyo Y, Kawamura S, Oota H1: J Physiol Anthropol 2016/9; 35 (1): 21. (Ÿ‘şŒ[Žj1, ‘ž“c”ŽŽ÷1: 1‰đ–U)

110003. [Œ´’˜] Transgenic medaka that overexpress growth hormone have a skin color that does not indicate the activation or inhibition of somatolactin-ƒż signal. Komine R, Nishimaki T1, Kimura T, Oota H2, Naruse K, Homma N1, Fukamachi S: Gene 2016/6; 584 (1): 38-46. (ź–Šr”V1, ‘ž“c”ŽŽ÷2: 1Œ`‘ÔŒn, 2‰đ–U)

120001. [Œ´’˜] ƒ~ƒgƒRƒ“ƒhƒŠƒADNA‰đÍ‚Š‚琄’股‚鍁ěŒ§ƒƒ_ƒJ‚̏W’cŽj. ŽR‰ş‰Ŕ“ß, Ÿ‘şŒ[Žj1, ”ö“cł“ń, Ąˆä@ł, ‹g‰YNŽő, ‘ž“c”ŽŽ÷1 (1‰đ–U): ’nˆćŽŠ‘RŽj‚Ć•Ű‘S 2016/6; 38 (1): 41-50.

[Šw‰ďEŒ¤‹†‰ď“™]

723001. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒjƒƒgƒŠ›z—‘ŠúéҌă‘Ě‚Š‚çěť‚ľ‚˝iPS—l×–E‚̉đÍ. ŽO‰Ył–ž (‰đ–U): ‘ć122‰ń“ú–{‰đ–UŠw‰ď‘‰ďE‘S‘ŠwpW‰ď (2017/3/28), ’ˇč.

723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰EŒű“Ş) ‰đ–UŠw‹łˆç (u‹`EŽŔK) ‚ÉŠÖ‚ˇ‚éˆęlŽ@. ŹěŒł”V1, ‘ž“c”ŽŽ÷1, ŽO‰Ył–ž1, Vˆä—Y‘ž1, ‹Ę–؉p–ž1 (1‰đ–U): ‘ć122‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2017/3/28-30), ’ˇč.

723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –쐜ƒƒ_ƒJ‚É‚Ý‚ç‚ę‚éÁ‰ťŠÇ’ˇ‚Ě‹Gß•Ď“Ž‚É‘ŠŠÖ‚ˇ‚éDNAƒƒ`ƒ‹‰ť•Ď“Ž—Ěˆć‚Ě–Ô—…“I‚Č’Tő. Ÿ‘şŒ[Žj1, ˛“Ą@Ž, ŽR‰ş‰Ŕ“ß, Šo’Ł—˛Žj, ”ö“cł“ń, Ąˆä@ł, ‹g‰YNŽő, •“‡O•F, ’|“ŕG–ž, ŹěŒł”V1, ‘ž“c”ŽŽ÷1 (1‰đ–U): ‘ć122‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2017/3/28-30), ’ˇč.

723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ň’Ĺ•ĎˆŮ‘Ěƒƒ_ƒJ‚ɑ΂ˇ‚é‚wüƒ}ƒCƒNƒCT‚Ć˜A‘ąŘ•Đ–@‚É‚ć‚éƒAƒvƒ[ƒ`|Ú×‚ČŒ`‘Ô‰đÍ‚đ–ÚŽw‚ľ‚ā|. źę r”V1, “ŕ“cŒ’‘ž˜Y, –ؐX‹`—˛, Ÿ‘şŒ[Žj, ‘ĺŠŃ—TŽq, ”ö“cł“ń, Ź‰ęŒú“ż, ‚‘ŠťŽm, ‘ž“c”ŽŽ÷2, ŹěŒł”V2 (1Œ`‘ÔŒn, 2‰đ–U): ‘ć122‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2017/3/28-30), ’ˇč.


‰đ–UŠw (ăă’PˆĘ)

[Šwp˜_•ś]

110004. [Œ´’˜] Distinct subcellular localization of alternative splicing variants of EFA6D, a guanine nucleotide exchange factor for Arf6, in the mouse brain. Fukaya M1. Ohta S. Hara Y1. Tamaki H1. Sakagami H1: Journal of Comparative Neurology 2016/9; 524 (13): 2531-52. ([’JšO1. Œ´@–FL1. ‹Ę–؉p–ž1. ăă—ms1: 1‰đ–U)


ś—Šw (ěă’PˆĘ)

[Šw‰ďEŒ¤‹†‰ď“™]

723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”|—{_Œo×–E‚Ě×–E•Ş—ô‚É‚¨‚Ż‚éOlig2‚Ě”­Œť. ”ä—ŻŠÔO”ü (ś—): ‘ć94‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2017/3/29), Ă‰Ş.


ś—Šw (‰ÍŒ´’PˆĘ)

[Šwp˜_•ś]

522001. [uŔ]y˜AÚ: Œ¤CˆăEt‘Ÿ“ü–ĺˆă‚Ě‚˝‚ß‚Ě‚â‚ł‚ľ‚˘…“d‰đŽżzŠî‘b•ŇI@…@‹ßˆĘ”A×ŠÇ‚Ě—n‰t—A‘—‚ƏW‡ŠÇ‚̐…—A‘—. ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2 (1ś—, 2ś•¨•¨—Œn): t‚Ć“§Í 2016/8; 81 (2): 174-6.

522002. [uŔ]y˜AÚ: Œ¤CˆăEt‘Ÿ“ü–ĺˆă‚Ě‚˝‚ß‚Ě‚â‚ł‚ľ‚˘…“d‰đŽżzŠî‘b•ŇI@…A”M’†Ç, ’E…Ç: ‘̉ˇE…“d‰đŽż’˛ß”\‚Ě”j’] (I). ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2 (1ś—, 2ś•¨•¨—Œn): t‚Ć“§Í 2016/9; 81 (3): 318-20.

522003. [uŔ]y˜AÚ: Œ¤CˆăEt‘Ÿ“ü–ĺˆă‚Ě‚˝‚ß‚Ě‚â‚ł‚ľ‚˘…“d‰đŽżzŠî‘b•ŇI@…B”M’†Ç, ’E…Ç: ‘̉ˇE…“d‰đŽż’˛ß”\‚Ě”j’] (II). ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2 (1ś—, 2ś•¨•¨—Œn): t‚Ć“§Í 2016/10; 81 (4): 466-8.

[’˜@‘]

620001. [Šwp‘ (•Ş’SŽˇ•M)]yt‚Ć“§Íf—ĂŽwj2016 (t‚Ć“§Í2016”N80ŠŞ‘Š§†)z‘ć10Í ”A×ŠÇŽžŠł“™ @4. t”A×ŠÇƒAƒVƒh[ƒVƒX, p.307-11. ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2, ˆŔ‰Ş—L‹IŽq1 (1ś—, 2ś•¨•¨—Œn): “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712001. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Acid-base imbalance due to inappropriate stimulation of Pendrin. Kawahara K1: International Conference: The kidney in genetic and rare disease (2016/10/27), Italy. (‰ÍŒ´Ž‰ë1: 1ś—)

713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Analysis of Vasopressin V1a Receptor Distribution and Function in the Mammalian Kidney. Giesecke T, Koshimizu K, Kawahara K1, Bachmann S, Mutig K: American Society of Nephrology (Kidney Week 2016 ) (2016/11/17), USA. (‰ÍŒ´Ž‰ë1: 1ś—)

713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Aldosterone and Vasopressin Are Erythropoietic Hormones. Nonoguchi H1, Izumi Y, Yasuoka Y2, Nakayama Y, Nagai T, Nanami M, Nakanishi T, Mukoyama M, Kawahara K2: American Society of Nephrology (Kidney Week 2016) (2016/11/18), USA. (–ěXŒű”ŽŽj1, ˆŔ‰Ş—L‹IŽq2, ‰ÍŒ´Ž‰ë2: 1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2ś—)

713003. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Decreased Renal Threshold for Urinary Excretion of Ammonia Underlies Proximal Renal Tubular Acidosis in TASK2 K Channel-Deficient Mice. Yasuoka Y1, Oshima T2, Sato Y3, Ohtsuka M, Kimura M, Nonoguchi H4, Kawahara K1: American Society of Nephrology(Kidney Week 2016 ) (2016/11/19), USA. (ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1: 1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

723006. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •”•Şt“Eƒ}ƒEƒX‚ĚNestin—U“ą. ‰ÍŒ´Ž‰ë1, ˆŔ‰Ş—L‹IŽq1, •Ÿ“c‰pˆę1, Îˆä‘ĺ•ă2, Šâ‘şłŽk2, –ěXŒű”ŽŽj3 (1ś—, 2”ĺ”AŠí, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć59‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2016/6/17), ‰Ą•l, “út‰ďŽ 2016; 58(3): 342.

723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’áPiHŽ”ˆçƒ}ƒEƒX‚Ě‘ăŽÓŤƒAƒVƒh[ƒVƒX|ƒAƒ‹ƒJƒŠ”A‚Ě•a‘Ԑś—‹@˜. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć59‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2016/6/19), _“ސě, “ú–{t‘ŸŠw‰ďŽ 2016; 58 (3): 391.

723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Sex difference in dendritic spine density related to extinction memory acquired after conditioned taste aversion in mice. ‹{–{•“T, ˆźěŽ‡‰‘, —é–Řœ¨‰ë, •ş“­”ü‰Ŕ, “’ŠˆŸ—ŽŃ, “ĄŒ´GŽq, “n•Óˆ¤Žq, âV“Ą—‰Ŕ, ˛“Ą—ş•˝1, P‰Ş—m‰E (1ś—): ‘ć39‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2016/7/20), _“ސě.

723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’჊ƒ“HŽ”ˆçƒ}ƒEƒX‚̍‚CaŒŒÇ‚Ć‘ăŽÓŤƒAƒVƒh[ƒVƒX‚Ě•a‘Ԑś—Šw. ‰ÍŒ´Ž‰ë1, ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2 (1ś—, 2ś•¨•¨—Œn): ‘ć20‰ń“ú–{•a‘Ô‰h—{Šw‰ď”NŽŸŠwpW‰ď (2017/1/15), ‹ž“s.

723010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’჊ƒ“HŽ”ˆçƒ}ƒEƒX‚É‚¨‚Ż‚é‹tŕ“IŽ_‰–ŠîƒCƒ“ƒoƒ‰ƒ“ƒX. ‰ÍŒ´Ž‰ë (ś—): ‘ć50‰ń“ú–{’É•—EŠjŽ_‘ăŽÓŠw‰ď‘‰ď (2017/2/17), “Œ‹ž.

723011. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The effect of testosterone on synaptic plasticity in brain areas related to extinction memory retention after conditioned taste aversion in mice. ˆźěŽ‡‰‘, —é–Řœ¨‰ë, •ş“­”ü‰Ŕ, “’ŠˆŸ—ŽŃ, “ĄŒ´GŽq, “n•Óˆ¤Žq, âV“Ą—‰Ŕ, ˛“Ą—ş•˝1, P‰Ş—m‰E, ‹{–{•“T (1ś—): ‘ć94‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2017/3/29), Ă‰Ş.

723012. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Epithelial ammonia transport through the thick ascending limb of Henle's loop may be required for the compensatory H+ excretion in kidney collecting duct. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć94‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2017/3/30), Ă‰Ş, J Physiol Sci 2017; 67 (Suppl 1): S171.

733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) t”A×ŠÇ‚ĚƒCƒIƒ“—A‘—‹@\. ‰ÍŒ´Ž‰ë1, ˆŔ‰Ş—L‹IŽq1 (1ś—): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/8), “Œ‹ž.

733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) tW‡ŠÇBŒ^|ŠÔÝ×–E‚Ě”ńś—“I‚ČƒAƒ‹ƒJƒŠ•Ş”ĺ. ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2, •Ÿ“c‰pˆę1, ˆŔ‰Ş—L‹IŽq1 (1ś—, 2ś•¨•¨—Œn): 2016”N“xś—ŠwŒ¤‹†ŠŒ¤‹†‰ďuă”ç–Œ—A‘—’˛ß’`”’‚ĚˆŮí‚Ć•a‘Ԑś—Šw‚Ě—Z‡v (2016/11/24), ˆ¤’m.

733003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒŒŸ÷ [Ca] ‚’l‚É‚ć‚étW‡ŠÇ‚̐…EƒCƒIƒ“—A‘—‚ĆŽ_EƒAƒ‹ƒJƒŠ•Ş”ĺ’˛ß. ‘ĺ“ˆ—F”ü1, •Ÿ“c‰pˆę2, ˆŔ‰Ş—L‹IŽq2, –ěXŒű”ŽŽj3, ‰ÍŒ´Ž‰ë2 (1ś•¨•¨—Œn, 2ś—, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć27‰ńƒoƒ]ƒvƒŒƒVƒ“Œ¤‹†‰ď (2017/1/7), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522001. [uŔ]y“ÁW: ‚â‚ł‚ľ‚˘Äśˆă—ÁzŠî‘b•ŇII@iPS×–E‚Ě—Ő°‰ž—p‚Ɖۑč. ‰ÍŒ´Ž‰ë1, ŽOˆäƒá2 (1ś—, 2”畆): t‚Ć“§Í 2015/12; 79 (6): 848-51.

[Šw‰ďEŒ¤‹†‰ď“™]

H27-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Metabolic acidosis with alkalinuria in phosphate-deprived mice: inappropriate stimulation of Pendrin in type B intercalated cells of kidney collecting ducts. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): •˝Ź28”N“x“Á•Ęu‹`EThe Second Kitasato-Yale Fluid Symposium: Molecular Control of Cellular and Epithelial Function (2015/12/5), “Œ‹ž.

H27-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Erythropoietin production by the nephron. –ěXŒű”ŽŽj1, ˆŔ‰Ş—L‹IŽq2, ‰ÍŒ´Ž‰ë2 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2ś—): •˝Ź28”N“x“Á•Ęu‹`EThe Second Kitasato-Yale Fluid Symposium: Molecular Control of Cellular and Epithelial Function (2015/12/5), “Œ‹ž.


ś‰ťŠw

[Šwp˜_•ś]

110005. [Œ´’˜] VAMP7 Regulates Autophagy to Maintain Mitochondrial Homeostasis and to Control Insulin Secretion in Pancreatic ƒŔ-Cells. Aoyagi K, Ohara-Imaizumi M, Itakura M1, Torii S, Akimoto Y, Nishiwaki C, Nakamichi Y, Kishimoto T, Kawakami H, Harada A, Takahashi M, Nagamatsu S: Diabetes 2016/6; 65 (6): 1648-59. (”‘q@˝1: 1ś‰ť)

110006. [Œ´’˜] Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Ichimura K, Fukushima S, Totoki Y, Matsushita Y, Otsuka A, Tomiyama A, Niwa T, Takami H, Nakamura T, Suzuki T, Fukuoka K, Yanagisawa T, Mishima K, Nakazato Y, Hosoda F, Narita Y, Shibui S, Yoshida A, Mukasa A, Saito N, Kumabe T, Kanamori M, Tominaga T, Kobayashi K, Shimizu S, Nagane M, Iuchi T, Mizoguchi M, Yoshimoto K, Tamura K, Maehara T, Sugiyama K, Nakada M, Sakai K, Kanemura Y, Nonaka M, Asai A, Yokogami K, Takeshima H, Kawahara N, Takayama T, Yao M, Kato M, Nakamura H, Hama N, Sakai R1, Ushijima T, Matsutani M, Shibata T, Nishikawa R; Intracranial Germ Cell Tumor Genome Analysis Consortium: Acta Neuropatho 2016/6; 131 (6): 889-901. (ä@—˛ˆę1: 1ś‰ť)

110007. [Œ´’˜] Dual mechanisms of rapid expression of anxiety-related behavior in pilocarpine-treated epileptic mice. Otsuka S, Ohkido T, Itakura M1, Watanabe S2, Yamamori S1, Iida Y3, Saito M3, Miyaoka H3, Takahashi M Epilepsy Res 2016/7; 123: 55-67. (”‘q@˝1, “n•Ó@Ž 2, ŽRX‘D1, ”Ń“c—@‹X3, âV“Ął”Í3, ‹{‰Ş@“™3: 1ś‰ť, 2ś•¨•¨—Œn, 3¸_)

110008. [Œ´’˜] Expression, purification and characterization of hepatitis B virus X protein BH3-like motif-linker-Bcl-xL fusion protein for structural studies. Kusunoki H, Tanaka T, Kohno T1, Kimura H, Hosoda K, Wakamatsu K, Hamaguchi I: Biochem Biophys Rep 2016/12; 9: 159-65. (‰Í–ěr”V1: 1ś‰ť)

[Šw‰ďEŒ¤‹†‰ď“™]

713004. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The signaling complex of tyrosine phosphatase SHP2 and docking protein ShcC regulates oncogenicity of neuroblastoma cells in a tyrosine-phosphorylation dependent manner. •xŽRV‘ž, ä@—˛ˆę1 (1ś‰ť): Advances in Neuroblastoma Research 2016 (2016/6/21), Australia.

713005. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Interaction of SHP2 with ALK regulates oncogenicity of neuroblastoma cells. •xŽRV‘ž, ”’–ŘŒ´‘ôĆ1, ’†“‡Ž•F, ŽRŒű‰pŽ÷, XŒ’‘ž˜Y, ä@—˛ˆę1 (1ś‰ť): The 12th International Conference on Protein Phosphatase (2016/10/28), ‘ĺă.

722001. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Interaction between carcinoma cells and stromal fibroblasts during invasion and metastasis of scirrhous gastric carcinoma. ŽRŒű‰pŽ÷, –öŒ´ŒÜ‹g, ”Ş‘ăł˜a, ä@—˛ˆę1 (1ś‰ť): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/12/1), _“ސě.

723013. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Two distinct NMDA-receptor contributions in synaptic tagging of Homer-1a proteins. ‰Ş“c‘ĺ• (ś‰ť): ‘ć39‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2016/7/21), _“ސě.

723014. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) CDCP1-PHCƒÂƒVƒOƒiƒ‹Œo˜H‚đŽŐ’f‚ˇ‚éV‹K‰ť‡•¨‚É‚ć‚éRŽîᇐi“WŒř‰Ę. ’†“‡Ž•F, ă–kŽł, ä@—˛ˆę1 (1ś‰ť): ‘ć25‰ń“ú–{‚Ş‚ń“]ˆÚŠw‰ďŠwpW‰ďE‘‰ď (2016/7/21), ’šŽć.

723015. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒLƒ‹ƒXˆÝŠŕ×–E‚É‚¨‚Ż‚éPLEKHA5‚Ě‹@”\‰đÍ. ŽRŒű‰pŽ÷, ”’–ŘŒ´‘ôĆ1, ä@—˛ˆę1 (1ś‰ť): ‘ć25‰ń“ú–{‚Ş‚ń“]ˆÚŠw‰ďŠwpW‰ďE‘‰ď (2016/7/21), ’šŽć.

723016. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒLƒ‹ƒXˆÝ‚Ş‚ń‚̐ZE• –Œ”dŽí‚ÉŠÖ—^‚ˇ‚銈Ť‰ťŽó—e‘ĚŒ^ƒ`ƒƒVƒ“ƒLƒi[ƒ[Œ‹‡ƒ^ƒ“ƒpƒNŽż‚̉đÍ. ”’–ŘŒ´‘ôĆ1, ŽRŒű‰pŽ÷, ä@—˛ˆę1 (1ś‰ť): ‘ć25‰ń“ú–{‚Ş‚ń“]ˆÚŠw‰ďŠwpW‰ďE‘‰ď (2016/7/21), ’šŽć.

723017. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) GPCR–Í•íƒyƒvƒ`ƒh‚ĆŒ‹‡‚ľ‚˝ŽO—Ę‘ĚGƒ^ƒ“ƒpƒNŽżƒżƒTƒuƒ†ƒjƒbƒg‚ĚˆŔ’艝–@‚ĚŒŸ“˘. Ź–ě’ËŽ÷, Ž›˜eTˆę, ‰Í–ěr”V1, Žáź@Š] (1ś‰ť): ‘ć89‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď (2016/9/26), ‹{é.

723018. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _Œo‰čŽî‚É‚¨‚Ż‚éShcC‚đ‰î‚ľ‚˝SHP2‚ĆALK‚ĚŒ‹‡‚Í, _Œo‰čŽî×–E‚ĚŽîᇌ´Ť‚đ§Œä‚ˇ‚é. •xŽRV‘ž, ”’–ŘŒ´‘ôĆ1, ’†“‡Ž•F, ŽRŒű‰pŽ÷, XŒ’‘ž˜Y, ä@—˛ˆę1 (1ś‰ť): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/8), _“ސě.

723019. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒLƒ‹ƒXˆÝ‚Ş‚ń‚É‚¨‚Ż‚éV‹Kƒ`ƒƒVƒ“ƒŠƒ“Ž_‰ťƒ^ƒ“ƒpƒNŽżPLEKHA5‚Ě‹@”\‰đÍ. ŽRŒű‰pŽ÷, ”’–ŘŒ´‘ôĆ1, ä@—˛ˆę1 (1ś‰ť): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/8), _“ސě.

723020. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒLƒ‹ƒXˆÝ‚Ş‚ń‚É‚¨‚Ż‚銈Ť‰ťŽó—e‘ĚŒ^ƒ`ƒƒVƒ“ƒLƒi[ƒ[Œ‹‡ƒ^ƒ“ƒpƒNŽż‚Ě“Ż’č‚Ć‹@”\‰đÍ. ”’–ŘŒ´‘ôĆ1, ŽRŒű‰pŽ÷, ä@—˛ˆę1 (1ś‰ť): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/8), _“ސě.

723021. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) BŒ^ŠĚ‰ŠX’`”’Žż (HBx) BH3—lƒ‚ƒ`[ƒt‚ĆBcl-XL‚ĚNMR‘ŠŒÝě—p‰đÍ. “í@‰pŽ÷, “c’†r”V, ‰Í–ěr”V1, –Ř‘ş”Žˆę, ×“c˜a’j, Žáź@Š], •lŒű@Œ÷ (1ś‰ť): ‘ć55‰ńNMR“˘˜_‰ď(2016) (2016/11/16), L“‡.

723022. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ESI-QTOF MS–@‚đ—p‚˘‚˝ƒAƒ~ƒƒCƒhƒx[ƒ^ƒyƒvƒ`ƒh‚ĚƒIƒŠƒSƒ}[Œ`Ź‹@\‚̉đÍ. ‹g“cW‘ž˜Y, ‹g‰i‘s˛, •“cŒőL, “c’†ˆ¤‹|, ŕ_Œű‹MŽj, ŽRŒű@“ľ, Šâ–{Źl, Ä“Ą‹MŽu, ‘ë˜Q‹Ó•F, ‰Í–ěr”V1, ź“š—˛b, Ž›‘ňG–ž (1ś‰ť): ‘ć54‰ń“ú–{ś•¨•¨—Šw‰ď”N‰ď (2016/11/26), ˆďé.

723023. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Control of Auto-oxidation of 9-Aminoanthracene and Its Application for an Imaging Reagent. Kurotaki T, Watanabe R, Sawamura Y, Ohtsuki T, Kikuchi Y, Kawakami F, ”‘q@˝1, Uchiyama K, Maruyama H, Uchiyama Y (1ś‰ť): “ú–{‰ťŠw‰ď‘ć97‰ńt‹G”N‰ď(2017) (2017/3/17), _“ސě.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-120001. [Œ´’˜] FT-IR ƒXƒyƒNƒgƒ‹‚đŽg‚Á‚˝“œ…—n‰tö”­‰ß’ö‚̉đÍ‚É‚ć‚鐅˜a” ÎˆäˆčŽq1, ŽP@F”V (1ś‰ť): “ú–{Ž•‰Č‘ĺŠw‹I—v 2016/3; 46: 21-8.


•ŞŽqˆâ“`Šw

[Šwp˜_•ś]

110009. [Œ´’˜] Gorlin syndrome with an ovarian leiomyoma associated with a PTCH1 second hit. Akizawa Y, Miyashita T1, Sasaki R, Nagata R, Aoki R, Ishitani K, Nagashima Y, Matsui H, Saito K: Am J Med Genet A 2016/4; 170 (4): 1029-34. (‹{‰şr”V1: 1•ŞŽqˆâ“`)

110010. [Œ´’˜] Maintenance of Xist Imprinting Depends on Chromatin Condensation State and Rnf12 Dosage in Mice. Fukuda A, Mitani A1, Miyashita T2, Sado T, Umezawa A, Akutsu H: PLoS Genet 2016/10; 12 (10): e1006375. (ŽO’J@‰ˇ1, ‹{‰şr”V2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•ŞŽqˆâ“`)

110011. [Œ´’˜] Spatiotemporal dynamics of OCT4 protein localization during preimplantation development in mice. Fukuda A, Mitani A1, Miyashita T2, Kobayashi H, Umezawa A, Akutsu H: Reproduction 2016/11; 152 (5): 417-30. (ŽO’J@‰ˇ1, ‹{‰şr”V2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•ŞŽqˆâ“`)

110012. [Œ´’˜] Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene. Kato C, Fujii K, Arai Y, Hatsuse H, Nagao K1, Takayama Y1, Kameyama K1, Fujii K, Miyashita T1: Fam Cancer 2017/1; 16 (1): 131-8. (’ˇ”ö˜a‰E1, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰şr”V1: 1•ŞŽqˆâ“`)

110013. [Œ´’˜] Somatic mosaicism containing double mutations in PTCH1 revealed by generation of induced pluripotent stem cells from nevoid basal cell carcinoma syndrome. Ikemoto Y, Takayama Y1, Fujii K, Masuda M, Kato C, Hatsuse H, Fujitani K, Nagao K1, Kameyama K1, Ikehara H, Toyoda M, Umezawa A, Miyashita T1: J Med Genet 2017/8; 54 (8): 579-84. (‚ŽR‹g‰i1, ’ˇ”ö˜a‰E1, ‹TŽRFŽO1, ‹{‰şr”V1: 1•ŞŽqˆâ“`)

[Šw‰ďEŒ¤‹†‰ď“™]

723024. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ę”ÁŠî’ę×–EŠŕÇŒóŒQ‚É‚¨‚Ż‚éƒXƒvƒ‰ƒCƒVƒ“ƒO•ĎˆŮ‚ĚŒŸ“˘. ‹{‰şr”V1, ‰Ł—m”ü2, ’ˇ”ö˜a‰E1, ‚ŽR‹g‰i1, ‹TŽRFŽO1, “ĄˆäŽ‘Ľ (1•ŞŽqˆâ“`, 2•a‘ԁEf—ĂŒn): ‘ć22‰ń“ú–{‰Ć‘°ŤŽîᇊw‰ďŠwpW‰ď (2016/6/4), ˆ¤•Q.

723025. [Šw‰ď (‘S‘)] GorlinÇŒóŒQ‚É‚¨‚Ż‚é”]Œ`‘Ô‰đÍ|ƒwƒbƒWƒzƒbƒOƒVƒOƒiƒ‹‚Ěƒqƒg”]‚ւ̉e‹ż|. ‰–•l@’ź, “ĄˆäŽ‘Ľ, ‹{‰şr”V1, “ŕě‰p‹I, …—ŽO”ü, ’rŒ´@•á, •ŸŒ´’m”V, ‰şđ’źŽ÷ (1•ŞŽqˆâ“`): ‘ć58‰ń“ú–{ŹŽ™_ŒoŠw‰ďŠwpW‰ď (2016/6/3-5), “Œ‹ž.

723026. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Entire PTCH1 deletions detected in 9 families with nevoid basal cell carcinoma syndrome (PTCH1ƒQƒmƒ€L”͈͌‡‘š‚̉đÍ). ‚ŽR‹g‰i1, ’ˇ”ö˜a‰E1, “ĄˆäŽ‘Ľ, ‹{‰şr”V1 (1•ŞŽqˆâ“`): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), _“ސě.

723027. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) GorlinÇŒóŒQŠłŽŇ—R—ˆ iPS×–E‚đ—p‚˘‚˝‘‰čŽí‚̍쐻. ’r–{@—D, –L“c‰ëŽm, “ߐ{“š˘, ‰Ł—m”ü1, ’ˇ”ö˜a‰E2, ‚ŽR‹g‰i2, ‹TŽRFŽO2, ”~ŕV–žO, ‹{‰şr”V2 (1•a‘ԁEf—ĂŒn, 2•ŞŽqˆâ“`): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/11/30), _“ސě.

723028. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ}ƒEƒX‰Šúăó‚É‚¨‚Ż‚é‘S”\ŤŠl“ž‚Ö‚Ě“]ŽĘˆöŽqOct4‚̉”\Ť. ŽO’J@‰ˇ1, •Ÿ“c@“Ä, ‹{‰şr”V2, ‹TŽRFŽO2, ‚ŽR‹g‰i2, ’ˇ”ö˜a‰E2, ‰Ł—m”ü3, Ź—Ń‹vl, ”~ŕV–žO, ˆ˘‹v’ÉpŒ› (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•ŞŽqˆâ“`, 3•a‘ԁEf—ĂŒn): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/12/1), _“ސě.

723029. [Šw‰ď (‘S‘)] Šp‰ťůN–EŤŽ•Œ´ŤŽîá‡‚đ‡•š‚ľ‚˝B‘O‹ě×–EŒ^‹}ŤƒŠƒ“ƒpŤ”’ŒŒ•a‚Ěˆę—á. “n粁@“Ö, ž[’ÐW•˝, ‘ĺé_Žq, Ô‰HOŽ‘, ‡ˆä‹v”üŽq, Œ˘Ž”ŠxŽj, “ĄˆäŽ‘Ľ, ‹{‰şr”V1, ™“cŠŽŽ˘ (1•ŞŽqˆâ“`): ‘ć58‰ń“ú–{ŹŽ™ŒŒ‰tE‚Ş‚ńŠw‰ďŠwpW‰ď (2016/12/15-17), “Œ‹ž.

733004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠłŽŇ—R—ˆiPS×–E‚đ—p‚˘‚˝GorlinÇŒóŒQŽžŠłƒ‚ƒfƒ‹‚̍\’z. ’r–{@—D, –L“c‰ëŽm, ”~ŕV–žO, ’ˇ”ö˜a‰E1, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰şr”V1 (1•ŞŽqˆâ“`): ‘ć29‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2016/8/4), “Œ‹ž.

733005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] ‘˝”­‚ˇ‚éŽčś‚̏ŹŠ×‰š‚đŒ_‹@‚É”­ŒŠ‚ł‚ę‚˝GorlinÇŒóŒQ‚Ě‚P—á. ‘ĺ‹´—m”V, •“ŕ‘”ü, –kŕV’qŽq, ‘şă•x”üŽq, ‹{‰şr”V1 (1•ŞŽqˆâ“`): ‘ć870‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď (2016/12/17), “Œ‹ž.


–ň—Šw

[Šwp˜_•ś]

110014. [Œ´’˜] Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1ƒŔ by Recruited Macrophages. Okizaki S1, Ito Y2, Hosono K3,4, Oba K1, Ohkubo H5, Kojo K6, Nishizawa N6, Shibuya M, Shichiri M1, Majima M4: Am J Pathol 2016/6; 186 (6): 1481-98. (‰Ťčiˆę˜Y1, ˆÉ“Ą‹`–ç2, ×–ě‰Á“ŢŽq3,4, ‘ĺ’ë˜al1, ‘ĺ‹v•Ű”Ž˘5, ŒĂé@Œ›6, źŕVL‹ą6, Žľ—˘áÁ‹`1, ”n“ˆł—˛4: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2ŠO‰Č, 3ś—, –ň—4, 5S‘ŸŒŒŠÇŠO, 6‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110015. [Œ´’˜] Thromboxane A synthase enhances blood flow recovery from hindlimb ischemia. Amano H1, Nakamura M2, Ito Y3, Kakutani H, Eshima K4, Kitasato H2, Narumiya S, Majima M1: J Surg Res 2016/7; 204 (1): 153-63. (“V–ě‰pŽ÷1, ’†‘şłŽ÷2, ˆÉ“Ą‹`–ç3, ]“‡k“ń4, –k—˘‰p˜Y2, ”n“ˆł—˛1: 1–ň—, 2ˆă—ÉqśŠw•”, 3ŠO‰Č, 4–Ɖu)

110016. [Œ´’˜] BLT1 signalling protects the liver against acetaminophen hepatotoxicity by preventing excessive accumulation of hepatic neutrophils. Kojo K1,2, Ito Y3, Eshima K4, Nishizawa N1,2, Ohkubo H5, Yokomizo T, Shimizu T, Watanabe M3, Majima M1: Sci Rep 2016/7; 6: 29650. (ŒĂé@Œ›1,2, ˆÉ“Ą‹`–ç3, ]“‡k“ń4, źŕVL‹ą1,2, ‘ĺ‹v•Ű”Ž˘5, “n粏š•F3, ”n“ˆł—˛1: 1–ň—, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŠO‰Č, 4–Ɖu, 5S‘ŸŒŒŠÇŠO)

110017. [Œ´’˜] Population Pharmacokinetic-Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects. Choi HK, Jung JA, Fujita T1, Amano H1, Ghim JL, Lee DH, Tabata K2, Song ID, Maeda M3, Kumagai Y4, Mendzelevski B, Shin JG: Clin Ther 2016/12; 38 (12): 2610-21. (“Ą“c•üŒb1, “V–ě‰pŽ÷1, “c”¨Œ’ˆę2, ‘O“cŽŔ‰Ô3, ŒF’J—Y“ń4: 1–ň—, 2”ĺ”AŠí, 3–ňÜ•”, 4—Տ°Œ¤‹†EŠé‰ć)

[Šw‰ďEŒ¤‹†‰ď“™]

723030. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒJƒ‰ƒQƒjƒ“‚¨‚ć‚ŃƒUƒCƒ‚ƒUƒ“‚É‚ć‚Á‚ÄŽä‹N‚ł‚ę‚鉊ÇŽž‚Ě‘gDƒŠƒ‚ƒfƒŠƒ“ƒO‚É‚¨‚Ż‚éŠÔŽżüˆŰ‰č×–E‚É”­Œť‚ˇ‚éCOX-2‚Ě–đŠ„. ě‘ş“šŽq (–ň—): ‘ć90‰ń“ú–{–ň—Šw‰ď”N‰ď (2017/3/17), ’ˇč.


”÷ś•¨Šw

[Šwp˜_•ś]

110018 [Œ´’˜] Analyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus). Uchiyama J, Suzuki M, Nishifuji K, Kato S, Miyata R, Nasukawa T, Yamaguchi K, Takemura-Uchiyama I, Ujihara T, Shimakura H, Murakami H, Okamoto N, Sakaguchi Y1, Shibayama K, Sakaguchi M, Matsuzaki S: Appl Environ Microbiol 2016/7; 82 (15): 4482-91. (ăŒű‹`•F1: 1”÷ś•¨)

110019. [Œ´’˜] Contamination of healthcare workers' hands with bacterial spores. Sasahara T, Ae R, Watanabe M, Kimura Y, Yonekawa C, Hayashi S1, Morisawa Y: J Infect Chemother 2016/8; 22 (8): 521-5. (—с@rŽĄ1: 1”÷ś•¨)

110020. [Œ´’˜] Screening of KHP30-like prophages among Japanese Helicobacter pylori strains, and genetic analysis of a defective KHP30-like prophage sequence integrated in the genome of the H. pylori strain NY40. Uchiyama J, Takemura-Uchiyama I, Kato S, Takeuchi H, Sakaguchi Y1, Ujihara T, Daibata M, Shimakura H, Okamoto N, Sakaguchi M, Matsuzaki S: FEMS Microbiol Lett 2016/8; 363 (16). pii: fnw157. doi: 10.1093/femsle/fnw157. (ăŒű‹`•F1: 1”÷ś•¨)

110021. [Œ´’˜] Active Secretion of Dimerized S100A11 Induced by the Peroxisome in Mesothelioma Cells. Saho S, Satoh H, Kondo E, Inoue Y, Yamauchi A, Murata H, Kinoshita R, Yamamoto KI, Futami J, Putranto EW, Ruma IM, Sumardika IW, Youyi C, Suzawa K, Yamamoto H, Soh J, Tomida S, Sakaguchi Y1, Saito K, Iioka H, Huh NH, Toyooka S, Sakaguchi M: Cancer Microenviron 2016/12; 9 (2-3): 93-105. (ăŒű‹`•F1: 1”÷ś•¨)

522004. [uŔ]yTopicszŒŒ‰t”|—{‚É‚¨‚Ż‚é Helicobacter‘Ž‹ŰŽí‚ĚŒŸo. —с@rŽĄ (”÷ś•¨): ”÷ś•¨Šw “ú–{ƒwƒŠƒRƒoƒNƒ^[Šw‰ďŽ 2016/5; 18 (1): 5-10.

522005. [uŔ]y“ÁW: Helicobacter pyloriˆČŠO‚ĚƒwƒŠƒRƒoƒNƒ^[‘ŽEĹV‚Ě˜b‘čzEnterohepatic Helicobacter‚ɏŠ‘Ž‚ˇ‚é‹ŰŽí. —с@rŽĄ (”÷ś•¨): Helicobacter Research 2016/6; 20 (3): 252-61.

522006. [uŔ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Ű‚É‚ć‚鎞Šł (ƒ{ƒcƒŠƒkƒXÇ) ‘ćŽl‰ńzƒ{ƒcƒŠƒkƒXÇ‚ĚŽĄ—Ă‚Ć—\–h. ăŒű‹`•F (”÷ś•¨): ‰qś‚Ě—F 2016/6: 59: 8.

522007. [uŔ]y˜AÚ: ĹV•śŒŁĐ‰îz<Šî‘b>uƒCƒmƒVƒV‚ć‚č•Ş—Ł‚ł‚ę‚˝V‚ľ‚˘‹ŰŽíHelicobacter aprivƒqƒ}ƒ‰ƒ„ƒ}[ƒ‚ƒbƒg‚ĚˆÝ”S–Œ‚Š‚ç•Ş—Ł‚ł‚ę‚˝‹ŰŽíHelicobacter himalayensis. —с@rŽĄ (”÷ś•¨): Helicobacter Research 2016/10; 20 (5): 540-1.

540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y‰ČŠwŒ¤‹†”ď•â•‹ŕEŠî”ŐŒ¤‹† (C)uCŒ^‚ĆDŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚Ě”ö•”‹z’…ƒ^ƒ“ƒpƒNŽż‚ƏhŽĺ‹ŰƒŒƒZƒvƒ^[‚̉đÍ (Œ¤‹†ŠúŠÔ: •˝Ź25”N“x`•˝Ź27”N“x)vzŒ¤‹†‘ă•\ŽŇ: ăŒű‹`•F (”÷ś•¨), Œ¤‹†•Ş’SŽŇ: źč–ΓW, “ŕŽR~•˝:uCŒ^‚ĆDŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚Ě”ö•”‹z’…ƒ^ƒ“ƒpƒNŽż‚ƏhŽĺ‹ŰƒŒƒZƒvƒ^[‚̉đÍv2015”N“xŽŔŃ•ń‘ 2016/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-25460541/254605412015jisseki/.

540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y‰ČŠwŒ¤‹†”ď•â•‹ŕEŠî”ŐŒ¤‹† (C)uCŒ^‚ĆDŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚Ě”ö•”‹z’…ƒ^ƒ“ƒpƒNŽż‚ƏhŽĺ‹ŰƒŒƒZƒvƒ^[‚̉đÍ (Œ¤‹†ŠúŠÔ: •˝Ź25”N“x`•˝Ź27”N“x)vzŒ¤‹†‘ă•\ŽŇ: ăŒű‹`•F (”÷ś•¨), Œ¤‹†•Ş’SŽŇ: źč–ΓW, “ŕŽR~•˝:uCŒ^‚ĆDŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚Ě”ö•”‹z’…ƒ^ƒ“ƒpƒNŽż‚ƏhŽĺ‹ŰƒŒƒZƒvƒ^[‚̉đÍvŒ¤‹†Ź‰Ę•ń‘ 2016/6; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-25460541/25460541seika/ (kaken.nii.ac.jp_
25460541seika.pdf).

[’˜@‘]

620002. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠíŽžŠłĹV‚ĚŽĄ—Ă2017-2018zIIIÍ Á‰ťŠÇŽžŠł@C. ’°@2. R‹Ű–ňŠÖ˜A’°‰Š@b. Clostridium difficileŠÖ˜A‰ş—ŸÇ (CDAD), p.193-6. —с@rŽĄ1, ůŒ´“S•˝ (1”÷ś•¨), •Ň: Ź’r˜a•F, ŽR–{”Ž“ż, ŁŒË‘×”V, “ě]“°, “Œ‹ž, 2017/2”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723031. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŞŽR‘ĺŠw•a‰@‚É‚¨‚Ż‚éHelicobacter pylori‚Ě–ňÜ‘ϐŤ—Ś‚ĚŒŸ“˘. Šě‘˝‰ë‰p, ŽO‰Y@Œö, žÄ@_s, ‰Í–ě‹g‘×, Œă“Ą“c’B—m, ŠâŽş‰ë–ç, _č—mŒő, ě–쐽“ń, ‰ÍŒ´Ë˜N, ‰Ą“cŒ›ŽĄ, —с@rŽĄ1, ‰Ş“c—T”V (1”÷ś•¨): ‘ć22‰ń“ú–{ƒwƒŠƒRƒoƒNƒ^[Šw‰ďŠwpW‰ď (2016/6/24), ‘ĺ•Ş.

723032. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Screening of KHP30-like prophage in Helicobacter pylori using Japanese strains, and analysis of their fate by in silico approach. Uchiyama J, Takemura-Uchiyama I, Kato S, Takeuchi H, Sakaguchi Y1, Ujihara T, Nasukawa T, Shimakura H, Okamoto N, Sakaguchi M, Matsuzaki S: “ú–{”÷ś•¨ś‘ÔŠw‰ď‘ć31‰ń‘ĺ‰ďƒtƒ@[ƒWEŠÂ‹ŤƒEƒCƒ‹ƒXŒ¤‹†‡“ŻƒVƒ“ƒ|ƒWƒEƒ€ (2016/10/21), ‰Ą{‰ę. (ăŒű‹`•F1: 1”÷ś•¨)

723033. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‹KPB1—lƒtƒ@[ƒWKPP22‚ƗΔ^‹ŰPAO1Š”‚đ—˜—p‚ľ‚˝‘O“K‰žƒtƒ@[ƒWKPP22Měť‰ß’ö‚Ěˆâ“`“I‰đÍ. “ߐ{ě’‰–í, “ŕŽR~•˝, —é–ؐml, ź“ĄŒöŽi, ‰Á“ĄLˆę˜Y, “ŕŽRˆÉ‘ă, ŽŒ´—˛Žq, “‡‘qGŸ, ‘şă—TM, ‰Ş–{Œ›–ž, ăŒű‹`•F1, ŽÄŽRŒbŒá, ăŒű‰ëO, źč–ΓW (1”÷ś•¨): “ú–{”÷ś•¨ś‘ÔŠw‰ď‘ć31‰ń‘ĺ‰ďƒtƒ@[ƒWEŠÂ‹ŤƒEƒCƒ‹ƒXŒ¤‹†‡“ŻƒVƒ“ƒ|ƒWƒEƒ€ (2016/10/21), ‰Ą{‰ę.

723034. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ß|Ž_ŠÜZƒƒCƒv‚É‚ć‚éƒZƒŒƒEƒX‹Ű‰č–E‚̏œ‹ŽŒř‰Ę‚ĚŒŸ“˘. —с@rŽĄ1, ůŒ´“S•˝, XŕV—YŽi (1”÷ś•¨): ‘ć32‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďEŠwpW‰ď (2017/2/25), _ŒË.

723035. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Analysis of botulinum neurotoxin type B6 gene-encoding plasmid in Clostridium botulinum type B. Sakaguchi Y1, Uchiyama J, Hosomi K, Kohda T, Ogura Y, Hayashi T, Hayashi S1, Kozaki S, Mukamoto M: ‘ć90‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2017/3/19), ĺ‘ä. (ăŒű‹`•F1, —с@rŽĄ1: 1”÷ś•¨)

723036. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Study of adsorption of AHJD-like phages infecting Staphylococcus aureus. Uchiyama J, Kurokawa K, Takemura-Uchiyama I, Ujihara T, Sakaguchi Y1, Sakaguchi M, Matsuzaki S (1”÷ś•¨): ‘ć90‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2017/3/19), ĺ‘ä. (ăŒű‹`•F1: 1”÷ś•¨)

733006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒNƒƒXƒgƒŠƒWƒEƒ€‘Ž‚É‚¨‚Ż‚éƒ{ƒcƒŠƒkƒX“Ĺ‘fˆâ“`Žq‚Ě“`’BƒƒJƒjƒYƒ€‚̉đÍ. ăŒű‹`•F (”÷ś•¨): ‘ć16‰ńŽáŽčLab (2016/11/21), ‘Š–ÍŒ´.

733007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰ß|Ž_ŠÜZƒƒCƒv‚É‚ć‚é‰č–Eœ‹ŽŒř‰Ę‚ĚŒŸ“˘. —с@rŽĄ1, ůŒ´“S•˝ (1”÷ś•¨): ‘ć80‰ń_“ŢěŒ§Š´őÇˆăŠw‰ď (2016/9/10), ‰Ą•l.


Šńś’ŽŠw

[Šwp˜_•ś]

110022. [Œ´’˜] 2-Cys peroxiredoxin is required in successful blood-feeding, reproduction, and antioxidant response in the hard tick Haemaphysalis longicornis. Kusakisako K, Galay RL, Umemiya-Shirafuji R, Hernandez EP Maeda H, Talactac MR, Tsuji N1, Mochizuki M, Fujisaki K, Tanaka T: Parasit Vectors 2016/8; 9: 457. (’ҁ@Ž—˜1: 1Šńś’Ž)

110023. [Œ´’˜] Establishment of a novel tick-Babesia experimental infection model. Maeda H, Hatta T1, Alim MA, Tsubokawa D1, Mikami F2, Matsubayashi M, Miyoshi T, Umemiya-Shirafuji R, Kawazu SI, Igarashi I, Mochizuki M, Tsuji N1, Tanaka T: Sci Rep 2016/11; 6: 37039. (”Ş“cŠxŽm1, ’ؐě‘ĺŒĺ1, ŽOă–[Žq2, ’ҁ@Ž—˜1: 1Šńś’Ž, 2—\–hˆăŠwŒn)

110024. [Œ´’˜] Identification of Eimeria acervulina conoid antigen using chicken monoclonal antibody. Matsubayashi M, Minoura C, Kimura S, Tani H, Furuya M, Lillehoj HS, Matsuda H, Takenaka S, Hatta T1, Tsuji N1, Sasai K: Parasitol Res 2016/11; 115 (11): 4123-8. (”Ş“cŠxŽm1, ’ҁ@Ž—˜1: 1Šńś’Ž)

110025. [Œ´’˜] Initial development of Babesia ovata in the tick midgut. Maeda H, Hatta T1, Alim MA, Tsubokawa D1, Mikami F, Kusakisako K, Matsubayashi M, Umemiya-Shirafuji R, Tsuji N1, Tanaka T: Vet Parasitol 2017/1; 233: 39-42. (”Ş“cŠxŽm1, ’ؐě‘ĺŒĺ1, ’ҁ@Ž—˜1: 1Šńś’Ž)

110026. [Œ´’˜] A cysteine protease from Spirometra erinaceieuropaei plerocercoid is a critical factor for host tissue invasion and migration. Tsubokawa D1, Hatta T1, Maeda H, Mikami F2, Goso Y3, Nakamura T, Alim MA, Tsuji N1: Acta Trop 2017/3; 167: 99-107. (’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ŽOă–[Žq2, ŒÜäzsM3, ’ҁ@Ž—˜1: 1Šńś’Ž, 2—\–hˆăŠwŒn, 3ś‰ť)

110027. [Œ´’˜] Report of fatal mixed infection with Cryptosporidium parvum and Giardia intestinalis in neonatal calves. Matsuura Y, Matsubayashi M, Nukata S, Shibahara T, Ayukawa O, Kondo Y, Matsuo T, Uni S, Furuya M, Tani H, Tsuji N1, Sasai K: Acta Parasitol 2017/3; 62 (1): 214-20. (’ҁ@Ž—˜1: 1Šńś’Ž)

110028. [Œ´’˜] A Large-Scale Survey of Trichinella spp. Infection in Japanese Wild Boars. Hatta T1, Imamura K, Yamamoto T, Matsubayashi M, Tsuji N1, Tsutsui T: Jpn J Infect Dis 2017/3; 70 (2): 219-20. (”Ş“cŠxŽm1, ’ҁ@Ž—˜1: 1Šńś’Ž)

110029. [Œ´’˜] Venestatin, a Ca++-binding protein from the parasitic nematode Strongyloides venezuelensis, is involved in the larval migration process. Tsubokawa D1, Hatta T1, Kikuchi T, Maeda H, Mikami F, Alim MA, Maruyama H, Tsuji N1: Int J Parasitol 2017/7l ;47 (8): 501-9. (’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ’ҁ@Ž—˜1: 1Šńś’Ž)

522008. [uŔ]y“ÁW: •aŒ´‘Ě”}‰îß‘Ť“Ž•¨‚ĚƒoƒCƒIƒƒW[zƒ}ƒ_ƒj‚Ě‹zŒŒś—|‹zŒŒƒvƒƒZƒX‚đŽx‚Ś‚éƒ}ƒ_ƒj‘Á‰t‘B•¨Žż‚Ěƒƒ“ƒMƒXƒ^ƒ`ƒ“. ’ҁ@Ž—˜1, ”Ş“cŠxŽm1 (1Šńś’Ž): ˆăŠw‚Ě‚ ‚ä‚Ý 2016/12; 259 (12/13): 1187-92.

[Šw‰ďEŒ¤‹†‰ď“™]

723037. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒPƒjƒAŽYƒRƒCƒ^ƒ}ƒ_ƒj‚É‚¨‚Ż‚éŽEƒ_ƒjÜ’ďRŤŠÓ•Ę‚Ě‚˝‚ß‚ĚSNPƒ^ƒCƒsƒ“ƒO–@‚ĚŒŸ“˘. ”Ş“cŠxŽm1, Muinde Martin D, Oluga Aboge G, Odongo David O, ’|’†ş—Y, Ngethe Esther W, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć68‰ń“ú–{‰qś“Ž•¨Šw‰ď‘ĺ‰ď (2016/4/15), “Č–Ř.

723038. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ{–Ó’°ƒRƒNƒVƒWƒEƒ€Eimeria tenellaƒWƒqƒhƒƒIƒƒgŽ_’E…‘fy‘f‚ĚXüŒ‹ť\‘˘‰đÍ. ˛“Ą@’g, ’ˇŕ_‚Ü‚Ç‚Š, ‹g‰ŞŽuŘ, ź—с@˝, Eri Amalia, Žu”g’qś, ˆî‰Şƒ_ƒjƒGƒ‹Œ’, ’ҁ@Ž—˜1, –k@@Œ‰, Œ´“c”ɏt (1Šńś’Ž): ‘ć16‰ń“ú–{’`”’Žż‰ČŠw‰ď”N‰ď (2016/6/7), •Ÿ‰Ş.

723039. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Babesia ovataŒ´’Ž‚É‚¨‚Ż‚éƒ}ƒ_ƒj’†’°Œ`‘Ô‚Ö‚ĚƒXƒe[ƒWƒVƒtƒg—U“ąŽŔŒą. ’ҁ@Ž—˜ (Šńś’Ž): ‘ć159‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2016/9/6), _“ސě.

723040. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Cryptosporidium parvum ‚É‚¨‚Ż‚éŒÄ‹z˝ŠÖ˜Ay‘f‚Ě“ÁŤ‰đÍ. ‚‹´˜a‰l, ź—с@˝, ˆî‰Şƒ_ƒjƒGƒ‹Œ’, ”Ş“cŠxŽm1, Ž›–{@ŒM, ‹ŕŽq@–ž, ŒĂ‰Ć@—D, ’J@_s, ’ҁ@Ž—˜1, ůˆä˜a”ü, –k@@Œ‰ (1Šńś’Ž): ‘ć159‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2016/9/6), _“ސě.

723041. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ}ƒ“ƒ\ƒ“ŒÇ’ŽƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[‚̏hŽĺ‘gDN“üEˆÚs‚Ö‚Ě–đŠ„. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ‘O“c‘ĺ‹P, ŽOă–[Žq2, ’†‘ş@Œ’, ’ҁ@Ž—˜1 (1Šńś’Ž, 2—\–hˆăŠwŒn): ‘ć159‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2016/9/7), _“ސě.

723042. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘“ŕ30•{Œ§‚ŕߊl‚ł‚ę‚˝ƒCƒmƒVƒV‚É‚¨‚Ż‚éů–Ń’Ž (ƒgƒŠƒqƒi) •Ű—L’˛¸‚ĚŒ‹‰Ę‚ɂ‚˘‚Ä. ”Ş“cŠxŽm1, Ą‘şŒ›‹g, ŽR–{Œ’‹v, ź—с@˝, ’ҁ@Ž—˜1, “›ˆär”V (1Šńś’Ž): ‘ć159‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2016/9/7), _“ސě.

723043. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒtƒ^ƒgƒQƒ`ƒ}ƒ_ƒj—‘‚É‚¨‚Ż‚éBabesia ovata ƒŔ-ƒ`ƒ…[ƒuƒŠƒ“ˆâ“`Žq‚ĚŒŸo. ”’“Ą (”~‹{) —œ‰Â, ”Ş“cŠxŽm1, ‘ĺ‹v•Ű˜a—m, ˛“Ą–GŽq, ‘O“c‘ĺ‹P, ‰ĄŽR’ź–ž, ŒÜ\—’ˆč’j, “ĄčK‘ , ˆäă@¸, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć25‰ń“ú–{ƒ_ƒjŠw‰ď‘ĺ‰ď (2016/10/15), –kŠC“š.

733008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰ä‚ލ‘‚ĚƒCƒmƒVƒV‚É‚¨‚Ż‚éů–Ń’Ž (ƒgƒŠƒqƒi) Šńś‚ɂ‚˘‚Ä‚Ě’˛¸Œ¤‹†. ”Ş“cŠxŽm1, ’ؐě‘ĺŒĺ1, Ą‘şŒ›‹g, ŽR–{Œ’‹v, ź—с@˝, ’ҁ@Ž—˜1, “›ˆär”V (1Šńś’Ž): ‘ć10‰ń徒ŽŒ¤‹†‰ď (2016/11/18), Ă‰Ş.

733009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •łü’Ž—R—ˆƒxƒlƒXƒ^ƒ`ƒ“‚̏hŽĺ‘Ě“ŕˆÚs‚É‚¨‚Ż‚é–đŠ„. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ‘O“c‘ĺ‹P, ŽOă–[Žq2, ‹e’n‘אś, ŠŰŽRŽĄ•F, ’ҁ@Ž—˜1 (1Šńś’Ž, 2—\–hˆăŠwŒn): ‘ć10‰ń徒ŽŒ¤‹†‰ď (2016/11/18), Ă‰Ş.

733010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ}ƒ_ƒj‚ĚŽŠ‘R–Ɖu‚ĆƒoƒxƒVƒA‚Ć‚Ć‚ŕ‚É. ‘O“c‘ĺ‹P, ”Ş“cŠxŽm1, ’ؐě‘ĺŒĺ1, ŽOă–[Žq2, ź—с@˝, ŽOD–Ґ°, ‘–Ř”—_‘ĺ, Remil Linggatong Galay, Melbourne Rio Talactac, ‹{“c@Œ’, ”’“Ą—œ‰Â, ‰Í’ÐMˆę˜Y, ŒÜ\—’ˆč’j, –]ŒŽ‰ë”ü, “ĄčK‘ , ’ҁ@Ž—˜1, “c’‡“N–ç (1Šńś’Ž, 2—\–hˆăŠwŒn): ‘ć14‰ń•ŞŽqŠńś’ŽEƒ}ƒ‰ƒŠƒAŒ¤‹†ƒtƒH[ƒ‰ƒ€ (2016/8/22), –kŠC“š.

733011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •łü’Ž—R—ˆƒƒ“ƒMƒXƒ^ƒ`ƒ“—l•ŞŽq‚̐Ťó. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ‘O“c‘ĺ‹P, ŽOă–[Žq2, ‹e’n‘אś, ŠŰŽRŽĄ•F, ’ҁ@Ž—˜1 (1Šńś’Ž, 2—\–hˆăŠwŒn): ‘ć24‰ń•ŞŽqŠńś’ŽŠwƒ[ƒNƒVƒ‡ƒbƒv&‘ć14‰ń•ŞŽqŠńś’ŽEƒ}ƒ‰ƒŠƒAŒ¤‹†ƒtƒH[ƒ‰ƒ€ (2016/8/22), –kŠC“š.

733012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ}ƒ“ƒ\ƒ“ŒÇ’ŽhŽĺ‘gDN“üEˆÚs‚É‚¨‚Ż‚é23kDaƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[‚Ě‹@”\. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ‘O“c‘ĺ‹P, ŽOă–[Žq2, ’†‘ş@Œ’, ’ҁ@Ž—˜1 (1Šńś’Ž, 2—\–hˆăŠwŒn): ‘ć29‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2016/8/4), “Œ‹ž.


•a—Šw (‘ş‰_’PˆĘ)

[Šwp˜_•ś]

110030. [Œ´’˜] Suppression of skin tumorigenesis in CD109-deficient mice. Sunagawa M, Mii S, Enomoto A, Kato T, Murakumo Y1, Shiraki Y, Asai N, Asai M, Nagino M, Takahashi M: Oncotarget 2016/12; 7 (50): 82836-50. (‘ş‰_–FŽ÷1: 1•a—)

110031. [Œ´’˜] Anti-tumor effects of interferon-beta cell therapy in murine model of melanoma. Nakamura M1, Kagawa L, Nakada N2, Satoh M3, Maehana S4, Kojima F1, Amano H5, Murakumo Y2, Iwabuchi K3, Majima M5, Kitasato H1: International Journal of Cancer Therapy and Oncology 2016/12; 4 (4): 4412. (’†‘şłŽ÷1, ’‡“c“TL2, ˛“Ą@‰ë3, ‘O‰ÔË‘ž˜Y4, Ź“‡ŽjÍ1, “V–ě‰pŽ÷5, ‘ş‰_–FŽ÷2, ŠâŸş˜a–ç3, ”n“ˆł—˛5, –k—˘‰p˜Y1: 1ˆă—ÉqśŠw•”, 2•a—, 3–Ɖu, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 5–ň—)

[’˜@‘]

620003. [Šwp‘ (•Ş’SŽˇ•M)]y•W€—Šw—Ă–@ŠwEě‹Ć—Ă–@Šw ę–ĺŠî‘b•Ş–ě@•a—Šw (‘ć4”Ĺ)z‘ލsŤ•a•Ď, isŤ•a•Ď, ‘ăŽÓáŠQ, p.15-36. ‘ş‰_–FŽ÷1 (1•a—), ŠÄC: ŠŒ´”Ž‹B, •Ň: ‰Ąˆä–LŽĄ, ‘ş‰_–FŽ÷1, ˆăŠw‘‰@, “Œ‹ž, 2017/2”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723044. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”畆ˆŤŤŽîᇂɂ¨‚Ż‚éREV7’`”’”­ŒťˆÓ‹`‚Ě’Tő. ’†ŽR’m‰Ŕ1, Ó@˘ˆŽ, ”~‘ň“ÖŽq2, ŸNˆä–ő‚3, ˆęŒËš–ž3, ’‡“c“TL3, ‘ş‰_–FŽ÷3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Œ`‘ÔŒn, 3•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723045. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) DNA‘š‰ž“š’`”’ŽżREV7‚Ěˆâ“`Žq”­Œť§Œä‚̉đÍ. “‡“c—TŽq1, ŸNˆä–ő‚2, ‘ş‰_–FŽ÷2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723046. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Erdheim-Chester•a‚Ě1–UŒŸ—á. ’‡“c“TL1, ˆęŒËš–ž1, –öŕVM”V, ‘ş‰_–FŽ÷1 (1•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723047. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”x‘BŠŕ‚É‚¨‚Ż‚éă”ç|ŠÔ—tˆÚs‚đ•W“I‚Ć‚ľ‚˝ŒŒ´f’fƒ}[ƒJ[‚ĚŠl“ž. “y‰Žg1, Ó@˘ˆŽ, ’ˇ‰–@—ş1, ‘ş‰_–FŽ÷2, ˛“Ą—Yˆę1 (1ˆă—ÉqśŠw•”, 2•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723048. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŠÖ˜AŽîᇂɂ¨‚Ż‚郀ƒ`ƒ“ƒRƒAƒ^ƒ“ƒpƒN‚Ě”­Œť‚ɂ‚˘‚Ä. ŽOă“N•v, —с@Gs, Ŕ“c‰ęŽq1, ‰ŞˆŔ@ŒM, ‘ş‰_–FŽ÷2 (1Œ`‘ÔŒn, 2•a—): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723049. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –Ť”畆‰ŠÇ‚𔺂¤CD109ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚É‚¨‚˘‚Ĕ畆Žîᇌ`Ź‚Í—}§‚ł‚ę‚é. ŽOˆäL“ń, ťě^‹P, ‰|–{@“Ä, ‘ş‰_–FŽ÷1, ž‹–쐳l, ‚‹´‰ë‰p (1•a—): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723050. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) REV7‚Ě—}§‚͐¸‘ƒăó×–EŽîᇂĚDNA‘š‚ɑ΂ˇ‚銴ŽóŤ‚đ‘‹­‚ˇ‚é. ŸNˆä–ő‚1, ‚‹´‰ë‰p, ‘ş‰_–FŽ÷1 (1•a—): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723051. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒnƒCƒŠƒXƒN‘O—§‘BŠŕ‚ɑ΂ˇ‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgHSV-tkˆâ“`ŽqŽĄ—Ă—á‚Ě•a—‘gDŠw“IŒŸ“˘. –öŕVM”V, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ’Ă‘şGN1, Thompson TC, ‰ŞˆŔ@ŒM, ‘ş‰_–FŽ÷2, ”nęŽu˜Y, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•a—): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723052. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒqƒgREV7‚Ě—}§‚͐¸‘ƒăó×–EŽîᇂ̃VƒXƒvƒ‰ƒ`ƒ“Š´ŽóŤ‚đ‘‹­‚ˇ‚é. ŸNˆä–ő‚1, ‹g“c˜aŽ÷, ‚‹´‰ë‰p, ‘ş‰_–FŽ÷1 (1•a—): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/11/30), ‰Ą•l.


•a—Šw (ŽOŽ}’PˆĘ)

[Šwp˜_•ś]

110032. [Œ´’˜] Vitamin A Inhibits Development of Dextran Sulfate Sodium-Induced Colitis and Colon Cancer in a Mouse Model Okayasu I, Hana K, Nemoto N, Yoshida T1, Saegusa M1, Yokota-Nakatsuma A, Song SY, Iwata M: Biomed Res Int 2016; 2016: 4874809. Published online 2016 May 19. doi: 10.1155/2016/4874809. (‹g“c@Œ÷1, ŽOŽ}@M1: 1•a—)

110033. [Œ´’˜] The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas Hara A1, Hashimura M2, Tsutsumi K, Akiya M1,3, Inukai M1, Ohta Y, Saegusa M1: Cancer Med 2016/12; 5 (12): 3412-25. (Œ´@“ÖŽq1, ‹´‘ş”ü‹I2, H’JšŽj1,3, Œ˘Ž”@‰~1, ŽOŽ}@M1: 1•a—, 2Œ`‘ÔŒn, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110034. [Œ´’˜] Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma Inoue H1, Hashimura M2, Akiya M1,3, Chiba R3, Saegusa M1: Mol Cancer 2017; 16: 37. Published online 2017 Feb 14. doi: 10.1186/s12943-017-0609-8. (ˆäă‹vŽq1, ‹´‘ş”ü‹I2, H’JšŽj1,3, ç—t—šŽq3, ŽOŽ}@M1: 1•a—, 2Œ`‘ÔŒn, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

[Šw‰ďEŒ¤‹†‰ď“™]

723053. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _ŒoäPŽî‚É‚¨‚Ż‚éALK(anaplastic lymphoma kinase)ƒVƒOƒiƒ‹Œn‚É‚ć‚é×–E‘B§Œä‹@\‚̉đ–ž. ç—t—ŽŃŽq, Œ´@“ÖŽq1, Œ˘Ž”@‰~1, ˆäă‹vŽq1, ŹŒINŽq2, ‹´‘ş”ü‹I2, ŽOŽ}@M1 (1•a—, 2Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723054. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Identification of Lefty as a molecular marker for ovarian clear cell carcinoma. H’JšŽj1, ź–{r‰p1, Š“cç”ü”T1, –Ř“‡‘ĺ‹P2, ç—t—ŽŃŽq2, ŽOŽ}@M1 (1•a—, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723055. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŠÇŤ’°ŽžŠł‚É‚¨‚Ż‚éƒoƒCƒIƒ}[ƒJ[olfactomedin-4‚Ě”­Œť‹@˜‚̉đ–ž. ‹´Œű@Žű1, ‹g“c@Œ÷2, ‘ĺŒF‘ń–ç, ‰i“c@ , —é–ؐl, ‹´‘ş”ü‹I3, ‰ŞˆŔ@ŒM, ŽOŽ}@M2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723056. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŠÇŤ’°ŽžŠłŠÓ•Ęf’f‚É‚¨‚Ż‚éOLFM4‹y‚Ńă—Ź•ŞŽq”­ŒťŒŸő‚Ě—L—pŤ. ‹g“c@Œ÷1, ‰i“c@ , ‹´Œű@Žű2, —é–ؐl, ‹´‘ş”ü‹I3, ŽOŽ}@M1 (1•a—, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723057. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “dŽq‰ť•W–{‰ć‘œ‰đÍ‚É‚ć‚é‹qŠĎ“I•a—f’f‚Ěƒ‚ƒfƒ‹‰ť. Œ´@“ÖŽq1, ŽOŽ}@M1 (1•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723058. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Žq‹{“ŕ–ŒŠŕ×–E‚Ě“]ˆĘ•Ş‰ť‰ß’ö‚É‚¨‚Ż‚éƒŔ-ƒJƒeƒjƒ“Œn‚ĆTGF-ƒŔ/LeftyŒnƒVƒOƒiƒ‹‚ĚƒNƒƒXƒg[ƒN‚̉đ–ž. ‹´–{䝎Ŕ1, –Ř“‡‘ĺ‹P1, ‚‹´”Ž”V2, ŹŒINŽq3, ‹´‘ş”ü‹I3, ŽOŽ}@M2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/13), ĺ‘ä.

723059. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’áŽ_‘fŠÂ‹Ť‚É‚ć‚éäP‰čŽî‚Ěƒeƒ‚ƒ]ƒƒ}ƒCƒh’ďRŤ‘‹­‹@\‚̉đÍ. Œ˘Ž”@‰~1, Œ´@“ÖŽq1, ˆŔˆä”ü]2, ŒG•”rG3, ŽOŽ}@M1 (1•a—, 2Œ`‘ÔŒn, 3”]ŠO): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/13), ĺ‘ä.

723060. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —‘‘ƒŠŕ“÷Žî”­ś‰ß’ö‚É‚¨‚Ż‚éTGF-ƒŔ/Smad2/LeftyŒnˆË‘śŤă”çŠÔ—t“]Šˇ‹@\‚̉đÍ. ź–{r‰p1, ‚‹´”Ž”V1, ‹´‘ş”ü‹I2, Š“cç”ü”T1, ŹŒINŽq2, ŽOŽ}@M1 (1•a—, 2Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/13), ĺ‘ä.

723061. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Leftyˆâ“`Žq‚ÍŽq‹{—Ţ“ŕ–ŒŠŕ×–E‚Ě•Ş‰ťE‘B‹@\‚̐V‹K§Œä•ŞŽq‚Ĺ‚ ‚é. –Ř“‡‘ĺ‹P1, ź–{r‰p2, ‹´–{䝎Ŕ1, ŹŒINŽq3, ‹´‘ş”ü‹I3, ŽOŽ}@M2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/14), ĺ‘ä.

723062. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —‘‘ƒEŽq‹{Œ´”­Šŕ“÷Žî‚ĚALKˆË‘śŤă”çŠÔ—t“]Šˇ (EMT)E×–E‘B§ŒäƒVƒOƒiƒ‹Œo˜H‚ĚŘ–ž. ˆäă‹vŽq1, ŽOŽ}@M1 (1•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/14), ĺ‘ä.

723063. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Sox4/ƒŔ-ƒJƒeƒjƒ“/p300/SlugŒn‚͏ă”çŠÔ—t“]Šˇ/‚Ş‚ńŠ˛×–E‰ť‚đ‰î‚ľ‚ÄŽq‹{Šŕ“÷Žî‚Ě“÷ŽîŹ•ŞŒ`Ź‚ÉŠÖ—^‚ˇ‚é. ‹´‘ş”ü‹I1, ‚‹´”Ž”V2, ˆäă‹vŽq2, ŽOŽ}@M2 (1Œ`‘ÔŒn, 2•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/14), ĺ‘ä.

723064. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) isŠú’ź’°Šŕ‚ĚƒŔ-ƒJƒeƒjƒ“/EMT—U“ąŠŕŠ˛×–E‰ť‚É‚ć‚鉝ŠwE•úŽËü—Ă–@‚̑ϐŤ‹@\‚̉đÍ. ‚‹´”Ž”V1, ‰F˛”üˆŠ, ç—t—ŽŃŽq2, ‹´‘ş”ü‹I3, ŽOŽ}@M1 (1•a—, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Œ`‘ÔŒn): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/14), ĺ‘ä.

723065. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —‘‘ƒ–ž×–E‘BŠŕ‚Ě”­ŠŕEi“W‰ß’ö‚É‚¨‚Ż‚éLefty‚Ě‹@”\‰đÍ. ź–{r‰p1, H’JšŽj1, ě“‡—S‰î, ŹŽ›‹`’j, ‚‹´”Ž”V1, ŽOŽ}@M1 (1•a—): “ú–{ƒvƒƒeƒI[ƒ€Šw‰ď2016”N‘ĺ‰ď (2016/7/29), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110001. [Œ´’˜] Cooperation of Sox4 with ƒŔ-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma. Inoue H1, Takahashi H1, Hashimura M2, Eshima K3, Akiya M1,4, Matsumoto T1, Saegusa M1: BMC Cancer 2016; 16: 53. Published online 2016 Feb 3. doi: 10.1186/s12885-016-2090-y. (ˆäă‹vŽq1, ‚‹´”Ž”V1, ‹´‘ş”ü‹I2, ]“‡k“ń3, H’JšŽj1,4, ź–{r‰p1, ŽOŽ}@M1: 1•a—, 2Œ`‘ÔŒn, 3–Ɖu, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)


‰qśŠw

[Šwp˜_•ś]

110035. [Œ´’˜] Acute exposure to cadmium induces prolonged neutrophilia along with delayed induction of granulocyte colony-stimulating factor in the livers of mice. Horiguchi H1, Oguma E: Arch Toxicol 2016/12; 90: 3005-15 (–xŒű•ş„1: 1‰qś)

120002. [Œ´’˜] Žż–⎆•[’˛¸‚É‚ć‚é‹i‰Œ˜J“­ŽŇ‚Ě‹Ö‰Œ–łŠÖSŽŇ‚Ě“Á’Ľ‚â”ń‹i‰ŒŽŇ‚Ö‚Ě”z—śó‹ľ‚Ć”ń‹i‰Œ˜J“­ŽŇ‚ĚŒ™‰ŒˆÓŽŻ. ‹{“‡]—˘Žq1,2, Šp“cłŽj1, ‰Ÿ“cŹ•S‡2, ŒÜ\—’ŒhŽq2, ŽOŽ}—zˆę2, ”üŒ´Ă, ‹g“c@‹I2, –ě“c‹g˜a2, ‘ĺˆä“cłl2 (1‰qś, 2‘Š–Í‚Ě•a‰@): ‘‡Œ’f 2017/3; 44 (2): 378-86.

220001. [€Œ´’˜] “űŽ•ƒGƒiƒƒ‹Žż‚đ—p‚˘‚˝‘ŮŽ™Šú—LŠQŒł‘f”˜˜I•]‰ż–@‚̉uŠw‰ž—p. źěŠx‹v, ‰ĄŽR˜am, ‘ĺX—R‹I1 (1‰qś): •˝Ź27”N“x‡“V“°‘ĺŠwƒnƒCƒeƒNĽƒŠƒT[ƒ`ƒZƒ“ƒ^[ŠÂ‹ŤˆăŠwŒ¤‹†Š‹I—v 2017; 57-9.

521001. [‰đŕ]y•śŒŁĐ‰îzd‹ŕ‘Ž‚̐E‹ĆŤ”˜˜I‚ÉŠÖ‚ˇ‚éĹ‹ß‚Ě’mŒŠ`“ú–{‚Ə”ŠO‘‚ĚŒťó`. ‘ĺX—R‹I1, Šp“cłŽj1, Ż@‰Ŕ–F1, –xŒű•ş„1, ‘ŠŕVDŽĄ1 (1‰qś): ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹ 2016/11; 39 (6): 72-5.

[’˜@‘]

620004. [Šwp‘ (•Ş’SŽˇ•M)]yt‚Ć“§Íf—ĂŽwj2016 (t‚Ć“§Í2016”N80ŠŞ‘Š§†)z‘ć10Í ”A×ŠÇŽžŠł“™@11. –ňÜE‰ťŠw•¨Žż‚É‚ć‚ét”A×ŠÇáŠQ p.334-6. –xŒű•ş„ (‰qś), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713006. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Behavior of inhaled three elements of the rare earth group in mice. Shinohara A, Matsukawa T, Kumasaka T, Chiba M, Omori Y1, Yokoyama K Rare Earth 2016 (2016/6/10), Sapporo. (‘ĺX—R‹I1: 1‰qś)

713007. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Cadmium exposure and its age-relevant hazardous effect on renal tubular function among rice farmers in a cadmium-polluted area of northern Japan. Horiguchi H1, Oguma E, Murata K, Komatsuda A, Sasaki S, Kumazawa Y, Ohno T, Miyamoto K Society of Toxicology 56th Annual Meeting (2017/3/14), Baltimore, USA. (–xŒű•ş„1: 1‰qś)

722002. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zƒVƒ“ƒ|ƒWƒEƒ€7 (˜AŒgŒ¤‹†‰ď: ƒqƒg‚đŽwŒü‚ľ‚˝•ďŠ‡“I“ŐŤŠwŒ¤‹†‰ď) ‰ˇŒĚ’mV|V‚˝‚ČŽ‹“_‚Š‚猊’ź‚ˇŒöŠQ. –xŒű•ş„ (‰qś): ‘ć86‰ń“ú–{‰qśŠw‰ď‘‰ď (2016/5/12), ˆŽě, “ú‰qŽ 2016/5; 71 (‘ć86‰ńŠwp‘‰ďu‰‰W†): S127.

722003. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€19: ƒJƒhƒ~ƒEƒ€Œ¤‹†‚̐V‚˝‚Č“WŠJ|‰uŠw‚Š‚ç•ŞŽq‹@\‚܂Ł|z–Y‚ę‚ç‚ę‚˝ƒJƒhƒ~ƒEƒ€‰˜ő’n|H“cŒ§‚Ě”_‰Ć‚É‚¨‚Ż‚éƒJƒhƒ~ƒEƒ€ŒoŒű”˜˜I‚Ć‚ť‚ĚŒ’N‰e‹ż‚ĚŒťó. –xŒű•ş„ (‰qś): ‘ć43‰ń“ú–{“ŐŤŠw‰ďŠwp”N‰ď (2016/7/1), –źŒĂ‰Ž.

723066. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) H“cŒ§“ŕ‚Ěˆă—Ă‹@ŠÖ‚É‚¨‚Ż‚éƒJƒhƒ~ƒEƒ€tÇƒXƒNƒŠ[ƒjƒ“ƒO. –xŒű•ş„1, ˛X–Ř‹œ, rě@–ž, ŹŒF‰xŽq, Źź“c“Ö, ‰ĄŽR˜am, ç—t•SŽq, źěŠx‹v, ‘ĺX—R‹I1, ăŹ–qŒ›Š° (1‰qś): ‘ć86‰ń“ú–{‰qśŠw‰ď‘‰ď (2016/5/13), ˆŽě, “ú‰qŽ 2016/5; 71 (‘ć86‰ńŠwp‘‰ďu‰‰W†): S233.

723067. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Žž•a‚ƏA‹Ć‚Ě—ź—§Žx‰‡‚đ‚ß‚´‚ˇ, ŽY‹Ćˆă‚Ǝ厥ˆă‚Ě˜AŒg‚ĚŒř‰Ę‚Ć, ”ń˜AŒg‚Ě•s—˜‰v, ‚ť‚ľ‚ĘAŒg‚̐Ź”ۂɉe‹ż‚ˇ‚é—vˆö|ŽY‹Ćˆă‘¤Ž–—á’˛¸‚ĚŽż“I•ŞÍ‚Š‚ç. •“Ą@„, ‰ĄŽR˜am, –k‘ş•ś•F, Ä“Ą­•F, Îˆä—“Ţ, ‘ĺX—R‹I1, źěŠx‹v (1‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡.

723068. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆę”Ę˜J“­ŽŇEŠłŽŇW’c‚ʼnťŠw•¨Žż‰ß•qÇ‚Ş‹^‚í‚ę‚él‚Ě•s‘ϐŤ•¨Žż‚ĚŒŸ“˘. ‹{“‡]—˘Žq1, Šp“cłŽj, ™‰Y—R”üŽq2, â•”@v (1‰qś, 2—\–hˆăŠwŒn): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/27),•Ÿ“‡, ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď´˜^W 2016; p.304.

723069. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MM040Žż–⎆•[‚ĚƒVƒbƒNƒnƒEƒXÇŒóŒQE‰ťŠw•¨Žż‰ß•qÇ‚ɑ΂ˇ‚é—L—pŤ‚ĚŒŸ“˘. ‹{“‡]—˘Žq1, Šp“cłŽj, ™‰Y—R”üŽq2, â•”@v (1‰qś, 2—\–hˆăŠwŒn): ‘ć25‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ďŠwpW‰ď (2016/6/18), ŒSŽR, ‘ć25‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ďŠwpW‰ď´˜^W 2016; p.75.

723070. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –âf•[Šů‰—đ‚Ě‚¤‚żśŠˆKŠľ•a, ”]ESŽžŠł, ‚Ş‚ń‚Ě–ł‹L“ü‚ɂ‚˘‚Ä‚Ě’˛¸. ‹{“‡]—˘Žq1, ‹g“c@‹I, ŽOŽ}—zˆę, ŒÜ\—’ŒhŽq, ‘ĺˆä“cłl, Šp“cłŽj, –ě“c‹g˜a (1‰qś): ‘ć57‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ď (2016/7/29), ź–{, ‘ć57‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ď´˜^W 2016; p.241.

723071. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’†ŹŠé‹Ć‚Ĺ‚ĚŽY‹Ćˆă‚Ǝ厥ˆă‚Ě˜AŒgŽŔ‘ÔĽ‰Ű‘č‚̐Ž—‚Ć, ‰đŒˆô‚Ě’ńˆÄ|Žž•aŽĄ—ÂƐE‹ĆśŠˆ‚Ě—ź—§Žx‰‡„i‚ÖŒü‚Ż‚˝‰Ë‚Ż‹´‚̍\’z. •“Ą@„, ‰ĄŽR˜am, –k‘ş•ś•F, ‘ĺX—R‹I1, ‰““ĄŒšŽ÷ (1‰qś): ‘ć26‰ń“ú–{ŽY‹Ć‰qśŠw‰ď‘S‘‹Ś‹c‰ď (2016/9/9), ‹ž“s.

723072. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘“ŕ’nkĐŠQŽž‚ĚŽ•‰Č•ŰŒ’ˆă—ÑΉžŽ–—á‚ĹŠw‚ń‚ž‚ą‚Ƃ͐˘ŠE‚ɏî•ń”­M‚ł‚ę‚Ä‚˘‚é‚Š? Ż@‰Ŕ–F1, “ŕ“c‘U”Ž, â–{‘×—2, Šp“cłŽj1, –xŒű•ş„1 (1‰qś, 2—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg): ‘ć75‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2016/10/26), ‘ĺă, ‘ć75‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď´˜^W “ú–{ŒöO‰qśŽGŽ “Á•Ę•˜^ 2016/10; 63 (10): 382.

723073. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’nˆć‚ƐEˆć‚Ěˆă—Ă˜AŒg‚ÉŠÖ‚ˇ‚éŽY‹Ćˆă‚ĚˆÓŽŻ‚ƍs“Ž|ŒÂlĽŠÂ‹ŤˆöŽq‚Ě‘w•Ę‰ť‚É‚ć‚é‰đÍ. •“Ą@„, ‰ĄŽR˜am, –k‘ş•ś•F, ‘ĺX—R‹I1, ‰““ĄŒšŽ÷ (1‰qś): ‘ć75‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2016/10/26), ‘ĺă.

723074. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –âf•[Šů‰—đ‚Ě–ł‹L“ü‚ɂ‚˘‚Ä‚Ě’˛¸. ‹{“‡]—˘Žq1, ‹g“c@‹ICŒÜ\—’ŒhŽq, ‰Ÿ“cŹ•S‡, ”üŒ´Ă, –ě“c‹g˜a, Šp“cłŽj, ‘ĺˆä“cłl (1‰qś): ‘ć45‰ń“ú–{‘‡Œ’fˆăŠw‰ď (2017/1/27), ç—t‘ć45‰ń“ú–{‘‡Œ’fˆăŠw‰ď´˜^W 2017; p.253.

723075. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’á”Z“x‚̉”‚É‚ć‚éƒAƒXƒgƒƒTƒCƒg“ŕƒJƒ‹ƒVƒEƒ€‰ž“š‚ւ̉e‹ż. ‘ĺX—R‹I1, ăŒE—T“ń, źěŠx‹v, ‰ĄŽR˜am, –xŒű•ş„1 (1‰qś): ‘ć87‰ń“ú–{‰qśŠw‰ďŠwp‘‰ď (2017/3/27), ‹{č.

723076. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“cŒ§‚̍zŽR‰ş—Źˆć”_‘ş‚Ěˆîě”_‹ĆŽŇ‚É‚¨‚Ż‚éƒJƒhƒ~ƒEƒ€”˜˜I‚Ć‚ť‚̐t‹@”\‚ւ̉e‹ż. –xŒű•ş„1, ŹŒF‰xŽq, ‘ş“cŸŒh, Źź“c“Ö, ˛X–Ř•q, ŒFŕV—R”üŽq, ‘ĺ–ě’qŽq, “ŕ“cł”ü (1‰qś): ‘ć87‰ń“ú–{‰qśŠw‰ď‘‰ď (2017/3/27), ‹{č.

732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv) y‘ć13‰ńf—ĂƒKƒCƒhƒ‰ƒCƒ“ěŹƒ[ƒNƒVƒ‡ƒbƒvzŠî‘bƒR[ƒXEƒƒ^ƒAƒiƒŠƒVƒX‚Ě“Ç‚Ý•ű. Ż@‰Ŕ–F (‰qś): Œúś˜J“­ČˆĎ‘őŽ–‹Ć (Œö‰vŕ’c–@l“ú–{ˆă—Ă‹@”\•]‰ż‹@\EEBMˆă—Ïî•ńŽ–‹Ć) EBM (Ş‹’‚ÉŠî‚Ă‚­ˆă—Ă) •‹y„iŽ–‹Ć@‘ć13‰ńf—ĂƒKƒCƒhƒ‰ƒCƒ“ěŹƒ[ƒNƒVƒ‡ƒbƒvuŠî‘bƒR[ƒXv (2016/11/26), “Œ‹ž.

732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ž{ô‚Ö‚ĚƒKƒCƒhƒ‰ƒCƒ“Šˆ—p. Ż@‰Ŕ–F (‰qś): Œúś˜J“­Č‘—§•ŰŒ’ˆă—ÉȊw‰@E•˝Ź28”N“x’ZŠúŒ¤Cu’nˆć•ŰŒ’Žx‰‡‚Ě‚˝‚ß‚Ě•ŰŒ’î•ńˆ—‹ZpŒ¤Cvu‹` (2016/11/29), é‹Ę.

732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒAƒ“ƒP[ƒg’˛¸‰‰K. Ż@‰Ŕ–F (‰qś): Œúś˜J“­Č‘—§•ŰŒ’ˆă—ÉȊw‰@E•˝Ź28”N“x’ZŠúŒ¤Cu’nˆć•ŰŒ’Žx‰‡‚Ě‚˝‚ß‚Ě•ŰŒ’î•ńˆ—‹ZpŒ¤Cvu‹` (2016/12/6), é‹Ę.

732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv) y‘ć14‰ńf—ĂƒKƒCƒhƒ‰ƒCƒ“ěŹƒ[ƒNƒVƒ‡ƒbƒvzŠî‘bƒR[ƒXEƒƒ^ƒAƒiƒŠƒVƒX‚Ě“Ç‚Ý•ű. Ż@‰Ŕ–F (‰qś): Œúś˜J“­ČˆĎ‘őŽ–‹Ć (Œö‰vŕ’c–@l“ú–{ˆă—Ă‹@”\•]‰ż‹@\EEBMˆă—Ïî•ńŽ–‹Ć) EBM (Ş‹’‚ÉŠî‚Ă‚­ˆă—Ă) •‹y„iŽ–‹Ć@‘ć14‰ńf—ĂƒKƒCƒhƒ‰ƒCƒ“ěŹƒ[ƒNƒVƒ‡ƒbƒv (2017/2/18), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522002. [uŔ]y•śŒŁĐ‰îzŽó“Ž‹i‰Œ‚̐¸_“I‰e‹ż. ‹{“‡]—˘Žq1, Šp“cłŽj, ‘ŠŕVDŽĄ (1‰qś): ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹ 2015/11; 38 (6): 93-7.

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹i‰Œ˜J“­ŽŇ‚Ě‹Ö‰ŒŠÖS‚ɉe‹ż‚ˇ‚éˆöŽq‚ĚŒŸ“˘. ‹{“‡]—˘Žq1, Šp“cłŽj, ‰Á“Ą@Ę, ŒÜ\—’ŒhŽq, ‹g“c@‹I, ‘ĺˆä“cłl, źŒłŽ›ŽâX (1‰qś): ‘ć56‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ď (2015/7/31), “Œ‹ž.


ŒöO‰qśŠw

[Šwp˜_•ś]

110036. [Œ´’˜] The association between job stress and leisure-time physical inactivity adjusted for individual attributes: evidence from a Japanese occupational cohort survey. Oshio T, Tsutsumi A1, Inoue A: Scand J Work Environ Health 2016/5; 42 (3): 228-36. (’ç@–žƒ1: 1ŒöO‰qś)

110037. [Œ´’˜] Predictors of a Desire to be Helpful to Professional Nurses Among Japanese Nursing Assistants in Small- to Medium-Sized Hospitals. Kudo Y, Kono K, Toyoshima Y, Sugisaki H, Matsuhashi A, Tsutsumi A1: J UOHE 2016/6; 38 (2): 119-28. (’ç@–žƒ1: 1ŒöO‰qś)

110038. [Œ´’˜] Validation of the Japanese version of the job crafting scale. Eguchi H1, Shimazu A, Bakker AB, Tims M, Kamiyama K, Hara Y, Namba K, Inoue A, Ono M, Kawakami N: J Occup Health 2016/6; 58 (3): 231-40. (]Œű@Ž1: 1ŒöO‰qś)

110039. [Œ´’˜] Can leisure-time physical activity improve health checkup results? Evidence from Japanese occupational panel data. Oshio T, Tsutsumi A1, Inoue A: J Occup Health 2016/7; 58 (4): 354-64. (’ç@–žƒ1: 1ŒöO‰qś)

110040. [Œ´’˜] Pilot Study Testing Associations Between Health Behaviors and Decline in Work Motivation Due to Poor Health Among Japanese Workers. Kudo Y, Kono K, Miwa Y, Ohata T, Tsutsumi A1: Journal of Japan Academy of Occupational Health Nursing 2016/7; 3 (1): 8-15. (’ç@–žƒ1: 1ŒöO‰qś)

110041. [Œ´’˜] The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population. Otowa T, Kawamura Y, Tsutsumi A1, Kawakami N, Kan C, Shimada T, Umekage T, Kasai K, Tokunaga K, Sasaki T: PLoS One 2016/8; 11 (8): e0160823. (’ç@–žƒ1: 1ŒöO‰qś)

110042. [Œ´’˜] Modification Effects of Changes in Job Demands on Associations Between Changes in Testosterone Levels and Andropause Symptoms: 2-Year Follow-up Study in Male Middle-Aged Japanese Workers. Hirokawa K, Taniguchi T, Fujii Y, Takaki J, Tsutsumi A1: Int J Behav Med 2016/8; 23 (4): 464-72. (’ç@–žƒ1: 1ŒöO‰qś)

110043. [Œ´’˜] Modifying effect of cigarette smoking on the association of organizational justice with serious psychological distress in Japanese employees: a cross-sectional study. Inoue A, Kawakami N, Eguchi H1, Tsutsumi A1: Int Arch Occup Environ Health 2016/8; 89 (6): 901-10. (]Œű@Ž1, ’ç@–žƒ1: 1ŒöO‰qś)

110044. [Œ´’˜] Source-specific workplace social support and high-sensitivity C-reactive protein levels among Japanese workers: A 1-year prospective cohort study. Eguchi H1, Shimazu A, Kawakami N, Inoue A, Tsutsumi A1: Am J Ind Med 2016/8; 59 (8): 676-84. (]Œű@Ž1, ’ç@–žƒ1: 1ŒöO‰qś)

110045. [Œ´’˜] Buffering effect of workplace social capital on the association of job insecurity with psychological distress in Japanese employees: a cross-sectional study. Inoue A, Kawakami N, Eguchi H1, Tsutsumi A1: J Occup Health 2016/9; 58 (5): 460-9. (]Œű@Ž1, ’ç@–žƒ1: 1ŒöO‰qś)

110046. [Œ´’˜] Effort-reward imbalance, cortisol secretion, and inflammatory activity in police officers with 24-h work shifts. Izawa S, Tsutsumi A1, Ogawa N: Int Arch Occup Environ Health 2016/10; 89 (7): 1147-54. (’ç@–žƒ1: 1ŒöO‰qś)

110047. [Œ´’˜] The Effect of Alternative Scoring Procedures on the Measurement Properties of a Self-Administered Depression Scale. Iwata N, Tsutsumi A1, Wakita T, Kumagai R, Noguchi H, Watanabe N: European Journal of Psychological Assessment 2016/11; https://doi.org/10.1027/1015-5759/a000371. (’ç@–žƒ1: 1ŒöO‰qś)

110048. [Œ´’˜] Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome. Suzuki T1, Zeng Z, Zhao B, Wei Z, Tanabe M, Shimbo T, Kajio H, Kato N, Naruse M: J Endocrinol Invest 2016/11; 39 (11): 1337-46. (—é–Ř’mŽq1: 1ŒöO‰qś)

110049. [Œ´’˜] Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVES-J study. Shibayama Y, Wada N, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T1, Naruse M: Clin Endocrinol (Oxf) 2016/11; 85 (5): 696-702. (—é–Ř’mŽq1: 1ŒöO‰qś)

110050. [Œ´’˜] Differences in stroke and ischemic heart disease mortality by occupation and industry among Japanese working-aged men. Wada K, Eguchi H1, Prieto-Merino D: SSM - Population Health 2016/12; 2: 745-9. (]Œű@Ž1: 1ŒöO‰qś)

110051. [Œ´’˜] The effects of workplace psychosocial factors on whether Japanese dual-earner couples with preschool children have additional children: a prospective study. Eguchi H1, Shimazu A, Fujiwara T, Iwata N, Shimada K, Takahashi M, Tokita M, Watai I, Kawakami N: Ind Health. 2016/12; 54 (6): 498-504. (]Œű@Ž1: 1ŒöO‰qś)

110052. [Œ´’˜] Does work-to-family conflict really matter for health? Cross-sectional, prospective cohort and fixed-effects analyses. Oshio T, Inoue A, Tsutsumi A1: Soc Sci Med 2017/2; 175: 36-42. (’ç@–žƒ1: 1ŒöO‰qś)

110053. [Œ´’˜] Lung, gastric and colorectal cancer mortality by occupation and industry among working-aged men in Japan. Eguchi H1, Wada K, Prieto-Merino D, Smith DR: Sci Rep 2017/2; 7: 43204. (]Œű@Ž1: 1ŒöO‰qś)

110054. [Œ´’˜] Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism. Umakoshi H1, Xiaomei Y1, Ichijo T1, Kamemura K1, Matsuda Y1, Fujii Y1, Kai T1, Fukuoka T1, Sakamoto R1, Ogo A1, Suzuki T1,2, Ogasawara T1, Tsuiki M1, Naruse M1 (1WAVES-J Study Group): Clin Endocrinol (Oxf) 2017/2; 86 (2): 170-6. (—é–Ř’mŽq1,2: 2ŒöO‰qś)

110055. [Œ´’˜] Co-worker perceptions of return-to-work opportunities for Japanese cancer survivors. Eguchi H1, Wada K, Higuchi Y, Smith DR: Psychooncology 2017/3; 26 (3): 309-15. (]Œű@Ž1: 1ŒöO‰qś)

110056. [Œ´’˜] Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism. Kamemura K, Wada N, Ichijo T, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T1, Umakoshi H, Tsuiki M, Naruse M: J Hum Hypertens 2017/3; 31 (3): 195-9. (—é–Ř’mŽq1: 1ŒöO‰qś)

120003. [Œ´’˜] ‰îŒě•ŸŽƒŽm‚đŠĹŒě•â•ŽŇ‚Ć‚ľ‚ÄŠˆ—p‚ˇ‚é‚˝‚ß‚Ě•űô|ŠĹŒěŽt‚ƏyŠĹŒěŽt‚̉îŒě•ŸŽƒŽm‚Ć‹¤‚É“­‚­‚ą‚Ć‚Ö‚ĚˆÓ—~‚ÉŠÖ˜A‚ˇ‚éˆöŽq‚Š‚ç|. H“ĄˆŔŽj, ‰Í–ěŒ[Žq, ”¨’†ƒŽq, Œă“Ą—R‹I, ’†_Ž”V, ź‹´ˆťŽq, ’ç@–žƒ1 (1ŒöO‰qś): “ŒŠCŒöO‰qśŽGŽ 2016/7; 4 (1): 76-85.

120004. [Œ´’˜] ’†ŹŠé‹Ć‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚đl—ś‚ľ‚˝‘gD•—“y‚ĚŠT”OŽ—‚Ć‚ť‚ę‚ÉŠî‚Ă‚˘‚˝‘gD•—“yŽÚ“x‚ĚŠJ”­. ]Œű@Ž1, ’ç@–žƒ1, –k‹@–ž, XŒűŽŸ˜Y, ě“‡ł•q, Œ´—Y“ń˜Y (1ŒöO‰qś): ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹ 2016/9; 39 (5): 46-52.

210001. [€Œ´’˜] Behavioral Medicine in the Asisa Pacific. Shimazu A, Tsutsumi A1, Yoshiuchi K: Int J Behav Med 2016/8; 23 (4): 393-4. (’ç@–žƒ1: 1ŒöO‰qś)

220002. [€Œ´’˜ (Šwś˜_•ś)] ŹŽ™‚É‚¨‚Ż‚é’n’†ŠCH‚̐ێć‚Ćšb‘§Çó‚Ě—L–ł‚Ć‚ĚŠÖ˜A. ‰Ş“c_K, ]Œű@Ž1, —é–Ř’mŽq1, ’ç@–žƒ1 (1ŒöO‰qś): –k—˘ˆăŠw 2016/12; 46 (2): 129-33.

520001. [‘ŕ] ƒXƒgƒŒƒX‚É‚ć‚ézŠÂŠíŽžŠł”­Ç‚ĚƒƒJƒjƒYƒ€ ’ç@–žƒ (ŒöO‰qś): q‹óŠÂ‹ŤŒ¤‹† 2016/4; 20: 3-12.

520002. [‘ŕ]yMEDICAL SCIENCE REVIEWzW’c•ŞÍ‚ĚŠˆ—p‚ƐEę‰ü‘P‚Ě•ű–@ ’ç@–žƒ (ŒöO‰qś): Vita 2016/4; 33 (2): 41-6.

520003. [‘ŕ]y“w—́|•ńV•s‹Ďtƒ‚ƒfƒ‹zE‹ĆŤƒXƒgƒŒƒXŒ¤‹†‚ĚƒgƒsƒbƒNƒX: ‘ă•\“I‚ȐE‹ĆŤƒXƒgƒŒƒXƒ‚ƒfƒ‹‚Ě“ŽŒü‚Ć’–Ú‚ł‚ę‚Ä‚˘‚éS—ŽĐ‰ď“I—vˆö. ’ç@–žƒ (ŒöO‰qś): ƒXƒgƒŒƒX‰ČŠw 2016/9; 31 (1): 12-20.

520004. [‘ŕ] ƒtƒBƒbƒgƒm[ƒg‚ĚĐ‰î‚Ć‚í‚Ş‘‚Ö‚Ě“ą“ü‚ĚŒŸ“˘. ’ç@–žƒ (ŒöO‰qś): ŽY‹ĆˆăŠwƒŒƒrƒ…[ 2017/1; 29 (3): 121-44.

521002. [‰đŕ] ƒXƒgƒŒƒXƒ`ƒFƒbƒN‚ĚŒ‹‰Ę‚đEęŠÂ‹Ť‰ü‘P‚ÉŠˆ‚Š‚ˇ‚˝‚߂̐i‚ß•ű. ’ç@–žƒ (ŒöO‰qś): ˆŔ‘S‚ĆŒ’N 2016/10; 17 (10): 32-5.

521003. [‰đŕ] ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x“ą“ü1”N@ŒŠ‚Ś‚Ä‚Ť‚˝‰Ű‘č‚ƍĄŒă‚ĚŠˆ—p‚Ě‚˝‚ß‚É. ’ç@–žƒ (ŒöO‰qś): Œ’N‚Š‚Č‚Ş‚í 2016/12; 585: 1.

521004. [‰đŕ] ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x|‚ť‚Ě—LŒř‚ČŠˆ—p‚đ–ÚŽw‚ľ‚ā|. ’ç@–žƒ (ŒöO‰qś): ‚Ż‚ń‚ą‚¤•Ÿ‰Ş 2017/2; 52: 10-1.

522009. [uŔ]y˜AÚ: One Point AdvicezEę‚É‚¨‚Ż‚éƒXƒgƒŒƒXƒ`ƒFƒbƒN‚Ě—ŻˆÓ“_. ’ç@–žƒ (ŒöO‰qś): Medical Practice 2016/4; 33 (4): 663.

522010. [uŔ]y“ÁW: ŽY‹Ć•ŰŒ’‚ĚƒgƒsƒbƒNƒXzáŠQŽŇE“ď•aŠłŽŇ“™‚̏A˜JŽx‰‡‚ĆŽY‹Ć•ŰŒ’. ]Œű@Ž (ŒöO‰qś): ŒöO‰qś 2016/4; 80 (4): 275-9.

522011. [uŔ]y˜AÚ: “ď•aŠłŽŇ‚ĚŽĄ—Ă‚ĆŽdŽ–‚Ě—ź—§Žx‰‡‚đl‚Ś‚é (12)zuŽY‹Ć•ŰŒ’ElŽ–’S“–ŽŇŒü‚Ż“ď•a‚ÉœëŠł‚ľ‚˝]‹Ćˆő‚̏A˜JŽx‰‡ƒnƒ“ƒhƒuƒbƒNv‚̍쐬. ]Œű@Ž (ŒöO‰qś): ˜J“­‚̉Ȋw 2016 /4; 71 (4): 226-30.

522012. [uŔ]y“ÁW: ŽŔ’nˆă‰Ć‚É•K—v‚Čƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXƒPƒA‚Ě’mŽŻzEę‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô. ’ç@–žƒ (ŒöO‰qś): —Őଂƌ¤‹† 2016/5; 93 (5): 589-94.

522013. [uŔ]y‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ďƒVƒ“ƒ|ƒWƒEƒ€: Œťę‚Š‚çƒGƒrƒfƒ“ƒX‚𔭐M‚ˇ‚é‚˝‚߂Ɂ|ŽáŽčŽŔ‘HŽŇ‚Š‚ç‚Ě’ńˆÄzŽáŽčŒ¤‹†ŽŇEŽŔŽ{ŽŇ‚Ě•L‚˘‚Â‚Č‚Ş‚č‚Ć˜AŒg‚Ö. ]Œű@Ž (ŒöO‰qś): ˜J“­‚̉Ȋw 2016/6; 71 (6): 368-71.

522014. [uŔ]y“ÁW: Eę‚Ěƒ|ƒWƒeƒBƒuƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX: Œťę‚É–đ—§‚ÂĹV—˜_zS—“IŽ‘–{: “­‚­l‚âEę‚đŠˆŤ‰ť‚ˇ‚éV‚ľ‚˘ŠT”O. ]Œű@Ž (ŒöO‰qś): ŽY‹ĆƒXƒgƒŒƒXŒ¤‹† 2016/7; 23 (3): 187-93.

522015. [uŔ]y“ÁW: Ž–‹Ćę‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚𑣐i‚ł‚š‚郊ƒXƒNƒAƒZƒXƒƒ“ƒgŽč–@‚ĚŠJ”­z3. ŽdŽ–‚ĚƒXƒgƒŒƒX‚ĚƒŠƒXƒNƒAƒZƒXƒƒ“ƒgƒc[ƒ‹‚ĚŠJ”­. ’ç –žƒ1, Ź“cŘ—DŽq (1ŒöO‰qś): ŽY‹Ć¸_•ŰŒ’ 2016/9; 24 (3): 198-203.

522016. [uŔ]y˜AÚ: ‚ ‚Č‚˝‚É‚ŕ‚í‚Š‚éŽY‹ĆƒXƒgƒŒƒXŒ¤‹† (‰uŠw•Ň)z6.“Œv‰đÍ‚̐i‚ß•ű. ]Œű@Ž (ŒöO‰qś): ŽY‹ĆƒXƒgƒŒƒXŒ¤‹† 2016/11; 23 (4): 351-4.

522017. [uŔ]y˜J“­‰qśEŒ’NzˆŔ‘S‰qś’S“–ŽŇ‚Ě‚˝‚ß‚ĚĹ‹ß‚ĚŒ¤‹†‚ĆŽŔ–ą‚ւ̉ž—p: ‚ć‚čŒř‰Ę“I‚ȏî•ń”­M‚Ě‚˝‚ß‚É, ­‚ľî•ń‚đ[–x‚ľ‚Ä‚Ý‚Ü‚š‚ń‚Š? ]Œű@Ž (ŒöO‰qś): ˆŔ‘S‚ĆŒ’N 2017/1; 68 (1): 582-4.

522018. [uŔ]yOCCUPATIONAL HEALTH@˜J“­‰qśEŒ’NzˆŔ‘S‰qś’S“–ŽŇ‚Ě‚˝‚ß‚ĚĹ‹ß‚ĚŒ¤‹†‚ĆŽŔ–ą‚ւ̉ž—p: ˜J“­ŽŇ‚ĚŒ’N‚ÉŠÖ‚ˇ‚錤‹†‚É•s‰ÂŒ‡‚ČŠé‹Ć‚Ě‹Ś—Í. ]Œű@Ž (ŒöO‰qś): ˆŔ‘S‚ĆŒ’N 2017/2; 68 (2): 165-16.

530001. [‚ť‚Ě‘ź (Editorial)] Recognition, Compensation, and Prevention of Karoshi, or Death due to Overwork. Eguchi H1, Wada K, Smith DR: J Occup Environ Med 2016/8; 58 (8): e313-4. (]Œű@Ž1: 1ŒöO‰qś)

540003. [‚ť‚Ě‘ź] ‘ć17‰ń“ŕŽR‹L”OÜ‚đŽóÜ‚ľ‚Ä: ˆăŠw‹łˆç‚ĚƒRƒA‚Ć‚ľ‚Ä‚Ěs“ŽˆăŠw. ’ç@–žƒ (ŒöO‰qś): s“ŽˆăŠwŒ¤‹† 2016/4; 22 (1): 25-6.

540004. [‚ť‚Ě‘ź]y“Še˜_•śĐ‰îz•œEŽx‰‡ƒvƒƒOƒ‰ƒ€‚Ů‚ŠƒIƒ‰ƒ“ƒ_‚É‚¨‚Ż‚éći“I‚ČŽY‹Ć•ŰŒ’‚ĚŽć‚č‘g. —L”nGW, “‡’Ă–žl, ]Œű@Ž1, ’ç@–žƒ1 (1ŒöO‰qś): ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹ 2016/5; 39 (3): 62-8.

540005. [‚ť‚Ě‘ź] ‰p•śŽ‚Š‚ç: ˆăŠw•”‚É‚¨‚Ż‚és“Ž‰ČŠwƒJƒŠƒLƒ…ƒ‰ƒ€‚Ě’ńˆÄ. ’ç@–žƒ (ŒöO‰qś): SgˆăŠw 2017/2; 57 (2): 190.

[’˜@‘]

610001. [Šwp‘ (•Ş’SŽˇ•M)]yWork Stress and Health in a Globalized Economy: The Model of Effort-Reward ImbalancezWork Stress and Health: The Case of Japan, p.173-88. Tsutsumi A1, Editors: Siegrist J, Wahrendolf M, Springer International Publishing, Switzerland, 2016/7. (’ç@–žƒ1: 1ŒöO‰qś)

620005. [Šwp‘ (•Ş’SŽˇ•M)]yŽg‚Ś‚é! Œ’N‹łˆçE˜J“­‰qś‹łˆç55‘Iz‘ć2•” ‹łˆçƒe[ƒ}•Ň@<Œ’N‹łˆç‚̏ę–Ę>@15. ƒXƒgƒŒƒXƒ}ƒlƒWƒƒ“ƒg, p.100-5. ’ç@–žƒ (ŒöO‰qś), •Ň: ŽY‹Ćˆă‰Č‘ĺŠwŽY‹ĆˆăŽŔ–ąŒ¤CƒZƒ“ƒ^[, “ú–{˜J–ąŒ¤‹†‰ď, “Œ‹ž, 2016/8”­s.

620006. [Šwp‘ (’P’˜)]y‚ą‚ę‚Č‚ç‚Ĺ‚Ť‚é! ŠĹŒěŽt‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ôƒnƒ“ƒhƒuƒbƒNz ’ç@–žƒ (ŒöO‰qś), Œd•śŽĐ, “Œ‹ž, 2016/12”­s.

620007. [Šwp‘ (•Ş’SŽˇ•M)]yŽĐ‰ďEŠÂ‹Ť‚ĆŒ’N@ŒöO‰qśŠw@2017”N“x”ŁzCHAPTER 9@¸_•ŰŒ’‘΍ô, p.97-104. ’ç@–žƒ (ŒöO‰qś), •Ň’˜: –öě@—m, ”ö“‡r”V, ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2017/2”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722004. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXŒ¤‹†‚Ě–˘—ˆ. ’ç@–žƒ (ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/25), •Ÿ“‡.

722005. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) E‹ĆŤƒXƒgƒŒƒXŒ¤‹†‚Ě“WŠJ. ’ç@–žƒ (ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/27), •Ÿ“‡.

722006. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) S16-2 ę‘ŽŽY‹Ćˆă‚Ć‘ĺŠw‹łˆő‚đŒoŒą‚ľ‚Ä. ]Œű@Ž (ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/27), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 186.

723077. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) _“ŢěŒ§‚É‚¨‚Ż‚éŽY‹Ć•ŰŒ’Šˆ“Ž’˛¸ (3)|ÝEŽŇŽ‰–b‚Ě’˛¸|. “n•”^‹|, ]Œű@Ž1, ç—tGˆę, ŒĂ‰Í@‘×, –kŒ´‰Ŕ‘ă, ŽO‰ô•””Ł, ‹{–{‹P˜a, •˝@vG, —é–Ř‹M‘ă”ü, ’‡‘ş@€ (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/25), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 350.

723078. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˜J“­ŽžŠÔ‚ĆŽdŽ–‚̐śŽYŤ (ƒvƒŒƒ[ƒ“ƒeƒB[ƒYƒ€) ‚ĚŠÖ˜A. —é–Ř’mŽq1, ‹{–؍Kˆę1, ]Œű@Ž1, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡.

723079. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’ʏí‹Î–ąŽŇ‚É‚¨‚Ż‚é˜J“­ŽžŠÔŒ¸­‚É‚ć‚é—}‚¤‚”­Ç‚ĚŠĎŽ@Œ¤‹†. ‰Á“Ą—œ‰Ŕ, tŽRN•v, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡.

723080. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) _“ŢěŒ§‰ş‚É‚¨‚Ż‚éŽY‹Ć•ŰŒ’Šˆ“Ž’˛¸ (1)|ŽY‹Ćˆă‘I”Có‹ľ‚ĆŠú‘Ň‚ˇ‚éŽY‹Ćˆă‹Ć–ą“ŕ—e|. –kŒ´‰Ŕ‘ă, ŒĂ‰Í@‘×, ŽO‰ô•””Ł, ]Œű@Ž1, —é–Ř‹M‘ă”ü, ç—tGˆę, ’‡‘ş@€, •˝@vG, ‹{–{‹P˜a, “n•”^‹| (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 427.

723081. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) _“ŢěŒ§‰ş‚É‚¨‚Ż‚éŽY‹Ć•ŰŒ’Šˆ“Ž’˛¸ (2)|ƒXƒgƒŒƒXƒ`ƒFƒbƒNEáŠVŽŇŒŮ—pE‹i‰Œ‘΍ô|. •˝@vG, ‹{–{‹P˜a, —é–Ř‹M‘ă”ü, ’‡‘ş@€, ŒĂ‰Í@‘×, –kŒ´‰Ŕ‘ă, “n•”^‹|, ŽO‰ô•””Ł, ç—tGˆę, ]Œű@Ž1 (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 428.

723082. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) A˜J˘‘ă‚É‚¨‚Ż‚é“ú–{l’jŤ‚̐E‹Ć•ĘEŽY‹Ć•Ę‚ĚŽŠŽEƒŠƒXƒN‚̍ˇ. ˜a“ckŽĄ, ]Œű@Ž1 (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 220.

723083. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Eˆć‚É‚¨‚Ż‚é“ď•aŠłŽŇ‚â’†“ráŠVŽŇ‚̏A˜JŽx‰‡‚Ě‚˝‚ß‚ĚŠÖŒWŽŇŠÔ‚Ě–]‚Ü‚ľ‚˘˜AŒg‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†. ]Œű@Ž1, ˜a“ckŽĄ, ”óŒű‘P”V (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/26), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 265.

723084. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’†ŹŠé‹Ć‚É‚¨‚Ż‚éƒc[ƒ‹‚đ—p‚˘‚˝ƒŠƒXƒNƒAƒZƒXƒƒ“ƒgŒ‹‰Ę‚Ć“˘˜_‚Ĺ’Šo‚ł‚ę‚˝‰Ű‘č‚ĚŠÖ˜AŤ‚ĚŒŸ“˘. XŒűŽŸ˜Y, ‘ĺ’Ë‘n•˝, “ŕ“c—z”V, ŒÜ\—’ç‘ă, Ź“cŘ—DŽq, “‡’Ă–žl, ’ç@–žƒ1, Žž“cŞl, ‹ŃŒË“TŽq, Œ´’J—˛Žj, ‹gě‰xŽq, ‹gě@“O, ěăŒ›l (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/27), •Ÿ“‡.

723085. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Eę‚Ö‚ĚOSHMS“ą“ü‚Ş‚ŕ‚˝‚炡ˆŔ‘S‰qś–Ę‚Ĺ‚ĚŒř‰Ę‚ÉŠÖ‚ˇ‚錤‹†`‘ć22•ń ŽŠŽĄ‘̐Eę‚É‚¨‚Ż‚éOSHMS’č’…‚ĆˆŔ‘S‰qśŽw•W‚⊈“Ž‚ւ̉e‹ż•]‰ż`. “n•Ó—TW, b“c–ÎŽ÷, ˛X–Ř‹B, ’ß“c—R‹IŽq, ˆÉ“ĄşD, ŒF’JM“ń, Œ´@–M•v, ’ç@–žƒ1, ŠŰŽRłŽĄ, ŽRŒűGŽ÷ (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/27), •Ÿ“‡.

723086. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˜J“­ŽŇ‚đ‘ÎŰ‚Ć‚ľ‚˝ƒWƒ‡ƒuEƒNƒ‰ƒtƒeƒBƒ“ƒOƒvƒƒOƒ‰ƒ€‚Ěƒ[ƒNƒGƒ“ƒQƒCƒWƒƒ“ƒg‚¨‚ć‚ѐS—“IƒXƒgƒŒƒX”˝‰ž‚ɑ΂ˇ‚éŒř‰Ę: ‘OŒă”äŠrŽŽŒą. ŸN’J‚ ‚ˇ‚Š, “‡’Ă–žl, Ą‘şK‘ž˜Y, “ď”gŽs, ]Œű@Ž1, Œ´—Y“ń˜Y, ěăŒ›l (1ŒöO‰qś): ‘ć89‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2016/5/27), •Ÿ“‡, ŽY‹Ć‰qśŠwŽGŽ 2016; 58 (—ŐŽž‘Š§†): 291.

723087. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) EˆćW’c‚É‚¨‚Ż‚é”­’BáŠQŒXŒü‚ƎЉďŒoĎó‹ľ, śŠˆKŠľ‚Ć‚ĚŠÖ˜A. —é–Ř’mŽq1, ‹{–؍Kˆę1, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć27‰ń“ú–{‰uŠw‰ďŠwp‘‰ď (2017/1/27), ŽR—œ.

723088. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒgƒŒƒXƒ`ƒFƒbƒNŽż–â•[‚Ě”ť’čŠî€‚ÉŠÖ‚ˇ‚錟“˘. ’ç–ž@ƒ1, ]Œű@Ž1, ˆäă˛b (1ŒöO‰qś): ‘ć75‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2016/10/27), ‘ĺă, “ú–{ŒöO‰qśŽGŽ 2016; 63 (10†“Á•Ę•˜^): 653.

723089. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ź“ú–{‚Ě—Ł“‡‚É‚¨‚Ż‚鍜‘ˆŮŒ`ŹÇŒóŒQ. •C“c‚ł‚â‚Š, ’ç@–žƒ1, ’|“‡‘ž˜Y, ‹Tč–LŽŔ, ’†‘şDˆę (1ŒöO‰qś): ‘ć27‰ń“ú–{‰uŠw‰ďŠwp‘‰ď (2017/1/27), ŽR—œ.

723090. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) śŠˆKŠľ•a‚đ—L‚ľ‚Č‚˘‘ÎŰŽŇ‚É‚¨‚Ż‚鐄ŽZŽ…‹…‘Ě‚ë‰ß—Ę‚Ć’`”’”A‚Ě‘g‚ݍ‡‚í‚š‚ĆŒŒˆł‚Ć‚ĚŠÖ˜A. ě“‡ł•q, X˜ełO, ‹vŠÔşŠ°, —é–Ř’mŽq1, ‰““c˜a•F, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć27‰ń“ú–{‰uŠw‰ďŠwp‘‰ď (2017/1/27), ŽR—œ.

731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x|‚ť‚Ě—LŒř‚ČŠˆ—p‚đ–ÚŽw‚ľ‚ā|. ’ç@–žƒ (ŒöO‰qś): ‘ć44‰ń•Ÿ‰ŞŒ§ŽY‹ĆˆăŠw‘ĺ‰ď (2016/10/5), •Ÿ‰Ş.

732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) “ď•aŠłŽŇE’†“ráŠQŽŇ‚̏A˜JŒp‘ąŽx‰‡. ]Œű@Ž (ŒöO‰qś): “ú–{ŽY‹Ć‰qśŠw‰ďŠÖ“Œ’n•ű‰ď‘ć273‰ń—á‰ď (2016/5/7), “Œ‹ž, ‘ć273‰ń“ú–{ŽY‹Ć‰qśŠw‰ďŠÖ“Œ’n•ű‰ď—á‰ďŒ¤C‰ďŽ‘—żuEˆćƒoƒŠƒAƒtƒŠ[Žx‰‡‚̐V‚˝‚Č“WŠJv.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522003. [uŔ]yTOPICSzA˜J˘‘ă‚É‚¨‚Ż‚é“ú–{l’jŤ‚̐E‹Ć•ĘEŽY‹Ć•Ę‚ĚŽŠŽEƒŠƒXƒN. ˜a“ckŽĄ, ]Œű@Ž1 (1ŒöO‰qś): ˆŔ‘S‚ĆŒ’N 2016/3; 67 (3): 254-5.


–@ˆăŠw

[Šwp˜_•ś]

110057. [Œ´’˜] Self-inflicted Firearm Discharge from Heating Using a Gas Burner. Osawa M, Matsushima Y, Kumar A, Tsuboi A, Kakimoto Y, Satoh F1: J Forensic Sci 2016/5; 61 (3): 845-7. (˛“Ą•śŽq1: 1–@ˆă)

110058. [Œ´’˜] Evaluation of Y chromosomal SNP haplogrouping in the HID-Ion AmpliSeqţ Identity Panel. Ochiai E, Minaguchi K, Nambiar P, Kakimoto Y, Satoh F1, Nakatome M, Miyashita K, Osawa M: Leg Med (Tokyo) 2016/9; 22: 58-61. (˛“Ą•śŽq1: 1–@ˆă)

110059. [Œ´’˜] Trend of homicide-suicide in Kanagawa Prefecture (Japan): Comparison with western countries. Satoh F1, Osawa M: Med Sci Law 2016/10; 56 (4): 258-63. (˛“Ą•śŽq1: 1–@ˆă)

120005. [Œ´’˜] “ü…‹y‚э‚Š“]—Ž‚É‚ć‚éŒđ’ĘŽ–ŒĚŽ€–SŽ–ŒĚ‚É”F‚ß‚ç‚ę‚é‰^“]Žč‚ĚŽŠŽEsˆ×. ‘ĺŕVŽ‘Ž÷, Š_–{—R•z, ˛“Ą•śŽq1, ’†–ěŽj’ (1–@ˆă): ”…ž‰ČŠw 2016/5; 44: 52-7.

310001. [Ç—á•ń] Cytokine Elevation in Sudden Death With Respiratory Syncytial Virus: A Case Report of 2 Children. Kakimoto Y, Seto Y, Ochiai E, Satoh F1, Osawa M: Pediatrics 2016/12; 138 (6). pii: e20161293. Epub 2016 Nov 10. (˛“Ą•śŽq1: 1–@ˆă)

[Šw‰ďEŒ¤‹†‰ď“™]

723091. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –@ˆă‰đ–U‚É‚¨‚Ż‚é‘ĺ“Ž–Ź”j—ô—á‚ɂ‚˘‚Ä. ˛“Ą•śŽq1, ŁŒË—Ç‹v, ’ŘˆäH’j, —Ž‡Œb—Žq, Š_–{—R•z, ‘ĺŕVŽ‘Ž÷ (1–@ˆă): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä.

723092. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒNŽ€–S—á‚É‚¨‚Ż‚é”x, äB‘Ÿ‚̖Ɖu‘gDŠw“IŒŸ“˘‚ɂ‚˘‚Ä. ˛“Ą•śŽq1, ŁŒË—Ç‹v, ’ŘˆäH’j, ź“‡@—T, —Ž‡Œb—Žq, Š_–{—R•z, ‘ĺŕVŽ‘Ž÷ (1–@ˆă): ‘ć100ŽŸ“ú–{–@ˆăŠw‰ďŠwp‘S‘W‰ď (2016/6/15), “Œ‹ž.

723093. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –UŒŸ‘gDŒŸ‘Ě‚đ—p‚˘‚˝microRNA Deep Sequencing‚ĚŒŸ“˘. Š_–{—R•z, ˛“Ą•śŽq1, —Ž‡Œb—Žq, ‘ĺŕVŽ‘Ž÷ (1–@ˆă): ‘ć100ŽŸ“ú–{–@ˆăŠw‰ďŠwp‘S‘W‰ď (2016/6/15-17), “Œ‹ž, “ú–{–@ˆăŠwŽGŽ 2016; 70: 77.

723094. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –@ˆă‰đ–U‚É‚¨‚Ż‚é’†“Ĺ“Œv’˛¸‚ÉŒü‚Ż‚˝–ň•¨ƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ĚŽć‘g‚Ý (1)|–ň•¨•ŞÍ˜AŒgƒvƒƒWƒFƒNƒg (DSMS: Drug Screening Method Sharing Project) ‚ĚĐ‰î|. ‘O‹´‹ąŽq, ˆŔ•”Š°Žq, ˛X–ؐçŽőŽq1, ŠâŁ”Ž‘ž˜Y, ˛“Ą•śŽq1, Šâ|Œö° (1–@ˆă): ‘ć41‰ń“ú–{ˆă—pƒ}ƒXƒXƒyƒNƒgƒ‹Šw‰ď”N‰ď (2016/9/16), –źŒĂ‰Ž.

723095. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –@ˆă‰đ–U‚É‚¨‚Ż‚é’†“Ĺ“Œv’˛¸‚ÉŒü‚Ż‚˝–ň•¨ƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ĚŽć‘g‚Ý (2)|•iŽżŠÇ—‚ÉŒü‚Ż‚˝ƒuƒ‰ƒCƒ“ƒhƒeƒXƒg‚ĚŽŔŽ{‚ɂ‚˘‚ā|. ˛X–ؐçŽőŽq1, ˆŔ•”Š°Žq, ‘O‹´‹ąŽq, ŠâŁ”Ž‘ž˜Y, Šâ|Œö°, ˛“Ą•śŽq1 (1–@ˆă): ‘ć41‰ń“ú–{ˆă—pƒ}ƒXƒXƒyƒNƒgƒ‹Šw‰ď”N‰ď (2016/9/16), –źŒĂ‰Ž.

723096. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –@ˆă‰đ–U‚É‚¨‚Ż‚é’†“Ĺ“Œv’˛¸‚ÉŒü‚Ż‚˝–ň•¨ƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ĚŽć‘g‚Ý (3)|ƒhƒ‰ƒbƒOƒXƒNƒŠ[ƒjƒ“ƒOƒŒƒ|[ƒgƒVƒXƒeƒ€‚ĚĐ‰î|. ˆŔ•”Š°Žq, ’†“‡W–ç, ˆÉ“Ą—S“ń, ‘O‹´‹ąŽq, —§źˆË’ˆ, ˛X–ؐçŽőŽq1, Šâ|Œö°, ˛“Ą•śŽq1, ŠâŁ”Ž‘ž˜Y (1–@ˆă): ‘ć41‰ń“ú–{ˆă—pƒ}ƒXƒXƒyƒNƒgƒ‹Šw‰ď”N‰ď (2016/9/16), –źŒĂ‰Ž.

723097. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –@ˆă‰đ–U‚É‚¨‚Ż‚é’†“Ĺ“Œv’˛¸‚ÉŒü‚Ż‚˝–ň•¨ƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ĚŽć‘g‚Ý (4). ˛X–ؐçŽőŽq1, ŒIŒ´Ž—R (1–@ˆă): ‘ć100ŽŸ“ú–{–@ˆăŠw‰ďŠwp‘S‘W‰ď (2016/6/17), “Œ‹ž.

723098. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ň“Ĺ•¨ŽŽŒą–@@II-4@Œü¸_–ňŽŽŒą–@@R‚¤‚–ň. ˛X–ؐçŽőŽq1, Ž›“c@ŒŤ, “a‰ŞŒbŽq, “c’†^—D, ‘şăçŽq1, “ü]@Â1, ŽÂ’Ë’B—Y, ˛“Ą•śŽq1 (1–@ˆă): “ú–{–ňŠw‰ď‘ć137”N‰ď (2017/3/26), ĺ‘ä.

733013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) S‹ŘÇ‹y‚ѐS”ě‘ĺEŠg’ŁŽ–—á‚É‚¨‚Ż‚郉ƒ~ƒ“A/Cˆâ“`Žq‚¨‚ć‚ŃƒTƒCƒtƒ@[ˆâ“`Žq‚Ě•ĎˆŮ‰đÍ. ‘O“cˆę•ă, ‘şăçŽq1, “ü]@Â1, ˛X–ؐçŽőŽq1, ’†‘ş–Ίî, ˛“Ą•śŽq1, ŒIŒ´Ž—R (1–@ˆă): ‘ć66‰ń“ú–{–@ˆăŠw‰ďŠwp‹ăB’n•űW‰ď (2016/10/14-15), •Ÿ‰Ş.

733014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Ž‰şó‹ľ‚É‹^–â‚ŞŽc‚é”ň‚э~‚莖—á. “ü]@Â1, ‘şăçŽq1, ˛X–ؐçŽőŽq1, ’†ŠŰŽ”ü2, ă–{“Žq2, ˛“Ą•śŽq1 (1–@ˆă, 2Œ`‘ÔŒn): ‘ć85‰ń“ú–{–@ˆăŠw‰ďŠwpŠÖ“Œ’n•űW‰ď (2016/10/29), ‰Ą{‰ę.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110002. [Œ´’˜] Effects of using the GlobalFilerTM multiplex system on parent-child analyses of cases with single locus inconsistency. Ochiai E, Osawa M, Tamura T, Minaguchi K, Miyashita K, Matsushima Y, Kakimoto Y, Satoh F1: Leg Med (Tokyo) 2016/1; 18: 72-4. (˛“Ą•śŽq1: 1–@ˆă)

[Šw‰ďEŒ¤‹†‰ď“™]

H26-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Determination of a synthetic cannabinoid, N-1-naphtalenyl-1-pentyl-1H-indole-3-carboxamide (NNEI) in blood, tissue and hair - An autopsy case. Sasaki C1, Saito T, Shinozuka T, Irie W1, Murakami C1, Maeda K, Nakamaru N2, Oishi M, Nakamura S, Kurihara K: 9th International Symposium on Advances in legal Medicine (2014/6/16-20), •Ÿ‰Ş. (˛X–ؐçŽőŽq1, “ü]@Â1, ‘şăçŽq1, ’†ŠŰŽ”ü2: 1–@ˆă, 2Œ`‘ÔŒn)

H27-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ň“Ĺ•¨ŽŽŒą–@@II-4@Œü¸_–ňŽŽŒą–@@ƒuƒƒ€ƒƒŒƒŠƒ‹”A‘f. Ž›“c@ŒŤ, ˛X–ؐçŽőŽq1, {“c@Œ÷, “a‰ŞŒbŽq, š ––—eŽq, ŽÂ’Ë’B—Y, “c’†žÄ”V‰î, ’ˇ’Jě’q‰Ř, •č‹vm•F (1–@ˆă): “ú–{–ňŠw‰ď‘ć136”N‰ď (2016/3/26), ‰Ą•l.

H27-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ň“Ĺ•¨ŽŽŒą–@@II-4@Œü¸_–ňŽŽŒą–@@ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn—U“ą‘Ě. ˛X–ؐçŽőŽq1, Ž›“c@ŒŤ, ŽÂ’Ë’B—Y, ‘şăçŽq1, “ü]@Â1, ‘O“cˆę•ă, ’†ŠŰŽ”ü2, ă–{“Žq2, ’†‘ş–Ίî, ŒIŒ´Ž—R (1–@ˆă, 2Œ`‘ÔŒn): “ú–{–ňŠw‰ď‘ć136”N‰ď (2016/3/26-29), ‰Ą•l.


ŽŔŒą“Ž•¨Šw

[Šwp˜_•ś]

110060. [Œ´’˜] Leucine-rich repeat kinase 2 (LRRK2) regulates ƒż-synuclein clearance in microglia. Maekawa T1, Sasaoka T, Azuma S2, Ichikawa T1, Melrose HL, Farrer MJ, Obata F1: BMC Neurosci 2016/11; 17 (1): 77. (‘Oě’B‘Ľ1, “Œ@’ĺG2, Žsě‘¸•ś1, Ź”Ś•ś–í1: 1ˆă—ÉqśŠw•”, 2ŽŔ“Ž)

[Šw‰ďEŒ¤‹†‰ď“™]

723099. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) VŠƒ‘ĺŠw”]Œ¤‹†Š“Ž•¨Ž‘ŒšŠJ”­Œ¤‹†•Ş–ě‚É‚¨‚Ż‚éƒ}ƒEƒXă󑀍ě|ŽŔŽ{ó‹ľ|. Ź“c‰Ŕ“ŢŽq, _•ŰKO, ‘O“c‹Xr, Žđˆä´Žq, ’†”ö‘G, “ĄŕVM‹`, ˛“ĄrĆ1, ‰ĄŽR•ő‰î, ů‰Şr–M (1ŽŔ“Ž): ‘ć50‰ńŽŔŒą“Ž•¨‹ZpŽŇ‹Ś‰ď‘‰ď (2016/10/1), ě‰z.

723100. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) VŠƒ‘ĺŠw”]Œ¤‹†Š“Ž•¨Ž‘ŒšŠJ”­Œ¤‹†•Ş–ě‚É‚¨‚Ż‚éƒ}ƒEƒX“€Œ‹ăóE“€Œ‹¸Žq‚ĚŠw“ŕ‹¤—LƒVƒXƒeƒ€‚̍\’z. _•ŰKO, Ź“c‰Ŕ“ŢŽq, ‘O“c‹Xr, Žđˆä´Žq, ’†”ö‘G, “ĄŕVM‹`, ˛“ĄrĆ1, ‰ĄŽR•ő‰î, ů‰Şr–M (1ŽŔ“Ž): ‘ć50‰ńŽŔŒą“Ž•¨‹ZpŽŇ‹Ś‰ď‘‰ď (2016/10/1), ě‰z.

723101. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚đ‰î‚ˇ‚é_Œo“`’B‚͉^“Žî•ń‚Ě“`’B‚Ɖ^“Ž‚Ě”­Œť‚É•s‰ÂŒ‡‚Ĺ‚ ‚é. ů‰Şr–M, ˛“Ą’ŠŽq (‘ĺ‹v•Ű’ŠŽq)1, ’mŒŠ‘”ü, ’†”ö‘G, ‘ĺ‹v•Ű’ź2, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ”něŒb—œŽq, ˛“ĄrĆ2, “ĄŕVM‹`, ‰ĄŽR•ő‰î, “ě•”@“Ä (1ś•¨•¨—Œn, 2ŽŔ“Ž): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/11/30), ‰Ą•l.

723102. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚đ‰î‚ˇ‚é_Œo“`’B‚͉^“Žî•ń‚Ě“`’B‚Ɖ^“Ž‚Ě”­Œť‚É•s‰ÂŒ‡‚Ĺ‚ ‚é. ů‰Şr–M, ˛“Ą’ŠŽq (‘ĺ‹v•Ű’ŠŽq)1, ’mŒŠ‘”ü, ‘ĺ‹v•Ű’ź2, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ’†”ö‘G, ˛“ĄrĆ2, “ĄŕVM‹`, “ě•”@“Ä (1ś•¨•¨—Œn, 2ŽŔ“Ž): ‘ć94‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2017/3/29), •lź.

732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łŽöA”Cu‰‰) ^‚̐_Œo•ĎŤŽžŠłƒ‚ƒfƒ‹‚đ–ÚŽw‚ľ‚Ä. ˛“ĄrĆ (ŽŔ“Ž): ‘ć42‰ń–k—˘ˆăŠw‰ď‘‰ď (2016/11/12), ‘Š–ÍŒ´.

733015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) D1/D2ƒh[ƒpƒ~ƒ“Žó—e‘ĚƒRƒ“ƒfƒBƒVƒ‡ƒiƒ‹”­Œťƒ}ƒEƒX‚É‚ć‚é‰^“Ž§Œä‹@\‚̉đ–ž. ů‰Şr–M, ˛“Ą’ŠŽq (‘ĺ‹v•Ű’ŠŽq)1, ’mŒŠ‘”ü, ‘ĺ‹v•Ű’ź2, ˆ˘•”@Šw, ě‘ş–źŽq, ’†”ö‘G, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ˛“ĄrĆ2, “ĄŕVM‹`, č‘şŒšŽi, “ě•”@“Ä (1ś•¨•¨—Œn, 2ŽŔ“Ž): •˝Ź28”N“xuć’[ƒ‚ƒfƒ‹“Ž•¨Žx‰‡ƒvƒ‰ƒbƒgƒtƒH[ƒ€vŹ‰Ę”­•\‰ď (2017/2/7), Ž ‰ę.

733016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”­śE”­’BŠú‚É‚¨‚Ż‚éƒh[ƒpƒ~ƒ“Žó—e‘ĚD1R‚Ě”­Œť‚ƍs“Ž‚ւ̉e‹ż. ‘ĺ‹v•Ű’ź1, ˛“ĄrĆ1 (1ŽŔ“Ž): •˝Ź28”N“xu”]Œ¤‹†Š‹¤“Ż—˜—p‹¤“ŻŒ¤‹†v‘ć1‰ń‡“ŻƒZƒ~ƒi[ (2016/12/27), VŠƒ.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoŽžŠłƒ‚ƒfƒ‹‚Š‚çŠw‚Ń‚ÄŽv‚¤. ˛“ĄrĆ (ŽŔ“Ž): ‘Š–ÍŒ´_ŒoƒtƒH[ƒ‰ƒ€ (2015/6/17), ‘Š–ÍŒ´.


–ƉuŠw

[Šwp˜_•ś]

110061. [Œ´’˜] Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice. Satoh M1, Hoshino M, Fujita K, Iizuka M, Fujii S, Clingan CS, Van Kaer L, Iwabuchi K1: Sci Rep 2016/6; 6: 28473. (˛“Ą@‰ë1, ŠâŸş˜a–ç1: 1–Ɖu)

110062. [Œ´’˜] Inhibitory function of NKT cells during early induction phase of nickel allergy. Okuno H, Satoh M1, Takeuchi E1, Eshima K1, Terashima M, Komotori J, Habu S, Tamauchi H, Iwabuchi K1: Immunobiology 2016/7; 221 (7): 833-8. (˛“Ą@‰ë1, ’|“ŕŒb”üŽq1, ]“‡k“ń1, ŠâŸş˜a–ç1: 1–Ɖu)

110031. [Œ´’˜] Anti-tumor effects of interferon-beta cell therapy in murine model of melanoma. Nakamura M1, Kagawa L, Nakada N2, Satoh M3, Maehana S4, Kojima F1, Amano H5, Murakumo Y2, Iwabuchi K3, Majima M5, Kitasato H1: International Journal of Cancer Therapy and Oncology 2016/12; 4 (4): 4412. (’†‘şłŽ÷1, ’‡“c“TL2, ˛“Ą@‰ë3, ‘O‰ÔË‘ž˜Y4, Ź“‡ŽjÍ1, “V–ě‰pŽ÷5, ‘ş‰_–FŽ÷2, ŠâŸş˜a–ç3, ”n“ˆł—˛5, –k—˘‰p˜Y1: 1ˆă—ÉqśŠw•”, 2•a—, 3–Ɖu, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 5–ň—)

110063. [Œ´’˜] Enterogenous bacterial glycolipids are required for the generation of natural killer T cells mediated liver injury. Wei Y, Zeng B, Chen J, Cui G, Lu C, Wu W, Yang J, Wei H, Xue R, Bai L, Chen Z, Li L, Iwabuchi K1, Uede T, Van Kaer L, Diao H: Sci Rep 2016/11; 6: 36365. doi: 10.1038/srep36365. (ŠâŸş˜a–ç1: 1–Ɖu)

110064. [Œ´’˜] Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Satoh M1, Namba KI, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, OnoŽ K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda KH, Van Kaer L, Iwabuchi K1: Exp Eye Res 2016/12; 153: 79-89. (˛“Ą@‰ë1, ŠâŸş˜a–ç1: 1–Ɖu)

511001. [‰đŕ] Communication between natural killer T cells and adipocytes in obesity. Satoh M1, Iwabuchi K1: Adipocyte 2016/9; 5 (4): 389-93. (˛“Ą@‰ë1, ŠâŸş˜a–ç1: 1–Ɖu)

522019. [uŔ]y“ÁW: ‘ăŽÓ’˛ß‚É‚¨‚Ż‚é–Ɖu×–E‚Ě–đŠ„zŽ‰–b‘gD: ’–Ú‚ł‚ę‚鎉–b‘gD‚̖Ɖu×–E@NKT×–EENK×–E‚ĚŽ‰–b‘gD‚Ĺ‚Ě–đŠ„. ˛“Ą@‰ë1, ŠâŸş˜a–ç1 (1–Ɖu): ˆăŠw‚Ě‚ ‚ä‚Ý 2016/5; 257 (6): 681-5.

540006. [‚ť‚Ě‘ź (Šwś˜_•ś)] CRISPR/Cas9‚đ—p‚˘‚˝CD1dŒ‡‘š‹š‘BŽî×–EŠ”‚̍쐻. ˛”Œ”ü”ż, ˛“Ą@‰ë1, ”Ń’Ë‚Ý‚ł‚đ2, ŠâŸş˜a–ç1 (1–Ɖu, 2—\–hˆăŠwŒn): –k—˘ˆăŠw 2016/6; 46 (1): 49-51.

[Šw‰ďEŒ¤‹†‰ď“™]

713008. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The effects of transgenic expression of a T-box molecule, Eomesodermin, in naive T cells on their activation and exhaustion status. Esima K1, Noma H, Misawa K2, Iwabuchi K1: 16th International Congress of Immunology (‘ć16‰ń‘Ű–Ɖu‰ď‹c) (2016/8/22), Melbourne, Australia. (]“‡k“ń1, –ěŠÔt, ŽOŕV‰Ŕ“Ţ2, ŠâŸş˜a–ç1: 1–Ɖu, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

723103. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NKT×–E-Ž‰–b×–E‚Ě‘ŠŒÝě—p‚É‚ć‚鎉–b‘gD‰ŠÇ—U“ąƒƒJƒjƒYƒ€. ˛“Ą@‰ë1, ŠâŸş˜a–ç1 (1–Ɖu): ‘ć27‰ń“ú–{ś‘Ě–hŒäŠw‰ďŠwp‘‰ď (2016/7/8), •Ÿ‰Ş.

723104. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NADPH oxidase defect leads to aristolochic acid induced acute tubule-interstitial nephritis resulting from imbalance of M1/M2 macrophages. Takeuchi E1, Morisawa S, Iizuka M, Takeuchi Y2, Iwabuchi K1: ‘ć45‰ń“ú–{–ƉuŠw‰ďŠwpW‰ď (2016/12/5-7), ‰Ť“ę. (’|“ŕŒb”üŽq1, ’|“ŕN—Y2, ŠâŸş˜a–ç1: 1–Ɖu, 2t‘Ÿ“ŕ)

723105. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Transgenic expression of a T-box molecule, Eomesodermin, in naive T cells induced expression of some activation/exhaustion markers without conferring functionality. Eshima K1, Misawa K2, Iwabuchi K1: ‘ć45‰ń“ú–{–ƉuŠw‰ď‘‰ďŠwpW‰ď (2016/12/5), ‰Ť“ę. (]“‡k“ń1, ŽOŕV‰Ŕ“Ţ2, ŠâŸş˜a–ç1: 1–Ɖu, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

723106. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NKT cell - adipocyte interaction is necessary to induce adipose tissue inflammation. Sato M1, Fujita K, Iizuka M, Iwabuchi K1 (1–Ɖu): ‘ć45‰ń“ú–{–ƉuŠw‰ďŠwpW‰ď (2016/12/5), ‰Ť“ę. (˛“Ą@‰ë1, ŠâŸş˜a–ç1: 1–Ɖu)

723107. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Functional analyses of peripheral T cells and of cortical thymic epithelial cells in immune-compromized, alymphoplasia mice. Misawa K1, Eshima K2, Iwabuchi K2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–Ɖu): ‘ć45‰ń“ú–{–ƉuŠw‰ď‘‰ďŠwpW‰ď (2016/12/7), ‰Ť“ę. (ŽOŕV‰Ŕ“Ţ1, ]“‡k“ń2, ŠâŸş˜a–ç2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–Ɖu)

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110003. [Œ´’˜] Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses. Kubo M1, Nagashima R2, Ohta E1, Maekawa T, Isobe Y, Kurihara M, Eshima K3, Iwabuchi K3, Sasaoka T, Azuma S4, Melrose HL, Farrer MJ, Obata F1: J Neuroimmunol 2016/3; 292: 1-8. (‹v•Ű@˝1, ’ˇ“‡—˛ˆę2, ‘ž“c‰x˜N1, ]“‡k“ń3, ŠâŸş˜a–ç3, “Œ@’ĺG4, Ź”Ś•ś–í1: 1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–Ɖu, 4ŽŔ“Ž)

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –Ť“÷‰čŽîÇƒ‚ƒfƒ‹ƒ}ƒEƒX‚É‚¨‚˘‚ăAƒŠƒXƒgƒƒLƒAŽ_—U“ąŤ”A×ŠÇ‰óŽ€Ťt‰Š‚Ş‘ˆŤ‚ˇ‚郁ƒJƒjƒYƒ€‚̉đÍ. ’|“ŕŒb”üŽq1, ’|“ŕN—Y2 (1–Ɖu, 2t‘Ÿ“ŕ): ‘ć43‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď (2015/10/23), _ŒË.


ˆă—ĂŒo‰cŠw


’nˆćŽ™“ś¸_‰Čˆă—ĂŠw


Äśˆă—ĂŒ`ŹŠO‰ČŠw


’nˆć‘‡ˆă—ĂŠw

[’˜@‘]

620008. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć1ŠŞ@ę–ĺŒ¤C‰Ű’öIz‘ć7Í ŠĹŽć‚č“™‚É‚¨‚Ż‚éŠĹŒěƒT[ƒrƒX‚ĚŠˆ—p‚ÉŠÖ‚ˇ‚鎖—á 1`5ß, p.288-308. VX‰Á“ŢŽq1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620009. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć1ŠŞ@ę–ĺŒ¤C‰Ű’öIz‘ć8Í ”F’mÇ‚ÉŠÖ‚ˇ‚鎖—á 1`3ß, p.332-61. X@hŽq1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620010. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć1ŠŞ@ę–ĺŒ¤C‰Ű’öIz‘ć9Í “ü‘މ@Žž“™‚É‚¨‚Ż‚éˆă—Ă‚Ć‚Ě˜AŒg‚ÉŠÖ‚ˇ‚鎖—á 1`3ß, p.380-404. ›–ě“N–ç1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620011. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć2ŠŞ@ę–ĺŒ¤C‰Ű’öIIz‘ć3Í ŠĹŽć‚č“™‚É‚¨‚Ż‚éŠĹŒěƒT[ƒrƒX‚ĚŠˆ—p‚ÉŠÖ‚ˇ‚鎖—á 1`4ß, p.114-30. VX‰Á“ŢŽq1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620012. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć2ŠŞ@ę–ĺŒ¤C‰Ű’öIIz‘ć4Í ”F’mÇ‚ÉŠÖ‚ˇ‚鎖—á 1`3ß, p.152-70. X@hŽq1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620013. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć2ŠŞ@ę–ĺŒ¤C‰Ű’öIIz‘ć5Í “ü‘މ@Žž‚É‚¨‚Ż‚éˆă—Ă‚Ć‚Ě˜AŒg‚ÉŠÖ‚ˇ‚鎖—á 1`3ß, p.194-211. ›–ě“N–ç1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620014. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć4ŠŞ@Žĺ”C‰îŒěŽx‰‡ę–ĺˆőXVŒ¤Cz‘ć3Í ŠĹŽć‚č“™‚É‚¨‚Ż‚éŠĹŒěƒT[ƒrƒX‚ĚŠˆ—p‚ÉŠÖ‚ˇ‚鎖—á 1`4ß, p.92-125. Îěƒ–ç1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/12”­s.

620015. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć4ŠŞ@Žĺ”C‰îŒěŽx‰‡ę–ĺˆőXVŒ¤Cz‘ć4Í ”F’mÇ‚ÉŠÖ‚ˇ‚鎖—á 1`3ß, p.128-60. X@hŽq1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/12”­s.

620016. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć4ŠŞ@Žĺ”C‰îŒěŽx‰‡ę–ĺˆőXVŒ¤Cz‘ć5Í “ü‘މ@Žž‚É‚¨‚Ż‚éˆă—Ă‚Ć‚Ě˜AŒg‚ÉŠÖ‚ˇ‚鎖—á 1`5ß, p.162-97. ›–ě“N–ç1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/12”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723108. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ý‘îˆă—Ă‚É‚¨‚Ż‚éuˆăŽt‚ĚƒWƒFƒ“ƒ_[ˇ‚É‚ć‚éf—Ă“ŕ—e‚ւ̉e‹żv‚ÉŠÖ‚ˇ‚鎖—á•ń. VX‰Á“ŢŽq1, –Ř‘ş‘ô–1,2, X@hŽq1, â@Ë•˝2, ůŔG”N2, Îěƒ–ç1, ⨍F‘ž˜Y2, ŠÖ—LŽq1, ÔŻ@“§1,2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă): ‘ć18‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď^‘ć21‰ń“ú–{Ý‘îƒPƒAŠw‰ďŠwpW‰ďE‡“Ż‘ĺ‰ď (2016/7/17), “Œ‹ž.

723109. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •a‰@‹Î–ą‚Ě‘ŸŠíE—Ěˆć‚̐ę–ĺˆăŽ‘Ši‚đ—L‚ˇ“ŕ‰ČŒnˆăŽt‚ŞŽuŒü‚ˇ‚éu‘‡f—Ăˆăv‚Ö“]Œü‚ˇ‚éŰ‚ĚŒ¤C“ŕ—e‚Ě’Tő. VX‰Á“ŢŽq1, –Ř‘ş‘ô–1,2, –ě‘ş‹ąŽq, Ą‰iŒő•F, ÔŻ@“§1,2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă): ‘ć7‰ń“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ďŠwp‘ĺ‰ď (2016/6/12), “Œ‹ž.


‰ŠÇŤ’°ŽžŠł‹łˆçE—Տ°Œ¤‹†Šw


Á‰ťŠí“ŕ‰ČŠw

[Šwp˜_•ś]

110065. [Œ´’˜] Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon. Kawashima R, Fujimaki M, Ikenoue Y, Danjo K, Koizumi W1, Ichikawa T: Support Care Cancer 2016/4; 24 (4): 1609-16. (Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110066. [Œ´’˜] Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer. Osumi H1, Yoshio T1, Chin K1, Ogura M1, Kumekawa Y1, Suenaga M1, Matsusaka S1, Shinozaki E1, Miyamoto Y1, Morishige K1, Ishiyama A1, Hirasawa T1, Tsuchida T1, Yamamoto Y1, Fujisaki J1, Igarashi M1,2, Mizunuma N1: Gastric Cancer 2016/4; 19 (2): 625-30. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

110067. [Œ´’˜] Three-dimensional computed tomography of portopulmonary venous anastomoses in patients with esophageal varices before treatment. Matsumoto Y1, Hidaka H1, Matsunaga K2, Kubota K1, Yamane K1, Inoue T1, Minamino T1, Takada J1, Tanaka Y1, Okuwaki Y1, Nakazawa T1, Shibuya A1,3, Koizumi W1: Hepatol Res 2016/5; 46 (6): 559-64. (ź–{ˆçG1, “ú‚@‰›1, ź‰iŒh“ń2, ŒE“cK‰î1, ŽRŞŒhŽq1, ˆäă’qm1, “ě–ě@•×1, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, ‰œ˜e—T‰î1, ’†ŕV‹MG1, a’J–ž—˛1,3, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2•úŽËü (‰ć‘œ), 3ˆă—ĂŠÇ—)

110068. [Œ´’˜] Randomized controlled exploratory study comparing the usefulness of two types of metallic stents with different axial forces for the management of duodenal obstruction caused by pancreatobiliary cancer. Okuwaki K1, Kida M1, Yamauchi H1, Imaizumi H1, Miyawaza S1, Iwai T1, Masutani1 H,1 Matsumoto T1, Hasegawa R1, Koizumi W1: J Hepatobiliary Pancreat Sci 2016/5; 23 (5): 289-97. (‰œ˜e‹ť‰î1, –Ř“cŒőL1, ŽR“ŕ_Žj1, Ąň@O1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ą’JŠ°ˆČ1, ź–{‚–ž1, ’ˇ’Jě—Í–ç1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110069. [Œ´’˜] Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer. Sunakawa Y, Cao S, Volz NB, Berger MD, Yang D, Parekh A, Zhang W, Matsusaka S, Ning Y, Stremitzer S, Stintzing S, Sebio A, Okazaki S, Wakatsuki T, Azuma M1, Watanabe M2, Koizumi W1, Wu AH, Lenz HJ: Pharmacogenomics J 2016/5. doi: 10.1038/tpj.2016.46. [Epub ahead of print] (“Œ@’q1, “n粏š•F2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ŠO‰Č)

110070. [Œ´’˜] Correlation of the location of superficial Barrett's esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux. Omae M1, Fujisaki J1, Shimizu T1, Horiuchi Y1, Ishiyama A1, Yoshio T1, Hirasawa T1, Yamamoto Y1, Tsuchida T1, Igarashi M1,2, Seto Y3: Endosc Int Open 2016/5; 4 (5): E515-20. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ, 3“Œ‹ž‘ĺŠw)

110071. [Œ´’˜] Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis. Naganuma M, Aoyama N, Suzuki Y, Nishino H, Kobayashi K1,2, Hirai F, Watanabe K, Hibi T3,4: J Crohns Colitis 2016/7; 10 (7): 828-36. (Ź—ѐ´“T1,2, “ú”ä‹I•ś3,4: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@)

110072. [Œ´’˜] Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. Bando H, Yamada Y, Tanabe S1,2, Nishikawa K, Gotoh M, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I: Gastric Cancer 2016/7; 19 (3): 919-26. (“c糁@‘1,2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

110073. [Œ´’˜] Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial. Ohba A, Kato K, Ito Y, Katada C1, Ishiyama H2, Yamamoto S, Ura T, Kodaira T, Kudo S, Tamaki Y: Adv Radiat Oncol 2016/7; 1 (4): 230-36. (Œ˜“ce—˜1, ÎŽR”ŽžŠ2: 1Á‰ťŠí“ŕ, 2•úŽËü (Žîá‡))

110074. [Œ´’˜] Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin. Nishikawa K, Yamada Y, Ishido K1, Gotoh M, Bando H, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I: Gastric Cancer 2017/7; 20 (4): 640-5. (ÎŒËŒŞŽŸ1: 1Á‰ťŠí“ŕ)

110075. [Œ´’˜] Surveillance for dysplasia in patients with ulcerative colitis: Discrepancy between guidelines and practice. Shinozaki M, Kobayashi K1,2, Kunisaki R, Hisamatsu T, Naganuma M, Takahashi KI, Iwao Y, Suzuki Y, Watanabe M, Itabashi M, Torii A, Takazoe M, Sugita A: Dig Endosc 2017/7; 29 (5): 584-93. (Ź—ѐ´“T1,2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ)

110076. [Œ´’˜] Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone. Hamada C, Yamada Y, Azuma M1, Nishikawa K, Gotoh M, Bando H, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hyodo I: Int J Clin Oncol 2016/8; 21 (4): 668-75. (“Œ@’q1: 1Á‰ťŠí“ŕ)

110077. [Œ´’˜] A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy. Yamauchi H1, Kida M1, Okuwaki K1, Miyazawa S1, Iwai T1, Imaizumi H1, Eiji M1, Hasegawa R1, Koizumi W1: Dig Dis Sci 2016/8; 61 (8): 2436-41. (ŽR“ŕ_Žj1, –Ř“cŒőL1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110078. [Œ´’˜] Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002). Ishido K1,2, Higuchi K1,2, Azuma M1,2, Sasaki T1,2, Tanabe S1,3, Katada C1,2, Yano T1,2, Wada T1,2, Koizumi W1,2 (1Kitasato Digestive Disease & Oncology Group): Anticancer Drugs 2016/10; 27 (9): 884-90. (ÎŒËŒŞŽŸ1,2, ”óŒűŸ•F1,2, “Œ@’q1,2, ˛X–Ř“O1,2, “c糁@‘1,3, Œ˜“ce—˜1,2, –î–ě‹MŽj1,2, ˜a“c‘ń–ç1,2, Źň˜aŽO˜Y1,2: 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

110079. [Œ´’˜] Superparamagnetic iron oxide-enhanced magnetic resonance imaging is useful in predicting malignant potential of vascular transformation of hypointense hypovascular nodules on gadoxetic acid-enhanced magnetic resonance imaging. Tanaka Y1, Nakazawa T1, Inoue T1, Yamane K1, Kubota K1, Uojima H1, Takada J1, Okuwaki Y1, Hidaka H1, Shibuya A2, Kokubu S3, Matsunaga K4, Koizumi W1: Hepatol Res 2017/10; 47 (11): 1118-26. (“c’†ŒŤ–ž1, ’†ŕV‹MG1, ˆäă’qm1, ŽRŞŒhŽq1, ŒE“cK‰î1, ‹›“ˆ°‹I1, ‚“cŽ÷ˆę1, ‰œ˜e—T‰î1, “ú‚@‰›1, a’J–ž—˛2, š •Ş–ΔŽ3, ź‰iŒh“ń4, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—, 3V•S‡ƒP‹u‘‡•a‰@, 4•úŽËü (‰ć‘œ))

110080. [Œ´’˜] Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck. Katada C1, Yokoyama T, Yano T, Kaneko K, Oda I, Shimizu Y, Doyama H, Koike T, Takizawa K, Hirao M, Okada H, Yoshii T, Konishi K, Yamanouchi T, Tsuda T, Omori T, Kobayashi N, Shimoda T, Ochiai A, Amanuma Y, Ohashi S, Matsuda T, Ishikawa H, Yokoyama A, Muto M: Gastroenterology 2016/11; 151 (5): 860-869.e7. (Œ˜“ce—˜1: 1Á‰ťŠí“ŕ)

110081. [Œ´’˜] A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn's Disease Treated with Adalimumab or Infliximab. Yokoyama K1, Yamazaki K, Katafuchi M, Ferchichi S: Adv Ther 2016/11; 33 (11): 1947-63. (‰ĄŽR@ŒO1: 1Á‰ťŠí“ŕ)

110082. [Œ´’˜] Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H, Kunisaki R, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Ohtsuka K, Murakami K, Kobayashi K1,2, Iwao Y, Nagahori M, Iizuka B, Hata K, Igarashi M, Hirata I, Kudo SE, Matsumoto T, Ueno F, Watanabe G, Ikegami M, Ito Y, Oba K, Inoue E, Tomotsugu N, Takebayashi T, Sugihara K, Suzuki Y, Watanabe M, Hibi T3,4: Gastroenterology 2016/12; 151 (6): 1122-30. (Ź—ѐ´“T1,2, “ú”ä‹I•ś3,4: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@)

110083. [Œ´’˜] Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical Esophagus. Zenda S, Kojima T, Kato K, Izumi S, Ozawa T, Kiyota N, Katada C1, Tsushima T, Ito Y, Akimoto T, Hasegawa Y, Kanamaru M, Daiko H: Int J Radiat Oncol Biol Phys 2016/12; 96 (5): 976-84. (Œ˜“ce—˜1: 1Á‰ťŠí“ŕ)

110084. [Œ´’˜] Clinical implications of doubling time of gastrointestinal submucosal tumors. Koizumi S1, Kida M1, Yamauchi H1, Okuwaki K1, Iwai T1, Miyazawa S1, Takezawa M1, Imaizumi H1, Koizumi W1: World J Gastroenterol 2016/12; 22 (45): 10015-23. (ŹňŽüŽq1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Šâˆä’m‹v1, ‹{ŕVŽu˜N1, ’|ŕVŽO‘ăŽq1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110085. [Œ´’˜] Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Sunakawa Y, Cao S, Berger MD, Matsusaka S, Yang D, Zhang W, Ning Y, Parekh A, Stremitzer S, Mendez A, Okazaki S, Wakatsuki T, Azuma M1, Shimada K, Watanabe M, Koizumi W1, Wu AH, H-J Lenz: The Pharmacogenomics Journal 2017/1; 17 (1): 36-41. (“Œ@’q1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110086. [Œ´’˜] Colonoscopy Withdrawal Time and Adenoma Detection Rate: A Japanese Multicenter Analysis. Kawamura T, Oda Y, Kobayashi K1,2, Matsuda K, Kida M2, Tanaka K, Kawahara Y, Yokota I, Koizumi W2, Yasuda K, Tajiri H: Journal of Gastroenterology and Hepatology Research 2017/2; 6 (1): 2273-8. (Ź—ѐ´“T1,2, –Ř“cŒőL2, Źň˜aŽO˜Y2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ)

110087. [Œ´’˜] Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer. Ioka T, Komatsu Y, Mizuno N, Tsuji A, Ohkawa S, Tanaka M, Iguchi H, Ishiguro A, Kitano M, Satoh T, Yamaguchi T, Takeda K, Kida M1, Eguchi K, Ito T, Munakata M, Itoi T, Furuse J, Hamada C, Sakata Y: Br J Cancer 2017/2; 116 (4): 464-71. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

110088. [Œ´’˜] Validation study of a health risk appraisal model and endoscopic screening for early esophageal cancer in men in specialized hospitals. Kondo Y1, Katada C1, Tanabe S1,2, Wada T1, Ishido K1, Yano T1, Kawanishi N1, Furue Y1, Yamane S1, Suzuki M, Watanabe A1, Azuma M1, Moriya H3, Yamashita K3, Koizumi W1, Yokoyama A: Esophagus 2017/2; 14 (3): 235-40. (‹ß“Ą—Y‹I1, Œ˜“ce—˜1, “c糁@‘1,2, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, –î–ě‹MŽj1, ‰Íź“Ţ’ĂŽq1, ŒĂ]N–ž1, ŽRŞ‘‹IŽq1, “n粍WŽŻ1, “Œ@’q1, X’JGŒő3, ŽR‰şŒpŽj3, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č)

110089. [Œ´’˜] Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials. Takahari D, Mizusawa J, Koizumi W1, Hyodo I, Boku N: Gastric Cancer 2017/2. doi: 10.1007/s10120-017-0702-0. [Epub ahead of print] (Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110090. [Œ´’˜] Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study. Tanabe S1,2, Ishido K2, Matsumoto T, Kosaka T, Oda I, Suzuki H, Fujisaki J, Ono H, Kawata N, Oyama T, Takahashi A, Doyama H, Kobayashi M, Uedo N, Hamada K, Toyonaga T, Kawara F, Tanaka S, Yoshifuku Y: Gastric Cancer 2017/3; 20 (Suppl 1): 45-52. (“c糁@‘1,2, ÎŒËŒŞŽŸ2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

110091. [Œ´’˜] A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer. Nakayama N1,2, Ishido K2, Chin K, Nishimura K1,2, Azuma M2, Matsusaka S, Inokuchi Y1, Tanabe S2,3, Kumekawa Y, Koizumi W2: Gastric Cancer 2017/3; 20 (2): 350-7. (’†ŽR¸“T1,2, ÎŒËŒŞŽŸ2, ź‘ş@ŒŤ1,2, “Œ@’q2, “c糁@‘2,3, Źň˜aŽO˜Y2: 1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

110092. [Œ´’˜] Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites. Uojima H1,2, Kinbara T1, Hidaka H2, Sung JH1, Ichida M1, Tokoro S1, Masuda S1, Takizawa S1, Sasaki A1, Koizumi K1, Egashira H1, Kako M1 (1Department of Gastroenterology, Shonan Kamakura General Hospital): Hepatol Res 2017 /3; 47 (3): E14-21. (‹›“ˆ°‹I1,2, “ú‚@‰›2: 2Á‰ťŠí“ŕ)

110093. [Œ´’˜] Clinical Outcomes in Patients with Cancer of Unknown Primary Site Treated By Gastrointestinal Oncologists. Yamane S1, Katada C2, Tanabe S2,3, Azuma M2, Ishido K2, Yano T2, Wada T2, Watanabe A1, Kawanishi N1, Furue Y2, Kondo Y2, Komori S4, Ishiyama H4, Hayakawa K4, Koizumi W2: J Transl Int Med 2017/3; 5 (1): 58-63. (ŽRŞ‘‹IŽq1, Œ˜“ce—˜2, “c糁@‘2,3, “Œ@’q2, ÎŒËŒŞŽŸ2, –î–ě‹MŽj2, ˜a“c‘ń–ç2, “n糍WŽŻ1, ‰Íź“Ţ’ĂŽq1, ŒĂ]N–ž2, ‹ß“Ą—Y‹I2, ŹXłŽq4, ÎŽR”ŽžŠ4, ‘ě˜ad4, Źň˜aŽO˜Y2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 4•úŽËü (Žîá‡))

120006. [Œ´’˜] ŠĚŤ•‚Žî‚ɑ΂ˇ‚éƒgƒ‹ƒoƒvƒ^ƒ“‚Ě—˜”AŒř‰Ę‚ĆˆŔ‘SŤ. ‹›“ˆ°‹I1,2, ‰ęŒĂ@áÁ1 (1Ă“슙‘q‘‡•a‰@, 2Á‰ťŠí“ŕ): “ú–ĺ–Źˆł˜´iÇ‰ďŽ 2016/6; 22 (2): 152-8.

220003. [€Œ´’˜] äX_Œo“ŕ•Ş”ĺŽîᇂ̈ŤŤ“xf’f‚É‚¨‚Ż‚éEUS‚Ě—L—pŤ‚ĚŒŸ“˘. “n•Ó^ˆč1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2016/6; 88 (1): 78-9.

310002. [Ç—á•ń] Delayed perforation after endoscopic submucosal dissection for early gastric cancer: Clinical features and treatment. Yano T1, TanabeS1,2, Ishido K1, Azuma M1, Wada T1, Suzuki M1, Kawanishi N1, Yamane S1, Sasaki T1, Katada C1, Mikami T, Katada N3, Koizumi W1: World J Gastrointest Endosc 2016/4; 8 (8): 368-73. (–î–ě‹MŽj1, “c糁@‘1,2, ÎŒËŒŞŽŸ1, “Œ@’q1, ˜a“c‘ń–ç1, —é–ؐl1, ‰Íź“Ţ’ĂŽq1, ŽRŞ‘‹IŽq1, ˛X–Ř“O1, Œ˜“ce—˜1, •Đ“c‰Ä–ç3, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č)

310003. [Ç—á•ń] A case of thrombus of the descending aorta successfully diagnosed on preoperative endoscopic ultrasonography. Iwai T1, Kida M1, Kaneko T1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Imaizumi H1, Koizumi W1: J Med Ultrason (2001) 2016/7; 43 (3): 439-42. (Šâˆä’m‹v1, –Ř“cŒőL1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

310004. [Ç—á•ń] Closure of pancreatic intraductal papillary mucinous carcinoma-colonic fistula using an over-the-scope clip. Yamauchi H1, Kida M1, Miyata E1, Okuwaki K1, Kawagishi K1, Imaizumi H1, Koizumi W1: Endoscopy 2016/10; 48 (S 01): E315-6. (ŽR“ŕ_Žj1, –Ř“cŒőL1, ‹{“c‰pŽĄ1, ‰œ˜e‹ť‰î1, ěŠÝ‰Á“Ţ1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

310005. [Ç—á•ń] Pancreatic Fistula Extending into the Thigh Caused by the Rupture of an Intraductal Papillary Mucinous Adenoma of the Pancreas. Shimizu Y1, Imaizumi H2, Yamauchi H2, Okuwaki K2, Miyazawa S2, Iwai T2, Takezawa M2, Kida M2, Suzuki E3, Saegusa M3, Koizumi W2: Intern Med 2017/2; 56 (3): 307-13. (´…—T‹M1, Ąň@O2, ŽR“ŕ_Žj2, ‰œ˜e‹ť‰î2, ‹{ŕVŽu˜N2, Šâˆä’m‹v2, ’|ŕVŽO‘ăŽq2, –Ř“cŒőL2, —é–ŘƒGƒŠ“Ţ3, ŽOŽ}@M3, Źň˜aŽO˜Y2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3•a—)

320001. [Ç—á•ń] ƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ“ŽŽŹ’°‹ž‚đ—p‚˘‚˝’źÚ’_“š‹ž‚Ş—L—p‚Ĺ‚ ‚Á‚˝ˆÝ‘S“EŒă‘’_ŠÇŒ‹ÎÇ‚Ě1—á. ăŒ´ˆę”ż1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2016/6; 88 (1): 170-1.

320002. [Ç—á•ń] ’´‰š”g“ŕŽ‹‹ž‰şŒoˆÝŒoŠĚ“I‡sŤ”rÎp‚đs‚Á‚˝’_ŠÇ‹ó’°•Ť‡pŒăRoux-en-Y–@ÄŒš‚Ě1—á. ăŒ´ˆę”ż1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ‹ŕŽq@‹œ1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2017/1; 89 (1): 148-9.

510001. [‘ŕ] Endoscopic ultrasonography diagnosis of subepithelial lesions. Kida M1, Kawaguchi Y1, Miyata E1, Hasegawa R1, Kaneko T1, Yamauchi H1, Koizumi S1, Okuwaki K1, Miyazawa S1, Iwai T1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: Dig Endosc 2017/5; 29 (4): 431-43. (–Ř“cŒőL1, ěŒű—C•ă1,‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ‹e’nG•F1, “n粐^˛1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

521005. [‰đŕ]y“ŕŽ‹‹žŽč‹Z‚̉đŕ|—Տ°‚ĚƒRƒc‚ĆƒeƒNƒjƒbƒN|zƒ_ƒuƒ‹ƒXƒR[ƒvESD (ƒVƒ“ƒOƒ‹ƒgƒ‰ƒ“ƒXƒVƒXƒeƒ€) ‚ĚƒRƒc‚ĆƒeƒNƒjƒbƒN. “c糁@‘1,2, “Œ@’q2, ÎŒËŒŞŽŸ2, –î–ě‹MŽj2, ˜a“c‘ń–ç2, Œ˜“ce—˜2, ˛X–Ř“O2, Źň˜aŽO˜Y2 (2V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): ˆÝ‚Ş‚ńperspective 2017/3; 9 (1): 40-47.

522020. [uŔ]y“ÁW: ‘ĺ’°“ŕŽ‹‹ž‘}“ü–@|‰i‰“‚Ěƒe[ƒ}z‘˜_E‘ĺ’°“ŕŽ‹‹ž‘}“ü–@‚ĚŠî–{’mŽŻ. ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Á‰ťŠí“ŕŽ‹‹ž 2016/4; 28 (4): 516-23.

522021. [uŔ]y“ÁW: ‘ĺ’°“ŕŽ‹‹ž‘}“ü–@|‰i‰“‚Ěƒe[ƒ}zŠe˜_ [V‚ľ‚˘“ŕŽ‹‹ž‹@Ží‚đ—p‚˘‚˝‘}“ü‚ĚŽŔŰ]@‹É×Œa“ŕŽ‹‹ž: ƒIƒŠƒ“ƒpƒX. ˛“c”ü˜a1, Ź—ѐ´“T1,2, ěŠÝ‰Á“Ţ1, ‘剪ł•˝1, ‰ĄŽR@ŒO1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2016/4; 28 (4): 619-23.

522022. [uŔ]y“ÁW: Á‰ťŠÇŒeŽş‚ĚĹ‹ß‚Ě˜b‘čz\“ńŽw’°ŒeŽş‚ĆŠÖ˜AŽžŠł. Ąň@O1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2016/4; 31 (4): 399-404.

522023. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł@V‚ľ‚˘l‚Ś‚Š‚˝‚ÉŠî‚Ă‚­ŽŔ’nf—Ă‚ĚŽŔ‘Hz ŽĄ—Ă: ŽŔ’nˆă‰Ć‚Ş’m‚Á‚Ä‚¨‚­‚ׂŤŽĄ—Â̐i•ŕ‚Ć‚ť‚ĚŠˆ—p@’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚é5-ƒAƒ~ƒmƒTƒŠƒ`ƒ‹Ž_ťÜ. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): Medical Practice 2016/5; 33 (5): 777-80.

522024. [uŔ]y“ÁW: äXŠŕ‚̐f’f‚ĆŽĄ—Ă2016`2018z2. äXŠŕ‚̐f’f@(2) EUSf’fEEUS-FNA. –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ƒRƒ“ƒZƒ“ƒTƒXŠŕŽĄ—Ă 2016/7; 14 (2): 67-70.

522025. [uŔ]y“ÁW: ‘ĺ’°Žîᇁ|E‚˘ă‚°‚Š‚琸–§f’f‚܂ŁzŠe˜_ [ƒRƒ‰ƒ€]E‘ŠúŠŕ‚̐[’B“xf’f|EUS. Ź—ѐ´“T1,2, âV“Ą—FĆ1, ź–{ˆçG1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2016/9; 28 (9): 1489-95.

522026. [uŔ]y“ÁW: ‚˘‚í‚ä‚ég‘Šú‚ĚäXŠŕh|‚ť‚Ě”­ś‹@˜‚Ɛf’fz3. äXŠŕf’f‚ĚStrategy. –Ř“cŒőL1, ź–{‚–ž1, ‹{“c‰pŽĄ1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Šâˆä’m‹v1, Ąň@O1 (1Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2016/12; 31 (13): 1687-93.

522027. [uŔ]y“ÁW: ‚˘‚í‚ä‚ég‘Šú‚ĚäXŠŕh|‚ť‚Ě”­ś‹@˜‚Ɛf’fz4-3.g‘Šú‚ĚäXŠŕh‚̐f’f@(3) ’´‰š”g“ŕŽ‹‹ž‚É‚ć‚鑁ŠúäXŠŕ‚̐f’f. ‰œ˜e‹ť‰î1, ź–{‚–ž1, ŽR“ŕ_Žj1, Šâˆä’m‹v1, Ąň@O1, –Ř“cŒőL1 (1Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2016/12; 31 (13): 1713-20.

522028. [uŔ]yŽĺ‘č: \“ńŽw’°‚̏ă”琍Žîᇁz\“ńŽw’°”ń“ű“Ş•”Žîᇂɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚Ć‹ô”­Ç‚ĚŒťó. Ź–ě—T”V1, ŠLŁ@–ž, –ě’†@“N, ă“°•ś–ç, •˝ŕVr–ž, ŹŽRP’j, –L‰i‚Žj, “yŽRŽőŽu, Ź“c“‡T–ç, •˝ŕV‹ÓŒá, “c糁@‘2,3, ŽR–{ŽŒČ, ‹ŕŽq˜aO (1Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3Á‰ťŠí“ŕ): ˆÝ‚Ć’° 2016/11; 51 (12): 1585-92.

522029. [uŔ]yŽĺ‘čI: ‘ĺ’°Šŕf’f‚ĚĹ‘OüzIII. ’´‰š”g“ŕŽ‹‹ž|3D-EUS‚đŠÜ‚ß‚Ä. Ź—ѐ´“T1,2, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Źň˜aŽO˜Y1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/11; 69 (10): 463-70.

522030. [uŔ]y“ÁW: ’_ŠÇŒ‹Î‚ĚŽĄ—Áz6. EPLBD (“ŕŽ‹‹ž“I“ű“Ş‘ĺŒűŒaƒoƒ‹[ƒ“Šg’Łp) ‚É‚ć‚é’_ŠÇŒ‹Î‚ĚŽĄ—Ă. –Ř“cŒőL1, ěŒű—C•ă1, ź–{‚–ž1, ’ˇ’Jě—Í–ç1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1 (1Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2017/1; 32 (1): 41-8.

522031. [uŔ]y˜AÚ: EUS, EUS-FNAf’fEŽĄ—Á|Tips & Tricksz1. ă•”Á‰ťŠÇ•a•Ď‚ɑ΂ˇ‚éEUSf’f (1). –Ř“cŒőL1, ěŒű—C•ă1, ź–{‚–ž1, ’ˇ’Jě—Í–ç1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1 (1Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2017/1; 32 (1): 121-4.

522032. [uŔ]y“ÁW: ’°‰Š‚Ü‚é‚í‚Š‚čzŠe˜_@[‰ŠÇŤ’°ŽžŠł (IBDˆČŠO)]E”ń“ÁˆŮŤ‘˝”­ŤŹ’°’×ᇏÇ. Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2017/1; 29 (1): 60-4.

522033. [uŔ]y“ÁW: ’°‰Š‚Ü‚é‚í‚Š‚čzŠe˜_@[Š´őŤ’°‰Š]E’°ŠÇoŒŒŤ‘ĺ’°‹Ű’°‰Š. ˛“c”ü˜a1, Ź—ѐ´“T1,2, âV“Ą—FĆ1, ź–{ˆçG1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2017/1; 29 (1): 71-4.

522034. [uŔ]y“ÁW: ’°‰Š‚Ü‚é‚í‚Š‚čzŠe˜_@[ŒŒ—ŹáŠQ]E“Á”­Ť’°ŠÔ–ŒĂ–Źd‰ťÇ. ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2017/1; 29 (1): 108-11.

522035. [uŔ]y“ÁW: Á‰ťŠíŽîᇐŤŽžŠłŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“‚Ěƒ|ƒCƒ“ƒgzˆÝŠŕŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“‚É‚¨‚Ż‚鉝Šw—Ă–@‚ɂ‚˘‚Ä. “Œ@’q1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): Źl‚ƐśŠˆKŠľ•a 2017/2; 47 (2): 178-83.

540007. [‚ť‚Ě‘ź (’˛¸•ń)] –{–M‚É‚¨‚Ż‚é–ĺ–ŹŒŒđÇ‚ĚŽŔ‘Ô: ‘S‘ƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę‚ć‚č. Ź“ˆ´ˆę˜Y, “n•ÓŒMŽj, ź’Jłˆę, ‰—•Ű˜a•F, ‘ž“cł”V, Źň@~, š •Ş–ΔŽ1, ’†–ě@–Î, ’†‘şŒ’ŽĄ, ’†‘ş^ˆę, “čŒ´‹`”V, “ú‚@‰›1, ź–{Í•v, ‘ş“‡’źĆ, ŹŒ´Ÿ•q (1Á‰ťŠí“ŕ): “ú–ĺ–Źˆł˜´iÇ‰ďŽ 2016/6; 22 (2): 176-89.

540008. [‚ť‚Ě‘ź (Ž‘—ż)] Japan Endoscopy Database (JED) Project@‘ćˆęŠúƒgƒ‰ƒCƒAƒ‹ŽŔŽ{•ń‘. Ź“c“‡T–ç1, “c’†šl1,2, ź“c_“ń1,2, “ĄéŒőO, Ö“Ą@–L1,2, ‘ĺ’˘a˜N1, Ź“cˆę˜Y1, Œ˜“ce—˜1,3, ‰Á“Ął”V1, –Ř“cŒőL1,3, Ź—ѐ´“T1,4, •z‘܉ŽC1, –xź‚”Ž1, ź“cŽ‹v1, •“Ą@Šw1, ŽR–{”Ž“ż1, —Ç‘ňş–Á1, ŠâŘ—´ˆę2, ‹v’ĂŒŠO2, ‹{“c—TÍ2, ‰Á“ĄŒłŽk2, tŠÔ@ŒŤ2, “Ą–{ˆęáÁ2, ă‘ş’źŽŔ2, ăź‹I•v2, “cK‹v—Y2 (1MSED-J (Minimal Standard Endoscopic Database) ěŹŹˆĎˆő‰ď, 2Japan Endoscopy Database (JED) Project, 3Á‰ťŠí“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): GASTROENTEROLOGICAL ENDOSCOPY 2017/1; 59 (1): 91-101.

[’˜@‘]

620017. [Šwp‘ (•Ş’SŽˇ•M)]yÇ—á‚Š‚çŠw‚Ô“ŕ‰ČŽžŠł‚̐f’fEŽĄ—ĂƒsƒbƒgƒtƒH[ƒ‹ ( “ŕ‰Č2016”N4ŒŽ‘‘ĺ†)z‘ć2Í Á‰ťŠí@1. ˆÝ‚Ş‚ń, p.608-13. “c糁@‘1,2, ÎŒËŒŞŽŸ2, ‰Íź“Ţ’ĂŽq2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “ě]“°, “Œ‹ž, 2016/4”­s.

620018. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć1Í ‘˜_ (Šî‘b)@–â‘č5, 6, p.10-1. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620019. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć2Í ă•”Á‰ťŠÇ@–â‘č22, 23, p.99-102. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620020. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć3Í ‰ş•”Á‰ťŠÇ@–â‘č11, 12, p.175-8. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620021. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć3Í ‰ş•”Á‰ťŠÇ@–â‘č19, 20, p.192-5. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620022. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć3Í ‰ş•”Á‰ťŠÇ@–â‘č27, 28, p.208-11. ˛“c”ü˜a (Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620023. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć4Í ’_EäX@–â‘č9, 10, p.255-8. Ąň@O (Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620024. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć4Í ’_EäX@–â‘č21, 22, p.279-82. Ąň@O (Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620025. [Šwp‘ (•Ş’SŽˇ•M)]yˆÝŽžŠłƒAƒgƒ‰ƒX (Á‰ťŠí“ŕŽ‹‹ž28ŠŞ8ŒŽ‘‘ĺ†)zŠe˜_@II. •˝’R‚Č•a•Ď@Ç—áƒAƒgƒ‰ƒX@‘ŠúˆÝŠŕ (0-IIb, ”­Ô‚ľ‚˝•Ş‰ťŒ^‘BŠŕ), p.1252-3. “c糁@‘1,2, ÎŒËŒŞŽŸ2, ‰Íź“Ţ’ĂŽq2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/8”­s.

620026. [Šwp‘ (•Ş’SŽˇ•M)]yˆÝŽžŠłƒAƒgƒ‰ƒX (Á‰ťŠí“ŕŽ‹‹ž28ŠŞ8ŒŽ‘‘ĺ†)zŠe˜_@III. Š×‰š‚đ’悡‚é•a•Ď@Ç—áƒAƒgƒ‰ƒX@Ąă”琍E”ńŽîᇐŤ@ˆÝ”~“Ĺ (ˆÝ”~“Ĺ‚É”ş‚¤AGML—l•a•Ď), p.1274-5. ÎŒËŒŞŽŸ1, —é–ؐl1, “c糁@‘1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/8”­s.

620027. [Šwp‘ (•Ş’SŽˇ•M)]yƒNƒ[ƒ“•a‚̐f—ĂƒKƒCƒh ‘ć2”Łz‘ć11Í ŽĐ‰ďŽx‰‡, p.112-7. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), •Ň: NPO–@l“ú–{‰ŠÇŤ’°ŽžŠł‹Ś‰ď (CCFJ), •śŒő“°, “Œ‹ž, 2016/10”­s.

620028. [Šwp‘ (•Ş’SŽˇ•M)]yŠĚ‘Ÿę–ĺˆăƒeƒLƒXƒg (‰ü’ů‘ć2”Ĺ)z[ŽĄ—Ă‚Ć—\–h•Ň]@‘ćXVÍ –ĺ–Źˆł˜´iÇ‚ĚŽĄ—Á@1. H“š (ˆÝ) ƒoƒ‹[ƒ“ƒ^ƒ“ƒ|ƒi[ƒf‚É‚ć‚éŽ~ŒŒ, 2. H“š (ˆÝ) Ă–ŹáŽd‰ť—Ă–@ (EIS), 3. “ŕŽ‹‹ž“IH“šĂ–ŹáŽŒ‹ăFq (EVL), p.442-50. “ú‚@‰› (Á‰ťŠí“ŕ), •Ň: “ú–{ŠĚ‘ŸŠw‰ď, “ě]“°, “Œ‹ž, 2016/11”­s.

620029. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠí‚Ş‚ń‰ťŠw—Ă–@ƒŒƒWƒƒ“ƒuƒbƒN<‘ć3”Ĺ>zEˆÝ‚Ş‚ń@10. IRI + CDDP (biweekly), p.33-6. “Œ@’q (Á‰ťŠí“ŕ), •Ň: Žş@@Œ\, “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 2016/11”­s.

620030. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠí‚Ş‚ń‰ťŠw—Ă–@ƒŒƒWƒƒ“ƒuƒbƒN<‘ć3”Ĺ>zEˆÝ‚Ş‚ń@17. DOC + CDDP + S-1 (TS-1) [DCS; –k—˘KDOGƒŒƒWƒƒ“], p.60-2. “Œ@’q (Á‰ťŠí“ŕ), •Ň: Žş@@Œ\, “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 2016/11”­s.

620031. [Šwp‘ (•ŇWE•Ş’SŽˇ•M)]yƒ`[ƒ€ˆă—Âɂ‚Ȃ°‚é!@IBDf—ĂƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒgz‘ć2Í IBD‚Ƃ́@8) IBD‚Ě’ˇŠú—\Œă, 9) IBD‚Ě‚Ş‚ń‰ťEƒT[ƒxƒCƒ‰ƒ“ƒX@…@’×ᇐŤ‘ĺ’°‰Š, p.66-70. ‰ĄŽR@ŒO1 (1Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś2,3 (2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@), •Ň: ‰ĄŽR@ŒO1, ꎓĄ‰rŽq, VˆäŸ‘ĺ, ´…‘׊x, ‘O–{“Ä’j, ‚’Ă“TF, “ŕ–ě@Šî, ‘č—ćŽq, —r“yŽĐ, “Œ‹ž, 2016/11”­s.

620032. [Šwp‘ (•ŇWE•Ş’SŽˇ•M)]yƒ`[ƒ€ˆă—Âɂ‚Ȃ°‚é!@IBDf—ĂƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒgz‘ć4Í IBD‚Ě“ŕ‰ČŽĄ—Á@A l‚Ś•ű‚Ć’ˆÓ“_@3) “úíśŠˆ‚Ě’ˆÓŽ–€EŠ´ő—\–h, p.119-24. ‰ĄŽR@ŒO1, Îě‚Š‚¨‚č (1Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś2,3 (2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@), •Ň: ‰ĄŽR@ŒO1, ꎓĄ‰rŽq, VˆäŸ‘ĺ, ´…‘׊x, ‘O–{“Ä’j, ‚’Ă“TF, “ŕ–ě@Šî, ‘č—ćŽq, —r“yŽĐ, “Œ‹ž, 2016/11”­s.

620033. [Šwp‘ (•ŇWE•Ş’SŽˇ•M)]yƒ`[ƒ€ˆă—Âɂ‚Ȃ°‚é!@IBDf—ĂƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒgz‘ć4Í IBD‚Ě“ŕ‰ČŽĄ—Á@A l‚Ś•ű‚Ć’ˆÓ“_@4) ‚—îŽŇ‚ɑ΂ˇ‚él‚Ś•ű‚Ć’ˆÓ“_, p.125-7. ‰ĄŽR@ŒO1 (1Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś2,3 (2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@), •Ň: ‰ĄŽR@ŒO1, ꎓĄ‰rŽq, VˆäŸ‘ĺ, ´…‘׊x, ‘O–{“Ä’j, ‚’Ă“TF, “ŕ–ě@Šî, ‘č—ćŽq, —r“yŽĐ, “Œ‹ž, 2016/11”­s.

620034. [Šwp‘ (•ŇWE•Ş’SŽˇ•M)]yƒ`[ƒ€ˆă—Âɂ‚Ȃ°‚é!@IBDf—ĂƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒgz‘ć4Í IBD‚Ě“ŕ‰ČŽĄ—Á@B “ŕ‰ČŽĄ—Ă‚ĚŽŔŰ@7) RTNF-ƒżR‘̐ťÜ@…@RTNF-ƒżR‘̐ťÜ‚Ć‚Í, p.159-64. ‰ĄŽR@ŒO1 (1Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś2,3 (2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@), •Ň: ‰ĄŽR@ŒO1, ꎓĄ‰rŽq, VˆäŸ‘ĺ, ´…‘׊x, ‘O–{“Ä’j, ‚’Ă“TF, “ŕ–ě@Šî, ‘č—ćŽq, —r“yŽĐ, , “Œ‹ž, 2016/11”­s.

620035. [Šwp‘ (•ŇWE•Ş’SŽˇ•M)]yƒ`[ƒ€ˆă—Âɂ‚Ȃ°‚é!@IBDf—ĂƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒgz‘ć5Í IBD‚̐HŽ–E‰h—{—Ă–@@1) IBD‚É‚¨‚Ż‚éHŽ–E‰h—{—Ă–@‚̍l‚Ś•ű, p.182-4. ‰ĄŽR@ŒO1 (1Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś2,3 (2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@), •Ň: ‰ĄŽR@ŒO1, ꎓĄ‰rŽq, VˆäŸ‘ĺ, ´…‘׊x, ‘O–{“Ä’j, ‚’Ă“TF, “ŕ–ě@Šî, ‘č—ćŽq, —r“yŽĐ, , “Œ‹ž, 2016/11”­s.

620036. [Šwp‘ (•Ş’SŽˇ•M)]y’_äX“ŕŽ‹‹žŽŠ—RŽŠÝ`Šî–{Žč‹Z‚đŠw‚щž—p—Í‚đ‚‚Ż‚éW’†uŔ` (’_‚ĆäX37ŠŞ—ŐŽž‘Š§“Á‘ĺ†)zIV. Interventional EUS@äX‰źŤůN–EEWON‚Ě•a‘Ô‚ĆŽĄ—Ð헪|f’f, ŽĄ—Ă–@‘I‘đ, ƒ^ƒCƒ~ƒ“ƒO|, p.1411-8. –Ř“cŒőL1, ‹{“c‰pŽĄ1, Šâˆä’m‹v1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, ’|ŕVŽO‘ăŽq1, r–ؐł—Y1, ‹e’rG•F1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ), ˆăŠw}‘o”Ĺ, é‹Ę, 2016/11”­s.

620037. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠí“ŕŽ‹‹ž‚ĚŠî‘b’mŽŻ‚ĆŠî–{ƒeƒNƒjƒbƒN (Á‰ťŠí“ŕŽ‹‹ž3ŒŽ‘‘ĺ†)z‘˜_@“ŕŽ‹‹žf—Ă‚É‚¨‚Ż‚é’ÁĂ–@‚Əp’†EpŒăŠÇ—, p.321-6. “c糁@‘1,2, ÎŒËŒŞŽŸ2, ˜a“c‘ń–ç2, Œ˜“ce—˜2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2017/3”­s.

620038. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠí“ŕŽ‹‹ž‚ĚŠî‘b’mŽŻ‚ĆŠî–{ƒeƒNƒjƒbƒN (Á‰ťŠí“ŕŽ‹‹ž3ŒŽ‘‘ĺ†)zŠe˜_@I. ă•”Á‰ťŠÇ“ŕŽ‹‹ž@ă•”Á‰ťŠÇ“ŕŽ‹‹žŽ~ŒŒŽč‹Z, p.415-8. “c糁@‘1,2, –î–ě‹MŽj2, ‰Íź“Ţ’ĂŽq2, ŽRŞ‘‹IŽq2, “n粍WŽŻ2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

711001. [Šw‰ď (‘Ű)] (“Á•Ęu‰‰) Endoscopic management of Bilio-pancreatic diseases in patients with surgically altered anatomy. Kida M1, Yamauchi H1: T-CAP Tokyo Conference for Asian Pacific Bilio-Pancreatic Intervention Endoscopy (2016/6/20), Tokyo. (–Ř“cŒőL1, ŽR“ŕ_Žj1: 1Á‰ťŠí“ŕ)

712002. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) EUS Anatomy of Bilio]pancreatic System (Linear). Kida M1: ‘ä˜p“ŕŽ‹‹žŠw‰ďDEST (2016/8/6), Taipei, Taiwan. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712003. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Techniques of gastric EUS. Kida M1: Asian EUS Summit (2016/9/9), Seoul, Korea. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712004. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Basic Techniques and utilities of EUS mini probe in Diagnosis and management of UGI Neoplas. Kida M1: 2nd KKUH -AEG Endoscopic Ultrasound Course (2016/10/1), Riyadh, Saudi Arabia. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712005. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Basic Techniques and Utility of IDUS in biliopancreatic disease. Kida M1: 2nd KKUH-AEG Endoscopic Ultrasound Course (2016/10/2), Riyadh, Saudi Arabia. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712006. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Interventional EUS: current indications and therapeutic perspectives. Kida M1: EUS-ERCP Connection (2016/12/1), Turin, Italy. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712007. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Basic Principle of Radial EUS. Kida M1: Thailand Advanced EUS Workshop (2017/1/13), Bangkok, Thailand. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712008. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Hands-On training. Kida M1: World Endoscopy Organization AEG EUS Hands-On training (2017/2/17), Hyderabad, India. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712009. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Basic EUS anatomy-Radial and Linear Kida M1: The 6th APSDE Indochina regional Outreach training in Myanmar (2017/3/30), Naypyidaw, Myanmar. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712010. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Interventional EUS-Celiac Plexus Neurolysis and Biliary Drainage. Kida M1: The 6th APSDE Indochina regional Outreach training in Myanmar (2017/3/30), Naypyidaw, Myanmar. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712011. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Interventional EUS-Pseudocyst. Kida M1: The 6th APSDE Indochina regional Outreach training in Myanmar (2017/3/30), Naypyidaw, Myanmar. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

713009. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Diagnosis and Intervention with a Forward-viewing Echoendoscope. Iwai T1, Kida M1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Imaizumi H1, Koizumi W1: Asian Ultrasonic Medical Biology Society (AFSUMB) The 12th Academic Meeting (2016/5/28), Kyoto. (Šâˆä’m‹v1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

713010. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Usefulness of the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) for the Evaluation of Short-term Treatment Response. Kawagishi K1, Yokoyama K1, Kobayashi K1,2: AOCC 2016 (2016/7/9), Kyoto. (ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713011. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Clinical Role of Forward Viewing Echoendoscope for EUS-FNA especially " suction method with cap" for EUS-FNA of submucosal tumors. Miyata E1, Kaneko T1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Iwai T1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: ‘ć24‰ń‰˘BÁ‰ťŠí•aTŠÔ (2016/10/19), Vienna, Australia. (‹{“c‰pŽĄ1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ‹e’nG•F1, “n•Ó^ˆč1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

713012. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Effectiveness and Limitations of Cytapheresis in Patients with Ulcerative Colitis. Yokoyama K1, Kawagishi K1, Saito T1, Matsumoto Y1, Sada M1, Kobayashi K1,2, Koizumi W1: APDW2016 (2016/11/5), Kobe, Japan. (‰ĄŽR@ŒO1, ěŠÝ‰Á“Ţ1, âV“Ą’mĆ1, ź–{ˆçG1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713013. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Current Status of the Effectiveness of Infliximab in Patients with Ulcerative Colitis. Yokoyama K1, Kawagishi K1, Kobayashi K1,2, Koizumi W1: 12th Congress of European Crohn's and Colitis Organisation (2017/2/17), Spain. (‰ĄŽR@ŒO1, ěŠÝ‰Á“Ţ1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713014. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Clinical Characteristics of Patients who have Inflammatory Bowel Disease Associated with Hyperamylasemia and Pancreatitis. Kawagishi K1, Yokoyama K1, Sada M1, Kobayashi K1,2: The 12th Congress of ECCO (2017/2/17), Barcelona, Spain. (ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

722007. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Ą, ’×ᇐŤ‘ĺ’°‰Š‚É‹‚ß‚ç‚ę‚é‚ą‚Ć LCAP‚މž‚Ś‚ç‚ę‚é‚ą‚Ć. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘ć102‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2016/4/21), “Œ‹ž.

722008. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yIBDŠÖ˜AŽîᇂɑ΂ˇ‚é“ŕŽ‹‹žf—Ẩۑč‚ƏŤ—ˆ“W–]z’×ᇐŤ‘ĺ’°‰ŠŠÖ˜AŽîᇂ̐[’B“xf’f‚É‚¨‚Ż‚é’´‰š”g“ŕŽ‹‹ž‚Ě—L—pŤ. ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 473.

722009. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y“ŕŽ‹‹ž•Ş–ě‚É‚¨‚Ż‚éƒf[ƒ^ƒx[ƒX‚ĚŒťó‚Ć‚ť‚̉”\Ť: Japan Endoscopy Database (JED) Project‚𒆐S‚Ć‚ľ‚āzJapan Endoscopy Database (JED) Project‚ĚŒťó‚ƍĄŒă‚̉ۑč: “Şčň•”EH“š—Ěˆć‚ɂ‚˘‚Ä. –xź‚”Ž1, Œ˜“ce—˜2, •“Ą@Šw1 (1‹ž“s‘ĺŠw‘ĺŠw‰@ˆăŠwŒ¤‹†‰ČŽîᇖň•¨ŽĄ—ĂŠw, 2Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 512.

722010. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y“ŕŽ‹‹ž•Ş–ě‚É‚¨‚Ż‚éƒf[ƒ^ƒx[ƒX‚ĚŒťó‚Ć‚ť‚̉”\Ť: Japan Endoscopy Database (JED) Project‚𒆐S‚Ć‚ľ‚āz’_äX“ŕŽ‹‹ž•Ş–ě‚É‚¨‚Ż‚é‘ć1ŠúJapan Endoscopy Database (JED) ƒvƒƒWƒFƒNƒg‚ĚŠˆ“Ž•ń. ‰Á“Ął”V1, —Ç‘ňş–Á2, –Ř“cŒőL3 (1“Œ‹žŽœŒb‰ďˆă‰Č‘ĺŠwŠ‹üˆă—ĂƒZƒ“ƒ^[, 2é‹Ęˆă‰Č‘ĺŠw‘Űˆă—ĂƒZƒ“ƒ^[, 3Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 513.

722011. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y’´‰š”g“ŕŽ‹‹žEUS/EUS-FNAf’f‚̐i•ŕzˆÝ”S–Œ‰şŽîᇂɑ΂ˇ‚éEchoTipUltraj‚ĆProCorej‚Ě”äŠr. Šâˆä’m‹v1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 559.

722012. [Šw‰ď (‘S‘)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv) ă•”Á‰ťŠÇEMR/ESD‚Ě‰Ű‘čŽ•ž‚ƐV‚˝‚Č“WŠJ ‘ŠúˆÝŠŕ‚É‚¨‚Ż‚éESDŽĄ—͢“ďÇ—á‚ɑ΂ˇ‚éƒ_ƒuƒ‹ƒXƒR[ƒvESD‚Ě—L—pŤ. –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, “c糁@‘1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 601.

722013. [Šw‰ď (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“) ’†‰ş•”ˆŤŤ’_“š‹ˇó‚ɑ΂ˇ‚éLow axial force covered self-expandable metallic stent‚ĚŽg—pŹŃ. “n•Ó^ˆč1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ‹{ŕVŽu˜N1, ŽR“ŕ_Žj1, Ąň@O1, Šâˆä’m‹v1, ‹ŕŽq@‹œ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, “n•Ó–€–ç1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 610.

722014. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)y‘ĺ’°ŒŸ¸modality‚̍ŐVî•ńz’´‰š”g“ŕŽ‹‹ž|3D-EUS‚đŠÜ‚ß‚Ä. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): “ú–{‘ĺ’°ăč–ĺ•aŠw‰ď‘ć25‰ń‹łˆçƒZƒ~ƒi[ (2016/5/22), “Œ‹ž.

722015. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Diagnosis and Intervention with a Forward-viewing Echoendoscope. Šâˆä’m‹v1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{’´‰š”gˆăŠw‰ď /Ultrasonic Week 2016 (2016/5/28), ‹ž“s.

722016. [Šw‰ď (‘S‘)] (‡“Żƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) yƒVƒƒƒ“ƒgŤŠĚŤ”]ÇzŠĚŤ”]Ç‚ɑ΂ˇ‚éB-RTO‚ĚŽĄ—ĂŒř‰Ę, ‹ô”­Ç, ŠĚ—\”ő”\‚̐„ˆÚ. “c’†ŒŤ–ž1, “ú‚@‰›1, ’†ŕV‹MG1, ŒE“cK‰î1, ŽRŞŒhŽq2, ˆäă’qm2, ‹›“ˆ°‹I1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2016/9/9-10), _ŒË, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 87.

722017. [Šw‰ď (‘S‘)] (‡“Żƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y“Ť‹šE• …: ŽĄ—Ă–@‚Ě•]‰żz• …‡•š”ń‘㏾ŤŠĚd•Ď‚É‚¨‚Ż‚éƒgƒ‹ƒoƒvƒ^ƒ““Š—^Œă‚Ě”A’†ƒiƒgƒŠƒEƒ€”rŸ•—Ę‚ĆŽŠ—R…ƒNƒŠƒAƒ‰ƒ“ƒX‚̕ωť. ‹›“ˆ°‹I1, “ú‚@‰›1, ˆäă’qm2, ŽRŞŒhŽq2, ŒE“cK‰î1, “c’†ŒŤ–ž1, ’†ŕV‹MG1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2016/9/10), _ŒË, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 97.

722018. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) RŒŒđ—Ă–@‰ş‚É‚¨‚Ż‚éÁ‰ťŠÇŠQ‚Ć“ŕŽ‹‹žf—Ăƒ}ƒl[ƒWƒƒ“ƒg. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć52‰ń“ú–{’_“šŠw‰ďŠwpW‰ď (2016/9/29), V‰Ą•l.

722019. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBD‰ć‘œf’fƒ[ƒNƒVƒ‡ƒbƒvzŠˆ“ŽŠú’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚éUlcerative colitis Endoscopic index of severity‚Ě—L—pŤ. ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć34‰ń“ú–{‘ĺ’°ŒŸ¸Šw‰ď‘‰ď (2016/10/7-8), “Œ‹ž, “ú–{‘ĺ’°ŒŸ¸Šw‰ďŽGŽ 2016; 32 (2): 127.

722020. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’×ᇐŤ‘ĺ’°‰Š’ˇŠúŒo‰ß—á‚É‚¨‚Ż‚éŽîᇃ}[ƒJ[‘Ş’č‚ĚˆÓ‹`. ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć34‰ń“ú–{‘ĺ’°ŒŸ¸Šw‰ď‘‰ď (2016/10/8), “Œ‹ž.

722021. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“2: ”S–ŒŽĄ–ü‚đ–ÚŽw‚ľ‚˝IBD‚ĚŽĄ—Ð헪zŠˆ“ŽŠú’×ᇐŤ‘ĺ’°‰Š‚ĚŽĄ—ĂŒř‰Ę”ť’č‚É—L—p‚Č“ŕŽ‹‹žƒXƒRƒA‚Ć‚Í? ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): JDDW2016 (2016/11/3), _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/9; 113: A504.

722022. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“6: ‘ĺ’°“ŕŽ‹‹žŒŸf‚̐¸“xŠÇ—z‘ĺ’°“ŕŽ‹‹ž”˛‹ŽŽžŠÔ‚Í–{–M‚É‚¨‚˘‚Ä‚ŕQuality indicator‚ɂȂ肤‚é‚Š? ‰Í‘ş‘ě“ń1, Ź—ѐ´“T2, ”ö“c@‹ą3 (1‹ž“s‘ć“ńÔ\Žš•a‰@, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3”ö“cˆÝ’°“ŕ‰Č): JDDW2016 (2016/11/3), _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/9; 113: A521.

722023. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–ĺ–Źˆł˜´iÇ‚ĚŽĄ—Ă‚Ě“K‰ž‚ĆŽŠ“Kƒ^ƒCƒ~ƒ“ƒOzƒAƒ“ƒ`ƒgƒƒ“ƒrƒ“III (AT-III) ’ቺ‚𔺂¤–ĺ–ŹŒŒđŠłŽŇ‚ɑ΂ˇ‚éAT-IIIťÜ“Š—^‚Ě—L—pŤ‚ĆˆŔ‘SŤ‚ĚŒŸ“˘. “ú‚@‰›1, ‰œ˜e—T‰î1, š •Ş–ΔŽ1,2 (1Á‰ťŠí“ŕ, 2V•S‡ƒ–‹u‘‡•a‰@): JDDW2016 (2016/11/4), _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/9; 113: A516.

722024. [Šw‰ď (‘S‘)] (ƒƒfƒBƒJƒ‹ƒXƒ^ƒbƒtƒvƒƒOƒ‰ƒ€) y‘‚Ś‘ą‚Ż‚鉊ÇŤ’°ŽžŠłŠłŽŇzƒ`[ƒ€ˆă—Ă‚Ě•K—vŤ. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): JDDW2016 (2016/11/5), _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/9; 113: A521.

722025. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) “IŠm‚Č•a‘Ô”cˆŹ‚Š‚ç‚̉ŠÇŤ’°ŽžŠłŽĄ—Ă‚ĚĹ“K‰ť. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ŽOd, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/10; 69: A10.

722026. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) Crohn•aś•¨Šw“IťÜna•ve—á‚É‚¨‚Ż‚é—Տ°“IŒŸ“˘. ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ŽOd, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/10; 69: A32.

722027. [Šw‰ď (‘S‘)] (ƒRƒAƒVƒ“ƒ|ƒWƒEƒ€) H“šG•˝ă”çŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—ĂŒă’ljÁ‰ťŠw•úŽËü—Ă–@‚Ě‘Ă“–Ť‚ĚŒŸ“˘. ˜a“c‘ń–ç1, Œ˜“ce—˜1, “c糁@‘1,2, ÎŒËŒŞŽŸ1, –î–ě‹MŽj1, “Œ@’q1, ŹXłŽq3, X’JGŒő4, ŽR‰şŒpŽj4, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3•úŽËü (Žîá‡), 4ŠO‰Č): ‘ć13‰ń“ú–{Á‰ťŠÇŠw‰ď‘‰ďŠwpW‰ď (2017/2/17), –źŒĂ‰Ž.

722028. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate`5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š`. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć13‰ń“ú–{Á‰ťŠÇŠw‰ď‘‰ďŠwpW‰ď (2017/2/18), –źŒĂ‰Ž.

723110. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) cStage 0/IA‚̐H“šG•˝ă”çŠŕ‚ɑ΂ˇ‚éWŠw“IŽĄ—Ă‚Ě‘k‹y“IŒŸ“˘. ˜a“c‘ń–ç1, Œ˜“ce—˜1, ÎŒËŒŞŽŸ1, “Œ@’q1, ˛X–Ř“O1, –î–ě‹MŽj1, X’JGŒő2, ŽR‰şŒpŽj2, ŹXłŽq3, “c糁@‘1,4, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ŠO‰Č, 3•úŽËü (Žîá‡), 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć102‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2016/4/21), “Œ‹ž, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 113 (—Ő‘‘‰ď): A247.

723111. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚錌‹…Ź•Ş‹z’…œ‹Ž—Ă–@‚ĚĹ‹ß‚ĚŽĄ—ÐŹŃ‚Š‚ç‚Ý‚˝V‚˝‚ČˆĘ’u‚Ă‚Ż. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘ć102‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2016/4/23), “Œ‹ž, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 113 (—Ő‘‘‰ď): A321.

723112. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠĚ‘gD‚Š‚çNASHŠĚŠŕ‚̍‚ŠëŒŻŒQ‚đ”@‰˝‚É’Šo‚ˇ‚é‚Š. ‘ĺ•”@˝1, ’†ŕV‹MG2, “ú‚@‰›2, ŒGŒł—Y‰î3 (1ˆă—ÉqśŠw•”, 2Á‰ťŠí“ŕ, 3ŠO‰Č): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12), ĺ‘ä, “ú–{•a—Šw‰ď‰ďŽ 2016/4; 105 (1): 382.

723113. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) úŽh—pƒoƒ‹[ƒ“•t‚ŤƒI[ƒo[ƒ`ƒ…[ƒu‚É‚ć‚é“ŕŽ‹‹ž•â•‰şŒo”çŒoH“šˆÝŠÇ‘}“üp (PTEG) ‚ĚŒoŒą. ‘şă‹§l1, ź–ěŒ\ˆę˜Y, ‘şădl, Šâ­Šě‹vŒb, X@Œö‰î, ‘şă–}•˝, “Œ@’q2, “c糁@‘2,3, –Ř“cŒőL2, Źň˜aŽO˜Y2 (1‘şă‹L”O•a‰@“ŕ‰Č, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 630.

723114. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) H“šĂ–ŹáŽ‚ɑ΂ˇ‚éEVLŽĄ—Ă‘OŒă‚Ĺ‚Ě, H“šˆÝ•Ť‡•”‚ĚpH’l‚Ě•Ď“Ž‚ÉŠÖ‚ˇ‚錤‹†. “ú‚@‰›1, “c糁@‘1,2, ŒE“cK‰î1, ˆäă’qm1, ŽRŞŒhŽq1, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, ‰œ˜e—T‰î1, ’†ŕV‹MG1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ˆă—ĂŠÇ—): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 640.

723115. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) 80ÎˆČă‚̍‚—îŽŇ‚Ě‘’_ŠÇŒ‹ÎÇ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Â̐ŹŃ‚ĆˆŔ‘SŤ. ăŒ´ˆę”ż1, ŽR“ŕ_Žj1, –Ř“cŒőL1, ěŒű—C•ă1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 650.

723116. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) äXŠŕ‚̏p‘O•a—f’f‚Ć‚ľ‚Ä‚ĚäX‰t×–Ef‚̐ŹŃ. Ą’JŠ°ˆČ1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, ‹ŕŽq@‹œ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, “n•Ó–€–ç1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 705.

723117. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Pancreatic fluid collection‚ɑ΂ˇ‚é’´‰š”g“ŕŽ‹‹ž‰şá‘EŒ`Źp‚Ĺ‚Ě‡•šÇ‚Ć‚ť‚Ě‘Îô. ‹ŕŽq@‹œ1, Ąň@O1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1 (1Á‰ťŠí“ŕ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 709.

723118. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŒ´‚Ć”A’†ƒiƒgƒŠƒEƒ€”Z“x‚Š‚猊‚˝ƒgƒ‹ƒoƒvƒ^ƒ“‚Ě‘Šú“ą“üˆÓ‹`. “ú‚@‰›1, ‚“cŽ÷ˆę1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć52‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2016/5/20), ç—t, ŠĚ‘Ÿ 2016/4; 57 (Suppl 1): A290.

723119. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) NS5—ĚˆćƒAƒ~ƒmŽ_–쐜Œ^CŒ^–ŤŠĚ‰ŠÇ—á‚ɑ΂ˇ‚éƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹EƒAƒXƒiƒvƒŒƒrƒ‹•š—p—Ă–@‚É‚¨‚Ż‚ébreakthroughÇ—á‚ĚŒŸ“˘. ŽRŞŒhŽq1, ’†ŕV‹MG2, “ú‚@‰›2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ): ‘ć52‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2016/5/20), ç—t. ŠĚ‘Ÿ 2016/4; 57 (Suppl 1): A314.

723120. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) CŒ^–ŤŠĚŽžŠłÇ—á‚ɑ΂ˇ‚éƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹EƒAƒXƒiƒvƒŒƒrƒ‹•š—p—Ă–@‚É‚¨‚Ż‚éSVR24Ç—á‚ĚFIB4index‚ĚŒŸ“˘. ŒE“cK‰î1, ’†ŕV‹MG1, ŽRŞŒhŽq2, “ú‚@‰›1, a’J–ž—˛1,3, ‰œ˜e—T‰î1, “c’†ŒŤ–ž1, ‚“cŽ÷ˆę1, ˆäă’qm2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć52‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2016/5/20), ç—t. ŠĚ‘Ÿ 2016/4; 57 (Suppl 1): A321.

723121. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) CŒ^–ŤŠĚ‰ŠÇ—á‚ɑ΂ˇ‚éƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹ (DCV)EƒAƒXƒiƒvƒŒƒrƒ‹ (ASV) •š—p—Ă–@‚É‚¨‚Ż‚ébreakthroughÇ—á‚ĚŒŸ“˘. ŽRŞŒhŽq1, ’†ŕV‹MG2, ŒE“cK‰î2, ˆäă’qm1, ‹›“ˆ°‹I2, “c’†ŒŤ–ž2, ‚“cŽ÷ˆę2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–ž—˛2,3, Źň˜aŽO˜Y2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3ˆă—ĂŠÇ—): ‘ć52‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2016/5/20), ç—t.

723122. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)u–ĺ–Źˆł˜´iÇvĂ–ŹáŽ‚ɑ΂ˇ‚éIVR‚ĚŒťó‚Ć‚ą‚ę‚Š‚ç`–{–M‚É‚¨‚Ż‚éŒÇ—§ŤˆÝĂ–ŹáŽ‚ɑ΂ˇ‚éBRTO`ˆăŽtŽĺ“ąŽĄŒą‚đŒo‚Ä. š •Ş–ΔŽ1,2, Ź‘ě‰ë•v, œA“cČŽO, ź“c“TŽj, Źň@~, “ú‚@‰›2, Ž“c@’q, •Ű–{@‘ě, ˆŔ“ŒKŒb, “c’†‹IŽq, “c“‡@‹­ (1V•S‡ƒ–‹u‘‡•a‰@ŠĚŽžŠł’áNPŽĄ—ĂƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć45‰ń“ú–{IVRŠw‰ď‘‰ď (2016/5/26-28), –źŒĂ‰Ž, IVR: Interventional Radiology 2016/4; 31 (Suppl): 90.

723123. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žó—e‘ĚŠˆŤ’˛ß’`”’1 (RAMP1) Žó—e‘ĚƒVƒOƒiƒ‹‚É‚ć‚éŠĚ‰Š§Œä‹@\. ˆäă’qm1, ˆÉ“Ą‹`–ç2, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 3–ň—): ‘ć37‰ń“ú–{‰ŠÇÄśˆăŠw‰ď (2016/6/15), ‹ž“s.

723124. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ESD + —\–h“ICRT‚É‚ć‚č, H“š•\ÝŠŕŽĄ—Ă‚Í•Ď‚í‚é‚Š?|–ŹŠÇNPE”S–Œ‰ş‘wZ‚𔺂¤“ŕŽ‹‹žŘœ—á‚ɑ΂ˇ‚é’ljÁ‰ťŠw•úŽËü—Ă–@‚Ě—Ő°“I‘Ă“–Ť|. ˜a“c‘ń–ç1, Œ˜“ce—˜1, “c糁@‘1,2, ÎŒËŒŞŽŸ1, “Œ@’q1, –î–ě‹MŽj1, ŹXłŽq3, X’JGŒő4, ŽR‰şŒpŽj4, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3•úŽËü (Žîá‡), 4ŠO‰Č): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/4-6), “Œ‹ž,

723125. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) äXŠÇ“ŕ“ű“Ş”S‰tŤŽîᇎw“E4”NŒă‚ÉäXŠŕ‚Ş”­ŒŠ‚ł‚ę‚˝1—á. ŒN’ˈč‘ă1, ‘“ăçť1, ăŒű‰ŔŽq1, â–{˜a‘ă1, ŹňŽüŽq2, ’|ŕVŽO‘ăŽq2, Ź™—Œb3, ‘şă‰ë”ü3, Ź—ѐ´“T2,4, ‰Ş“c@ƒ5 (1“Œ•a‰@Œ’N‰ČŠwƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ, 3zŠÂŠí“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 5–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@): ‘ć57‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ď (2016/7/29), ’ˇ–ě, lŠÔƒhƒbƒN 2016/7; 31 (2): 330.

723126. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) 5-Fluorouracil‹NˆöŤÁ‰ťŠÇ”S–ŒŠQ‚ɑ΂ˇ‚鐏•Ş‰h—{Ü‚Ě–hŒä“I–đŠ„. “n@—D1, ě“‡@—í2, ěă•ś‹M2, ÎŒ´˜a•F3, ŒÜäzsM4, Žsě‘¸•ś2 (1Á‰ťŠí“ŕ, 2ˆă—ÉqśŠw•”, 3–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@, 4ś‰ť): ‘ć44‰ń“ú–{’×ᇊw‰ď (2016/9/2), ˆŽě.

723127. [Šw‰ď (‘S‘)] (ƒfƒWƒ^ƒ‹ƒ|ƒXƒ^[) “–‹łŽş‚ĚTS1äXŠŕ‚̐ŹŃ‚ƏŹäXŠŕ”­ŒŠ‚Ě‚˝‚߂̐f’fƒXƒgƒ‰ƒeƒW[‚É‚¨‚Ż‚é“ŕŽ‹‹ž‚Ě–đŠ„. ź–{‚–ž1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): JDDW2016 (2016/11/3), _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/9; 113: A687.

723128. [Šw‰ď (‘S‘)] (ƒfƒWƒ^ƒ‹ƒ|ƒXƒ^[) Genotype2Œ^CŒ^–ŤŠĚ‰Š‚ɑ΂ˇ‚éƒ\ƒzƒXƒuƒrƒ‹/ƒŠƒoƒrƒŠƒ“•š—p—Ă–@‚ĚŽĄ—ĂŒř‰Ę‚ĆˆŔ‘SŤ. ě–ěšć’ˆ1, “c’†ŒŤ–ž1, ’†ŕV‹MG1, ‚“cŽ÷ˆę1, ŒE“cK‰î1, ŽRŞŒhŽq2, ˆäă’qm2, “ě–ě@•×1, ‰œ˜e—T‰î1, “n粐^˛1, “ú‚@‰›1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): JDDW2016 (2016/11/4), _ŒË, ŠĚ‘Ÿ 2016/9; 57 (Suppl 2): A575.

723129. [Šw‰ď (‘S‘)] (ƒfƒWƒ^ƒ‹ƒ|ƒXƒ^[) “ŕŽ‹‹ž“IƒlƒNƒƒ[ƒNƒgƒ~[‚̍H•v‚ĆŽĄ—ÐŹŃ. Šâˆä’m‹v1, –Ř“cŒőL1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): JDDW2016 (2016/11/5), _ŒË.

723130. [Šw‰ď (‘S‘)] (ƒfƒWƒ^ƒ‹ƒ|ƒXƒ^[) Patients with Infectious Colitis Suggestive of Inflammatory Bowel Disease. ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ‰Á“Ą@Ę1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): APDW 2016 (2016/11/5), _ŒË.

723131. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺ’°ESD‚É‚¨‚Ż‚éƒfƒBƒXƒ|[ƒUƒuƒ‹ƒXƒ‰ƒCƒfƒBƒ“ƒOƒ`ƒ…[ƒu‚ĚŽg—pŒoŒą. ź–{ˆçG1, ěŠÝ‰Á“Ţ1, âV“Ą—FĆ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ŽOd, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/10; 69: A61.

723132. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žs’†•a‰@‚É‚¨‚Ż‚é‘ĺ’°ESD‚ĚŽ{sŒoŒą. Œ}@”üK1, ’†–Ú“N•˝1, r–ؐł—Y1, –Š@Ž‹M1, ŽO“‡Fm1, ‹gŕV“Ţ’ĂŽq1, ˛“Œäm1, Î•N_1, ‘ş“c@“Œ1, •—ŠÔ‹Ĺ’j (1Á‰ťŠí“ŕ): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ŽOd, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/10; 69: A214.

723133. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) lŠÔƒhƒbƒNŽóf‚đŒ_‹@‚É”­ŒŠ‚ł‚ę‚˝t“ŽĂ–Źá‘‚Ěˆę—á. ‘“ăçť1, ŒN’ˈč‘ă1, â–{˜a‘ă1, ăŒű‰ŔŽq1, ˆüŽR‹IŽq1, Ź™—Œb2, “Œ–ě‹IŽq3, ‘şă‰ë”ü2, “ü]@•ś4, Ź—ѐ´“T4,5, ‰Ş“c@ƒ6 (1“Œ•a‰@Œ’N‰ČŠwƒZƒ“ƒ^[, 2zŠÂŠí“ŕ, 3äPŒ´•aEŠ´ő“ŕ, 4Á‰ťŠí“ŕ, 5V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 6–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@): “ú–{‘‡Œ’fˆăŠw‰ď‘ć45‰ń‘ĺ‰ď (2017/1/27), ç—t.

723134. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚écold polypectomy‚ĚˆŔ‘SŤ‚¨‚ć‚Ń—LŒřŤ‚ĚŒŸ“˘. âV“Ą—FĆ1, ěŠÝ‰Á“Ţ1, ź–{ˆçG1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1, ŽOŽ}@M3 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3•a—): ‘ć13‰ń“ú–{Á‰ťŠÇŠw‰ď‘‰ďŠwpW‰ď (2017/2/17), –źŒĂ‰Ž.

723135. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ŠúˆÝ‚Ş‚ń‚É‚¨‚Ż‚éESDŒăoŒŒ‚Ě“Á’Ľ. –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, “c糁@‘1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/9), L“‡, ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2017/3; p.371.

723136. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) isˆÝŠŕ, ‘ĺ’°“]ˆÚ‚Ě1—á. –Š@Ž‹M1, ‘ş“c@“Œ1, r–ؐł—Y1, Î•N_1, Œ}@”üK1, ˛“Œäm1, ‹gŕV“Ţ’ĂŽq1, ŽO“‡Fm1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/10), L“‡, ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2017/3; p.420.

723137. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺ’°LST—l‚ĚŒ`‘Ô‚đ’ć‚ľ‚˝‘ŠúˆÝŠŕpŒă‘˝”­‘ĺ’°“]ˆÚ‚Ěˆę—á. ‹v•Ű“c—z1, ˜a“c‘ń–ç1, “c糁@‘1,2, “Œ@’q1, ÎŒËŒŞŽŸ1, Œ˜“ce—˜1, –î–ě‹MŽj1, –ƒśŒ’ˆę˜N1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/10), L“‡, ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2017/3; p.515.

731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) LCAP‚Á‚Ä, ‚˘‚ÂŽg‚Ś‚Ηǂ˘‚Ĺ‚ˇ‚Š? ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ŽáŽč‚Ě‚Ý‚ń‚Č‚ĹUC‚ĚLCAP‚đl‚Ś‚é‰ďin•Ÿ‰Ş (2016/4/28), •Ÿ‰Ş.

731003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ŠÇŤ’°ŽžŠł‚É‚¨‚Ż‚鐜•¨Šw“IťÜ‚Ě“ÁŤ‚ɂ‚˘‚Ä. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): 6ŒŽ–ňŠw‡“ŻŒ¤C‰ď (2016/6/16), ‰Ą•l.

731004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éCAP—Ă–@`‚Ç‚¤‚â‚Á‚ÄŽg‚Á‚Ä‚Ü‚ˇ‚Š?`. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ŒQ”nƒjƒ…[ƒgƒŠƒVƒ‡ƒ“EƒAƒtƒFƒŒ[ƒVƒXIBDŒ¤‹†‰ď (2016/11/11), ‘O‹´.

731005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚̐f’f‚ĆŽĄ—Ă. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): é‹ĘŒ§•a‰@–ňÜŽt‰ď‘ć280‰ń•a‰@–ňŠwŒ¤C‰ď (2016/11/15), ‘ĺ‹{.

731006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) LCAP‚Á‚Ä‚˘‚ÂŽg‚Ś‚Ηǂ˘‚Ĺ‚ˇ‚Š? ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ç‘Ę–ŘUCu‰‰‰ď (2017/1/25), “Œ‹ž.

731007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚Ěup to date. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘ć268‰ń‘ĺ˜aŽsÁ‰ťŠí•aŒ¤‹†‰ď (¸“xŠÇ—ŒŸ“˘‰ď) (2017/2/10), ‘Š–ÍŒ´.

731008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate|5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ŠâŽčŒ§ƒŠƒAƒ‹ƒ_ů”­”„‹L”Ou‰‰‰ď (2017/2/15), ˇ‰Ş.

731009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate|5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ƒŠƒAƒ‹ƒ_”­”„‹L”Ou‰‰‰ď in “Ţ—Ç (2017/3/2), “Ţ—Ç.

731010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate|5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ƒŠƒAƒ‹ƒ_ů”­”„‹L”Ou‰‰‰ď (2017/3/14), Œú–Ř.

731011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěup to-date. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): Œ§“ěƒGƒŠƒA‰ŠÇŤ’°ŽžŠłŒ¤‹†‰ď (2017/3/24), ěŒű.

732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yH“š•\ÝŠŕ‚Ě“ŕŽ‹‹žf’f‚ĆŽĄ—Ă‚ĚŒť‹ľ‚Ć“W–]zH“š•\ÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“I‹zˆř”S–ŒŘœp (EAM) ‚Ć“ŕŽ‹‹ž“I”S–Œ‰ş‘w”—Łp (ESD) ‚ÉŠÖ‚ˇ‚錟“˘. ŒĂ]N–ž1, Œ˜“ce—˜1, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, “c糁@‘1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2016/6; 89 (Suppl): s87.

732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰ťŠí“ŕŽ‹‹žŽĄ—Ă‚É‚¨‚Ż‚éŠO‰Č‚Ć“ŕ‰Č‚ĚƒRƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“z• o‹ž“ŕŽ‹‹ž‡“ŻŽčp‚Ĺ“Eo‚ľ“ž‚˝‹‘ĺ–Ń”ŻˆÝÎ‚Ě1—á. •{‹M_1, “c糁@‘1,2, ’ˇ’Jě—Í–ç1, ÎŒËŒŞŽŸ1, X’JGŒő3 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/12), “Œ‹ž, Progress of Digestive Endoscopy 2016/6; 89 (Suppl): s95.

732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yäX’_“š“ŕŽ‹‹ž|ˆŔ‘S‚ĹŠmŽŔ‚ČŽĄ—Ă–@‚̍H•vzEUS‰ş’_ŠÇ\“ńŽw’°•Ť‡ (EUS-CDS) ‚É‚¨‚Ż‚é“–‰@‚Ĺ‚ĚH•v. ‹ŕŽq@‹œ1, –Ř“cŒőL1, Ąň@O1 (1Á‰ťŠí“ŕ): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/12), “Œ‹ž, Progress of Digestive Endoscopy 2016/6; 89 (Suppl): s99.

732010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‚˘‚E’N‚ށE‚Ç‚ą‚ŁE‚Ç‚¤‚â‚Á‚ÄACP‚đs‚¤‚Ě‚Š. ‰œ˜e‹ť‰î1, Ź–ě‘ňŽ , ‹ß“Ą‚Ü‚ä‚Ý2, ÷ˆä‚Č‚¨‚Ý, “c”¨Œ’ˆę3, ‘ě˜ad4 (1Á‰ťŠí“ŕ, 2ŠĹŒě•”, 3”ĺ”AŠí, 4•úŽËü (Žîá‡)): ‘ć31‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€ (2016/9/2), ‘Š–ÍŒ´.

732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠĚ•s‘SŽĄ—Â̐V‚˝‚Č“WŠJz”A’†ƒiƒgƒŠƒEƒ€”rŸ•—Ę‚đl—ś‚ľ‚˝• …‡•šŠĚd•Ď‚ɑ΂ˇ‚é—˜”AÜ‘I‘đ. ‹›“ˆ°‹I1, “ú‚@‰›1, ‹ŕŒ´@–Ň (1Á‰ťŠí“ŕ): ‘ć41‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď (2016/12/8), “Œ‹ž, ŠĚ‘Ÿ 2016/10; 57 (Suppl 3): A677.

732012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€)yˆô“ށEH“š—Ěˆć‚É‚¨‚Ż‚é‘˝”­ŠŕEd•ĄŠŕ‚̐f’f‚ĆŽĄ—Ă‚ĚŒť‹ľ|ˆô“ށEH“š—Ěˆć‚É‚¨‚Ż‚éˆŮŽžŤ‘˝”­ŠŕEd•ĄŠŕ‚̐f’f‚ĆŽĄ—ÁzJapan Esophageal Cohort study: JECŽŽŒą‚ĚŠĎ“_‚Š‚ç. Œ˜“ce—˜ (Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s79.

732013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv)yˆŤŤÁ‰ťŠÇ‹ˇó‚ɑ΂ˇ‚éƒXƒeƒ“ƒgŽĄ—Ă‚ĚƒRƒc‚Ćƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOz’_äXŠŕ‚É‚ć‚éˆŤŤˆÝ\“ńŽw’°‹ˇó‚ɑ΂ˇ‚éÁ‰ťŠÇƒXƒeƒ“ƒg—Ż’up‚Ě“–Ž{Ý‚É‚¨‚Ż‚éH•v. ˆŔ’B@‰ő1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s94.

732014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yäX’_“šŒ‹ÎÇ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚Ěƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOzˆÝŘœŒăRoux-en-Y–@ÄŒšŠłŽŇ‚ɑ΂ˇ‚éƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ“ŽŽŹ’°‹ž‚đ—p‚˘‚˝’_ŠÇŒ‹Îˆ’u˘“ď—á‚Ö‚ĚH•v. ŽR“ŕ_Žj1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s97.

732015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yäX’_“šŽžŠł‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IƒhƒŒƒi[ƒW‚ĚĹ‘OüzŠĚ–ĺ•”ˆŤŤ’_“š‹ˇó—á‚É‚¨‚Ż‚éside by side stenting‚̐ŹŃ. ‹ŕŽq@‹œ1, –Ř“cŒőL1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s102.

732016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒAƒ_ƒŠƒ€ƒ}ƒu‚É‚ć‚éƒNƒ[ƒ“•aŽĄ—Ă‚ĚŽŸ‚ĚˆęŽč. ‰ĄŽR ŒO (Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/18), “Œ‹ž.

732017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yÁ‰ťŠÇoŒŒ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽč‹Z‚̍H•v|RŒŒđ—Ă–@‚Ěƒ}ƒl[ƒWƒƒ“ƒg‚ŕŠÜ‚߂āz‘ĺ’°ŒeŽşoŒŒ‚Ě“ŕŽ‹‹žf’f‚ĆŽĄ—Ă. ź–{ˆçG1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/18), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s89.

732018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘ĺ’°Žîᇂ̐f’f‚É‚¨‚Ż‚郂ƒ_ƒŠƒeƒB[‚đl‚Ś‚é|‘ĺ’°Žîᇂ̐f’f‚É‚¨‚Ż‚éEUS‚Ě–đŠ„. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć16‰ń‘ĺ’°‰ć‘œƒAƒJƒfƒ~[ (CIA) (2017/1/14), “Œ‹ž.

732019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) IBDŽĄ—Ă–ň‚ĚŠî‘b’mŽŻ: ś•¨Šw“IťÜ. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘ć13‰ń IBD Schola (2017/3/5), “Œ‹ž.

733017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒXƒeƒƒCƒh—Ă–@‚Ş‘tŒř‚ľ‚˝ƒwƒmƒbƒzEƒVƒF[ƒ“ƒ‰ƒCƒ“Ž‡”Á•a‚Ě1—á. ŒE“cK‰î1, “ú‚@‰›1, Źň˜aŽO˜Y1, ‘ĺ–ě@—˛1, Ź–ěO“ń1 (1Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć623‰ńŠÖ“Œ’n•ű‰ď (2016/5/14), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď623‰ń´˜^EƒvƒƒOƒ‰ƒ€W 2016/5; p.20.

733018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚ÉŒ´”­Ťd‰ťŤ’_ŠÇ‰Š, ŠĚ“ŕ’_ŠÇŠŕ‚đ‡•š‚ľ‚˝1—á. ‰ŹŒ´šD1, ‰ĄŽR@ŒO 1, ‹{“c‰pŽĄ1, Ö“Ą—FĆ1, ěŠÝ‰Á“Ţ1, ‰œ˜e‹ť‰î1, ‚“cŽ÷ˆę1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć339‰ń“ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/5/21), “Œ‹ž.

733019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) NAFLD/NASH‚ĚĹ‹ß‚ĚŽĄ—Ă. ŽRŞŒhŽq1, ’†ŕV‹MG2, ŒE“cK‰î2, ˆäă’qm1, ‹›“ˆ°‹I2, “c’†ŒŤ–ž2, ‚“cŽ÷ˆę2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–ž—˛2,3, ‘ĺ•”@˝4, Źň˜aŽO˜Y2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3ˆă—ĂŠÇ—, 4ˆă—ÉqśŠw•”): ‘ć99‰ń‚ł‚Ş‚ÝƒŠƒo[ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/5/23), _“ސě.

733020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: PTEG‚đ‰î‚ľ‚˝NBƒ`ƒ…[ƒu‚É‚ć‚錸‰Š‚đs‚Á‚˝ˆę—á. “Œ@’q1, ‘şă‹§l, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć15‰ńPTEGŒ¤‹†‰ď (2016/5/28), ’W˜H“‡.

733021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éInfliximabŽĄ—Ă‚É‚¨‚Ż‚銰‰đ‚Ć‹x–ň‚ɂ‚˘‚Ä. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘ć4‰ńIBD’nˆć˜AŒg‚̉ď (2016/6/2), _“ސě.

733022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: “ž’B˘“ď‚Č’_“ŕŒ‹ÎÇ‚ɑ΂ľ‚ÄŒoˆÝŒoŠĚ“I‡sŤ”rÎp‚Ş—L—p‚Ĺ‚ ‚Á‚˝’_ŠÇ‹ó’°•Ť‡pŒăRoux-en-Y–@ÄŒš‚Ě1—á. ăŒ´ˆę”ż1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ěŒű—C•ă1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ‹ŕŽq@‹œ1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2016/6; 89 (Suppl): s106.

733023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’´‰š”g“ŕŽ‹‹ž‰şŒoˆÝŒoŠĚ“I‡sŤ”rÎp‚đs‚Á‚˝’_ŠÇ‹ó’°•Ť‡pŒăRoux-en-Y–@ÄŒš‚Ě1—á. ăŒ´ˆę”ż1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ‹ŕŽq@‹œ1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2016/12; 89 (1): 148.

733024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: ‘ĺ’°”S–Œ‰ş‘w”—Łp‚É‚ÄŞŽĄŘœ‚ľ‚˝’ź’°_Œo“ŕ•Ş”ĺŽîᇠ(NET) ‚Ě1—á. ě–ěšć’ˆ1, ˛“c”ü˜a1, ěŠÝ‰Á“Ţ1, ‘剪ł•˝1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1, Ť@˘ˆŽ3 (1Á‰ťŠí“ŕ‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3•a—): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2016/6; 89 (Suppl) s109.

733025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œo‰ß’†, ‘˝”­ŠĚEäBŒ‹ß‚̏oŒť‚É‚ć‚č“]ˆÚŤˆŤŤŽîᇂƂ̊ӕʂđ—v‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě1—á. ’†’JŞŒá1, “c’†ŒŤ–ž1, ’†ŕV‹MG1, ŒE“cK‰î1, ŽRŞŒhŽq2, ˆäă’qm2, ‹›“ˆ°‹I1, “ú‚@‰›1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć624‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/6/11), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď624‰ń´˜^EƒvƒƒOƒ‰ƒ€W 2016/6; p.26.

733026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚ÉŒ´”­Ťd‰ťŤ’_ŠÇ‰Š‚ĆŠĚ“ŕ’_ŠÇŠŕ‚đ‡•š‚ľ‚˝1—á. ‰ŹŒ´šD1, ‰ĄŽR@ŒO1, ‹{“c‰pŽĄ1, ěŠÝ‰Á“Ţ1, ‰œ˜e‹ť‰î1, ‚“cŽ÷ˆę1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć61‰ń_“ŢěŒ§Á‰ťŠí•aŒ¤‹†‰ď (2016/6/18), _“ސě.

733027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) • •”’´‰š”gŒŸ¸‚ɂĈݓŕ‚É”­ŒŠ‚ł‚ę‚˝‹‘ĺ‚Č”~Šą‚ľ‚ĚŽíŽq‚ɑ΂ľ“ŕŽ‹‹ž“I‚ɏœ‹Ž‚ľ‚˝1—á. ŠâčGˆę˜Y1, –î–ě‹MŽj1, “c糁@‘1,2, ‰Íź“Ţ’ĂŽq3, ŽRŞ‘‹IŽq3, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, “Œ@’q1, Œ˜“ce—˜1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć625‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/7/10), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď625‰ń´˜^EƒvƒƒOƒ‰ƒ€W 2016/6; p.30.

733028. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œo”çŒoH“šˆÝŠÇ‘}“üp (PTEG) ‚Ěƒ‹[ƒg‚đ‰ž—p‚ľŒo•@“I’_“šƒhƒŒƒi[ƒWƒ`ƒ…[ƒu‚É‚ć.‚錸‰Š‚đs‚Á‚˝ˆę—á. ‘şă‹§l, “Œ@’q1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć21‰ńPEGEÝ‘îˆă—ĂŒ¤‹†‰ďŠwpW‰ď (2016/9/3), ‚ź.

733029. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œ¤CˆăƒZƒbƒVƒ‡ƒ“: Stage IVˆÝŠŕ‚ɑ΂ľ‚ÄDCS—Ă–@‚Ş‘tŒ÷‚ľ, conversion surgery‚đŽ{s‚ľ‚˝1—á. “c糔ü“Ţ, “Œ@’q1, ˜a“c‘ń–ç1, –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, Œ˜“ce—˜1, “c糁@‘1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć25‰ńÁ‰ťŠíŽžŠł•a‘ÔŽĄ—ĂŒ¤‹†‰ď (2016/9/6), ‘O‹´.

733030. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) adalimumab—Ă–@’†‚ÉŒř‰ĘŒ¸Žă‚đ‚Ť‚˝‚ľ, ‰h—{—Ă–@‚Ş—LŒř‚Ĺ‚ ‚Á‚˝Crohn•a‚Ě1—á. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): _“ސěIBDƒtƒH[ƒ‰ƒ€ (2016/9/27), ‰Ą•l.

733031. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Řœ•s”\ˆŤŤŠĚ–ĺ•”’_ŠÇ‹ˇó‚ɑ΂ˇ‚éƒXƒeƒ“ƒeƒBƒ“ƒO. Šâˆä’m‹v (Á‰ťŠí“ŕ): ŠÖ“Œ’_äX“ŕŽ‹‹žƒtƒH[ƒ‰ƒ€ (2016/9/30), V‰Ą•l.

733032. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď) (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰Š“—á‚ɑ΂ľ‚Ä‚ĚŽĄ—Ă‘I‘đ. ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1 (1Á‰ťŠí“ŕ): ‘ć144‰ń‘Š–ÍŒ´ˆÝ‚Ć’°Œ¤‹†‰ď (2016/10/26), _“ސě.

733033. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠĚ•s‘SŽĄ—Â̐V‚˝‚Č“WŠJ ”A’†ƒiƒgƒŠƒEƒ€”rŸ•—Ę‚đl—ś‚ľ‚˝• …‡•šŠĚd•Ď‚ɑ΂ˇ‚é—˜”AÜ‘I‘đ. ‹›“ˆ°‹I1, “ú‚@‰›1, ‹ŕŒ´@–Ň (1Á‰ťŠí“ŕ): ‘ć41‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď (2016/12/8), “Œ‹ž.

733034. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 80%”Z“xƒqƒXƒgƒAƒNƒŠƒ‹‚đ—p‚˘‚˝“ŕŽ‹‹ž“IˆÝĂ–ŹáŽŽĄ—Ă–@ (‰ď‹c˜^). ‘ĺ‚Žjš1, “ú‚@‰›1, ŽRŞŒhŽq2, ˆäă’qm2, ‹›“ˆ°‹I1, ŒE“cK‰î1, “c’†ŒŤ–ž1, ’†ŕV‹MG1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć41‰ń“ú–{ŠĚ‘ŸŠw‰ď“Œ•”‰ď (2016/12/9), “Œ‹ž, ŠĚ‘Ÿ 2016; 57 (Suppl 3): A824.

733035. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: “–‰@‚É‚¨‚Ż‚é‘ĺ’°ˆŤŤ‹ˇó‚ɑ΂ˇ‚éŠÉ˜a–Ú“I‚Ě‘ĺ’°ƒXƒeƒ“ƒg—Ż’uÇ—á‚ĚŒŸ“˘. ‹ß“Ą—Y‹I1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, âV“Ą—FĆ1, ź–{ˆçG1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s111.

733036. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: p‘O[’B“xf’f‚ލ˘“ď‚Ĺ‚ ‚Á‚˝‘ŠúˆÝŠŕ‚Ě1—á. –kŒ´@Œž1, ˜a“c‘ń–ç1, –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, “Œ@’q1, Œ˜“ce—˜1, “c糁@‘1,2, ‘ş‰_–FŽ÷3 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3•a—): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s115.

733037. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: ERCP˘“ď‚ȏpŒăÄŒš’°ŠÇ—á‚ĚŠĚ“ŕŒ‹Î‚ɑ΂ľ‚ÄEUS‰ş‡sŤŽĄ—Ă‚ĹŠŽ‘SĚÎ‚đ“ž‚˝1—á. ’†’JŞŒá1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ăŒ´ˆę”ż1, Ą’JŠ°ˆČ1, ‹{“c‰pŽĄ1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s119.

733038. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: äXŠŕ‚ĆŠÓ•Ę˘“ď‚Ĺ‚ ‚Á‚˝ŽŠŒČ–ƉuŤäX‰Š‚Ěˆę—á. ”öă”üŒb1, ’ˇ’Jě—Í–ç1, •{‹M_1, ěŒű—S•ă1, ‘ĺ’ˏr˜a1, “cŒ´‹v”üŽq2, “n粐^˛1, –Ř“cŒőL1 (1Á‰ťŠí“ŕ, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[Á‰ťŠí“ŕ‰Č): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s121.

733039. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Ç—ጟ“˘ƒZƒbƒVƒ‡ƒ“: äX”X–EŤ•a•Ď‚Ě1—á. Šâˆä’m‹v (Á‰ťŠí“ŕ): ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/18), “Œ‹ž.

733040. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ęCˆăƒZƒbƒVƒ‡ƒ“: ŠĚśŒŸŒă‚̉Ƒ°‚Ö‚ĚÚ×‚Č•a—đ’ŽŽć‚É‚ć‚čf’f‚ł‚ę‚˝ŠĚ‹@”\•aŠQ‚Ě1—á. ˜a“cŽ‹v1, “ú‚@‰›1, ŽRŞŒhŽq2, ˆäă’qm2, ŒE“cK‰î1, ‹›“ˆ°‹I1, “c’†ŒŤ–ž1, ’†ŕV‹MG1, a’J–ž—˛1,3, ‘ĺ•”@˝4, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—, 4ˆă—ÉqśŠw•”): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć343‰ń—á‰ď (2017/2/4), ě‰z.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-722001. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) IBD‰ć‘œf’fƒ[ƒNƒVƒ‡ƒbƒv`Šˆ“ŽŠú’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚éUlcerative colitis Endoscopic index of severity‚Ě—L—pŤ`. ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć33‰ń“ú–{‘ĺ’°ŒŸ¸Šw‰ď‘‰ď (2015/11/6-7), “Œ‹ž, “ú–{‘ĺ’°ŒŸ¸Šw‰ďŽGŽ 2016/3; 32 (2): 127.

‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č@Á‰ťŠí“ŕ‰ČŠw
Šń•uŔu‰ŠÇŤ’°ŽžŠł—Տ°Œ¤‹†uŔv

[Šwp˜_•ś]

110094. [Œ´’˜] Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan. Komoto S1, Motoya S1, Nishiwaki Y1, Matsui T1, Kunisaki R1, Matsuoka K1, Yoshimura N1, Kagaya T1, Naganuma M1, Hida N1, Watanabe M1, Hibi T1-3, Suzuki Y1, Miura S1, Hokari R1 (1Japanese study group for pregnant women with IBD): Intest Res 2016/4; 14 (2): 139-45. (“ú”ä‹I•ś1-3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110095. [Œ´’˜] Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study. Sawada K, Ohdo M, Ino T, Nakamura T, Numata T, Shibata H, Sakou J, Kusada M, Hibi T1,2: Ther Apher Dial 2016/4; 20 (2): 197-204. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110096. [Œ´’˜] Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite_Canada syndrome: a Japanese nationwide survey. Watanabe C, Komoto S, Tomita K, Hokari R, Tanaka M, Hirata I, Hibi T1,2, Kaunitz JD, Miura S: J Gastroenterol 2016/5; 51 (4): 327-36. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110097. [Œ´’˜] Cross-sectional small intestinal surveillance of maintenance hemodialysis patients using video capsule endoscopy: SCHEMA study. Hosoe N, Matsukawa S, Kanno Y, Naganuma M, Imaeda H, Ida Y, Tsuchiya Y, Hibi T1,2, Ogata H, Kanai T: Endosc Int Open 2016/5; 4 (5): E589-96. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110098. [Œ´’˜] First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis. Kobayashi T, Suzuki Y, Motoya S, Hirai F, Ogata H, Ito H, Sato N, Ozaki K, Watanabe M, Hibi T1,2: J Gastroenterol 2016/5; 51 (3): 241-51. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110099. [Œ´’˜] Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Hibi T1,2, Hirohata S3, Kikuchi H, Tateishi U, Sato N, Ozaki K, Kondo K, Ishigatsubo Y: Medicine (Baltimore) 2016/6; 95 (24): e3863. (“ú”ä‹I•ś1,2, œA”¨rŹ3: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3äPŒ´•aEŠ´ő“ŕ)

110100. [Œ´’˜] Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease. Ogata H, Watanabe M, Matsui T, Hase H, Okayasu M, Tsuchiya T, Shinmura Y, Hibi T1,2: J Crohns Colitis 2016/9; 10 (9): 1033-41. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110101. [Œ´’˜] Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Toyonaga T1, Matsuura M, Mori K, Honzawa Y, Minami N, Yamada S, Kobayashi T1,2, Hibi T1,2, Nakase H: Sci Rep 2016/10; 6: 35014. (Ź—с@‘ń1,2, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110102. [Œ´’˜] Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial. Matsumoto T1, Motoya S1, Watanabe K1, Hisamatsu T1, Nakase H1, Yoshimura N1, Ishida T1, Kato S1, Nakagawa T1, Esaki M1, Nagahori M1, Matsui T1, Naito Y1, Kanai T1, Suzuki Y1, Nojima M1, Watanabe M1, Hibi T1-3 (1Diamond Study Group): J Crohns Colitis 2016/11; 10 (11): 1259-66. (“ú”ä‹I•ś1-3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110103. [Œ´’˜] Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis. Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T1,2, Kanai T, Takehara T, Naka T: J Crohns Colitis 2017/1; 11 (1): 84-91. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110104. [Œ´’˜] Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey. Shimizu S, Kobayashi T1,2, Tomioka H, Ohtsu K, Matsui T, Hibi T1,2: J Gastroenterol 2017/3; 52 (3): 308-314. (Ź—с@‘ń1,2, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

120007. [Œ´’˜] ’°ŠÇƒXƒsƒƒw[ƒ^Ç (human intestinal spirochetosis; HIS) ‚Ě—Ő°“IˆÓ‹`‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ”~“c’qŽq1, ‹ÚŕV@G1, Ź—с@‘ń1,2, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, ”óŒű@”Ł1, íź@—ß1, “n粌›–ž1, “ú”ä‹I•ś1,2, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2017/2; 114 (2): 230-7.

220004. [€Œ´’˜] Ĺ‹ß‚Ě˜b‘č: ”ń“ÁˆŮŤ‘˝”­ŤŹ’°’×ᇏǂ̓ď•aŽw’č‚ĆSLCO2A1ŠÖ˜AŹ’°Ç. Ź—с@‘ń1,2, ”~–ě~Žk, ‹vź—ˆę, ]čŠ˛G, źˆä•qK, ź–{Žĺ”V, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/8; 113 (8): 1380-5.

320003. [Ç—á•ń] \“ńŽw’°”S–Œ‰şŽîá‡‚Ć‚ĚŠÓ•Ę‚Ş˘“ď‚Ĺ‚ ‚Á‚˝Gastric mucosal prolapse polyp‚Ě1—á. …’J—m—S1, ’†–ě@‰ë1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓĄ‰rŽq1, Ź—с@‘ń1,2, ”óŒű@”Ł1, íź@—ß1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, —é–ŘŒcˆę1, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Progress of Digestive Endoscopy 2016/6; 88 (1): 106-7.

522036. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł|IBD‚ƍ‡•šÇ‚ɑ΂ˇ‚鎥—Ă–ň‚̍l‚Ś•ű‚ĆŽg‚˘•űz“O’ę‰đŕ!@RTNF-ƒżR‘Ě‚ÉŠÖ‚ˇ‚éƒMƒ‚ƒ“‚đ‰đŒˆ!@ERTNF-ƒżR‘Ě‚đu’†Ž~‚ˇ‚év‚Ć‚Ť‚đŒŠ‹É‚ß‚éƒ|ƒCƒ“ƒg. Ź—с@‘ń1,2, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): –ň‹Ç 2016/5; 67 (6): 2174-7.

522037. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł|IBD‚ƍ‡•šÇ‚ɑ΂ˇ‚鎥—Ă–ň‚̍l‚Ś•ű‚ĆŽg‚˘•űzŽŔ‘H! IBD‚ĚŽĄ—Ă‚É‚¨‚Ż‚é–ňŠw“IŠÇ—‚Ěƒ|ƒCƒ“ƒg. ”Ş–ŘŕVŒ[Ži1, źŒ´@”Ł2, “ú”ä‹I•ś1,3 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2–ňŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): –ň‹Ç 2016/5; 67 (6): 2220-6.

522038. [uŔ]y“ÁW: “Ť’×ᇐŤ‘ĺ’°‰Š‚Ě“KŘ‚ČŽĄ—Ð헪‚đl‚Ś‚é!zƒ`ƒIƒvƒŠƒ“Œn–Ɖu’˛ß–ň‚É‚ć‚é“Ť’×ᇐŤ‘ĺ’°‰Š‚ĚŽĄ—Ð헪. Ź—с@‘ń1,2, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): IBD Research 2016/6; 10 (2): 85-9.

522039. [uŔ]y˜AÚ: IBD ŽĄ—Ă‚ĚƒsƒbƒgƒtƒH[ƒ‹zIBDŠłŽŇ‚ĚƒAƒhƒqƒAƒ‰ƒ“ƒX•s—Ç—á. –L‰i‹M•F1, Ź—с@‘ń1,2, ꎓĄ‰rŽq1, ‰Ş—ѐT“ń1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): IBD Research 2017/3; 11 (1): 42-6.

522040. [uŔ]y“ÁW: ŹŽ™E”D•wE‚—îŽŇ‚ɑ΂ˇ‚éIBDf—Áz8. ”D•wEŽö“űŠú‚É‚¨‚Ż‚鉊ÇŤ’°ŽžŠłŽĄ—Ă–ň‚ĚŽg‚˘•ű. ꎓĄ‰rŽq1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): INTESTINE 2017/3; 21 (2): 155-60.

522041. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł|Ĺ‹ß‚̐f’fEŽĄ—Á|zI. ‘˜_@‰ŠÇŤ’°ŽžŠł‚Ě•a‘Ô. “ú”ä‹I•ś1,2, Ź—с@‘ń1,2, ‹vź—ˆę1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{—Őଠ2017/3; 75 (3): 364-70.

[Šw‰ďEŒ¤‹†‰ď“™]

711002. [Šw‰ď (‘Ű)] (“Á•Ęu‰‰) What do we know about the impact of nutrients on the mucosal immune system? Hibi T1,2: AAA IBD 2016 (Asia America Assembly of IBD) (2016/4/7), Beijing. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

712012. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Efficacy and safety of golimumab subcutaneous administration in Japanese patients with moderately to severely active ulcerative colitis. Hibi T1,2, Imai Y, Ota T: AOCC2016 (2016/7/9), Kyoto. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

712013. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy. Hibi T1,2, Motoya S, Wallace K, Lazar A, Nishimura Y, Ozawa M, Thakkar R, Robinson AM, Watanabe M: AOCC2016 (2016/7/9), Kyoto. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713015. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Chronic enteropathy associated with SLCO2A1 gene,encoding prostaglandin transporter (CEAS): relationship with primary hypertrophic osteoarthropathy. Uemeno J, Esaki M, Hisamatu T, Hirano A, Kochi S, Watanabe K, Aoyagi K, Hirai F, Matsui T, Yao T, Hibi T1,2, Kanai T, Matsumoto T, Kitazono T: AOCC2016 (2016/7/9), Kyoto. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713016. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) The role of NLRP3 in the regulation of IL-10@production in gut macrophages. Tablante MC, Toyonaga T1, Kobayashi T1,2, Kuronuma S, Takeuchi O, Nakano M1, Saito E1, Umeda S1, Hibi T1,2: AOCC2016 (2016/7/9), Kyoto. (–L‰i‹M•F1, Ź—с@‘ń1,2, ’†–ě@‰ë1, ꎓĄ‰rŽq1, ”~“c’qŽq1, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713017. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Tofacitinib induction therapy in East Asian patients with active ulcerative colitis:subgroup analyses in two multinational, Phase 3 clinical trials. Motoya S, Watanabe M, Kim HJ, Km YH, Han DS, Arai S, Yuasa H, Isogawa N, Tabira J, Hibi T1,2: AOCC2016 (2016/7/9), Kyoto. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713018. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Effects of CYP3A5 genotype on efficacy and safety of tacrolimus in refractory ulcerative colitis-experience from a tertiary referral center. Saito E1, Kobayashi T1,2, Umeda T1, Nakano M1, Toyonaga T1, Kuronuma S, Takeuchi O, Hibi T1,2: AOCC2016 (2016/7/9), Kyoto. (ꎓĄ‰rŽq1, Ź—с@‘ń1,2, ”~“c’qŽq1, ’†–ě@‰ë1, –L‰i‹M•F1, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713019. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Clinical features of chronic enteropathy associated with SLCO2A1 gene (CEAS). Umeno J, Esaki M, Hirano A, Hisamatsu T, Watanabe K, Hirai F, Matsui T, Hibi T1,2, Kitazono T, Matsumoto T: ECCO2017 (2017/2/15), Barcelona. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713020. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Histological risk factors to predict clinical relapse in Ulcerative Colitis in mucosal healing. Ozaki R, Kobayashi T1,2, Saito E1, Toyonaga T1, Okabayashi S, Umeda S1, Nakano M1, Matsuoka K, Morinaga S, Hisamatsu T, Hibi T1,2: ECCO2017 (2017/2/15), Barcelona. (Ź—с@‘ń1,2, ꎓĄ‰rŽq1, –L‰i‹M•F1, ”~“c’qŽq1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713021. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Combination therapy with adalimumab and immunomodulators decreases incidence of intestinal resection in Crohn's Disease patients previously treated with infliximab: A large, multicentre cohort study. Tanaka H1, Kamata N1, Yamada A1, Fujii T1, Endo K1, Yoshino T1, Sugaya T1, Kawaguchi T1, Bamba S1, Ishii M1, Shinzaki S1, Toya Y1, Yanai Y1, Yokoyama Y1, Umeno J1, Okada T1, Kobayashi T1-3, Nojima M1, Hibi T1-3 (1the ADJUST study group): ECCO2017 (2017/2/15), Barcelona. (Ź—с@‘ń1-3, “ú”ä‹I•ś1-3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713022. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Efficacy of anti-TNF for internal fistula in Crohn's Disease - results from a retrospective multicenter cohort study. KobayashiT1-3, Hishida A1, Tanaka H1, Bamba S1, Yamada A1, Toshimitsu F1, Shinichiro S1, Kamata N1, Yoshino T1, Hibi T1-3 (1AIM Jr. Internal Fistula Study Group): ECCO2017 (2017/2/15), Barcelona. (Ź—с@‘ń1-3, “ú”ä‹I•ś1-3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713023. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naive Crohn's Disease: A subanalysis of DIAMOND trial. Motoya S1, Nakase H1, Matsumoto T1, Watanabe K1, Hisamatsu T1, Yoshimura N1, Ishida T1, Kato S1, Nakagawa T1, Nagahori M1, Esaki M1, Matsui T1, Naito Y1, Kanai T1, Suzuki Y1, Nojima M1, Watanabe M1, Hibi T1-3 (1the DIAMOND study group): ECCO2017 (2017/2/15), Barcelona. (“ú”ä‹I•ś1-3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713024. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Comparison of endoscopic responses to adalimumab monotherapy and combination therapy with azathioprine in patients with Crohn's Disease:A sub-analysis of DIAMOND trial. Watanabe K, Matsumoto T, Motoya S, Hisamatsu T, Nakase H, Yoshimura N, Ishida T, Kato S, Nakagawa T, Nagahori M, Esaki M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T1,2: ECCO2017 (2017/2/17), Barcelona. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713025. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission,mucosal healing and histological response in left-sided Ulcerative Colitis patients with Moderate-to-Severe disease. KŸhbacher T, Waldner MJ, Hirschmann S, Drvarov O, Hashem RA, Maaser C, Kucharzik T, Dinter J, C. Schramm C, J.Mertens, B. Holler, Mossner J, Suzuki K, Yokoyama J, Terai S, Yoneyama H, Asakura H, Hibi T1,2, Neurath MF: ECCO2017 (2017/2/17), Barcelona. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

722029. [Šw‰ď (‘S‘)](‹łˆçu‰‰)yŽi‰ďz‰ŠÇŤ’°ŽžŠł‚đ“ŕŽ‹‹žŒŸ‘Ě‚đ—p‚˘‚Äㆂ­. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/14), “Œ‹ž.

722030. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yPanel discussion 2: ƒ`[ƒ€ˆă—Ă‚ÉĹ“_‚đ! (Ži‰ď)zŽŸ˘‘ă‚ĚIBDŠłŽŇƒ}ƒl[ƒWƒƒ“ƒg‚ÉŒü‚Ż‚ā|Medical Staff‚ĚŽ‹“_‚Š‚ç‚Ý‚˝‚ą‚ę‚Š‚ç‚ĚIBDŽĄ—Á|. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń“ú–{‰ŠÇŤ’°ŽžŠłŠw‰ďŠwpW‰ď (2016/7/10), •Ÿ‰Ş.

722031. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y“Á•Ę”­Œžz‰ŠÇŤ’°ŽžŠł‚Ě’ˇŠúŒo‰ß‚Ćƒ‚ƒjƒ^ƒŠƒ“ƒO. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): JDDW 2016 (2016/11/4), _ŒË.

722032. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “IŠm‚Č•a‘Ô”cˆŹ‚Š‚ç‚̉ŠÇŤ’°ŽžŠłŽĄ—Ă‚ĚĹ“K‰ť. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ŽOd.

722033. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y“Á•Ę”­ŒžzIBD“ŕ‰ČŽĄ—Ă‚ĚForefront. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/19), ŽOd.

722034. [Šw‰ď (‘S‘)] (Šî’˛u‰‰) —Տ°‰ž—p15”N‚ĚŒoŒą‚Š‚ç’T‚é”’ŒŒ‹…œ‹Ž—Ă–@‚̐V“WŠJ|–žŠm‚Ć‚Č‚Á‚˝ě—p‹@˜‚Ć’ˇŠú—\Œă‚đŒŠ˜‚Ś‚˝ˆĘ’u‚Ă‚Ż|. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): JDDW 2016 (2016/11/3), _ŒË.

723138. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’°ŠÇƒXƒsƒƒw[ƒ^Ç‚Ě—Ő°“IˆÓ‹`‚ÉŠÖ‚ˇ‚é‘k‹y“IŒŸ“˘. ”~“c’qŽq1, ‹ÚŕV@G1, Ź—с@‘ń1,2, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, ”óŒű@”Ł1, íź@—ß1, “n粌›–ž1, “ú”ä‹I•ś1,2, X‰ił“ń˜Y (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12), “Œ‹ž.

723139. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒNƒ[ƒ“•a‰“ˆĘ‰ń’°•a•ĎŒŸő‚Ě‚˝‚ß‚Ě‚l‚qƒGƒ“ƒeƒƒOƒ‰ƒtƒB[‚ĆPCF-PQ260LŽg—p‘ĺ’°‹ž•š—p‚ĚŽŽ‚Ý. ’†–ě@‰ë1, Ź—с@‘ń1,2, ’†—˘Œ\G1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓĄ‰rŽq1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/13), “Œ‹ž.

723140. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‰ŠÇŤ’°ŽžŠł‚É‚¨‚Ż‚éƒCƒ“ƒtƒŠƒLƒVƒ}ƒuŒŒ’†”Z“x‘Ş’č‚ĆĹ“K‰ť. Ź—с@‘ń1,2, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć102‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2016/4/21), “Œ‹ž.

723141. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚Ě•a¨ƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚Ż‚éS100A12‘Ş’č‚Ě—L—pŤ. –L‰i‹M•F1, Ź—с@‘ń1,2, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć102‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2016/4/23), “Œ‹ž.

723142. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) High fat low carbohydrate diet reduces T cell mediated colitis in mice with increased Lactobacillales and decreased Bacteroides. Kuronuma S, Takeuchi O, Kobayashi T1,2, Toyonaga T1, Carla M, Hibi: T1,2: GI Research Academy 2016 (2016/6/10), Tokyo. (Ź—с@‘ń1,2, –L‰i‹M•F1, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

723143. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’†“™Ç‚Š‚çdÇ‚ĚƒNƒ[ƒ“•a‚Ě“ú–{lŠłŽŇ‚ɑ΂ˇ‚éƒEƒXƒeƒLƒkƒ}ƒu‚Ě—LŒřŤ‹y‚ŃˆŔ‘SŤ: ‘Ű‹¤“ŻŽŽŒą‚̐ŹŃ. Ąˆä—Y–ç, ‘ĺ“cFK, ‘ş“c—mŽq, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń“ú–{‰ŠÇŤ’°ŽžŠłŠw‰ďŠwpW‰ď (2016/7/10), •Ÿ‰Ş.

723144. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’°ŠÇƒXƒsƒƒw[ƒ^Ç‚đ‡•š‚ľ‚˝IBD5—á‚ĚŒŸ“˘. ”~“c’qŽq1, Ź—с@‘ń1,2, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, íź@—ß1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń“ú–{‰ŠÇŤ’°ŽžŠłŠw‰ďŠwpW‰ď (2016/7/10), •Ÿ‰Ş.

723145. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰ŠŠłŽŇ‚Ö‚Ě‹ÇŠťÜŽg—pƒAƒhƒqƒAƒ‰ƒ“ƒX‚ĆŽĄ—ÐŹŃ. ”Ş–ŘŕVŒ[Ži1, ꎓĄ‰rŽq1, Ź—с@‘ń1,2, ”öč@—Ç1, ‰Ş—ѐT“ń1, ”~“c’qŽq1, –L‰i‹M•F1, ’†–ě@‰ë1, źŒ´@”Ł1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń“ú–{‰ŠÇŤ’°ŽžŠłŠw‰ďŠwpW‰ď (2016/7/10), •Ÿ‰Ş.

723146. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‚Ž‰–b’á’Y…‰ť•¨H‚Í’°“ŕ×‹Ű‘p‚̕ωť‚𔺂˘ƒ}ƒEƒXŽŔŒą“I‘ĺ’°‰Š‚đŒ¸Žă‚ł‚š‚é. •Ŕ@’q, Ź—с@‘ń1,2, ’|“ŕ@C, –L‰i‹M•F1, Maria Carla, Villanueva Tablante, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć53‰ń“ú–{Á‰ťŠí–ƉuŠw‰ď‘‰ď (2016/7/15), ‘ĺă.

723147. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) üˆŰ‹Ř’ɏǂސćs‚ľ‚˝A”ń“TŒ^—Տ°Œo‰ß‚đ’ć‚ľ‚˝ƒNƒ[ƒ“•a‚Ě1—á. ‰Ş—ѐT“ń1, Ź—с@‘ń1,2, ”öč@—Ç1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, “c’†~ˆę1, “ú”ä‹I•ś1,2, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć44‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď (2016/9/8), “Œ‹ž.

723148. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚é‘ĺ’°“ŕŽ‹‹ž‰şśŒŸ‘gD‚É‚ć‚é—Տ°“IÄ”R—\‘Ş. ”öč@—Ç1, Ź—с@‘ń1,2, ꎓĄ‰rŽq1, –L‰i‹M•F1, ‰Ş—ѐT“ń1, ”~“c’qŽq1, ’†–ě@‰ë1, X‰ił“ń˜Y1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć34‰ń“ú–{‘ĺ’°ŒŸ¸Šw‰ď‘‰ď (2016/10/8), “Œ‹ž.

723149. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Lipocalin2 affecting bacterial clearance in activated macrophages contributes to the onset of intestinal inflammation. Toyonaga T1, Matsuura M, Nakase H, Mori K, Kobayashi T1,2, Hibi T1,2: APDW 2016 (2016/11/3), Kobe. (–L‰i‹M•F1, Ź—с@‘ń1,2, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

723150. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) The role of NLRP3 in the regulation of Il10 expression in gut macrophages. Tablante MC, Kobayashi T1,2, Toyonaga T1, Kuronuma S, Takeuchi O, Nakano M1, Saito E1, Umeda S1, Sollano J, Hibi T1,2: APDW 2016 (2016/11/3), Kobe. (Ź—с@‘ń1,2, –L‰i‹M•F1, ’†–ě@‰ë1, ꎓĄ‰rŽq1, ”~“c’qŽq1, “ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

723151. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ś•¨Šw“IťÜ’ďR‰ŠÇŤ’°ŽžŠł‚É‚¨‚Ż‚éƒCƒ“ƒtƒŠƒLƒVƒ}ƒuŒŒ’†”Z“x‘Ş’č‚ĆĹ“K‰ť‚ɂ‚˘‚Ä. ꎓĄ‰rŽq1, Ź—с@‘ń1,2, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): JDDW 2016 (2016/11/4), _ŒË.

723152. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚Ě•a¨ƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚Ż‚é•Ö’†ƒJƒ‹ƒvƒƒeƒNƒ`ƒ“ES100A12‚Ě—L—pŤ. –L‰i‹M•F1, Ź—с@‘ń1,2, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): JDDW 2016 (2016/11/4), _ŒË.

723153. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚é‘ĺ’°ƒJƒvƒZƒ‹“ŕŽ‹‹žŒŸ¸‚ĚŽó—eŤŒüă‚Ć•‹y‚đ–ÚŽw‚ľ‚˝ę—pƒŒƒWƒƒ“‚ĚŠJ”­. ‰Ş—ѐT“ń1, Ź—с@‘ń1,2, ”öč@—Ç1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć10‰ń“ú–{ƒJƒvƒZƒ‹“ŕŽ‹‹žŠw‰ďŠwpW‰ď (2017/2/19), –źŒĂ‰Ž.

723154. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ĺ’°ƒJƒvƒZƒ‹“ŕŽ‹‹ž‚É‚ć‚é’×ᇐŤ‘ĺ’°‰ŠdÇ“xƒXƒRƒA‚̍쐬. ×]’źŽ÷, ’†–ě@‰ë1, ’|“ŕ@Œ’, ‰““Ą@–L, ź‰ŞŽ‘P, ‘ĺX“S•˝, —Ń“c^—, ’ˇŔ@˝, Ź—с@‘ń1,2, ‹g“c“ÄŽj, r–؏ş”Ž, ‹{‰i—şˆę, ’†—˘Œ\G, ‹ŕˆä—˛“T, “ú”ä‹I•ś1,2, —é–؍N•v, ă–ě•śş, “n•Ó@Žç, •ű°•F (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć10‰ń“ú–{ƒJƒvƒZƒ‹“ŕŽ‹‹žŠw‰ďŠwpW‰ď (2017/2/19), –źŒĂ‰Ž.

733041. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒNƒ[ƒ“•a‰“ˆĘ‰ń’°•a•Ď‚ĚŒŸő‚É‚¨‚Ż‚é×Œa‘ĺ’°“ŕŽ‹‹žPCF-PQ260L‚Ě—L—pŤ‚ĚŒŸ“˘. ”~“c’qŽq1, ’†–ě@‰ë1, Ź—с@‘ń1,2, ’†—˘Œ\G1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/11), “Œ‹ž.

733042. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) •nŒŒ‚đŒ_‹@‚ɐf’f‚ł‚ę‚˝”ń“ÁˆŮŤ‘˝”­ŤŹ’°’×ᇏǂĚ1—á. Â–ö—´‘ž˜Y, ĄŽ}”Ž”V, ŽR‰Ş@–Ť, ˆ°’JŒ[Œá, ‘ĺŒÉGŽ÷, ”~–ě~Žk, ‹vź—ˆę, ×]’źŽ÷, ŽR“cŒ’l, ‹{ě‹`—˛, ‹´–{ł—Ç, ŽR–{Œ[“ń, ’†ŒłG—F, “ú”ä‹I•ś1,2, ź–{Žĺ”V (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć102‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/6/11), “Œ‹ž.


zŠÂŠí“ŕ‰ČŠw

[Šwp˜_•ś]

110105. [Œ´’˜] Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy. Ikeda Y1, Inomata T1, Iida Y2, Iwamoto-Ishida M1, Nabeta T1, Ishii S1, Sato T1, Yanagisawa T1, Mizutani T1, Naruke T1, Koitabashi T1, Takeuchi I3, Nishii M1, Ako J1: Heart Vessels 2016/4; 31 (4): 545-54. (’r“c—S‹B1, ’––”FŒł1, ”Ń“c—Sˆę˜Y2, Î“cŽO˜a1, “ç“c@Œ’1, Îˆär•ă1, ˛“Ą“N˜Y1, –öŕV’q‹`1, …’J’m‘×1, Ź–с@’1, Ź”‹´r”ü1, ’|“ŕˆę˜Y3, źˆäŠîŒp1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

110106. [Œ´’˜] Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention in a real-life setting: the final report (J-PLACE Final). Ako J1, Morino Y, Okuizumi K, Usami M, Nakamura M: Cardiovasc Interv Ther 2016/4; 31 (2): 101-13. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110107. [Œ´’˜] Efficacy and Limitations of Tachycardia Detection Interval Guided Reprogramming for Reduction of Inappropriate Shock in Implantable Cardioverter-Defibrillator Patients. Fujiishi T1, Niwano S2, Murakami M2, Nakamura H1, Igarashi T1, Ishizue N1, Oikawa J2, Kishihara J2, Fukaya H2, Niwano H, Ako J2: Int Heart J 2016/5; 57 (3): 304-9. (“ĄÎŽě”ü1, ’ë–ěTˆę2, ‘şă‰ë”ü2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, ‹yě@~2, ŠÝŒ´@~2, [’J‰p•˝2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

110108. [Œ´’˜] Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome. Aizawa Y, Takatsuki S, Kaneko Y, Noda T, Katsumata Y, Nishiyama T, Kimura T, Nishiyama N, Fukumoto K, Niwano S1, Kurita T, Mitsuhashi T, Kamakura S, Shimizu A, Horie M, Aizawa Y, Fukuda K: Int J Cardiol Heart Vasc 2016/5; 11: 104-10. (’ë–ěTˆę1: 1zŠÂŠí“ŕ)

110109. [Œ´’˜] Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management. Nabeta T1, Inomata T1, Iida Y2, Ikeda Y1, Iwamoto-Ishida M1, Ishii S1, Naruke T1, Mizutani T1, Shinagawa H, Koitabashi T1, Takeuchi I3, Ako J1: Heart Vessels 2016/7; 31 (7): 1109-16. (“ç“c@Œ’1, ’––”FŒł1, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B1, Î“cŽO˜a1, Îˆär•ă1, Ź–с@’1, …’J’m‘×1, Ź”‹´r”ü1, ’|“ŕˆę˜Y3, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

110110. [Œ´’˜] Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Hashikata T1, Yamaoka-Tojo M2, Kakizaki R3, Nemoto T3, Fujiyoshi K3, Namba S3, Kitasato L1, Hashimoto T3, Kameda R1, Maekawa E1, Shimohama T1, Tojo T1, Ako J1: Heart Vessels 2016/8; 31 (8): 1303-10. (”˘•űŒ’G1, “ŒžŠ”ü“ŢŽq2, Š`ř“—Ç‘ž3, Ş–{Ć˘Žu3, “Ą‹g˜a”Ž3, “ď”g‘–퍁3, –k—˘—œŽŃ1, ‹´–{‘ń–í3, ‹T“c@—Ç1, ‘OěŒb”ü1, ‰ş•lF˜Y1, “ŒžŠ‘ĺ‹P1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110111. [Œ´’˜] Polytherapy with sodium channel-blocking antiepileptic drugs is associated with arrhythmogenic ST-T abnormality in patients with epilepsy. Ishizue N1, Niwano S2, Saito M3, Fukaya H2, Nakamura H1, Igarashi T1, Fujiishi T1, Yoshizawa T2, Oikawa J2, Satoh A2, Kishihara J2, Murakami M2, Niwano H, Miyaoka H3, Ako J2: Seizure 2016/8; 40: 81-7. (Î––ŹĆ1, ’ë–ěTˆę2, âV“Ął”Í3, [’J‰p•˝2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ‹yě@~2, ˛“Ą@—z2, ŠÝŒ´@~2, ‘şă‰ë”ü2, ‹{‰Ş@“™3, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3¸_)

110112. [Œ´’˜] Discrimination of Paroxysmal and Persistent Atrial Fibrillation in Patients With New-Onset Atrial Fibrillation. Igarashi T1, Niwano S2, Fukaya H2, Yoshizawa T2, Nakamura H1, Fujiishi T1, Ishizue N1, Oikawa J2, Kishihara J2, Murakami M2, Niwano H, Ako J2: Int Heart J 2016/9; 57 (5): 573-9. (ŒÜ\—’Œš1, ’ë–ěTˆę2, [’J‰p•˝2, ‹gŕV’qŽĄ2, “ĄÎŽě”ü1, Î––ŹĆ1, ‹yě@~2, ŠÝŒ´@~2, ‘şă‰ë”ü2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

110113. [Œ´’˜] Successful Retrieval of Entrapped Balloon With Optical Coherence Tomography Guidance. Minami Y1, Meguro K1, Shimohama T1, Yanagisawa T1, Kakizaki R2, Tojo T1, Ako J1: JACC Cardiovasc Interv 2016/10; 9 (19): 2070-1. (“ě@ŽŒŤ1, –ڍ•Œ’‘ž˜Y1, ‰ş•lF˜Y1, –öŕV’q‹`1, Š`ř“—Ç‘ž2, “ŒžŠ‘ĺ‹P1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110114. [Œ´’˜] Cardiac resynchronization therapy reduces left ventricular energy loss. Kakizaki R1, Nabeta T2, Ishii S2, Koitabashi T2, Itatani K, Inomata T2, Ako J2: Int J Cardiol 2016/10; 221: 546-8. (Š`ř“—Ç‘ž1, “ç“c@Œ’2, Îˆär•ă2, Ź”‹´r”ü2, ’––”FŒł2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

110115. [Œ´’˜] Tumor Plop Sound. Kakizaki R1, Nabeta T2, Mizutani T2, Koitabashi T2, Ako J2: Circ J 2016/10; 80 (11): 2407-8. (Š`ř“—Ç‘ž1, “ç“c@Œ’2, …’J’m‘×2, Ź”‹´r”ü2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

110116. [Œ´’˜] Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy. Ikeda Y1, Inomata T1, Fujita T2, Iida Y2, Nabeta T1, Ishii S1, Maekawa E1, Yanagisawa T1, Mizutani T1, Naruke T1, Koitabashi T1, Takeuchi I3, Ako J1: Heart Vessels 2016/11; 31 (11): 1817-25. (’r“c—S‹B1, ’––”FŒł1, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, “ç“c@Œ’1, Îˆär•ă1, ‘OěŒb”ü1, –öŕV’q‹`1, …’J’m‘×1, Ź–с@’1, Ź”‹´r”ü1, ’|“ŕˆę˜Y3, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

110117. [Œ´’˜] Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy. Ishii S1, Inomata T1, Fujita T2, Iida Y2, Ikeda Y1, Nabeta T1, Yanagisawa T1, Naruke T1, Mizutani T1, Koitabashi T1, Takeuchi I3, Ako J1: Heart Vessels 2016/12; 31 (12): 1960-8. (Îˆär•ă1, ’––”FŒł1, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B1, “ç“c@Œ’1, –öŕV’q‹`1, Ź–с@’1, …’J’m‘×1, Ź”‹´r”ü1, ’|“ŕˆę˜Y3, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

110118. [Œ´’˜] Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation. Satoh A1, Niwano S1, Niwano H, Kishihara J1, Aoyama Y1, Oikawa J1, Fukaya H1, Tamaki H2, Ako J1: Heart Vessels 2017/1; 32 (1): 90-100. (˛“Ą@—z1, ’ë–ěTˆę1, ŠÝŒ´@~1, ÂŽR—S–ç1, ‹yě@~1, [’J‰p•˝1, ‹Ę–؉p–ž2, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‰đ–U)

110119. [Œ´’˜] Safety of low-dose dabigatran in patients with atrial fibrillation and mild renal insufficiency. Fukaya H1, Niwano S1, Oikawa J1, Nishinarita R2, Horiguchi A2, Nakamura H2, Fujiishi T2, Igarashi T2, Ishizue N2, Yoshizawa T1, Satoh A1, Kishihara J1, Murakami M1, Ako J1: J Cardiol 2017/3; 69 (3): 591-5. ([’J‰p•˝1, ’ë–ěTˆę1, ‹yě@~1, źŹ“c—ş2, –xŒű@ˆ¤2, ’†‘ş—m”Í2, “ĄÎŽě”ü2, ŒÜ\—’Œš2, Î––ŹĆ2, ‹gŕV’qŽĄ1, ˛“Ą@—z1, ŠÝŒ´@~1, ‘şă‰ë”ü1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110120. [Œ´’˜] Prognostic impact of intestinal wall thickening in hospitalized patients with heart failure. Ikeda Y1, Ishii S1, Fujita T2, Iida Y2, Kaida T2, Nabeta T1, Maekawa E1, Yanagisawa T1, Koitabashi T1, Takeuchi I3, Inomata T1, Ako J1: Int J Cardiol 2017/3; 230: 120-6. (’r“c—S‹B1, Îˆär•ă1, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, b”ă“c–L“ń2, “ç“c@Œ’1, ‘OěŒb”ü1, –öŕV’q‹`1, Ź”‹´r”ü1, ’|“ŕˆę˜Y3, ’––”FŒł1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

110121. [Œ´’˜] Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy. Ikeda Y1, Inomata T1, Fujita T2, Iida Y2, Kaida T2, Nabeta T1, Ishii S1, Maekawa E1, Yanagisawa T1, Mizutani T1, Naruke T1, Koitabashi T1, Takeuchi I3, Ako J1: Heart Vessels 2017/4; 32 (4): 446-57. (’r“c—S‹B1, ’––”FŒł1, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, b”ă“c–L“ń2, “ç“c@Œ’1, Îˆär•ă1, ‘OěŒb”ü1, –öŕV’q‹`1, …’J’m‘×1, Ź–с@’1, Ź”‹´r”ü1, ’|“ŕˆę˜Y3, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

110122. [Œ´’˜] Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study. Nabeta T1, Inomata T1, Fujita T2, Iida Y2, Ikeda Y1, Sato T1, Ishii S1, Maekawa E1, Mizutani T1, Naruke T1, Koitabashi T1, Inoue Y3, Ako J1: J Cardiol 2017/8; 70 (2): 185-91. (“ç“c@Œ’1, ’––”FŒł1, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B1, ˛“Ą“N˜Y1, Îˆär•ă1, ‘OěŒb”ü1, …’J’m‘×1, Ź–с@’1, Ź”‹´r”ü1, ˆäă—D‰î3, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•úŽËü (‰ć‘œ))

310006. [Ç—á•ń] Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report. Fujita T1, Inomata T1, Kaida T1, Iida Y1, Ikeda Y1, Nabeta T1, Ishii S1, Maekawa E1, Naruke T1, Koitabashi T1, Kitamura E2, Sekijima Y1, Ako J1: Cardiology 2017/2; 137 (2): 74-7. (“Ą“c“S•˝1, ’––”FŒł1, b”ă“c–L“ń1, ”Ń“c—Sˆę˜Y1, ’r“c—S‹B1, “ç“c@Œ’1, Îˆär•ă1, ‘OěŒb”ü1, Ź–с@’1, Ź”‹´r”ü1, –k‘ş‰p“ń2, ŠÖ“‡—ÇŽ÷1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2_Œo“ŕ)

520005. [‘ŕ] •ďŠ‡“IS•s‘SŠÇ—‚ĚƒXƒXƒ. ’––”FŒł (zŠÂŠí“ŕ): Œúś˜A”ö“š‘‡•a‰@ˆă•ń 2016/12; 26: 17-22.

521006. [‰đŕ]yS“dŠwƒ}ƒCƒ‹ƒXƒg[ƒ“: d—v˜_•ś‚đ‰đŕ‚ˇ‚ézECG Features Asscoiated With Adverse Cardiovascular Outocomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF-CHF Analysis. ’ë–ěTˆę (zŠÂŠí“ŕ): S“d} 2016/5; 36 (2): 137.

521007. [‰đŕ] S•s‘S‚É‚¨‚Ż‚éƒŔŽŐ’f–ň‚Ěˆľ‚˘•ű. ’––”FŒł (zŠÂŠí“ŕ): Suzuken Medical 2016/8; 19 (4): 7-10.

522042. [uŔ]y“ÁW: S•s‘SŠłŽŇ‚ĚÝ‘î‚É‚¨‚Ż‚é‘̉tŠÇ—zŒŒs“Ž‘Ôƒ‚ƒjƒ^ƒŠƒ“ƒO. ’––”FŒł (zŠÂŠí“ŕ): Fluid Management Renaissance 2016/5; 6 (2): 66-71.

522043. [uŔ]y“ÁW:uRŒŒđ—Ă–@‚̍Ąv‚đŒę‚ézŠe˜_@–ňÜ—noŤƒXƒeƒ“ƒg‚ƍRŒŒŹ”—Ö@. ‰ş•lF˜Y1, ˛“ĄL—m1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): f’f‚ĆŽĄ—Ă 2016/5; 104 (5): 579-84.

522044. [uŔ]y“ÁW: ŽăƒJƒeŽş—ŻŠw! SƒJƒeƒi[ƒX‚Ě‚˝‚ß‚Ě PCIŠî‘b‚ą‚ę‚ž‚ŻƒZƒ~ƒi[ •a“‚É“\‚Á‚Ä—v’ˆÓƒ][ƒ“‚đƒ`ƒFƒbƒN! ƒJƒeŽş‚Ě”í‚΂­–hŒěMAP‚‚Ťz‘ć1•” ƒJƒeŽş‚Á‚Ä‚Ç‚ń‚Č‚Ć‚ą‚ë? ‰ş•lF˜Y (zŠÂŠí“ŕ): HEART nursing 2016/5; 29 (5): 6-9.

522045. [uŔ]y“ÁW: ŽăƒJƒeŽş—ŻŠw! SƒJƒeƒi[ƒX‚Ě‚˝‚ß‚Ě PCIŠî‘b‚ą‚ę‚ž‚ŻƒZƒ~ƒi[ •a“‚É“\‚Á‚Ä—v’ˆÓƒ][ƒ“‚đƒ`ƒFƒbƒN! ƒJƒeŽş‚Ě”í‚΂­–hŒěMAP‚‚Ťz‘ć2•” PCIŠî‘bƒZƒ~ƒi[‚ւ悤‚ą‚ť!@3ŽžŠÔ–Ú ƒfƒoƒCƒX‚ĆŽĄ—Á@Eƒp[ƒg1 ‚ą‚ą‚ʼnŸ‚ł‚Ś‚éƒL[ƒ[ƒhcƒKƒCƒfƒBƒ“ƒOƒJƒe[ƒeƒ‹, ƒKƒCƒhƒƒCƒ„[, ƒoƒ‹[ƒ“ƒJƒe[ƒeƒ‹, ƒXƒeƒ“ƒg, ƒ[ƒ^ƒuƒŒ[ƒ^[. –ڍ•Œ’‘ž˜Y (zŠÂŠí“ŕ): HEART nursing 2016/5; 29 (5): 21-6.

522046. [uŔ]y“ÁW: S–[×“Ž‚ƍRŒŒđ—Ă–@@ƒGƒrƒfƒ“ƒX‚É— ‚Ă‚Ż‚ç‚ę‚˝—Տ°Œťę‚Ĺ‚ĚŽŔ‘H‚Ě‹ÉˆÓQ&AzR‹ĂŒĹ—Ă–@‚ĚŠJŽn!@ƒGƒLƒXƒp[ƒg‚͉˝‚đ‚Ç‚¤l‚Ś“Š—^ÝŒv‚ˇ‚é!?@ENOAC‚Ćƒƒ‹ƒtƒ@ƒŠƒ“‚Ě‚Ç‚ż‚ç‚đŽg‚¤? ’ë–ěTˆę (zŠÂŠí“ŕ): zŠÂŠí“ŕ‰ČŠw –ň‹Ç 2016/7; 67 (7): 2289-93.

522047. [uŔ]y“ÁW: •Ď‚í‚č‚‚‚ ‚鍂—îŽŇS•s‘S‚̍l‚Ś•ű‚ĆŽĄ—Ă–@z‹}Ť‘ˆŤŠú‚ĚŽĄ—Ă‚Ćworsening renal function (WRF). ’––”FŒł (zŠÂŠí“ŕ): Geriatric Medicine 2016/7; 54 (7): 681-4.

522048. [uŔ]y“ÁW: Ĺ‹ß‚̐t‘ŸE“§Í—Ěˆć‚̐V–ň‚Ć‚ť‚ĚŽg‚˘•ű‚ĚƒRƒczƒgƒ‹ƒoƒvƒ^ƒ“@1) S•s‘S. ’––”FŒł (zŠÂŠí“ŕ): t‚Ć“§Í 2016/8; 81 (2): 181-3.

522049. [uŔ]y“ÁW: S•s‘S‚ƐS–[×“ŽzS•s‘S‚É‚¨‚Ż‚éS–[×“Ž‚Ě—\–h“IˆÓ‹`. ’––”FŒł (zŠÂŠí“ŕ): zŠÂŠí“ŕ‰Č 2016/8; 80 (2): 107-10.

522050. [uŔ]y“ÁW: ƒJƒe[ƒeƒ‹‚đŽg‚Á‚˝ĹV‚ĚŽĄ—ÁzƒJƒe[ƒeƒ‹‚đŽg‚Á‚˝zŠÂ•â• ’––”FŒł (zŠÂŠí“ŕ): f’f‚ĆŽĄ—Ă 2016/9; 104 (9): 1121-6.

522051. [uŔ]y“ÁW: IVUS vs. OCT: ŒŒŠÇ“ŕƒCƒ[ƒWƒ“ƒO‚̍ĄzGray scale IVUS‚Ě’ˇŠ‚ĆŒŔŠE‚đŽŻ‚é. ‰ş•lF˜Y1, ˛“ĄL—m1 ‹T“c@—Ç1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): Heart View 2016/9; 20 (9): 31-7.

522052. [uŔ]y“ÁW: •ę‘Ě‹~–˝|ŽY‰Čˆă‚Ć‚Ć‚ŕ‚ɁzŽY‰Č‹~‹}ŽžŠł@ŽüŽYŠúS‹ŘÇ. Ź”‹´r”ü (zŠÂŠí“ŕ): ‹~‹}ˆăŠw 2016/9; 40 (9): 1071-80.

522053. [uŔ]y“ÁW: ŽĄ—Ă‚Ě—Ź‚ę‚đ•Ď‚Ś‚éSƒGƒR[z•sŽ–ŹŽžŠł‚É‚¨‚Ż‚égame-changing echocardiography@SŽş•p”. Ź”‹´r”ü (zŠÂŠí“ŕ): SƒGƒR[ 2016/9; 17 (9): 826-34.

522054. [uŔ] —Տ°uŔ: ƒTƒ‹ƒRƒCƒh[ƒVƒX‚É‚¨‚Ż‚éĹ‹ß‚Ě˜b‘č. Ź”‹´r”ü (zŠÂŠí“ŕ): ’´‰š”gŒŸ¸‹Zp 2016/10; 41 (5): 521-7.

522055. [uŔ]y“ÁW: Clinical Scenario ‚É‚ć‚é‹}ŤS•s‘SŽĄ—ÁzCongestion‚Ƃ͉˝‚Š? ’––”FŒł (zŠÂŠí“ŕ): zŠÂŠíƒWƒƒ[ƒiƒ‹ 2017/1; 65 (1): 52-8.

530002. [‚ť‚Ě‘ź (’ůł)] Erratum to: Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Hashikata T1, Yamaoka-Tojo M2, Kakizaki R3, Nemoto T3, Fujiyoshi K3, Namba S3, Kitasato L1, Hashimoto T3, Kameda R1, Maekawa E1, Shimohama T1, Tojo T1, Ako J1: Heart Vessels 2016/8; 31 (8): 1311-2. (”˘•űŒ’G1, “ŒžŠ”ü“ŢŽq2, Š`ř“—Ç‘ž3, Ş–{Ć˘Žu3, “Ą‹g˜a”Ž3, “ď”g‘–퍁3, –k—˘—œŽŃ1, ‹´–{‘ń–í3, ‹T“c@—Ç1, ‘OěŒb”ü1, ‰ş•lF˜Y1, “ŒžŠ‘ĺ‹P1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

530003. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification. (Circ J 2016; 80 (2): 354-62.)zTriple Antithrombotic Therapy - Always One Too Many? Fukaya H1, Ako J1: Circ J 2016; 80 (2): 316-7. ([’J‰p•˝1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

[’˜@‘]

620039. [Šwp‘ (•Ş’SŽˇ•M)]y‰ES•s‘S‚đŽŻ‚č •]‰ż‚ľ‚ÄŽĄ—Ă‚ÉŠˆ‚Š‚ˇzVI. ‰EŽşS‹Ř‚ĚˆŮí‚É”ş‚¤‰ES•s‘S@2. ƒAƒ~ƒƒCƒh[ƒVƒX‚Í‚ą‚ą‚Ü‚Ĺ‚í‚Š‚č‚Ü‚ľ‚˝, p.147-53. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: źř“‰v“ż, Ó”C•ŇW: ˆÉ“Ą@_, “›ˆä—T”V, •Ň: ’†‘şˆę•ś, •śŒő“°, “Œ‹ž, 2016/4”­s.

620040. [Šwp‘ (•Ş’SŽˇ•M)]yƒi[ƒX‚Ş‚í‚Š‚é&‚Í‚Č‚š‚é@S•s‘S‚Ü‚é‚í‚Š‚čBOOK (ƒn[ƒgƒi[ƒVƒ“ƒO2016”Nt‹G‘Š§)z‘ć1Í •a‘Ô‚ĆŽĄ—Ă ‚ą‚ą‚ž‚Ż‚͉Ÿ‚ł‚Ś‚悤! •KCS•s‘S’mŽŻ@13. ‘ŸŠí˜AŠÖ‚đ’m‚é S‘Ÿ‚ž‚Żf‚Ä‚˘‚é‚Ě‚Ĺ‚Í•s\•Ş?, p.102-9. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: ˛“Ą’źŽ÷, ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2016/4”­s.

620041. [Šwp‘ (•Ş’SŽˇ•M)]yƒGƒLƒXƒp[ƒg‚ŞŒťę‚Ĺ–ž‚Š‚ˇ S•s‘SŽĄ—Ă‚Ě‹ÉˆÓ 1”ŁzV. ‚—îŽŇS•s‘S@25. –ł—‚đ‚ľ‚Ä‚Ü‚Ĺ‚—îŽŇ‚ɃŔŽŐ’f–ň‚đ“ü‚ę‚é‚ׂŤ‚Š?, p.148-50. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ˛“ĄKl, “ěŽR“°, “Œ‹ž, 2016/4”­s.

620042. [Šwp‘ (•Ş’SŽˇ•M)]ySƒGƒR[ƒnƒ“ƒhƒuƒbƒN@S•s‘SzC Œťę‚ł̐S•s‘S•]‰ż (SƒGƒR[‚Ć‘ź‚Ě•ű–@‚ĚŽg‚˘•Ş‚Ż)@3 W’†ŽĄ—ĂŽş: 2. ŠÓ•Ę‚ˇ‚ׂŤ“ńŽŸŤS‹ŘÇ p.151-8. Ź”‹´r”ü (zŠÂŠí“ŕ)2, •Ň: ’|’†@Ž, ŒËo_”V, ‹ŕ–F“°, ‹ž“s, 2016/5”­s.

620043. [Šwp‘ (•Ş’SŽˇ•M)]yĹVŠĽ“Ž–ŹŽžŠłŠw ă|ŠĽ“Ž–ŹŽžŠł‚̍ŐVŽĄ—Ð헪|(“ú–{—ŐŕŹ74ŠŞ‘Š§†4)zVI. ŠĽ“Ž–ŹŽžŠł‚ĚŽĄ—Á@8. ‚ť‚Ě‘ź‚ĚŽĄ—ÁE—\–hEŠÇ—@(3) S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ɖ^“Ž—Ă–@, p.648-53. –ě“cçt (zŠÂŠí“ŕ), “ú–{—Ő଎Đ, “Œ‹ž, 2016/6”­s.

620044. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘S~•sŽ–Źz‘ć2Í S•s‘S‡•š•sŽ–Ź‚Ě“d‹Cś—Šw@3. S•s‘S‚É”ş‚¤S‹ŘL“WE_Œo‘̉tˆöŽqˆŮí‚Ş•sŽ–Ź‚đŽä‹N‚ˇ‚é, p.44-52. ’ë–ěTˆę (zŠÂŠí“ŕ), •Ň’˜: ˛“ĄKl, ŽR‰ş•Žu, ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2016/9”­s.

620045. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘S~•sŽ–Źz‘ć8Í “ÁŽę‚ȐS•s‘SŽžŠł‚É‚¨‚Ż‚é•sŽ–Ź@3. ‹}ŤS‹Ř‰Š, p.237-42. ’––”FŒł (zŠÂŠí“ŕ), •Ň’˜: ˛“ĄKl, ŽR‰ş•Žu, ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2016/9”­s.

620046. [Šwp‘ (•Ş’SŽˇ•M)]ydÇS•s‘S‚ĚŠłŽŇ‚ł‚ń‚Ş—ˆ‚Ü‚ľ‚˝z‘ć4Í dÇS•s‘S‚Ě•a‘Ô‚Ě—‰đ@HFrEF, p.175-82. ’––”FŒł (zŠÂŠí“ŕ), •Ň’˜: –k•—­Žj, ’†ŠOˆăŠwŽĐ, 2016/9”­s.

620047. [Šwp‘ (•Ş’SŽˇ•M)]yÝ‘î‰h—{ŠÇ—|ŒoŒű‚Š‚çˆÝᑁEŒoĂ–Ź‰h—{‚܂Ł|‰ü’ů2”ŁzIII. Ý‘î‚Ĺ‚ć‚­‚Ý‚éŠeŽíŽžŠł‚̉h—{ŠÇ—@7. S•s‘SŠłŽŇ‚ւ̑Ήž, p.238-46. ’––”FŒł (zŠÂŠí“ŕ), •Ň’˜: Ź–ě‘ňŽ , “ěŽR“°, “Œ‹ž, 2016/9”­s.

620048. [Šwp‘ (•Ş’SŽˇ•M)]yzŠÂŠí–ň•¨—Ă–@UPDATE (ˆăŠw‚Ě‚ ‚ä‚Ý259ŠŞ14†E‘ć5“y—j“ÁW†)z[Žĺ—v‚Č–ň•¨‚Ě“Á’Ľ‚ĆƒGƒrƒfƒ“ƒX]@ÉŽ_–ň‚ĆƒjƒRƒ‰ƒ“ƒWƒ‹, p.1401-5. –ڍ•Œ’‘ž˜Y1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ), •Ň: ŹŽşˆęŹ, ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2016/12”­s.

620049. [Šwp‘ (•Ş’SŽˇ•M)]yzŠÂŠí–ň•¨—Ă–@UPDATE (ˆăŠw‚Ě‚ ‚ä‚Ý259ŠŞ14†E‘ć5“y—j“ÁW†)z[Žĺ—v‚Č–ň•¨‚Ě“Á’Ľ‚ĆƒGƒrƒfƒ“ƒX]@ƒWƒMƒ^ƒŠƒXťÜ (ƒWƒSƒLƒVƒ“), p.1449-52. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ŹŽşˆęŹ, ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2016/12”­s.

620050. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ę‚ž‚Ż‚Í’m‚Á‚Ä‚¨‚Ť‚˝‚˘zŠÂŠÇ—|Œ¤Cˆă‚Š‚ç‚ĚŽż–â323|(‹~‹}EW’†ŽĄ—ĂVol.28—ŐŽž‘Š§†)zIV. ‹}Ť”ń‘㏾ŤS•s‘S (ADHF)@Q26. Œo”ç“IŽ_‘fƒ‚ƒjƒ^[, p.160-4. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ŽR‰Č@Í, ‘‡ˆăŠwŽĐ, “Œ‹ž, 2016/12”­s.

620051. [Šwp‘ (•Ş’SŽˇ•M)]y–ž“ú‚Š‚ç–𗧂‹}ŤS•s‘S–ň•¨—Ă–@‚ĚƒeƒNƒjƒbƒNzI ‚Ü‚¸‚Í•a‘Ô”cˆŹ‚ ‚č‚Ť!@3. ‘̉t’™—Ż, p.14-9. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: ź_‰v_, Ó”C•ŇW: ˆÉ“Ą@_, “›ˆä—T”V, •Ň: ˛“Ą’źŽ÷, •śŒő“°, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

711003. [Šw‰ď (‘Ű)] (“Á•Ęu‰‰) Beta-blocade in the Management of Heart Failure. Inomata T1: The 10th International Joint Meeting on Cardiovascular Diseases "Gunma Symposium" (2016/9/9), Maebashi. (’––”FŒł1: 1zŠÂŠí“ŕ)

712014. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) WCD for prevention of SCD after infected ICD removal. Niwano S1, Kishihara J1: Asian Pasific Heart Rhythm Society 2017 (2017/9/15), Yokohama. (’ë–ěTˆę1, ŠÝŒ´@~1: 1zŠÂŠí“ŕ)

713026. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Usefulness of intracardiac echocardiography during balloon aortic valvuloplasty. Meguro K1: EuroPCR 2016 (2016/5/17), Paris, France. (–ڍ•Œ’‘ž˜Y1: 1zŠÂŠí“ŕ)

713027. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Yin and Yang of Antithrombotic Therapy. Ako J1: 10th APSAVD Congress (2016/7/15), Tokyo. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

713028. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) DPP-4 inhibitor Suppresses the Electrical and Structural Remodeling through the Acute Phase Oxidative stress in the Myocardial Injury Model in Rat. Ishizue N1, Niwano S2, Oikawa J2, Nakamura H1, Igarashi T1, Fujiishi T1, Kishihara J2, Murakami M2, Fukaya H2, Niwano H, Ako J2: European Society of Cardiology Congress 2016 (2016/8/28), Roma, Italy. (Î––ŹĆ1, ’ë–ěTˆę2, ‹yě@~2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

713029. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Linagliptin Prevents Atrial Electrical Remodeling through the Decrease of Reactive Oxygen Species (ROS) of Atrial Tissue in Canine Model of Atrial Fibrillation. Igarashi T1, Niwano S2, Niwano H, Nakamura H1, Ishizue N1, Fujiishi T1, Yoshizawa T2, Oikawa J2, Kishihara J2, Murakami M2, Fukaya H2, Ako J2: European Society of Cardiology Congress 2016 (2016/8/29), Roma, Italy. (ŒÜ\—’Œš1, ’ë–ěTˆę2, ’ë–ě—TŒb, ’†‘ş—m”Í1, Î––ŹĆ1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ‹yě@~2, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

713030. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Day-to-day variation of J-wave Predicts Life-Threatening Arrhythmias in Patients with Myocardial Infarction. Ishizue N1, Niwano S2, Fukaya H2, Nishinarita R1, Horiguchi A1, Nakamura H1, Igarashi T1, Fujiishi T1, Oikawa J2, Kishihara J2, Murakami M2, Niwano H, Ako J2: European Society of Cardiology Congress 2016. (2016/8/29), Roma, Italy. (Î––ŹĆ1, ’ë–ěTˆę2, [’J‰p•˝2, źŹ“c—ş1, –xŒű@ˆ¤1, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹yě@~2, ŠÝŒ´@~2, ‘şă‰ë”ü2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

713031. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Glucagon-like-peptide-1 (GLP-1) Suppresses the Induction of Atrial Fibrillation in Canine Model of Atrial Fibrillation. Nakamura H1, Niwano S2, Niwano H, Fukaya H2, Murakami M2, Kishihara J2, Satoh A2, Yoshizawa T2, Oikawa J2, Igarashi T1, Ishizue N1, Fujiishi T1, Ako J2: European Society of Cardiology Congress 2016 (2016/8/29), Roma, Italy. (’†‘ş—m”Í1, ’ë–ěTˆę2, ’ë–ě—TŒb, [’J‰p•˝2, ‘şă‰ë”ü2, ŠÝŒ´@~2, ˛“Ą@—z2, ‹gŕV’qŽĄ2, ‹yě@~2, ŒÜ\—’Œš1, Î––ŹĆ1, “ĄÎŽě”ü1, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

713032. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Fibirillation cyc le length in the surface ECG predicts future congestive heart failure event in patients with long-lasting atrial fibrillation. Igarashi T1, Niwano S2, Nakamura H1, Ishizue N1, Fujiishi T1, Yoshizawa T2, Satoh A2, Kishihara J2, Murakami M2, Fukaya H2, Niwano H, Ako J2: Asian Pacific Heart Rhythm Society and Japanese Heart Rhythm Society Meeting 2017 (2017/9/15), Yokohama. (ŒÜ\—’Œš1, ’ë–ěTˆę2, ’†‘ş—m”Í1, Î––ŹĆ1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ˛“Ą@—z2, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

713033. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Differences of dose reduction criteria in each DOACs may cause bleeding complication. Fukaya H1, Niwano S1, Nakamura H2, Igarashi T2, Fujiishi T2, Yoshizawa T1, Oikawa J1, Satoh A1, Kishihara J1, Ako J1: Asian Pacific Heart Rhythm Society and Japanese Heart Rhythm Society Meeting 2017 (2017/9/17), Yokohama. ([’J‰p•˝1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ‹yě@~1, ˛“Ą@—z1, ŠÝŒ´@~1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713034. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Predictive factors of new onset atrial fibrillation after pacemaker implantation. Oikawa J1, Fukaya H1, Sato T1, Miyagishima K, Yasuno N, Kubo T, Niwano S1, Ako J1: Asian Pacific Heart Rhythm Society and Japanese Heart Rhythm Society Meeting 2017 (2017/9/17), Yokohama. (‹yě@~1, [’J‰p•˝1, ˛“Ą“N˜Y1, ’ë–ěTˆę1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

713035. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Predicting Factors for Chronic Phase Ventricular Tachycardia in Cardiac Sarcoidosis under Corticosteroid Therapy. Fujiishi T1, Fukaya H2, Niwano S2, Nakamura H1, Igarashi T1, Ishizue N1, Nabeta T2, Yoshizawa T2, Oikawa J2, Ishii S2, Kishihara J2, Satoh A2, Murakami M2, Niwano H, Ako J2: Annual Scientific Meeting of American Heart Association 2016 (2016/11/14), New Orlins, USA. (“ĄÎŽě”ü1, [’J‰p•˝2, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, “ç“c@Œ’2, ‹gŕV’qŽĄ2, ‹yě@~2, Îˆär•ă2, ŠÝŒ´@~2, ˛“Ą@—z2, ‘şă‰ë”ü2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

721001. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) Źlć“VŤSŽžŠłf—Âɖ𗧂ĂéSƒGƒR[ŒŸ¸`‚Ç‚¤f‚˝‚炢‚˘? “ŕ‰Č‚É‚Ť‚Ä‚ľ‚Ü‚Á‚˝ć“VŤSŽžŠł. Ź”‹´r”ü (zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18-20), ĺ‘ä.

721002. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Í‚Ç‚ą‚ÉŒü‚Š‚¤‚Ě‚Š. ’––”FŒł (zŠÂŠí“ŕ): Samsca Heart Forum 2016 in Kobe (2016/6/18), _ŒË.

721003. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) SƒGƒR[‚Ě‹@”\f’f. Ź”‹´r”ü (zŠÂŠí“ŕ): ‘ć14‰ńŹlć“VŤSŽžŠłƒZƒ~ƒi[ (2016/6/25-26), “Œ‹ž.

721004. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) physical examination‚đŠw‚Ô: S•s‘S‚̐f‚Š‚˝. ’––”FŒł (zŠÂŠí“ŕ): ‘ć64‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/9/25), “Œ‹ž.

721005. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) S–[×“Ž‚͐S•s‘SŠÇ—‚đ‚Ç‚¤•Ď‚Ś‚é‚Ě‚Š. ’––”FŒł (zŠÂŠí“ŕ): S–[×“ŽwebƒZƒ~ƒi[ (2017/2/13), webu‰‰‰ď.

722035. [Šw‰ď (‘S‘)] (‹łˆçƒZƒbƒVƒ‡ƒ“) ”ě‘ĺS‚Ě‚Ý‚Š‚˝. Ź”‹´r”ü (zŠÂŠí“ŕ): “ú–{’´‰š”gˆăŠw‰ď‘ć15‰ń‹łˆçƒZƒbƒVƒ‡ƒ“ (2016/5/27), ‹ž“s.

722036. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) SƒAƒ~ƒƒCƒh[ƒVƒX`zŠÂŠíˆă‚Š‚ç‚ĚƒAƒvƒ[ƒ`. ’––”FŒł (zŠÂŠí“ŕ): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2016/10/8), ŽD–y.

722037. [Šw‰ď (‘S‘)] (uK‰ď) •Ç‚ĚŒú‚˘S‘Ÿ‚̊ӕʐf’f. Ź”‹´r”ü (zŠÂŠí“ŕ): “ú–{SƒGƒR[}Šw‰ď‘ć13‰ńHŠúuK‰ď (2016/11/5), “Œ‹ž.

722038. [Šw‰ď (‘S‘)] (ƒEƒBƒ“ƒ^[ƒZƒ~ƒi[) ‘ĺl‚ĚŠĽ“Ž–ŹŽžŠł. Ź”‹´r”ü (zŠÂŠí“ŕ): ‘ć19‰ńƒGƒR[ƒEƒBƒ“ƒ^[ƒZƒ~ƒi[ (2017/2/25), ’ˇ–ě.

722039. [Šw‰ď (‘S‘)] (ƒTƒ}[ƒZƒ~ƒi[) WPWÇŒóŒQ‚ĚƒAƒuƒŒ[ƒVƒ‡ƒ“. ’ë–ěTˆę (zŠÂŠí“ŕ): EPƒTƒ}[ƒZƒ~ƒi[2017 (2017/7/23), “Œ‹ž.

722040. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‹@”\ŤMR‚ĚŽčp“K‰ž‚đŒˆ‚ß‚éSƒGƒR[‚Ć‚Í. Ź”‹´r”ü1, ’––”FŒł1, Š`ř“—Ç‘ž2, b”ă“c–L“ń2, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B2, “ç“c@Œ’1, Îˆär•ă1, –öŕV’q‹`1, ‘OěŒb”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{SƒGƒR[}Šw‰ď‘ć27‰ńŠwpW‰ď (2016/4/22-24), ‘ĺă.

722041. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Shorting the period of Triple Anti-platelet and anti-coagulation therapy: STAP trial. ‰––ě•ű–ž1, ˛“Ą‘ĺ•ă1, ˛“ĄF“T1, Œj@—L’q1, Ź—ŃŽü•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć25‰ń“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ďŠwp‘‰ď (2016/7/9), “Œ‹ž.

722042. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Practical Indication of Wearable Cardioverter Defibrillator in Japanese Population -Opinion through the initial experiences of WCD use in outpatient setting-. ’ë–ěTˆę1, ŠÝŒ´@~1 (1zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/15), ŽD–y.

722043. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Žc‚¤‚ÁŒŒ`V‚˝‚ȐS•s‘S•W“I`. ’––”FŒł (zŠÂŠí“ŕ): ‘ć64‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/9/24), “Œ‹ž.

722044. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ŠĽ“Ž–ŹƒXƒeƒ“ƒgA‚Śž‚ÝŒă, ŽOŽí‚̍RŒŒđÇÜ“Š—^ŠúŠÔ‚Ě’Zk‚ĚŽŽ‚Ý. ‰––ě•ű–ž1, ˛“Ą‘ĺ•ă1, ˛“ĄF“T1, Œj@—L’q1, Ź—ŃŽü•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć64‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/9/25), “Œ‹ž.

722045. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) BNP‚ސS•s‘SŠÇ—‚É–đ‚É—§‚‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2016/10/7), ŽD–y.

722046. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) `Pro vs. Con debate`‚ť‚ę‚Ĺ‚ŕ‚Ü‚žBAV‚â‚č‚Ü‚ˇ‚Š? –ڍ•Œ’‘ž˜Y (zŠÂŠí“ŕ): ƒXƒgƒ‰ƒNƒ`ƒƒ[ƒNƒ‰ƒuƒWƒƒƒpƒ“@ƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“ 2016 (2016/10/7), ‹ž“s.

722047. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Higher daily physical activity is associated with subsequent prevented decreasing left ventricular diastolic function in patient with ischemic heart disease. ŠĄ’J‰p‹I, š“ߏrŽ÷, ‰“Œ´^ˆę, ‚‹´—R”ü, ŠÖŞŒb”üŽq, –ě“cçt1, ź‰i“Ä•F2, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2016/10/7-9), ŽD–y.

722048. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘m–X•ŮŽžŠł‚ɑ΂ˇ‚镉‰×SƒGƒR[`‹@”\Ť‘m–X•Ů‹t—Ź‚ɂ‚˘‚Ä. Ź”‹´r”ü1, Îˆär•ă1, b”ă“c–L“ń2, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B2, “ç“c@Œ’1, ‘OěŒb”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć53‰ń“ú–{—Տ°ś—Šw‰ďŠw‘‰ď (2016/10/28-29), “Œ‹ž.

722049. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) S•s‘SŠÇ—‚É‚¨‚Ż‚錌ŠÇ“ŕvolume‚Ě•]‰ż‚ƑΉž. ’––”FŒł (zŠÂŠí“ŕ): Samsca Heart Forum 2017 in Yokohama (2017/1/7), ‰Ą•l.

722050. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Unknown Tracings: ƒfƒoƒCƒXS“d}‚đ“ǂ݉đ‚­. ’ë–ěTˆę1, “n粉pˆę (1zŠÂŠí“ŕ): ‘ć9‰ńAž‚݃fƒoƒCƒXŠÖ˜A“~‹G‘ĺ‰ď (2017/2/18), ‘ĺă.

722051. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) S‘Ÿ“Ë‘RŽ€ƒŠƒXƒNÇ—á‚Ěƒ}ƒlƒWƒƒ“ƒg|œ×“ŽƒfƒoƒCƒX‚đ‹ěŽg‚ľ‚˝—Տ°ŽĄ—Ă‚ĚĹ‘Oü|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘ć81‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2017/3/18), ‹ŕ‘ň.

722052. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ’…—pŒ^ŽŠ“Žœ×“ŽŠí (WCD) ‚Ě—Ő°“I—L—pŤ. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘ć65‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2017/9/29), ‘ĺă.

723155. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—î‹•ŒŒŤSŽžŠłŠłŽŇ‚É‚¨‚Ż‚é’Ⴂg‘ĚŠˆ“Ž—Ę‚Í‚ť‚ĚŒă‚̍śŽşŠg’Ł”\‚̒ቺ‚ÉŠÖ—^‚ˇ‚é ŠĄ’J‰p‹I, ź‰i“Ä•F1, š“ߏrŽ÷, ‰“Œ´^ˆę, ŠÖŞŒb”üŽq, –ě“cçt2, “ŒžŠ”ü“ŢŽq1, ˆ˘ŒĂĆ2 (1ˆă—ÉqśŠw•”, 2zŠÂŠí“ŕ‰Č): ‘ć52‰ń“ú–{zŠÂŠí•a—\–hŠw‰ďŠwpW‰ď (2016/6/17), é‹Ę.

723156. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Pharmacotherapy during and after Endovascular Intervention ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć“ń‰ńJ-ISCPŠwpW‰ď (2016/6/26), “ż“‡.

723157. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The Day-to-Day Variation of J-wave Predicts Life-Threatening Arrhythmias in Patients with Old Myocardial Infarction. Î––ŹĆ1, ’ë–ěTˆę2, [’J‰p•˝2, źŹ“c—ş1, –xŒű@ˆ¤1, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹yě@~2, ŠÝŒ´@~2, ‘şă‰ë”ü2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/15), ŽD–y.

723158. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Relationship between Late Phase Ventricular Tachycardia and Gallium-Scintigraphy in Cardiac Sarcoidosis after Corticosteroid Therapy. “ĄÎŽě”ü1, [’J‰p•˝2, ’ë–ěTˆę2, źŹ“c—ş1, –xŒű@ˆ¤1, ŒÜ\—’Œš1, Î––ŹĆ1, “ç“c@Œ’2, ‹gŕV’qŽĄ2, ‹yě@~2, Îˆär•ă2, ŠÝŒ´@~2, ˛“Ą@—z2, ‘şă‰ë”ü2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwp‘ĺ‰ď (2016/7/15), ŽD–y.

723159. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Low Dose Dabigatran in Patients with Atrial Fibrillation and Mild Renal Insufficiency. [’J‰p•˝1, ’ë–ěTˆę1, ‹yě@~1, źŹ“c—ş2, –xŒű@ˆ¤2, ’†‘ş—m”Í2, ŒÜ\—’Œš2, “ĄÎŽě”ü2, Î––ŹĆ2, ‹gŕV’qŽĄ1, ˛“Ą@—z1, ŠÝŒ´@~1, ‘şă‰ë”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/16), ŽD–y.

723160. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) An inappropriate shock of the wearable cardioverter defibrillator in outpatient setting during hemodialysis therapy. ŠÝŒ´@~1, ’ë–ěTˆę1, [’J‰p•˝1, źŹ“c—ş2, –xŒű@ˆ¤2, ’†‘ş—m”Í2, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ‹yě@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/16), ŽD–y.

723161. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Catheter Ablation for Atrial Tachy-Arrhythmia Improved Hemodynamics in End-Stage Heart Failure ~A Case Report~. źŹ“c—ş1, [’J‰p•˝2, ŠÝŒ´@~2, –xŒű@ˆ¤1, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, “ĄÎŽě”ü1, ‹yě@~2, ’ë–ěTˆę2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/16), ŽD–y.

723162. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Real World Regimen in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention. –xŒű@ˆ¤1, [’J‰p•˝2, ‹yě@~2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ŠÝŒ´@~2, ‘şă‰ë”ü2, ’ë–ěTˆę2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/16), ŽD–y.

723163. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Accessory Pathway in Wolf-Parkinson-White Syndrome Causes False Positive in Myocardial perfusion SPECT ~Differences in Left Bundle Branch Block. ˛“Ą@—z1, [’J‰p•˝1, ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/16), ŽD–y.

723164. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Determinants of Fibrillation Cycle Length in the Surface ECG in Patients with Long-lasting Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ěTˆę2, ’†‘ş—m”Í1, Î––ŹĆ1, “ĄÎŽě”ü1, ‹yě@~2, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwp‘ĺ‰ď (2016/7/16), ŽD–y.

723165. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹•ŒŒŤSŽžŠłS“d}f’f‚ĚŠî‘b. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/16), “Œ‹ž.

723166. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “œ”A•aŽĄ—Ă, Ž‰Žż’ቺ—Ă–@‚̐V‚˝‚Č“WŠJ. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

723167. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—îSŽžŠłŠłŽŇ‚Ě•ŕs‹@”\‹y‚Ńƒoƒ‰ƒ“ƒX‹@”\‚Ć‘O“Ş—t‹@”\‚Ć‚ĚŠÖ˜A. “Ą‹g˜a”Ž1, “ŒžŠ”ü“ŢŽq2, š“ߏrŽ÷, ‰“Œ´^ˆę, ŠÖŞŒb”üŽq, ‚‹´—R”ü, “ď”g‘–퍁1, ‘OěŒb”ü3, –ě“cçt3, ‘“c@‘ě2, ˆ˘ŒĂĆ3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

723168. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠO—ˆS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚ć‚čŒ’NŠÖ˜AQOL‚ŞŒüă‚ľ‚˝ÇŒóŤ‚“x‘ĺ“Ž–Ź•Ů‹ˇóÇ‚Ěˆę—á. ‘OěŒb”ü1, ‘“c@‘ě2, “c’†L–í3, –ěčN•˝4, ź‘ň—Ç‘ž4, ŕ_čL–ž4, _’JŒ’‘ž˜Y4, ŒÜ\—’ˆŸŠóŽq4, ‰Í–ě^—4, Šâ‘ş‹M”ü4, “Ą‹g˜a”Ž3, ‘ĺ“ŕ@•, –ě“cçt1, ’––”FŒł1, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ƒŠƒnƒrƒŠ•”): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

723169. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Serum Troponin T Level in the Stable State Predicts the Cardiac Death Events in Patients with Left Ventricular Dysfunction. ’†‘ş—m”Í1, ’ë–ěTˆę2, ’ë–ě—TŒb, [’J‰p•˝2, ‘şă‰ë”ü2, ŠÝŒ´@~2, Î––ŹĆ1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/17), ŽD–y.

723170. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Prognostication factors for the neurological outcomes in patients with hypothermia therapy after ventricular fibrillation. ‹yě@~1, ’ë–ěTˆę1, [’J‰p•˝1, –xŒű@ˆ¤2, źŹ“c—ş2, ’†‘ş—m”Í2, ŒÜ\—’Œš2, “ĄÎŽě”ü2, Î––ŹĆ2, ‹gŕV’qŽĄ1, ŠÝŒ´@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, ’|“ŕˆę˜Y3, ó—˜@–ő3, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝): ‘ć63‰ń“ú–{•sŽ–ŹS“dŠw‰ďŠwpW‰ď (2016/7/17), ŽD–y.

723171. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇ‘ĺ“Ž–Ź•Ů‹ˇóÇ‹y‚э‚KŒŒÇ‚É‚ć‚čSŽş×“Ž‚đŒoŒą‚ľ‚˝ŠłŽŇ‚ÉTAVI‚đŽ{s‚ľ‚˝ˆę—á. –ڍ•Œ’‘ž˜Y1, –öŕV’q‹`1, ˛“ĄL—m2, ˛“ĄF“T2, ‘OěŒb”ü1, Ź”‹´r”ü1, ’|“ŕˆę˜Y2, –k‘ş@—Ľ3, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‹~–˝, 3S‘ŸŒŒŠÇŠO): J-TVT 2016 (2016/8/11), ‘ĺă.

723172. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Źlć“VŤŽžŠł‚É‚¨‚Ż‚é‰ESŠg‘ĺ‚̍S‘ŠŤŠˇ‹CáŠQ‚ւ̉e‹ż|ŠO‰Č“I‰î“ü‚É‚ć‚é‰ESkŹ‚ĚŒř‰Ę. Ź”‹´r”ü1, ’––”FŒł1, b”ă“c–L“ń2, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, “ç“c@Œ’1, ’r“c—S‹B1, Îˆär•ă1, –öŕV’q‹`1, ‘OěŒb”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć64‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/9/23-25), “Œ‹ž.

723173. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MALTƒŠƒ“ƒpŽî‰Á—Ă’†‚É‚˝‚ą‚‚ڌ^S‹ŘÇ‚ĆŠĽškŤ‹ˇSÇ‚đ•š”­‚ľ‚˝1—á. ‹gŕV’qŽĄ1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹yě@~1, ˛“Ą@—z1, ŠÝŒ´@~1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć64‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/9/23), “Œ‹ž.

723174. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠĽ“Ž–ŹƒCƒ[ƒWƒ“ƒO‚̐i•ŕ. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć36‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď (2016/10/1), ‰Ą•l.

723175. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) TAVI’†‚É•Ů—Ö”j—ô‚ľ‹~–˝‚Ĺ‚Ť‚Č‚Š‚Á‚˝Ç—á. –ڍ•Œ’‘ž˜Y1, –öŕV’q‹`1, ˆ˘ŒĂĆ1, –k‘ş@—Ľ2 (1zŠÂŠí“ŕ, 2S‘ŸŒŒŠÇŠO): ƒXƒgƒ‰ƒNƒ`ƒƒ[ƒNƒ‰ƒuEƒWƒƒƒpƒ“ ƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“ 2016 (2016/10/7), ‹ž“s.

723176. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) RŒŒđ—Ă–@Up to date. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ƒXƒgƒ‰ƒNƒ`ƒƒ[ƒNƒ‰ƒuEƒWƒƒƒpƒ“ ƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“2016 (2016/10/8), ‹ž“s.

723177. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž–‘O‚É”­ÇƒŠƒXƒN‚đ”cˆŹ‚ľ,@v‘Ź‚ɑΉž‚Ĺ‚Ť‚˝ŽüŽYŠúS‹ŘÇ‚Ěˆę—á. Ź”‹´r”ü1, ’––”FŒł1, ’r“c—S‹B1, –]ŒŽƒŽq2, ŠC–ěM–ç2, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ŽY‰Č): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2016/10/7-9), ŽD–y.

723178. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) BRSŽž‘ă‚̍RŒŒŹ”—Ö@. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): CCT2016 (2016/10/21), _ŒË.

723179. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Revisit of polymer drug-eluting stents. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): CCT2016 (2016/10/22), _ŒË.

723180. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Parahishian pacing‚̏ŠŒŠ‚ć‚č, ‰E–[-ś–[ŠÔ‚Ě•›“`“ą˜H‚ŞŽŚ´‚ł‚ę‚˝ŠŽ‘S‰E‹rƒuƒƒbƒN‚đ’悡‚éöÝŤWPWÇŒóŒQ‚Ě1—á. ˛“Ą@—z1, [’J‰p•˝1, ’†‘ş—m”Í2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ŠÝŒ´@~1, ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723181. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ÁˆŮ‚ČŒ`‘Ô‚đ—L‚ˇ‚鍶–[“VŠW•””xĂ–Ź‚ɑ΂ľ, ś–[‘¤‚Ĺ‚ĚŠu—Ł‚đŽŔŽ{‚ľ‚˝”­ěŤS–[×“Ž‚Ě1—á. [’J‰p•˝1, ŠÝŒ´@~1, ’†‘ş—m”Í2, Î––ŹĆ2, “ĄÎŽě”ü2, ŒÜ\—’Œš2, ‹gŕV’qŽĄ1, ‹yě@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723182. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ş‘ĺĂ–Ź-ŽOë•Ů‹ˇ•”“ŕƒŠƒGƒ“ƒgƒŠ[ŤS–[‘e“Ž‚̉ń˜H“Ż’č‚É3D mapping system‚Ş—L—p‚Ĺ‚ ‚Á‚˝1—á. ŠÝŒ´@~1, [’J‰p•˝1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ‹yě@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723183. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ş‘ĺĂ–ŹŒă•Ç‘¤‚Ěፍ­‚đů‰ń˜H‚ÉŠÜ‚Ţ”ń’ʏíŒ^S–[‘e“Ž‚Ě1—á. “ĄÎŽě”ü1, [’J‰p•˝2, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, ˛“Ą@—z2, ‘şă‰ë”ü2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723184. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽOë•Ů—Ö-‰ş‘ĺĂ–Ź‹ˇ•”“ŕ‚đFigure 8‚ɐů‰ń‚ˇ‚é‹H—LŒ^S–[‘e“Ž‚Ě1—á. ŒÜ\—’Œš1, [’J‰p•˝2, ’†‘ş—m”Í1, Î––ŹĆ1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ˛“Ą@—z2, ŠÝŒ´@~2, ’ë–ěTˆę2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723185. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ś–[“VŠW•”SŠO–Œ‘¤‚É“`“ą’x‰„‚Ě‘śÝ‚ŞŽŚ´‚ł‚ę‚˝”xĂ–ŹŠu—ŁpŒăS–[•p”‚Ě1—á. Î––ŹĆ1, [’J‰p•˝2, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, ˛“Ą@—z2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723186. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —ź‘¤”xĂ–ŹŠu—ŁpŒă‚ɏoŒť‚ľ‚˝‘m–[•Ů‹ß–T‹NŒš‚Ěfocal AT‚ɑ΂ľƒAƒuƒŒ[ƒVƒ‡ƒ“‚đŽ{s‚ľ‚˝1—á. ’†‘ş—m”Í1, [’J‰p•˝2, ’ë–ěTˆę2, ŠÝŒ´@~2, ˛“Ą@—z2, ‹yě@~2, ‹gŕV’qŽĄ2, Î––ŹĆ1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‘şă‰ë”ü2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2016 (2016/10/28), •Ÿ‰Ş.

723187. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PCI OVER USE:ƒOƒ[ƒoƒ‹‚ČŽ‹“_‚Š‚玄‚˝‚ż‚̐i‚߂ׂŤ“š‚đl‚Ś‚é. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ARIA2016 (2016/11/30), •Ÿ‰Ş.

723188. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠúŒo‰ß‚đŠĎŽ@‚ľ“ž‚˝–łÇŒóŤValsalva“´“Ž–ŹáŽ”j—ô‚Ěˆę—á. Ź”‹´r”ü1, –îř“–ƒ—R1, “Ą“c“S•˝2, ‘OěŒb”ü1, –ڍ•Œ’‘ž˜Y1, ÂŽR’ź‘P3, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć19‰ńŹlć“VŤSŽžŠłŠw‰ď‘‰ďEŠwpW‰ď (2017/1/14), ŽOd.

723189. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —źSŽş‘ĚŠOÝ’uŒ^•â•lHS‘Ÿ“ą“üŒă1”N6ƒ–ŒŽ‚Ě’ˇŠúW’†ŽĄ—ĂŠÇ—‚đŒo‚ĐS‘ŸˆÚA‚đŽ{s‚ľ“ž‚˝ˆę—á. Îˆär•ă1, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B1, –k‘ş@—Ľ3, ‹{’n@ŠÓ3, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3S‘ŸŒŒŠÇŠO): ‘ć45‰ńlHS‘Ÿ‚Ć•â•zŠÂ§˜b‰ďŠwpW‰ď (2017/2/1), Î˜a.

723190. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é’…—pŒ^œ×“ŽŠí (WCD) ‚ĚŽg—pŒoŒą. ŠÝŒ´@~1, ’ë–ěTˆę1, [’J‰p•˝1, ’†‘ş—m”Í2, Î––ŹĆ2, “ĄÎŽě”ü2, ŒÜ\—’Œ’2, ‹gŕV’qŽĄ1, ‹yě@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć9‰ńAž‚݃fƒoƒCƒXŠÖ˜A“~‹G‘ĺ‰ď (2017/2/16), ‘ĺă.

723191. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Fibrillation cycle length is associated with efficacy of anti-arrhythmic therapy in patients with persistent atrial fibrillation. Î––ŹĆ1, ’ë–ěTˆę2, [’J‰p•˝2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, ˛“Ą@—z2, ‘şă‰ë”ü2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć81‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2017/3/18), ‹ŕ‘ň.

723192. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The usefulness of the combination of 67-Ga scintigraphy and fasting 18F-FDG PET for stratification of patients with cardiac sarcoidosis. Ź”‹´r”ü (zŠÂŠí“ŕ): ‘ć81‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2017/3/18), ‹ŕ‘ň.

723193. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The change of fragmented QRS and the clinical implication in cardiac sarcoidosis before and after corticosteroid therapy. “ĄÎŽě”ü1, [’J‰p•˝2, ’ë–ěTˆę2, źŹ“c—ş1, –xŒű@ˆ¤1, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, “ç“c@Œ’2, ‹gŕV’qŽĄ2, ‹yě@~2, Îˆär•ă2, ŠÝŒ´@~2, ˛“Ą@—z2, ‘şă‰ë”ü2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć81‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2017/3/19), ‹ŕ‘ň.

731012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘SŠÇ—‚Ö‚Ě’§í`decongestion‚đ‚˘‚Š‚ɐi‚ß‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): –kŠC“šˆăŽt‰ďS•s‘S’nˆć˜AŒgƒZƒ~ƒi[ (2016/4/15), ŽD–y.

731013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ˆÓŠO‚Ć’m‚ç‚Č‚˘S•s‘SŠłŽŇ‚̐śŠˆKŠľ•aŠÇ—. ’––”FŒł (zŠÂŠí“ŕ): ‘ć11‰ń–k‘˝–€CKDƒtƒH[ƒ‰ƒ€ (2016/4/20), ‹gËŽ›.

731014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Ă-‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ. ’ë–ěTˆę (zŠÂŠí“ŕ): RŒŒđ—Ă–@ƒZƒ~ƒi[ Up to date (2016/4/26), ŽRŒ`.

731015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć11‰ńS•s‘S‚Ɛ…—˜”AŒ¤‹†‰ď (2016/5/11), ‰Y˜a.

731016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć9‰ńŒQ”nS•s‘S‚ĆVasopressinu‰‰‰ď (2016/5/13), ‘O‹´.

731017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ES•s‘S‚đ‚Ç‚¤f‚é‚Š? ’––”FŒł (zŠÂŠí“ŕ): ‘ć5‰ń‘ĺă‰ES‚̉ď (2016/5/20), ‘ĺă.

731018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ. ’ë–ěTˆę (zŠÂŠí“ŕ): RŒŒđ—Ă–@ Up to data (2016/5/30), ‰Ą•l.

731019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SÄ“ü‰@|‚Ç‚¤‘Λł‚ˇ‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć20‰ń“ŒVŠƒzŠÂŠíŒ¤‹†‰ď (2016/6/3), VŠƒ.

731020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ. ’ë–ěTˆę (zŠÂŠí“ŕ): –ž“ú‚ɖ𗧂S–[×“Žƒg[ƒ^ƒ‹ƒ}ƒl[ƒWƒƒ“ƒg (2016/6/16), ěč.

731021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SÇ—á‚É‚¨‚Ż‚éR‹ĂŒĹ—Ă–@`‰˝‚Ş‚í‚Š‚Á‚Ä‚˘‚ĉ˝‚Ş‚í‚Š‚Á‚Ä‚˘‚Č‚˘‚Ě‚Š`. ’––”FŒł (zŠÂŠí“ŕ): S•s‘SUp To Date (2016/6/17), ‰Ą•l.

731022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ^‚ĚƒnƒCƒuƒŠƒbƒhS•s‘SŠÇ—‚É’§‚Ţ. ’––”FŒł (zŠÂŠí“ŕ): ‘ć17‰ńě—Տ°S‘Ÿ•aƒtƒH[ƒ‰ƒ€ (2016/6/24), ‚ź.

731023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ES•s‘S‚đ‚Ç‚¤f‚é‚Š? ’––”FŒł (zŠÂŠí“ŕ): ‘ć6‰ńŒŒ‰tň‰ťS•s‘SŽĄ—ĂŒ¤‹†‰ď (2016/7/3), ź].

731024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚Ě”][Ç—\–h|DOAC‘卬íŽž‘ă‚Ě“KŘ‚Č‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘ć43‰ńŠÖ“Œ”_‘şˆăŠw‰ď (2016/7/9), ” Ş.

731025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹}‘‚ˇ‚éS•s‘SŠÇ—‚ĚĹ‘Oü`‰ˇŒĚ’mV‚Ě’Ş—Ź‚Ć‚Í. ’––”FŒł (zŠÂŠí“ŕ): ‘ć326‰ńS“d}‚đ“ǂމď@ŠwpW‰ď (2016/7/11), ç—t.

731026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć2‰ńS•s‘SŽĄ—ĂƒXƒgƒ‰ƒeƒW[ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/7/15), ‘ĺă.

731027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): R‹ĂŒĹ—Ă–@ up to date (2016/7/22), •˝’Ë.

731028. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘̉t—ĘşÝÄ۰قđ‚Ç‚¤l‚Ś‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‹›ŔCVƒlƒbƒgƒ[ƒNƒ~[ƒeƒBƒ“ƒO (2016/7/29), VŠƒ.

731029. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): R‹ĂŒĹ—Ă–@ƒZƒ~ƒi[ (2016/8/5), _ŒË.

731030. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ^‚ĚƒnƒCƒuƒŠƒbƒhS•s‘SŠÇ—‚É’§‚Ţ. ’––”FŒł (zŠÂŠí“ŕ): ‘ć23‰ńź”ZS‘Ÿ•aŒ¤‹†‰ď (2016/8/20), ‘ĺŠ_.

731031. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ” ŞR‹ĂŒĹ—Ă–@ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/8/22), ” Ş.

731032. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) l: S•s‘Sf—Ă‚Ě’n—Í‚đ‚‚Ż‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć6‰ńźŽRSŒŒŠÇ•aƒtƒH[ƒ‰ƒ€ (2016/9/9), źŽR.

731033. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) SƒTƒ‹ƒRƒCƒh[ƒVƒX. Ź”‹´r”ü (zŠÂŠí“ŕ): _“ŢěŒŸ¸‹ZŽtzŠÂŠíę–ĺƒOƒ‹[ƒvu‰‰‰ď (2016/9/11), _“ސě.

731034. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ą‚Ç‚Ť‚Ědecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ĺ•Ş…—˜”A–ňŠwpu‰‰‰ď (2016/9/16), ‘ĺ•Ş.

731035. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) zŠÂŠíf—ẨˇŒĚ’mV`—˜”A–ň‚đŽg‚˘‚ą‚Č‚ˇ`. ’––”FŒł (zŠÂŠí“ŕ): “Œ‹ž’†‰›ƒGƒŠƒAHypertension Forum (2016/10/5), “Œ‹ž.

731036. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) zŠÂŠíf—ẨˇŒĚ’mV`Ą‚ ‚ç‚˝‚ß‚Ä‚¤‚ÁŒŒ‚Ɛ키`. ’––”FŒł (zŠÂŠí“ŕ): Šâ’ΈăŽt‰ďS•s‘SŠwpu‰‰‰ď (2016/10/11), é‹Ę.

731037. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): S–[×“ŽŽĄ—Ă Up to Date (2016/10/15), –źŒĂ‰Ž.

731038. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ^‚ĚƒnƒCƒuƒŠƒbƒhS•s‘SŠÇ—‚É’§‚Ţ. ’––”FŒł (zŠÂŠí“ŕ): ‘ć31‰ńclinical cardiac conference (2016/10/15), –źŒĂ‰Ž.

731039. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ą‚Ç‚Ť‚Ědecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ć|‘S•s‘S’nˆć˜AŒgu‰‰‰ď (2016/10/21), ć|‘.

731040. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|DOAC‘卬íŽž‘ă‚É‹‚ß‚ç‚ę‚éV‚˝‚ČƒGƒrƒfƒ“ƒX\’z|. ’ë–ěTˆę (zŠÂŠí“ŕ): ƒCƒOƒUƒŒƒ‹ƒg”­”„4Žü”N‹L”Ou‰‰‰ď (2016/10/25), ŽRŒ`.

731041. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): S–[×“ŽŽĄ—Ă Up to Date in Kazusa (2016/10/25), –؍X’Ă.

731042. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ą‚Ç‚Ť‚̐S•s‘S‚Ć‚Ç‚¤‘Λł‚ˇ‚é‚Š`ˆę”Ęˆă‚Ć‚ľ‚Ä, ę–ĺˆă‚Ć‚ľ‚ā`. ’––”FŒł (zŠÂŠí“ŕ): ‘ć19‰ńJƒlƒbƒg (2016/10/25), ŒÜ”˝“c.

731043. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹}‘‚ˇ‚éS•s‘SŠÇ—‚ĚĹ‘Oü`‰ˇŒĚ’mV‚Ě’Ş—Ź‚Ć‚Í. ’––”FŒł (zŠÂŠí“ŕ): –ڍ•‹ćzŠÂŠíę–ĺˆă§˜b‰ď (2016/10/27), –ڍ•.

731044. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘SŠÇ—‚Ö‚Ě’§í. ’––”FŒł (zŠÂŠí“ŕ): ‘ć14‰ń‰ŞŽRS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Œ¤‹†‰ď (2016/11/5), ‰ŞŽR.

731045. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘SŠÇ—‚đl‚Ś‚é`–ň•¨, ‚ť‚ľ‚Ä, CRT`. ’––”FŒł (zŠÂŠí“ŕ): ‘ć3‰ńƒGƒLƒXƒp[ƒg‚ÉŠw‚ԐS•s‘SE•sŽ–Ź (2016/11/5), L“‡.

731046. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): Thrombosis Meeting in Makuhari (2016/11/9), –‹’Ł.

731047. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚¤‚ÁŒŒ‚Ć‚Ç‚¤‘Λł‚ˇ‚é‚Š`Ą‚Ç‚Ť‚Ědecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‚˘‚í‚ŤS•s‘SŠwpu‰‰‰ď (2016/11/11), ‚˘‚í‚Ť.

731048. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S‹Ř‘gDŤó‚ÉŠî‚Ă‚­V‚˝‚ȐS•s‘SŠÇ—. ’––”FŒł (zŠÂŠí“ŕ): ‘ć19‰ńS˘‘ăŠjˆăŠwŒ¤‹†‰ď (2016/11/19), “Œ‹ž.

731049. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|DOAC‘卬íŽž‘ă‚É‹‚ß‚ç‚ę‚éV‚˝‚ČƒGƒrƒfƒ“ƒX\’z|. ’ë–ěTˆę (zŠÂŠí“ŕ): •ŸˆäzŠÂŠí§˜b‰ď (2016/11/25), •Ÿˆä.

731050. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): S•s‘SŠÇ—Up-to-Date 2016 (2016/12/2), ŽD–y.

731051. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): –źŒĂ‰ŽS•s‘SFORUM (2017/1/12), –źŒĂ‰Ž.

731052. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): –źŒĂ‰Ž“Œ•”zŠÂŠíƒtƒH[ƒ‰ƒ€ (2017/1/18), –źŒĂ‰Ž.

731053. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹}‘‚ˇ‚éS•s‘SŠÇ—‚ĚĹ‘Oü`‰ˇŒĚ’mV‚Ě’Ş—Ź‚Ć‚Í. ’––”FŒł (zŠÂŠí“ŕ): ‘ć10‰ń_ŒËzŠÂŠí“ŕ‰ČƒtƒH[ƒ‰ƒ€ (2017/1/26), _ŒË.

731054. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŠÇ—‚ł̐g‘̏ŠŒŠ‚̐f‚Š‚˝`‚ť‚Ěƒcƒ{‚Ć‚Í. ’––”FŒł (zŠÂŠí“ŕ): MINATOS•s‘SLIVE2017 (2017/1/27), “Œ‹ž.

731055. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “ú–{‚É‚¨‚Ż‚éS•s‘Sf—Ă‚ĚŒťó‚Ɖۑč`Improve-HF Japanƒgƒ‰ƒCƒAƒ‹‚Š‚猊‚Ś‚鏫—ˆ. ’––”FŒł (zŠÂŠí“ŕ): ‘ć10‰ńS•s‘SŽĄ—Ð헪EÇ—ጟ“˘‰ď (2017/1/28), “Œ‹ž.

731056. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘˝ŽĄŒŠRŒŒđ—Ă–@ƒtƒH[ƒ‰ƒ€ (2017/2/8), ‘˝ŽĄŒŠ.

731057. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ˆÓŠO‚Ć’m‚ç‚Č‚˘S•s‘SŠłŽŇ‚̐śŠˆKŠľ•aŠÇ—. ’––”FŒł (zŠÂŠí“ŕ): Hypertension Meeting (2017/2/21), “Œ‹ž.

731058. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): Œ§‰›R‹ĂŒĹ—Ă–@Up To Date (2017/2/22), _“ސě.

731059. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒyÇS•s‘S‚ɑ΂ˇ‚éĹć’[ŽĄ—Ă. ’––”FŒł (zŠÂŠí“ŕ): Ă‰ŞƒfƒoƒCƒXŒ¤‹†‰ď (2017/2/24), Ă‰Ş.

731060. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žc‚¤‚ÁŒŒ‚Ć—˜”A–ň’ďRŤ`V‚˝‚ČŽĄ—Ă•W“I‚Š‚çÄl‚ˇ‚éS•s‘Sf—Ă. ’––”FŒł (zŠÂŠí“ŕ): ƒTƒ€ƒXƒJ”­”„6Žü”N‹L”Ou‰‰‰ď (2017/2/25), “Œ‹ž.

731061. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) g‹ß‚ɐö‚ސS•s‘S. ’––”FŒł (zŠÂŠí“ŕ): Meet the specialist in ŽOđ (2017/3/3), ŽOđ.

731062. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘Sˆă‚ĚƒIƒsƒjƒIƒ“`decongestion‚đ‚Ç‚¤l‚Ś‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć42‰ńzŠÂŠí“ŕ‰ČEŠO‰ČƒtƒH[ƒ‰ƒ€ (2017/3/4), ‹ž“s.

731063. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹ł‚Ś‚Ü‚ˇ, S•s‘SŠÇ—‚Ć‚Ě•t‚Ť‡‚˘•ű. ’––”FŒł (zŠÂŠí“ŕ): ‘ć2‰ńź•”S•s‘S‚É‚¨‚Ż‚é’nˆćˆă—Ă˜AŒg‚̉ď (2017/3/10), •Ÿ‰Ş.

731064. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): R‹ĂŒĹ—Ă–@•×‹­‰ď2017 in Handa (2017/3/29), ”ź“c.

731065. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|DOAC‘卬íŽž‘ă‚É‹‚ß‚ç‚ę‚éV‚˝‚ČƒGƒrƒfƒ“ƒX\’z. ’ë–ěTˆę (zŠÂŠí“ŕ): Š‹ü‹ć@R‹ĂŒĹ—Ă–@‚đl‚Ś‚é‰ď 2017 (2017/5/17), Š‹ü.

731066. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): x‰Í DOAC meeting (2017/5/31), Ă‰Ş.

731067. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘ć4‰ń Circulation Network Conference (2017/6/16), –źŒĂ‰Ž.

731068. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|DOAC‘卬íŽž‘ă‚É‹‚ß‚ç‚ę‚éV‚˝‚ČƒGƒrƒfƒ“ƒX\’z|. ’ë–ěTˆę (zŠÂŠí“ŕ): zŠÂŠíƒZƒ~ƒi[ in Saitama 2017 (2017/6/27), ‰Y˜a.

731069. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|DOACŒƒíŽž‘ă‚É‚¨‚Ż‚éƒvƒ‰ƒUƒLƒT‚Ě–đŠ„|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘Ů“ŕ’n‹ć Network Meeting 2017 (2017/9/5), ‘Ů“ŕ.

731070. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): Šwpu‰‰‰ď@‚—îŽŇ‚̍R‹ĂŒĹ—Ă–@‚đl‚Ś‚é@in Niigata (2017/9/22), VŠƒ.

731071. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚Ě”]Çđ—\–h|DOAC‘卬íŽž‘ă‚Ě“KŘ‚Č–ň•¨‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): MASTER CLASS in Kanagawa (2017/10/2), _“ސě.

732020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) SƒTƒ‹ƒRƒCƒh[ƒVƒX‚̉ŠÇŠˆ“ŽŤ•]‰ż: SƒGƒR[}ŒŸ¸, 67GaƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ĆFDG-PET‚ĚˆÓ‹`. Ź”‹´r”ü1, ’––”FŒł1, b”ă“c–L“ń2, ’r“c—S‹B1, “ç“c@Œ’1, Îˆär•ă1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć2‰ń“ú–{S‹ŘÇŒ¤‹†‰ď (2016/5/14), ź–{.

733143. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) DAPTÄl`‚Ü‚žŽc‚é–â‘č“_`. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć35‰ń“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ď“ŒŠC–k—¤’n•ű‰ď (2016/4/8), –źŒĂ‰Ž.

733144. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ¸“ǂւ̑Ήž. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): TOPIC2016 (2016/7/23), “Œ‹ž.

733145. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) zŠÂŠíˆă‚ĚŽ‹“_‚Š‚ç‚ą‚ę‚Š‚ç‚Ě“œ”A•aŽĄ—Ă‚đlŽ@‚ˇ‚é. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć49‰ń“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/10/15), “Œ‹ž.

733146. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠĽ“Ž–ŹŽžŠł“ńŽŸ—\–hŠłŽŇ‚É‚¨‚Ż‚鎉Žż’ቺ—Ă–@‚̏d—vŤ. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): PAC16 (2016/11/19), ‹ž“s.

733147. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RŒŒđ—Ă–@‚É‚¨‚Ż‚鐍ˇ. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ”]SŒŒŠÇR‰Á—‹†‰ď2016 (2016/12/17), “Œ‹ž.

733148. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‚—îSŒŒŠÇŽžŠł‚É‚¨‚Ż‚éƒtƒŒƒCƒ‹‚ĆŒŒŠÇ“ŕ”ç‹@”\‚ĚŠÖ˜A. “Ą‹g˜a”Ž1, “ŒžŠ”ü“ŢŽq2, š“ߏrŽ÷, ‰“Œ´^ˆę, ÂŽRW‘ĺ1, ŠÖŞŒb”üŽq, ‚‹´—R”ü, ˛“ĄF“T3, –ě“cçt4, ˆ˘ŒĂĆ4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3‹~–˝, 4zŠÂŠí“ŕ): “ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď ‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), ‘ĺ‹{.

733149. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) g‘Ě‹@”\‚Ć QOL‚̕ωť‚đŒoŽž“I‚ÉŠĎŽ@‚ľ‚˝Œo”ç“I‘ĺ“Ž–Ź•Ů’uŠˇpŒă‚Ěˆę—á. ‘OěŒb”ü1, _’JŒ’‘ž˜Y2, “c’†L–í3, –ěčN•˝2, ź‘ň—Ç‘ž2, ŕ_čL–ž3, ’†‘ş“ŢŽq, ŒÜ\—’ˆŸŠóŽq2, –ڍ•Œ’‘ž˜Y1, –ě“cçt1, ‰ş•lF˜Y1, “ŒžŠ”ü“ŢŽq4, ‘“c@‘ě4, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ƒŠƒnƒrƒŠ•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ˆă—ÉqśŠw•”): “ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď ‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), ‘ĺ‹{.

733150. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –Ťt‘Ÿ•a‚đ‡•š‚ľ‚˝ˆŰŽŠúSŒŒŠÇŽžŠłŠłŽŇ‚̐g‘Ě‹@”\‚ɂ‚˘‚Ä. ÂŽRW‘ĺ1, “ŒžŠ”ü“ŢŽq2, š“ߏrŽ÷, ‰“Œ´^ˆę, ŠÖŞŒb”üŽq, ‚‹´—R”ü, –ě“cçt3, ź‰i“Ä•F2, ˆ˘ŒĂĆ3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ): “ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), ‘ĺ‹{.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H15-522001. [uŔ]yuŔ: ƒ~ƒjEƒR[ƒXzS‹Ř‰Š‚̐V‚ľ‚˘f’fŽĄ—Ă‚Ěstrategy. źˆäŠîŒp1, ˜aň@“O1 (1zŠÂŠí“ŕ): S‘Ÿ 2003/9; 35 (9): 603-10.

H16-110001. [Œ´’˜] Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. Nishii M1, Inomata T1, Takehana H, Takeuchi I2, Nakano H, Koitabashi T1, Nakahata J, Aoyama N3, Izumi T1: J Am Coll Cardiol 2004/9; 44 (6): 1292-7. (źˆäŠîŒp1, ’––”FŒł1, ’|“ŕˆę˜Y2, Ź”‹´r”ü1, ÂŽR’ź‘P3, ˜aň@“O1: 1zŠÂŠí“ŕ, 2‹~–˝, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H23-522001. [uŔ]y“ÁW: S‹ŘÇ|Œ¤‹†‚Ɛf—Ă‚ĚŒťó‚ƉۑčzŠe˜_@Šg’ŁŒ^S‹ŘÇ‚Ě”­Ç‹@˜|ƒEƒCƒ‹ƒXŠ´ő‚ĆŽŠŒČ–Ɖu‰ž“š. źˆäŠîŒp1, ˜aň@“O1 (1zŠÂŠí“ŕ): CARDIAC PRACTICE 2011/7; 22 (3).

H25-110001. [Œ´’˜] Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production. Valaperti A, Nishii M1, Liu Y, Naito K, Chan M, Zhang L, Skurk C, Schultheiss HP, Wells GA, Eriksson U, Liu PP: Circulation 2013/10; 128 (14): 1542-54. (źˆäŠîŒp1: 1zŠÂŠí“ŕ)

H25-110002. [Œ´’˜] Vaccination with Flt3L-induced CD8ƒż+ dendritic cells prevents CD4+ T helper cell-mediated experimental autoimmune myocarditis. Valaperti A, Nishii M1, Germano D, Liu PP, Eriksson U: Vaccine 2013/10; 31 (42): 4802-11. (źˆäŠîŒp1: 1zŠÂŠí“ŕ)

H25-110003. [Œ´’˜] Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy. Ishii S1,2, Inomata T2, Ikeda Y1,2, Nabeta T1,2, Iwamoto M, Watanabe I, Naruke T2, Shinagawa H2, Koitabashi T2, Nishii M2, Takeuchi I3, Izumi T2: Heart Vessels 2014/1; 29 (1): 88-96. (Îˆär•ă1,2, ’––”FŒł2, ’r“c—SˆĐ1,2, “ç“c@Œ’1,2, Ź–с@’2, •iě–íl2, Ź”‹´r”ü2, źˆäŠîŒp2, ’|“ŕˆę˜Y3, ˜aň@“O2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3‹~–˝)

H25-110004. [Œ´’˜] Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction. Aoyama N1, Imai H, Kurosawa T, Fukuda N, Moriguchi M, Nishinari M1, Nishii M1, Kono K, Soma K, Izumi T1: J Artif Organs 2014/3; 17 (1): 33-41. (ÂŽR’ź‘P1, źŹ^‹Ő1, źˆäŠîŒp1, ˜aň@“O1: 1zŠÂŠí“ŕ)

H26-110001. [Œ´’˜] The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity. Valaperti A, Nishii M1, Liu Y, Yang H, Naito K, Liu PP, Eriksson U: Basic Res Cardiol 2014/5; 109 (3): 411. (źˆäŠîŒp1: 1zŠÂŠí“ŕ)

H26-110002. [Œ´’˜] Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy. Nabeta T1, Inomata T2, Iida Y1, Ikeda Y1, Iwamoto M, Ishii S2, Sato T2, Watanabe I, Naruke T2, Shinagawa H2, Koitabashi T2, Takeuchi I3, Nishii M2, Inoue Y4, Izumi T2: Heart Vessels 2014/11; 29 (6): 784-92. (“ç“c@Œ’1, ’––”FŒł2, ”Ń“c—Sˆę˜Y1, ’r“c—S‹B1, Îˆär•ă2, ˛“ĄF“T2, Ź–с@’2, •iě–íl2, Ź”‹´r”ü2, ’|“ŕˆę˜Y3, źˆäŠîŒp2, ˆäă—D‰î4, ˜aň@“O2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3‹~–˝, 4•úŽËü (‰ć‘œ))

H27-110004. [Œ´’˜] Evaluation of R-wave offset in the left chest leads for estimating the left ventricular activation delay: An evaluation based on coronary sinus electrograms and the 12-lead electrogram. Hara H, Niwano S1, Ito H, Kaeakawa M, Ako J1: Journal of Electrocardiology 2015/12; 49 (2): 148-53. (’ë–ěTˆę1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

H27-110005. [Œ´’˜] Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study. Hashikata T1, Tojo T1, Namba S2, Kitasato L1, Hashimoto T2, Kameda R1, Shimohama T1, Yamaoka-Tojo M3, Ako J1: Heart Vessels 2016/2; 31 (2): 206-11. (”˘•űŒ’G1, “ŒžŠ‘ĺ‹P1, “ď”g‘–퍁2, –k—˘—œŽŃ1, ‹´–{‘ń–í2, ‹T“c@—Ç1, ‰ş•lF˜Y1, “ŒžŠ”ü“ŢŽq3, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

H27-110006. [Œ´’˜] Giant cell myocarditis associated with multiple autoimmune disorders following highly active antiretroviral therapy for human immunodeficiency virus type 1 infection. Ikeda Y1, Inomata T1, Nishinarita R2, Oikawa J1, Kishihara J1, Koitabashi T1, Wada T3, Takeuchi I4, Ako J1: Int J Cardiol 2016/3; 206: 79-81. (’r“c—S‹B1, ’––”FŒł1, źŹ“c—ş2, ‹yě@~1, ŠÝŒ´@~1, Ź”‹´r”ü1, ˜a“c’B•F3, ’|“ŕˆę˜Y4, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3äPŒ´•aEŠ´ő“ŕ, 4‹~–˝)

H27-310001. [Ç—á•ń] An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting. Kishihara J1, Niwano S1, Nakamura H2, Igarashi T2, Ishizue N2, Fujiishi T2, Oikawa J1, Murakami M1, Fukaya H1, Ako J1: J Arrhythm 2016/2; 32 (1): 67-9. (ŠÝŒ´@~1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œ’2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹yě@~1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

H27-522004. [uŔ]y˜AÚ: EBM Hot FlashzPEGASUS-TIMI 54. –öŕV’q‹`1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): CARDIAC PRACTICE 2016/2; 27 (1): 64-7.

H27-522005. [uŔ]y“ÁW: ŠĽ“Ž–ŹƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—Ă‚ĚƒgƒsƒbƒNƒXzRŒŒđ–ň‚̐i‰ť‚ĆŽc‚ł‚ę‚˝‰Ű‘č. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): “ú–{ŠĽŽžŠłŠw‰ďŽGŽ 2016/3; 22 (1): 45-50.

H27-522006. [uŔ]y“ÁW: ‚ť‚ą‚ŞŽŻ‚č‚˝‚˘•â•zŠÂ|Œťę‚ĹŠˆ‚Š‚ˇbest strategy|zŽĄ‚ˇ@9c. ‚˘‚Â, ’N‚ÉŽg‚¤‚Š@Œo”ç“IS”x•â•‘•’u. ’––”FŒł (zŠÂŠí“ŕ): Heart View 2016/3; 20 (4): 71-5.

[’˜@‘]

H19-620001. [Šwp‘ (•Ş’SŽˇ•M)]yˆă–ň•i•›ě—pŠw|–ňÜ‚ĚˆŔ‘SŽg—pƒAƒbƒvƒf[ƒg|(“ú–{—ŐŕŹ2007‘Š§†)zII. •›ě—pŠT˜_@1. ‘ŸŠí•Ę•›ě—p@5) zŠÂŠíáŠQ|”ńzŠÂŠíŒn–ňÜ‚̐S“ŐŤ, p.112-8. źˆäŠîŒp1, ˜aň@“O1 (1zŠÂŠí“ŕ), “ú–{—Ő଎Đ, “Œ‹ž, 2007”­s.

H23-620001. [Šwp‘ (•Ş’SŽˇ•M)]yV–ň“W–]2012 (ˆă–ňƒWƒƒ[ƒiƒ‹Vol.48 S-1)z‘ćIII•” ŽĄ—Ă‚É‚¨‚Ż‚éĹ‹ß‚̐V–ň‚ĚˆĘ’u•t‚Żq–ňŒř•Ęr`V–ň‚̍Lę`@S•s‘SŽĄ—Ă–ň`Šg’ŁŒ^S‹ŘÇ‚𒆐S‚É, p.451-9. źˆäŠîŒp1, ˜aň@“O1 (1zŠÂŠí“ŕ), ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 2012/1”­s.

H23-620002. [Šwp‘ (•Ş’SŽˇ•M)]yAnnual Review zŠÂŠí 2012zIII. f’f‚ĆŽĄ—Á|ĹV‚̐i•ŕ@B. S•s‘S@1. ƒoƒ\ƒvƒŒƒbƒVƒ“V2Žó—e‘̝hRÜ‚̐S•s‘SŽĄ—ĂŒř‰Ę. źˆäŠîŒp (zŠÂŠí“ŕ), •Ň: ŽRŒű@“O, ‘ź, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2012/1”­s.

H24-620001. [Šwp‘ (•Ş’SŽˇ•M)]yˆă–ň•i•›ě—pŠw (‘ć2”Ĺ)|–ňÜ‚ĚˆŔ‘SŽg—pƒAƒbƒvƒf[ƒg|(“ú–{—ŐŕŹ2012‘Š§†)zII. •›ě—pŠT˜_@1. ‘ŸŠí•Ę•›ě—p@(7) zŠÂŠíáŠQ, p.97-105. źˆäŠîŒp1, ˜aň@“O1 (1zŠÂŠí“ŕ), “ú–{—Ő଎Đ, “Œ‹ž, 2012/8”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŰŽŒŒ‰t“§ÍŠłŽŇ‚ɑ΂ˇ‚é ƒGƒCƒRƒTƒyƒ“ƒ^ƒGƒ“Ž_‚Ě“Š—^‚ÍŒŒŠÇ“ŕ”ç‹@”\‚đ‰ü‘P‚ľ“Ž–Źd‰ť‚̐i“W‚đ—}§‚ˇ‚é. Š™“c—TŽŔ1, ‘“c@‘ě2, •Đ‹Ë–ƒ–ů, ’|’†@˝, ˆÉ“Ą—zŽq, XŒű‚˘‚Ô‚Ť, Ź—Ń’ź”V, ‘ĺ‹v•Ű[l, Žç‰Ž—˜‰Ŕ3, ’|“ŕN—Y4, Š™“cvšć (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ˆăŠw‹łˆç, 4t‘Ÿ“ŕ): ‘ć59‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2014/6/13), _ŒË.

H27-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŰŽŒŒ‰t“§ÍŠłŽŇ‚ɑ΂ˇ‚éƒJƒ‹ƒjƒ`ƒ““Š—^‚͏I––“œ‰ťŽY•¨‚đŒ¸­‚ľ“Ž–Źd‰ť‚đ—\–h‚ˇ‚é. Š™“c—TŽŔ1, ‘“c@‘ě2, ˆÉ“Ą—zŽq, XŒű‚˘‚Ô‚Ť, Ź—Ń’ź”V, ‘ĺ‹v•Ű[l, Žç‰Ž—˜‰Ŕ3, ’|“ŕN—Y4, Š™“cvšć, Ź’J˜a•F (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ˆăŠw‹łˆç, 4t‘Ÿ“ŕ): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l.

H27-723006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŕ‰Č‚Őf‚éƒtƒ@ƒ[Žl’ĽÇ‚Ě‘˝—lŤ. Ź”‹´r”ü1, ’––”FŒł1, Š`ř“—Ç‘ž2, “Ą“c“S•˝2, ‘OěŒb”ü1, ˆ˘ŒĂ Ć1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć18‰ń“ú–{Źlć“VŤSŽžŠłŠw‰ďŠwpW‰ď (2016/1/16-17), ‘ĺă.

H27-723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Distinguished Features of Cases with Tetralogy of Fallot in Adulthood Consulted to General Cardiologists -From the Standpoint of Real-World Practice. Ź”‹´r”ü1, ’––”FŒł1, b”ă“c–L“ń2, “Ą“c“S•˝2, ”Ń“c—Sˆę˜Y2, ’r“c—S‹B1, “ç“c@Œ’1, ‘ĺ“ŕ@•, Îˆär•ă1, –öŕV’q‹`1, ‘OěŒb”ü1, …’J’m‘×1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18-20), ĺ‘ä.

H27-723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Group Guidance and Video-based Education of Self-care Managements of Heart Failure are More Effective than Individual Counseling. –ě“cçt1, ’––”FŒł1, _’JŒ’‘ž˜Y2, ŕ_čL–ž2, Ź”‹´r”ü1, ‘OěŒb”ü1, ”Ń“c—Sˆę˜Y3, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ƒŠƒnƒrƒŠ•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18), ĺ‘ä.

H27-723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) DESAž‚ÝŠłŽŇ‚É‚¨‚Ż‚鎉Žż’ቺ—Ă–@‚̏d—vŤ. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18), ĺ‘ä.

H27-723010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) DOAC‚ÉŽc‚ł‚ę‚˝‰Ű‘č‚Ć‚Í? ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/19), ĺ‘ä.

H27-733003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) DAPTÄl: ‚Ü‚žŽc‚é–â‘č“_. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): CVIT‹ß‹E’n•ű‰ď (2016/2/13), ‘ĺă.


_Œo“ŕ‰ČŠw

[Šwp˜_•ś]

110123. [Œ´’˜] A clinical approach to diagnosis of autoimmune encephalitis. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Hšftberger R, Iizuka T1, Irani SR, Lancaster E, Leypoldt F, PrŸss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rost‡sy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J: Lancet Neurol 2016/4; 15 (4): 391-404. (”Ń’Ë‚_1: 1_Œo“ŕ)

110124. [Œ´’˜] Implementation of a Community-Based Triage for Patients with Suspected Transient Ischemic Attack or Minor Stroke Study: A Prospective Multicenter Observational Study. Taguchi H, Hasegawa Y, Bandoh K, Koyasu H, Watanabe Y, Yamashita K, Shimazaki K, Shima H, Miyakawa M, Niwa Y; COMBAT-TIA Study Investigators (Collaborators: Taguchi H, Bandoh K, Koyasu H, Shima H, Yamashita K, Hattori I, Ozaki S, Nemoto A, Morimoto M, Takizawa S, Uesugi T, Honma K, Mizuma A, Yutani S, Nakayama T, Kohchi M, Niwa Y, Yamamoto M, Shimazaki K, Sakuda K, Kitamura Y, Mitomi M, Miyaji Y, Nakano T, Hasegawa Y, Usuki N, Shimizu T, Hagiwara Y, Tsuruoka A, Ozawa H, Nagumo K, Kikuchi R, Hirose S, Takise Y, Nishiyama K1, Kasakura S, Ishima D, Mori T, Miyasaki H, Sakai R, Takada H, Nonaka F, Nonaka T, Suzuki S, Mizuno Y, Nagaseki K, Kawase J, Mori T, Ohta S, Oshima J, Watanabe H, Chang CC, Naitou M, Nakayama S, Utsuki S, Tanaka F, Joki H, Kunii M, Takahashi T, Hakii Y, Maruyama M, Sugitani M, Matsuzaki T, Iwamoto T, Kaku S, Furuichi S): J Stroke Cerebrovasc Dis 2016/4; 25 (4): 745-51. (źŽR˜a—˜1: 1_Œo“ŕ)

110125. [Œ´’˜] Motor neuron disease with saccadic abnormalities similar to progressive supranuclear palsy. Tokushige S, Terao Y, Matsuda S, Inomata-Terada S, Shimizu T1, Tanaka N, Hamada M, Yugeta A, Hanajima R1, Mori H, Tsuji S, Ugawa Y: Neurology and Clinical Neuroscience 2016/6; 4 (4): 146-52. (´…’G1, ‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110126. [Œ´’˜] Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Iizuka T1, Kaneko J1, Tominaga N1, Someko H1, Nakamura M1, Ishima D1, Kitamura E1, Masuda R1, Oguni E, Yanagisawa T, Kanazawa N2, Dalmau J, Nishiyama K1: JAMA Neurol 2016/6; 73 (6): 706-13. (”Ń’Ë‚_1, ‹ŕŽq~‘ž˜Y1, •x‰i“Ţ•Ű”ü1, őŹ‰pO1, ’†‘şŠ˛ş1, ˆä“‡‘ĺ•ă1, –k‘ş‰p“ń1, ‘“c@—ă1, ‹ŕŕV’ź”ü2, źŽR˜a—˜1: 1_Œo“ŕ, 2•a‘ԁEf—ĂŒn)

110127. [Œ´’˜] Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder. Martinez-Hernandez E, Arino H, McKeon, A, Iizuka T1, Titulaer, JM, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planaguma` J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J: JAMA Neurol 2016/6; 73 (6): 714-20. (”Ń’Ë‚_1: 1_Œo“ŕ)

110128. [Œ´’˜] Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Arihiro S1, Todo K1, Koga M1, Furui E1, Kinoshita N1, Kimura K1, Yamagami H1, Terasaki T1, Yoshimura S1, Shiokawa Y1, Kamiyama K1, Takizawa S1, Okuda S1, Okada Y1, Nagakane Y1, Kameda T1, Hasegawa Y1, Shibuya S1, Ito Y1, Nakashima T1, Takamatsu K1, Nishiyama K1,2, Matsuki T1, Homma K1, Takasugi J1, Tokunaga K1, Sato S1, Kario K1, Kitazono T1, Toyoda K1 (1SAMURAI Study Investigators): Int J Stroke 2016/7; 11 (5): 565-74. (źŽR˜a—˜1,2: 2_Œo“ŕ)

110129. [Œ´’˜] Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J). Watanabe Y1, Beeldman E1, Raaphorst J1, Izumi Y1, Yoshino H1, Masuda M1, Atsuta N1, Ito S1, Adachi T1, Adachi Y1, Yokota O1, Oda M1, Hanashima R1,2, Ogino M1,3, Ichikawa H1, Hasegawa K1, Kimura H1, Shimizu T1,2, Aiba I1, Yabe H1, Kanba M1, Kusumi K1, Aoki T1, Hiroe Y1, Watanabe H1, Nishiyama K1,2, Nomoto M1, Sobue G1, Nakashima K1 (1ALS-FTD-Q-J Research Group): J Neurol Sci 2016/8; 367: 51-5. (‰Ô“‡—ĽŽq1,2, ‰Ź–ě”üŒbŽq1,3, ´…’G1,2, źŽR˜a—˜1,2: 2_Œo“ŕ, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110130. [Œ´’˜] Cerebellar dysfunction in essential tremor. Hanajima R1, Tsutsumi R1, Shirota Y, Shimizu T1, Tanaka N, Ugawa Y: Mov Disord 2016/8; 31 (8): 1230-4. (‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…’G1: 1_Œo“ŕ)

110131. [Œ´’˜] Saccade abnormalities associated with focal cerebral lesions - How cortical and basal ganglia commands shape saccades in humans. Terao Y, Fukuda H, Tokushuge S, Nomura Y, Hanajima R1, Ugawa Y: Clin Neurophysiol 2016/8; 127 (8): 2953-67. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110132. [Œ´’˜] Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation. Koga M1, Yoshimura S1, Hasegawa Y1, Shibuya S1, Ito Y1, Matsuoka H1, Takamatsu K1, Nishiyama K1,2, Todo K1, Kimura K1, Furui E1, Terasaki T1, Shiokawa Y1, Kamiyama K1, Takizawa S1, Okuda S1, Okada Y1, Kameda T1, Nagakane Y1, Yagita Y1, Kario K1, Shiozawa M1, Sato S1, Yamagami H1, Arihiro S1, Toyoda K1 (1SAMURAI Study Investigators): Stroke 2016/10; 47 (10): 2582-8. (źŽR˜a—˜1,2: 2_Œo“ŕ)

110133. [Œ´’˜] A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-BarrŽ Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). Yamaguchi N1, Misawa S1, Sato Y1, Nagashima K1, Katayama K1, Sekiguchi Y1, Iwai Y1, Amino H1, Suichi T1, Yokota T1, Nishida Y1, Kohara N1, Hirata K1, Nishiyama K1,2, Yabe I1, Kaida K1, Suzuki N1, Nodera H1, Tsuji S1, Koike H1, Kira JI1, Hanaoka H1, Kusunoki S1, Kuwabara S1 (1JET-GBS Group): JMIR Res Protoc 2016/11; 5 (4): e210. (źŽR˜a—˜1,2: 2_Œo“ŕ)

110134. [Œ´’˜] Variability in Response to Quadripulse Stimulation of the Motor Cortex. Nakamura K, Groiss SJ, Hamada M, Enomoto H, Kadowaki S, Abe M, Murakami T, Wiratman W, Chang F, Kobayashi S, Hanajima R1, Terao Y, Ugawa Y: Brain Stimul 2016/11-12; 9 (6): 859-66. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110135. [Œ´’˜] Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Meininger V1, Genge A1, van den Berg LH1, Robberecht W1, Ludolph A1, Chio A1, Kim SH1, Leigh PN1, Kiernan MC1, Shefner JM1, Desnuelle C1, Morrison KE1, Petri S1, Boswell D1, Temple J1, Mohindra R1, Davies M1, Bullman J1, Rees P1, Lavrov A1 (1NOG112264 Study Group), Collaborators: Nishiyama K2, et al.: Lancet Neurol 2017/3; 16 (3): 208-16. (źŽR˜a—˜2: 2_Œo“ŕ)

120008. [Œ´’˜] “ü‰@’†‚̍‚—îŽŇŽ{Ý“üŠŽŇ‚É‚¨‚Ż‚é‚š‚ń–Ď‚đ—\‘Ş‚ˇ‚é. ŒŠ“c@‘1, ”Ńƒ–’J”ü•ô1,2, ŽR–{G–ž3, ’Š•ä”ü‹LŽq1, d“c@‹Ĺ1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2_Œo“ŕ‰Č, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ě‹Ć—Ă–@ 2016/12; 35 (6): 604-10.

310007. [Ç—á•ń] Autoimmune brachial amyotrophic diplegia and sensory neuronopathy with Sjšgren's syndrome: A case report. Tominaga N1, Iizuka T1, Kaneko J1, Nagai M1, Hara A2, Onozawa Y3, Kanazawa N4, Nishiyama K1: J Neurol Sci. 2016/9; 368: 1-3. (•x‰i“Ţ•Ű”ü1, ”Ń’Ë‚_1, ‹ŕŽq~‘ž˜Y1, ‰iˆä^‹MŽq1, Œ´@“ÖŽq2, Ź–ěŕV—T–ç3, ‹ŕŕV’ź”ü4, źŽR˜a—˜1: 1_Œo“ŕ, 2•a—, 3—ŐŒŸ•”, 4•a‘ԁEf—ĂŒn)

310008. [Ç—á•ń] Coexistence of Charcot-Marie-Tooth disease type 1A and chronic inflammatory demyelinating polyradiculoneuropathy with conduction blocks: Case Report. Shimizu K1, Hanajima R1, Shimizu T1, Usui R1, Yanagida A1, Akutsu T1, Iizuka T1, Nishiyama K1: Neurol Clin Neurosci 2016/9; 4 (5): 192-4. (´…˜aŒh1, ‰Ô“‡—ĽŽq1, ´…’G1, ‰Oˆä@—É1, ů|“c“ÖŽq1, ˆ˘‹v’Ă“ń•v1, ”Ń’Ë‚_1, źŽR˜a—˜1: 1_Œo“ŕ)

310009. [Ç—á•ń] Holmes' tremor caused by coexisting Parkinson's disease in a case of spinocerebellar ataxia type 31. Shimizu K1, Hanajima R1, Satou S2, Shimizu T1, Watanabe K, Kaneko A1, Iizuka T1, Nishiyama K1: Neurol Clin Neurosci 2017/3; 5 (2): 71-2. (´…˜aŒh1, ‰Ô“‡—ĽŽq1, ˛“ĄŸl2, ´…’G1, ‹ŕŽq@Œú1, ”Ń’Ë‚_1, źŽR˜a—˜1: 1_Œo“ŕ, 2”]ŠO)

510002. [‘ŕ] Hemiplegic migraine. Is it a typical migraine with aura or a migraine subtype? Iizuka T1: Japanese Journal of Headache 2016/7; 43 (1): 65-70. (”Ń’Ë‚_1: 1_Œo“ŕ)

520006. [‘ŕ] _Œo‹ŘƒTƒ‹ƒRƒCƒh[ƒVƒX‚̐f—ĂƒKƒCƒhƒ‰ƒCƒ“‰ü’ů‚đ‚ß‚Ž‚Á‚Ä. źŽR˜a—˜1, ‰ĄŽR˜ał, •“c@’ˆ, ‘ęŽR—eŽq1, –Ř‘şŹŽu (1_Œo“ŕ): “ú–{ƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽîŤŽžŠłŠw‰ďŽGŽ 2016/10; 36 (1-2): 13-6.

520007. [‘ŕ] •Đ“Ş’É‚ĚŠî‘b‚ĆĹ‹ß‚ĚŽĄ—Á|“Á‚É–ňÜ‚ĚŽg—p‰ß‘˝‚É‚ć‚é“Ş’ɂɂ‚˘‚ā|. ”Ńƒ–’J”ü•ô (_Œo“ŕ): “s–ňŽGŽ 2016/12; 38 (12): 4-7.

521008. [‰đŕ] ŕ_“cˆęćś‚ĚŒ¤‹†‚Ě‹OŐ. źŽR˜a—˜1, –k‘ş‰p“ń1 (1_Œo“ŕ): “ú–{“Ş’ÉŠw‰ďŽ 2016/7; 43 (1): 1-4.

521009. [‰đŕ]yQ&Az”][ÇƒŠƒXƒN‚Ş‚ ‚é“Ş’ÉŠłŽŇ‚̐fŽ@EŽĄ—Ă‚Ě’ˆÓ“_|–âf‚Š‚ç‘Š‘΃ŠƒXƒN‚đŒŠ‹É‚ß, •Đ“Ş’É‚Ě•p“xŒyŒ¸‚Č‚Ç‚Ě—\–hŽĄ—Ă‚đŽ{‚ˇ. ’O‰H@Œ‰, źŽR˜a—˜1 (1_Œo“ŕ): “ú–{ˆăŽ–V•ń 2016/11; 4831: 58-61.

521010. [‰đŕ]yQ&Az”][Ç‚Ě’´‹}ŤŠúŽĄ—Ă‚ĚĹV“ŽŒü|rt-PAĂ’—Ă–@‚đ‘O’ń‚Ć‚ľ‚˝ƒXƒeƒ“ƒgŒ^ŒŒđ‰ńŽűƒfƒoƒCƒX‚đ—p‚˘‚˝Œo”ç“I”]ŒŒđ‰ńŽűp‚Ě•š—p—Ă–@‚ŞŽĺ—Ź. źŽR˜a—˜1, _’J—YŒČ (1_Œo“ŕ): “ú–{ˆăŽ–V•ń 2017/1; 4839: 56-7.

522056. [uŔ]y“ÁW: “÷‰čŽîŤŽžŠł‚đl‚Ś‚éz ŒÄ‹zŠí“ŕ‰Čˆă‚Ş’m‚Á‚Ä‚¨‚­‚ׂŤƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě‘Sg•a‘ԁ@4) _ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě“Á’Ľ. źŽR˜a—˜ (_Œo“ŕ): ŒÄ‹zŠí“ŕ‰Č 2016/4; 29 (4): 285-8.

522057. [uŔ]y“ÁW: ”]ƒhƒbƒN|ć§ˆă—Â̐؂čŽD‚ցz”]ƒhƒbƒN‚ĚŽŔŰ@ŒŒ‰tE”AŒŸ¸. {‰ę—TŽ÷1, źŽR˜a—˜1 (1_Œo“ŕ): Clinical Neuroscience 2016/4; 34 (4): 415-8.

522058. [uŔ]yControversyzŒ’NH•i (“`“ˆă—Ă, ”ޏĄ“¤, …‘f…‚đŠÜ‚Ţ) ‚̓p[ƒLƒ“ƒ\ƒ“•a‚É—L—p‚Š? ‰Ô“‡—ĽŽq1, źě“TŽq (1_Œo“ŕ): MDSJ Letters 2016/4; 9 (1): 1-3.

522059. [uŔ]yŔ’k‰ďz”玿Šg‰„Ť—}§ (CSD) ‚đl‚Ś‚é. —é–Ř‘ĽG (Ži‰ď), ”Ń’Ë‚_1, ‰i“c‰hˆę˜Y, “n糗R‰Ŕ (1_Œo“ŕ): Headache Clinical & Science 2016/5; 7 (1): 5-13.

522060. [uŔ]y“ÁWII: RNMDAŽó—e‘Ě”]‰ŠzRNMDAŽó—e‘Ě”]‰Š‚ĚŽĄ—Ă. ”Ń’Ë‚_ (_Œo“ŕ): ¸_‰Č 2016/6; 28 (6): 496-502.

522061. [uŔ]y“ÁW: Šî’ęŠj‚ƏŹ”]|‚ť‚Ě‘Šˆá‚Ć˜AŠÖzÇó@Uí|‚Ç‚ą‚Ĺ‚ŕ‹N‚Ť‚é. ‰Ô“‡—ĽŽq (_Œo“ŕ): Clinical Neuroscience 2017/1; 35 (1): 68-71.

522062. [uŔ]y“ÁWI: _Œoś—ŒŸ¸update:‘ĺ ”]Šî’ęŠjŽžŠłEŹ”]ŽžŠł‚É‚¨‚Ż‚éĹV’mŒŠzƒvƒŠƒYƒ€‡‰ž. ´…’G1, ‰Ô“‡—ĽŽq1 (1_Œo“ŕ): _Œo“ŕ‰Č 2017/3; 86 (3): 290-4.

540009. [‚ť‚Ě‘ź (ˆĎˆő‰ď•ń)] _ŒoŠw‰ď“ü‰ď„iƒAƒ“ƒP[ƒg‚̉đÍŒ‹‰Ę. źŽR˜a—˜1, “V–ě—˛O, Â–ؐłŽu, Œ˘’ˁ@‹M, ’J˜el‹ą, –L“‡@ŽŠ, ‹´–{—mˆę˜Y, •Ÿ••q•v, ‹gˆä•ś‹Ď, ˆŔ“Œ—RŠě—Y (1_Œo“ŕ): —Տ°_ŒoŠw2016/12; 56 (12): 866-72.

[’˜@‘]

620052. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ‰Čf’f‚Ě“š‚ľ‚é‚ׁ@‚ť‚ĚÇŒó, ‚Ç‚¤f‚é ‚Ç‚¤l‚Ś‚é (medicina 53 (4) (2016”N4ŒŽ‘Š§†))zĄ_ŒoE¸_ @‰^“Ž–ƒáƒ, p.419-24. ˆ˘‹v’Ă“ń•v (_Œo“ŕ), •ŇW:umedicinav•ŇWˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/4”­s.

620053. [Šwp‘ (•Ş’SŽˇ•M)]y_Œo“ŕ‰ČClinical Questions and Pearls [“Ş’É]zI. “ޒɐf—Ă‘˜_@3. “ޒɐf—Ă‚ĚŽč‡ (f—ĂƒAƒ‹ƒSƒŠƒYƒ€‚Č‚ÇŠÜ‚ß‚˝‰đŕ), p.23-30. ”ŃƒP’J”ü•ô (_Œo“ŕ), ƒVƒŠ[ƒYŠÄC: —é–Ř‘ĽG, •Ň: ´…—˜•F, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/5”­s.

620054. [Šwp‘ (•Ş’SŽˇ•M)]y_Œo“ŕ‰ČClinical Questions and Pearls [“Ş’É]zVI. “ńŽŸŤ“ޒɁ@9. MELAS‚É‚ć‚é“Ş’ɂɂ͂ǂ̂悤‚Č“Á’Ľ‚Ş‚ ‚č‚Ü‚ˇ‚Š? p.248-50. Case approach MELAS‚É‚ć‚é“Ş’ɏǗá, p.292-5. ”Ń’Ë‚_ (_Œo“ŕ), ƒVƒŠ[ƒYŠÄC: —é–Ř‘ĽG, •Ň: ´…—˜•F, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/5”­s.

620055. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐¸_ŽžŠłŽĄ—ĂŽwj ‘ć2”Łz14 –ňÜŤ¸_áŠQ‚Ć‘ź‚̏Ǐ󐫐¸_áŠQ@RNMDAŽó—e‘Ě”]‰Š, p.528-31. ”Ń’Ë‚_ (_Œo“ŕ), •Ň: ”óŒű‹P•F, ŽsěGL, _’ëdM, ’Š“c@—˛, ’†ž˜aK, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620056. [Šwp‘ (•Ş’SŽˇ•M)]yƒ~ƒgƒRƒ“ƒhƒŠƒA•af—Ăƒ}ƒjƒ…ƒAƒ‹2017zE. MELAS@CQ34 ”]‘˛’†—l”­ě‚Ě•a‘Ô‚Ěl‚Ś•ű‚Í? p.103-5. CQ35 MELAS‚Ĺ’m‚ç‚ę‚Ä‚˘‚éˆâ“`Žq•ĎˆŮ‚Í? p.106-8. ”Ń’Ë‚_ (_Œo“ŕ), •Ň: “ú–{ƒ~ƒgƒRƒ“ƒhƒŠƒAŠw‰ď (•ŇWˆĎˆő’ˇ: ‘şŽR@Œ\, •›•ŇWˆĎˆő’ˇ: Źâ@m, •Ä“c@˝), f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/12”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712015. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Biphasic neurovascular changes during prolonged hemiplegic migraine FHM2. Iizuka T1: 58th annual scientific meeting - American Headache Society (2016/6/9), San Diego, USA. (”Ń’Ë‚_1: 1_Œo“ŕ)

712016. [Šw‰ď (‘Ű)] (Late Afternoon Session) Influence of anti-Parkinsons disease drugs on the neuro-plasticity induced by quadripulse transcranial magnetic stimulation (QPS). Hanajima R1, Enomoto H, Tanaka N, Tsutsumi R1, Shimizu T1, Shirota Y, Terao y, Abe M, Ugawa Y: 6th International Conference on Transcranial Brain Stimulation 2016 (2016/9/10), Germany. (‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…’G1: 1_Œo“ŕ)

713036. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Incidence of TDP-43 Proteinopathy in the aging human brain. Uchino A1: 91th American Assosiation of Neuropathologists (2016/6/12), USA. (“ŕ–쏲Žq1: 1_Œo“ŕ)

713037. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Effects of Zonisamide on human motor cortical plasticity: a TMS study. Shimizu T1, Hanajima R1, Tanaka N, Tsutsumi R1, Shirota Y, Terao Y, Ugawa Y: 6th International Conference on Transcranial Brain Stimulation 2016 (2016/9/8), Germany. (´…’G1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1: 1_Œo“ŕ)

713038. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Different roles of pre-SMA and in human visuomotor sequence learning: a TMS study. Shimizu T1, Hanajima R1, Tsutsumi R1, Shirota Y, Tanaka N, Hamada M, Ugawa Y: 2nd International Brain Stimulation Conference (2017/3/7), Spain. (´…’G1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1: 1_Œo“ŕ)

722053. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇzRŒŒđ—Ă–@‚ĚŒťó‚Ć“W–]. źŽR˜a—˜1, ˆÉ“Ą‹`˛ (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14), ŽD–y.

722054. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y”]_Œo‹~‹}EW’†ŽĄ—Ă—Ěˆć‚Ĺˆľ‚¤‘SgŽžŠł‚Ć”]_ŒoŒn•a‘Ô (“ú–{‹~‹}ˆăŠw‰ď, “ú–{_Œo‹~‹}ˆăŠw‰ď, Neurocritical Care Society‡“ŻŠé‰ć)z‚˘‚Š‚Éstroke mimics‚đŠÓ•Ę‚ˇ‚é‚Š, ”]‘˛’†ƒzƒbƒgƒ‰ƒCƒ“‚Ĺ”Ŕ‘—‚ł‚ę‚˝stroke mimics‚ĚŒŸ“˘. ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, ’†‘şŠ˛ş1, ‰Oˆä@—É1, ů|“c“ÖŽq1, ‹ŕŽq~‘ž˜Y1, ´…’G1, –k‘ş‰p“ń1, ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj2, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO ): ‘ć19‰ń“ú–{—Տ°‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/05/12-4), ŒSŽR, “ú–{‹~‹}ˆăŠw‰ďŽGŽ 2016/09; 27 (9): 310.

722055. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) UíUpdate. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/05/18), _ŒË.

722056. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) •Đ“Ş’É‚ĚƒƒJƒjƒYƒ€‚ĆŽĄ—Âɂ‚˘‚Ä‚ĚĹVî•ń. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/19), _ŒË.

722057. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒIƒVƒƒƒW[‚Š‚ç‚Ý‚˝_ŒoŽžŠł‚Ě•a‘Ô‚ĆŽĄ—Ă. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/20), _ŒË.

722058. [Šw‰ď (‘S‘)] (ƒzƒbƒgƒgƒsƒbƒNƒX) –ƉuŤ_ŒoŽžŠł‚É‚¨‚Ż‚鎊ŒČR‘Ě: ’m‚Á‚Ä‚¨‚­‚ׂŤŽĄ‚š‚é•a‘ԁ|RNMDAŽó—e‘̍R‘ĚŠÖ˜AÇŒóŒQ|. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/20), _ŒË.

722059. [Šw‰ď (‘S‘)] (‹łˆçƒR[ƒX(ę–ĺˆăˆçŹ)) ”­ě—l_ŒoÇŒó‚Ě‘˝—lŤ: “KŘ‚ČŠÓ•Ę‚ĆŽĄ—Âց|‹}Ť”]‰Š‚̉^“ŽÇó (ŽŠŒČ–ƉuŤ”]‰Š)|. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/21), _ŒË.

722060. [Šw‰ď (‘S‘)] (‹łˆçƒR[ƒX(‘˛‘OE‰ŠúŒ¤Cˆă)) ‘ĺŠw•a‰@‚É‚¨‚Ż‚égeneral neurology. źŽR˜a—˜ (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/21), _ŒË.

722061. [Šw‰ď (‘S‘)] (—Տ°ŒnƒVƒ“ƒ|ƒWƒEƒ€Eƒqƒg‚Ě•sˆÓ‰^“Ž)yƒI[ƒKƒiƒCƒU[z‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć31‰ń“ú–{‘ĺ”]Šî’ęŠjŒ¤‹†‰ď (2016/7/23), H“c.

722062. [Šw‰ď (‘S‘)] (—Տ°ŒnƒVƒ“ƒ|ƒWƒEƒ€) uƒqƒg‚Ě•sˆÓ‰^“Žv ƒ~ƒIƒŠƒYƒ~ƒA. ´…’G (_Œo“ŕ): ‘ć31‰ń“ú–{‘ĺ”]Šî’ęŠjŒ¤‹†‰ď (2016/7/23), H“c.

722063. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Probable RNMDAŽó—e‘Ě”]‰Š‚̐f’fŠî€‚Ě—L—pŤ‚Ćpitfall. ‹ŕŽq@Œú1, ”Ń’Ë‚_1, ‹ŕŽq~‘ž˜Y1, •x‰i“Ţ•Ű”ü1, –k‘ş‰p“ń1, ‹ŕŕV’ź”ü2, Josep Dalmau, źŽR˜a—˜1 (1_Œo“ŕ, 2•a‘ԁEf—ĂŒn): ‘ć28‰ń“ú–{_Œo–ƉuŠw‰ďŠwpW‰ď (2016/9/29), ’ˇč, _Œo–ƉuŠw 2016/9; 21 (1): 105.

722064. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ŽŠŒČ–ƉuŤ‚Ä‚ń‚Š‚ń‚É‚¨‚Ż‚éR_Œo×–E•\–ʍRŒ´R‘Ě‚ÉŠÖ‚ˇ‚錟“˘. ‹ŕŽq~‘ž˜Y1, ”Ń’Ë‚_1, ‹ŕŽq@Œú1, •x‰i“Ţ•Ű”ü1, –k‘ş‰p“ń1, ‹ŕŕV’ź”ü2, Josep Dalmau, źŽR˜a—˜1 (1_Œo“ŕ, 2•a‘ԁEf—ĂŒn): ‘ć28‰ń“ú–{_Œo–ƉuŠw‰ďŠwpW‰ď (2016/9/30), ’ˇč, _Œo–ƉuŠw 2016/9; 21 (1): 135.

722065. [Šw‰ď (‘S‘)] (”]_Œo‹~‹}EW’†ŽĄ—ĂƒVƒ“ƒ|ƒWƒEƒ€) ”]_Œo‹~‹}EW’†ŽĄ—Ă—Ěˆć‚Ĺˆľ‚¤‘SgŽžŠł‚Ć”]_ŒoŒn•a‘ԁ`‚˘‚Š‚Éstroke mimics‚đŠÓ•Ę‚ˇ‚é‚Š, ”]‘˛’†ƒzƒbƒgƒ‰ƒCƒ“‚Ĺ”Ŕ‘—‚ł‚ę‚˝stroke mimics‚ĚŒŸ“˘`. ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, ’†‘şŠ˛ş1, ‰Oˆä@—É1, ů|“c“ÖŽq1, ‹ŕŽq~‘ž˜Y1, ´…’G1, –k‘ş‰p“ń1, ŽR–{‘ĺ•ă2, ‹ß“Ą—łŽj2, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO): ‘ć44‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/11/19), “Œ‹ž, “ú–{‹~‹}ˆăŠw‰ďŽGŽ 2016/9; 27 (9): 310.

722066. [Šw‰ď (‘S‘)] (ƒI[ƒvƒjƒ“ƒOƒZƒ~ƒi[) –{‘ԐŤUí‚ĚŠî‘b‚Ć—Ő°. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć10‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2016/10/6), ‹ž“s, ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒXƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; 10: 49.

722067. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Inter-individual variability of quadri-pulse magnetic stimulation(QPS). ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡, —Տ°_Œoś—Šw 2016/10/; 44 (5): 322.

722068. [Šw‰ď (‘S‘)] (ƒGƒLƒXƒp[ƒgƒŒƒNƒ`ƒƒ[)yŔ’ˇz‰Ô“‡—ĽŽq(_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡.

722069. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇz‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡.

722070. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) Ź”]‚ĆƒvƒŠƒYƒ€“K‰ž. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/29), •Ÿ“‡, —Տ°_Œoś—Šw 2016/10/; 44 (5): 369.

722071. [Šw‰ď (‘S‘)] (ƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€-‘ć3‰ń_Œo‹Ř’´‰š”gŒ¤‹†‰ď-) ’´‰š”gŒŸ¸‚É‚¨‚Ż‚é“ú–{lăŽˆ––˝_ŒoEčň•”_ŒoŞŠî€’l‚̍쐬: ‘˝Ž{Ý‹¤“ŻŒ¤‹†. ’Ë–{@_, ‰z’qˆęG, ‚ź’źŽq, –쎛—T”V, ’Ň—LŠóŽq, ŕ_Œű_•q, ŽOŕV‰€Žq, ŠÖŒűŒ“Ži, ŹX“N•v, KŒ´ L•v, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡, —Տ°_Œoś—Šw 2016/10/; 44 (5): 389.

722072. [Šw‰ď (‘S‘)] (ƒƒfƒBƒJƒ‹ƒXƒ^ƒbƒtƒŒƒNƒ`ƒƒ[)yŔ’ˇz“Ş’É‚Ě•a‘Ԑś—‚ĆŽĄ—Ă. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć34‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2016/11/5), •ÄŽq.

722073. [Šw‰ď (‘S‘)] (Žs–ŻŒöŠJuŔ) ”]‚Ě‚Í‚˝‚ç‚Ť‚Ć•a‹C`”F’mÇ,”]ŽîᇂȂǁ`Šî‘b‚Š‚ç‚í‚Š‚é”]‚̍\‘˘‚Ć‹@”\. źŽR˜a—˜ (_Œo“ŕ): ‘ć21‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2016/11/13), “Œ‹ž.

722074. [Šw‰ď (‘S‘)] (‡“Ż‹łˆçƒZƒ~ƒi[) ’čˆĘE‹@”\_ŒoŠO‰ČŠw‰ď‚Ě•”`•sˆÓ‰^“ŽÇ‚Ě•a‘Ԑś—`. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć56‰ń“ú–{’čˆĘE‹@”\_ŒoŠO‰ČŠw‰ď (2017/1/27), ‘ĺă.

722075. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) u•sˆÓ‰^“ŽÇ‚ɑ΂ˇ‚éƒjƒ…[ƒƒ‚ƒfƒ…ƒŒ[ƒVƒ‡ƒ“vƒp[ƒLƒ“ƒ\ƒ“•a‚Ě–ň•¨—Ă–@‚ĆŽhŒƒ—Ă–@|‚Č‚É‚đ‘I‚Ô‚Š|. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć56‰ń“ú–{’čˆĘE‹@”\_ŒoŠO‰ČŠw‰ď (2017/1/28), ‘ĺă.

722076. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) čň“Ž–Ź‹ˇó‚Ö‚Ě“ŕ‰ČŽĄ—Ă‚ĚŒťó‚Ć“W–], ŠO‰Č“IŽĄ—Ă‚Ě“K‰ž. źŽR˜a—˜ (_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/17), ‘ĺă.

722077. [Šw‰ď (‘S‘)] (‹łˆçu‰‰)yŔ’ˇz”]oŒŒ‚Ě“ŕ‰ČŽĄ—Ă. źŽR˜a—˜ (_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/18), ‘ĺă.

723194. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Žá”NŤ”]ŒŒŠÇáŠQ‚ĚŒ´ˆöŒŸő‚É‚¨‚Ż‚éˆâ“`Šw“If’f‚ĚˆÓ‹`. ‘“c@—ă1, Š}‘qŽŠŒž1, ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14), ŽD–y.

723195. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”][Ç’´‹}ŤŠú‚Ě‹}‘Ź‚ȏǏó‰ü‘PŒăÄ‘žˆŤ‚ɂ‚˘‚Ä. ˆ˘‹v’Ă“ń•v1, ˆä“‡‘ĺ•ă1, ‰Oˆä@—É1, őŹ‰pO1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ‘“c@—ă1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14), ŽD–y.

723196. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ\[ƒVƒƒƒ‹ƒ[ƒJ[‚̉î“ü‚Ş”]‘˛’†ƒZƒ“ƒ^[“ü‰@ŠłŽŇ‚Ě“]‰@Žx‰‡‚É‹y‚Ú‚ˇ‰e‹ż‚ɂ‚˘‚Ä‚ĚŒ¤‹†. ’†‘ş‹…Œb1, “ń‹{‰h”ü1, ś‰E“c“N1, Ź–ěŕVŽ 1, ˆä“‡‘ĺ•ă2, ‹ß“Ą—łŽj3, ˆ˘‹v’Ă“ń•v2, ŒG•”rG3, źŽR˜a—˜2 (1ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 2_Œo“ŕ, 3”]ŠO): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14), ŽD–y.

723197. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) _“ŢěŒ§‘Sˆć‚É‚¨‚Ż‚é”]‘˛’†’nˆć˜AŒgƒpƒX‚̉^—pŽŔŃ‚̐„ˆÚ`_“ސě”]‘˛’†LˆćƒV[ƒ€ƒŒƒXˆă—ĂŒ¤‹†‰ď‚Ě•ń. ‚‹´—łĆ, źŽR˜a—˜1, ź‘OŒő‹I, ’ˇ’Jě‘׍O, ěŒ´M—˛ (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14), ŽD–y.

723198. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž¸Œę‚đ’ć‚ľ‚˝‰E‘O‘ĺ”]“Ž–Ź[Ç‚Ě1—á. ‹ŕŽq~‘ž˜Y1, őŹ‰pO1,ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14), ŽD–y.

723199. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œy“x”]’ę“Ž–Ź‹ˇó‚É‚ć‚萜‚ś‚˝‹´‰ş•”—ź‘¤‰„‘“ŕ‘¤[Ç‚Ě1—á. ů|“c“ÖŽq1, ˆä“‡‘ĺ•ă1, őŹ‰pO1, –k‘ş‰p“ń1, ‘“c@—ă1, ‹ß“Ą—łŽj2, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/15), ŽD–y.

723200. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •wl‰ČŽžŠł‚ÉŠÖ˜A‚ľ‚ÄRCVS‚đ”­Ç‚ľ‚˝2—á. ‰Oˆä@—É1, ˆä“‡‘ĺ•ă1, •x‰i“Ţ•Ű”ü1, –k‘ş‰p“ń1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/15), ŽD–y.

723201. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ŞŒz•”Šŕ•úŽËüŽĄ—ĂŒă‚ÉŒz“Ž–Ź‹ˇó•a•Ď‚𐜂ś, ”][Ç‚đ—ˆ‚ľ‚˝Ç—á‚ĚŒŸ“˘. őŹ‰pO1, ˆ˘‹v’Ă“ń•v1, ‚‹´˜aš1, •x‰i“Ţ•Ű”ü1, ˆä“‡‘ĺ•ă1, ´…’O1, ‹ŕŽq~‘ž˜Y1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/15), ŽD–y.

723202. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹š•”‘ĺ“Ž–Ź‰đ—Ł‚É”ş‚˘ś‚ś‚é‹•ŒŒŤ”]‘˛’†‚Ě“Ş•”CTA‚É‚ć‚é‰ć‘œ“IŒŸ“˘. ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, ů|“c“ÖŽq1, ‹ß“Ą—TŽq1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ‘“c@—ă1, ‹ß“Ą—łŽj2, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/15), ŽD–y.

723203. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚Ě”n”ö“`“ąŽžŠÔ. ź–{‰p”V, ‰Ô“‡—ĽŽq1, Ž›”öˆŔś, ‹´“cGŽi, ‰Fě‹`ˆę (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/05/18), _ŒË.

723204. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) The influence of telmisartan to cortical spreading depression on Zucker fatty rat. –k‘ş‰p“ń1, ‹ŕŕV’ź”ü2, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ, 2•a‘ԁEf—ĂŒn): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/18), _ŒË.

723205. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) CADASILŠłŽŇ‚É‚¨‚Ż‚é, MRI T2*‰ć‘œ‚Ĺ‚ĚŒoŽž“I•Ď‰ť‚Ć”]‘˛’†”­ě‚Ě—L–ł‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, őŽq‰pO1, ů|“c“ÖŽq1, ‹ŕŽq~‘ž˜Y1, ´…’G1, ‰iˆä^‹MŽq1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/18), _ŒË.

723206. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Neuropathological examination of familial Parkinson's disease with LRRK2 I2020T mutation. “ŕ–쏲Žq1, “Ąƒ–čƒŽq, ’ˇ’JěˆęŽq1, –ö‰şŽO˜Y, ‘ĺŔšD, ‰Ź–ě”üŒbŽq2, ‰Ź–ě@—T, ’†–ě—Y‘ž, ‘şŽR”É—Y, źŽR˜a—˜1 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/18), _ŒË.

723207. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) RMuSKR‘Ě—zŤdÇ‹Ř–ł—ÍÇ‚Ě—Ő°‘œ‚Ě‘˝—lŤ. ‰Oˆä@—É1, ‰Ô“‡—ĽŽq1, –k‘ş‰p“ń1, ˆä“‡‘ĺ•ă1, •x‰i“Ţ•ä”ü1, ˆ˘‹v’Ă“ń•v1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/18), _ŒË.

723208. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) MELASŠłŽŇ‚É‚¨‚Ż‚é‹@ŠB“IƒCƒŒƒEƒX‚̍‡•š‚ɂ‚˘‚Ä‚ĚŒŸ“˘. {‰ę—TŽ÷1, ‘“c@—ă1, ˆ˘•”—L‹N1, ‹ŕŽq@Œú1, ‰Oˆä@—É1, ů|“c“ÖŽq1, őŽq‰pO1, •x‰i“Ţ•Ű”ü1, ˆä“‡‘ĺ•ă1, Š}‘qŽŠŒž1, –k‘ş‰p“ń1, ˆ˘‹v’Ă“ń•v1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/18), _ŒË.

723209. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚Ě”F’mÇ‚Ě‚Č‚˘ƒp[ƒLƒ“ƒ\ƒ“•aŠłŽŇ‚Ĺ‚ĚƒpƒŒƒCƒhƒŠƒA‚Ě•p“x‚ĆˆÓ‹`‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ‚‹´˜aš1, ‹ŕŽq~‘ž˜Y1, ‰Oˆä@—É1, ů|“c“ÖŽq1, őŽq‰pO1, •x‰i“Ţ•Ű”ü1, ´…˜aŒh1, ‘“c@—ă1, ‰iˆä^‹MŽq1, ‰Ô“‡—ĽŽq1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/18), _ŒË.

723210. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) CMT‚É‚¨‚Ż‚é‹}Ť‘ˆŤ—á‚ĚŒŸ“˘. ´…˜aŒh1, ‰Ô“‡—ĽŽq1, ‘ĺŔšD, ‹ŕŽq~‘ž˜Y1, ‹ß“Ą—TŽq1, ů|“c“ÖŽq1, ‰Oˆä@—É1, ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/19), _ŒË.

723211. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) GCH1ˆâ“`ŽqˆŮí‚đ—L‚ˇ‚é‰ĆŒn‚É‚¨‚Ż‚éDAT SCAN‹y‚ŃMIBGS‹ŘƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚̏ŠŒŠ. őŹ‰pO1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, •x‰i“Ţ•Ű”ü1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1, –ě‘ş–FŽq, Ż–ě‹ąŽq (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/19), _ŒË.

723212. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ň‘Ź”]•ĎŤÇ‚Ĺ‚ĚƒvƒŠƒYƒ€‡‰ž‰Ű‘č‚ɑ΂ˇ‚éTRH—Ă–@‚ĚŒř‰Ę. ´…’G1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…˜aŒh1, ‰Fě‹`ˆę, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/20), _ŒË.

723213. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒNƒƒCƒcƒtƒFƒ‹ƒgEƒ„ƒRƒu•a‚É‚¨‚Ż‚éMRIŠgŽU‹­’˛‘œ‚ĚˆÓ‹`. ‹ŕŽq@Œú1, ‰Ô“‡—ĽŽq1, ‘“c@—ă1, ů|“c“ÖŽq1, őŹ‰pO1, ‰Oˆä@—É1, ˆ˘‹v’Ă“ń•v1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/20),_ŒË.

723214. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[E‰pŒęƒZƒbƒVƒ‡ƒ“)yCommentatorzMND (Animal model). Nagai M1: ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/20), _ŒË. (‰iˆä^‹MŽq1: 1_Œo“ŕ)

723215. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) _Œo“ď•aŠłŽŇ‚É‚¨‚Ż‚éƒXƒRƒ|ƒ‰ƒ~ƒ““îpŽg—pŽž‚ĚˆŔ‘SŤ‚Ć—LŒřŤ‚ɂ‚˘‚Ä. ˆ˘‹v’Ă“ń•v1, •x‰i“Ţ•Ű”ü1, ů|“c“ÖŽq1, őŹ‰pO1, ’ˇ“ˆ˜a–ž, ‰Ź–ě”üŒbŽq2, ”Ń’Ë‚_1, ‘O“cŽŔ‰Ô3, ŒF’J—YŽĄ3, źŽR˜a—˜1 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3—Տ°ŽŽŒąƒZ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/20), _ŒË.

723216. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[E‰pŒęƒZƒbƒVƒ‡ƒ“) Significance of cell-based assay in possible autoimmune encephalitis or related disorders: Part I. Tominaga N1, Iizuka T1, Kaneko J1, Someko H1, Ishima D1, Kitamura E1, Masuda R1, Nagai M1, Hanajima R1, Takiyama Y1, Akutsu T1, Kanazawa N2, Hara M, Dalmau J, Hirose R1, Nishiyama K1: ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/21), _ŒË. (•x‰i“Ţ•Ű”ü1, ”Ń’Ë‚_1, ‹ŕŽq~‘ž˜Y1, őŹ‰pO1, ˆä“‡‘ĺ•ă1, –k‘ş‰p“ń1, ‘“c—ă1, ‰iˆä^‹MŽq1, ‰Ô“‡—ĽŽq1, ‘ęŽR—eŽq1, ˆ˘‹v’Ă“ń•v1, ‹ŕŕV’ź”ü2, œAŁ—˛ˆę1, źŽR˜a—˜1: 1_Œo“ŕ, 2•a‘ԁEf—ĂŒn)

723217. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[E‰pŒęƒZƒbƒVƒ‡ƒ“) Significance of cell-based assay in possible autoimmune encephalitis or related disorders: Part II. Kaneko J1, Iizuka T1, Tominaga N1, Ishima D1, Shimizu T1, Shimizu K1, Kitamura E1, Masuda R1, Nagai M1, Hanajima R1, Takiyama Y1, Akutsu T1, Kanazawa N2, Hara M, Dalmau J, Hirose R1, Nishiyama K1: ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/21), _ŒË. (‹ŕŽq~‘ž˜Y1, ”Ń’Ë‚_1, •x‰i“Ţ•Ű”ü1, ˆä“‡‘ĺ•ă1, ´…’G1, ´…˜aŒh1, –k‘ş‰p“ń1, ‘“c@—ă1, ‰iˆä^‹MŽq1, ‰Ô“‡—ĽŽq1, ‘ęŽR—eŽq1, ˆ˘‹v’Ă“ń•v1, ‹ŕŕV’ź”ü2, œAŁ—˛ˆę1, źŽR˜a—˜1: 1_Œo“ŕ, 2•a‘ԁEf—ĂŒn)

723218. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yƒRƒƒ“ƒe[ƒ^[zClinical Neurophysiology. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć57‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2016/5/21), _ŒË.

723219. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)“–ˆă‰@‚É‚¨‚Ż‚é”x“ŽĂ–Ź‚낤‚É”ş‚˘ś‚ś‚˝ŠďˆŮŤ”]Çđ3Ç—á. ů|“c“ÖŽq1, ˆä“‡‘ĺ•ă1, ´…’G1, ‘“c@—ă1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć3‰ń“ú–{SŒŒŠÇ”]‘˛’†Šw‰ďŠwpW‰ď (2016/6/17), “Œ‹ž.

723220. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yŔ’ˇz–łÇŒóŤčň“Ž–Ź‹ˇó‚đ‚Ç‚¤ŽĄ—Ă‚ˇ‚é‚Š. źŽR˜a—˜ (_Œo“ŕ): ‘ć3‰ń“ú–{SŒŒŠÇ”]‘˛’†Šw‰ďŠwpW‰ď (2016/6/18), “Œ‹ž.

723221. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒqƒgŽ€Œă”]‚É‚¨‚Ż‚éLRRK2•Ş•z‚ĚŒŸ“˘. “ŕ–쏲Žq1, “Ąƒ–čƒŽq, ’†–ě—Y‘ž, źŽR˜a—˜2, ‘şŽR”É—Y (1“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[‚—îŽŇƒuƒŒƒCƒ“ƒoƒ“ƒN, 2_Œo“ŕ): ‘ć10‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2016/10/6), ‹ž“s, ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒXƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; 10: 75.

723222. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) SCA31‚Ě’ˇŠúŒo‰ßŠĎŽ@’†‚Ƀzƒ‹ƒ€ƒXUí‚đ’ć‚ľ‚˝ˆę—á. ´…˜aŒh1, ‰Ô“‡—ĽŽq1, ´…’G1, ‹ŕŽq@Œú1, őŹ‰pO1, ů|“c“ÖŽq1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć10‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2016/10/6), ‹ž“s, ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒXƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; 10: 78.

723223. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ň‘Ź”]•ĎŤÇ‚Ĺ‚ĚƒvƒŠƒYƒ€‡‰ž‰Ű‘č‚ɑ΂ˇ‚éTRH—Ă–@‚ĚŒř‰Ę. ´…’G1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…˜aŒh1, ‰Fě‹`ˆę, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć10‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX(2016/10/7),‹ž“s, ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒXƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; 10: 91.

723224. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) íőF‘Ě—DŤˆâ“`Œ`ŽŽ‚đ—L‚ˇ‚é‰Ć‘°ŤisŤŠjăŤ–ƒáƒ‚Ş‹^‚í‚ę‚˝–{–Mˆę‰ĆŒn‚ÉŠÖ‚ˇ‚é—Տ°Œ¤‹† (‘ć1•ń). ‚‹´˜aš1, ”Ń’Ë‚_1, •x‰i“Ţ•Ű”ü1, ‰Ź–ě”üŒbŽq2, ˆ˘‹v’Ă“ń•v1, ‹ŕŕV’ź”ü3, ‚‹´—S“ń, źŽR˜a—˜1 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3•a‘ԁEf—ĂŒn): ‘ć10‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2016/10/7), ‹ž“s, ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒXƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; 10: 92.

723225. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) RNMDAŽó—e‘Ě”]‰Š‚É‚¨‚Ż‚鎊ŒČ–ƉuŤ“Ş’É. •x‰i“Ţ•Ű”ü1, ”Ń’Ë‚_1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć44‰ń“ú–{“Ş’ÉŠw‰ď‘‰ď (2016/10/21), ‹ž“s.

723226. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Chronic migraine‚ĚƒŠƒXƒN‚Ć‚ľ‚Ä‚Ě‚ƒŒƒvƒ`ƒ“ŒŒÇ‚ĆƒsƒIƒOƒŠƒ^ƒ]ƒ“‚ĚŒř‰Ę. –k‘ş‰p“ń1, ‹ŕŕV’ź”ü1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć44‰ń“ú–{“Ş’ÉŠw‰ď‘‰ď (2016/10/22), ‹ž“s.

723227. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yŔ’ˇzŽĽ‹CŽhŒƒ. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡.

723228. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚Ě”n”ö“`“ąŽžŠÔ. ź–{‰p”V, –ŘŠÔ—[Žq, Ô–x‚‚Ž‚Ý, ‰Ş•”TŒá, ‰Ô“‡—ĽŽq1, Ž›”öˆŔś, ‰Fě‹`ˆę (1_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡, —Տ°_Œoś—Šw 2016/10/; 44 (5): 421.

723229. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Ň‘Ź”]•ĎŤÇ‚Ĺ‚ĚƒvƒŠƒYƒ€‡‰ž‰Ű‘č‚ɑ΂ˇ‚éTRH—Ă–@‚ĚŒř‰Ę. ´…’G1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…˜aŒh1, ‰Fě‹`ˆę, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/27), •Ÿ“‡, —Տ°_Œoś—Šw 2016/10/; 44 (5): 449.

723230. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’´‹}ŤŠú”][ÇŠłŽŇ‚É‚¨‚Ż‚é”]ŒŒŠÇÄŠJ’Ę—Ă–@ŽžŠÔ’Zk‚Ö‚ĚŽć‚č‘g‚Ý. ů|“c“ÖŽq1, ˆ˘‹v’Ă“ń•v1, ‹ŕŽq@Œú1, •x‰i“Ţ•Ű”ü1, ˆä“‡‘ĺ•ă1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć34‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2016/11/3), •ÄŽq, _ŒoŽĄ—ĂŠw 2016/10; 33(5): S205.

723231. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Ň‘Ź”]Ž¸’˛Ç31Œ^‚Ćƒp[ƒLƒ“ƒ\ƒ“•a‚̍‡•š‚É‚ć‚éƒzƒ‹ƒ€ƒXUí‚ɑ΂ľVim-thalamotomy‚Ş’˜Œř‚ľ‚˝1—á. ´…˜aŒh1, ‰Ô“‡—ĽŽq1, ´…’G1, ˛“ĄŸl2, “n•ÓŽŹ, ‹ŕŽq@Œú1, őŹ‰pO1, ů|“c“ÖŽq1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO): ‘ć56‰ń“ú–{’čˆĘE‹@”\_ŒoŠO‰ČŠw‰ď (2017/1/27), ‘ĺă.

723232. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇz‹•ŒŒŤ”]ŒŒŠÇáŠQ‚ť‚Ě‘ź…A. ˆ˘‹v’Ă“ń•v (_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/17), ‘ĺă.

723233. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) D’†‹…×–EŽżR‘Ě (ANCA) —zŤ‚Ĺ”][Ç‚đ’ć‚ľ‚˝Ç—á‚Ě—Ő°“IŒŸ“˘. ’†‘şŠ˛ş1, ˆ˘‹v’Ă“ń•v1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, “c’†Z–ž2, źŽR˜a—˜1 (1_Œo“ŕ, 2äPŒ´•aEŠ´ő“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/17), ‘ĺă.

723234. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) rt-PAEŒŒŠÇ“஡—ĂŽ{s—á‚É‚¨‚Ż‚é—ˆ‰@ŽžASPECTS‚Ě•”ˆĘ‚Ć—\Œă‚ĚŒŸ“˘. ‰Oˆä@—É1, ˆä“‡‘ĺ•ă1, ů|“c“ÖŽq1, ‹ŕŽq~‘ž˜Y1, ´…’G1, –k‘ş‰p“ń1, ŽR–{‘ĺ•ă2, ‹ß“Ą—łŽj2, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/17), ‘ĺă.

723235. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹}ŤŠú”]‘˛’†ŠłŽŇ‚É‚¨‚Ż‚é“ü‰@Œă1T‚Ě•a“•ŕsŽŠ—§‰Â”Ű‚Ě—\‘Ş. •Ÿ“c—Ď–ç1, źˆäˆŸš”ü2, “š–”“Ţ’Ă”ü2, ‰“Œ´‚Ü‚č‚Ś2, ě’[—ÇŽĄ2, ‹ß“Ą—łŽj3, ˆ˘‹v’Ă“ń•v4, źŽR˜a—˜4 (1ˆă—ÉqśŠw•”, 2ƒŠƒnƒrƒŠ•”, 3”]ŠO, 4_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/17), ‘ĺă.

723236. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) iv-tPA‚đŽ{s‚ľˆę’U_ŒoÇó‚̉ü‘P‚đ”F‚ß‚˝‚Ş, 24ŽžŠÔŒăˆČ“ŕ‚ɍč[Ç‚đ”F‚ß‚˝3Ç—á‚ĚŒŸ“˘. ˆä“‡‘ĺ•ă1, ˆ˘‹v’Ă“ń•v1, ‰Oˆä@—É1, ’†‘şŠ˛ş1, ů|“c“ÖŽq1, ‰iˆärs1, ‹ŕŽq~‘ž˜Y1, ŽR–{‘ĺ•ă2, ‹ß“Ą—łŽj2, źŽR˜a—˜1 (1_Œo“ŕ, 2”]ŠO): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/18), ‘ĺă.

723237. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) SCU‚É‚¨‚Ż‚鑁Šú‘މ@Žx‰‡‚Ě—L—pŤ`‘Šú–Ę’k’˛Ž‚Ƒމ@Žx‰‡‚Ěƒpƒ“ƒtƒŒƒbƒg“ą“ü‚É‚ć‚éÝ‰@“ú”‚̕ωť`. –öŕVŒ’‘ž˜Y, •˝“‡—DŽq, “ń–Ř’ŹŽq, ‰Ąaˆç”ü, ’†‘ş‹…Œb, –k‘ş‰p“ń1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/18), ‘ĺă.

723238. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŒđ—n‰đ—Ă–@‚đŽó‚Ż‚˝–łÇŒóŤ”]oŒŒ‚đ—L‚ˇ‚銳ŽŇ‚ÉŠÖ‚ˇ‚錟“˘. ˆ˘‹v’Ă“ń•v1, ů|“c“ÖŽq1, ‰Oˆä@—É1, ’†‘şŠ˛ş1, ˆä“‡‘ĺ•ă1, ´…’G1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/18), ‘ĺă.

731072. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŠŒČ–ƉuŤ”]‰Š‚É‚¨‚Ż‚éĹ‹ß‚Ě“ŽŒü (f’fEŽĄ—Ïă‚ĚPitfall). ”Ń’Ë‚_ (_Œo“ŕ): ‘ć86‰ń‘ĺăŹŽ™_ŒoŠw§˜b (2016/5/23), ‘ĺă.

731073. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŠŒČ–ƉuŤ”]‰Š‚É‚¨‚Ż‚éĹ‹ß‚Ě“ŽŒü (f’fEŽĄ—Ïă‚ĚPitfall). ”Ń’Ë‚_ (_Œo“ŕ): ‘ć86‰ń‘ĺăŹŽ™_ŒoŠw§˜b‰ď (2016/6/23), ‘ĺă.

731074. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): Total management of elderly patients (2016/5/31), ‰Ą•l.

731075. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”][ÇUpdate`”]‘˛’†ŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“2015‚đ‚Ó‚Ü‚Ś‚ā`. źŽR˜a—˜ (_Œo“ŕ): ‘ć10‰ń–źŒĂ‰Ž”]ŒŒŠÇáŠQƒtƒH[ƒ‰ƒ€ (2016/6/2), –źŒĂ‰Ž.

731076. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): Epilepsy Meeting in Sagamihara (2016/7/1), ‘Š–ÍŒ´.

731077. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ƒmƒEƒŠƒAƒXƒg”­”„3Žü”N‹L”Ou‰‰‰ďin‘Š–ÍŒ´ (2016/7/19), ‘Š–ÍŒ´.

731078. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒťsŽĄ—Ă‚ÖƒmƒEƒŠƒAƒXƒg‚đ•š—p‚ˇ‚é‚ą‚Ć‚Ě—Ő°–Ę‚Ĺ‚ĚƒƒŠƒbƒg. ‰Ô“‡—ĽŽq (_Œo“ŕ): ƒmƒEƒŠƒAƒXƒgWebu‰‰‰ď (2016/7/27), “Œ‹ž.

731079. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”]ŒŒŠÇáŠQf—Ă‚ĚŒťę‚Š‚ç`“ú–{‚̐_Œo“ŕ‰Čˆă‚Ć‚Í‚Č‚É‚Š? źŽR˜a—˜ (_Œo“ŕ): ‘ć7‰ń‹@”\‰ń•œ_ŒoƒTƒ}[ƒZƒ~ƒi[ŽD–y (2016/8/19), ŽD–y.

731080. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _Œo“ŕ‰Čf—Ă‚ĚŒťę‚Š‚ç`“ú–{‚̐_Œo“ŕ‰Čˆă‚Ƃ͉˝‚Š`. źŽR˜a—˜(_Œo“ŕ): ŒF–{Ô\Žš•a‰@_Œo“ŕ‰Č (2016/9/21), ŒF–{.

731081. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) SŒ´Ť”]ÇđÇŽĄ—Ă‚Ě“ŽŒü. źŽR˜a—˜ (_Œo“ŕ): ƒGƒŠƒAƒGƒLƒXƒp[ƒg‰ď‹c (2016/10/8), ‹ž“s.

731082 [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚ĚĹ‹ß‚Ě–ň•¨ŽĄ—Ă. ‰Ô“‡—ĽŽq (_Œo“ŕ): ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—Ð헪u‰‰‰ď (2016/10/21), ŒQ”n.

731083. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ‚ą‚ę‚Š‚ç‚̍‚—îŽŇˆă—Ă‚đl‚Ś‚é`S–[×“Ž‚Ć”F’mÇ` (2016/10/26), ’Ź“c.

731084. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Uí‚̐f’f‚Ć•a‘Ԑś—. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć17‰ńé‹Ęƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂŒ¤‹†‰ď (2016/11/15), ‘ĺ‹{.

731085. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ě•a‘Ԑś—. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć14‰ń‰Ą•lƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂŒ¤‹†‰ď (2016/11/17), ‰Ą•l.

731086. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) SŒ´Ť”][ÇđÇ‚̍ŐVŽĄ—Ă. źŽR˜a—˜ (_Œo“ŕ): ‘ć16‰ń‰Ą•l”]‘˛’†EƒŠƒn˜AŒgŒ¤‹†‰ď (Y-CIRCLE) (2016/11/30), ‰Ą•l.

731087. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ě•a‘Ԑś‚ĆŽĄ—Ă. ‰Ô“‡—ĽŽq (_Œo“ŕ): Šwpu‰‰‰ď (2017/1/13), b•{.

732021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒZƒ~ƒi[) ‰Ô“‡—ĽŽq (_Œo“ŕ): “ú–{—Տ°_Œoś—Šw‰ď‘ć13‰ń_Œo‹Ř“d‹Cf’fƒZƒ~ƒi[ (2016/7/2-3), –L“‡‹ć.

732022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Short Lecture) ƒp[ƒLƒ“ƒ\ƒ“•a–ň•¨ŽĄ—Ă‚ĚŽŔŰ-“–‰@‚ĹŒoŒą‚ľ‚˝Ç—á‚ɂ‚˘‚Ä. ‰Ô“‡—ĽŽq (_Œo“ŕ): ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂƒZƒ~ƒi[ (2016/6/29), ‘Š–ÍŒ´.

732023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‘‡“˘˜_) ‹ęa‚ˇ‚éPDÇó‚É‚¨‚Ż‚é, ”ńƒhƒpƒ~ƒ“Œn–ňÜ‚ĚˆĘ’u‚Ă‚Ż. ’ˇ’JěˆęŽq1, ě“‡”T—˘Žq, ‰Ô“‡—ĽŽq1, –x“ŕœ¨”üŽq, “n•ÓG‹v (1_Œo“ŕ): ƒmƒEƒŠƒAƒXƒg”­”„3Žü”N‹L”Ou‰‰‰ďin‘Š–ÍŒ´ (2016/7/19), ‘Š–ÍŒ´.

732024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Šî’˛u‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚ĚŽĄ—Ð헪. źŽR˜a—˜ (_Œo“ŕ): ƒp[ƒLƒ“ƒ\ƒ“•aŠwpu‰‰‰ď (2016/9/2), ‹ú˜H.

732025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) –ƉuŤ”]_ŒoŽžŠł‚Ě•a‘ԂƐf’f. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć2‰ńMDSJ’nˆćŒ¤‹†‰ď (2016/9/19), ÂX.

732026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ‘ć31‰ń_Œo“ď•aŒ¤C‰ď (2016/11/14), ‘Š–ÍŒ´.

732027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) _Œo“ď•a‚ĚŽĺ—v‚ČÇŒó‚ɂ‚˘‚Ä. ‰iˆä^‹MŽq (_Œo“ŕ): ‘ć31‰ń_Œo“ď•aŒ¤C‰ď (2016/11/14), ‘Š–ÍŒ´.

732028. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yƒpƒlƒŠƒXƒgz‚ą‚ę‚Š‚ç‚̍R‹ĂŒĹ—Ă–@‚Í‚Ç‚¤•Ď‰ť‚ľ‚Ä‚˘‚­‚Š? ˆä“‡‘ĺ•ă (_Œo“ŕ): Advancing Anticoagulation Care`‚ą‚ę‚Š‚ç‚̍R‹ĂŒĹ—Ă–@‚đl‚Ś‚é‰ď` (2016/11/28), ‘Š–ÍŒ´.

733151. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]y•˝Ź28”N“x“ú–{ˆă—ĂŒ¤‹†ŠJ”­‹@\ˆĎ‘ő”ď (zŠÂŠíŽžŠłE“œ”A•a“™śŠˆKŠľ•a‘΍ôŽŔ—p‰ťŒ¤‹†Ž–‹Ć)u”­ÇŽž•s–ž‚Ě”][ÇŠłŽŇ‚ɑ΂ˇ‚éĂ’ŒŒđ—n‰đ—Ă–@‚Ě“K‰žŠg‘ĺ‚đ–ÚŽw‚ľ‚˝—Տ°Œ¤‹†vz”]‘˛’†Œ¤‹†ŽŇVƒlƒbƒgƒ[ƒN‚đŠˆ—p‚ľ‚˝”]ESŒŒŠÇŽžŠł‚É‚¨‚Ż‚éRŒŒđ—Ă–@‚ĚŽŔ‘Ô‚ĆˆŔ‘SŤ‚̉đ–ž. źŽR˜a—˜ (_Œo“ŕ): •˝Ź28”N“x‘ć1‰ń‘S‘̉ď‹c (‡“Ż‰ď‹c) (2016/5/19), _ŒË.

733152. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) SCA31‚Ě’ˇŠúŒo‰ßŠĎŽ@’†‚ɐÎ~“IUí‚ޏoŒť‚ľ‚˝67Î—Ť—á. ‰Ô‰Ş‘ž˜Y1, ´…˜aŒh1, ‰Ô“‡—ĽŽq1, ´…’G1, őŽq‰pO1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć217‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2016/6/4), “Œ‹ž, —Տ°_ŒoŠw 2016/9; 56 (9): 656.

733153. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]yŔ’ˇzƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂƒZƒ~ƒi[. źŽR˜a—˜ (_Œo“ŕ): ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂƒZƒ~ƒi[ (2016/6/29), ‘Š–ÍŒ´.

733154. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ‘Š–ÍŒ´_ŒoŽžŠłƒZƒ~ƒi[ (2016/7/12), ‘Š–ÍŒ´.

733155. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽĽ‹CŽhŒƒŒŸ¸‚ĆHAL‚đ—p‚˘‚˝Œ¤‹†\‘z. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘—§•a‰@‹@\VŠƒ•a‰@ˆă—Íu‰‰‰ď (2016/7/15), VŠƒ.

733156. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Տ°–Ę‚Ĺ‚ĚƒmƒEƒŠƒAƒXƒg‚ĚˆĘ’u•t‚Ż. ‰Ô“‡—ĽŽq (_Œo“ŕ): ƒmƒEƒŠƒAƒXƒgWebu‰‰‰ď (2016/7/27), ‘Š–ÍŒ´.

733157. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “Ş’É, —}ŸTÇó‚Ĺ”­Ç‚ľ, ŠÖßƒŠƒEƒ}ƒ`‚ɍ‡•š‚ľ‚˝ŽŠŒČ–ƉuŤ”]‰Š‚Ě57Î’jŤ—á. ‹ß“Ą—TŽq1, –k‘ş‰p“ń1, ”Ń’Ë‚_1, ‘“c@—ă1, ‰Oˆä@—É1, ů|“c“ÖŽq1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć216‰ń“ú–{_ŒoŠwŠÖ“ŒEbM‰z’n•ű‰ď (2016/7/28), “Œ‹ž, —Տ°_ŒoŠw 2016/7; 56 (7): 510.

733158. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚ĚŽĄ—Ă. ‰Ô“‡—ĽŽq (_Œo“ŕ): “ú–{ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłŠw‰ď‘ć1‰ńƒp[ƒLƒ“ƒ\ƒ“•aƒi[ƒXŒ¤C‰ď (2016/8/27), “Œ‹ž.

733159. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’ˇŠúŒo‰ß‚đŠĎŽ@‚ľ“ž‚˝fukutinˆâ“`Žq•ĎˆŮ‚𔺂¤Šg’ŁŒ^S‹ŘÇ‚ƐisŤ‹ŘƒWƒXƒgƒƒtƒB[‚Ě62Î—Ť—á. ů|“c“ÖŽq1, ě˜Q@•ś1, ‰iˆä^‹MŽq1, ‰Ô“‡—ĽŽq1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć218‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2016/9/3), “Œ‹ž, —Տ°_ŒoŠw 2016/12; 56 (12): 887.

733160. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ALS‚̏‰”­Çó‚Ě‘˝—lŤ‚Ɛf’f‚ĚŽŔŰ. ‰iˆä^‹MŽq (_Œo“ŕ): _Œo“ŕ‰Čˆă‚Ě‚˝‚߂̐_Œo“ŕ‰Čˆă‚É‚ć‚éALSuŔ (2016/9/18), “Œ‹ž.

733161. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚̐ł‚ľ‚˘—‰đ‚ƍŐVŽĄ—Ă–@. źŽR˜a—˜ (_Œo“ŕ): ƒxƒlƒbƒZ‚Ě’nˆćˆă—ĂƒZƒ~ƒi[ (2016/10/2), ’Ź“c.

733162. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): _“ŢěŒ§MGŠwpu‰‰‰ď (2016/10/4), ŠC˜V–ź.

733163. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]yŠJ‰ď‚ĚŽŤzźŽR˜a—˜ (_Œo“ŕ): ‘ć3‰ń_Œo‹Ř’´‰š”gŒ¤‹†‰ď (2016/10/27), ŒSŽR.

733164. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]yŔ’ˇzĐŠQ‚Ɛ_Œo“ď•a. źŽR˜a—˜1, ‰iˆä^‹MŽq1 (1_Œo“ŕ): ‘ć31‰ń_Œo“ď•aŒ¤C‰ď (2016/11/14), ‘Š–ÍŒ´.

733165. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ĐŠQ‚Ɛ_Œo“ď•a|_Œo“ŕ‰Čˆă‚Ě—§ę‚Š‚ç. źŽR˜a—˜ (_Œo“ŕ): ‘ć31‰ń_Œo“ď•aŒ¤C‰ď (2016/11/14), ‘Š–ÍŒ´.

733166. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‘˝”­Ťd‰ťÇ‚Ě—Ő°‚Ć–ň•¨ŽĄ—Âɂ‚˘‚ā`“–‰@‚ĹŒo‰ßŠĎŽ@‚ľ‚Ä‚˘‚éTumefactive MS‚ĚŒŸ“˘‚ŕŠÜ‚߂ā`. ‹ŕŽq~‘ž˜Y (_Œo“ŕ): źĂ-Œ§‰›_Œo“ŕ‰Čƒlƒbƒgƒ[ƒN(2016/11/15), ‘Š–ÍŒ´.

733167. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŽi‰ďzźŽR˜a—˜ (_Œo“ŕ): źĂ-Œ§‰›_Œo“ŕ‰Čƒlƒbƒgƒ[ƒN (2016/11/15), ‘Š–ÍŒ´.

733168. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) RAMPARR‘Ě, RCV2/CRMP5R‘Ě, RGABAA RR‘Ě‚Ş—zŤ‚Ĺ‚ ‚Á‚˝Stiff-personÇŒóŒQ‚Ěˆę—á. Žń“Ą“ÄŽj, —§‰Ô‹vŽk, ‚“c^—˜Žq, çŒ´“T•v, ă“cŒ’”Ž, ŠÖŒűŒ“Ži, ŒĂ˜a‹v•ü, ”Ń’Ë‚_1, ŠĄ“c“Tś, ŒË“c’BŽj (1_Œo“ŕ): ‘ć106 ‰ń“ú–{_ŒoŠw‰ď‹ß‹E’n•ű‰ď (2016/11/19), ‹ž“s, —Տ°_ŒoŠw 2017/3; 57 (3): 143.

733169. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]y•Â‰ď‚ĚŽŤzźŽR˜a—˜ (_Œo“ŕ): Advancing Anticoagulation Care`‚ą‚ę‚Š‚ç‚̍R‹ĂŒĹ—Ă–@‚đl‚Ś‚é‰ď` (2016/11/28), ‘Š–ÍŒ´.

733170. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 3Ží—Ţ‚ĚR_Œo×–E•\–ʍRŒ´R‘Ě‚Ş—zŤ‚Ĺ‚ ‚Á‚˝—‘‘ƒŠďŒ`Žî‚ɐ”ş‚ľ‚˝ŽŠŒČ–ƉuŤ”]‰Š‚Ě27Î—Ť—á. ‚‹´˜aš1, –k‘ş‰p“ń1, ’†‘şŠ˛ş1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć219‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2016/12/3), “Œ‹ž —Տ°_ŒoŠw 2017/4; 57 (4): 191.

733171. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ˆę”ʍu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ‘ć18‰ń_“ŢěŒ§_Œo–ƉuƒtƒH[ƒ‰ƒ€(ˆÄ) (2016/12/7), ‰Ą•l.

733172. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŽŠŒČ–ƉuŤ”]‰Š‚ĚĹ‹ß‚Ě˜b‘č. ‹ŕŽq~‘ž˜Y (_Œo“ŕ): ‘ć18‰ń_“ŢěŒ§_Œo–ƉuƒtƒH[ƒ‰ƒ€ (2016/12/7), ‰Ą•l.

733173. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RNMDAŽó—e‘Ě”]‰Š‚Ć‚ť‚ĚŽü•ÓŽžŠł. ”Ń’Ë‚_ (_Œo“ŕ): •şŒÉŒ§—§•P˜HzŠÂŠí•aƒZƒ“ƒ^[Œ¤C‰ď (2016/12/8), •P˜H.

733174. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 75ÎŽž‚Ɉâ“`ŽqŒŸ¸‚ɂĐҐ‘Ť‹ŘˆŢkÇ3Œ^‚Ɛf’f‚ľ“ž‚˝1—á. ‘ĺˆä^—˘“Ţ, ´…˜aŒh1, ‰Ô“‡—ĽŽq1, ‰iˆä^‹MŽq1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć629‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/12/10), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď 2016/12; 629: 55.

733175. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ě•a‘Ԑś—. ‰Ô“‡—ĽŽq (_Œo“ŕ): ƒnƒbƒs[ƒtƒFƒCƒXƒZƒ~ƒi[ (2016/12/17), “Œ‹ž.

733176. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]y‘˝”­Ťd‰ťÇś‘ĚŽŽ—żƒoƒ“ƒN‚đŠˆ—p‚ľ‚˝ƒAƒWƒAl“Á—L‚Ěˆâ“`ŠÂ‹ŤˆöŽq’Tő‚É‚ć‚é•a‘Ô‰đ–žŒ¤‹†”ǁzRNMDAŽó—e‘Ě”]‰Š‚É‚¨‚Ż‚é”]‚ĚˆŢk‚Ć‹@”\—\Œă: ’E‘ŤŽžŠł‚Ć‚ĚˆŮ“Ż. ”Ń’Ë‚_1, ‹ŕŽq~‘ž˜Y1, •x‰i“Ţ•Ű”ü1, ‹ŕŽq@Œú1, –k‘ş‰p“ń1, ‹ŕŕV’ź”ü2, źŽR˜a—˜1 (1_Œo“ŕ, 2•a‘ԁEf—ĂŒn):u‘˝”­Ťd‰ťÇś‘ĚŽŽ—żƒoƒ“ƒN‚đŠˆ—p‚ľ‚˝ƒAƒWƒAl“Á—L‚Ěˆâ“`ŠÂ‹ŤˆöŽq’Tő‚É‚ć‚é•a‘Ô‰đ–žŒ¤‹†”ǁv•˝Ź28”N“x‡“Ż”ljď‹c (2017/1/18), “Œ‹ž.

733177. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]y•˝Ź28”N“xu‰^“ŽŽ¸’˛Ç‚Ěˆă—ĂŠî”Ő‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v”ǁzŇ‘Ź”]•ĎŤÇ‚Ö‚ĚTRH—Ă–@‚ĚŒř‰Ę‚ĆƒvƒŠƒYƒ€‡‰ž‰Ű‘č‚ւ̉e‹ż. ‰Fě‹`ˆę, ´…’G1, ‰Ô“‡—ĽŽq1 (1_Œo“ŕ):u‰^“ŽŽ¸’˛Ç‚Ě•ŞŽq•a‘ԉ𖞁EŽĄ—Ă–@‚ĚŠJ”­‚ÉŠÖ‚ˇ‚錤‹†v”Ç ‡“ŻŒ¤‹†•ń‰ď(2017/1/19), “Œ‹ž.uŒ¤‹†•ń‘v‚Š‚çˆÚ“ŽŒfÚ

733178. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’˜–ž‚Č‘ĚdŒ¸­‚đŒ_‹@‚ÉACTH’P“ĆŒ‡‘šÇ‚Ɛf’f‚ľ‚˝1—á. ‹g•ô’mG1, ‰i‹v‘žˆę1, ”Ńƒ–’J”ü•ô1,2, “c”¨Œő‹v1, ŽR“c@Œĺ1, “c’†~ˆę1 (1–k—˘Œ¤‹†Š•a‰@, 2_Œo“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć630‰ńŠÖ“Œ’n•ű‰ď (2017/2/11), “Œ‹ž.

733179. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]y•Â‰ďˆĽŽAzźŽR˜a—˜ (_Œo“ŕ): ‘ć3‰ń_“ސě_Œo•ĎŤE–ƉuŽžŠł•a‘ÔŒ¤‹†‰ď (2017/2/24), ‰Ą•l.

733180. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)]y•Â‰ďˆĽŽAzźŽR˜a—˜ (_Œo“ŕ): ‘ć18‰ń_“ސěMovement Disorder ƒtƒH[ƒ‰ƒ€(2017/3/1), ‰Ą•l.

733181. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’Pƒƒwƒ‹ƒyƒX”]‰Š‰ń•œŒă‚ɏd“x‚Ě‚¤‚ó‘Ԃ𐜂ś‚˝RNMDAŽó—e‘̍R‘Ě—zŤ‚Ě34Î—Ť—á. ‰iˆärs1, –k‘ş‰p“ń1, ”Ń’Ë‚_1, –Ř‹–‘ń”n1, ‚‹´˜aš1,’†‘şŠ˛ş1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć220‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2017/3/4), “Œ‹ž.


ŒŒ‰t“ŕ‰ČŠw

[Šwp˜_•ś]

110136. [Œ´’˜] Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation. Ishida T1, Takahashi S, Chen-Yi Lai, Yamamoto R, Takeuchi E2, Takeuchi Y3, Higashihara M1, Nakauchi H, Otsu M: Journal of Experimental Medicine 2016/8; 213 (9): 1865-80. (Î“c@—˛1, ’|“ŕŒb”üŽq2, ’|“ŕN—Y3, “ŒŒ´ł–ž1: 1ŒŒ‰t“ŕ, 2–Ɖu, 3t‘Ÿ“ŕ)

110137. [Œ´’˜] Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan. Sugimoto M, Ito S, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Ashizawa M, Yamamoto C, Fujiwara S, Okazuka K, Hatano K, Sato K, Oh I, Ohmine K, Suzuki T1, Muroi K, Kako S, Kanda Y: Ann Hematol 2016/9; 95 (9): 1513-9. (—é–Ř—˛_1: 1ŒŒ‰t“ŕ)

110138. [Œ´’˜] Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations. Suzuki T1, Kobayashi H, Kawasaki Y, Okazuka K, Hatano K, Fujiwara S, Oh I, Ohmine K, Kanda Y: Int J Hematol 2016/10; 104 (4): 446-53. (—é–Ř—˛_1: 1ŒŒ‰t“ŕ)

110139. [Œ´’˜] Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia. Yamamoto C, Ito S, Mashima K, Umino K, Minakata D, Yamasaki R, Kawasaki Y, Sugimoto M, Nakano H, Ashizawa M, Okazuka K, Hatano K, Sato K1, Oh I, Fujiwara S, Ohmine K, Suzuki T1, Muroi K, Kanda Y: Leuk Lymphoma 2016/11; 57 (11): 2541-7. (—é–Ř—˛_1: 1ŒŒ‰t“ŕ)

110140. [Œ´’˜] High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Umino K, Fujiwara SI, Sato K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Yamamoto C, Hatano K, Okazuka K, Oh I, Ohmine K, Suzuki T1, Muroi K, Kanda Y: Acta Haematol 2017/1; 137 (2): 93-9. (—é–Ř—˛_1: 1ŒŒ‰t“ŕ)

110141. [Œ´’˜] Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma. Umino K, Fujiwara SI, Ito S, Mashima K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T1, Muroi K, Kanda Y: Leuk Lymphoma 2017/2; 58 (2): 316-23. (—é–Ř—˛_1: 1ŒŒ‰t“ŕ)

110142. [Œ´’˜] Mutation in the tail region of MYH9 inhibits disassembly of nonmuscle myosin IIA. Kamata H1, Miyazaki K2, Komatsu S, Jung HS, Craig R, Higashihara M3, Suzuki T3, Ikebe M: Kitasato Med J 2017/3; 47 (1): 31-42. (Š™“c_–Ť1, ‹{č_“ń2, “ŒŒ´ł–ž3, —é–Ř—˛_3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2—AŒŒE×–EˆÚA, 3ŒŒ‰t“ŕ)

110143. [Œ´’˜] Iron overload patients with unknown etiology from national survey in Japan. Ikuta K, Hatayama M, Addo L, Toki Y, Sasaki K, Tatsumi Y, Hattori A, Kato A, Kato K, Hayashi H, Suzuki T1, Kobune M, Tsutsui M, Gotoh A, Aota Y, Matsuura M, Hamada Y, Tokuda T, Komatsu N, Kohgo Y: Int J Hematol 2017/3; 105 (3): 353-60. (—é–Ř—˛_1: 1ŒŒ‰t“ŕ)

310010. [Ç—á•ń] Successful treatment with ibrutinib of intractable thrombocytopenia associated with recurrent chronic lymphocytic leukemia. Ishida T1, Yokoyama M2, Danbara M1, Michishita Y1, Horie R3, Higashihara M1, Miyazaki K4: Kitasato Med J 2017/3; 47 (1): 81-6. (Î“c@—˛1, ‰ĄŽR^Šě2, ’hŒ´Š˛ś1, “š‰ş—Y‰î1, –x]—Lję3, “ŒŒ´ł–ž1, ‹{č_“ń4: 1ŒŒ‰t“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”, 4—AŒŒE×–EˆÚA)

522063. [uŔ]y“ÁW: “úíf—Ă‚Ĺ‘˜‹ö‚ˇ‚é“Ť‘˘ŒŒŠíŽîᇂ̘b‘č‚Ć‚ť‚ĚƒAƒvƒ[ƒ`zAzacitidine ’ďRŤMDS‚ɑ΂ˇ‚鎥—Ð헪. —é–Ř—˛_ (ŒŒ‰t“ŕ): ŒŒ‰t“ŕ‰Č 2016/5; 72 (5): 557-61.

522064. [uŔ]y“ÁW: ”ÄŒŒ‹…Œ¸­ÇzŠ´őÇ‚É‚ć‚é”ÄŒŒ‹…Œ¸­. –x•Ä—Cˆę (ŒŒ‰t“ŕ): ŒŒ‰t“ŕ‰Č 2016/6; 72 (6): 800-5.

522065. [uŔ]y“ÁW: ÔŒŒ‹…ŒnŽžŠłz“SÜ•s‰ž‚Ě“SŒ‡–RŤ•nŒŒ. —é–Ř—˛_ (ŒŒ‰t“ŕ): —Տ°ŒŒ‰t 2016/10; 57 (10): 1881-9.

522066. [uŔ]y“ÁW: •nŒŒ|ŽŔ’nˆă‰Ć‚ɖ𗧂’mŽŻ‚Ɛf—Â̐i‚ß‚Š‚˝zEƒZƒ~ƒi[^—Տ°‚ɖ𗧂’mŽŻ‚Əî•ń@Äś•s—ǐŤ•nŒŒ‚ƍœ‘ˆŮŒ`ŹÇŒóŒQ‚ĚŠÓ•Ę. —é–Ř—˛_ (ŒŒ‰t“ŕ): Medical Practice 2016/9; 33 (9): 1407-12.

522067. [uŔ]y“ÁW: ‰ü’ů‘˘ŒŒŠíŽîá‡WHO•Ş—Ţ2016`ŠT—v‚ĆˆÓ‹``z2. œ‘ˆŮŒ`ŹÇŒóŒQ. —é–Ř—˛_ (ŒŒ‰t“ŕ): ŒŒ‰tƒtƒƒ“ƒeƒBƒA 2017/3; 27 (3): 367-75.

540010. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)]yf—ĂƒKƒCƒhƒ‰ƒCƒ“ at a glancez—AŒŒŒă“S‰ßčÇ‚̐f—ĂƒKƒCƒh (Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á”­Ť‘˘ŒŒáŠQ‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v(•˝Ź20”N“x)). —é–Ř—˛_ (ŒŒ‰t“ŕ): “ú–{“ŕ‰ČŠw‰ďŽGŽ 2017/4; 106 (4); 786-91.¨H29”N“x”­s‚Č‚Ě‚Ĺ—ˆ”N“x”Ĺ‚ÉŒfÚ‚ľ‚Ü‚ˇ

[’˜@‘]

620057. [Šwp‘ (•Ş’SŽˇ•M)]yŒŒ‰t‰ČŒ¤Cƒm[ƒgz‘ć5Í ŒŒ‰t‰ČŽžŠł‚̐f—Á@1. “SŒ‡–RŤ•nŒŒ, p.220-4. —é–Ř—˛_ (ŒŒ‰t“ŕ), ‘ŠÄC: ‰iˆä—ÇŽO, Ó”C•ŇW: _“c‘PL, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/5”­s.

620058. [Šwp‘ (•Ş’SŽˇ•M)]yEBMŒŒ‰tŽžŠł‚ĚŽĄ—Ă2017-2018zII. ÔŒŒ‹…ŒnŽžŠł@3. ’჊ƒXƒNMDS‚ĚŽĄ—Ă, p.32-8. —é–Ř—˛_ (ŒŒ‰t“ŕ), •Ň: ‹ŕ‘q@÷, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/10”­s.

620059. [Šwp‘ (•Ş’SŽˇ•M)]y”’ŒŒ•aŠw (‰ş)|ĹV‚ĚŠî‘b, —Տ°Œ¤‹†|(“ú–{—ŐŕŹ74ŠŞ‘Š§†10)zVIII. ”’ŒŒ•a‚ĚŽĄ—Ă: Še˜_ (‰ťŠw—Ă–@‚Ć•ŞŽq•W“I—Ă–@)@6. ‚ƒŠƒXƒNœ‘ˆŮŒ`ŹÇŒóŒQ, p.115-121. —é–Ř—˛_ (ŒŒ‰t“ŕ), “ú–{—Ő଎Đ, “Œ‹ž, 2016/12”­s.

620060. [Šwp‘ (•Ş’SŽˇ•M)]y•nŒŒŠw|ĹV‚̐f’fEŽĄ—Ă“ŽŒü|(“ú–{—ŐŕŹ75ŠŞ‘Š§†1)zIII. ‘˘ŒŒˆöŽqŒ‡–R‚É‚ć‚é•nŒŒ@5) “S‰ßčÇ‚Ě•a‘Ô‚ĆŽĄ—Ă, p.118-22. —é–Ř—˛_ (ŒŒ‰t“ŕ), “ú–{—Ő଎Đ, “Œ‹ž, 2017/1”­s.

620061. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚ĚŽĄ—ĂŽwj 2017”N”Łz10 ŒŒ‰tŽžŠł@œ‘úŽh–@, śŒŸ–@ (“K‰ž‚Ć•ű–@), p.624. —é–Ř—˛_ (ŒŒ‰t“ŕ), ‘•ŇW: •ŸˆäŽŸ–î, ‚–؁@˝, ŹŽşˆęŹ, ˆăŠw‘‰@, “Œ‹ž, 2017/1”­s.

620062. [Šwp‘ (•Ş’SŽˇ•M)]yŒŒ‰t‚Ş‚ń`ĹVŽĄ—Ă‚ĆŽxŽ—Ă–@` (‚Ş‚ńŠĹŒě2017”N1-2ŒŽ‘Š§†)z‘ćIIIÍ V‹K–ňÜ‚É‚ć‚鎥—Ð헪‚ĆƒPƒA‚ĚŽŔŰ@<”’ŒŒ•a> œ‘ˆŮŒ`ŹÇŒóŒQ, p.194-201. —é–Ř—˛_ (ŒŒ‰t“ŕ), “ě]“°, “Œ‹ž, 2017/2”­s.

620063. [Šwp‘ (•Ş’SŽˇ•M)]yŒŒ‰tŽžŠłĹV‚ĚŽĄ—Ă2017-2019zIII ‘˘ŒŒŒnEƒŠƒ“ƒpŒnŽžŠł@7. ’჊ƒXƒNœ‘ˆŮŒ`ŹÇŒóŒQ, p.145-8. —é–Ř—˛_ (ŒŒ‰t“ŕ), •Ň: ŹŕVŒh–ç, ’†”öáÁ“ń, ź‘ş@“ž, “ě]“°, “Œ‹ž, 2017/2”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722078. [Šw‰ď (‘S‘)] (ƒR[ƒ|ƒŒ[ƒgƒZƒ~ƒi[) MDS•Ş—Ţ‚ĆŽĄ—Â̐i‰ť. —é–Ř—˛_ (ŒŒ‰t“ŕ): ‘ć78‰ń“ú–{ŒŒ‰tŠw‰ďŠwpW‰ď (2016/10/13-5), ‰Ą•l, —Տ°ŒŒ‰t 2016; 57 (9): 28.

722079. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) “SÜ•s‰ž‚Ě“SŒ‡–RŤ•nŒŒ. —é–Ř—˛_ (ŒŒ‰t“ŕ): ‘ć78‰ń“ú–{ŒŒ‰tŠw‰ďŠwpW‰ď (2016/10/13-5), ‰Ą•l, —Տ°ŒŒ‰t 2016; 57 (9): 66.

723239. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚Ń‚Ü‚ńŤ‘ĺ×–EŤB×–EƒŠƒ“ƒpŽî‚É‚¨‚Ż‚éCD109‚Ě”­Œť‚Ć‹@”\‚ɂ‚˘‚Ä. ‰ĄŽR^Šě1, ˆęŒËš–ž2, ‰Ľ@‘c˝3, ŸNˆä–ő‚2, ’‡“c“TL2, “ŒŒ´ł–ž3, ‘ş‰_–FŽ÷2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3ŒŒ‰t“ŕ): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723240. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Efficacy and safety of anagrelide in essential thrombocythemia - an analysis of our institute. “š‰ş—Y‰î1, ‹{č_“ń2, Ź‘qTŽi1, –x•Ä—Cˆę1, ‰HŽRŒdˆČ3, ‹{“c’m”ü1, “cŽ›”͍s1, Î“c@—˛1, ‰Ľ@‘c˝1, ’hŒ´Š˛ś1, “ŒŒ´ł–ž1 (1ŒŒ‰t“ŕ, 2—AŒŒE×–EˆÚA, 3Œ’NŠÇ—ƒZ): ‘ć78‰ń“ú–{ŒŒ‰tŠw‰ďŠwpW‰ď (2016/10/13-5), ‰Ą•l, —Տ°ŒŒ‰t 2016; 57 (9): 90.

723241. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Up-regulation of CD109 expression is associated with the poor prognosis of patients with DLBCL. ‰ĄŽR^Šě1, ˆęŒËš–ž2, ‰Ľ@‘c˝3, ’‡“c“TL2, ŸNˆä–ő‚2, “ŒŒ´ł–ž3, ‘ş‰_–FŽ÷2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3ŒŒ‰t“ŕ): ‘ć78‰ń“ú–{ŒŒ‰tŠw‰ďŠwpW‰ď (2016/10/13-5), ‰Ą•l, —Տ°ŒŒ‰t 2016; 57 (9): 111.

723242. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) High expression of REV7 is an independent prognostic indicator in DLBCLs with R-CHOP. ‰Ľ@‘c˝1, ‰ĄŽR^Šě2, Ź‘qTŽi1, “š‰ş—Y‰î1, ‰HŽRŒdˆČ3, –x•Ä—Sˆę1, “cŽ›”͍s1, ’hŒ´Š˛ś1, ‹{č_“ń4, ‘ş‰_–FŽ÷5, “ŒŒ´ł–ž1 (1ŒŒ‰t“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Œ’NŠÇ—ƒZ, 4—AŒŒE×–EˆÚA, 5•a—): ‘ć78‰ń“ú–{ŒŒ‰tŠw‰ďŠwpW‰ď (2016/10/13-5), ‰Ą•l, —Տ°ŒŒ‰t 2016; 57 (9): 171.

723243. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Multiple allogeneic progenitors in combination can support early hematopoiesis in transplantation. Î“c@—˛1, ‚‹´@‘, —Š@’ĺ‹V, ’†“ŕŒ[Œő, ‘ĺ’Á@^, “ŒŒ´ł–ž1 (1ŒŒ‰t“ŕ): ‘ć78‰ń“ú–{ŒŒ‰tŠw‰ďŠwpW‰ď (2016/10/13-5), ‰Ą•l,

732029. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) œ‘ˆŮŒ`ŹÇŒóŒQ (MDS)|f—Ă‚ĚŠî‘b‚ĆĹ‹ß‚Ěi•ŕ. —é–Ř—˛_ (ŒŒ‰t“ŕ): ‘ć54‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“ŒŽx•”ŽĺĂśŠU‹łˆçu‰‰‰ď (2016/7/10“ú), “Œ‹ž.

732030. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) MDS‚Ě•a‘Ô‚ĆŽĄ—Á|Ĺ‹ß‚Ě˜b‘č|. —é–Ř—˛_ (ŒŒ‰t“ŕ): “ú–{—AŒŒE×–EŽĄ—ĂŠw‰ď“Œ–kŽx•”—á‰ď (2016/9/3), ŽRŒ`.

733182. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒAƒ‹ƒR[ƒ‹ŤŠĚd•Ď‚ɍ‡•š‚ľ‚˝HHV-8-unrelated Primary effusion lymphoma-like lymphoma‚Ěˆę—á. ×’J^Ži, ‰Ľ@‘c˝1, Ź‘qTŽi1, “š‰ş—Y‰î1, ‰HŽRŒdˆČ1, –x•Ä—Cˆę1, “cŽ›”͍s1, Î“c@—˛1, ’hŒ´Š˛ś1, ‹{č_“ń2, “ŒŒ´ł–ž1 (1ŒŒ‰t“ŕ, 2—AŒŒE×–EˆÚA): Ă“ěŒŒ‰tƒZƒ~ƒi[ (2016/5/29), ěč.

733183. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Bcl-2 negativebó‘Bŕh–EŤƒŠƒ“ƒpŽî‚ĚŽŠŒą—á. ˆŔ’BOl, ‰Ľ@‘c˝1, Ź‘qTŽi1, “š‰ş—Y‰î1, ‰HŽRŒdˆČ1, –x•Ä—Cˆę1, “cŽ›”͍s1,Î“c@—˛1, ’hŒ´Š˛ś1, ‹{č_“ń2, “ŒŒ´ł–ž1 (1ŒŒ‰t“ŕ, 2—AŒŒE×–EˆÚA): ‘ć74‰ń_“ŢěŒŒ‰tŒ¤‹†‰ď, (2016/9/10), ‰Ą•l.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-733004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œ‡‘šÇŒóŒQ‚ɍ‡•š‚ľ‚˝BSS‚ĚˆęÇ—á. Ş–{—YŽu1, ŽO‘ş—I—C, “š‰ş—Y‰î1, –x•Ä—Cˆę1, ‰HŽRŒdˆČ1, ‹{“c’m”ü1, “cŽ›”͍s1, Ôě’ź”V1, ’hŒ´Š˛ś1, ‹{č_“ń2, –x]—Lję1, “ŒŒ´ł–ž1 (1ŒŒ‰t“ŕ, 2—AŒŒE×–EˆÚA): ‘ć73‰ń_“ŢěŒŒ‰tŒ¤‹†‰ď (2016/2/27), _“ސě, _“ŢěŒŒ‰tŒ¤‹†‰ďŽ 2016; 36: 108-10.


ŒÄ‹zŠí“ŕ‰ČŠw

[Šwp˜_•ś]

110144. [Œ´’˜] Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer. Igawa S1, Sasaki J2, Otani S1, Shirasawa M1, Niwa H1, Kusuhara S1, Harada S1, Kubota M1, Katagiri M3, Masuda N1: Oncology 2016/5; 91 (1): 41-7. (ˆäě@‘1, ˛X–ŘŽĄˆę˜Y2, ‘ĺ’JçŽq1, ”’ŕVš”V1, ’O‰H‰p”V1, “팴­ˆę˜Y1, Œ´“c^–ç1, ‹v•Ű“cŸ1, •Đ‹Ë^l3, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ÉqśŠw•”)

110145. [Œ´’˜] Predictive significance of thyroid transcription factor-1 expression in patients with non-squamous non-small cell lung cancer with wild-type epidermal growth factor receptor treated with erlotinib. Nakahara Y1, Hosomi Y, Saito M, Ogawa M, Hishima T, Okamura T, Sasaki J2, Masuda N1: Mol Clin Oncol 2016/7; 5 (1): 14-8. (’†Œ´‘P˜N1, ˛X–ŘŽĄˆę˜Y2, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110146. [Œ´’˜] EGFR Mutation Genotype Impact on the Efficacy of Pemetrexed in Patients with Nonsquamous Nonsmall Cell Lung Cancer. Igawa S1, Sato Y2, Ishihara M1, Kasajima M1, Kusuhara S1, Nakahara Y1, Otani S1, Fukui T1, Katagiri M2, Sasaki J3, Masuda N1: Asian Pac J Cancer Prev 2016/8; 17 (7): 3249-53. (ˆäě@‘1, ˛“Ą—Yˆę2, ÎŒ´–˘ŠóŽq1, Š}“‡^Žu1, “팴­ˆę˜Y1, ’†Œ´‘P˜N1, ‘ĺ’JçŽq1, •Ÿˆä•ü–ç1, ˛X–ŘŽĄˆę˜Y3, •Đ‹Ë^l2, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110147. [Œ´’˜] Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1. Nakahara Y1, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T: Onco Targets Ther 2016/8; 9: 5287-95. (’†Œ´‘P˜N1: 1ŒÄ‹zŠí“ŕ)

110148. [Œ´’˜] Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations. Igawa S1, Ryuge S1, Ichinoe M2, Nakashima H5, Otani S1, Nakahara Y1, Fukui T1, Sasaki J4, Kubota M1, Katagiri M5, Murakumo Y2, Satoh Y5, Sato Y5, Masuda N1: Oncol Res Treat 2017/1; 40 (1-2): 7-13. (ˆäě@‘1, —´‰ŘTˆę˜Y1, ˆęŒËš–ž2, ’†“‡—TN3, ‘ĺ’JçŽq1, ’†Œ´‘P˜N1, •Ÿˆä•ü–ç1, ˛X–ŘŽĄˆę˜Y4, ‹v•Ű“cŸ1, •Đ‹Ë^l5, ‘ş‰_–FŽ÷2, ˛“Ą”Vr5, ˛“Ą—Yˆę5, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2•a—, 3ŒÄ‹zŠíŠO, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 5ˆă—ÉqśŠw•”)

110149. [Œ´’˜] Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer. Igawa S1, Sato Y2, Ryuge S1, Ichinoe M3, Katono K1, Hiyoshi Y1, Otani S1, Nagashio R2, Nakashima H4 Katagiri M2, Sasaki J5, Murakumo Y3, Satoh Y4, Masuda N1: Oncology 2017/2; 92 (5): 283-90. (ˆäě@‘1, ˛“Ą—Yˆę2, —´‰ŘTˆę˜Y1, ˆęŒËš–ž3, ă‰“–ěŒ’1, “ú‹gNO1, ‘ĺ’JçŽq1, ’ˇ‰–@—ş2, ’†“‡—TN4, •Đ‹Ë^l2, ˛X–ŘŽĄˆę˜Y5, ‘ş‰_–FŽ÷3, ˛“Ą”Vr4, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3•a—, 4ŒÄ‹zŠíŠO, 5V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110150. [Œ´’˜] Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer. Kasajima M1, Igawa S1, Ishihara M1, Otani S1, Takakura A1, Yokoba M2, Kubota M1, Sasaki J3, Katagiri M2, Masuda N1: Oncol Lett 2017/3; 13 (3): 1719-24. (Š}“‡^Žu1, ˆäě@‘1, ÎŒ´–˘ŠóŽq1, ‘ĺ’JçŽq1, ‚‘q@W1, ‰Ąęł“T2, ‹v•Ű“cŸ1, ˛X–ŘŽĄˆę˜Y3, •Đ‹Ë^l2, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110151. [Œ´’˜] Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers. Ryuge S1, Sato Y2, Nagashio R2, Hiyoshi Y1, Katono K1, Igawa S1, Nakashima H3, Shiomi K3, Ichinoe M4, Murakumo Y4, Saegusa M4, Satoh Y3, Masuda N1: PLoS One 2017/3; 12 (3): e0173886. (—´‰ŘTˆę˜Y1, ˛“Ą—Yˆę2, ’ˇ‰–@—ş2, “ú‹gNO1 ă‰“–ěŒ’1, ˆäě@‘1, ’†“‡—TN3, ‰–ŒŠ@˜a3, ˆęŒËš–ž4, ‘ş‰_–FŽ÷4, ŽOŽ}@M4, ˛“Ą”Vr3, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3ŒÄ‹zŠíŠO, 4•a—)

310011. [Ç—á•ń] Alectinib as a treatment option following recovery from crizotinib-induced interstitial lung disease in patients with anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. Nukaga S, Naoki K1, Kamo T, Masuzawa K, Yasuda H, Soejima K, Betsuyaku T: Mol Clin Oncol 2016/6; 4 (6): 1085-7. (—P–؍Ž•F1: 1ŒÄ‹zŠí“ŕ)

310012. [Ç—á•ń] Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report. Shirasawa M1, Kubota M1, Harada S1, Niwa H1, Kusuhara S1, Kasajima M1, Hiyoshi Y1, Ishihara M1, Igawa S1, Masuda N1: Lung Cancer 2016/9; 99: 66-8. (”’ŕVš”V1, ‹v•Ű“cŸ1, Œ´“c^–ç1, ’O‰H‰p”V1, “팴­ˆę˜Y1, Š}“‡^Žu1, “ú‹gNO1, ÎŒ´–˘ŠóŽq1, ˆäě@‘1, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ)

310013. [Ç—á•ń] Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report Tani T, Naoki K1, Asakura T, Hirano T, Suzuki S, Masuzawa K, Hasegawa H, Kuroda A, Yasuda H, Ishii M, Soejima K, Betsuyaku T: Mol Clin Oncol 2016/10; 5 (4): 488_90. (—P–؍Ž•F1: 1ŒÄ‹zŠí“ŕ)

310014. [Ç—á•ń] Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer. Shirasawa M1, Nakahara Y1, Niwa H1, Harada S1, Ozawa T1, Kusuhara S1, Kasajima M1, Hiyoshi Y1, Sasaki J2, Masuda N1: Mol Clin Oncol 2016/12; 5 (6): 714-6. (”’ŕVš”V1, ’†Œ´‘P˜N1, ’O‰H‰p”V1, Œ´“c^–ç1, ŹŕV‹M—T1, “팴­ˆę˜Y1, Š}“‡^Žu1, “ú‹gNO1, ˛X–ŘŽĄˆę˜Y2, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

310015. [Ç—á•ń] A Case of Non-Small Cell Lung Cancer with Possible "Disease Flare" on Nivolumab Treatment Chubachi S, Yasuda H, Irie H, Fukunaga K, Naoki K1, Soejima K, Betsuyaku T: Case Rep Oncol Med 2016; 2016: 1075641. (—P–؍Ž•F1: 1ŒÄ‹zŠí“ŕ)

522068. [uŔ]y“ÁW: COPD update|ĹV‚̐f’fEŽĄ—Ă“ŽŒü|zIII. COPD‚ĚŒŸ¸Ef’f@2. ŒÄ‹z‹@”\ŒŸ¸. ‹v•Ű“cŸ (ŒÄ‹zŠí“ŕ): “ú–{—Őଠ2016/5; 74 (5): 763-7.

522069. [uŔ]y“ÁW: ”xŠŕ•ŞŽq•W“IŽĄ—ÁE–Ɖu—Ă–@‚ĚĹ‘Oüz‘ć1, 2˘‘ăEGFR-TKI‚Ě‘•œK: ƒQƒtƒBƒ`ƒjƒu, ƒGƒ‹ƒƒ`ƒjƒu, ƒAƒtƒ@ƒ`ƒjƒu‚ĚŽg‚˘•Ş‚Ż‚Í? ˆäě@‘1, ˛X–ŘŽĄˆę˜Y2 (1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ŒÄ‹zŠí“ŕ‰Č 2016/7; 30 (1): 1-9.

522070. [uŔ] KEYNOTE-024ŽŽŒą‚ĆCheckMate 026ŽŽŒą. ˆäě@‘ (ŒÄ‹zŠí“ŕ): ‚Ş‚ń•ŞŽq•W“IŽĄ—Ă 2017/3; 15 (1): 76-81.

[’˜@‘]

620064. [Šwp‘ (•Ş’SŽˇ•M)]y—Տ°ŒÄ‹z‹@”\ŒŸ¸ ‘ć8”ŁzŠî–{•Ň 11. ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚Ć—Ő°‰ž—p, p.112-6. ŒK•˝ˆę˜Y, ˆ˘•”@’ź, ‹v•Ű“cŸ1 (1ŒÄ‹zŠí“ŕ), •Ň: “ú–{ŒÄ‹zŠíŠw‰ď”xś—ę–ĺˆĎˆő‰ď, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/8”­s.

620065. [Šwp‘ (•Ş’SŽˇ•M)]y—Տ°ŒÄ‹z‹@”\ŒŸ¸ ‘ć8”Łz‰ž—p•Ň 20. Šî€’l‚ĆŠeŽíƒ‚ƒmƒOƒ‰ƒ€, p.312-21. ‹v•Ű“cŸ1, ěŽR’q—˛ (1ŒÄ‹zŠí“ŕ), •Ň: “ú–{ŒÄ‹zŠíŠw‰ď”xś—ę–ĺˆĎˆő‰ď, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/8”­s.

620066. [Šwp‘ (•Ş’SŽˇ•M)]y—Տ°ŒÄ‹z‹@”\ŒŸ¸ ‘ć8”Łz‰ž—p•Ň 21. s­ŠÖ˜A€–ځ|g‘̏áŠQŽŇ•ŸŽƒ–@, “ď•a‘΍ô, ‚ś‚ń”x–@, Î–Č”íŠQ‹~Ď–@, ‰îŒě•ŰŒŻ–@, p.322-32. ‹v•Ű“cŸ1, ‹ŕŕV@›‰, ‹v•Űœ¨Žk (1ŒÄ‹zŠí“ŕ), •Ň: “ú–{ŒÄ‹zŠíŠw‰ď”xś—ę–ĺˆĎˆő‰ď, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/8”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713039. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Synergistic anti-tumor effect of the combination of amrubicin and erlotinib in non-small cell lung cancer with wild type EGFR. Otani S1, Sasaki J2, Okamoto K, Masuda K, Igawa S1, Fukui T1, Nakahara Y1, Ishihara M3, Nambu A, Matsumoto T, Tanaka M, Masuda N1: AACR Annual Meeting 2016 (2016/4/19), New Orleans, USA. (‘ĺ’JçŽq1, ˛X–ŘŽĄˆę˜Y2, ˆäě@‘1, •Ÿˆä•ü–ç1, ’†Œ´‘P˜N1, ÎŒ´–˘ŠóŽq3, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713040. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-stage small-cell lung cancer (LD-SCLC): The final results of TORG 0604. Misumi Y, Okamoto H, Naoki K1, Hosomi Y, Ogura T, Masuda N, Minato K, Yokoyama T, Kishi K, Nishikawa M, Kato T, Seki N, Goto I, Watanabe K: ESMO 2016 (2016/10/7-11), Copenhagen, Denmark. (—P–؍Ž•F1: 1ŒÄ‹zŠí“ŕ)

713041. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for stage III NSCLC: TORG1018. Yamada K, Shimokawa T, Okamoto H, Tanaka H, Kubota K, Kishi K, Saito H, Takiguchi Y, Hosomi Y, Kato T, Harada D, Masuda N, Kasai H, Nakamura Y, Minato K, Kaburagi K, Naoki K1, Hikino K, Yamanaka T, Watanabe K: IASLC WCLC 2016 (2016/12/4-7), Vienna, Austria. (—P–؍Ž•F1: 1ŒÄ‹zŠí“ŕ)

722080. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yCOPD‚Ě‘Šú”­ŒŠ‚đ–ÚŽw‚ľ‚āzV‚˝‚ČƒXƒpƒCƒƒƒgƒŠ[Šî€’l‚ÉŠÖ‚ˇ‚éƒXƒe[ƒgƒƒ“ƒg. ‹v•Ű“cŸ (ŒÄ‹zŠí“ŕ): “ú–{‘‡Œ’fˆăŠw‰ď‘ć45‰ń‘ĺ‰ď (2017/1/28), ç—t.

723244. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) COPD‡•š”xŠŕŽčpŠłŽŇ‚É‚¨‚Ż‚ép‘OŽc‘ś”x‹@”\—\‘Ş’l‚ƏpŒă”x‹@”\ŽŔ‘Ş’l‚ɂ‚˘‚Ä. ‰Ąęł“T1, Žsě@‹B, ‚‘q@W, •Ÿˆä•ü–ç2, ˆäě@‘2, ˛“Ą”Vr3, ‰v“c“TK2, •Đ‹Ë^l1 (1ˆă—ÉqśŠw•”, 2ŒÄ‹zŠí“ŕ, 3ŒÄ‹zŠíŠO): ‘ć56‰ń“ú–{ŒÄ‹zŠíŠw‰ďŠwpu‰‰‰ď (2016/4/8-10), ‹ž“s.

723245. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) is”ńŹ×–E”xŠŕ‚ɑ΂ˇ‚éS-1‚Ě—LŒřŤ‚ɃyƒƒgƒŒƒLƒZƒh (PEM) ‚Ě‘OŽĄ—Ă—đ‚Ş‹y‚Ú‚ˇ‰e‹ż. ’†Œ´‘P˜N1, ‚–Ř—Y—ş, ‹´–{‰Ŕ“Ţ, œ\čӎ›‹I‰h, ŽO—ց@–Š, ‹Tˆäç“ß, ’ˇ–”@˝, “n粌i–ž, ‚‹´@‘, Žl•ű“c^‹IŽq, ‘ĺŒF—T‰î, ×ŒŠKś, ’O‰H‰p”V1, “팴­ˆę˜Y1, ŽO“Ą@‹v2, Ź—эO—S3, ‰Ş‘ş@Ž÷, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ, 2ŠĹŒěŠw•”, 3ˆă—ÉqśŠw•”): ‘ć56‰ń“ú–{ŒÄ‹zŠíŠw‰ďŠwpu‰‰‰ď (2016/4/9), ‹ž“s.

723246. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”ńŹ×–E”x‚Ş‚ńŠłŽŇ‚É‚¨‚Ż‚é‹CŠÇŽx‹ž‚ȂǐNP“IŒŸ¸ÄŽ{s‚ÉŠÖ‚ˇ‚銳ŽŇˆÓŽŻ’˛¸. •Ÿˆä•ü–ç1, Š}“‡^Žu1, “ú‹gNO1, ’†Œ´‘P˜N1, ‚‘q@W1, ă‰“–ěŒ’1, ˆäě@‘1, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ): ‘ć39‰ń“ú–{ŒÄ‹zŠí“ŕŽ‹‹žŠw‰ďŠwpW‰ď (2016/6/24), –źŒĂ‰Ž.

723247. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹š…ESůN…‚đ—L‚ˇ‚éis”ńG•˝ă”ç”ńŹ×–E”xŠŕ‚É‚¨‚Ż‚éƒxƒoƒVƒYƒ}ƒu‚đŠÜ‚މťŠw—Ă–@‚Ě—LŒřŤ. ’†Œ´‘P˜N1, Ź–ě‘ו˝1, ™–{@—•1, ‘ĺŒF—F—œŽq1, ‘q—ѐT‘ž˜Y1, ™“cŒi—C1, “팴­ˆę˜Y1, ’O‰H‰p”V1, ˛X–ŘŽĄˆę˜Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć57‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2016/12/19), •Ÿ‰Ş.

733184. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) pŒăÄ”­‹š‘BŠŕ (‘ĺ×–E_Œo“ŕ•Ş”ĺŠŕ) ‚ɃJƒ‹ƒ{ƒvƒ‰ƒ`ƒ“ + ƒiƒuƒpƒNƒŠƒ^ƒLƒZƒ‹•š—p—Ă–@‚Ş‘tŒř‚ľ‚˝1—á. ‘q—ѐT‘ž˜Y1, ˆäě@‘1, ‘ĺŒF—F—œŽq1, ™“cŒi—C1, ’O‰H‰p”V1, ˛“Ą”Vr2, ‘ĺ’JçŽq1, ’†Œ´‘P˜N1, ‰v“c“TK1, •Ÿˆä•ü–ç1 (1ŒÄ‹zŠí“ŕ, 2ŒÄ‹zŠíŠO): ‘ć177‰ń“ú–{”xŠŕŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2016/11/26), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110007. [Œ´’˜] Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis. Ebata T, Okuma Y, Nakahara Y1, Yomota M, Takagi Y, Hosomi Y, Asami E, Omuro Y, Hishima T, Okamura T, Takiguchi Y: Thorac Cancer 2016/1; 7 (1): 39-43. (’†Œ´‘P˜N1: 1ŒÄ‹zŠí“ŕ)

H27-110008. [Œ´’˜] Activation of EGFR Bypass Signaling by TGFƒż Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells. Tani T, Yasuda H, Hamamoto J, Kuroda A, Arai D, Ishioka K, Ohgino K, Miyawaki M, Kawada I, Naoki K1, Hayashi Y, Betsuyaku T, Soejima K: Mol Cancer Ther 2016/1; 15 (1): 162-71. (—P–؍Ž•F1: 1ŒÄ‹zŠí“ŕ)

H27-110009. [Œ´’˜] Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy. Takagi Y, Hosomi Y, Nagamata M, Watanabe K, Takahashi S, Nakahara Y1, Yomota M, Sunami K, Okuma Y, Shimokawa T, Okamura T: Cancer Chemother Pharmacol 2016/3; 77 (3): 559-64. (’†Œ´‘P˜N1: 1ŒÄ‹zŠí“ŕ)


“ŕ•Ş”ĺ‘ăŽÓ“ŕ‰ČŠw

[Šwp˜_•ś]

110152. [Œ´’˜] Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study. Chida S1, Fujita Y, Ogawa A2, Hayashi A1, Ichikawa R1, Kamata Y1, Takeuchi A3, Takano K1, Shichiri M1: Sci Rep 2016/5; 6: 26380. (ç“cŤ”n1, ŹěŒ°Žj2, —с@“N”Í1, Žsě—‹Žt1, Š™“c—T“ń1, ’|“ŕş”Ž3, ‚–ěK˜H1, Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—Ïî•ń‹łˆç)

110014. [Œ´’˜] Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1ƒŔ by Recruited Macrophages. Okizaki S1, Ito Y2, Hosono K3,4, Oba K1, Ohkubo H5, Kojo K6, Nishizawa N6, Shibuya M, Shichiri M1, Majima M4: Am J Pathol 2016/6; 186 (6): 1481-98. (‰Ťčiˆę˜Y1, ˆÉ“Ą‹`–ç2, ×–ě‰Á“ŢŽq3,4, ‘ĺ’ë˜al1, ‘ĺ‹v•Ű”Ž˘5, ŒĂé@Œ›6, źŕVL‹ą6, Žľ—˘áÁ‹`1, ”n“ˆł—˛4: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2ŠO‰Č, 3ś—, 4–ň—, 5S‘ŸŒŒŠÇŠO, 6‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110153. [Œ´’˜] Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration. Yamamoto K, Tajima Y, Hasegawa A, Takahashi Y, Kojima M, Watanabe R, Sato K, Shichiri M1, Watanabe T: Peptides 2016/8; 82: 120-7. (Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

110154. [Œ´’˜] Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis. Hayashi A1, Takano K1, Masaki T1, Yoshino S2, Ogawa A2, Shichiri M1: J Diabetes Complications 2016/11-12; 30 (8): 1494-99. (—с@“N”Í1, ‚–ěK˜H1, ł–ŘŽkl1, ‹g–쉑”ü2, ŹěŒ°Žj2, Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110155. [Œ´’˜] Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress. Suzuki S1, Kodera Y2, Saito T, Fujimoto K, Momozono A1, Hayashi A3, Kamata Y3, Shichiri M3: Sci Rep 2016/12; 6: 38299. (—é–Ř’qŽq1, ŹŽ›‹`’j2, “‰€@–ž1, —с@“N”Í3, Š™“c—T“ń3, Žľ—˘áÁ‹`3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2—Šw•”, 3“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

110156. [Œ´’˜] Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. Kamata Y1, Takano K1, Kishihara E1, Watanabe M1, Ichikawa R1, Shichiri M1: J Diabetes Complications 2017 /2; 31 (2): 468-472. (Š™“c—T“ń1, ‚–ěK˜H1, ŠÝŒ´ŠG—œŽq1, “n•Ó“šŽq1, Žsě—‹Žt1, Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

320004. [Ç—á•ń] 1Œ^“œ”A•a‚Ɛf’f‚ł‚ę‚Ä‚˘‚˝‚Ş, ”˝•œ‚ˇ‚é—L’ɐŤ‹Řázš‚đŒ_‹@‚Ƀ~ƒgƒRƒ“ƒhƒŠƒA“œ”A•a‚ĆŠm’čf’f‚ł‚ę‚˝1—á. ł–ŘŽkl1, Žsě—‹Žt1, ŹěŒ°Žj2, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “œ”A•a 2017/2; 60 (2): 91-7.

522071. [uŔ]y“ÁW: “œ”A•a‚Ɗ᎞Šł|“œ”A•aŠá‡•šÇ‚Ě‚˝‚ß‚ÉŽ„‚˝‚ż‚Ş‚Ĺ‚Ť‚é‚ą‚Ɓ|z—ǍD‚ČŠá‰ČE“ŕ‰Č˜AŒg‚Ě‚˝‚߂Ɂ|“–‰@‚ĚŽć‚č‘g‚Ý‚Ć–â‘č“_|. —с@“N”Í (“ŕ•Ş”ĺ‘ăŽÓ“ŕ): DM Ensemble 2016/5; 5 (1): 8-12.

[’˜@‘]

620067. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ•Ş”ĺ‘ăŽÓę–ĺˆăƒKƒCƒhƒuƒbƒN ‰ü’ů‘ć4”Łz‘ć2Í Žĺ—vÇŒó‚Š‚ç‚̊ӕʐf’f@4. ‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ, p.18-9. ‚–ě‡Žq, ‚–ěK˜H1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ), •Ň: ŹŁŒő‰h, •˝“cŒ‹Šě, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/4”­s.

620068. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ•Ş”ĺ‘ăŽÓę–ĺˆăƒKƒCƒhƒuƒbƒN ‰ü’ů‘ć4”Łz‘ć12Í ‘ăŽÓŽžŠł@22. ‚”AŽ_ŒŒÇ, p.442-4. ł–ŘŽkl1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ), •Ň: ŹŁŒő‰h, •˝“cŒ‹Šě, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/4”­s.

620069. [Šwp‘ (•Ş’SŽˇ•M)]y•a‹C‚Ć‚­‚ˇ‚č2017@Šî‘b‚ĆŽŔ‘H Expert's Guide (–ň‹Ç2017”N3ŒŽ‘Š§†)z5. ‘ăŽÓŒnE“ŕ•Ş”ĺŒn‚Ě•a‹C‚Ć‚­‚ˇ‚č@A ‘ăŽÓŒnŽžŠł@E“œ”A•a (‡•šÇ‚đŠÜ‚Ţ), p.852-64. —с@“N”Í1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ), “ěŽR“°, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723248. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”DPˆŤ‘j‚đŒ_‹@‚É‹}Ť•›t•s‘S‚đ—ˆ‚ľ‚˝21…Ž_‰ťy‘fŒ‡‘šÇ (21-OHD) ‚ĚÇ—á. ˆäăŒőŽq1, ‘ş“cH•ä2, “‰€@–ž1, Š™“c—T“ń2, ‚–ěK˜H2, Žľ—˘áÁ‹`2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć89‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwpW‰ď‘‰ď (2016/4/21), ‹ž“s, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 260.

723249. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’jŤ‰ť’ĽŒó‚ĆƒNƒbƒVƒ“ƒOÇŒóŒQ‚đ’ć‚ľ‚˝•›tŠŕ‚Ěˆę—á. Vˆä—œˆß“ß1, ç“cŤ”n1, “‰€@–ž2, —с@“N”Í1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć89‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwpW‰ď‘‰ď (2016/4/22), ‹ž“s, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 287.

723250. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •›t‹ô”­Žî‚Ĺ”­ŒŠ‚ł‚ę‚˝ŠŒF×–EŽî. “cŒű@•ü1, ‰Ťčiˆę˜Y1, “‰€@–ž2, —с@“N”Í1, ç“cŤ”n1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć89‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwpW‰ď‘‰ď (2016/4/22), ‹ž“s, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2016; 92: 295.

723251. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) CSIIŽg—p“œ”A•aŠłŽŇ‚ĚŠłŽŇ”wŒi‚Ć, —ǍD‚ČŒŒ“œŠÇ—‚ÉŒq‚Ş‚é—vˆö‚ÉŠÖ‚ˇ‚錟“˘. ˆäăŒőŽq1, —с@“N”Í2, ‰Í‡š—FŠó2, “‰€@–ž1, Vˆä—œˆß“ß2, ˛X–ŘŽŃ–ç‰Á2, ‘ş“cH•ä2, Š™“c—T“ń2, ‚–ěK˜H2, Žľ—˘áÁ‹`2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď(2016/5/19), ‹ž“s, “œ”A•a, 2016; 59: S216.

723252. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) InsulinŽĄ—Ă’†2Œ^“œ”A•a4—á‚ɑ΂ˇ‚éDapagliflozin•š—p‚ĚŒř‰Ę`3‚ŠŒŽŒă‚ĚŒŒ“œ“Ž‘ԁE’~”AE‘Ě‘gŹ‚ĚŒŸ“˘`. ‰Í‡š—FŠó1, —с@“N”Í1, ˆäăŒőŽq2, ł–ŘŽkl1, ŽRŠÝ‹M—m1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19), ‹ž“s, “œ”A•a, 2016; 59: S229.

723253. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) SGLT2‘jŠQ–ň‚̐V‚˝‚Č“K‰ž‚̉”\Ť`ƒCƒ“ƒXƒŠƒ“R‘Ě—zŤŠłŽŇ‚ɑ΂ˇ‚éŒř‰Ę`. —с@“N”Í1, ‰Í‡š—FŠó1, “‰€@–ž2, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a, 2016; 59: S275.

723254. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Ž‰ŽżˆŮí‚Ş“œ”A•aŠłŽŇ‚ĚƒOƒŠƒRƒAƒ‹ƒuƒ~ƒ“’l‚É—^‚Ś‚é‰e‹ż‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ŻŽRˆťŽq1, ŹěŒ°Žj1, “y•M’qť2, ’†čLŽq2, Žľ—˘áÁ‹`3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2—ŐŒŸ•”, 3“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a, 2016; 59: S288.

723255. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŒ´1,5AG‚Í“œ”A•a‡•š”DP—á‚ĚŒŒ“œƒRƒ“ƒgƒ[ƒ‹ó‘Ԃ𔽉f‚ľ‚Č‚˘. ŠÝŒ´ŠG—œŽq1, ŒĂ‰ęłŽj, źŒ´‚Ü‚Ç‚Š2, X@”ŽŽq, ‰Ş“c—m‰E, Žľ—˘áÁ‹`1, Žç‰Ž’B”ü2 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2Œ’NŠÇ—ƒZ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a, 2016; 59: S313.

723256. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ×“Ž–ŹÉŽq‰ť‚Í, “ú–{l2Œ^“œ”A•aŠłŽŇ‚É‚¨‚Ż‚éƒAƒ‹ƒuƒ~ƒ“”A‚Ě‘‰Á‚¨‚ć‚ŃGFR’ቺ‚đ—\‘Ş‚ˇ‚é‘gDŠw“IŽw•W‚Ĺ‚ ‚é. ‘ĺ‘ş˜a‹K1, ‰Ş“cç•ä, Â–ŘŠG–ƒ, •˝“ˆ—EŽm1, ‹’°’źŽ÷, “c’†GŽ÷, —é–Ř“Ţ’ĂŽq, ‘ĺXˆŔŒb, Žľ—˘áÁ‹`1, Žç‰Ž’B”ü2 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2Œ’NŠÇ—ƒZ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a, 2016; 59: S316.

723257. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É“ü‰@‚ľ‚˝‰”­1Œ^“œ”A•aŠłŽŇ‚É‚¨‚Ż‚ébó‘BŽŠŒČR‘Ě—zŤ—Ś‚ĚŒŸ“˘. Vˆä—œˆß“ß1, Žsě—‹Žt1, ç“cŤ”n1, —с@“N”Í1, ‰Ťčiˆę˜Y1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a, 2016; 59: S361.

723258. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”A’†ƒAƒ‹ƒuƒ~ƒ“ƒŒƒxƒ‹‚É‚ć‚é2Œ^“œ”A•aŒ°ŤƒAƒ‹ƒuƒ~ƒ“”A”­Ç—\‘z|”ń“œ”A•aŤtŽžŠł‚đœŠO‚ľ‚˝Œă‚ëŒü‚ŤƒRƒz[ƒgŒ¤‹†|. ç“cŤ”n1, “Ą“c–F–M, ŹěŒ°Žj2, —с@“N”Í1, Žsě—‹Žt1, Š™“c—T“ń1, ’|“ŕş”Ž3, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—Ïî•ń‹łˆç): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a 2016; 59: S316.

723259. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 2Œ^“œ”A•aŠłŽŇ‚É‚¨‚Ż‚郊ƒ‰ƒOƒ‹ƒ`ƒh‚ĆƒŠƒLƒVƒZƒiƒ`ƒh‚ĚŽĄ—ĂŒř‰Ę‚¨‚ć‚Ń—Ő°“I“Á’Ľ‚ÉŠÖ‚ˇ‚錟“˘. ‰–ŒŠ‚ß‚Ž‚Ý, “c’†—fˆę, â–{Ť‹K, ˆéŒł@W, ‹v•Ű“c—Œb, ‚“c“NG1, Ź‹{ŽR‹MŽq (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19-21), ‹ž“s.

723260. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰@“ŕ‚É‚¨‚Ż‚é“œ”A•aƒf[ƒCƒxƒ“ƒgu“œ”A•aƒtƒFƒAv‚Ě•]‰ż. X@^Šó, ‚“c“NG1, Źě“Ő˜Y1, ě‘ă‚䂤Žq, —é–؍D, ˜kŸşNˆę˜Y, Ą‰Ô—zŽq, •ÄŕV—˛‰î, â–{Ť‹K, ˆéŒł@W, ”¨@ŒÜŒŽ, ‹{‰i”ü˛Žq, ‹{Œ´—zŽq (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19-21), ‹ž“s.

723261. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “œ”A•aŠÖ˜AŒŸ¸•ń‘‚̍쐬. —é–؍D, ‚“c“NG1, Źě“Ő˜Y1, Ą‰Ô—zŽq, ˜k•ŁNˆę˜Y, źŕV—éŽq, ‰|–{”ü‰ŔŽq, œAŁ•ÄŽu (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19-21), ‹ž“s.

723262. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NAFLD‡•š2Œ^“œ”A•aŠłŽŇ‚ɑ΂ˇ‚éƒtƒBƒuƒƒXƒLƒƒƒ“‚đ—p‚˘‚˝ŠĚŽ‰–b—Ę, ŠĚd“x‚ĚŒŸ“˘. Źě“Ő˜Y1, —é–؍D, ˜k•ŁNˆę˜Y, Ą‰Ô—zŽq, źŕV—éŽq, Vˆä—œˆß“ß1, ‚“c“NG1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19-21), ‹ž“s.

723263. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’˜–ž‚ȍ‚NaŒŒÇ, ˆÓŽŻáŠQ‚Ĺ”Ŕ‘—‚ł‚ęZ“§ˆłŤ’E‘ÇŒóŒQ‚Ć•”•ŞŒ^”A•öÇ‚Ş‹^‚í‚ę‚˝ˆę—á. ”’ě—‰i1, ‰Í‡š—FŠó1, ˛X–ŘŽŃ–ç‰Á1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć43‰ń“ú–{_Œo“ŕ•Ş”ĺŠw‰ďŠwpW‰ď (2016/10/14), •lź, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 295.

723264. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) GH•â[‚đI—šŒă‚ɍœ–§“x‚̒ቺ‚đ—ˆ‚ľ‚˝‰ş‚‘Ě‘O—t‹@”\’ቺÇ‚Ěˆę—á. “cŒű@•ü1, —с@“N”Í1, ˛X–ŘŽŃ–ç‰Á1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć43‰ń“ú–{_Œo“ŕ•Ş”ĺŠw‰ďŠwpW‰ď (2016/10/14), •lź, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 295.

723265. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆę‰ßŤ‚Éčň•”’É‚đ—ˆ‚ľ, f’f‚É‹ę—ś‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX‡•š‚Ě‹´–{•a‚Ěˆę—á. Vˆä—œˆß“ß1, ŻŽRˆťŽq2, “‰€@–ž2, Žsě—‹Žt1, ‰Á“Ą@O3, Š™“c—T“ń2, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŠO‰Č): ‘ć59‰ń“ú–{bó‘BŠw‰ďŠwpW‰ď (2016/11/4), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 295.

723266. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–Ž{Ý‚Ĺ•Ş•Ř‚ľ‚˝’P‘ĚGDM”D•w‚ĚƒCƒ“ƒXƒŠƒ“ŽĄ—Ă‚ĚŽŔ‘Ô‚ÉŠÖ‚ˇ‚錟“˘. —é–Ř‚Ü‚čd1, Žsě—‹Žt1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć32‰ń“ú–{“œ”A•aE”DPŠw‰ď”NŽŸŠwpW‰ď (2016/11/19), ‰ŞŽR, “œ”A•a‚Ć”DP 2016; 16(3): S-68.

723267. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p’†‚Ě‘˝”A, ŒŒˆł’ቺ‚đŒ_‹@‚ɐf’f‚ł‚ę‚˝˜R“l‰ş‚‘ĚŒă—t‰Š‚Ě1—á. ”’ě—‰i1, ł–ŘŽkl1, ˛X–ŘŽŃ–ç‰Á1, —с@“N”Í1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć26‰ń—Տ°“ŕ•Ş”ĺ‘ăŽÓUpdate (2016/11/18-19), ‘ĺ‹{, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 468.

723268. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’YŽ_ƒŠƒ`ƒEƒ€‚Ş‘tŒ÷‚ľ‚˝ŽĄ—Ă’ďRŤbó‘BƒNƒŠ[ƒ[‚Ěˆę—á. Źň’mŽq1, ‰Ťčiˆę˜Y1, Vˆä—œˆß“ß1, “‰€@–ž2, —с@“N”Í1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć26‰ń—Տ°“ŕ•Ş”ĺ‘ăŽÓUpdate (2016/11/18-19), ‘ĺ‹{, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2016; 92: 504.

723269. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 2Œ^“œ”A•aŒŒ‰t“§ÍŠłŽŇ‚É‚¨‚Ż‚éHbA1c‚ĆƒOƒŠƒRƒAƒ‹ƒuƒ~ƒ“‚ĚˆÓ‹`. —с@“N”Í1, ‚–ěK˜H1, ł–ŘŽkl1, ‹g–쉑”ü2, ŹěŒ°Žj1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć28‰ń“ú–{“œ”A•aŤtÇŒ¤‹†‰ď (2016/12/3-4), “Œ‹ž.

723270. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŕ•Ş”厞Šł‚̉h—{Šw“I‰î“ü‚Ě•K—vŤ`ŽžŠł‚É‚ć‚éˆŔĂŽž‘ăŽÓ—Ę‚ĚˇˆŮ‚Ć, ŽĄ—Ă‚É‚ć‚é•Ď‰ť`. —с@“N”Í1, ěă—IŽq2, lŒŠ–ƒ”üŽq2, ˛“ĄĆŽq2, ‰Í‡š—FŠó1, “‰€@–ž3, ł–ŘŽkl1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‰h—{•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć20‰ń“ú–{•a‘Ô‰h—{Šw‰ď”NŽŸŠwpW‰ď (2017/1/13-15), ‹ž“s. (ŽáŽč—DG“Ć‘nŒ¤‹†ÜŽóÜ)

733185. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 2Œ^“œ”A•a‚đ”wŒi‚ɍ‚—î‚Ĺ”­Ç‚ľ‚˝bó‘BŽŠŒČR‘Ě—zŤ, Œ€Ç1Œ^“œ”A•a‚Ě1—á. Vˆä—œˆß“ß1, Žsě—‹Žt1, ŠCŁˆťŽq, —é–Ř—z•F1, —с@“N”Í1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć53‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/1/23), ‰Ą•l.

733186. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ‰ƒ“ƒŒƒIƒ`ƒh‚É‚ć‚éƒCƒ“ƒXƒŠƒ“•Ş”ĺ’ቺ, ‚ŒŒ“œ‚đ”F‚ß‚˝ć’[‹‘ĺÇ‚Ě1—á. –öŕV^ŽŔ1, ˆäăŒőŽq2, ‰Í‡š—FŠó1, “‰€@–ž2, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć53‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/1/23), ‰Ą•l.

733187. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “œ”A•aŠłŽŇ‚Ě—ÇD‚Čƒgƒ‰ƒ“ƒWƒVƒ‡ƒ“‚đl‚Ś‚é`ŠĹŒěŽt‚ĚŽ‹“_‚Š‚ç`. ‘ĺŠŃŒbŽq1, —с@“N”Í2, â–{”~Žq1, Žsě—‹Žt2, ‚–ěK˜H2, Žľ—˘áÁ‹`2 (1ŠĹŒě•”, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć53‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/1/23), ‰Ą•l.

733188. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) SAP“ą“ü‚ޏdÇ’ጌ“œ‚̉ń”đ‚ĆƒZƒ‹ƒtƒPƒAs“Ž‚ĚŒüă‚É—L—p‚Ĺ‚ ‚Á‚˝1Œ^“œ”A•a‚Ě2Ç—á. ”’ě—‰i1, Žsě—‹Žt1, “cŒű@•ü1, ‘ş“cH•ä1, Vˆä—œˆß“ß1, ˛X–ŘŽŃ–ç‰Á1, ‰Í‡š—FŠó1, “‰€@–ž2, —с@“N”Í1, ‰Ťčiˆę˜Y1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć33‰ń_“Ţě“œ”A•aŒ¤‹†‰ď (2016), ‰Ą•l.

733189. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’jŤ‰ť’ĽŒó‚ĆƒNƒbƒVƒ“ƒOÇŒóŒQ‚đ’ć‚ľ‚˝•›t”玿Šŕ‚Ěˆę—á. Vˆä—œˆß“ß1, Š™“c—T“ń1, “‰€@–ž2, ç“cŤ”n1, —с@“N”Í1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, ‚–ěK˜H1, ŽRč—Ll, ů–ěŒöL, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć49‰ń_“ސě“ŕ•Ş”ĺE‘ăŽÓƒZƒ~ƒi[(2016/7/2), ‰Ą•l.

733190. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹´–{•a‚ƐqíŤ”’”Á‚ĚŒo‰ß’†, —n˜A‹ŰŠ´ő‚đŒ_‹@‚É‹}Ť•›t•s‘S‚ÉŽŠ‚čPCPS“ą“ü‚É‚ć‚č‹~–˝‚ľ“ž‚˝ACTH’P“ĆŒ‡‘šÇ‚Ěˆę—á. ‰Í‡š—FŠó1, ç“cŤ”n1, ˛X–ŘŽŃ–ç‰Á1, “‰€@–ž2, ł–ŘŽkl1, —с@“N”Í1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć17‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠÖ“ŒbM‰zŽx•”ŠwpW‰ď (2016/9/10), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 295.

733191. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —ź‘¤•›t‹ô”­ŽîᇂŔ­ŒŠ‚ł‚ę, p‘Of’f‚É‹ę—ś‚ľ‚˝•›t”玿Šŕ‚Ěˆę—á. “cŒű@•ü1, Š™“c—T“ń1, ˆäăŒőŽq2, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć17‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠÖ“ŒbM‰zŽx•”ŠwpW‰ď (2016/9/10), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 295.

733192. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “œ”A•aŤƒPƒg[ƒVƒX‚Ĺ”­Ç‚ľ,•a—đ‚Š‚çƒ~ƒgƒRƒ“ƒhƒŠƒAˆŮíÇ‚Ş‹^‚í‚ę‚˝1—á. ŽRč@—D, Vˆä—œˆß“ß1, —с@“N”Í1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć629‰ńŠÖ“Œ’n•ű‰ď (2016/12/10), “Œ‹ž.

733193. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “œ”A•a‡•šŹlŹ’ˇƒzƒ‹ƒ‚ƒ“•Ş”ĺ•s‘S‚É‚¨‚Ż‚鐏’ˇƒzƒ‹ƒ‚ƒ“•â[‚É‚ć‚錌“œ“Ž‘Ԃ̕ωť. Źň˜aŽq1, —с@“N”Í1, ‰Í‡š—FŠó1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć54‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/1/21), ‰Ą•l.

733194. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) SAP“ą“ü‚ޏdÇ’ጌ“œ‚̉ń”đ‚ĆƒZƒ‹ƒtƒPƒAs“Ž‚ĚŒüă‚É—L—p‚Ĺ‚ ‚Á‚˝1Œ^“œ”A•a‚Ě2Ç—á. ”’ě—‰i1, Žsě—‹Žt1, “cŒű@•ü1, Vˆä—œˆß“ß1, ˛X–ŘŽŃ–ç‰Á1, ‰Í‡š—FŠó1, —с@“N”Í1, ‰Ťčiˆę˜Y1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć54‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/1/21), ‰Ą•l.

733195. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •p‰ń‚Ě’áŒŒ“œ, “űŽ_ƒAƒVƒh[ƒVƒX‚đ”F‚ß‚˝•›t•s‘S‚Ě1—á. “Ą“ˆ@—ŕ, “cŒű@•ü1, ł–ŘŽkl1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć630‰ńŠÖ“Œ’n•ű‰ď (2017/2/11), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H10-220001. [€Œ´’˜] NIDDM‚É‚¨‚Ż‚é”÷—ĘƒAƒ‹ƒuƒ~ƒ“”A‚Ě’ˇŠú—\Œă|”AAlbECr”ä‚É‚ć‚錟“˘|. _@N”V, ‰œ‘şr–ž, ‚“c“NG1, ‹´’Ü—m”ü, Ź‹v•Ű–ƒŽq, ’†“ˆ^ˆę, ”~ŕVTˆę, ‹ŕX@W, “Ię´˜a, “Ą“c–F–M, –‹`’‰ (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): “œ”A•a 1998/8; 41 (8): 757-8.

H15-110001. [Œ´’˜] Hyperglycemia-induced Alteration in Proteomes of the Rat Renal Cortex. Takada T1, Matsubara M2, Okumura T, Saigenji K, Majima M3, Hayashi I, Furudate S, Oh-Ishi M, Kodera Y, Maeda T, Fujita Y: Kitasato Medicine 2003/8; 33 (4): 223-32. (‚“c“NG1, źŒ´‚Ü‚Ç‚Š2, ”n“ˆł—˛3: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2Œ’NŠÇ—ƒZ, 3–ň—)

H23-320001. [Ç—á•ń] Ź’ˇƒzƒ‹ƒ‚ƒ“•â[‚É‚ć‚čˆŔĂŽž‘ăŽÓ—Ę‚ŞŽŠŠoÇóE‘̉t‘gŹ‚ć‚葁Šú‚ɉü‘P‚ľ‚˝Ź’ˇƒzƒ‹ƒ‚ƒ“•Ş”ĺ•s‘SÇ‚Ě1Ç—á. —с@“N”Í1, •˝“‡—EŽm1, ŹěŒ°Žj1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚“c“NG1, Žç‰Ž’B”ü2, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2Œ’NŠÇ—ƒZ): “ú–{•a‘Ô‰h—{Šw‰ďŽ 2012/1; 15 (1): 89-93.

H27-110010. [Œ´’˜] Salusin-ƒŔ as a powerful endogenous antidipsogenic neuropeptide Suzuki-Kemuriyama N, Nakano-Tateno T, Tani Y1, Hirata Y, Shichiri M1: Sci Rep 2016; 6: 20988. Published online 2016 Feb 12. doi: 10.1038/srep20988. (’J@—SŽŠ1, Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723011. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) RathkeůN–E‚Ć‚ĚŠÓ•Ę‚É‹ę—ś‚ľ‚˝, “ŞŠWˆô“ŞŽîEŠáâ|ć’[•”Ž‹_Œo‰Š‚̍‡•š—á. ł–ŘŽkl1, ‚–ěK˜H1, ŽR“cłŽO, ˆä‰şŽŽq (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć26‰ń“ú–{ŠÔ”]‰ş‚‘ĚŽîᇊw‰ď (2016/2/19), •Ÿ“‡, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2016; 92: 260.


t‘Ÿ“ŕ‰ČŠw

[Šwp˜_•ś]

110157. [Œ´’˜] Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. Zhang J, Pippin JW, Krofft RD, Naito S1, Liu ZH, Shankland SJ: Am J Physiol Renal Physiol 2013/6; 304 (11): F1375-89. (“ŕ“Ął‹g1: 1t‘Ÿ“ŕ)

110158. [Œ´’˜] Incidence and clinical significance of anti-moesin autoantibodies in small-vessel vasculitis. Murano J1, Kamata K1, Naito S1, Okamoto T, Kamata M1, Okina C1, Sano T1, Takeuchi Y1, Aoyama T1: Kitasato Med J 2015/9; 45 (2): 105-13. (‘ş–ě‡–ç1, Š™“cvšć1, “ŕ“Ął‹g1, ‰Ş–{’qŽq, Š™“c^—Žq1, ‰ĽçŽq1, ˛–ě@—˛1, ’|“ŕN—Y1, ÂŽR“ŒŒÜ1: 1t‘Ÿ“ŕ)

520008. [‘ŕ] ƒ|ƒhƒTƒCƒgáŠQ‚Ćƒlƒtƒ[ƒ[ÇŒóŒQ. “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ě“‡‰iŽq1, ‰ĽçŽq1, ’|“ŕ˜a”Ž1, ’|“ŕŒb”üŽq2, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2–Ɖu): –k—˘ˆăŠw 2016/6; 46 (1): 1-12.

520009. [‘ŕ] ƒlƒtƒ[ƒ[ÇŒóŒQ‚Ě•a‘ԉ𖞂đ–ÚŽw‚ľ‚Ä. “ŕ“Ął‹g1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ): _“ސěˆăŽt‰ď•ń 2016; 804: 6-9.

540011. [‚ť‚Ě‘ź (Ŕ’k‰ď)] ADPKD‚̍ŐVŽĄ—Ă‚ĚŒťó. –î”öł—S, ’|“ŕN—Y1, ŹŠâ•ś•F, ‹g“cˆęŹ2,3, ’J’ĂŒ\‰î (1t‘Ÿ“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3”ĺ”AŠí): “úŒoƒƒfƒBƒJƒ‹Online 2016/12; p.1-4.

[Šw‰ďEŒ¤‹†‰ď“™]

713042. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) ROLES OF HIGH AFFINITY LEUKOTRIENE B-4 RECEPTOR SIGNALING IN ENHANCEMENT OF FIBROSIS DURING UNILATERAL URETERAL OBSTRUCTION IN MICE. Naito S1: ERA-EDTA 53rd Congress (2016/5/21-24), Vienna, Austria. (“ŕ“Ął‹g1: 1t‘Ÿ“ŕ)

713043. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) CARNITINE ADMINISTRATION PREVENTS THE PROGRESS OF ARTERIOSCLEROSIS BY REDUCING ADVANCED GLYCATION END PRODUCTS IN NON-DIABETIC MAINTENANCE HEMODIALYSISPATIENTS. Kamada Y, Masuda T, Nakamura T, Yabu K, Tanaka S, Yamazaki J, Hamazaki N, Aoyama A, Itoh Y, Moriguchi I, Kobayashi N, Okubo M, Kotani K, Takeuchi K1, Naito S2, Takeuchi Y2: ERA-EDTA 53rd Congress (2016/5/21-24), Vienna, Austria. (’|“ŕ˜a”Ž1, “ŕ“Ął‹g2, ’|“ŕN—Y2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2t‘Ÿ“ŕ)

713044. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) THE ANALYSES OF NEPHROTIC SYNDROME MODEL MICE INDUCED BY ANTI-NEPHRIN ANTIBODY USED BY GENE-IMMUNIZATION. Naito S1: ERA-EDTA 53rd Congress (2016/5/21-24), Vienna, Austria. (“ŕ“Ął‹g1: 1t‘Ÿ“ŕ)

713045. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Gadolinium-Contrast Nephrotoxicity in Patients with Chronic Kidney Disease Stage 1. Naito S1: ƒAƒƒŠƒJt‘ŸŠw‰ď (Kidney Week 2016) (2016/11/17-20), Chicago, USA. (“ŕ“Ął‹g1: 1t‘Ÿ“ŕ)

722081. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‚—îŽŇtˆÚAŠłŽŇ‚ĚŽŠ“K–Ɖu—}§—Ă–@`Overview`. ’|“ŕN—Y1, ˆ˘•”“N–ç1, ‹´–{ŒbŽq1, ’r“cŹ]2, –ěŒű•ś”T3, ě‘ş•ä2, Îˆä‘ĺ•ă2, ‹g“cˆęŹ2,4 (1t‘Ÿ“ŕ, 2”ĺ”AŠí, 3ŠĹŒě•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË.

723271. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒlƒtƒŠƒ“R‘Ě—U“ąŤFSGSƒ}ƒEƒX‚É‚¨‚Ż‚éƒ{[ƒ}ƒ“ůN•Ç×–E‚Ě‘B”\‚ĚŒŸ“˘. “ŕ“Ął‹g1, ě“‡‰iŽq1, ’|“ŕ˜a”Ž2, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć60‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2017/5/27), ĺ‘ä.

723272. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’_”X‰Š‚đŒ_‹@‚ɍĔR‚ľ‚˝TAFROÇŒóŒQ‚Ě1—á. ŠÖ–{ŒbŽq (‹´–{ŒbŽq)1, ˛–ě@—˛1, ˆ˘•”“N–ç1, ‚‹´@—É1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ď‘‰ď (2016/6/10), ‘ĺă.

723273. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) oŽY‚đŒ_‹@‚É”ń“TŒ^—nŒŒŤ”A“ĹÇÇŒóŒQ‚đ”­Ç‚ľ—ź‘¤–Ô–Œ’†SĂ–Ź•ÂÇÇ‚đ‡•š‚ľ‚˝ˆę—á. ˛–ě@—˛1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq (‹´–{ŒbŽq)1, ‚‹´@—É1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž1, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1, _œä’m“š3, Š™“cvšć (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ď‘‰ď (2016/6/11), ‘ĺă.

723274. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“‚É‚ć‚éDŽ_‹…Ť‘˝”­ŒŒŠÇ‰ŠŤ“÷‰čŽîÇ‚Ěˆę—á. ˆ˘•”“N–ç1, “ŕ“Ął‹g1, ŠÖ–{ŒbŽq (‹´–{ŒbŽq)1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1, ŹŒ´GĆ3 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3”畆): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ď‘‰ď (2016/6/11), ‘ĺă.

723275. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}Ťt•s‘S‚đ’ć‚ľ, ƒXƒeƒƒCƒhŽĄ—Ă‚Ş‘tŒř‚ľ‚˝TAFROÇŒóŒQ‚Ě1—á. ‚‹´@—É1, Š™“c^—Žq1, ŠÖ–{ŒbŽq (‹´–{ŒbŽq)1, ˆ˘•”“N–ç1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ď‘‰ď (2016/6/11), ‘ĺă.

732031. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) CKDŠłŽŇ‚ĚƒŠƒ“ŠÇ—–Ú•W. “ŕ“Ął‹g (t‘Ÿ“ŕ): ƒzƒXƒŒƒm[ƒ‹”­”„7Žü”N‹L”Ou‰‰‰ď (2016/6/3), ‘Š–ÍŒ´.

732032. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒlƒtƒŠƒ“‚Ćƒ|ƒhƒTƒCƒgƒpƒ`[. “ŕ“Ął‹g1, ě“‡‰iŽq1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ): ‘Š–ÍŒ´ƒ|ƒhƒTƒCƒgƒZƒ~ƒi[ (2017/7/4), ‘Š–ÍŒ´.

732033. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒlƒtƒŠƒ“R‘Ě—U“ąŤŽ…‹…‘̐t‰Šƒ‚ƒfƒ‹ƒ}ƒEƒX‚Ć‚ť‚̉ž—p. “ŕ“Ął‹g1, ě“‡‰iŽq1 (1t‘Ÿ“ŕ): ŒF–{‘ĺŠw‹’“_Œ`ŹŒ¤‹†AŽĺĂu‰‰‰ď (2016/10/14), ŒF–{.

732034. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) tˆÚAŒă’źŒă‚Š‚çTMA•a‘Ô‚đ”­Ç‚ľ, ‰ü‘P‚ĆÄ”R‚đŒJ‚č•Ô‚ľt‹@”\”pâ‚ÖŽŠ‚Á‚˝ˆę—á. ’|“ŕN—Y1, Îˆä‘ĺ•ă2, ‹g“cˆęŹ2,3 (1t‘Ÿ“ŕ, 2”ĺ”AŠí, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘Š–ÍŒ´TMAÇ—ጟ“˘‰ď (2017/3/31), ‘Š–ÍŒ´.

733196. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă’†‚ɃJƒ“ƒWƒ_ŒŒÇ‚đ‡•š‚ľ‹}Ťt•s‘S‚đ’ć‚ľ‚˝ˆę—á. ˆ˘•”“N–ç1, ˛–ě@—˛1, ˆä“c^śŽq1, ŕV“c@Ę1, •x‰i‘ĺŽu1, ‹´–{ŒbŽq1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć66‰ń_“ސět‰ŠŒ¤‹†‰ď (2016/9/24), ‰Ą•l.

733197. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ANCAŠÖ˜AŒŒŠÇ‰Š‚É‘Ť×–EŠ×“üŽ…‹…‘ĚÇ (PIG) ‚Ş”F‚ß‚ç‚ę‚˝1—á. ‚‹´@—É1, ‘ş–ě‡–ç1, ˆä“c^śŽq1, ŕV“c@Ę1, •x‰i‘ĺŽu1, ˆ˘•”“N–ç1, ‹´–{ŒbŽq1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/7), “Œ‹ž.

733198. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒXƒeƒƒCƒhŽĄ—ĂŽ{s‚š‚¸‚ɐt‹@”\‚̉ü‘P‚đŽŚ‚ľ‚˝TINUÇŒóŒQ‚Ěˆę—á. ˆä“c^śŽq1, ˛–ě@—˛1, ŕV“c@Ę1, •x‰i‘ĺŽu1, ˆ˘•”“N–ç1, ‹´–{ŒbŽq1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/7), “Œ‹ž.

733199. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”j‰ó“I‘Oˆ’u‚É‚ć‚éä`‘ŃŒŒˆÚAŒă‚ÉŒŒđŤ”÷ŹŒŒŠÇÇ (TMA) ‚đ‚Ť‚˝‚ľ‚˝ˆę—á. ˆ˘•”“N–ç1, Š™“c^—Žq1, ˆä“c^śŽq1, ŕV“c@Ę1, •x‰i‘ĺŽu1, ‹´–{ŒbŽq1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/7), “Œ‹ž.

733200. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ{ƒ‹ƒeƒ]ƒ~ƒuEƒfƒLƒTƒƒTƒ]ƒ“—Ă–@‚Ş’˜Œř‚ľ‚˝IgG-ƒÉŒ^Œ´”­Ťƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ‚𔺂¤POEMSÇŒóŒQ‚Ěˆę—á. •x‰i‘ĺŽu1, “ŕ“Ął‹g1, ˆä“c^śŽq1, ŕV“c@Ę1, ˆ˘•”“N–ç1, ‹´–{ŒbŽq1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1, ’hŒ´Š˛ś3 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŒŒ‰t“ŕ): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/7), “Œ‹ž.

733201. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) BD—Ă–@‚ĆŽŠ‰Ć––˝ŒŒŠ˛×–EˆÚA‚É‚ć‚č‹}ŤtáŠQ‚̉ü‘P‚Ş“ž‚ç‚ę‚˝Œy˝’ž’…Ç‚Ě1—á. ‹´–{ŒbŽq1, ÂŽR“ŒŒÜ1, ˆä“c^śŽq1, ŕV“c@Ę1, •x‰i‘ĺŽu1, ˆ˘•”“N–ç1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ˛–ě@—˛1, ’|“ŕN—Y1, ’Ě–ě•x‹P3, Š™“cvšć (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŒŒ‰t“ŕ): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/8), “Œ‹ž.

733202. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˘‰eCTŠŒŠ‚ސf’f‚ĚŒ_‹@‚Ć‚Č‚Á‚˝IgG4ŠÖ˜At‘Ÿ•a‚Ěˆę—á. ŕV“c@Ę1, ˛–ě@—˛1, ˆä“c^śŽq1, •x‰i‘ĺŽu1, ˆ˘•”“N–ç1, ‹´–{ŒbŽq1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć46‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2016/10/8), “Œ‹ž.

733203. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Œ‹ßŤ‘˝”­“Ž–Ź‰Š‚Ĺ•a—‰đ–U‚đ‚ľ‚˝ˆę—á. ŕV“c@Ę1, “ŕ“Ął‹g1, ł–Ř‹M‹ł1, ‚‹´@—É1, ˆ˘•”“N–ç1, ‹´–{ŒbŽq1, •x‰i‘ĺŽu1, ˆä“c^śŽq1, ’|“ŕ˜a”Ž2, Š™“c•‡”ü1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ˆäă‹vŽq3, Œ´@“ÖŽq3, ƒEƒbƒhƒnƒ€ƒX—ćŽq4, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•a—, 4•úŽËü (‰ć‘œ)): ‘ć92‰ń_“ސětŒ¤‹†‰ď (2016/10/30), ‰Ą•l.


äPŒ´•aEŠ´ő“ŕ‰ČŠw

[Šwp˜_•ś]

110159. [Œ´’˜] Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arinuma Y1, Kikuchi H, Wada T1, Nagai T1, Tanaka S1, Oba H, Hirohata S1: Lupus Sci Med 2014; 1 (1): e000050. (—LŔ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

110160. [Œ´’˜] Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01. Furukawa H, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T1, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S1, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N: PLoS One 2016/4; 11 (4): e0154255. (‰iˆä—§•v1, œA”¨rŹ1: 1äPŒ´•aĽŠ´ő“ŕ)

110161. [Œ´’˜] Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Ogawa E1, Nagai T1, Sakuma Y2, Arinuma Y1, Hirohata S1: Modern Rheumatology 2016/5; 26 (3): 377-83. (Źě‰p—C1, ‰iˆä—§•v1, ˛‹vŠÔ—TŽq2, —LŔ—ǍK1, œA”¨rŹ1: 1äPŒ´•aĽŠ´ő“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110162. [Œ´’˜] Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study. Hamaguchi Y, Sumida T, Kawaguchi Y, Ihn H, Tanaka S1, Asano Y, Motegi S, Kuwana M, Endo H, Takehara K: JOURNAL OF DERMATOLOGY 2017/1; 44 (1): 13-7. (“c’†Z–ž1: 1äPŒ´•aĽŠ´ő“ŕ)

110163. [Œ´’˜] Long-term survival of patients with pulmonary arterial hypertension associated with connective tissue disease: beneficial effects of beraprost sodium, an oral prostacyclin analog. Tanaka S1, Matsueda Y1, Wada T1, Tanaka J1, Nagai T1, Hirohata S1: Kitasato Med J 2017/3; 47 (1): 52-61. (“c’†Z–ž1, źŽ}@—C1, ˜a“c’B•F1, “c’†~ˆę1, ‰iˆä—§•v1, œA”¨rŹ1: 1äPŒ´•aĽŠ´ő“ŕ)

310016. [Ç—á•ń] Transverce myelitis extended to disseminated encephalitis in systemic lupus erythematosus: Histological evidence for vasculitis. Tono T1, Nagai T1, Hoshiyama T1, Sakuma Y2, Wada T1, Tanaka S1, Hirohata S1: Modern Rheumatology 2016/11; 26 (6): 958-62. (“Œ–ěr—m1, ‰iˆä—§•v1, ŻŽR—˛s1, ˛‹vŠÔ—TŽq2, ˜a“c’B•F1, “c’†Z–ž1, œA”¨rŹ1: 1äPŒ´•aĽŠ´ő“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

521011. [‰đŕ]y˜b‘čz‹­”çÇ‚Ě—\Œă—\‘ވöŽq‚Ě‘Ă“–Ť. “c’†Z–ž (äPŒ´•aĽŠ´ő“ŕ): ƒŠƒEƒ}ƒ`‰Č 2017/1; 57 (1): 73-7.

[’˜@‘]

620070. [Šwp‘ (’P’˜)]yƒŠƒEƒ}ƒ`äPŒ´•af—ĂƒKƒCƒh@•a‘ԁE•a—‚Š‚çf—Ă‚ĚTips‚܂ŁzœA”¨rŹ (äPŒ´•aEŠ´ő“ŕ), •śŒő“°, “Œ‹ž, 2016/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713046. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Enhanced Expression of mRNA for Response Gene to Complement 32 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis. Nagai T1, Tomita T, Yoshikawa H, Tanaka S1, Hirohata S1: 2016 ACR/ARHP (2016/11/14), Washington, USA. (‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

713047. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Therapy in Survival of Patients with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis and Other Connective Tissue Diseases. Tanaka S1, Matsueda Y2, Abe G1, Okada J3, Hirohata S1: 2016 ACR/ARHP (2016/11/14), Washington, USA. (“c’†Z–ž1, źŽ}@—C2, ˆŔ•”Šw˜N1, ‰Ş“c@ƒ3, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@)

723276. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ɖu•s‘S‚ɍ‡•š‚ľ‚˝Mycobacterium abscessusŠ´őÇ‚Ě2—á. ˜a“c’B•F1, ‚ŽR—zŽq2, “c’†’mŽ÷1, ‘ĺěŒ´—TŽ÷3, ‚é—R”üŽq4, “Ą–Ř‚­‚ÉŽq4, “ń–{–öL5, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3–ňÜ•”, 4Š´őŠÇ—Žş, 5—ŐŒŸ•”): ‘ć90‰ń“ú–{Š´őÇŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/4/16), ĺ‘ä.

723277. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹­”çÇSSc‡•šPAH‚ɑ΂ˇ‚é“ÁˆŮ“IPAHŽĄ—Ă–ň•š—p—Ă–@‚ĚŒŸ“˘. “c’†Z–ž1, “c’†’mŽ÷1, źŽ}@—C2, ˆŔ•”Šw˜N1, Źě‰p—C1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć60‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2016/4/21-24), ‰Ą•l.

723278. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) SLEERƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ: ¸__Œoƒ‹[ƒvƒXAcute confusional state (ACS) ‚É‚¨‚Ż‚é“Ş•”MRI‰ć‘œ‚Ć—Ő°‘œ‚¨‚ć‚ŃŒŸ¸ŠŒŠ‚ĚŒŸ“˘. ˆŔ•”Šw˜N1, “c’†’mŽ÷1, ’J@@–ź, Ž™‹Ę‰ŘŽq1, ˛‹vŠÔ—TŽq2, H“Ą—Y‘ĺ1, Źě‰p—C1, —LŔ—ǍK1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć60‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2016/4/21-24), ‰Ą•l.

723279. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚錰”÷‹ž“I‘˝”­ŒŒŠÇ‰Š‚Ě—\Œă‚ĚŒŸ“˘. H“Ą—Y‘ĺ1, “c’†Z–ž1, “c’†’mŽ÷1, ’J@@–ź, Ž™‹Ę‰ŘŽq1, ˆŔ•”Šw˜N1, Źě‰p—C1, ˜a“c’B•F1, ‰iˆä—§•v1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć60‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2016/4/21-24), ‰Ą•l.

723280. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) SLEERƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ: ¸__Œoƒ‹[ƒvƒX|_Œo¸_ƒ‹[ƒvƒX‚ɑ΂ˇ‚éƒ~ƒRƒtƒFƒm[ƒ‹Ž_ƒ‚ƒtƒFƒ`ƒ‹‚Ě—LŒřŤ‚ÉŠÖ‚ˇ‚錟“˘|. Ž™‹Ę‰ŘŽq1, Źě‰p—C1, “c’†Z–ž1, ’J@@–ź, “c’†’mŽ÷1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, ˜a“c’B•F1, ‰iˆä—§•v1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć60‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2016/4/21-24), ‰Ą•l.

723281. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Acute on Chronic‚Ĺ”­Ç‚ľ‚˝–ŤisŒ^_Œoƒx[ƒ`ƒFƒbƒg‚Ěˆę—á. Źě‰p—C1, ’J@@–ź, “c’†’mŽ÷1, Ž™‹Ę‰ŘŽq1, H“Ą—Y‘ĺ1, ˆŔ•”Šw˜N1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć60‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2016/4/21-24), ‰Ą•l.

723282. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒTƒ‰ƒ]ƒXƒ‹ƒtƒ@ƒsƒŠƒWƒ“‚É‚ć‚éŠÖßƒŠƒEƒ}ƒ`ŠłŽŇ‚Ĺ‚Ěƒjƒ…[ƒ‚ƒVƒXƒ`ƒX”x‰Š”­Ç—}§‚̉”\Ť‚ɂ‚˘‚Ä. ’J@@–ź, ‰iˆä—§•v1, “c’†’mŽ÷1, Ž™‹Ę‰ŘŽq1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, Źě‰p—C1, “c’†Z–ž1, ‰Ş“c@ƒ2, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ, 2–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@): ‘ć60‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2016/4/21-24), ‰Ą•l.

723283. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠÔŽżŤ”x•a•Ď‚𔺂Á‚˝ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‡•š”x‚ŒŒˆłÇ‚Ě1—á. źŽ}@—C1, “c’†Z–ž2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2äPŒ´•aEŠ´ő“ŕ): ‘ć1‰ń“ú–{”x‚ŒŒˆłE”xzŠÂŠw‰ďŠwpW‰ď (2016/10/1), “Œ‹ž.

723284. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”畆‹Ř‰Š—lÇó‚đ’ć‚ľ‚˝IgG4ŠÖ˜AŽžŠł‚Ě1—á. ‘‘@M”Ž1, “c’†’mŽ÷1, ‹ß“Ą“Őˆę1, ’ˇ’Jě–ő_1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–ž1, Žş@Œc’ź, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć31‰ń“ú–{—Տ°ƒŠƒEƒ}ƒ`Šw‰ď (2016/10/29), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H25-110005. [Œ´’˜] Evaluation of renal adverce effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients. Tanaka H, Arai M, Tomoda Y, Wada T1, Yago K, Satoh M1 Journal of pharmacy & phamaceutical sciences 2013; 16 (3): 405-13. (˜a“c’B•F1: 1äPŒ´•aĽŠ´ő“ŕ)


ŠO‰ČŠw
[Šwp˜_•ś]

110164. [Œ´’˜] Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer. Yamashita K1, Kuno A, Matsuda A, Ikehata Y, Katada N, Hirabayashi J, Narimatsu H, Watanabe M1: Gastric Cancer 2016/4; 19 (2): 531-42. (ŽR‰şŒpŽj1, •Đ“c‰Ä–ç, “n粏š•F1: 1ŠO‰Č)

110165. [Œ´’˜] Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis. Yamashita K1, Katada N1, Moriya H1, Hosoda K1, Mieno H1, Katada C2, Koizumi W2, Hoshi K3, Watanabe M1: Gen Thorac Cardiovasc Surg 2016/4; 64 (4): 209-15. (ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, Œ˜“ce—˜2, Źň˜aŽO˜Y2, Ż@‰Ŕ–F3, “n粏š•F1: 1ŠO‰Č, 2Á‰ťŠí“ŕ, 3‰qś)

110166. [Œ´’˜] Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer. Shigeta K, Ishii Y1,2, Hasegawa H, Okabayashi K, Kitagawa Y: World J Surg. 2016/4; 40 (4): 1019-20. (Îˆä—ǍK1,2: 1ŠO‰Č, 2–k—˘Œ¤‹†Š•a‰@)

110167. [Œ´’˜] 12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study. Yamanaka T, Oki E, Yamazaki K, Yamaguchi K, Muro K, Uetake H, Sato T1, Nishina T, Ikeda M, Kato T, Kanazawa A, Kusumoto T, Chao C, Lopatin M, Krishnakumar J, Bailey H, Akagi K, Ochiai A, Ohtsu A, Ohashi Y, Yoshino T: J Clin Oncol 2016/8; 34 (24): 2906-13. (˛“Ą•˜Y1: 1ŠO‰Č)

110168. [Œ´’˜] Lower body mass index predicts worse cancer-specific prognosis in octogenarians with colorectal cancer. Adachi T, Hinoi T, Kinugawa Y, Enomoto T, Maruyama S, Hirose H, Naito M1, Tanaka K, Miyake Y, Watanabe M1: J Gastroenterol 2016/8; 51 (8): 779-87. (“ŕ“Ął‹K1, “n粏š•F1: 1ŠO‰Č)

110169. [Œ´’˜] Risk Factors for Surgical Site Infection after Laparoscopic Surgery for Colon Cancer. Nakamura T1, Sato T1, Takayama Y2, Naito M1, Yamanashi T1, Miura H1, Tsutsui A1, Yamashita K1, Watanabe M1: Surg Infect (Larchmt) 2016/8; 17 (4): 454-8. (’†‘ş—˛r1, ˛“Ą•˜Y1, ‚ŽR—zŽq2, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR‰şŒpŽj1, “n粏š•F1: 1ŠO‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110170. [Œ´’˜] A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1) Sato T1, Hayakawa K2, Tomita N, Noda M, Kamikonya N, Watanabe T, Kato D, Sakai Y, Hiraoka M, Shimada M, Ikushima H, Baba H, Oya N, Oya M, Nemoto-Murofushi K, Takeuchi M, Watanabe M1: Radiother Oncol 2016/8; 120 (2): 222-7. (˛“Ą•˜Y1, ‘ě˜ad2, “n粏š•F1: 1ŠO‰Č, 2•úŽËü (Žîá‡))

110171. [Œ´’˜] Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer. Shigeta K, Hasegawa H, Okabayashi K, Tsuruta M, Ishii Y1,2, Endo T, Ochiai H, Kondo T, Kitagawa Y: Int J Cancer 2016/8; 139 (4): 946-54. (Îˆä—ǍK1,2: 1ŠO‰Č, 2–k—˘Œ¤‹†Š•a‰@)

110172. [Œ´’˜] Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer. Ishii S1, Yamashita K2, Kato H2, Nishizawa N1, Ushiku H1, Mieno H2, Moriya H2, Hosoda K2, Katada N2, Kikuchi S3, Tanabe S4, Koizumi W5, Saegusa M6, Watanabe M2: Surg Today 2016/9; 46 (9): 1031-8. (Îˆä@’q1, ŽR‰şŒpŽj2, ‰Á“Ą@O2, źŕVL‹ą1, ‹‹vGŽ÷1, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, •Đ“c‰Ä–ç2, ‹e’rŽj˜Y3, “c糁@‘4, Źň˜aŽO˜Y5, ŽOŽ}@M6, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç, 4V˘‹Iˆă—ÁEć’[ˆă—Ă, 5Á‰ťŠí“ŕ, 6•a—)

110173. [Œ´’˜] Homeobox-Only Protein Expression Is a Critical Prognostic Indicator of Pancreatic Neuroendocrine Tumor and Is Regulated by Promoter DNA Hypermethylation. Ushiku H1, Yamashita K2, Kawamata H2, Waraya M2, Katoh H2, Yokoi K1, Tanaka T1, Ishii S1, Nishizawa N1, Kikuchi M2, Minatani N1, Kojo K1, Tajima H2, Nishiyama R2, Kaizu T2, Kumamoto Y2, Watanabe M2: Pancreas 2016/10; 45 (9): 1255-62. (‹‹vGŽ÷1, ŽR‰şŒpŽj2, ‰Í–”@Š°2, ˜m’J”ü“Ţ2, ‰Á“Ą@O2, ‰ĄˆäŒ\Œĺ1, “c’†r“š1, Îˆä@’q1, źŕVL‹ą1, ‹e’r^—Žq2, “ě’JŘ•äŽq1, ŒĂé@Œ›1, “c“‡@O2, źŽR@—ş2, ŠC’Ă‹MŽj2, ŒGŒł—Y‰î2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110174. [Œ´’˜] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Tanino H1, Kosaka Y1, Nishimiya H1, Tanaka Y2, Minatani N2, Kikuchi M1, Shida A1, Waraya M1, Katoh H1, Enomoto T, Sengoku N1, Kajita S3, Hoffman RM, Watanabe M1: PLoS ONE 2016/12; 11 (12): e0165721. (’J–ě—Tˆę1, Źâ–ůŒŤ1, ź‹{—mŽj1, “c’†—uŽq2, “ě’JŘ•äŽq2, ‹e’r^—Žq1, M‘žşŽq1, ˜m’J”ü“Ţ1, ‰Á“Ą@O1, ‰|–{‘ń–Î, ĺÎ‹I•F1, Š“cç”ü”T3, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•a—)

110175. [Œ´’˜] Prognostic Advantage of Docetaxel/Cisplatin/5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence. Yamashita K1, Hosoda K1, Moriya H1, Katada C2, Sugawara M3, Mieno H1, Komori S4, Katada N1, Watanabe M1: Oncology 2017/1; 92 (4): 221-8. (ŽR‰şŒpŽj1, ×“c@Œj1, X’JGŒő1, Œ˜“ce—˜2, ›Œ´[L3, ŽOd–ě_˜N1, ŹXłŽq4, •Đ“c‰Ä–ç1, “n粏š•F1: 1ŠO‰Č, 2Á‰ťŠí“ŕ, 3–ňÜ•”, 4•úŽËü (Žîá‡))

110176. [Œ´’˜] Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer. Kikuchi M1, Katoh H1, Waraya M1, Tanaka Y2, Ishii S2, Tanaka T2, Nishizawa N2, Yokoi K2, Minatani N2, Ema A1, Kosaka Y1, Tanino H1, Yamashita K1, Watanabe M1: Cancer Lett 2017/1; 384: 70-8. (‹e’r^—Žq1, ‰Á“Ą@O1, ˜m’J”ü“Ţ1, “c’†—uŽq2, Îˆä@’q2, “c’†r“š2, źŕVL‹ą2, ‰ĄˆäŒ\Œĺ2, “ě’JŘ•äŽq2, ]ŠÔ@—ć1, Źâ–ůŒŤ1, ’J–ě—Tˆę1, ŽR‰şŒpŽj1, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110177. [Œ´’˜] Effect of Preoperative Nutritional Status on Surgical Site Infection in Colorectal Cancer Resection. Tanaka T1, Sato T2, Yamashita K2, Hosoda K2, Nakamura T2, Watanabe M2: Dig Surg 2017; 34: 68-77. (“c’†r“š1, ˛“Ą•˜Y2, ŽR‰şŒpŽj2, ×“c@Œj2, ’†‘ş—˛r2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110178. [Œ´’˜] Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma. Ushiku H1, Yamashita K2, Katoh H2, Ema A2, Minatani N1, Kikuchi M2, Kojo K1, Yokoi K1, Tanaka T1, Nishizawa N1, Ishii S1, Hosoda K2, Moriya H2, Mieno H2, Katada N, Kikuchi S3, Watanabe M2: Dis Esophagus 2017/2; 30 (2): 1-9. (‹‹vGŽ÷1, ŽR‰şŒpŽj2, ‰Á“Ą@O2, ]ŠÔ@—ć2, “ě’JŘ•äŽq1, ‹e’r^—Žq2, ŒĂé@Œ›1, ‰ĄˆäŒ\Œĺ1, “c’†r“š1, źŕVL‹ą1, Îˆä@’q1, ×“c@Œj2, X’JGŒő2, ŽOd–ě_˜N2, •Đ“c‰Ä–ç, ‹e’rŽj˜Y3, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç)

110179. [Œ´’˜] Safety and efficacy of a novel linear staple device with bioabsorbable polyglicolic acid felt in laparoscopic colorectal surgery. Naito M1, Yamanashi T1, Nakamura T1, Miura H1, Tsutsui A1, Sato T1, Watanabe M1: Asian J Endosc Surg 2017/2; 10 (1): 35-9. (“ŕ“Ął‹K1, ŽR—œ‚L1, ’†‘ş—˛r1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, “n粏š•F1: 1ŠO‰Č)

110180. [Œ´’˜] Prospective randomized controlled study on the validity and safety of an absorbable adhesion barrier (InterceedŇ) made of oxidized regenerated cellulose for laparoscopic colorectal surgery. Naito M1, Ogura N1, Yamanashi T1, Sato T1, Nakamura T1, Miura H1, Tsutsui A1, Sakamoto Y2, Tanaka R2, Kunugi Y2, Watanabe M1: Asian J Endosc Surg 2017/2; 10 (1): 7-11. (“ŕ“Ął‹K1, Ź‘q’źl1, ŽR—œ‚L1, ˛“Ą•˜Y1, ’†‘ş—˛r1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, â–{‘×—2, “c’†—‰pŽq2, ŒF’J—YŽĄ2, “n粏š•F1: 1ŠO‰Č, 2—Տ°Œ¤‹†EŠé‰ć)

110181. [Œ´’˜] Risk factors for perineal wound infection after abdominoperineal resection of advanced lower rectal cancer. Nakamura T1, Sato T1, Hayakawa K2, Takayama Y3, Naito M1, Yamanashi T1, Tsutsui A1, Miura H1, Watanabe M1: Ann Med Surg (Lond) 2017/2; 15: 14-8. (’†‘ş—˛r1, ˛“Ą•˜Y1, ‘ě˜ad2, ‚ŽR—zŽq3, “ŕ“Ął‹K1, ŽR—œ‚L1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, “n粏š•F1: 1ŠO‰Č, 2•úŽËü (Žîá‡), 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110182. [Œ´’˜] The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma. Kojima K1, Yamashita K2, Ushiku H1, Katoh H2, Ishii S1, Tanaka T1, Yokoi K1, Suzuki M, Ooizumi Y1, Igarashi K1, Hosoda K2, Moriya H2, Mieno H2, Katada N, Tanabe S3, Watanabe M2: Dis Esophagus 2017/3; 30 (3): 1-9. (Ź›¸Œc‘ž1, ŽR‰şŒpŽj2, ‹‹vGŽ÷1, ‰Á“Ą@O2, Îˆä@’q1, “c’†r“š1, ‰ĄˆäŒ\Œĺ1, ‘ĺň—z‰î1, ŒÜ\—’ˆę°1, ×“c@Œj2, X’JGŒő2, ŽOd–ě_˜N2, •Đ“c‰Ä–ç, “c糁@‘3, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

110183. [Œ´’˜] Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer. Yokoi K1, Yamashita K2, Ishii S1, Tanaka T1, Nishizawa N1, Tsutsui A2, Miura H2, Katoh H2, Yamanashi T2, Naito M2, Sato T2, Nakamura T2, Watanabe M2: Br J Cancer 2017/4; 116 (8): 1046-56. (‰ĄˆäŒ\Œĺ1, ŽR‰şŒpŽj2, Îˆä@’q1, “c’†r“š1, źŕVL‹ą1, “›ˆä“ÖŽq2, ŽO‰YŒ[šć2, ‰Á“Ą@O2, ŽR—œ‚L2, “ŕ“Ął‹K2, ˛“Ą•˜Y2, ’†‘ş—˛r2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110184. [Œ´’˜] Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer. Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Nishimura Y, Katoh H1, Yamashita K1, Watanabe M1, Yamaguchi K: J Gastrointest Surg 2017/5; 21 (5): 867-78. (‰Á“Ą@O1, ŽR‰şŒpŽj1, “n粏š•F1: 1ŠO‰Č)

110185. [Œ´’˜] Complications after implantation of subcutaneous central venous ports (PowerPortŇ). Nakamura T1, Sasaki J2, Asari Y3, Sato T1, Torii S4, Watanabe M1: Ann Med Surg 2017/5; 17: 1-6. (’†‘ş—˛r1, ˛X–ŘŽĄˆę˜Y2, ó—˜@–ő3, ˛“Ą•˜Y1, ’šˆäWŽO4, “n粏š•F1: 1ŠO‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3‹~–˝, 4ˆă—ĂˆŔ‘SŠw‹łˆç)

110186. [Œ´’˜] DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer. Ushiku H1, Yamashita K2, Ema A2, Minatani N1, Kikuchi M2, Kojo K1, Yokoi K1, Tanaka T1, Nishizawa N1, Ishii S1, Hosoda K2, Moriya H2, Mieno H2, Katada N, Kikuchi S3, Katoh H2, Watanabe M2: Gastric Cancer 2017/9; 20 (5): 784-92. (‹‹vGŽ÷1, ŽR‰şŒpŽj2, ]ŠÔ@—ć2, “ě’JŘ•äŽq1, ‹e’r^—Žq2, ŒĂé@Œ›1, ‰ĄˆäŒ\Œĺ1, “c’†r“š1, źŕVL‹ą1, Îˆä@’q1, ×“c@Œj2, X’JGŒő2, ŽOd–ě_˜N2, •Đ“c‰Ä–ç, ‹e’rŽj˜Y3, ‰Á“Ą@O2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç)

120009. [Œ´’˜] äXŠÇ’_“š‡—ŹˆŮíÇ‚É‚¨‚Ż‚鏬Ž™‚ƐŹl‚Ě—Ő°‘œ‚ĚŒŸ“˘. •“cŒ›Žq1, “c’†@Œ‰2, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): –k—˘ˆăŠw 2016/6; 46 (1): 13-8.

320005. [Ç—á•ń] ’á’`”’ŒŒÇ‚𔺂Á‚˝self-limited coeliac disease-like enteropathy‚Ě1—á. Îˆä@’q1, ’†‘ş—˛r2, ŽO•xO”V, ˛“Ą•˜Y2, ŽR‰şŒpŽj2, “c’†r“š1, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): “ú–{—Տ°ŠO‰ČŠw‰ďŽGŽ 2016/6; 77 (6): 1464-70.

320006. [Ç—á•ń] ‘ĺ‘Úƒwƒ‹ƒjƒA›Ć“Ú‚Ě—pŽč“IŠŇ”[Œă‚É’°ŠÇ–Œ‰ťŹ“Ž–ŹáŽ‚đŒ`Ź‚ľ‚˝Ç—á‚ɑ΂ľ, • o‹ž‰şƒwƒ‹ƒjƒAŞŽĄp‚đŽ{s‚ľ‚˝1—á. ’†ź@—ş1, ’†‘ş—˛r1, ƒEƒbƒhƒnƒ€ƒX—ćŽq2, “Ą“căĕ˝1, ‰Ą“c˜aŽq3, ŠC’Ă‹MŽj1, ŽR‰şŒpŽj1, “c“‡@O1, ŽR—œ‚L1, “n粏š•F1 (1ŠO‰Č, 2•úŽËü (‰ć‘œ), 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{Á‰ťŠíŠO‰ČŠw‰ďŽGŽ 2016/12; 49 (12): 1268-74.

320007. [Ç—á•ń] ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒu“űŠŕ (TNBC) ‚ŏp‘O‰ťŠw—Ă–@‚đs‚˘pCR‚Ş“ž‚ç‚ę‚é‚ŕ6‚ŠŒŽ‚ĹÄ”­‚ľ‚˝1—á. —с@‹žŽq1, ˜m’J”ü“Ţ1, ‰HœAŒ’m, ×’J@’q1, ĺÎ‹I•F1, ’J–ě—Tˆę1, ‘ě˜ad2, Œ˘Ž”@‰~3, ŽOŽ}@M3, “n粏š•F1 (1ŠO‰Č, 2•úŽËü (Žîá‡), 3•a—): Šŕ‚ƉťŠw—Ă–@ 2016/11; 43 (12): 2050-3.

320008. [Ç—á•ń] Gemcitabine + Nab-Paclitaxel•š—p—Ă–@Œă‚ÉŞŽĄŘœ‚މ”\‚Ć‚Č‚Á‚˝Řœ•s”\äXŠŕ‚Ě1—á. ’†–{CŽi1, źŽR@—ş1, ‹ŕ“c’—Ç, ‰Ą“cŒő‰›, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, ŽR“ŕ_Žj2, ‰œ˜e‹ť‰î2, Šâˆä’m‹v2, Ąň@O2, —é–ŘƒGƒŠ“Ţ3, Œ´@“ÖŽq3, ˆęŒËš–ž3, –Ř“cŒőO2, “n糏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 3•a—): Šŕ‚ƉťŠw—Ă–@ 2017/2; 44 (2): 173-6.

320009. [Ç—á•ń] • o‹ž‰ş‚ÉŠŽ‘SŘœ‚ľ‚˝• o“ŕ“ˏoŒ^• •ÇŽ‰–bŽî‚Ě1—á. ‰Ą“c˜aŽq1, ’†‘ş—˛r2, ˛“Ą•˜Y2, ”óŒű@Ši, ŽR‰şŒpŽj2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): “ú–{—Տ°ŠO‰ČŠw‰ďŽGŽ 2017/3; 78 (3): 615-9.

511002. [‰đŕ] Present laparoscopic surgery for colorectal cancer in Japan. Sato T1, Watanabe M1: World J Clin Oncol 2016/4; 7 (2): 155-9. (˛“Ą•˜Y1, “n粏š•F1: 1ŠO‰Č)

522072. [uŔ]y“ÁW: äXŘœEäXÄŒš‚đÄl‚ˇ‚ézIII. äXÄŒš@9. äX‹ó’°•Ť‡|Š`“c–@‚É‚ć‚éŠŃ’Ę–§’…•Ť‡. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, źŽR@—ş1, Š`“c@Í, “n粏š•F1 (1ŠO‰Č): Žčp 2016/6; 70 (7): 957-62.

522073. [uŔ]y“ÁW: ŹŽ™Šż•ű: ‰ˇŒĚ’mV|Œš’†“’E•âÜE—˜…Üz¸Œn…ᎂɑ΂ˇ‚éŒÜ—čŽU‚ĚŒř‰Ę. •“cŒ›Žq1, “c’†@Œ‰2, Š`Œ´@’m, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ŹŽ™ŠO‰Č 2016/7; 48 (7): 739-42.

522074. [uŔ]y‘ć30‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€zV‹Kƒ^ƒLƒTƒ“ŒnRˆŤŤŽîᇖň‚É‚ć‚é”­]‚ÉŠÖ‚ˇ‚錟“˘. M‘žşŽq1, Źâ–ůŒŤ1, ˜m’J”ü“Ţ1, “c’†—uŽq2, ‹e’r^—Žq1, “ě’JŘ•äŽq2, ‰Á“Ą@O1, ĺÎ‹I•F1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): –k—˘ˆăŠw 2016/12; 46 (2): 123-7.

522075. [uŔ]y“ÁW: ĹV‚Ě“ŕŽ‹‹žŠO‰ČŽčp‚Ě“K‰ž‚Ć’ˆÓ“_z‘˜_: “ú–{‚É‚¨‚Ż‚é“ŕŽ‹‹žŠO‰ČŽčp‚ĚŒťó‚ƍĄŒă‚Ě“W–]. ŽR—œ‚L1, “n粏š•F1 (1ŠO‰Č): —Տ°ŠO‰Č 2017/1; 72 (1): 6-11.

522076. [uŔ]y“ÁW: ‹@”\‰ˇ‘śpŽŽ‚̍ŐVî•ńzŠmŽŔ‚Ȑ_Œo‰ˇ‘ś‚ĆD3ƒŠƒ“ƒpßŠs´‚𔺂¤SóŒ‹’°Řœp. “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č): Žčp 2017/1; 71 (1): 43-7.

522077. [uŔ] ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é• o‹ž•â•‰ş—H–ĺ•Ű‘śˆÝŘœp. ×“c@Œj1, ŽR‰şŒpŽj1, źŕVL‹ą2, ŽOd–ě_˜N1, X’JGŒő1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Žčp 2017/1; 71 (1): 79-85.

[’˜@‘]

620071. [Šwp‘ (•Ş’SŽˇ•M)]yV/ƒAƒgƒ‰ƒX‚ĹŠw‚Ô’Bl‚ĚŽčp (Á‰ťŠíŠO‰Č2016”N4ŒŽ‘Š§†)zII. Ź’°EŒ‹’°‚ĚŽčp@3. • o‹ž‰ş‰ĄsŒ‹’°Řœp, p.617-24. “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č), ‚ւ邡o”Ĺ, “Œ‹ž, 2016/4”­s.

620072. [Šwp‘ (•Ş’SŽˇ•M)]y<‚Ş‚ńŠĹŒěŽŔ‘HƒKƒCƒh> •a‘ԁEŽĄ—Ă‚đ‚Ó‚Ü‚Ś‚˝‚Ş‚ńŠłŽŇ‚Ě”r•ÖƒPƒAz‘ć1Í ‚Ş‚ńŠłŽŇ‚Ě”r•ÖƒPƒA‚É•K—v‚ČŠî‘b’mŽŻ@1. ”r•Ö‚ĚƒƒJƒjƒYƒ€‚Ć‚ť‚̏áŠQ, p.2-6. “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{‚Ş‚ńŠĹŒěŠw‰ď, •Ň: źŒ´N”ü, ˆăŠw‘‰@, “Œ‹ž, 2016/6”­s.

620073. [Šwp‘ (•Ş’SŽˇ•M)]y<‚Ş‚ńŠĹŒěŽŔ‘HƒKƒCƒh> •a‘ԁEŽĄ—Ă‚đ‚Ó‚Ü‚Ś‚˝‚Ş‚ńŠłŽŇ‚Ě”r•ÖƒPƒAz‘ć1Í ‚Ş‚ńŠłŽŇ‚Ě”r•ÖƒPƒA‚É•K—v‚ČŠî‘b’mŽŻ@4. ”r•ÖáŠQ‚ĚŽĄ—Ă, p.25-30. ’†‘ş—˛r (ŠO‰Č), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{‚Ş‚ńŠĹŒěŠw‰ď, •Ň: źŒ´N”ü, ˆăŠw‘‰@, “Œ‹ž, 2016/6”­s.

620074. [Šwp‘ (•Ş’SŽˇ•M)]y<‚Ş‚ńŠĹŒěŽŔ‘HƒKƒCƒh> •a‘ԁEŽĄ—Ă‚đ‚Ó‚Ü‚Ś‚˝‚Ş‚ńŠłŽŇ‚Ě”r•ÖƒPƒAz‘ć3Í is‚Ş‚ń‚É”ş‚¤”r•ÖƒPƒA@1. ”dŽíŤ•a•Ď‚Ş‚ ‚éę‡‚Ě•Ö’Ę‘Îô‚ƏǏóŠÉ˜a, p.58-63. “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{‚Ş‚ńŠĹŒěŠw‰ď, •Ň: źŒ´N”ü, ˆăŠw‘‰@, “Œ‹ž, 2016/6”­s.

620075. [Šwp‘ (•Ş’SŽˇ•M)]yäXŘœEäXÄŒš‚đÄl‚ˇ‚é (Žčp2016”N6ŒŽ‘‘ĺ†)zIII. äXÄŒš@9. äX‹ó’°•Ť‡|Š`“c–@‚É‚ć‚éŠŃ’Ę–§’…•Ť‡, p.957-62. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, źŽR@—ş1, Š`“c@Í, “n粏š•F1 (1ŠO‰Č), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/6”­s.

620076. [Šwp‘ (•Ş’SŽˇ•M)]y•ŞŽqŽîᇃ}[ƒJ[f—ĂƒKƒCƒhƒ‰ƒCƒ“ (‘ć1”Ĺ)zŠe˜_7 ‘ĺ’°Šŕ, p.78-91. ‰ĄˆäŒ\Œá1, ‰Á“Ą@O2, ŽR‰şŒpŽj2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č), •Ň: “ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

620077. [Šwp‘ (•Ş’SŽˇ•M)]y•ŞŽqŽîᇃ}[ƒJ[f—ĂƒKƒCƒhƒ‰ƒCƒ“ (‘ć1”Ĺ)zŠe˜_21 RASˆâ“`Žq, p.180-91. “c’†r“š1, ‰Á“Ą@O2, ŽR‰şŒpŽj2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č), •Ň: “ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

620078. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠíEˆę”ĘŠO‰Čˆă‚Ě‚˝‚ß‚Ě‹~‹}EW’†ŽĄ—Ă‚Ě‚ˇ‚×‚Ä (—Տ°ŠO‰Č2016”N10ŒŽ‘Š§†)zIIIÍ Á‰ťŠí‹~‹}ŽžŠł@3. ŠĚ’_äX@‹}Ť’_ŠÇ‰Š, p.297-300. ŒGŒł—Y‰î (ŠO‰Č), ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620079. [Šwp‘ (•Ş’SŽˇ•M)]yƒCƒ‰ƒXƒg‚ĹŠw‚ԏÁ‰ťŠíŠO‰ČÄŒš–@‚Ě‚ˇ‚×‚Ä (—Տ°ŽGŽŠO‰Č2016”N11ŒŽ‘Š§†)zV. äX@1. äXŘœŒăÄŒš@3) äX’°•Ť‡|Š`“c–@, p.1437-42. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, Š`“c@Í, “n粏š•F1 (1ŠO‰Č), “ě]“°, “Œ‹ž, 2016/11”­s.

620080. [Šwp‘ (•Ş’SŽˇ•M)]yŽčp—pƒV[ƒ‰ƒ“ƒgŢE–ü’…–hŽ~Ţ‚Ě—˜•Ö‰ťŒüă‚đ–ÚŽw‚ľ‚˝ť•iŠJ”­z‘ć6Í —Տ°Œťę (—Ěˆć–ˆ) ‚ĚŽg—pŒťó‚ƍĄŒă‹‚ß‚ç‚ę‚鐝•i‘œ@‘ć1ß Á‰ťŠíŠO‰Č‚É‚¨‚˘‚Ä‹‚ß‚ç‚ę‚鐝•i‘œ, p.353-8. “ŕ“Ął‹K (ŠO‰Č), ‹Zpî•ń‹Ś‰ď, “Œ‹ž, 2016/12”­s.

620081. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠíŠŕŽčp‚É•K—v‚ČŠg‘压‚É‚ć‚é‹ÇŠ”÷×‰đ–UƒAƒgƒ‰ƒX (Žčp2017”N3ŒŽ—ŐŽž‘Š§†)zIII. ‘ĺ’°@4. ”÷×‰đ–U‚ɏ€‚ś‚˝śŒ‹’°“Ž–Ź‰ˇ‘śNo.253ƒŠƒ“ƒpßŠs´, p.505-13. ŽR—œ‚L1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽO‰YŒ[šć1, “n粏š•F1 (1ŠO‰Č), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713048. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Safety and indications of laparoscopic surgery for post-operative small-bowel obstruction: Asingle-center study in 121 patients. Nakamura T1, Ishii Y1, Tsutsui A1, Kaneda M, Sato T1, Watanabe M1: The American Society of Colon and Rectal Surgeons Annual Scientific Meeting(ASCRS 2016) (2016/4/30-5/4), LosAngeles, USA. (’†‘ş—˛r1, Îˆä—ǍK1, “›ˆä“ÖŽq1, ‹ŕ“c@‹v, ˛“Ą•˜Y1, “n粏š•F1: 1ŠO‰Č)

713049. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Laparoscopic surgery for locally advanced colon and rectosigmoid cancer: clinical outcomes and prognostic factors. Yamanashi T1, Nakamura T1, Sato T1, Naito M1, Miura H1, Tsutsui A1, Watanabe M1: 24th International congress of the European Association for Endoscopic Surgery (EAES) (2016/6/16), Amsterdam, Netherlands. (ŽR—œ‚L1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1: 1ŠO‰Č)

713050. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A multisenter phase II study of preoperative concurrent chemoradiotherapy with S-1 plus irinotecan for locally advanced rectal cancer: SAMRAI-2. Noda M, Sato T1, Hayakawa K2, Tomita N, Kamikonnya N, Matoba S, Uki A, Baba H, Oya N, Hasegawa H, Shigematu N, Hida K, Furuhata T, Naitou T, Shimada M, Higuchi K, Sakai Y, Takeuchi M, Watanabe M1: European Society for Medical Oncology(ESMO)2016 (2016/10/8), Copenhagen, Denmark. (˛“Ą•˜Y1, ‘ě˜ad2, “n粏š•F1: 1ŠO‰Č, 2•úŽËü (Žîá‡))

713051. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Difficulty of removing peripherally inserted central venous catheters: Analysis of six cases. Okamoto M1, Tanaka K2, Takeda N1, Kakihara T1: 5th World Congress of Pediatric Surgery (2016/10/11), Washington, USA. (‰Ş–{Œő‹FŽq1, “c’†@Œ‰2, •“cŒ›Žq1, Š`Œ´@’m1: 1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713052. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Promoter DNA Hypermethylation of CDO1 Geneand High Chemosensitivity Through Modification of Mitochondrial Membrane Potential in Colorectal Cancer. Kojima K, Ishii S1, Tanaka T1, Nishizawa N1, Katoh H2, Sato T2, Nakamura T2, Watanabe M2: Society Surgical Oncology2017(SSO2017) (2017/3/15), Seattle, USA. (Îˆä@’q1, “c’†r“š1, źŕVL‹ą1, ‰Á“Ą@O2, ˛“Ą•˜Y2, ’†‘ş—˛r2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

713053. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Potential Utility of Cysteine Dioxygenase 1 Gene Promoter Methylation as a Marker of Tumor Diagnosis in Pancreatic Adenocarcinoma. Yokoi K1, Nishiyama R2, Katoh H2, Kaizu T2, Kumamoto Y2, Watanabe M2: Society Surgical Oncology2017 (SSO2017) (2017/3/15), Seattle, USA. (‰ĄˆäŒ\Œĺ1, źŽR@—ş2, ‰Á“Ą@O2, ŠC’Ă‹MŽj2, ŒGŒł—Y‰î2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

721006. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) äX‹ó’°ŠŃ’Ę–§’…•Ť‡p (Š`“c–@) ‚Ě‹ÉˆÓ. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, Š`“c@Í, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), “Œ‹ž.

722082. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‹ÇŠis’ź’°Šŕ‚ɑ΂ˇ‚鉝Šw•úŽËü—Ă–@‚đ—p‚˘‚˝WŠw“IŽĄ—Ă. ˛“Ą•˜Y1, ’†‘ş—˛r1, “ŕ“Ął‹K1, Ź‘q’źl1, ŽR—œ‚L1, ŽO‰YŒ[Žő1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/15), ‘ĺă.

722083. [Šw‰ď (‘S‘)] (—v–]ƒrƒfƒI) “ŕŽ‹‹ž—pƒzƒ‹ƒ_EMARO‚đ—p‚˘‚˝‹šo‹žŽčp‚ĚŒoŒą. _’J‹I‹P1, •gě˜a–ç1, ŠÖ@‘ĺm1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, Îˆä—ǍK1,2, óŔŽjŽ÷1, ‘ĺěš‹`1 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č): ‘ć33‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2016/5/13), ‹ž“s, “ú–{ŒÄ‹zŠíŠO‰ČŠw‰ďŽGŽ 2016/4; 30 (3): RV4-2.

722084. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) • o‹ž•â•‰ş—H–ĺ•Ű‘śˆÝŘœp‚É‚¨‚Ż‚éPGSAS-45‚đ—p‚˘‚˝QOL’˛¸. ×“c@Œj1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, X’JGŒő1, •Đ“c‰Ä–ç, ÷–{Mˆę, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/14), “ż“‡.

722085. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yisˆÝŠŕ‚ɑ΂ˇ‚鉝Šw—Ă–@Œă‘ĺ“Ž–ŹŽüˆÍƒŠƒ“ƒpßŠs´‚ĚˆÓ‹`z‘ĺ“Ž–ŹŽüˆÍƒŠƒ“ƒpß“]ˆÚ‚𔺂¤isˆÝŠŕ‚ɑ΂ˇ‚éDCS—Ă–@Œă‚ĚŽčpŹŃ. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, X’JGŒő1, ×“c@Œj1, “Œ@’q2, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/14), “ż“‡, “ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď 2016/7; 71: WS13-5.

722086. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Á‰ťŠÇŠŕf—Ă‚É‚¨‚Ż‚éƒoƒCƒIƒ}[ƒJ[‚Ě–đŠ„. ŽR‰şŒpŽj1, ×“c@Œj1, X’JGŒő1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ‹‹vGŽ÷2, ‰ĄˆäŒ\Œĺ2, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/16), “ż“‡.

722087. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) äX‹ó’°ŠŃ’Ę–§’…•Ť‡p (Š`“c–@) ‚ĚƒRƒc ŒGŒł—Y‰î (ŠO‰Č): ‘ć23‰ńŠO‰ČƒtƒH[ƒ‰ƒ€ (2016/7/23), “Œ‹ž.

722088. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) • o‹ž‰ş”ö‘¤Řœ‚Ĺ‚ĚNeedlescopic surgery. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): 5th Reduced Port Surgery Forum 2016 in Osaka (2016/8/6), ‘ĺă.

722089. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) • o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚éReduced Port Surgery (RPS) ‚ĚŽŽ‚Ý. ’†–{CŽi1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “c“‡@O1, źŽR@—ş1, ‰Í–”@Š°1, “n粏š•F1 (1ŠO‰Č): 5th Reduced Port Surgery Forum 2016 in Osaka (2016/8/6), ‘ĺă.

722090. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‹ÇŠis’ź’°Šŕ‚ɑ΂ˇ‚éTS-1/CPT-11•š—pp‘O‰ťŠw•úŽËü—Ă–@‚Ě—Ő°‘ć… ‘ŠŽŽŒą: SAMRAI-2. “IęŽüˆę˜Y, “n粏š•F1, ˛“Ą•˜Y1, ‘ě˜ad2, •y“cŽ—T, ăŽ‰ŽŒ›•F, ‰F–؏ͩě, ”nęG•v, ‘剎‰Äś, ’ˇ’Jě”Žr, –Ώź’ź”V, •˝‰ŞáÁŠ°, ŹŒűł•F, ‘ĺ–î‰ë•q, ’|“ŕłO (1ŠO‰Č, 2•úŽËü (Žîá‡)): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

722091. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Řœ‰Â”\‹ŤŠEäXŠŕ‚ɑ΂ˇ‚éƒwƒpƒŠƒ“•š—pGS—Ă–@‚É‚ć‚éNACR‚ĚŽĄ—ĂŒoŒą. —é–ŘŒcˆę1, —é–ŘŠ˛l1, –îě‰ëŽj1, ‘ş“c@Œ’1, ‹ŕ“c@‹v1, Îˆä—ǍK1,2, _’J‹P‹I1 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l, “ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď´˜^W 2016/10; 54: WS4-5.

722092. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ˆÝŠŕstageIBÇ—á‚Ě—\Œă‚ĚŒŸ“˘. ˜h”ö^—ˆ¤1, ŽR‰şŒpŽj1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, ÷–{Mˆę, “n粏š•F1 (1ŠO‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/21), ‰Ą•l.

722093. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ’_ůNŠŕ‡•š‹}Ť’_”X‰Š‚ɑ΂ˇ‚éENGBD’_`×–E‚Ě—L—pŤ. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, “n粏š•F1, –Ř“cŒőL2, Ąň@O2, Šâˆä’m‹v2, ‰œ˜e‹ť‰î2, ŽR“ŕ_Žj2, ‹ŕŽq@‹œ2 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/21), ‰Ą•l.

722094. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Stage II/IIIˆÝŠŕS-1•â•‰ťŠw—Ă–@Ç—á‚ĚŽĄ—ÐŹŃ‚ĆÄ”­Œ`ŽŽ‚ĚŒŸ“˘. ]ŠÔ@—ć1, ŽR‰şŒpŽj1, Îˆä@’q2, ˜h”ö^—ˆ¤1, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/22), ‰Ą•l.

722095. [Šw‰ď (‘S‘)] (—v–]‰‰‘č) “÷ŠáŒ^0-Ip‚đ’ć‚ľ‚˝‘B“ŕ•Ş”ĺ×–EŠŕ‚Ě1Žčp—á. –îě‰ëŽj1, Îˆä—ǍK1,2, —é–ŘŠ˛l1, ‘ş“c@Œ’1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, _’J‹I‹P1, óŔŽjŽ÷1, ‘ĺěš‹`1, ‹e’rŽj˜Y3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@ŠO‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ˆÉ¨, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/10; 69: A92.

722096. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ’°•ÂÇ‚ĚŽż“If’f‚ĆŽĄ—Ð헪 • o‹ž‰şpŒăŹ’°’°•ÂÇŽčp‚É‚¨‚Ż‚éŠJ• ˆÚs‚ĚŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛•q1, Îˆä—ǍK1,2, “›ˆä“ÖŽq1, ‹ŕ“c@‹v2, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, “n粏š•F1 (1ŠO‰Č, 2–k—˘Œ¤‹†Š•a‰@): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/24), ‚—Ö, “ú–{—Տ°ŠO‰ČŠw‰ďŽGŽ 2016/10; 77 (‘Š§): 383.

722097. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) • o‹ž‰ş‘ĺ’°Řœ‚É‚¨‚Ż‚éƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO`ŽŸ‚ĚˆęŽč‚Ě‚ť‚Ě‘O‚Ɂ`. “ŕ“Ął‹K1, ’†‘ş—˛r1, ŽR—œ‚L1, ŽO‰YŒ[Žő1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), “Œ‹ž.

722098. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) IPMN‚ĚŽčp“K‰ž‚ĆŽŠ“KpŽŽ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. źŽR@—ş1, ŒGŒł—Y‰î1, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), “Œ‹ž.

722099. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘ŠúŠŕ‚ɑ΂ˇ‚é• o‹ž‰ş—H–呤ˆÝŘœp‚̏pŒă’ˇŠúŹŃ. ŽR‰şŒpŽj1, ×“c@Œj1, ŽOd–ě_˜N1, X’JGŒő1, ]ŠÔ@—ć1, ˜h”ö^—ˆ¤1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l.

722100. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) • o‹ž•â•‰ş—H–呤ˆÝŘœ‚É‚¨‚Ż‚éNo.6Šs´‚¨‚ć‚ŃB-1ƒT[ƒLƒ…ƒ‰[ÄŒš. ÷–{Mˆę, ŒQŽi@‹v, Žá“cŒő’j, ’†”nŠî”Ž1, r’JŒ›ˆę, ‹{˜e@–L, ˛“Ą@O, ‰Ş–{Œő‡, ŽRŒű–ÎŽ÷, ŹŽR@—E, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723285. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MLPA–@‚É‚ć‚éBRCAness‚Ětriple negative“űŠŕ‚ɑ΂ˇ‚ép‘O‰ťŠw—Ă–@Œř‰Ę—\‘ށ|‘˝Ž{Ý‹¤“ŻŒ¤‹†|. ‚–썁•c, –žÎ’čŽq, ’J–ě—Tˆę, ź‹{—mŽj1, Źâ–ůŒŤ1, ˆ˘‘˝ˆŸ—˘š, ’†ŽRŽŃ—R, “a“ŕ—S”ü, ˛“Ą‘ĺŽ÷, Ź™“Ţ’ĂŽq, ’r“c@Ž‡, ˆäo‰Ŕ”ü, ‘“chŽq, ‹´–{—œ‰ŔŽq, ‘ĺŽR@Žm, ‹g“c—ćŽq, X@”üŽ÷, ŒKŽR—˛Žu, ‘ň“c@W, ’†‘ş´Œá (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/14), ‘ĺă.

723286. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒNƒ[ƒ“•a‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ‚ĚŒŸ“˘. “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, Ź‘q’źl1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŒĂé@Œ›2, ŹŕV•˝‘ž, ’r“c@“Ä1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/14), ‘ĺă.

723287. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺ’°Šŕ‚ɑ΂ˇ‚éReduced Port Surgery‚ĚŽĄ—ÐŹŃ. Îˆä—ǍK1,2, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, ‘ĺěš‹`1, –kě—YŒő3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 3Œcœä‹`m‘ĺŠwˆăŠw•”ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/14), ‘ĺă, ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď´˜^W 2016/4; 116: PS-059-5.

723288. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰şŒ‹’°ŠŕŽčpŒă‚Ě‘nŠ´őŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, Ź‘q’źl1, ŽR—œ‚L1, ŽO‰YŒ[Žő1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/15), ‘ĺă.

723289. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ÇŠis’ź’°Só•”Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp|ŽĄ—ÐŹŃ‚Ć—\Œă—\‘ވöŽq‚ĚŒŸ“˘|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl1, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/15), ‘ĺă.

723290. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “űŠŕ‚É‚¨‚Ż‚éHOPXˆâ“`Žqƒƒ`ƒ‹‰ť‚Ě—Ő°“IˆÓ‹`. ‹e’r^—Žq1, ‰Á“Ą@O1, ŽR‰şŒpŽj1, ‰Í–ě—uŽq1, M‘žşŽq1, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, ‰|–{‘ń–Î1, ĺÎ‹I•F1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/15), ‘ĺă.

723291. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Gemcitabine‘ϐŤƒqƒgäXŠŕŠ”‚ɑ΂ˇ‚éMetformin‚̍RŽîᇌř‰Ę. —é–ŘŒcˆę1, ’|“ŕ@C1, Îˆä—ǍK1,2, ‘ĺěš‹`1 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/15), ‘ĺă, ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď´˜^W 2016/4; 116: OP-034-6.

723292. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Siewert type II, IIIH“šˆÝÚ‡•”Šŕ‚ɑ΂ˇ‚鎥—Ð헪. ×“c@Œj1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/16), ‘ĺă.

723293. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“šŠŕŽüpŠú‚É‚¨‚Ż‚ép‘OŒÄ‹zƒŠƒnƒrƒŠ‚ĚˆÓ‹`. X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ×“c@Œj1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/16), ‘ĺă.

723294. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) CDO1ˆâ“`Žqƒvƒƒ‚[ƒ^[—Ěˆć‚̍‚ƒƒ`ƒ‹‰ť‚ÍStage IIIŒ‹’°Šŕ‚É‚¨‚Ż‚鉝Šw—Ă–@Š´ŽóŤ‚Ć‘ŠŠÖ‚ˇ‚é. ‰ĄˆäŒ\Œĺ1, ŽR‰şŒpŽj2, Îˆä@’q1, “c’†r“š1, źŕVL‹ą1, ]ŠÔ@—ć2, ‰Á“Ą@O2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/16), ‘ĺă.

723295. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒvƒƒyƒ“ƒVƒeƒBƒXƒRƒA‚đ‰ž—p‚ľ‚˝ZŤäXŠÇŠŕ‚Ě—\ŒăˆöŽq‰đÍ. źŕVL‹ą1, ŽR‰şŒpŽj2, ŒÜ\—’ˆę°1, źŽR@—ş2, ‰Í–”@Š°2, “c“‡@O2, ŠC’Ă‹MŽj2, ŒGŒł—Y‰î2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/16), ‘ĺă.

723296. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠĚ‰~őEŠĚŠ™óŠÔ–Œ‚¨‚ć‚Ń’ZŠĚĂ–Ź‚đŘ‚炸‚ɉˇ‘ś‚ˇ‚é• o‹ž‰şŠĚ‰E—tŽö“ŽŽč‹Z. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, źŽR@—ş1, “c“‡@O1, ‰Í–”@Š°1, “n粏š•F1 (1ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/16), ‘ĺă.

723297. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “űŠŕp‘O‰ťŠw—Ă–@‚É‚¨‚Ż‚épCR—\‘Ş‚Ć‚ľ‚Ä‚ĚElastography‚Ě—L—pŤ. ŠÖ@‘ĺm1, ‹v•Ű”ŠD1, ’†“ˆƒŽq1, óŔŽjŽ÷1, X‰ił“ń˜Y1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, _’J‹I‹P1, Îˆä—ǍK1,2, ‘ĺěš‹`1, ’r“c@ł1 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/16), ‘ĺă, ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď´˜^W 2016/4; 116: PS-166-7.

723298. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆÝᑃoƒ‹[ƒ“”j‘šÇ—á‚ĚŒŸ“˘. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć53‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠwpW‰ď (2016/5/26), •Ÿ‰Ş.

723299. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŹŽ™¸Œn…ᎂɑ΂ˇ‚éŒÜ—čŽU‚ĚŒř—p. •“cŒ›Žq1, “c’†@Œ‰2, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć53‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠwpW‰ď (2016/5/26), •Ÿ‰Ş, “úŹŠO‰ďŽ 2016/5; 52 (3): 755.

723300. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚Ĺ‚Ě• o‹ž‰ş”ö‘¤äXŘœ‚Ě•Ď‘J. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, •Đ‹ËŠ°”V, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2016/6/2-4), ‘ĺă.

723301. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p‘O‚ɐf’f‚ľ“ž‚˝äX“Ş•”Mixed acinar-endocrine carcinoma‚Ě1—á. ‘şăᩑĽ, źŽR@—ş1, ‰ĄŠÖ—Y“ń1, b”ă“c•Žu2, Œ´“cG‹P2, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć28‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2016/6/2-4), ‘ĺă.

723302. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Borderline resectableäXŠŕ‚ɑ΂ˇ‚éƒwƒpƒŠƒ“•š—pNACR‚Ě”F—eŤ‚ĆŒř‰Ę‚ĚŒŸ“˘. —é–ŘŒcˆę1, •gě˜a–ç1, ‹ŕ“c@‹v1, Îˆä—ǍK1,2, _’J‹I‹P1, ‘ĺěš‹`1 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č): ‘ć28‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2016/6/3), ‘ĺă, ‘ć28‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ďƒvƒƒOƒ‰ƒ€ 2016/6; p.586.

723303. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p‘Of’f‚É“ďa‚ľ‚˝Solid pseudopapillary neoplasm‚Ě1—á. ‰ĄŠÖ—YŽi, “c“‡@O1, ‘şăě‘Ľ, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2016/6/4), ‘ĺă.

723304. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş‘ĺ’°Řœp‚ɑ΂ˇ‚éƒ|ƒŠƒOƒŠƒR[ƒ‹Ž_ƒV[ƒg•t‰ÁŽŠ“Ž–D‡Ší‚Ě—L—p‚ČŽč‹Z. “ŕ“Ął‹K1, ’†‘ş—˛r1, ŽO‰YŒ[šć1, ŽR—œ‚L1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć41‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ďŠwpW‰ď (2016/6/15), ‘ĺă.

723305. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “űŠŕŠ”‰ť×–E‚ɑ΂ˇ‚éƒtƒFƒjƒ‹ƒuƒ`ƒŒ[ƒg‚ĚŒř‰Ę‹y‚ŃŠ´ŽóŤŠÖ˜Aˆâ“`Žq‚Ě’Tő. ‹e’r^—Žq1, ˜m’J”ü“Ţ1, “c’†—uŽq2, M‘žşŽq1, “ě’JŘ•äŽq2, ‰Á“Ą@O1, Źâ–ůŒŤ1, ĺÎ‹I•F1, ‰|–{‘ń–Î, ’J–ě—Tˆę, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/16), “Œ‹ž.

723306. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) pŒă•â•—Ă–@‚Ć‚ľ‚ÄTrastuzumab‚đ“Š—^‚ľ‚˝HER2—zŤ“űŠŕ‚Ě—\Œă‰đÍ. “ě’JŘ•äŽq1, Źâ–ůŒŤ2, “c’†—uŽq1, M‘žşŽq2, ‹e’r^—Žq2, ˜m’J”ü“Ţ2, ‰Á“Ą@O2, ‰|–{‘ń–Î, ĺÎ‹I•F2, ’J–ě—Tˆę, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/16), “Œ‹ž.

723307. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş—H–呤ˆÝŘœp‚ĚˆŔ‘S‚Č“ą“ü. ×“c@Œj1, ŽOd–ě_˜N1, ŽR‰şŒpŽj1, X’JGŒő1, •Đ“c‰Ä–ç, “n粏š•F1 (1ŠO‰Č): ‘ć41‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ďŠwpW‰ď (2016/6/16), ‘ĺă.

723308. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ź’°úE‚É‚Ä• o‹ž‰şŹ’°•”•ŞŘœ‚đŽ{s‚ľ‚˝’°ŠÇÇŒ^T×–EƒŠƒ“ƒpŽî‚Ě1—á. “n•”WŽq1, “ŕ“Ął‹K1, ’†‘ş—˛r1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ‰––ĄŒcŽq1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć41‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ďŠwpW‰ď (2016/6/16), ‘ĺă.

723309. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Mayer-Rokitansky-Kuster-HauserÇŒóŒQ‚ɑ΂ľ‚Ä• o‹ž‰ş‘˘äSp‚đŽ{s‚ľ‚˝1—á. ‰––ĄŒcŽq1, “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, ŽR—œ‚L1, ŽO‰YŒ[Žő1, “›ˆä“ÖŽq1, “n•”WŽq1, –{“c‰ëŽq2, źŽRD3, ě“ŕ”Žl4, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŽY‰Č, 4•wl): ‘ć41‰ń“ú–{ŠO‰ČŒn˜A‡Šw‰ďŠwpW‰ď (2016/6/16), ‘ĺă.

723310. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ä”­ŠłŽŇ‚Ě•sˆŔƒRƒ“ƒgƒ[ƒ‹‚ĆƒAƒhƒoƒ“ƒXƒPƒAƒvƒ‰ƒ“ƒjƒ“ƒO. ’J–ě—Tˆę, ĺÎ‹I•F1, ‰|–{‘ń–Î, Źâ–ůŒŤ1, ˜m’J”ü“Ţ1, ‹e’r^—Žq1, “ě’JŘ•äŽq2, M‘žşŽq1, ŁŒË–qŽq, ‹{“š“ń—t3 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–ňÜ•”): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723311. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ńZŤ“űŠÇŠŕ‚É‚¨‚Ż‚錴”­”ńŘœEƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpßśŒŸČ—Ş‚Ě‰Â”\Ť‚ÉŠÖ‚ˇ‚錟“˘. Źâ–ůŒŤ1, “c’†—uŽq2, M‘žşŽq1, “ě’JŘ•äŽq2, ‹e’r^—Žq1, ˜m’J”ü“Ţ1, ‰Á“Ą@O1, ‰|–{‘ń–Î, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723312. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éPEG-G(pegfilgrastim) ‚ĚŽg—pŒoŒą ĺÎ‹I•F1, HŽRŽjD (“Ą–ěŽjD)1, “c’†—uŽq2, “ě’JŘ•äŽq2, ‹e’r^—Žq1, M‘ž–žŽq1, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, ‰|–{‘ń–Î, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723313. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éƒgƒ‰ƒXƒcƒYƒ}ƒuƒGƒ€ƒ^ƒ“ƒVƒ“ (T-DM1) Žg—p—á‚ĚŒŸ“˘. M‘žşŽq1, ˜m’J”ü“Ţ1, “c’†—uŽq2, ‹e’r^—Žq1, “ě’J“ޏŽq2, Źâ–ůŒŤ1, ‰Á“Ą@O1, ‰|–{‘ń–Î, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723314. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) p‘O‰ťŠw—Ă–@’†‚É‹}‘Ź‘‘ĺ‚đ”F‚ß‚˝ƒAƒ|ƒNƒŠƒ“Šŕ‚ƝG•˝ă”çŠŕ‚Ş•š‘ś‚ľ‚˝“űŠŕ‚Ěˆę—á. “c’†—uŽq1, ‹e’r^—Žq2, M‘žşŽq2, ˜m’J”ü“Ţ2, ‰Á“Ą@O2, Źâ–ůŒŤ2, ‰|–{‘ń–Î, ĺÎ‹I•F2, ’J–ě—Tˆę, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723315. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒoƒJƒe[ƒeƒ‹“I“Ž–ŹÇđp (TAE) ‚đŽ{s‚ľŽ~ŒŒ‚ľ‚˝‹ÇŠis“űŠŕ‚Ě2—á. ”Ń’Ë”ü, ˆäă€l, ’†žŒ\Žq, “ń“nM]1, •˝ěk‘ĺ, ‘ëě­˜a, ‹e’r^—Žq1, ĺÎ‹I•F1, ’J–ě—Tˆę, “n糏š•F1 (1ŠO‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723316. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ńZŤ“űŠÇŠŕ‚É‚¨‚Ż‚錴”­”ńŘœEƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpßśŒŸČ—Ş‚Ě‰Â”\Ť‚ÉŠÖ‚ˇ‚錟“˘. Źâ–ůŒŤ1, “c’†—uŽq2, M‘žşŽq1, “ě’JŘ•äŽq2, ‹e’r^—Žq1, ˜m’J”ü“Ţ1, ‰Á“Ą@O1, ‰|–{‘ń–Î, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/17), “Œ‹ž.

723317. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ű‘BüˆŰŽîÇ‚Ě‹ÇŠÄ”­‚ɑ΂ľ‹š•ÇŽîᇐ؏œp‚đŽ{s‚ľ‚˝ˆę—á. ’ˇ“c^—RŽq, M‘žşŽq1, “c’†—uŽq2, ‹e’r^—Žq1, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, ĺÎ‹I•F1, ‰Á“Ą@O1, ‰|–{‘ń–Î, ’J–ě@—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/18), “Œ‹ž.

723318. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) f’f‚É“ďa‚ľ‚˝ˆŤŤ—tóŽîᇂĚ1—á —Ń@‹žŽq1, ‰HœAŒšm, ×’J@’q1, Œ˘Ž”@‰~2, Š“cç”ü”T2, ˜m’J”ü“Ţ1, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1, ‘ě˜ad3 (1ŠO‰Č, 2•a—, 3•úŽËü (Žîá‡)): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/18), “Œ‹ž.

723319. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ű‘BˆŤŤ‹Řă”çŽî‚Ě1 —á. ’†ŒF‘¸Žm, ă–ě‘ˆę˜Y, ‹ß“ĄNŽj1, ĺÎ‹I•F1, ’J–ě—Tˆę (1ŠO‰Č): ‘ć24‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2016/6/18), “Œ‹ž.

723320. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) p‘Of’f‚Ĺ‚Ť‚Č‚Š‚Á‚˝’°ƒAƒjƒTƒLƒXÇ‚É‚ć‚é’°•ÂÇ‚Ě1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć30‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2016/7/2), ĺ‘ä.

723321. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Siewert type IIH“šˆÝÚ‡•”‘BŠŕ‚ɑ΂ˇ‚郊ƒ“ƒpßŠs´”ÍˆÍ‚ĆƒŠƒ“ƒpß“]ˆÚ–§“x‚Ě–đŠ„. ×“c@Œj1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/5), “Œ‹ž.

723322. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŕŽ‹‹žŠO‰Č‚đ—p‚˘‚˝H“šŠŕ‚ɑ΂ˇ‚éH“šŘœp‚Ě’ˇŠ‚ĆŒ‡“_. ŽR‰şŒpŽj1, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/5), “Œ‹ž.

723323. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ä”­H“šŠŕÇ—á‚ɑ΂ľ‚Ä‚Ě‚ ‚Ť‚ç‚ß‚Č‚˘ŽĄ—Ă. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, X’JGŒő1, ×“c@Œj1, •Đ“c‰Ä–ç, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/5), “Œ‹ž.

723324. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) isH“šŠŕŽĄ—Ă‚É‚¨‚Ż‚éDCF•â•—Ă–@‚ĚˆÓ‹`. X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ×“c@Œj1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/6), “Œ‹ž.

723325. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆÝŠŕ‚É‚¨‚Ż‚éKK-LC-1‚•p“x”­Œť‚ĚŒ´ˆö‰đ–ž. ]ŠÔ@—ć1, “ń“nM]1, •ŸŽR@—˛, ŽRř“@“™2, ‚‹´’ől1,2, ź@”ŞŽk2, “n粏š•F1 (1ŠO‰Č, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/14), “ż“‡.

723326. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŔ‘SŠmŽŔ‚ČŠ`“cŽŽäX‹ó’°ŠŃ’Ę–§’…•Ť‡‚Ě—˜_‚ĆŽŔ‘H. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/14), “ż“‡.

723327. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺ“Ž–ŹŽüˆÍƒŠƒ“ƒpß“]ˆÚ‚𔺂¤isˆÝŠŕ‚ɑ΂ˇ‚éDCS—Ă–@Œă‚ĚŽčpŹŃ. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, X’JGŒő1, ×“c@Œj1, “Œ@’q2, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/14), “ż“‡.

723328. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éreduced port surgery‚ĚŽč‹Z‚ƍH•v. Îˆä—ǍK1,2, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, ‘ĺěš‹`1, óŔŽjŽ÷1, ‹e’rŽj˜Y3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/14), “ż“‡, ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď´˜^W 2016/7; 71: P1-43-9.

723329. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p‘OŽĄ—ĂŒă‚ÉR0Řœ‚ľ‚˝äXŠŕÇ—á‚̏p‘O‰ć‘œ‚Ć•a—‚Ě˜¨—Ł. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/15), “ż“‡.

723330. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p‘O‰ťŠw•úŽËü—Ă–@‚Ş• ‰ď‰AŽŽ’ź’°Ř’fpŒă‚̉ď‰A‘w‚É‹y‚Ú‚ˇ‰e‹ż. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/15), “ż“‡.

723331. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Stage IV‘ĺ’°Šŕ‚É‚¨‚Ż‚錴”­‘ƒŘœ‚ĚˆÓ‹`. “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, Ź‘q’źl1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/15), “ż“‡.

723332. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚éŽč‹Z‚Ě•Ď‘J. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/15), “ż“‡.

723333. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’jŤ‚É”­Ç‚ľ‚˝Indeterminate mucin-producing cystic adenoma‚Ěˆę—á. •gě˜a–ç1, —é–ŘŒcˆę1, ŠÖ@‘ĺm1, ‹ŕ“c@‹v1, Îˆä—ǍK1,2, _’J‹I‹P1, ‘ĺěš‹`1, óŔŽjŽ÷1, ‹e’rŽj˜Y3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/15), “ż“‡, ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď´˜^W 2016/7; 71: P2-62-9.

723334. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ÇŠisŒ‹’°ŠŕE’ź’°Só•”Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚ĚŒŸ“˘|T4Ç—á‚É‚¨‚Ż‚鎥—ÐŹŃ‚Ć—\Œă—\‘ވöŽq|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl1, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/16), “ż“‡.

723335. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş‘ĺ’°Řœp‚É‚¨‚Ż‚éƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚đŽg—p‚ľ‚˝pŒăáu’ÉŠÇ—‚Ě—L—pŤ‚ɂ‚˘‚Ä. “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, Ź‘q’źl1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2016/7/16), “ż“‡.

723336. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠĚ\“ńŽw’°x‘Ń“ŕ‚É”­ś‚ľ‚˝‘ŮŽ™“ŕ‘ŮŽ™‚Ě1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/18), •xŽR.

723337. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ENGBDŒo—R×–Ef‚É‚Ä’_ůNŠŕ‚đ‹^‚˘ˆęŠú“IŞŽĄp‚đŽ{s‚ľ‚Ś‚˝‹}Ť’_ůN‰Š”­Ç’_ůNŠŕ‚ĚŽčp—á. ŒGŒł—Y‰î1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, ŠC’Ă‹MŽj1, –Ř“cŒőL2, Ąň@O2, Šâˆä’m‹v2, ‰œ˜e‹ť‰î2, ŽR“ŕ_Žj2, ‹ŕŽq@‹œ2, ‹{“c‰pŽĄ2, “n糏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć52‰ń“ú–{’_“šŠw‰ďŠwpW‰ď (2016/9/29), V‰Ą•l, ’_“š 2016/8; 30 (3): 570.

723338. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆÝŠŕ‚É‚¨‚Ż‚éHelicobacter pyloriŠ´ő‚ĆŠŕ^¸‘ƒRŒ´‚Ě”­Œť‚Ć‚ĚŠÖ˜AŤ. ×“c@Œj1, •ŸŽR@—˛, ]ŠÔ@—ć1, ŽR‰şŒpŽj1, “ń“nM]1, ‚‹´’ől1,2, “n粏š•F1 (1ŠO‰Č, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723339. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒvƒƒ‚[ƒ^[DNAƒƒ`ƒ‹‰ť‚ĚˆÝŠŕ—Տ°‚É‚¨‚Ż‚é—L—pŤ‚ɂ‚˘‚Ä. ŽR‰şŒpŽj1, Ź›¸Œc‘ž2, ‹‹vGŽ÷2, ]ŠÔ@—ć1, ×“c@Œj1, ŽOd–ě_˜N1, X’JGŒő1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723340. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒzƒ‹ƒ‚ƒ“Žó—e‘Ě—zŤ“űŠŕ‚É‚¨‚˘‚ăŠƒ“ƒpß“]ˆÚ‚͏d—v‚Č—\ŒăˆöŽq‚Ĺ ‚ ‚é. “ě’JŘ•äŽq1, Źâ–ůŒŤ2, “c’†—uŽq1, M‘žşŽq2, ‹e’r^—Žq2, ‰Á“Ą@O2, ĺÎ‹I•F2, ’J–ě—Tˆę, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20-22), ‰Ą•l.

723341. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é“ű–[“ŻŽžÄŒšŽčpÇ—á‚ĚŒŸ“˘. ˜m’J”ü“Ţ1, Ž›‰ŞáŽq, ‹e’r^—Žq1, “ě’JŘ•äŽq2, ź‹{—mŽj1, ‰|–{‘ń–Î, Źâ–ůŒŤ1, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20-22), ‰Ą•l.

723342. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺ’°Šŕ×–EŠ”‚É‚¨‚Ż‚é•úŽËüŠ´ŽóŤ‹K’čˆöŽq‚ĚŒŸő. ‰ĄˆäŒ\Œĺ1, ŽR‰şŒpŽj2, Îˆä@’q1, “c’†r“š1, źŕVL‹ą1, ‰Á“Ą@O2, “n粏š•F1 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

723343. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”牺–„‚ߍž‚ÝŒ^’†SĂ–Źƒ|[ƒg‚đˆŔ‘S‚É•a‰@“ŕ‚ĹŽg—p‚ˇ‚é‚˝‚ß‚ĚH•v. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

723344. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The clinical outcome of conversion surgery after DCS chemotherapy in primary unresectable gastric cancer. ×“c@Œj1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ˜h”ö^—ˆ¤1, “n粏š•F1 (1ŠO‰Č): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/21), ‰Ą•l.

723345. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’_ůNŠŕ‡•š‹}Ť’_”X‰Š‚ɑ΂ˇ‚éENGBD’_`×–Ef‚Ě—L—pŤ. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, “n糏š•F1, –Ř“cŒőL2, Ąň@O2, Šâˆä’m‹v2, ‰œ˜e‹ť‰î2, ŽR“ŕ_Žj2, ‹ŕŽq@‹œ2 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/21) ‰Ą•l.

723346. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • –Œ“]ˆÚ—zŤ (P1and/orCY1) ˆÝŠŕ‚ɑ΂ˇ‚éDCS—Ă–@‚Ěconversion surgery. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, X’JGŒő1, ×“c@Œj1, “Œ@’q2, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/22), ‰Ą•l.

723347. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Paucicellular variantbó‘B–˘•Ş‰ťŠŕ‚ĚŒoŒą. ‰Á“Ą@O1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č): ‘ć49‰ń“ú–{bó‘BŠO‰ČŠw‰ďŠwp‘‰ď (2016/10/27), ŽR—œ.

723348. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆę‰ßŤ‚Éčň•”’É‚đ—ˆ‚ľ, f’f‚É‹ę—ś‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX‡•š‚Ě‹´–{•a‚Ěˆę—á. ‰Á“Ą@O (ŠO‰Č): ‘ć59‰ń“ú–{bó‘BŠw‰ďŠwpW‰ď (2016/11/3-5), “Œ‹ž.

723349. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž•â•‰ş•Ź–呤ˆÝŘœpŠĎ‰šŠJ‚Ť–@‚É‚ć‚éH“šŽcˆÝ•Ť‡‚̐ŹŃ‚Ć‹@”\•]‰ż. ×“c@Œj1, X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç, “n粏š•F1 (1ŠO‰Č): ‘ć24‰ń“ú–{Á‰ťŠíŠÖ˜AŠw‰ďTŠÔJDDW2016 ‘ć14‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘ĺ‰ď (2016/11/5), _ŒË.

723350. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺ’°ŠŕpŒă‘nŠ´ő‘΍ô‚ƍĄŒă‚̑Ήž. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ˆÉ¨.

723351. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éŠO‰ČŽĄ—Ă‚Ě•Ď‘J‚Ć• o‹ž‰şŽčp‚ĚˆĘ’u•t‚Ż. “ŕ“Ął‹K1, ’†‘ş—˛r1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ˆÉ¨.

723352. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ÇŠisś‘¤Œ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp|ŽĄ—ÐŹŃ‚Ć—\ŒăˆöŽq‚ĚŒŸ“˘|. ŽR—œ‚L1, ’†‘ş—˛r1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ˆÉ¨.

723353. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p‘O‰ťŠw•úŽËüŽĄ—ĂŒă‚Ě• o‹ž‰ş’ź’°Žčp. ŽO‰YŒ[šć1, “ŕ“Ął‹K1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ˛“Ą•˜Y1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ˆÉ¨.

723354. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’ź’°Šŕ‚ɑ΂ˇ‚éreduced port surgery‚ĚŽč‹Z‚ĆŽĄ—ÐŹŃ. Îˆä—ǍK1,2, –îě‰ëŽj1, –kě—YŒő3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 3Œcœä‹`m‘ĺŠwˆăŠw•”ŠO‰Č): ‘ć71‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2016/11/18), ˆÉ¨, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/10; 69: A121.

723355. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MorgagniEƒwƒ‹ƒjƒA‚ɑ΂ˇ‚éLPECj‚đ—p‚˘‚˝• o‹ž‰şŞŽĄp‚Ě—L—pŤ. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/24), “Œ‹ž.

723356. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“šŠŕ“÷Žî‚Ě6—á. Œ´“cG‹P1, ŽR‰şŒpŽj2, ]ŠÔ@—ć2, ˜h”ö^—ˆ¤2, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, •Đ“c‰Ä–ç, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/24), “Œ‹ž.

723357. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰şpŒăŹ’°’°•ÂÇŽčp‚É‚¨‚Ż‚éŠJ• ˆÚs‚ĚŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛r1, Îˆä—ǍK1, “›ˆä“ÖŽq1, ‹ŕ“c@‹v, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/24), “Œ‹ž.

723358. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş• •Çፍ­ƒwƒ‹ƒjƒAC•œp‚ĚŽĄ—ÐŹŃ. ‰Ą“cŒő‰›1, ŠC’Ă‹MŽj1, ’†–{CŽi1, źŽR@—ş1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), “Œ‹ž.

723359. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Řœ•s”\äX“Ş•”Šŕ‚ɑ΂ľGemcitabine+nad-paclitaxelŽ{sŒă, Žčp‚ÉŽŠ‚Á‚˝ˆę—á. ‹ŕ“c’—Ç1, źŽR@—ş1, ’†–{CŽi1, ‰Ą“cŒő‰›1, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), “Œ‹ž.

723360. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŠF“÷‰čŽîŤ’_”X‰Š‚Ć‚ĚŠÓ•Ę‚É‹ę—ś‚ľ‚˝’_ůNŠŕ‚Ěˆę—á. ꎓĄ‘ĺŽ÷, ‰Í–”@Š°1, źŽR@—ş1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), “Œ‹ž.

723361. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰ş‚É“Eop‚đŽ{s‚ľ‚˝“Á”­ŤŒă• –ŒŒŒŽî‚Ě1—á. —é–ŘŠ˛l1, –îě‰ëŽj1, Îˆä—ǍK1,2, ‘ş“c@Œ’1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, _’J‹I‹P1, óŔŽjŽ÷1, ‘ĺěš‹`1, ‹e’rŽj˜Y3, “n粏š•F2, X‰ił“ń˜Y1 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/25), ‚—Ö, “ú–{—Տ°ŠO‰ČŠw‰ďŽGŽ 2016/10; 77 (‘Š§): 914.

723362. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş•Ź–呤ˆÝŘœŠĎ‰šŠJ‚Ť–@ÄŒš‚Ć, pŒăH“š‰^“Ž‹@”\‚ĆˆÝH“š‹t—Ź‚Ě•]‰ż. ×“c@Œj1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ˜h”ö^—ˆ¤1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/26), “Œ‹ž.

723363. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş—H–呤ˆÝŘœpB-IÄŒš‚É‚¨‚Ż‚édelta•Ť‡‚Ćcircular•Ť‡‚Ě”äŠrŒŸ“˘. ‰i‰ŞNŽu1, ×“c@Œj1, “‡’Á@Ť1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/26), “Œ‹ž.

723364. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş—H–ĺ•Ű‘śˆÝŘœp (LAPPG) ‚É‚¨‚Ż‚éPGSAS-45‚đ—p‚˘‚˝pŒăQOL’˛¸. ]ŠÔ@—ć1, ×“c@Œj1, ŽR‰şŒpŽj1, ˜h”ö^—ˆ¤1, ŽOd–ě_˜N1, X’JGŒő1, •Đ“c‰Ä–ç, ÷–{Mˆę, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l.

723365. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş•Ź–呤ˆÝŘœp|ŠĎ‰šŠJ‚Ť–@H“šŽcˆÝ•Ť‡‚Ě’ZŠúŹŃ|. ˜h”ö^—ˆ¤1, ŽR‰şŒpŽj1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, •Đ“c‰Ä–ç, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l.

723366. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚éŽč‹Z‚̍H•v. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, źŽR@—ş1, “c“‡@O1, ‰Í–”@Š°1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l.

723367. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰şŒn““IŠĚŘœ‚É‚¨‚Ż‚éŠĚ–ĺ•”ˆ—‚̍H•v. źŽR@—ş1, ŠC’Ă‹MŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l.

723368. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚épŒă’°•ÂÇ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚ĚŽĄ—ÐŹŃ. –îě‰ëŽj1, Îˆä—ǍK1,2, —é–ŘŠ˛l1, ‘ş“c@Œ’1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, _’J‹I‹P1, óŔŽjŽ÷1, ‘ĺěš‹`1, ‹e’rŽj˜Y3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l, “ú–{“ŕŽ‹‹žŠO‰ČŠw‰ďŽGŽ 2016/12; 21 (7): OS30-8.

723369. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş”ö‘¤äXŘœ‚Ĺ‚ĚŽ‹–ě“WŠJ‚̍H•v. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/9), ‰Ą•l.

723370. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰şˆÝŒĹ’čp‚đŽ{s‚ľ‚˝ŹlŽ˛”P“]Ç‚Ěˆę—á. ‘ĺěš‹`1, –îě‰ëŽj1, ‘ş“c@Œ’1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, Îˆä—ǍK1,2, _’J‹I‹P1, óŔŽjŽ÷1, ‹e’rŽj˜Y3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/9), ‰Ą•l, “ú–{“ŕŽ‹‹žŠO‰ČŠw‰ďŽGŽ 2016/12; 21 (7): DP46-8.

723371. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ĺ’°ŽžŠł‚ɑ΂ˇ‚éReduced Port Surgery‚ĚŽč‹Z‚ƍH•v. Îˆä—ǍK1,2, –îě‰ëŽj1, —é–ŘŠ˛l1, ‘ş“c@Œ’1, ‹ŕ“c@‹v1, —é–ŘŒcˆę1, _’J‹I‹P1, ‘ĺěš‹`1, óŔŽjŽ÷1, ‹e’rŽj˜Y3, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/9), ‰Ą•l, “ú–{“ŕŽ‹‹žŠO‰ČŠw‰ďŽGŽ 2016/12; 21 (7): OS101-5.

723372. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰ş’PEŽŽˆÝŘœp‚Ě“ą“ü‚ĚƒRƒc‚Ć–â‘č“_. X’JGŒő1, ŽR‰şŒpŽj1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, ×“c@Œj1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723373. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰şˆÝŘœp‚ĚˆŔ‘S‚Č“ą“ü. ×“c@Œj1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, •Đ“c‰Ä–ç, X’JGŒő1, ˜h”ö^—ˆ¤1, “n粏š•F1 (1ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723374. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚éMorgagniEƒwƒ‹ƒjƒA‚ɑ΂ˇ‚é• o‹ž‰şŽčp. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723375. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) _ŒoŒ´ŤŽîᇂɑ΂ˇ‚é‹šo‹žŽčp. _’J‹I‹P1, —é–ŘŠ˛l1, –îě‰ëŽj1, ‘ş“c@Œ’1, óŔŽjŽ÷1, —é–ŘŒcˆę1, ‘ĺěš‹`1, Îˆä—ǍK1,2, “n粏š•F2 (1–k—˘Œ¤‹†Š•a‰@, 2ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l, “ú–{“ŕŽ‹‹žŠO‰ČŠw‰ďŽGŽ 2016/12; 21 (7): OS190-6.

723376. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Struma Ovarii‚Ěˆę—á. “Ą–ěŽjD1, •“cŒ›Žq1, Š`Œ´@’m1, “c’†@Œ‰2 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć58‰ń“ú–{ŹŽ™ŒŒ‰tE‚Ş‚ńŠw‰ďŠwpW‰ď (2016/12/17), “Œ‹ž.

723377. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ä”­Ť‹‘ĺ“ű‘BüˆŰŽîÇ‚ɑ΂ľ‹š•ÇŽîᇐ؏œp‚đŽ{s‚ľ‚˝1—á. “Ą–ěŽjD1, ĺÎ‹I•F1, M‘žşŽq1, ‹e’r^—Žq1, Źâ–ůŒŤ1, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č): ‘ć23‰ń“ú–{“ű‘BŽžŠłŒ¤‹†‰ď (2017/2/25), ‰Ą•l.

723378. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”xŠŕŹ’°“]ˆÚ‚̐úE‚É‚ć‚č‹Ů‹}Žčp‚đ—v‚ľ‚˝1—á. ‰––ĄŒcŽq1, ‰Ô“‡@Ž‘2, ŽO‰YŒ[šć1, •Đ‰Ş—Sˆę2 (1ŠO‰Č, 2‹~–˝): ‘ć53‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2017/3/2), ‰Ą•l.

723379. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Mesodiverticular band‚𔺂¤MeckelŒeŽş‚É‚ć‚éiNŤ’°•ÂÇ‚Ě1—á. Œă“Ą‘ě–ç1, ’†‘ş—˛r1, “Y–ěF•ś1, Îˆä@’q2, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć53‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2017/3/2), ‰Ą•l.

723380. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’°dĎ‚đ‚Ť‚˝‚ľ‚˝ˆŤŤ•FŽîŹ’°“]ˆÚ‚Ě1—á. “Y–ěF•ś1, ’†‘ş—˛r1, ŠŰŽRł—T1, “‡’Á@Ť1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć53‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2017/3/2), ‰Ą•l.

723381. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) pŒă’°•ÂÇ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[Žő1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć53‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2017/3/3), ‰Ą•l.

723382. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • o‹ž‰şˆÝ‘S“Ep‚É‚¨‚Ż‚éH“š‹ó’°‹@”\“I’[X•Ť‡ÄŒš. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, X’JGŒő1, ×“c@Œj1, “n粏š•F1 (1ŠO‰Č): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/9), L“‡.

723383. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰şˆÝŘœp‚ĚˆŔ‘S‚Č“ą“ü. ]ŠÔ@—ć1, ×“c@Œj1, ˜h”ö^—ˆ¤1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/9), L“‡.

723384. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Stage IIˆÝŠŕ‚É‚¨‚Ż‚éÄ”­—\‘ވöŽq: p‘O’P‹…”‚Ć‘gD‚É‚¨‚Ż‚éMDSCs‚ĚŒŸ“˘. Îˆä@’q1, ‰Á“Ą@O2, ˜h”ö^—ˆ¤2, ]ŠÔ@—ć2, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, ŽR‰şŒpŽj2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/9), L“‡.

723385. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ{ƒmƒvƒ‰ƒUƒ“ (P-CAB) ‚Ş’˜Œř‚ľ‚˝•Ź–ĺ‘ŞˆÝŘœŒă, “ŤGERD‚ĚŒoŒą. ˜h”ö^—ˆ¤1, ŽR‰şŒpŽj1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, “n粏š•F1 (1ŠO‰Č): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/10), L“‡.

723386. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The role of preoperative chemotherapy for Siewert type II esophagogastric junction cancer. ×“c@Œj1, ŽR‰şŒpŽj1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, X’JGŒő1, “n粏š•F1 (1ŠO‰Č): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/10), L“‡.

723387. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Prognosis of Borrmann Type IV Gastric Cancer Modified by the Latest Multimodality Treatments. ×“c@Œj1, ŽOd–ě_˜N1, X’JGŒő1, ]ŠÔ@—ć1, ˜h”ö^—ˆ¤1, “Œ@’q2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/10), L“‡.

723388. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) NAC-DOSŒă‚ÉŞŽĄ“IŘœp‚đs‚Á‚˝H“šˆÝÚ‡•”Šŕ‚Ěˆę—á. Îčƒ˜Y, ×“c@Œj1, ‰Ą“cŒő‰›1, ‰i‰ŞNŽu1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, “Œ@’q2, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2017/3/10), L“‡, ‘ć89‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2017/3; p.525.

732035. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‰ş•”is’ź’°Šŕ‚ɑ΂ˇ‚ép‘O‰ťŠw•úŽËüŽĄ—ĂŒă‚Ě• o‹ž‰şŽčp‚Ě’ZŠúŹŃ. ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć24‰ń“ú–{Á‰ťŠíŠÖ˜AŠw‰ďTŠÔE‘ć14‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘ĺ‰ď (2016/11/4), _ŒË.

733204. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠJ• Žž‚Éä`•”‚đ’ʂ鐳’†ŘŠJ‚đŽ{s‚ľ‚˝ŹŽ™ŽčpÇ—á‚ĚŒŸ“˘. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć2‰ń“ú–{ŹŽ™‚Ö‚ťŒ¤‹†‰ď (2016/4/14), ‘ĺă.

733205. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) pŒă–ü’…Ť’°•ÂÇ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć45‰ń_“ŢěŒ§Á‰ťŠíŠO‰ČŒ¤‹†‰ď (2016/6/11), ‰Ą•l.

733206. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) čň•”ƒAƒvƒ[ƒ`‚É‚ć‚荪ŽĄp‚đŽ{s‚ľ‚˝Gross CŒ^H“š•Â˝Ç‚Ě1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć114‰ń“Œ‹žŹŽ™ŠO‰ČŒ¤‹†‰ď (2016/6/14), “Œ‹ž.

733207. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚éˆÝᑃoƒ‹[ƒ“”j‘š‚ĚŒXŒü‚ĆŒŸ“˘. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć30‰ń“ú–{ŹŽ™ƒXƒg[ƒ}E”rŸ•E‘nŠÇ—Œ¤‹†‰ď (2016/6/25), –źŒĂ‰Ž.

733208. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) VitB12Œ‡–R‚É‚ć‚č—AŒŒ‚đ—v‚ˇ‚鍂“x•nŒŒ‚đ’ć‚ľ‚˝’Z’°ÇŒóŒQ‚Ě2—á. “n•”WŽq1, “c’†@Œ‰2, •“cŒ›Žq1, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć32‰ń_“ŢěŒ§ŹŽ™ŠĚEÁ‰ťŠíŽžŠłŒ¤‹†‰ď (2016/9/24), ‰Ą•l.

733209. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Struma ovarii‚Ěˆę—á. “Ą–ěŽjD1, •“cŒ›Žq1, Š`Œ´@’m1, “c’†@Œ‰2 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć65‰ń_“ސ쏬Ž™Žîᇌ¤‹†‰ď (2016/10/3), ‰Ą•l.

733210. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’°dĎ‚đ‚Ť‚˝‚ľ‚˝ˆŤŤ•FŽîŹ’°“]ˆÚ‚Ě1—á. “Y–ěF•ś1, ’†‘ş—˛r1, ŠŰŽRł—T1, “‡’Á@Ť1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć44‰ń_“ސě‘ĺ’°ăč–厞Šł§˜b‰ď (2016/10/4), ‰Ą•l.

733211. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) VitB12Œ‡–R‚É‚ć‚č—AŒŒ‚đ—v‚ˇ‚鍂“x•nŒŒ‚đ’ć‚ľ‚˝’Z’°ÇŒóŒQ‚Ě2—á. “n•”WŽq1, “c’†@Œ‰2, •“cŒ›Žq1, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć51‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/10/8), b•{.

733212. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Struma ovarii‚Ěˆę—á. “Ą–ěŽjD1, •“cŒ›Žq1, Š`Œ´@’m1, “c’†@Œ‰2 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć51‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/10/8), b•{.

733213. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Gross CŒ^H“š•Â˝Ç‚ɑ΂ľ‚Äčň•”ƒAƒvƒ[ƒ`‚ĹŞŽĄp‚đŽ{s‚ľ‚˝1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć36‰ń“ú–{ŹŽ™“ŕŽ‹‹žŠO‰ČEŽčpŽč‹ZŒ¤‹†‰ď (2016/10/27), ‚ł‚˘‚˝‚Ü.

733214. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) VitB12Œ‡–R‚É‚ć‚č—AŒŒ‚đ—v‚ˇ‚鍂“x•nŒŒ‚đ’ć‚ľ‚˝’Z’°ÇŒóŒQ‚Ě2—á. “n•”WŽq1, “c’†@Œ‰2, •“cŒ›Žq1, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć46‰ń“ú–{ŹŽ™ŠO‰Č‘ăŽÓŒ¤‹†‰ď (2016/10/27), ‚ł‚˘‚˝‚Ü.

733215. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŹŽ™ŠO‰ČŽžŠł‚ɑ΂ˇ‚élŽQ—{‰h“’‚ĚŽg—pŒoŒą. •“cŒ›Žq1, “c’†@Œ‰2, Š`Œ´@’m1, ŽR–{—T‹P1, ’Ç–ŘGé1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć21‰ń“ú–{ŹŽ™ŠO‰ČŠż•űŒ¤‹†‰ď(2016/10/28), ‚ł‚˘‚˝‚Ü.

733216. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰şˆÝŘœp‚ĚˆŔ‘S‚Č“ą“ü. ]ŠÔ@—ć1, ×“c@Œj1, ˜h”ö^—ˆ¤1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć46‰ńˆÝŠO‰ČEpŒăáŠQŒ¤‹†‰ď (2016/10/28), •ÄŽq.

733217. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) • o‹ž‰şˆÝ‘S“Ep‚É‚¨‚Ż‚éH“š‹ó’°FEEAÄŒš. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, ˜h”ö^—ˆ¤1, ]ŠÔ@—ć1, X’JGŒő1, ×“c@Œj1, “n粏š•F1 (1ŠO‰Č): ‘ć46‰ńˆÝŠO‰ČEpŒăáŠQŒ¤‹†‰ď (2016/10/28), •ÄŽq.

733218. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Bag“ŕ‚Ĺ•ŞŠ„‚ľ‚Ä“Eo‚ľ‚˝‹‘ĺŠĚŒŒŠÇŽî‚Ěˆę—á. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “c“‡@O1, źŽR@—ş1 (1ŠO‰Č): ‘ć10‰ńŠĚ‘Ÿ“ŕŽ‹‹žŠO‰ČŒ¤‹†‰ď (2016/11/23), “Œ‹ž.

733219. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) pŒă’°•ÂÇ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[Žő1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć147‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠw‰ďW’k‰ď (2016/12/23), ‰Ą•l.

733220. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ź’°ŠÔ–ŒƒfƒXƒ‚ƒCƒhŽîᇂɑ΂ľ, • o‹ž‰ş•â•‰ş‚ɏŹ’°•”•ŞŘœp‚đŽ{s‚ľ‚˝ˆę—á. â“c–F—m, ’†‘ş—˛r1, “n•”WŽq1, ‰Ą“cŒő‰›1, “‡’Á@Ť1, “y‹“í‘ž˜Y, ź‰iă”V, ŽR—œ‚L1, ŽO‰YŒ[šć1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć147‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠw‰ďW’k‰ď (2016/12/23), ‰Ą•l.

733221. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚é• o‹ž‰şMorgagniEƒwƒ‹ƒjƒAŞŽĄp. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć8‰ń_“ސěƒwƒ‹ƒjƒAŒ¤‹†‰ď (2017/1/14), ‘Š–ÍŒ´.

733222. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –TƒXƒg[ƒ}ƒwƒ‹ƒjƒA‚ĚŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć8‰ń_“ސěƒwƒ‹ƒjƒAŒ¤‹†‰ď (2017/1/14), ‘Š–ÍŒ´.

733223. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) • o‹ž‰ş• ‰ď‰AŽŽ’ź’°Ř’fpŒă‚ɉď‰Aƒwƒ‹ƒjƒA‚đ”­Ç‚ľ‚˝1—á. “n•”WŽq1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć8‰ń_“ސěƒwƒ‹ƒjƒAŒ¤‹†‰ď (2017/1/14), ‘Š–ÍŒ´.

733224. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) • o‹ž‰şH“š—ôEƒwƒ‹ƒjƒAC•œp‚̍H•v. ˜h”ö^—ˆ¤1, X’JGŒő1, ]ŠÔ@—ć1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć8‰ń_“ސěƒwƒ‹ƒjƒAŒ¤‹†‰ď (2017/1/14), ‘Š–ÍŒ´.

733225. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) SóŒ‹’°‹ˇó‚𔺂Á‚˝•Ş—Ţ•s”\‘ĺ’°‰Š‚Ě1—á. Œ•Ž“ޏ”ü, ’†‘ş—˛r1, Œ˜“ce—˜2, ‰Ą“cŒő‰›1, ’†–{CŽi1, â“c–F—m, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ): ‘ć148‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠw‰ďW’k‰ď (2017/2/25), ‰Ą•l.

733226. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”­”M‚đŒ_‹@‚É1Î‚ĹCaroli•a‚Ɛf’f‚ł‚ę, Œo‰ß’†‚É–ĺ–Źˆł˜´iÇ‚ސis‚ľ‚˝1—á. ’Ç–ŘGé1, “c’†@Œ‰2, •“cŒ›Žq1, ŽR–{—T‹P1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć30‰ń“ú–{ŹŽ™äB‘ŸŒ¤‹†‰ď (2017/3/11), –‡•ű.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H23-510001. [‘ŕ] Secondary Thyroid Cancer after Exposure to Radioactive Iodine from the Fukushima Daiichi Nuclear Power Plant accident (Editorial). Katoh H1, Watanabe M1, Adachi M: Otolaryngology 2012/2; 2 (3): e104. (‰Á“Ą@O1, “n粏š•F1: 1ŠO‰Č)

H23-520001. [uŔ]y“ÁW: ŠŕŠ˛×–E‚ĆŒŸ¸ˆăŠwzŠe˜_: ‘ĺ’°Šŕ. ‰Á“Ą@O1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): —Տ°ŒŸ¸ 2011/5; 55 (5): 489-94.

H27-110011. [Œ´’˜] Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis. Yamashita K1, Katada N, Moriya H1, Hosoda K1, Mieno H1, Katada C2, Koizumi W2, Hoshi K3, Watanabe M1: Gen Thorac Cardiovasc Surg 2016/2; 64 (4): 209-15. (ŽR‰şŒpŽj1, •Đ“c‰Ä–ç, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, Œ˜“ce—˜2, Źň˜aŽO˜Y2, Ż@‰Ŕ–F3, “n粏š•F1: 1ŠO‰Č, 2Á‰ťŠí“ŕ, 3‰qś)

H27-110012. [Œ´’˜] Long-term prognostic outcome of cT1 gastric cancer patients who underwent laparoscopic gastrectomy after 5-year follow-up. Yamashita K1, Hosoda K1, Moriya H1, Mieno H1, Katada N, Watanabe M1: Langenbecks Arch Surg 2016/3; 401 (3): 333-9. (ŽR‰şŒpŽj1, ×“c@Œj1, X’JGŒő1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç, “n粏š•F1: 1ŠO‰Č)

H27-310002. [Ç—á•ń] Superior vena cava syndrome due to mediastinal adenomatous goitre. Katoh H1, Enomoto T, Watanabe M1: BMJ Case Rep 2015/6; 2015. pii: bcr2015210634. doi: 10.1136/bcr-2015-210634. (‰Á“Ą@O1, ‰|–{‘ń–Î, “n粏š•F1: 1ŠO‰Č)

H27-320001. [Ç—á•ń] Œă• –Œ“]ˆÚ‘ƒ‚Ĺ”­ŒŠ‚ł‚ę‚˝¸‘ƒŒ´”­‘ŮŽ™ŤŠŕ‚Ě1—á. ŸN’J”ü‹MŽq1, Š™“cOŽ÷1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): “ú–{—Տ°ŠO‰ČŠw‰ďŽGŽ 2016/3; 77 (3): 674-9.

[’˜@‘]

H27-620001. [Šwp‘ (•Ş’SŽˇ•M)]yƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOˆăŠw‚ĚŠî‘b‚Ć—Ő° (‘ć3”Ĺ)zIV ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO (R‰Á—î) ˆăŠw‚Ě—Ő°@D. ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOEƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“@b) ‚Ş‚ń‚ĆƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO@4. Á‰ťŠí‚ĚŠŕ‚ĆƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO, p.380-2. ‰Á“Ą@O1, “n粏š•F1 (1ŠO‰Č), •Ň: “ú–{R‰Á—îˆăŠw‰ď ę–ĺˆăEŽw“ąŽm”F’čˆĎˆő‰ď, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2015/9”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723012. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚ĹŒoŒą‚ľ‚˝“ű‘B‘B—lůN–EŠŕ‚Ě3Ç—á. Œď]‚ß‚Ž‚Ý1, ˜m’J”ü“Ţ1, ‹e’r^—Žq1, “ě’JŘ•äŽq2, ź‹{—mŽj1, ‰Á“Ą@O1, Źâ–ůŒŤ1, ‰|–{‘ń–Î, ĺÎ‹I•F1, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ď‘‰ď (2015/7/3), “Œ‹ž.

H27-723013. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŮŽžŤ—ź‘¤“ű–[Paget•a‚Ě1Ç—á. HŽRŽjD (“Ą–ěŽjD)1, ĺÎ‹I•F1, “c’†—uŽq2, “ě’JŘ•äŽq2, ‹e’r^—Žq1, ź‹{—mŽj1, ˜m’J”ü“Ţ1, ‰Á“Ą@O1, ‰|–{‘ń–Î, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ď‘‰ď (2015/7/3), “Œ‹ž.

H27-723014. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹CŠÇŘŠJ‚𔺂¤bó‘BŠŕŞŽĄpŒă‚É‚Ý‚ç‚ę‚˝‰E‘Œz“Ž–Ź‘ĺ—ʏoŒŒÇ—á‚ĚŒoŒą. ‰Á“Ą@O1, ‰|–{‘ń–Î, ’J–ě—Tˆę, “n粏š•F1 (1ŠO‰Č): ‘ć48‰ń“ú–{bó‘BŠO‰ČŠw‰ďŠwpW‰ď (2015/10/29), “Œ‹ž.


S‘ŸŒŒŠÇŠO‰ČŠw

[Šwp˜_•ś]

110187. [Œ´’˜] Impact of top end anastomosis design on patency and flow stability in coronary artery bypass grafting. Koyama S, Kitamura T1, Itatani K, Yamamoto T, Miyazaki S2, Oka N, Nakashima K1, Horai T1, Ono M, Miyaji K1: Heart Vessels 2016/5; 31 (5): 643-8. (–k‘ş@—Ľ1, ‹{čăĕ˝2, ’†“‡Œő‹M1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110188. [Œ´’˜] Synchronization of the Flow and Pressure Waves Obtained With Non-Simultaneous Multipoint Measurements. Goto S, Nakamura M, Itatani K, Miyazaki S1, Oka N, Honda T2, Kitamura T3, Horai T3, Ishii M2, Miyaji K3: Int Heart J 2016/7; 57 (4): 449-55. (‹{čăĕ˝1, –{“c@’2, –k‘ş@—Ľ3, •ó—ˆ“N–ç3, Îˆäł_2, ‹{’n@ŠÓ3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŹŽ™, 3S‘ŸŒŒŠÇŠO)

110189. [Œ´’˜] Effects of arterial blood flow on walls of the abdominal aorta: distributions of wall shear stress and oscillatory shear index determined by phase-contrast magnetic resonance imaging. Sughimoto K1, Shimamura Y, Tezuka C, Tsubota K, Liu H, Okumura K, Masuda Y, Haneishi H: Heart and Vessels 2016/7; 31 (7): 1168-75. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

110190. [Œ´’˜] Randomized Study of a New Noninvasive Skin Closure Device for Use After Congenital Heart Operations. Tanaka Y1, Miyamoto T1, Naito Y, Yoshitake S, Sasahara A1, Miyaji K1: Ann Thorac Surg 2016/10; 102 (4): 1368-74. (“c’†—C‹M1, ‹{–{—˛Ži1, ůŒ´‘–L1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

110191. [Œ´’˜] Epicardial Implantable Cardioverter-Defibrillator in a 2-Month-Old Infant. Sughimoto K1, Tsuchida Y1, Hayashi H1, Torii S2, Kitamura T1, Horai T1, Miyaji K1: Ann Thorac Surg 2017/3; 103 (3): e263-e5. (™–{Wˆę1, “y“c—E‘ž1, —с@GŒ›1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç)

310017. [Ç—á•ń] Two-stage operation for Stanford type A acute aortic dissection originating from Kommerell's diverticulum. Tanaka Y1, Kitamura T1, Horai T1, Miyaji K1: Interact Cardiovasc Thorac Surg 2016/5; 22 (5): 695-7. (“c’†—C‹M1, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

310018. [Ç—á•ń] Aorto-Left Ventricular Tunnel Successfully Repaired Immediately After Birth. Nakamura Y1, Miyaji K1, Yoshii T, Ootomo Y1, Kimura S2: Ann Thorac Surg 2016/5; 101 (5): 1988-90. (’†‘ş—SŠó1, ‹{’n@ŠÓ1, ‘ĺ—F—EŽ÷1, –Ř‘şƒl2: 1S‘ŸŒŒŠÇŠO, 2ŹŽ™)

310019. [Ç—á•ń] An Extremely Rare Variant of Pulmonary Venous Atresia. Nakamura Y1, Miyaji K1, Miyata Y1, Kitagawa A2: Ann Thorac Surg 2016/6; 101 (6): 2382-4. (’†‘ş—SŠó1, ‹{’n@ŠÓ1, ‹{“c—L—œ¨1, –kě“ÄŽj2: 1S‘ŸŒŒŠÇŠO, 2ŹŽ™)

310020. [Ç—á•ń] Surgical management of left ventricular thrombus following severe dehydration. Tanaka Y1, Nie M, Yamamoto N, Ohara K, Miyaji K1: Heart Vessels 2016/8; 31 (8): 1389-92. (“c’†—C‹M1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

530004. [‚ť‚Ě‘ź (Reply)] eReply. Re: Addition of the frozen elephant trunk to the ascending aorta and aortic arch replacement in case of Stanford type A aortic dissection occurring in the presence of Kommerell's diverticulum. Kitamura T1, Tanaka Y1, Horai T1, Miyaji K1: Interact Cardiovasc Thorac Surg 2016/5; 22 (5): 697. (–k‘ş@—Ľ1, “c’†—C‹M1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

[’˜@‘]

620082. [Šwp‘ (•Ş’SŽˇ•M)]y’áNPŽčp‚ĚĹ‘Oü (‹š•”ŠO‰Č2016”N7ŒŽ‘Š§†)zI. S‘ŸŒŒŠÇ—Ěˆć@10. “ŕŽ‹‹ž‰ş“Ž–ŹŠÇ•Â˝p, p.622-5. ‹{’n@ŠÓ (S‘ŸŒŒŠÇŠO), “ě]“°, “Œ‹ž, 2016/7”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713054. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Direct true lumen cannulation reduces time for cooling in surgery for acute stanford type A aortic dissection. Kitamura T1, Torii S2, Hirata M3, Mishima T1, Horai T1, Sughimoto K1, Yoshii T, Miyaji K1: The 24th Annual Meeting of Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2016/4/1), Taiwan. (–k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ™–{Wˆę1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713055. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Use of surgical head camera system in surgical training and education - seeing is believing. Kitamura T1, Torii S2, Hirata M3, Mishima T1, Horai T1, Sughimoto K1, Yoshii T, Miyaji K1: The 24th Annual Meeting of Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2016/4/1), Taiwan. (–k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ™–{Wˆę1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713056. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Long Term Outcomes of Patients Who Declined Surgery for Acute Stanford Type A Aortic Dissection. Kitamura T1, Torii S2, Hirata M3, Mishima T1, Horai T1, Sughimoto K1, Yoshii T, Tomoyasu T1, Ohkubo H1, Matsushiro T1, Tsuchida Y1, Miyaji K1: AATS Aortic Symposium 2016 (2016/5/1), New York, USA. (–k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ™–{Wˆę1, —F•Ű‹M”Ž1, ‘ĺ‹v•Ű”Ž˘1, ź‘ă‘ě–ç1, “y“c—E‘ž1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713057. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Direct True Lumen Cannulation ("Samurai" Cannulation) and Continuous Suture Technique in Aortic Root Replacement for Acute Stanford Type A Aortic Dissection. Kitamura T1, Torii S2, Hirata M3, Mishima T1, Horai T1, Sughimoto K1, Yoshii T, Tomoyasu T1, Ohkubo H1, Matsushiro T1, Tsuchida Y1, Miyaji K1: AATS Aortic Symposium 2016 (2016/5/1), New York, USA. (–k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ™–{Wˆę1, —F•Ű‹M”Ž1, ‘ĺ‹v•Ű”Ž˘1, ź‘ă‘ě–ç1, “y“c—E‘ž1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713058. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Surgical Strategy for Aortic Arch Reconstruction after Norwood Procedure based on a Virtual Operation with Numerical Flow Analysis. Miyazaki S1, Itatani K, Oka N, Goto S, Nakamura M, Kitamura T2, Horai T2, Nakamura Y2, Miyaji K2: The 96th Annual Meeting of American Association for Thoracic Surgery (AATS) 2016 (2016/5/1), Baltimore, USA. (‹{čăĕ˝1, –k‘ş@—Ľ2, •ó—ˆ“N–ç2, ’†‘ş—SŠó2, ‹{’n@ŠÓ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2S‘ŸŒŒŠÇŠO)

713059. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Novel surgical strategy for complicated pulmonary stenosis using hemodynamic analysis based on a virtual operation with numerical flow analysis. Miyaji K1: The 10th Society for International Joint Meeting (SIJM) Meet the Experts - JAPAN, GERMANY, CHINA "Gunma Symposium" (2016/9/8), Gunma, Japan. (‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

713060. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Outcomes of patients who declined surgery for acute Stanford type A aortic dissection with patent false lumen of the ascending aorta. Kitamura T1, Torii S2, Horai T1, Sughimoto K1, Irisawa Y1, Hayashi H1, Matsushiro T1, Miyaji K1: The 30th Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS) 2016 (2016/10/1), Barcelona, Spain, (–k‘ş@—Ľ1, ’šˆäWŽO2, •ó—ˆ“N–ç1, ™–{Wˆę1, “üŕV—F•ă1, —с@GŒ›1, ź‘ă‘ě–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç)

713061. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Computational Blood Flow Analysis of the Aortic Arch and the Neck Vessels: Total Arch Replacement vs Stent Graft With Neck Vessel Debranching. Horai T1, Kitamura T1, Torii S2, Sughimoto K1, Kobayashi K1, Irisawa Y1, Hayashi H1, Matsushiro T1, Tsuchida Y1, Miyata Y1, Miyaji K1: The American Heart Association's Scientific Sessions 2016 (2016/11/14), New Orleans, USA. (•ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, ™–{Wˆę1, Ź—ŃŒ’‰î1, “üŕV—F•ă1, —с@GŒ›1, ź‘ă‘ě–ç1, “y“c—E‘ž1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç)

713062. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Direct True Lumen Cannulation ("Samurai" Cannulation) for Acute Stanford Type A Aortic Dissection. Kitamura T1, Horai T1, Sughimoto K1, Kobayashi K1, Irisawa Y1, Hayashi H1, Matsushiro T1, Miyata Y1, Tsuchida Y1, Miyaji K1: The 53th Annual Meeting of Society of Thoracic Surgeons (STS) 2017 (2017/1/1), Houston, Texas, USA. (–k‘ş@—Ľ1, •ó—ˆ“N–ç1, ™–{Wˆę1,Ź—ŃŒ’‰î1, “üŕV—F•ă1, —с@GŒ›1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, “y“c—E‘ž1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

713063. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Higher Oxygen Delivery Is an Important Factor for Adequate Peripheral Perfusion during High Flow Regional Cerebral Perfusion at Aortic Arch Repair in Neonates and Small Infants. Sughimoto K1, Kohira S2, Hayashi H1, Tsuchida Y1, Torii S3, Kitamura T1, Horai T1, Miyaji K1: The 53th Annual Meeting of Society of Thoracic Surgeons (STS) 2017 (2017/1/1), Houston, Texas, USA. (™–{Wˆę1, ŒĂ•˝@‘2, —с@GŒ›1, “y“c—E‘ž1, ’šˆäWŽO3, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ME•”, 3ˆă—ĂˆŔ‘SŠw‹łˆç)

713064. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Opening pattern of bicuspid aortic valve influences hemodynamics of the aorta and wall shear stress:A left ventricle-aortic valve-aorta computational model study. Sughimoto K1, Fujiwara T, Alex J. Barker, Torii S2, Kitamura T1, Motokawa M1, Miyata Y1, Miyaji K1, Liu H: HVS-2nd Annual Meeting 2017 (2017/3/1), Monaco. (™–{Wˆę1, ’šˆäWŽO2, –k‘ş@—Ľ1, –{ě^”ü‰Á1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç)

722101. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ƒtƒHƒ“ƒ^ƒ“zŠÂ‚É‚¨‚Ż‚éƒtƒFƒlƒXƒgƒŒ[ƒVƒ‡ƒ“‚ĚˆĘ’u‚Ć‚ť‚Ě–đŠ„|3Dƒ}ƒ‹ƒ`ƒXƒP[ƒ‹zŠÂƒ‚ƒfƒ‹‚É‚ć‚é‰đÍ|. ™–{Wˆę1, ’Š‘q—S‘ž, —Ť@@_, Îˆäł_2, –Ř‘şƒl2, –kě“ÄŽj2, •ô”öŒb—œ2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŹŽ™): ‘ć52‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2016/7/7), “Œ‹ž.

723389. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]ŒŒŠÇ•a•Ď‚đ•š”­‚ľ‚˝Š´őŤS“ŕ–Œ‰ŠÇ—á‚ɑ΂ˇ‚éŠO‰ČŽĄ—Â̐ŹŃ. •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, ‘ĺ‹v•Ű”Ž˘1, —F•Ű‹M”Ž1, ‹ß“Ą@^1, ™–{Wˆę1, ‹gˆä@„, ź‘ă‘ě–ç1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/1), ‘ĺă.

723390. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹}ŤAŒ^‘ĺ“Ž–Ź‰đ—ŁŽčp‚É‚¨‚Ż‚éFrozen elephant trunk‚Ě—LŒřŤ. –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ™–{Wˆę1, ‹gˆä@„, —F•Ű‹M”Ž1, ‘ĺ‹v•Ű”Ž˘1, ź‘ă‘ě–ç1, ‹ß“Ą@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/1), ‘äę. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/5; 25 (suppl): 60.

723391. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚é”j—ôŤ• •”‘ĺ“Ž–ŹáŽ‚ɑ΂ˇ‚éƒXƒeƒ“ƒgƒOƒ‰ƒtƒg“ŕ‘}p‚ĚŒoŒą. ”ü“‡—˜ş1, ‘ĺ‹v•Ű”Ž˘1, •˝“cŒő”Ž2, ‹ß“Ą@^1, ź‘ă‘ě–ç1, —F•Ű‹M”Ž1, ‹gˆä@„, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć44‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/1), ‘äę. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/5; 25 (suppl): 80.

723392. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”j—ôŤ‹š• •”‘ĺ“Ž–ŹáŽpŒă‚Ě•Ť‡•”‰źŤ“Ž–ŹáŽ‚ɑ΂ľƒXƒeƒ“ƒgƒOƒ‰ƒtƒg“ŕ‘}p‚đŽ{s‚ľ‚˝1—á. ŽO’J—D‘ž˜N, ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, ‹ß“Ą@^1, ź‘ă‘ě–ç1, —F•Ű‹M”Ž1, ‹gˆä@„, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, •˝“cŒő”Ž2, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć44‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/1), ‘äę. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/5; 25 (suppl): 90.

723393. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰ş\“ńŽw’°Šp‚ÉᑍEŒ`Ź‚Ş‹^‚í‚ę‚˝• •”‘ĺ“Ž–ŹáŽ‚Ěˆę—á. ź‘ă‘ě–ç1, ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, —F•Ű‹M”Ž1, ‹ß“Ą@^1, ‹gˆä@„, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć44‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/1), ‘äę. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/5; 25 (suppl): 90.

723394. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • •”“Ý“IŠO‚É‚ć‚é‘ĺ“Ž–Ź`‰ş‘ĺĂ–Źá‘‚Ěˆę—á. ‹ß“Ą@^1, ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, ź‘ă‘ě–ç1, “c’† —C‹M1, —F•Ű‹M”Ž1, ‹gˆä@„, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, •˝“cŒő”Ž2, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć44‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/1), ‘äę. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/5; 25 (suppl): 91.

723395. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚Ĺ‚ĚŒŒŠÇŠO‰ČES‘ŸŠO‰Č—Z‡‚É‚ć‚é•Ď‰ť. ‘ĺ‹v•Ű”Ž˘1, –k‘ş@—Ľ1, ”ü“‡—˜ş1, ‹ß“Ą@^1, ź‘ă‘ě–ç1, —F•Ű‹M”Ž1, ‹gˆä@„, ™–{Wˆę1, •ó—ˆ“N–ç1, •˝“cŒő”Ž2, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć44‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/1), ‘äę. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/5; 25 (suppl): 107.

723396. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ď‹É“I‚ÉPrimary NorwoodŽčp‚đ‘I‘đ‚ľ‚˝ŽĄ—Ð헪‚Ĺ‚ĚFontanŽčp“ž’B‚Ö‚ĚŽčpŹŃ‚ĚŒŸ“˘. ™–{Wˆę1, ‹gˆä@„, ‹ß“Ą@^1, –Ř‘şƒl2, •ô”öŒb—œ2, –kě“ÄŽj2, ˆŔ“Ą@Žő2, Îˆäł_2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŹŽ™): ‘ć52‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2016/7/6), “Œ‹ž.

723397. [Šw‰ď (‘S‘)] (ƒNƒŠƒjƒJƒ‹ƒrƒfƒI) Double aortic arch, right descending aorta, left ligamentum arteriosus‚ɑ΂ľAVideo Assisted Thoracic Surgery (VATS) ‚É‚ÄŽĄ—Ă‚ľ‚˝ˆęÇ—á. –{ě^”ü‰Á1, Ž›ěŸ–ç2, ůŒ´‘–L1, ‹{’n@ŠÓ1, ‹{–{—˛Ži1 (1S‘ŸŒŒŠÇŠO, 2ŒQ”nŒ§—§ŹŽ™ˆă—ĂƒZƒ“ƒ^[): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/9/30), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.144.

723398. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ^o’źÚ‘—ŒŒ–@‚đ—p‚˘‚˝‹}ŤAŒ^‘ĺ“Ž–Ź‰đ—ŁŽčp‚̏‰ŠúŹŃ. –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, •ó—ˆ“N–ç1, ™–{Wˆę1, “üŕV—F•ă1, ź‘ă‘ě–ç1, —с@GŒ›1, ‹{“c—L—˘œ¨1, “y“c—E‘ž1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/9/30), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.159.

723399. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) TEVARpŒă‰“ŠuŠú“Ż•”ˆĘ‚ĚŠJ‹šŽčp. ‹{“c—L—œ¨1, ’šˆäWŽO2, –k‘ş@—Ľ1, •˝“cŒő”Ž3, •ó—ˆ“N–ç1. ™–{Wˆę1, “üŕV—F•ă1, —с@GŒ›1, ź‘ă‘ě–ç1, “y“c—E‘ž1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/9/30), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.165.

723400. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒtƒ@ƒ[Žl’ĽÇS“ŕC•œpŒă‚Ě”x“Ž–Ź•Ů‹t—Ź‚É‚ć‚錌—ŹƒGƒlƒ‹ƒM[‘šŽ¸. ŽÄ“c[á1, ”Â’JŒcˆę, —с@‘×—C, –{“c@’2, –kě“ÄŽj2, ‹{’n@ŠÓ1, Ź–ě@–Ť (1S‘ŸŒŒŠÇŠO, 2ŹŽ™): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/10/1), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.182.

723401. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”xŒŒ—Ź’˛ßŒ^—ź‘¤”x“Ž–ŹiNp‚đ—p‚˘‚˝‘“Ž–ŹŠ˛Ç‚Ě“ńŠú“IC•œp‚ĚŒŸ“˘. ůŒ´‘–L1, –{ě^”ü‰Á1, Ž›ěŸ–ç2, ‹{’n@ŠÓ1, ‹{–{—˛Ži1 (1S‘ŸŒŒŠÇŠO, 2ŒQ”nŒ§—§ŹŽ™ˆă—ĂƒZƒ“ƒ^[): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/10/1), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.183.

723402. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Primary Suture-lessƒeƒNƒjƒbƒN‚đ—p‚˘‚Č‚˘Conventional Repair‚Ĺ‚Ě‘”xĂ–ŹŠŇ—ŹˆŮíÇC•œp‚Ě’†ŠúŹŃ. ™–{Wˆę1, —с@GŒ›1, “y“c—E‘ž1, ’šˆäWŽO2, –k‘ş@—Ľ1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ‘ĺ‹v•Ű”Ž˘1, “üŕV—F•ă1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/10/1), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.183.

723403. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) High flow strategy‚đ—p‚˘‚˝‘I‘đ“I”]ŠŇ—Ź‚É‚ć‚é‘ĺ“Ž–Ź‹|•”C•œp‚̐lHS”x’†ˆöŽq‚ĚŒŸ“˘. ™–{Wˆę1, ŒĂ•˝@‘2, —с@GŒ›1, “y“c—E‘ž1, ’šˆäWŽO3, –k‘ş@—Ľ1, •˝“cŒő”Ž4, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ‘ĺ‹v•Ű”Ž˘1, “üŕV—F•ă1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ME•”, 3ˆă—ĂˆŔ‘SŠw‹łˆç, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/10/1), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.184.

723404. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚銴őŤS“ŕ–Œ‰Š˜A‘ą80Ç—á‚ĚŠO‰ČŽĄ—ĂŒoŒą. •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ™–{Wˆę1, “üŕV—F•ă1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, “y“c—E‘ž1, —с@GŒ›1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/10/1), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.196.

723405. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘J‰„‚ˇ‚éSŽşŤ•p–Ź”­ě‚Ě2ƒ•ŒŽŽ™‚ɑ΂ľƒRƒCƒ‹ƒŠ[ƒh‚đSůN“ŕ‚ÉŽg—p‚ľ‚˝ICDA‚Śž‚ݏp‚Ě1—á. —с@GŒ›1, ™–{Wˆę1, ’šˆäWŽO2, “y“c—E‘ž1, –k‘ş@—Ľ1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, ‘ĺ‹v•Ű”Ž˘1, Ź—ŃŒ’‰î1, “üŕV—F•ă1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć54‰ń“ú–{lH‘ŸŠíŠw‰ď‘ĺ‰ď (2016/11/1), ‰ŞŽR. lH‘ŸŠí 2016/11; 45 (2): S-176.

723406. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • •”“Ý“IŠO‚É‚ć‚é‘ĺ“Ž–Ź|‰ş‘ĺĂ–Źá‘‚Ě1—á. ‹ß“Ą@^1, ‘ĺ‹v•Ű”Ž˘1, “c’†—C‹M1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, ’†‘ş—SŠó1, ‹gˆä@„, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć169‰ńŒŒŠÇŠO‰ČÇ—ጟ“˘‰ď (2016/10/29), “Œ‹ž. ŒŒŠÇŠO‰Č 2016/10; 35 (1): 162-3.

723407. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ş\“ńŽw’°Šp‚ÉᑍEŒ`Ź‚Ş‹^‚í‚ę‚˝• •”‘ĺ“Ž–ŹáŽ‚Ě1—á. ź‘ă‘ě–ç1, ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, —F•Ű‹M”Ž1, ‹ß“Ą@^1, ‹gˆä@„, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć169‰ńŒŒŠÇŠO‰ČÇ—ጟ“˘‰ď (2016/10/29), “Œ‹ž. ŒŒŠÇŠO‰Č 2016/10; 35 (1): 177-8.

723408. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • •”‘ĺ“Ž–Ź\“ńŽw’°á‘‚ɑ΂ľ‚Ä2Šú“IŞŽĄp‚đŽ{s‚ľ‚˝1—á. ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, “c‘şK•ä1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć169‰ńŒŒŠÇŠO‰ČÇ—ጟ“˘‰ď (2016/10/29), “Œ‹ž. ŒŒŠÇŠO‰Č 2016/10; 35 (1): 181-2.

723409. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) S‘ŸŽčp‚É‚¨‚Ż‚é‹ßÔŠOü•ŞŒő–@”]‹ÇŠŽ_‘f–O˜a“x (rSO2) ‚̒ቺ‚ÉŠÖŒW‚ˇ‚é—v‘f‚ĚŒŸ“˘. Ź—ŃŒ’‰î1, –k‘ş@—Ľ1, ŒĂ•˝@‘2, ’šˆäW‘˘3, •ó—ˆ“N–ç1, •˝“cŒő”Ž4, ”ü“‡—˜ş1, ™–{Wˆę1, ‘ĺ‹v•Ű”Ž˘1, “üŕV—F•ă1, ź‘ă‘ě–ç1, —с@GŒ›1, ‹{“c—L—œ¨1, “y“c—E‘ž1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ME•”, 3ˆă—ĂˆŔ‘SŠw‹łˆç, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2017/2/27), “Œ‹ž. ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď´˜^W 2017/2; p.122.

723410. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éTARˆęŠú“IŽčp‚ĆTAR ET + “ńŠú“ITEVAR‚ĚŽčpŹŃŒŸ“˘. “üŕV—F•ă1, –k‘ş@—Ľ1, ‹{“c—L—œ¨1, “y“c—E‘ž1, Š`čt“Ţ1, ź‘ă‘ě–ç1, ŽÄ“c[á1, ‘ĺ‹v•Ű”Ž˘1, ™–{Wˆę1, •ó—ˆ“N–ç1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2017/2/28), “Œ‹ž. ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď´˜^W 2017/2; p.285.

723411. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”j—ôŤ• •”‘ĺ“Ž–ŹáŽ‚ɑ΂ˇ‚éƒXƒeƒ“ƒgƒOƒ‰ƒtƒg“ŕ‘}p. ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, ‹{“c—L—œ¨1, “y“c —E‘ž1, ź‘ă‘ě–ç1, ŽÄ“c[á1, “üŕV—F•ă1, –{ě^”ü‰Á1, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2017/2/28), “Œ‹ž. ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď´˜^W 2017/2; p.296.

723412. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ŠúFontanŽčp‚Ě’†Šú‰“ŠuŠúŹŃ‚ĚŒŸ“˘. ŽÄ“c[á1, ™–{Wˆę1, –{ě^”ü‰Á1, “y“c—E‘ž1, ’šˆäWŽO2, •˝“cŒő”Ž3, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, ”ü“‡—˜ş1, “üŕV—F•ă1, ‘ĺ‹v•Ű”Ž˘1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2017/3/1), “Œ‹ž. ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď´˜^W 2017/2; p.274.

733227. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠĽ“Ž–Ź‹NŽnˆŮí‚É‚ć‚č‹Ů‹}ƒoƒCƒpƒXŽčp‚đ—v‚ľ‚˝‚ŕ‚Ě‚ĚŒŔ‹ÇŤ‘ĺ“Ž–Ź‰đ—Ł‚Ĺ‚ ‚Á‚˝1—á. ĺŒ’Ži˜N1, ’†“‡Œő‹M1, ćс@łŠî2, ŹŒ´–M‹`2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–ź‘‡•a‰@): ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/6/11), “Œ‹ž. ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/6; p.11.

733228. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒfƒSƒX•a‚ɍ‡•š‚ľ‚˝ŽűkŤS–Œ‰Š‚ĚŽčp—á. “cŠ—S‹I, •ó—ˆ“N–ç1, ’šˆäWŽO2, –k‘ş@—Ľ1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, ‘ĺ‹v•Ű”Ž˘1, ź‘ă‘ě–ç1, ™–{Wˆę1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/6/11), “Œ‹ž. ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/6; p.17.

733229. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰şs‘ĺ“Ž–Ź‚Ş’Ĺ‘Ě‚Ě‰E‘¤‚đ‘–s‚ˇ‚鍶‘ĺ“Ž–Ź‹|, ‘ĺ“Ž–ŹkóÇ‚Ě1 —á. “y“c—E‘ž1, —с@GŒ›1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, “üŕV—F•ă1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, ™–{Wˆę1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/6/11), “Œ‹ž. ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/6; p.231.

733230. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éRAAA‚ɑ΂ˇ‚éEVAR‚̏‰ŠúŹŃ. ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, ‹{“c—L—˘œ¨1, “y“c—E‘ž1, ź‘ă‘ě–ç1, —с@GŒ›1, “üŕV—F•ă1, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć24‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/10/8), “Œ‹ž. “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2016/10; suppl: p.10.

733231. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) čň“Ž–Ź•ŞŠňˆŮíA‰E‘¤‘ĺ“Ž–Ź‹|‚ɍ‡•š‚ľ‚˝‹|•”‘ĺ“Ž–ŹáŽ‚ɑ΂ľ‘S‹|•”lHŒŒŠÇ’uŠˇp + ƒXƒeƒ“ƒgƒOƒ‰ƒtƒg“ŕ‘}p‚đŽ{s‚ľ‚˝Ç—á. ’†“‡Œő‹M1, ĺŒ’Ži˜N1, ŹŒ´–M‹`2, ćс@łŠî2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–ź‘‡•a‰@): ‘ć172‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/11/5), “Œ‹ž. ‘ć172‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/11; p.10.

733232. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) p’†‚É‘ĺ“Ž–Źkó‚Ş”ť–ž‚ľ‚˝‘”xĂ–ŹŠŇ—ŹˆŮí‚Ěˆę—á. —с@GŒ›1, ™–{Wˆę1, “y“c—E‘ž1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, Ź—ŃŒ’‰î1, “üŕV—F•ă1, ź‘ă‘ě–ç1, ‹{“c—L—œ¨1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć172‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/11/5), “Œ‹ž. ‘ć172‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/11; p.27.

733233. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒJ‚č•Ô‚ˇ‘˝”­”][Ç‚đ”­Ç‚ľ‚˝S–[’†ŠuŒ‡‘šÇ‚Ě1Žčp—á. ˆäă’“š1, ŽR–{Ms2, –k‘ş@—Ľ1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V•S‡ƒ–‹u‘‡•a‰@): ‘ć172‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/11/5), “Œ‹ž. ‘ć172‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/11; p.30.

733234. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “Ý“IŠO‚É‚ć‚é‹}Ť‘m–X•Ů•Â˝•s‘SÇ‚Ě1—á. ź‘ă‘ě–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, ™–{Wˆę1, ‘ĺ‹v•Ű”Ž˘1, Ź—ŃŒ’‰î1, –{ě^”ü‰Á1, ŽÄ“c[á1, ˆäă’“š1, r‹Lt“Ţ1, ‹{“c—L—˘œ¨1, “y“c—E‘ž1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/3/11), “Œ‹ž. ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2017/3; p.8.

733235. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘m–X•Ů“ű“Ş‹Ř’f—ô‚đ”­Ç‚ľ€‹Ů‹}“I‚ɐś‘Ě•Ů’uŠˇp‚đs‚˘‹~–˝‚ľ‚˝ˆęÇ—á. ’†“‡Œő‹M1, ĺŒ’Ži˜N1, ŹŒ´–M‹`2, ćс@łŠî2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–ź‘‡•a‰@): ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/3/11), “Œ‹ž. ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2017/3; p.10.

733236. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒnƒCƒuƒŠƒbƒhŽčp (ƒJƒe[ƒeƒ‹“I”x“Ž–Ź—ôŠJp + BTƒVƒƒƒ“ƒg) Œă‚É1 + 1/2SŽşC•œp‚đs‚Á‚˝ƒŒ^”x“Ž–Ź•Â˝E‰EŽş’áŒ`Ź‚Ěˆę—á. ‹{“c—L—œ¨1, ™–{Wˆę1, –{ě^”ü‰Á1, ’šˆäWŽO2, –k‘ş@—Ľ1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, ‘ĺ‹v•Ű”Ž˘1, Ź—ŃŒ’‰î1, ŽÄ“c[á1, ˆäă’“š1, ź‘ă‘ě–ç1, r‹Lt“Ţ1, “y“c—E‘ž1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—ĂˆŔ‘SŠw‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/3/11), “Œ‹ž. ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2017/3; p.31.


ŒÄ‹zŠíŠO‰ČŠw

[Šwp˜_•ś]

110192. [Œ´’˜] Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung. Naito M, Aokage K, Saruwatari K, Hisakane K, Miyoshi T, Hishida T, Yoshida J, Masato S, Kojima M, Kuwata T, Fujii S, Ochiai A, Satoh Y1, Tsuboi M, Ishii G: Lung Cancer 2016/10; 100: 53-62. (˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

310021. [Ç—á•ń] Multiple primary pulmonary meningiomas: 20-year follow-up findings for a first reported case confirming a benign biological nature. Satoh Y1, Ishikawa Y: Int J Surg Case Rep 2017/1; 31: 58-60. (˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

310022. [Ç—á•ń] Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation. Sonoda D1, Mikubo M2, Shiomi K1, Satoh Y1: Ann Thorac Surg 2017/2; 103 (2): e119-20. (‰€“c@‘ĺ1, ŽOŒEŤŽj2, ‰–ŒŠ@˜a1, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

510003. [‘ŕ] Management of chest drainage tubes after lung surgery. Satoh Y1: Gen Thorac Cardiovasc Surg 2016/6; 64 (6): 305-8. (˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

[’˜@‘]

620083. [Šwp‘ (•Ş’SŽˇ•M)]yŒÄ‹zŠíŠO‰ČƒeƒLƒXƒgz‘ćVIÍ ”x‚ĚŽîᇐŤŽžŠł@C ”xŠŕ‚Ě‘gDŒ^•Ş—Ţ, p.208-12. ˛“Ą”Vr (ŒÄ‹zŠíŠO), •Ň: “ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď^ŒÄ‹zŠíŠO‰Čę–ĺˆă‡“ŻˆĎˆő‰ď, “ě]“°, “Œ‹ž, 2016/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712017. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Introduction for the molecular testing in cytology for lung cancer. Satoh Y1: The 19th International Congress of Cytology (2016/5/29), Yokohama. (˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

713065. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Cytotechnology educational program in Kitasato University. Nishimura Y1, Hattori M1, Tanaka K, Suzuki A, Satoh Y2, Sato Y1, Ohbu M, Furuta R1, Kitasato H1: The 19th International Congress of Cytology (2016/6/1), Yokohama. (ź‘ş—R—˘1, •ž•”@Šw1, ˛“Ą”Vr2, ˛“Ą—Yˆę1, ŒĂ“c—ćŽq1, –k—˘‰p˜Y1: 1ˆă—ÉqśŠw•”, 2ŒÄ‹zŠíŠO)

713066. [Šw‰ď(‘Ű)] (ˆę”ʍu‰‰) Lung metastases of uterine tumor resembling ovarian sex-cord tumor. a case report. Kondo Y1, Sakaguti S2, Mikubo M3, Naito M1, Shiomi K1, Nakashima H1, Obu M4, Satoh Y1: 15th Japan-Korea Joint Meeting for Diagnostic Cytopathology (2016/10/29), Korea. (‹ß“Ą‘אl1, âŒű@”E2, ŽOŒEŤŽj3, “ŕ“Ą‰ëm1, ‰–ŒŠ@˜a1, ’†“‡—TN1,‘ĺ•”@˝4, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO, 2•a—•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ˆă—ÉqśŠw•”)

713067. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The impact of lung age on postoperative complications in patients with lung cancer combined with pulmonary fibrosis and emphysema. Naito M1, Kondo Y1, Yamazaki H1, Nakashima H1, Matsui Y1, Shiomi K1, Satoh Y1: The 17th World Conference on Lung Cancer (2016/12/4-7), Vienna, Austria (“ŕ“Ą‰ëm1, ‹ß“Ą‘אl1, ŽRř“GŒp1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

713068. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Impact of micropapillary pattern in nodal upstaging of lung adenocarcinoma 2cm or less. Yamazaki H1, Kondo Y1, Naito M1, Nakashima H1, Matsui Y1, Shiomi K1, Satoh Y1: The 17th World Conference on Lung Cancer (2016/12/4-7), Vienna, Austria (ŽRř“GŒp1, ‹ß“Ą‘אl1, “ŕ“Ą‰ëm1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

713069. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Microenvironmental changes in the progression from adenocarcinoma in situ to "early-invasive" adenocarcinoma of the lung. Naito M1, Satoh Y1, Ishii G: AACR Annual Meeting 2017 (2017/4/5), Washington,DC, USA. (“ŕ“Ą‰ëm1, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

722102. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ”xŠŕWHO•Ş—Ţ(2015)‚ÉŠî‚Ă‚­V‚˝‚ČŒÄ‹zŠí×–Ef. ˛“Ą”Vr (ŒÄ‹zŠíŠO): ‘ć57‰ń“ú–{—Տ°×–EŠw‰ď‘‰ďtŠú‘ĺ‰ď (2016/5/28), ‰Ą•l.

723413. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺ’°ŠŕpŒă”x“]ˆÚÇ—á‚ɑ΂ˇ‚é”xŘœŒă•â•‰ťŠw—Ă–@‚Ě—LŒřŤ‚ĚŒŸ“˘. ‰–ŒŠ@˜a1, “ŕ“Ął‹K2, “n粏š•F2, ŽOŒEŤŽj3, ’†“‡—TN1, —с@ËŽq1, Ź–ěŒłŽk1, ‰€“c@‘ĺ1, źˆäŒ[•v1, ŽRř“GŒp1, “ŕ“Ą‰ëm1, ‹ß“Ą‘אl1, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2ŠO‰Č, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć116‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/4/15), ‘ĺă.

723414. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚ĹŽčp‚đŽ{s‚ľ‚˝8—á‚̍~‰şŤ‰óŽ€ŤcŠu‰Š‚ÉŠÖ‚ˇ‚錟“˘. ‰€“c@‘ĺ1, Ź–ěŒłŽk1, —с@ËŽq1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ´–ě—R”y2, ‹{–{r•ă2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć33‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2016/5/12-13), ‹ž“s.

723415. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇ‹Ř–ł—͏ǂɑ΂ˇ‚錕ó“Ë‹N‰şƒAƒvƒ[ƒ`‚É‚ć‚é‹šo‹ž‰şŠg‘ĺ‹š‘B‘S“Ep‚ĚŒŸ“˘. ‰–ŒŠ@˜a1, źˆäŒ[•v1, Ź–ěŒłŽk1, —с@ËŽq1, ‰€“c@‘ĺ1, ’†“‡—TN1, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO): ‘ć33‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2016/5/12-13), ‹ž“s.

723416. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŽ‘S‹žŽ‹‰ş‚ɐ؏œ‚ľ“ž‚˝cŠuŒ´”­‹‘厉–b“÷Žî‚Ěˆę—á. źˆäŒ[•v1, Ź–ěŒłŽk1, —с@ËŽq1, ‰€“c@‘ĺ1, ’†“‡—TN1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1, Ó@˘ˆŽ2 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć33‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2016/5/12-13), ‹ž“s.

723417. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹š–Œ”­ś‚ľ‚˝‰Ą–ä‹ŘŒ´ŤŽîᇂ̈ęŘœ—á. ’†“‡—TN1, Ó@˘ˆŽ2, Ź–ěŒłŽk1, —с@ËŽq1, ‰€“c@‘ĺ1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ‘ş‰_–FŽ÷2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/12-14), ĺ‘ä.

723418. [Šw‰ď(‘S‘)] (ˆę”ʍu‰‰) ‘OcŠuŽîᇂɑ΂ˇ‚錕ó“Ë‹N‰şƒAƒvƒ[ƒ`‚É‚ć‚é’PEŽŽ‹šo‹ž‰şŽčp. “ŕ“Ą‰ëm1, ‹ß“Ą‘אl1, ŽRř“GŒp1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO‰Č): ‘ć78‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2016/11/24-26), “Œ‹ž.

723419. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŤŤ•FŽî”x“]ˆÚ3Řœ—á‚ĚŒŸ“˘. ‹ß“Ą‘אl1, ŽRř“GŒp1, “ŕ“Ą‰ëm1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1, ’‡“c“TL2, ŽOŽ}@M2 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć57‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2016/12/19-21), •Ÿ‰Ş.

723420. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹CŽî‡•š”xüˆŰÇ (CPFE) ‡•š”xŠŕ‚ĚŽüpŠú‡•šÇ‚É‚¨‚Ż‚é”x”N—î‚ĚˆÓ‹`. “ŕ“Ą‰ëm1, ‹ß“Ą‘אl1, ŽRř“GŒp1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO): ‘ć57‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2016/12/19-21), •Ÿ‰Ş.

723421. [Šw‰ď(‘S‘)] (ˆę”ʍu‰‰) “ű“ŞŒ^”x‘BŠŕ‚Ě•Ş‰ť“x‚Ć—Ő°•a—Šw“IˆöŽq‚ĚŒŸ“˘. ’†“‡—TN1, ‹ß“Ą‘אl1, ŽRř“GŒp1, “ŕ“Ą‰ëm1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ’‡“c“TO2, Ó@˘ˆŽ2, ‘ş‰_–FŽ÷2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć57‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2016/12/19-21), •Ÿ‰Ş.

731088. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)ySpecial Lecture Iz‚í‚ę‚í‚ę‚Ě–ÚŽw‚ˇ‚ŕ‚́|‰ˇŒĚ’mV, ‰ÂˆČˆ×Žt|. ˛“Ą”Vr (ŒÄ‹zŠíŠO): ‘ć26‰ń“ú–{ŒÄ‹zŠíŠO‰Čˆă‰ď “~‹GŠwpW‰ď (2017/2/24), ’ˇ–ě.

733237. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) SVCÄŒš‚𔺂¤‹š‘BŠŕ‚Ě1Řœ—á. ’†“‡—TN1, Ź–ěŒłŽk1, —с@ËŽq1, ‰€“c@‘ĺ1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ’‡“c“TO2, Ó@˘ˆŽ2, ‘ş‰_–FŽ÷2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć171‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/6/11), “Œ‹ž.

733238. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) t×–EŠŕpŒă14”N–Ú‚É‹š•Ç,S–Œ,”x‚Ě“]ˆÚ‚đ“ŻŽžŘœ‚ľ‚˝1—á. ź“‡Œ\Œá1, ‹ß“Ą‘אl1, ŽRř“GŒp1, “ŕ“Ą‰ëm1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO): ‘ć178‰ń“ú–{”xŠŕŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2017/3/4), “Œ‹ž.

733239. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹š˝ŠÖß‰Š‚É‚ć‚é”^ᇂɑ΂ľƒhƒŒƒi[ƒW‚đŽ{s‚ľ‚˝1—á. ŽRř“GŒp1, ‹ß“Ą‘אl1, “ŕ“Ą‰ëm1, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1, –ŕŽR•Ű2, –q@“ÖŽq2, ‰Á”[Fˆę2 (1ŒÄ‹zŠíŠO, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć173‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/3/11), “Œ‹ž.


”]_ŒoŠO‰ČŠw

[Šwp˜_•ś]

110193. [Œ´’˜] Low Stroke Rate of Carotid Stenosis Under the Guideline-Oriented Medical Treatment Compared With Surgical Treatment. Sato K1, Fujiyoshi K2, Hoshi K3, Noda C4, Yamaoka-Tojo M5, Ako J4, Kumabe T1: Int Heart J 2016/4; 57 (1): 80-6. (˛“ĄŒör1, “Ą‹g˜a”Ž2, Ż@‰Ŕ–F3, –ě“cçt4, “ŒžŠ”ü“ŢŽq5, ˆ˘ŒĂĆ4, ŒG•”rG1: 1”]ŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‰qś, 4zŠÂŠí“ŕ, 5ˆă—ÉqśŠw•”)

110194. [Œ´’˜] Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AA, Giannini C, Li KK, Ng HK, Yao Y, Kumabe T1, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DC, Seow WT, Chang KT, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, F`evre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortob‡gyi T, Klekner A, L‡szlŽ B, P—cza T, Hauser P, ScŸller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, L—pez-Aguilar E, Lyden D, Garzia L, Shih DJ, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DT, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD: Lancet Oncol 2016/4; 17 (4): 484-95. (ŒG•”rG1: 1”]ŠO)

110195. [Œ´’˜] Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Ichimura K1, Fukushima S1, Totoki Y1, Matsushita Y1, Otsuka A1, Tomiyama A1, Niwa T1, Takami H1, Nakamura T1, Suzuki T1, Fukuoka K1, Yanagisawa T1, Mishima K1, Nakazato Y1, Hosoda F1, Narita Y1, Shibui S1, Yoshida A1, Mukasa A1, Saito N1, Kumabe T1,2, Kanamori M1, Tominaga T1, Kobayashi K1, Shimizu S1, Nagane M1, Iuchi T1, Mizoguchi M1, Yoshimoto K1, Tamura K1, Maehara T1, Sugiyama K1, Nakada M1, Sakai K1, Kanemura Y1, Nonaka M1, Asai A1, Yokogami K1, Takeshima H1, Kawahara N1, Takayama T1, Yao M1, Kato M1, Nakamura H1, Hama N1, Sakai R1, Ushijima T1, Matsutani M1, Shibata T1, Nishikawa R1 (1Intracranial Germ Cell Tumor Genome Analysis Consortium): Acta Neuropathol 2016/6; 131 (6): 889-901. (ŒG•”rG1,2: 2”]ŠO)

110196. [Œ´’˜] Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease. Sato K1, Yamada M1, Kuroda H1, Yamamoto D1, Asano Y2, Inoue Y2, Fujii K, Kumabe T1: AJNR Am J Neuroradiol 2016/7; 37 (7): 1244-8. (˛“ĄŒör1, ŽR“c@Ÿ1, •“c”Ž‹I1, ŽR–{‘ĺ•ă1, ó–ě—Y“ń2, ˆäă—D‰î2, ŒG•”rG1: 1”]ŠO, 2•úŽËü (‰ć‘œ))

110197. [Œ´’˜] Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T1, Tominaga T: J Neurooncol 2016/9; 129 (3): 505-14. (ŒG•”rG1: 1”]ŠO)

110198. [Œ´’˜] Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development. Takai Y, Misu T, Nishiyama S, Ono H, Kuroda H, Nakashima I, Saito R, Kanamori M, Sonoda Y, Kumabe T1, Mugikura S, Watanabe M, Aoki M, Fujihara K: Neurology 2016/11; 87 (19): 2000-5. (ŒG•”rG1: 1”]ŠO)

110199. [Œ´’˜] A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosiső. Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki S, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T1, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake S: Neurooncol Pract 2016/12; 3 (4): 272-80. (ŒG•”rG1: 1”]ŠO)

110200. [Œ´’˜] Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Fukushima S1, Yamashita S1, Kobayashi H1, Takami H1, Fukuoka K1, Nakamura T1, Yamasaki K1, Matsushita Y1, Nakamura H1, Totoki Y1, Kato M1, Suzuki T1, Mishima K1, Yanagisawa T1, Mukasa A1, Saito N1, Kanamori M1, Kumabe T1,2, Tominaga T1, Nagane M1, Iuchi T1, Yoshimoto K1, Mizoguchi M1, Tamura K1, Sakai K1, Sugiyama K1, Nakada M1, Yokogami K1, Takeshima H1, Kanemura Y1, Matsuda M1, Matsumura A1, Kurozumi K1, Ueki K1, Nonaka M1, Asai A1, Kawahara N1, Hirose Y1, Takayama T1, Nakazato Y1, Narita Y1, Shibata T1, Matsutani M1, Ushijima T1, Nishikawa R1, Ichimura K1 (1Intracranial Germ Cell Tumor Genome Analysis Consortium): Acta Neuropathol 2017/3; 133 (3): 445-62. (ŒG•”rG1,2: 2”]ŠO)

220005. [€Œ´’˜] Transsylvian approach‚Š‚çExtradural temporalolar approach‚Ě‚˝‚ß‚ĚŒŒŠÇ‰đ–U‚ĆƒRƒc. ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ďu‰‰W 2017/3; p.10-2.

220006. [€Œ´’˜] ăˆßčň’ł̐ҒŒŠÇ• ‘¤•”ŽîᇂɊ֘A‚ˇ‚éanterior internal vertebral venous plexus‚Ćanterior meningeal artery‚ĚŽčp‰đ–U. ´…@ú1, ‘ĺŕVŹ”V1, –]ŒŽ’O, ŠÖŒű•üŽq1, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ďu‰‰W 2017/3; p.63-5.

220007. [€Œ´’˜] Ň‘‘“ŕŽîᇎčp‚É‚¨‚Ż‚éŇ‘‘O•ű‚Ě”÷ŹŠO‰Č‰đ–U. ŽOˆäŒö•F1, ´…@ú1, ŽO“‡‘ĺ“ż, z–K’m–ç, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ďu‰‰W 2017/3; p.66-8.

220008. [€Œ´’˜] ‚ˆĘčň’Ő‘–ŒŽî‚Ě“Eop‚É‚ć‚艓Šu•”‚Ě’Ĺœ“Ž–Ź‚ɉźŤ“Ž–ŹáŽ‚𐜂ś‚˝1—á. ´…@ú1, ŹňŠ°”V1, ŽR“c@Ÿ1, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ďu‰‰W 2017/3; p.87-8.

310023. [Ç—á•ń] Extremely Late Recurrence 21 Years after Total Removal of Immature Teratoma: A Case Report and Literature Review. Mano Y, Kanamori M, Kumabe T1, Saito R, Watanabe M, Sonoda Y, Tominaga T: Neurol Med Chir (Tokyo) 2017/1; 57 (1): 51-6. (ŒG•”rG1: 1”]ŠO)

310024. [Ç—á•ń] Total Resection of Brainstem Extension of Tentorial Schwannoma Using an Occipital Transtentorial Approach. Xinrui L, Sato Y, Dan M1, Kuroda H1, Kumabe T1: World Neurosurg 2017/2; 98: 879.e13-6. (’h@@[1, •“c”Ž‹I1, ŒG•”rG1: 1”]ŠO)

320010. [Ç—á•ń] čň“Ž–Ź“ŕ–Œ”—Łp‚Ě‘Sg–ƒŒ“ą“ü‚đŒ_‹@‚ÉŠĽšk‚É‚ć‚éS’âŽ~‚đ—ˆ‚ľ‚˝1—á. ˛“ĄŒör1, ˆ˘•”Ž’q1, ŹâN°2, ‘ĺ“ŕ@•3, ‰Ş–{_Žk2, ˆ˘ŒĂ–ç3, ŒG•”rG1 (1”]ŠO, 2–ƒŒ, 3zŠÂŠí“ŕ): ”]_ŒoŠO‰Č2016/7; 44 (7): 591-8.

320011. [Ç—á•ń] ‚Ü‚ę‚ȉđ–UŠw“I‘fˆö‚ŞŠÖ—^‚ľ‚˝Œz‘Ç. ´…@ú1, ‘ĺŕVŹ”V1, –]ŒŽ’O, ŠÖŒű•üŽq1, ‹ß“Ą—łŽj1, ŒG•”rG1 (1”]ŠO): ”]_ŒoŠO‰ČƒWƒƒ[ƒiƒ‹ 2016/6; 25 (6): 520-4.

520010. [‘ŕ]y“ÁW: ƒOƒŠƒI[ƒ}z_ŒoäPŽî‚ɑ΂ˇ‚éŽčp‚Ě—đŽj. ŒG•”rG (”]ŠO): ”]_ŒoŠO‰ČƒWƒƒ[ƒiƒ‹ 2016/7; 25 (7): 548-54.

521012. [‰đŕ] ‰Šú‰ć‘œ•]‰ż‚ÉCT‚đ—p‚˘‚˝ŒŒđ‰ńŽű—Ă–@‚Ě—LŒřŤ‚ĆˆŔ‘SŤ. ‹ß“Ą—łŽj1, ’†Œ´–Mť1, ˆ˘•”Ž’q1, ŽR–{‘ĺ•ă1, ‹{â˜aO1, ŒG•”rG1, ˆä“‡‘ĺ•ă2, źŽR˜a—˜2 (1”]ŠO, 2_Œo“ŕ): The Mt. Fuji Workshop on CVD 2016/8; 34: 137-9, 166.

522078. [uŔ]y˜AÚ: ”]Žîá‡UpdatezEmbriomnnal tumors (‘ŮŽ™ŤŽîá‡). ‰Ş@GG (”]ŠO): ”]_ŒoŠO‰Č 2016/4; 44 (4): 335-45.

522079. [uŔ]y‘ć2“ÁW: ‚ą‚ą‚܂Ői‚ń‚ž! ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂUp to datez[3] ƒp[ƒLƒ“ƒ\ƒ“•a‚ĚŠO‰Č“IŽĄ—Ă Up to date. ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO 2016/12; 32 (12): 93-7.

[’˜@‘]

620084. [Šwp‘ (•Ş’SŽˇ•M)]y”]_ŒoŠO‰Čf—Ăƒvƒ‰ƒNƒeƒBƒX7@ƒOƒŠƒI[ƒ}ŽĄ—Ă‚ĚDecision MakingzIII. ŠO‰ČŽĄ—Ă‚ĚDecision Making@2. ƒOƒŠƒI[ƒ}“Eo‚É•K—v‚ȉđ–U’mŽŻ‚Əp’†‹@”\ŒŸ¸@f. “‡, p.170-6. ŒG•”rG (”]ŠO), •Ň: ŽOš MŒ[, Œő•ś“°, “Œ‹ž, 2016/5”­s.

620085. [Šwp‘ (•Ş’SŽˇ•M)]y_ŒoÇŒóáŠQŠw@•a‘Ô‚ĆƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚­ŽĄ—Ă‚Ć—Šw—Ă–@z‘ćIIÍ _ŒoŽžŠł‚ĚŽĄ—Ă‚Ć—Šw—Ă–@@1. ”]ŒŒŠÇáŠQ <Še˜_>^‹}ŤŠú@A •a‘Ô‚ĆŽĄ—Á@…BoŒŒŤŒŒŠÇáŠQ, p.87-94. ˛“ĄŒör1, ‰Ş@GG1 (1”]ŠO), •Ň: “ŕŽR@–ő, œAŁ—˛ˆę2 (2_Œo“ŕ), •śŒő“°, “Œ‹ž, 2016/5”­s.

620086. [Šwp‘ (•Ş’SŽˇ•M)]y_ŒoÇŒóáŠQŠw@•a‘Ô‚ĆƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚­ŽĄ—Ă‚Ć—Šw—Ă–@z‘ćIIÍ _ŒoŽžŠł‚ĚŽĄ—Ă‚Ć—Šw—Ă–@@1. ”]ŒŒŠÇáŠQ <Še˜_>^–ŤŠúEˆŰŽŠú@B •a‘Ô‚ĆŽĄ—Á^ŒŒsÄŒšp (CEA, CAS), p.154-62. ˛“ĄŒör1, ‰Ş@GG1 (1”]ŠO), •Ň: “ŕŽR@–ő, œAŁ—˛ˆę2 (2_Œo“ŕ), •śŒő“°, “Œ‹ž, 2016/5”­s.

620087. [Šwp‘ (•Ş’SŽˇ•M)]y_ŒoÇŒóáŠQŠw@•a‘Ô‚ĆƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚­ŽĄ—Ă‚Ć—Šw—Ă–@z‘ćIIÍ _ŒoŽžŠł‚ĚŽĄ—Ă‚Ć—Šw—Ă–@@8. _ŒoŠO@A •a‘Ô‚ĆŽĄ—Ă, p295-305. ‹ß“ĄGŽĄ1, ‰Ş@GG1 (1”]ŠO), •Ň: “ŕŽR@–ő, œAŁ—˛ˆę2 (2_Œo“ŕ), •śŒő“°, “Œ‹ž, 2016/5”­s.

620088. [Šwp‘ (•Ş’SŽˇ•M)]y_ŒoÇŒóáŠQŠw@•a‘Ô‚ĆƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚­ŽĄ—Ă‚Ć—Šw—Ă–@z‘ćIIÍ _ŒoŽžŠł‚ĚŽĄ—Ă‚Ć—Šw—Ă–@@9. ”]Žîᇁ@A •a‘Ô‚ĆŽĄ—Ă, p.318-23. ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO), •Ň: “ŕŽR@–ő, œAŁ—˛ˆę2 (2_Œo“ŕ), •śŒő“°, “Œ‹ž, 2016/5”­s.

620089. [Šwp‘ (•Ş’SŽˇ•M)]y“ŞŠWˆô“ŞŽîƒp[ƒtƒFƒNƒgƒuƒbƒNzCHAPTER 5@ŠO‰ČŽĄ—Á@4. Transventricular approach, p.81-6. ‰Ş@GG (”]ŠO), ŠÄC: ‰ĂŽRFł, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/9”­s.

620090. [Šwp‘ (•Ş’SŽˇ•M)]y”]Žîᇊw (–{—Ő଑Š§†No.1106)zX. ŹŽ™”]Žîᇁ@3. ”ń’čŒ^ŠďŒ`Žî—lƒ‰ƒuƒhƒCƒhŽîá‡, p.714-8. ‰Ş@GG (”]ŠO), “ú–{—Ő଎Đ, “Œ‹ž, 2016/9”­s.

620091. [Šwp‘ (•Ş’SŽˇ•M)]y‰ş‚‘ĚŽžŠłf—Ăƒ}ƒjƒ…ƒAƒ‹ ‘ć2”ŁzII Še˜_•Ň@‘ć2Í —Տ°’mŽŻ@D ‰ş‚‘Ě‘O—tŽžŠłŠe˜_@34. “ŞŠWˆô“ŞŽî, p.227-30. ‰Ş@GG (”]ŠO), •Ň: •˝“cŒ‹Šě, ŽR“cłŽO, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/11”­s.

620092. [Šwp‘ (•Ş’SŽˇ•M)]yƒvƒ‰ƒCƒ€”]_ŒoŠO‰Č1@”]“Ž–ŹáŽz‘ćVIIIÍ “ÁŽę‚Č“Ž–ŹáŽ@3. ’ōœ”]’ę“Ž–Ź‰đ—ŁŤ“Ž–ŹáŽ‚ĚŒŒŠÇ“஡—Ă, p.317-22. ‹ß“Ą—łŽj1, ź–{NŽj (1”]ŠO), ŠÄC: –Ř“ŕ”Ž”V, Ä“Ą‰„l, •Ň: –Ř“ŕ”Ž”V, ŽO—֏‘“X, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712018. [Šw‰ď (‘Ű)] (Scientific Session 6)ySurgical Strategy and Approachz8SS6-4. Surgical strategy for craniopharyingimas: neuroendoscopic and microscopic hybrid surgery. Oka H1, Kusumi M1, Kondo K1: 5th Mt.Bandai & Pan-Pacific Neurosurgical Convention (2016/4/8), Phnom Penh, Cambodia. (‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1: 1”]ŠO)

712019. [Šw‰ď (‘Ű)] (Treatment and Advanced Operative Techniques) Surgical strategy for craniopharyngiomas by hybrid surgery using endoscope and microscope. Oka H1, Kusumi M1, Kondo K1: 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery (2016/8/24), Wein, Austria. (‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1: 1”]ŠO)

713070. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Efficacy and adverse events of carmustine wafers implantation for the treatments of high grade gliomas in a single institute. Kumabe T1, Dan M1, Kuroda H1, Sato Y2, Miyazaka K1, Yamamoto D1, Miyajima Y, Osawa S1, Sato S1, Akabane A: 21st International Conference on Brain Tumor Research and Therapy (2016/4/13), ‰Ť“ę. (ŒG•”rG1, ’h@@[1, •“c”Ž‹I1, ˛“Ą—Yˆę2, ‹{â˜aO1, ŽR–{‘ĺ•ă1, ‹{“‡—Ç‹P, ‘ĺŕVŹ”V1, ˛“ĄŸl1, Ô‰H“ÖŽj: 1”]ŠO, 2ˆă—ÉqśŠw•”)

713071. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Cortical Stimulation Mapping: How do we do it. Kumabe T1: First International Brain Mapping Course (2016/4/29), Chicago, USA. (ŒG•”rG1: 1”]ŠO)

713072. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Functional Mapping Course of the Cerebral Cortex: Advantages and Limitations. Kumabe T1: First International Brain Mapping Course (2016/5/2), Chicago, USA. (ŒG•”rG1: 1”]ŠO)

713073. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Surgeris of gliomas & perforating arteries. Kumabe T1: The 7th Japan-India Neurosurgical Conference (2016/6/18), Osaka. (ŒG•”rG1: 1”]ŠO)

721007. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ŹŽ™ˆŤŤ”]Žîᇂ̏WŠw“IŽĄ—Ă. ŒG•”rG (”]ŠO): ‘ć36‰ń“ú–{”]_ŒoŠO‰ČƒRƒ“ƒOƒŒƒX‘‰ď (2016/5/22), ‘ĺă.

721008. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ’áˆŤŤ“x_ŒoäPŽî‚ɑ΂ˇ‚é‰Â‹y“I“Eop‚ĚˆÓ‹`. ŒG•”rG (”]ŠO): ‘ć21‰ń”]ŽîᇃŒƒrƒ…[ (2016/6/4), “Œ‹ž.

721009. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) _Œo“ŕŽ‹‹žŽčp20”N‚đŒo‚ÄŽŠ–₡‚é–{“–‚Ě’áNPŽčp‚Ć‚Í?: Šw–â‚̐i•ŕ‚Ćˆă—ĂˆŔ‘S. ‰Ş@GG (”]ŠO): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

722103. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ”]—Ŕ—ź‘¤Ť‚ɐZ‚ˇ‚é_ŒoäPŽî“Eop. ŒG•”rG (”]ŠO): ‘ć26‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/4/14), ŽR—œ.

722104. [Šw‰ď (‘S‘)] (“ú–{”]_ŒoŒŒŠÇ“஡—ĂŠw‰ď‡“ŻƒVƒ“ƒ|ƒWƒEƒ€)y”]‘˛’†“ŕ‰Čˆă, ”]‘˛’†ŠO‰Čˆă‚É•K—v‚Č”]ŒŒŠÇ“஡—Ă‚ĚƒgƒsƒbƒNƒXzCAS‚đ‚¤‚Ü‚­s‚¤ˆ×‚É. ‹ß“Ą—łŽj1, ŽR–{‘ĺ•ă1, ‹{â˜aG1, ŹňŠ°”V2, ŒG•”rG1, ˆä“‡‘ĺ•ă3, źŽR˜a—˜3 (1”]ŠO, 2‹~–˝, 3_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/15), ŽD–y.

722105. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ‰”­äP‰čŽî‚Ě”N—î‚ĚŒoŽž“I•Ď‰ť‚ÉŠÖ‚ľ‚Ä. ŒG•”rG1, ‹TŽRšK1, ’h@@[1, ˛“Ą—Yˆę2, ’ˇ“ě‰ëŽu, áÁ–ě@—B, âV“Ą—ł‘ž, ‹ŕX­”V, ‹{â˜aO1, ‘ĺŕVŹ”V1, ˛“ĄŸl1, ‰€“c‡•F1, •y‰i’î“ń (1”]ŠO, 2ˆă—ÉqśŠw•”): ‘ć29‰ń“ú–{˜V”N”]_ŒoŠO‰ČŠw‰ď (2016/4/23), “Ţ—Ç.

722106. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€6)yŠJ“ŞŽčp vs “ŕŽ‹‹žŽčp`‚Ç‚ĚÇ—á‚ɉ˝‚đ‘I‘đ‚ˇ‚é‚Š?`zS6-3. ”]Žîᇎčp‚Ě‚˝‚ß‚ĚŒ°”÷‹žE“ŕŽ‹‹ž‚ĚŽg‚˘•Ş‚Ż. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1 (1”]ŠO): ‘ć21‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2016/9/10), “Œ‹ž.

722107. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ’áˆŤŤ“x_ŒoäPŽî‚ĚŽĄ—Ð헪. ŒG•”rG (”]ŠO): ‘ć21‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2016/9/10), “Œ‹ž.

722108. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[3) ‘ćŽO”]ŽşŽîᇂ̉đ–UE‹@”\EƒAƒvƒ[ƒ`. ‰Ş@GG (”]ŠO): ‘ć21‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2016/9/10), “Œ‹ž.

722109. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™ (ƒrƒfƒI)) –TˆĆ•”‘–ŒŽîp‚ɑ΂ˇ‚épitfall‚Ćrecovery. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć75‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

722110. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ”][ÇÇ‚Ěƒ}ƒlƒWƒƒ“ƒg`’´‹}ŤŠúÄŠJ’Ę‚Š‚ç“ńŽŸ—\–h‚܂Ł`. ‹ß“Ą—łŽj (”]ŠO): ‘ć75‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠwp‘‰ď (2016/10/1), •Ÿ‰Ş.

722111. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€2)y”]ŽŔŽż“ŕŽîᇁzS2-4. –{–M‰‚Ě3D“ŕŽ‹‹ž (Visionsense) ‚đ—p‚˘‚˝_Œo“ŕŽ‹‹žŽčpŒoŒą. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1 (1”]ŠO): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

722112. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[3) _Œo“ŕŽ‹‹žŽčp20”N‚đŒo‚ÄŽŠ–₡‚é–{“–‚Ě’áNPŽčp‚Ć‚Í?: Šw–â‚̐i•ŕ‚Ćˆă—ĂˆŔ‘S. ‰Ş@GG (”]ŠO): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

722113. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€3)yp’†’´‰š”gf’fzS3-1. p’†’´‰š”g‰ć‘œf’f‚É‚ć‚éŇ’ŁEŇ‘•a•Ď‚Ě•]‰ż‚Ć—L—pŤ. ‚—œ~Žq1, ‹ß“ĄGŽĄ2, ‹v{”ü^—2, ‰Ş@GG2 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2”]ŠO): ‘ć17‰ń“ú–{p’†‰ć‘œî•ńŠw‰ď (2017/3/2), Ž­Ž™“‡.

723422. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –TˆĆ•”‘–ŒŽîŽčp‚ɑ΂ˇ‚éH•v. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć26‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/4/14), ŽR—œ.

723423. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’†”]ł’†•”ŠC–ČóŒŒŠÇŽî‚ɑ΂ľanterior interhemispheric transcallosal/ foraminal approach‚Ĺ“Eo‚ľ‚˝ˆę—á. ŽÄŒ´ˆę—z1, űŒ´Œől1, ’h@@[1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć26‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/4/14), ŽR—œ.

723424. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘Ě˜H‚đ‰h—{‚ˇ‚éSubependymal artery‚Ě—Ő°‰đ–U‚Ć”]Žîᇎčp‚É‚¨‚Ż‚钍ˆÓ“_. űŒ´Œől1, ’h@@[1, ŽÄŒ´ˆę—z1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć26‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/4/14), ŽR—œ.

723425. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒoƒCƒ|[ƒ‰ƒVƒXƒeƒ€uƒxƒUƒŠƒEƒXv‚ĚŠî‘bŒ¤‹†‚Ć—Ő°‰ž—p: ŠJ”­‚Š‚ç10”NŠÔ‚̐i‰ť. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1 (1”]ŠO): ‘ć26‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/4/15), ŽR—œ.

723426. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) p’†ICG‚É‚Ä”ť–ž‚ľ‚˝”j—ô‰“ˆĘŒă‰şŹ”]“Ž–ŹáŽ‚É“ŽĂ–ŹŠďŒ`‚ލ‡•š‚ľ‚˝ˆę—á: “KŘ‚ȏp‘Of’fEŽčp•űj‚ĚŒŸ“˘. ‹v{”ü^—1, ŒG•”rG1 (1”]ŠO): ‘ć45‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2016/4/16), ŽD–y.

723427. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ăˆĘčň’ł̐ҒŊǕ ‘¤•”ŽîᇂɊ֘A‚ˇ‚éanterior internal vertebral venous plexus‚Ćanterior meningeal artery‚ĚŽčp‰đ–U. ´…@ú1, ‘ĺŕVŹ”V1, –]ŒŽ’O, ŠÖŒű•üŽq1, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰ČŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

723428. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ň‘‘“ŕŽîᇎčp‚É‚¨‚Ż‚éŇ‘‘O•ű‚Ě”÷ŹŠO‰Č‰đ–U. ŽOˆäŒö•F, ´…@ú1, ŽO“‡‘ĺ“ż, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰ČŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

723429. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) d–Œ“ŽĂ–Źá‘‚ĚŽĄ—Ă‚É•K—v‚ČŠC–Čó–Ź“´ŽüˆÍ‚Ě”÷Ź‰đ–U. ‹ß“Ą—łŽj1, ŽR–{‘ĺ•ă1, ‹{â˜aO1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰ČŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

723430. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚ˆĘčň’Ő‘–ŒŽî‚Ě“Eop‚É‚ć‚艓Šu•”‚Ě’Ĺœ“Ž–Ź‚ɉźŤ“Ž–ŹáŽ‚𐜂ś‚˝1—á. ´…@ú1, ŹňŠ°”V2, ŽR“c@Ÿ1, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰ČŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

723431. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’†•_ŒoŒ´”­ˆÚAŒăƒŠƒ“ƒp‘BŤŽžŠł‚Ě3—á. ’h@@[1, ˛“ĄŸl1, ‹{â˜aO1, H’JšŽj2, –k‘ş‰p“ń3, Œ´@“ÖŽq2, ‹g“cˆęŹ4, ŒG•”rG1 (1”]ŠO, 2•a—, 3_Œo“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć34‰ń“ú–{”]Žîᇕa—Šw‰ď (2016/5/28), “Œ‹ž.

723432. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “Á”­ŤŇ‘ƒwƒ‹ƒjƒA‚̍d–Œ‘gDŠŒŠ`Ç—á•ń. ´…@ú1, ‘ĺŕVŹ”V, –]ŒŽ’O, Ź—Ń—m‰î, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO): ‘ć31‰ń“ú–{Ň‘ŠO‰ČŠw‰ď (2016/6/9), “Œ‹ž.

723433. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ň‘‘“ŕŽîᇎčp‚É‚¨‚Ż‚éŇ‘‘O•ű‚Ě”÷ŹŠO‰Č‰đ–U. ŽOˆäŒö•F1, ´…@ú1, ŽO“‡‘ĺ“ż, z–K’m–ç (1”]ŠO): ‘ć31‰ń“ú–{Ň‘ŠO‰ČŠw‰ď (2016/6/10), “Œ‹ž.

723434. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘Ě˜H‚đ‰h—{‚Ć‚ˇ‚éSubependymal artery‚Ě—Ő°‰đ–U: p’†‚É“Ż’č‚ľ“ž‚˝2Ç—á•ń. űŒ´Œől1, ‹{â˜aO1, ’h@@[1, ŽÄŒ´ˆę—z1, ˛“ĄŸl1, âV“Ą—ł‘ž, ‹ŕX­”V, ‰€“c‡•F, •y‰i’î“ń, ŒG•”rG1 (1”]ŠO): ‘ć21‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2016/9/9), “Œ‹ž.

723435. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒoŹ”]‰„‘—ôƒAƒvƒ[ƒ`‚É‚ć‚鐳í”]‰đ–U‚ĆŒŒŠÇ‘–s. ŽÄŒ´ˆę—z1, ‹{â˜aO1, ’h@@[1, űŒ´Œől1, ŒG•”rG1 (1”]ŠO): ‘ć21‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2016/9/10), “Œ‹ž.

723436. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ň‘Šg‘ĺd–ŒŒ`Ź‚É‚¨‚Ż‚é’ũԩ֐ߏă‚Ěƒ~ƒjƒXƒNƒŠƒ…[‚Ö‚Ěd–Œ’Ý‚čă‚°: ŠČ•ÖEŒř‰Ę“I‚Ȑ‘o‚ĚˆŰŽ–@. ´…@ú1, ‘ĺŕVŹ”V1, –]ŒŽ’G, ‰Íˆä‘ě–ç, ŽOˆäŒö•F1, ŒG•”rG1 (1”]ŠO): ‘ć23‰ń“ú–{Ň’ŁEŇ‘_ŒoŽčpŽč‹ZŠw‰ďŠwpW‰ď (2016/9/16), ŽD–y.

723437. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’†•_ŒoŒ´”­ˆÚAŒăƒŠƒ“ƒp‘BŤŽžŠł‚Ě3—á. ’h@@[1, ˛“ĄŸl1, ‹{â˜aO1, H’JšŽj2, –k‘ş‰p“ń3, ‹g“cˆęŹ4, ŒG•”rG1 (1”]ŠO, 2•a—, 3_Œo“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/29), •Ÿ‰Ş.

723438. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) G“‘Ě‚Š‚ç’W‘“‹…‚֐Z‚ľ‚˝äP‰čŽî‚ĚŽĄ—Ð헪. űŒ´Œől1, Ô‰H“ÖŽj, ‹{â˜aO1, ’h@@[1, ŽÄŒ´ˆę—z1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/29), •Ÿ‰Ş.

723439. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Neurofibromatosis 1‚ɍ‡•š‚ľ‚˝Glioblastoma‚ĚŒŸ“˘. ŽÄŒ´ˆę—z1, ‰€“c‡•F, —é–Ř”Ž‹`, ‹ŕX­”V, âV“Ą—ł‘ž, —é–Ř•ŰG, ‘ŽRË“ń, ă”VŒ´LŽi, “n•Ó‚Ý‚Š, •“c”Ž‹I1, ŒG•”rG1, •y‰i’î“ń (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/29), •Ÿ‰Ş.

723440. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œz•”“ŕŒz“Ž–Ź‹ˇó‚É‹Nˆö‚ˇ‚éŠá‹•ŒŒÇŒóŒQ‚Ě”­Ç—lŽŽ‚ĆŒŒsÄŒšpŒăŽ‹‹@”\‚ĚŠÖŒW. ‹{â˜aO1, ‹ß“Ą—łŽj1, ˆä“‡‘ĺ•ă2, ˆ˘•”Ž’q1, ŽR–{‘ĺ•ă1, ŹňŠ°”V3, ŒG•”rG1 (1”]ŠO, 2_Œo“ŕ, 3‹~–˝): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/29), •Ÿ‰Ş.

723441. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ä”­äP‰čŽî‚ɑ΂ˇ‚é’čˆĘ•úŽËüŽĄ—Ă + ƒxƒoƒVƒYƒ}ƒu•š—p—Ă–@‚Ě—L—pŤ‚Ɖۑč. Ô‰H“Ö–ç, ŒG•”rG1, ‹ŕ‘ň@ŽŠ, “c’†@ŽŔ, “Ą“°‹ď‹L (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/29), •Ÿ‰Ş.

723442. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _ŒoäPŽî‚É‚¨‚Ż‚éIDHˆâ“`Žq•ĎˆŮ‚Ɛ[•”Ă–ŹŒŒđÇ‚¨‚ć‚Ń”xÇđÇ‚ĚŠÖ˜A. ’ˇ“ě‰ëŽu, ‹ŕX­”V, ěŒű•ň—m, Ö“Ą—ł‘ž, ŻŽi‘ń‘ĺ, ŽÄŒ´ˆę—z1, ‰€“c‡•F, ŒG•”rG1, •y‰i’î“ń (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/29), •Ÿ‰Ş.

723443. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚ŒŒˆłŤŹ”]oŒŒ‚É‚¨‚Ż‚é’´‹}ŤŠú“ŕŽ‹‹ž‰şŒŒŽîœ‹Žp‚Ě—LŒřŤ. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, Ż@‰Ŕ–F3, ŒG•”rG2 (1‹~–˝, 2”]ŠO, 3‰qś): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723444. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹ßˆĘe“Ž–Ź•ÂÇpŒă‚ĚŠC–ȐÖŹ“´“ŕŒz“Ž–ŹáŽ‚Ě᎓ŕÇŒŒđ‰ť‰ß’ö`MRIŠŒŠ‚ĚŒoŽž“I•Ď‰ť`. ‹ß“Ą—łŽj1, ŹňŠ°”V2, •“c”Ž‹I1, ŽR–{‘ĺ•ă1, ‹{â˜aO1, ŒG•”rG1 (1”]ŠO, 2‹~–˝): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723445. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŔ‘S‚Ččň“Ž–ŹƒXƒeƒ“ƒg—Ż’up‚đs‚¤ă‚Ĺ—‰đ‚ˇ‚ׂŤŠOčň“Ž–Ź‚Ě•ŞŠň—lŽŽ. ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj1, ‹{â˜aO1, ’h@@[1, ˆä“‡‘ĺ•ă2, ŹňŠ°”V3, ŒG•”rG1 (1”]ŠO, 2_Œo“ŕ, 3‹~–˝): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723446. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MEPƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚Ż‚é‰A‹ÉŽhŒƒ‚ĚˆÓ‹`. ˛“ĄŸl1, Ź–ěŕV—T–ç2, ‹{â˜aO1, ’h@@[1, ŽR–{‘ĺ•ă1, •“c”Ž‹I1, ŹňŠ°”V3, ŒG•”rG1 (1”]ŠO, 2—ŐŒŸ•”, 3‹~–˝): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723447. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –{–M‰‚̍ŐV3D_Œo“ŕŽ‹‹žƒVƒXƒeƒ€ (Visionsense): Exoscope Neurosurgery‚ĚŒťó‚Ć“W–]. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹ (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723448. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰”­äP‰čŽî‚É‚¨‚Ż‚éƒMƒŠƒAƒfƒ‹—Ż’u—pÜ‚ĚŽĄ—ĂŒř‰Ę‚ɂ‚˘‚ā|7‘ĺŠw‚É‚¨‚Ż‚é‘˝Ž{Ý‹¤“ŻŒ¤‹†|. ‰€“c‡•F, ź“cŒ›ˆę˜N, Ö“Ą—ł‘ž, ě‘ë’q”V, Ź“cłĆ, ˛“Ą—Yˆę, ’ĺœA_˜a, ŸN“c@, ů“ˆŽő˜Y, •Ę•{‚–ž, ŒG•”rG1, •y‰i’î“ń, –Ř“ŕ”Ž”V, ´…G–ž, ŹŠ}Œ´–Mş, —é–Ř—Ď•Ű (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723449. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒiƒrƒP\ƒVƒ‡ƒ“‰şśŒŸ‚ĹŠm’č‚ł‚ę‚˝Ž‹_ŒoƒAƒXƒyƒ‹ƒMƒ‹ƒX“÷‰čŽî. ‹ß“ĄGŽĄ1, ‹v{”ü^—1, –Ř“‡çq1, ŽRč@“™2, ‰Ş@GG1 (1”]ŠO, 2•a—): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/10/1), •Ÿ‰Ş.

723450. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹: –{–M‰‚̍ŐV3D_Œo“ŕŽ‹‹žƒVƒXƒeƒ€ (Visionsense)|Exoscope Neurosurgery‚ĚŒťó‚Ć“W–]|. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1 (1”]ŠO): ‘ć75‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠwp‘‰ď (2016/9/29-10/1), •Ÿ‰Ş.

723451. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚ŒŒˆłŤŹ”]oŒŒ‚É‚¨‚Ż‚é’´‹}ŤŠú“ŕŽ‹‹ž‰şŒŒŽîœ‹Žp‚Ě—LŒřŤ. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, Ż@‰Ŕ–F3, ŒG•”rG2 (1‹~–˝, 2”]ŠO, 3‰qś): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

723452. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yÇ—á•ń2: …“ޏÇ/ETV2z‘ćŽO”]Žş’ęŠJ‘‹p‚Ş’˜Œř‚ľ‚˝Sylvian aqueductÇŒóŒQ‚đ’ć‚ľ‚˝’†”]”íŠW•”oŒŒ‚Ěˆę—á. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

723453. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yÇ—á•ń7: Š´őE‰ŠÇzƒiƒrƒQ[ƒVƒ‡ƒ“Žx‰‡‰ş‚̐_Œo“ŕŽ‹‹ž‚ĚŽg—p‚É‚ć‚萜ŒŸ‚Ĺ‚Ť‚˝, Ž‹_ŒoŠÇŽüˆÍ‚ĚƒAƒXƒyƒ‹ƒMƒ‹ƒX“÷‰čŽî‚ĚÇ—á. ‹ß“ĄGŽĄ1, ‹v{”ü^—1, ź–{çq1, ‰Ş@GG1 (1”]ŠO): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

723454. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”]ŠO‰ČŽčp‚É‚¨‚Ż‚ép’†‘˘‰eCT‚đ—p‚˘‚˝ú’ĘŽ}‚Ć“Eo”ÍˆÍ‚Ě•`o. ’h@@[1, ‹{â˜aO1, űŒ´Œől1, ŽÄŒ´ˆę—z1, •“c”Ž‹I1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć40‰ń“ú–{”]_ŒoCIŠw‰ď‘‰ď (2017/3/3), Ž­Ž™“‡.

723455. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Indocyanine green videoangiography‚É‚ć‚éSubependymal artery‚Ě—Ő°‰đ–U‚ĚŒŸ“˘. űŒ´Œől1, ‹{â˜aO1, ’h@@[1, ŽÄŒ´ˆę—z1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć40‰ń“ú–{”]_ŒoCIŠw‰ď‘‰ď (2017/3/3), Ž­Ž™“‡.

723456. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠJ“ޏp‚Őś‚ś‚˝–Č•ĐˆâŽc‚ւ̉ńŽűŽčp‚̐Ľ”ń. ´…@ú1, ŒG•”rG1 (1”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2017/3/16), ‘ĺă.

723457. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _ŒoäPŽî“Eop‚Š‚ç–ž‚ç‚Š‚Ć‚Č‚Á‚˝[•”×“Ž–Ź‘š‚É‚ć‚é‹•ŒŒ•”ˆĘ‚Ɛ_ŒoáŠQ. ŒG•”rG (”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2017/3/17), ‘ĺă.

723458. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) CEAŽž‚̐jŒŠoŒŒ‚ɑ΂ˇ‚é”÷‘@ˆŰŤƒRƒ‰[ƒQƒ“‚Ě—L—pŤ. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1 (1”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ď (2017/3/16-19), ‘ĺă.

731089. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚Ä‚ń‚Š‚ńf’f‚ĆŽĄ—Ă. ‰Ş@GG (”]ŠO): UCB Japan Role PlayŒ¤C‰ď (2016/6/2), ŽD–y.

731090. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “ŕŽ‹‹žŽčpVŽž‘ă‚ÉŒü‚Ż‚Ä. ‰Ş@GG (”]ŠO): ‘ć3‰ńWet field‚̉ď (2016/7/1), –źŒĂ‰Ž.

731091. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘¤”]Žş‹ß–TŽîᇂ̎čp‚É•K—v‚Č”÷Ź‰đ–U‚ĆŽŔŰ. ‰Ş@GG (”]ŠO): ‘ć11‰ń’ˇč”]ŽžŠłŒ¤‹†‰ď (2016/7/6), ’ˇč.

731092. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚Ä‚ń‚Š‚ń‚̐f’f‚ĆŽĄ—Ă. ‰Ş@GG (”]ŠO): –ké‹ĘˆăŽt‰ďŠwpu‰‰‰ď (2016/7/12), ‰Á{.

731093. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”]Žîᇂƒ†•ŤŠá‹…‰^“ŽáŠQ‚𒆐S‚Ć‚ľ‚˝Ž‹‹@”\áŠQ‚Ć‚ĚŠÖ˜A. ŒG•”rG (”]ŠO): ‘ć29‰ń‹ß‹E_ŒoŠá‰ČƒZƒ~ƒi[ (2016/7/17), ‘ĺă.

731094. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoäPŽîŽčp: Žčp‡•šÇ”­ś‚đ‚˘‚Š‚É—}‚Ś‚é‚Š. ŒG•”rG (”]ŠO): ‘ć13‰ń_ŒË”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/7/22), _ŒË.

731095. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”]_ŒoŠO‰Č—ĚˆćUP TO DATE. ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO): é‹ĘŒ§‰›”]ŽžŠłu‰‰‰ď (2016/9/7), é‹Ę.

731096. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŠÔˆá‚Á‚˝‚Ä‚ń‚Š‚ńE”F’mÇ‚̐f’fEŽĄ—Ă‚đ‚ľ‚Ä‚˘‚Ü‚š‚ń?|“Á‚ÉŠÔˆá‚˘‚₡‚˘‘Sg‚Ż‚˘‚ę‚ńŽĄ—Â𒆐S‚Ɂ|. ‰Ş@GG (”]ŠO): ‹vŠěŽsŽOŽt‰ďŠwpu‰‰‰ď (2016/11/2), ‹vŠě.

731097. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •a‘Ô‚Š‚猊‚é”]‚̐łí\‘˘. ŒG•”rG (”]ŠO): ‘ć9‰ń‹ŕ‘ň”]ŽîᇃZƒ~ƒi[ (2017/1/28), ‹ŕ‘ň.

732036. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰1)yŠî‘b•Ňz2. Transylvian approach‚Š‚çExtradural temporopolar approach‚Ě‚˝‚ß‚ĚŒŒŠÇ‰đ–U‚ĆƒRƒc. ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

732037. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰2)yŠî‘b•Ňz1. CEA‚É•K—v‚ȉđ–U‚ĆŽŔŰ. ˛“ĄŒör1, ‰Ş@GG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

732038. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰2)yŠî‘b•Ňz3. ‘¤”]ŽşE‘ć3”]Žş‹ß–TŽčp‚Ě‚˝‚ß‚Ě”÷Ź‰đ–U‚ĆƒRƒc. ‹ß“ĄGŽĄ1, ‰Ş@GG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

732039. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ”]ŒŒŠÇ“஡—Ă‚É•K—v‚Č“ŕŒz“Ž–Ź‚̉đ–U. ‹ß“Ą—łŽj (”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

732040. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ’áˆŤŤ“x_ŒoäPŽî‚ɑ΂ˇ‚é‰Â‹y“I“Eop‚Ě‹`. ŒG•”rG (”]ŠO): ‘ć21‰ń”]ŽîᇃŒƒrƒ…[ (2016/6/4), “Œ‹ž.

732041. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) “nq‚Š‚犴‚ś‚é“ú–{‚ĆŠCŠO‚Ěˆă—Ă‚Ěˆá‚˘. ‰Ş@GG (”]ŠO): –k—˘‘ĺŠwƒƒfƒCƒJƒ‹ƒZƒ“ƒ^[Žs–ŻuŔ (2016/12/21), –k–{.

733240. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Ł•”‚Š‚ç‘OŇ‘“Ž–Ź‚Ş‹NŽn‚ľ‚Ä‚˘‚˝”j—ô’ōœ“Ž–Ź‰đ—Ł‚ɑ΂ľ‚Ä, ŒŒŠÇ“஡—Ă‚Ć’ź’BŽčp‚É‚ć‚荪ŽĄ‚đ“ž‚˝1—á. ‹{â˜aO1, ‹ß“Ą—łŽj1, ’h@@[1, ‹TŽRšK1, ˆ˘•”Ž’q1, ŽR–{‘ĺ•ă1, ŹňŠ°”V2, ˛“ĄŸl1, ŒG•”rG1, ŹŠ}Œ´–Mş (1”]ŠO, 2‹~–˝): ‘ć129‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2016/4/2), “Œ‹ž.

733241. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˝”­ŤůNó”j—ôŒă‰şŹ”]“Ž–ŹáŽ‚Ě1—á. ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj1, ŹňŠ°”V2, ‹{â˜aO1, ’h@@[1, ˆ˘•”Ž’q1, ŒG•”rG1, ´…G–ž (1”]ŠO, 2‹~–˝): ‘ć129‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2016/4/2), “Œ‹ž.

733242. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “ŞŠWŒz’ĹˆÚs•”‚Ö‚Ě”dŽíÄ”­•a•Ď‚ɑ΂ľ‚Ä‰ć‘œă‘S“E‚đs‚Á‚˝‘¤“Ş—täP‰čŽîÇ—á. űŒ´Œől1, ‹{â˜aO1, ’h@@[1, ‘ĺ‰z—Tl, ŽÄŒ´ˆę—z1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć132‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2016/4/8), “Œ‹ž.

733243. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠO‘¤Œă“މşƒAƒvƒ[ƒ`‚É‚¨‚Ż‚ébridged craniotomy•Ď–@. ´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŠÖŒű•üŽq1, ŒG•”rG1 (1”]ŠO): ‘ć10‰ń“ú–{Ž—e”]_ŒoŠO‰ČŒ¤‹†‰ď (2016/4/15), ŽR—œ.

733244. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‚ˆĘčň’Ő‘–ŒŽî‚Ě“Eop‚É‚ć‚艓Šu•”‚Ě’Ĺœ“Ž–Ź‚ɉźŤ“Ž–ŹáŽ‚𐜂ś‚˝1—á. ´…@ú1, ŹňŠ°”V2, ŽR“c@Ÿ1, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

733245. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ăˆĘčň’ł̐ҒŒŠÇ• ‘¤•”ŽîᇂɊ֘A‚ˇ‚éanterior internal vertebral venous plexus ‚Ćanterior meningeal artery‚ĚŽčp‰đ–U. ´…@ú1, ‘ĺŕVŹ”V1, –]ŒŽ’O, ŠÖŒű•üŽq1, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

733246. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ň‘‘“ŕŽîᇎčp‚É‚¨‚Ż‚éŇ‘‘O•ű‚Ě”÷ŹŠO‰Č‰đ–U. ŽOˆäŒö•F1, ´…@ú1, ŽO“‡‘ĺ“ż, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

733247. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) d–Œ“ŽĂ–Źá‘‚ĚŽĄ—Ă‚É•K—v‚ČŠC–ȐÖŹ“´ŽüˆÍ‚Ě”÷Ź‰đ–U. ‹ß“Ą—łŽj1, ŽR–{‘ĺ•ă1, ‹{â˜aO1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2016/4/23), “Œ‹ž.

733248. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”]ŒŒŠÇ“஡—ĂŒă‚̍RŒŒŹ”—Ö@`Ž_•Ş”ĺ—}§–ň‚ĚˆĘ’u•t‚Ż`. ‹ß“Ą—łŽj (”]ŠO): ‘ć13‰ńNPO–@l“ú–{”]_ŒoŒŒŠÇ“஡—ĂŠw‰ďŠÖ“Œ’n•ű‰ď (2016/7/9), “Œ‹ž.

733249. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Atypical choroid plexus papilloma‚Ěˆę—á. ŒG•”rG1, ’h@@[1, ‹{â˜aO1, űŒ´Œől1, ŽÄŒ´ˆę—z1, Ź–ěŕV—T–ç2, Ô‰H“Ö–ç (1”]ŠO, 2—ŐŒŸ•”): ‘ć11‰ńŠÖ“ŒŹŽ™”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/7/30), “Œ‹ž.

733250. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠC–ȐÖŹ“´•”d–Œ“ŽĂ–Źá‘‚Ěretorograde leptomeningeal venous drainage. ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj1, ‹{â˜aO1, ’h@@[1, ‹“‡‘ĺ•ă, ŹňŠ°”V2, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć130‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2016/9/17), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723015. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Indocyanine green videoangiography‚É‚ć‚éSubependymal artery‚Ě—Ő°‰đ–U‚ĚŒŸ“˘. űŒ´Œől1, ‹{â˜aO1, ’h@@[1, ŽÄŒ´ˆę—z1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć40‰ń“ú–{”]_ŒoCIŠw‰ď‘‰ď (2016/3/3), Ž­Ž™“‡.

H27-723016. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”]ŠO‰ČŽčp‚É‚¨‚Ż‚ép’†‘˘‰eCT‚đ—p‚˘‚˝ú’ĘŽ}‚Ć“Eo”ÍˆÍ‚Ě•`o. ’h@@[1, ‹{â˜aO1, űŒ´Œől1, ŽÄŒ´ˆę—z1, •“c”Ž‹I1, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO): ‘ć40‰ń“ú–{”]_ŒoCIŠw‰ď‘‰ď (2016/3/3), Ž­Ž™“‡.

H27-723017. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Susceptibility-weighted imaging‚Ş—L—p‚Ĺ‚ ‚Á‚˝ŒÇ—§Ť”玿Ă–ŹŒŒđÇ‚Ěˆę—á. ‹ß“ĄGŽĄ1, ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO): ‘ć40‰ń“ú–{”]_ŒoCIŠw‰ď‘‰ď (2016/3/3), Ž­Ž™“‡.

H27-723018. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”j—ô”]“Ž–ŹáŽƒNƒŠƒbƒsƒ“ƒOpŒă‚ÉŠ{‰ş‘BŽî’Ż‚É‚ć‚é‹C“š‹ˇó‚đ—ˆ‚ľ‚˝1—á. ŹňŠ°”V1, ŒG•”rG2 (1‹~–˝, 2”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2016/3/16), ‘ĺă.

H27-723019. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠJ“ޏp‚Őś‚ś‚˝–Č•ĐˆâŽc‚ւ̉ńŽűŽčp‚̐Ľ”ń. ´…@ú1, ŒG•”rG1 (1”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2016/3/16), ‘ĺă.

H27-723020. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) _ŒoäPŽî“Eo‚Š‚ç–ž‚ç‚Š‚Ć‚Č‚Á‚˝[•”×“Ž–Ź”j‘š‚É‚ć‚é‹•ŒŒ•”ˆĘ‚Ɛ_ŒoáŠQ. ŒG•”rG (”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2016/3/17), ‘ĺă.

H27-733005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”j—ô”]“Ž–ŹáŽƒNƒŠƒbƒsƒ“ƒOpŒă‚ÉŠ{‰ş‘BŽî’Ż‚É‚ć‚é‹C“š‹ˇó‚đ—ˆ‚ľ‚˝1—á. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, ‹ß“Ą—łŽj2, ŒG•”rG2 (1‹~–˝, 2”]ŠO): ‘ć26‰ń_“ސě”]_ŒoŠO‰ČŽčpŽč‹ZŒ¤‹†‰ď (2016/1/7), ‰Ą•l.

H27-733006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Non-Vitamin K Antagonist Oral Anticoagulant (NOACs) “ŕ•žŠłŽŇ‚É‚¨‚Ż‚é“ŞŠW“ŕoŒŒ‚Ě“Á’Ľ. ‹ß“Ą—łŽj1, ŒG•”rG1, ˆä“‡‘ĺ•ă2, źŽR˜a—˜2 (1”]ŠO, 2_Œo“ŕ): ‘ć27‰ń_“ސěStroke Forum (2016/3/11), ‰Ą•l.


ŹŽ™‰ČŠw

[Šwp˜_•ś]

110201. [Œ´’˜] Natural history of immediate-type hen's egg allergy in Japanese children. Ohtani K1-3, Sato S3, Syukuya A4, Asaumi T3, Ogura K3, Koike Y5, Iikura K3, Yanagida N3, Imai T3,6, Ebisawa M3: Allergol Int 2016/4; 65 (2): 153-7. (‘ĺ’J´F1-3: 1ŹŽ™, 2‘Š–ÍŒ´‹Ś“Ż•a‰@, 3‘—§‘Š–ÍŒ´•a‰@, 4‚Ó‚˝‚΂ą‚Ç‚ŕƒNƒŠƒjƒbƒN, 5’ˇ–ěŒ§—§‚ą‚Ç‚ŕ•a‰@, 6ş˜a‘ĺŠw)

110202. [Œ´’˜] Interictal high-frequency oscillations generated by seizure onset and eloquent areas may be differentially coupled with different slow waves. Nonoda Y1, Miyakoshi M2, Ojeda A2, Makeig S2, Csaba Juh‡sz3, Sood S4, Asano E3: Clin Neurophysiol 2016/6; 127 (6): 2489-99. (–ěX“c–L1: 1ŹŽ™, 2ƒJƒ‹ƒtƒHƒ‹ƒjƒA‘ĺŠwƒTƒ“ƒfƒBƒGƒSZ, 3ƒ~ƒVƒKƒ“ŹŽ™•a‰@ŹŽ™_Œo‰Č, 4ƒ~ƒVƒKƒ“ŹŽ™•a‰@_Œo‰Č)

110203. [Œ´’˜] Changes in Neonatal Microbiota Distribution Influenced by the Environment of the Neonatal Intensive Care Unit in the First Month of Life. Ooka M1, Ito T2, Kitsunezaki M1, Nomoto K3, Bando Y1,4, Ishii M1: J Neonatal Biol 2016/5; 5 (2): 222. doi:10.4172/2167-0897.1000222. (‘剪–ƒ—1, ŒĎ’ˉëŽq1, –ěŒł‚Ż‚˘Žq3, â“Œ—R‹I1,4, Îˆäł_1: 1ŹŽ™, 2–k—˘Œ¤‹†Š, 3•a‘́Ef—ĂŒn, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

110204. [Œ´’˜] Timing of Haemophilus influenzae type b vaccination after cardiac surgery. Takanashi M1, Ogata S1, Honda T1, Nomoto K2, Mineo E1, Kitagawa A1, Ando H1, Kimura S1, Nakahata Y3, Oka N4, Miyaji K5, Ishii M1: Pediatr Int 2016/8; 58 (8): 691-7. (‚—œ@Šw1, •űš•˝1, –{“c@’1, –ěŒł‚Ż‚˘Žq2, •ô”öŒb—œ1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ’†”¨–퐜3, ‰Ş@“ż•F4, ‹{’n@ŠÓ5, Îˆäł_1 (1ŹŽ™, 2•a‘́Ef—ĂŒn, 3“Ą–ě‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN, 4˜a‰ĚŽRŒ§—§ˆă‰Č‘ĺŠw, 5S‘ŸŒŒŠÇŠO‰Č)

110205. [Œ´’˜] Contributions of Respiration and Heartbeat to the Pulmonary Blood Flow in the Fontan Circulation. Honda T1, Itatani K2, Takanashi M1, Kitagawa A1, Ando H1, Kimura S1, Nakahata Y3, Oka N4, Miyaji K5, Ishii M1: Ann Thorac Surg 2016/11; 102 (5): 1596-606. (–{“c@’1, ”Â’JŒcˆę2, ‚—œ@Šw1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ’†”¨–퐜3, ‰Ş@“ż•F4, ‹{’n@ŠÓ5, Îˆäł_1 (1ŹŽ™, 2‹ž“s•{—§ˆă‰Č‘ĺŠw, 3“Ą–ě‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN, 4˜a‰ĚŽRŒ§—§ˆă‰Č‘ĺŠw, 5S‘ŸŒŒŠÇŠO‰Č)

110206. [Œ´’˜] Topiramate Blood Levels During Polytherapy for Epilepsy in Children. Toki T1, Iwasaki T1, Ishii M1: Am J Ther 2016 Nov 14. [Epub ahead of print] (“yŠň@•˝1, Šâčr”V1, Îˆäł_1: 1ŹŽ™)

120010. [Œ´’˜] “–‰@‚ĹŒoŒą‚ľ‚˝‰Ć‘°Ť’n’†ŠC”M”ń“TŒ^—á‚̏ŹŽ™2—á. ‘ĺ’J´F1,2, ˆîŠ_@“ľ1,2 (1ŹŽ™, 2‘Š–ÍŒ´‹Ś“Ż•a‰@): ŹŽ™Š´ő–Ɖu 2016/11; 28 (4): 271-7.

310025. [Ç—á•ń] Fetal arrhythmogenic right ventricular cardiomyopathy with double mutations in TMEM43. Honda T1, Kanai Y2, Ohno S3, Ando H1, Honda M2, Niwano S4, Ishii M1: Pediatr Int 2016/5; 58 (5): 409-11. (–{“c@’1, ‹ŕˆä—Y“ń2, ‘ĺ–쐚Žq3, ˆŔ“Ą@Žő1, –{“c‰ëŽq2, ’ë–ěTˆę3, Îˆäł_1: 1ŹŽ™, 2ŽY‰Č, 3Ž ‰ęˆă‰Č‘ĺŠw, 4zŠÂŠí“ŕ‰Č)

320012. [Ç—á•ń] H•¨‚É‚ć‚éƒAƒiƒtƒBƒ‰ƒLƒV[‚ɑ΂ľ‚ăAƒhƒŒƒiƒŠƒ“ŽŠŒČ’ŽËťÜ‚Ş‘tŒ÷‚ľ‚˝‘̏d15kg–˘–ž‚Ě1’jŽ™—á. ‘ĺ’J´F1,2, “Ą–{‚Ü‚ä1,2, ˆîŠ_@“ľ1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): “ú–{”_‘şˆăŠw‰ďŽGŽ 2016/11; 65 (4): 862-7.

320013. [Ç—á•ń] ŽŠŽE–Ú“I‚ɉ–Ž_ƒWƒtƒFƒ“ƒqƒhƒ‰ƒ~ƒ“‚đ‘ĺ—Ę“ŕ•ž‚ľ‚˝14Î’jŽ™—á. •’ms•ă1, ˆŔ“Ą@Žő1, •ô”öŒb—œ1, ‹ŕŽq’‰O1, Îˆäł_1 (1ŹŽ™): “ú–{ŹŽ™‹~‹}ˆăŠw‰ďŽGŽ 2017/2; 16 (1): 72-5.

320014. [Ç—á•ń] ć“V”~“Ĺ‚Ě3Ç—á. ‰iˇ—T‰ŔŽq1,2, ‚—œ@Šw1,3, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1,3, ‰ĄŠÖ—Sˆę˜Y1,2, ŒĎč‰ëŽq1, çݎ@Šw1, –ě“n‰ë•F4, Îˆäł_1 (1ŹŽ™, 2‘Š–Í–ě•a‰@, 3‘Š–ÍŒ´‹Ś“Ż•a‰@, 4‚ˇ‚­‚ˇ‚­‚ ‚Š‚ż‚á‚ń‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN): “ú–{VśŽ™ŹˆçˆăŠw‰ďŽGŽ 2017/2; 29 (1): 79-84.

[Šw‰ďEŒ¤‹†‰ď“™]

712020. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Update on Kawasaki disease from pathophysiology to mediacal therapy. Ishii M1: 66th KPS (Korean Pediatric Society) Annual Meeting Invitation (2016/11/10), Korea. (Îˆäł_1: 1ŹŽ™)

713074. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Four-Dimensional Magnetic Resonance Imaging (4D-MRI) Flow Energy Loss: New Insight Into Fontan Circulation in Adult Patients. Kitagawa A1, Itatani K2, Takanashi M1, Honda T1, Kimura S1, Miyaji K3, Ishii M1: ACC 2016 - American College of Cardiology (ACC) 65th Annual Scientific Session and Expo (2016/4/1), Chicago, USA. (–kě“ÄŽj1, ”Â’JŒcˆę2, ‚—œ@Šw1, –{“c@’1, –Ř‘şƒl1, ‹{’n@ŠÓ3, Îˆäł_1: 1ŹŽ™, 2‹ž“s•{—§ˆă‰Č‘ĺŠw, 3S‘ŸŒŒŠÇŠO)

713075. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Impact of Left-to-Right Ventricular Shunts on Circulating MicroRNA Expression. Honda T1, Nomoto K2, Kitagawa A1, Mineo E1, Takanashi M1, Ando H1, Kimura S1, Ishii M1: ACC 2016 - American College of Cardiology (ACC) 65th Annual Scientific Session and Expo (2016/4/2), Chicago, USA. (–{“c@’1, –ěŒł‚Ż‚˘Žq2, –kě“ÄŽj1, •ô”öŒb—œ1, ‚—œ@Šw1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, Îˆäł_1: 1ŹŽ™, 2•a‘́Ef—ĂŒn)

713076. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Relationship Between Myocardial Strain Measured by Tagged Magnetic Resonance Imaging, Myocardial Viability, and Serum Biomarkers of Fibrosis in Single Ventricular Morphology Long-Term After Fontan Operation. Kitagawa A1, Takanashi M1, Honda T1, Kimura S1, Miyaji K2, Ishii M1: ACC 2016 - American College of Cardiology (ACC) 65th Annual Scientific Session and Expo (2016/4/2), Chicago, USA. (–kě“ÄŽj1, ‚—œ@Šw1, –{“c@’1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1: 1ŹŽ™, 2SŠO)

713077. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Clinical Utility and Safety of New Strategy for Patients With Refractory Kawasaki Disease: Single Institution Experience. Ebato T1, Ogihara Y1, Ogata S1, Ishii M1: ACC 2016 - American College of Cardiology (ACC) 65th Annual Scientific Session and Expo (2016/4/2), Chicago, USA. (]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1: 1ŹŽ™)

722114. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒCƒ“ƒtƒŠƒLƒVƒ}ƒuŽĄ—Ă‚Ě“K‰ž‚ĆƒƒJƒjƒYƒ€. Îˆäł_ (ŹŽ™): ‘ć52‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2016/7/7), “Œ‹ž.

722115. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “Ťěč•a‚É‚¨‚Ż‚éƒCƒ“ƒtƒŠƒLƒVƒ}ƒu—Ă–@‚Ě•ŞŽqś•¨Šw“IƒƒJƒjƒYƒ€‚¨‚ć‚ŃŽĄ—Ð헪. îŒ´‹`l1,2, ]”gŒËF•ă1, •űš•˝1, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@): ‘ć36‰ń“ú–{ěč•aŠw‰ďŠwpW‰ď (2016/9/30), ‰Ą•l.

723459. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œo‰ß’†SŽşáŽ‚ĆáŽ“ŕŒŒđ‚ĚŒ`Ź‚đ”F‚ß‚˝śŽşS‹Řăk–§‰ťáŠQ‚Ěˆę—á. –Ř‘şƒl1, ˆŔ“Ą@Žő1, –kě“ÄŽj1, –{“c@’1, ‚—œ@Šw1,3, •ô”öŒb—œ1, Žs“c•™Žq2, Îˆäł_1 (1ŹŽ™, 2•xŽR‘ĺŠwˆăŠw•”ŹŽ™‰Č, 3‘Š–ÍŒ´‹Ś“Ż•a‰@): ‘ć27‰ń“ú–{SƒGƒR[}Šw‰ďŠwpW‰ď (2016/4/23), ‘ĺă.

723460. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒtƒ@ƒ[Žl’ĽÇpŒă‚ĚŠŽ‘S‰E‹rƒuƒƒbƒN‚ޏpŒă‰“ŠuŠú‚É‹y‚Ú‚ˇ‰e‹ż: S‘ŸMRI‚É‚ć‚錟“˘. –kě“ÄŽj1, •ô”öŒb—œ1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2SŠO): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/13), ŽD–y, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ 2016/5; 120 (2): 225

723461. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NICUƒxƒbƒh‚Ě—LŒřŠˆ—p‚đ–ÚŽw‚ľ‚˝Žć‚č‘g‚Ý. çݎ@Šw1, ‰ĄŠÖ—Sˆę˜Y1, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ŒĎč‰ëŽq1, Îˆäł_1 (1ŹŽ™): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/13), ŽD–y.

723462. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰‰ńŽĄ—Ă‚Ć‚ľ‚ăCƒ“ƒtƒŠƒVƒLƒ}ƒu—Ă–@‚đŽ{s‚ľ‚˝ěč•a2Ç—á. îŒ´‹`l1,2, •űš•˝1, ]”gŒËF•ă1, –{“c@’1, źŽ}GŽ2, Â–؍N”V2, ˛“Ą‰Á‘ăŽq1,2, ě‘ş“N•v2, –Ľ‰YŽ‘Ľ1,2, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/13), ŽD–y.

723463. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œy”÷‚ČŽĺ—vÇó‚Ě‚˝‚ߌŠ“Ś‚ł‚ę‚˝ŠĽ“Ž–ŹáŽ‡•š•s‘SŒ^ěč•a3ƒPŒŽ’jŽ™—á. ]”gŒËF•ă1, îŒ´‹`l1,2, •űš•˝1, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/13), ŽD–y.

723464. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ěč•a–ƉuƒOƒƒuƒŠƒ“•s‰ž—\‘ŞŒQ‚ɑ΂ˇ‚鏉‰ńƒXƒeƒƒCƒhƒpƒ‹ƒX•š—p—Ă–@‚Ě’ˇŠúŒo‰ß. •űš•˝1, ]”gŒËF•ă1, îŒ´‹`l1, Îˆäł_1 (1ŹŽ™): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/14), ŽD–y.

723465. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒJ‚č•Ô‚ˇ”x‰Š‹…‹ŰŠ´őÇ‚Š‚çf’f‚ł‚ę‚˝ć“VŤ•â‘̐Ź•ŞC2Œ‡‘šÇ—á. îŒ´‹`l1,2, â“Œ—R‹I1,3, ]”gŒËF•ă1, •űš•˝1, –Ľ‰YŽ‘Ľ1, Ąˆäk•ă4, X”ö—FG4, –k–ě‰xŽq5, –k‘ş@Š]5, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4“Œ‹žˆă‰ČŽ•‰Č‘ĺŠw, 5_ŒËí”Ő‘ĺŠw•ŰŒ’‰ČŠw•”ˆă—ĂŒŸ¸Šw‰Č): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/14), ŽD–y.

723466. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”DPŒăŠú‚É‚¨‚Ż‚鏬Ž™ƒAƒŒƒ‹ƒM[ŽžŠł‚ÉŠÖ‚ˇ‚éˆÓŽŻ’˛¸. ‘ĺ’J´F1,2, ˆîŠ_@“ľ1,2, ‚—œ@Šw1,2, źě‹ĹŽq1,2, ‰ĄŠÖ—Sˆę˜Y1,2, ’†‘şM–ç1,2 (1ŹŽ™, 2‘Š–ÍŒ´‹Ś“Ż•a‰@): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/14), ŽD–y.

723467. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠwZŒŸf‚đŒ_‹@‚É”­ŒŠ‚ł‚ę‚˝Žá”NŤƒlƒtƒƒ“ᔂĚ2Ç—á. Š@L–ç1,2, ’†‘şM–ç1,3, źě‹ĹŽq1,3, Šâ”g’ź”ü4, ‘ĺŒF_]5, Žç‰Žr‰î6, ‰Íź‹Iş7, Îˆäł_1 (1ŹŽ™, 2‹~–˝, 3‘Š–ÍŒ´‹Ś“Ż•a‰@, 4‘Š“ěƒLƒbƒYƒNƒŠƒjƒbƒN, 5‰z–쏬Ž™‰Č, 6Ă“ěƒLƒbƒYƒNƒŠƒjƒbƒN, 7Â—t‚Ě‹u): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/14), ŽD–y.

723468. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽvtŠú‚É’áƒSƒiƒhƒgƒƒsƒ“ŤŤ‘B‹@”\’ቺÇ‚đŒ_‹@‚ɐf’f‚ľ‚˝Sox2ˆâ“`ŽqˆŮí‚Ě1’jŽ™—á. Î“c—Ď–ç, ź‰YM•v, ”’ˆä”Ž”V, Îˆäł_1 (1ŹŽ™): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/14) ŽD–y.

723469. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ďŠ‡ˆă—Ч“x‰ş‚Ĺ‚Ě”N’ˇěč•aŽ™‚ɑ΂ˇ‚é–ƉuƒOƒƒuƒŠƒ“—Ă–@‚Ě–â‘č“_. Ž–ě@Žő1, •űš•˝1, ]”gŒËF•ă1, îŒ´‹`l1,2, Źă—T‰ŔŽq1,3, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@, 3‘Š–Í–ě•a‰@): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/15), ŽD–y.

723470. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠwZŒŸf‚Ĺ”­ŒŠ‚ł‚ę‚˝ŠO‰Č“I‰î“ü‚đ•K—v‚Ć‚ľ‚˝ć“VŤSŽžŠłÇ—á. –Ř‘şƒl1, ˆŔ“Ą@Žő1, –kě“ÄŽj1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, Îˆäł_1 (1ŹŽ™): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/15), ŽD–y.

723471. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŠÇÇó‚đŽŚ‚ł‚¸‹}Œƒ‚ČŒÄ‹z•s‘S‚đ’ć‚ľ‚˝JAK3Œ‡‘šÇ‚Ě1“űŽ™—á. ě“cF‘ž1, ]”gŒËF•ă1, îŒ´‹`l1,2, â“Œ—R‹I1,3, ˆŔ“Ą@Žő1, •űš•˝1, Îˆäł_1, ‹ŕŒ“O˜a4, Ąˆäk•ă4, X”ö—FG4 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4“Œ‹žˆă‰ČŽ•‰Č‘ĺŠwˆăŠw•”•t‘Ž•a‰@): ‘ć119‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2016/5/15), ŽD–y.

723472. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) AlportÇŒóŒQ‚ÉIgAtÇ‚đ‡•š‚ľ‚˝1Ç—á. Š@L–ç1,2, ’†‘şM–ç1,3, źě‹ĹŽq1,3, Šâ”g’ź”ü4, ‘ĺŒF_]5, Žç‰Žr‰î6, ‰Íź‹Iş7, Îˆäł_1 (1ŹŽ™, 2‹~–˝, 3‘Š–ÍŒ´‹Ś“Ż•a‰@, 4‘Š“ěƒLƒbƒYƒNƒŠƒjƒbƒN, 5‰z–쏬Ž™‰Č, 6Ă“ěƒLƒbƒYƒNƒŠƒjƒbƒN, 7Â—t‚Ě‹u): ‘ć51‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ďŠwpW‰ď (2016/7/7), ˆ¤’m.

723473. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}Ť‘ƒó×‹ŰŤt‰Š‚ɍ‡•š‚ľ‚˝ŠĽ“Ž–Ź•a•Ď‚Ě1—á. źě‹ĹŽq1,2, ‚—œ@Šw1,2, ˆîŠ_@“ľ1,2, Š@L–ç1,3, ‰ĄŠÖ—Sˆę˜Y1,2, ‘ĺ’J´F1,2, –Ř‘şƒl1, ’†‘şM–ç1,2, Îˆäł_1 (1ŹŽ™, 2‘Š–ÍŒ´‹Ś“Ż•a‰@, 3‹~–˝): ‘ć51‰ń“ú–{ŹŽ™t‘Ÿ•aŠw‰ďŠwpW‰ď (2016/7/8), ˆ¤’m.

723474. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) —ź‰şŽˆ‚̋ؗ͒ቺ‚đŽĺ‘i‚ÉŽóf‚ľ, f’f‚É“ďa‚ľ‚˝—cŽ™—á. ě“cF‘ž1, ě‘ş“TŽq1, Š@L–ç1,2, ‹ŕŽq’‰O1, ˆŔ“Ą@Žő1, Îˆäł_1 (1ŹŽ™, 2‹~–˝): ‘ć30‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2016/7/2), ĺ‘ä.

723475. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆÓŽŻ•Ď—e‚đ—ˆ‚ľ, f’f‚É“ďa‚ľ‚˝ƒWƒtƒFƒ“ƒqƒhƒ‰ƒ~ƒ“’†“Ĺ‚Ě1—á. •’mr•ă1, ˆŔ“Ą@Žő1, •ô”öŒb—œ1, Îˆäł_1 (1ŹŽ™): ‘ć30‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2016/7/2), ĺ‘ä.

723476. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 4D-MRI‚đ—p‚˘‚ĉ𖞂ˇ‚éƒtƒHƒ“ƒ^ƒ“zŠÂ‚̐V‚˝‚Č’mŒŠ. –kě“ÄŽj1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2SŠO): ‘ć52‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2016/7/6), “Œ‹ž.

723477. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Tracking of tricuspid annular displacement‚đ—p‚˘‚˝‰EŽşŽűk”\•]‰ż: ŽOŽŸŒł’´‰š”g‚Ć‚Ě”äŠrŒŸ“˘. –Ř‘şƒl1, ˆŔ“Ą@Žő1, –kě“ÄŽj1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, Îˆäł_1 (1ŹŽ™): ‘ć52‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2016/7/7), “Œ‹ž.

723478. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠĽ“ŽĂ–Źá‘‚đAmplatzer Vascular Plug‚Ĺ•Â˝‚ľ‚˝1—á. ‚—œ@Šw1, –Ř‘şƒl1, •ô”öŒb—œ1, –{“c@’1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, •x“c@‰p2, Îˆäł_1 (1ŹŽ™, 2ş˜a‘ĺŠw‰Ą•lŽs–k•”•a‰@): ‘ć52‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2016/7/8), “Œ‹ž.

723479. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) NICU“ü‰@Ž™‚Ö‚ĚƒV[ƒgŒ^‘̐U“ŽŒv‚ĚŽg—pŒoŒą. çݎ@Šw1, ˆäă’qŽq2, ‘剪–ƒ—1, HŽR˜a­1, ŒĎč‰ëŽq1, Îˆäł_1 (1ŹŽ™, 2ƒpƒ‰ƒ}ƒEƒ“ƒgƒxƒbƒh‡–°Œ¤‹†Š): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/17), •xŽR.

723480. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 14”ԐőF‘Ě•ƒŤ•ĐeŤƒ_ƒCƒ\ƒ~[‚Ě2Ç—á. •’ms•ă1, HŽR˜a­1, ŽRŒűˆť”T1, ‘剪–ƒ—1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, `Œ’ˆę˜Y3, çݎ@Šw1, ‚“cŽj’j2, Îˆäł_1 (1ŹŽ™, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č—Տ°ˆâ“`Šw, 3‘—§Źˆçˆă—ĂŒ¤‹†ƒZƒ“ƒ^[): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/17), •xŽR.

723481. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ä`“÷‰čŽí‚ɑ΂ˇ‚éƒXƒeƒƒCƒhŠO—p–ň‚ĚŽĄ—Âɂ‚˘‚ā|“–‰@‚Ĺ‚ĚŒŸ“˘|. ‰ĄŠÖ—Sˆę˜Y1, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ŒĎč‰ëŽq1, çݎ@Šw1, Îˆäł_1 (1ŹŽ™): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/18), •xŽR.

723482. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚ĹŒoŒą‚ľ‚˝–˘Žóf”D•w‹y‚ŃŽ™‚Ě“Á’Ľ. ŽRŒűˆť”T1, çݎ@Šw1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, Îˆäł_1 (1ŹŽ™): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/18), •xŽR.

723483. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ěč•a‚Ć‚ľ‚úŽĄ—Ă‚ł‚ę‚Č‚Ş‚çĹIf’f‚ŞˆŮ‚Č‚Á‚˝ŽŠŒą—á‚ĚŒŸ“˘. Ž–ě@Žő1, •űš•˝1, ]”gŒËF•ă1, îŒ´‹`l1,2, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@): ‘ć36‰ń“ú–{ěč•aŠw‰ďŠwpW‰ď (2016/9/30), ‰Ą•l.

723484. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ť”^Ťčň•”ƒŠƒ“ƒpß‰Š‚đ‡•š‚ľ, ŽĄ—Ă‚É“ďa‚ľ‚˝ěč•a‚Ě1—á. •’ms•ă1, îŒ´‹`l1,2, ‹ÚŕV—zŘ1, ‹ŕŽq‰ë‹I1, ě‘ş“TŽq1, ]”gŒËF•ă1, ˆŔ“Ą@Žő1, •űš•˝1, –Ľ‰YŽ‘Ľ1, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@): ‘ć36‰ń“ú–{ěč•aŠw‰ďŠwpW‰ď (2016/9/30), ‰Ą•l.

723485. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ěč•a‚ĚŽŠ‘R–Ɖu‹@\‚̉𖞁`ěč•aImmuno netwaork‰đÍ`. ]”gŒËF•ă1, •űš•˝1, ’|“ŕŒb”üŽq2, –ěŒł‚Ż‚˘Žq3, îŒ´‹`l1,4, Îˆäł_1 (1ŹŽ™, 2–Ɖu, 3•a‘ԁEf—ĂŒn, 4ŠC˜V–ź‘‡•a‰@): ‘ć36‰ń“ú–{ěč•aŠw‰ďŠwpW‰ď (2016/10/1), ‰Ą•l.

723486. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) BiotŒÄ‹z‚ć‚čMERS‚̐f’f‚ÉŽŠ‚Á‚˝ěč•a1’jŽ™—á. ě“cl‘ž1, •űš•˝1, Ž–ě@Žő1, ]”gŒËF•ă1, îŒ´‹`l1,2, Îˆäł_1 (1ŹŽ™, 2ŠC˜V–ź‘‡•a‰@): ‘ć36‰ń“ú–{ěč•aŠw‰ďŠwpW‰ď (2016/10/1), ‰Ą•l.

723487. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@ŹŽ™‰Č‚É‚¨‚Ż‚éŒÄ‹zŠí“ŕŽ‹‹ž‚ĚŒťó. ‹ŕŽq’‰O1, ă“cN‹v2, ě‘ş“TŽq1, “ě–ě‰3, •Ÿ“‡’‹`4, Œ´@^l5, ”~Œ´@ŽŔ6, Îˆäł_1 (1ŹŽ™, 2‚¤‚Ś‚ž‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN, 3š—ęŽO•űŒ´•a‰@, 4•Ÿ“‡ŹŽ™‰Čˆă‰@, 5‚ą‚Ç‚ŕ‚̍‘‚ą‚Ç‚ŕ‚ĚƒNƒŠƒjƒbƒN, 6‚¤‚ß‚Í‚ç‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN): ‘ć49‰ń“ú–{ŹŽ™ŒÄ‹zŠíŠw‰ď (2016/10/28), •xŽR.

723488. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”sŒŒÇŤ”xÇđÇ‚đ‡•š‚ľ‚˝‰ť”^Ťĺ’°ŠÖß‰Š‚Ě1’jŽ™—á. ě‘ş“TŽq1, ‹ŕŽq’‰O1, ě“cF‘ž1, Š@L–ç1,2, ˆŔ“Ą@Žő1, Îˆäł_1 (1ŹŽ™, 2‹~–˝): ‘ć49‰ń“ú–{ŹŽ™ŒÄ‹zŠíŠw‰ď (2016/10/28), •xŽR.

723489. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NICU“ü‰@Ž™‚ɑ΂ˇ‚éVśŽ™-“űŽ™Á‰ťŠÇƒAƒŒƒ‹ƒM[f’f‚Ě‚˝‚ß‚ĚALST (RŒ´“ÁˆŮ“IƒŠƒ“ƒp‹…ŽhŒƒŽŽŒą) ŒŸ¸‚Ě—L—pŤ‚ĚŒŸ“˘. çݎ@Šw1, HŽR˜a­1, ŽRŒűˆť”T1, ‘剪–ƒ—1, ‰ĄŠÖ—Sˆę˜Y1, Îˆäł_1 (1ŹŽ™): ‘ć61‰ń“ú–{VśŽ™ŹˆçˆăŠw‰ďEŠwpW‰ď (2016/12/1), ‘ĺă.

723490. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —AŒŒŠÖ˜A‰óŽ€Ť’°‰Š (TANEC) ‚ƍl‚Ś‚ç‚ę‚˝1—á. ‘剪–ƒ—1, çݎ@Šw1, ŽRŒűˆť”T1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, Îˆäł_1 (1ŹŽ™): ‘ć61‰ń“ú–{VśŽ™ŹˆçˆăŠw‰ďEŠwpW‰ď (2016/12/2), ‘ĺă.

723491. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ośŽž‚ɏd“x‚Ě‹C“š‹ˇó‚đ”F‚ß‚˝Cerebro-costo-mandibularÇŒóŒQ (CCMS) ‚ĚVLBW‘o‘Ů—á. ‹´–{‰č‹v”ü1, çݎ@Šw1, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, Îˆäł_1 (1ŹŽ™): ‘ć61‰ń“ú–{VśŽ™ŹˆçˆăŠw‰ďEŠwpW‰ď (2016/12/2), ‘ĺă.

723492. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) d“Ä‚ČŒo‰ß‚đ‚˝‚Ç‚Á‚˝, ć“VŤŠĚ‰čŽî‚Ě1—á. ź“cŽŽj1, ŒĎč‰ëŽq1, Źă—T‰ŔŽq1,2, Š`Œ´@’m3, HŽR˜a­1,4, •“cŒ›Žq3, çݎ@Šw1, “c’†@Œ‰5, Îˆäł_1 (1ŹŽ™, 2‘Š–Í–ě•a‰@, 3ŠO‰Č, 4‘Š–ÍŒ´‹Ś“Ż•a‰@, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć58‰ń“ú–{ŹŽ™ŒŒ‰tE‚Ş‚ńŠw‰ďŠwpW‰ď (2016/12/17), “Œ‹ž.

723493. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”x“Ž–Ź•Ů•Â˝•s‘SÇ‚ɑ΂ˇ‚é”x“Ž–Ź•Ů’uŠˇp‚̐S‹@”\‚É—^‚Ś‚é‰e‹ż. –kě“ÄŽj1, –Ř‘şƒl1, ˆŔ“Ą@Žő1, ™–{Wˆę2, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2SŠO): ‘ć19‰ń“ú–{Źlć“VŤSŽžŠłŠw‰ď‘‰ďEŠwpW‰ď (2017/1/15), ŽOd.

723494. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‘fŢ‚ĚƒRƒCƒ‹‚đ—p‚˘‚Ä‘¤•›ŒŒs˜H‚ɃRƒCƒ‹Çđp‚đŽ{s‚ľ‚˝6—á‚Ě—Ő°ŒŸ“˘. ‚—œ@Šw1, –Ř‘şƒl1, •ô”öŒb—œ1, –{“c@’1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, •x“c@‰p2, Îˆäł_1 (1ŹŽ™, 2ş˜a‘ĺŠw‰Ą•lŽs–k•”•a‰@): ‘ć28‰ń“ú–{Pediatric Interventional CardiologyŠw‰ďŠwpW‰ď (2017/1/26), “Œ‹ž.

731098. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŽ™‚ĚŽžŠł‚đl‚Ś‚é`ŹŽ™‚̍‚Ž‰ŒŒÇ, “œ”A•a‚ĚŽŔŰ`. Îˆäł_ (ŹŽ™): ŹŽ™‚ĚŽžŠł‚đl‚Ś‚é‰ď (2016/4/13), ‘Š–ÍŒ´.

731099. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ěč•a‹}ŤŠú‚É‚¨‚Ż‚éŒř‰Ę“IŽĄ—Ă‚Ć‚ť‚ĚƒƒJƒjƒYƒ€. Îˆäł_ (ŹŽ™): ‘ć18‰ń“Ą“c•ŰŒ’‰qś‘ĺŠwˆăŠw•”ŹŽ™‰ČŒăŠúŒ¤CƒZƒ~ƒi[ (2016/7/9), –źŒĂ‰Ž.

731100. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žq‚Ç‚ŕ‚Ě‚Ä‚ń‚Š‚ń‚đ‚ŕ‚Á‚Ć’m‚ë!`”­ě‚Ě‹@˜E‰e‹żE‘Ήž‚ɂ‚˘‚ā`. Šâčr”V (ŹŽ™): •˝Ź28”N“xŹŽ™–Ť“Á’ču‰‰‰ď (2016/10/21), Œú–Ř.

731101. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ěč•a‹}ŤŠú‚ĚŒř‰Ę“IŽĄ—Ă‚Ć‚ť‚ĚƒƒJƒjƒYƒ€. Îˆäł_ (ŹŽ™): ‘ć31‰ń˜a‰ĚŽRěč•aŒ¤‹†‰ď (2016/12/3), ˜a‰ĚŽR.

731102. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ěč•a‹}ŤŠú‚̊ӕʐf’f: Œř‰Ę“I‹}ŤŠúŽĄ—Ă‚đ‘I‘đ‚ˇ‚é‚˝‚ß. Îˆäł_ (ŹŽ™): ‘ć3‰ń‚ł‚Ę‚Ťěč•a§˜b‰ď (2017/1/19), ě.

732042. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľżu‰‰) ŹŽ™‚Ä‚ń‚Š‚ń‚Ě•a‘Ô‚ĆĹVŽĄ—Ă. Šâčr”V (ŹŽ™): VŠƒ–ň‰Č‘ĺŠw•˝Ź28”N“x–ňÜŽtśŠU‹łˆçuŔƒvƒƒOƒ‰ƒ€ (2016/4/16), VŠƒ.

733251. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •Ű‘ś“IŽĄ—Ă‚ĹŒy‰ő‚ľ‚˝H‰aŤƒCƒŒƒEƒX‚Ě12Î’jŽ™—á. Î“c—Ď–ç, ”’ˆäGK1, ź‰YM•v, r–Řˆę•ş‘ž2, ‘O“c—TŽŸ, â–{‚˘‚¸‚Ý, ‘ĺ’J„ł, ź@’źŽq, ŽRč‰ë•F, Š`Œ´@’m2, •“cŒ›Žq2, “c’†@Œ‰3, Îˆäł_1 (1ŹŽ™, 2ŠO‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć340‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď (2016/4/16), ‰Ą•l.

733252. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) DravetÇŒóŒQŽĄ—Ă’†‚Ě–°‹C‚â‚Ó‚ç‚‚Ť‚ĚŒ´ˆö–ňÜ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Šâčr”V1,2, –ěX“c–L1,2, “yŠň@•˝1, Î“c—Ď–ç3, ”’ˆäGK1,3, Îˆäł_1 (1ŹŽ™, 2–k—˘‘ĺŠw“Œ•a‰@ŹŽ™Ý‘îŽx‰‡ƒZƒ“ƒ^[, 3‘Š–Í‘ä•a‰@): ‘ć58‰ń_“ސ쏬Ž™_Œo§˜b‰ď (2016/7/23), ‰Ą•l.

733253. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ĺ‹ß2”NŠÔ‚ŐVśŽ™|“űŽ™Á‰ťŠÇƒAƒŒƒ‹ƒM[‚Ɛf’f‚ľ‚˝Ç—á‚Ě—Ő°‘œ|. ŽRŒűˆť”T (ŹŽ™): ‘ć408‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŒŽ—፧˜b‰ď (2016/11/16), ‘Š–ÍŒ´.

733254. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽüŽYŠúˆă—Â̐i•ŕ‚Ć, “–‰@NICU‚Ş‚ą‚ę‚Š‚ç–ÚŽw‚ˇˆă—Ă. çݎ@Šw (ŹŽ™): ‘ć408‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŒŽ—፧˜b‰ď (2016/11/16), ‘Š–ÍŒ´.

733255. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’´“ěč•a‚ɑ΂ˇ‚éƒAƒvƒ[ƒ`: ŠĽ“Ž–ŹáŠQ‚đŽc‚ł‚Č‚Š‚Á‚˝1—á. ]”gŒËF•ă1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć12‰ń_“ŢěŒ§ěč•aŒ¤‹†‰ď (2017/2/25), V‰Ą•l.

733256. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éěč•aÇ—á‚ĚŒŸ“˘. ‚—œ@Šw1,2, źě‹ĹŽq1,2, ˆîŠ_@“ľ1,2, ‰Ą‘q—F—Č1,2, HŽR˜a­1,2, ‘ĺ’J´F1,2, ’†‘şM–ç1,2, Îˆäł_ 1 (1ŹŽ™, 2‘Š–ÍŒ´‹Ś“Ż•a‰@): ‘ć12‰ń_“ŢěŒ§ěč•aŒ¤‹†‰ď (2017/2/25), V‰Ą•l.

733257. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “űŽ™Šú‚É‘Ěd‘‰Á•s—Ç‚Ĺ”­ŒŠ‚ł‚ę‚˝‚CaŒŒÇ‚Ě1—á. ‹´–{‰č‹v”ü1, ‹k“cˆę‹P1, Îˆäł_1 (1ŹŽ™): ‘ć340‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď (2016/4/16), ‰Ą•l.

733258. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ˆÓŠO‚Čó‹ľ‚Ĺ‘˜‹ö‚ľ‚˝ŹŽ™Á‰ťŠíŽžŠł‚Ě2Ç—á. Źă—T‰ŔŽq1,2, ‰ĄŠÖ—Sˆę˜Y1,2, “Ą•‹`l1,2, ĄˆäƒD1,2 (1ŹŽ™, 2‘Š–Í–ě•a‰@): ‘ć402‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŠwpW‰ď (2016/5/25), ‘Š–ÍŒ´.

733259. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰ŠÇ•a‘Ô‚đŽŚ‚ł‚¸ŒÄ‹z•s‘SÇó‚ސis‚ľ‚˝Jak3Œ‡‘šÇƒJƒŠƒj”x‰Š‚Ě“űŽ™—á. ě“cF‘ž1, ]”gŒËF•ă1, ‹ŕŽq’‰O1, ˆŔ“Ą@Žő1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć341‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď (2016/6/11), ‰Ą•l.

733260. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ˆôŒă”^ᇂދ^‚í‚ę‚˝ěč•a‚Ěˆę—Ž™—á. ‹Ú‘ň—zŘ (ŹŽ™): ‘ć403‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŒŽ—፧˜b‰ď (2016/6/15), ‘Š–ÍŒ´.

733261. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŹŽ™W’†ŽĄ—Ă. ˆŔ“Ą@Žő (ŹŽ™): ‘ć403‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŒŽ—፧˜b‰ď (2016/6/15), ‘Š–ÍŒ´.

733262. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒtƒHƒ“ƒ^ƒ“pŒă‰“ŠuŠúÇ—á‚ɑ΂ˇ‚éƒ{ƒZƒ“ƒ^ƒ“‚ĚŽĄ—ĂŒř‰Ę. –kě“ÄŽj (ŹŽ™): ‘ć2‰ń_“ސ쐏lć“VŤS‘Ÿ•aŒ¤‹†‰ď (2016/6/16), ‰Ą•l.

733263. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰ČPICU‚É‚¨‚˘‚Ä1”NŠÔ‚ĹŒoŒą‚ľ‚˝HMPVŠ´őÇ‚Ě“Á’Ľ. ‹ŕŽq‰ë‹I (ŹŽ™): ‘ć10‰ń‘Š–ÍŒ´DRIAOMSu‰‰‰ď (2016/7/5), ’Ź“c.


ŽY‰ČŠw^•wl‰ČŠw

[Šwp˜_•ś]

110207. [Œ´’˜] Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602. Onda T1,2, Satoh T1, Saito T1, Kasamatsu T1, Nakanishi T1, Nakamura K1, Wakabayashi M1, Takehara K1, Saito M1, Ushijima K1, Kobayashi H1, Kawana K1, Yokota H1, Takano M1, Takeshima N1, Watanabe Y1, Yaegashi N1, Konishi I1, Kamura T1, Yoshikawa H1 (1Japan Clinical Oncology Group): Eur J Cancer 2016/9; 64: 22-31. (‰ś“c‹MŽu1,2: 2•wl)

110208. [Œ´’˜] Absence of neonatal intensive care units in secondary medical care zones is an independent risk factor of high perinatal mortality in Japan. Matsumoto Y, Nakai A, Nishijima Y, Kishita E, Hakuno H, Sakoi M, Kusuda S, Unno N1, Tamura M, Fujii T: J Obstet Gynaecol Res 2016/10; 42 (10): 1304-9. (ŠC–ěM–ç1: 1ŽY‰Č)

120011. [Œ´’˜] ‹ß”N‚ĚÄ”­Žq‹{‘ĚŠŕ‚Ě—Ő°•a—Šw“I“Á’Ľ|Ä”­•”ˆĘ‚É‚ć‚é—\Œă‚Ěˆá‚˘|. ŠâŁtŽq1, ˛“ĄG‹M1, Ź–ěd–ž1, Vˆä@“w1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): “ú–{•wl‰ČŽîᇊw‰ďŽGŽ 2016/4; 34 (2): 101-11.

120012. [Œ´’˜] ƒŒƒ~ƒtƒFƒ“ƒ^ƒjƒ‹‚đ—p‚˘‚˝ŒoĂ–Ź“IŠłŽŇŽŠŒČ’˛ß’Á’É–@‚É‚ć‚é–ł’É•Ş•Ř‚Ě•ęŽ™‚ւ̉e‹ż . źŕVW‘ă1, –]ŒŽƒŽq1, ‘吟—fŽq1, ‰Í–ěĆŽq1, “‡‰Ş‹ś1, ŠÖŒű˜aŠé1, ‹ŕˆä—Y“ń1, “úŒür•ă2, ×ěKŠó2, ‰Á“Ą—˘ŠG3, ‰œ•xr”V2, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č, 2–ƒŒ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{ŽüŽYŠúĽVśŽ™ˆăŠw‰ďŽGŽ 2016/9; 52 (3): 836-9.

120013. [Œ´’˜] ŽY•wl‰ČˆăŽtƒŠƒNƒ‹[ƒgŠˆ“Ž‚Ö‚Ěƒqƒ“ƒg”­Œ@ (‘ć1•ń): _“ŢěŒ§“ŕŽ„—§‘ĺŠwˆăŠwś‚Ö‚Ě’˛¸. ŽOăŠ˛’j, M“c­Žq, ŽÄ“cŒ’—Y, –žÎ•q’j, Vˆä@“w1, VˆäłG1, ŒÜ\—’‹, Î–{lŽm, ˆÉ“Ą‚ß‚Ž‚Ţ, ŹěŒöˆę, ĺŒ´G–ç, ő’JŒ’ˆę, ’†‘ň˜a”ü, ’ˇ’ːłW, źˆä@C, •˝’m—Y, ź“‡@—˛, ŽŠŰ‰Ŕ”V, Šp“cV•˝, —é–؁@’ź, ŠC–ěM–ç2, ’†–ěáÁ˛’j, ‚‹´P’j (1•wl, 2ŽY‰Č): “ú–{ˆăŽt‰ďŽGŽ 2017/1; 145 (10): 2155-62.

120014. [Œ´’˜] ŽY•wl‰ČˆăŽtƒŠƒNƒ‹[ƒgŠˆ“Ž‚Ö‚Ěƒqƒ“ƒg”­Œ@ (‘ć2•ń): _“ŢěŒ§“ŕ‰Šú—Տ°Œ¤Cˆă‚Ö‚Ě’˛¸. ŽOăŠ˛’j, M“c­Žq, ŽÄ“cŒ’—Y, –žÎ•q’j, Vˆä@“w1, VˆäłG1, ŒÜ\—’‹, Î–{lŽm, ˆÉ“Ą‚ß‚Ž‚Ţ, ŹěŒöˆę, ĺŒ´G–ç, ő’JŒ’ˆę, ’†‘ň˜a”ü, ’ˇ’ːłW, źˆä@C, •˝’m—Y, ź“‡@—˛, ŽŠŰ‰Ŕ”V, Šp“cV•˝, —é–؁@’ź, ŠC–ěM–ç2, ’†–ěáÁ˛’j, ‚‹´P’j (1•wl, 2ŽY‰Č): “ú–{ˆăŽt‰ďŽGŽ 2017/1; 145 (10): 2163-8.

120015. [Œ´’˜] ŽY•wl‰ČˆăŽtƒŠƒNƒ‹[ƒgŠˆ“Ž‚Ö‚Ěƒqƒ“ƒg”­Œ@ (‘ć3•ń): _“ŢěŒ§“ŕŽY•wl‰ČˆăŽt‚Ö‚Ě’˛¸. ŽOăŠ˛’j, M“c­Žq, ŽÄ“cŒ’—Y, –žÎ•q’j, Vˆä@“w1, VˆäłG1, ŒÜ\—’‹, Î–{lŽm, ˆÉ“Ą‚ß‚Ž‚Ţ, ŹěŒöˆę, ĺŒ´G–ç, ő’JŒ’ˆę, ’†‘ň˜a”ü, ’ˇ’ːłW, źˆä@C, •˝’m—Y, ź“‡@—˛, ŽŠŰ‰Ŕ”V, Šp“cV•˝, —é–؁@’ź, ŠC–ěM–ç2, ’†–ěáÁ˛’j, ‚‹´P’j (1•wl, 2ŽY‰Č): “ú–{ˆăŽt‰ďŽGŽ 2017/2; 145 (11): 2393-400.

120016. [Œ´’˜] •˝Ź27”N“x _“ސěŽY‰Č•wl‰ČŠw‰ď •wl‰ČˆŤŤŽîᇓo˜^WŒv•ń. Ŕč—ߎq1, ™‰Y@ŒŤ1, ‘ĺŒ´@Ž÷1, Vˆä@“w1,2, ‚“c‹ąb1,2, –Ř”ŇvŽœ1, ˛X–؍N1, –Γc”Žs1, •ÄŽR„ˆę1, ‹{é‰xŽq1, ’‡‘ňŒo•v1, —с@NŽq1, •˝ŕV@–Ň1, ŽsŒ´ŽO‹`1, “n粖LŽĄ1, ŽOăŠ˛’j1, ‰Á“Ą‹vˇ1, ’†–ěáÁ˛’j1, ŠC–ěM–ç1,3, ‚‹´P’j1 (1_“ސěŽY‰Č•wl‰ČŠw‰ď•wl‰ČˆŤŤŽîᇑ΍ô•”, 2•wl, 3ŽY‰Č): _“ސěŽY‰Č•wl‰ČŠw‰ďŽ 2017/2; 53 (2): 148-54.

120017. [Œ´’˜] •˝Ź27”N“x _“ŢěŒ§ŽY‰Č•wl‰Čˆă‰ď •wl‰ČˆŤŤŽîᇓo˜^WŒv•ń. Ŕč—ߎq1, ™‰Y@ŒŤ1, ‘ĺŒ´@Ž÷1, ‚“c‹ąb1,2, Vˆä@“w1,2, –Ř”ŇvŽœ1, ˛X–؍N1, –Γc”Žs1, •ÄŽR„ˆę1, ‹{é‰xŽq1, ’‡‘ňŒo•v1, —с@NŽq1, •˝ŕV@–Ň1, ŽsŒ´ŽO‹`1, “n糖LŽĄ1, ’†–ěáÁ˛’j1, ‰Á“Ą‹vˇ1, ŽOăŠ˛’j1, ŠC–ěM–ç1,3, ‚‹´P’j1 (1_“ސěŽY‰Č•wl‰ČŠw‰ď•wl‰ČˆŤŤŽîᇑ΍ô•”, 2•wl, 3ŽY‰Č): _“ސěŽY‰Č•wl‰ČŠw‰ďŽ 2017/2; 53 (2): 203.

310026. [Ç—á•ń] Ultrasonic findings of fetal axillary lymphangioma with intralesional hemorrhage. Furue A1, Mochizuki J1, Onishi Y1, Kawano S1, Kanai Y1, Kemmochi M2, Tanaka K3, Unno N1: J Med Ultrasonics 2015/12; 43 (2): 285-9. (ŒĂ]–žŽq1, –]ŒŽƒŽq1, ‘吟—fŽq1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, çݎ@Šw2, “c’†@Œ‰3, ŠC–ěM–ç1: 1ŽY‰Č, 2ŹŽ™, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

320015. [Ç—á•ń] •Ş•ŘŒă‘ĺ—ʏoŒŒ‚đ‚Ť‚˝‚ľ‚˝Žq‹{“ŽĂ–ŹŠďŒ`‚Ě1—á. ’†‘şŠîŠ°1, ŒĂ]–žŽq1, Šâ’[r•ă2, •ž•”‹żŽq3, ‘ŽR@Ę2, ‹v“ˆ‘Ľs1, Ż“c@—˛3: (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2•wl, 3ŽY‰Č): é‹ĘŽY‰Č•wl‰ČŠw‰ďŽGŽ 2016/5; 46 (1): 15-20.

[’˜@‘]

620093. [Šwp‘ (•Ş’SŽˇ•M)]y—ŤˆăŠwƒKƒCƒhƒuƒbƒN@ŽvtŠúEŤŹnŠú•Ň 2016”N“x”Łz‘ć1Í ŽvtŠú@2 Œ´”­Ť–łŒŽŒo@4. Žq‹{Ť‚Ě–łŒŽŒo, p.40-5. ‹ŕˆä—Y“ń (ŽY‰Č), •Ň: “ú–{—ŤˆăŠwŠw‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713078. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Accuracy of preoperative imaging diagnosis as a possible new staging system in advanced ovarian, tubal, and peritoneal cancer: Using data from Japan Clinical Oncology Group study JCOG0602. Onda T1,2, Tanaka Y1, Ishikawa M1, Hasumi Y1, Kitai S1, Manabe T1, Satoh T1, Saito T1, Kasamatsu T1, Nakanishi T1, Yamamoto K1, Seki H1, Shibata T1, Miyamoto K1, Konishi I1, Yegashi N1, Yoshikawa H1 (1Japan Clinical Oncology Group): 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) (2016/6/3-7), Chicago, USA. (‰ś“c‹MŽu1,2: 2•wl)

713079. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Earthquake and Perinatal Medicine in Japan -Disaster Liaison in Paediatrics and Perinatal Medicine (DLPPM)-. Unno N1, Tsuruwa M, Itoh T, Tsuda N, Nishigaya Y, Hattori K1, Sugawara J, Suzuki M, Nakai A, Wada K, Nakamura T, Masuzaki H: 43rd Annual Meeting of Fetal and Neonatal Physiological Society 2016 (2016/9/20), Cambridge, UK. (ŠC–ěM–ç1, •ž•”‹żŽq1: 1ŽY‰Č)

713080. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Clinico-pathological features of uterine clear cell carcinoma: a single-institution experience. Furukawa S1, Iwase H1, Endo S1, Tazo Y1, Sato H1, Takada T1, Arai M1, Onda T1: 16th Biennial Meeting of the International Gynecologic Cancer Society (2016/10/29), Lisbon, Portugal. (ŒĂěł‹`1, ŠâŁtŽq1, ‰““Ą^ˆę1, “cŽG—L‹I1, ˛“Ą‰p‹M1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1: 1•wl)

713081. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) CLINICAL FEATURES OF RECURRENT ENDOMETRIAL CANCER IN JAPAN-RECURRENT PATTERNS AND PROGNOSIS-. Iwase H1, Furukawa S1, Hirasawa T, Asai S, Ohara T, Hosonuma S, Endo S1, Tazo Y1, Sato H1, Takada T1, Arai M1, Ikeda M, Shida M, Yoshioka N, Tozawa A, Suzuki N, Mikami M, Onda T1: 16th Biennial Meeting of the International Gynecologic Cancer Society (2016/10/29), Lisbon, Portugal. (ŠâŁtŽq1, ŒĂěł‹`1, ‰““Ą^ˆę1, “cŽG—L‹I1, ˛“Ą‰p‹M1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1: 1•wl)

713082. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Immunohistochemical expression of survivin and its splicing variants in endometrial carcinoma. Tazo Y1, Endo S1, Furukawa S1, Sato H1, Takada T1, Arai M1, Iwase H1, Saegusa M2, Onda T1: 16th Biennial Meeting of the International Gynecologic Cancer Society (2016/10/29), Lisbon, Portugal. (“cŽG—L‹I1, ‰““Ą^ˆę1, ŒĂěł‹`1, ˛“Ą‰p‹M1, ‚“c‹ąb1, VˆäłG1, ŠâŁtŽq1, ŽOŽ}@M2, ‰ś“c‹MŽu1: 1•wl, 2•a—)

722116. [Šw‰ď (‘S‘)] (śŠUŒ¤CƒvƒƒOƒ‰ƒ€6)yŔ’ˇzŽ™“ś‹s‘Ň. ŠC–ěM–ç1, ‰Ź“c˜aG (1ŽY‰Č): ‘ć68‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/4/23), “Œ‹ž.

722117. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) —‘‘ƒŠŕ‚ĚŽĄ—Ð헪uŽîᇌ¸—ʏp: ŠŽ‘S“Eo‚Ö‚Ě’§ívNACŒă‚ĚIDS|ŽčpŠŽ‹Š„‡‚ĚŒüă‚ƐNP‚ĚŒyŒ¸|. ‰ś“c‹MŽu (•wl): ‘ć58‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2016/7/9), •ÄŽq.

722118. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) lHŽq‹{‚ĆƒqƒcƒW‘ŮŽe•›t“Eoƒ‚ƒfƒ‹‚ɂ‚˘‚Ä. ŠC–ěM–ç (ŽY‰Č): ‘ć39‰ń“ú–{•ę‘Ě‘ŮŽ™ˆăŠw‰ďŠwpW‰ď (2016/8/27), •Ÿ“‡.

722119. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) 18ƒgƒŠƒ\ƒ~[‚ĚŽüŽYŠúŠÇ—‚ĆŽ™‚Ě“]‹A. –]ŒŽƒŽq1, ™›Ž@Šw2, “c’†@Œ‰3, ‘吟—fŽq1, Îˆä—˛ŽO1, źŕVW‘ă1, ŠÖŒű˜aŠé1, ‰Í–ěĆŽq1, •ž•”‹żŽq1, “‡‰Ş‹œś1, ŽRŒűˆť”T2, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č, 2ŹŽ™, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć35‰ńŽüŽYŠúŠwƒVƒ“ƒ|ƒWƒEƒ€ (2017/2/11), ‘ĺă.

723495. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚É‚¨‚Ż‚é—‘ŠÇ”^Žî‚ɑ΂ˇ‚鎥—ÐŹŃ‚ĚŒŸ“˘. ˆÉ“ĄŽŔ1, ě“ŕ”Žl1, –{“c‰ëŽq2, Šâ’[r•ă1, ‰ş“c—˛m1, ‰ś“c‹MŽu1, ŠC–ěM–ç3 (1•wl, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŽY‰Č): ‘ć68‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/4/23), “Œ‹ž.

723496. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”DP‰Šú‚ĚHbA1c‘Ű•W€’l (NGSP) ‚ĆŽ™‚ĚŒ`‘ÔˆŮí”­Ç•p“x‚ĚŒŸ“˘. –]ŒŽƒŽq1, źŕVW‘ă1, ŠÖŒű˜aŠé1, ‘吟NŽq1, ‰Í–ěĆŽq1, Îě—˛ŽO1, “‡‰Ş‹ś1, •ž•”‹żŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć68‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/4/23), “Œ‹ž.

723497. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “sS“ě•”’ź‰ş’nkŽž‚Ě‹}ŤŠú•Ş•Ř‘Ήž‚É‚¨‚Ż‚é_“ŢěŒ§‚̉ۑč. •ž•”‹żŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŹŠÖ@‘, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć68‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/4/24), “Œ‹ž.

723498. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–Ž{Ý‚É‚¨‚Ż‚鍂”N‰ŽY’P‘ِłŠúŽYÇ—á‚Ě•Ş•Ř—lŽŽ‚ĚŒŸ“˘. ‹g‘ş‰ĂL1, –]ŒŽƒŽq1, •ž•”‹żŽq1, “‡‰Ş‹ś1, ŠÖŒű˜aŠé1, źŕVW‘ă1, ‰Í–ěĆŽq1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/17), •xŽR.

723499. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ŽY‚Ć‚­‚É30T–˘–ž‚Ě•Ş•”—lŽŽ‚ÉŠÖ‚ˇ‚錟“˘. ‘吟—fŽq1, •ž•”‹żŽq1, źŕVW‘ă1, ŠÖŒű˜aŠé1, “‡‰Ş‹œś1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/17), •xŽR.

723500. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) _“ŢěŒ§ŽüŽYŠúˆă—Ă‹@ŠÖ‚É‚¨‚Ż‚éĐŠQŽž‚Ě•Ş•Ř‘Î‰ž‚ÉŠÖ‚ˇ‚錟“˘. •ž•”‹żŽq1, –]ŒŽƒŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/18), •xŽR.

723501. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰Č‚ĹŒoŒą‚ľ‚˝WunderlichÇŒóŒQ, OHVIRAÇŒóŒQ‚ĚˆŸŒ^2—á‚ĚŒŸ“˘. Šâ’[r•ă1, ě“ŕ”Žl1, –{“c‰ëŽq2, ‰ş“c—˛m1, ‰ś“c‹MŽu1, ŠC–ěM–ç3 (1•wl, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŽY‰Č): ‘ć56‰ń“ú–{ŽY‰Č•wl‰Č“ŕŽ‹‹žŠw‰ďŠwpu‰‰‰ď (2016/9/2), ’ˇč.

723502. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 14q32—Ěˆć‚Ě’áƒƒ`ƒ‹‰ť‚É‚ć‚éKagami-Ogata syndrome‚Ěˆę—á. ‘吟NŽq1, –{“c‰ëŽq2, ”’ˆäG’ź, HŽR˜a­, r–؏Ž”ü, –]ŒŽƒŽq1, ŠC–ěM–ç1, ‚“cŽj’j2 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć40‰ń“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ďŠwpW‰ď (2016/4/5), ‹ž“s.

723503. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —\Œă—ǍD‚ČŽq‹{‘Ě•”—Ţ“ŕ–Œ‘BŠŕ‚đ‚•Ş‰ťŒ^ (G1) ‚Ć’†•Ş‰ťŒ^ (G2) ‚É•Ş—Ţ‚ˇ‚é—Տ°“IˆÓ‹`. ŒĂěł‹`1, ŠâŁtŽq1, ‘P•˝š–퍁1, “cŽG—L‹I1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć58‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2016/7/8), •ÄŽq.

723504. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Žq‹{‘ĚŠŕIIICŠúÇ—á‚ɑ΂ˇ‚éŒă—Ă–@‚Ě—L—pŤ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ŠâŁtŽq1, ŒĂěł‹`1, ‰““Ą^ˆę1, ‘P•˝š–퍁1, “cŽG—L‹I1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď (2016/10/20), ‰Ą•l.

723505. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Propensity score‚đ—p‚˘‚˝Žq‹{čňŠŕŽčpÇ—á‚Ć•úŽËüŽĄ—ĂÇ—á‚Ě—\Œă‚̉đÍ. ‚“c‹ąb1, Ź–ěd–ž1, ‰““Ą^ˆę1, ŒĂěł‹`1, “cŽG—L‹I1, ˛“Ą‰p‹M1, ŠâŁtŽq1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ď (2016/10/20), ‰Ą•l.

723506. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •s”DŽĄ—ĂŒoŒą‚Ş‚Č‚˘“ú–{l—Ť‚ĚAMH normograms‚ƐśŠˆKŠľ‚Ć‚ĚŠÖ˜A. •ž•”‹żŽq1, —é–؁@^, ’ߘa”ü•ä, ˆÉ“Ą—F–í, ‰ę—ˆ“T”V, ’Ă“cŽ•, âŒű@ŒM, ‘ĺę@—˛, •ĐŸşG—˛, ›Œ´€ˆę, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć44‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/11/17), “Œ‹ž.

723507. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) NADPH oxidase‚É‚ć‚é—‘‘ƒ‚Ş‚ńŠ˛×–E‚̐§Œä‹@\. “ŕ–ě—Úˆß, ˛“Ą@ˆ¤, ‘唨L˜a, Î•—ł–ç, ‚źM•F1, ‰ś“c‹MŽu2, ‰Á“Ą—FN, ‰|–{—˛”V, ‰Ş–{NŽi (1—Šw•”, 2•wl): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/11/30), ‰Ą•l.

723508. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •s”DŽĄ—ĂŒoŒą‚Ş‚Č‚˘“ú–{l—Ť‚ĚAMH normograms‚ƐśŠˆKŠľ‚Ć‚ĚŠÖ˜A. ăŕV‰xŽq, ’†ŽR”ü—R‹I, Üâ@˝, ě“ŕ”Žl1 (1•wl): ‘ć61‰ń“ú–{śBˆăŠw‰ďŠwpu‰‰‰ďE‘‰ď (2016/11/3), ‰Ą•l.

731103. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’nˆć•Ş•ŘŠÂ‹ŤŠm•Ű‚Ě•űô. ŠC–ěM–ç (ŽY‰Č): “ż“‡Œ§ŽY•wl‰ČŒ¤CƒZƒ~ƒi[ƒLƒƒƒŠƒAŒ`ŹƒZƒ~ƒi[ (2017/2/25), “ż“‡.

732043. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľżu‰‰) ‚í‚Ş‘‚ĚŽY•wl‰Č`ŒťóE‰Ű‘čEŤ—ˆ`. ŠC–ěM–ç (ŽY‰Č): ‘ć141‰ń“Œ–k˜A‡ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ďľżu‰‰ (2016/6/19), ˇ‰Ş.

732044. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ’nˆć•Ş•ŘŠÂ‹ŤŠm•Ű‚Ě•űô‚ɂ‚˘‚Ä. ŠC–ěM–ç (ŽY‰Č): ‘ć26‰ń]’˛•z•{’†ŽY•wl‰Č—Տ°Œ¤‹†‰ď/ŽœŒbˆă‘ĺŽY•wl‰ČW’k‰ď‡“ŻŠwpu‰‰‰ď (2017/2/2), ].

732045. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)uŽY•wl‰Čˆă—ÉüŠvƒOƒ‰ƒ“ƒhƒfƒUƒCƒ“2015v‚Ć’nˆć‚̏•ŽYŽt‚Ö‚ĚŠú‘Ň. ŠC–ěM–ç (ŽY‰Č): _“ŢěŒ§•ŽYŽt‰ď•˝Ź28”N“x“ě–kŠÖ“Œ’n‹ćŒ¤C‰ď (2016/9/24), ‰Ą•l.

732046. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ’nˆć•Ş•ŘŠÂ‹ŤŠm•Ű‚Ě•űô‚ɂ‚˘‚Ä. ŠC–ěM–ç (ŽY‰Č): •˝Ź28”N“xŠň•ŒŽY‰Č•wl‰ČŠw‰ďEŠň•ŒŒ§ŽY•wl‰Čˆă‰ď‡“ŻŠwpŒ¤C‰ď (2016/12/11), Šň•Œ.

733264. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 2015”N“x‚ĚŒ§‰›–k‘Š’n‹ćŽüŽYŠú‹~‹}”Ŕ‘—‚Ě‚Ü‚Ć‚ß. “‡‰Ş‹ś (ŽY‰Č): Œ§‰›–k‘Š’n‹ćŽüŽYŠú‹~‹}ŒŸ“˘‰ď (2016/5/26), _“ސě.

733265. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Žq‹{‘B‹ŘÇŠjopŒă”DP‚Őú’Ę‘Ů”Ő‚đ‡•š‚ľ‚˝1—á. “‡‰Ş‹ś1, –]ŒŽƒŽq1, ‹g‘ş‰ĂL1, •ž•”‹żŽq1, ŠÖŒű˜aŠé1, źŕVW‘ă1, ‰Í–ěĆŽq1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć131‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/6/19), “Œ‹ž.

733266. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‰ć‘œf’f‚É‚ć‚čˆŤŤ‚Ş‹^‚í‚ę‚˝VśŽ™“Ş‘ĺ‚Ě‹ŘŽî•Ş•Ř”S–Œ‰ş•x×–EŤ•˝ŠŠ‹ŘŽî‚Ě1—á. ˛“Ą‰p‹M1, ŠâŁtŽq1, źŽRD1, ŒĂěł‹`1, ‰““Ą^ˆę1, “cŽG—L‹I1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć131‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/6/19), “Œ‹ž.

733267. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽYŒăoŒŒ‚Ö‚ĚIVR‚ĹŒŒŠÇ”j—ô‚đ’ć‚ľ‚˝ˆę—á. ‹g‘ş‰ĂL1, ‹ŕˆä—Y“ń1, •ž•”‹żŽq1, ŠÖŒű˜aŠé1, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć375‰ńŽl…‰ď (2016/6/29), “Œ‹ž.

733268. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) Žqᒔ­ěŒă‚É”­Ç‚ľ‚˝ŽüŽYŠúS‹ŘÇ‚Ě1—á. ŒĂ]–žŽq1, –]ŒŽƒŽq1, •ž•”‹żŽq1, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć132‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/9/15), “Œ‹ž.

733269. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Žq‹{čň•”G•˝ă”çŠŕ‚ɑ΂ˇ‚é“ŻŽž‰ťŠw•úŽËü—Ă–@‚Š‚ç10”NŒă‚É”­Ç‚ľ‚˝Žq‹{‘Ě•”–ž×–E‘BŠŕ‚Ě1—á. “cŽG—L‹I1, ŠâŁtŽq1, ŒĂ]–žŽq1, ‰““Ą^ˆę1, ŒĂěł‹`1, ˛“Ą‰p‹M1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć132‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/9/16), “Œ‹ž.

733270. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŽüŽYŠúTAE‚É‚ć‚鑁Šú‡•šÇ‚ĆŽŸ‰ń”DP—\Œă‚ĚŒŸ“˘. ‹g‘ş‰ĂL1, ‹ŕˆä—Y“ń1, •ž•”‹żŽq1, ŠÖŒű˜aŠé1, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć132‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/9/16), “Œ‹ž.

733271. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žqᒔ­ěŒă‚É”­Ç‚ľ‚˝ŽüŽYŠúS‹ŘÇ‚Ě1—á. ŒĂ]–žŽq1, –]ŒŽƒŽq1, •ž•”‹żŽq1, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć132‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď@‘‰ďEŠwpW‰ď (2016/10/15), “Œ‹ž.

733272. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽüŽYŠúTAE‚É‚ć‚鑁Šú‡•šÇ‚ĆŽŸ‰ń”DP—\Œă‚ĚŒŸ“˘. ‹g‘ş‰ĂL1, ‹ŕˆä—Y“ń1, •ž•”‹żŽq1, ŠÖŒű˜aŠé1, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć132‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď@‘‰ďEŠwpW‰ď (2016/10/16), “Œ‹ž.

733273. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žq‹{Œz•”G•˝ă”çŠŕ‚ɑ΂ˇ‚é“ŻŽž‰ťŠw•úŽËü—Ă–@‚Š‚ç10”NŒă‚É”­Ç‚ľ‚˝Žq‹{‘Ě•”–ž×–EüŠŕ‚Ě1—á. “cŽG—L‹I1, ŠâŁtŽq1, ŒĂ]–žŽq1, ‰““Ą^ˆę1, ŒĂěł‹`1, ˛“Ą‰p‹M1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć132‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď@‘‰ďEŠwpW‰ď (2016/10/16), “Œ‹ž.

733274. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Interventional RadiologyŒă”DP‚Ěˆę—á. ŽRč@—D1, ‘吟—fŽq2, ŒĂ]–žŽq2, ‹g‘ş‰ĂL2, •ž•”‹żŽq2, źŕVW‘ă2, ŠÖŒű˜aŠé2, Îě—˛ŽO2, ‹ŕˆä—Y“ń2, –]ŒŽƒŽq2, ŠC–ěM–ç2 (1Œ¤Cˆă, 2ŽY‰Č): ‘ć416‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/11/20), ‰Ą•l.

733275. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹}‘Ź‚Č“]‹A‚đ‚Ć‚Á‚˝G-CSFŽYśŽq‹{čň•”‘BŠŕ‚Ěˆę—á. “că˜a–1, ˛“Ą‰p‹M2, ź“‡ƒˆę1, ‰““Ą^ˆę2, ŒĂěł‹`2, “cŽG—L‹I2, ‚“c‹ąb2, VˆäłG2, ŠâŁtŽq2, ‰ś“c‹MŽu2, ŠC–ěM–ç3 (1Œ¤Cˆă, 2•wl, 3ŽY‰Č): ‘ć416‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/11/20), ‰Ą•l.

733276. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —‘‘ƒ–˘nŠďŒ`Žî‚É”ş‚Á‚˝RNMDAŽó—e‘̍R‘Ě”]‰Š‚Ěˆę—á. ź“‡ƒˆę1, VˆäłG2, “că˜a–1, ‰““Ą^ˆę2, ŒĂěł‹`2, “cŽG—L‹I2, ˛“Ą‰p‹M2, ‚“c‹ąb2, ŠâŁtŽq2, ‰ś“c‹MŽu2, ŠC–ěM–ç3 (1Œ¤Cˆă, 2•wl, 3ŽY‰Č): ‘ć416‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/11/20), ‰Ą•l.

733277. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ¸_‰Č‚̉î“ü‚đ‹‘”Ű‚ľ‚˝‘ŮŽ™ŽžŠł‚Ě1—á. ’†‘şŠîŠ°1, ‘吟—fŽq1, Îě—˛ŽO1, źŕVW‘ă1, ŠÖŒű˜aŠé1, •ž•”‹żŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć376‰ńŽl…‰ď (2016/11/30), “Œ‹ž.

733278. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰‰ńŽĄ—Ă‚Ć‚ľ‚Ä•úŽËüŽĄ—Ă‚đs‚Á‚˝“–‰@‚ĚŽq‹{čň•”‘BŠŕÇ—á‚ĚŒŸ“˘. ˛“Ą‰p‹M1, ŠâŁtŽq1, ŒĂěł‹`1, “cŽG—L‹I1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć37‰ń“Œ‹ž‘ĺŠw•wl‰ČŠŕ–Ɖu‰ťŠw—Ă–@Œ¤‹†‰ď (2016/12/5), “Œ‹ž.

733279. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽüŽYŠúˆă—Ñ̐§‚̉ۑč`’nˆć‚É‚¨‚Ż‚é•Ş•ŘŠÂ‹Ť‚ĚŠm•Ű‚Ə•ŽYŽt‚Ö‚ĚŠú‘ҁ`“ú–{ŠĹŒě‹Ś‰ď•˝Ź28”N“x. ŠC–ěM–ç (ŽY‰Č): ‘ć1‰ń‘‡ŽüŽYŠú•ęŽqˆă—ĂƒZƒ“ƒ^[ŠĹŒěŠÇ—ŽŇ‡“Ż‰ď‹c (2016/6/15), “Œ‹ž.

733280. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •Ş•ŘŒă‘ĺ—ʏoŒŒ‚đ‚Ť‚˝‚ľ‚˝Žq‹{“ŽĂ–ŹŠďŒ`‚Ě1—á. ’†‘şŠîŠ°1, ŒĂ]–žŽq1, Šâ’[r•ă2, •ž•”‹żŽq3, ‘ŽR@Ę2, ‹v“ˆ‘Ľs1, Ż“c@—˛3 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2•wl, 3ŽY‰Č): “ú–{ŽY‰Č•wl‰ČŠw‰ďé‹Ę’n•ű•”‰ď (2016/6/28), é‹Ę.

733281. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) oŒŒŤƒVƒ‡ƒbƒN‚đ‚Ť‚˝‚ľ‚˝Ÿ÷–Œ‰ş‹ŘŽî‚Ěˆę—á. ‹e’rŽŔ—D1, ‚“c‹ąb2, ŒĂ]–žŽq3, ‰““Ą^ˆę2, Šâ’[r•ă2, “cŽG—L‹I2, ˛“Ą‰p‹M2, ŠâŁtŽq2, VˆäłG2, ‰ś“c‹MŽu2, ŠC–ěM–ç3 (1Œ¤Cˆă, 2•wl, 3ŽY‰Č): ‘ć414‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/7/2), ‰Ą•l.

733282. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •˝Ź28”NŒF–{’nk‚É‚¨‚Ż‚éuŹŽ™ŽüŽYŠúƒŠƒGƒ]ƒ“vŠˆ“Ž•ń. •ž•”‹żŽq1, —é–؁@^, ›Œ´€ˆę (1ŽY‰Č): ‘ć2‰ńALSO-JapanŠwpW‰ď (2016/9/10), ‰ŞŽR.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H18-522001. [uŔ]y“ÁW: ŠŽ‘Sƒ}ƒXƒ^[ ŽY‰Č‚ĚƒoƒCƒ^ƒ‹ƒTƒCƒ“‚ĆŒŸ¸’lzd—v‚Č•a‘Ô‚ĆŒŸ¸ŠŒŠ@35. HELLPÇŒóŒQE‹}Ť”DPŽ‰–bŠĚ (AFLP). ‹ŕˆä—Y“ń (ŽY‰Č): ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA 2006/4: 363-4.

[’˜@‘]

H18-620001. [Šwp‘ (•Ş’SŽˇ•M)]yŽY•wl‰Č‚Ĺ‚ĚƒXƒNƒŠ[ƒjƒ“ƒO‚ĚŽŔŰ (ŽY•wl‰Č‚ĚŽŔŰ2006”N10ŒŽ—ŐŽž‘Š§†)zI ŽY‰Č@7. ä`‘Ń‚ĚƒXƒNƒŠ[ƒjƒ“ƒO, p.1733-40. ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č), Šé‰ć: ’Š‘qŒ[•ś, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2006/10”­s.


ŽŒ`ŠO‰ČŠw

[Šwp˜_•ś]

110209. [Œ´’˜] Quantified Mechanical Properties of the Deltoid Muscle Using the Shear Wave Elastography: Potential Implications for Reverse Shoulder Arthroplasty. Hatta T, Giambini H, Sukegawa K1, Yamanaka Y, Sperling JW, Steinmann SP, Itoi E, An KN: PLoS One 2016/5; 11 (5): e0155102. (•ě_Žm1: 1ŽŠO)

110210. [Œ´’˜] Acceleration of bone formation during fracture healing by poly(pro-hyp-gly)10 and basic fibroblast growth factor containing polycystic kidney disease and collagen-binding domains from Clostridium histolyticum collagenase. Sekiguchi H1, Uchida K2, Inoue G2, Matsushita O, Saito W2, Aikawa J1, Tanaka K, Fujimaki H1, Miyagi M2, Takaso M2: J Biomed Mater Res A 2016/6; 104 (6): 1372-8. (ŠÖŒű—T”V1, “ŕ“cŒ’‘ž˜Y2, ˆäă@Œş2, âV“Ą@˜j2, ‘Šě@~1, “ĄŠŞŽőŽq1, ‹{éłs2, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

110211. [Œ´’˜] Influence of Wound Dressing on the Fracture Healing Effect of Low-Intensity Pulsed Ultrasound (LIPUS). Naruse K1, Uchino M1, Hirakawa N1, Toyama M1, Miyajima G1, Mukai M1, Urabe K1, Uchida K1, Itoman M: J Orthop Trauma 2016/8; 30 (8): S5. (ŹŁNŽĄ1, “ŕ–쐳—˛1, •˝ě‹IŽq1, “hŽRłG1, ‹{“‡Œş—z1, Œ}@@Šw1, č•”@Œ›1, “ŕ“cŒ’‘ž˜Y1: 1ŽŠO)

110212. [Œ´’˜] Accelerated Fracture Healing Targeting Periosteal Cells: Possibility of Combined Therapy of Low-Intensity Pulsed Ultrasound (LIPUS), Bone Graft, and Growth Factor (bFGF). Uchida K1, Urabe K1, Naruse K1, Mikuni-Takagaki Y, Inoue G1, Takaso M1: J Orthop Trauma 2016/8; 30 (8): S3. (“ŕ“cŒ’‘ž˜Y1, č•”@Œ›1, ŹŁNŽĄ1, ˆäă@Œş1, ‚‘ŠťŽm1: 1ŽŠO)

110213. [Œ´’˜] The Low-Intensity Pulsed Ultrasound (LIPUS) Mechanism and the Effect of Teriparatide on Fracture Healing. Naruse K1, Uchino M1, Hirakawa N1, Toyama M1, Miyajima G1, Mukai M1, Urabe K1, Uchida K1, Itoman M: J Orthop Trauma 2016/8; 30 (8): S3. (ŹŁNŽĄ1, “ŕ–쐳—˛1, •˝ě‹IŽq1, “hŽRłG1, ‹{“‡Œş—z1, Œ}@@Šw1, č•”@Œ›1, “ŕ“cŒ’‘ž˜Y1: 1ŽŠO)

110214. [Œ´’˜] Anatomic cadaveric study of the extensile extensor digitorum communis splitting approach for exposing the ulnar coronoid process. Sukegawa K1, Suzuki T, Ogawa Y, Ueno K, Kiuchi H, Kanazuka A, Matsuura Y, Kuniyoshi K: J Shoulder Elbow Surg 2016/8; 25 (8): 1268-73. (•ě_Žm1: 1ŽŠO)

110215. [Œ´’˜] Anatomical Cadaver Study of the Hotchkiss Over-the-Top Approach for Exposing the Anteromedial Facet of the Ulnar Coronoid Process: Critical Measurements and Implications for Protecting the Median Nerv. Sukegawa K1, Suzuki T, Ogawa Y, Kobayashi T, Matsuura Y, Kuniyoshi K: Journal of Hand Surgery (American Volume) 2016/8; 41 (8): 819-23. (•ě_Žm1: 1ŽŠO)

110216. [Œ´’˜] Nerve Growth Factor Regulation by TNF-ƒż and IL-1ƒŔ in Synovial Macrophages and Fibroblasts in Osteoarthritic Mice. Takano S1, Uchida K2, Miyagi M2, Inoue G2, Fujimaki H1, Aikawa J1, Iwase D2, Minatani A2, Iwabuchi K3, Takaso M2: J Immunol Res 2016/8; 2016: 5706359. (‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ˆäă@Œş2, “ĄŠŞŽőŽq1, ‘Šě@~1, ŠâŁ@‘ĺ2, “ě’J@~2, ŠâŸş˜a–ç3, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3–Ɖu)

110217. [Œ´’˜] Treatment for Gustilo type IIIB open tibial fractures: the significance of early soft-tissue coverage. Uchino M1, Urabe K1, Takaso M1: Kitasato Med J 2016/9; 46 (2): 156-60. (“ŕ–쐳—˛1, č•”@Œ›1, ‚‘ŠťŽm1: 1ŽŠO)

110218. [Œ´’˜] The incidence of deep vein thrombosis (DVT) during hip arthroscopic surgery. Fukushima K1, Takahira N2, Uchiyama K1, Moriya M1, Minato T1, Takaso M1: Arch Orthop Trauma Surg 2016/10; 136 (10): 1431-5. (•Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, –Š@„Ž÷1, ‚‘ŠťŽm1: 1ŽŠOŠO, 2ˆă—ÉqśŠw•”)

110219. [Œ´’˜] ELUTION MECHANISM OF VANCOMYCIN AND GENTAMICIN FROM CALCIUM PHOSPHATE CEMENT. Sugo K, Uchida K1, Naruse K1, Uchino M1, Hirakawa N1, Toyama M1, Miyajima G1, Ikeda S2, Urabe K1: Phosphorus Research Bulletin 2016/10; 32: 1-4. (“ŕ“cŒ’‘ž˜Y1, ŹŁNŽĄ1, “ŕ–쐳—˛1, •˝ě‹IŽq1, “hŽRłG1, ‹{“‡Œş—z1, ’r“cM‰î2, č•”@Œ›1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110220. [Œ´’˜] Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients. Minatani A1, Uchida K1, Inoue G1, Takano S2, Aikawa J2, Miyagi M1, Fujimaki H2, Iwase D1, Onuma K1, Matsumoto T3, Takaso M1: J Orthop Surg Res 2016/10; 11 (1): 117. (“ě’J@~1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‚–쏸‘ž˜Y2, ‘Šě@~2, ‹{éłs1, “ĄŠŞŽőŽq2, ŠâŁ@‘ĺ1, ŹŔŒŤŽi1, ź–{r‰p3, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•a—)

110221. [Œ´’˜] Prevalence of radiological findings related to femoroacetabular impingement in professional baseball players in Japan. Fukushima K1, Takahira N2, Imai S, Yamazaki T, Kenmoku T1, Uchiyama K1, Takaso M1: J Orthop Sci 2016/11; 21 (6): 821-5. (•Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

110222. [Œ´’˜] The efficacy of nerve growth factor antibody in a mouse model of neuropathic cancer pain. Miyagi M1, Ishikawa T, Kamoda H, Suzuki M, Inoue G1, Sakuma Y, Oikawa Y, Uchida K1, Suzuki T, Takahashi K, Takaso M1, Ohtori S: Exp Anim 2016/11; 65 (4): 337-43. (‹{éłs1, ˆäă@Œş1, “ŕ“cŒ’‘ž˜Y1, ‚‘ŠťŽm1: 1ŽŠO)

110223. [Œ´’˜] Alendronate does not prevent long bone fragility in an inactive rat model. Naruse K1, Uchida K1, Suto M, Miyagawa K, Kawata A, Urabe K1, Takaso M1, Itoman M, Mikuni-Takagaki Y: J Bone Miner Metab 2016/11; 34 (6): 615-26. (ŹŁNŽĄ1, “ŕ“cŒ’‘ž˜Y1, č•”@Œ›1, ‚‘ŠťŽm1: 1ŽŠO)

110224. [Œ´’˜] Clinical results of arthroscopic surgery in patients over 50 years of age-what viability does it have as a joint preservative surgery? Moriya M1, Fukushima K1, Uchiyama K1, Takahira N2, Yamamoto T1, Minegishi Y3, Takaso M1: J Orthop Surg Res 2017/1; 12 (1): 2. (X’JŒőr1, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ‚•˝ŽL2, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y3, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110225. [Œ´’˜] Oriented collagen tubes combined with basic fibroblast growth factor promote peripheral nerve regeneration in a 15 mm sciatic nerve defect rat model. Fujimaki H1, Uchida K1, Inoue G1, Miyagi M1, Nemoto N, Saku T, Isobe Y, Inage K, Matsushita O, Yagishita S, Sato J, Takano S2, Sakuma Y, Ohtori S, Takahashi K, Takaso M1: J Biomed Mater Res A 2017/1; 105 (1): 8-14. (•Ÿ“‡Œ’‰î1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‹{éłs1, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110226. [Œ´’˜] Adrenomedullin Regulates IL-1ƒŔ Gene Expression in F4/80+ Macrophages during Synovial Inflammation. Takano S1, Uchida K2, Miyagi M2, Inoue G2, Aikawa J1, Iwabuchi K3, Takaso M2: J Immunol Res 2017/2; 2017: 9832430. (‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ˆäă@Œş2, ‘Šě@~1, ŠâŸş˜a–ç3, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3–Ɖu)

110227. [Œ´’˜] Pre-operative simulation of periacetabular osteotomy via a three-dimensional model constructed from salt. Fukushima K1, Takahira N2, Uchiyama K1, Moriya M1, Takaso M1: SICOT J 2017; 3: 14. (•Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

120018. [Œ´’˜] •G‘OŠO‘¤x‘Ń (ALL) ÄŒšpŽž‚Ě‘ĺ‘ڍœœEěŹ‚É‚¨‚Ż‚é2‚Â‚ĚƒAƒvƒ[ƒ`–@‚Ě”äŠr. “ŒŽR—玥1, “n糉pˆę˜Y, ‚XˆŃ”V, –Ř“‡ä”Ž, š˘ˆä–F°, ‚‘ŠťŽm1 (1ŽŠO): Ă‰ŞŽŒ`ŠO‰ČˆăŠwŽGŽ 2016/6; 9 (1): 8-11.

120019. [Œ´’˜] 3ŽŸŒł‘Ş’č‚đ—p‚˘‚˝ŒŇŠÖßƒ‚[ƒVƒ‡ƒ“‚Ě’č—Ę•]‰ż‚Ö‚Ě’§í. ŠâŁ@‘ĺ1, ź”ö@—˛, ź”ö@“Ä, ‹´–{—T”üŽq, ]’[ˆę”Ž, ‘Šě@~2, “ĄŠŞŽőŽq2, “ŕ“cŒ’‘ž˜Y1, “ŒŽR—玥1, “ě’J@~1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{”]Ť–ƒáƒ‚ĚŠO‰ČŒ¤‹†‰ďŽ 2016/7; 26: 141-4.

120020. [Œ´’˜] FAI‚ÉŠÖ‚ˇ‚éŒŇŠÖßŠw‰ďf’fŽwj‚ÉŠî‚Ă‚­‘˝Ž{Ý‰uŠw’˛¸ •Ÿ“‡Œ’‰î1, ŽRč‘ô–, Ź—Ń’źŽŔ, “Ąˆä‰p‹I, ‹´–{TŒá, “Ąˆä­“ż, ’†“‡N°, “ŕŽRŸ•ś1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): Hip Joint 2016/8; 42: 27-9.

310027. [Ç—á•ń] Remarkable regression of a giant cell tumor of the cervical spine treated conservatively with denosumab: A case report. Nakazawa T1, Inoue G1, Imura T1, Miyagi M1, Saito W1, Namba T1, Shirasawa E1, Uchida K1, Takahira N2, Takaso M1: Int J Surg Case Rep 2016/5;@24:@22-5. (’†ŕVr”V1, ˆäă@Œş1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, “ď”gF“ż1, ”’ŕV‰hŽ÷1, “ŕ“cŒ’‘ž˜Y1, ‚•˝ŽL2, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

310028. [Ç—á•ń] Ankle fracture as a complication of hip arthroscopy: A case report. Fukushima K1, Takahira N2, Uchiyama K1, Moriya M1, Yamamoto T1, Takaso M1: J Orthop Sci 2016/7. pii: S0949-2658(16)30086-0. doi: 10.1016/j.jos.2016.06.007. (•Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

310029. [Ç—á•ń] Osteochondritis dissecans of the fourth proximal interphalangeal joint in a Japanese drummer. Takata K1, Onuma K1, Sukegawa K1, Takaso M1: Case Reports Plast Surg Hand Surg 2016/11; 3 (1): 83-5. (‚“c@Œ¤1, ŹŔŒŤŽĄ1, •ě_Žm1, ‚‘ŠťŽm1: 1ŽŠO)

320016. [Ç—á•ń] U“ŽŽhŒƒ‚Í•\ÝŤ‚Ě’É‚Ý‚đŒ¸Žă‚ˇ‚é@ŽŔŒą“IŒ¤‹†. —é–ؐ’Ş, š ‹gˆęŽ÷, ź‰Y—C‰î, ˆŔ•”@—ć, –Ř“ŕ@‹Ď, ă–ěŒ[‰î, Ôâ•ü‘ă, ‹ŕ’ˁ@Ę, ŠâŁ^Šó, œAŕV’ź–ç, ‚‹´@m, Š`č@, ‘Žirˆę, ‘şăŒŤˆę, •ě_Žm1, Šâ‘qŘ•äŽq, ‚‹´˜a‹v (1ŽŠO): ç—tˆăŠwŽGŽ 2016/4; 92 (2): 11-4.

320017. [Ç—á•ń] äCœ‹ŘäF’E‰P‚ɑ΂ľŒă‘Ť•”“ŕŽ‹‹ž‰şPeroneal Groove Deepening‚đŽ{s‚ľ‚˝1—á. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{‘Ť‚ĚŠO‰ČŠw‰ďŽGŽ 2016/9; 37 (1): 276-8.

320018. [Ç—á•ń] “ŻŽíƒAƒLƒŒƒXäF‚đ—p‚˘‚˝‰đ–UŠw“I‹žŽ‹‰şATFLECFLÄŒšp‚đŽ{s‚ľ‚˝ƒoƒŒƒGƒ_ƒ“ƒT[‚Ě1—á. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, “cŕV@—Č2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{‘Ť‚ĚŠO‰ČŠw‰ďŽGŽ 2016/9; 37 (1): 279-83.

522080. [uŔ]y‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ďƒVƒ“ƒ|ƒWƒEƒ€3: œ‘e頏ǐŤ’Ĺ‘ĚœÜ‚Ě—\–h, f’f, ŽĄ—Á|Update|z4. œ‘e頏ǂ𔺂¤ŹlŇ’Œ•ĎŒ`Žčp‚É‚¨‚Ż‚鍜Ü—\–h‘΍ô. ˆäă@Œş (ŽŠO): “ú–{œ‘e頏NJw‰ďŽGŽ 2016/8; 2 (3): 293-5.

522081. [uŔ]y“ÁW: ŒŇŠÖß‹žŽ‹‰şŽčp‚̍ŏŹNPŽčpzŠÖßO’f—ôEFAI@ŹŘŠJ–@‚đ•š—p‚ˇ‚éŒŇŠÖß‹žŽ‹‰şŽčp. •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŽŒ`ŠO‰ČĹŹNPŽčpƒWƒƒ[ƒiƒ‹ 2016/9; 80: 51-6.

522082. [uŔ]y“ÁW: _ŒoŠw“IŠŒŠ‚É–R‚ľ‚˘˜’É‚ĚŽĄ—Áz–Ť˜’ɂɑ΂ˇ‚éŽčp—Ă–@. ˆäă@Œş (ŽŠO): ƒyƒCƒ“ƒNƒŠƒjƒbƒN 2016/10; 37 (10): 1289-95.

522083. [uŔ]y“ÁW: FAI (‘ĺ‘ڍœŠ°œ‰PƒCƒ“ƒsƒ“ƒWƒƒ“ƒg) ‚̍ŐV’mŒŠzFAI‚ÉŠÖ‚ˇ‚é‰uŠw. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŠÖßŠO‰Č 2017/2; 36 (2): 47-50.

540012. [‚ť‚Ě‘ź]yNomadez–ź”n‚Š? ”ŒŠy‚Š? ‚‘ŠťŽm (ŽŠO): Ň’ŐҐ‘ƒWƒƒ[ƒiƒ‹ 2016/5; 29 (5): 517-8.

[’˜@‘]

610002. [Šwp‘ (•Ş’SŽˇ•M)]yStandards for Tissue BankingzAPASTB standaeds for Tissue Banking, p.1-68. Urabe K1, The republic of Korea, 2016/12.(č•”@Œ›1: 1ŽŠO)

620094. [Šwp‘ (•Ş’SŽˇ•M)]yVę–ĺˆă§“x‚É”ő‚Ś‚˝•K—šC•Ş–ě‚Ě‹ł‚Ś•űEŠw‚Ń•ű (ŠÖßŠO‰Č2016”N4ŒŽ‘Š§†)zII. •K—šC•Ş–ě‚ĚŒ¤C•ű–@@•G. č•”@Œ› (ŽŠO), Šé‰ćE•ŇW: “c’†Nm, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/4”­s.

620095. [Šwp‘ (•Ş’SŽˇ•M)]y•ĎŒ`ŤŒŇŠÖßÇf—ĂƒKƒCƒhƒ‰ƒCƒ“2016‰ü’ů‘ć2”Łz•ĎŒ`ŤŒŇŠÖßÇ‚ĚŽŠ‘RŒo‰ß, p.27-9. “ŕŽRŸ•ś (ŽŠO), ŠÄC: “ú–{ŽŒ`ŠO‰ČŠw‰ď^“ú–{ŒŇŠÖßŠw‰ď, •Ň: “ú–{ŽŒ`ŠO‰ČŠw‰ďf—ĂƒKƒCƒhƒ‰ƒCƒ“ˆĎˆő‰ď, •ĎŒ`ŤŒŇŠÖßÇf—ĂƒKƒCƒhƒ‰ƒCƒ“ô’čˆĎˆő‰ď, “ě]“°, “Œ‹ž, 2016/5”­s.

620096. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐ŽŒ`ŠO‰ČŽĄ—Ă•űj (‘ć7”Ĺ)z[ć’[ˆă—Ă] ”ńś‘Ěƒhƒi[‚Š‚çĚŽć‚ł‚ę‚˝“ŻŽíœEx‘Ń‘gD‚Ě“€Œ‹•Ű‘ś, p.29. ŹŁNŽĄ (ŽŠO), •Ň: “y‰ŽOs, Ž–ěœÄˆę, “c’†Nm, “c’†@‰h, ź“cGˆę, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620097. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐ŽŒ`ŠO‰ČŽĄ—Ă•űj (‘ć7”Ĺ)z1 f’f‚ĆŽĄ—Ă‘˜_ @[ŽĄ—Ă‘˜_] œˆÚA‚ƍœƒoƒ“ƒN, p.30-1. ˆäă@Œş (ŽŠO), •Ň: “y‰ŽOs, Ž–ěœÄˆę, “c’†Nm, “c’†@‰h, ź“cGˆę, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620098. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐ŽŒ`ŠO‰ČŽĄ—Ă•űj (‘ć7”Ĺ)z18 Ň’Œ•ĎŒ`@’Ĺ‹|ŘœŒă‚̐ҒŒ•ĎŒ`, p.594-5. ˆäă@Œş (ŽŠO), •Ň: “y‰ŽOs, Ž–ěœÄˆę, “c’†Nm, “c’†@‰h, ź“cGˆę, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620099. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐ŽŒ`ŠO‰ČŽĄ—Ă•űj (‘ć7”Ĺ)z18 Ň’Œ•ĎŒ`@Ň’ĹŠOŒă‚̐isŤŇ’Œ•ĎŒ`, p.595-6. ‚‘ŠťŽm (ŽŠO), •Ň: “y‰ŽOs, Ž–ěœÄˆę, “c’†Nm, “c’†@‰h, ź“cGˆę, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620100. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐ŽŒ`ŠO‰ČŽĄ—Ă•űj (‘ć7”Ĺ)z18 Ň’Œ•ĎŒ`@_ŒoE‹ŘŒ´ŤŽžŠł‚É”ş‚¤Ň’Œ•ĎŒ`, p.596-9. ‚‘ŠťŽm (ŽŠO), •Ň: “y‰ŽOs, Ž–ěœÄˆę, “c’†Nm, “c’†@‰h, ź“cGˆę, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620101. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐ŽŒ`ŠO‰ČŽĄ—Ă•űj (‘ć7”Ĺ)z24 ‰şŽˆ‘S‘Ě‚Ě–â‘č@‰şŽˆ‚É‚¨‚Ż‚éiNŤ_ŒoáŠQ, p.743-4. č•”@Œ› (ŽŠO), •Ň: “y‰ŽOs, Ž–ěœÄˆę, “c’†Nm, “c’†@‰h, ź“cGˆę, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620102. [Šwp‘ (•Ş’SŽˇ•M)]yŇ’ŐҐ‘ŠO‰ČƒeƒLƒXƒgzII. Še˜_: ŽžŠł•Ň@A. ŠOŤŽžŠł@1. Ň’Ĺ‘š, p.100-9. ˆäă@Œş (ŽŠO), •Ň: ‚‹´˜a‹v, “ě]“°, “Œ‹ž, 2016/8”­s.

620103. [Šwp‘ (•Ş’SŽˇ•M)]yŇ’ŐҐ‘ŠO‰ČƒeƒLƒXƒgzII. Še˜_: ŽžŠł•Ň@C. Ň‘ŽžŠłE––˝_ŒoŽžŠłEŒŒŠÇŽžŠł@1. Ň‘ŒW—ŻÇŒóŒQ, p.222-4. ˆäă@Œş (ŽŠO), •Ň: ‚‹´˜a‹v, “ě]“°, “Œ‹ž, 2016/8”­s.

620104. [Šwp‘ (•Ş’SŽˇ•M)]yŇ’ŐҐ‘ŠO‰ČƒeƒLƒXƒgzII. Še˜_: ŽžŠł•Ň@C. Ň‘ŽžŠłE––˝_ŒoŽžŠłEŒŒŠÇŽžŠł@2. Ň‘‹ó“´Ç, p.225-9. ˆäă@Œş (ŽŠO), •Ň: ‚‹´˜a‹v, “ě]“°, “Œ‹ž, 2016/8”­s.

[Šw‰ďEŒ¤‹†‰ď“™]


712021. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Oblique lumbar interbody fusion -Radiological & clinical results in adult spinal deformity. Inoue G1: The 1st Annual Misscot Conference and Hands-on Cadaveric Workshop for Minimally Invasive Spine Surgery (2016/6/25), Bangkok, Thailand. (ˆäă@Œş1: 1ŽŠO)

712022. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Oblique lumbar interbody fusion -Indication and Technique. Inoue G1: The 1st Annual Misscot Conference and Hands-on Cadaveric Workshop for Minimally Invasive Spine Surgery (2016/6/26), Bangkok, Thailand. (ˆäă@Œş1: 1ŽŠO)

712023. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Current trends in bone grafting based on the sixth nationwide survey of bone grafting status from 2010 to 2014. Urabe K1: The 16th Asia Association of Surgical Tissue Banking (2016/7/1), Korea. (č•”@Œ›1: 1ŽŠO)

712024. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Ethical challenges in the Asia Pacific region. Urabe K1: 7th Congress of the Latin American Association of Tissue Banks (2016/11/2), Buenos Aires, Argentina. (č•”@Œ›1: 1ŽŠO)

713083. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Anatomical Arthroscopic ATFL and CFL reconstruction using an Achilles tendon allograft; A case report of ballerina. Higashiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Tazawa R2, Minehara H3, Matsuura T1, Kwamura T1, Takaso M1: 17th European Congress of Trauma & Emergency Surgery(ECTES) (2016/4/24), Vienna, Austria. (“ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, “cŕV@—Č2, •ôŒ´Gš3, ź‰YWł1, ‰Í‘ş@’ź1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝)

713084. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A case report of a high school soccer player who was performed with hybrid technique of two syndesmotic screws and a suture-button for a syndesmosis injury. Higasiyama R1, Minehara H2, Matsuura T1, Kawamura T1, Aikawa J3, Iwase D1, Minatani A1, Yoshihira T1, Shoji S1, Takaso M1: 17th European Congress of Trauma & Emergency Surgery (ECTES) (2016/4/25), Vienna, Austria. (“ŒŽR—玥1, •ôŒ´Gš2, ź‰YWł1, ‰Í‘ş@’ź1, ‘Šě@~3, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v1, ŻŽi^‘ž˜Y1, ‚‘ŠťŽm1: 1ŽŠO, 2‹~–˝, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713085. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Arthroscopic Anterior Talo-Fibular Ligament Reconstruction using a Gracilis Tendon. Higashiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Watanabe H3, Watanabe E, Takaso M1: 17th ESSKA (ƒˆ[ƒƒbƒpƒXƒ|[ƒcŠOE•GEŠÖß‹žŠw‰ď) (2016/5/4), Barcelona, Spain. (“ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, “n粗T”V3, “n糉pˆę˜Y, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

713086. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Anatomical Arthroscopic Double Bundle Anterolateral Ligament Reconstruction using a Gracilis tendon; a cadaveric study. Higashiyama R1, Kasiwa K, Aikawa J2, Iwase D1, Minatani A1, Takano S2, Watanabe H3, Takaso M1: 17th ESSKA (ƒˆ[ƒƒbƒpƒXƒ|[ƒcŠOE•GEŠÖß‹žŠw‰ď) (2016/5/4), Barcelona, Spain. (“ŒŽR—玥1, ”@@ŒO, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‚–쏸‘ž˜Y2, “n粗T”V3, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

713087. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Arthroscopic Rectangular Anterior Cruciate Ligament Reconstruction Using A 15-mm Wide Bone-Patellar Tendon-Bone Allograft. Minatani A1, Higashiyama R1, Iwase D1, Uchida K1, Inoue G1, Watanabe H2, Urabe K1, Takaso M1: 17th ESSKA (ƒˆ[ƒƒbƒpƒXƒ|[ƒcŠOE•GEŠÖß‹žŠw‰ď) (2016/5/4), Barcelona, Spain. (“ě’J@~1, “ŒŽR—玥1, ŠâŁ@‘ĺ1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, “n粗T”V2, č•”@Œ›1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

713088. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Lumbar disc degeneration and Modic change 35 years after surgery for adolescent idiopathic scoliosis: Long-term MRI follow-up. Akazawa T, Kotani T, Sakuma T, Minami S, Takaso M1, Inoue G1, Miyagi M1, Aoki Y, Orita S, Takahashi K, Ohtori S: 43rd The International Society for the Study of the Lumbar Spine Annual Meeting (2016/5/18), Singapore. (‚‘ŠťŽm1, ˆäă@Œş1, ‹{éłs1: 1ŽŠO)

713089. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Macrophages in the degenerated intervertebral disc produce inflammatory cytokines, but not growth factors, in a mouse model of disc injury. Miyagi M1, Uchida K1, Fujimaki H2, Inoue G1, Nakazawa T1, Imura T1, Saito W1, Takahira N3, Takaso M1: 43rd The International Society for the Study of the Lumbar Spine Annual Meeting (2016/5/19), Singapore. (‹{éłs1, “ŕ“cŒ’‘ž˜Y1, “ĄŠŞŽőŽq2, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, ‚•˝ŽL3, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

713090. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Transforming growth factor-activated kinase 1 induces an inflammatory response in spinal microglia in vitro. Fujimaki H1, Inoue G2, Uchida K2, Miyagi M2, Sekiguchi H1, Aikawa J1, Saito W2, Takaso M2: 43rd The International Society for the Study of the Lumbar Spine Annual Meeting (2016/5/19), Singapore. (“ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ŠÖŒű—T”V1, ‘Šě@~1, âV“Ą@˜j2, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

713091. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Effects of hip diseases on the measurement of pelvic tilt parameters. Shoji S1, Miyagi M1, Fukushima K1, Inoue G1, Nakazawa T1, Imura T1, Saito W1, Namba T1, Shirasawa E1, Takahira N2, Takaso M1: 43rd The International Society for the Study of the Lumbar Spine Annual Meeting (2016/5/19), Singapore. (ŻŽi^‘ž˜Y1, ‹{éłs1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, “ď”gF“ż1, ”’ŕV‰hŽ÷1, ‚•˝ŽL2, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

713092. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Nerve reconstruction with oriented collagen tubes combined with basic fibroblast growth factor. Fujimaki H1, Inoue G2, Uchida K2, Miyagi M2, Saito W2, Takaso M2: 43rd The International Society for the Study of the Lumbar Spine Annual Meeting (2016/5/19), Singapore. (“ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, âV“Ą@˜j2, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

713093. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Correlation between acetabular opening angle and spinal alignment in patients with acetabular dysplasia. Shirasawa E1, Fukushima K1, Miyagi M1, Inoue G1, Uchiyama K1, Moriya M1, Takahira N2, Takaso M1: 17th EFORT Congress (2016/6/1), Geneva, Switzerland. (”’ŕV‰hŽ÷1, •Ÿ“‡Œ’‰î1, ‹{éłs1, ˆäă@Œş1, “ŕŽRŸ•ś1, X’JŒőr1, ‚•˝ŽL2, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

713094. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Prevalence of Radiological Findings Related to Femoroacetabular Impingement in Professional Baseball Players in Japan. Fukushima K1, Takahira N2, Uchiyama K1, Takaso M1: European Federation of National Associations of Orthopaedics and Traumatology 2016 (2016/6/3), Geneva, Switzerland. (•Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

713095. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Hyaluronic acid supplementation of UW solution improves viability of osteochondral grafts and reduces MMP expression during cold preservation. Onuma K1, Yamada T, Uchida K1, Inoue G1, Aikawa J2, Naruse K1, Urabe K1, Takaso M1: The 16th Asia Association of Surgical Tissue Banking (2016/7/1), Seoul, Korea. (ŹŔŒŤŽĄ1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‘Šě@~2, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713096. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Additional Harvest of the Gracilis Tendon Affect Knee Flexor Muscle Strength at the Fast Angular Speed 3 Months after Double-bundle ACL reconstruction. Metoki Y1, Higashiyama R1, Aikawa J2, Iwase D1, Minatani A1, Takano S2, Watanabe H3, Takaso M1: 37th SICOT Orthopaedic World Congress (‘ć37‰ń@‘ŰŽŒ`ŠO‰ČEĐŠQŠO‰ČŠw‰ď) (2016/9/8), Rome, Italy. (–ÚŽž—LŠóœ¨1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‚–쏸‘ž˜Y2, “n粗T”V3, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

713097. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Harvest of the Gracilis tendon does not affect Post-operative Knee Flexion Strength after Arthroscopic Lateral Ankle Ligament Reconstruction. Mukae M1, Higashiyama R1, Watanabe H2, Aikawa J3, Iwase D1, Minatani A1, Takano S3, Takaso M1: 37th SICOT Orthopaedic World Congress (‘ć37‰ń‘ŰŽŒ`ŠO‰ČEĐŠQŠO‰ČŠw‰ď) (2016/9/8), Rome, Italy. (Œ}@@Šw1, “ŒŽR—玥1, “n粗T”V2, ‘Šě@~3, ŠâŁ@‘ĺ1, “ě’J@~1, ‚–쏸‘ž˜Y3, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713098. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Development of Arthroscopic PTFL/ATFL/CFL Reconstruction using a Free Tendon: A cadaveric study. Higashiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Takano S2, Takaso M1: 37th SICOT Orthopaedic World Congress (‘ć37‰ń‘ŰŽŒ`ŠO‰ČEĐŠQŠO‰ČŠw‰ď) (2016/9/8), Rome, Italy. (“ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713099. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Matsuo method of sliding lengthening technique. Iwase D1, Aikawa J2, Higashiyama R1, Minatani A1, Takaso M1: 37th SICOT Orthopaedic World Congress (‘ć37‰ń‘ŰŽŒ`ŠO‰ČEĐŠQŠO‰ČŠw‰ď) (2016/9/8), Rome, Italy. (ŠâŁ@‘ĺ1, ‘Šě@~2, “ŒŽR—玥1, “ě’J@~1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713100. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Simultaneous injury of the ACL rupture and patella dislocation: A case report. Murata K1, Higashiyama R1, Aikawa J2, Iwase D1, Minatani A1, Koyama T1, Kuroda A1, Takaso M1: 37th SICOT Orthopaedic World Congress (‘ć37‰ń‘ŰŽŒ`ŠO‰ČEĐŠQŠO‰ČŠw‰ď) (2016/9/8), Rome, Italy. (‘ş“cK—S1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŹŽR’q‹v1, •“cW‹`1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713101. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Preoperative tranexamic acid administration in total hip arthroplasty may end the use of postoperative drain system. Moriya M1, Uchiyama K1, Takahira N2, Fukushima K1, Yamamoto T1, Minegishi Y3, Takaso M1: 37th SICOT Orthopaedic World Congress (‘ć37‰ń‘ŰŽŒ`ŠO‰ČEĐŠQŠO‰ČŠw‰ď) (2016/9/9), Rome, Italy. (X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL2, •őŠÝ—mŽŸ˜Y3, •Ÿ“‡Œ’‰î1, ŽR–{‹˜N1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713102. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Usefulness of oriented collagen tubes combined with basic fibroblast growth factor for the treatment of large peripheral nerve defect. Fujimaki H1, Inoue G2, Uchida K2, Miyagi M2, Takaso M2: 16th World Congress on Pain (IASP2016) (2016/9/26), Yokohama. (“ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

713103. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Ulnar corrective osteotomy using the external fixator "MultiPlanar MiniRail" for pediatric patients with chronic radial head dislocation. Ohtake Y1, Onuma K1, Sukegawa K1, Fujimaki H2, Minato T1, Kenmoku T1, Takaso M1: ASSH 2016 (American Society for Surgery of the Hand Annual Meeting) (2016/9/29), Austin, USA. (‘ĺ’|—IĆ1, ŹŔŒŤŽĄ1, •ě_Žm1, “ĄŠŞŽőŽq2, –Š@„Ž÷1, ŒŠ–Ú’q‹I1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713104. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Wrist Arthrodesis with the Cannulated Intramedullary Nail for Patients with Rheumatoid arthritis. Onuma K1, Shintani R, Sukegawa K1, Kenmoku T1, Takaso M1: ASSH 2016 (American Society for Surgery of the Hand Annual Meeting) (2016/9/29), Austin, USA. (ŹŔŒŤŽĄ1, •ě_Žm1, ŒŠ–Ú’q‹I1, ‚‘ŠťŽm1: 1ŽŠO)

713105. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A New Arthroscopic PTFL/ATFL/CFL Reconstruction Using Free Tendon: A Cadaveric Study. Higashiyama R1, Hanada M, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Takano S2, Shoji S1, Yoshihira T, Takaso M1: 6th AFFAS Asian Federation of Foot and Ankle Surgeons (2016/11/19), Nara, Japan. (“ŒŽR—玥1, ‰Ô“c@[, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ŻŽi^‘ž˜Y1, ‘P•˝“N•v, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713106. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Enhanced Bone Formation Using Freeze-dried Allograft Bone With Human Basic Fibroblast Growth Factor Containing A Collagen-bonding Domain From Clostridium Histolyticum Collagenase After Lumbar Posterolateral Fusion Surgery In Rats. Inoue G1, Uchida K1, Fujimaki H2, Saito W1, Miyagi M1, Sekiguchi H2, Aikawa J2, Nagura N2, Takano S2, Takaso M1: Orthopaedic Research Society 2017 Annual Meeting (2017/3/21), San Diego, USA. (ˆäă@Œş1, “ŕ“cŒ’‘ž˜Y1, “ĄŠŞŽőŽq2, âV“Ą@˜j1, ‹{éłs1, ŠÖŒű—T”V2, ‘Šě@~2, –ź‘q’źd2, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713107. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Transforming Growth Factor activated Kinase 1 Induces An Inflammatory Response And Neuropathic Pain In Spinal Microglia In Vitro. Fujimaki H1, Inoue G2, Uchida K2, Miyagi M2, Sekiguchi H1, Aikawa J1, Takaso M2: Orthopaedic Research Society 2017 Annual Meeting (2017/3/22), San Diego, USA. (“ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ŠÖŒű—T”V1, ‘Šě@~1, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

713108. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Acceleration Of Bone Repair During Fracture Healing By Poly(pro-hyp-gly)10 And Basic Fibroblast Growth Factor Containing Collagen-binding Domains From Clostridium Histolyticum Collagenase. Sekiguchi H1, Uchida K2, Inoue G2, Takaso M2: Orthopaedic Research Society 2017 Annual Meeting (2017/3/22), San Diego, USA. (ŠÖŒű—T”V1, “ŕ“cŒ’‘ž˜Y2, ˆäă@Œş2, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

721010. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) œŒ‡‘š‚𔺂¤THAÄ’uŠˇp|“ŻŽíœ‚đ—p‚˘‚˝‹~Ď–@|. “ŕŽRŸ•ś1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/15), ‰Ą•l. “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ 2016/3; 90 (3): S986.

721011. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‚í‚Ş‘‚Ĺ‚Í‘ĺ‚Ť‚˘“ŻŽíœ‚ÍŽg‚Ś‚Č‚˘‚Ć‚Í‚ŕ‚¤Œž‚í‚š‚Č‚˘|–k—˘‘ĺŠw•a‰@œƒoƒ“ƒN (KUBB) ‚Ě‚ą‚ę‚Ü‚Ĺ‚ĚŽć‚č‘g‚Ý‚Ć•ŰŒŻŽűÚŒă‚Ě‚ą‚ę‚Š‚ç|. •Ÿ“‡Œ’‰î (ŽŠO): ‘ć43‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2016/11/5), ‘ĺă.

722120. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ”ń“ÁˆŮ“I˜’É‚Ě”­śŒš‚Ĺ‚ ‚é’ŊԔ—R—ˆ˜’É‹@˜‚ÉŠÖ‚ˇ‚錟“˘. ‹{éłs1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‘ĺ’š¸Ži, Îě“N‘ĺ, Š›“c”Žl, ˛‹vŠÔÚ_, ź”\@Œ’, ěă@Žç, ‚‹´˜a‹v, ‚‘ŠťŽm1 (1ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/14), ç—t.

722121. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) –Ť˜’ɏǂɑ΂ˇ‚é–ň•¨—Ă–@‚Ě”ď—p‘ÎŒř‰Ę. “c‘q’q”V, ŽR‰ş•q•F, ‹g“c@l, źŽRKO, ‚‹´˜a‹v, ˆÉ“Œ@Šw, ĄŠ˜Žj˜Y, ˆäă@Œş1, ěă@Žç, ŽíŽs@—m, ź“cN‘ž˜Y, ”g˜C_F, ‹{˜Ž‹v, •Ä‰„ô—Y, ŠC“n‹MŽi, Ž“c÷ŽĄ (1ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/15), ç—t.

722122. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) –Ť˜’ÉÇ‚Ě–ň•¨—Ă–@‚ÉŠłŽŇ”wŒi‚Ş‹y‚Ú‚ˇ‰e‹ż. ŽR‰ş•q•F, ‹g“c@l, źŽRKO, ‚‹´˜a‹v, ˆÉ“Ą@Šw, ĄŠ˜Žj˜Y, ˆäă@Œş1, ěă@Žç, ŽíŽs@—m, ź“cN‘ž˜Y, ”g˜C_F, ‹{˜Ž‹v, ŠC“n‹MŽi, “c‘q’q”V, •Ä‰„ô—Y, Ž“c÷ŽĄ (1ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/15), ç—t.

722123. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) –Ť˜’ɏǂɑ΂ˇ‚é–ň•¨—Ă–@‚Ě—Ő°•]‰ż. ŠC“n‹MŽi, ŽR‰ş•q•F, ‹g“c@l, źŽRKO, ‚‹´˜a‹v, ˆÉ“Œ@Šw, ĄŠ˜Žj˜Y, ˆäă@Œş1, ěă@Žç, ŽíŽs@—m, ź“cN‘ž˜Y, ”g˜C_F, ‹{˜Ž‹v, “c‘q’q”V, •Ä‰„ô—Y, Ž“c÷ŽĄ (1ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/15), ç—t.

722124. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) THAŽüˆÍœÜ‚ɑ΂ˇ‚éÄ’uŠˇp. “ŕŽRŸ•ś1, ‚•˝ŽL2, •Ÿ“‡Œ’‰î1, X’JŒőr1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y3, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/12), ‰Ą•l. “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ 2016/3; 90 (2): S114.

722125. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) œ‘e頏ǂ𔺂¤ŹlŇ’Œ•ĎŒ`Žčp‚É‚¨‚Ż‚鍜Ü—\–h‘΍ô. ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/12), ‰Ą•l.

722126. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Ň’ĹŽčpŒăSSI‚ɂ‚˘‚Ä‚ĚƒGƒrƒfƒ“ƒX. “ď”gF“ż1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ă–쐳Šě, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/12), ‰Ą•l.

722127. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Žá”NŽŇ––ŠúŒŇŠÖßÇ‚Ö‚Ě‘ĺ‘ڍœŠO”˝œŘ‚čp. ‚•˝ŽL1, “ŕŽRŸ•ś2, •Ÿ“‡Œ’‰î2, ŽR–{‹–ž2, X’JŒőr2, ‚‘ŠťŽm2, Ž…–žˇŒ›3 (1ˆă—ÉqśŠw•”, 2ŽŠO, 3”Ş‹ă\‰ď‚”ö•a‰@): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/13), ‰Ą•l. “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ 2016/3; 90 (2): S327.

722128. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‹ŘƒWƒXƒgƒƒtƒB[‚É”ş‚¤‘¤œ^Ç‚ɑ΂ˇ‚éŽčp—Ă–@|Žčp‚ĚˆÓ‹`‚ƍĄŒă‚̉ۑč|. âV“Ą@˜j1, ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, ‹{éłs1, “ď”gF“ż1, ”’ŕV‰hŽ÷1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ď‘‰ď (2016/5/14), ‰Ą•l.

722129. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) •ĎŒ`ŤŒŇŠÖßÇ‚đ—L‚ˇ‚éÇ—á‚ɑ΂ˇ‚éŒŇŠÖß‹žŽ‹‰şŽčp‚Ě“K‰ž‚Ć—L—pŤ. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/14), ‰Ą•l.

722130. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) •ĎŒ`ŤŒŇŠÖßÇf—ĂƒKƒCƒhƒ‰ƒCƒ“: ‰uŠw‚É‚¨‚Ż‚é‰ü’ů. ˆî—t@—T1, Ö“Ą@[, ‰HŽR“Nś2, ‚•˝ŽL3, “ŕŽRŸ•ś4 (1‰Ą•lŽs‘ĺ, 2ŽœŒbˆă‘ĺ, 3ˆă—ÉqśŠw•”, 4ŽŠO): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/15), ‰Ą•l. “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ 2016/3; 90 (3): S1039.

722131. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘ĺ‘ڍœŠ°œ‰PƒCƒ“ƒsƒ“ƒWƒƒ“ƒg‚̉uŠw, •a‘Ô, f’fŽwj. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

722132. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) •˝Ź28”N“xf—Ă•ńV‰ü’č‚É‚ć‚é.”ď—p‰ńŽűŒŠž‚݂ɂ‚˘‚Ä ‘ĺ’JŒö‹M1, “ŕ“cŒ’‘ž˜Y2, Š}Œ´‚Ý‚Ç‚č3, ˆäă@Œş2, ‚‘ŠťŽm2 (1œƒoƒ“ƒN, 2ŽŠO, 3ŠĹŒě•”): ‘ć15‰ń“ú–{‘gDˆÚAŠw‰ď (2016/8/27), •xŽR.

722133. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ŹlŇ’Œ•ĎŒ`Žčp‚Ě’áNP‰ť. ˆäă@Œş (ŽŠO): ‘ć24‰ń“ú–{˜’ÉŠw‰ď (2016/9/3), b•{.

722134. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ŒŇŠÖß‰ˇ‘śŽčp‚É‚¨‚Ż‚éMIS. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć44‰ń“ú–{ŠÖß•aŠw‰ď (2016/11/12), •Ę•{.

723509. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹlŇ’Œ•ĎŒ`Žčp‚É‚¨‚Ż‚épŒă–ž‘Ť“x‚ÉŠÖ‚ˇ‚錟“˘. “ď”gF“ż1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/14), ç—t.

723510. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ć10‰ńAsia Traveling Fellowship@ƒxƒgƒiƒ€EŠŘ‘‚đI‚Ś‚Ä. ˆäă@Œş1, Ź—Ń˜aŽ (1ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/14), ç—t.

723511. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Microglial basic fibroblast growth factor contributes neuropathic pain via myeloperoxidase production. “ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, âV“Ą@˜j2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/14), ç—t.

723512. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒŇŠÖß’É‚đ—L‚ˇ‚銳ŽŇ‚̐ҒŒƒAƒ‰ƒCƒƒ“ƒg: Hip Spine Syndrome‚Ě•a‘Ô‚ÉŠÖ‚ˇ‚錟“˘. ‹{éłs1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/15), ç—t.

723513. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒŇŠÖß’ÉŠłŽŇ‚ލœ”ŐŒXŽÎŠp‘Ş’č‚É‹y‚Ú‚ˇ‰e‹ż‚ĚŒŸ“˘. ŻŽi^‘ž˜Y1, ‹{éłs1, ˆäă@Œş1, •Ÿ“‡Œ’‰î1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, “ď”gF“ż1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/15), ç—t.

723514. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠÖß‰tCRP’l‘Ş’č‚͐lHŠÖßŽüˆÍŠ´ő‚̐f’f‚É—L—p‚Š? •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś2, ‚ŽR—zŽq3, ˜a“c’B•F4, ’†‘şłŽ÷5, “ń–{–öL6, ‘ĺěŒ´—TŽ÷7, ‰Ô–؏G–ž, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4äPŒ´•aEŠ´ő“ŕ, 5ˆă—ÉqśŠw•”, 6—ŐŒŸ•”, 7–ňÜ•”): ‘ć90‰ń“ú–{Š´őÇŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/4/16), ĺ‘ä. ‘ć90‰ń“ú–{Š´őÇŠw‰ďŠwpu‰‰‰ď´˜^W 2016/3; 90: p.276.

723515. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 16S rRNAˆâ“`Žq”z—ń‚đ—p‚˘‚˝ƒV[ƒPƒ“ƒX‰đÍ‚É‚¨‚Ż‚é–â‘č“_‚̉ü‘Pô|lHŠÖßŽüˆÍŠ´ő‚Ě‹N‰Š‹ŰŒŸő|. “ŕŽRŸ•ś1, ŸNˆäŒc‘˘2, •őŠÝ—mŽŸ˜Y3, ‚ŽR—zŽq4, ˜a“c’B•F5, ’†‘şłŽ÷6, “ń–{–öL7, ‘ĺěŒ´—TŽ÷8, ‰Ô–؏G–ž, ‚‘ŠťŽm1 (1ŽŠO, 2—ŐŒŸ•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 5äPŒ´•aEŠ´ő“ŕ, 6ˆă—ÉqśŠw•”, 7—ŐŒŸ•”, 8–ňÜ•”): ‘ć90‰ń“ú–{Š´őÇŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/4/16), ĺ‘ä. ‘ć90‰ń“ú–{Š´őÇŠw‰ďŠwpu‰‰‰ď´˜^W 2016/3; 90: p.276.

723516. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŔˆĘŽp¨‚Ĺ‚Ě˜J“­ŽŇ‚É”­ś.‚ˇ‚鍘’É‚Ě”­ś•p“x‚Ć“Á’Ľ ˆäă@Œş1, ‘ĺ’š¸Ži, ‹{éłs, Îě“N‘ĺ, Š›“c”Žl, ]Œű@˜a, Ü“cƒ‹v, ‚‘ŠťŽm1, ‚‹´˜a‹v (1ŽŠO): ‘ć45‰ń“ú–{Ň’ŐҐ‘•aŠw‰ďŠwpW‰ď (2016/4/16), ç—t.

723517. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) lHŠÖßŽüˆÍŠ´ő‚ɑ΂ˇ‚éRMRSA–ň‚Ěˆá‚˘‚É‚ć‚épŒăŹŃ‚Ě”äŠr|ƒoƒ“ƒRƒ}ƒCƒVƒ“‚Ćƒ_ƒvƒgƒ}ƒVƒ“‚Ě”äŠr|. “c“‡Gˆę˜Y1, “ŕŽRŸ•ś1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, ‚‘ŠťŽm1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/12), ‰Ą•l. “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ 2016/3: 90 (2): S248.

723518. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) pŒă•˝‹Ď20”N‚ĚCLSƒXƒeƒ€ŽüˆÍ‚̍œ–§“x•]‰ż|”ńŽčp‘¤‚Ć‚Ě”äŠr|. X’JŒőr1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/12), ‰Ą•l.

723519. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Š°œ‰P‰ń“]œŘ‚čp (CPO) ‚ĚŽüpŠúŠÇ—|ôňŽŽŽŠŒČŒŒ‰ńŽű‘•’u (OrthoPAT) ‚Ə]—ˆ–@‚Ć‚Ě”äŠr|. ŹŽR’q‹v1, X’JŒőr1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, ‚‘ŠťŽm1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/14), ‰Ą•l. “ú–{ŽŒ`ŠO‰ČŠw‰ďŽGŽ 2016/3; 90 (3): S923.

723520. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •15 mm‚Ě“ŻŽíœ•t‚Ť•GŠWäF‚đ—p‚˘‚˝’ˇ•űŒ`œE‘O\ŽščՑэȚpŒă‚Ě•G‹Ř—Í‚ĚŒŸ“˘. “ě’J@~1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, ‚–쏸‘ž˜Y2, ‘P•˝“N•v, “n粗T”V3, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/14), ‰Ą•l.

723521. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ŤŠÖßŒă•űƒCƒ“ƒsƒ“ƒWƒƒ“ƒgÇŒóŒQ‚Ć‘ŤŠÖßŠO‘¤•sˆŔ’čÇ‚̍‡•š—á‚ĚŽčpŹŃ. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ‘P•˝“N•v, “n糉pˆę˜Y, “n粗T”V3, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/14), ‰Ą•l.

723522. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •I•”ŠÇÇŒóŒQ‚đ‡•š‚ľ‚˝¸__ŒoŽžŠłœëŠłŠłŽŇ‚Ě.—U”­‹Ř“d}‚ƐS“d}‚ĚŒŸ“˘. ŹŔŒŤŽĄ1, ŒŠ–Ú’q‹I1, •ě_Žm1, “ĄŠŞŽőŽq2, –ź‘q’źd2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć89‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2016/5/15), ‰Ą•l.

723523. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚đ—p‚˘‚˝MRSAŠ´őÇf’f|•]‰ż–@E—Տ°‘œE‚ť‚ĚˆÓ‹`‚ɂ‚˘‚ā|. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś2, ‚ŽR—zŽq3, ˜a“c’B•F4, ’†‘şłŽ÷5, “ń–{–öL6, ‰Ô–؏G–ž, ťěŒc‰î7, ‚‘ŠťŽm1 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4äPŒ´•aEŠ´ő“ŕ, 5ˆă—ÉqśŠw•”, 6—ŐŒŸ•”, 7Š´őŠÇ—Žş): ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď (2016/6/10), _ŒË. ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď´˜^W 2016/6; p.169.

723524. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ_ƒvƒgƒ}ƒCƒVƒ“8 mg/kg“Š—^‚ĚˆŔ‘SŤ‚Ć—LŒřŤ. “ŕŽRŸ•ś1, ‚ŽR—zŽq2, ˜a“c ’B•F3, ’†‘şłŽ÷4, “ń–{–öL5, ‘ĺěŒ´—TŽ÷6, •őŠÝ—mŽŸ˜Y7, ‰Ô–؏G–ž, ‚‘ŠťŽm1 (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4ˆă—ÉqśŠw•”, 5—ŐŒŸ•”, 6–ňÜ•”, 7‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď (2016/6/10), _ŒË. ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď´˜^W 2016/6; p.170.

723525. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ_ƒvƒgƒ}ƒCƒVƒ“’ኴŽóŤMSSA‚Ş•Ş—Ł‚ł‚ę‚˝‘ĺ‘ڍœ“]Žq•”œÜpŒăŠ´ő‚Ě1—á. ’†‘şłŽ÷1, “ŕŽRŸ•ś2, ‚ŽR—zŽq3, ˆŔ’B@÷4, “ń–{–öL4, ‘ĺěŒ´—TŽ÷5, ˜a“c’B•F6, –k—˘‰p˜Y1, ‰Ô–؏G–ž (1ˆă—ÉqśŠw•”, 2ŽŠO, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4—ŐŒŸ•”, 5–ňÜ•”, 6äPŒ´•aEŠ´ő“ŕ): ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď (2016/6/10), _ŒË.

723526. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) œEŠÖßŠ´őÇ‚ɑ΂ˇ‚éƒ_ƒvƒgƒ}ƒCƒVƒ“8 mg/kg“Š—^‚ĚˆŔ‘SŤ‚Ć—LŒřŤ. “ŕŽRŸ•ś1, ‚ŽR—zŽq2, ˜a“c’B•F3, ’†‘şłŽ÷4, “ń–{–öL5, ‘ĺěŒ´—TŽ÷6, •őŠÝ—mŽŸ˜Y1, ‰Ô–؏G–ž, ťěŒc‰î7, ‚‘ŠťŽm1 (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4ˆă—ÉqśŠw•”, 5—ŐŒŸ•”, 6–ňÜ•”, 7Š´őŠÇ—Žş): ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď (2016/6/10), _ŒË.

723527. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŠ–Œ‘gDƒ}ƒNƒƒtƒ@[ƒW—R—ˆ‚ĚTNF-ƒż‚¨‚ć‚ŃIL-1ƒŔ‚Í•ĎŒ`Ť•GŠÖßÇƒ}ƒEƒX‚ĚŠŠ–Œ‘gD‚É‚¨‚Ż‚éNGF‚Ě”­Œť‚đ§Œä‚ˇ‚é. ‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ˆäă@Œş2, ‘Šě@~1, “ĄŠŞŽőŽq1, “ě’J@~2, ŠâŁ@‘ĺ2, “ŒŽR—玥2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć38‰ń“ú–{áu’ÉŠw‰ď (2016/6/24-25), ŽD–y.

723528. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) TNF-ƒż‚͍œ–Œ×–E‚É‚¨‚Ż‚éNGF”­Œť‚đ§Œä‚ˇ‚é. ŠÖŒű—T”V1, “ŕ“cŒ’‘ž˜Y2, ˆäă@Œş2, ‹{éłs2, “ĄŠŞŽőŽq1, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć38‰ń“ú–{áu’ÉŠw‰ď (2016/6/24-25), ŽD–y.

723529. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ‰ƒbƒgżœ_Œo‘šƒ‚ƒfƒ‹‚ɑ΂ˇ‚évein wrapping‚Ěáu’É‹@˜‚Ě‰đ–ž‚ÉŒü‚Ż‚Ä. œAŕV’ź–ç, “ŕ“cŒ’‘ž˜Y1, ‘şăŒŤˆę, Ü“cƒ‹v, ‹{éłs1, ź‰Y—C‰î, ]Œű@˜a, ˆî–ŃˆęG, —é–؁@“s, —é–ؐ’Ş, ‘‹gˆęŽ÷, ‚‘ŠťŽm1, ‘ĺ’š¸Ži (1ŽŠO): ‘ć38‰ń“ú–{áu’ÉŠw‰ď (2016/6/24-25), ŽD–y.

723530. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹š˜ˆÚs•””j—ôœÜ‚Ć•sˆŔ’čŒ^ĺœœÜ‚đ‡•š‚ľ‚˝’Ä—ŽŠO‚ĚŽĄ—ĂŒoŒą. “Ą–쏯‘ž˜Y1, ‹{éłs1, ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, •ôŒ´Gš2, ź‰YWł1, ‰Í‘ş@’ź1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‹~–˝, 3ˆă—ÉqśŠw•”): ‘ć42‰ń“ú–{œÜŽĄ—ĂŠw‰ď (2016/7/2), “Œ‹ž.

723531. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒeƒƒCƒh’ˇŠú•ž—p‚̖Ɖu•s‘SŠłŽŇ‚É”­Ç‚ľ‚˝”dŽíŤƒmƒJƒ‹ƒWƒAŠ´őÇ‚Ě1—á. X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL2, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y3, ’r“cM‰î3, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć39‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď (2016/7/8), ‰ŞŽR. ‘ć39‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď´˜^W 2016/7; p.104.

723532. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) lHŒŇŠÖßŽüˆÍŠ´ő‚ɑ΂ˇ‚éƒXƒeƒ€‚đ‰ˇ‘ś‚ľ‚˝ŽĄ—Ă–@‚̍H•v. “ŕŽRŸ•ś1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y2, ’r“cM‰î2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć39‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď (2016/7/9), ‰ŞŽR. ‘ć39‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď´˜^W 2016/7; p.141.

723533. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) œ”j‰ó”ńˆË‘śŤ‚Ě‚Ş‚ńŤáu’ÉŽä‹NƒƒJƒjƒYƒ€‚̉đÍ. ‘Šě@~1, “ŕ“cŒ’‘ž˜Y2, ˆäă@Œş2, ‹{éłs2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć34‰ń“ú–{œ‘ăŽÓŠw‰ďŠwpW‰ď^‘ć3‰ńƒAƒWƒA‘ž•˝—mœ‘ăŽÓŠw‰ď‹c (2016/7/23), ‘ĺă.

723534. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) FAIŽčpÇ—á‚É‚¨‚Ż‚éŇ’ōœ”Ő–îó–ĘƒAƒ‰ƒCƒƒ“ƒg‚ĚŒŸ“˘. ‘ĺ’|—IĆ1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ‹{éłs1, X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/28), •Ÿ‰Ş.

723535. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Pian DETECT‚ŞŒŇŠÖßO‘šŠłŽŇ‚ĚŽĄ—Ă•űj‚ĚŒˆ’č‚É—L—p‚Ĺ‚ ‚Á‚˝3Ç—á. ’†˜e[Í1, •Ÿ“‡Œ’‰î2, ˆäă@Œş2, ‹{éłs2, X’JŒőr2, “ŕŽRŸ•ś2, ‚•˝ŽL3, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/28), •Ÿ‰Ş.

723536. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒŇŠÖßO‘šŠłŽŇ‚Ě—Šw“I“Á’Ľ|Š°œ‰PŒ`Ź•s‘SŠłŽŇ‚Ć‚Ě”äŠr|. “cŕV@—Č1, •Ÿ“‡Œ’‰î2, ‚•˝ŽL3, “ŕŽRŸ•ś2, X’JŒőr2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/28), •Ÿ‰Ş.

723537. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ĎŒ`Ť•GŠÖßÇƒ}ƒEƒX‚ĚŠŠ–Œ‘gD‚É‚¨‚˘‚ă}ƒNƒƒtƒ@[ƒW—R—ˆTNF-ƒż‚¨‚ć‚ŃIL-1ƒŔ‚ÍNGF‚Ě”­Œť‚đ§Œä‚ˇ‚é. ‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ‘Šě@~1, “ŒŽR—玥2, ŠâŁ@‘ĺ2, “ě’J@~2, ˆäă@Œş2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/28), •Ÿ‰Ş.

723538. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽŠ‰Ć”–‹ŘäF‚đ—p‚˘‚˝‘ŤŠÖß‹žŽ‹‰şx‘ŃÄŒšp‚̏pŒă•G‹ü‹Č‹Ř—Í. “ŒŽR—玥1, “n粗T”V2, ‘Šě@~3, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v, ŠÖŒű—T”V3, ‚–쏸‘ž˜Y3, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723539. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹žŽ‹‰şPTFL/ATFL/CFLÄŒšp‚ĚŠJ”­: Cadaver‚Ĺ‚ĚŽŽ‚Ý. “ŒŽR—玥1, ‰Ô“c@[, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ŻŽi^‘ž˜Y1, ‚”öšl, ‚‘ŠťŽm1 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723540. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’‹ŒŤƒŠƒXƒtƒ‰ƒ“ŠÖß‘š‚ÉMini Tightrope‚đŽg—pŒăƒ{ƒ^ƒ“‚ލœ‚É–„–v‚ľ‚˝ˆę—á. Œ}@@Šw1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, “n粗T”V3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723541. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}ŤŠúƒŠƒXƒtƒ‰ƒ“ŠÖß‘š‚ɑ΂ľMini Tightrope‚đ—p‚˘‚ÄŽčp‰ß—ż‚ľ‚˝1—á. –Ř“‡ä”Ž, “ŒŽR—玥1, ™Œ´—˛”V (1ŽŠO): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723542. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’‹ŒŤƒŠƒXƒtƒ‰ƒ“x‘Ń‘š‚ɑ΂ľ”–‹ŘäF‚É‚ć‚é”w‘¤EœŠÔE’ꑤƒŠƒXƒtƒ‰ƒ“x‘Ń‚đÄŒš‚ľ‚˝—Žq‚ZƒTƒbƒJ[‘IŽč‚Ě1—á. “ŒŽR—玥1, ™Œ´—˛”V, –Ř“‡ä”Ž, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v, “ŕ“c‘U”Ž, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723543. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •GŠWœ’E‰P‚Ć‘O\Žšx‘Ń’f—ô‚đ“ŻŽž‚Ɏ󏝂ľ‚˝ˆęÇ—á. ‘ş“cK—S1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‚–쏸‘ž˜Y2, ŹŽR’q‹v1, •“cW‹`1, “n粗T”V3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723544. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •G•Ą‡x‘Ń‘š‚ɑ΂ľ“ŻŽí‘gD‚đ—p‚˘ˆę„“I‚ɍČšp‚đs‚Á‚˝ˆę—á. ˆäăG‰î1, ŠâŁ@‘ĺ1, “ŒŽR—玥1, “ě’J@~1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723545. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚ˆĘăřœœŘ‚čp‚ĆŒú‚Ý‚đ”{‚É‚ľ‚˝15 mm•‚Ě“ŻŽíœ•t‚Ť•GŠWäF‚É‚ć‚é’ˇ•űŒ`œEACLÄXXŒšp‚đ“ńŠú“I‚ÉŽ{s‚ľ‚˝1—á. ŻŽi^‘ž˜Y1, “ŒŽR—玥1, ŠâŁ@‘ĺ1, ‘Šě@~2, “ě’J@~1, ‚–쏸‘ž˜Y2, ’†˜e[Í2, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, “n粗T”V3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć8‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2016/7/29), •Ÿ‰Ş.

723546. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŻŽí’°ăřx‘Ń‚đ—p‚˘‚˝•G‘OŠO‘¤x‘Ń (ALL) ÄŒšp‚đŽ{s‚ľ‚˝1—á. ’r“cM‰î1, “ŒŽR—玥2, ‘Šě@~1, ŠâŁ@‘ĺ2, “ě’J@~2, ŒŠ–Ú’q‹I2, •Ÿ“‡Œ’‰î2, “n粗T”V3, ‘q’Ř—ş‘ž4, ‚•˝ŽL3, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3ˆă—ÉqśŠw•”, 4ƒŠƒnƒrƒŠ•”): ‘ć42‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2016/9/16), ŽD–y.

723547. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰đ–UŠw“I2d‘ŠACLÄŒšp‚ÉŽŠ‰Ć”–‹ŘäF‚đ—p‚˘‚˝ŠĎŒŒ“I•G‘OŠO‘¤x‘Ń (ALL) ÄŒšp‚đ’ljÁ‚ľ‚˝Ç—á‚Ě’ZŠúŹŃ. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, “n粗T”V3, ‚•˝ŽL3, –Ř“‡ä”Ž, “n糉pˆę˜Y, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć42‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2016/9/16), ŽD–y.

723548. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹žŽ‹‰ş‘O‹—äCx‘ŃÄŒšp‚̐ŹŃ. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, “n粗T”V3, ‚•˝ŽL3, “n糉pˆę˜Y, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć42‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2016/9/16), ŽD–y.

723549. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŠ–Œ‰Šƒ‚ƒfƒ‹ƒ}ƒEƒX‚É‚¨‚˘‚ăAƒhƒŒƒmƒƒfƒ…ƒŠƒ“‚ÍIL-1B‚ĚƒlƒKƒeƒBƒuƒtƒB[ƒhƒoƒbƒN‹@\‚ÉŠÖ—^‚ˇ‚é. ‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ‘Šě@~1, Œ}@@Šw2, “ě’J@~2, ŠâŁ@‘ĺ2, “ŒŽR—玥2, ˆäă@Œş2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć35‰ń“ú–{‰^“ŽŠíˆÚAEÄśˆăŠwŒ¤‹†‰ď (2016/9/24), L“‡.

723550. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŠ–Œ‘gDƒ}ƒNƒƒtƒ@[ƒW—R—ˆ‚ĚIL-1B‚Í•ĎŒ`Ť•GŠÖßÇƒ}ƒEƒX‚Ě‚Š‚Šނ­‘gD‚É‚¨‚Ż‚éƒJƒ‹ƒVƒgƒjƒ“ˆâ“`ŽqŠÖ˜Aƒyƒvƒ`ƒhŽó—e‘Ě‚Ě”­Œť‚đ§Œä‚ˇ‚é. ‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ˆäă@Œş2, ‘Šě@~1, “ĄŠŞŽőŽq1, “ě’J@~2, ŠâŁ@‘ĺ2, “ŒŽR—玥2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723551. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ńŒĂ“T“IWntŒo˜H‚É‚ć‚éä`‘ŃŒŒŠÔ—tŒnŠ˛×–E‚Ě“îœ•Ş‰ť§Œä. “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, —é–؍š‰p, ‚‘ŠťŽm1 (1ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723552. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ĎŒ`Ť•GŠÖßÇ‚ĚŠŠ–Œ‘gD‚É‚¨‚˘‚ÄCOX-2/PGE2Œo˜H‚̓Jƒ‹ƒVƒgƒjƒ“ˆâ“`ŽqŠÖ˜Aƒyƒvƒ`ƒh‚Ě”­Œť‚đ§Œä‚ˇ‚é. “ě’J@~1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‘Šě@~2, ‚–쏸‘ž˜Y2, ‹{éłs1, “ĄŠŞŽőŽq2, ŠâŁ@‘ĺ1, ˆä‘ş‹M”V1, “ŒŽR—玥1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723553. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) TAK1‚É‚ć‚éŇ‘ƒ~ƒNƒƒOƒŠƒAŠˆŤ§Œä‹@\‚̉đ–ž. “ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723554. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) TNF-ƒż‚͍œ–Œ×–E‚É‚¨‚Ż‚éNGF”­Œť‚đ§Œä‚ˇ‚é. ŠÖŒű—T”V1, “ŕ“cŒ’‘ž˜Y2, ˆäă@Œş2, ‹{éłs2, ‘Šě@~1, “ĄŠŞŽőŽq1, ‚–쏸‘ž˜Y1, –ź‘q’źd1, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723555. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ×–E”zŒüŤƒRƒ‰[ƒQƒ“ƒ`ƒ…[ƒu‚É‚ć‚é––˝_ŒoÄś|ƒi[ƒuƒŠƒbƒWTM‚Ć‚Ě”äŠrŒŸ“˘|. “ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ‘ĺ’š¸Ži, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723556. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ‰ƒbƒgżœ_Œo‘šƒ‚ƒfƒ‹‚ɑ΂ˇ‚évein wrapping‚Ě’Á’É‹@˜‚Ě‰đ–ž‚ÉŒü‚Ż‚Ä. œAŕV’ź–ç, “ŕ“cŒ’‘ž˜Y1, ‘şăŒŤˆę, Ü“cƒ‹v, ‹{éłs1, ź‰Y—C‰î, ˆî–ŃˆęG, —é–؁@“s, ŽR“ŕ‚Š‚Ă‘ă, ˛“Ą@~, Ôâ•ü‘ă, ˆäă@Œş1, —é–ؐ’Ş, ‘‹gˆęŽ÷, ‚‘ŠťŽm1, ‘ĺ’š¸Ži (1ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723557. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) œ‘—R—ˆ–Ɖu—}§×–E‚Í‚Ş‚ńŤáu’É‚ÉŠÖ—^‚ˇ‚é. ‘Šě@~1, “ŕ“cŒ’‘ž˜Y2, “V–ě‰pŽ÷3, ˛“ĄˆĐ•ś4, ‹{éłs2, ”n“ˆł—˛3, ˆäă@Œş2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3–ň—, 4”ĺ”AŠí): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723558. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‹KƒRƒ‰[ƒQƒ“Œ‹‡Œ^üˆŰ‰č×–E‘BˆöŽq‚É‚ć‚鍜Œ`Ź‘Łi–@‚ĚŠJ”­. ŠÖŒű—T”V1, “ŕ“cŒ’‘ž˜Y2, ˆäă@Œş2, ‘Šě@~1, âV“Ą@˜j2, ‹{éłs2, ź‰ş@ŽĄ, “ĄŠŞŽőŽq1, ‚–쏸‘ž˜Y1, –ź‘q’źd1, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723559. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Transforming growth factor beta-activated kinase 1‚ÍŠŠ–Œ×–E‚É‚¨‚Ż‚éƒ}ƒgƒŠƒbƒNƒX•Ş‰đy‘f‚Ćáu’ÉŠÖ˜AˆöŽq‘o•ű‚Ě”­Œť‚đ§Œä‚ˇ‚é. “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, “ě’J@~1, ‚–쏸‘ž˜Y2, ‘Šě@~2, ŠâŁ@‘ĺ1, “ŒŽR—玥1, ‹{éłs1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723560. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ}ƒNƒƒtƒ@[ƒW‚ŞŽYś‚ľ‚˝‰ŠÇŤƒTƒCƒgƒJƒCƒ“‚Ş’ĹŠÔ”Â×–E‚đŽhŒƒ‚ľ, ŠeŽíŹ’ˇˆöŽqŽYś‚𑣐i‚ˇ‚é: ’ŊԔŤ˜’É”­ś‹@˜‚ĚŒŸ“˘. ‹{éłs1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, “ĄŠŞŽőŽq2, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723561. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘O—§‘B‚Ş‚ń×–EŠ”RM9‚͍œ‹zŽű”ńˆË‘śŤ‚ɐҐ‘_ŒoŒăŞ_Œoß‚É‚¨‚Ż‚éƒJƒ‹ƒVƒgƒjƒ“ˆâ“`ŽqŠÖ˜Aƒyƒvƒ`ƒhŽó—e‘Ě‚Ě”­Œť‚đă¸‚ł‚š‚é. ‘Šě@~1, “ŕ“cŒ’‘ž˜Y2, “V–ě‰pŽ÷3, ˛“ĄˆĐ•ś4, ‹{éłs2, ”n“ˆł—˛3, ˆäă@Œş2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3–ň—, 4”ĺ”AŠí): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/13-14), •Ÿ‰Ş.

723562. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚Ć16SrRNA—zŤ—á‚ĚƒV[ƒPƒ“ƒX‰đÍ‚đ—p‚˘‚˝×‹ŰŠ´őf’f‚Ě–đŠ„|×‹Ű”|—{ŒŸ¸‚Ć‚Ě”äŠr|. “ŕŽRŸ•ś1, ŸNˆäŒc‘˘2, •őŠÝ—mŽŸ˜Y3, X’JŒőr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, ’r“cM‰î3, Žë–ě—Lě4, ‚•˝ŽL5, ‚‘ŠťŽm1 (1ŽŠO, 2—ŐŒŸ•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4—ŐŒŸŠw, 5ˆă—ÉqśŠw•”): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/14), •Ÿ‰Ş, “ú–{ŽŒ`ŠO‰ČŠw‰ďŽ 2016/12; 90 (8): S1716.

723563. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚đ—p‚˘‚˝ŽŒ`ŠO‰Č—ĚˆćŠ´őÇf’f‚ĚŽŽ‚Ý. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś2, ŸNˆäŒc‘˘3, “ń–{–öL3, Žë–ě—Lě4, •Ÿ“‡Œ’‰î2, ŽR–{‹–ž2, X’JŒőr2, ’r“cM‰î1, ‚•˝ŽL5, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3—ŐŒŸ•”, 4—ŐŒŸŠw, 5ˆă—ÉqśŠw•”): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/14), •Ÿ‰Ş, “ú–{ŽŒ`ŠO‰ČŠw‰ďŽ 2016/12; 90 (8): S1819.

723564. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŠ–Œ“ŕ‰ŠÇŤƒTƒCƒgƒJƒCƒ“‚Ě”­Œť‚ÍŒŇŠÖß‹žŽ‹‰şŽčp‚Ě—\Œă—\‘ވöŽq‚Ć‚Č‚é‚Š. •Ÿ“‡Œ’‰î1, ˆäă@Œş1, “ĄŠŞŽőŽq2, “ŕ“cŒ’‘ž˜Y1, ‹{éłs1, X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć31‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/10/14), •Ÿ‰Ş.

723565. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹlŇ’Œ•ĎŒ`ŽčpŒă‚ĚŒĹ’č‹ßˆĘ’[œÜ‚ÉŠÖ‚ˇ‚錟“˘. ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć25‰ń“ú–{Ň’ĹƒCƒ“ƒXƒgƒDƒ‹ƒƒ“ƒe[ƒVƒ‡ƒ“Šw‰ď (2016/10/28), ’ˇč.

723567. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹlŇ’Œ•ĎŒ`Žčp‚É‚¨‚˘‚ÄS2 alar screw‚ĚŒĹ’čŤ‚Í•s\•Ş‚Š. ˆäă@Œş1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ’†ŕVr”V1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć25‰ń“ú–{Ň’ĹƒCƒ“ƒXƒgƒDƒ‹ƒƒ“ƒe[ƒVƒ‡ƒ“Šw‰ď (2016/10/29), ’ˇč.

723568. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹š˜ˆÚs•””j—ôœÜ‚Ć•sˆŔ’čŒ^ĺœœÜ‚đ‡•š‚ľ‚˝’Ä—ŽŠOŽĄ—Ă‚ĚŹŒoŒą. ‹{éłs1, ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, •ôŒ´Gš2, ź‰YWł1, ‰Í‘ş@’ź1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‹~–˝, 3ˆă—ÉqśŠw•”): ‘ć25‰ń“ú–{Ň’ĹƒCƒ“ƒXƒgƒDƒ‹ƒƒ“ƒe[ƒVƒ‡ƒ“Šw‰ď (2016/10/29), ’ˇč.

723569. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒŇŠÖßŽžŠł‚ŞŇ’ĹƒAƒ‰ƒCƒƒ“ƒg‚É‹y‚Ú‚ˇ‰e‹ż. ‹{éłs1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć25‰ń“ú–{Ň’ĹƒCƒ“ƒXƒgƒDƒ‹ƒƒ“ƒe[ƒVƒ‡ƒ“Šw‰ď (2016/10/29), ’ˇč.

723570. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŤŠEŒ^Š°œ‰PŒ`Ź•s‘S (borderline dysplasia) ‚É‚¨‚Ż‚éŠÖß“K‡Ť‚Ě•]‰ż. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, X’JŒőr1, “ŕŽRŸ•ś1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć43‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2016/11/4), ‘ĺă.

723571. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •Đ‘¤•ĎŒ`ŤŒŇŠÖßÇŠłŽŇ‚É‚¨‚Ż‚銼ó–ĘŇ’ĹƒAƒ‰ƒCƒƒ“ƒg‚ĚŒŸ“˘. X’JŒőr1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ‹{éłs1, ŽR–{‹–ž1, “ŕŽRŸ•ś1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć43‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2016/11/4), ‘ĺă. ‘ć43‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď´˜^W 2016/11; p.307.

723572. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •xŽmŽs’†ŠwZ‰^“Ž‰ďŽí–ځu‚Ţ‚Š‚Ĺ‹Ł‘ˆv‚ĚŠO’˛¸: 2015”N‚Ü‚Ĺ‚Ě5”NŠÔ‚̉đÍ. “ŒŽR—玥1, Ż@‰Ŕ–F2 (1ŽŠO, 2‰qś): ‘ć27‰ń“ú–{—Տ°ƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2016/11/5), ç—t.

723573. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •Đ‘¤ƒnƒ€ƒXƒgƒŠƒ“ƒOäF‚đ—p‚˘‚Ä—ź‘¤‹žŽ‹‰ş‘O‹—äCx‘сEćůäCx‘ŃÄŒšp‚đŽ{s‚ľ‚˝1—á. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, ŒŠ–Ú’q‹I1, “n粗T”V3, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—Տ°ƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2016/11/6), ç—t.

723574. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Resident's Tip‚ć‚艓ˆĘ‚ÉäCœœE‚đěŹ‚ľ‚˝‹žŽ‹‰ş‘O‹—äCx‘сEćůäCx‘ŃÄŒšp‚Ě’ZŠúŹŃ. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ŻŽi^‘ž˜Y1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć41‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ďEŠwpW‰ď (2016/11/17), “Ţ—Ç.

723575. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŻŽí‘ĺ‘Ú‹Ř–Œ‚đ—p‚˘‚Ä—ź‘¤“ŻŽž‚É‹žŽ‹‰ş‘O‹—äCx‘сEćůäCx‘ŃÄŒšp‚đŽ{s‚ľ‚˝1—á. “ŒŽR—玥1, ‘P•˝“N•v, ‰Ô“c@[, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć41‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ďEŠwpW‰ď (2016/11/18), “Ţ—Ç.

723576. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽŠ‰Ć”–‹ŘäF‚đ—p‚˘‚Ä‘ŤŠÖß‹žŽ‹‰şŒă‹—äCx‘сE‘O‹—äCx‘сEćůäCx‘ŃÄŒšp‚đŽ{s‚ľ‚˝1—á. “ŒŽR—玥1, ‰Ô“c@[, ‘P•˝“N•v, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć41‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ďEŠwpW‰ď (2016/11/18), “Ţ—Ç.

723577. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) S2 alar screw‚đ”ö‘¤ŒĹ’č’[‚É—p‚˘‚˝ŹlŇ’Œ•ĎŒ`Žčp—á‚ĚŒŸ“˘. ˆäă@Œş1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ’†ŕVr”V1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć7‰ń“ú–{ŹlŇ’Œ•ĎŒ`Šw‰ď (2017/3/5), “Œ‹ž.

723578. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—îŽŇœ‘e頏NJłŽŇ‚É‚¨‚Ż‚éŇ’ĹƒAƒ‰ƒCƒƒ“ƒg‚ƍœ–§“x‚Ć‹Ř“÷—Ę‚ĚŠÖŒW. ‹{éłs1, “ĄŠŞŽőŽq2, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, “ŕ“cŒ’‘ž˜Y1, ”’ŕV‰hŽ÷1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŹlŇ’Œ•ĎŒ`Šw‰ď (2017/3/5), “Œ‹ž.

731104. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) FAI. •Ÿ“‡Œ’‰î (ŽŠO): ‘ć8‰ńJOSKASƒZƒ~ƒi[ (2016/7/30), •Ÿ‰Ş.

731105. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŇŠÖß‚̐g‘̏ŠŒŠ‚ĚŽć‚č•ű. •Ÿ“‡Œ’‰î (ŽŠO): ‘ć8‰ńJOSKASƒZƒ~ƒi[ (2016/7/30), •Ÿ‰Ş.

731106. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Evidence‚Š‚ç‚Ý‚éFAI|•ĎŒ`ŤŒŇŠÖßÇf—ĂƒKƒCƒhƒ‰ƒCƒ“‰ü’ů‚đ‚Ó‚Ü‚Ś‚ā|. •Ÿ“‡Œ’‰î (ŽŠO): ‘ć12‰ń“ú–{ŒŇŠÖß‹žŒ¤‹†‰ď (2016/9/4), •lź.

732047. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘ŤŠÖß‹žŽ‹‰şx‘ŃÄŒšp‚Ö‚Ě’§í. “ŒŽR—玥 (ŽŠO): ‘ć32‰ń_“ސ쐎Œ`ŠO‰ČŽčpŽč‹ZŒ¤‹†‰ď (2016/6/17), ‰Ą•l.

732048. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘ĺ‘ڍœœŘ‚čp. X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL2, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y3, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć65‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/9/22), ” Ş. ‘ć65‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď´˜^W 2016/9; p.206.

732049. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “ŻŽíˆÚAœ‚đ—p‚˘‚˝lHŒŇŠÖßÄ’uŠˇp‚ĚƒRƒc‚Ć—Ž‚Ć‚ľŒŠ. “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, X’JŒőr1, •őŠÝ—mŽŸ˜Y2, ’r“cM‰î2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć65‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/9/23), ” Ş. “Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ďŽGŽ 2016/9; 3(28): p.249.

732050. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) lH•GŠÖß‘S’uŠˇpŽž‚ĚăřœƒRƒ“ƒ|[ƒlƒ“ƒgÝ’u‚É‚¨‚Ż‚éƒRƒ“ƒ|[ƒlƒ“ƒg‚ĚŠO‘¤•ĎˆĘ. č•”@Œ›1, •˝ě‹IŽq1, ŹŁNŽĄ1, “ŕ–쐳—˛1 (1ŽŠO): ‘ć37‰ńƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (2017/3/11), “Œ‹ž.

732051. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) DupuytrenSk‚ɑ΂ˇ‚éŠO‰Č“IŽĄ—Ă–@‚ĚŒŸ“˘. ŹŔŒŤŽĄ1, •ě_Žm1, •“cW‹`1, ‹´’܍F“T1, ‘ĺ’|—IĆ1, Ź—Ń–žł, ‚‘ŠťŽm1 (1ŽŠO): ‘ć57‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2017/3/17), “Œ‹ž.

732052. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒfƒmƒXƒ}ƒu‚Ş‘tŒ÷‚ľ‚˝Ň’ōœ‹×–EŽî‚Ě2—á. “cŕV@—Č1, ˆäă@Œş2, ’†ŕVr”V2, ˆä‘ş‹M”V2, ‹{éłs2, âV“Ą@˜j2, ”’ŕV‰hŽ÷2, ‚‘ŠťŽm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć57‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2017/3/18), “Œ‹ž.

733283. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) FBSS‚ƂȂ萏lŇ’Œ•ĎŒ`Žčp‚ÖŽŠ‚Á‚˝ˆęÇ—á. ˆäă@Œş (ŽŠO): ‘ć90‰ń_“ސěŇ’ŐҐ‘Œ¤‹†‰ď (2016/6/3), _“ސě.

733284. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’‹ŒŤƒŠƒXƒtƒ‰ƒ“ŠÖß‘š‚ÉMini Tightrope‚đŽg—pŒăƒ{ƒ^ƒ“‚ލœ‚É–„–v‚ľ‚˝1—á. Œ}@@Šw1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć157‰ń_“ސ쐎Œ`ĐŠQŠO‰ČŒ¤‹†‰ď (2016/6/18), ‰Ą•l.

733285. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ACL’P“ĆÄŒš‚ĆACLEALL“ŻŽžÄŒšŒă‚̏pŒăŒo‰ß‚ɂ‚˘‚Ä‚ĚŒŸ“˘. “y‰Žj‹I, “y‰Ž‹•˝, “n糉pˆę˜Y, “ŒŽR—玥1 (1ŽŠO): ‘ć20‰ńĂ‰ŞŒ§—Šw—Ă–@ŽmŠw‰ď (2016/6/19), Ŕ’Ă.

733286. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ACL, ALL“ŻŽžÄŒšpŒă‚Ě1Ç—á`ŠÖß‰Â“Žˆć‚É’…–Ú‚ľ‚ā`. “y‰Ž‹•˝, “y‰Žj‹I, “n糉pˆę˜Y, “ŒŽR—玥1 (1ŽŠO): ‘ć20‰ńĂ‰ŞŒ§—Šw—Ă–@ŽmŠw‰ď (2016/6/19), Ŕ’Ă.

733287. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒtƒHƒ‹ƒNƒ}ƒ“Sk‚ɑ΂ľ‚Ämuscle sliding operation‚đŽ{s‚ľ‚˝1—á. “팴Œ’Žj1, ŹŔŒŤŽĄ1, ‰Ş“c‹M[, •ě_Žm1, ŒŠ–Ú’q‹I1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď (2016/6/25), “Œ‹ž.

733288. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽŠ•Ş‚Ĺ‚â‚Á‚Ä‚Ý‚˝Surgical Hip Dislocaton‚Ćƒxƒ‹ƒ“‚Ĺ‚â‚Á‚Ä‚˘‚˝Surgical Hip Dislocation. ŽR–{‹–ž1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, X’JŒőr1, •őŠÝ—mŽŸ˜Y2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): Hip Forum 2016 (2016/7/29), Ž ‰ę.

733289. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹Ů‹}Žčp‚Ć‚ľ‚Ĉľ‚í‚ę‚鍂—îŽŇ‘ĺ‘ڍœ‹ŕˆÝ•”œÜ‚ĚŒťó. č•”@Œ›1, “ŕ–쐳—˛1, •˝ě‹IŽq1, ŹŁNŽĄ1 (1ŽŠO): –k‘Ť—§ŒSŽsˆăŽt‰ďˆăŠw‰ď (2016/10/15), é‹Ę.

733290. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘ĺ‘ڍœ“ŕ‘¤č÷ŠJ•úœÜ‚É‚ć‚Á‚Đś‚ś‚˝L”͈͍œ“Œ‡‘š‚ɑ΂ľ‚Ä“ŻŽíœˆÚAp‚ĆŽŠ‰Ć”|—{“×–EˆÚA‚đ•š—p‚ľ‚˝1—á. č•”@Œ›1, •˝ě‹IŽq1, ŹŁNŽĄ1, “ŕ–쐳—˛1 (1ŽŠO): –k‘Ť—§ŒSŽsˆăŽt‰ďˆăŠw‰ď (2016/10/15), é‹Ę.

733291. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ň’Œ•ĎŒ`Žčp‚É‚¨‚Ż‚éŽüpŠú‚̍H•v. ˆäă@Œş (ŽŠO): ‘ć7‰ń’ˇ‹vŽčŇ’ŐҐ‘ƒZƒ~ƒi[ (2016/10/20), –źŒĂ‰Ž.

733292. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •ęćäŽíŽqœáŠQ‚ɑ΂ľŠÖß‹žŽ‹‰ş“Eop‚đŽ{s‚ľ‚˝ˆę—á. –Ř“‡ä”Ž, “ŒŽR—玥1, “n糉pˆę˜Y, ‚XˆŃ”V, •Đ‹Ë@‘, –xˆä^l, ×ě@ˆč, š˘ˆä–F° (1ŽŠO): ‘ć184‰ńĂ‰ŞŒ§ŽŒ`ŠO‰Čˆă‰ď@W’k‰ď (2016/11/19), Ă‰Ş.

733293. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •xŽmŽs’†ŠwZ‰^“Ž‰ďŽí–ځu‚Ţ‚Š‚Ĺ‹Ł‘–v‚ĚŠO’˛¸: 7”NŠÔ‚Ě—đŽj. “ŒŽR—玥1, ŒŠ–Ú’q‹I1, ‹{éłs1, ˆäă@Œş1, ‚‘ŠťŽm1, –Ř“‡ä”Ž, –xˆä^l, ‚XˆŃ”V, š˘ˆä–F°, “n糉pˆę˜Y (1ŽŠO): ‘ć1346‰ńç—tˆăŠw‰ďŽŒ`ŠO‰Č—á‰ď (2016/12/11), ç—t.

733294. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) L”͈͕GŠÖßœ“Œ‡‘š‚ɑ΂ˇ‚鎥—Ð헪. č•”@Œ›1, •˝ě‹IŽq1, ŹŁNŽĄ1, “hŽRłG1, ‘ĺ’|—IĆ1, “ŕ–쐳—˛1 (1ŽŠO): ‘ć57‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2017/3/18), “Œ‹ž.

733295. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‚“x‘ĺ‘ڍœ“Ş‚ˇ‚ׂčÇŒă‚ĚSecondary FAI‚ɑ΂ˇ‚é“–‰@‚ĚŽĄ—Ð헪. X’JŒőr1, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ŽR–{‹–ž1, •őŠÝ —mŽŸ˜Y2, ’r“cM‰î2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć57‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2017/3/18), “Œ‹ž. ‘ć57‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď´˜^W 2017/3; p.138.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-320001. [Ç—á•ń] lH•GŠÖß‘S’uŠˇp (TKA) ŠłŽŇ‚É‚¨‚Ż‚é•GŠWäFÄŒšpŒă‚ĚŠ´ő‚ɑ΂ˇ‚éSalvageŽčp. ‘Šě@~1, ŠâŁ@‘ĺ2, “ŒŽR—玥2, “ě’J@~2, •őŠÝ—mŽŸ˜Y2, ‚–쏸‘ž˜Y1, ŹŁNŽĄ2, •ôŒ´Gš3, ‚‘ŠťŽm2, č•”@Œ›2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3‹~–˝) “ú–{ŠÖß•aŠw‰ďŽ 2014; 33 (2): 189-94.

H27-110013. [Œ´’˜] A Cadaver Study of Median-to-Radial Nerve Transfer for Radial Nerve Injuries. Sukegawa K1, Suzuki T, Ogawa Y, Kobayashi T, Matsuura Y, Kuniyoshi K: J Hand Surg Am 2016/1; 41 (1): 20-6. (•ě_Žm1: 1ŽŠO)

H27-110014. [Œ´’˜] Synovial macrophage-derived IL-1ƒŔ regulates the calcitonin receptor in osteoarthritic mice. Takano S1, Uchida K2, Miyagi M2, Inoue G2, Aikawa J1, Fujimaki H1, Minatani A2, Sato M3, Iwabuchi K3, Takaso M2: Clin Exp Immunol 2016/1; 183 (1): 143-9. (‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ˆäă@Œş2, ‘Šě@~1, “ĄŠŞŽőŽq1, “ě’J@~2, ˛“Ą@‰ë3, ŠâŸş˜a–ç3, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3–Ɖu)

H27-110015. [Œ´’˜] Elevation of Microglial Basic Fibroblast Growth Factor Contributes to Development of Neuropathic Pain after Spinal Nerve Ligation in Rats. Fujimaki H1, Inoue G2, Uchida K2, Miyagi M2, Saito W2, Sato A, Takaso M2: Spine (Phila Pa 1976) 2016/2; 41 (3): E108-15. (“ĄŠŞŽőŽq1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, âV“Ą@˜j2, ˛“Ą–ƒŽq, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

H27-110016. [Œ´’˜] Protective effects of pressurized xenon gas against cold damage in a cell monolayer. Seino K1, Sato K2, Kawaguchi S2, Kiyokawa S2, Uchida K3, Ujihira M2: Kitasato Med J 2016/3; 46 (1): 73-80. (Â–ě‰ŔŘŽq1, ˛“Ąq‘ž2, ěŒűăĎq2, ´ěš–ë‰Ô2, “ŕ“cŒ’‘ž˜Y3, Ž•˝­L2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ŽŠO)

H27-120002. [Œ´’˜] ă˜rœ‹ßˆĘ•”œÜ‚ɑ΂ˇ‚é‹tsŤ‘“ŕ“B‚ĚŒĹ’čŤ•]‰ż. Žđˆä—˜“Ţ1, “ŕ–쐳—˛2, ˆÉ“Ą‘ĺŠí, “c’†Œ’˝, ’†”öŤ‹P, –{–ź”ü‰Ŕ, ŽR“c‘ńĆ, č•”@Œ›2, ŒÜ–Ą@•×1, ”nŸş´Ž‘1 (1ˆă—ÉqśŠw•”, 2ŽŠO): ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ďŽ 2016/2; 40 (2): 131-6.

H27-320002. [Ç—á•ń] ƒAƒŒƒ“ƒhƒƒl[ƒg‚Ş’˜Œř‚ľ‚˝SAPHOÇŒóŒQ‚Ě1—á. —é–ؐ’Ş, š ‹gˆęŽ÷, ź‰Y—C‰î, Š`č@, •ě_Žm1, Źě‘׎j1, Ź—Ń—ĎŽq, ˆŔ•”@—ć, –Ř“ŕ@‹Ď, ă–ěŒ[‰î, Ôâ•ü‘ă, ‹ŕ’ˁ@Ę, ‚‹´˜a‹v (1ŽŠO): ç—tˆăŠwŽGŽ 2015/10; 91 (5): 29-32.

[’˜@‘]

H18-620002. [Šwp‘ (•Ş’SŽˇ•M)]y‘Ě‘€—Ă–@ƒI[ƒ‹ƒuƒbƒN@‚Đ‚Ć‚ß‚Ĺ‚í‚Š‚éŒř‰Ę“I‚Č‹Ř‚ĚŽg‚˘•űz06 •G’ɁEꋌa•”’É (ƒOƒ[ƒCƒ“ƒyƒCƒ“) ‚Ě‘Ě‘€. “ŒŽR—玥 (ŽŠO), •Ň: ‚•˝ŽL, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/3”­s.

H18-620003. [Šwp‘ (•Ş’SŽˇ•M)]y‘Ě‘€—Ă–@ƒI[ƒ‹ƒuƒbƒN@‚Đ‚Ć‚ß‚Ĺ‚í‚Š‚éŒř‰Ę“I‚Č‹Ř‚ĚŽg‚˘•űz07 ‘ŤŠÖßE‘Ť’É‚Ě‘Ě‘€, p.82-7. “ŒŽR—玥 (ŽŠO), •Ň: ‚•˝ŽL, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723021. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •I•”ŠÇÇŒóŒQ‚đ‡•š‚ľ‚˝¸__ŒoŽžŠłœëŠłŠłŽŇ‚Ě—U”­‹Ř“d}‚ƐS“d}‚ĚŒŸ“˘. ŹŔŒŤŽĄ1, ŒŠ–Ú’q‹I1, ’†˜e[Í2, ŹŽR’q‹v1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć28‰ń“ú–{•IŠÖßŠw‰ďŠwpW‰ď (2016/2/12), ‰ŞŽR.

H27-723022. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) CT based Navigation‚đ—p‚˘‚čs‚Á‚˝TES‚̏ŹŒoŒą. ˆäă@Œş1, ˆä‘ş‹M”V1, ‹{éłs1, ’†ŕVr”V1, âV“Ą@˜j1, “cŕV@—Č2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć10‰ń“ú–{CAOSŒ¤‹†‰ď (2016/3/25), Œ˘ŽR.

H27-731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚ł‚Ü‚´‚܂ȐҒŒ•ĎŒ`‚ɑ΂ˇ‚鎥—Ă. ‚‘ŠťŽm (ŽŠO): Ă‰ŞŽŒ`ŠO‰ČŒ¤‹†‰ď (2015/6/5), •lź.

H27-731003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ň’Œ•ĎŒ`‚̐f’f‚ĆŽĄ—Ă. ‚‘ŠťŽm (ŽŠO): ‘ĺăƒIƒ‹ƒ\ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/9/17), ‘ĺă.

H27-731004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ň’Œ•ĎŒ`‚̐f’f‚ĆŽĄ—Ă. ‚‘ŠťŽm (ŽŠO): —ű”nŒő‚Ş‹u•a‰@‰@“ŕŒ¤C‰ď (2015/10/7), “Œ‹ž.

H27-733007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •G‘OŠO‘¤čŐ‘Ń (ALL) ÄŒšpŽž‚Ě‘ĺ‘ڍœœEěŹ‚É‚¨‚Ż‚é2‚Â‚ĚƒAƒvƒ[ƒ`–@‚Ě”äŠr. “ŒŽR—玥1, “n糉pˆę˜Y, ‚XˆŃ”V, –Ř“‡ä”Ž, Ź‘]Ş‰p, š˘ˆä–F° (1ŽŠO): ‘ć182‰ńĂ‰ŞŽŒ`ŠO‰Čˆă‰ďW’k‰ď (2016/3/19), ŽO“‡.


Œ`ŹŠO‰ČE”ü—eŠO‰ČŠw

[Šwp˜_•ś]

110228. [Œ´’˜] Bioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model. Takagi R, Ishimaru J, Sugawara A, Toyoshima KE, Ishida K, Ogawa M, Sakakibara K, Asakawa K, Kashiwakura A, Oshima M, Minamide R, Sato A1, Yoshitake T1, Takeda A1, Egusa H, Tsuji T: Sci Adv 2016/4; 2 (4): e1500887. (˛“Ą–ž’j1, ‹g’|r—T1, •“c@Œ[1: 1Œ`ŹE”üŠO)

[’˜@‘]

620105. [Šwp‘ (•Ş’SŽˇ•M)]yŽčEăŽˆ‚Ě‘gD‘šEŒ‡‘šŽĄ—Ăƒ}ƒjƒ…ƒAƒ‹ (PEPARS No.144)zŽwë•”Œ‡‘š‚ɑ΂ˇ‚鎥—Ă, p.8-17. Ş–{@[1, ŒFŕVŒ›ˆę2, •“c@Œ[1 (1Œ`ŹE”ü—eŠO, 2‹~–˝), ‘S“ú–{•a‰@o”ʼnď, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712025. [Šw‰ď (‘Ű)] (ƒpƒlƒ‹ƒZƒbƒVƒ‡ƒ“) Secondary rhinoplasty using diced cartilage wrapped with tempral fascia. Takeda A1, Nakakita N, Furuyama N, Ishikawa S1, Sugimoto T1, Sugimoto Y1, Shimakura Y1: The 13th Japan-Korea Congress of Plastic and Reconstructive Surgery (2016/5/17), Ishikawa, Japan. (•“c@Œ[1, ÎěS‰î1, ™–{F”V1, ™–{‰Ŕ1, “‡‘qNl1: 1Œ`ŹE”üŠO)

713109. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Availability of conditioned medium from human autologous bone-derived mesenchymal cells -Experimental study-. Yamazaki Y1, Sugimoto T1, Sone Y2, Takeda A1: 10th World Biomaterial Congress (2016/5/20), Montreal, Canada. (ŽRčˆŔ°1, ™–{F”V1, ‘]Ş—R”üŽq2, •“c@Œ[1: 1Œ`ŹE”üŠO, 2•a‘ԁEf—ĂŒn)

713110. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Cytogenetic safety of hBT-MSCs after long-term cryopreservation. Sugimoto T1, Yamazaki Y1, Kumazawa K2, Sone Y3, Takeda A1: 10th World Biomaterial Congress (2016/5/20), Montreal, Canada. (™–{F”V1, ŽRčˆŔ°1, ŒFŕVŒ›ˆę2, ‘]Ş—R”üŽq3, •“c@Œ[1: 1Œ`ŹE”üŠO, 2‹~–˝, 3•a‘ԁEf—ĂŒn)

713111. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Effects of Collagen Binding Domain (CBD) - VEGF on TRAM Flap Viability in a Rat Model. Kounoike N1, Akimoto M1, Sone Y2, Takeda A1, Matsushita O: The 5th World Congress of the World Union of Wound Healing Societies (2016/9/25), Firenze, Italy. (ƒ’r“Ţ’ĂŽq1, H–{•ôŽ1, ‘]Ş—R”üŽq2, •“c@Œ[1: 1Œ`ŹE”üŠO, 2•a‘ԁEf—ĂŒn)

713112. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Long-term Results of Surgical Excision Using Tissue Expander Only For Congenital Giant Nevus. Takeda A1, Kounoike N1, Akimoto M1, Park K1, Nemoto M1, Sezaki K1: The 5th World Congress of the World Union of Wound Healing Societies (2016/9/25), Firenze, Italy. (•“c@Œ[1, ƒ’r“Ţ’ĂŽq1, H–{•ôŽ1, –p@Œ\ˆę1, Ş–{@[1, ŁčWˆę˜Y1: 1Œ`ŹE”üŠO)

713113. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Vascular Endothelial Growth Facotor Receptor 1 (VEGFR1) tyrosine kinase signaling facilitates granulation tissue formation and angiogenesis via recruitment of VEGFR1+ cells from bone marrow. Park K1, Amano H2, Kashiwagi S1, Yamazaki Y1, Shibuya M, Majima M2, Takeda A1: The 5th World Congress of the World Union of Wound Healing Societies (2016/9/25), Firenze, Italy. (–p@Œ\ˆę1, “V–ě‰pŽ÷2, ”–ؐT–ç1, ŽRčˆŔ°1, ”n“ˆł—˛2, •“c@Œ[1: 1Œ`ŹE”üŠO, 2–ň—)

722135. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) dÇŽlŽˆŠJ•úœÜ‚ɑ΂ˇ‚鑁Šú”畆“î•”‘gDÄŒš. Ş–{@[1, ŒFŕVŒ›ˆę2, “ŕ–쐳—˛3, •ôŒ´Gš2, ”–ؐT–ç1, H–{•ôŽ1, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝, 3ŽŠO): ‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/4/13), •Ÿ‰Ş.

722136. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ”ç•Ů‚É‚ć‚é•I•””畆“î•”‘gDÄŒš. Ş–{@[1, ŒFŕVŒ›ˆę2, H–{•ôŽ1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć59‰ń“ú–{ŽčŠO‰ČŠw‰ďŠwpW‰ď (2016/4/21), L“‡.

722137. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ńdáَčp|–„–v–@‚ĚŒŠ’n‚Š‚ç|. “‡‘qNl1, ’r“c‹Óś (1Œ`ŹE”üŠO): ‘ć104‰ń“ú–{”ü—eŠO‰ČŠw‰ď (2016/5/18), “Œ‹ž.

722138. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —ź‘¤ŤOŠ{ŒűŠW—ô‚Ě‹¸łŽĄ—Ă‚đ˘“ď‚Ć‚ˇ‚é—vˆö‚ɂ‚˘‚Ä. •{ěr•F, Ź—ŃáÁŽi, •˝ě@âM, ‘ĺ‘ş@i, ŽRčˆŔ°1, ’šŽ”Ÿs, ‘Oě“ń˜Y (1Œ`ŹE”üŠO): ‘ć40‰ń“ú–{ŒűŠW—ôŠw‰ď‘‰ďEŠwpW‰ď (2016/5/27), ‘ĺă.

722139. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šááىş‚Žčp, Ž„‚ŞŽ¸”s‚Š‚çŠw‚ń‚ž‚ą‚Ć. “‡‘qNl1, ’r“c‹Óś (1Œ`ŹE”üŠO): “ú–{”ü—eŠO‰ČŠw‰ď (JSAPS) ‘ć126‰ńŠwpW‰ď (2016/7/2), VŠƒ.

722140. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Äś–Ń•ďŒ´Šî‚ĚˆÚA°‚Ć‚ľ‚Ä‚Ěƒqƒg”畆ŒnˆÚASCIDƒ}ƒEƒX‚ĚŒŸŘ. ‹g’|r—T1, •“c@Œ[2, Ş–{@[2, H–{•ôŽ2, “‡‘qNl2, ™–{F”V2, ƒ’r“Ţ’ĂŽq2, –öŕVł”V1, Źź’źŽ÷, –L“‡Œö‰h, ’ҁ@@F, ˛“Ą–ž’j (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Œ`ŹE”üŠO): ‘ć25‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/9/15-16), ‘ĺă.

722141. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ”ü—eˆă—Ă‚É‚¨‚Ż‚éƒqƒAƒ‹ƒƒ“Ž_’“ü‚ĚˆĘ’u•t‚Ż. ˛“Ą‰p–ž1, •“c@Œ[2 (1–k—˘Œ¤‹†Š•a‰@, 2Œ`ŹE”üŠO): ‘ć39‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď (2016/10/23-25), ‹ž“s.

723579. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’Ü•”ˆŤŤ•FŽî‚ĚŽčp‚ɂ‚˘‚Ä‚ĚŒŸ“˘. H–{•ôŽ1, Ş–{@[1, ƒ’r“Ţ’ĂŽq1, ’r“cŹ”ü1, Šâě‚ł‚¨‚č1, ‰ş‘şŽŔ‹MŽq1, •ş“Ş“O–ç1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć59‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/4/15), •Ÿ‰Ş.

723580. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒtƒ[ƒYƒ“ƒfƒU[ƒgƒ[ƒJ[‚É‚ć‚鏬Ž™ŽčŠO`‘˝EŽí‚Ě‹Ś—Í‚É‚ć‚č2ŽŸ‘š‚đ–h‚Ź“ž‚˝1—á`. •–ö”ü—˘, Ş–{@[1, ”–ؐT–ç1, ŒFŕVŒ›ˆę2 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć59‰ń“ú–{ŽčŠO‰ČŠw‰ďŠwpW‰ď (2016/4/22), L“‡.

723581. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šááىş‚Žčp‚Ć‚ť‚̏CłŽčp‚ɂ‚˘‚Ä. “‡‘qNl (Œ`ŹE”üŠO): ‘ć104‰ń“ú–{”ü—eŠO‰ČŠw‰ď (2016/5/18), “Œ‹ž.

723582. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “űŒ˘Ž•”˛‹Ž‚ĆŠJ‘‹‚É‚ć‚čŒ˘Ž•–GoáŠQ‚đŽĄ—Ă‚ľ‚˝•Đ‘¤OŠ{ŒűŠW—ô‚Ě3Ç—á. Î“n–ő•v, —é–ŘˆęŽj, ‹´–{KŽĄ, ŽRčˆŔ°1, ™–{F”V1, ’r–{”ɍO, ŁčWˆę˜Y1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć40‰ń“ú–{ŒűŠW—ôŠw‰ď‘‰ďEŠwpW‰ď (2016/5/26), ‘ĺă.

723583. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’†ŘŽ•E‘¤ŘŽ•‚ĚŒ‡‘š‚â–Goó‘Ô‚đl—ś‚ľ‚˝‘ŠúŠ{—ô•”œˆÚA‚Ě’ˇŠú•]‰ż. ™–{F”V1, ŽRčˆŔ°1, Î“n–ő•v, ŁčWˆę˜Y1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć40‰ń“ú–{ŒűŠW—ôŠw‰ď‘‰ďEŠwpW‰ď (2016/5/27), ‘ĺă.

723584. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚é—ź‘¤OŠ{ŒűŠW—ô‚É‚ć‚éŠ{•ĎŒ`Ç‚̏p‘O•]‰ż‚ĆŠî–{pŽŽ‚ɂ‚˘‚Ä. ™–{F”V1, ŽRčˆŔ°1, Î“n–ő•v, ‘Oěr•F, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć26‰ń“Á’č”ń‰c—˜Šˆ“Ž–@l“ú–{Š{•ĎŒ`ÇŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2016/6/24), “Œ‹ž.

723585. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Š{•ĎŒ`Ç‚ɑ΂ľ‚ĉşŠ{Ž}–îó•ŞŠ„p‚ɉşŠ{œ‘Ě•”œŘ‚č‚đ•š—p‚ľ‚˝2Ç—á. ÎěS‰î1, ŽRčˆŔ°1, ™–{F”V1, ’r–{”ɍO, ŽR‰ş—ŠG, ‹{–{@‡, XŽRŒ[Ži, ˆî–ŃŽ ŽŠ, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć26‰ń“Á’č”ń‰c—˜Šˆ“Ž–@l“ú–{Š{•ĎŒ`ÇŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2016/6/24), “Œ‹ž.

723586. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ‹Šj‹Ű‚É‚ć‚é‰óŽ€Ť‹Ř–Œ‰Š‚Ě1—á. ’r“cŹ”ü1, Ş–{@[1, H–{•ôŽ1, ƒ’r“Ţ’ĂŽq1, Šâě‚ł‚¨‚č1, ‰ş‘şŽŔ‹MŽq1, ‘Oě“ń˜Y, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć8‰ń“ú–{‘nŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/7/22), “Œ‹ž.

723587. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) œ‘gDÄśˆă—Ă‚É‚¨‚Ż‚鍜‘gD—R—ˆŠÔ—tŒn×–E‚Ć‚ť‚Ě”|—{ă´‚ĚŽg‚˘•Ş‚Ż. ™–{‰Ŕ1, ŽRčˆŔ°1, ™–{F”V1, ŒFŕVŒ›ˆę2, ‘]Ş—R”üŽq3, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝, 3•a‘ԁEf—ĂŒn): ‘ć25‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/9/15-16), ‘ĺă.

723588. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘nŽĄ–ü‚Ć‚­‚É“÷‰č‘gDŒ`Ź‚É‚¨‚Ż‚éVascular Endothelial Growth Factor Receptor 1 (VEGFR1) ‚Ě–đŠ„. –p@Œ\ˆę1, “V–ě‰pŽ÷2, ”–ؐT–ç1, ŽRčˆŔ°1, ŕF’JłŽj, ”n“ˆł—˛2, •“c@Œ[1 (1Œ`ŹE”üŠO, 2–ň—): ‘ć25‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2016/9/15-16), ‘ĺă.

723589. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒűŠp‹“ăp‚ɂ‚˘‚Ä‚ĚŒŸ“˘. —ŃŒ´LŽĄ1, “‡‘qNl2, ˜e“c‰ÁŒb3 (1—ŃŒ´ˆă‰@, 2Œ`ŹE”üŠO, 3ƒXƒLƒ“ƒ\ƒŠƒ…[ƒVƒ‡ƒ“ƒNƒŠƒjƒbƒN): ‘ć39‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď (2016/10/23-25), ‹ž“s.

723590. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Îpƒ‚ƒfƒ‹‚ÉŠî‚Ă‚˘‚˝ŽčŽwÄŒšŽčpƒfƒUƒCƒ“. Ş–{@[1, ŒFŕVŒ›ˆę2, H–{•ôŽ1, ƒ’r“Ţ’ĂŽq1, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć43‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ďŠwpW‰ď (2016/11/17), L“‡.

723591. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) œ‘gD—R—ˆŠÔ—tŒn×–E‚Ě‘˝•Ş‰ť”\‚ÍŠ{œ‘gD‚Ć’°œ‘gD‚Ĺ‚Íˆá‚¤‚Š? ŽRčˆŔ°1, ‹S’ˁ@—, ™–{F”V1, ŒFŕVŒ›ˆę2, ™–{‰Ŕ1, ”nęŽq, ‘]Ş—R”üŽq3, Šâ“c—˛‹I, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝, 3•a‘ԁEf—ĂŒn): ‘ć16‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2017/3/7), ĺ‘ä.

723592. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚é‘Ť’×ᇊłŽŇ‚Ě‘Šú‘މ@‚Ö‚ĚŽć‚č‘g‚Ý. ˜a“‚ƒ•˝1, –p@Œ\ˆę1, H–{•ôŽ1, Ş–{@[1, •“c@Œ[1, –––ؐ^“Ţ”ü2, źˆäŠG—˘Žq2, Žt‰ŞŒbŽq3, Îˆä—T”ü3, ‘â—R”üŽq3 (1Œ`ŹE”üŠO, 2–k—˘‘ĺŠw•a‰@ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 3ŠĹŒě•”): ‘ć15‰ń“ú–{ƒtƒbƒgƒPƒAŠw‰ď”NŽŸŠwpW‰ď (2017/3/25), ‰ŞŽR.

733296. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”A“š‰ş—ô‚𔺂Á‚˝“ű–[ŠOPaget•a‚Ě1—á. ˜a“‚ƒ•˝1, ƒ’r“Ţ’ĂŽq1, H–{•ôŽ1, •ş“Ş“O–ç1, ŽÂč’qŒö1, •“c@Œ[1 (1Œ`ŹE”üŠO): _“ŢěŒ§Œ`ŹŠO‰ČÇ—ጟ“˘‰ď (2016/6/4), _“ސě.

733297. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —ź‘¤’ˇŽ˛Œ`ŹáŠQ‚Ě1—á. Ş–{@[ (Œ`ŹE”üŠO): ‘ć9‰ńŠÖ“ŒăŽˆć“VˆŮíÇ—ጟ“˘‰ď (2016/7/13), “Œ‹ž.

733298. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Á‰ťŠÇúE‚Ş‹^‚í‚ę‚˝dÇ”M‚Ě1—á. “cŒűŹ”ü, ŒFŕVŒ›ˆę1, Šâě‚ł‚¨‚č2, H–{•ôŽ2, Ş–{@[2, •“c@Œ[2 (1‹~–˝, 2Œ`ŹE”üŠO): ‘ć24‰ńVh”MƒtƒH[ƒ‰ƒ€ (2016/9/9), Vh.

733299. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽĄ—Ă‚É“ďa‚ľ‚˝ƒAƒ‹ƒR[ƒ‹ŤŠĚáŠQ‡•šŽč•””M‚Ě1—á. ˜a“‚ƒ•˝1, ŒFŕVŒ›ˆę2, ƒ’r“Ţ’ĂŽq1, H–{•ôŽ1, Ş–{@[1, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć24‰ńVh”MƒtƒH[ƒ‰ƒ€ (2016/9/9), Vh.

733300. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Effects of Collagen Binding Domain (CBD) - VEGF on TRAM Flap Viability in a Rat Model. ƒ’r“Ţ’ĂŽq1, H–{•ôŽ1, ‘]Ş—R”üŽq2, •“c@Œ[1, ź‰ş@ŽĄ (1Œ`ŹE”üŠO, 2•a‘ԁEf—ĂŒn): ‘ć19‰ń–k—˘Œ`ŹŠO‰ČƒtƒH[ƒ‰ƒ€ (2016/10/10), ‰Ą•l.

733301. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘lŒaƒŠƒ“ƒpßŠs´Œă‚ĚNPWT‚ĚŒŸ“˘. ‰F‰ę_Š”ü1, H–{•ôŽ1, ƒ’r“Ţ’ĂŽq1, –p@Œ\ˆę1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć19‰ń–k—˘Œ`ŹŠO‰ČƒtƒH[ƒ‰ƒ€ (2016/10/10), ‰Ą•l.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522007. [uŔ]y“ÁW: ‰şŠááق̌`Źpz‰şŠááق̂ľ‚í‚Ć‚č. ˛“Ą‰p–ž1, •“c@Œ[2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2Œ`ŹE”üŠO): Œ`ŹŠO‰Č 2016/1; 59 (1): 29-37.


”畆‰ČŠw

[Šwp˜_•ś]

110229. [Œ´’˜] Aging hair follicles rejuvenated by transplantation to a young subcutaneous environment. Cao W, Li L, Kajiura S1, Amoh Y1, Tan Y, Liu F, Hoffman RM: Cell Cycle 2016/4; 15 (8): 1093-8. (Š‰Y’qŽk1, “V‰HN”V1: 1”畆)

110230. [Œ´’˜] Early-age-dependent selective decrease of differentiation potential of hair-follicle-associated pluripotent (HAP) stem cells to beating cardiac-muscle cells. Yamazaki A1, Hamada Y2, Arakawa N2, Yashiro M3, Mii S3, Aki R3, Kawahara K4, Hoffman RM, Amoh Y3: Cell Cycle 2016/10; 15 (19): 2619-25. (ŽRč—•Žq1, •l“c—SŽq2, rěLŽq2, ‰Ž‘㐳W3, ŽOˆäƒá3, ˆŔĺY—Lję3, ‰ÍŒ´Ž‰ë4, “V‰HN”V3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a‘ԁEf—ĂŒn, 3”畆, 4ś—)

110231. [Œ´’˜] Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma. Honda Y, Otsuka A, Ono S1, Yamamoto Y, Seidel JA, Morita S, Hirata M, Kataoka TR, Takenouchi T, Fujii K, Kanekura T, Okubo Y, Takahashi K, Yanagi T, Hoshina D, Hata H, Abe R, Fujimura T, Funakoshi T, Yoshino K, Masuzawa M, Amoh Y1, Tanaka R, Fujisawa Y, Honda T, Kabashima K: Oncoimmunology 2016/11; 6 (1): e1253657. (“V‰HN”V1: 1”畆)

110232. [Œ´’˜] Human hair-follicle associated pluripotent (hHAP) stem cells differentiate to cardiac-muscle cells. Tohgi N1, Obara K1, Yashiro M1, Hamada Y2, Arakawa N2, Mii S1, Aki R1, Hoffman RM, Amoh Y1: Cell Cycle 2017/1; 16 (1): 95-9. (“Œ‹V“ß’ĂŽq1, ŹŒ´GĆ1, ‰Ž‘㐳W1, •l“c—SŽq2, rěLŽq2, ŽOˆäƒá1, ˆŔĺY—Lję1, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ĂŒn)

110233. [Œ´’˜] Hypoxia Enhances Differentiation of Hair Follicle-Associated-Pluripotent (HAP) Stem Cells to Cardiac-Muscle Cells. Shirai K, Hamada Y1, Arakawa N1, Yamazaki A2, Tohgi N3, Aki R3, Mii S3, Hoffman RM, Amoh Y3: J Cell Biochem 2017/3; 118 (3): 554-8. (•l“c—SŽq1, rěLŽq1, ŽRč—•Žq2, “Œ‹V“ß’ĂŽq3, ˆŔĺY—Lję3, ŽOˆäƒá3, “V‰HN”V3: 1•a‘ԁEf—ĂŒn, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3”畆)

110234. [Œ´’˜] Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway. Yamada-Kanazawa S, Kajihara I, Fukushima S, Jinnin M, Masuzawa M, Masuzawa M, Amoh Y1, Hoshina D, Abe R, Ihn H: Br J Dermatol 2017/8; 177 (2): 456-69. (“V‰HN”V1: 1”畆)

320019. [Ç—á•ń]y“ÁW: ×‹ŰŠ´őÇzŠO‰A•””^”çÇ‚É”ş‚Á‚˝‹CŽîŤäNă÷‰Š‚Ě1—á. ‹{ŕV—ŒbŽq1, “n˜đ@W1, “Œ‹V“ß’ĂŽq1, ŽOˆäƒá1, “V‰HN”V1, •˝–ěC•˝2 (1”畆, 2”ĺ”AŠí): ”畆‰Č‚Ě—Ő° 2016/11; 58 (12): 1803-5.

420001. [—Տ°ŽŽŒą] —Ť‚É‚¨‚Ż‚é’jŤŒ^’E–ŃÇ‚É‘Î‚ˇ‚鏗Ťƒzƒ‹ƒ‚ƒ“ŠÜ—Lˆç–ŃÜ‚ĚŽg—pŽŽŒą. ˆÉ“Ą‘׉î, ŒË‘qVŽ÷, ‘O“‡‰pŽ÷, “V‰HN”V1, ”ÂŒŠ@’q (1”畆): ”畆‚̉Ȋw 2016/12; 15 (6): 502-12.

512001. [uŔ]yMultipotent Stem Cells of the Hair FolliclezPeripheral-Nerve and Spinal-Cord Regeneration in Mice Using Hair-Follicle-Associated Pluripotent (HAP) Stem Cells. Amoh Y1, Kensei K, Hoffman RM: Methods in Molecular Biology 2016/7; 1453: 21-32. (“V‰HN”V1: 1”畆)

512002. [uŔ]yMultipotent Stem Cells of the Hair FolliclezNestin-Expressing Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Promote Whisker Sensory-Nerve Growth in Long-Term 3D-Gelfoam_ Histoculture. Mii S1, Duong J, Tome Y, Uchugonova A, Liu F, Amoh Y1, Saito N, Katsuoka K, Hoffman RM: Methods in Molecular Biology 2016/7; 1453: 39-47. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

512003. [uŔ]yMultipotent Stem Cells of the Hair FolliclezProtocols for Ectopic Hair Growth from Transplanted Whisker Follicles on the Spinal Cord of Mice. Cao W, Liu F, Amoh Y1, Hoffman RM: Methods in Molecular Biology 2016/7; 1453: 137-44. (“V‰HN”V1: 1”畆)

512004. [uŔ]yMultipotent Stem Cells of the Hair FolliclezProtocols for Efficient Differentiation of Hair Follicle-Associated Pluripotent (HAP) Stem Cells to Beating Cardiac Muscle Cells. Yashiro M1, Mii S1, Aki R1, Hamada Y2, Arakawa N2, Kawahara K3, Hoffman RM, Amoh Y1: Methods in Molecular Biology 2016/7; 1453: 151-9. (‰Ž‘㐳W1, ŽOˆäƒá1, ˆŔĺY—Lję1, •l“c—SŽq2, rěLŽq2, ‰ÍŒ´Ž‰ë3, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ĂŒn, 3ś—)

512005. [uŔ]yMultipotent Stem Cells of the Hair FolliclezProtocols for Cryopreservation of Intact Hair Follicle That Maintain Pluripotency of Nestin-Expressing Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Kajiura S1, Mii S1, Aki R1, Hamada Y2, Arakawa N2, Kawahara K3, Li L, Katsuoka K, Hoffman RM, Amoh Y1: Methods in Molecular Biology 2016/7; 1453: 173-8. (Š‰Y’qŽk1, ŽOˆäƒá1, ˆŔĺY—Lję1, •l“c—SŽq2, rěLŽq2, ‰ÍŒ´Ž‰ë3, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ĂŒn, 3ś—)

512006. [uŔ]yBiobanking and Cryopreservation of Stem CellszCryopreservation of Hair-Follicle Associated Pluripotent (HAP) Stem Cells Maintains Differentiation and Hair-Growth Potential. HoffmanRM, Kajiura S1, Cao W, Liu F, Amoh Y1: Advances in Experimental Medicine and Biology 2016/11; 951: 191-8. (Š‰Y’qŽk1, “V‰HN”V1: 1”畆)

522084. [uŔ]y“ÁW: ŠÓ•Ę‚É‹ę—ś‚ľ‚˝”畆•a (2)z—Տ°—á@DLE‚đ•š”­‚ľ‚˝C1 inhibitorŒ‡‘šÇ. ‘O“‡‰pŽ÷1, “n˜đ@W1, ŽOˆäƒá1, “c’†Z–ž2, —§Î@‹B (1”畆, 2äPŒ´•aĽŠ´ő“ŕ): ”畆•af—Ă 2016/6; 38 (6): 583-6.

522085. [uŔ]y“ÁW: ×‹ŰŠ´őÇzŠO‰A•””^”çÇ‚É”ş‚Á‚˝‹CŽîŤäNă÷‰Š‚Ě1—á. ‹{ŕV—ŒbŽq1, “n˜đ@W1, “Œ‹V“ß’ĂŽq1, ŽOˆäƒá1, “V‰HN”V1, •˝–ěC•˝1 (1”畆): ”畆‰Č‚Ě—Ő° 2016/11; 58 (12): 1803-5.

[Šw‰ďEŒ¤‹†‰ď“™]

722142. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‚—îŽŇ‚Ě’E–ŃÇ‚đ–ѕ×–E‹@”\‚Š‚ç–ž‚ç‚Š‚É‚ˇ‚é. “V‰HN”V (”畆): ‘ć115‰ń“ú–{”畆‰ČŠw‰ď‘‰ď (2016/6/5), ‹ž“s.

722143. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‰şŽˆ‚̓Ť’×ᇂ̐f’f‚ĆŽĄ—Âɂ‚˘‚Ä. ‘ŕV^ŽŔŽq (”畆): ‘ć115‰ń“ú–{”畆‰ČŠw‰ď‘‰ď (2016/6/5), ‹ž“s.

723593. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Žw’[‰óŽ€‚𐜂ś‚˝RARSR‘Ě—zŤ”畆‹Ř‰Š‚Ě2—á. “Œ‹V“ß’ĂŽq1, ‘ŕV^ŽŔŽq1, “n˜đ@W, ŽOˆäƒá1, “V‰HN”V1 (1”畆): ‘ć115‰ń“ú–{”畆‰ČŠw‰ď‘‰ď (2016/6/3-5), ‹ž“s.

723594. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Anti-M.leprae antibodies block the endothelial cell invasion by Mce1A-expressing E.coli. Fathul Rachman, ˛“Ą’źĆ1, Viesta baby Fadlitha, “Ą‘ş‹ż’j1, Takimoto H (1”畆): ‘ć90‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2017/3/20), ĺ‘ä.

733302. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “ŤŽčŽw”畆‰Š: ƒƒ^ƒNƒŠƒ‹ƒŒƒWƒ“ƒAƒŒƒ‹ƒM[‚ŞŒ´ˆö‚Ĺ‚ ‚Á‚˝1—á. ‘ŕV^ŽŔŽq1, ’†‘ş”ü‰Ä, “V‰HN”V1 (1”畆): “ú–{”畆‰ČŠw‰ď‘ć868‰ń“Œ‹ž’n•ű‰ď (2016/9/10), “Œ‹ž.

733303. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RHCVŽĄ—Âɂĉü‘P‚ľ‚˝“Ť‰ş‘Ú’×ᇂđ’悡‚éƒNƒŠƒIƒOƒƒuƒŠƒ“ŒŒÇŤŽ‡”Á‚Ě1—á. –î–ěŽu‚¸‚Š1, ŽOˆäƒá1, Ö“Ą‹ąŽq1, ŹŒ´GĆ1, ‰Ž‘㐳W1, ‰Ž‘ă–˘‰Ŕ1, ‘ŕV^ŽŔŽq1, “V‰HN”V1, “c’†ŒŤ–ž2 (1”畆, 2Á‰ťŠí“ŕ): “ú–{”畆‰ČŠw‰ď‘ć868‰ń“Œ‹ž’n•ű‰ď (2016/9/10), “Œ‹ž.

733304. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) HPV16Œ^—zŤ‚ĚŠO‰A•”Bowen•a‚Ě1—á. –î–ěŽu‚¸‚Š1, ‘ŕV^ŽŔŽq1, •l“c—SŽq2, “V‰HN”V1, ƒ’r“Ţ’ĂŽq1, VˆäłG3 (1”畆, 2•a‘ԁEf—ĂŒn, 3•wl): “ú–{”畆‰ČŠw‰ď‘ć869‰ń“Œ‹ž’n•ű‰ď (2016/11/19), “Œ‹ž.

733305. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”畆Œ^Œ‹ßŤ‘˝”­“Ž–Ź‰Š‚ɂ‚˘‚Ä: –k—˘‘ĺŠw‰ß‹Ž10”N‚ĚÇ—á‚Ě‚Ü‚Ć‚ß. ‘ŕV^ŽŔŽq1, “Œ‹V“ß’ĂŽq1, Žé‘VŽ›“TŽq1, “V‰HN”V1 (1”畆): ‘ć40‰ń”畆–ŹŠÇäPŒ´•aŒ¤‹†‰ď (2017/1/20), •Ÿ“‡.

733306. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒjƒ{ƒ‹ƒ}ƒu“Š—^Œă‚ć‚čŒűo”S–ŒáŠQ‚𐜂ś, ‘gDŠw“I‚É‘Űᝌ^”˝‰ž‚đ”F‚ß‚˝2—á. ŹŒ´GĆ1, ‘ŕV^ŽŔŽq1, “V‰HN”V1, •Ÿˆä•ü–ç2, ‹v•Ű“cŸ2 (1”畆, 2ŒÄ‹zŠí“ŕ): ‘ć80‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŽx•”Šwp‘ĺ‰ď (2017/2/11), ‰Ą•l.

733307. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒpƒ]ƒpƒjƒu“Š—^‚É‚ć‚čŒŒ‹C‹š‚Ć‹ÇŠÄ”­‚Ş’˜–ž‰ü‘P‚ľ‚˝“Ş•”ŒŒŠÇ“÷Žî‚Ě1—á. ‘ŕV^ŽŔŽq1, Žé‘VŽ›“TŽq1, ‚–ě“N˜Y1, ŽOˆäƒá1, “V‰HN”V1, ŒüŠƒŽq (1”畆): ‘ć80‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žŽx•”Šwp‘ĺ‰ď (2017/2/11-12), ‰Ą•l.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110017. [Œ´’˜] Isoproterenol directs hair follicle-associated pluripotent (HAP) stem cells to differentiate in vitro to cardiac muscle cells which can be induced to form beating heart-muscle tissue sheets. Yamazaki A1, Yashiro M2, Mii S2, Aki R2, Hamada Y3, Arakawa N3, Kawahara K4, Hoffman RM, Amoh Y2: Cell Cycle 2016/3; 15 (5): 760-5. (ŽRč—•Žq1, ‰Ž‘㐳W2, ŽOˆäƒá2, ˆŔĺY—Lję2, •l“c—SŽq3, rěLŽq3, ‰ÍŒ´Ž‰ë4, “V‰HN”V2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2”畆, 3•a‘ԁEf—ĂŒn, 4ś—)

[Šw‰ďEŒ¤‹†‰ď“™]

H27-733008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “Ž–ŹŤoŒŒ‚đ‹@‚ÉŽóf‚ľ‚˝“ŞŠWŠO“ŽĂ–ŹŠďŒ`‚Ě1—á. ‹{ŕV—ŒbŽq1, ‘ŕV^ŽŔŽq1, “V‰HN”V1, H–{•ôŽ, ó’J‰ë•ś (1”畆): “ú–{”畆‰ČŠw‰ď@865‰ń“Œ‹ž’n•ű‰ď (2016/1/16), “Œ‹ž.


”ĺ”AŠí‰ČŠw

[Šwp˜_•ś]

110235. [Œ´’˜] Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer. Tsumura H1, Satoh T1, Ishiyama H2, Tabata K1, Komori S2, Sekiguchi A2, Ikeda M1, Kurosaka S1, Fujita T1, Kitano M, Hayakawa K2, Iwamura M1: J Contemp Brachytherapy 2016/4; 8 (2): 95-103. (’Ă‘şGN1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, “c”¨Œ’ˆę1, ŹXłŽq2, ŠÖŒűˆŠˆß2, ’r“cŸb1, •âáÁ“ń1, “Ą“c“N•v1, ‘ě˜ad2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2•úŽËü (Žîá‡))

110236. [Œ´’˜] Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma. Sonpavde G, Pond GR, Choueiri TK, Mullane S, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Buonerba C, Rozzi A, Matsumoto K1, Lee JL, Kitamura H, Kume H, Bellmunt J: Eur Urol 2016/4; 69 (4): 634-41. (ź–{˜aŤ1: 1”ĺ”AŠí)

110237. [Œ´’˜] Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model. Salah S, Lee JL, Rozzi A, Kitamura H, Matsumoto K1, Srinivas S, Morales-Barrera R, Carles J, Al-Wardat R, Al-Rabi K, Maakoseh M: Clin Genitourin Cancer 2016/6; 14 (3): 255-60. (ź–{˜aŤ1: 1”ĺ”AŠí)

110238. [Œ´’˜] Clinical and molecular characteristics of East Asian patients with von Hippel-Lindau syndrome. Wong M, Chu YH, Tan HL, Bessho H1, Ngeow J, Tang T, Tan MH: Chin J Cancer 2016/8; 35 (1): 79. (•ĘŠ‰pŽĄ1: 1”ĺ”AŠí)

110239. [Œ´’˜] Abiraterone acetate after progression with enzalutamide in chemotherapy-na_ve patients with metastatic castration-resistant prostate cancer: a multi-center retrospective analysis. Yamada Y, Matsubara N, Tabata K1, Satoh T1, Kamiya N, Suzuki H, Kawahara T, Uemura H, Yano A, Kawakami S: BMC Res Notes 2016/10; 9 (1): 471. (“c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1: 1”ĺ”AŠí)

110240. [Œ´’˜] Overall prognostic impact of C-reactive protein level in patients with metastatic renal cell carcinoma treated with sorafenib. Fujita T1, Nishi M1, Tabata K1, Matsumoto K1, Yoshida K2, Iwamura M1: Anticancer Drugs 2016/11; 27 (10): 1028-32. (“Ą“c“N•v1, ź@ˇG1, “c”¨Œ’ˆę1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

110241. [Œ´’˜] Improvement in Renal Function and Symptoms of Patients Treated with Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction with Less Than 20% Split Renal Function. Nishi M1, Matsumoto K1, Fujita T1, Iwamura M1: J Endourol 2016/11; 30 (11): 1214-8. (ź@ˇG1, ź–{˜aŤ1, “Ą“c“N•v1, Šâ‘şłŽk1: 1”ĺ”AŠí)

110242. [Œ´’˜] Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma. Sonpavde G, Pond GR, Di Lorenzo G, Buonerba C, Rozzi A, Lanzetta G, Necchi A, Giannatempo P, Raggi D, Matsumoto K1, Choueiri TK, Mullane S, Niegisch G, Albers P, Lee JL, Kitamura H, Kume H, Bellmunt J: Clin Genitourin Cancer 2016/12; 14 (6): 494-8. (ź–{˜aŤ1: 1”ĺ”AŠí)

110243. [Œ´’˜] Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer. Tsumura H1, Satoh T1, Ishiyama H2, Tabata K1, Takenaka K2, Sekiguchi A2, Nakamura M3, Kitano M, Hayakawa K2, Iwamura M1: Int J Mol Sci 2017/1; 18 (1): 1-10. (’Ă‘şGN1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, “c”¨Œ’ˆę1, ’|’†_“ń2, ŠÖŒűˆŠˆß2, ’†‘şłŽ÷3,‘ě˜ad2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2•úŽËü (Žîá‡), 3ˆă—ÉqśŠw•”)

220009. [€Œ´’˜]y‘ć8‰ńBCG’“ü—Ă–@Œ¤‹†‰ď‹L˜^ ˆę”ʉ‰‘č —Ő°2z‹Ř‘w”ńZŤäNă÷Šŕ‚ɑ΂ˇ‚éBCG“ą“üEˆŰŽ—Ă–@‚ÉŠÖ‚ˇ‚錟“˘ . ź–{˜aŤ1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “c”¨Œ’ˆę1, ź@ˇG1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, “ü]@Œ[1, Šâ‘şłŽk1 (1”ĺ”AŠí): ”ĺ”AŠíŠO‰Č 2016/4; 29 (4): 399-400.

220010. [€Œ´’˜]y‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^WzƒVƒ“ƒ|ƒWƒEƒ€4 ‹Ž¨’ďRŤ‘O—§‘BŠŕ (CRPC) ‚ւ̐V‚˝‚Ȃ鎥—Ð헪: Pre-chemoŠłŽŇ‚ɑ΂ˇ‚鎥—Ă‚ĚŒÂ•Ę‰ť@3. ƒAƒrƒ‰ƒeƒƒ“‚ĚƒGƒrƒfƒ“ƒX‚ĆĹ“K‚ČŠłŽŇ‘œ. ě‘ş•ä1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ’Ă‘şGN1, ”‹Œ´ł”Ž1, —§‰Ô‹MŽj1, Ş–{—Žq1, –ź–؏l1, “V–ě“”V1, Žu‘ş‘sˆę˜N1, ˆî–ě@Š°2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2–ňÜ•”): ”ĺ”AŠíŠO‰Č 2016/5; 29 (—ŐŽž‘Š§): 683-5.

220011. [€Œ´’˜]y‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^WzƒVƒ“ƒ|ƒWƒEƒ€6 t×–EŠŕ‚ɑ΂ˇ‚ét‰ˇ‘śŽčp‚ĚŒť‹ľ‚ƏŤ—ˆ“W–]@2. T1bÇ—á‚ɑ΂ˇ‚ét•”•ŞŘœp. “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ”ĺ”AŠíŠO‰Č 2016/5; 29 (—ŐŽž‘Š§): 705-7.

220012. [€Œ´’˜]y‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^Wzƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“5 ‘O—§‘BŠŕ‹ÇŠŽĄ—ĂŒăÄ”­‚̐f’f‚ĆŽĄ—Ă: Ä”­Œă‚ĚŞŽĄ‚̉”\Ť‚đ’T‚é@1. ‘O—§‘BŠŕ‹ÇŠŽĄ—ĂŒă‚Ě‹ÇŠÄ”­f’fƒXƒgƒ‰ƒeƒW[. —§‰Ô‹MŽj1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, “c”¨Œ’ˆę1, –öŕVM”V2, Œ´@•qŤ3, ÎŽR”ŽžŠ4, –ě‘ş@Œb1, â“c—T‰î1, –Ȋс@ăÄ1, Žt”ö”ɍF1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•a—, 3•úŽËü (‰ć‘œ), 4•úŽËü (Žîá‡)): ”ĺ”AŠíŠO‰Č 2016/5; 29 (—ŐŽž‘Š§): 843-5.

310030. [Ç—á•ń] Ureteral Stone in the Distal Blindending Branch of a Bifid Ureter. Niwa N, Ohigashi T, Bessho H1, Arakawa T: UROLOGY 2017/1; 99: 23-4. (•ĘŠ‰pŽĄ1: 1”ĺ”AŠí)

320020. [Ç—á•ń] ‰ťŠw•úŽËü—Ă–@‚Ş‘tŒ÷‚ľ‚˝”A“šŠŕ‚Ě2—á|80Î‚đ’´‚Ś‚鏗ŤÇ—á‚ĚŒoŒą|. —§‰Ô‹MŽj1, ź–{˜aŤ1, –ź–؏l1, ”‹Œ´ł”Ž1, Ź—ŃŒ’‘ž˜Y1, ’Ă‘şGN1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ”ĺ”AŠí‰Č‹I—v 2016/7; 62 (7): 367-71.

320021. [Ç—á•ń] ‰ş‘ĺĂ–Ź“ŕŽîᇍǐđ‚𔺂Á‚˝•›tŒ´”­ˆŤŤƒŠƒ“ƒpŽî‚Ě1—á. •˝–ěC•˝1, “Ą“c“N•v1, ‘ĺŽR“N•˝1, –ź–؏l1, ‹ŕŽqŽu•Ű1, ‚Œű@‘ĺ1, “c”¨Œ’ˆę1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ”ĺ”AŠí‰Č‹I—v 2016/8; 62 (8): 403-6.

320022. [Ç—á•ń] ‘ĺ—ʏoŒŒ‚É‚ć‚čƒvƒŒƒVƒ‡ƒbƒN‚đ‚Ť‚˝‚ľ‚˝”A“šƒJƒe[ƒeƒ‹ŽŠŒČ”˛‹Ž‚É‚ć‚é”A“š—ô‚Ě1—á. ™“c‰ŔŽq1, ÝŠy•q–ç1, “Ą“c“N•v2, •˝ŽR‹M”Ž2, ‹g“cˆęŹ3, ‹v•ŰŻˆę1, Šâ‘şłŽk2 (1Ÿş–ě•Ó‘‡•a‰@, 2”ĺ”AŠí, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ”ĺ”AŠíŠO‰Č 2016/12; 29 (12): 1789-91.

521013. [‰đŕ (‘ć21‰ńPKD‚̉ďu‰‰‰ď)]yƒgƒ‹ƒoƒvƒ^ƒ“ (ƒTƒ€ƒXƒJŇ) ‚É‚ć‚鎥—Ă‚ĚŒťózŽż‹^‰ž“š. •“Ą@’q, ‘ştˆę, ‹g“cˆęŹ1,2 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): –k“lŻ 2016/9; 33: 14-24.

521014. [‰đŕ] ‘O—§‘B‚Ş‚ń (LAT1ƒgƒ‰ƒ“ƒXƒ|[ƒ^[). ˛“ĄˆĐ•ś1, –öŕVM”V (1”ĺ”AŠí): t‘Ÿ“ŕ‰ČE”ĺ”AŠí‰Č 2016/11: 4 (5): 508-13.

522086. [uŔ]yRound Table Discussionz“]ˆÚŤ‘O—§‘BŠŕ–ň•¨ŽĄ—Â̐V‚˝‚Č’Ş—Ź. _’J’źl, ˛“ĄˆĐ•ś1, ěă@— (1”ĺ”AŠí): Prostate Cancer Front Line 2016/8; 5 (1): 2-10.

522087. [uŔ]y“ÁW: ƒŠƒEƒ}ƒ`ŤŽžŠł‚É‚¨‚Ż‚é”ĺ”AŠíEt•a•ĎzBCGäNă÷“ŕ’“ü—Ă–@‚É‚ć‚é”˝‰žŤŠÖß‰Š. ™“c@“Ö1, Žu‘ş@“N (1”ĺ”AŠí): ƒŠƒEƒ}ƒ`‰Č 2016/8: 56 (2): 171-5.

522088. [uŔ]y“ÁW: ‘O—§‘BŠŕ|‚Ş‚ńE‡•šÇE—LŠQŽ–Ű‚Ĺ‚Ě–ň•¨ŽĄ—Ð헪‚đ‘‚Ü‚Ć‚ßzV‚˝‚É“oę‚ľ‚˝ˆă–ň•i‚ĚƒmƒEƒnƒE‚ĆƒsƒbƒgƒtƒH[ƒ‹@EƒAƒrƒ‰ƒeƒƒ“. ”‹Œ´ł”Ž1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ’Ă‘şGN1, ˆî–ě@Š°2, Œú“cKˆę˜Y2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2–ňÜ•”): –ň‹Ç 2016/10; 67 (11): 56-7.

522089. [uŔ]y‘ć30‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€zisŤt×–EŠŕ‚ɑ΂ˇ‚é•ŞŽq•W“I–ňŽĄ—Ă‚É‚¨‚Ż‚é–âf•[“ą“ü‚ĚŽć‚č‘g‚Ý. “Ą“c“N•v1, •˝ŽR‹M”Ž1, “c”¨Œ’ˆę1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): –k—˘ˆăŠw 2016/12; 46 (2): 117-21.

540013. [‚ť‚Ě‘ź (L•ńŽ)]yf—Ă‰ČĐ‰î: ”ĺ”AŠí‰Čz80ÎˆČă‚Ě’jŤ‚Ě2l‚É1l‚Ş‚Ş‚ń‚É‚Č‚é!?|‘O—§‘B‚Ş‚ń‚ɂ‚˘‚ā|. Šâ‘şłŽk (”ĺ”AŠí): –k—˘‘ĺŠw•a‰@‚ž‚ć‚ču‚Ż‚â‚Ťv2016/4; 3: 2-3.

540014. [‚ť‚Ě‘ź (L•ńŽ)]yf—Ă‰ČĐ‰î: ”ĺ”AŠí‰Čz’j—–â‚킸‚—îŽŇ‚Ě‘˝‚­‚ŞŒoŒą‚ ‚č|”AŽ¸‹Ö‚ɂ‚˘‚ā|. •˝ŽR‹M”Ž (”ĺ”AŠí): –k—˘‘ĺŠw•a‰@‚ž‚ć‚ču‚Ż‚â‚Ťv2016/4; 3: 4-5.

540015. [‚ť‚Ě‘ź (L•ńŽ)] ‘ć16‰ń_“ސ쐍Š´őÇŠw‰ď‚đŽĺĂ‚ľ‚Ä. ź–{˜aŤ (”ĺ”AŠí): –k—˘‘ĺŠwˆăŠw•”ƒjƒ…[ƒY 2016/4; 365: 12.

540016. [‚ť‚Ě‘ź] ’jŤ‚Ě”A˜R‚ę. Šâ‘şłŽk (”ĺ”AŠí): NHK‚Ť‚傤‚ĚŒ’N 2016/4; 338: 119.

540017. [‚ť‚Ě‘ź] •ďŠ‡“I‘O—§‘B‚Ş‚ń’nˆć˜AŒg: Kitasato Prostate Cancer Network (KP-Net) ‚É‚ć‚銳ŽŇŽx‰‡‚ĚŽć‚č‘g‚Ý‚ĆŒř‰Ę`CRPC‚ɑ΂ˇ‚éV‚˝‚Č“WŠJ`. ˛“ĄˆĐ•ś1, ‹ß“Ą‚Ü‚ä‚Ý2, “c”¨Œ’ˆę1, ’Ă‘şGN1, Ź–ě‘ňŽ , ”nęŽu˜Y, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ŠĹŒě•”): “ú–{—Տ°”ĺ”AŠí‰Čˆă‰ď_“ސěŽx•”‰ď•ń 2016/9; 23: 6.

540018. [‚ť‚Ě‘ź (Ŕ’k‰ď)] œ“]ˆÚ‚Ě‚ ‚éCRPC‚ɑ΂ˇ‚鎥—Ð헪. Ži‰ď: —é–Ř˜a_, Źň@–ž, ˛“ĄˆĐ•ś1, ‰Ąa@W (1”ĺ”AŠí): Prostate Journal 2016/10; 3 (2): 195-202.

540019. [‚ť‚Ě‘ź (‚Đ‚Ć‚­‚żƒƒ‚)] ‘O—§‘B‘S“EœpŒă‚̏dÇ”AŽ¸‹Ö‚ɑ΂ˇ‚élH”A“šŠ‡–ń‹ŘA‚Śž‚ݏp. Šâ‘şłŽk1, •˝ŽR‹M”Ž1 (1”ĺ”AŠí): “ú–{ˆăŽt‰ďŽGŽ 2016/11; 145 (8): 1620.

540011. [‚ť‚Ě‘ź (Ŕ’k‰ď)] ADPKD‚̍ŐVŽĄ—Ă‚ĚŒťó. –î”öł—S, ’|“ŕN—Y1, ŹŠâ•ś•F, ‹g“cˆęŹ2,3, ’J’ĂŒ\‰î (1t‘Ÿ“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3”ĺ”AŠí): “úŒoƒƒfƒBƒJƒ‹Online 2016/12; p.1-4.

540020. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘O—§‘B‚Ş‚ńœ“]ˆÚ: ŠłŽŇ‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): “Œ‰œ“ú•ń 2016/12.

540021. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] œ“]ˆÚ‚Ö‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): ŽRŒűV•ˇ 2016/12.

540022. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘O—§‘B‚Ş‚ńœ“]ˆÚ‚ĚŠëŒŻZ“§‚š‚¸. ˛“ĄˆĐ•ś (”ĺ”AŠí): –kŠC“šV•ˇ 2016/12; p.14.

540023. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] œ“]ˆÚ‚Ö‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): ŽR—œ“ú“úV•ˇ 2016/12; p.11.

540024. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] œ“]ˆÚ‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): –kš V•ˇ (—[Š§) 2016/12; p.4.

540025. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] œ“]ˆÚ‚Ö‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): é‹ĘV•ˇ 2016/12; p.17.

540026. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘O—§‘B‚Ş‚ńœ“]ˆÚ: ŠłŽŇ‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): –ˆ“úV•ˇ 2016/12; p.11.

540027. [‚ť‚Ě‘ź (ŽGŽ‹LŽ–)] ‘O—§‘B‚Ş‚ń‚̍œ“]ˆÚ. ˛“ĄˆĐ•ś1, —é–ŘŒ[‰x (1”ĺ”AŠí): TŠ§’Š“ú 2016/12; 121 (65): 91-3.

540028. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘O—§‘B‚Ş‚ńŠłŽŇ, œ“]ˆÚ‚Ö‚Ě—‰đ•s\•Ş. ˛“ĄˆĐ•ś (”ĺ”AŠí): _ŒËV•ˇ 2017/1; p.16.

540029. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘O—§‘B‚Ş‚ń‘˝‚˘œ“]ˆÚ. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‰Ť“ęƒ^ƒCƒ€ƒX 2017/2; p.21.

[’˜@‘]

610003. [Šwp‘ (•Ş’SŽˇ•M)]yRole of Biomarkers in MedicinezChapter 2: Dynamics of Cancer-Related Proteins in Patients with Bladder Cancer, p.33-45. Matsumoto K1, Nishi M1,Tsumura H1, Tabata K1, Fujita T1, Iwamura M1, Editors: Wang M, Witzmann FA, INTECH, Rijeka, Croatia, 2016/8. (ź–{˜aŤ1, ź@ˇG1, ’Ă‘şGN1, “c”¨Œ›ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1: 1”ĺ”AŠí)

610004. [Šwp‘ (•Ş’SŽˇ•M)]yChemoradiotherapy: Concurrent Uses, Efficacy and Impact on PrognosiszChapter 2: The Efficacy of Radiation with Chemotherapy in Patients with Locally Advanced Bladder Cancer, p.35-51. Matsumoto K1, Ikeda M1, Hirayama T1, Ishii D1, Iwamura M1, Editor: Sullivan D, Nova Sience Publishers, Inc, NewYork, USA, 2017/1. (ź–{˜aŤ1, ’r“cŸb1, •˝ŽR‹M”Ž1, Îˆä‘ĺ•ă1, Šâ‘şłŽk1: 1”ĺ”AŠí)

620106. [Šwp‘ (•Ş’SŽˇ•M)]yt‚Ć“§Íf—ĂŽwj2016 (t‚Ć“§Í2016”N80ŠŞ‘Š§†)z‘ć18Í tˆÚA@4. ‹‘â”˝‰ž, p.692-5. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/6”­s.

620107. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚ĚŽĄ—ĂŽwj2017”N”Ĺ [ƒfƒXƒN”ť]@Ž„‚Í‚ą‚¤ŽĄ—Ă‚ľ‚Ä‚˘‚éz19. ”ĺ”AŠí‰ČŽžŠł@tṁE”AŠÇŽîá‡, p.1115-6. Šâ‘şłŽk (”ĺ”AŠí), ‘•ŇW: •ŸˆäŽŸ–î, ‚–؁@˝, ŹŽşˆęŹ, Ó”C•ŇW: –x]d˜Y, ˆăŠw‘‰@, “Œ‹ž, 2017/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713114. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Anti-PPP1CA autoantibody detected by proteomics analyses is associated with biological aggressiveness and poor prognosis in patients with bladder cancer. Hirano S1, Matsumoto K1, Minami S, Nishi M1, Tabata K1, Fujita T1, Sato Y2, Iwamura M1: 111st Annual Meeting American Urological Association (2016/5/6), San Diego, USA. (•˝–ěC•˝1, ź–{˜aŤ1, ź@ˇG1, “c”¨Œ’ˆę1, “Ą“c“N•v1, ˛“Ą—Yˆę2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2ˆă—ÉqśŠw•”)

713115. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Impact of warm ischemia time on renal functional outcome after laparoscopic partial nephrectomy using dynamic renal scintigraphy. Fujita T1, Nishi M1, Ishii D1, Tabata K1, Matsumoto K1, Yoshida K1,2, Iwamura M1: 111st Annual Meeting American Urological Association (2016/5/6), San Diego, USA. (“Ą“c“N•v1, ź@ˇG1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, ź–{˜aŤ1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713116. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Radiotherapy for prostate in men with metastatic prostate cancer: a propensity-score matching analysis. Tabata K1, Satoh T1, Tsumura H1, Ishii D1, Fujita T1, Matsumoto K1, Yoshida K1,2, Iwamura M1: 111st Annual Meeting American Urological Association (2016/5/6), San Diego, USA. (“c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ź–{˜aŤ1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713117. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Second-line chemotherapy in older pateints with metastatic urothelial carcinoma: Pooled analysis of 10 second-line studies. Salah S, Lee JL, Rozzi A, Kitamura H, Matsumoto K1, Vis DJ, Wesseles LFA, Srinivas S, Morales R, Carles J, Toubasi S, Lee S, Kim HK, Izumi K: 52nd American Society of Clinical Oncology Annual Meeting (2016/6/3), Chicago, USA. (ź–{˜aŤ1: 1”ĺ”AŠí)

713118. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer. Tsumura H1, Satoh T1, Tabata K1, Ishiyama H2, Watanuki S1, SakataY1, Sekiguchi A2, Kawamura M1, Kitano M, Fujita T1, Hayakawa K2, Iwamura M1: World Congress of Brachytherapy (WCB) (2016/6/29), San Francisco, USA. (’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, –Ȋс@ăÄ1, â“c—T‰î1, ŠÖŒűˆŠˆß2, ě‘ş•ä1, “Ą“c“N•v1, ‘ě˜ad2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2•úŽËü (Žîá‡))

713119. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) The prevention of urosepsis post-retrograde intrarenal surgery with holmium-YAG laser lithotripsy for radiopaque renal calculi greater than 20 mm: A single centre experience. Bessho H1, Koshida T, Komatsuda A, Ohigashi T, Iwamura M1, Arakawa T: 14th Urological Association of Asia Congress 2016 (2016/7/20), Singapore. (•ĘŠ‰pŽĄ1, Šâ‘şłŽk1: 1”ĺ”AŠí)

713120. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Long period follow-up of renal function of living renal donor. Yoshida K1,2, Ishii D1, Takeuchi Y3, Noguchi F4, Ikeda M1, Tanaka M4, Iriki R, Wakai H: 26th INTERNATIONAL CONGRESS OF THE TRANSPLANTATION SOCIETY (2016/8/20), Hong Kong. (‹g“cˆęŹ1,2, Îˆä‘ĺ•ă1, ’|“ŕN—Y3, –ěŒű•ś”T4, ’r“cŹ]1, “c’†”üŽ÷4: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3t‘Ÿ“ŕ, 4ŠĹŒě•”)

713121. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Survey of questionnaire for transplant and dialysis patients on preparation for disaster. Ikeda M1, Ishii D1, Ogura H, Miyasaka Y, Noguchi F2, Tanaka M2, Iwamura M1, Yoshida K1,3: 26th INTERNATIONAL CONGRESS OF THE TRANSPLANTATION SOCIETY (2016/8/20), Hong Kong. (’r“cŹ]1, Îˆä‘ĺ•ă1, –ěŒű•ś”T2, “c’†”üŽ÷2, Šâ‘şłŽk1, ‹g“cˆęŹ1,3: 1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

713122. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Outcomes of peri-operative chemotherapy (PO-CT) for locally advanced penile squamous cell carcinoma (LA-PSCC): results from a multicenter analysis. Necchi A, Pond GR, Raggi D, Ottenhof S, Horenblas S, Khoo V, Hakenberg O, Heidenreich A, Eigl BJ, Nappi L, Matsumoto K1, Vaishampayan U, Woods M, Giannatempo P, Geynisman D, Preto M, Xylinas E, Milowsky MI, Di Lorenzo G, Sonpavde G: 41st European Society for Medical Oncology Congress (2016/10/7), Copenhagen, Denmark, Annals of Oncology 2016; 27 (Suppl 6): 299-300. (ź–{˜aŤ1: 1”ĺ”AŠí)

713123. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Laparoscopic pyeloplasty for Ureteropelvic Junction Obstruction with failed prior surgical interventions. Nishi M1, Ishii D1, Tsuchida M1, Ikeda M1, Matsuda D1, Tabata K1, Matsumoto K1, Iwamura M1: 34th World Congress of Endourology (2016/11/9), Cape Town, South Africa. (ź@ˇG1, Îˆä‘ĺ•ă1, ˆŔ“Ą–š”ü1, ’r“cŹ]1, ź“c‘ĺ‰î1, “c”¨Œ’ˆę1, ź–{˜aŤ1, Šâ‘şłŽk1: 1”ĺ”AŠí)

713124. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Metachronous laparoscopic nephrectomy for bilateral RCC in hemodialysis patients. Ishii D1, Yoshida K1,2, Hagiwara M1, Kawamura M1, Sugita A1, Hirayama T1, Tabata K1, Fujita T1, Iwamura M1: 34th World Congress of Endourology (2016/11/9), Cape Town, South Africa. (Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,2, ”‹Œ´ł”Ž1, ě‘ş•ä1, ™“c@“Ö1, •˝ŽR‹M”Ž1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713125. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Existence of Gleason pattern 5 is possible pathologic predictor for biochemical recurrence after laparoscopic radical prostatectomy. Ikeda M1, Amano N1, Yamashita H1, Takashima R, Ishii J, Irie A1: 13th Annual Meeting of the East Asian Society of Endourology (2016/11/20), ‘ĺă. (’r“cŹ]1, “V–ě“”V1, ŽR‰ş‰p”V1, “ü]@Œ[1: 1”ĺ”AŠí)

713126. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Perioperative search for circulating tumor cells in patients undergoing prostate brachytherapy for clinically nonmetastatic prostate cancer. Tsumura H1, Satoh T1, Tabata K1, Ishiyama H2, Takenaka K2, Sekiguchi A2, Kitano, Hayakawa K2, Iwamura M1: 32nd Annual EAU Congress (2017/3/26), London, UK. (’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ’|’†_Ži2, ŠÖŒűˆŠˆß2, ‘ě˜ad2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2•úŽËü (Žîá‡))

713127. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Impact of adjuvant chemotherapy in high-risk patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A multi-institutional retrospective study. Ikeda M1, Matsumoto K1, Hirayama T1, Koguchi D1, Murakami Y1, Matsuda D1, Okuno N, Utsunomiya T, Taoka Y1, Irie A1, Iwamura M1: 32nd Annual EAU Congress (2017/3/27), London, UK. (’r“cŹ]1, ź–{˜aŤ1, •˝ŽR‹M”Ž1, ‚Œű@‘ĺ1, ‘şă‘א´1, ź“c‘ĺ‰î1, “c‰Ş‰ŔŒ›1, “ü]@Œ[1, Šâ‘şłŽk1: 1”ĺ”AŠí)

713128. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Impact of ISUP new grading system on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy. Tsumura H1, Satoh T1, Tabata K1, Ishiyama H2, Ikeda M1, Kurosaka S1, Fujita T1, Hayakawa K2, Iwamura M1: 32nd Annual EAU Congress (2017/3/27), London, UK. (’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ’r“cŹ]1, •âáÁ“ń1, “Ą“c“N•v1, ‘ě˜ad2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2•úŽËü (Žîá‡))

721012. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‹}‘‚ˇ‚é˜V”N‘O—§‘B‚Ş‚ń: –k—˘‚É‚¨‚Ż‚é‘˝EŽí˜AŒg‚ĚŽć‚č‘g‚݂Ɖۑč. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć29‰ń“ú–{˜V”N”ĺ”AŠí‰ČŠw‰ď (2016/5/14), •Ÿ‰Ş.

722144. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) VƒOƒŒ[ƒhƒOƒ‹[ƒv•Ş—Ţ‚Í‚Ç‚¤Žg‚¤‚ׂŤ‚Š? Žg‚í‚ę‚é‚ׂŤ‚Š? ‹{–{_, —é–ŘŒ[‰x, ˛“ĄˆĐ•ś1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

722145. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) NMIBC‚ĚŽĄ—Ð헪‚Ć‚ť‚ĚŽŔŰ. ź–{˜aŤ (”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

722146. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) œ“]ˆÚ‚đ—L‚ˇ‚é‹Ž¨’ďRŤ‘O—§‘BŠŕ:V‚ľ‚˘WŠw“IŽĄ—ĂƒXƒgƒ‰ƒeƒW[. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

722147. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒtƒŒƒLƒVƒuƒ‹‚ČƒxƒbƒZƒ‹ƒV[ƒ‰[‚đŽg—p‚ľ‚˝ƒƒ{ƒbƒg•â•‰ş‘O—§‘B‘S“Ep. “c”¨Œ’ˆę (”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/18), ‘ĺă.

722148. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) œ“]ˆÚ‚đ—L‚ˇ‚é‹Ž¨’ďRŤ‘O—§‘BŠŕ: Radium-223‚É‚ć‚éV‚˝‚ČŽĄ—Ð헪. ˛“ĄˆĐ•ś (”ĺ”AŠí): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/26), ‹ž“s.

722149. [Šw‰ď (‘S‘)] (•˝Ź29”N“x‹łˆçƒZƒ~ƒi[) ŽĄ—ĂŒp‘ą‚ľ‚Ä‚˘‚é‘O—§‘B‚Ş‚ńŠłŽŇ‚ĚQOL‚đŽx‚Ś‚éƒPƒA. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć31‰ń“ú–{‚Ş‚ńŠĹŒěŠw‰ďŠwpW‰ď (2016/2/4), ‚’m.

722150. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‹Ř‘wZŤäNă÷‚Ş‚ń‚ɑ΂ˇ‚éäNă÷‘S“EpŒă•â•‰ťŠw—Ă–@‚Ě“K‰ž. ‰YăTŽi, “c”¨^—œŽq, ’r“cŸb1, •ŕV˜aG, ăŒű˜aŽ , ˆŔHt‹P, ‰i–{Ťˆę, ‰Ş@@—D, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

722151. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) is”A˜Hă”çŠŕ‚É‚¨‚Ż‚é“]ˆÚ‘ƒŘœp: ’ˇŠúś‘ś‚Ş“ž‚ç‚ę‚éÇ—á‚Ć‚Í? ’†ě@“O, “cŒű@Œd, ‹ŕ’J~Žu, ‹ß“Ą–őŽi, ‰|–{@—T, ě‡„l, ‘ĺ’ː^Žj, “c’†—Ç“T, ź–{–ž•F, ’ˇŁ@‘×, •Ä’Ž—Ljň, źźŠ°–ž, •˝–ě”ü˜a, ŽR“c‘ĺ‰î, âŔ˜a“cŽ , ’r“cŸb1, ‰ŞŞ’J—˜ˆę, ‹{ěm•˝, —é–ŘŠî•ś, ‹{›˝‰p˘, “Ą‘ş“N–ç, •ŸŒ´@_, ‹v•ÄtŠě, –{ŠÔ”V•v (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

722152. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ĄŒă‚Ě“W–]‚Ɖۑč. Žáˆä—zŠó, ˆ˘•”“Ţ’Ă”ü, –Ř‘şŠG”ü, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 362.

722153. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yƒ[ƒNƒVƒ‡ƒbƒv3@“ú–{‚Ě“§Íˆă—Ă‚Ě—Ao: ”­“W“ră‘‚ɉ—‚Ż‚鎝‘ą‰Â”\‚Č“§Í—Ă–@‚đl‚Ś‚ézƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚éJapanese Assistance Council of establishing Dialysis Specialists system in Cambodia (JAC-DSC) ‚Ě‹OŐ|ĄŒă‚Ě“W–]‚Ɖۑč. Žáˆä—zŠó, ˆ˘•”“Ţ’Ă”ü, –Ř‘şŠG”ü, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă.

722154. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Ž{Ý‚đ‰z‚Ś‚˝t•s‘Sƒ`[ƒ€‚̏î•ńE’mŽŻ‚Ě‹¤—LƒVƒXƒeƒ€‚̍\’z: Kicos‚̐ݗ§. ’r“cŹ]1, –ěŒű•ś”T2, Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 330.

722155. [Šw‰ď (‘S‘)] (‘ŸŠí‰Ą’f“Iƒ[ƒNƒVƒ‡ƒbƒv) –Ɖuƒ‚ƒjƒ^ƒŠƒ“ƒO‚ĚŒťó‚Ɖۑč. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/10/1), `‹ć, ˆÚA 2016; 51 (‘‰ď—ŐŽž): 205.

722156. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ”ĺ”AŠí‰Čˆă‚Ě“§Íˆă—Ă‚É‚¨‚Ż‚é–đŠ„. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

722157. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‚¤‚ż‚Ĺ‚ŕRARP‚Ĺ‚Ť‚Ü‚ˇ: ƒƒ{ƒbƒgŽx‰‡ŽčpƒVƒXƒeƒ€‚̍\’z (“ą“ü‘O|“ą“ü‰Šú‚𒆐S‚É). ‰Š@‰p–Î, ‚“cŽĄŽq1, ‘şă‘א´1 (1”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

722158. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‘O—§‘BŠŕ‚ɑ΂ˇ‚éI-125–§••ŹüŒš—Ă–@: p’†O-Arm‚É‚ć‚éReal-time hybrid –@‚ĚŒŸ“˘. ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, ’Ă‘şGN1, ŠÖŒűˆŠˆß2, ’|’†_“ń2, ěăłŒĺ2, “c”¨Œ’ˆę1, Ź—ŃŒ’‘ž˜Y1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

722159. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‘O—§‘BŠŕ–§••ŹüŒš—Ă–@‚É‚¨‚Ż‚錌’†zŠÂŽîᇍזE‚ÉŠÖ‚ˇ‚錤‹†. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ŠÖŒűˆŠˆß2, ’|’†_“ń2, â“c—T‰î1, –Ȋс@ăÄ1, “Ą“c“N•v1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

722160. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) “]ˆÚŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚é‘O—§‘BĆŽË‚Ě—LŒřŤ‚ĚŒŸ“˘; propensity-score matching‰đÍ. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ź–{˜aŤ1, ÎŽR”ŽžŠ2, –k–ě‰ëŽj, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

722161. [Šw‰ď (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€) –Ťt‘Ÿ•a‚ÍäNă÷‘S“Eœp‚đŽó‚Ż‚˝äNă÷ŠŕŠłŽŇ‚Ě—\ŒăˆöŽq‚ƂȂ肤‚é‚Š: ‘˝Ž{Ý‹¤“ŻŒ¤‹†. ź–{–ž•F, ’†ě@“O, ‹ŕ’J~Žu, ’r“cŸb1, ’†ź‘׈ę, ě‡„l, ‹{ěm•˝, “cŒű@Œd, —é–ŘŠî•ś, ŒĂ‰ę•ś—˛, ’ˇŁ@‘×, ‹ß“Ą–őŽi, ‰ŞŞ’J—˜ˆę, “c’†—Ç“T, –{ŠÔ”V•v (1”ĺ”AŠí): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), ‰Ą•l.

722162. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) LRP ‚ĚŒoŒą‚Í RALP ‚Ě“ą“ü‚É‚˘‚Š‚ł‚ę‚é‚Š? “c”¨Œ’ˆę (”ĺ”AŠí): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

722163. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘O—§‘BŠŕ–§••ŹüŒš—Ă–@‚É‚¨‚Ż‚錌’†zŠÂŽîᇍזE‚ÉŠÖ‚ˇ‚錤‹†. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ŠÖŒűˆŠˆß2, ’|’†_“ń2, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć32‰ń‘O—§‘BƒVƒ“ƒ|ƒWƒEƒ€ (2016/12/10), `‹ć.

722164. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) PSAƒoƒEƒ“ƒX. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć12‰ńJ-POPS’†ŠÔ•ń‰ď (2016/1/21), –ڍ•‹ć.

722165. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) –k—˘‘ĺŠw‚É‚¨‚Ż‚étˆÚA—Տ°ŒoĎ‚ĚŒŸ“˘. ‹g“cˆęŹ1,2, ‹e’nO”ü, “c‘q’q”V (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/15), _ŒË.

722166. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) “ú–{‚̐t‘ă‘Öˆă—Ă‚ĚŒťó‚Ɖۑč (over view). ‹g“cˆęŹ1,2, –ěŒű•ś”T3, Îˆä‘ĺ•ă2, ’r“cŹ]2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3ŠĹŒě•”): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË.

722167. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ISUP2014‚Š‚猊‚Ś‚Ä‚Ť‚˝ŽŔ—Տ°‚É‚¨‚Ż‚é‰Ű‘č‚ƐV‚˝‚ȉ”\Ť‚ɂ‚˘‚Ä. ˛“ĄˆĐ•ś1, ’Ă‘şGN1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ěăłŒĺ2, –k–ě‰ëŽj, –öŕVM”V, ‘ş‰_–FŽ÷3, ŽOŽ}@M3, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡), 3•a—): ‘ć6‰ń“ú–{”ĺ”AŠí•a—Œ¤‹†‰ď (2017/2/18), `‹ć.

723595. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Overexpression of 14-3-3 Protein Beta/Alpha in Urine Is Correlated With Advanced Stage and Poor Survival in Patients With Clear Cell Renal Cell Carcinoma. Kaneko S1, Matsumoto K1, Minamida S1, Hirayama T1, Fujita T1, Kodera Y, Iwamura M1: ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä. (‹ŕŽqŽu•Ű1, ź–{˜aŤ1, “ě“c@—@1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, Šâ‘şłŽk1, 1”ĺ”AŠí)

723596. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B“Eœp‚Ě—LŒřŤ‚ĆˆŔ‘SŤ. ‘şă‘א´1, ‰Š@‰p–Î, ‚“cŽĄŽq1, –]ŒŽN•˝1, Žá“c•”—zŽi1, “y‹´łl1, “c”¨Œ’ˆę1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä.

723597. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘BŠŕ–§••ŹüŒš—Ă–@‚É‚¨‚Ż‚錌’†zŠÂŽîᇍזE‚ÉŠÖ‚ˇ‚錤‹†. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ŠÖŒűˆŠˆß2, ’|’†_“ń2, â“c—T‰î1, –Ȋс@ăÄ1, ”‹Œ´ł”Ž1, •˝ŽR‹M”Ž1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä.

723598. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) äNă÷Šŕ35Î–˘–ž”­śÇ—á‚ÉŠÖ‚ˇ‚é—Տ°“IŒŸ“˘. •˝–ěC•˝1, ź–{˜aŤ1, ’Ă‘şGN1, ź@ˇG1, Ÿ“c^s, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä.

723599. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) äNă÷Šŕ‚É‚¨‚Ż‚éPPP1CAR‘Ě”­Œť‚Ć—Ő°•a—Šw“IˆöŽq‚ĚŒŸ“˘. Ź—ŃŒ’‘ž˜Y1, ź–{˜aŤ1, “ě@@Ž, •˝–ěC•˝1, –]ŒŽN•˝1, “Ą“c“N•v1, ’ˇ‰–@—ş2, ˛“Ą—Yˆę2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ˆă—ÉqśŠw•”): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä.

723600. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) äNă÷Šŕ×–EŠ”‚đ—p‚˘‚˝ƒVƒXƒvƒ‰ƒ`ƒ“‘ϐŤ‚ÉŠÖ‚í‚é’`”’Žż‚ĚŒŸo. ”‹Œ´ł”Ž1, ź–{˜aŤ1, “c‰Ş‰ŔŒ›1, –ź–؏l1, “ě“c@—@1, ŹŽ›‹`’j, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä.

723601. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Efficacy of high dose prostate radiotherapy in patients with metastatic prostate cancer. Murakami Y1, Okusa H, Tojo T, Utsunomiya T: ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/23), ĺ‘ä. (‘şă‘א´1: 1”ĺ”AŠí)

723602. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰ťŠw—Ă–@–˘Ž{s‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éƒGƒ“ƒUƒ‹ƒ^ƒ~ƒh, ƒAƒrƒ‰ƒeƒƒ“’€ŽŸ—Ă–@‚Ě‘˝Ž{Ý‹¤“ŻŒă‚ëŒü‚ŤŒ¤‹†. –î–쏻‘ĺ, ěă—, “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, _’J’źl, —é–ŘŒ[‰x, ‰ÍŒ´’Ži, ă‘ş”ŽŽi, ŽR“c—yŽq, źŒ´LW (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

723603. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰ßŠˆ“ŽäNă÷‚ɑ΂ˇ‚éŒo”ç‹zŽűŒ^ƒIƒLƒVƒuƒ`ƒjƒ“‰–Ž_‰–‚ĚŽg—pŒoŒą. Žu‘ş‘sˆę˜N1, ‚Œű@‘ĺ1, “ě“c@—@1, “c‰Ş‰ŔŒ›1, ’ŘˆärŽ÷, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

723604. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) t“Ž‘ÔƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚đ—p‚˘‚˝• o‹ž‰şt•”•ŞŘœpŒăt‹@”\‚ĚŒŸ“˘. “Ą“c“N•v1, ź@ˇG1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, ź–{˜aŤ1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

723605. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •sŠŽ‘Sd•Ąt᱔AŠÇ‡—Ź•”‹ˇó‚É‚ć‚鐅t‚ɑ΂ˇ‚é• o‹ž‰şt᱌`Źp. ź@ˇG1, “Ą“c“N•v1, ź–{˜aŤ1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

723606. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰ş‘O—§‘B‘S“E“Eop‚É‚¨‚Ż‚鍂‰đ‘œ“x3DƒCƒ[ƒWƒVƒXƒeƒ€‚Ě—L—pŤ: ‚‰đ‘œ“x2DƒCƒ[ƒWƒVƒXƒeƒ€‚Ć‚Ě–łěˆ×”äŠrŽŽŒą‚Š‚çŠw‚ń‚ž‚ą‚Ć. –؉şG•ś, ’†ě@Œ’, ‰PˆäK’j, Šâ‘şłŽk1, ˆÉ“Ą–žG, ‹{“ˆ@“N, Ż@ş•v, rˆä—zˆę, ”nęŽu˜Y, Ž›’n•q˜Y, ź“cŒöŽu (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

723607. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw‚É‚¨‚Ż‚郍ƒ{ƒbƒgŽx‰‡• o‹ž‰şŞŽĄ“IäNă÷“Eœp‚̏‰ŠúŒoŒą. ź–{˜aŤ1, “c”¨Œ’ˆę1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, ź@ˇG1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/24), ĺ‘ä.

723608. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŞŽĄ“I‘O—§‘B‘S“EœpŒă‚Ě”AŽ¸‹Ö‚É‚¨‚Ż‚élH”A“šŠ‡–ń‹Ř‚Ě—L—pŤ. ě‘ş•ä1, •˝ŽR‹M”Ž1, ”‹Œ´ł”Ž1, •âáÁ“ń1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723609. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŽüpŠú‚É‚¨‚Ż‚é”ě–ž‚Ć• o‹ž‰şt”AŠÇ“Eœp (Œă• –ŒƒAƒvƒ[ƒ`) ‚ĚŒŸ“˘. •˝ŽR‹M”Ž1, ź–{˜aŤ1, •˝–ěC•˝1, Ź—ŃŒ’‘ž˜Y1, ź@ˇG1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723610. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) isŤă•””A˜Hă”çŠŕ‚ɑ΂ˇ‚épŒă•â•‰ťŠw—Ă–@‚ĚŽĄ—ÐŹŃ. ’r“cŸb1, ź–{˜aŤ1, “V–ě“”V1, ăŒű˜aŽ , •ŕV˜aG, ŽR‰ş‰p”V1, Îˆä~ˆę˜Y, “Ą“c“N•v1, ‰YăTŽi, ‰ŞŞ’J—˜ˆę, “ü]@Œ[1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723611. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘BŠŕ‚ɑ΂ˇ‚郈ƒE‘f125‰i‹v‘}“ü–§••ŹüŒš—Ă–@: ––˝ŒŒ‚É‚¨‚Ż‚éRŽîᇖƉu‰ž“š‚ĚŒŸ“˘. ˛“ĄˆĐ•ś1, ‹v•Ű@˝2, “c”¨Œ’ˆę1, ’Ă‘şGN1, ÎŽR”ŽžŠ3, ‘ě˜ad3, ”nęŽu˜Y, Ź”Ś•ś–í2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ˆă—ÉqśŠw•”, 3•úŽËü (Žîá‡)): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723612. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •úŽËüŽĄ—ĂŒă‚Ě‹ÇŠÄ”­‘O—§‘BŠŕ‚ɑ΂ˇ‚éfocal salvage HDR brachytherapy‚ĚŒŸ“˘. â“c—T‰î1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, ’Ă‘şGN1, “c”¨Œ’ˆę1, Œ´@•qŤ3, –öŕVMs, ’r“cŸb1, •âáÁ“ń1, –k–ě‰ëŽj, ”nęŽu˜Y1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡), 3•úŽËü (‰ć‘œ)): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723613. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é”A’†ƒLƒmƒƒ“‘ϐŤ‹Ű‚ÉŠÖ‚ˇ‚錟“˘. ŽR“c‘׎j1, ‘OŽR—Ç‘ž1, ‰Ş“c@Šw, ŽR‰ş‰p”V1, ‰œ–ě‹I•F, ‰Š@‰p–Î, ěă’B‰›, ź“c‘ĺ‰î1 (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723614. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): ƒRƒz[ƒg1—\Œă‰đÍŒ‹‰Ę|‘ć1•ń. ˆÉ“Ąˆęl, Ä“ĄŽj˜Y, ä݁@“ÄŒ›, Â–؁@Šw, ŒĂ‰ęŠ°Žj, ˛“ĄˆĐ•ś1, ‘ĺ‹´r•v, –Ώź’ź”V, ‹e’r—˛, Ź“‡L‰î, “yŠí‰Ž‘ěŽu, •Ÿ“‡‰ë“T, ŽR’†‰pšć (1”ĺ”AŠí): ‘ć104‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/25), ĺ‘ä.

723615. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ACTH”ńˆË‘śŤ‘ĺŒ‹ßŤ•›t”玿‰ßŒ`Ź‚ɑ΂ˇ‚é• o‹ž‰ş•Đ‘¤•›t“Eœ‚Ě2—á. ’Ă‘şGN1, “Ą“c“N•v1, •˝ŽR‹M”Ž1, –Ȋс@ăÄ1, â“c—T‰î1, ě‘ş•ä1, ”‹Œ´ł”Ž1, ź@ˇG1, “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć28‰ń“ú–{“ŕ•Ş”ĺŠO‰ČŠw‰ď‘‰ď (2016/5/27), ‰Ą•l, “ú–{“ŕ•Ş”ĺEbó‘BŠO‰ČŠw‰ďŽGŽ 2016; 33 (‘Š§†): S133.

723616. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •›tŽîᇂƂľ‚Ä• o‹ž‰ş“Eœp‚đŽ{s‚ľ‚˝Œă• –ŒŒ´”­_ŒoŒ´ŤŽîᇂ̌Ÿ“˘. •˝ŽR‹M”Ž1, “Ą“c“N•v1, ź@ˇG1, ’Ă‘şGN1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć28‰ń“ú–{“ŕ•Ş”ĺŠO‰ČŠw‰ď‘‰ď (2016/5/27), ‰Ą•l, “ú–{“ŕ•Ş”ĺEbó‘BŠO‰ČŠw‰ďŽGŽ 2016; 33 (‘Š§†): S135.

723617. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŠłŽŇ‚É‚¨‚Ż‚éƒAƒhƒqƒAƒ‰ƒ“ƒX‚ĚŒŸ“˘`ƒmƒ“ƒAƒhƒqƒAƒ‰ƒ“ƒX‚É‚ć‚铧ÍÄ“ą“ü`. Îˆä‘ĺ•ă1, ”‹Œ´ł”Ž1, ě‘ş•ä1, “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, Žáˆä—zŠó, –ěŒű•ś”T2, ‹{â—Dl, ˆî–ě@Š°, Šâ‘şłŽk1, ‹g“cˆęŹ1,3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 433.

723618. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚Œř—ŚHemodiafiltration‚ĚŒp‘ą‚Ĺ“§ÍŠłŽŇ‚ĚFGF-23 Level‚͉ş‚Ş‚é‚Š? ŒIŒ´‰ŔF, ×’JLŠC, ŽR“ŕ•‡”ü, —é–؁@•ŕ, •ŕVD, ‘ĺ‹ŽŃ—F—˘, ’J—Ń—R”ü, âV“Ą@‹B, ŸNˆäŒ’ŽĄ, Žá—Ń–ő‹v, Îˆä‘ĺ•ă1, ˛“ĄˆĐ•ś1 (1”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 456.

723619. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒCƒ“ƒXƒŠƒ“Žg—p’†‚Ě“œ”A•a“§ÍŠłŽŇ‚ɑ΂ˇ‚鉞—pƒJ[ƒ{ƒJƒEƒ“ƒg. ŽOăŒ›Žq, –k“‡KŽ}, •ş“Ą@“§, ‘ĺ’†‰ŔŽq, ŽR“cN•ă, Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,2, ”ň“c”ü•ä, ‘q“cN‹v (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 473.

723620. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ~ƒƒƒ“ƒ}[‚Š‚çˆăŽt‚Ě2‚ŠŒŽŠÔ‚ĚŒ¤CŽó‚Ż“ü‚ęŒoŒą. Ź—Ń‚ą‚¸Œb1, ‰Y糏rˆę˜Y2, Ź‹v•ŰŒŞˆę1, Îˆä‘ĺ•ă3, ‹g“cˆęŹ3,4, •ş“Ą@“§, ěźGŽ÷, ě‘ş–ž•v, Ź—эO—S1 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3”ĺ”AŠí, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 483.

723621. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “§ÍÇ—á‚Ěƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‘O—§‘BŠjop (HoLEP) ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ™“c‰ŔŽq, ÝŠy•q–ç, ˛“Ą’ź”V, ‘ĺ’JŠ°”V, ˆÉŒ´Œş‰p, ˜ZŠp@Žü, “Ą“c“N•v1, ‹g“cˆęŹ1,2, ‹v•ŰŻˆę, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 667.

723622. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “§ÍŠłŽŇ‚̉şŽˆ‘nŽĄ—Ă‚É‚¨‚Ż‚é•]‰ż. Žu‘ş@“N, ™“c@“Ö1, ‹e’n‹ą‘ž, “Œ“c—˛ŽĄ (1”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 671.

723623. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ˆę‚ľ‚˝“§Í—p—Ż’uƒJƒe[ƒeƒ‹ŠÇ—‚đs‚¤‚˝‚ß‚É. —Ž‡^Šó, •˝ŕV–ƒ—R‰Ŕ, ‚‹´@—ş, ‚‹´_—Y, Îˆä‘ĺ•ă1, Šp“c—˛r, ‹g“cˆęŹ1,2, ‚‹´—Tˆę˜Y (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 701.

723624. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’ˇŠú—Ż’uŒ^ƒJƒe[ƒeƒ‹‚đ—p‚˘‚˝Ý‘‰t“§Í—Ă–@‚ɂ‚˘‚Ä. ˆ˘•”“Ţ’Ă”ü, ‰Í‘ş”ŽŽq, –Ř‘şŠG”ü, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 722.

723425. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O’uŠˇOn-LineHDF‚Ĺ‚ĚƒŠƒ“‚̏o”[. ŽOăŒ›Žq, –k“‡KŽ}, •ş“Ą@“§, ‘ĺ’†‰ŔŽq, ŽR“cN•ă, Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,2, Žáˆä—zŠó, ‚“‡—Í–í, aŒűG”V, Žu‘ş@“N, ”ň“c”ü•ä, ‘q“cN‹v (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 535.

723626. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒAƒNƒZƒXŠÖ˜Aáu’É‚Ě—Ő°“IŒŸ“˘. ŒK“c”䍻], Îˆä‘ĺ•ă1, óˆä—FŠî, ă‘ş@ŒO, “ş’J_”ü, ŽR“ŕ‚Ć‚ľŽq, ‹vŠL”ü“o—˘, ‰Ąa‹žŽq, “ߐ{—ć“Ţ, Žsě@–ž, ´‹{—Ç‘ž, ‹ŕ“cKi, ‚‹´”ÍŽq, ‹g“cˆęŹ1,2, ‹g“c@ŕˆ (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 763.

723627. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰h—{Žm‚Ě‘śÝ‚ľ‚Č‚˘ƒJƒ“ƒ{ƒWƒA‚ł̐t‘Ÿ•a‰h—{Žw“ą•ű–@Šm—§‚ÉŒü‚Ż‚˝Žć‚č‘g‚Ý. –k“‡KŽ}, “c‘ş’qŽq, ’ˇŔrG, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2, ěźGŽ÷ (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 790.

723628. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚Ĺ‚ĚW’†ƒZƒ~ƒi[ŠJĂ‚đŒoŒą‚ľ‚Ä. –Ř‘şŠG”ü, ˆ˘•”“Ţ’Ă”ü, ŠÚ–ě—Y‹M, ŽR’†—˘‰Ŕ, “n糗FŽq, Žáˆä—zŠó, Ź‹v•ŰŒŞˆę1, ‹g“cˆęŹ2,3, •ş“Ą@“§, ěźGŽ÷, ě‘ş–ž•v (1ˆă—ÉqśŠw•”, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 791.

723629. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒ“ƒ}ü–ŋۉń˜H (DEHPƒtƒŠ[) ‚Ě—Ő°•]‰ż. ’Ł‘ň^ˆ¤, ‚‹´@—ş, ‚‹´_—Y, Îˆä‘ĺ•ă1, Šp“c—˛r, ‹g“cˆęŹ1,2, ‚‹´—Tˆę˜Y (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 838.

723630. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) HDŠłŽŇ‚Ö‚ĚƒfƒmƒXƒ}ƒu“ą“üŽž‚ĚŒƒ—ó‚Č’áCaŒŒÇ‚ĆŒoŒűVt.D2ƒpƒ‹ƒX—Ă–@. •ş“Ą@“§, X@—˛Ži, •˝–ěC•˝1, ”‹Œ´ł”Ž1, —§‰Ô‹MŽj1, ™“c‰ŔŽq, ™“c@“Ö1, ‘şăN´1, ŽR“c‘׎j1, —äˆä’čŽk, “ě“c@—@1, ŽR‰ş‰p”V1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, ’|ěŸŽĄ, Ź–““ń–ç, “ŕ“c–Lş, ”nęŽu˜Y, ‰““Ą’‰—Y (1”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/12), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 594.

723631. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚Ĺ‚Ě“œ”A•aŤtÇ‚ɑ΂ˇ‚étˆÚA‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,2, •˝–ěC•˝1, ”‹Œ´ł”Ž1, ’|“ŕN—Y3, ě‘ş•ä1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3t‘Ÿ“ŕ): ‘ć59‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2016/6/18), ‰Ą•l, “út‰ďŽ 2016; 58 (3): 359.

723632. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”Aᑂđ—L‚ˇ‚鏬Ž™•ĄŽG[ÝŤt‘š‚Ě2—á. ź@ˇG1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć25‰ń“ú–{ŹŽ™”ĺ”AŠí‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/6/30), ‹ž“s, “ú–{ŹŽ™”ĺ”AŠí‰ČŠw‰ďŽGŽ 2016; 25 (3): 139.

723633. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”AŠÇˆŮŠŠJŒű‚É‚ÄŒo‰ßŠĎŽ@’†, ‰Œo‚É‚ć‚čŠm’čf’f‚ÉŽŠ‚Á‚˝WunderlichÇŒóŒQ‚Ěˆę—á. ě‘ş•ä1, ź@ˇG1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć25‰ń“ú–{ŹŽ™”ĺ”AŠí‰ČŠw‰ď‘‰ďEŠwpW‰ď (2016/6/30), ‹ž“s, “ú–{ŹŽ™”ĺ”AŠí‰ČŠw‰ď‘‰ďŽGŽ 2016; 25 (3): 167.

723634. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é’ˇŠú“§Í—đ‚đ—L‚ˇ‚étˆÚA‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, ě‘ş•ä1, •˝–ěC•˝1, Žáˆä—zŠó, •˝ŽR‹M”Ž1, –ěŒű•ś”T2, Šâ‘şłŽk1, ‹g“cˆęŹ1,3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć25‰ń“ú–{t•s‘SŠO‰ČŒ¤‹†‰ď (2016/7/9), ‹ž“s.

723635. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) tŒ‹Î‡•št–Đ”AŠÇˆÚs•”‹ˇóÇ‚ɑ΂ˇ‚é• o‹ž‰şt–ĐŒ`Źp, pŒă”jÓŽĄ—ÐŹŃ‚ĚŒŸ“˘. ź@ˇG1, “Ą“c“N•v1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): “ú–{”A˜HŒ‹ÎÇŠw‰ď‘ć26‰ńŠwpW‰ď (2016/7/20), ç—t, “ú–{”A˜HŒ‹ÎÇŠw‰ďŽ 2016; 15 (2): 105-6.

723636. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Efficacy of adjuvant chemotherapy on patients with high risk advanced upper tract urothelial carcinoma. ’r“cŸb1, ź–{˜aŤ1, “V–ě“”V1, •ŕV˜aG, ŽR‰ş‰p”V, Îˆä~ˆę˜Y, “Ą“c“N•v1, ‰YăTŽi, ‰ŞŞ’J—˜ˆę, “ü]@Œ[1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć14‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď (2016/7/28), _ŒË.

723637. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‰ťŠw—Ă–@–˘Ž{s—á‚ɑ΂ˇ‚éƒGƒ“ƒUƒ‹ƒ^ƒ~ƒh, ƒAƒrƒ‰ƒeƒƒ“’€ŽŸ—Ă–@‚ĚŒŸ“˘: ‘˝Ž{Ý‹¤“ŻŒă‚ëŒü‚ŤŒ¤‹†. –î–쏻‘ĺ, ěă@—, “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, _’J’źl, —é–ŘŒ[‰x, ‰ÍŒ´’Ži, ă‘ş”ŽŽi, ŽR“c—yŽq, źŒ´LW (1”ĺ”AŠí): ‘ć14‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď (2016/7/28), _ŒË.

723638. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “]ˆÚŤ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éAbiraterone“Š—^Œă‚ĚALP-bounce‚ĚŒŸ“˘. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, ’r“cŸb1, “Ą“c“N•v1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć14‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď (2016/7/28), _ŒË.

723639. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺŒűŒa‘̍o‹ž‚É‚ć‚čƒJƒe[ƒeƒ‹—Ż’uŒă‚É’”p‰t•s—Ç‚đ—ˆ‚ľ• o‹ž‚É‚ć‚čƒJƒe[ƒeƒ‹‘ĺ–ÔŠŞ—‚ޏCł‰Â”\‚Ĺ‚ ‚Á‚˝ŹŽ™• –Œ“§Í‚ĚˆęÇ—á. Îˆä‘ĺ•ă1, ”‹Œ´ł”Ž1, ě‘ş•ä1, •ş“Ą@“§, •˝–ěC•˝1, Šâ‘şłŽk1, Š@L–ç2, ‹g“cˆęŹ1,3 (1”ĺ”AŠí, 2‹~–˝, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć22‰ń“ú–{• –Œ“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/9/24), ŽD–y.

723640. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚étˆÚAŒă‚ĚŽ€–SÇ—á‚Ě—Ő°“IŒŸ“˘. Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,2, ě‘ş•ä1, ”‹Œ´ł”Ž1, —§‰Ô‹MŽj1, ’r“cŹ]1, –ěŒű•ś”T3, ’|“ŕN—Y4, ‰““Ą’‰—Y, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠĹŒě•”, 4t‘Ÿ“ŕ): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/9/30), `‹ć, ˆÚA 2016; 51 (‘‰ď—ŐŽž): 297.

723641. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚̍‚—ƒVƒsƒGƒ“ƒgś‘̐tˆÚAÇ—á‚ÉŠÖ‚ˇ‚錟“˘. ě‘ş•ä1, Îˆä‘ĺ•ă1, ‹´–{ŒbŽq2, ”‹Œ´ł”Ž1, –ěŒű•ś”T3, ’r“cŹ]1, ‰““Ą’‰—Y, Žáˆä—zŠó, ’|“ŕN—Y2, ‹g“cˆęŹ1,4, Šâ‘şłŽk1 (1”ĺ”AŠí, 2t‘Ÿ“ŕ, 3ŠĹŒě•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/10/1), `‹ć, ˆÚA 2016; 51 (—ŐŽž‘‰ď): 393.

723642. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ý“úŠO‘l‚ĚŒŁtˆÚA“o˜^‚ÉŰ‚ľ‚Ä‹ę—ś‚ľ‚˝2—á. ’r“cŹ]1, ś‰E“c“N, Îˆä‘ĺ•ă1, –ěŒű•ś”T2, ‹g“c•üŽq3, ‰““Ą’‰—Y, ^‰şß•v, Šâ‘şłŽk1, ‹g“cˆęŹ1,4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3‰h—{•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/10/1), `‹ć, ˆÚA 2016; 51 (‘‰ď—ŐŽž): 396.

723051. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒnƒCƒŠƒXƒN‘O—§‘BŠŕ‚ɑ΂ˇ‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgHSV-tkˆâ“`ŽqŽĄ—Ă—á‚Ě•a—‘gDŠw“IŒŸ“˘. –öŕVM”V, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ’Ă‘şGN1, Thompson TC, ‰ŞˆŔ@ŒM, ‘ş‰_–FŽ÷2, ”nęŽu˜Y, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•a—): ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), ‰Ą•l.

723643. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) tŒ`‘ԁE‹@”\‚ĚˆŤ‰ť‚đ”F‚ߊO‰Č“IŽĄ—Ă‚đ—L‚ľ‚˝Œy“x‘ŮŽ™…t‚Ě2Ç—á. ě‘ş•ä1, ź@ˇG1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “c”¨Œ’ˆę1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/8), ÂX.

723644. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é• o‹ž‰ş‘O—§‘B‘S“Eœp (LRP) ‚Ćƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“Eœp (RALP) ‚É‚¨‚Ż‚鑁Šú”A‹Ö§ƒAƒEƒgƒJƒ€‚Ě”äŠr. ‘şă‘א´1, ‰Š@‰p–Î, ‚“cŽĄŽq1, Žá“c•”—zŽi1, Ź—ŃŒ’‘ž˜Y1, “y‹´łl1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/8), ÂX.

723645. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰ş‘O—§‘B‘S“Eœp‚¨‚ć‚Ńƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“Eœp‚É‚¨‚Ż‚éŘœ’f’[—zŤ‚ĚŒŸ“˘. –Ȋс@ăÄ1, “c”¨Œ’ˆę1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, ź@ˇG1, Žt”ö”ɍF1, â“c—T‰î1, ź–{˜aŤ1, “Ą“c“N•v1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/8), ÂX.

723646. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) HIVŠ´őŽŇ‚É”­Ç‚ľ‚˝äNă÷Šŕ‚Ě1—á. â“c—T‰î1, ź–{˜aŤ1, Žt”ö”ɍF1, —§‰Ô‹MŽj1, •˝ŽR‹M”Ž1, Îˆä‘ĺ•ă1, “ü]@Œ[1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

723647. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“EœpŽ{s’†‚ɏŹ’°‘š‚𐜂ś‚˝1—á. ‚“cŽĄŽq1, ‰Š@‰p–Î, ‘şă‘א´1, Žá“c•”—zŽi1, “c”¨Œ’ˆę1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

723648. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ř‘w”ńZŤäNă÷Šŕ‚ɑ΂ˇ‚éBCGˆŰŽ—Ă–@‚ÉŠÖ‚ˇ‚錟“˘. –]ŒŽN•˝1, ź–{˜aŤ1, •˝ŽR‹M”Ž1, ź@ˇG1, ’Ă‘şGN1, “c”¨Œ’ˆę1, “Ą“c“N•v1, •˝ˆäËŽi, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

723649. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘BŠŕ‚ɑ΂ˇ‚郈ƒE‘f125‰i‹v‘}“ü–§••ŹüŒš—Ă–@:p’†O-Arm‚đ—p‚˘‚˝Real-time hybrid implant–@‚ĚŒŸ“˘. ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, ’Ă‘şGN1, ’|’†_“ń2, “c”¨Œ’ˆę1, ‹ŕŽqŽu•Ű1, ŠÖŒűˆŠˆß2, ěăłŒĺ2, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

723650. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) t᱔AŠÇˆÚs•”‹ˇóÇ‚ɍ‡•š‚ľ‚˝tŒ‹ÎÇ—á‚Ě—Ő°“IŒŸ“˘. ź@ˇG1, ź–{˜aŤ1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/17), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 205.

723651. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ă•””A˜HŒ‹ÎŽĄ—ĂŽž‚É‚¨‚Ż‚é”AŠÇƒXƒeƒ“ƒg‚Ě×‹ŰŠw“IŒŸ“˘. ™“c@“Ö1, ŽRŒű@‘, “żŒőłs, ‘ˆä‘Ľş, ‹ŕŽq–Î’j, Î“c—T‘Ľ (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/18), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 271.

723652. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰şŘœp‚đŽ{s‚ľ‚˝tŽüˆÍ”˝‰žŤƒŠƒ“ƒp‘BŤ•Ď‰ť‚Ě1—á. ”‹Œ´ł”Ž1, “Ą“c“N•v1, –Ȋс@ăÄ1, –ź–؏l1, —§‰Ô‹MŽj1, ě‘ş•ä1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/18), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 279.

723653. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Gleason pattern 5 ‚Ć• o‹ž‰şŞŽĄ“I‘O—§‘B‘S“EœpŒă‚Ě PSA Ä”­‚ĚŠÖ˜AŤ. ’r“cŸb1, “V–ě“”V1, ŽR‰ş‰p”V, ‚“ˆ—Í–í, Îˆä~ˆę˜Y, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/18), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 287.

723654. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚o—̓Œ[ƒU”­ś‘•’u (LumenisR PulseTM 120H) ‚đŽg—p‚ľ‚˝HoLEP. ÝŠy•q–ç, ™“c‰ŔŽq, ‹v•ŰŻˆę, {ŽRˆę•ä, “Ą“c“N•v1, •˝ŽR‹M”Ž1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 248.

723655. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰ş‘O—§‘B‘S“Eœp, ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“Eœp‚É‚¨‚Ż‚éŘœ’f’[‚ĚŒŸ“˘. “c”¨Œ’ˆę1, ’Ă‘şGN1, ź–{˜aŤ1, •˝ŽR‹M”Ž1, Îˆä‘ĺ•ă1, ź@ˇG1, “Ą“c“N•v1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 308.

723656. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éLRP‚ĆRALP‚Ě’ZŠúŽüpŠúŹŃ‚ɂ‚˘‚Ä‚Ěƒ‰[ƒjƒ“ƒOƒJ[ƒu‚Ě”äŠrŒŸ“˘. ‘şă‘א´1, ‰Š@‰p–Î1, ‚“cŽĄŽq1, Ź—ŃŒ’‘ž˜Y1, Žá“c•”—zŽi1, “y‹´łl1, “c”¨Œ’ˆę1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 315.

723657. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) t“Ž‘ÔƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚đ—p‚˘‚˝• o‹ž‰şt•”•ŞŘœpŒăt‹@”\‚ĚŒŸ“˘. “Ą“c“N•v1, ź@ˇG1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 327.

723658. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚—î (60ÎˆČă) ƒhƒi[‚É‚¨‚Ż‚é• o‹ž‰ştĚŽćp‚Ě—Ő°“IŒŸ“˘. Îˆä‘ĺ•ă1, ‹g“cˆęŹ1, ”‹Œ´ł”Ž1, ě‘ş•ä1, —§‰Ô‹MŽj1, Ş–{—Žq1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 329.

723659. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡Žčp‚É‚ć‚č“Eœ‚ľ“ž‚˝‚“xœ”Ő“ŕ–ü’…‚đ”F‚ß‚˝äNă÷Šŕ‚Ě1—á. ź–{˜aŤ1, “c”¨Œ’ˆę1, ’Ă‘şGN1, —§‰Ô‹MŽj1, Îˆä‘ĺ•ă1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 332.

723660. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) _Œo‰ˇ‘ś• o‹ž‰ş‘O—§‘B‘S“EœpŒă‚Ěƒwƒ‚ƒƒbƒN–Ŕ“ü‚É‚ć‚éäNă÷Œ‹ÎÇ‚Ě1—á. ’Ă‘şGN1, ź@ˇG1, “c”¨Œ’ˆę1, â“c—T‰î1, ”‹Œ´ł”Ž1, ě‘ş•ä1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ˛“ĄˆĐ•ś1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć30‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/11/19), ‘ĺă, Japanese Journal of Endourology 2016; 29 (3): 348.

723661. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“EœpŽŽs’†‚ɏŹ’°‘š‚𐜂ś‚˝1—á. ‚“cŽĄŽq1, ‰Š@‰p–Î, ‘şă‘א´1, Žá“c•”—zŽi1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/8), ‰Ą•l.

723662. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œo• –Œ“ž’B–@‚É‚ć‚é• o‹ž‰şt•”•ŞŘœp‚É‚¨‚Ż‚ét—â‹pŒř‰Ę‚ĚŒŸ“˘. “Ą“c“N•v1, ź@ˇG1, Îˆä‘ĺ•ă1, ź–{˜aŤ1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723663. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŒăŠúŒ¤Cˆă‚đpŽŇ‚Ć‚ľ‚˝HoLEP‚É‚¨‚Ż‚éLearning curve‚ɂ‚˘‚Ä‚ĚŒŸ“˘. •˝ŽR‹M”Ž1, â“c—T‰î1, —§‰Ô‹MŽj1, ě‘ş•ä1, ”‹Œ´ł”Ž1, ź@ˇG1, Îˆä‘ĺ•ă1, ÝŠy•q–ç, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723664. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚ˆĘ˝ăčE”n’űt‡•šd•Ąt᱔AŠÇ‚ɑ΂ľ• o‹ž‰ş”źt“Eœp‚đŽ{s‚ľ‚˝ˆęŹŽ™—á. ź@ˇG1, “c’†@Œ‰2, •“cŒ›Žq3, ź–{˜aŤ1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723665. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰ş“Ż‘¤t“Eœp‚đŽ{s‚ľś‘̐tˆÚA‚đ‚¨‚ą‚Č‚Á‚˝íőF‘Ě—DŤ‘˝”­ůN–Et (ADPKD) ‚Ě1—á. Îˆä‘ĺ•ă1, ‹g“cˆęŹ1,2, ”‹Œ´ł”Ž1, ě‘ş•ä1, —§‰Ô‹MŽj1, Ş–{—Žq1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

723666. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éŒŁtˆÚA‚Ě—Ő°“IŒŸ“˘. Îˆä‘ĺ•ă1, ě‘ş•ä1, Žáˆä—zŠó, “Ą“c“N•v1, ‰““Ą’‰—Y, ’|“ŕN—Y2, ’r“cŹ]1, –ěŒű•ś”T3, ‹g“cˆęŹ1,4, Šâ‘şłŽk1 (1”ĺ”AŠí, 2t‘Ÿ“ŕ, 3ŠĹŒě•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/15), _ŒË.

723667. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) XVƒVƒXƒeƒ€‚Ĺ•sˆŔ‚đ’ć‚ľ‚˝ŠłŽŇŒŸ“˘‚Ɖ@“ŕŒŸ¸•”‚Ć‚Ě˜AŒg‹­‰ť. ’r“cŹ]1, ŽR•Ó°”ü, Îˆä‘ĺ•ă1, –ěŒű•ś”T2, rě–@Žq2, ‹g“c•üŽq3, Šâ‘şłŽk1, ‹g“cˆęŹ1,4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3‰h—{•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/16), _ŒË.

723668. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 2Œ^“œ”A•aŠłŽŇ‚ɑ΂ˇ‚étˆÚA‚̐f—Ñ̐§‚Ć—Ő°“IŹŃ‚ĚŒŸ“˘. ě‘ş•ä1, Îˆä‘ĺ•ă1, —§‰Ô‹MŽj1, ”‹Œ´ł”Ž1, ‹g“c•üŽq2, –ěŒű•ś”T3, ’r“cŹ]1, ˆä‘ş—[•P3, ’|“ŕN—Y4, ‹g“cˆęŹ1,5, Šâ‘şłŽk1 (1”ĺ”AŠí, 2‰h—{•”, 3ŠĹŒě•”, 4t‘Ÿ“ŕ, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË.

723669. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Thulium laser‚đ—p‚˘‚˝Œo”A“š“I‘O—§‘BŠjop (Thulium Laser Enucleation of the Prostate: ThuLEP) ‚Ě—Ő°“IŒŸ“˘. Žá“c•”—zŽi1, ‘ĺŽR“N•˝1, ‰œ–ě‹I•F (1”ĺ”AŠí): ‘ć70‰ń‘—§•a‰@‘‡ˆăŠw‰ď (2016/11/12), ‰Ť“ę.

723670. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒcƒŠƒEƒ€ƒŒ[ƒU[‚đŽg—p‚ˇ‚é‚ą‚Ć‚ĹR‹ĂŒĹ–ň‚𒆎~‚š‚¸‚ÉŒo”A“š“I‘O—§‘BŘœp‚đŽ{s‚Ĺ‚Ť‚˝1—á. ‘ĺŽR“N•˝1, Žá“c•”—zŽi1, ‰œ–ě‹I•F (1”ĺ”AŠí): ‘ć70‰ń‘—§•a‰@‘‡ˆăŠw‰ď (2016/11/12), ‰Ť“ę.

723671. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒAƒNƒZƒXŠÖ˜Aáu’Ę‚ĆƒoƒXƒLƒ…ƒ‰[ƒAƒNƒZƒXƒgƒ‰ƒuƒ‹‚ĚŠÖ˜AŤ`’´‰š”gŒŸ¸‚É‚ć‚錟“˘`. ă‘ş@ŒO, Îˆä‘ĺ•ă1, ŒK“c”䍻], •Ä–؁@Œc, Žsě“Ţ•Ű”ü, ‹ŕ“cKi, óˆä—FŠî, ‹g“cˆęŹ1,2, ’|“ŕN—Y3, ‹g“c@ŕˆ (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3t‘Ÿ“ŕ): ‘ć20‰ń“ú–{ƒAƒNƒZƒXŒ¤‹†‰ďŠwpW‰ďE‘‰ď (2016/11/13), ŒF–{.

731107. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yisŤäNă÷Šŕ‚ĚŽĄ—Áz`ƒƒ{ƒbƒgŽx‰‡Žčp‚𒆐S‚Ɂ`. ź–{˜aŤ (”ĺ”AŠí): ‘ć11‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/4/2), Vh.

731108. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ă•””A˜H’Ę‰ßáŠQ‚ɑ΂ˇ‚é• o‹žŽčp. Šâ‘şłŽk (”ĺ”AŠí): Clinical Oncology Meeting RCC 2016 (2016/4/14), •ś‹ž‹ć.

731109. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ă•””A˜H’Ę‰ßáŠQ‚ɑ΂ˇ‚é• o‹žŽčp. Šâ‘şłŽk (”ĺ”AŠí): ‘ć142‰ń’}Œă”ĺ”AŠí‰Čˆă‰ďŒ¤C‰ď (2016/4/19), ‹v—Ż•Ä.

731110. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) CRPCí‘Žž‘ă: ŒQ—YŠ„‹’ŽĄ—Ă‚ĚŒŸŘ. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć2‰ńˆ¤•QCRPCŒ¤‹†‰ďŠwpW‰ď (2016/6/11), ˆ¤•Q.

731111. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) • o‹ž‰ş‘O—§‘B‘S“Eœp‚ĚŒŸŘ: LRP‚ĚŒoŒą‚ÍRALP‚ɐś‚Š‚ł‚ę‚é‚Š? Šâ‘şłŽk (”ĺ”AŠí): ‘ć15‰ń’†‘’n‹ć‘O—§‘BŠŕ—Տ°‰Ű‘čŒ¤‹†‰ď (2016/6/25), L“‡.

731112. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “]ˆÚŤE‹Ž¨’ďRŤ‘O—§‘B‚Ş‚ń‚ɑ΂ˇ‚éV‚ľ‚˘WŠw“IŽĄ—Ð헪. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć12‰ńź–Ń’n‹ć”ĺ”AŠí‰Č§’k‰ď (2016/9/9), ‚č.

731113. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “]ˆÚŤE‹Ž¨’ďRŤ‘O—§‘B‚Ş‚ń‚ɑ΂ˇ‚éV‚ľ‚˘WŠw“IŽĄ—Ð헪. ˛“ĄˆĐ•ś (”ĺ”AŠí): Meet the Expert in Žu‘žYŒ´ (2016/9/13), “ĄŽ}.

731114. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ßŠˆ“ŽäNă÷‚ɑ΂ˇ‚é–ň•¨—Ă–@`ƒKƒCƒhƒ‰ƒCƒ“‚ɉˆ‚Á‚˝ŽĄ—ÂƂ́`. •˝ŽR‹M”Ž (”ĺ”AŠí): ‘Š–ÍŒ´Žs•af˜AŒgu‰‰‰ď`LUTSŽĄ—ĂĹ‘Oü` (2016/10/14), ‘Š–ÍŒ´.

731115. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “]ˆÚŤE‹Ž¨’ďRŤ‘O—§‘B‚Ş‚ń‚ɑ΂ˇ‚éV‚ľ‚˘WŠw“IŽĄ—Ð헪. ˛“ĄˆĐ•ś (”ĺ”AŠí): CRPC Seminar in KAWASAKI (2016/10/18), ěč.

731116. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”ĺ”AŠí• o‹žŽčp‚ĚŠî–{Žč‹Z`‹Zp”F’čŽć“ž‚đ–ÚŽw‚ľ‚ā`. Šâ‘şłŽk (”ĺ”AŠí): ‘ć50‰ń•Ÿ‰Ş˛‰ę”ĺ”AŠí‰ČŽčpŽč‹ZŒ¤‹†‰ď (2016/11/2), •Ÿ‰Ş.

731117. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) lH”A“šŠ‡–ń‹ŘA‚Śž‚ݏp AMS800TM. •˝ŽR‹M”Ž (”ĺ”AŠí): “ú–{—Տ°”ĺ”AŠí‰Čˆă‰ďE_“ސ암‰ď (2016/11/5), V‰Ą•l.

731118. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “]ˆÚŤE‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éV‚ľ‚˘WŠw“IŽĄ—ÂƐV‚˝‚ȉۑč. ˛“ĄˆĐ•ś (”ĺ”AŠí): UROLOGIC ONCOLOGY FORUM (2016/11/11), –źŒĂ‰Ž.

731119. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) isŤäNă÷Šŕ‚ĚŽĄ—Âɂ‚˘‚Ä. ź–{˜aŤ (”ĺ”AŠí): ‘ć58‰ń_“ސěˆăŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2016/11/23), ‰Ą•l.

731120. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ISUP2014‚Š‚猊‚Ś‚Ä‚Ť‚˝‰Â”\Ť‚Ɖۑč: V‚˝‚ČŽĄ—Ð헪. ˛“ĄˆĐ•ś (”ĺ”AŠí): Prostate Cancer frontier conference (2016/11/30), V‰Ą•l.

731121. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Abiraterone“Š—^Œă‚ĚALPƒoƒEƒ“ƒXŒťŰ‚đŒŸŘ‚ˇ‚é. “c”¨Œ’ˆę (”ĺ”AŠí): CRPC WebƒZƒ~ƒi[ (2016/12/2), “Œ‹ž.

731122. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) M1 CRPC: ŽĄ—ĂƒV[ƒPƒ“ƒX‚đ‚ǂ̂悤‚ɍl‚Ś‚é‚ׂŤ‚Š. ˛“ĄˆĐ•ś (”ĺ”AŠí): “ú–{‚ĚCRPCŽĄ—Ă‚đl‚Ś‚é (2016/12/3), ç‘ă“c‹ć.

731123. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘BŠŕf—ĂƒKƒCƒhƒ‰ƒCƒ“2016‚đ“Ľ‚Ü‚Ś‚˝V‚ľ‚˘WŠw“IŽĄ—ĂƒAƒvƒ[ƒ`. ˛“ĄˆĐ•ś (”ĺ”AŠí): Prostate Cancer Meeting in Hiroshima (2017/1/19), L“‡.

731124. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ă•””A˜H’Ę‰ßáŠQ‚ɑ΂ˇ‚é• o‹žŽčp. Šâ‘şłŽk (”ĺ”AŠí): ‘ć12‰ń“Ţ—Ç”ĺ”AŠí‰ČŽčpŽč‹ZŒ¤‹†‰ď (2017/1/21), “Ţ—Ç.

731125. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘B‚Ş‚ń`‚Ş‚ń”­ŒŠ‚Ě‚˝‚ß‚ĚPSAŒŸ¸‚ĆŽĄ—Ă‚Ě‚¨˜b`. Šâ‘şłŽk (”ĺ”AŠí): ‘Š–ÍŒ´ŽsˆăŽt‰ď@Žs–ŻŒöŠJuŔ (2017/1/28), ‘Š–ÍŒ´.

731126. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) œ“]ˆÚ‚đ—L‚ˇ‚é‹Ž¨’ďRŤ‘O—§‘BŠŕ: ƒ][ƒtƒBƒS‚É‚ć‚éV‚ľ‚˘WŠw“IŽĄ—ĂƒXƒgƒ‰ƒeƒW[. ˛“ĄˆĐ•ś (”ĺ”AŠí): ƒ][ƒtƒBƒSWebƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/2/2), ’†‰›‹ć.

731127. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘BŠŕf—ĂƒKƒCƒhƒ‰ƒCƒ“2016‚đ“Ľ‚Ü‚Ś‚˝V‚ľ‚˘WŠw“IŽĄ—ĂƒAƒvƒ[ƒ`. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘O—§‘BŠŕ–ň•¨—Ă–@u‰‰‰ď`‘O—§‘BŠŕf—ĂƒKƒCƒhƒ‰ƒCƒ“2016` (2017/2/10), ě‰z.

731128. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŔ‹ÇŤ‘O—§‘BŠŕ‚É‚¨‚Ż‚é‹ÇŠ—Ă–@ (Focal therapy): Pro and Cons. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć18‰ńç—t”ĺ”AŠí‰Č’nˆć˜AŒgŒ¤‹†‰ď (2017/2/15), ç—t.

731129. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) t×–EŠŕ‚Ě–ň•¨ŽĄ—Âɂ‚˘‚Ä. “Ą“c“N•v (”ĺ”AŠí): tŠŕ•×‹­‰ď (2017/2/24), ‘Š–ÍŒ´.

731130. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘BŠŕ. ˛“ĄˆĐ•ś (”ĺ”AŠí): –§••ŹüŒšŽĄ—ĂˆŔ‘SŽćˆľuK‰ď (2017/2/25), ç‘ă“c‹ć.

731131. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘BŠŕf—ĂƒKƒCƒhƒ‰ƒCƒ“2016‚đ“Ľ‚Ü‚Ś‚˝V‚ľ‚˘WŠw“IŽĄ—ĂƒAƒvƒ[ƒ`. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘O—§‘BŠŕŽĄ—Ă‚đl‚Ś‚é‰ďinŠC˜V–ź (2017/3/7), ŠC˜V–ź.

731132. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘BŠŕf—ĂƒKƒCƒhƒ‰ƒCƒ“2016‚đ“Ľ‚Ü‚Ś‚˝V‚ľ‚˘WŠw“IŽĄ—ĂƒAƒvƒ[ƒ`. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć8‰ńěčŽs”ĺ”AŠí‰Čˆă‰ď (2017/3/16), ěč.

731133. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) HSPCECRPC‚É‚¨‚Ż‚é–ň•¨—Ă–@. ’Ă‘şGN (”ĺ”AŠí): ‘ć8‰ńUrology Conference in Sagamihara (2017/3/22), ‘Š–ÍŒ´.

731134. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹žŽ‹‰şt•”•ŞŘœp. “Ą“c“N•v (”ĺ”AŠí): ‘ć1‰ńL“‡”ĺ”AŠí“ŕŽ‹‹žƒrƒfƒIƒZƒ~ƒi[ (2017/3/25), L“‡.

732053. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘O—§‘B‚Ş‚ń‚ɑ΂ˇ‚é–ň•¨—Ă–@: ‘˝EŽí˜AŒg‚É‚ć‚銳ŽŇƒ}ƒl[ƒWƒƒ“ƒg‚Ć’ŽËŽč‹Z. ˛“ĄˆĐ•ś (”ĺ”AŠí): ŠĹŒěŽtWEBƒVƒ“ƒ|ƒWƒEƒ€ (2016/7/14), ‘Š–ÍŒ´.

732054. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ŹüŒšŽĄ—Ă‚Ě‹ÇŠisŠŕ‚ĚƒAƒbƒvƒf[ƒg`HDRƒuƒ‰ƒLƒZƒ‰ƒs[`. ’Ă‘şGN (”ĺ”AŠí): ‘ć23‰ń“Œ‹ž‘O—§‘BŠŕƒtƒH[ƒ‰ƒ€ (2016/10/15), ’†‰›‹ć.

732055. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘O—§‘BŠŕ‚ɑ΂ˇ‚éŠeŽíŽĄ—Ă‚ĆĄŒă‚Ě“W–]. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć2‰ńŠâŽč‘O—§‘BƒVƒ“ƒ|ƒWƒEƒ€ (2016/11/4), ˇ‰Ş.

732056. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘O—§‘BŠŕŽĄ—Ă. “c”¨Œ’ˆę1, –î–쏻‘ĺ, “’ó@Œ’ (1”ĺ”AŠí): ‘O—§‘BŠŕ“˘˜_‰ď (2016/11/27), `‹ć.

732057. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) BCGˆŰŽ—Ă–@‚ĚŒť‹ľ`‘O‰ń’˛¸ˆČ~‚ĚŒoˆÜ‚đ“Ľ‚Ü‚Ś‚Ä. ź–{˜aŤ1, Ź—с@‹ą, ´“‡Œ\“ń˜Y (1”ĺ”AŠí): ‘ć9‰ńBCG’“ü—Ă–@Œ¤‹†‰ď (2016/12/2), ’†‰›‹ć.

732058. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) CRPC 1st Line‰ťŠw—Ă–@‚ĚŽg—p‚đ–Ŕ‚¤ƒP[ƒX‚ɂ‚˘‚Ä. “c”¨Œ’ˆę (”ĺ”AŠí): CRPC Round Table Discussion (2016/12/13), ‰Ą•l.

733308. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) Airseal system‚É‚¨‚Ż‚éƒAƒNƒZƒXƒV[ƒX•”ƒ|[ƒgƒTƒCƒgƒwƒ‹ƒjƒA‚Ě1—á. ’Ă‘şGN1, “c”¨Œ’ˆę1, ”‹Œ´ł”Ž1, ź@ˇG1, •˝ŽR‹M”Ž1, ź–{˜aŤ1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć11‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/4/2), Vh.

733309. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‘O—§‘BŠŕ‚É‚¨‚Ż‚郍ƒ{ƒbƒgŽx‰‡Žčp‚Ě’ZŠúŽĄ—ÐŹŃ. “c”¨Œ’ˆę1, ’Ă‘şGN1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, •˝ŽR‹M”Ž1, ź@ˇG1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć11‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/4/2), Vh.

733310. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‚¤‚í‚Ü‚ż•a‰@‚É‚¨‚Ż‚éRALP‚Ě’ZŠúŹŃ. ‰Š@‰p–Î, ‚“cŽĄŽq1, ‘şă‘א´1 (1”ĺ”AŠí): ‘ć11‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/4/2), Vh.

733311. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) ”AŽ¸‹Ö‚ĚĹ‹ß‚Ě˜b‘č. •˝ŽR‹M”Ž (”ĺ”AŠí): ‘ć11‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/4/2), Vh.

733312. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) “–‰@‚ł̐tˆÚAŒăCMVŠ´őÇ. ”‹Œ´ł”Ž1, Îˆä‘ĺ•ă1, ě‘ş•ä1, “c’†”üŽ÷2, ’r“cŹ]1, –ěŒű•ś”T2, ‹g“cˆęŹ1,3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć28‰ńtˆÚA–Ɖu—Ă–@ƒZƒ~ƒi[ (2016/5/14), •iě.

733313. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ˆÚAŽž• o‹ž‰şt“Eœp‚đ‚¨‚ą‚Č‚Á‚˝ADPKDtˆÚA‚Ě2Ç—á. Îˆä‘ĺ•ă1, ”‹Œ´ł”Ž1, ě‘ş•ä1,•˝–ěC•˝1, “c’†”üŽ÷2, –ěŒű•ś”T2, ’r“cŹ]1, ‰““Ą’‰—Y, ’|“ŕN—Y3, Šâ‘şłŽk1, ‹g“cˆęŹ1,4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3t‘Ÿ“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć32‰ńtˆÚAEŒŒŠÇŠO‰ČŒ¤‹†‰ď (2016/5/27), •P˜H.

733314. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ś‘̐tˆÚAƒŒƒVƒsƒGƒ“ƒg‚Ě‘O—§‘B”ě‘ĺÇ‚ɑ΂ľƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‘O—§‘BŠjop (HoLEP) ‚đŽ{s‚ľ‚˝ˆę—á. ™“c‰ŔŽq, ÝŠy•q–ç, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ‹g“cˆęŹ1,2, ‹v•ŰŻˆę, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć32‰ńtˆÚAEŒŒŠÇŠO‰ČŒ¤‹†‰ď (2016/5/27), •P˜H.

733315. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) Ž{Ý‚đ‰z‚Ś‚˝î•ńE’mŽŻ‚Ě‹¤—LWebƒVƒXƒeƒ€‚̍\’z|t•s‘Sƒ`[ƒ€ˆă—Ă‹Ś‹c‰ď (Kicos) ‚Ě—§‚żă‚°|. ’r“cŹ]1, –ěŒű•ś”T2, ˆÉ“Ą’qŒbŽq, ‰Í–ě@Œb, ŹâŽu•Ű, ’‡‹{—DŽq, ‹´‹l@—ş, ŽRăFŽq, Îˆä‘ĺ•ă1, Žáˆä—zŠó1, Šâ‘şłŽk1, ‹g“cˆęŹ1,3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć32‰ńtˆÚAEŒŒŠÇŠO‰ČŒ¤‹†‰ď (2016/5/28), •P˜H.

733316. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ŒJ‚č•Ô‚ˇpŒăoŒŒ‚Ě‚˝‚߃uƒ‰ƒbƒhƒAƒNƒZƒXěŹ‚É‹ę—ś‚ľ‚˝1Ç—á. –ź–؏l1, ˆŔ“Ą–š”ü1, —§‰Ô‹MŽj1, Îě@–í1, ŠŰ@“T•v, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć90‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/6/11), ‘Š–ÍŒ´, _“ŢěŒ§ˆăŠw‰ďŽGŽ 2016; 43 (2): 136.

733317. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”AŠÇ’°ŠÇᑂĚ1—á. Žt”ö”ɍF1, •˝ŽR‹M”Ž1, â“c—T‰î1, –Ȋс@ăÄ1, Ş–{—Žq1, —§‰Ô‹MŽj1, ź@ˇG1, ’Ă‘şGN1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć90‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/6/11), ‘Š–ÍŒ´, _“ŢěŒ§ˆăŠw‰ďŽGŽ 2016; 43 (2): 137.

733318. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) cŠuƒŠƒ“ƒpß“]ˆÚ‚̐S‹ŘZ, ‘˝”­ƒŠƒ“ƒpß“]ˆÚ‚đ”F‚ß‚éś¸‘ƒŽîᇂĚ1—á. ‘ĺŽR“N•˝1, Žá“c•”—zŽi1, ‰œ–ě‹I•F, –x“cˆťŽq, âV“Ąś˜N, o“‡@“O, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć90‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/6/11), ‘Š–ÍŒ´, _“ŢěŒ§ˆăŠw‰ďŽGŽ 2016; 43 (2): 140.

733319. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ŞŽĄ“I‘O—§‘B‘S“E™ppŒă”AŽ¸‹Ö‚É‚¨‚Ż‚é‹@”\ÄŒšp‚Ć‚ľ‚Ă̐lH”A“šŠ‡–ń‹Ř‚Ě—L—pŤ. •˝ŽR‹M”Ž1, •âáÁ“ń1, ź@ˇG1, “c”¨Œ’ˆę1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć13‰ń”ĺ”AŠí‰ČÄŒšÄśŒ¤‹†‰ď (2016/6/18), ’šŽć.

733320. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é• o‹ž‰şt᱌`Źp222—á‚Ě‚Ü‚Ć‚ß. ź@ˇG1, “Ą“c“N•v1, •˝ŽR‹M”Ž1, •˝–ěC•˝1, “c”¨Œ’ˆę1, ’Ă‘şGN1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć13‰ń”ĺ”AŠí‰ČÄŒšÄśŒ¤‹†‰ď (2016/6/18), ’šŽć.

733321. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“EœpŒă‚É• •Ç“ŕ›Ć“Úƒwƒ‹ƒjƒA‚đ‚Ť‚˝‚ľ‚˝2—á. “c”¨Œ’ˆę1, ’Ă‘şGN1, ˛“ĄˆĐ•ś1, •˝ŽR‹M”Ž1, ź@ˇG1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ź–{˜aŤ1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć33‰ń_“ŢěŒ§‘O—§‘BŽîᇌ¤‹†‰ď (2016/7/2), V‰Ą•l.

733322. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‘O—§‘BŠŕ‚ɑ΂ˇ‚郈ƒE‘f125‰i‹v‘}“ü–§••ŹüŒš—Ă–@: p’†O-Arm‚đ—p‚˘‚˝Real-time hybrid implant–@‚ĚŒŸ“˘. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ‹ŕŽqŽu•Ű1, Šâ‘şłŽk1, ÎŽR”ŽžŠ2, ’|’†_“ń2, ŠÖŒűˆŠˆß2, ěăłŒĺ2, ‘ě˜ad2 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć33‰ń_“ŢěŒ§‘O—§‘BŽîᇌ¤‹†‰ď (2016/7/2), V‰Ą•l.

733323. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‹‘ĺ‘O—§‘B‚Ěˆę—á. ‘şă‘א´1, ‰Š@‰p–Î, ‚“cŽĄŽq1 (1”ĺ”AŠí): ‰Ą{‰ęƒEƒƒGƒŠƒAƒ~[ƒeƒBƒ“ƒO (2016/7/6), ‰Ą{‰ę.

733324. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw‚É‚¨‚Ż‚é‘O—§‘B‘S“Eœp. “c”¨Œ’ˆę1, ’Ă‘şGN1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, •˝ŽR‹M”Ž1, ź@ˇG1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć5‰ńUrological Network Operation Seminar (2016/7/8), ‰Ą•l.

733325. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) mCRPC‚É‚¨‚Ż‚éAbiraterorone“Š—^Œă‚ĚALP-bounce‚ĚŒŸ“˘. “c”¨Œ’ˆę (”ĺ”AŠí): _“ސěCRPC Seminar (2016/7/20), ‰Ą•l.

733326. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‘O—§‘B”ě‘ĺÇ‚̐V‚ľ‚˘ƒŒ[ƒU[ŽĄ—Ă. Žá“c•”—zŽi1, ‘ĺŽR“N•˝1, ‰œ–ě‹I•F (1”ĺ”AŠí): ‘Š–ÍŒ´’nˆć˜AŒg‚̉ď (2016/7/25), ’Ź“c.

733327. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) t᱊ŕ‚Ć‚ĚŠÓ•Ę‚đ•K—v‚Ć‚ľ‚˝tMALTƒŠƒ“ƒpŽî‚Ěˆę—á. “V–ě“”V1, ’Ă‘şGN1, Žt”ö”ɍF1, Ş–{—Žq1, —§‰Ô‹MŽj1, ě‘ş•ä1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć54‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2016/9/8), ‰Ą•l.

733328. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) “]ˆÚŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚é‘O—§‘B‚Ö‚Ě•úŽËüŽĄ—Ă‚Ě—LŒřŤ‚ÉŠÖ‚ˇ‚錟“˘: propensity score ƒ}ƒbƒ`ƒ“ƒO‰đÍ. “c”¨Œ’ˆę1, ’Ă‘şGN1, Îˆä‘ĺ•ă1, “V–ě“”V1, â“c—T‰î1, Žu‘ş‘sˆę˜N1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

733329. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) BCG’ďRŤ‚Ě”ń‹Ř‘wZŤ”A˜Hă”çŠŕ‚Ěˆę—á. â“c—T‰î1, ’r“cŸb1, ŽR‰ş‰p”V1, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć12‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/10/29), Vh.

733330. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) isŤt×–EŠŕ‚ɑ΂ˇ‚é•ŞŽq•W“I–ňŽĄ—Ă‚É‚¨‚Ż‚é–âf•[“ą“ü‚ĚŽć‚č‘g‚Ý. “Ą“c“N•v (”ĺ”AŠí): ‘ć12‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/10/29), Vh.

733331. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ¸őŽ‰–b“÷Žî‚Ěˆę—á. –ź–؏l1, ŠŰ@“T•v1, ˆŔ“Ą–š”ü1, Îě@–í1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć12‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/10/29), Vh.

733332. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) äNă÷“ŕ‚ɍL”͈͂ɑ˝”­‚ˇ‚éInverted urothelial papilloma‚Ěˆę—á. –Ȋс@ăÄ1, Žu‘ş‘sˆę˜N1, ‚Œű@‘ĺ1, “ě“c@—@1, ŽRč@“™2, “c‰Ş‰ŔŒ›1 (1”ĺ”AŠí, 2•a—): ‘ć12‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2016/10/29), Vh.

733333. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”A–ŒŠÇŠŕ‚ĆŠÓ•Ę˘“ď‚Ĺ‚ ‚Á‚˝ˆÝŠŕ• –Œ“]ˆÚ‚Ěˆę—á. •˝–ěC•˝1, Îˆä~ˆę˜Y, Ź‘q@—Ţ, “y‹´łl1, ěă’B‰›, –ĺ˜e˜ab, ŽlŒłG˜a, ‹ŕj—F–ŘŽq (1”ĺ”AŠí): ‘ć66‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď’†•”‘‰ď (2016/10/29), Žl“úŽs.

733334. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ƒNƒŠƒvƒgƒRƒbƒJƒX‘O—§‘B‰Š‚Ě1—á. Žu‘ş‘sˆę˜N1, ’Ă‘şGN1, —§‰Ô‹MŽj1, •˝ŽR‹M”Ž1, ź@ˇG1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć91‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/11/5), V‰Ą•l.

733335. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ŠJ• p‚đ—v‚ľ‚˝‹‘ĺ‘O—§‘B”ě‘ĺÇ‚Ě1—á. ‘şă‘א´1, ‰Š@‰p–Î, ‚“cŽĄŽq1, Žá“c•”—zŽi1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć91‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/11/5), V‰Ą•l.

733336. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) Œă• –Œganglioneuroma‚Ě1—á. –]ŒŽN•˝1, “c”¨Œ’ˆę1, •˝ŽR‹M”Ž1, •˝ˆäËŽi, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć91‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/11/5), V‰Ą•l.

733337. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”]oŒŒŒă‚É”­ś‚ľ‚˝Ž‘ą–u‹NÇ‚Ě1—á. ’†‘şŒł‹I, ‘ĺŽR“N•˝1, Žá“c•”—zŽi1, ‰œ–ě‹I•F1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć91‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/11/5), V‰Ą•l.

733338. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) •\ÝŤäNă÷Šŕ‚Š‚牓Šu“]ˆÚ‚đ‚Ť‚˝‚ľ‚˝1Ç—á. –ź–؏l1, Îě@–í1, —§‰Ô‹MŽj1, ”‹Œ´ł”Ž1, ě‘ş•ä1, ˆŔ“Ą–š”ü1, ŠŰ@“T•v, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć91‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2016/11/5), V‰Ą•l.

733339. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ŽŠ‘RŒo‰ß‚ɂĉü‘P‚ľ‚˝”AŠÇżœEƒwƒ‹ƒjƒA‚Ěˆę—á. Ź‘q@—Ţ, “y‹´łl1, •˝–ěC•˝1, ŽR“c‘׎j1, ěă’B‰›, –ĺ˜e˜ab, Îˆä~ˆę˜Y (1”ĺ”AŠí): ‘ć68‰ńź“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/11/25), ‰şŠÖ.

733340. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éV‹Kƒzƒ‹ƒ‚ƒ“—Ă–@–ň‚̏‰ŠúŽg—pŒoŒą. “V–ě“”V1, ’r“cŸb1, ŽR‰ş‰p”V1, ‚“ˆ—Í–í, ‚‹´—Tˆę˜Y, –ĺ˜e˜ab, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć68‰ńź“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/11/26), ‰şŠÖ, ź“ú–{”ĺ”AŠí‰Č 2016; 78 (‘Š§†): 202.

733341. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) äNă÷Žq‹{“ŕ–ŒÇ‚Ě1—á. â“c—T‰î1, ’r“cŸb1, ŽR‰ş‰p”V1, ‚“ˆ—Í–í, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć622‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ‹ž’n•ű‰ď (2016/12/8), ç‘ă“c‹ć.

733342. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‘O—§‘BŠŕ–§••ŹüŒš—Ă–@‚É‚¨‚Ż‚錌’†zŠÂŽîᇍזE‚ÉŠÖ‚ˇ‚錤‹†. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ŠÖŒűˆŠˆß2, ’|’†_“ń2, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć1‰ńLiquid BiopsyŒ¤‹†‰ď (2017/1/21), Vh‹ć.

733343. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é‘O—§‘BŠŕŒŸf‚ĹŒŠ‚‚Š‚Á‚˝isŤ‘O—§‘BŠŕ‚Ě1—á. ‘şă‘א´1, ‰Š@‰p–Î, ‚“cŽĄŽq1 (1”ĺ”AŠí): ‰Ą{‰ęŽs‘O—§‘B‚Ş‚ńŒŸfu‰‰‰ď (2017/1/30), ‰Ą{‰ę.

733344. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ¸‘ƒŽîᇂɑ΂ˇ‚éŒă• –ŒƒŠƒ“ƒpßŠs´pŒă‚ĚƒŠƒ“ƒp˜R‚É‚ć‚艺’°ŠÔ–Œ“Ž–Ź‚ސL“W’f—ô‚ľ‚˝1—á. Žt”ö”ɍF1, “c”¨Œ’ˆę1, “V–ě“”V1, Žu‘ş‘sˆę˜N1, Ş–{—Žq1, —§‰Ô‹MŽj1, ě‘ş•ä1, ”‹Œ´ł”Ž1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, ź@ˇG, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ1,2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć55‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2017/2/9), ‰Ą•l.

733345. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) “–‰@‚̐…tÇf—Ă. ź@ˇG (”ĺ”AŠí): ‘ć7‰ń–k—˘‹@”\‰ć‘œƒZƒ~ƒi[ (2017/2/9), ‘Š–ÍŒ´.

733346. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”r”AƒPƒAƒ`[ƒ€`“–‰@‚Ĺ‚Ě”r”AŽŠ—§Žw“ą‚ĚŽŔŰ`. •˝ŽR‹M”Ž (”ĺ”AŠí): LUTS Expert Forum (2017/2/22), ŠC˜V–ź.

733347. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) \“ńŽw’°Z‚𔺂Á‚˝tŽîᇂ̈ę—á. ‘şă‘א´1, ‰Š@‰p–Î, ‚“cŽĄŽq1 (1”ĺ”AŠí): ‘ć17‰ń‰Ą{‰ęƒEƒƒGƒŠƒAƒ~[ƒeƒBƒ“ƒO (2017/2/22), ‰Ą{‰ę.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110018. [Œ´’˜] Risk Factors for Hypocalcemia following Treatment with Denosumab in Patients with Bone Metastases from Prostate Cancer. Koguchi D1, Satoh T1, Tsumura H1, Tabata K1, Oyama T1, Ishikawa W1, Hirai S, Maru N, Okazaki M2, Baba S, Iwamura M1: J Clin Trials 2016/2; 6: 251. doi:10.4172/2167-0870.1000251. (‚Œű@‘ĺ1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, “c”¨Œ’ˆę1, ‘ĺŽR“N•˝1, Îě@–í1, ‰Şč”ü‘ăŽq2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2–ňÜ•”)

[’˜@‘]

H27-620002. [Šwp‘ (•Ş’SŽˇ•M)]y•a‹C‚Ć‚­‚ˇ‚č2016@Šî‘b‚ĆŽŔ‘H Expert's Guide (–ň‹Ç2016”N‘Š§67 (4))z7. •aŒ´”÷ś•¨EˆŤŤVś•¨‚Ć‚­‚ˇ‚č@O. ˆŤŤŽîᇁ@
EäNă÷Šŕ, p.1464-8. ’r“cŸb1, “ü]@Œ[1 (1”ĺ”AŠí), “ěŽR“°, “Œ‹ž, 2016/3”­s.

H27-620003. [Šwp‘ (•Ş’SŽˇ•M)]y•a‹C‚Ć‚­‚ˇ‚č2016@Šî‘b‚ĆŽŔ‘H Expert's Guide (–ň‹Ç2016”N‘Š§67 (4))z7. •aŒ´”÷ś•¨EˆŤŤVś•¨‚Ć‚­‚ˇ‚č@O. ˆŤŤŽîᇁ@
E‘O—§‘BŠŕ, p.1469-73. ’r“cŸb1, “ü]@Œ[1 (1”ĺ”AŠí), “ěŽR“°, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723023. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) PCA3ƒXƒRƒA‚ĆPSA free/total”ä‚đ—p‚˘‚˝—vŽĄ—Ă‘O—§‘BŠŕ—\‘ރmƒ‚ƒOƒ‰ƒ€‚̍쐬. ‘ĺ“Œ‹MŽu, •ĘŠ‰pŽĄ1, ‰z“c’|˜N, rě@F, …–ě—˛ˆę, ’†“‡@~ (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2016/4/21), ‹ŕ‘ň.

H27-723024. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”AŠÇŽîᇂɑ΂ľ‚Ä”AŠÇ‹ž‰şƒŒ[ƒU[Řœp‚đs‚Á‚˝1—á. ŽR‰ş‰p”V1, Îˆä~ˆę˜Y1, –{“c’qŽk1, X‰ił“ń˜Y, ‚“ˆ—Í–í, ‚‹´—Tˆę˜Y, –ĺ˜e˜ab, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), “Œ‹ž.

H27-733009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) f’f‚É‹ę—ś‚ľ‚˝SóŒ‹’°äNă÷ᑂ̈ę—á. “V–ě“”V1,2, ŽR‰ş‰p”V1,2, ’r“cŸb1,2, ‚“ˆ—Í–í2, ‚‹´—Tˆę˜Y2, •gě˜a–ç2, Îˆä—ǍK2, ‹kě“ސś2,3, –î“ŕŒ´‹v2,3, X‰ił“ń˜Y2, “ü]@Œ[1,2 (1”ĺ”AŠí, 2–k—˘Œ¤‹†Š•a‰@, 3•úŽËü (‰ć‘œ)): ‘ć619‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ‹ž’n•ű‰ď (2015/12/3), “Œ‹ž, ”ĺ”AŠíŠO‰Č 2016/7; 29 (7): 1201.


Šá‰ČŠw

[Šwp˜_•ś]

110244. [Œ´’˜] Effects of Age and Sex on Values Obtained by RAPDx_ Pupillometer, and Determined the Standard Values for Detecting Relative Afferent Pupillary Defect. Satou T1, Goseki T1, Asakawa K2, Ishikawa H2, Shimizu K1: Transl Vis Sci Technol 2016/4; 5 (2): 18. (˛“Ą@Ži1, ŒăŠÖ—˜–ž1, óě@ŒŤ2, Îě@‹Ď2, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110245. [Œ´’˜] Effect of hole size on fluid dynamics of a posterior-chamber phakic intraocular lens with a central perforation by using computational fluid dynamics. Kawamorita T1, Shimizu K2, Shoji N3: Graefes Arch Clin Exp Ophthalmol 2016/4; 254 (4): 739-44. (ěŽç“c‘ńŽu1, ´…Œö–ç2, ŻŽiMs3: 1ˆă—ÉqśŠw•”, 2ŽR‰¤•a‰@ƒAƒCƒZƒ“ƒ^[, 3Šá‰Č)

110246. [Œ´’˜] Relationship of cornial asphericity to intraocular lens power calculations after myopic laser in situ keratomileusis. Mori Y1,2, Shimizu K2, Minami K1, Kamiya K2, Shoji N2, Miyata K1: J Cataract Refract Surg 2016/5; 42 (5): 703-9. (X@—mÄ1,2, ´…Œö–ç2, “ěŒcˆę˜Y1, _’J˜aF2, ŻŽiMs2, ‹{“c˜a“T1: 1‹{“cŠá‰Č, 2Šá‰Č)

110247. [Œ´’˜] Pre- and postsynaptic effects of brimonidine on isolated rabbit iris dilator muscles. Tatsui S1, Ishikawa H2, Shimizu K1, Mashimo K1: Clin Ophthalmol 2016/5; 10: 845-9. (—´ˆä‰‘Žq1, Îě@‹Ď2, ´…Œö–ç1, áÁ‰ş‹I”ü‘ă1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110248. [Œ´’˜] Short-term evaluation of Trabectome surgery performed on Japanese patients with open-angle glaucoma. Shoji N1, Kasahara M1, Iijima A1, Takahashi M1, Tatsui S1, Matsumura K1, Morita T1, Shimizu K1: Jpn J Ophthalmol 2016/5; 60 (3): 156-65. (ŻŽiMs1, Š}Œ´łs1, ”Ń“‡ˆč‰Ă1, ‚‹´ł‰p1, —´ˆä‰‘Žq1, ź‘şˆęO1, X“c“N–ç1, ´…Œö–ç1: 1Šá‰Č)

110249. [Œ´’˜] Evaluation of Relative Afferent Pupillary Defect Using RAPDx Device in Patients with Optic Nerve Disease. Satou T1, Ishikawa H2, Asakawa K2, Goseki T1, Niida T1,3, Shimizu K1: Neuroophthalmology 2016/6; 40 (3): 120-4. (˛“Ą@Ži1, Îě@‹Ď2, óě@ŒŤ2, ŒăŠÖ—˜–ž1, Vˆä“cF—T1,3, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”, 3‘Űˆă—Ă•ŸŽƒ‘ĺŠw)

110250. [Œ´’˜] Effects of periocular warm compresses with or without menthol stimulation on visual function and autonomic nervous system. Shimada Y, Iimori N, Igaki M, Iwata Y1, Asakawa K2, Ishikawa H2: The Autonomic Nervous System 2016/7; 53 (2): 173-7. (Šâ“c@ęĄ1, óě@ŒŤ2, Îě@‹Ď2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”)

110251. [Œ´’˜] Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed. Hong Y, Shoji N1, Morita T1, Hirasawa K2, Matsumura K1, Kasahara M1, Shimizu K1: Int J Ophthalmol 2016/7; 9 (7): 973-8. (ŻŽiMs1, X“c“N–ç1, •˝ŕVˆę–@2, ź‘şˆęO1, Š}Œ´łs1, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110252. [Œ´’˜] Changes in astigmatism and corneal higher-order aberrations after phacoemulsification with toric intraocular lens implantation for mild keratoconus with cataract. Kamiya K1, Shimizu K1, Miyake T1: Jpn J Ophthalmol 2016/7; 60 (4): 302-8. (_’J˜aF1, ´…Œö–ç1, ŽO‘îr”V1: 1Šá‰Č)

110253. [Œ´’˜] Effects of Target Size and Test Distance on Stereoacuity. Iwata Y1, Fujimura F2, Handa T2, Shoji N3, Ishikawa H2: Journal of Ophthalmology 2016/8; 2016: Article ID 7950690, 5 pages. http://dx.doi.org/10.1155/2016/7950690. (Šâ“c@—y1, “Ą‘ş•‡˛Žq2, ”ź“c’m–ç2, ŻŽiMs3, Îě@‹Ď2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3Šá‰Č)

110254. [Œ´’˜] A novel method to predict visual field progression more accurately, using intraocular pressure measurements in glaucoma patients. Asaoka R1, Fujino Y1, Murata H1, Miki A1, Tanito M1, Mizoue S1, Mori K1, Suzuki K1, Yamashita T1, Kashiwagi K1, Shoji N1,2 (1Japanese Archive of Multicentral Database in Glaucoma (JAMDIG) construction group): Sci Rep 2016/8; 6: 31728. (ŻŽiMs1,2: 2Šá‰Č)

110255. [Œ´’˜] Retinal vessel diameters in a Japanese population: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study. Tano T1,2, Ono K, Hiratsuka Y, Otani K, Sekiguchi M, Konno S, Kikuchi S, Onishi Y, Takegami M, Yamada M, Fukuhara S, Murakami A: Acta Ophthalmol 2016/9: 94 (6): e432-41. (“c–ě‹Mr1,2: 1Šá‰Č, 2‡“V“°‘ĺŠw‘ĺŠw‰@ˆăŠwŒ¤‹†‰ČŠá‰ČŠw)

110256. [Œ´’˜] Smaller Fixation Target Size Is Associated with More Stable Fixation and Less Variance in Threshold Sensitivity. Hirasawa K1, Okano K1, Koshiji R1, Funaki W1, Shoji N2: PLoS One 2016/11; 11 (11): e0165046. (•˝ŕVˆę–@1, ‰Ş–ě‰ÄŘ1, ‰z’n—šŽq1, M–ŘŽá“Ţ1, ŻŽiMs2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

110257. [Œ´’˜] Assessment of subjective intraocular forward scattering and quality of vision after posterior chamber phakic intraocular lens with a central hole (Hole ICL) implantation. Iijima A1, Shimizu K1, Yamagishi M1, Kobashi H1, Igarashi A1, Kamiya K1: Acta Ophthalmol 2016/12: 94 (8): e716-20. (”Ń“‡ˆč‰Ă1, ´…Œö–ç1, ŽRŠÝ^‹|1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, _’J˜aF1: 1Šá‰Č)

110258. [Œ´’˜] Bilateral Concurrent Eye Examination with a Head-Mounted Perimeter for Diagnosing Functional Visual Loss. Goseki T1, Ishikawa H2, Shoji N1: Neuroophthalmology 2016/12; 40 (6): 281-5. (ŒăŠÖ—˜–ž1, Îě@‹Ď2, ŻŽiMs1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110259. [Œ´’˜] Histopathological Changes of Inner Retina, Optic Disc, and Optic Nerve in Rabbit with Advanced Retinitis Pigmentosa. Asakawa K1, Ishikawa H1, Uga S2, Mashimo K2, Kondo M, Terasaki H: Neuroophthalmology 2016/12; 40 (6): 286-91. (óě@ŒŤ 1, Îě@‹Ď 1, ‰F‰ę–ÎŽO2, áÁ‰ş‹I”ü‘ă2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

110260. [Œ´’˜] Suppression of surface light scattering in intraocular lenses manufactured using an improved production process. Miyata K1, Ogata M1, Honbo M1, Mori Y1,2, Minami K1: J Cataract Refract Surg 2016/12; 42 (12): 1716-20. (X@—mÄ1,2: 1‹{“cŠá‰Č, 2Šá‰Č)

110261. [Œ´’˜] Effects of Ripasudil Hydrochloride Hydrate Instillation on Pupil Dynamics. Satou T1, Ishikawa H2, Asakawa K2, Goseki T1, Shimizu K1: Current Eye Research 2017/1; 42 (1): 54-7. (˛“Ą@Ži1, Îě@‹Ď2, óě@ŒŤ2, ŒăŠÖ—˜–ž1, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110262. [Œ´’˜] Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty. Kobashi H1,2, Kamiya K1, Shimizu K1: J Ocul Pharmacol Ther 2017/1; 33 (1): 13-8. (Ź‹´‰p’ˇ1,2, _’J˜aF1, ´…Œö–ç1: 1Šá‰Č, 2SchepenŠáŒ¤‹†Š)

110263. [Œ´’˜] Dry Eye After Small Incision Lenticule Extraction and Femtosecond Laser-Assisted LASIK: Meta-Analysis. Kobashi H1,2, Kamiya K1, Shimizu K1: Cornea 2017/1; 36 (1): 85-91. (Ź‹´‰p’ˇ1,2, _’J˜aF1, ´…Œö–ç1: 1Šá‰Č, 2SchepenŠáŒ¤‹†Š)

110264. [Œ´’˜] Effect of the administration period of perioperative topical levofloxacin on normal conjunctival bacterial flora. Nejima R1,2, Shimizu K2, Ono T, Noguchi Y, Yagi A, Iwasaki T, Shoji N2, Miyata K: J Cataract Refract Surg 2017/1; 43 (1): 42-8. (Žq“‡—Ç•˝1,3, ´…Œö–ç2, ŻŽiMs2: 1‹{“cŠá‰Č, 2Šá‰Č)

110265. [Œ´’˜] Validating the Usefulness of the ""Random Forests"" Classifier to Diagnose Early Glaucoma With Optical Coherence Tomography. Ryo Asaoka R, Hirasawa K1, Iwase A, Fujino Y, Murata H, Shoji N2, Araie M: American Journal of Ophthalmology 2017/2; 174: 95-103. (•˝ŕVˆę–@1, ŻŽiMs2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

110266. [Œ´’˜] A Multicenter Prospective Cohort Study on Refractive Surgery in 15 011 Eyes. Kamiya K1, Igarashi A1,2, Hayashi K, Negishi K, Sato M, Bissen-Miyajima H: Am J Ophthalmol 2017/3; 175: 159-68. (_’J˜aF1, ŒÜ\—’ÍŽj1,2: 1Šá‰Č, 2ŽR‰¤•a‰@)

110267. [Œ´’˜] Comparison of laser in situ ketatomileusis and photorefractive keratectomy for myopia using a mixed-effects model. Mori Y1, Miyata K, Ono T, Yagi Y, Kamiya K1, Amano S: PLoS One 2017/3; 12 (3): e0174810. (X@—mÄ1, _’J˜aF1: 1Šá‰Č)

120021. [Œ´’˜] “Œ‹ž“sŹŠ}Œ´‘ş‚É‚¨‚Ż‚é—‡ŠáŽ‹—͂̕ωť. ˆÉ“Ą”üšŠG1, ´…Œö–ç2, ěŽç“c‘ńŽu1, ŻŽiMs2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): “ú–{Šá‰ČŠw‰ďŽGŽ 2016/4; 120 (4): 296-302.

120022. [Œ´’˜] ‹ßÔŠO•ŞŒő–@‚đ—p‚˘‚˝VśŽ™‚Ě‘źŠo“IŽ‹‹@”\ŒŸ¸‘•’u‚ĚŠJ”­. Šâ“c@—y1, ’r“c“N–ç2, ”ź“c’m–ç3, Îě@‹Ď3, ŻŽiMs2, ´…Œö–ç2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č, 3ˆă—ÉqśŠw•”): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2016/5; 33 (5): 749-54.

120023. [Œ´’˜] 3D Visual Function Trainer-ORTe‚đ—p‚˘‚˝ăŽÎ‹Ř–ƒáƒŠłŽŇ‚Ě9•űŒüŠáˆăŒŸ¸. •Ű‰Č”üŠó1, Îě@‹Ď2, ŒăŠÖ—˜–ž1, ”ź“c’m–ç2, ˛“Ą@Ži1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2016/6; 33 (6): 915-9.

120024. [Œ´’˜]y‘ć26‰ń“ú–{—ΓŕáŠw‰ď Œ´’˜zOCTOPUS600Ž‹–ěŒv10-2‚ĆHumphreyŽ‹–ěŒv10-2‚Ě”äŠr. ‚‹´‰ÄŽŔ1, ˛“Ą@Ži1, ź‘şˆęO1, Š}Œ´łs1, •˝ŕVˆę–@2, ŻŽiMs1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2016/7; 33 (7): 1044-8.

120025. [Œ´’˜]y‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď Œ´’˜zLENSTARS900҂̉ÁŽZˆ—‚É‚ć‚é‘Ş’č‰Â”\—Ś‚ƏpŒă‹üÜŒëˇ. –îƒm–Ú‹ž•˝1, ”Ń“c‰Ă•F1, ´…Œö–ç1 (1Šá‰Č): —Տ°Šá‰Č 2016/8; 70 (8): 1239-43.

120026. [Œ´’˜]y‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď Œ´’˜z‘˝Ĺ“_Šá“ŕƒŒƒ“ƒYŒđŠˇÇ—á‚Ě”wŒiˆöŽq‚ĚŒŸ“˘. Î“c@‹Ĺ1, ´…Œö–ç1, ”Ń“c‰Ă•F1, ˆÉ“Ą”üšŠG2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): —Տ°Šá‰Č 2016/9; 70 (9): 1419-23.

120027. [Œ´’˜]yŠw‰ďŒ´’˜z”’“ŕáŠá‚É‚¨‚Ż‚éIOLMaster700Ň‚Ě‘Ş’č‰Â”\—Ś‚ƏpŒă‹üÜŒëˇ. ŽRěç‰Ŕ1, ”Ń“c‰Ă•F1, Ö“Ą@Ę1, –îƒm–Ú‹ž•˝1, ěŽç“c‘ńŽu2, ´…Œö–ç3 (1Šá‰Č, 2ˆă—ÉqśŠw•”, 3ŽR‰¤•a‰@ƒAƒCƒZƒ“ƒ^[): IOL&RS 2016/12; 30 (4): 565-70.

120028. [Œ´’˜] Œ’í‚Zś1–ź‚ĚŒ‹–Œ”X“ŕŒŸoMRSE‚Ć•@o“ŕŒŸoMRSE‚Ě“ŻˆęŤ‚ĚŒŸ“˘‚Ć•ŞŽq‰uŠw. â–{‘Ľ•q1, ´…Œö–ç2, ’†‘şłŽ÷3, –k—˘‰p˜Y3 (1â–{Šá‰ČĂ“ěƒNƒŠƒjƒbƒN, 2Šá‰Č, 3ˆă—ÉqśŠw•”): “Ą‘ňŽs“ŕ‰ČˆăŠw‰ďŽGŽ 2016; 28: 24-6.

120029. [Œ´’˜]y‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď Œ´’˜zOcclu-pad҂đ—p‚˘‚˝ŽăŽ‹ŒP—ű‚ĚƒRƒ“ƒvƒ‰ƒCƒAƒ“ƒXŒüăŒř‰Ę. ŒË’ˁ@Œĺ1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): Šá‰Č—Տ°‹I—v 2017/1; 10 (1): 49-52.

120030. [Œ´’˜]y‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď Œ´’˜z•˝Ź27”N“x‘Š–ÍŒ´ŽsAŠwŽžŒ’Nf’f‚É‚¨‚Ż‚鎋—ÍŒŸ¸ŽŔŽ{•ń. “Ą‘ş•‡˛Žq1, ”ź“c’m–ç1, ěŽç“c‘ńŽu1, Šâ“c@—y2, ŻŽiMs3 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Šá‰Č): Šá‰Č—Տ°‹I—v 2017/2; 10 (2): 157-60.

310013. [Ç—á•ń] Electroretinography and Pupillography in Unilateral Foveal Hypoplasia. Asakawa K1, Ishikawa H1: J Pediatr Ophthalmol Strabismus 2016/6; 53 Online: e26-8. (óě@ŒŤ1, Îě@‹Ď1: 1ˆă—ÉqśŠw•”)

320031. [Ç—á•ń] ŽĄ—Ă’ďRŤ‚ĚŠ´őŤŠp–Œ’×ᇂɑ΂ľ‚ÄŠp–ŒƒRƒ‰[ƒQƒ“ƒNƒƒXƒŠƒ“ƒLƒ“ƒO•š—p‚Ş—LŒř‚ƍl‚Ś‚ç‚ę‚˝2—á. ‰Í–ě—Y—ş1, _’J˜aF1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): “ú–{Šá‰ČŠw‰ďŽGŽ 2016/12; 120 (12): 831-6.

520011. [‘ŕ] Šá“ŕƒŒƒ“ƒY‚É‚ć‚郂ƒmƒrƒWƒ‡ƒ“. ”Ń“c‰Ă•F (Šá‰Č): IOL&RS 2016/12; 30 (4): 528-32.

520012. [‘ŕ] ’áNP—ΓŕáŽčp (MIGS). ŻŽiMs (Šá‰Č): Šá‰Č 2017/3; 59 (3): 263-73.

521015. [‰đŕ] ƒv[ƒ‹‚Ĺ‚Ě’ˆÓ“_, ĄŒŽ‚Ě‚Đ‚Ć‚ą‚Ć. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‰Ą•lŽsŠá‰Čˆă‰ď‰ď•ń 2016/5/1.

521016. [‰đŕ] yĄŒŽ‚Ě•\Ž†z‘˝”­ÁŽ¸Ť”’“_ÇŒóŒQ. ‰i–ěKˆę1, —é–؍N”V2 (1Šá‰Č, 2“ŒŠC‘ĺŠw): —Տ°Šá‰Č 2016/6; 70 (6): 810.

521017. [‰đŕ] Žq‹Ÿ‚ĚŠá‚ĚŒ’N‚Ć‹ł‰Č‘, ‹łŢ“™‚Ě“dŽq‰ť. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‰Ą•lŽsŠá‰Čˆă‰ď‰ď•ń 2016/7; 60: 32-5.

521018. [‰đŕ] “ľEŒŸ¸|ŒŸ¸‚Ěƒcƒ{|. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”): Šá‰Čˆăƒ}ƒ‹ƒ`ƒtƒ@ƒCƒ“ƒ_[ 2016/7; 30: 4.

521019. [‰đŕ]yĄŒŽ‚Ě˜b‘čz”’“ŕáŽčp‚Ě•Ď‘J. ´…Œö–ç (Šá‰Č): —Տ°Šá‰Č 2016/8; 70 (8): 1187-92.

521020. [‰đŕ] ƒƒ‰ƒmƒvƒVƒ“ŠÜ—L–Ô–Œ_Œoß×–E. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”): “ú–{‚ĚŠá‰Č 2016/8; 87 (8): 1095-6.

521021. [‰đŕ] TS-1҂ɂć‚éŠááŠQ. ”–؍LĆ1,2 (1Šá‰Č, 2Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[): “ú–{‚ĚŠá‰Č 2016/9; 87 (9): 1231.

521022. [‰đŕ]y˜b‘čz”]Ň‘‰tŒ¸­Ç‚ĆŽ‹‹@”\. ‚‹´_ˆę1, ŽRă–žŽq2, Îě@‹Ď3, ”ü”n’B•v1 (1ŽR‰¤•a‰@, 2ˆäăŠá‰Č•a‰@, 3Šá‰Č): _ŒoŠá‰Č 2016/9; 33 (3): 283-6.

521023. [‰đŕ]yĹV‹@ŠíƒŒƒ|[ƒgzOCTƒAƒ“ƒMƒI. ŒăŠÖ—˜–ž1, ŽO‰Y‰ë”Ž2 (1Šá‰Č, 2“Œ‹žˆă‰Č‘ĺŠwˆďéˆă—ĂƒZƒ“ƒ^[): _ŒoŠá‰Č 2016/9; 33 (3): 302-9.

521024. [‰đŕ]y”jůN, ‡•šÇˆ—z ƒCƒ“ƒWƒFƒNƒ^[‚đ—p‚˘‚˝Šá“ŕƒŒƒ“ƒY–D’…p. ”Ń“c‰Ă•F (Šá‰Č): IOL&RS 2016/9; 30 (3): 370-4.

521025. [‰đŕ] ƒv[ƒŠ[‚ĚˆŮí‚ĆŽĄ—Ă. ŒăŠÖ—˜–ž (Šá‰Č): “ú–{‚ĚŠá‰Č 2016/10; 87 (10): 1330-5.

521026. [‰đŕ]yŠwpî•ńzC-Quant‚đ—p‚˘‚˝‹üÜ‹¸łŽčp‘OŒă‚ĚŽ‹‹@”\•]‰ż‚Ć‘źŠo“I‘O•űŽU—‚Ć‚Ě‘ŠŠÖ. _’J˜aF (Šá‰Č): Chuo Sangio Times 2016/10; 9: 7.

521027. [‰đŕ]yŠw‰ďƒgƒsƒbƒNƒX: ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ďz“–‰@‚É‚¨‚Ż‚éAŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘fťÜ (ƒ{ƒgƒbƒNƒXŇ)‚đ—p‚˘‚˝ŽÎŽ‹ŽĄ—Ă‚Ě‰Šú—Տ°ŹŃ. ŒăŠÖ—˜–ž1, Îě@‹Ď2, ’r“c“N–ç1, —´ˆä‰‘Žq1 (1Šá‰Č, 2ˆă—Éqś): “ú–{Šá‰ČŠw‰ďŽGŽ 2016/10; 120 (10): 697-8.

521028. [‰đŕ] ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY“KłŽg—p‚ւ̑Ήž. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): _“ŢěŒ§Šá‰Čˆă‰ď‰ď•ń 2016/10; 225: 2.

521029. [‰đŕ] FSLŠˆ—p‚Ĺ‘OŠá•”Žčp‚Ě–˘—ˆ‘œ‚đ“W–]‚Ö. _’J˜aF (Šá‰Č): “ú–{Šá‰ČŠw‰ďŒö”F“Á•Ę•ŇW”Ĺ 2016/11; 1: 3.

521030. [‰đŕ]yŹŽ™Šá‰ČQ•AzI Šw“ś‹ßŽ‹E‹ßŽ‹ŒŸ¸E‹üÜˆŮí‚Ȃǁ@Q4 Šw“ś‚Ě‹üÜŒŸ¸‚É‚¨‚Ż‚é’˛ß–ƒáƒ–ň‚ĚŽg—p‚Ě•K—vŤ‚Ćƒ|ƒCƒ“ƒg‚ɂ‚˘‚Ä‹ł‚Ś‚Ä‚­‚ž‚ł‚˘. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2016/11; 33 (—ŐŽž‘Š§†): 13-6.

521031. [‰đŕ] ŒuŒőŠá’ꑢ‰eŒŸ¸‚ĚŠî‘b. ŽRŒű@ƒ (Šá‰Č): Šá‰ČŽĘ^2016/12; 33: 8-14.

521032. [‰đŕ]yĹV‹@ŠíƒŒƒ|[ƒgzƒwƒbƒhƒ}ƒEƒ“ƒgŒ^Ž‹–ěŒvƒAƒCƒ‚|Intoroduction|. ŒăŠÖ—˜–ž (Šá‰Č): _ŒoŠá‰Č 2017/3; 34 (1): 73.

521033. [‰đŕ]yĹV‹@ŠíƒŒƒ|[ƒgzƒwƒbƒhƒ}ƒEƒ“ƒgŒ^Ž‹–ěŒvƒAƒCƒ‚|User's CommentsyĹV‹@ŠíƒŒƒ|[ƒgzƒwƒbƒhƒ}ƒEƒ“ƒgŒ^Ž‹–ěŒvƒAƒCƒ‚|. ‹˝‰E‹ß”ŽN1, ŻŽiMs1 (1Šá‰Č): _ŒoŠá‰Č 2017/3; 34 (1): 79-80.

522090. [uŔ]y“ÁW: ‹üÜ‹¸ł‚đŒŠ’ź‚ˇ!zPhakic IOL‚É‚ć‚é‹­“x‹ßŽ‹ŽĄ—Ă. _’J˜aF (Šá‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2016/6; 33 (6): 779-86.

522091. [uŔ]y“ÁW: Žq‚Ç‚ŕ‚ĆƒƒfƒBƒAIIzƒƒfƒBƒA‚ŞŽq‚Ç‚ŕ‚̖ڂ⎨‚É—^‚Ś‚é‰e‹ż. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ŠwZ•ŰŒ’ 2016/7; 319: 2.

522092. [uŔ]y“ÁW: Šp–ŒˆÚA‚ĚƒAƒbƒvƒf[ƒg^Ř‚炸‚ÉŽĄ‚ˇŠáŽîᇁ|Žĺ–đ‚É”—‚é•â•—Ă–@|zƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚É‚ć‚éŠp–ŒˆÚA|Ť—ˆ‚ĚŠp–ŒˆÚA‚Ě•K{ƒAƒCƒeƒ€‚Š?|. _’J˜aF (Šá‰Č): Šá‰ČŽčp 2016/7; 29 (3): 370-3.

522093. [uŔ]y“ÁW: łŠm‚ČŒŸ¸’l‚̏o‚ľ‚Š‚˝‚đ‘ŹK! Šá‰ČŽĺ—vŒŸ¸‚Ě‚ą‚ę‚ž‚Ż! d—vƒ|ƒCƒ“ƒg50zŒőŠąÂ’f‘wŒvŒŸ¸. ‰i–ěKˆę (Šá‰Č): Šá‰ČƒPƒA 2016/8; 18 (8): 773-9.

522094. [uŔ]y“ÁW (2): –Ú‚Š‚çƒEƒƒR‚ĚƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[ Ž^ŹVS”˝‘΁zŠw“ś‚ɑ΂ˇ‚éƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[@”˝‘Δh‚Ě—§ę‚Š‚ç. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): Šá‰ČƒOƒ‰ƒtƒBƒbƒN 2016/10; 5 (5): 458-64.

522095. [uŔ]y“ÁW: Minimally Invasive Glaucoma Surgery (MIGS)zƒgƒ‰ƒxƒNƒg[ƒ€Žčp. Š}Œ´łs1, ŻŽiMs1 (1Šá‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2017/1; 34 (1): 23-8.

522096. [uŔ]y“ÁW: ŽÎŽ‹f’f‚ĚŠî–{zSagging Eye Syndrome. ŒăŠÖ—˜–ž (Šá‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2016/12; 33 (12): 1721-4.

522097. [uŔ]y“ÁW: How to…ť‘ĚÄŒšzŠá“ŕƒŒƒ“ƒYŒvŽZŽŽ‚Ě‘I‘đ‚Ć’ˆÓ“_. ”Ń“c‰Ă•F (Šá‰Č): Monthly Book OCULISTA 2016/12; 45: 48-55.

522098. [uŔ]y“ÁW (3): ‚Ç‚ą‚ĹŽčp‚É“Ľ‚Ý‚Ť‚é? —Γŕáz‚Ç‚ą‚ĹŽčp‚É“Ľ‚Ý‚Ť‚é? •ÂÇ‹÷Šp—Γŕá. ŻŽiMs (Šá‰Č): Šá‰ČƒOƒ‰ƒtƒBƒbƒN 2017/2; 6 (1): 67-72.

522099. [uŔ]y“ÁW: ƒ[ƒrƒWƒ‡ƒ“‚Ɛ_ŒoŠá‰Čz˜˜_. Žs粋`Í1,2 (1Šá‰Č, 2_“ސ쎕‰Č‘ĺŠw•t‘Ž‰Ą•lƒNƒŠƒjƒbƒN): _ŒoŠá‰Č 2017/3; 34 (1): 4.

522100. [uŔ]y“ÁW: ƒ[ƒrƒWƒ‡ƒ“‚Ɛ_ŒoŠá‰ČzŒŠ‚Ś‚Č‚˘‚ž‚Ż‚ރ[ƒrƒWƒ‡ƒ“‚Ĺ‚Í‚Č‚˘|ƒ[ƒrƒWƒ‡ƒ“‚Ě‘ÎŰ‚Ć‚Č‚é—lX‚ČŽžŠł|. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@): _ŒoŠá‰Č 2017/3; 34 (1): 25-32.

530005. [‚ť‚Ě‘ź (Œ¤‹†•ń)] Effect of Light Scattering and Higher-order Aberrations on Visual Performance in Eyes with Granular Corneal Dystrophy. Kamiya K1, Kobashi H1, Igarashi A1, Shoji N1, Shimizu K1: Sci Rep. 2016/4; 6: 24677. (_’J˜aF1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, ŻŽiMs1, ´…Œö–ç1: 1Šá‰Č)

530006. [‚ť‚Ě‘ź (Œ¤‹†•ń)] Comparison of size modulation and conventional standard automated perimetry with the 24-2 test protocol in glaucoma patients. Hirasawa K1, Shoji N2, Kasahara M2, Matsumura K2, Shimizu K2: Sci Rep 2016/5; 6: 25563. (•˝ŕVˆę–@1, ŻŽiMs2, Š}Œ´łs2, ź‘şˆęO2, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

530007. [‚ť‚Ě‘ź (Œ¤‹†•ń)] Long-Term Comparison of Posterior Chamber Phakic Intraocular Lens With and Without a Central Hole (Hole ICL and Conventional ICL) Implantation for Moderate to High Myopia and Myopic Astigmatism: Consort-Compliant Article. Shimizu K1, Kamiya K1, Igarashi A1, Kobashi H1: Medicine (Baltimore) 2016/4; 95 (14): e3270. (´…Œö–ç1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1: 1Šá‰Č)

530008. [‚ť‚Ě‘ź (Œ¤‹†•ń)] Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG). Fujino Y1, Asaoka R1, Murata H1, Miki A1, Tanito M1, Mizoue S1, Mori K1, Suzuki K1, Yamashita T1, Kashiwagi K1, Shoji N1,2 (1Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG) Construction Group): Invest Ophthalmol Vis Sci 2016/4; 57 (4): 2012-20. (ŻŽiMs1,2: 2Šá‰Č)

540030. [‚ť‚Ě‘ź] ŠwZ‚ł̐FŠoŒŸ¸, ƒƒWƒJƒ‹ƒŒƒ|[ƒg (1). ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰Ą•lŽsŠá‰Čˆă‰ď): _“ŢěŒ§ˆăŽt‰ď•ń 2016/5/10.

540031. [‚ť‚Ě‘ź] ŠŞ“ŞŒž. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‰Ą•lŽsŠá‰Čˆă‰ď‰ď•ń 2016/7; 60: 14-5.

540032. [‚ť‚Ě‘ź (Šw‰ďˆóŰ‹L)]yˆóŰ‹Lz‘ć15‰ń”]Ň‘‰tŒ¸­ÇŒ¤‹†‰ď. ŽRă–žŽq1,2 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@): _ŒoŠá‰Č 2016/9; 33 (3): 287-8.

540033. [‚ť‚Ě‘ź (’˛¸•ń)] 2014E2015”N“xJSCRS‰ďˆőƒAƒ“ƒP[ƒg. ˛“ĄłŽ÷1, —с@@Œ¤2, ŞŠÝˆę”T3, _’J˜aF4, ƒrƒbƒZƒ“‹{“‡OŽq5 (1ƒTƒgƒEŠá‰Č, 2—ŃŠá‰Čˆă‰@, 3Œcœä‹`m‘ĺŠw, 4Šá‰Č, 5JSCRS—Ž–’ˇE“Œ‹žŽ•‰Č‘ĺŠw…“š‹´•a‰@): IOL&RS 2016/9; 30 (3): 385-401.

540034. [‚ť‚Ě‘ź (’˛¸•ń)] •˝Ź27”N“xŠwZˆă’čŠúŒ’Nf’fƒAƒ“ƒP[ƒg•ń (Šá‰Č). ‰F’ĂŒŠ‹`ˆę1,2, ‰Á“Ą—˜”Ž, ‰Ş“c@—T, ‹ŕˆä@Œő (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‰Ą•lŽsˆăŽt‰ďŠwZˆă•”‰ďƒŒƒ|[ƒg 2016/12; 31: 58-9.

540035. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)]yyomiDr.z—Ł‚ę‚˝‚ŕ‚Ě‚Şd‚Č‚Á‚ÄŒŠ‚Ś‚é. ŒăŠÖ—˜–ž (Šá‰Č): “Ç”„V•ˇ 2016/5/28: https://yomidr.yomiuri.co.jp/article/20160523-OYTET50004/.

540036. [‚ť‚Ě‘ź] “ú–{_ŒoŠá‰ČŠw‰ď—Ž–’ˇ‚ɏA”C‚ľ‚Ä. Îě@‹Ď (ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2017/3; 34 (1): 2-3.

540037. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@ŒŸf‚Ĺ‘Šú”­ŒŠ. ŻŽiMs (Šá‰Č): Ă‰ŞV•ˇ 2016/12; p.5.

540038. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@’čŠúŒŸf‚Ş‘ĺŘ. ŻŽiMs (Šá‰Č): ‰Í–kV•ń 2016/12; p.21.

540039. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@’čŠúŒŸf@‘Šú”­ŒŠ‚đ. ŻŽiMs (Šá‰Č): ŒF–{“ú“úV•ˇ 2016/12; p.22.

540040. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] Ž¸–ž‚Ě‹°‚ę@—Γŕá‚É’ˆÓ. ŻŽiMs (Šá‰Č): _ŒËV•ˇ 2016/12; p.14.

540041. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] Šáˆłłí‚Ĺ‚ŕ”­Ç. ŻŽiMs (Šá‰Č): ˆďéV•ˇ 2016/12; p.19.

540042. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@’čŠú“IŒŸf‚đ. ŻŽiMs (Šá‰Č): ’ˇčV•ˇ 2016/12; p.26.

540043. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@‘Šú”­ŒŠ‚Ş‘ĺŘ. ŻŽiMs (Šá‰Č): ˆ¤•QV•ˇ 2016/12; p.24.

540044. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ’čŠúŒŸf‚Ĺ‘Šú”­ŒŠ‚đ@—Γŕá. ŻŽiMs (Šá‰Č): ‹ž“sV•ˇ 2016/12; p.17.

540045. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@’čŠúŒŸf‚Ĺ‘Šú”­ŒŠ‚đ. ŻŽiMs (Šá‰Č): —Ž‹…V•ń 2016/12; p.18.

540046. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] Ž¸–ž‚ÉŽŠ‚é@—Γŕá@‹C•t‚Š‚¸is. ŻŽiMs (Šá‰Č): “ż“‡V•ˇ 2016/12; p.25.

540047. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@ŒŸf‚Ĺ‘Šú”­ŒŠ‚đ. ŻŽiMs (Šá‰Č): M”Z–ˆ“úV•ˇ 2016/12; p.27.

540048. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] Ž¸–ž‚ÉŽŠ‚é—Γŕá. ŻŽiMs (Šá‰Č): ç—t“ú•ń 2016/12; p.6.

540049. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘Šú”­ŒŠ‚Ě‚˝‚ߌŸ¸‚đ. ŻŽiMs (Šá‰Č): é‹ĘV•ˇ 2016/12; p.15.

540050. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@‹C•t‚Ť‚É‚­‚˘u–Ťv. ŻŽiMs (Šá‰Č): ŽR—œ“ú“úV•ˇ 2016/12; p.14.

540051. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@–R‚ľ‚˘ŽŠŠoÇó. ŻŽiMs (Šá‰Č): ‚’mV•ˇ 2016/12; p.13.

540052. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] Ž¸–ž‚ÉŽŠ‚é—Γŕá@‘Šú”­ŒŠ‚ÖŒŸ¸‚đ. ŻŽiMs (Šá‰Č): ’†•”ŒoĎV•ˇ 2016/12; p.8.

540053. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@Ž‹–ě‚ÉˆŮí, Ž¸–ž‚Ě‹°‚ę. ŻŽiMs (Šá‰Č): Šň•ŒV•ˇ 2016/12; p.10.

540054. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘Šú”­ŒŠ‚Ě‚˝‚ߌŸ¸‚đ. ŻŽiMs (Šá‰Č): ˛‰ęV•ˇ 2016/12; p.15.

540055. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘Šú”­ŒŠ‚Ě‚˝‚ߌŸ¸‚đ@łíŠáˆł‚Ĺ‹N‚ą‚éƒP[ƒX‚ŕ. ŻŽiMs (Šá‰Č): Žlš V•ˇ 2017/1; p.19.

540056. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ‘Šú”­ŒŠ‚Ě‚˝‚ߌŸ¸‚đ@Šáˆł‰ş‚°, is—}§. ŻŽiMs (Šá‰Č): _“ސěV•ˇ 2017/1; p.8.

540057. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] –Ť—Γŕá‚É’ˆÓ. ŻŽiMs (Šá‰Č): •Ÿ“‡–Ż—F 2017/1; p.17.

540058. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] —Γŕá@‘Šú”­ŒŠ‚ÖŒŸ¸‚đ. ŻŽiMs (Šá‰Č): ŽR—zV•ˇ 2017/1; p.4.

[’˜@‘]

610005. [Šwp‘ (•Ş’SŽˇ•M)]yAdvances in Medicine and Biology. Volume 118zRecent topics in the Retinal Ganglion Cells, p.1-8. Asakawa K1, Editor: Berhardt LV, Nova Science Publishers Inc., New York, 2017/1. (óě@ŒŤ1: 1ˆă—ÉqśŠw•”)

620108. [Šwp‘ (•Ş’SŽˇ•M)]yę–ĺˆă‚Ě‚˝‚ß‚ĚŠá‰Čf—ĂƒNƒIƒŠƒtƒ@ƒC29@ŠáŒ`ŹŽčpz3 ŽîᇐŤŽžŠł@CQ Šáâ|Žîᇂɑ΂ˇ‚é•úŽËüŽĄ—Âɂ‚˘‚Ä‹ł‚Ś‚Ä‚­‚ž‚ł‚˘, p.260-5. ”–؍LĆ1,2 (1Šá‰Č, 2Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[), •Ň: ‰Ă’šM’‰, “n•Ó˛‰p, ’†ŽR‘“X, “Œ‹ž, 2016/4”­s.

620109. [Šwp‘ (•Ş’SŽˇ•M)]y‘ŽŽ110‰đŕ‘-‘ć110‰ńˆăŽt‘‰ĆŽŽŒą–â‘č‰đŕ‘zp.9-10, p.74-5, p.84, p.117-8, p.162, p.182-3, p.225-6, p.253-4, p.308-10, p.415-6, p.451-2, p.492. ŒăŠÖ—˜–ž (Šá‰Č), •Ň: ˆăŽt‘‰ĆŽŽŒą–â‘č‰đŕ‘•ŇWˆĎˆő‰ď, ˆăŠw•]˜_ŽĐ, “Œ‹ž, 2016/4”­s.

620110. [Šwp‘ (•Ş’SŽˇ•M)]yę–ĺˆă‚Ě‚˝‚ß‚ĚŠá‰Čf—ĂƒNƒIƒŠƒtƒ@ƒC30@Šá‚Ě”­ś‚Ɖđ–UE‹@”\z4 Šá•\–Ę, ‹­Šp–Œ@Šp–Œ“ŕ”ç×–E, p..125-33. X@—mÄ1,2 (1Šá‰Č, 2‹{“cŠá‰Č), •Ň: ‘厭“N˜Y, ’†ŽR‘“X, “Œ‹ž, 2016/5”­s.

620111. [Šwp‘ (•Ş’SŽˇ•M)]yƒuƒ‹[ƒ‰ƒCƒgƒeƒLƒXƒgƒuƒbƒNzĄƒ`ƒƒƒvƒ^[3 ƒuƒ‹[ƒ‰ƒCƒg‚ĆŠá‰ČŽžŠł, Šá¸”ć˜J, •Đ“ޒɁ@1. ƒuƒ‹[ƒ‰ƒCƒg‚Ć“ľE”˝‰ž, p.70-6. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), •Ň: ’Ř“cˆę’j, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/6”­s.

620112. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸ƒKƒCƒh‘ć2”Łz20. “ľEŒŸ¸@1) “ľEŒaŒv‘Ş, p.639-41. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), ŠÄC: Ş–؁@ş, •śŒő“°, “Œ‹ž, 2016/9”­s

620113. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸ƒKƒCƒh‘ć2”Łz20. “ľEŒŸ¸@2) “ľE”˝‰žŒŸ¸, p.642-5. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), ŠÄC: Ş–؁@ş, •śŒő“°, “Œ‹ž, 2016/9”­s.

620114. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸ƒKƒCƒh‘ć2”Łz20. “ľEŒŸ¸@3) “_ŠáŽŽŒą, p.646-8. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), ŠÄC: Ş–؁@ş, •śŒő“°, “Œ‹ž, 2016/9”­s.

620115. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸ƒKƒCƒh‘ć2”Łz20. “ľEŒŸ¸@4) ÔŠOü“ľEŒv, p.649-53. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), ŠÄC: Ş–؁@ş, •śŒő“°, “Œ‹ž, 2016/9”­s.

620116. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸ƒKƒCƒh‘ć2”Łz23. ŠeŽí•â•ŒŸ¸@2) _ŒoŠá‰ČŽžŠł‚Ě•â•ŒŸ¸@…@ƒAƒCƒXƒeƒXƒgEƒeƒ“ƒVƒƒ“ƒeƒXƒg, p.745-6. ŒăŠÖ—˜–ž (Šá‰Č), ŠÄC: Ş–؁@ş, •śŒő“°, “Œ‹ž, 2016/9”­s.

620117. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸‚̍ŐVî•ń2016”N10ŒŽ—ŐŽž‘Š§†zI. ‘OŠá•”@5. ŒőŠwŽŽŠáŽ˛’ˇŒv‘Ş‘•’u (IOLƒ}ƒXƒ^[), p.1153-7. _’J˜aF (Šá‰Č), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

620118. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸‚̍ŐVî•ń2016”N10ŒŽ—ŐŽž‘Š§†zI. ‘OŠá•”@9. ‘ÎŒő”˝ŽË‰đÍ‘•’uRAPD, p.1179-87. ˛“Ą@Ži1, ŒăŠÖ—˜–ž2, óě@ŒŤ3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č, 3ˆă—ÉqśŠw•”), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

620119. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŒŸ¸‚̍ŐVî•ń2016”N10ŒŽ—ŐŽž‘Š§†zV. ŠáˆĘEŠá‹…‰^“ŽE—źŠáŽ‹‹@”\@1. —źŠáŽ‹‹@”\ŒŸ¸EŒP—űƒVƒXƒeƒ€|ORTe‚ĆOcclu-pad|, p.1368-73. ”ź“c’m–ç (ˆă—ÉqśŠw•”), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

620120. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z1 ŒŸ¸‘˜_ @1 Ž‹—Í‹üÜ‘Ş’č@ƒI[ƒgƒŒƒtƒ‰ƒNƒgƒ[ƒ^, p.6-8. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620121. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z1 ŒŸ¸‘˜_ @1 Ž‹—Í‹üÜ‘Ş’č@ƒŒƒ“ƒYƒ[ƒ^, p.8-9. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620122. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z1 ŒŸ¸‘˜_ @1 Ž‹—Í‹üÜ‘Ş’č@“ľEŒŸ¸E“ľEŒnŒv‘Ş, p.39-41. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620123. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z1 ŒŸ¸‘˜_@2 ‘OŠá•”@ŽÎĆ–@‚Ć“OĆ–@, p.41. Žsěˆę•v1,2 (1Šá‰Č, 2’†‹žŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620124. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z1 ŒŸ¸‘˜_ @5 _ŒoŠá‰Č@“ľEŒŸ¸: “ľE”˝‰žŒŸ¸, p.127-9. óě@ŒŤ1, Îě@‹Ď1 (1ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620125. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z1 ŒŸ¸‘˜_ @5 _ŒoŠá‰Č@“ľEŒŸ¸: ÔŠOü“ľEŒv, p.129-32. óě@ŒŤ2, Îě@‹Ď2 (2ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620126. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z7 …ť‘ĚŽžŠł@5 ”’“ŕápŒă‡•šÇ@”’“ŕápŒă—Ž‹, p.402-3. _’J˜aF (Šá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620127. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z12 Ž‹_ŒoEŽ‹˜HŽžŠł@Ž‹_Œo“ű“ރhƒ‹[ƒ[ƒ“, p.631. Šâ˛^‹|2, Žá‘q‰ë“o1,2 (2ˆäăŠá‰Č, 2Šá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620128. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z12 Ž‹_ŒoEŽ‹˜HŽžŠł@“ű“Ş‘O“Ž–Źƒ‹[ƒv, p.632. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620129. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z12 Ž‹_ŒoEŽ‹˜HŽžŠł@“ű“Ş•”‚Ě‘¤•›ŒŒŠÇŒ`Ź, p.632-3. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620130. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z12 Ž‹_ŒoEŽ‹˜HŽžŠł@ŒĄˆř“ű“Ş, p.633. Šâ˛^‹|1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č, 2Šá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620131. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z12 Ž‹_ŒoEŽ‹˜HŽžŠł@“ű“Ş‹tˆĘ, p.633-4. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620132. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z12 Ž‹_ŒoEŽ‹˜HŽžŠł@ŒXŽÎ“ű“ޏnjóŒQ, p.634-5. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620133. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z13 “ľEŽžŠł@–ň•¨’†“Ĺ‚É”ş‚¤“ľEˆŮí, p.662. Îě@‹Ď (ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620134. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z13 “ľEŽžŠł@“ľE•s“Ż, p.663-4. Îě@‹Ď (ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620135. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z17 ‘SgŤŠáŽžŠł@•›bó‘B‹@”\’ቺÇ, p.766-7. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620136. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z21 Šá¸”ć˜J, •s’čD‘i, SˆöŤŠáŽžŠł@Šá¸”ć˜J, p.817-8. Îě@‹Ď (ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620137. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z21 Šá¸”ć˜J, •s’čD‘i, SˆöŤŠáŽžŠł@ƒeƒNƒmƒXƒgƒŒƒXŠáÇ (ITŠáÇ), p.818-20. Îě@‹Ď (ˆă—ÉqśŠw•”), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620138. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̊᎞ŠłŽĄ—ĂŽwj (‘ć3”Ĺ)z21 Šá¸”ć˜J, •s’čD‘i, SˆöŤŠáŽžŠł@•s’čD‘i, p.820-2. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ‘ĺ˜Hłl, Œă“Ą@_, ŽR“cš˜a, –ě“c@“O, ˆăŠw‘‰@, “Œ‹ž, 2016/10”­s.

620139. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŽĘ^ŽB‰eA to ZzLecture 5 ‚ť‚Ě‘ź‚ĚŠá’ęŽĘ^@1 –łŽU“ľŠá’ęƒJƒƒ‰, p.65-73. ‰i–ěKˆę (Šá‰Č), ŠÄC: –؉ş@–Î, ’|“ŕ@”E, •Ň: “ú–{Šá‰ČŽĘ^‹Ś‰ď, ƒŠƒuƒEƒTƒCƒGƒ“ƒX, “Œ‹ž, 2016/10”­s.

620140. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰ČŽĘ^ŽB‰eA to ZzLecture 13 ŠOŠá•”ŽB‰e, p.214-27. ‰i–ěKˆę (Šá‰Č), ŠÄC: –؉ş@–Î, ’|“ŕ@”E, •Ň: “ú–{Šá‰ČŽĘ^‹Ś‰ď, ƒŠƒuƒEƒTƒCƒGƒ“ƒX, “Œ‹ž, 2016/10”­s.

620141. [Šwp‘ (•Ş’SŽˇ•M)]yŹŽ™Šá‰ČQ&A (‚ ‚˝‚ç‚ľŠá‰Č —ŐŽž‘Š§†)zQ9 ŽÎŽ‹‚Ě’áNPŽčp‚đ‹ł‚Ś‚Ä‚­‚ž‚ł‚˘, p.110-3. ŒăŠÖ—˜–ž (Šá‰Č), ƒƒfƒBƒJƒ‹ˆ¨o”Ĺ, “Œ‹ž, 2016/11”­s.

620142. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰Čf—Ăƒ}ƒCƒXƒ^[1 fŽ@‚ĆŒŸ¸z_ŒoŠá‰Č, Šáâ|@ŠááقŻ‚˘‚ę‚ńf—Ă‚ĚƒRƒc, p.282-3. ŒăŠÖ—˜–ž (Šá‰Č), •Ň: ”Ń“c’mO, ’†ŕV@“O, –x@—Tˆę, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/11”­s.

620143. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰Č—Տ°ƒGƒLƒXƒp[ƒg@ŠáŒ`ŹŽčp@ŠááقŠ‚ç—ÜŠí‚܂Łz‘ć2Í ‘˜_@III —Ü“š@A ‘ÎŰ‚Ć‚Č‚éŽžŠłŠTŕ@III. —܏ŹŠÇ‹ˇóE•ÂÇ, p.135-6. ”–؍LĆ1,2 (1Šá‰Č, 2Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[), •Ň: ‚”ä—ljë”V, Œă“Ą@_, ˆăŠw‘‰@, “Œ‹ž, 2016/11”­s.

620144. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰Č—Տ°ƒGƒLƒXƒp[ƒg@ŠáŒ`ŹŽčp@ŠááقŠ‚ç—ÜŠí‚܂Łz‘ć3Í Še˜_@I Šááق̌`ŹŽčp@I ‘ލsŤŠááŮ“ŕ”˝: Wheeler-Hisatomi–@, p.199-204. ź–{_”V (Šá‰Č), •Ň: ‚”ä—ljë”V, Œă“Ą@_, ˆăŠw‘‰@, “Œ‹ž, 2016/11”­s.

620145. [Šwp‘ (•Ş’SŽˇ•M)]yƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYˆ•ű‚Ɣ̔„ (“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ďŽ)zŠŞ“ŞŒž, p.1. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@), •Ň: “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ďŽ•ŇW•”, “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď, ‘ĺă, 2016/11”­s.

620146. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰Čf—Ăƒ}ƒCƒXƒ^[II@f’f‚ĆŽĄ—ÁzŽ‹‹@”\@‹ßŽ‹‹¸łŽčp‚Ě“K‰ž‚ƏpŽŽ‘I‘đ, p.9-14. ŒÜ\—’ÍŽj1,2 (1Šá‰Č, 2ŽR‰¤•a‰@), •Ň: ”Ń“c’mO, ’†ŕV@“O, –x@—Tˆę , ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2017/1”­s.

620147. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰Čf—Ăƒ}ƒCƒXƒ^[II@f’f‚ĆŽĄ—Áz_ŒoŠá‰Č, Šáâ|@ŠááقŻ‚˘‚ę‚ń‚̐f’f‚ĆŽĄ—Ă•űj‚ĚŒˆ’č, p.295-7. ŒăŠÖ—˜–ž (Šá‰Č), •Ň: ”Ń“c’mO, ’†ŕV@“O, –x@—Tˆę , ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2017/1”­s.

620148. [Šwp‘ (•Ş’SŽˇ•M)]yŠá‰Čf—Ăƒ}ƒCƒXƒ^[II@f’f‚ĆŽĄ—Áz_ŒoŠá‰Č, Šáâ|@bó‘BŠáÇ, dÇ‹Ř–ł—͏Ç, “Á”­ŤŠOŠá‹Ř‰Š, p.298-301. ŽRă–žŽq1,2 (1Šá‰Č, 2ˆäăŠá‰Č), •Ň: ”Ń“c’mO, ’†ŕV@“O, –x@—Tˆę , ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2017/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713129. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Higher-order aberrations (HOAs) in children. Saito A1, Ito M1,2, Kawamorita T1, Shimizu K2,3: 13th International Orthoptic Congress 2016 (2016/6/30), Rotterdam, Nederland, 13th International Orthoptic Congress 2016 program 2016; p.85. (âV“Ą@Ę1, ˆÉ“Ą”üšŠG1,2, ěŽç“c‘ńŽu1, ´…Œö–ç2,3: 1ˆă—ÉqśŠw•”, 2ŽR‰¤•a‰@ƒAƒCƒZƒ“ƒ^[, 3Šá‰Č)

713130. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) The relationship between corneal nerve morphology and subjective symtom in dry eye disease. Kobashi H1,2, Kamiya K1: 8th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance (2016/9/7), Montpellier, France. (Ź‹´‰p’ˇ1,2, _’J˜aF1: 1Šá‰Č, 2Harvest Medical Scool)

713131. [Šw‰ď (‘Ű)] (E-POSTERS) Novel Equipment for the Diagnosis of Function Visual Loss with a Head-Mounted Perimeter. Goseki T1, Ishikawa H2, Shoji N1: 32nd ASIA-PACIFIC ACADEMY OF OPHTHALMOLOGY CONGRESS (APAO) (2017/3/1), Singapore. (ŒăŠÖ—˜–ž1, Îě@‹Ď2, ŻŽiMs1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

713132. [Šw‰ď (‘Ű)] (E-POSTERS) Clinical Features of Optic Nerve Head Avulsion and Optic Nerve Transection. Yoneyama R1, Goseki T1, Ishikawa H2, Shoji N1: 32nd ASIA-PACIFIC ACADEMY OF OPHTHALMOLOGY CONGRESS (APAO) (2017/3/1), Singapore. (•ÄŽR@—Č1, ŒăŠÖ—˜–ž1, Îě@‹Ď2, ŻŽiMs1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

713133. [Šw‰ď (‘Ű)] (E-POSTERS) Piggyback Intraocular Lens Implantation for Eyes with Extremely Short Axial Lenrth and an Eye with Refractive Error After the First Intraocular Lens Implantation. Furuta Y1, Hoshikawa R1, Iida Y1, Ishida A1, Sato N1, Shoji N1: 32nd ASIA-PACIFIC ACADEMY OF OPHTHALMOLOGY CONGRESS (APAO) (2017/3/1), Singapore. (ŒĂ“c—S‰ŔŽq1, Šąě—˘ŠG1, ”Ń“c‰Ă•F1, Î“c@‹Ĺ1, ˛“ĄM”V1, ŻŽiMs1: 1Šá‰Č)

713134. [Šw‰ď (‘Ű)] (POSTERS) Screening Capability and Reliability of a Newly Developed Glaucoma Screening Test Program. Takahashi N1, Hirasawa K2, Matsumura K1, Shoji N1, Yazaki K1: 32nd ASIA-PACIFIC ACADEMY OF OPHTHALMOLOGY CONGRESS (APAO) (2017/3/1), Singapore. (‚‹´‰ÄŽŔ1, •˝ŕVˆę–@2, ź‘şˆęO1, ŻŽiMs1, –îčŘ1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

721013. [Šw‰ď (‘S‘)] (“Á•Ę•ń) ‹üÜ‹¸łŽčp‚Ě‘OŒü‚Ť‘˝Ž{Ý‹¤“ŻŒ¤‹†. _’J˜aF (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2015; p.106.

721014. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) R‚Ş‚ńÜ‚É‚ć‚éŠá‚Ě•›ě—p. ”–؍LĆ1,2 (1Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č): ‘ć36‰ń“ú–{Šá–ň—Šw‰ď (2016/9/11), “Œ‹ž.

722168. [Šw‰ď (‘S‘)] (‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ďŠwp“WŽŚ—DGÜŽóÜu‰‰) –k—˘‘ĺŠw•a‰@‚Ć‚ť‚ĚŠÖ˜A•a‰@‚É‚¨‚Ż‚é–˘nŽ™–Ô–ŒÇf—Ă‚ĚŒťó. ’r“c“N–ç1, ´…Œö–ç1, —´ˆä‰‘Žq2, Î“c@‹Ĺ1, ŒăŠÖ—˜–ž1, Îě@‹Ď3 (1Šá‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/8), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.162.

722169. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) —Γŕáf—Ă‚ĚŽOŽí‚̐_Ší: f—Ă˜^EŒŸ¸‹@ŠíEŽĄ—Ă–ň. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/8), ĺ‘ä.

722170. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) —L…ť‘ĚŠá“ŕƒŒƒ“ƒY. _’J˜aF (Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/9), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.108.

722171. [Šw‰ď (‘S‘)] (ƒTƒuƒXƒyƒVƒƒƒŠƒeƒBƒTƒ“ƒf[) —Źo˜HÄŒšp|trabectome‚¨‚ć‚ŃŠÖ˜ApŽŽ|. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/10), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.149.

722172. [Šw‰ď (‘S‘)] (‹üÜ‹¸łŽčpuK‰ď) ‡•šÇ‚Ć‚ť‚Ě‘Îˆ. _’J˜aF (Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/10), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.162.

722173. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Ž‹‹@”\‚Š‚ç‘I‚ԍ‚‹@”\Šá“ŕƒŒƒ“ƒY. _’J˜aF (Šá‰Č): ‘ć5‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2016/5/14), •şŒÉ.

722174. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Ž‹˜HŽžŠł‚É‚¨‚Ż‚鎋–ěŒŸ¸‚Ěraison d'etre. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć5‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2016/5/15), •şŒÉ.

722175. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‚ą‚ę‚Š‚ç‚̉~Šp–Œf—Ă. _’J˜aF (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď 2016/6/24), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.20.

722176. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) AŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘fťÜƒ{ƒgƒbƒNƒXҍuKEŽŔ‹ZƒZƒ~ƒi[uŽÎŽ‹v`ŽžŠł•Ň`. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

722177. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) —źŠáŠJ•úŒP—ű“ą“üŽŔŃ‚Ć‚ť‚̍lŽ@3. ŒË’ˁ@Œĺ (Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

722178. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ďÇ—á‚Ö‚Ě‹üÜ‹¸łŽčp`‹­“x‹ßŽ‹`. _’J˜aF (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.55.

722179. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”’“ŕá‚Ě—Ő°Œ¤‹†`…ť‘́EŠá“ŕƒŒƒ“ƒY‚ĚŒőŠwŤ`. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.60.

722180. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX)yƒI[ƒKƒiƒCƒU[zQOV‚É‚ą‚ž‚í‚é”’“ŕáŽčp. ”Ń“c‰Ă•F (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.67.

722181. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“ŕáŽčp ‚Ç‚¤‹ł‚Ś‚ę‚Ηǂ˘‚Š. ”Ń“c‰Ă•F (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.68.

722182. [Šw‰ď (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX)yƒ‚ƒfƒŒ[ƒ^[z‹üÜ‹¸łŽčpŠłŽŇ‚̐fŽ@–@. _’J˜aF (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.64.

722183. [Šw‰ď (‘S‘)] (uK‰ďu‰‰) Sagging Eye Syndromef’f‚ĆŽĄ—Ă. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/25), _“ސě.

722184. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒnƒCƒŠƒXƒNŠá‚Ö‚Ě”’“ŕáŽčp`Šp–ŒŹ‘÷Šá‚Ö‚Ě”’“ŕáŽčp`. Žq“‡—Ç•˝1,2 (1Šá‰Č, 2‹{“cŠá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.112.

722185. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒnƒCƒŠƒXƒNŠá‚Ö‚Ě”’“ŕáŽčp`‹­“x‹ßŽ‹Šá‚ɑ΂ˇ‚é”’“ŕáŽčp`. ”Ń“c‰Ă•F (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.112.

722186. [Šw‰ď (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX) ”’“ŕáE‹üÜ‹¸łŽčp‚É•K—v‚ČŠáŒőŠw`‹üÜ‹¸ł–@‚ĆŠáŒőŠw`. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.116.

722187. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇzZEISS Cataract Suite-Refractive Surprise 0‚đ‚ß‚´‚ľ‚Ä. Žsěˆę•v1,2 (1’†‹ž•a‰@, 2Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.64.

722188. [Šw‰ď (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX) ”’“ŕáE‹üÜ‹¸łŽčp‚É•K—v‚ČŠáŒőŠw`Šp–Œ‹üÜ‹¸łŽčp‚ĆŠáŒőŠw`. _’J˜aF (Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.116.

722189. [Šw‰ď (‘S‘)] (Ž‹”\ŒP—űŽmƒvƒƒOƒ‰ƒ€) Ž‹—Í‹üÜŒŸ¸‚Ě‹ÉˆÓ‚đ’m‚낤!`Ž‹—ÍŒŸ¸‚ĚŠî‘b`. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.118.

722190. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Ž™“śś“k‚ĆƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[, ƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[ƒAƒbƒvƒf[ƒg. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (2016/7/2), “Œ‹ž, ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.110.

722191. [Šw‰ď (‘S‘)] (ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYuK‰ď) Ź’†Šwś‚ރRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚đ‚ľ‚˝‚˘Žž, ƒGƒLƒXƒp[ƒg‚ÉŠw‚Ô, ‚ą‚ń‚ČŽž‚Ç‚¤‚ˇ‚é (–âf‚Š‚ç’čŠúŒŸ¸‚Ü‚Ĺ). ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (2016/7/3), “Œ‹ž, ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.128.

722192. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ŒŠ‚Ś‚Č‚˘‚ŕ‚Ě‚ŞŒŠ‚Ś‚é|Charles BonneÇŒóŒQ‚đŠÜ‚߂ā|. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@): ‘ć17‰ń “ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ďŠwp‘‰ď (2016/8/26), VŠƒ.

722193. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Žčp‡•šÇ ˘‚Á‚˝Ç—á‚ƑΉžô`—Źo˜HÄŒšp‚Ě“ďÇ—á`. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/17), _“ސě.

722194. [Šw‰ď (‘S‘)] (SSS (Subspecialty & Staff) ƒvƒƒOƒ‰ƒ€)yƒI[ƒKƒiƒCƒU[zŽŔ‘H! Ž‹–ěˆŮí‚ɑ΂ˇ‚é‹üÜ‹¸ł‚Ćƒ[ƒrƒWƒ‡ƒ“ƒPƒA. ź‘şˆęO (Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/18), _“ސě.

722195. [Šw‰ď (‘S‘)] (SSS (Subspecialty & Staff) ƒvƒƒOƒ‰ƒ€) Ž‹–ěˆŮí‚ɑ΂ˇ‚é‹üÜ‹¸ł‚¨‚ć‚Ńƒ[ƒrƒWƒ‡ƒ“ƒPƒA‚Ě—˜_. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/18), _“ސě.

722196. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zŠJ‘ń! ŠáŒŒ—ŹŒ¤‹†‚Ě–˘—ˆ. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/19), _“ސě.

722197. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ľEŽ‹–ě‘Ş’č‚Ě—L—pŤ‚ƏŤ—ˆ“W–]. óě@ŒŤ (ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/19), _“ސě.

722198. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇz—ΓŕáŠá‚Ě”’“ŕáŽčpuGla‚Á‚Ć‚ľ‚˝Žž, ’Bl‚ĚCat‚ˇ‚é‹Zv`—ΓŕáŠá‚É‚¨‚Ż‚éŠá“ŕƒŒƒ“ƒY“x”Œˆ‚ß‚Ě–â‘č“_‚âƒRƒc`. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/19), _“ސě.

722199. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) —ΓŕáŠá‚Ě”’“ŕáŽčpuGla‚Á‚Ć‚ľ‚˝Žž, ’Bl‚ĚCat‚ˇ‚é‹Zv`—ΓŕáŠá‚É‚¨‚Ż‚éŠá“ŕƒŒƒ“ƒY“x”Œˆ‚ß‚Ě–â‘č“_‚âƒRƒc`. ”Ń“c‰Ă•F (Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/19), _“ސě.

722200. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒgƒ‰ƒxƒNƒg[ƒ€Žčp. Š}Œ´łs (Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/19), _“ސě.

722201. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒ{ƒcƒŠƒkƒX“Ĺ‘fŽĄ—Ă‚ĚŽn‚ß•űuŽÎŽ‹v`ŽÎŽ‹‚Ěƒ{ƒcƒŠƒkƒX“Ĺ‘f—ź•ű‚ĚŠî–{Žč’i`. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć3‰ń“ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď (2016/9/30), “Œ‹ž, ‘ć3‰ń“ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.39.

722202. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒ{ƒcƒŠƒkƒX“Ĺ‘fŽĄ—Ă‚ĚŽn‚ß•űuŽÎŽ‹v`ŽÎŽ‹‚ɑ΂ˇ‚éƒ{ƒcƒŠƒkƒX—Ă–@‚Ě“K‰ž‚ɂ‚˘‚ā`. ŽRă–žŽq1,2 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@): ‘ć3‰ń“ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď (2016/9/30), “Œ‹ž, ‘ć3‰ń“ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.39.

722203. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’ˇŠúŽg—p‚É‚¨‚Ż‚é–â‘č“_(ƒ{ƒcƒŠƒkƒXŽĄ—Ă, ’ˇŠú“Š—^‚É‚¨‚Ż‚é–â‘č“_, Šá‰Č‚Ě—§ę‚Š‚ç). Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@): ‘ć3‰ń“ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď (2016/10/1), “Œ‹ž, ‘ć3‰ń“ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.44.

722204. [Šw‰ď (‘S‘)] (‡“ŻƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇz‡•šÇ—\–h‚đl‚Ś‚˝“œ”A•a—Ă—{Žw“ą`“œ”A•aŠłŽŇ‚ĚƒZƒ‹ƒtƒPƒA‚Ćˆă—Ă˜AŒg‚đŽx‰‡‚ˇ‚éŽć‚č‘g‚݁`. Žs粋`Í1,2 (1Šá‰Č, 2_“ސ쎕‰Č‘ĺŠw•t‘Ž‰Ą•lƒNƒŠƒjƒbƒN): ‘ć31‰ń“ú–{“œ”A•a‡•šÇŠw‰ď/‘ć22‰ń“ú–{“œ”A•aŠáŠw‰ď‘‰ď (2016/10/7), ‹{é.

722205. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yŔ’ˇzII. ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“. _’J˜aF1, ěŽç“c‘ńŽu2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): The 20th IRSJ (2016) (2016/10/22), _“ސě.

722206. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŔ’ˇzI. u‰‰. _’J˜aF1, ěŽç“c‘ńŽu2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): The 20th IRSJ (2016) (2016/10/22), _“ސě.

722207. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‚ć‚čˆŔ’č‚ľ‚˝Šá“ŕƒŒƒ“ƒY–D’…‚đs‚¤‚˝‚ß‚Ě–D’…Ž…. ”Ń“c‰Ă•F (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722208. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŔ’ˇzII. ‘OŠá•”OCT. ”Ń“c‰Ă•F (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722209. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŔ’ˇzI. V‚ľ‚˘Žčp—pŽ…. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722210. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) V‚ľ‚˘ŽÎŽ‹Žčp—p–D‡Ž…|distinguishable suture|. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722211. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ”’“ŕá—Ěˆć‚É‚¨‚Ż‚é‘OŠá•”‚ĚOCT: CASIA2‚ĚŽg—pŒoŒą. ˛“ĄM”V (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722212. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘OŠá•”OCT‚É‚ć‚éPhakic IOL‚ĚƒŒƒ“ƒYƒTƒCƒY‘I‘đ. ŒÜ\—’ÍŽj1,2 (1ŽR‰¤•a‰@ƒAƒCƒZƒ“ƒ^[, 2Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722213. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŔ’ˇzIII. OCT angiography. –ö“c’q•F (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722214. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) OCT angiography‚ĚŒ´—‚Ć“Á’Ľ. t–ؐ’G (Šá‰Č): ‘ć16‰ńŠá‰Č—Տ°‹@ŠíŒ¤‹†‰ď (2016/10/22), _“ސě.

722215. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ŽŔ—ÍŒŸŘ! ƒg[ƒŠƒbƒNŠá“ŕƒŒƒ“ƒY. Žsěˆę•v1,2 (1Šá‰Č, 2’†‹ž•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.43.

722216. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚É‚ć‚é‘OŠá•”Žčp‚̐i•ŕ. _’J˜aF (Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.14.

722217. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) Ç—á‚Š‚çŠw‚ÔŠ´őÇE‰ŠÇŤŽžŠł`‚ą‚ę‚Á‚ÄŠ´ő? ‚ť‚ę‚Ć‚ŕ”ńŠ´ő?`. —é–؁@’1, ˆäă’q”V2, Žq“‡—Ç•˝3,4, ]Œű@—m5, ŒËŠ‘ĺ•ă6, ‹´“c“żN7, ‰Pˆä‰Ă•F8 (1ˆ¤•Q‘ĺ, 2‘˝Ş‹L”OŠá‰Č•a‰@, 3Šá‰Č, 4‹{“cŠá‰Č•a‰@, 5‹ß‹E‘ĺŠwˆăŠw•”ä•a‰@, 6ŒQ”n‘ĺŠw, 7‘ĺă‘ĺŠw, 8“Œ‹žˆă‰Č‘ĺŠw): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.53.

722218. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‘OŠá•”pŽŇ‚Ě‚˝‚ß‚Ě, ”íůN‡•šÇˆ—ƒtƒ‹ƒR[ƒX. ‘ĺ“ŕł”V1, ‘ž“cr•F2, ‰i“c–œ—R”ü3, ”Ń“c‰Ă•F4 (1‘ĺ“ŕŠá‰Č, 2‡“V“°‘ĺŠwˆăŠw•”•‘ŽĂ‰Ş•a‰@, 3ŕՋŚˆă‰Č‘ĺŠw, 4Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.100.

722219. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ŠwZŒŸf‚É‚¨‚Ż‚éFŠoŒŸ¸‚Ě‚ ‚č•ű‚Ć—Ő°f’f‚¨‚ć‚ŃŽw“ą. Žsěˆę•v1,2, ’†‘ş‰pŽ÷3, “c•ÓŮŽq2, ŽRoVˆę4, ‘ş–Ř‘•c4, ‰Ş“‡@C5, ’†‘ş‚Š‚¨‚é (1Šá‰Č, 2’†‹ž•a‰@, 3–ź“ŒŠá‰Č, 4Ž ‰ęˆă‰Č‘ĺŠw, 4ŽOŠy•a‰@, 5“Œ‹ž—Žqˆă‰Č‘ĺŠw): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.101.

722220. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇz‘ć22‰ńVISION TIMESƒZƒ~ƒi[Ž‹Šoî•ń‚ĆŽŠ“Ž‰^“]. ”Ń“c‰Ă•F (Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.50.

722221. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) Ž‹‹@”\‚މ^“]”\—Í‚É‹y‚Ú‚ˇ‰e‹ż. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.50.

722222. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“ŕáƒT[ƒWƒƒƒ“‚ŕ•KŒŠ! LI•s—v! ŽŔ‘H‚Š‚çŠw‚ÔŠŃ’ĘE•t‚Ť—L…ť‘ĚŠá“ŕƒŒƒ“ƒY. ´…Œö–ç1,2, _’J˜aF1, Žsěˆę•v1,3, ’†‘ş—Fş4, –kŕV˘Žu”Ž5 (1Šá‰Č, 2ŽR‰¤•a‰@, 3’†‹ž•a‰@, 4–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 5_ŒË_“ސěƒAƒCƒNƒŠƒjƒbƒN): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.141.

722223. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹­“x‹ßŽ‹Šá‚ɑ΂ˇ‚é‹üÜ‹¸łŽčp. _’J˜aF (Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.110.

722224. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z“Ť_ŒoÇ‚̐f’fEŽĄ—Âɑ΂ˇ‚éĹ‹ß‚̍l‚Ś•ű. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.114.

722225. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Rƒ~ƒGƒŠƒ“ƒIƒŠƒSƒfƒ“ƒhƒƒTƒCƒgƒOƒŠƒRƒvƒƒeƒCƒ“R‘Ě—zŤŽ‹_Œo‰Š‚̐f’f‚ĆŽĄ—Ă. –Ń’Ë„Ži1,2, Îě@‹Ď2,3, ŒăŠÖ—˜–ž2,4, ŽO‘ş@ŽĄ2,5, ‹g•xŒ’Žu2,6, •~“‡ŒhŒĺ2,7, •˝‰Ş”ü‹I2,8, ’†”nGŽ÷2,9, ’†‘ş@˝2,10, “c’†œ¨Žq2,11 (1“Œ‹žˆă‰Č‘ĺŠw, 2RMOGR‘Ě—zŤŽ‹_Œo‰Š’˛¸”Ç, 3ˆă—ÉqśŠw•”, 4Šá‰Č, 5•şŒÉˆă‰Č‘ĺŠw, 6H“c‘ĺŠw, 7“Œ‹žŽœŒb‰ďˆă‰Č‘ĺŠw, 8ŽD–yˆă‰Č‘ĺŠw, 9‹{č‘ĺŠw, 10_ŒË‘ĺŠw, 11VŠƒ‘ĺŠw”]Œ¤‹†Š): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.115.

722226. [Šw‰ď (‘S‘)] (Late Breaking Session) Šá‰Č‚Ć‘ź‰Č‚Š‚ç•Ş—Ł‚ł‚ę‚˝’°‹…‹Ű‚ĚƒLƒmƒƒ“‘ϐŤ—Ś‚ƑϐŤ‰ť‹@\. ŒËŠ‘ĺ•ă1,2, ]Œű@—m2,3, –x“c•‡”ü2,3, —é–؁@’2,4, ˆäă’q”V2,5, Ż@Ĺ’q2,6, Žq“‡—Ç•˝2,7,8, •ž•”‹M–ž2,9, ‹{–{—´˜Y2,10 (1ŒQ”n‘ĺŠw, 2OMIC working group, 3‹ß‹E‘ĺŠwˆăŠw•”ä•a‰@, 4‚˘‚ľ‚Ă‚żŠá‰Č, 5‘˝Ş‹L”OŠá‰Č•a‰@, 6‚¨‚¨‚˝‚ŻŠá‰Č‚‚Ť‚Ý–ě•a‰@, 7Šá‰Č, 8‹{“cŠá‰Č•a‰@, 9“Œ‹žˆă‰Č‘ĺŠw, 10“ż“‡‘ĺŠw): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.138.

722227. [Šw‰ď (‘S‘)] (ƒtƒFƒAƒEƒFƒ‹ƒZƒ~ƒi[) ’†‚ś‚ĚŠá‚ŞŠë‚Č‚˘!!`Žq‹Ÿ‚˝‚ż‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹ľ‚ƑΉž`. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/6), ‹ž“s.

722228. [Šw‰ď (‘S‘)] (“ú–{Šá‰ČŠw‰ď‹üÜ‹¸łŽčpuK‰ď) ‹üÜ‹¸łŽčpE‘“ŕŠO‚ĚŒťó‚ƍĄŒă‚Ě“W–]. _’J˜aF (Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/6), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.24.

723672. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇzŠJ•ú‹÷Šp—Γŕá. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä.

723673. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Occlu-pad҂đ—p‚˘‚˝ŽăŽ‹ŒP—űŽžŠÔ‚ĚƒRƒ“ƒvƒ‰ƒCƒAƒ“ƒX. ŒË’ˁ@Œĺ1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä.

723674. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ’íŽŇ‚É‚¨‚Ż‚é0.1%ƒuƒŠƒ‚ƒjƒWƒ“ŽđÎŽ_‰–“_Šá‰t“_Šá‘OŒă‚Ě‘ÎŒő”˝ŽË. ‰Á“ĄŽŃ–1, _’J˜aF1, ŒÜ\—’ÍŽj1, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.202.

723675. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘˝Ĺ“_ƒŒƒ“ƒYƒKƒ“‚ĚŽ‹–ěŒŸ¸‚É‚¨‚Ż‚é‹üÜ‹¸ł. •˝ŕVˆę–@1, ˆÉ“Ą@Œő1, ‘ĺ–x—R‰Á—˘1, ‚–ě—Rˆß1, ŻŽiMs2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.200.

723676. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) FuchsŠp–Œ“ŕ”çƒWƒXƒgƒƒtƒB‚É‚¨‚Ż‚鋸łŽ‹—͂ɉe‹ż‚đ‹y‚Ú‚ˇˆöŽq‚Ě‘˝•Ď—ʉđÍ. Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.202.

723677. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ź‡Œř‰Ęƒ‚ƒfƒ‹‰đÍ‚É‚ć‚éLASIK‚ĆPRK‚̏pŒă’ˇŠúˆŔ’萍‚ĚŒŸ“˘. X@—mÄ1,2, ”Ş–Ř—I•ă2, •ű”ü—R‹I2, Žq“‡—Ç•˝1,2, “ěŒcˆę˜Y2, _’J˜aF1, ‹{“c˜a“T2 (1Šá‰Č, 2‹{“cŠá‰Č•a‰@): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.202.

723678. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒAƒgƒs[”’“ŕá‚É‚¨‚Ż‚éƒg[ƒŠƒbƒNŠá“ŕƒŒƒ“ƒY‚̏pŒă‰ń“]‚ĚŒŸ“˘. —´ˆä‰‘Žq1, ´…Œö–ç1, ŽO‘îr”V1, íœAr‘ž˜Y1, ”Ń“c‰Ă•F1, _’J˜aF1, ‰F‰ę–ÎŽO (1Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/7), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.208.

723679. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘˝Ü•š—pŽĄ—ĂÇ—á‚É‚¨‚Ż‚éƒ^ƒtƒ‹ƒvƒƒXƒgEƒ`ƒ‚ƒ[ƒ‹”z‡Ü‚ւ̐ؑւŚŒř‰Ę. ź‘şˆęO1,  ŻŽiMs1, Š}Œ´łs1, –Ř‘ş“TŒh1, t“úˆähŽq1,2, ŽRě–퐜1,3, •˝ŕVˆę–@4, ´…Œö–ç1 (1Šá‰Č, 2‘Š–Í–ě•a‰@, 3‘ĺ˜aŽs—§•a‰@, 4ˆă—ÉqśŠw•”): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/8), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.304.

723680. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) —źŠáŠJ•úŽ‹—ÍŒŸ¸‚̐V‚˝‚ČƒRƒ“ƒZƒvƒg. ”ź“c’m–ç1, ´…Œö–ç2, ěŽç“c‘ńŽu1, Šâ“c@—y3, ŻŽiMs2 (1ˆă—ÉqśŠw•”, 2Šá‰Č, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/8), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.323.

723681. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŕh‰ß–EŠ´ő”­ś—Ś‚¨‚ć‚ŃŽĄ—Ă‚ÉŠÖ‚ˇ‚é‘˝Ž{Ý‹¤“ŻŒ¤‹†‚É‚¨‚Ż‚é‹K’č‚ĚŽĄ—Ð헪‚Ě—LŒřŤ. ŻŽiMs1, VŠ_i–M2, ’†ŒłŒ““ń3, ŽR–{“N–ç4, ŒKŽR‘×–ž5 (1Šá‰Č, 2—Ž‹…‘ĺŠw, 3“ú–{ˆă‰Č‘ĺŠw, 4Šň•Œ‘ĺŠw, 5•Ÿ“‡ƒAƒCƒNƒŠƒjƒbƒN): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/8), ĺ‘ä.

723682. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) —źŠáŠJ•ú‰ş‚Ĺ‚Ě’˛ß‚Ć“ľE‚ɑ΂ˇ‚éŠá—DˆĘŤ‚̉e‹ż. “Ą‘ş•‡˛Žq1, ”ź“c’m–ç1, ěŽç“c‘ńŽu1, ŻŽiMs2, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/8), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.324.

723683. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒVƒƒƒCƒ“ƒvƒ‹[ƒNŽŽ‘OŠá•”‰đÍ‘•’u‚đ—p‚˘‚˝‰~Šp–Œ‚ɑ΂ˇ‚é”’“ŕáŽčp‚Ě—\‘ސŤ‚ĚŒŸ“˘. _’J˜aF1, ”Ń“‡@Œh1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2016/4/9), ĺ‘ä, ‘ć120‰ń“ú–{Šá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016/3; p.206.

723684. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʉ‰‘čIV. ŻŽiMs (Šá‰Č): ‘ć5‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2016/5/14), •şŒÉ.

723685. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ĐŠáblur‚Ş—źŠáŠJ•úŽ‹–ě‚É‹y‚Ú‚ˇ‰e‹ż‚ĚŒŸ“˘. “Ą‘ş•‡˛Žq1, ŻŽiMs2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć5‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2016/5/14), •şŒÉ.

723686. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) OCTOPUSŽ‹–ěŒv‚̐V‚ľ‚˘Glaucoma Screening Test‚Ě—L—pŤ. •Ű‰Č”üŠó1, •˝ŕVˆę–@2, ź‘şˆęO1, Š}Œ´łs1, ŻŽiMs1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć5‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2016/5/14), •şŒÉ.

723687. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ú–{lŒă‚ëŒü‚Ť‘˝Ž{Ý—Γŕáƒf[ƒ^ƒx[ƒX (JAMDIG): —ΓŕáŽ‹–ěis‚Ě•]‰ż. “Ą–ě—F—˘1, ’Š‰Ş@—ş1, ‘ş“c@”Ž1, ŽO–Ř“Ä–ç2, ’JŒËłŽ÷3,4, aăŽu˜N5, X@˜a•F6, —é–؍Ž‰Ŕ7, ŽR‰ş‚–ž8, ”–ŘŒŤŽĄ9, ŻŽiMs10 (1“Œ‹ž‘ĺŠw, 2‘ĺă‘ĺŠw, 3“‡Ş‘ĺŠw, 4ź]Ô\Žš•a‰@, 5ˆ¤•Q‘ĺŠw, 6‹ž“s•{ˆă‰Č‘ĺŠw, 7ŽRŒű‘ĺŠw, 8Ž­Ž™“‡‘ĺŠw, 9ŽR—œ‘ĺŠw, 10Šá‰Č): ‘ć5‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2016/5/14), •şŒÉ.

723688. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒQ[ƒ€‹@Ší‚ދߌŠ”˝‰ž‚É—^‚Ś‚é‰e‹ż‚ĚŒŸ“˘. ‘ž“c@—¤1, Œ´@’źl2, ŒĂěŽě‹I2, “ŕŽRmŽu2, Vˆä“cF—T2,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽ‹‹@”\—Ă–@Šw, 3Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723689. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‰“Ž‹Ť•s“ŻŽ‹ŽăŽ‹‚ĚŒ’ŠáŽ‹—Í‚Ě•Ş•z‚Ć—źŠáŽ‹—͍ˇ‚ÉŠÖ‚ˇ‚錟“˘. ‹g“c”ü•ä1,2, “ŕŽRmŽu2, ŽO‰YŘ“sŽq1, —é–Řˆ¤—1, Vˆä“cF—T2,3, –ě“c‰pˆę˜Y1 (1“Œ‹ž“s—§ŹŽ™‘‡ˆă—ĂƒZƒ“ƒ^[, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽ‹‹@”\—Ă–@Šw, 3Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723690. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Occlu-pad҂đ—p‚˘‚˝ŽăŽ‹ŽĄ—Ă‚ĚƒRƒ“ƒvƒ‰ƒCƒAƒ“ƒXŒüăŒř‰Ę. ŒË’ˁ@Œĺ1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723691. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) HoleICLƒ‚ƒmƒrƒWƒ‡ƒ“‚Ě—L—pŤ. ‚‹´‰ÄŽŔ1, ˆŔ“Ą˜a‰ĚŽq1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/24), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.22.

723692. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O”XŘŠJ‚Ě‘ĺ‚Ť‚ł‚É‚ć‚éŒă”­”’“ŕá‚Ě”­ś‚ƏpŒă‹üÜ’l‚ւ̉e‹ż‚ĚŒŸ“˘. t“úˆähŽq1, ´…Œö–ç1 (1Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/24), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.33.

723693. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yŔ’ˇzŽăŽ‹Eƒ[ƒrƒWƒ‡ƒ“. Vˆä“cF—T1,2 (1Šá‰Č, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723694. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž‹ü‰đÍ‘•’u‚đ—p‚˘‚˝Ő“ŽŤŠá‹…‰^“Ž‚Ě˜A‘ąŽ{s‚É‚ć‚é”ć˜J‚Ö‚ĚŒŸ“˘. ‚‹´—RŽk1, Žl”V‹{—C”n1, —é–ŘŒŤŽĄ1, –ěă‹Žu1, Ź–ě‹|ŠG2, Vˆä“cF—T1,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2–žŽĄ‘ĺŠw—HŠw, 3Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723695. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž‹ü‰đÍ‘•’u‚É‚ć‚éŐ“ŽŤŠá‹…‰^“Ž‚̐öŽžŒv‘Ş. Žl”V‹{—C”n1, ‚‹´—RŽk1, —é–ŘŒŤŽĄ1, –ěă„Ži1, Ź–ě‹|ŠG2, Vˆä“cF—T1,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2–žŽĄ‘ĺŠw—HŠw, 3Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723696. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •˝Ź27”N“x‘Š–ÍŒ´ŽsAŠwŽžŒ’Nf’f‚É‚¨‚Ż‚鎋—ÍŒŸ¸ŽŔŽ{•ń. “Ą‘ş”ü˛Žq1, ”ź“c’m–ç1, ěŽç“c‘ńŽu1, Šâ“c@—y2, ŻŽiMs3 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723697. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éAŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘fťÜ (ƒ{ƒgƒbƒNƒX) ‚đ—p‚˘‚˝ŽÎŽ‹ŽĄ—Ă‚Ě‰Šú—Տ°ŹŃ. ŒăŠÖ—˜–ž1, Îě@‹Ď2, ’r“c“N–ç1, —´ˆä‰‘Žq1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723698. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 7Î—Ž™‚Ě•ĐŠá‰ń•œ‚ľ‚˝LHON. ’r“c“N–ç1, Îě@‹Ď2, Î“c@‹Ĺ1, ŒăŠÖ—˜–ž1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723699. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žá”NŤ”][Ç‚É‚ć‚čClaudeÇŒóŒQ‚đ”­Ç‚ľ‚Ä‚ť‚ĚŒăŽÎˆĘ‹ßŽ‹‚đ’ć‚ľ‚˝1—á. ’ËŒ´–ƒ—R‰Ŕ1, Ź–ě—˘‹KŽq1, ŠŰŽR–ž•ä1, ŽRŒű‰l–˘1, Œ´@’źl1,2, Vˆä“cF—T1-3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw, 3Šá‰Č): ‘ć72‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć41‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď‡“ŻŠw‰ď (2016/6/24), _“ސě.

723700. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”’“ŕápŒă‚ĚŽ˛Ť•s“™‘œŽ‹3—á. ˛“ĄM”V1, ”Ń“c‰Ă•F1, ´…Œö–ç1, Šąě—˘ŠG1, Î“c@‹Ĺ1, t–ؐ’G1 (1Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.75.

723701. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) IOLƒ}ƒXƒ^[700‚Ě—L—pŤ. ŽRěç‰Ŕ1, ”Ń“c‰Ă•F1, âV“Ą@Ę1, –îƒm–Ú‹ž•˝1, ěŽç“c‘ńŽu2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.76.

723702. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) LASIKŒăŠá‚ĚIOL“x”ŒvŽZ. X@—mÄ1,2, “ěŒcˆę˜Y2, ‹{“c˜a“T2, ”Ń“c‰Ă•F1, _’J˜aF1, ´…Œö–ç1 (1Šá‰Č, 2‹{“cŠá‰Č•a‰@): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.77.

723703. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PTKpŒă‚ĚŠp–Œ—Ž‹•Ş•z. –îƒm–Ú‹ž•˝1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/25), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.78.

723704. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PTAK‚Ě—Ő°ŹŃ. –îčŘ1, ‰Á“ĄŽŃ–1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć31‰ńJSCRSŠwp‘‰ď (2016/6/26), ‹ž“s, ‘ć31‰ńJSCRSŠwp‘‰ď 2016; p.129.

723705. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •˝Ź27”N“xŠwZŒťę‚Ĺ‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹ľ’˛¸, ŽĄŒąE’˛¸. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (2016/7/2), “Œ‹ž, ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.124.

723706. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʍu‰‰3u“_Šá–ňv. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (2016/7/2), “Œ‹ž, ‘ć59‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p.121.

723707. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇz‰ď’ˇÜŒű‰‰ The 27th JGS Congress President's Award. ŻŽiMs (Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/17), _“ސě.

723708. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹UŒĹŽ‹•s—Ç—á‚É‚¨‚Ż‚鎋–ěŒŸ¸Œ‹‰Ę‚̐M—ŠŤ. ‹˝‰E‹ß”ŽN1, •˝ŕVˆę–@2, –Ř‘ş“TŒh1, ‹ŕŽRr‰î1, Š}Œ´łs1, ź‘şˆęO1, ŻŽiMs1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/17), _“ސě.

723709. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘Šú—Γŕá‚É‚¨‚Ż‚éPulsarŽ‹–ě‚ĚˆŮíŒŸo—Í. •˝ŕVˆę–@1, ‚‹´‰ÄŽŔ2, •Ű‰Č”üŠó2, –Ř‘ş“TŒh2, ‹ŕŽRr‰î2, Š}Œ´łs2, ź‘şˆęO2, ŻŽiMs2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/17), _“ސě.

723710. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —Γŕá‚Ě•a‹C•Ę‚É‚¨‚Ż‚éGlaucoma Screening Test‚ĚˆŮíŒŸo—Í. ‚‹´‰ÄŽŔ1, •˝ŕVˆę–@2, •Ű‰Č”üŠó1, –Ř‘ş“TŒh1, ‹ŕŽRr‰î1, Š}Œ´łs1, ź‘şˆęO1, ŻŽiMs1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/17), _“ސě.

723711. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒgƒ‰ƒxƒNƒŒƒNƒgƒ~[’P“ĆŽčp‚Ć”’“ŕá“ŻŽžŽčp‚Ć‚ĚŽčpŹŃ‚Ě”äŠr. ‹ŕŽRr‰î1, Š}Œ´łs1, ź‘şˆęO1, –Ř‘ş“TŒh1, ŻŽiMs1 (1Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/18), _“ސě.

723712. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒŠƒpƒXƒWƒ‹“_Šá–ň‚đ’ljÁ“Š—^‚ľ‚˝‘˝Ü“_Šá•š—p—Í“ŕŠłŽŇ‚Ě12‚ŠŒŽ‚É‚¨‚Ż‚éŠáˆł‰ş~Œř‰Ę. –Ř‘ş“TŒh1, ŻŽiMs1, ź‘şˆęO1, Š}Œ´łs1, ‹ŕŽRr‰î1 (1Šá‰Č): ‘ć27‰ń“ú–{—ΓŕáŠw‰ď (2016/9/18), _“ސě.

723713. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •˝Ź27”N“xŠwZ‚Ĺ‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—pó‹ľ’˛¸. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‘ć47‰ń‘S‘ŠwZ•ŰŒ’EŠwZˆă‘ĺ‰ď (2016/10/29), ŽD–y.

723714. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰~Šp–ŒŠá‚É‚¨‚Ż‚é”’“ŕáŽčp‚Ě‘źŽ{Ý‹¤“ŻŒ¤‹† (‘ć1•ńpŒă‹üÜŒëˇ). _’J˜aF1, ”Ń“‡@Œh1, X@—mÄ1,2, ‹{“c˜a“T2, ŽRŒű„Žj3, “‡č@3, “n•Ó^–î4, ‘O“c’ź”V4 (1Šá‰Č, 2‹{“cŠá‰Č•a‰@, 3“Œ‹žŽ•‰Č‘ĺŠwŽsě‘‡•a‰@, 4‘ĺă‘ĺŠw): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.38.

723715. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) IOLŒĹ’荢“ďÇ—á‚ɑ΂ˇ‚éSulcus-Subcapsular fixation‚̏pŒă‹üÜŒëˇ‚ĚŒŸ“˘. Î“c@‹Ĺ1, ”Ń“c‰Ă•F1, ˛“ĄM”V1, ’Ň‘ň’C•F1, ´…Œö–ç1,2 (1Šá‰Č, 2ŽR‰¤•a‰@ƒZƒ“ƒ^[): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.38.

723716. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠOŽÎŽ‹‚ɑ΂ˇ‚é’Zk‘O“]‚ĆPlication‚ĚŽčpŹŃ‚Ě”äŠr. ŒăŠÖ—˜–ž1, Îě@‹Ď2, —´ˆä‰‘Žq1, ŒN“‡^ƒ3, Žs粋`Í3 (1Šá‰Č, 2ˆă—ÉqśŠw•”, 3_“ސ쎕‰Č‘ĺŠw): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.28.

723717. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒqƒgś‘ĚŠá‚Ěƒ`ƒ“Ź‘Ń‘–s‚ÉŠÖ‚ˇ‚é’˛¸. ”n“‡´”@1, Žsě@Œc2, ŽđˆäKO3, “ŕ“ĄŽ‹v3, •Đ‰Ş“”Ž4, ˆé’JŽ‹P4, ’†‘ş—Fş4, Žsěˆę•v3,5 (1Šá‰Č–žŠá‰@, 2Šň•ŒÔ\Žš•a‰@, 3’†‹ž•a‰@, 4–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.40.

723718. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) RƒAƒNƒAƒ|ƒŠƒ“4R‘Ě—zŤŽ‹_Œo‰Š‚É‚¨‚Ż‚é’j—ŠÔ‚Ě—Ő°‘œ‚Ě”äŠrŒŸ“˘. ťěLŠC1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.35.

723719. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇz_ŒoŠá‰Č2. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.36.

723720. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”]Ň‘‰tŒ¸­ÇÇ—á‚Ě’˛ßáŠQ‚ĚŒŸ“˘. ŽRă–žŽq1,2, Žá‘q‰ë“o1,2, ˆäăŒŤŽĄ2, Îě@‹Ď3, ‚‹´_ˆę4 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@, 3ˆă—ÉqśŠw•”, 4ŽR‰¤•a‰@”]_ŒoŠO‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.36.

723721. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒőŠąÂ’f‘wŒv‚đ—p‚˘‚˝‘Šú—Γŕáf’f‚É‚¨‚Ż‚éRandom Forest–@‚Ě—L—pŤ. •˝ŕVˆę–@1, ’Š‰Ş@—ş2, ŠâŁˆ¤Žq3, “Ą–ě—F—˘2, ‘ş“c”ŽŽj2, ŻŽiMs4, V’J@áÁ5 (1ˆă—ÉqśŠw•”, 2“Œ‹ž‘ĺŠw, 3‚˝‚ś‚݊␣Šá‰Č, 4Šá‰Č, 5ŠÖ“Œ’†‰›•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.24.

723722. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Corvis ST‚¨‚ć‚ŃOcular Response Analyzer‚É‚ć‚éŠp–Œ“ÁŤ‚ĆŽ‹–ěis‘Ź“x‚ĚŠÖ˜A‚ĚŒŸ“˘. ‘ş“c”ŽŽj1, ź‰YŤl1, •˝ŕVˆę–@2, ’†”ö‘P—˛3, ’†‘qr—S4, –Ř“ŕ—Ç–ž3, ’Š‰Ş@—ş1 (1“Œ‹ž‘ĺŠw, 2ˆă—ÉqśŠw•”, 3L“‡‘ĺŠw, 4ŽO‰h‰ďƒcƒJƒUƒL•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.25.

723723. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Small incision lenticule extractionpŒă‚ĚŽ‹—͉ń•œ‚ĚŒŸ“˘. Ź“‡—˛Ži1,2, •Đ‰Ş“”Ž2, ’†‘ş—Fş2, Žsěˆę•v3,4 (1Šň•ŒÔ\Žš•a‰@, 2–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 3’†‹ž•a‰@, 4Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.42.

723724. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŃ’ʍE•t‚ŤŒă–[Œ^—L…ť‘ĚŠá“ŕƒŒƒ“ƒY‚̏pŒă3”N‚Ě—Ő°ŹŃ. ‚‹´ł‰p1, _’J˜aF2, ˆŔ—˘@“ľ3, Ź‹´‰p’ˇ2, ŒÜ\—’ÍŽj2,4, ´…Œö–ç2,4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č, 3‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽO“c•a‰@, 4ŽR‰¤•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.42.

723725. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒAƒCƒgƒ‰ƒbƒJ[‚đ—p‚˘‚˝Ž‹‰^“ŽŤŠáU‚̩ɏ™‘Š‘Ź“x‚Ě•]‰ż. —é–ŘŒŤŽĄ1, Vˆä“cF—T1,2, Œ´@’źl1, “ĄŽR—R‹IŽq1 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.173.

723726. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –˘AŠwŽ™‚Ě‚¨‚Ż‚éŠáˆĘ‚Ć—§‘ĚŽ‹‚ĚŒŸ“˘. ‚‹´—RŽk1, ˛“Ą@Ži1, ˆÉ“Ą”üšŠG2, Vˆä“cF—T1,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2ˆă—ÉqśŠw•”, 3Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.178.

723727. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –˘AŠwŽ™‚Ě‚¨‚Ż‚é‹üÜ’l‚ĆŽ‹—Í‚ĚŒŸ“˘. ˛“Ą@Ži1, ‚‹´‹gŽk1, ˆÉ“Ą”üšŠG1,2, Vˆä“cF—T1,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2ˆă—ÉqśŠw•”, 3Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.178.

723728. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘OŠá•”3ŽŸŒłŒőŠąÂ’f‘wŒv‚É‚ć‚鐅ť‘Ě‚ĆŠá“ŕƒŒƒ“ƒY‚ĚŒXŽÎ‚ƕΐS‚ÉŠÖ‚ˇ‚錟“˘. Žsě@ăÄ1, Ź“‡—˛Ži2, ‹Ę’u–ž–ě1,3, –ŘŒ´—˘“Ţ1, ‰Á‰ę’BŽu1, Žsěˆę•v1,4 (1’†‹ž•a‰@, 2Šň•ŒÔ\Žš•a‰@, 3MB‘ĺŠw‘ĺŠw‰@‘‡HŠwŒnŒ¤‹†‰Č, 4Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.195.

723729. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”’“ŕáp‘OŒv‘Ş’l‚ĆŠá“ŕƒŒƒ“ƒY‚ĚŒX‚Ť‚ÉŠÖ‚ˇ‚錟“˘. ‹Ę’u–ž–ě1,2, Ź“‡—˛Ži3, –ŘŒ´—˘“Ţ1, Žsě@ăÄ1, ‰Á‰ę’BŽu1, “c’†@´2, Žsěˆę•v1,4 (1’†‹ž•a‰@, 2MB‘ĺŠw‘ĺŠw‰@‘‡HŠwŒnŒ¤‹†‰Č, 3Šň•ŒÔ\Žš•a‰@, 4Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.195.

723730. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇzŽ‹–ě. ŻŽiMs (Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/3), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.196.

723731. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ä”­—ƒó•Đ‚ɑ΂ˇ‚éƒ}ƒCƒgƒ}ƒCƒVƒ“C•š—pƒAƒŠp–Œ—Ö•”ˆÚAE—r–ŒˆÚA‚Ě’ˇŠúŹŃ. Ź–ě@‹Ş1, X@—mÄ1,2, Žq“‡—Ç•˝1,2, “ż‰i’‰r1, ‹{“c˜a“T1, “V–ěŽj˜Y3 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č, 3ˆäăŠá‰Č•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.83.

723732. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘I‘đ“IƒŒ[ƒU[‘@ˆŰ’Œ‘ŃŒ`Źp‚Ě’ˇŠúŹŃ. ‹ŕŽRr‰î1, Š}Œ´łs1, X“c“N–ç1, ź‘şˆęO1, –Ř‘ş“TŒh1, ŻŽiMs1 (1Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.201.

723733. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹}Ť•ÂÇ‹÷ŠpÇ‚ɑ΂ˇ‚é”’“ŕáŽčp‹üÜŒëˇ‚ĚŒŸ“˘. ‰Í–ě—Y—ş1, _’J˜aF1, ”Ń“c‰Ă•F1, ˛“ĄM”V1, ‚‹´ł‰p1, ŠFě—FŒ›1, Î“c@‹Ĺ1 (1Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.221.

723734. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”’“ŕápŒă‹üÜŒëˇ‚Ě•]‰żŽÚ“x. íœAr‘ž˜Y1,2, ´…Œö–ç1,2, ŒÜ\—’ÍŽj1,2, —`…@Šw1,2 (1Šá‰Č, 2ŽR‰¤•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.221.

723735. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇzˆă—ÁEˆă­E‚ť‚Ě‘ź. Žá‘q‰ë“o1,2 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/4), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.216.

723736. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘OŠá•”OCT‚ĆŠp–ŒŒ`ó‰đÍ‘•’u‚É‚¨‚Ż‚éŠp–Œ‹üÜ—Í‚Ě”äŠr. ŒÜ\—’ÍŽj1,2, ´…Œö–ç1,2, íœAr‘ž˜Y1,2, —`…@Šw1,2, {’ˇ@Œj2, Â–ŘŠó”ü2, ěŽç“c‘ńŽu3, _’J˜aF1 (1Šá‰Č, 2ŽR‰¤•a‰@, 3ˆă—ÉqśŠw•”): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.133.

723737. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”’“ŕáŠá‚É‚¨‚Ż‚éŒőŠwŽŽŠáŽ˛’ˇ‘Ş’č‘•’u‚Ě”äŠr. –îƒm–Ú‹ž•˝1, ”Ń“c‰Ă•F1, ŻŽiM”V1 (1Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.133.

723738. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”’“ŕáŠá‚É‚¨‚Ż‚éIOLMaster700‚Ě‘Ş’č¸“xEM—Š“x‚¨‚ć‚яpŒă‹üÜŒëˇ. âV“Ą@Ę1, ”Ń“c‰Ă•F1, –îƒm–Ú‹ž•˝1, ŽRěç‰Ŕ1 (1Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.133.

723739. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇz_ŒoŠá‰Č3. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.231.

723740. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Extended Muller Tucking–@‚É‚ć‚éŠááىş‚ŽčpŒă‚ĚŽ‹‹@”\•]‰ż. ’h”Vă˜a•F1, ˛“Ą’ź”ü1, •˝ŕVˆę–@2, ‹{“cM”V3 (1‚ž‚ń‚Ě‚¤‚ŚŠá‰ČƒNƒŠƒjƒbƒN, 2ˆă—ÉqśŠw•”, 3‰Ş“cŠá‰Č): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.235.

723741. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Late-onset TASS‚đ’ć‚ľ‚˝IOL‚̐ť‘˘H’ö•ĎXŒă‚̏pŒă‘OŠá•”‰ŠÇ•]‰ż. ˛X–ŘŒ÷1, X@•ś•F1, ]ŒűGˆę˜Y1, X@—mÄ2,3, Œ´ŕV‡Žq3, “Œ”ü—R‹I3, ‹{“c˜a“T3, –]ŒŽ@›{3,4 (1]ŒűŠá‰Č•a‰@, 2Šá‰Č, 3‹{“cŠá‰Č•a‰@, 4“Œ‹žˆă‰ČŽ•‰Č‘ĺŠw): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/5), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď 2016; p.251.

723742. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yŔ’ˇzˆę”ĘŒű‰‰2@“ľEEŽ‹‹@”\E‚ť‚Ě‘ź. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/19), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p58-62.

723743. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •ĐŠáŤ‰Š”Á’áŒ`Ź‚É‚¨‚Ż‚鉊”ÁˆČă‚ƐFZŽhŒƒ‚É‚ć‚é“ľE”˝‰ž. óě@ŒŤ1, Îě@‹Ď1, —´ˆä‰‘Žq2, ŒăŠÖ—˜–ž2, ’r“c“N–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p58.

723745. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Occlu-pad‚đ—p‚˘‚˝—źŠáŠJ•ú‰ş‚Ě”ń—DˆĘŠáŽg—pŒP—ű‚É‚ć‚éŠá—DˆĘŤ•Ď‰ť‚ĚŽŽ‚Ý. Šâ“c@—y1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3Šá‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p60.

723746. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠOŤŽ‹_Œo“ű“Ş—Ł’f‚¨‚ć‚ŃŽ‹_Œo’f—ô‚Ě—Ő°“I“Á’Ľ. •ÄŽR@—Č1, ŒăŠÖ—˜–ž1, —´ˆä‰‘Žq1, Îě@‹Ď2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p118.

723747. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚—î”­Ç‚ĚƒŒ[ƒxƒ‹ˆâ“`ŤŽ‹_ŒoÇ10Ç—á‚ĚŒŸ“˘. Šâ˛^‹|1, ‰–ě”üŘŽq1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p122.

723748. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”­Ç2”NŒă‚ĚBalintÇŒóŒQ‚ɑ΂ˇ‚鎋‹@”\•]‰ż. Ź–ě—˘‹KŽq1, Œ´@’źl1,2, “ŕŽRmŽu2, ’ËŒ´–ƒ—R‰Ŕ1, Vˆä“cF—T1-3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•a‰@Šá‰Č, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 3Šá‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p128.

723749. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž‹_ŒoŽžŠł‚É‚¨‚Ż‚éRAPDx҂đ—p‚˘‚˝ŽĄ—Ă‘OŒă‚Ě‘Š‘ΓI“ľE‹S˜HáŠQ‚Ě•]‰ż. ˛“Ą@Ži1, ŒăŠÖ—˜–ž2, Îě@‹Ď3, óě@ŒŤ3, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2Šá‰Č, 3ˆă—ÉqśŠw•”): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p130.

723750. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆŮ‚Č‚Á‚˝FŒőŽhŒƒ‚É‚ć‚é‘ÎŒő”˝ŽË‚ĚŒoŽž•Ď‰ť‚đ’Ç‚Ś‚˝“űŽ™‚Ěˆę—á. ŒË’ˁ@Œĺ1, óě@ŒŤ2, ŒăŠÖ—˜–ž1, ’r“c“N–ç1, Îě@‹Ď2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p130.

723751. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒLƒ…[ƒoƒ_ƒCƒrƒ“ƒOŒă‚É’˛ßáŠQ‚đ’ć‚ľ‚˝ˆęÇ—á. ‰–ě”üŘŽq1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p132.

723752. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Šááىş‚Žčp‚đŽ{sŒă‚ĚŠááŮázšÇ—á‚ĚŒŸ“˘. ‰Í–{‚Đ‚ë”ü1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/25), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p150.

723753. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒXƒeƒƒCƒh‚ɗǍD‚Č”˝‰ž‚đ’ć‚ľ‘ą‚Ż‚˝Ž‹_Œoâ‘–ŒŽî. ŽRă–žŽq1,2, Šâ˛^‹|2, Šâ‘q‰ë“o1,2, ˆäăŒŤŽĄ2, Vˆä@ˆę3, ‹ß“Ą‘n‰p3 (1Šá‰Č, 2ˆäăŠá‰Č•a‰@, 3‡“V“°ˆă‰@”]_ŒoŠO‰Č): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/26), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p78.

723754. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŤŽ‹_Œo‰Š‘S‘’˛¸|Œv‰ć‹y‚Ń“ą“ü‚ɂ‚˘‚ā|. –Ń’Ë„Žu1,2, Îě@‹Ď2,3, ŒăŠÖ—˜–ž2,4, ŽO‘ş@ŽĄ2,5, ‹g•xŒ’Žu2,6, •~“‡ŒhŒĺ2,7, •˝‰Ş”ü‹I2,8, ’†“‡GŽ÷2,9, ’†‘ş@˝2,10, “c’†œ¨Žq2,11 (1“Œ‹žˆă‘ĺŠá‰Č, 2RMOGR‘Ě—zŤŽ‹_Œo‰Š’˛¸”Ç, 3ˆă—ÉqśŠw•”, 4Šá‰Č, 5•şŒÉˆă‘ĺŠá‰Č, 6H“c‘ĺŠá‰Č, 7“Œ‹žŽœŒbˆă‘ĺŠá‰Č, 8ŽD–yˆă‘ĺŠá‰Č, 9‹{č‘äŠá‰Č, 10_ŒË‘ĺŠá‰Č, 11VŠƒ‘ĺŠw”]Œ¤‹†Š): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/26), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p82.

723755. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŤŽ‹_Œo‰Š‘S‘’˛¸|’†ŠÔŒ‹‰Ę•ń|. ŒăŠÖ—˜–ž1,2, Îě@‹Ď1,3, –Ń’Ë„Ži2,4, ŽO‘ş@ŽĄ2,5, ‹g•xŒ’Žu2,6, •~“‡ŒhŒĺ2,7, •˝‰Ş”ü‹I2,8, ’†“‡GŽ÷2,9, ’†‘ş@˝2,10, “c’†œ¨Žq2,11 (1Šá‰Č, 2RMOGR‘Ě—zŤŽ‹_Œo‰Š’˛¸”Ç, 3ˆă—ÉqśŠw•”, 4“Œ‹žˆă‘ĺŠá‰Č, 5•şŒÉˆă‘ĺŠá‰Č, 6H“cˆă‘ĺŠá‰Č, 7“Œ‹žŽœŒbˆă‘ĺŠá‰Č, 8ŽD–yˆă‘ĺŠá‰Č, 9‹{č‘ĺŠá‰Č, 10_ŒË‘ĺŠá‰Č, 11VŠƒ‘ĺŠw”]Œ¤‹†Š): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/26), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p84.

723756. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ú–{lƒŒ[ƒxƒ‹ˆâ“`ŤŽ‹_ŒoÇ (ƒŒ[ƒxƒ‹•a) ŠłŽŇ‚Ěƒ~ƒgƒRƒ“ƒhƒŠƒADNAƒnƒvƒƒ^ƒCƒv‰đÍ. áÁ“‡s•F1,2, ŹŒű–F‹v1, ‘ĺoŽ˜Y1, ‹C‰ę‘ňˆę‹P2, Žá‘q‰ë“o3,4, Marzuki Anngkot5 (1Œcœä‹`m‘ĺŠwŠá‰Č, 2ˆÇ—Ń‘ĺŠwƒAƒCƒZƒ“ƒ^[, 3Šá‰Č, 4ˆäăŠá‰Č•a‰@, 5ƒGƒCƒNƒ}ƒ“Œ¤‹†Š): ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2016/11/26), ‹{č, ‘ć54‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď ƒvƒƒOƒ‰ƒ€E´˜^W 2016; p88.

731135. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —Γŕáf—Ă‚ĆŠáˆł. ŻŽiMs (Šá‰Č): ‘ć152‰ń˜a‰ĚŽRŠá‰ČŠw‰ď (2016/4/17), ˜a‰ĚŽR.

731136. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”z‡“_Šá–ň‚ɑ΂ˇ‚él‚Ś•ű. ŻŽiMs (Šá‰Č): ‘ć10‰ń‚ł‚Ş‚ÝŠá‰ČŒ¤‹†‰ď (2016/6/1), _“ސě.

731137. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “úíŽ‹—Í•]‰ż‚̐V‚˝‚ČƒAƒvƒ[ƒ`. ”ź“c’m–ç (ˆă—ÉqśŠw•”): ‘ć10‰ń‚ł‚Ş‚ÝŠá‰ČŒ¤‹†‰ď (2016/6/1), _“ސě.

731138. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzŠp–ŒŽžŠł‚Ě•a‘Ô”cˆŹ‚É‚¨‚Ż‚鐜‘Ě‹¤Ĺ“_Œ°”÷‹ž‚Ě—L—pŤ. _’J˜aF (Šá‰Č): ‘ć8‰ńOSKA (ocular Surface Seminar in Kanagawa) (2016/6/2), _“ސě.

731139. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —Γŕáf’f‚Ć•af˜AŒg. ŻŽiMs (Šá‰Č): •Ÿ“‡Glaucoma Seminar (2016/7/29), •Ÿ“‡.

731140. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz“Á•Ęu‰‰. ŻŽiMs (Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

731141. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —ΓŕáŽčp—Ă–@‚ɑ΂ˇ‚él‚Ś•ű. ŻŽiMs (Šá‰Č): ƒ~ƒPƒ‹ƒi”z‡“_Šá‰tť‘˘ł”F‹L”Ou‰‰‰ď (2016/11/12), •Ÿ‰Ş.

731142. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz—ΓŕáŽčpUpdate. ŻŽiMs (Šá‰Č): ‘ć14‰ńBay Ophthalmic Surgical Seminar (2016/11/19), _“ސě.

731143. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ĹV‚̐_ŒoŠá‰Č‚Ě˜b‘č. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć 9 ‰ń‚’mOPHTHALMIC. ƒZƒ~ƒi[ (2017/1/21), ‚’m.

731144. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —Γŕá–ň•¨ŽĄ—Ă‚Ö‚ĚŠú‘Ň. ŻŽiMs (Šá‰Č): ‘ć2‰ńOS-GƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/1/25), _“ސě.

731145. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)uŠá‚Š‚çl‚Ś‚éŒđ’ĘˆŔ‘SvŠˆ“Ž‚ĚĐ‰î. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): •˝Ź28”N“x_“ŢěŒ§“sŽsŒđ’ĘˆŔ‘S‘΍ô˜A—‹Ś‹c‰ďŒ¤C‰ď (2017/1/25), _“ސě.

731146. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Šá‚Š‚çl‚Ś‚éŒđ’ĘˆŔ‘S`‚—îŽŇ‚ĚŒđ’ĘˆŔ‘S`. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): •˝Ź28”N“xŒđ’ĘˆŔ‘S‹łˆçŽw“ąŽŇŒ¤C‰ď (2017/1/30), “Œ‹ž.

731147. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚í‚Š‚č‚₡‚˘ŠáŒőŠw`Ž‹—́E‹üÜŒŸ¸‚̂΂ç‚‚Ť‚đŒ¸‚ç‚ˇH•v`(‰‹‰•Ň). ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć7‰ńƒ[ƒrƒWƒ‡ƒ“EŒ’fŒ¤‹†‰ďin‘˝–€ (2017/2/5), _“ސě.

731148. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz“Á•Ęu‰‰ Ŕ’ˇ. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć1‰ńESG in KANAGAWA (2017/2/10), _“ސě.

731149. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘Š–ÍŒ´ŽsAŠwŽžŒ’Nf’f‚É‚¨‚Ż‚鎋—ÍŒŸ¸‚ĚŽŔŽ{ó‹ľ. “Ą‘ş•‡˛Žq (ˆă—ÉqśŠw•”): ‘ć6‰ń_“ŢěŒ§Ž‹”\ŒP—űŽm‚̉ď (2017/2/18), _“ސě.

731150. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzu‰‰II. ”ź“c’m–ç (ˆă—ÉqśŠw•”): ‘ć6‰ń_“ŢěŒ§Ž‹”\ŒP—űŽm‚̉ď (2017/2/18), _“ސě.

731151. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —ΓŕáŽĄ—Ă•űj‚̍l‚Ś•ű. ŻŽiMs (Šá‰Č): ‘ć14‰ńšƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwŠá‰ČŠw‹łŽş“Ż‘‹‰ďŠw‰ď (2017/2/19), _“ސě.

731152. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —Γŕá–ň•¨ŽĄ—Ă‚Š‚çŽčp‚Ö. ŻŽiMs (Šá‰Č): ‘ć2‰ńƒOƒ‰ƒlƒAƒZƒ~ƒi[in“Œ‹ž (2017/2/24), “Œ‹ž.

731153. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —ΓŕáŽĄ—Ă•űj‚Ě—§‚Ä•ű. ŻŽiMs (Šá‰Č): ‘ć39‰ń‹žŽ —ΓŕáƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/3/11), ‹ž“s.

731154. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Šáâ|ƒv[ƒŠ[‚Š‚çl‚Ś‚ég•ĄŽ‹hŒ´ˆö‚ĆŽĄ—Ă. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć11‰ńěŠá‰ČƒVƒ“ƒ|ƒWƒ…ƒEƒ€ (2017/3/11), ě.

731155. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ç—á‚Š‚çŠw‚ԍŐV‚̐_ŒoŠá‰Č. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć129‰ń‰Ť“ęŠá‰ČW’c‰ď (2017/3/26), ‰Ť“ę.

731156. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —Γŕá‚Ě–ň•¨ŽĄ—ĂĹ‘Oü. ŻŽiMs (Šá‰Č): —ΓŕáŠwpu‰‰‰ďin“ŕ–[ (2017/3/31), ç—t.

732059. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ”’“ŕá“ďÇ—á‚ɑ΂ˇ‚éƒAƒvƒ[ƒ`. ”Ń“c‰Ă•F (Šá‰Č): Ž‹Šo‚đŒě‚éEŽć‚č–ß‚ˇ2016 (2016/4/16), ‹{é.

732060. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Ü‹u•”‚É”­ś‚ľ‚˝ (Oncocytoma) DŽ_Ť‘BŽî‚Ě1—á. ”–؍LĆ1,2 (1Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č): ‘ć86‰ń‹ăBŠá‰ČŠw‰ď/‘ć49‰ńŠá‰Č—Տ°•a—‘gDŒ¤‹†‰ď (2016/5/28), •Ÿ‰Ş, ‘ć86‰ń‹ăBŠá‰ČŠw‰ď/‘ć49‰ńŠá‰Č—Տ°•a—‘gDŒ¤‹†‰ď ƒvƒƒOƒ‰ƒ€E´˜^W@p.24.

732061. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (•˝Ź28”N“x‹ăBƒuƒƒbƒNŠá‰ČuK‰ď) Ž‹_Œo‰Š. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć86‰ń‹ăBŠá‰ČŠw‰ď/‘ć49‰ńŠá‰Č—Տ°•a—‘gDŒ¤‹†‰ď (2016/5/29), •Ÿ‰Ş, ‘ć86‰ń‹ăBŠá‰ČŠw‰ď/‘ć49‰ńŠá‰Č—Տ°•a—‘gDŒ¤‹†‰ď ƒvƒƒOƒ‰ƒ€E´˜^W@p.29.

732062. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) IOLŒĹ’荢“ďÇ—á‚ɑ΂ˇ‚éSulcus-subcapsular fixation. Î“c@‹Ĺ (Šá‰Č): ‘ć7‰ńƒRƒ‹ƒjƒAƒtƒFƒCƒRƒZƒ~ƒi[ (2016/6/9), _“ސě.

732063. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçuŔ) —Γŕá|Žčp‚Ěƒ^ƒCƒ~ƒ“ƒO‚ƏpŒăŠÇ—|. ŻŽiMs (Šá‰Č): “ú–{Šá‰Čˆă‰ď‘ć71‰ńśŠU‹łˆçuŔ (2016/7/17), “Œ‹ž.

732064. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒŒƒbƒcƒgƒ‰ƒC! Œ‹–Œ’oŠÉÇŽčp. ’†ź@Šî1,2 (1Šá‰Č, 2•‘ –ěÔ\Žš•a‰@): ‘ć2‰ńH&C‚̉ď (2016/7/23), “Œ‹ž.

732065. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçuŔ) —Γŕá|Žčp‚Ěƒ^ƒCƒ~ƒ“ƒO‚ƏpŒăŠÇ—|. ŻŽiMs (Šá‰Č): “ú–{Šá‰Čˆă‰ď‘ć71‰ńśŠU‹łˆçuŔ (2016/7/24), _ŒË.

732066. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçuŔ) —Γŕá|Žčp‚Ěƒ^ƒCƒ~ƒ“ƒO‚ƏpŒăŠÇ—|. ŻŽiMs (Šá‰Č): “ú–{Šá‰Čˆă‰ď‘ć71‰ńśŠU‹łˆçuŔ (2016/7/31), ˆ¤’m.

732067. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçuŔ) —Γŕá|Žčp‚Ěƒ^ƒCƒ~ƒ“ƒO‚ƏpŒăŠÇ—|. ŻŽiMs (Šá‰Č): “ú–{Šá‰Čˆă‰ď‘ć71‰ńśŠU‹łˆçuŔ (2016/8/21), •Ÿ‰Ş.

732068. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Γŕáf—Ă‚ĚŽż‚đl‚Ś‚é. ŻŽiMs (Šá‰Č): ‘ć13‰ń‹{éŒ§ƒZƒ~ƒi[ (2016/8/27), ‹{é.

732069. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒwƒbƒhƒ}ƒEƒ“ƒgŒ^Ž‹–ěŒvimo‚Ě‹ZpŽw“ą‹y‚ŃŽg—pŒoŒą’k. ‹˝‰E‹ß”ŽN (Šá‰Č): ‘ć13‰ń–k‹ß‹EŽ‹”\ŒP—űŽm‰ď•×‹­‰ď (2016/9/3), ‹ž“s.

732070. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ’m‚Á‚Ä‚¨‚Ť‚˝‚˘–Ú‚Ě•a‹C`”’“ŕá. ”Ń“c‰Ă•F (Šá‰Č): –Ú‚Ěˆ¤Œěƒf[Žs–Żu‰‰‰ď (2016/10/2), _“ސě.

732071. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰)yŔ’ˇz‹łˆçu‰‰. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

732072. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) –k—˘‘ĺŠw•a‰@Šá‰Č—ΓŕáŠO—ˆ‚ĚŒťó. ź‘şˆęO (Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

732073. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ĺ‹ß‚̗ΓŕáŽčp‚ɂ‚˘‚Ä. ŻŽiMs (Šá‰Č): Clinical Network of Tokyo Glaucoma Specialist (CNTGS) (2016/11/11), “Œ‹ž.

732074. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒgƒ‰ƒxƒNƒg[ƒ€Žčp‚Ě’ˇŠúŹŃ. Š}Œ´łs (Šá‰Č): ŽQ“Vť–ňŽĐ“ŕu‰‰‰ď (2016/11/11), _“ސě.

732075. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Minimally invasive glaucoma surgery (MIGS) ‚ɂ‚˘‚Ä. Š}Œ´łs (Šá‰Č): ‘ĺ’ːť–ňŽĐ“ŕu‰‰‰ď (2016/11/28), _“ސě.

732076. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzi‰ť‚ˇ‚é—ΓŕáŽčp. ŻŽiMs (Šá‰Č): ‘ć52‰ńĂ“ěŠá‰Č—Տ°ƒtƒH[ƒ‰ƒ€ (2016/12/8), _“ސě.

732077. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ŽÎŽ‹_ŒoŠO—ˆ‚Í‚ś‚ß‚Ü‚ľ‚˝. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć19‰ń…ŒËŠá‰Čf—ĂƒZƒ~ƒi[ (2016/12/9), ˆď–Ř.

732078. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“˘˜_‰ď)yŽi‰ďzƒI[ƒvƒ““˘˜_‰ď. Žs粋`Í1,2 (1Šá‰Č, 2_“ސ쎕‰Č‘ĺŠw•t‘Ž‰Ą•lƒNƒŠƒjƒbƒN): ‘ć13‰ń_“ŢěŒ§Šá‰ČDMƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/1/14), _“ސě.

732079. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“˘˜_‰ď)yŽi‰ďzƒI[ƒvƒ““˘˜_‰ď. –ö“c’q•F (Šá‰Č): ‘ć13‰ń_“ŢěŒ§Šá‰ČDMƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/1/14), _“ސě.

732080. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —ΓŕáŽĄ—Ă•űj‚đ‚ǂ̂悤‚É‚˝‚Ä‚Ä‚˘‚­‚Š? ŻŽiMs (Šá‰Č): ‘ć5‰ńEast Tokyo Ophthalmic Seminar (ETOS) (2017/1/18), “Œ‹ž.

732081. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzŔ’ˇ. ”Ń“c‰Ă•F (Šá‰Č): ‘ć14‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2017/1/19), _“ސě.

732082. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘ć27‰ń“ú–{—ΓŕáŠw‰ď‚Ě•ń. ź‘şˆęO (Šá‰Č): ‘ć14‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2017/1/19), _“ސě.

732083. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “ú–{_ŒoŠá‰ČŠw‰ď‹y‚ŃŽŸ”N“x‘ć55‰ń‘‰ď‚ɂ‚˘‚Ä. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć14‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2017/1/19), _“ސě.

732084. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) –k—˘‘ĺŠw‚Ě‚ą‚ę‚Š‚ç‚ĚŠá‰Č•af˜AŒg‚ɂ‚˘‚Ä. ŻŽiMs (Šá‰Č): ‘ć14‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2017/1/19), _“ސě.

732085. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (•×‹­‰ď) ŽĐ“ŕ•×‹­‰ď. ”Ń“c‰Ă•F (Šá‰Č): HOYA (Š”) ŽĐ“ŕ•×‹­‰ď (2017/1/20), “Œ‹ž.

732086. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Œđ’ĘˆŔ‘Sƒg[ƒN: Ž‹Šo‚Ĺ•Ď‚í‚é‰^“]‚Ć‚Í. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): Œđ’ĘŽ–ŒĚƒ[ƒƒtƒFƒXƒ^2017 (2017/1/21), _“ސě.

732087. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) HOYA (Š”) ť•iŕ–ž‰ďEŽ‹‹@”\‚Š‚çl‚Ś‚鍂‹@”\Šá“ŕƒŒƒ“ƒY. _’J˜aF (Šá‰Č): ‘ć6‰ń–k—¤crystalmeeting (2017/2/4), Îě.

732088. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ŠááقŻ‚˘‚ę‚ń‚Ćƒhƒ‰ƒCƒAƒC. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć1‰ńESG in KANAGAWA (2017/2/10), _“ސě.

732089. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —ΓŕáŽĄ—Âɂ‚˘‚Ä. Š}Œ´łs (Šá‰Č): ƒtƒ@ƒCƒU[Š”ŽŽ‰ďŽĐŽĐ“ŕ•×‹­‰ď (2017/2/13), _“ސě.

732090. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Տ°‚ÉŠˆ—p‚ˇ‚é‚í‚Š‚č‚₡‚˘ŠáŒőŠw. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): é‹ĘŒ§–k•”Šá‰Č‚̉ď (2017/2/17), é‹Ę.

732091. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzŔ’ˇ. •x‰Ş•q–ç1,2 (1Šá‰Č, 2‰Ą•lŽs—§Žs–Ż•a‰@): ‘ć9‰ń“ŒŠC“šŠá‰ČŒ¤‹†‰ď (2017/2/18), _“ސě.

732092. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒrƒ}ƒgƒvƒƒXƒg‚Ö‚ĚŘ‘ÖŒă‚ĚŒŸ“˘. •x‰Ş•q–ç1,2 (1Šá‰Č, 2‰Ą•lŽs—§Žs–Ż•a‰@): ‘ć9‰ń“ŒŠC“šŠá‰ČŒ¤‹†‰ď (2017/2/18), _“ސě.

732093. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[‚É‚¨‚Ż‚é, ‚ą‚Ě2”NŠÔ‚Ě‘Š‡. ”–؍LĆ1,2 (1Šá‰Č, 2Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[): ‘ć9‰ń“ŒŠC“šŠá‰ČŒ¤‹†‰ď (2017/2/18), _“ސě.

732094. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —ΓŕáŽčp‚Ěƒ^ƒCƒ~ƒ“ƒO. ŻŽiMs (Šá‰Č): ‘ć28‰ń–ś“‡Šá‰ČŒ¤čr‰ď (2017/2/25), ‹{č.

732095. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzu‰‰1. ŻŽiMs (Šá‰Č): ƒ€ƒRƒXƒ^5Žü”N&ƒ~ƒPƒ‹ƒi”z‡“_Šá‰t”­”„‹L”Ou‰‰‰ď (2017/3/10), _“ސě.

732096. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Տ°ˆă‚É‚Ć‚Á‚Ä‚ĚŽ‹–ěŒŸ¸. ŻŽiMs (Šá‰Č): ‘ć2‰ńŽ‹Šoś—ŠwŠî‘bƒZƒ~ƒi[ (2017/3/12), _“ސě.

732097. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —ΓŕáŽĄ—Âɑ΂ˇ‚él‚Ś•ű. ŻŽiMs (Šá‰Č): ‘ć53‰ńĂźŠá‰Č—Տ°ƒtƒH[ƒ‰ƒ€ (2017/3/16), _“ސě.

733348. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”’“ŕápŒă‚ɏd“Ä‚ČŠp–ŒáŠQ‚𐜂ś‚˝Šá—Ţ“Vávጂ̈ę—á. ’†ź@Šî1,2 (1Šá‰Č, 2•‘ –ěÔ\Žš•a‰@): ‘ć7‰ń“Œ‹ž‘˝–€Šá‰Č˜AŒgƒZƒ~ƒi[ (2016/4/16), “Œ‹ž.

733349. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzƒhƒ‰ƒCƒAƒC, Ĺ‹ß‚Ě˜b‘č. _’J˜aF (Šá‰Č): ‘ć1‰ńOS-GƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/6/8), _“ސě.

733350. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇz”’“ŕáŽčp “—á‘΍ô‚ĆĹ‹ß‚Ě˜b‘č. ”Ń“c‰Ă•F (Šá‰Č): ‘ć51‰ńĂźŠá‰Č—Տ°ƒtƒH[ƒ‰ƒ€ (2016/7/14), _“ސě.

733351. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽĄ—Ă’ďRŤ‚ĚŠ´őŤŠp–Œ’×ᇂɑ΂ľ‚ÄŠp–ŒƒRƒ‰[ƒQƒ“ƒNƒƒXƒŠƒ“ƒLƒ“ƒO•š—p‚Ş—LŒř‚ƍl‚Ś‚ç‚ę‚˝2—á. ‰Í–ě—Y—ş1, Ź‹´‰p’ˇ1, ‚‹´ł‰p1, _’J˜aF1 (1Šá‰Č): ‘ć8‰ń_“ސěŠá‰ČŠw‰ď (2016/7/31), _“ސě.

733352. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é‘I‘đ“IƒŒ[ƒU[üˆŰ’Œ‘ŃŒ`Źp (SLT) ‚Ě’ˇŠúŹŃ. ‹ŕŽRr‰î1, Š}Œ´łs1, X“c“N–ç, ź‘şˆęO1, –Ř‘ş“TŒh1, ŻŽiMs1 (1Šá‰Č): ‘ć8‰ń_“ސěŠá‰ČŠw‰ď (2016/7/31), _“ސě.

733353. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) IOLŒĹ’荢“ďÇ—á‚ɑ΂ˇ‚éSulcus-Subcapsular fixation‚Ě—Ő°ŹŃ. Î“c@‹Ĺ1, ”Ń“c‰Ă•F1, ˛“ĄM”V1, ’Ň‘ň’C•F1 (1Šá‰Č): ‘ć8‰ń_“ސěŠá‰ČŠw‰ď (2016/7/31), _“ސě.

733354. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚鎋_Œo“ű“Ş—Ł’f‚đ”F‚ß‚˝3—á. •ÄŽR@—Č1, ŒăŠÖ—˜–ž1, ”Ń“‡@ˆť1, Îě@‹Ď2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć8‰ń_“ސěŠá‰ČŠw‰ď (2016/7/31), _“ސě.

733355. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇz—ΓŕáŽĄ—Ă: NP“IŽĄ—Ă‚Ě‘O‚ĆŒă. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2_“ŢěŒ§Šá‰Čˆă‰ď): ‘ć129‰ń_“ŢěŒ§Šá‰ČW’k‰ď (2016/7/31), _“ސě.

733356. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʍu‰‰Ŕ’ˇ. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/20), Îě.

733357. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰Š”ÁˆŮí‚ƐF‘ÎŒő”˝ŽË‚Ć‚Şˆę’v‚ľ‚Ä‚˘‚˝‰Š”Á’áŒ`Ź‚Ěˆę—á. óě@ŒŤ1, Îě@‹Ď1, —´ˆä‰‘Žq2, ŒăŠÖ—˜–ž2, ’r“c“N–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/20), Îě.

733358. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Occulu-pad‹y‚ŃƒAƒCƒpƒbƒ`‚đ—p‚˘‚˝Šá—DˆĘŤ•Ď‰ť‚ĚŽŽ‚Ý. Šâ“c@—y1, ”ź“c’m–ç2, Îě@‹Ď2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/20), Îě.

733359. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éŠOŤŽ‹_Œo“ű“Ş—Ł’fEŽ‹_Œo’f—ô‚Ě‚Ü‚Ć‚ß. •ÄŽR@—Č1, ŒăŠÖ—˜–ž1, ”Ń“‡@ˆť1, —´ˆä‰‘Žq1, Îě@‹Ď2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/20), Îě.

733360. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 0ÎŽ™‚É‚¨‚Ż‚é‘ÎŒő”˝ŽË‚ĚŒoŽž•Ď‰ť. ŒË’ˁ@Œĺ1, óě@ŒŤ2, ŒăŠÖ—˜–ž1, ’r“c“N–ç1, Îě@‹Ď2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/20), Îě.

733361. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[‚É‚¨‚Ż‚éRŠŕÜTS-1‚Ě—Ü“šáŠQ98–ź‚Ě‘Š‡. ”–؍LĆ1,2 (1Šá‰Č, 2Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[): ‘ć67‰ńĂ‰ŞŒ§Šá‰Čˆă‰ď (2016/8/20), Ă‰Ş.

733362. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RMOGR‘́ERAQP4R‘Ě—zŤŽ‹_Œo‰Š‘S‘’˛¸|Œv‰ć‚Ć“ą“ü‚ɂ‚˘‚ā|. –Ń’Ë„Ži1, Îě@‹Ď2,3, ŒăŠÖ—˜–ž2,4, ŽO‘ş@ŽĄ2,5, ‹g•xŒ’Žu2,6, •~“‡ŒhŒĺ2,7, •˝‰Ş”ü‹I2,8, ’†”nGŽ÷2,9, ’†‘ş@˝2,10, “c’†œ¨Žq2,11 (1‹ž“s•{—§ˆă‰Č‘ĺŠw, 2RMOGR‘Ě—zŤŽ‹_Œo‰Š’˛¸”Ç, 3ˆă—ÉqśŠw•”, 4Šá‰Č, 5•şŒÉˆă‰Č‘ĺŠw, 6H“c‘ĺŠw, 7“Œ‹žŽœŒb‰ďˆă‰Č‘ĺŠw, 8ŽD–yˆă‰Č‘ĺŠw, 9‹{č‘ĺŠw, 10_ŒË‘ĺŠw, 11VŠƒ‘ĺŠw”]Œ¤‹†Š): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/21), Îě.

733363. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RMOGR‘́ERAQP4R‘Ě—zŤŽ‹_Œo‰Š‘S‘’˛¸|’†ŠÔŒ‹‰Ę•ń|. ŒăŠÖ—˜–ž1,2, Îě@‹Ď2,3, –Ń’Ë„Ži2,4, ŽO‘ş@ŽĄ2,5, ‹g•xŒ’Žu2,6, •~“‡ŒhŒĺ2,7, •˝‰Ş”ü‹I2,8, ’†”nGŽ÷2,9, ’†‘ş@˝2,10, “c’†œ¨Žq2,11 (1Šá‰Č, 2RMOGR‘Ě—zŤŽ‹_Œo‰Š’˛¸”Ç, 3ˆă—ÉqśŠw•”, 4“Œ‹žˆă‰Č‘ĺŠw, 5•şŒÉˆă‰Č‘ĺŠw, 6H“c‘ĺŠw, 7“Œ‹žŽœŒb‰ďˆă‰Č‘ĺŠw, 8ŽD–yˆă‰Č‘ĺŠw, 9‹{č‘ĺŠw, 10_ŒË‘ĺŠw, 11VŠƒ‘ĺŠw”]Œ¤‹†Š): ‘ć32‰ń^’߃Zƒ~ƒi[ (2016/8/21), Îě.

733364. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •˝Ź27”N“x‘S‘ŠwZƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—p’˛¸‚Ć‚ť‚̑Ήž, ˆă—Ă‹@Ší‚̏î•ń’ń‹Ÿ. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2_“ŢěŒ§Šá‰Čˆă‰ď): •˝Ź28”N“x‚“xŠÇ—ˆă—Ă‹@Ší”Ě”„ŠÇ—ŽŇ‚ɑ΂ˇ‚éŒp‘ą“IŒ¤C (2016/9/1), _“ސě.

733365. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʉ‰‘č. _’J˜aF (Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

733366. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”’“ŕápŒăŠá“ŕ‰Š‚đ‹^‚˘ÉŽq‘ĚŽčp‚đŽ{s‚ľ‚˝Ç—á‚ĚŒŸ“˘. ’Ň‘ň’C•F1, –ö“c’q•F1, t–ؐ’G1, ”Ń“‡@ˆť1, ŠFě—FŒ›1 (1Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

733367. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˝Ü“_Šá•š—p’†‚ĚƒuƒŠƒ‚ƒjƒWƒ“‚đƒŠƒpƒXƒWƒ‹‚ɐ؂č‘Ö‚Ś‚˝Ç—á‚ĚŒŸ“˘. –Ř‘ş“TŒh1, ‹ŕŽRr‰î1, Š}Œ´łs1, ź‘şˆęO1, ŻŽiM”V1 (1Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

733368. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) • ‰çˆĘ‚Ƌ‰çˆĘŽčp’†‚ĚŒoŽž“IŠáˆł•Ď‰ť. ’r“c“N–ç1, Îě@‹Ď2, ŒăŠÖ—˜–ž1, “c’†—R1, ’|˜Q–Ż]3, ŻŽiMs1 (1Šá‰Č, 2ˆă—ÉqśŠw•”, 3–ƒŒ): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

733369. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’´’ZŠáŽ˛’ˇŒŔ‚âpŒă‹üÜŒëˇ‚ɑ΂ˇ‚épiggyback IOL. ŒĂ“c—S‰ŔŽq1, ”Ń“c‰Ă•F1, Î“c@‹Ĺ1, ˛“ĄM”V1, Šąě—˘ŠG1 (1Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

733370. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Œă–[Œ^—L…ť‘ĚŠá“ŕƒŒƒ“ƒY‘}“üp‚Ě’ˇŠúŹŃ. ‚‹´ł‰p1, _’J˜aF1, ‰Í–ě—Y—ş1 (1Šá‰Č): ‘ć52‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/10/6), _“ސě.

733371. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Γŕáf—Ă‚ĚŽż‚đ‚‚ß‚é‚˝‚ß‚É. ŻŽiMs (Šá‰Č): ‘ć128‰ńŽRŒűŒ§Šá‰Čˆă‰ďH‹G‘‰ď•Ŕ‚Ń‚ÉW’k‰ď (2016/11/13), ŽRŒű.

733372. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʉ‰‘č Session1. ŻŽiMs (Šá‰Č): ‘ć14‰ńBay Ophthalmic Surgical Seminar (2016/11/19), _“ސě.

733373. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒgƒ‰ƒxƒNƒg[ƒ€Žčp. Š}Œ´łs (Šá‰Č): ‘ć14‰ńBay Ophthalmic Surgical Seminar (2016/11/19), _“ސě.

733374. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] •Â‰ďˆĽŽA. ŻŽiMs (Šá‰Č): ‘ć14‰ńBay Ophthalmic Surgical Seminar (2016/11/19), _“ސě.

733375. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽÎŽ‹_Œoup-to-date. ŒăŠÖ—˜–ž (Šá‰Č): ‘ĺ˜aŽsŠá‰Čˆă‰ďu‰‰ (2017/2/7), _“ސě.

733376. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 2017”NŠO—ˆf—Ă‚É‚¨‚Ż‚é•ŰŒŻż‹‚Ě’ˆÓ“_‚ɂ‚˘‚Ä. ź–{_”V (Šá‰Č): •˝Ź28”N“x_“ŢěŒ§Šá‰Čˆă‰ďŒ’•Ű§˜b‰ď (2017/2/25), ěč.

733377. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˝Ü•š—pŽĄ—ĂÇ—á‚É‚¨‚Ż‚éƒ^ƒtƒ‹ƒvƒƒXƒgEƒ`ƒ‚ƒ[ƒ‹”z‡Ü‚Ö‚ĚŘ‘ÖŒř‰Ę. ź‘şˆęO1, Š}Œ´łs1, ŽRě–퐜1,2, t“úˆähŽq1,3, ŻŽiMs1 (1Šá‰Č, 2‘ĺ˜aŽs—§•a‰@, 3‘Š–Í–ě•a‰@): ‘ć33‰ń_“ŢěŒ§—Γŕá’k˜b‰ď (2017/3/4), _“ސě.

733378. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žčp‚Ü‚Ĺ‚ĚŠáˆłă¸ŠúŠÔ•Ę‚É‚¨‚Ż‚éƒgƒ‰ƒxƒNƒg[ƒ€Žčp‚̐ŹŃ. Š}Œ´łs1, ’Ň‘ň’C•F1, •ÄŽR@—Č1, ź‘şˆęO1, ŒĂ“c—S‰ŔŽq1, ŻŽiMs1 (1Šá‰Č): ‘ć33‰ń_“ŢěŒ§—Γŕá’k˜b‰ď (2017/3/4), _“ސě.

733379. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šáâ|ƒv[ƒŠ[‚Š‚çl‚Ś‚ég•ĄŽ‹hŒ´ˆö‚ĆŽĄ—Ă. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć4‰ń_“ސ쏬Ž™Šá‰ČE_ŒoŠá‰ČƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/3/9), _“ސě.

733380. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzu‰‰2. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć4‰ń_“ސ쏬Ž™Šá‰ČE_ŒoŠá‰ČƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/3/9), _“ސě.

733381. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzÇ—á•ń. ŻŽiMs (Šá‰Č): ‘ć9‰ń_“ސěƒNƒƒXƒI[ƒo[ƒVƒ“ƒ|ƒWƒEƒ€ (2017/3/18), _“ސě.

733382. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šç–ʍœ‘˝”­œÜ‚É”ş‚Á‚˝Purtscher–Ô–ŒÇ‚Ě1—á. ]•—Ft (Šá‰Č): ‘ć9‰ń_“ސěƒNƒƒXƒI[ƒo[ƒVƒ“ƒ|ƒWƒEƒ€ (2017/3/18), _“ސě.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110019. [Œ´’˜] Efficacy of an Amblyopia Treatment Program With Both Eyes Open: A Functional Near-Infrared Spectroscopy Study. Iwata Y1, Handa T2, Ishikawa H2, Shoji N3, Shimizu K3: Am Orthopt J 2016/1; 66 (1), 87-91. (Šâ“c@—y1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs3, ´…Œö–ç3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3Šá‰Č)

H27-110020. [Œ´’˜] Association Between Ocular Dominance and Anisometropic Hyperopia. Hoshikawa R1, Ito M2, Shimizu K1: American Orthoptic Journal 2016/1; 66 (1): 107-13. (Šąě—˘ŠG1, ˆÉ“Ą”üšŠG2, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

H27-110021. [Œ´’˜] The effect of pupil size and wavefront aberration of the eye on binocular summation. Kawamorita T1, Shoji N2: Glob J Adv Eng Tech Sci 2016/1; 3 (3): 4-12. (ěŽç“c‘ńŽu1, ŻŽiMs2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

H27-320003. [Ç—á•ń]y—Տ°•ńz3D Visual Function Trainer-ORTe҂đ—p‚˘‚˝ŽăŽ‹ŒP—ű. ŒË’ˁ@Œĺ1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): —Տ°Šá‰Č 2016/3; 70 (3): 301-6.

H27-521001. [‰đŕ] ŠwZ‚Ĺ‚ĚŽ‹—Í, ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY, ƒXƒ|[ƒcŠáŠO, FŠoŒŸ¸‚Ȃǂւ̑Ήž. ‰F’ĂŒŠ‹`ˆę1,2 (1Šá‰Č, 2‰F’ĂŒŠŠá‰Čˆă‰@): ‰Ą•lŽsˆăŽt‰ďŠwZˆă•”‰ďƒŒƒ|[ƒg 2016/3; 31: 71-80.

H27-521002. [‰đŕ]yĹV‹@ŠíƒŒƒ|[ƒgzTobiiŽĐťŠá‹…‰^“ŽŒv‘Ş‘•’u. ŒăŠÖ—˜–ž1, Ż”ň—Y^2, ‘ĺ–ě–žŽq3, L“c‰ë˜a4, _“cŠ°s4 (1Šá‰Č, 2ƒgƒr[EƒeƒNƒmƒƒW[, 3“Œ‹ž“s—§‘˝–€‘‡ˆă—ĂƒZƒ“ƒ^[Šá‰Č, 4‘ĺă‘ĺŠw‘ĺŠw‰@): _ŒoŠá‰Č 2016/3: 33 (1): 47-52.


Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠw

[Šwp˜_•ś]

110268. [Œ´’˜] Neoglottal revisions after Supracricoid laryngectomy with cricohyoidoepiglottopexy. Nakayama M, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1: Jpn J Clin Oncol 2016/5; 46 (7): 642-5. (‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1: 1Ž¨•@ˆôAE“ŞčňŠO)

110269. [Œ´’˜] Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model. Kamide D1, Yamashita T2, Araki K1, Tomifuji M1, Tanaka Y1, Tanaka S1, Shiozawa S3, Shiotani A1. Cancer Sci. 2016/5; 107 (5): 666-73. (ăo‘ĺ‰î1, ŽR‰ş@‘ń2, r–؍Km1, •y“Ą‰ë”V1, “c’†—Y–ç1, “c’†LŒá1, ‰–‘ňrˆę3, ‰–’J˛_1F1–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA, 2Ž¨•@ˆôAE“ŞčňŠO, 3‹ăB‘ĺŠw•Ę•{•a‰@“ŕ‰Č)

110270. [Œ´’˜] Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma. Yamaguchi T1, Ishii T1, Yamamoto K, Higashi N, Taniguchi M, Okamoto M: Auris Nasus Larynx 2016/6; 43 (3) 304-8. (ŽRŒű’mŽq1, Îˆä–L‘ž1: 1Ž¨•@ˆôAE“ŞčňŠO)

110271. [Œ´’˜] Value of a novel PGA-collagen tube on recurrent laryngeal nerve regeneration in a rat model. Suzuki H1, Araki K1, Matsui 2, Tomifuji M1, Yamashita T3, Kobayashi Y2, Shiotani A1. Laryngoscope. 2016/7;126 (7): E233-9. (—é–؁@—m1, r–؍Km1, źˆä—˜N2, •y“Ą‰ë”V1, ŽR‰ş@‘ń3, Ź—с@–ő2, ‰–’J˛_1: 1–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA, 2–h‰qˆă‰Č‘ĺŠwZ‰đ–U, 3Ž¨•@ˆôAE“ŞčňŠO)

110273. [Œ´’˜] Audiological care following newborn hearing screening: a follow-up study on NISU infants and well-baby nursery infants. Inoue R1, Umehara S1, Suzuki K2, Hara Y2, Maki A3, Sano H2, Okamoto M3: Kitasato Med J 2016; 46: 136-145. (ˆäă—ŠG1, ”~Œ´KŒb1, —é–ŘŒbŽq2, Œ´@—R‹I2, –q@“ÖŽq3, ˛–ě@”Ł2, ‰Ş–{–ql3: 1–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 2ˆă—ÉqśŠw•”, 3Ž¨•@ˆôAE“ŞčňŠO)

110274. [Œ´’˜] Wernicke's encephalopathy with upbeat nystagmus. Ochiai A1, Naganuma H2: Wernick's encephalopathy with upbeat nystagmus. Equilibrium Research 2016/12; 75 (6): 505-10. (—Ž‡@“Ö1, ’ˇŔ‰p–ž2: 1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

120031. [Œ´’˜] —v‰îŒě‚—îŽŇ‚Ě’ŽŠo•]‰ż|’ŽŠoŒŸ¸|. ˆäă—ŠG1, —é–ŘŒbŽq2, ”~Œ´KŒb1, `@ŽáŘ, ´…@•˝, ˛–ě@”Ł3, ‰Ş–{–ql3 (1–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 2ˆă—ÉqśŠw•”, 3Ž¨•@ˆôAE“ŞčňŠO): Audiology Japan 2016/4; 59. (2): 124-31.

120032. [Œ´’˜] —v‰îŒě‚—îŽŇ‚Ě’ŽŠo•]‰ż|‰îŒěEˆő‚Ě“ď’Ž”FŽŻ‚Ɖî“ü‘O‚̑Ήž|. —é–ŘŒbŽq1, ˆäă—ŠG,2 ”~Œ´KŒb2, `@ŽáŘ, ´…@•˝, ˛–ě@”Ł1, ‰Ş–{–ql3 (1ˆă—ÉqśŠw•”, 2–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 3Ž¨•@ˆôAE“ŞčňŠO): Audiology Japan. 2016/4; 59. (2): 132-40.

120033. [Œ´’˜] –k—˘‘ĺŠw“Œ•a‰@_ŒoŽ¨‰Č‚̂܂Ƃ߁|ŽžŠłŒQ‚̐„ˆÚ|. —Ž‡@“Ö1, ’ˇŔ‰p–ž2 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): Equilibrium Research 2016/4; 75 (2): 54-60.

120034. [Œ´’˜] ‘O’됅ŠÇŠg‘ĺÇ‚Ě’ˇŠúŒo‰ß. ‘ĺ‹´Œ’‘ž˜Y1, ˛–ě@”Ł2, ‰Ş–{–ql (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): Ž¨•@—Տ° 2016/7; 109 (7): 469-73.

120035. [Œ´’˜] f’f‚É‹ę—ś‚ľ‚˝ŹlStill•a‚Ě1—á. ’†ŔŽ‘ŽŔ1, ‘ĺ‹´Œ’‘ž˜Y1,2, ‘ĺ–ŘŠ˛•ś1,2 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č 2016/9; 88 (10): 781-5.

120036. [Œ´’˜] –k—˘‘ĺŠwŠç–ʐ_Œoę–ĺŠO—ˆ‚É‚¨‚Ż‚éŠç–ʐ_Œo–ƒáƒŽĄ—Á|“Á‚ɓ—á‚ĚŽĄ—Âɂ‚˘‚ā|. ŽRŒű’mŽq1,2, ˛–ě@”Ł3, Îˆä–L‘ž1, –q–슰”V1, “n•ÓˆŸŠóŽq1, “ߐ{–ě’qŒő2,4, ‰Ş–{–ql2,4 (1‘Š–ÍŒ´•a‰@, 2Ž¨•@ˆôAE“ŞčňŠO, 3ˆă—ÉqśŠw•”, 4“ŒŽĹ—ŃŠÔ•a‰@): –k—˘ˆăŠw 2016/12; 46 (2): 101-8.

120037. [Œ´’˜] Ž¨‰ş‘B‚É”­Ç‚ľ‚˝solitary fibrous tumor (SFT)‚Ěˆę—á. “ߐ{–ě’qŒő1,2, ’|“cš•F3, ‘ĺ‹´Œ’‘ž˜Y4, ´–ě—R”y2, ŽRŒű’mŽq2,5, ‰Ş–{–ql1,2, ŽR‰ş@‘ń2 (1“ŒŽĹ—ŃŠÔ•a‰@, 2Ž¨•@ˆôAE“ŞčňŠO, 3‹´–{ƒ^ƒ[Ž¨•@ˆôA‰Č, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 5‘Š–ÍŒ´•a‰@): –k—˘ˆăŠw 2016/12; 46 (2): 109-15.

310032. [Ç—á•ń] Large laryngeal polyp causing airway obstruction. Ochiai A1: OMCR 2016/8; 8: 219-20. (—Ž‡@“Ö1: 1Ž¨•@ˆôAE“ŞčňŠO)

320023. [Ç—á•ń] ƒiƒrƒQ[ƒVƒ‡ƒ“ƒKƒCƒh‰ş‚ɐ؏œ‚ľ‚˝Œsó“Ë‹N‰ß’ˇÇ—á. —é–ŘˆťŽq1, ‹{–{r•ă1, ’†ŽR–žm, ‰Ş–{–ql (1Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@—Տ° 2016/5; 109 (5): 327-31.

320024. [Ç—á•ń] ‹CŠÇŘŠJpŒă‚ɐś‚ś‚˝‘Sg”牺ŽîEcŠu‹CŽî—á. –ŕŽR•Ű1, –q@“ÖŽq1, ‰Á”[Fˆę1, ‰Ş–{–ql (1Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@—Տ° 2016/6; 109 (6): 433-7.

520013. [‘ŕ]“Şčň•”Šŕ‚Ćƒqƒg“ű“ŞŽîƒEƒCƒ‹ƒX. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): –k—˘ˆăŠw 2016/12; 46 (2): 81-91.

522101. [uŔ]y“ŕŽ‹‹žŘœ‚đ‹É‚ß‚é|Šî–{‚Š‚çŠoŒĺ‚đ—v‚ˇ‚éŽč‹Z‚܂ŁzIII. ă‹‰•Ň@ˆô“Ş•\ÝŠŕ‚ɑ΂ˇ‚éŒoŒű“IŽčp‚Ć‚Í! |ELPS‚𒆐S‚É. ‰Á”[Fˆę1, ‰Ş–{—ˇl1, Œ˜“ce—˜2, ˆęŒËš–ž3, ‹{–{r•ă1, ´–ě—R”y1, ˜a“c‘ń–ç2, ŽR‰ş@‘ń1, “c糁@‘4, Źň˜aŽO˜Y2 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3•a—, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2016/7; 28 (7): 1048-54.

522102. [uŔ]y“ÁW: čň•”ŽîáŽ‚đŒŠ‹É‚ß‚ézbó‘BŽî’ŻEŽîá‡. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č 2016/8; 88 (9): 684-92.

522103. [uŔ]y“ÁW: ŠO—ˆ‚É•K{!@ŠO—p–ň‚̏ăŽč‚ČŽg‚˘•űzĄŒűoEˆôA“Ş—Ěˆć@Œű“ŕ‰ŠŽĄ—Ă–ň. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č 2016/11; 88 (12): 944-7.

522104. [uŔ] “Şčň•”Šŕ‚ɑ΂ˇ‚éŽîᇃ}[ƒJ[‚ĚˆÓ‹`. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@ˆôA‰Č—Տ°2017/2; 110 (2): 81-91.

522105. [uŔ]y“ÁW: ”S–Œ, ”S–Œ‰ş‘w, ‚ł‚ç‚É‹Ř‘w‚ĚŽž‘ă‚ց`Minimally Invasive Treatment‚̐V‚˝‚Č’Ş—Ź`zŠe˜_: ”S–Œ‚ɑ΂ˇ‚éƒAƒvƒ[ƒ`@ˆô“Ş•\ÝŠŕ‚ɑ΂ˇ‚éŒoŒű“IŽčp|ELPS‚𒆐S‚É. ‰Á”[Fˆę1, ‰Ş–{—ˇl1, Œ˜“ce—˜2, ˆęŒËš–ž3, ‹{–{r•ă1, ´–ě—R”y1, ˜a“c‘ń–ç2, ŽR‰ş@‘ń1, “c糁@‘4, Źň˜aŽO˜Y2 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3•a—, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2017/2; 29 (2): 207-14.

522106. [uŔ]y“ÁW: Ą, ˜b‘č‚É‚Č‚Á‚Ä‚˘‚é‚ą‚Ɓ|Ž¨•@ˆôA‰Č•Ňz“Şčň•”Šŕ‚̍ŐVŽĄ—Ă. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): “ú–{ˆăŽ–V•ń 2017/3; 4846: 34-6.

540059. [‚ť‚Ě‘ź (Šw‰ď´˜^)] ƒAƒNƒ`ƒOƒ‰ƒt‚É‚ć‚é‰Ô•˛ÇŠłŽŇ‚Ě“úíŠˆ“Ž‚¨‚ć‚ѐ‡–°“Ž‘Ô‚ĚŠĎŽ@. ‘ĺ–ŘŠ˛•ś1, —é–Ř—§r1 (1Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@–ƉuƒAƒŒƒ‹ƒM[ 2016/6; 34 (2); 190-1.

[’˜@‘]

620149. [Šwp‘ (•Ş’SŽˇ•M)]y‹}Ť•@•›•@o‰Š‚ɑ΂ˇ‚éƒlƒuƒ‰ƒCƒU[—Ă–@‚ĚŽčˆř‚Ť 2016”N”Łz‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO), •Ň: “ú–{Ž¨•@ˆôA‰ČŠ´őÇEƒGƒAƒƒ]ƒ‹Šw‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/5”­s.

620150. [Šwp‘(•Ş’SŽˇ•M)]y•ŞŽqŽîᇃ}[ƒJ[f—ĂƒKƒCƒhƒ‰ƒCƒ“‘ćˆę”ŁzŠe˜_2 “Şčň•”Šŕ, p.33-40. ŽR‰ş@‘ń1, r–؍Km2, ‰–’J˛_2 (1Ž¨•@ˆôAE“ŞčňŠO, 2–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA), •Ň: “ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

620151. [Šwp‘(•Ş’SŽˇ•M)]y•ŞŽqŽîᇃ}[ƒJ[f—ĂƒKƒCƒhƒ‰ƒCƒ“‘ćˆę”ŁzŠe˜_3 bó‘BŠŕ, p.41-52. r–؍Km1 , ŽR‰ş@‘ń2, ‰–’J˛_1 (1–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA, 2Ž¨•@ˆôAE“ŞčňŠO), •Ň: “ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713135. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The observation of sleep disturbance in patients with allergic rhinitis using Actigraph. Ohki M1, Ohashi K1, Nakaza M1, Suzuki T1, Takano H: the 26th Congress of the European Rhinologic Society (2016/7/3-7), Stockholm, Sweden. (‘ĺ–ŘŠ˛•ś1, ‘ĺ‹´Œ’‘ž˜Y1, ’†ŔŽ‘ŽŔ1, —é–Ř—§r1: 1Ž¨•@ˆôAE“ŞčňŠO)

713136. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Fluorescence Sentinel Node Mapping in Oral and Oropharyngeal Cancer (Oral presentation). Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Kano K1, Tsutsumi S1, Yamashita T1: AAO-HNSF 120th Annual Meeting & OTO EXPO (2016/9/18), San Diego, USA. (‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ç@ăĕ˝1, ŽR‰ş@‘ń1: 1Ž¨•@ˆôAE“ŞčňŠO)

713137. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The clinical outcomes of endoscopictransoral surgeries. Kano K1, Miyamoto S1, Katada C2, Tsutsumi S1, Seino Y1, Okamoto T1, Yamashita T1: AAO-HNSF 120th Annual Meeting & OTO EXPO (2016/9/18), San Diego, USA. (‰Á”[Fˆę1, Œ˜“ce—˜2, ‹{–{r•ă1, ’ç@ăĕ˝1, ´–ě—R”y1, ‰Ş–{—ˇl1, ŽR‰ş@‘ń1: 1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ)

713138. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Usefulness of Narrow-Band Imaging with Magnifying Endoscopy for Diagnosis of Laryngeal Lesions. Hosono H1, Katada C2, Tsutsumi S1, Kano K1, Okamoto T1, Seino Y1, Miyamoto S1, Murata A2, Tanabe S3, Koizumi W2, Yamashita T1: APDW2016 (Asian Pacific Digestive Week) (2016/11/3), Kobe, Japan. (×–ě_Žj1, Œ˜“ce—˜2, ’ç@ăĕ˝1, ‰Á”[Fˆę1, ‰Ş–{—ˇl1, ´–ě—R”y1, ‹{–{r•ă1, ‘ş“c@“Œ2, “c糁@‘3, Źň˜aŽO˜Y2, ŽR‰ş@‘ń1: 1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

713139. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Safety and Efficacy of Transoral Surgery Using a Gastrointestiinal Endoscope for Superficaial Pharyngeal Cancer. Kano K1, Katada C2, Tsutsumi S1, Hosono H1, Okamoto T1, Seino Y1, Miyamoto S1, Murata A2, Tanabe S3, Koizumi W2, Yamashita T: APDW2016 (Asian Pacific Digestive Week) (2016/11/4), Kobe, Japan. (‰Á”[Fˆę1, Œ˜“ce—˜2, ’ç@ăĕ˝1, ×–ě_Žj1, ‰Ş–{—ˇl1, ´–ě—R”y1, ‹{–{r•ă1, ‘ş“c@“Œ2, “c糁@‘3, Źň˜aŽO˜Y2, ŽR‰ş@‘ń1: 1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

722229. [Šw‰ď (‘S‘)] (ƒGƒAƒƒ]ƒ‹ƒVƒ“ƒ|ƒWƒEƒ€) ‹}Ť•@•›•@o‰Š‚ɑ΂ˇ‚éƒlƒuƒ‰ƒCƒU[—Ă–@‚ĚŽčˆř‚Ť‚ĚŠT—v‚Ć‚ť‚ĚŠˆ—p–@`ŽŔŰ‚ĚŽg—p–@‚Ć—ŻˆÓ“_`. ‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO): ‘ć4‰ń“ú–{Ž¨•@ˆôA‰ČŠ´őÇEƒGƒAƒƒ]ƒ‹Šw‰ď (2016/9/2), ‘q•~.

722230. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) wĄ“ú‚Š‚ç‚Í‚ś‚ß‚éŹŽ™‚ĚOSAS (•ÂÇŤ‡–°Žž–łŒÄ‹zÇŒóŒQ)f—ÏŹŽ™OSASxŠłŽŇ‚É‚¨‚Ż‚é•@o’Ę‹C“x|•@o‚ŕ‹C“š‚Ěˆę•”‚Ĺ‚ˇ|. ‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO): ‘ć49‰ń“ú–{ŹŽ™ŒÄ‹zŠíŠw‰ď (2016/10/28), •xŽR.

723757. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw•a‰@•â’ŽŠO—ˆ‚É‚¨‚Ż‚é—ź‘¤“ď’ŽŽ™‚ĚŒŸ“˘. –q@“ÖŽq1, ’†ě‹Mm1, —é–ŘˆťŽq1, ˛–ě@”Ł2 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć117‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď’Ęí‘‰ďEŠwpu‰‰‰ď (2016/5/19), –źŒĂ‰Ž.

723758. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚É‚¨‚Ż‚éăˆô“ŞŠŕ‚ĚŽĄ—ÐŹŃ. ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć117‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď’Ęí‘‰ďEŠwpu‰‰‰ď (2016/5/19), –źŒĂ‰Ž.

723759. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) H“šŠŕH“šˆŸ‘S“EpŒă‚Ěš‹‰ş‹@”\‚ĚŒŸ“˘. ´–ě—R”y1, —é–Ř—§r1, ×–ě_Žj1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć117‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď’Ęí‘‰ďEŠwpu‰‰‰ď (2016/5/19), –źŒĂ‰Ž.

723760. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹}Ť•@•›•@o‰Š‚ɑ΂ˇ‚éƒlƒuƒ‰ƒCƒU[—Ă–@‚Ě–â‘č“_‚ƑΉž. ‘ĺ–ŘŠ˛•ś1, •–ě—Yˆę, ‘ĺ‰zr•v, •ş@s‹` (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć117‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď’Ęí‘‰ďEŠwpu‰‰‰ď (2016/5/21), –źŒĂ‰Ž.

723761. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚é“ŕŽ‹‹ž‚đ—p‚˘‚˝ŒoŒű“IŽčp‚ĚŒŸ“˘. ‰Á”[Fˆę1, Œ˜“ce—˜2, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ’ç@Ë•˝1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ): ‘ć40‰ń“ú–{“Şčň•”ŠŕŠw‰ď (2016/6/9), é‹Ę “Şčň•”Šŕ 2016/5; 42 (2): 150.

723762. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) cN0ăŠŕ‚̐öÝŤčň•”“]ˆÚ‚ÉŠÖ‚í‚é—Տ°“IE•a—“IˆöŽq‚ĚŒŸ“˘. ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ç@ăĕ˝1, —é–ŘˆťŽq1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć40‰ń“ú–{“Şčň•”ŠŕŠw‰ď (2016/6/9), é‹Ę.

723763. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”x“Ž–ŹŽîᇍǐđ‚đ‚Ť‚˝‚ľ‚˝—֏ó““÷Žî‚Ě1—á. ’ç@ăĕ˝1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć40‰ń“ú–{“Şčň•”ŠŕŠw‰ď (2016/6/9), é‹Ę.

723764. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 3“x‚ĚŽčp‚É‚ÄŠm’čf’f‚ÉŽŠ‚Á‚˝Deamoid type fibromatosis‚Ě1—á. ’†ě‹Mm1, ‹{–{r•ă1, ‹{‰şŒ\ˆę1, ‰Á”[Fˆę1, —é–ŘˆťŽq1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć78‰ńŽ¨•@ˆôA‰Č—Տ°Šw‰ď‘‰ďEŠwpu‰‰‰ď (2016/6/23), Ž­Ž™“‡.

723765. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚ĹŽ{s‚ľ‚˝ŹŽ™‚É‚¨‚Ż‚éCAP-RASTŒ‹‰Ę‚ĚŒŸ“˘. ŒĂ–ŘČŒá1, ‘ĺŒ´‘ěĆ1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć78‰ńŽ¨•@ˆôA‰Č—Տ°Šw‰ď‘‰ďEŠwpu‰‰‰ď (2016/6/23), Ž­Ž™“‡.

723766. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž¨‰ş‘BƒŠƒ“ƒp‘BŽî‚Ě1Ç—á. —é–ŘˆťŽq1, ‹{–{r•ă1, –ŕŽR•Ű1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć78‰ńŽ¨•@ˆôA‰Č—Տ°Šw‰ď‘‰ďEŠwpu‰‰‰ď (2016/6/23), Ž­Ž™“‡.

723767. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŠO‘lŹŽ™“ď’ŽÇ—á‚ĚŒŸ“˘. –q@“ÖŽq1, ‘ĺŒ´‘ěĆ1, ’†ě‹Mm1, ˛–ě@”Ł2, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć11‰ń“ú–{ŹŽ™Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/6/30), “ż“‡.

723768. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŹŽ™—p‹CŠÇŘŠJƒJƒjƒ…[ƒŒ‚É‚ć‚č‚Š‚Š‚é—Í‚ĚŒŸ“˘. ‘ĺŒ´‘ěĆ1, –q@“ÖŽq1, –ŕŽR•Ű1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć11‰ń“ú–{ŹŽ™Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/6/30), “ż“‡.

723769. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹CŠÇŘŠJp‚đ—v‚ľ‚˝ŹŽ™ş–剺ˆŮ•¨‚ĚˆęÇ—á. –ŕŽR•Ű1, ‘ĺŒ´‘ěĆ1, –q@“ÖŽq1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć11‰ń“ú–{ŹŽ™Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/7/1), “ż“‡.

723770. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “úíf—Ă‚É‚¨‚Ż‚é’´‰š”gƒlƒuƒ‰ƒCƒU[‚ɑ΂ˇ‚éƒfƒBƒXƒ|[ƒUƒuƒ‹ŽÖŠÇ‚ĚŒř‰Ę‚ɂ‚˘‚Ä. ’†ŔŽ‘ŽŔ1, ‘ĺ–ŘŠ˛•ś1, ‘ĺ‹´Œ’‘ž˜Y1, Šƒ–’J’źŽq2, œAŁ•ÄŽu2 (1Ž¨•@ˆôAE“ŞčňŠO, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć4‰ń“ú–{Ž¨•@ˆôA‰ČŠ´őÇEƒGƒAƒƒ]ƒ‹Šw‰ď (2016/9/3), ‘q•~.

723771. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˆô“ނɐś‚ś‚˝”X–EŤŽîᎂĚ1—á. ‰iˆä_–¤1, ´–ě—R”y1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć29‰ń“ú–{ŒűoEˆô“Ş‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/9/8), ź].

723772. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŒá‚Eˆô“Ş’É‚đŒ_‹@‚ɐf’f‚ł‚ę‚˝ƒƒgƒgƒŒƒLƒT[ƒgŠÖ˜AƒŠƒ“ƒp‘BŤŽžŠł‚Ě1—á. ´–ě—R”y1, ‰Ş–{—ˇl1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć29‰ń“ú–{ŒűoEˆô“Ş‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/9/8), ź].

723773. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Œűo—pƒXƒeƒƒCƒhEƒOƒŠƒZƒŠƒ“Ź‡ŠÜšu‰t‚Ş‘tŒ÷‚ľ‚˝”S–Œ—DˆĘŒ^qíŤ“V•űávጂĚ1—á. ”g‘˝–ě‰l‘ž1, ´–ě—R”y1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć29‰ń“ú–{ŒűoEˆô“Ş‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/9/8), ź].

723774. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •@•Â‚É‚ć‚é“ú’†–°‹C‚Ě‹qŠĎ“I•]‰ż‚ĚŽŽ‚Ý. ‘ĺ–ŘŠ˛•ś1, —é–Ř—§r1, ’†ŔŽ‘ŽŔ1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć55‰ń“ú–{•@‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/14), ‰F“s‹{.

723775. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆę‘¤ŤăŠ{“´•a•Ď‚ĚŽčpƒ‹[ƒg‚ĆŽĄ—ÐŹŃ‚ĚŒŸ“˘. —é–Ř—§r1, V“c‹`—m1, ŽR‰ş@‘ń1, ‘ĺ–ŘŠ˛•ś1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć55‰ń“ú–{•@‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/14), ‰F“s‹{.

723776. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰îŒě˜Vl•ŰŒ’Ž{Ý“üŠŽŇ‚Ě•â’ŽŠíŽŽ’Ž (1)|•â’ŽŠí“K‡‚ĆŽŽ’Ž‚ĚŒ‹‰Ę|. ˆäă—ŠG1, —é–ŘŒbŽq2, ”~Œ´KŒb1, `@ŽáŘ2, ´…@•˝, ˛–ě@”Ł2, ‰Ş–{–ql3, ŽR‰ş@‘ń3 (1–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 2ˆă—ÉqśŠw•”, 3Ž¨•@ˆôAE“ŞčňŠO): ‘ć61‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/20), ˇ‰Ş.

723777. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰îŒě˜Vl•ŰŒ’Ž{Ý“üŠŽŇ‚Ě•â’ŽŠíŽŽ’Ž (2)|‘•—pŽžŠÔ‚̐„ˆÚ|. —é–ŘŒbŽq1, ˆäă—ŠG2, ”~Œ´KŒb2, `@ŽáŘ1, ´…@•˝, ˛–ě@”Ł1, ‰Ş–{–ql3, ŽR‰ş@‘ń3 (1ˆă—ÉqśŠw•”, 2–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 3Ž¨•@ˆôAE“ŞčňŠO): ‘ć61‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/20), ˇ‰Ş.

723778. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰îŒě˜Vl•ŰŒ’Ž{Ý“üŠŽŇ‚Ě•â’ŽŠíŽŽ’Ž—Í (3)|Ž–—á•ń|. ”~Œ´KŒb1, ˆäă—ŠG1, —é–ŘŒbŽq2, `@ŽáŘ2, ´…@•˝, ˛–ě@”Ł1, ‰Ş–{–ql3, ŽR‰ş@‘ń3 (1–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 2ˆă—ÉqśŠw•”, 3Ž¨•@ˆôAE“ŞčňŠO): ‘ć61‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/20), ˇ‰Ş.

723779. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŒy“xE’†“™“x“ď’ŽŽ™‚Ě•â’ŽŠí‘•—pŒo‰ß‚ĚŒŸ“˘. –q@“ÖŽq1, ’†ě‹Mm1, ˛–ě@”Ł2, ”~Œ´KŒb3, ˆäă—ŠG3, Œ´@—R‹I2, —é–ŘŒbŽq2, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞăřŠO, 2ˆă—ÉqśŠw•”, 3–k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č, 2ˆă—ÉqśŠw•”): ‘ć61‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/21), ˇ‰Ş.

723780. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Ë”­Ť“ď’Ž (Grade4) ‚ɑ΂ˇ‚éƒGƒ_ƒ‰ƒ{ƒ“ŒŰŽş“ŕ’“ü—Ă–@‚ĚŒŸ“˘. ’†ě‹Mm1, “n•Ó—T”V1, ˛–ě@”Ł2, –q@“ÖŽq1, Ź–ě—Yˆę, ’–@Œ’Žu1 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć61‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/21), ˇ‰Ş.

723781. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚鏬Ž™‚ß‚Ü‚˘Ç—á‚Ě—Ő°“IŒŸ“˘. —Ž‡@“Ö1, ’†ě‹M”V1, ’ˇŔ‰p–ž2 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć75‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/27), ‘ĺă.

723782. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚đ‹^‚Á‚˝’Ž_ŒoŽîá‡2—á. ’†ě‹M”V1, ’ˇŔ‰p–ž2, —Ž‡@“Ö1 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć75‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/27), ‘ĺă.

723783. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚Ě—ź‘¤‚Ě’Ž—Í•Ď“Ž•‚ɂ‚˘‚Ä‚ĚŒŸ“˘. V“c‹`—m1, ’†ŔŽ‘ŽŔ1, ’†ě‹M”V1, —Ž‡@“Ö1, ’ˇŔ‰p–ž2 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć75‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/27), ‘ĺă.

723784. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ÁŽź‚𒆐S‚Ć‚ľ‚˝ŒűoEˆô“ރPƒA‚̏d—vŤ|”ńŒoŒűŰŽćƒp[ƒLƒ“ƒ\ƒ“•aŠłŽŇ‚Ĺ‚ĚŒoŒą|. ’rŽR‡Žq, ˆäă´], Š‹ź”ü‰Á, ‚‹´—ˆĚŽq, ‚–ěˆ¤”ü, –q–슰”V1, –x“ŕœ¨”üŽq, ’J“ˆŽőXŽq, ’ˇ’JěˆęŽq2 (1Ž¨•@ˆôAE“ŞčňŠO, 2_Œo“ŕ): ‘ć70‰ń‘—§•a‰@‘‡ˆăŠw‰ď (2016/11/12), ‰Ť“ę.

723785. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) NBIŠg‘ĺ“ŕŽ‹‹ž‚É‚ć‚éA“Ş•a•Ď‚ĚŠŕE”ńŠŕ‚̊ӕʐf’f‚É‚¨‚Ż‚éˆŮíŒŒŠÇ‚Ě—L—pŤ. ×–ě_Žj1, Œ˜“ce—˜2, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ´–ě—R”y1, ‹{–{r•ă1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ): ‘ć68‰ń“ú–{‹CŠÇH“š‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/11/17), “Œ‹ž.

723786. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) H“šŠŕ‚ɑ΂ˇ‚éH“šˆŸ‘S“Ep‚Ěš‹‰ş‹@”\‚ւ̉e‹ż. ´–ě—R”y1, X’JGŒő2, —é–Ř—§r1, V“c‹`—m1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2ŠO‰Č): ‘ć68‰ń“ú–{‹CŠÇH“š‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/11/17), “Œ‹ž.

731157. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) HPV‚Ş•Ď‚Ś‚é’†ˆô“ŞŠŕf—Ă. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): ‘ć84‰ń‘Š•Ž¨•@‰ČŒ¤‹†‰ď (2016/4/2), ‘Š–Í‘ĺ–ě.

731158. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) HPVŠÖ˜A“Şčň•”Šŕ. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ďé‹ĘŒ§’n•ű•”‰ď (2016/10/16), ‰Y˜a.

731159. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “Şčň•”Šŕ‚Ě˜b‘č`ŽĄ—ĂŒÂ•Ę‰ť‚Ć‹@”\‰ˇ‘ś‚𒆐S‚Ɂ`. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď“Č–ŘŒ§’n•ű•”‰ď (2016/12/11), ‰F“s‹{.

732098. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒVƒƒƒ“ƒg”­şŽŇ‚ĚQOL’˛¸‚Ɖšş‹@”\. ŽR‰ş@‘ń1, ‰Ş•”‘•c1, ’J‡Mˆę2, •y“Ą‰ë”V2, r–؍Km2 (1Ž¨•@ˆôAE“ŞčňŠO, 2–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA): ‘ć9‰ńA“Ş‹@”\‰ˇ‘śŽĄ—ĂŒ¤‹†‰ď(2016/11/19), “Œ‹ž.

732099. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€)yˆô“ށEH“š—Ěˆć‚É‚¨‚Ż‚é‘˝”­ŠŕEd•ĄŠŕ‚̐f’f‚ĆŽĄ—Ă‚ĚŒť‹ľzčň•”Šŕ‚ƐH“šŠŕ‚Ě“ŻŽžŤd•ĄŠŕ‚ɑ΂ˇ‚鎥—Ă‚ÉŠÖ‚ˇ‚éŒă•űŽ‹“IŒŸ“˘. ‰Ş–{—ˇl1, Œ˜“ce—˜2, ‹{–{r•ă1, “c糁@‘2,3, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă: ‘ć103‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2016/12/17), “Œ‹ž, Progress of Digestive Endoscopy 2017; 90 (Suppl): s78.

733383. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚é“Şčň•”Šŕ‚Ě“ŕŽ‹‹ž“If’f‚ɂ‚˘‚Ä. ‰Ş–{—ˇl (Ž¨•@ˆôAE“ŞčňŠO): ‘ć84‰ń‘Š•Ž¨•@‰ČŒ¤‹†‰ď (2016/4/2), ‘Š–Í‘ĺ–ě.

733384. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •úŽËüŤŒűoˆô“Ş”S–Œ‰Š‚Ö‚Ě‘Îô. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): ‘ć16‰ń_“ސ쓪čň•”ŠŕƒtƒH[ƒ‰ƒ€ (2016/4/20), ‰Ą•l.

733385. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚鏬Šwś‚ĚƒƒjƒG[ƒ‹•a. —Ž‡@“Ö1, ’ˇŔ‰p–ž2, ’†ě‹M”V1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć17‰ń_“ސě‚ß‚Ü‚˘ƒtƒH[ƒ‰ƒ€ (2016/4/21), ‰Ą•l.

733386. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) HPVŠÖ˜A“Şčň•”Šŕ‚ĚĹ‹ß‚Ě˜b‘č. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): ‘ć25‰ńˆÇ—Ń‘ĺŠwŽ¨•@ˆôA‰Č•af˜AŒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/4/23), “Œ‹ž.

733387. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) œ]‹ČŒ^A“Ş‹ž‰ş‚É“Eo‚ľ‚˝‹›œˆŮ•¨‚Ěˆę—á. ”g‘˝–ě‰l‘ž1, ×–ě_Žj1, ´–ě—R”y1, V“c‹`—m1, —é–ŘˆťŽq1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć175‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2016/6/4), ‰Ą•l.

733388. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’†ˆô“ŞŠŕ`uHPVvŽž‘ă‚É‚¨‚Ż‚éŽčp‚Ě–đŠ„‚đ’†S‚Ɂ`. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): ‘ć43‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ďŠwpW‰ď (2016/6/18), ‰Ą•l.

733389. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é“Şčň•”•\ÝŠŕ‚ĚƒŠƒ“ƒpß“]ˆÚ‚ĚŒŸ“˘. ‰Ş–{—ˇl1, Œ˜“ce—˜2, ‹{–{r•ă1, ´–ě—R”y1, ‰Á”[Fˆę1, ˆęŒËš–ž3, ’ç@ăĕ˝1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3•a—): ‘ć17‰ń“Şčň•”•\ÝŠŕŒ¤‹†‰ď (2016/6/25), “Œ‹ž.

733390. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •a•ĎŒa‚Ş5 cm‚đ’´‚Ś‚é’†ˆô“Ş•\ÝŠŕ‚ɑ΂ľŒoŒű“IŽčp‚đŽ{s‚ľ‚˝ˆę—á. ‰Á”[Fˆę1, Œ˜“ce—˜2, ˆęŒËš–ž3, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ’ç@ăĕ˝1, ŽR‰ş@‘ń1, “c糁@‘4, Źň˜aŽO˜Y2 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3•a—, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć17‰ń“Şčň•”•\ÝŠŕŒ¤‹†‰ď (2016/6/25), “Œ‹ž.

733391. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •@oś—Šw‚Š‚ç‚Ý‚˝•@ŽžŠł‚¨‚ć‚ѐ‡–°ŒÄ‹záŠQ. ‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO): ‘ć123‰ń“úŽ¨•@é‹ĘŒ§’n•ű•”‰ďŠwpu‰‰‰ď (2016/6/26), ‰Y˜a.

733392. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č‚Ĺ‚ĚƒVƒ_ƒgƒŒƒ“Eƒ~ƒeƒBƒLƒ…ƒAŽĄ—Ă‚ÉŠÖ‚ľ‚Ä. —é–Ř—§r (Ž¨•@ˆôAE“ŞčňŠO): ‘Š–ÍŒ´ƒAƒŒƒ‹ƒQƒ“•×‹­‰ď (2016/6/30), ‘Š–ÍŒ´.

733393. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚éŸřoŤ’†Ž¨‰Š‚ɑ΂ˇ‚éŠO‰Č“I‰î“ü‚ĚŒŸ“˘. –ŕŽR•Ű (Ž¨•@ˆôAE“ŞčňŠO): ‘ć10‰ń‘Š–ÍŒ´DRIAOMSu‰‰‰ď (2016/7/5), ’Ź“c.

733394. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) wš‹‰şŽčp/Œëš‹–hŽ~x“–‰Č‚É‚¨‚Ż‚é“ŕŽ‹‹ž‰ş—֏óˆô“Ş‹ŘŘ’fp. ´–ě—R”y (Ž¨•@ˆôAE“ŞčňŠO): ‘ć29‰ń_“ŢěŒ§Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŽčpŽč‹ZŒ¤‹†‰ď (2016/7/14), ‰Ą•l.

733395. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) …“—‘яóáv]ƒEƒBƒ‹ƒX‚É‚ć‚é‘˝”­”]_Œo–ƒáƒ‚Ě1—á. ’ç@ăĕ˝1, —é–ŘˆťŽq1, ‘ĺŒ´‘ěĆ1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć176‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2016/9/3), ‰Ą•l.

733396. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠO—ˆ‚ĹŒÄ‹z’âŽ~‚đ—ˆ‚ľ‚˝‹}ŤA“ŞŠW‰Š‚Ěˆę—á. “n•Ó—T”V1, ’–@Œ’Žu1, ’ˇ’J•”ł”V1, ”g‘˝–ě‰l‘ž1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć176‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2016/9/3), ‰Ą•l.

733397. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’´‚—îŽĐ‰ď‚É‚¨‚Ż‚é’ŽŠoáŠQ‚Ě–â‘č“_, —v‰îŒě‚—îŽŇ‚Ö‚Ě•â’Ž. ˛–ě@”Ł (ˆă—ÉqśŠw•”): ‘ć10‰ń“ż“‡Ž¨•@ˆôA‰ČŠO—ˆf—ĂŒ¤‹†‰ď (2016/10/2), “ż“‡.

733398. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “Şčň•”Šŕ‚ɑ΂ˇ‚錌´midkine‘Ş’č‚ĚˆÓ‹`. ŽR‰ş@‘ń1, ‰–’J˛_2, “‡“c‰pş3 (1Ž¨•@ˆôAE“ŞčňŠO, 2–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA‰Č, 3“Œ–M‘ĺŠwˆăŠw•”ŠO‰ČŠwuŔ): ‘ć36‰ń“ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď (2016/10/5), ‰Ą•l.

733399. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘O’됅ŠÇŠg‘ĺÇ‚Ě’ˇŠúŒo‰ßŠĎŽ@‚މ”\‚Ĺ‚ ‚Á‚˝3Ç—á‚ɂ‚˘‚Ä. ‘ĺ‹´Œ’‘ž˜Y1, ’†ŔŽ‘ŽŔ1, ‘ĺ–ŘŠ˛•ś1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć124‰ń“úŽ¨•@é‹ĘŒ§’n•ű•”‰ďŠwpu‰‰‰ď (2016/10/16), ‰Y˜a.

733400. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •@ƒAƒŒƒ‹ƒM[E‰Ô•˛Ç‚Ě–ň•¨ŽĄ—Ă. ‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO): ‘ć2‰ńé‹ĘŒ§Œ§‰›’nˆćŽ¨•@ˆôA‰ČŒ¤‹†‰ď (2016/11/2), –k–{.

733401. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) dÇSgáŠQŽ™EŽŇ‚Ěˆă—Ă1 (‹CŠÇŘŠJ‚ɂ‚˘‚Ä). ‘ĺŒ´‘ěĆ (Ž¨•@ˆôAE“ŞčňŠO): •˝Ź28”N“x‘Š–ÍŽsdÇSgáŠQŽ™ (ŽŇ) ŠĹŒěŒ¤CŽ–‹Ć (2016/11/5), ‘Š–ÍŒ´.

733402. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •úŽËüŤŒű“ŕ‰Š‚ɑ΂ˇ‚锟‰ÄŕbS“’ŽĄ—Á|Šî‘b‚Š‚ç—Տ°‚܂Ł|. ŽR‰ş@‘ń (Ž¨•@ˆôAE“ŞčňŠO): V“sSKAMPOƒtƒH[ƒ‰ƒ€ (2016/11/10), “Œ‹ž.

733403. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚đ‹^‚Á‚˝’Ž_ŒoŽîᇏǗá. ’†ě‹M”V (Ž¨•@ˆôAE“ŞčňŠO): ‘Š–ÍŒ´Ž¨•@‰Čˆă‰ďŠwpu‰‰‰ď (2016/11/24), ‘Š–Í‘ĺ–ě.

733404. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •a•ĎŒa‚Ş5 cm‚đ’´‚Ś‚é’†ˆô“Ş•\ÝŠŕ‚ɑ΂ľŒoŒű“IŽčp‚đŽ{s‚ľ‚˝ˆę—á. ‰Á”[Fˆę1, ‹{–{r•ă1, Œ˜“ce—˜2, ‰Ş–{—ˇl1, ´–ě—R”y1, ’ç@ăĕ˝1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć177‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2016/12/3), ‰Ą•l.

733405. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚éŸřoŤ’†Ž¨‰Š‚ɑ΂ˇ‚éŠO‰Č“I‰î“ü‚ĚŒŸ“˘. –ŕŽR•Ű1, –q@“ÖŽq1, ‘ĺŒ´‘ěĆ1, ŒĂ–ŘČŒá1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć177‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2016/12/3), ‰Ą•l.

733406. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘ĺ—Ę‚Ěˆô“ޏoŒŒ‚đ—ˆ‚ľ‚˝‹}Ť‘ĺ“Ž–Ź‰đ—Ł‚Ěˆę—á. —é–ŘˆťŽq1, ‘ĺŒ´‘ěĆ1, –ŕŽR•Ű1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć178‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2017/3/25), ‰Ą•l.

733407. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ˆô“Ş’É, ”­”M‚đŽĺ‘i‚É—ˆ‰@‚ľ, f’f‚É‹ę—ś‚ľ‚˝ƒ}ƒCƒRƒvƒ‰ƒYƒ}Š´őÇ‚Ěˆę—á. ‹{‰şŒ\ˆę1, ‰iˆä_–¤1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć178‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2017/3/25), ‰Ą•l.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-110022. [Œ´’˜] Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma. Yamashita T1, Shimada H2, Tanaka S3, Araki K3, Tomifuji M3, Mizokami D3, Tanaka N3, Kamide D3, Miyagawa Y3, Suzuki H3, Tanaka Y3, Shiotani A3: Cancer Med. 2016/3; 5 (3): 415-25. (ŽR‰ş@‘ń1, “‡“c‰pş2, “c’†LŒá3, r–؍Km3, •y“Ą‰ë”V3, aă‘ĺ•ă3, “c’†L–ž3, ăo‘ĺ‰î3, ‹{ě‹`O3, —é–؁@—m3, “c’†—Y–ç3, ‰–’J˛_3: 1Ž¨•@ˆôAE“ŞčňŠO, 2“Œ–M‘ĺŠwˆăŠw•”ŠO‰Č, 3–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA)

H27-120003. [Œ´’˜] “ŕŽ‹‹ž•â•‰şŒoŒűŠW–@‚É‚ć‚éÄ”­ăˆô“ŞŠŕ‚̐؏œ. ‹{–{r•ă1, ’†ŽR–žm, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): “Şčň•”ŠO‰Č 2015; 25 (3): 365-72.

H27-520001. [‘ŕ]y—Տ°ƒ~ƒjƒZƒ~ƒi[: f’f‚ĆŽĄ—Ă‚ĚƒRƒczŒoŒű“Iˆô“ŞŠŕŘœp: inside out anatomy‚Š‚猊‚˝Žč‹Z‚ĚƒRƒc@Transoral Videolaryngoscopic Surgery‚É‚¨‚Ż‚éˆôA“Ş“ŕo‚Š‚ç‚̉đ–U. •y“Ą‰ë”V1, ŽR‰ş@‘ń2, r–Ř Km1, ‰–’J ˛_1 (1–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA, 2Ž¨•@ˆôAE“ŞčňŠO):ŒűoEˆô“މČ2016/3; 29 (1): 63-9.

H27-522008. [uŔ]y“ÁW: ‰şˆô“ށEčň•”H“š•\ÝŠŕ‚Ě“ŕŽ‹‹žf’f‚ĆŽĄ—ÁzŒoŒű“I‰şˆô“Ş•”•ŞŘœpŒă‚̉šş‹@”\ŒP—ű‚Ɖşˆô“ލA“Ş‘S“EŒă‚̉šşÄŒš. ŽR‰ş@‘ń1, ’J‡Mˆę2, ‰–’J˛_2 (1Ž¨•@ˆôAE“ŞčňŠO, 2–h‰qˆă‰Č‘ĺŠwZŽ¨•@ˆôA): Á‰ťŠí“ŕŽ‹‹ž 2016/1; 28 (1): 130-8.

[Šw‰ďEŒ¤‹†‰ď“™]

H27-733010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒAƒŒƒ‹ƒM[Ť•@‰Š‚Ć“–‰@‚Ĺ‚ĚŽĄ—Ă. ’–@Œ’Žu (Ž¨•@ˆôAE“ŞčňŠO): ‘ć31‰ńŽs–ŻŒ’N‹łˆçŒöŠJuŔ (2016/1/25), ‘Š–ÍŒ´.


¸_‰ČŠw

[Šwp˜_•ś]

110275. [Œ´’˜] Relationship between xerostomia and psychotropic drugs in patients with schizophrenia: evaluation using an oral moisture meter. Okamoto A, Miyachi H1, Tanaka K2, Chikazu D, Miyaoka H1: J Clin Pharm Ther 2016/12; 41 (6): 684-8. (‹{’n‰p—Y1, “c’†Žr2, ‹{‰Ş@“™1: 1¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110276. [Œ´’˜] Changes in job stress and coping skills among caregivers after dementia care practitioner training. Takizawa T1, Takahashi M2, Takai M, Ikeda T, Miyaoka H2: Psychogeriatrics 2017/1; 17 (1): 52-60. (‘ęŕV‹B–î1, ‚‹´@Œb2, ‹{‰Ş@“™2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2¸_)

110277. [Œ´’˜] Which assessment tool is most useful to diagnose adult autism spectrum disorder? Inoue K1, Tsuzaki S2, Suzuki S3, Takizawa T3, Miyaji S1, Miyachi H1, Uematsu M2, Miyaoka H1: Kitasato Med J 2017/3; 47 (1): 26-30. (ˆäăŸ•v1, ’ÍčS–ç2, —é–ؐÎq3, ‘ęŕV‹B–î3, ‹{’nLŒá1, ‹{’n‰p—Y1, Aź”ü”ż2, ‹{‰Ş@“™1: 1¸_, 2–k—˘‘ĺŠw“Œ•a‰@S—ƒJƒEƒ“ƒZƒŠƒ“ƒOŽş, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110278. [Œ´’˜] The relationship between organizational justice and work stress among nurses in a general hospital. Suzuki S1, Kamata N2, Araki M1, Oshima Y1, Tanaka M3, Miyaoka H2: Kitasato Med J 2017/3; 47 (1): 71-7. (—é–ؐÎq1, Š™“c’źŽ÷2, r–؁@Œő1, ‘哇—TŽq1, “c’†”ü‰Á3, ‹{‰Ş@“™2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2¸_, 3ŠĹŒěŠw•”)

120038. [Œ´’˜] ƒsƒƒJƒ‹ƒsƒ““Š—^‚É‚ć‚č‚Ä‚ń‚Š‚ń—l”­ě‚ވř‚Ť‹N‚ą‚ł‚ę‚˝ƒ}ƒEƒX‚Ě”]“ŕƒ‚ƒmƒAƒ~ƒ“‚Ě“Ž‘Ԃ̉đ–ž. ”Ń“c—@‹X (¸_): ˆä”V“Ş•a‰@Œ¤‹†ŠT—v•˝Ź27”N“x 2016/12: 64-8.

522107. [uŔ]y“ÁW (‘ć16‰ńŠwpW‰ď): ƒVƒ“ƒ|ƒWƒEƒ€11z[Ŕ’k‰ď] ¸_ŽžŠłƒPƒA‰ÂŽ‹‰ť‚Ö‚Ě’Ş—Ź`ƒuƒŒƒCƒNƒXƒ‹[‚ĚŒŽ‚đ’T‚é`. ’†ˆä”ü•ä, Źź•q˜Y, •Ÿ“c—S“T, ‘ĺÎ@’q1, ‰ş‘ş—TŒŠŽq2 (1¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{ƒNƒŠƒeƒBƒJƒ‹ƒpƒXŠw‰ďŽ 2016/9; 18 (3): 241-8.

522108. [uŔ]y“Á•ĘŠé‰ć: Žq‚Ç‚ŕ‚Ě–ň•¨—Ă–@@”Y‚ń‚žŽ–—á‚đ’Ę‚ľ‚čl‚Ś‚éz‘˜_: ‘ĺl‚̐¸_‰Čˆă‚Š‚ç‚Ý‚˝Žq‚Ç‚ŕ‚̐¸_‰Č–ň•¨—Ă. ‹{‰Ş@“™ (¸_): ‚ą‚ą‚ë‚̉Ȋw 2016/11; 190: 16-20.

522109. [uŔ]y“Á•ĘŠé‰ć: Žq‚Ç‚ŕ‚Ě–ň•¨—Ă–@@”Y‚ń‚žŽ–—á‚đ’Ę‚ľ‚čl‚Ś‚ézŽ–—á‚đ’Ę‚ľ‚čl‚Ś‚é: Ž„‚Í‚˘‚‚ŕ–Ŕ‚Á‚Ä‚˘‚é. ‚ž‚Š‚ç, ‚˘‚Â‚ŕŠłŽ™‚Š‚ç‹ł‚í‚Á‚Ä‚˘‚é. ˆäăŸ•v (¸_): ‚ą‚ą‚ë‚̉Ȋw 2016/11; 190: 67-71.

522110. [uŔ]y“ÁW: ‚Ç‚¤‚ˇ‚é? ƒƒ“ƒ^ƒ‹‚Č–â‘č@¸_Çó‚ɑ΂ľ‚Ä“ŕ‰Čˆă‚Ş‚Ĺ‚Ť‚é‚ą‚ƁzEditorial: “ŕ‰Č‚É‚¨‚Ż‚郁ƒ“ƒ^ƒ‹‚Č–â‘č‚̍l‚Ś•ű‚ƑΉž. ‹{‰Ş@“™ (¸_): medicina 2016/11; 53 (12): 1887-9.

522111. [uŔ]y“ÁW: ‚Ç‚¤‚ˇ‚é? ƒƒ“ƒ^ƒ‹‚Č–â‘č@¸_Çó‚ɑ΂ľ‚Ä“ŕ‰Čˆă‚Ş‚Ĺ‚Ť‚é‚ą‚ƁzŠłŽŇ‚â‰Ć‘°‚Ě˜b‚Š‚烁ƒ“ƒ^ƒ‹‚Č–â‘č‚đl‚Ś‚˝Žž:uˆăŠw“I‚É‰đŒˆ‚ˇ‚ׂŤv‚ĆŒž‚˘Ř‚ę‚Č‚˘–â‘č‚đ‘Š’k‚ł‚ę‚˝. ”Ń“c—@‹X1, ‘ĺÎ@’q1 (1¸_): medicina 2016/11; 53 (12): 1979-82.

522112. [uŔ]y“ÁW: ‚Ç‚¤‚ˇ‚é? ƒƒ“ƒ^ƒ‹‚Č–â‘č@¸_Çó‚ɑ΂ľ‚Ä“ŕ‰Čˆă‚Ş‚Ĺ‚Ť‚é‚ą‚Ɓz¸_Çó‚ɑΉž‚ˇ‚é‚˝‚ß‚Ě’mŽŻEl‚Ś•ű: g‘̂Ɛ¸_‚Ě‹ŤŠE—Ěˆć•a–ź‚̐f’f‚ƍ’m‚ÉŠÖ˜A‚ˇ‚é–â‘č. ‹{’n‰p—Y (¸_): medicina 2016/11; 53 (12): 2002-5.

522113. [uŔ]y“ÁW: ‚Ç‚¤‚ˇ‚é? ƒƒ“ƒ^ƒ‹‚Č–â‘č@¸_Çó‚ɑ΂ľ‚Ä“ŕ‰Čˆă‚Ş‚Ĺ‚Ť‚é‚ą‚Ɓz¸_Çó‚ɑΉž‚ˇ‚é‚˝‚ß‚Ě’mŽŻEl‚Ś•ű: ¸_‰Čˆă‚Ě‘I‚Ń•ű. ‹{‰Ş@“™ (¸_): medicina 2016/11; 53 (12): 2011-3.

522114. [uŔ]yƒVƒ“ƒ|ƒWƒEƒ€5z‘ĺl‚ĚŽŠ•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ|–k—˘‘ĺŠw‚É‚¨‚Ż‚éf’f‚ĆŽx‰‡. ˆäăŸ•v (¸_): ŠO—ˆ¸_ˆă—Ă 2017/1; 17 (1): 55-7.

522115. [uŔ] Ž‘—ż: “d‹C‚Ż‚˘‚ę‚ń—Ă–@ƒNƒŠƒjƒJƒ‹ƒpƒX‰ü’č‚ĚŽć‚č‘g‚݁|‚ć‚čˆŔ‘S‚Ĺ“KŘ‚ČŽ{s‚đ–ÚŽw‚ľ‚ā|. ‰ş‘ş—TŒŠŽq1, ŕVŽRŒb”g2, ‰ÄŽR@‘ě1, ‹{’nLŒá3, ŒË“c‰ë–ç4, ŽRŒű–žŽq5, “c‘ş‘ń–˛5, ŠÖX‘쉛5, ´@„Žm5, —é–؁@‘đ5, –{‘˝—]5, ‘ĺÎ@’q3, ‹{‰Ş@“™3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Œ’NŠÇ—ƒZ, 3¸_, 4–ƒŒ, 5“Œ•a‰@ŠĹŒě•”): ¸_‰ČŽĄ—ĂŠw 2017/2; 32 (2): 265-70.

522116. [uŔ]y˜AÚ‘ć2‰ń: ”F’mÇ‚̐f’f‚Ć‚Ć‚ŕ‚ÉŠłŽŇ‚ł‚ń‚É“`‚Ś‚˝‚˘‚ą‚Ɓzu”F’mÇ‘Šú”­ŒŠE‘ŠúŽĄ—Áv‚đŠú‘Ň‚ľ‚Ä—ˆ‰@‚ľ‚˝l‚ƉƑ°‚É“`‚Ś‚˝‚˘‚ą‚Ć. ‘ĺÎ@’q (¸_): Modern Physician 2017/2; 37 (2): 211-5.

522117. [uŔ]y˜AÚ‘ć3‰ń: ”F’mÇ‚̐f’f‚Ć‚Ć‚ŕ‚ÉŠłŽŇ‚ł‚ń‚É“`‚Ś‚˝‚˘‚ą‚ƁzuMCIv‚đl‚Ś‚˝Žž‚É—ˆ‰@‚ľ‚˝l‚ƉƑ°‚É“`‚Ś‚˝‚˘‚ą‚Ć. ‘ĺÎ@’q (¸_): Modern Physician 2017/3; 37 (3): 299-303.

522118. [uŔ]y“ÁW: áŠQŽŇ—‰đ‚Ć“Á•ĘŽx‰‡‹łˆçzŽ‹“_4: ”­’BáŠQŽŇ‚ވř‚Ť‹N‚ą‚ˇ“ńŽŸáŠQ‚Ö‚ĚƒPƒA‚ĆƒTƒ|[ƒg‚Ć‚ť‚Ě‘O’ń. ˆäăŸ•v (¸_): ŠwZ‰^‰c 2017/3; 58 (12): 24-7.

[’˜@‘]

620152. [Šwp‘ (•Ş’SŽˇ•M)]y¸_‰ČŒ¤Cƒm[ƒg@‰ü’č‘ć2”Łz‘ć2Í ¸_‰ČŒ¤C‚Ĺƒ}ƒXƒ^[‚ˇ‚ׂŤ‚ą‚Ɓ@C –ʐځE•]‰ż•ű–@@1. –ʐڂ̋Z–@Eƒ}ƒi[, p.142-4. ‹{‰Ş‰ŔŽq, ‹{‰Ş@“™1 (1¸_), ƒVƒŠ[ƒY‘ŠÄC: ‰iˆä—ÇŽO, •Ň: Š}ˆä´“o, ŽO‘ş@›’, ‘şˆärĆ, ‰Ş–{‘׏š, ‹ß“ĄL‰î, ‘哇‹Il, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/4”­s.

620153. [Šwp‘ (•Ş’SŽˇ•M)]y’nˆć•ďŠ‡ƒPƒA‚ĆƒNƒŠƒeƒBƒJƒ‹ƒpƒXz‘ć4Í ”F’mÇ‚Ě’nˆć˜AŒg‚ĆƒNƒŠƒeƒBƒJƒ‹ƒpƒX, p.21-5. ‘ĺÎ@’q (¸_), Šé‰ć: ‹{č‹v‹`, ’†ŠOť–ň, “Œ‹ž, 2016/4”­s.

620154. [Šwp‘ (•Ş’SŽˇ•M)]yŒö”FS—Žt•KŒg@¸_ˆă—ÁE—Տ°S—‚Ě’mŽŻ‚Ć‹Z–@z‘ć2•” ¸_ˆă—Ă‚ĚŠî–{@‘ć5Í f’f‚Ć‚ť‚ĚŒo‰ß@’˜”j‰ó“IEŐ“Ž§ŒäE‘fsÇŒQ, p.99-100. ˆäăŸ•v (¸_), •Ň: ‰şŽR°•F, ’†“ˆ‹`•ś, ˆăŠw‘‰@, “Œ‹ž, 2016/9”­s.

620155. [Šwp‘ (•Ş’SŽˇ•M)]y¸_ˆăŠwƒeƒLƒXƒg ‰ü’ů‘ć4”Ł@¸_áŠQ‚Ě—‰đ‚ĆŽĄ—Ă‚Ě‚˝‚߂ɁzII ¸_áŠQ‚Ě—‰đ‚Ě‚˝‚ß‚Ě’mŽŻ@B. “ŕˆöŤ‚̐¸_áŠQ@2. “‡Ž¸’˛Œ^áŠQ‚Ć–Ď‘zŤáŠQ, p.165-9. âV“Ął”Í (¸_), •Ň: ă“‡‘—˜, —§ŽRäݗ˘, ŽO‘ş@Ť, “ě]“°, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713140. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Trial Use of Aripiprazole for Severe Hyperacusis with Autism Spectrum Disorder -Case Report-. Inoue K1, Kamitani S2, Miyaoka H1: ‘ć22‰ń‘ŰŽ™“śÂ”N¸_ˆăŠw‰ď‹c (IACAPAP2016) (2016/9/22), Calgary, Canada. (ˆäăŸ•v1, _’Jr‰î2, ‹{‰Ş@“™1: 1¸_, 2’nˆćˆă—и_)

722231. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŽŠ•ÂƒXƒyƒNƒgƒ‰ƒ€Ç‚Ě—Ő°ŽŔ‘H|‰ßčf’f‚Ɛf’fŒŠ“Ś‚ľ‚ĚƒWƒŒƒ“ƒ}‚Ě’†‚ŁzŽŠ•ÂƒXƒyƒNƒgƒ‰ƒ€Ç‚̐f’f‚É‚¨‚Ż‚éć“üŠĎ‚̍Ž•ž. ˆäăŸ•v (¸_): ‘ć112‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2016/6/2), ç—t.

722232. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ƒ\[ƒVƒƒƒ‹EƒXƒLƒ‹ƒYEƒgƒŒ[ƒjƒ“ƒO (SST) ‚đŽY‹Ć¸_•ŰŒ’‚É‚˘‚Š‚ˇ. ‚‹´@Œb (¸_): ‘ć112‰ń“ú–{¸__ŒoŠw‰ď (2016/6/3), ç—t.

722233. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ŒűL‚Ö‚ĚS‚č‚đ‚Ç‚¤•]‰ż‚ľ‘Ήž‚ˇ‚é‚Š|–âf‚̐i‚ß•űEŒŸ¸|. ‹{’n‰p—Y (¸_): ‘ć7‰ń“ú–{ŒűLŠw‰ďŠwp‘ĺ‰ď (2016/6/18), ˆ¤’m.

722234. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€ƒR[ƒfƒBƒl[ƒ^) y‘ĺl‚ĚŽŠ•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQz–k—˘‘ĺŠw‚É‚¨‚Ż‚éf’f‚ĆŽx‰‡. ˆäăŸ•v (¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/9), ‰Ą•l.

722235. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€ƒR[ƒfƒBƒl[ƒ^)y‘ĺl‚ĚŽŠ•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ‚̐f—Ă‚É‚¨‚˘‚ÄŠO—ˆ‚Ő¸_‰Čˆă‚ŞŽŔŽ{‚ˇ‚ׂŤŽ–€z‘­ŕEŒë‰đ‚Ě‘Ĺ”j. ˆäăŸ•v (¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/9), ‰Ą•l.

722236. [Šw‰ď (‘S‘)] (‰ď’ˇu‰‰) ŠO—ˆ¸_ˆă—Ă‚Ö‚ĚŠú‘ҁ|“§–ž‰ť‚Ć•W€‰ť‚Ě‚˝‚߂Ɂ|. ‹{‰Ş@“™ (¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/10), ‰Ą•l.

722237. [Šw‰ď (‘S‘)] (‘Î’k) ƒ}ƒXƒƒfƒBƒA‚Ɛ¸_‰Čˆă. ŽRƒŠƒJ, ‹{‰Ş@“™1 (1¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/10), ‰Ą•l.

722238. [Šw‰ď (‘S‘)] (Žs–ŻŒöŠJuŔ)yŽs–ŻŒöŠJuŔ1z¸_‰Čˆă‚đ‚Ç‚¤‘I‚Ô‚Š. ‹{‰Ş@“™ (¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/10), ‰Ą•l.

722239. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ‰‰ń–ʐڂ̐S“ž. ˆäăŸ•v (¸_): ‘ć19‰ń“ú–{ŹŽ™¸_ˆăŠwŒ¤‹†‰ď‹łˆçƒZƒ~ƒi[ (2016/8/19), _ŒË.

722240. [Šw‰ď (‘S‘)] (‰ď’ˇu‰‰) ƒXƒ|[ƒc¸_ˆăŠw‚ĚŠˆ‚Š‚ľ•ű`‚ł‚ç‚Č‚é”­“W‚Ě‚˝‚߂Ɂ`. ‹{‰Ş@“™ (¸_): ‘ć14‰ń“ú–{ƒXƒ|[ƒc¸_ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/9/3), “Œ‹ž.

722241. [Šw‰ď (‘S‘)] (‹łˆçu‰‰)yŠî–{‚Š‚çŠw‚ÔŽ™“śÂ”N¸_ˆăŠw (fŽ@E•a—đ‚ĚŽć‚č•ű)z¸_ˆăŠw‘ĚŒn‚ÉŠî‚Ă‚˘‚˝‰‰ń–ʐڂ̐S“žE’mŽŻ‚Ć‚ť‚ĚŽŔ‘H. ˆäăŸ•v (¸_): ‘ć57‰ń“ú–{Ž™“śÂ”N¸_ˆăŠw‰ď‘‰ď (2016/10/27), ‰ŞŽR.

723787. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”­’BáŠQŽ™‚É‚¨‚Ż‚é“ǂݏ‘‚Ť”\—͂ɂ‚˘‚Ä (3): ‘ŽšŒŸ¸‚Ě•ŞÍ. ŽÄ@—ćŽq, ˆäăŸ•v1, ˜a“c^—Žq, “ĄŒ´‰Á“ލ], Ź‘ň@_ (1¸_): ‘ć42‰ń“ú–{ƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQŠw‰ďŠwpu‰‰‰ď (2016/5/14), ç—t.

723788. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œö—§Ź’†ŠwZ‹łEˆő‚̐¸_•ŰŒ’‰‡•‚É‚¨‚Ż‚鐸_‰Čˆă‚Ć•ŰŒ’Žt‚Ě˜AŒg. ‘ĺÎ@’q1, Š™“c’źŽ÷1, “ńˆä–îˆťŽq, ‹{’nLŒá1, ’†“‡LŽq, ‘ĺX^‹|, “c’†Žr2, ‹{‰Ş@“™1 (1¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć112‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2016/6/2), ç—t.

723789. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—îŽŇ‚Ě–]‚Ţˆă—ĂƒVƒXƒeƒ€\’z‚ÉŠÖ‚ˇ‚錤‹† ‘ć1•ń@’nˆćZ–Ż‚ĚƒŠƒrƒ“ƒOƒEƒBƒ‹‚ÉŠÖ‚ˇ‚é—\”ő’˛¸. ‚‹´@Œb1, ”ŃƒP’J”ü•ô2, —L“c‰xŽq, ‘şč”ü˜a, ˆŔ’B—ŕ‰š“Ţ, Îˆä—Y‹g (1¸_, 2_Œo“ŕ): ‘ć31‰ń“ú–{˜V”N¸_ˆăŠw‰ď (2016/6/24), ‹ŕ‘ň.

723790. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ¸_‰ČŠO—ˆ‰fŠłŽŇ‚É‚¨‚Ż‚éQT‰„’ˇ‚Ě—L–ł‚ÉŠÖ‚ˇ‚é’˛¸•ń. ŸNˆäGŽ÷1, ‘ĺÎ@’q1, ‘ęŕV‹B–î2, ‹{’nLŒá1, ‹{‰Ş@“™1 (1¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/9), ‰Ą•l.

723791. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Źl‚ĚŽŠ•ÂƒXƒyƒNƒgƒ‰ƒ€Çf’f‚É‚¨‚Ż‚éS—ŒŸ¸‚Ě—L—pŤ|WAIS-III, L”ĐŤ”­’BáŠQ“ú–{ŽŠ•ÂÇ‹Ś‰ď•]’čŽÚ“x (PARS), AQ“ú–{Œę”Ł|. ’Ăř“S–ç, ˆäăŸ•v1, ‹ů’J”ü‰Ř, źě@‰p, ’Ăř“–ƒˆß, Aź”ü”ż (1¸_): “ú–{S——Տ°Šw‰ď‘ć35‰ńH‹G‘ĺ‰ď (2016/9/5), ‰Ą•l.

723792. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Rey-Osterrieth•ĄŽG}Œ`ŒŸ¸|”˝‰ž}‚Ě—ŢŒ^‚Ć36“_–@‚ĚŠÖ˜A. ˆäăŸ•v1, ˜a“c^—Žq (1¸_): “ú–{S——Տ°Šw‰ď‘ć35‰ńH‹G‘ĺ‰ď (2016/9/5), ‰Ą•l.

723793. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Rey-Osterrieth•ĄŽG}Œ`ŒŸ¸|”˝‰ž}‚Ě—ŢŒ^•Ď‰ť‚Ć”F’m“ÁŤ. ˜a“c^—Žq, ˆäăŸ•v1 (1¸_): “ú–{S——Տ°Šw‰ď‘ć35‰ńH‹G‘ĺ‰ď (2016/9/5), ‰Ą•l.

723794. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒh[ƒpƒ~ƒ“D3ƒŒƒZƒvƒ^[‚̓}ƒEƒX‚Ě“Á’č‚Ě•sˆŔ—ls“Ž‚ÉŠÖ—^‚ľ‚Ä‚˘‚é. ”Ń“c—@‹X1, Ź“‡Fm, ‰iŽR”Ž’Ę, “c’†@—Á, X“ŕ—I‘ž, “n•Ó@Ž 2, ŽRX‘D3, ”‘q@˝3, ů‰Şr–M, ‹{‰Ş@“™1, ‚‹´łg (1¸_, 2ś•¨•¨—Œn, 3ś‰ť): ‘ć59‰ń“ú–{_Œo‰ťŠw‰ď‘ĺ‰ď (2016/9/8), •Ÿ‰Ş.

723795. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇ‚Ě’ŽŠo‰ß•q‚đ’ć‚ľ‚˝ŽŠ•ÂƒXƒyƒNƒgƒ‰ƒ€ÇÂ”NŠúÇ—á‚Ö‚Ě–ň—|S—|ŽĐ‰ď“I‰‡•. ˆäăŸ•v1, _’Jr‰î2, ‹{‰Ş@“™1 (1¸_, 2’nˆćˆă—и_): ‘ć57‰ń“ú–{Ž™“śÂ”N¸_ˆăŠw‰ď‘‰ď (2016/10/28), ‰ŞŽR.

723796. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŽi‰ďzŠO—ˆE“ü‰@“Œv. ˆäăŸ•v (¸_): ‘ć57‰ń“ú–{Ž™“śÂ”N¸_ˆăŠw‰ď‘‰ď (2016/10/29), ‰ŞŽR.

723797. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) yˆę”ʉ‰‘čŔ’ˇz •p‰ń‚Čšq“f‚Ć‘ĚdŒ¸­‚đŽĺ‘i‚É—ˆ‰@‚ľ‚˝11Î’jŽ™‚ɑ΂ľ‚Ä—Í“Ž“IƒAƒvƒ[ƒ`‚đs‚¤‚ą‚Ć‚ĹÇó‰ü‘P‚ƉƑ°ŠÖŒW‚Ě•Ď—e‚đ”F‚ß‚˝1—á. ˆäăŸ•v (¸_): ‘ć34‰ń“ú–{Â”NŠú¸_—Ă–@Šw‰ď‘‰ď (2016/11/20), ŒF–{.

723798. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”F’mÇ‰îŒěŠÇ—ŽŇŒ¤C‘OŒă‚É‚¨‚Ż‚é‰îŒěEˆő‚̐E‹ĆƒXƒgƒŒƒX‚ĆƒR[ƒsƒ“ƒOƒXƒLƒ‹‚̕ωť. ‘ęŕV‹B–î1, ‚‹´@Œb2, ‹{‰Ş@“™2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2¸_): ‘ć35‰ń“ú–{”F’mÇŠw‰ďŠwpW‰ď (2016/12/1), “Œ‹ž.

731160. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”F’mÇ‚Ě—‰đ‚Ɖ‡•|–ňÜŽt‚É‹‚ß‚ç‚ę‚é˜AŒg|. ‘ĺÎ@’q (¸_): ‘ć46‰ń’nˆć¸_•a‰@–ňÜŽtŒ¤‹†‰ď (2016/6/17), ’Ź“c.

731161. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŠO‰Čˆă‚ޏo‰ď‚¤¸_Çó‚Ɛ¸_‰Č–ň‚ĚŽg‚˘•ű|‚š‚ń–Ď‚Ć‚¤‚Â‚ĚŒ´ˆö‚Ć‘Îô|. ‹{‰Ş@“™ (¸_): ‘ć28‰ńěŒ§ŠO‰Čˆă‰ďE“ú–{—Տ°ŠO‰ČŠw‰ďěŒ§Žx•”‰ď (2016/11/12), ě.

731162. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žq‚Ç‚ŕ‚̐S‚Ě—Ő°ŽŔ‘H‚Ĺ‚ĚH•v‚Ć—ŻˆÓ. ˆäăŸ•v (¸_): ‘ć37‰ńL“‡Ž™“śÂ”N¸_ˆăŠwŒ¤‹†‰ď (2017/1/28), L“‡.

731163. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzƒŠƒGƒ]ƒ“EƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“‚Ě–â‘č“_. ‹{’n‰p—Y (¸_): ‘ć44‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ďƒvƒƒOƒ‰ƒ€ (2017/3/18), ‰Ą•l.

732100. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇzŠÉ˜aƒPƒA‚ĚŒťó‚Ć“W–]. ˆî–{~Žq, ‹{’n‰p—Y1 (1¸_): ‘ć43‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/9/10), ‰Ą•l.

733408. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”­’BáŠQŽ™‚É‚¨‚Ż‚銿Žš‘Žš‚ĚŒë”˝‰ž•ŞÍ|”F’m“ÁŤ‚Ć‚ĚŠÖ˜A|. ŽÄ@—ćŽq, ˜a“c^—Žq, ˆäăŸ•v1, “ĄŒ´‰Á“ލ], Ź‘ň@_ (1¸_): ‘ć16‰ń”­’BŤƒfƒBƒXƒŒƒNƒVƒAŒ¤‹†‰ď (2016/7/2), ‹ŕ‘ň.

733409. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Œü¸_–ň‚ĆOTCˆă–ň•i‚ŞŠÖ˜A‚ľ‚˝‹}Ťö—ó‘Ô‚đ’ć‚ľ‘[’u“ü‰@‚ÉŽŠ‚Á‚˝1Ç—á. ‹´–{@Ž÷1, ŸNˆäGŽ÷1, ‹{’nLŒá1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_): “Œ‹ž¸_ˆăŠw‰ď‘ć107‰ńŠwpW‰ď (2016/7/16), •ś‹ž‹ć.

733410. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇ: Ç—ጟ“˘z‰ß“x‚Ě•sˆŔ‚đŽĺÇó‚Ć‚ľ“ü‰@‚Ć‚Č‚Á‚˝’jŽq—á`10”N‚ĚŒo‰ß. ˆäăŸ•v (¸_): ‘ć30‰ń“ú–{ŹŽ™¸_ˆăŠwŒ¤C‰ď (JSPP) ŒQ”n‘ĺ‰ď (2017/2/18), ŒQ”n.


•úŽËü‰ČŠw (‰ć‘œf’fŠw)

[Šwp˜_•ś]

110279. [Œ´’˜] Measurement of Renal Depth in Dynamic Renal Scintigraphy Using Ultralow-Dose CT. Inoue Y1, Itoh H2, Tagami H2, Miyatake H2, Asano Y1: Clin Nucl Med 2016/6; 41 (6): 434-41. (ˆäă—D‰î1, ˆÉ“ĄŠ°‘×2, “că_ˆę2, ‹{•”ä˜CŽ÷2, ó–ě—Y“ń1: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110280. [Œ´’˜] Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging. Inoue Y1, Abe Y2, Kikuchi K2, Matsunaga K1, Masuda R3, Nishiyama K3: J Nucl Cardiol 2016/6. doi:10.1007/s12350-016-0546-8. (ˆäă—D‰î1, ˆ˘•”@–L2, ‹e’r@Œh2, ź‰iŒh“ń1, ‘“c@—ă3, źŽR˜a—˜3: 1•úŽËü (‰ć‘œ), 2•úŽËü•”, 3_Œo“ŕ)

110281. [Œ´’˜] Evaluation of a respiratory navigator-gating technique in Gd-EOB-DTPA-enhanced magnetic resonance imaging for the assessment of liver tumors. Ogasawara G1, Inoue Y1, Matsunaga K1, Fujii K1, Hata H2, Miyatake H2, Iwadate Y3: Eur J Radiol 2016/6; 85 (6): 1232-7. (ŹŠ}Œ´‹1, ˆäă—D‰î1, ź‰iŒh“ń1, “Ąˆä@Š]1, `@”Ž•ś2, ‹{•”ä˜CŽ÷2,ŠâŠŮ—YŽĄ3: 1•úŽËü (‰ć‘œ), 2•úŽËü•”, 3GE ƒwƒ‹ƒXƒPƒAEƒWƒƒƒpƒ“)

110282. [Œ´’˜] Image Non-Uniformity Correction for 3-T Gd-EOB-DTPA-Enhanced MR Imaging of the Liver. Ogasawara G1, Inoue Y1, Matsunaga K1, Fujii K1, Hata H2, Takato Y2: Magn Reson Med Sci 2017; 16 (2): 115-22. Published Online: 2016/7/5. (ŹŠ}Œ´‹1, ˆäă—D‰î1, ź‰iŒh“ń1, “Ąˆä@Š]1, `@”Ž•ś2, ‚“Ą—D‹P2: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110283. [Œ´’˜] A multi-institutional survey of interventional radiology for type II endoleaks after endovascular aortic repair: questionnaire results from the Japanese Society of Endoluminal Metallic Stents and Grafts in Japan. Ogawa Y, Nishimaki H, Osuga K, Ikeda O, Hongo N, Iwakoshi S, Kawasaki R, Woodhams R1, Yamaguchi M, Kamiya M, Kanematsu M, Honda M, Kaminou T, Koizumi J, Kichikawa K: Jpn J Radiol 2016/8; 34 (8): 564-71. (ƒEƒbƒhƒnƒ€ƒX—ćŽq1: 1•úŽËü (‰ć‘œ))

110284. [Œ´’˜] Monitoring dose-length product in computed tomography of the chest considering sex and body weight. Inoue Y1, Nagahara K2, Hayakawa N2, Hanawa H2, Hata H2: Radiat Prot Dosimetry 2016/11; 171 (3): 375-81. (ˆäă—D‰î1, ‰iŒ´˜aŒ›2, ‘ě’ź“š2, ”ˇ@G“T2, `@”Ž•ś2: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110285. [Œ´’˜] The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice. Akai H, Kiryu S, Ohta Y, Yasaka K, Nakano Y, Inoue Y1, Ohtomo K: Magn Reson Imaging 2017/5; 38: 123-8. doi: 10.1016/j.mri.2016.12.027. Epub 2017/1/3. (ˆäă—D‰î1: 1•úŽËü (‰ć‘œ))

320025. [Ç—á•ń] ƒŠƒ“ƒp–ŹŠÇ‹ŘŽîÇ‚É‚¨‚Ż‚郊ƒ“ƒpƒVƒ“ƒ`ƒOƒ‰ƒtƒBŠŒŠ. Œ´@•qŤ1, ˆäă—D‰î1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ‘ĺ’ˈŸš–˘1 (1•úŽËü (‰ć‘œ)): —Տ°ŠjˆăŠw 2016/9; 49 (5): 66-8.

522119. [uŔ]y“ÁW: ŽY‰ČŠë‹@“IoŒŒzŽY‰ČŠë‹@“IoŒŒ‚É‚¨‚Ż‚éIVR‚Ě—L—pŤ‚ĆŒŔŠE. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): “ú–{ŽY‰Č•wl‰ČŠw‰ďŽGŽ 2016/6; 68 (6): 1354-65.

522120. [uŔ]y“ÁW: ŽY•wl‰Č•a‘Ô‚Ö‚ĚŒŒŠÇ‚̐f’f‚ĆŽĄ—Ă Ąf’f•Ňz‘˜_@3. ŒŒŠÇ‘˘‰e–@. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ŽY•wl‰Č‚ĚŽŔŰ 2016/8; 65 (8): 903-14.

522121. [uŔ]y“ÁW: ŽY•wl‰Č•a‘Ô‚Ö‚ĚŒŒŠÇ‚̐f’f‚ĆŽĄ—Ă ĄŽĄ—Õҁz2. ŽY‰ČoŒŒ‚ɑ΂ˇ‚é interventional radiology (IVR). ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ŽY•wl‰Č‚ĚŽŔŰ 2016/9; 65 (9): 1009-17.

522122. [uŔ]y“ÁW: ‘O—§‘B‚Ş‚ńf—Áz‚Đ‚Ć‚­‚żƒƒ‚: Šú‘Ň‚ł‚ę‚éPETŒŸ¸–ň|•Ď‰ť‚ˇ‚é‘O—§‘B‚Ş‚ńf—Ă‚Ě’†‚Ĺ. ˆäă—D‰î (•úŽËü (‰ć‘œ)): “ú–{ˆăŽt‰ďŽGŽ 2016/11; 145 (8): 1610.

522123. [uŔ]y“ÁW: ĹV”Ĺ! •úŽËü•”–ĺ‚ĚIT‰ťí—ށ@ˆă—p‰ć‘œŠÇ—‚Ć‹Ć–ąŠÂ‹Ť‚đ•Ď‚Ś‚éƒVƒXƒeƒ€\’z‚Ě‚ ‚č•űzShowcase|ĹVƒVƒXƒeƒ€EƒT[ƒrƒX“ą“üŽ–—á@
E‰šş“ü—̓\ƒtƒgƒEƒGƒA‚đ—p‚˘‚˝“lje‹Ć–ą‚ĚŒř—Ś‰ť. •‚F—´‘ž˜Y (•úŽËü‰Č (‰ć‘œ)): ITvision 2017/2; 35 (ŒŽŠ§ƒCƒ“ƒi[ƒrƒWƒ‡ƒ“2017”N2ŒŽ†•t˜^): 24-5.

[’˜@‘]

620156. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ę‚ž‚Ż‚Í’m‚Á‚Ä‚¨‚Ť‚˝‚˘CT/MRI‚ĚŠî–{@Œ¤Cˆă‚Ě•K{’mŽŻ (—Տ°‰ć‘œ2016”N4ŒŽ‘Š§†)z[ŽîᇐŤ•a•Ď]@“Şčň•”, p.160-9. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)), ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/4”­s.

620157. [Šwp‘ (•Ş’SŽˇ•M)]y‰ć‘œf’fƒKƒCƒhƒ‰ƒCƒ“2016 ‘ć2”Łz<ŽB‘œ–@‚¨‚ć‚ŃCQ>@(2) “Şčň•”@E“Şčň•”—Ěˆć‚Ě•W€“IŽB‘œ–@, p.108-17. •‚F—´‘ž˜Y (•úŽËü‰Č (‰ć‘œ)), •Ň: “ú–{ˆăŠw•úŽËüŠw‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/9”­s.

620158. [Šwp‘ (•Ş’SŽˇ•M)]yMulti-Organ Disease|‘ŸŠí‚Š‚çƒAƒvƒ[ƒ`‚ˇ‚é‘SgŽžŠł|(—Տ°•úŽËü2016”N10ŒŽ—ŐŽž‘Š§†)z“Şčň•” Head and Neck@Š´őÇ, p.1355-62. •‚F—´‘ž˜Y (•úŽËü‰Č (‰ć‘œ)), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2016/10”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712026. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰) Emotion evokes anticipation: Event-related potential and fMRI studies. Kotani Y1, Ohgami Y1, Kiryu S2, Inoue Y3: 31st International Congress of Psychology (2016/7/24), Kanagawa, Japan, Scientific Program Book, Invited Addresses IA27-03 Cognitive 2016/7; p.70. (ˆäă—D‰î3: 1“Œ‹žH‹Ć‘ĺŠw, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 3•úŽËü (‰ć‘œ))

712027. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰) TAE postpartum hemorrhage. Woodhams R1: Seminar for Interventional Radiology in Asia-Pacific (SIRAP 2016) (2016/10/30), Tokyo, Japan, SIRAP2016 PROGRAM 2016; p.3. (ƒEƒbƒhƒnƒ€ƒX—ćŽq1: 1•úŽËü (‰ć‘œ))

713141. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Non-uniformity correction of Gd-EOB-DTPA- enhanced magnetic resonance imaging of the liver at 3T. Inoue Y1, Ogasawara G1, Matsunaga K1, Fujii K1, Hata H2, Takato Y2: ISMRM 24th Annual Meeting and Exhibition (2016/5/7-13), Singapore, ISMRM 24th Annual Meeting and Exhibition Program 2016; p.2950. (ˆäă—D‰î1, ŹŠ}Œ´‹1, ź‰iŒh“ń1, “Ąˆä@Š]1, `@”Ž•ś2, ‚“Ą—D‹P2: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

713142. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Correction of collimator-dependent diffarences of the heart-to-mediastinum ratios in cardiac sympathetic imaging. Inoue Y1, Abe Y2, Kikuchi K2, Matsunaga K1, Masuda R3, Nishiyama K3: SNMMI 2016 Annual Meeting (2016/6/11-16), San Diego, USA, J Nucl Med 2016; 57: 226. (ˆäă—D‰î1, ˆ˘•”@–L2, ‹e’r@Œh2, ź‰iŒh“ń1, ‘“c@—ă3, źŽR˜a—˜3: 1•úŽËü (‰ć‘œ), 2•úŽËü•”, 3_Œo“ŕ)

713143. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Effect of Reward Information on Right Anterior Insular Cortex in Anticipation of Instruction. Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: OHBM 2016 Annual Meeting (2016/6/27-28), Geneva, Swiss, E-posters /Poster ListingBook 2016/6; p.129. (ˆäă—D‰î4: 1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ))

713144. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Effect of Modality of Auditory Stimulus on Stimulus-Preceding Negativity. Ohgami Y1, Kotani Y1, Arai J2, Kiryu S3, Inoue Y4: OHBM 2016 Annual Meeting (2016/6/27-28), Geneva, Swiss, E-posters /Poster ListingBook 2016/6; p.55. (ˆäă—D‰î4: 1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ))

713145. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Two cases of tracheocarotid fistula after tracheostomy: endovascular management with covered stent placement. Woodhams R1, Yamane T1, Fujii K1, Nishimaki H2, Inoue Y1: CIRSE 2016 (2016/9/10-14), Barcelona, Spain, CIRSE 2016 Pocket guide 2016; p.111. (ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ŽRŞ‘ń˜Y1, “Ąˆä@Š]1, ˆäă—D‰î1: 1•úŽËü (‰ć‘œ), 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwS‘ŸŒŒŠÇŠO‰Č)

713146. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Analysis of risk factors for the recanalization of gelatin sponge during transcatheter arterial embolization for primary postpartum hemorrhage. Woodhams R1, Fujii K1, Ogasawara G1, Yamane T1, Sugawara H1, Matsunaga K1, Nishimaki H2, Inoue Y1: CIRSE 2016 (2016/9/10-14), Barcelona, Spain, CIRSE 2016 Pocket guide 2016; p.138. (ƒEƒbƒhƒnƒ€ƒX—ćŽq1, “Ąˆä@Š]1, ŹŠ}Œ´‹1, ŽRŞ‘ń˜Y1, ›Œ´’g“l1, ź‰iŒh“ń1, ˆäă—D‰î1: 1•úŽËü (‰ć‘œ), 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwS‘ŸŒŒŠÇŠO‰Č)

713147. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Activation in the right anterior insular cortex in anticipation of reward information. Kotani Y1, Ohgami Y1, Yoshida N2, Kiryu S2, Inoue Y3: The 56th Annual Meeting of Society for Psychophysiological Research (2016/9/21), Minneapolis, USA, The 56th Annual Meeting of Society for Psychophysiological Research Program 2016; p.47. (ˆäă—D‰î3: 1“Œ‹žH‹Ć‘ĺŠw, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 3•úŽËü (‰ć‘œ))

713148. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Stimulus-preceding negativity prior to voice, beep, and rhythmic sound. Ohgami Y1, Kotani Y1, Yoshida N2, Kiryu S2, Inoue Y3: The 56th Annual Meeting of Society for Psychophysiological Research (2016/9/21-25), Minneapolis, USA, Psychophysiology 2016; 53 (suppl 1): s18. (ˆäă—D‰î3: 1“Œ‹žH‹Ć‘ĺŠw, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 3•úŽËü (‰ć‘œ))

721015. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‘O—§‘B‚Ş‚ńf—Â̐V‹Zp ‰”­‘O—§‘BŠŕ‚ɑ΂ˇ‚éV‹KPETf’fÜNMK36‚̐f’f”\‹y‚ŃˆŔ‘SŤ‚Ě•]‰ż ‘˝Ž{Ý‹¤“ŻŽŽŒą. [‘ň@ŒŤ1, A“c@Œ’1, —é–ŘŒ[‰x2, ˆäă—D‰î3, “ĄŒł”Žs4, •ÄŁ~“ń5, “c糈ꐏ6, ˆäă“o”ü•v7, Ä“ĄŽj˜Y8, ă–ě@‹v9, ‘ĺ‚–žŽĄ10 (1ç—tŒ§‚Ş‚ńƒZƒ“ƒ^[E‘O—§‘BƒZƒ“ƒ^[”ĺ”AŠí‰Č, 2“Œ–M‘ĺŠwEˆă—ĂƒZƒ“ƒ^[˛‘q•a‰@”ĺ”AŠí‰Č, 3•úŽËü (‰ć‘œ), 4‘—§Œ¤‹†ŠJ”­–@l‘—§‚Ş‚ńŒ¤‹†ƒZƒ“ƒ^[’†‰›•a‰@”ĺ”AŠí‰ČŒă• –ŒŽîᇉČ, 5Œö‰vŕ’c–@l‚Ş‚ńŒ¤‹†‰ď—L–ž•a‰@”ĺ”AŠí‰Č, 6“Œ‹ž—Žqˆă‰Č‘ĺŠw”ĺ”AŠí‰Č, 7‰Ą•lŽs—§‘ĺŠw‘ĺŠw‰@•úŽËü‰Č, 8“Ć—§s­–@l‘—§•a‰@‹@\“Œ‹žˆă—ĂƒZƒ“ƒ^[”ĺ”AŠí‰Č, 9é‹Ęˆă‰Č‘ĺŠw‘Űˆă—ĂƒZƒ“ƒ^[”ĺ”AŠíŽîᇉČ, 10“ú–{ƒƒWƒtƒBƒWƒbƒNƒXŠ”ŽŽ‰ďŽĐ—Տ°ŠJ”­•”): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20-22), ‰Ą•l, “ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď´˜^W54‰ń 2016/10; p.WS7-3.

721016. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰)y“Á•ĘŠé‰ć: Œo”ç“IŽ~ŒŒpzŽY•wl‰Č‹Ů‹}IVR‚É‚¨‚Ż‚éÇđ•¨Žż‚Ě‘I‘đ; NBCA‚ĚŽg—p‚ÉŠÖ‚ˇ‚élŽ@. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć53‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2017/3/2), ‰Ą•l, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2017/2; 37 (2): 225.

722242. [Šw‰ď (‘S‘)] (‹łˆç“WŽŚ) Visual Pathway: Anatomy, Diseases, and the Role of Imaging Studies. •‚F—´‘ž˜Y1, ›Œ´’g“l1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): ‘ć75‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2016/4/14-17), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2016/2; p.S151.

722243. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) fMRI‚ĆŽ–ŰŠÖ˜A“dˆĘ‚Š‚猊‚˝‰E‘O•”“‡”玿‚ĚŽžŠÔ“IŠˆ“Ž. Ź’J‘בĽ1, ‘ĺăi”ü1, ‹Ëś@–Î2, ˆäă—D‰î3 (1“Œ‹žH‹Ć‘ĺŠw, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 3•úŽËü (‰ć‘œ)): ‘ć34‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ď (2016/5/14), –źŒĂ‰Ž, ‘ć34‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ďƒvƒƒOƒ‰ƒ€Ľ—\eW 2016/5; p.33.

722244. [Šw‰ď (‘S‘)] (Featured Abstract) The potential of Imipenem/Cilastatin as an embolic material; A prospective study. ƒEƒbƒhƒnƒ€ƒX—ćŽq1, “Ąˆä@Š]1, ŹŠ}Œ´‹1, ŽRŞ‘ń˜Y1, Œ´@•qŤ1, ›Œ´’g“l1, ź‰iŒh“ń1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ): ‘ć45‰ń“ú–{IVRŠw‰ď‘‰ď (2016/5/26), –źŒĂ‰Ž, IVR:Interventional Radiology 2016/4; 31(suppl): 120.

722245. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰) “ű–[MRI; BI-RADS MRI‚ÉŠî‚Ă‚­f’fstrategy‚Ć‚ť‚ĚŒŔŠE. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): JCRƒ~ƒbƒhƒTƒ}[ƒZƒ~ƒi[2016 (2016/7/17), _ŒË.

722246. [Šw‰ď (‘S‘)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv) BRTO‚Ě‹Zp“IH•v Ť‘BĂ–Ź‚đ”rŒŒ˜H‚Ć‚ˇ‚é–ĺ–Ź-‘̏zŠÂƒVƒƒƒ“ƒg‚ɑ΂ľdouble balloon technique‚Ş—LŒř‚Ĺ‚ ‚Á‚˝3—á. •˝ěk‘ĺ1, ‘ëě­˜a1, “cŒű’qŽq1, •Ę‹{ŠG”ü^1, ‘ĺX’qŽq1, “Ąˆä@Š]2, ˛X–ؐ^‹|3, ó–ě—Y“ń1 (1‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, 2•úŽËü (‰ć‘œ), 3ŽŠ˝‰ď‘ć“ń•a‰@): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď (2016/9/10), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 108.

722247. [Šw‰ď (‘S‘)] (‹łˆç“WŽŚ) ’†“ŞŠW’ę‚ĆŽüˆÍ\‘˘: ‰đ–UEŽB‘œEf’f. •‚F—´‘ž˜Y1, ›Œ´’g“l1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď (2016/9/16-18), “Œ‹ž, ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď´˜^W 2016/8; p.S520.

722248. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰) ŽŔ‘H! ŠjˆăŠw“lje‚ĚƒRƒc‹ł‚Ś‚Ü‚ˇpart 2. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď (2016/9/18), “Œ‹ž, ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď´˜^W 2016/8; p.S388.

722249. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) EVER‚ĚŒťó‚Ɖۑč Endoleak‚ĚŽĄ—Ă: ‘˝Ž{Ý’˛¸‚ĚŒ‹‰Ę‚đŠÜ‚ß‚Ä. Źě•‹v1, źŠŞ@”Ž2, ‘ĺ{‰ęŒcŒĺ3, ’r“c@—4, –{‹˝“N•v5, Šâ‰zMˆę6, ěč—ł‘ž7, ƒEƒbƒhƒnƒ€ƒX—ćŽq8, ŽRŒű‰ël9, _’J”ü‰Ŕ10, Œ“ź‰ë”V11, –{‘˝ł“ż12, _”[•q•v13, Źň@~14, ‹gěŒö•F6 (1šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠw•úŽËü‰Č, 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwS‘ŸŒŒŠÇŠO‰Č, 3‘ĺă‘ĺŠwˆăŠw•”, 4ŒF–{‘ĺŠwˆăŠw•”, 5‘ĺ•Ş‘ĺŠwˆăŠw•”•úŽËüˆăŠw, 6“Ţ—ÇŒ§—§ˆă‰Č‘ĺŠw•úŽËü‰Č, 7•şŒÉŒ§—§•P˜HzŠÂŠí•aƒZƒ“ƒ^[•úŽËü‰Č, 8•úŽËü (‰ć‘œ), 9_ŒË‘ĺŠwˆăŠw•”•úŽËü‰Č, 10•lź‘ĺŠw@ˆăŠw•”•úŽËü‰Č, 11Šň•Œ‘ĺŠw•‘Ž•a‰@•úŽËü‰Č, 12Ďś‰ď‰F“s‹{•a‰@•úŽËü‰Č, 13’šŽć‘ĺŠwˆăŠw•”•a‘Ô‰đÍˆăŠwuŔ‰ć‘œf’fŽĄ—ĂŠw•Ş–ě•úŽËü‰Č, 14“ŒŠC‘ĺŠw‰ć‘œf’f‰Č): ‘ć57‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď (2016/10/13), “Ţ—Ç, –ŹŠÇŠw 2016/10; 56 (suppl): S95.

722150. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) 2. •ŞŽqE‹@”\‰ć‘œEƒf[ƒ^ƒx[ƒX@ƒX[ƒp[Œ¤Cˆă‚đ‚ß‚´‚ˇˆăŠwśŒ¤Cˆă‚Ě‚˝‚ß‚É 2. ŒőƒCƒ[ƒWƒ“ƒO. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć56‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď (2016/11/3), –źŒĂ‰Ž, ‘ć56‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď“dŽq´˜^ 2016/10; p.S210.

722251. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰) ”ńŠOŤoŒŒ‚Ě‰ć‘œf’f‚ĆIVR. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć30‰ńJCRƒ~ƒbƒhƒEƒBƒ“ƒ^[ƒZƒ~ƒi[ (2017/1/28), •Ÿ‰Ş.

722252. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰) “Şčň•”Šŕ|ŽĄ—Ă•űjś‰E‚ˇ‚é‰ć‘œŠŒŠ‚đŒŠ‹É‚ß‚ć‚¤|. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)): ‘ć30‰ńJCRƒ~ƒbƒhƒEƒBƒ“ƒ^[ƒZƒ~ƒi[ (2017/1/29), •Ÿ‰Ş,

722253. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) isŠú‘O—§‘BŠŕf—Ă‚É‚¨‚Ż‚é‰ć‘œŒŸ¸: ‚ą‚ę‚Š‚ç‚Ě–đŠ„ 3)ŠjˆăŠwŒŸ¸: “Á‚ÉPET‚Ö‚ĚŠú‘Ň. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć36‰ń“ú–{‰ć‘œˆăŠw‰ď (2017/2/26), “Œ‹ž, “ú–{‰ć‘œˆăŠw‰ďŽGŽ ‘ć36‰ń“ú–{‰ć‘œˆăŠw‰ď´˜^W 2017/2; 35 (1): 78.

723799. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Methods of optimizing the display conditions of brain MR images. Œ´@•qŤ1, ˆäă—D‰î1, •‚F—´‘ž˜Y1, `@”Ž•ś2, ˆä—́@~2 (1•úŽËü (‰ć‘œ), 2•úŽËü•”): ‘ć75‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2016/4/15), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2016/2; p.S282.

723800. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰šşEƒƒƒfƒB[‰šEƒr[ƒv‰š‚Ě—\Šú‚ĆŠÖ˜A‚ˇ‚éŽhŒƒćs‰AŤ“dˆĘ (SPN). ‘ĺăi”ü1, Ź’J‘בĽ1, ‹g“c‹X´2, ‹Ëś@–Î2, ˆäă—D‰î3 (1“Œ‹žH‹Ć‘ĺŠw, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 3•úŽËü (‰ć‘œ)): ‘ć34‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ď (2016/5/15), –źŒĂ‰Ž, ‘ć34‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ďƒvƒƒOƒ‰ƒ€E—\eW 2016/5; p.64.

723801. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ăsŒ‹’°‚ĚŒŒŠÇŠďŒ`‚ɑ΂ľ“ŕŽ‹‹ž‚Ĺ‚ĚŠĎŽ@, ICG’“ü‚đ•š—p‚ľ‘I‘đ“I‚ÉTAE‚đŽ{s‚ľ“ž‚˝1—á. •˝ěk‘ĺ1, ‘ëě­˜a1, “cŒű’qŽq1, ‘ĺX’qŽq1,3, ˛X–ؐ^‹|2 (1‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, 2ŽŠ˝‰ď‘ć“ń•a‰@, 3•úŽËü (‰ć‘œ)): ‘ć45‰ń“ú–{IVRŠw‰ď‘‰ď (2016/5/26), –źŒĂ‰Ž, IVR:Interventional Radiology 2016/4; 31 (suppl): 239.

723802. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •”•ŞäB“Ž–ŹÇđp‚Ş—LŒř‚ž‚Á‚˝äXŠŕ‚É‚ć‚éˆÝ\“ńŽw’°Ă–ŹáŽoŒŒ‚Ě1—á. “Ąˆä@Š]1, ›Œ´’g“l1, ŽRŞ‘ń˜Y1, ŹŠ}Œ´‹1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ź‰iŒh“ń1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): ‘ć45‰ń“ú–{IVRŠw‰ď‘‰ď (2016/5/27), –źŒĂ‰Ž, IVR:Interventional Radiology 2016/4; 31(suppl): 244.

723803. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) GD-EOB-DTPA‘˘‰eMRI‚É‚¨‚Ż‚éNASHƒ‚ƒfƒ‹ƒ}ƒEƒX‚ĚŽŠ‘RŽj ”ńŠĚ‰ŠŽ‰–bŠĚƒ}ƒEƒX‚Ć‚Ě”äŠr (Natural history of nonalcoholic steatohepatitis model mouse examined by Gd-EOB-DTPA-enhanced MRI:comparison with fatty liver model mouse). ÔˆäGs1, ‹Ëś@–Î1, ‘ĺ“c‘דż2, ’†”W—ǍN1, ˆäă—D‰î3, ‘ĺ—F@–M4 (1“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•a—•”, 3•úŽËü (‰ć‘œ), 4“Œ‹ž‘ĺŠwˆăŠw•”•úŽËü‰Č): ‘ć11‰ń“ú–{•ŞŽqƒCƒ[ƒWƒ“ƒOŠw‰ď‘‰ďĽŠwp‘ĺ‰ď (2016/5/28), _ŒË, JSMI Report 2016/4; 9 (2): 158.

723804. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Žîᇂ̑S‘Ě‚É’˜–ž‚ȐΊD‰ť‚đ—ˆ‚ľ, p‘Of’f˘“ď‚Ĺ‚ ‚Á‚˝äXSPN‚Ě1—á. ›Œ´’g“l1, ź‰iŒh“ń1, “Ąˆä@Š]1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): ‘ć30‰ń“ú–{• •”•úŽËüŠw‰ď (2016/6/24-25), ‹ŕ‘ň.

723805. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) lHăč–ĺĂ–ŹáŽ‚Š‚ç‚̏oŒŒ‚ɑ΂ľ‚ÄBRTO‚đs‚˘Ž~ŒŒ‚ľ‚˝ˆę—á. •Ę‹{ŠG”ü^1, ‘ëě­˜a1, •˝ěk‘ĺ1, “cŒű’qŽq1, ‘ĺX’qŽq1,2, ó–ě—Y“ń1,2, ŠřŽč˜a•F1, ‹ŕŕVG‹I1, ‹ŕ“cŒĺ˜Y1 (1‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, 2•úŽËü (‰ć‘œ)): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď (2016/9/9-10), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 135.

723806. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚éIVRŽx‰‡‹Zp (1•ń) CT/CBCT FusionˆĘ’u¸“x. ‹{čhŽ÷1, ěč”ŽŽi2, ”Ń“‡@éD2, ‰iˆä‹œ–í2, •˝ěk‘ĺ2, ‘ĺX’qŽq2,3, ‘ëě­˜a2 (1‘—§‚Ş‚ńŒ¤‹†ƒZƒ“ƒ^[’†‰›•a‰@•úŽËü‹Zp•”, 2‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, 3•úŽËü (‰ć‘œ)): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď (2016/9/9-10), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 153.

723807. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŒŠÇ“஡—Ă‚Şs‚í‚ę‚˝äB“Ž–ŹáŽ21—á‚ĚŒă•űŽ‹“I‰đÍ. ›Œ´’g“l1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ź‰iŒh“ń1, “Ąˆä@Š]1, ŹŠ}Œ´‹1, ŽRŞ‘ń˜Y1, “ú‚@‰›2, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ), 2Á‰ťŠí“ŕ): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď/‘ć5‰ńäB‘ŸŒ¤‹†‰ď (2016/9/9-10), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 168.

723808. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) BRTO‚É‚¨‚Ż‚éƒfƒoƒCƒXƒeƒNƒjƒbƒN‚Ć–ňÜ‚ĚŽg‚˘•Ş‚Ż`‹‘ĺˆÝĂ–ŹáŽ‚ɑ΂ľNBCA‚É‚Ä‹tsŤÇđp‚đŽ{s‚ľ‚˝ˆę—á`. “Ąˆä@Š]1, ’†’JŞŒá2, “ú‚@‰›2, “c’†ŒŤ–ž2, ŒE“cK‰î2, ‹›“ˆ°‹I2, ›Œ´’g“l1, ŹŠ}Œ´‹1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ź‰iŒh“ń1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1, Źň˜aŽO˜Y2 (1•úŽËü (‰ć‘œ), 2Á‰ťŠí“ŕ): ‘ć23‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2016/9/10), _ŒË, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2016/8; 22 (3): 160.

723809. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”x“Ž–ŹŽîᇐđ‚đ‡•š‚ľ‚˝A“ޓ“÷Žî‚Ěˆę—á. ŽRŞ‘ń˜Y1, •‚F—´‘ž˜Y1, ›Œ´’g“l1, ˆäă—D‰î1, ’ç@ăĕ˝2, ‹{–{r•ă2, ŽR‰ş@‘ń2, H’JšŽj3 (1•úŽËü (‰ć‘œ), 2Ž¨•@ˆôAE“ŞčňŠO, 3•a—•”): ‘ć29‰ń“Şčň•”•úŽËüŒ¤‹†‰ď (2016/9/17), “Œ‹ž, ‘ć52‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď´˜^W 2016/8; p.S564.

723810. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒgƒŒ[ƒTƒuƒ‹Ge-68/Ga-68“_óüŒš‚ÉŠÖ‚í‚éˆĘ’uˆË‘śŤ‚ĚŠî–{“I•]‰ż. ŹŽRăĎi1, ’ˇ’Jě’q”V2, âŒű˜a–ç3, ‹e’r@Œh4, ‹{•”ä˜CŽ÷4, ˆäă—D‰î5, ‰äČ@Œd6, D“cŒ\ˆę7 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3’šŽćŒ§—§’†‰›•a‰@•úŽËüŽş, 4•úŽËü•”, 5•úŽËü (‰ć‘œ), 6“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[Œ¤‹†Š, 7–kŠC“š‰ČŠw‘ĺŠw): ‘ć44‰ń“ú–{•úŽËü‹ZpŠw‰ďH‹GŠwp‘ĺ‰ď (2016/10/13), ‚ł‚˘‚˝‚Ü, “ú–{•úŽËü‹ZpŠw‰ďŽGŽ 2016/9; 72 (9): 826-7.

723811. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) SŒđŠ´_ŒoƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚ć‚éScŠu”ä‚ĚƒRƒŠƒ[ƒ^[ˆË‘śŤ•âł: “_üŒš‚đ—p‚˘‚˝•ĎŠˇŽŽ„’č. ˆäă—D‰î1, ˆ˘•”@–L2, ‹e’r@Œh2, ź‰iŒh“ń1, ‘“c@—ă3, źŽR˜a—˜3 (1•úŽËü (‰ć‘œ), 2•úŽËü•”, 3_Œo“ŕ): ‘ć56‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď (2016/11/3), –źŒĂ‰Ž, ‘ć56‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď“dŽq´˜^ 2016/10; p.S288.

723812. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒgƒŒ[ƒTƒuƒ‹“_óüŒš‚đ—p‚˘‚é’č—ʐŤ•]‰żZł–@. ’ˇ’Jě’q”V1, ŹŽRăĎi2, ‹{•”ä˜CŽ÷3, ‹e’r@Œh3, ˆäă—D‰î4, ˛“Ą@‘×5, ‰äČ@Œd6, D“cŒ\ˆę7, ˜a“cNO8, ŽO—ÖŒ’‘ž9, ‘ş“c‘וă10 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•úŽËü•”, 4•úŽËü (‰ć‘œ), 5ŽY‹Ć‹Zp‘‡Œ¤‹†Š, 6“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[Œ¤‹†Š, 7–kŠC“š‰ČŠw‘ĺŠw, 8“Ć—§s­–@l—‰ťŠwŒ¤‹†Š•ŞŽqƒCƒ[ƒWƒ“ƒO‰ČŠwŒ¤‹†ƒZƒ“ƒ^[, 9‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 10ç—t‘ĺŠwˆăŠw•”•‘Ž•a‰@): ‘ć56‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď (2016/11/3), –źŒĂ‰Ž, ‘ć56‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď“dŽq´˜^ 2016/10; p.S307.

723813. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –Tˆô“ŞŠÔŒ„‚ɐś‚ś‚˝ŠC–ČóŒŒŠÇŽî‚Ěˆę—á. ›Œ´’g“l1, •‚F—´‘ž˜Y1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1, ‹{–{r•ă2, ŽR‰ş@‘ń2, H’JšŽj3, ‘ş‰_–FŽ÷4 (1•úŽËü (‰ć‘œ), 2Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠw, 3•a—•”, 4•a—): ‘ć36‰ń“ú–{‰ć‘œˆăŠw‰ď (2017/2/25), “Œ‹ž, “ú–{‰ć‘œˆăŠw‰ďŽGŽ ‘ć36‰ń“ú–{‰ć‘œˆăŠw‰ď´˜^W 2017/2; 35 (1): 91.

731164. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽY‰ČIVR; •a‘Ԃɉž‚ś‚˝Žč‹Z‚Ě‘I‘đ. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć24‰ńŒSŽRŒŒŠÇ‘˘‰eEIVRŒ¤‹†‰ď (2016/7/22), ŒSŽR.

731165. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žč‹ZŹŒ÷‚Ě‚˝‚ß‚Ě“KŘ‚ČƒfƒoƒCƒX‘I‘đ. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): 2016”N“x”Ě”„‘ă—“XƒZƒ~ƒi[For Endovascular Therapy (2016/8/27), “Œ‹ž.

731166. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)ypNET: f’f‚ĆŽĄ—Ă‚ĚĹ‘OüzpNETŠjˆăŠwf’f‚̐i•ŕ‚ĆŽĄ–ü‰ž—p. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć4‰ńš•˝âRadiology (2016/9/23), “Œ‹ž.

731167. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽY‰ČoŒŒIVR; •a‘Ԃɉž‚ś‚˝IVR‚̐헪. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć24‰ńŽ­Ž™“‡IVRŒ¤‹†‰ď (2016/10/21), Ž­Ž™“‡.

731168. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “ŞŠW’ę‚Í”˛‚Ż“š‚ž‚ç‚Ż|ŽĄ—Ă•űj‚đś‰E‚ˇ‚éCTEMRIŠŒŠ|. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)): ‘ć45‰ń’f‘w‰f‘œŒ¤‹†‰ď (2016/10/22), ‰ŞŽR.

731169. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) BI-RADS MRI‚ÉŠî‚Ă‚˘‚˝“ű–[MRI‚̓lje. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć34‰ń_“ސěMRI‹ZpŒ¤‹†‰ď (2016/11/25), ‰Ą•l.

731170. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •úŽËü•”–ĺ‚Ěˆă—Ïî•ńƒVƒXƒeƒ€: \’z‚ĚŽŔŰ. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć450‰ń“ú–{ˆăŠw•úŽËüŠw‰ďŠÖ“Œ’n•ű‰ď’čŠú‘ĺ‰ď (2016/12/10), “Œ‹ž, ‘ć450‰ń“ú–{ˆăŠw•úŽËüŠw‰ďŠÖ“Œ’n•ű‰ď’čŠú‘ĺ‰ď´˜^W 2016/11; p.42.

731171. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”ĺ”AŠí‰ČŽžŠł‚É‚¨‚Ż‚éŠjˆăŠwŒŸ¸: Žîᇐf’f‚Š‚ç‹@”\‘Ş’č‚Ü‚Ĺ. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć21‰ń“Č–Ř”ĺ”AŠí‰ć‘œf’fƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/12/14), ‰F“s‹{.

731172. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŠjˆăŠwf—Ă‚É‚¨‚Ż‚é’č—Ę‚đl‚Ś‚é. ˆäă—D‰î (•úŽËü (‰ć‘œ)): “ú–{ŠjˆăŠw‹ZpŠw‰ďŠÖ“Œ’n•ű‰ď ‘ć34‰ńƒCƒ“ƒtƒH[ƒ}ƒ‹ƒ~[ƒeƒBƒ“ƒO (2017/1/7), “Œ‹ž.

732101. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰) Anticipation and insular cortex: ERP and fMRI studies. Ź’J‘בĽ1, ‘ĺăi”ü1, ‹Ëś@–Î2, ˆäă—D‰î3 (1“Œ‹žH‹Ć‘ĺŠw, 2“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 3•úŽËü (‰ć‘œ)): Symposium at Keio University "Emotion, interoception, and the sense of agency", (2016/8/27), “Œ‹ž.

733411. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) •@•›•@oŒÇ—§ŤüˆŰŤŽîᇂĚ1—á. ›Œ´’g“l1, •‚F—´‘ž˜Y1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1, —é–Ř—§r2, ŽR‰ş@‘ń2, H’JšŽj3, Š“cç”ü”T4, ‘ş‰_–FŽ÷4 (1•úŽËü (‰ć‘œ), 2Ž¨•@ˆôAE“ŞčňŠO, 3•a—•”, 4•a—): ‘ć45‰ń“Şčň•”Ľ‹š•”‰ć‘œŒ¤‹†‰ď (2016/5/28), “Œ‹ž.

733412. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‹CŠÇ”畆ᑑ˘ÝŒă‚Ě‹CŠÇ|‘čň“Ž–Źá‘oŒŒ‚ɑ΂ľ, covered stent —Ż’u‚É‚ÄŽ~ŒŒ‚ľ‚˝2—á. ŽRŞ‘ń˜Y1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, “Ąˆä@Š]1, ‘ĺ‹v•Ű”Ž˘2, ”ü“‡—˜ş2, •˝“cŒő”Ž2, ‹ß“Ą—łŽj3, źŠŞ@”Ž4, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ), 2S‘ŸŒŒŠÇŠO, 3”]ŠO, 4šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠw•a‰@S‘ŸŒŒŠÇŠO‰Č): ‘ć34‰ń“ú–{Metallic Stents & GraftsŒ¤‹†‰ď (2016/5/28), –źŒĂ‰Ž.

733413. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŽĺŽîᇂ̍ǐđp‚É‚ć‚č–˘ŽĄ—Ăˆć‚ĚŠĚ“ŕ“]ˆÚ‘ƒ‚ŕ‘ޏk‚đŽŚ‚ľ‚˝‹‘劲×–EŠŕÇ—á‚ĚŒŸ“˘. ŽRŞ‘ń˜Y (•úŽËü (‰ć‘œ)): ‘ć13‰ń–k—˘ŒŒŠÇƒtƒH[ƒ‰ƒ€ (2016/12/5), ‘Š–ÍŒ´.

733414. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŽĺŽîᇂ̍ǐđp‚É‚ć‚č–˘ŽĄ—Ăˆć‚ĚŠĚ“ŕ“]ˆÚ‘ƒ‚ŕ‘ޏk‚đŽŚ‚ľ‚˝‹‘劲×–EŠŕ‚Ě1—á. ŽRŞ‘ń˜Y1, ź‰iŒh“ń1, ›Œ´’g“l1, Œ´@•qŤ1, “Ąˆä@Š]1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ˆäă—D‰î1, ‹›“ˆ°‹I2, “c’†ŒŤ–ž2 (1•úŽËü (‰ć‘œ), 2Á‰ťŠí“ŕ): ‘ć450‰ń“ú–{ˆăŠw•úŽËüŠw‰ďŠÖ“Œ’n•ű‰ď’čŠú‘ĺ‰ď (2016/12/10), “Œ‹ž, ‘ć450‰ń“ú–{ˆăŠw•úŽËüŠw‰ďŠÖ“Œ’n•ű‰ď’čŠú‘ĺ‰ď´˜^W 2016/11; p.24.

733415. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) lHăč–ĺĂ–ŹáŽoŒŒ‚ɑ΂ľ‚Ä’źÚúŽh‚ĹŽĄ—Ă‚ľ‚Ś‚˝ˆę—á. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć487‰ń“Œ‹žƒAƒ“ƒMƒIEIVR‰ď (2017/1/12), “Œ‹ž.

733416. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) t“Ž‘ÔƒVƒ“ƒ`‚ĚŒŸ¸•ű–@. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć7‰ń–k—˘‹@”\‰ć‘œƒZƒ~ƒi[ (2017/2/9), ‘Š–ÍŒ´.

733417. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) pŒă‡•šÇ‚Ě‰ć‘œf’f‚Ć‘Îˆ–@3@śB”ĺ”AŠí: tśŒŸ, tᑑ˘Ý, ŽY‰ČoŒŒ, ˆâŽc‘Ů”Ő. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): “ú–{ˆăŠw•úŽËüŠw‰ďŠÖ“Œ’n•ű‰ďƒZƒ~ƒi[ (2017/2/11), “Œ‹ž.

733418. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽOł_Œo‘ćˆęŽ}—R—ˆ‚̐_ŒoâŽî. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)): ‘ć2‰ńŽáŽč•úŽËü‰Čˆă‡“Ż•×‹­‰ď (2017/2/11), ‰Ą•l.

733419. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”ńŒ‹ŠjŤRŽ_‹ŰŤčň•”ƒŠƒ“ƒpß‰Š. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)): ‘ć2‰ńŽáŽč•úŽËü‰Čˆă‡“Ż•×‹­‰ď (2017/2/11), ‰Ą•l.

733420. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éHCC‹y‚Ń–ĺ–Źˆł˜´iÇ‚ĚIVR‚ɂ‚˘‚Ä. “Ąˆä@Š] (•úŽËü (‰ć‘œ)): ‘Š–ÍŒ´IVRƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2017/2/24), ‘Š–ÍŒ´.

H27”N“xˆČ‘O•Ş

[’˜@‘]

H27-620004. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ę‚ž‚Ż‚Í’m‚Á‚Ä‚¨‚Ť‚˝‚˘CT/MRI‚ĚŠî–{@Œ¤Cˆă‚Ě•K{’mŽŻ (—Տ°‰ć‘œ2016”N4ŒŽ‘Š§†)z[ŽîᇐŤ•a•Ď] “Şčň•”, p.160-9. •‚F—´‘ž˜Y (•úŽËü‰Č (‰ć‘œ)), Šé‰ćE•ŇW: ŒăŠŐ••F, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/3”­s.


•úŽËü‰ČŠw (•úŽËüŽîᇊw)

[Šwp˜_•ś]

110286. [Œ´’˜] Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system Katoh N, Soda I1, Tamamura H, Takahashi S, Uchinami Y, Ishiyama H1, Ota K, Inoue T, Onimaru R, Shibuya K, Hayakawa K1, Shirato H: Radiat Oncol. 2017; 12: 3. Published online 2017 Jan 5. doi: 10.1186/s13014-016-0742-3. (‘“c@Ši1, ÎŽR”ŽžŠ1, ‘ě˜ad1: 1•úŽËü (Žîá‡))

110287. [Œ´’˜] Practical use of a plastic scintillator for quality assurance of electron beam therapy. Yogo K1, Tatsuno Y, Tsuneda M, Aono Y, Mochizuki D, Fujisawa Y, Matsushita A, Ishigami M, Ishiyama H2, Hayakawa K2: Phys Med Biol 2017/6; 62 (11): 4551-70. (—]ŒęŽ‹I1, ÎŽR”ŽžŠ2, ‘ě˜ad2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü (Žîá‡))

511003. [‰đŕ] Association between hypomethylation of specific smoking-related CpG sites and lung cancer. Niibe Y, Terahara A, Yamashita H, Hayakawa K1: Translational cancer research 2017/2; 6 (Supplement 1): S3-S4. (‘ě˜ad1: 1•úŽËü (Žîá‡))

521034. [‰đŕ] •úŽËüŽĄ—Ă‘•’u—p“Ž‘Ě’ÇŐƒVƒXƒeƒ€SyncTraX‚ĚŽg—pŒoŒą. ‘ě˜ad (•úŽËü (Žîá‡)): MEDICAL NOW 2016/9; 80: 22-5.

522124. [uŔ]y“ÁW: •úŽËüŽĄ—Á|Ĺ‹ß‚Ě“ŽŒü‚Ć“W–]|z•úŽËüŽĄ—Ă‚ĚĹ‹ß‚Ě“ŽŒü@‹ÇŠisŠú”xŠŕ‚Ö‚Ě•úŽËüŽĄ—Ă. ‘ě˜ad (•úŽËü (Žîá‡)): ƒJƒŒƒ“ƒgƒeƒ‰ƒs[ 2016/5; 34 (5): 442-8.

522125. [uŔ]y“ÁW: ”xŠŕŽĄ—Ă‚Ş–ÚŽw‚ˇ’ˇŠúś‘ś‚Ě•Ď‘J‚ĆˆÓ‹`z3. ”xŠŕ•úŽËü—Ă–@‚Ş–ÚŽw‚ˇ’ˇŠúś‘ś: •úŽËüŽîᇈオ–ÚŽw‚ˇ’ˇŠúś‘ś‚Ć‚Í. ‘ě˜ad (•úŽËü (Žîá‡)): “ú–{‹š•”—Տ° 2016/7; 75 (7): 749-57.

[’˜@‘]

620159. [Šwp‘ (•Ş’SŽˇ•M)]y•ĘűuˆăŠw‚Ě‚ ‚ä‚݁v‘ĺ’°Šŕf—ĂUpdatezŽĄ—Ă‚ĚUPDATE@19. ‘ĺ’°Šŕ‚ɑ΂ˇ‚é•úŽËüŽĄ—Ă‚ĚˆÓ‹`‚Ɖž—p, p.118-23. ‘ě˜ad (•úŽËü (Žîá‡)), •Ň: “n粏š•F, ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713149. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Comparison of Prostate Contours Between Conventional Stepping Transverse Imaging and Twister Based Sagittal Imaging in Permanent Interstitial Prostate Brachytherapy Ishiyama H1, Kawakami S1, Satoh T2, Sekiguchi A1, Tsumura H2, Takenaka K1, Iwamura M2, Hayakawa K1: 6th World Congress of Brachytherapy (2016/6/29), San Francisco, USA. (ÎŽR”ŽžŠ1, ěăłŒĺ1, ˛“ĄˆĐ•ś2, ŠÖŒűˆŠˆß1, ’Ă‘şGN2, ’|’†_“ń1, Šâ‘şłŽk2, ‘ě˜ad1: 1•úŽËü (Žîá‡), 2”ĺ”AŠí)

713150. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A multicenter phase II study of preoperative concurrent chemoradiotherapy with S-1 plus irinotecan for locally advanced rectal cancer: SAMRAI-2 Noda M, Sato T, Hayakawa K1, Tomita N, Kamikonnya N, Matoba S, Uki A, Baba H, Oya N, Hasegawa H, Shigematu N, ida K, Furuhata T, Naitou T, Shimada M, Otuka K, Higuchi Y, Sakai Y, Takeuchi M, Watanabe M: EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY(ESMO 2016) (2016/10/8), Copenhagen, Denmark. (‘ě˜ad1: 1•úŽËü (Žîá‡)):

713151. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A Phase II Study of Endoscopic Resection and Chemoradiation Therapy for Clinical Stage I Esophageal Carcinoma (JCOG 0508): A Report of Radiation Therapy Quality Assurance Program. “ń•rŒ\“ń, ŽO—œŒjŽq, –î–ě—F‹K, •“Ą@Šw, Î‘q@‘, ‘ě˜ad1 (1•úŽËü (Žîá‡)): MULTIDISCPLINARY THORACIC CANCERS SYMPOSIUM 2017 (2017/3/16), San Francisco, USA.

722254. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ŽĄ—Ă1: “Şčň•”EŒÄ‹zŠí ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć75‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2016/4/16), ‰Ą•l.

722255. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yBrachytherapy‚Ě‘˝Ž{ÝŒ¤‹†‚Ěó‹ľz‘O—§‘BŠŕ‚g‚c‚q‚É‚¨‚Ż‚é‘˝Ž{ÝŒ¤‹†‚ƍĄŒă‚̉ۑč. ÎŽR”ŽžŠ (•úŽËü(Žîá‡): “ú–{•úŽËüŽîᇊw‰ďŹüŒšŽĄ—Ă•”‰ď‘ć18‰ńŠwp‘ĺ‰ď (2016/5/28), ‘ĺă, ŹüŒšŽĄ—Ă•”‰ď‘ć18‰ńŠwp‘ĺ‰ď´˜^W 2016/5; 18: 26.

722256. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŔ’ˇzTreatment for Stage I Non-small Cell Lung Cancer:Surgery versus SBRT ‘ě˜ad (•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/26), ‹ž“s.

722257. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)yŔ’ˇzcllA-N2”ńŹ×–E”xŠŕ‚ɑ΂ˇ‚鎥—Ð헪|ƒRƒ“ƒZƒ“ƒTƒX‚̍\’z‚ÖŒü‚Ż‚ā|. ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć57‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2016/12/20), •Ÿ‰Ş.

723814. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘O—§‘BŠŕ‚ɑ΂ˇ‚éŠOĆŽË‚đ•š—p‚ľ‚˝‚ü—Ę—Ś‘gD“ŕĆŽË—Ă–@‚Ě‘˝Ž{Ý‹¤“Ż‘k‹y“IŠĎŽ@Œ¤‹†. ÎŽR”ŽžŠ1, _’JL•F, ‰Í‘ş‰pŤ, ‰Á“ĄáÁŒá, Â–؁@Šw, Š ’J^Ž˘, ŠC’ĂŒłŽ÷, ‹g“c@ŒŞ, ‹´–{–íˆę˜Y, –ě“c‘׍F, Keith Lim, ěŁ‹MŽk, ‚‹´Œ’•v, ˆî—t_“ń, ˆÉ’O@ƒ, •˝’ˏƒˆę, ’†‘ş˜ał, ‘ě˜ad1 (1•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ďŹüŒšŽĄ—Ă•”‰ď‘ć18‰ńŠwp‘ĺ‰ď (2016/5/27), ‘ĺă.

723815. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“š_Œo“ŕ•Ş”ĺŠŕ‚ɑ΂ˇ‚鍪ŽĄ“I‰ťŠw•úŽËüŽĄ—Ă—á‚Ě‘k”T“IŒŸ“˘. ŹXłŽq1, Œ˜“ce—˜2, ‹g“c@Œ÷3, “Œ@’q2, ÎŒËŒŞŽŸ2, –î–ě‹MŽj2, ˜a“c‘ń–ç2, “c糁@‘4, Źň˜aŽO˜Y2, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2Á‰ťŠí“ŕ, 3•a—, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/5), “Œ‹ž, “ú–{H“šŠw‰ďŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/7; 70: 115.

723816. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Xü—U”­‚ĚDNA‘š‚ɑ΂ˇ‚郁ƒ`ƒIƒjƒ“‚Ě•úŽËü•ŰŒěŒř‰Ę‚ĚŒŸ“˘. “ĄŕV‹`Ž÷1, —]ŒęŽ‹I1, ˆÉ“Ą‘žÄ, ’ˇ–쏫‘ĺ, Š™“cW•˝1, “y–{“”V, “Ą‰Ş—D“Ţ, ˜e”¨Żl, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü (Žîá‡)): ‘ć112‰ń“ú–{ˆăŠw•¨—Šw‰ďŠwp‘ĺ‰ď (2016/9/10), ‰Ť“ę.

723817. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) d—ąŽqü‚É‚ć‚éDNA‘š‚ɑ΂ˇ‚郁ƒ`ƒIƒjƒ“‚Ě–hŒěŒř‰Ę. —]ŒęŽ‹I1, ‘şŽRçŒbŽq, “ĄŕV‹`Ž÷1, Š™“cW•˝1, ź‰ş–žO1, ŹŕV‘ńŠC1, ’C–ě—SĆ1, •˝ŽR—şˆę, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü (Žîá‡)): ‘ć59‰ń•úŽËü‰ťŠw“˘˜_‰ď (2016/9/20), ‚č.

723818. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Protective effect of methionine on plasmid DNA damage induced by carbon ion irradiation. —]ŒęŽ‹I1, ‘şŽRçŒbŽq, “ĄŕV‹`Ž÷1, Š™“cW•˝1, ź‰ş–žO1, ŹŕV‘ńŠC1, ’C–ě—CĆ1, •˝ŽR—şˆę, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü (Žîá‡)): “ú–{•úŽËü‰e‹żŠw‰ď‘ć59‰ń‘ĺ‰ď (2016/10/26), L“‡.

723819. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Comparison of two types of TRUS images during seed implantation:the second report. ěăłŒĺ1, ÎŽR”ŽžŠ1, ˛“ĄˆĐ•ś2, ’Ă‘şGN2, ŠÖŒűˆŠˆß1, ’|’†_“ń1, “c”¨Œ’ˆę2, Šâ‘şłŽk2, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2”ĺ”AŠí): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/25), ‹ž“s.

723820. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Intracavitary brachytherapy combined with interstitial brachytherapy for uterine cervical cancer. Hayakawa T1, Tetsuo N, Yuko N, Nobutaka M, Yasuhito H, Shogo K, Ryo O, Hisamori K: “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/25), ‹ž“s, “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď´˜^W 2016/11; 288. (‘ě–L˜a1: 1•úŽËü(Žîá‡))

723821. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) A quality assurance tool for HDR brachytherapy using light from water irradiated with Ir-192 source. ź‰ş–žO1, —]ŒęŽ‹I1, Ž›ř“„Žj2, “ĄŕV‹`Ž÷1, ŹŕV‘ńŠC1, ’C–ě—SĆ1, Š™“cW•˝1, Žń“Ąéş2, ÎŽR”ŽžŠ3, ‘ě˜ad3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü•”, 3•úŽËü(Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/26), ‹ž“s.

723822. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Study of protective effect of methionine on DNA damage induced by X-ray. “ĄŕV‹`Ž÷1, —]ŒęŽ‹I1, ˆÉ“Ą‘žÄ, ’ˇ–쏫‘ĺ, Š™“cW•˝1, “y–{“”V, “Ą‰Ş—D“Ţ, ˜e”¨Żl, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü(Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/27), ‹ž“s.

723823. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Protective effect of methionine on plasmid DNA damage induced by carbon ion irradiation. —]ŒęŽ‹I1, ‘şŽRçŒbŽq, “ĄŕV‹`Ž÷1, Š™“cW•˝1, ź‰ş–žO1, ŹŕV‘ńŠC1, ’C–ě—CĆ1, •˝ŽR—şˆę, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü(Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/27), ‹ž“s.

723824. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Usefulness of the coronal plane for detection of local recurrene after stereotactic radiotherapy. ‘“c@Ši1, ’|’†_“ń1, ÎŽR”ŽžŠ1, ŠÖŒűˆŠˆß1, ŹXłŽq1, –ěŕVääť‰Ô1: 1•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/27), ‹ž“s, “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď´˜^W 2016/11; 275.

723825. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) d—ąŽqü‚É‚ć‚éDNA‘š‚ɑ΂ˇ‚éƒAƒ~ƒmŽ_‚Ě•ŰŒěŒř‰Ę. —]ŒęŽ‹I1, ‘şŽRçŒbŽq, “ĄŕV‹`Ž÷1, Š™“cW•˝1, ‘OŽR‘ńĆ, ź‰ş–žO1, ŹŕV‘ńŠC1, ’C–ě—CĆ1, •˝ŽR—şˆę, ź–{ŒŞˆę˜Y, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•úŽËü (Žîá‡)): ‘ć19‰ńŠŕŽĄ—Ă‘Š´Œ¤‹†ƒVƒ“ƒ|ƒWƒEƒ€ (2017/2/3), “Ţ—Ç.

731173. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘B‚Ş‚ń•úŽËüŽĄ—Ă‚ĚŒťó‚ƏŤ—ˆ“W–]. ‘ě˜ad (•úŽËü (Žîá‡)): ‘O—§‘B‚Ş‚ńƒZƒ~ƒi[@ŠłŽŇE‰Ć‘°‚̏W‚˘@2016“Œ‹ž (2016/7/16), “Œ‹ž.

731174. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •úŽËüŽîᇊw. ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć3‰ńŠÖ“ŒRTŒ¤‹†‰ďƒZƒ~ƒi[ (ŽŔ‹@ƒR[ƒX) (2016/9/24), _“ސě.

731175. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ĹV‚Ě‚Ş‚ńŽĄ—Âɂ‚˘‚ā`•úŽËüŽĄ—Ă‚Ě—§ę‚Š‚ç`. ‘ě˜ad (•úŽËü (Žîá‡)): Oncology ƒ‰ƒEƒ“ƒhƒe[ƒuƒ‹ƒ~[ƒeƒBƒ“ƒO (2017/2/22), “Œ‹ž.

732102. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‚Ş‚ńŤáu’ɂɑ΂ˇ‚é‚­‚ŕ–Œ‰şƒ|[ƒg‚đ—p‚˘‚˝–ƒŒŠÇ—. ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć22‰ń‘ĺŠw•a‰@‚ĚŠÉ˜aƒPƒA‚đl‚Ś‚é‰ď@‘‰ďEŒ¤‹†‰ď (2016/9/17), _“ސě.

732103. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇzƒV[ƒh—Ă–@‚É‚¨‚Ż‚鎥—ĂŒv‰ć‚Ě‘˝—lŤ‚ÉŠÖ‚ˇ‚é‘˝Ž{Ý‹¤“ŻŽŔŒą|ƒSƒbƒhƒnƒ“ƒh‚Í’N‚ž!|. ÎŽR”ŽžŠ (•úŽËü(Žîá‡): ‘ć13‰ń‘O—§‘BŠŕ–§••ŹüŒš‰i‹v‘}“üŽĄ—ĂŒ¤‹†‰ď (2017/1/22), “Œ‹ž, ‘ć13‰ń‘O—§‘BŠŕ–§••ŹüŒš‰i‹v‘}“üŽĄ—ĂŒ¤‹†‰ď|´˜^EƒL[ƒXƒ‰ƒCƒhW| 2017/1; 2.

732104. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz”xŠŕWŠw“IŽĄ—Ă‚É‚¨‚Ż‚é•úŽËüŽĄ—Ă‚ĚŒťó‚ƏŤ—ˆ“W–]. ‘ě˜ad (•úŽËü (Žîá‡)): ‹ăB‚Ş‚ńƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹—{ŹŠî”Ր„iƒvƒ‰ƒ“@ƒ[ƒNƒVƒ‡ƒbƒv˘‰Ť“ęŒ§‚Ě”xŠŕWŠw“IŽĄ—Ă‚ĚŒťó‚Ć‰Ű‘čŁ (2017/2/11), ‰Ť“ę.

733421. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚é•úŽËüŽĄ—ĂŠÖ˜AƒCƒ“ƒVƒfƒ“ƒg‚̏WŒv: Tomotherapy‚ĆTrue beam‚Ě”äŠr. ÎŽR”ŽžŠ (•úŽËü(Žîá‡): ‘ć5‰ńTomotherapyƒZƒ~ƒi[2016 (2016/5/14), ‰Ť“ę.

733422. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Recent Aspect and Future Prospective for Localized Prostate Cancer Treatment. ‘ě˜ad (•úŽËü (Žîá‡)): Brachytherapy Update 2016 in Tokyo (2016/5/25), “Œ‹ž.

733423. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 3DƒvƒŠƒ“ƒ^[‚Ĺƒ{[ƒ‰ƒX? ‘“c@Ši (•úŽËü(Žîá‡): •˝Ź28”N“x ‘ć1‰ń_“ŢěŒ§•úŽËüŽĄ—Ă‹ZpŒ¤‹†‰ď (2016/5/28), ěč.

733424. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŽi‰ďzŽĄ—Ă‹@ŠíEü—ĘŒv‰ć‘•’u‚đ—p‚˘‚˝‹ZpƒgƒŒ[ƒjƒ“ƒO. ÎŽR”ŽžŠ (•úŽËü(Žîá‡): ‘ć18‰ńƒˆƒE‘f125ƒV[ƒhüŒš‰i‹v‘}“ü‚É‚ć‚é‘O—§‘BŠŕ–§••ŹüŒš—Ă–@‹ZpuK‰ď (2016/7/9), “Œ‹ž.

733425. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •úŽËüŽĄ—Ă‚Á‚ÄŒř‚Ť‚Ü‚ˇ‚Š? ‘“c@Ši (•úŽËü(Žîá‡): ˆîéŽs—§•a‰@•úŽËüŽĄ—Íu‰‰‰ď (2016/6/8), “Œ‹ž.

733426. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘O—§‘BŠŕ‚ɑ΂ˇ‚éƒV[ƒhŽĄ—Ă‚É‚¨‚Ż‚éV‚ľ‚˘Žč–@‚ɂ‚˘‚Ẳđŕ. ÎŽR”ŽžŠ (•úŽËü(Žîá‡): ‘ć2‰ńŠâŽč‘O—§‘BƒVƒ“ƒ|ƒWƒEƒ€ (2016/11/4), ˇ‰Ş.


–ƒŒ‰ČŠw

[Šwp˜_•ś]

110288. [Œ´’˜] Perioperative risk factors for death among patients with symptomatic pulmonary thromboembolism. Working Group for Audit about Perioperative Accident and Pulmonary Embolism of Japanese Society of Anesthesiologists: J Anesth 2017/6; 31 (3): 478-82. doi: 10.1007/s00540-017-2324-4. Epub 2017 Mar 9. (•Šâ­”V: –ƒŒ)

120039. [Œ´’˜] p‘OŒoŒű•â…‚ŞŇ‘‚­‚ŕ–Œ‰ş–ƒŒ’źŒă‚ĚŒŒˆł’ቺ‚É‹y‚Ú‚ˇ‰e‹ż. ˆÉ“Ą‘s•˝1, VˆäłN2, •Šâ­”V1, ˆŔ“ĄŽőŒb1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): –ƒŒ 2016/8; 65 (8): 786-9.

320026. [Ç—á•ń] Žľ•¨~‰ş“’‚Ş”ç]‚É—LŒř‚ž‚Á‚˝3Ç—á. ‹ŕŽq‹MŽq1, ‹yě“N˜Y1, –xě•üŒb1, —L“‡•Žu, –]ŒŽ—ÇŽq, ‰œ•xr”V2, ‰Ô—Öšć•F3 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2–ƒŒ, 3“Œ—mˆăŠw‹łˆç): “ú–{“Œ—mˆăŠwŽGŽ 2016; 67 (1): 38-44.

320027. [Ç—á•ń] ‚ŕ‚â‚ŕ‚â•a‡•š”DPÇ—á‚Ě•Ş•Ř—lŽŽ‚ÉŠÖ‚ˇ‚éŒă•űŽ‹“IŒŸ“˘. ×ěKŠó1, ´ŕVŒ¤‹g, ‰Á“Ą—˘ŠG2, ‰œ•xr”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): –ƒŒ 2016/8; 65 (8): 811-6.

320028. [Ç—á•ń] pŒă‚ÉCADASIL‚Ɛf’f‚ł‚ę‚˝dÇ”DP‚ŒŒˆłtÇ‚̒鉤ŘŠJ‚Ě–ƒŒŒoŒą. ‹ŕŽq°1, ‰Á“Ą—˘ŠG2, ‰œ•xr”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): –ƒŒ 2016/10; 65 (10): 1043-7.

320029. [Ç—á•ń] ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ŘÇ‡•šŠłŽŇ‚Ě• o‹ž‰ş’_ůN“Eop‚Ě–ƒŒŒoŒą. “Ą“c“ߌb1, ’|˜Q–Ż]1, ’Ă—Ż˘—˘2, ăˆä䝗LŽq1, “c’†ˆęś1, ‰Ş–{_Žk1 (1–ƒŒ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): –ƒŒ 2017/2; 66 (2): 164-7.

522126. [uŔ]y“ÁW: “ŕŽ‹‹ž‰şŽčp‚Ć–ƒŒŠÇ—zŒž‚Ć‚Ü‚Ć‚ß. ŽR‰ş@“Ö1, ‰Ş–{_Žk1 (1–ƒŒ): –ƒŒ 2016/9; 65 (9): 892-3.

522127. [uŔ]y“ÁW: “ŕŽ‹‹ž‰şŽčp‚Ć–ƒŒŠÇ—zŹŽ™‹šo‹ž‰şŽčp‚Ć–ƒŒŠÇ—|‹C“šŠÇ—‚𒆐S‚Ɂ|. ŽR‰ş@“Ö1, ‰Ş–{_Žk1 (1–ƒŒ): –ƒŒ 2016/9; 65 (9): 930-6.

[’˜@‘]

610006. [Šwp‘ (•Ş’SŽˇ•M)]yCesarean Delivery: A Comprehensive Illustrated Practical Guide (Series in Maternal-Fetal Medicine)zLocal Anesthesia for cesarean delivery: epidural, spinal, and combined spinal-epidural anesthesia. Kuczkowski K, Okutomi T1, Kato R2, Editors: Di Renzo GC, Malvasi A, CRC Press, USA, 2016/11. (‰œ•xr”V1, ‰Á“Ą—˘ŠG1: 1–ƒŒ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

620160. [Šwp‘ (•Ş’SŽˇ•M)]y–ƒŒ‰Čˆă‚Ě‚˝‚ß‚Ě˘‚Á‚˝Žž‚Ě3•ŞƒRƒ“ƒTƒ‹ƒgz‘ćIÍ p‘O•]‰żEŠÇ—‚ĆŽüpŠúŒv‰ć@29. RƒŠƒ“Ž‰ŽżR‘ĚÇŒóŒQ, p.114-7 “úŒür•ă1, ‰œ•xr”V1, ‘ź (1–ƒŒ), •Ň: ˆî“c‰pˆę, Ž˝“°o”Ĺ, “Œ‹ž, 2016/6”­s.

620161. [Šwp‘ (•Ş’SŽˇ•M)]y–ƒŒ‰Čˆă‚Ě‚˝‚ß‚Ě˘‚Á‚˝Žž‚Ě3•ŞƒRƒ“ƒTƒ‹ƒgz‘ćIIÍ p’†ŠÇ—‚É‚¨‚Ż‚éƒgƒ‰ƒuƒ‹@67. Ň‘‚­‚ŕ–Œ‰ş–ƒŒ, ’ጌˆł, p.247-9 ” Ş‰ëŽq, ‰œ•xr”V1, ‘ź (1–ƒŒ), •Ň: ˆî“c‰pˆę, Ž˝“°o”Ĺ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713152. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Perioperative management of extreamly low-birth weight infants underwent Video-Assisted Thoracoscopic Interruption of Patent Ductus Arteriosus VATS-PDA: 41 cases. Komiya A1, Takenami T1, Toda M1, Okamoto H1: Euroanaesthesia 2016 (2016/5/28), London, UK. (Ź‹{–ž“ú (‘şź–ž“ú)1, ’|˜Q–Ż]1, ŒË“c‰ë–ç1, ‰Ş–{_Žk1: 1–ƒŒ)

713153. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Intraoperative rise in intraocular pressure in the prone position. Tanaka K1, Takenami T1, Yamashita A1, Sakai M1, Okamoto M1: Euroanaesthesia 2016 (2016/5/28), London, UK. (“c’†ˆęś1, ’|˜Q–Ż]1, ŽR‰ş@“Ö1, ăˆä䝗LŽq1, ‰Ş–{_Žk1: 1–ƒŒ)

722258. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) TEE‚É‚ć‚é‘ĚŠOzŠÂ’†‚Ěƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. ‰Ş–{_Žk (–ƒŒ): ‘ć42‰ń“ú–{‘ĚŠOzŠÂ‹ZpˆăŠw‰ď‘ĺ‰ď (2016/10/22), “Œ‹ž.

722259. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚é‰@“ŕICU‚Ć‹~–˝ƒZƒ“ƒ^[ICU‚Ě‘Šˆá‚Ć‘ŠŒÝ‹Ś—͑̐§. •Šâ­”V1, —é–Ř—D‘ž˜Y1, ‘ĺ’Ë’q‹v1, źŕV‹`”V1, VˆäłN2, _œä’m“š3, •Đ‰Ş—Sˆę3, ó—˜@–ő3, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11), ŽD–y.

723826. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “]“|–hŽ~Œ^’eŤƒXƒgƒbƒLƒ“ƒO‚ĚŠJ”­Œ¤‹†@‚ť‚Ě2. ăˆä䝗LŽq1, •Šâ­”V1, H“Ą‰Â“ŢŽq1, r@Ť’q1, —é–Ř›’Žk1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/26), •Ÿ‰Ş.

723827. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”x‚ŒŒˆłÇ‚đ‡•š‚ľ‚˝ŹŽ™SŽş’†ŠuŒ‡‘šÇ•Â˝p‚É‚¨‚Ż‚éŽčpŽş”˛ŠÇŠî€‚ĚŒŸ“˘. “Ą–ěŽŃ‹M1, ŒË“c‰ë–ç1, H“Ą‰Â“ŢŽq1, Ź‹{–ž“ú (‘şź–ž“ú)1, r@Ť’q1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/26), •Ÿ‰Ş.

723828. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • ‰çˆĘŽčp’†‚Ě“Ş•”ŒĹ’čŠí‹ď‚Ěˆá‚˘‚ĹŠáˆłă¸’ö“x‚ɍˇ‚Í‚ ‚é‚Š. Ź‹{–ž“ú(‘şź–ž“ú)1, ’|˜Q–Ż]1, —é–Ř’mŽq, ăˆä䝗LŽq1, ŽÂŒ´ŒcŽq1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/26), •Ÿ‰Ş.

723829. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“šŠŕpŒă‚Ě”˝‰ń_Œo–ƒáƒ‚ĆŒÄ‹zŠí‡•šÇ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ŠÖ“cş•F1, Ź‹{–ž“ú (‘şź–ž“ú)1, ŽÂŒ´ŒcŽq1, H“Ą‰Â“ŢŽq1, “Ą–ěŽŃ‹M1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/27), •Ÿ‰Ş.

723830. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šá_Œo‘яóáv]Œă_Œo’ɂɑ΂ˇ‚郍ƒsƒoƒJƒCƒ““_Šá‚Ě’Á’ÉŒř‰Ę. r@Ť’q1, ‹ŕˆäş•ś2, —с@Œol1, ’ˇŒ´—R‹M, “ˆ”ö~Žq1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/27), •Ÿ‰Ş.

723831. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‚ľ‚˘ICU‘ŢŽşŽž•]‰ż‚Ě—L—pŤ‚ĚŒŸ“˘`ICUÄ“üŽş‚Č‚ç‚Ń‚ÉRapid Response System‹N“Ž‚Š‚ç‚ĚŒŸ“˘`. —é–Ř—D‘ž˜Y1, VˆäłN2, ‹g–ě˜a‹v3, ‘ĺ’Ë’q‹v1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/27), •Ÿ‰Ş.

723832. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽčpŽşŠO‘Sg–ƒŒ79—á‚É‚¨‚Ż‚éŽüpŠúŠÇ—‚ĚŒŸ“˘. ŽÂŒ´ŒcŽq1, źŕV‹`”V1, —é–Ř›’Žk1, •s•ˇˆę‹M1, ŹâN°1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/27), •Ÿ‰Ş.

723833. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆÓŽŻ‰ş‘}ŠÇ‚É‚¨‚Ż‚é’ÁĂ“x‹y‚яpŒă‹L‰Ż‚ÉŠÖ‚ˇ‚éŒă‚ëŒü‚ŤŒŸ“˘. ˆÉ“Ą—@Žq1, ŹâN°2, “c’†ˆęś2, ˆÉ“Ą‘s•˝2, VˆäłN3, ‰Ş–{_Žk2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ƒŒ, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/27), •Ÿ‰Ş.

723834. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠJ• Žčp‚đŒ_‹@‚ÉŒ°Ý‰ť‚ľ‚˝’†•Ť”A•öÇ‚Ě1—á. —é–Ř—D‘ž˜Y1, •Šâ­”V1, VˆäłN2, ŹâN°1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/3), ‚’m.

723835. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ŘÇ‡•šŠłŽŇ‚Ě• o‹ž‰ş’_”X“Eop‚Ě–ƒŒŒoŒą. “Ą“c“ߌb1, ’|˜Q–Ż]1, ăˆä䝗LŽq1, “c’†ˆęś1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/3), ‚’m.

723836. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •Ş—Ł”xŠˇ‹C‚ĚŰ‚ĚƒfƒXƒtƒ‹ƒ‰ƒ“, ƒZƒuƒtƒ‹ƒ‰ƒ“, ƒvƒƒ|ƒtƒH[ƒ‹‚Ě’áŽ_‘fŤ”xŒŒŠÇ. –Ř”Ś‚ ‚â“ß1, “c’†ˆęś1, ‰Ş–{_Žk1, ŒË“c‰ë–ç1, •Šâ­”V1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/3), ‚’m.

723837. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Churg-StrausÇŒóŒQ‚đ‡•š‚ľ‚˝ŠłŽŇ‚É‚¨‚Ż‚éMeigsÇŒóŒQ‚Ě–ƒŒŒoŒą. –ě˜H–ƒ”ü, ˆÉ“Ą‘s•˝, —é–Ř›’Žk1, ç“cˆşŽq1, ŠÖŒű—R‰Ŕ—˘, m–Ř—L—Žq, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/3), ‚’m.

723838. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”xŠŕpŒă”^‹š‚ɑ΂ľƒfƒNƒXƒƒfƒgƒ~ƒWƒ“‚đŽg—p‚ľ‹ÇŠ–ƒŒ•š—p’ÁĂ‰ť‚Ĺ‚Ě‹šo‹ž‰ş”x”—Łp‚đŽ{s‚ľ‚˝ˆę—á. _“c‰Â“ŢŽq1, źŕV‹`”V1, “Ą–ěŽŃ‹M1, —é–Ř›’Žk1, ě’[䝗˜Žq1, ’†ŕVˆş”T1, –{“c’h1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/3), ‚’m.

723839. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ŠúˆÝŠŕE“ŕŽ‹‹ž“I”S–Œ‰ş‘w”—Łp‚ɑ΂ˇ‚é–ƒŒ‰Č‚Ö‚Ě’ÁĂˆË—ŠƒvƒƒgƒR[ƒ‹‚ĚĐ‰î. —é–Ř›’Žk1, ‘ĺ’Ë’q‹v1, źŕV‹`”V1, ź“cO”ü1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/4), ‚’m.

723840. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘S‹|•”’uŠˇpŒă‚É‚¨‚Ż‚鍂‘̉ˇ‚ĚƒŠƒXƒNˆöŽq‚ɂ‚˘‚Ä‚ĚŒŸ“˘. źŕV‹`”V1, •Šâ­”V1, –k‘ş@—Ľ2, ‘ĺ’Ë’q‹v1, ‹g–ě˜a‹v3, ź–{ŽœŠ°1, —é–Ř—D‘ž˜Y1, ŠÖ“cş•F1, VˆäłN4, ‰Ş–{_Žk1 (1–ƒŒ, 2S‘ŸŒŒŠÇŠO, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y.

723841. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰şŽˆŘ’fpÇ—á‚É‚¨‚Ż‚éŽüpŠúŽ€–S‚ÉŠń—^‚ˇ‚éˆöŽq‚ĚŒŸ“˘. ‘ĺ’Ë’q‹v1, •Šâ­”V1, —é–Ř›’Žk1, ‹g–ě˜a‹v2, VˆäłN3, ‰Ş–{_Žk1 (1–ƒŒ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y.

723842. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@ICU ‚É‚¨‚Ż‚é[Š{•”ŽîᇁE~‰şŤ‰óŽ€ŤcŠu‰ŠŠłŽŇ8Ç—á‚ĚŒŸ“˘. —é–Ř—D‘ž˜Y1, VˆäłN2, ‚‹´@—É3, źŕV‹`”V1, ‘ĺ’Ë’q‹v1, ‹g–ě˜a‹v4, ˆÉ“Ą‘s•˝1, ŹâN°1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3t‘Ÿ“ŕ, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y.

723843. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚é‰@“ŕICU‚Ć‹~–˝ƒZƒ“ƒ^[ICU‚Ě‘Šˆá‚Ć‘ŠŒÝ‹Ś—͑̐§. •Šâ­”V1, VˆäłN2, •Đ‰Ş—Sˆę3, ó—˜@–ő3 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y.

732105. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) yS2-4: Ă–ŹŒŒđÇđÇ‚Ě—\–hz–ƒŒ‰Č—Ěˆć‚É‚¨‚Ż‚é—\–h|ŽüpŠú—\–h‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę|. •Šâ­”V (–ƒŒ): ”xÇđÇŒ¤‹†‰ď@ŠwpW‰ď (2016/11/26), “Œ‹ž.

733427. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”˝•œ‚ľ‚˝Sepsis‚Ě‘ŠúÇó‚Ć‚ľ‚Ä, ‚š‚ń–Ď‚ŞŒ°’˜‚Ĺ‚ ‚Á‚˝”Ä”­Ť• –Œ‰Š‚Ěˆę—á. ‘ĺ’Ë’q‹v1, VˆäłN2, r@Ť’q1, ‹g–ě˜a‹v1, “c’†ˆęś1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć25‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/8/20), “Œ‹ž.

733428. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Cetuximab‚É‚ć‚é‚ĆŽv‚í‚ę‚éŠÔŽżŤ”xŽžŠł‚ŏW’†ŽĄ—Ă‚É‚ć‚č‹~–˝‚ľ‚Ś‚˝1—á. —é–Ř—D‘ž˜Y1, VˆäłN2, ‹g–ě˜a‹v1, ‘ĺ’Ë’q‹v1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć25‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/8/20), “Œ‹ž.

733429. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’×ᇐŤ‘ĺ’°‰Š‚É•š”­‚ľ‚˝Sepsis Induced Cardiac Dysfunction‚ɑ΂ľVA-ECMO‚Ě“ą“ü‚É‚ć‚č‹~–˝‚ľ‚Ś‚˝ˆę—á. ăˆä䝗LŽq1, VˆäłN2, —é–Ř—D‘ž˜Y1, ‹g‰Şr•ă1, ‘ĺ’Ë’q‹v1, źŕV‹`”V1, ˆÉ“Ą‘s•˝1, ŹâN°1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć25‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/8/20), “Œ‹ž.

733430. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) AŒQ—n˜A‹ŰŠ´őÇ‚É‚ć‚é”sŒŒÇ‚ŏzŠÂŠÇ—‚É“ďa‚ľACTH’P“ĆŒ‡‘šÇ‚É‚ć‚é•›t•s‘S‚̐f’f‚ÉŽŠ‚Á‚˝1—á. ‹g–ě˜a‹v1, VˆäłN2, źŕV‹`”V1, —é–Ř—D‘ž˜Y1, ‘ĺ’Ë’q‹v1, ŠÖ“cş•F1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć25‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/8/20), “Œ‹ž.

733431. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) TEN‚É•š”­‚ľ‚˝ŒÄ‹zEzŠÂ•s‘S‚ɑ΂ˇ‚éVAV-ECMO‚ĚŽg—pŒoŒą. źŕV‹`”V1, VˆäłN2, —é–Ř—D‘ž˜Y1, ‘ĺ’Ë’q‹v1, ‹g–ě˜a‹v1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć13‰ń‘ŸŠí•s‘SŠłŽŇ‚ɑ΂ˇ‚éŠO‰ČEŠÇ—Œ¤‹†‰ď (COSMOF) (2016/11/19), “Œ‹ž.

733432. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰Š‚É•š”­‚ľ‚˝Sepsis Induced Cardiac Dysfunction‚ɑ΂ľVA-ECMO‚Ě“ą“ü‚É‚ć‚č‹~–˝‚ľ‚Ś‚˝ˆę—á. ăˆä䝗LŽq1, VˆäłN2, —é–Ř—D‘ž˜Y1, ‹g‰Şr•ă1, ‘ĺ’Ë’q‹v1, źŕV‹`”V1, ˆÉ“Ą‘s•˝1, ŹâN°1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć13‰ń‘ŸŠí•s‘SŠłŽŇ‚ɑ΂ˇ‚éŠO‰ČEŠÇ—Œ¤‹†‰ď (COSMOF) (2016/11/19), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522009. [uŔ]y“ÁW: Ă–ŹŒŒđÇđÇ2016`‚í‚Ş‘‚̍ŐV‚̏î•ń‚Š‚ç`z2. ‚í‚Ş‘‚ĚŽüpŠú”xŒŒđÇđÇ‚Ě•Ď‘J. •Šâ­”V (–ƒŒ): ŒŒ‰tƒtƒƒ“ƒeƒBƒA 2016/3; 26 (3): 331-7.


—Տ°ŒŸ¸f’fŠw

[’˜@‘]

620162. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@ŒŸ‘ĚŒŸ¸@‘ć1Í ”AE•ł•Ö“™ŒŸ¸@•ł•Ö“h–•Œ°”÷‹žŒŸ¸ (•ÖŽ‰–b, Á‰ťó‹ľŠĎŽ@), p.16. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620163. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@ŒŸ‘ĚŒŸ¸@‘ć1Í ”AE•ł•Ö“™ŒŸ¸@‘‰tˆę”ĘŒŸ¸, p.18. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620164. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@ŒŸ‘ĚŒŸ¸@‘ć1Í ”AE•ł•Ö“™ŒŸ¸@“űŽ_ƒfƒqƒhƒƒQƒi[ƒ[ (LD) ”ź’č—Ę, p.20. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620165. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@ŒŸ‘ĚŒŸ¸@‘ć1Í ”AE•ł•Ö“™ŒŸ¸@ƒIƒŠƒSƒNƒƒi[ƒ‹ƒoƒ“ƒh, p.21. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620166. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@ŒŸ‘ĚŒŸ¸@‘ć1Í ”AE•ł•Ö“™ŒŸ¸@ƒ~ƒGƒŠƒ“‰–ŠîŤ’`”’ (MBP) (‘‰t), p.21. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620167. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć11Í _ŒoE‹ŘŒŸ¸@äNă÷“ŕˆł‘Ş’č, p.256. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620168. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć16Í •‰‰×ŽŽŒą“™@ƒtƒBƒVƒ…ƒo[ƒO (ƒ‚[ƒ[ƒ“ƒ^[ƒ‹–@), p.290. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620169. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć16Í •‰‰×ŽŽŒą“™@…—˜”AŽŽŒą, p.290. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620170. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć16Í •‰‰×ŽŽŒą“™@ƒˆ[ƒhƒJƒŠŽŽŒą, p.291. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620171. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć16Í •‰‰×ŽŽŒą“™@”AŽ¸‹Ö’č—ĘƒeƒXƒg (ƒpƒbƒhƒeƒXƒg), p.292. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620172. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć18Í “ŕŽ‹‹žŒŸ¸@äNă÷”A“šƒtƒ@ƒCƒo[ƒXƒRƒs[, p.307. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620173. [Šwp‘ (•Ş’SŽˇ•M)]yĹV ŒŸ¸E‰ć‘œf’fŽ–“T 2016-17”N”Łz<ŒŸ¸•Ň>@‘ć18Í “ŕŽ‹‹žŒŸ¸@äNă÷”A“š‹žŒŸ¸, p.307. Žë–ě—Lě (—ŐŒŸŠw), •Ň’˜: “ú–{—Տ°ŒŸ¸ˆăŠw‰ď, ˆăŠw’ʐMŽĐ, “Œ‹ž, 2016/5”­s.

620174. [Šwp‘ (•Ş’SŽˇ•M)]yĹVŠĽ“Ž–ŹŽžŠłŠw ă|ŠĽ“Ž–ŹŽžŠł‚̍ŐVŽĄ—Ð헪|(“ú–{—ŐŕŹ74ŠŞ‘Š§†4)zV. ŠĽ“Ž–ŹŽžŠł‚ĚŒŸ¸Ef’f@14. ŒŒ‰t‹ĂŒĹü—nŒnŒŸ¸, p.301-5. Žë–ě—Lě (—ŐŒŸŠw), “ú–{—Ő଎Đ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

731176. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žîᇃ}[ƒJ[. Žë–ě—Lě (—ŐŒŸŠw): “ú–{—Տ°ŒŸ¸ę–ĺŠw‰@śŠU‹łˆçuŔ (2016/11/21), “Œ‹ž.

732106. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) R-CPC (Reverse-Clonicopathological Conference). Žë–ě—Lě (—ŐŒŸŠw): •˝Ź28”N“xŒŸ¸ŕ–žE‘Š’k‚Ş‚Ĺ‚Ť‚é—Տ°ŒŸ¸‹ZŽtˆçŹuK‰ď (2017/3/5), ‘Š–ÍŒ´.


—AŒŒE×–EˆÚAŠw

[Šwp˜_•ś]

120040. [Œ´’˜] f—ÉȕʗAŒŒťÜ•›ě—p”­ś—Ś‚Ě’˛¸. “ĄˆäN•F, “c’†’ŠŽu, Ź‚ç‰Á‘ă, ‰Á“Ą‰hŽj, •Ä‘ş—YŽm, “Ą“‡’źm, ˛X–Ř‚ł‚ŤŽq, “Ţ—Çčłr, ‘ĺŕVr–ç, “cč“N“T, ‹gęŽj˜N, Šâ”öŒ›–ž, ‰z’m‘Ľ—\, Ź—Ń—mŽq, ‹´–{@˝, Ž™‹Ę‚é‚Ý, ě–ě—m”V, ’|ƒm“ŕ”Ž”V, ‹ŕŒő@–ő, –ěŠÔŒű—R—˜Žq, ‹I–ěCˆę, ŒÜ\—’Ž , Îˆä”Ž”V, ‘ĺ’JTˆę1, ‘ĺŒG@˜a, ‰Şč@m, –kŕV~ˆę, “ú–ě@Šw, •SŁr–ç, •lŒű@Œ÷ (1—AŒŒE×–EˆÚA): “ú–{—AŒŒ×–EŽĄ—ĂŠw‰ďŽGŽ 2016/6; 62 (3): 451-8.

540060. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)u—AŒŒˆă—Ă‚É‚¨‚Ż‚éƒgƒŒ[ƒTƒrƒŠƒeƒBŠm•Ű‚ÉŠÖ‚ˇ‚錤‹†vzƒgƒŒ[ƒTƒrƒŠƒeƒB‚ÉŠÖ‚ˇ‚éƒpƒCƒƒbƒgƒXƒ^ƒfƒB.•˝Ź28”N“x•Ş’SŒ¤‹†•ń‘ •lŒű@Œ÷, ‘ĺ’JTˆę1, –kŕV~ˆę, –L“c‹ă˜N, •˝@—Í‘˘, ‹I–ěCˆę, “c’†’ŠŽu, •Ä‘ş—YŽm, “ĄˆäN•F, ‘ĺâŒ°“š, ‰Şč@m, ‰Á“Ą‰hŽj, ź‰Ş˛•ŰŽq (1—AŒŒE×–EˆÚA): Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)u—AŒŒˆă—Ă‚É‚¨‚Ż‚éƒgƒŒ[ƒTƒrƒŠƒeƒBŠm•Ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź28”N“x•Ş’SŒ¤‹†•ń‘ 2017/3; p.3-15.

540061. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)u—AŒŒˆă—Ă‚É‚¨‚Ż‚éƒgƒŒ[ƒTƒrƒŠƒeƒBŠm•Ű‚ÉŠÖ‚ˇ‚錤‹†vzôňŒŒŹ”ťÜŽg—p‚É‚ć‚é•›ě—p”­śŒyŒ¸Œř‰Ę‚ĚŒŸ“˘.•˝Ź28”N“x•Ş’SŒ¤‹†•ń‘ •lŒű@Œ÷, ‘ĺ’JTˆę1, –kŕV~ˆę, –L“c‹ă˜N, •˝@—Í‘˘, ‹I–ěCˆę, “c’†’ŠŽu, •Ä‘ş—YŽm, “ĄˆäN•F, ‘ĺâŒ°“š, ‰Şč@m, ‰Á“Ą‰hŽj, ź‰Ş˛•ŰŽq (1—AŒŒE×–EˆÚA): Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)u—AŒŒˆă—Ă‚É‚¨‚Ż‚éƒgƒŒ[ƒTƒrƒŠƒeƒBŠm•Ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź28”N“x•Ş’SŒ¤‹†•ń‘ 2017/3; p.27-33.

[Šw‰ďEŒ¤‹†‰ď“™]

713154. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Slow responders to H pylori eradication in adult Japanese patients with immune thrombocytopenia. Miyazaki K1, Satoh T, Higashihara M2: 62nd Annual ISTH (the International Society on Thrombosis and Haemostasis) SCC Meeting (2016/5/25), Montpellier, France. (‹{č_“ń1, “ŒŒ´ł–ž2: 1—AŒŒE×–EˆÚA, 2ŒŒ‰t“ŕ)

722260. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ŠłŽŇˆŔ‘SƒKƒCƒh (—AŒŒ•Ň) Ver.1.0‚ĚŠŽŹ‚Č‚ç‚Ń‚ÉĄŒă‚Ěƒ^ƒXƒNƒtƒH[ƒX‚Ě“WŠJ‚ɂ‚˘‚Ä. ‘ĺ’JTˆę (—AŒŒE×–EˆÚA): ‘ć64‰ń“ú–{—AŒŒE×–EŽĄ—ĂŠw‰ď‘‰ď (2016/4/30), ‹ž“s.


‹~–˝‹~‹}ˆăŠw

[Šwp˜_•ś]

120041. [Œ´’˜] ¸_‰Čg‘̍‡•šÇ•a“‚É“ü‰@‚ľ‚˝‚Ş‚ń‚đ‡•š‚ˇ‚鐸_ŽžŠłŠłŽŇ‚É‚Š‚ń‚ˇ‚錟“˘. Vˆä‹v–Ť1, ŽR–{ŒŤŽi2, ˆäăŸ•v2, ŠŰ“ŢŒb, ’ËŒ´“ÖŽq, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ¸_ˆăŠwŽGŽ 2016/4; 58 (4): 289-96.

120042. [Œ´’˜]y“ÁW: ACS ‚É‚¨‚Ż‚é‰h—{ŠÇ—zdÇŠOŠłŽŇ‚ɑ΂ˇ‚é‰h—{ŠÇ—‚ƕ“Iƒ`[ƒ€ˆă—Ă‚Ě•K—vŤ. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, ó—˜@–ő1 (1‹~–˝): Japanese Journal of Acute Care Surgery 2016; 6 (1): 26-31.

120043. [Œ´’˜] ’nˆćĐŠQˆă—ĂŒv‰ćô’č‚Ě‚˝‚߂̐V‚˝‚ȍЩQˆă—ĂŽů‹‹‹ĎtŽw•W (ĐŠQˆă—ĂƒŠƒXƒNƒŠƒ\[ƒX”ä) ‚Ě“ą“ü. X‘şŽ“o, –â“cçť, ˆŔ•”@–Ň, ’|“ŕˆę˜Y1, •ž•”@1, •ž•”‹żŽq2, ‚‹´k•˝, –{‘˝‰pŠě, “ŕŽR@l, ź“c@Œ‰, ’†ě‹V‰p, ó—˜@–ő1 (1‹~–˝, 2ŽY‰Č): Japanese journal of disaster medicine 2016/6; 21 (1): 10-7.

120044. [Œ´’˜] ‹~–˝‹~‹}ƒZƒ“ƒ^[‚É”Ŕ‘—‚ł‚ꎊŽEŠé}‚Ş‹^‚í‚ę‚Ä“ü‰@‚Ć‚Č‚Á‚˝ŠłŽŇ‚̑Ήž|¸_‰Čˆă‚Ě–đŠ„‚ÉŠÖ‚ľ‚ā|. Vˆä‹v–Ť1, ˆäăŸ•v2, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ¸_‰ČŠw ‘‡•a‰@¸_ˆăŠw 2017/1; 29 (1): 15-23.

[Šw‰ďEŒ¤‹†‰ď“™]

711004. [Šw‰ď (‘Ű)] (“Á•Ęu‰‰) How do we manage E-CPR Patients 4th annual meeting of Chinese Extracorporeal Life Support (Ch ECLS) Management of E-CPR in the World. Takeuchi I1: ChECLS annual meeting (2016/6/15), Beijing, China. (’|“ŕˆę˜Y1: 1‹~–˝)

722261. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‚â‚Ü‚ä‚艀‘˝”•aŽŇ”­śŽ–—á‚đĐŠQˆă—Ă‚Ě—§ę‚ōl‚Ś‚é|14–ź‚Ě‘˝”•aŽŇ‚đŽó‚Ż“ü‚ę‚˝“–‰@‚ł̑Ήž|. •Đ‰Ş—Sˆę1, •ž•”@1, ó—˜@–ő1 (1‹~–˝): ‘ć22‰ń“ú–{W’cĐŠQˆăŠw‰ď‘‰ďEŠwpW‰ď (2017/2/13), –źŒĂ‰Ž.

722262. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) dÇŠO‚ɑ΂ˇ‚éŠO‰ČŽĄ—Ă‚ĆIVR‚ĚƒRƒ“ƒrƒl[ƒVƒ‡ƒ“ŽĄ—Ă. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, ŠŰ‹´Fş1 (1‹~–˝): ‘ć53‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2017/3/2), ‰Ą•l.

723844. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) œ”ՍœÜ‚ɑ΂ˇ‚é—ź‘¤“ŕ’°œ“Ž–ŹÇđp‚Ćä\‹Ř‰óŽ€‚ĚŠÖ˜AŤ. ŠŰ‹´Fş1, Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć30‰ń“ú–{ŠOŠw‰ď‘‰ďEŠwpW‰ď (2016/5/30), “Œ‹ž.

723845. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇ• •”œ”ŐŠO‚ɑ΂ˇ‚éIVR‚Ě—L—pŤ‚Ć–â‘č“_. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, ŠŰ‹´Fş1, •ôŒ´Gš1, ó—˜@–ő1 (1‹~–˝): ‘ć30‰ń“ú–{ŠOŠw‰ď‘‰ďEŠwpW‰ď (2016/5/31), “Œ‹ž.

723846. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —ˆ‰@ŽžCT‚¨‚ć‚Ń• •”ŠŒŠ‚ɂĐf’f‚Ĺ‚Ť‚Č‚Š‚Á‚˝’°ŠÇE’°ŠÔ–Œ‘šÇ—á. ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć30‰ń“ú–{ŠOŠw‰ď‘‰ďEŠwpW‰ď (2016/5/31), “Œ‹ž.

723847. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Ý“IŠĚ‘š‚ĚŽĄ—Ð헪. Š~ŒŠ•śŽ}1, ŠŰ‹´Fş1, ŽR’J—§‘ĺ1, ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć30‰ń“ú–{ŠOŠw‰ď‘‰ďEŠwpW‰ď (2016/5/31), “Œ‹ž.

723848. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ć‘œă“Ż’č‚ľ‚Ś‚˝tĂ–Ź•ŞŽ}‘š‚Ěˆę—á. ŠŰ‹´Fş1, Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć30‰ń“ú–{ŠOŠw‰ď‘‰ďEŠwpW‰ď (2016/5/31), “Œ‹ž.

723849. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹~–˝‹~‹}ƒZƒ“ƒ^[‚ÉŽŠŽEŠé}‚Ĺ”Ŕ‘—“ü‰@‚Ć‚Č‚Á‚˝ƒp[ƒ\ƒiƒŠƒeƒBáŠQ‚Ć‹C•ŞáŠQ‚Ě—Ő°“I“Á’Ľ. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‘ĺÎ@’q2, ó—˜@–ő1 ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć112‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2016/6/2-4), ç—t.

723850. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹~–˝‹~‹}ƒZƒ“ƒ^[‚É‹}Ť–ň•¨’†“Ĺ‚Ĺ”Ŕ‘—‚ł‚ę‚˝ŠłŽŇ‚Ě—Ő°“I“Á’Ľ‚Ɛ¸_‰ČŠO—ˆ˜AŒg‚̉ۑč. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‘ĺÎ@’q2, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/9), ‰Ą•l.

723851. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ€ÇŒ^‰óŽ€Ť“î•”‘gDŠ´őÇ‚Ě—Ő°“I“Á’Ľ‚ĆŽĄ—Ð헪‚ĚŒŸ“˘. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, ó—˜@–ő1 (1‹~–˝): ‘ć8‰ń“ú–{Acute Care SurgeryŠw‰ďŠwpW‰ď (2016/9/24), ‘ĺă.

723852. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒnƒCƒuƒŠƒbƒhŽĄ—Ă‚Ş—LŒř‚Ĺ‚ ‚Á‚˝• •”Žh‘n‚É‚ć‚éŠĚ‘š‚Ě1—á. ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć8‰ń“ú–{Acute Care SurgeryŠw‰ďŠwpW‰ď (2016/9/24), ‘ĺă.

723443. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚ŒŒˆłŤŹ”]oŒŒ‚É‚¨‚Ż‚é’´‹}ŤŠú“ŕŽ‹‹ž‰şŒŒŽîœ‹Žp‚Ě—LŒřŤ. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, Ż@‰Ŕ–F3, ŒG•”rG2 (1‹~–˝, 2”]ŠO, 3‰qś): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć75‰ńŠwp‘‰ď (2016/9/30), •Ÿ‰Ş.

723451. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚ŒŒˆłŤŹ”]oŒŒ‚É‚¨‚Ż‚é’´‹}ŤŠú“ŕŽ‹‹ž‰şŒŒŽîœ‹Žp‚Ě—LŒřŤ. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, Ż@‰Ŕ–F3, ŒG•”rG2 (1‹~–˝, 2”]ŠO, 3‰qś): ‘ć23‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2016/11/17), “Œ‹ž.

723853. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) • •”ŠO‚É‚¨‚Ż‚édelayed laparotomyÇ—á‚ĚŒŸ“˘. ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć44‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/11/18), “Œ‹ž.

723854. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒJƒtƒFƒCƒ“’†“Ĺ‚É‚ć‚鎊ŽEŠé}‚Ĺ‹~–˝‹~‹}ƒZƒ“ƒ^[‚É”Ŕ‘—‚ł‚ę‚˝Ç—á‚ĚŒŸ“˘. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‹g‘ş‹vmŽq, ‘ĺÎ@’q2, ŽR’J—§‘ĺ1, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć29‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ďŠwp‘‰ď (2016/11/25), “Œ‹ž.

723855. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹~‹}ˆă—Ă‚É‚¨‚Ż‚éI––Šúˆă—Ă‚Ćƒ`[ƒ€ˆă—Á`ƒOƒŠ[ƒtƒPƒAƒ`[ƒ€‚Ě—L—pŤ`. •Đ‰Ş—Sˆę1, Vˆä‹v–Ť1, ó—˜@–ő1 (1‹~–˝): ‘ć44‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/11/18), “Œ‹ž.

723856. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒOƒŠ[ƒtƒPƒAƒ`[ƒ€‚É‚ć‚é‹~‹}EW’†ŽĄ—Ă‚É‚¨‚Ż‚éI––Šúˆă—Ă‚Ö‚ĚŽć‚č‘g‚Ý. •Đ‰Ş—Sˆę1, Vˆä‹v–Ť1, ó—˜@–ő1 (1‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y.

723857. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹~‹}EW’†ŽĄ—Ă—Ěˆć‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚¨‚Ż‚é•ďŠ‡“Iƒ`[ƒ€ˆă—Ă‚Ě•K—vŤ. •Đ‰Ş—Sˆę1, •ž•”@1, ó—˜@–ő1 (1‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/11), ŽD–y.

723858. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”j—ô”]“Ž–ŹáŽƒNƒŠƒbƒsƒ“ƒOpŒă‚ÉŠ{‰ş‘BŽî’Ż‚É‚ć‚é‹C“š‹ˇó‚đ—ˆ‚ľ‚˝1—á. ŹňŠ°”V1, ŒG•”rG2 (1‹~–˝, 2”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2017/3/16), ‘ĺă.

733433. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹~–˝‹~‹}EĐŠQˆă—ĂƒZƒ“ƒ^[‚É“ü‰@‚Ć‚Č‚Á‚˝_ŒoŤ–łH—~ÇŠłŽŇ‚Ě—Ő°“I“Á’Ľ`ŽŠŽEŠé}, g‘̍‡•šÇ‚Ě”äŠr`. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‘ĺÎ@’q2, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć43‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/9/10), ‰Ą•l.

733434. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‹~‹}ĐŠQˆă—ĂƒZƒ“ƒ^[‚É‚¨‚Ż‚éŽh‘n/’Ä—ŽŠOŽŠŽEŠé}“ü‰@ŠłŽŇ‚Ě—Ő°“IˇˆŮ‚ĚŒŸ“˘. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‘ĺÎ@’q2, ˆäă•üŽq2, ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć44‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2017/3/18), ‰Ą•l.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-723018. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”j—ô”]“Ž–ŹáŽƒNƒŠƒbƒsƒ“ƒOpŒă‚ÉŠ{‰ş‘BŽî’Ż‚É‚ć‚é‹C“š‹ˇó‚đ—ˆ‚ľ‚˝1—á. ŹňŠ°”V1, ŒG•”rG2 (1‹~–˝, 2”]ŠO): ‘ć46‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2016/3/16), ‘ĺă.

H27-733005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”j—ô”]“Ž–ŹáŽƒNƒŠƒbƒsƒ“ƒOpŒă‚ÉŠ{‰ş‘BŽî’Ż‚É‚ć‚é‹C“š‹ˇó‚đ—ˆ‚ľ‚˝1—á. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, ‹ß“Ą—łŽj2, ŒG•”rG2 (1‹~–˝, 2”]ŠO): ‘ć26‰ń_“ސě”]_ŒoŠO‰ČŽčpŽč‹ZŒ¤‹†‰ď (2016/1/7), ‰Ą•l.


‘‡f—ĂˆăŠw

[Šwp˜_•ś]

110289. [Œ´’˜] Rapidity and Severity of Hemoglobin Decreasing Associated with Erythrocyte Inosine Triphosphatase Activity and ATP Concentration during Chronic Hepatitis C Treatment. Tanaka Y, Tamura Y, Yokomori H1,2, Komiyama T: Biol Pharm Bull 2016/4; 39 (4): 615-9. (‰ĄXOş1,2: 1‘‡f—Ă, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

110290. [Œ´’˜] Hepatobiliary and Pancreatic: Acute liver injury induced by Vigna angularis (adzuki bean) pastry. Takeda K1, Yamazaki H1,2, Oda M1, Yokomori H1,3: J Gastroenterol Hepatol 2016/6; 31 (6): 1072. (ŽRč@“™1,2, ‰ĄXOş1,3: 1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2•a—, 3‘‡f—Ă)

310033. [Ç—á•ń] Over-the-counter Drug Induced Autoimmune Hepatitis. Takeda K1, Oda M, Okada T1, Yamazaki H1,2, Ohbu M3, Watanabe M1,4, Yokomori H1,5: Intern Med 2016/5; 55 (10): 1293-7. (ŽRč@“™1,2, ‘ĺ•”@˝3, “n粐^˛1,4, ‰ĄXOş1,5: 1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 3•a—, 3ˆă—ÉqśŠw•”, 4Á‰ťŠí“ŕ, 5‘‡f—Ă)

310034. [Ç—á•ń] 18F-FDG PET/CT for Diagnosis of Castleman Disease: A Case Report. Suzuki S1, Takeda K1, Okada T1, Yamazaki H1,2, Yasutaka Senpuku Y, Yokomori H1,3: J Gastrointest Dig Syst 2016/5; 6: 431. (ŽRč@“™1,2, ‰ĄXOş1,3: 1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2•a—, 3‘‡f—Ă)

310035. [Ç—á•ń] Primary hepatic angiomyolipoma: immunohistochemistry and electron microscopic observations: a case report. Kubo H1, Yamazaki H1,2, Okada T1, Takahashi Y1,3, Nishi Y1, Yokomori H1,4: J Med Case Rep 2017; 11: 76. Published online 2017 Mar 22. doi: 10.1186/s13256-017-1235-1. (ŽRč@“™1,2, ‚‹´’ől1,3, ‰ĄXOş1,4: 1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2•a—, 3ŠO‰Č, 4‘‡f—Ă)

320030. [Ç—á•ń] ŒQ”­“ޒɂɑ΂ľ‚Ä‘IŠď“’‚Ě“Ú—p‚Ş’˜Œř‚ľ‚˝1—á. X—T‹IŽq1, ŒÜ–ě—R‰Ŕ—2, ‹yě“N˜Y1, Ź“cŒű_1, ‰Ô—Öšć•F3 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2‘‡f—Ă, 3“Œ—mˆăŠw‹łˆç): “ú–{“Œ—mˆăŠwŽGŽ 2016/7; 67 (3): 274-9.

320031. [Ç—á•ń] ŽlŽˆ‚Š‚ç‘ĚŠ˛‚É‚¨‚ć‚Ô—L’ɐŤ‹Řázš‚ɑ΂ľ‚Ä“–‹AŽl‹t‰ÁŒŕäŁäΐś›I“’‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆęÇ—á ŒÜ–ě—R‰Ŕ—1, Ź“cŒű_, ‰Ô—Öšć•F2 (1‘‡f—Ă, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2016/10; 63 (10): 1397-402.

522128. [uŔ]y“ÁW: V–ň‚É”ň‚т‚Š‚Č‚˘! Šů‘ś–ňEV–ň‚Ć‚ĚăŽč‚Ȃ‚Ť‚ ‚˘•űzV–ň vs Šů‘ś–ň@ARB”z‡–ň. ůŔG”N, –Ř‘ş‘ô–1 (1‘‡f—Ă): ŽĄ—Ă 2016/8; 98 (8): 1200-5.

522129. [uŔ]y“ÁW: “ޒɁE‚ß‚Ü‚˘zŽĄ—Á^’m‚Á‚Ä‚¨‚­‚ׂŤŽĄ—Ă‚Ěƒ|ƒCƒ“ƒg‚Ć’ˆÓ“_@“ޒɐf—Ă‚É‚¨‚Ż‚銿•ű–ň‚ĚŽg‚˘‚Š‚˝. ŒÜ–ě—R‰Ŕ—1, r–ؐM•v (1‘‡f—Ă): Medical Practice 2017/2; 34 (2): 313-7.

540062. [‚ť‚Ě‘ź (Web‹LŽ–)] ‚—îŽŇ‚́g‚Š‚şh‚đ‚ ‚Ü‚­ŒŠ‚Ä‚Í‚˘‚Ż‚Č‚˘. –Ř‘ş‘ô– (‘‡f—Ă): Medical Tribune 2016/4/13.

540063. [‚ť‚Ě‘ź (Web‹LŽ–)] ‚ ‚č‚Ş‚ż‚ȍ‚—îŽŇ‚̐H—~•sU‚É‚Í‚ą‚¤‘Ήž‚ˇ‚é. –Ř‘ş‘ô– (‘‡f—Ă): Medical Tribune 2016/4/16.

540064. [‚ť‚Ě‘ź (Web‹LŽ–)] ‚—îŽŇ‚Ě”F’m‹@”\‚Ş’á‰ş‚ľ‚Ä‚Ť‚˝’ĽŒó‚Ć‚Í? –Ř‘ş‘ô– (‘‡f—Ă): Medical Tribune 2016/6/16.

540065. [‚ť‚Ě‘ź (Web‹LŽ–)] ‚—îŽŇƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚́u—Ž‚Ć‚ľŒŠv‚Ɋׂç‚Č‚˘. –Ř‘ş‘ô– (‘‡f—Ă): Medical Tribune 2016/7/13.

540066. [‚ť‚Ě‘ź (Web‹LŽ–)] u•t‚Ť“Y‚˘ŽŇ‚ĆŠO—ˆŽóf‚ľ‚˝‚—îŽŇv‚É‚Ç‚¤Ú‚ˇ‚é‚Š. –Ř‘ş‘ô– (‘‡f—Ă): Medical Tribune 2016/11/24.

[’˜@‘]

620175. [Šwp‘ (•Ş’SŽˇ•M)]y_Œo“ŕ‰ČClinical Questions and Pearls [“Ş’É]zII. •Đ“ޒɁ@3. •Đ“ޒɂɑ΂ˇ‚銿•űŽĄ—Âɂ͂ǂ̂悤‚Č‚ŕ‚Ě‚Ş‚ ‚č‚Ü‚ˇ‚Š? p.78-81. ŒÜ–ě—R‰Ŕ— (‘‡f—Ă), ƒVƒŠ[ƒYŠÄC: —é–Ř‘ĽG, •Ň: ´…—˜•F, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/5”­s.

620176. [Šwp‘ (•Ş’SŽˇ•M)]y‘‡f—Ðę–ĺŒ¤C‚ĚŽčˆř‚Ť4@‰˝‚đ‚Ç‚¤‹ł‚ŚŠw‚Ô‚Š@H•v‚ĆŽŔ—áz2 Œ¤C‚đ‚ǂ̂悤‚ÉŠw‚ń‚Ĺ‚ä‚­‚Š@‘˝—l‚ČŒ¤C‚̏ę‚ɉž‚ś‚˝Šw‚Ń‚ĚH•v@‘ź‚Ě—Ěˆć•ĘŒ¤C@ƒp[ƒgƒ^ƒCƒ€Œ¤C‚đs‚¤Ű‚̍H•v, p.267-71. –Ř‘ş‘ô– (‘‡f—Ă), •ŇWŽĺŠ˛: ‘ę“SŽü, ’†ŽR‘“X, “Œ‹ž, 2016/6”­s.

620177. [Šwp‘ (•Ş’SŽˇ•M)]y‰îŒěŽx‰‡ę–ĺˆőŒť”CŒ¤CƒeƒLƒXƒg‘ć1ŠŞ@ę–ĺŒ¤C‰Ű’öIz‘ć5Í ƒPƒAƒ}ƒlƒWƒƒ“ƒg‚É•K—v‚Čˆă—Ă‚Ć‚Ě˜AŒg‹y‚Ń‘˝EŽí‹Ś“­‚ĚŽŔ‘H, p.192-218. ⨍F‘ž˜Y1, –Ř‘ş‘ô–1 (1‘‡f—Ă), •Ň: ”’ŕV­˜a, ‰Ş“ciˆę, ě‰zł•˝, ”’–Ř—TŽq, •Ÿ•xšé, ’†‰›–@‹Ko”Ĺ, “Œ‹ž, 2016/11”­s.

620178. [Šwp‘ (•Ş’SŽˇ•M)]yˆăŠw‹łˆç—pŒęWz“Á’č‹@”\•a‰@. ’|–{@‹B (‘‡f—Ă), “ú–{ˆăŠw‹łˆçŠw‰ď, “Œ‹ž, 2016 (Web‰{——).

620179. [Šwp‘ (•Ş’SŽˇ•M)]yˆăŠw‹łˆç—pŒęWzf—Ă˜^. ’|–{@‹B (‘‡f—Ă), “ú–{ˆăŠw‹łˆçŠw‰ď, “Œ‹ž, 2016 (Web‰{——).

620180. [Šwp‘ (•Ş’SŽˇ•M)]yˆăŠw‹łˆç—pŒęWz‰“Šuˆă—Ă. ’|–{@‹B (‘‡f—Ă), “ú–{ˆăŠw‹łˆçŠw‰ď, “Œ‹ž, 2016 (Web‰{——).

620181. [Šwp‘ (•Ş’SŽˇ•M)]yˆăŠw‹łˆç—pŒęWzˆăŽt”…žÓ”C•ŰŒŻ. ’|–{@‹B (‘‡f—Ă), “ú–{ˆăŠw‹łˆçŠw‰ď, “Œ‹ž, 2016 (Web‰{——).

622001. [Šwp‘ (–|–ó)]y10•Ş‚Ĺ‚Ĺ‚Ť‚é”F’ms“Ž—Ă–@“ü–ĺz’|–{@‹B (‘‡f—Ă), “úŒoBPŽĐ, “Œ‹ž, 2016/6”­s.

622002. [Šwp‘ (–|–ó)]yˆăŠw‹łˆç•Ş–ě•Ę•]‰żŠî€“ú–{”Ł@˘ŠEˆăŠw‹łˆç˜A–ż (WFME) ƒOƒ[ƒoƒ‹ƒXƒ^ƒ“ƒ_[ƒh2015”N”ŏ€‹’ (Continuing Professional Development of Medical Doctors WFME Global Standards for Quality Improvement The 2015 Revision)zŒ´’˜47-9. ’|–{@‹B (‘‡f—Ă), “ú–{ˆăŠw‹łˆçŠw‰ď, “Œ‹ž, 2016”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713155. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Expression of MMP-1 in hepatic progenitor cells is a significant biomarker of human early nonalcoholic steatohepatitis. Yokomori H1,2, Inagaki Y, Ando W2, Oda M2, Okazaki I: The Liver Meeting 2016 - American Association for the Study of Liver Diseases, 67th Annual Meeting (2016/11/11-15), Boston, USA, Hepatology 2016; 62: 533A. (‰ĄXOş1,2, ˆŔ“Ą@q2: 1‘‡f—Ă 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[):

713156. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) An angiotensin receptor-like 1 receptor, APJ, plays an important role in promoting fibrosis and angiogenesis in an early stage of non-alcoholic steatohepatitis. Ando W1, Yokomori H1,2, Inagaki Y, Kubota R3, Otori K3, Okazaki I: The Liver Meeting 2016 - American Association for the Study of Liver Diseases, 67th Annual Meeting (2016/11/11-15), Boston, USA, Hepatology 2016; 62: 563A. (ˆŔ“Ą@q1, ‰ĄXOş1,2, ‹v•Ű“c—Œb3, ”ö’šŸ–ç3: 1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2‘‡f—Ă, 3–ňŠw•”)

713157. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Caveolin-1 targets lipid droplets formation in human hepatic stellate cells. Yokomori H1,2, Ando W2, Oda M2: The Liver Meeting 2016 - American Association for the Study of Liver Diseases, 67th Annual Meeting (2016/11/11-15), Boston, USA, Hepatology 2016; 62: 838A. (‰ĄXOş1,2, ˆŔ“Ą@q2: 1‘‡f—Ă, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

723859. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •a‰@‹Î–ą‚Ě‘ŸŠíE—Ěˆć‚̐ę–ĺˆăŽ‘Ši‚đ—L‚ˇ“ŕ‰ČŒnˆăŽt‚ŞŽuŒü‚ˇ‚éu‘‡f—Ăˆăv‚Ö“]Œü‚ˇ‚éŰ‚ĚŒ¤C“ŕ—e‚Ě’Tő. –Ř‘ş‘ô– (‘‡f—Ă): ‘ć7‰ń“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ďŠwp‘ĺ‰ď (2016/6/12), ó‘.

723860. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ý‘îˆă—Ă‚đ’S‚¤f—ÏŠ‚É‚¨‚Ż‚é–éŠÔ‹x“ú—ŐŽž‘Ήž‚ĚŽŔ‘Ô. –Ř‘ş‘ô–1, ‹g]@Œĺ, –ěŒű–ƒˆßŽq, ŽR’†@’, ”Ń“‡Ÿ–î, ’ҁ@“N•v, H‰ş‰ëO (1‘‡f—Ă): ‘ć18‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2016/7/17), “Œ‹ž.

723861. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –éŠÔ‹x“ú‚É‚¨‚Ż‚éƒtƒ@[ƒXƒgƒR[ƒ‹‘Ήž‹@ŠÖ‚ĆŠłŽŇE‰Ć‘°‚ĚˆŔSŠ´E–ž‘ŤŠ´, ˆăŽt‚âŠĹŒěŽt‚ĚƒWƒ‡ƒuEƒRƒ“ƒgƒ[ƒ‹‚Ć‚ĚŠÖ˜A. ‹g]@Œĺ, –Ř‘ş‘ô–1, –ěŒű–ƒˆßŽq, ŽR’†@’, ”Ń“‡Ÿ–î, ’ҁ@“N•v, H‰ş‰ëO (1‘‡f—Ă): ‘ć18‰ń“ú–{Ý‘îˆăŠw‰ď^‘ć21‰ń“ú–{Ý‘îƒPƒAŠw‰ďE‡“Ż‘ĺ‰ď (2016/7/17), “Œ‹ž.

723862. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}‘Ź‚ČADL‰ü‘P‚đ—ˆ‚ľÝ‘îˆă—Ă‚É‚¨‚Ż‚é“]“|ƒAƒZƒXƒƒ“ƒg‚Ş •s\•Ş‚Ĺ‚ ‚Á‚˝ˆę—á. ⨍F‘ž˜Y1, –Ř‘ş‘ô–1, Îěƒ–ç2, â@Ë•˝1, VX‰Á“ŢŽq2, ŠÖ—LŽq2, X@hŽq2, ÔŻ@“§1 (1‘‡f—Ă, 2’nˆć‘‡ˆă—Ă): ‘ć18‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2016/7/17), “Œ‹ž.

731177. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)g‘‡f—Áh„i‚Ě‚˝‚߂ɉäX‚͍Ą‚Ç‚¤‚ˇ‚é‚ׂŤ‚Š. –Ř‘ş‘ô– (‘‡f—Ă): ‘ć5‰ń“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ď’†•”ƒuƒƒbƒNŽx•”ŠwpW‰ď (2016/11/27), Šň•Œ.


ˆăŠw•”•‘ŽˆăŠw‹łˆçŒ¤‹†ŠJ”­ƒZƒ“ƒ^[

ˆăŠw‹łˆçŒ¤‹†•”–ĺ

[Šwp˜_•ś]

120045. [Œ´’˜] “Œ“ú–{‘ĺkĐ‚Ě”íĐ3Œ§‚ĚÝ‘î—Ă—{Žx‰‡f—ÏŠ‚É‚¨‚Ż‚銈“Žó‹ľ‚̐„ˆÚ|kĐ‘OŒă‚Ě”äŠr|. ŽOŕVm•˝, ç—tG‹B1, ”öŒ`—Ď–ž, ÷ŕV–M’j (1ˆăŠw‹łˆç): Œúś‚ĚŽw•W 2016/10; 63 (12): 27-33.

220014. [€Œ´’˜] “ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŽ‚É‚¨‚Ż‚éŠwp—pŒę‚Ě“ŽŒü|’Tő“I‚¨‚ć‚ŃŒv—Ę“I•ŞÍ|. ç—tG‹B1, ˆÉ“Ą“šĆ, ’rčŸ], ˆÉ“ĄOl, “ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŠwpî•ńˆĎˆő‰ď (1ˆăŠw‹łˆç): “ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŽ 2016/10; 53 (4): 227-37.

[Šw‰ďEŒ¤‹†‰ď“™]

723863. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Œ–k‚ĚÝ‘î—Ă—{‚Ě•sˆŔ—v‘f‚ƉƑ°‰îŒě‚ĚˆÓŽŻ. ”öŒ`—Ď–ž, ŽOŕVm•˝, ç—tG‹B1, ‚˝‚çŕV–M’j (1ˆăŠw‹łˆç): ‘ć18‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď/‘ć21‰ń“ú–{Ý‘îƒPƒAŠw‰ďŠwpW‰ď/‡“Ż‘ĺ‰ď (2016/7/16), “Œ‹ž.

723864. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ý‘î—Ă—{Œp‘ą‚ĚŽŔŒť‰Â”\Ť‚ƎЉďŒoĎ“I—vˆö‚Ć‚ĚŠÖ˜A. ŽOŕVm•˝, ”öŒ`—Ď–ž, ç—tG‹B1, ‚˝‚çŕV–M’j (1ˆăŠw‹łˆç): ‘ć18‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď/‘ć21‰ń“ú–{Ý‘îƒPƒAŠw‰ďŠwpW‰ď/‡“Ż‘ĺ‰ď (2016/7/17), “Œ‹ž.

723865. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ[ƒ‹ƒvƒŒƒC‚đŽć‚č“ü‚ę‚˝Ă–ŹĚŒŒŒŸ¸‚ĚƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹łˆç‚É‚¨‚Ż‚éˆăŠwś‚ĚŠw‚Ń. –ĺ”n–ő•, Îˆä˝ˆę, r“c—I‘ž˜Y, ź“cĘ‰š, ç—tG‹B1, ‰Á‰ę’J–L (1ˆăŠw‹łˆç): ‘ć48‰ń“ú–{ˆăŠw‹łˆçŠw‰ď‘ĺ‰ď (2016/7/29), ‘ĺă.

723866. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠwˆăŠw•”4”Nś‚ĚƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚ɑ΂ˇ‚é”FŽŻ‚Ćˆă—ÖʐڎŔK‚É‚¨‚Ż‚鎊ŒČ•]‰żE‰Ű‘č‚ÉŠÖ‚ˇ‚élŽ@. ç—tG‹B1, Â–ؐߎq, âV“Ął”Í2, Žç‰Ž—˜‰Ŕ1 (1ˆăŠw‹łˆç, 2¸_): ‘ć48‰ń“ú–{ˆăŠw‹łˆçŠw‰ď‘ĺ‰ď (2016/7/30), ‘ĺă.

723867. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ŠłŽŇ‚ĚŒoĎ•‰’S‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†1|ˆă—Ă”ďŽxo. ˆÉ“Ą“šĆ, ”öŒ`—Ď–ž, ç—tG‹B1, ”ZŔM•v (1ˆăŠw‹łˆç): ‘ć54‰ń“ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŠwp‘‰ď (2016/9/17), “Œ‹ž.

723868. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALSŠłŽŇ‚ĚŒoĎ•‰’S‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†2|‰îŒě”ďŽxo. ”öŒ`—Ď–ž, ˆÉ“Ą“šĆ, ç—tG‹B1, ”ZŔM•v (1ˆăŠw‹łˆç): ‘ć54‰ń“ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŠwp‘‰ď (2016/9/17), “Œ‹ž.

723869. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) DPCŒöŠJƒf[ƒ^‚đ—p‚˘‚˝“Œ“ú–{‘ĺkĐ‘OŒă‚É‚¨‚Ż‚é”íĐ’n‚Ě‹}ŤŠúˆă—Ă‚Ě“ŽŒü. ‚˝‚çŕV–M’j, ”öŒ`—Ď–ž, ŽOŕVm•˝1, ç—tG‹B1 (1ˆăŠw‹łˆç): ‘ć54‰ń“ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŠwp‘‰ď (2016/9/17), “Œ‹ž.

723870. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Œ–k‚É‚¨‚Ż‚éŽá”NE’†”N˘‘ă‚ĚÝ‘î—Ă—{‚ĚˆÓŒü‚ƉƑ°‰îŒě‚ĚˆÓŽŻ. ”öŒ`—Ď–ž, ŽOŕVm•˝, ç—tG‹B1, ‚˝‚çŕV–M’j (1ˆăŠw‹łˆç): ‘ć75‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2016/10/28), ‘ĺă.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522010. [uŔ]y“ÁW: —ŤˆăŽt‚ĚƒLƒƒƒŠƒA‹łˆçz—ŤˆăŽtƒLƒƒƒŠƒAŒŸ“˘ˆĎˆő‰ď•ń@2.1 —ŤˆăŽtƒLƒƒƒŠƒA‹łˆç‚É‚¨‚Ż‚éŠwK–Ú•W. –؉ş–qŽq, Ź—ŃŽu’ĂŽq, ´…‹MŽq, Î•’źŽq, ĺŒ´G–ç, ]“ސłl, Žç‰Ž—˜‰Ŕ1 (1ˆăŠw‹łˆç): ˆăŠw‹łˆç 2015/3; 46 (3): 211-6.

H27-522011. [uŔ]y“ÁW: —ŤˆăŽt‚ĚƒLƒƒƒŠƒA‹łˆçz—ŤˆăŽtƒLƒƒƒŠƒAŒŸ“˘ˆĎˆő‰ď•ń@2.2 ŠwKŽžŠú‚ɑΉž‚ľ‚˝“ž’B–Ú•W‚̐ݒč‚Ć‚ť‚ĚŠwK•ű–@‹y‚Ń•]‰ż‚Ěˆę—á. Î•’źŽq, –؉ş–qŽq, Ź—ŃŽu’ĂŽq, ´…‹MŽq, ĺŒ´G–ç, ]“ސłl, Žç‰Ž—˜‰Ŕ1 (1ˆăŠw‹łˆç): ˆăŠw‹łˆç 2015/3; 46 (3): 217-23.

H27-530001. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] Medical English education guidelines corresponding to the Global Standards for Medical Education. Fukuzawa Y1, Hitosugi M1, Breugelmans R1, Hattori S1, Hirokawa S1, Ishii S1, Kameoka J1, Kenpe K1, Mori S1, Moriya R1,2, Takata J1, Yoshioka T1 (1Japan Society for Medical English Education Guidlines Committee): Journal of Medical English Education 2015/10; 14 (3): 136-42. (Žç‰Ž—˜‰Ŕ2: 2ˆăŠw‹łˆç)

H27-540001. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] ˆăŠw‹łˆç‚ĚƒOƒ[ƒoƒ‹ƒXƒ^ƒ“ƒ_[ƒh‚ɑΉž‚ˇ‚é‚˝‚ß‚ĚˆăŠw‰pŒę‹łˆçƒKƒCƒhƒ‰ƒCƒ“. •Ÿ‘ň‰ĂF1, ˆę™łm1, Îˆä˝ˆę1, ‹T‰Ş~ˆę1, Œš•”ˆę•v1, ‚“c@~1, •ž•”‚ľ‚Ě‚Ô1, œAěTˆę˜Y1, X@@–Î1, Žç‰Ž—˜‰Ŕ1,2, ƒ‰ƒEƒ‹Eƒuƒ‹[ƒwƒ‹ƒ}ƒ“ƒX1, ‹g‰Şrł1 (1“ú–{ˆăŠw‰pŒę‹łˆçŠw‰ď, 2ˆăŠw‹łˆç): Journal of Medical English Education 2015/10; 14 (3): 130-5.

[’˜@‘]

H26-620001. [Šwp‘ (•Ş’SŽˇ•M)]yˆăŠw‹łˆç•ĘűwˆăŠw‹łˆç”’‘2014”N”Ĺ ('11`'14)xz‘ć1•” Œťó‚ƐU‚č•Ô‚č@8. ˆă—ÖʐڋZ”\, p.41-4. Žç‰Ž—˜‰Ŕ (ˆăŠw‹łˆç), ŠÄC: “ú–{ˆăŠw‹łˆçŠw‰ď, •Ň: “ú–{ˆăŠw‹łˆçŠw‰ďL•ńEî•ńŠî”ŐŠJ”­ˆĎˆő‰ď, ŽÂŒ´o”ŐVŽĐ, “Œ‹ž, 2014/7”­s.


ŠwKŽx‰‡Œ¤‹†•”–ĺ


ˆăŠwŒ´˜_Œ¤‹†•”–ĺ


ˆă—ĂŠÇ—ŠwŒ¤‹†•”–ĺ


ˆă—Ă‹Zp‹łˆçŒ¤‹†•”–ĺ


ˆă—Ïî•ń‹łˆçŒ¤‹†•”–ĺ


“Œ—mˆăŠw‹łˆçŒ¤‹†•”–ĺ

[Šwp˜_•ś]

110291. [Œ´’˜] Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells. Nishmura Y, Hyuga, S1, Takiguchi S, Hyuga M, Itoh K1, Hanawa T1,2: Int J Oncol 2016/5; 48 (5): 1895-906. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

110292. [Œ´’˜] Efficiently prepared ephedrine alkaloids-free Ephedra Herb extract: a putative marker and antiproliferative effects. Oshima N, Yamashita T, Hyuga S1, Hyuga M, Kamakura H, Yoshimura M, Maruyama T, Hakamatsuka T, Amakura Y, Hanawa T1,2, Goda Y: J Nat Med 2016/7; 70 (3): 554-62. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

110293. [Œ´’˜] Ephedrine alkaloids-free Ephedra Herb extract: a safer alternative to ephedra with comparable analgesic, anticancer, and anti-influenza activities. Hyuga S1, Hyuga M, Oshima N, Maruyama T, Kamakura H, Yamashita T, Yoshimura M, Amakura Y, Hakamatsuka T, Odaguchi H, Goda Y, Hanawa T1,2: J Nat Med 2016/7; 70 (3):571-83. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

110294. [Œ´’˜] Ephedra Herb extract activates/desensitizes transient receptor potential vanilloid 1 and reduces capsaicin-induced pain. Nakamori S, Takahashi J, Hyuga S1, Tanaka-Kagawa T, Jinno H, Hyuga M, Hakamatsuka T, Odaguchi H, Goda Y, Hanawa T1,2, Kobayashi Y: J Nat Med 2017/1; 71 (1): 105-13. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

[Šw‰ďEŒ¤‹†‰ď“™]

712028. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) An acupuncture and moxibustion treatment with Kitasato style of meridian therapy. Kohama S, Ito G, Odaguchi H, Hanawa T1,2: The 5th Joint Symposium - WHO CCs for Traditional Medicine in Japan & Korea (2016/5/20), Daejeon, Korea. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

713158. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰)Discovery of a New Meridian Vessel Derived from the Extra Point of Dorsal Digital Regions between the 3rd Toe and the 4th Toe. Ito G, Hanawa T1,2: International Conference of World Federation of Acupuncture & Moxobustion (2016/11/6), Ibaraki. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

723871. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) The combined effect of Ephedra Herb and Erlotinib on growth of Met-overexpressed non-small cell lung cancer, H1993 cells. Hyuga S1, Hyuga M, Nishimura Y, Itoh K1, Odaguchi H, Hanawa T1,2: ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2016/10/6), _“ސě. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)


4•a‰@˜AŒg‹łˆçŒ¤‹†•”–ĺ


ˆă—ĂˆŔ‘SŠwŒ¤‹†•”–ĺ


ˆăŠw•”•‘Ž—Տ°Œ¤‹†ƒZƒ“ƒ^[

Šé‰ćŠJ”­•”–ĺ^ƒvƒƒWƒFƒNƒgŽŔŽ{•”–ĺ

[’˜@‘]

620182. [Šwp‘ (•Ş’SŽˇ•M)]y’´ŠČ’P!! ˜_•śěŹƒKƒCƒh`wŒ¤‹†x‚ľ‚悤`z‘ć4Í Œ¤‹†‚Ć—Ď—, p.43-70. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć), –ňŽ–“ú•ńŽĐ, “Œ‹ž, 2016/4”­s.

620183. [Šwp‘ (•Ş’SŽˇ•M)]y’J–{ŠwZ@“ŐŤŽż–â” @‘ć18†zƒŒƒNƒ`ƒƒ[@1 SŒŒŠÇŒnˆŔ‘SŤ•]‰ż@S“ŐŤŠÖ˜A‚Ě”ń—Տ°ƒf[ƒ^‚Ě’…–Ú“_, p.38-40. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć), •Ň: ˆŔ‘SŤ•]‰żŒ¤‹†‰ď•ŇWˆĎˆő‰ď, ƒTƒCƒGƒ“ƒeƒBƒXƒgŽĐ, “Œ‹ž, 2016/9”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712029. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Strategy for efficient drug development utilizing functions of ARO. Kumagai Y1: JSCPT-KSCPT Joint Symposium 2016 (2016/11/18), Jeonju, Korea. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg)

712030. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Multi-Regional Clinical Trials(MRCT) and Incorporating GCP-related Considerations. Kumagai Y1: 2016 PKU APEC Regulatory Sciences Center of Excellence pilot Multi-Regional Clinical Trials & Good Clinical Practice Workshop (2016/7/12), Beijing, China. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg)

712031. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) How should we promote early clinical trials in East Asia? Kumagai Y1: The 5th Annual Seoul-Kitasato Joint Symposium (2017/2/11), Shirokane. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg)

721017. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ƒtƒ‰ƒ“ƒX—Տ°ŽŽŒą‚Ě”]Ž€—á‚ÉŠw‚Ô. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‘ć37‰ń“ú–{—Տ°–ň—Šw‰ďŠwp‘‰ď (2016/12/1), •ÄŽq.

722263. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ʃ̏áŠQ. ŒF’J—YŽĄ (—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/3), ‚’m.

723872. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽŠŽĺŒ¤‹†ƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚˘‚Ä, ŽŔŽ{ŒoŒą‚Ě‚Č‚˘Œ¤‹†ŽŇECRC‚Ş’ź–Ę‚ˇ‚é–â‘č“_. ŠÖŞ–ƒ—Žq, Žá™ˆŔŠó”T, ˛X–Ř‘PM, Šâ“c•c, –ƒś‰ëŽq, ŒF’J—YŽĄ1, Ź“cŒű_ (1—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‘ć37‰ń“ú–{—Տ°–ň—Šw‰ďŠwp‘‰ď (2016/12/2), •ÄŽq.

723873. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —Տ°ŽŽŒąƒlƒbƒgƒ[ƒN‚đŠˆ—p‚ľ‚˝‘ćI‘ŠŽŽŒą‚ĚŽŔŽ{`˘ŠE‚ɐć‹ě‚Ż‚˝”F’mÇ‹y‚ŃŒy“x”F’máŠQ‚đ‘ÎŰ‚Ć‚ľ‚˝ŽĄŒą‚ĚŽŔŽ{‚đ–ÚŽw‚ľ‚ā`. ]ŒŠ”ü˜aŽq, “yˆä‹KŽq, ŽR“c—Ż”ü, ‹`•˝ËŘ, “Ą“c—R‰Ŕ, ź‰Y—T”üŽq, Ź“c–Ť•F, “Ą“c–ő”V, ŽR–{‘׎i, ŒF’J—YŽĄ1, •˝“cŒ‹Šě, ç“c“š—Y (1—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‘ć37‰ń“ú–{—Տ°–ň—Šw‰ďŠwp‘‰ď (2016/12/2), •ÄŽq.

731178. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‰ä‚ލ‘‚É‚¨‚Ż‚é‰uŠw’˛¸Œ‹‰Ę‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‘ĺ•ŞŒ§•a‰@–ňÜŽt‰ď7ŒŽ—á‰ď (2016/7/7), ‘ĺ•Ş.

731179. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‰ä‚ލ‘‚É‚¨‚Ż‚é‰uŠw’˛¸Œ‹‰Ę‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‘ć230‰ń‘ĺ•Ş“ŒŒ¤‹†‰ď (2016/9/13), ‘ĺ•Ş.

732107. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ”ń—Տ°ƒf[ƒ^‚ÉŠî‚Ă‚­—Տ°ŽŽŒąŒv‰ć. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): “ú–{–ň•¨“Ž‘ÔŠw‰ď‘ć30‰ńƒ[ƒNƒVƒ‡ƒbƒv (2016/5/12), ‘ĺă.

732108. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‚—p—ĘƒAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ĚŠĚ‹@”\ŒŸ¸’l‚ÉŠÖ‚ˇ‚é‰uŠw’˛¸‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‰ŞŽRŒ§•a‰@–ňÜŽt‰ďŠwpu‰‰‰ď (2016/6/10), ‰ŞŽR.

732109. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒŒƒ“ƒkŽ–Œ‚ÉŠw‚Ô. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ‘ć18‰ń—Տ°–ň—ŽŽŒąŒ¤‹†‰ď (2016/8/20), ”’‹ŕ.

732110. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‚—p—ĘƒAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ĚŠĚ‹@”\ŒŸ¸’l‚ÉŠÖ‚ˇ‚é‰uŠw’˛¸‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): “‡ŞŒ§•a‰@–ňÜŽt‰ďŠwpŒ¤C‰ď (2016/11/12), “‡Ş.

732111. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘Ű‹¤“ŻŽŽŒą—§ˆÄ‚É—ŻˆÓ‚ˇ‚ׂŤ”ˆöŽq. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć^ƒvƒƒWƒFƒNƒg): ˆăŠw“ŒvŒ¤‹†‰ď“Á’čŽĺ‘čƒVƒ“ƒ|ƒWƒEƒ€2017u‘Ű‹¤“ŻŽĄŒą‚É‚¨‚Ż‚éĹ‹ß‚Ě˜b‘č: “Œv“I‰Ű‘č‚ĆŽ–—ጤ‹†v (2017/2/4) “Œ‹ž.


ƒoƒCƒIƒGƒVƒbƒNƒX•”–ĺ


‘n–ňƒV[ƒYŒ¤‹†ŠJ”­•”–ĺ


ˆăŠw•”•‘ŽV˘‹Iˆă—ĂŠJ”­ƒZƒ“ƒ^[

ć’[ˆă—Ă—ĚˆćŠJ”­•”–ĺ

(“c糁@‘)

[Šwp˜_•ś]

110072. [Œ´’˜] Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. Bando H, Yamada Y, Tanabe S1,2, Nishikawa K, Gotoh M, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I: Gastric Cancer 2016/7; 19 (3): 919-26. (“c糁@‘1,2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

110090. [Œ´’˜] Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study. Tanabe S1,2, Ishido K2, Matsumoto T, Kosaka T, Oda I, Suzuki H, Fujisaki J, Ono H, Kawata N, Oyama T, Takahashi A, Doyama H, Kobayashi M, Uedo N, Hamada K, Toyonaga T, Kawara F, Tanaka S, Yoshifuku Y: Gastric Cancer 2017/3; 20 (Suppl 1): 45-52. (“c糁@‘1,2, ÎŒËŒŞŽŸ2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

521005. [‰đŕ]y“ŕŽ‹‹žŽč‹Z‚̉đŕ|—Տ°‚ĚƒRƒc‚ĆƒeƒNƒjƒbƒN|zƒ_ƒuƒ‹ƒXƒR[ƒvESD (ƒVƒ“ƒOƒ‹ƒgƒ‰ƒ“ƒXƒVƒXƒeƒ€) ‚ĚƒRƒc‚ĆƒeƒNƒjƒbƒN. “c糁@‘1,2, “Œ@’q2, ÎŒËŒŞŽŸ2, –î–ě‹MŽj2, ˜a“c‘ń–ç2, Œ˜“ce—˜2, ˛X–Ř“O2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): ˆÝ‚Ş‚ńperspective 2017/3; 9 (1): 40-47.

522028. [uŔ]yŽĺ‘č: \“ńŽw’°‚̏ă”琍Žîᇁz\“ńŽw’°”ń“ű“Ş•”Žîᇂɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚Ć‹ô”­Ç‚ĚŒťó. Ź–ě—T”V1, ŠLŁ@–ž, –ě’†@“N, ă“°•ś–ç, •˝ŕVr–ž, ŹŽRP’j, –L‰i‚Žj, “yŽRŽőŽu, Ź“c“‡T–ç, •˝ŕV‹ÓŒá, “c糁@‘2,3, ŽR–{ŽŒČ, ‹ŕŽq˜aO (1Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3Á‰ťŠí“ŕ): ˆÝ‚Ć’° 2016/11; 51 (12): 1585-92.

[’˜@‘]

620017. [Šwp‘ (•Ş’SŽˇ•M)]yÇ—á‚Š‚çŠw‚Ô“ŕ‰ČŽžŠł‚̐f’fEŽĄ—ĂƒsƒbƒgƒtƒH[ƒ‹ ( “ŕ‰Č2016”N4ŒŽ‘‘ĺ†)z‘ć2Í Á‰ťŠí@1. ˆÝ‚Ş‚ń, p.608-13. “c糁@‘1,2, ÎŒËŒŞŽŸ2, ‰Íź“Ţ’ĂŽq2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “ě]“°, “Œ‹ž, 2016/4”­s.

620018. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć1Í ‘˜_ (Šî‘b)@–â‘č5, 6, p.10-1. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620019. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďę–ĺˆăŠwpŽŽŒą–â‘č@‰đ“š‚Ɖđŕ (‘ć4”Ĺ)z‘ć2Í ă•”Á‰ťŠÇ@–â‘č22, 23, p.99-102. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), ŠÄC: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď, Ó”C•ŇW: ˆę”ĘŽĐ’c–@l “ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď ę–ĺˆăŽŽŒąˆĎˆő‰ď, ˆăŠw‘‰@, “Œ‹ž, 2016/5”­s.

620025. [Šwp‘ (•Ş’SŽˇ•M)]yˆÝŽžŠłƒAƒgƒ‰ƒX (Á‰ťŠí“ŕŽ‹‹ž28ŠŞ8ŒŽ‘‘ĺ†)zŠe˜_@II. •˝’R‚Č•a•Ď@Ç—áƒAƒgƒ‰ƒX@‘ŠúˆÝŠŕ (0-IIb, ”­Ô‚ľ‚˝•Ş‰ťŒ^‘BŠŕ), p.1252-3. “c糁@‘1,2, ÎŒËŒŞŽŸ2, ‰Íź“Ţ’ĂŽq2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/8”­s.

620038. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠí“ŕŽ‹‹ž‚ĚŠî‘b’mŽŻ‚ĆŠî–{ƒeƒNƒjƒbƒN (Á‰ťŠí“ŕŽ‹‹ž3ŒŽ‘‘ĺ†)zŠe˜_@I. ă•”Á‰ťŠÇ“ŕŽ‹‹ž@ă•”Á‰ťŠÇ“ŕŽ‹‹žŽ~ŒŒŽč‹Z, p.415-8. “c糁@‘1,2, –î–ě‹MŽj2, ‰Íź“Ţ’ĂŽq2, ŽRŞ‘‹IŽq2, “n粍WŽŻ2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722018. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) RŒŒđ—Ă–@‰ş‚É‚¨‚Ż‚éÁ‰ťŠÇŠQ‚Ć“ŕŽ‹‹žf—Ăƒ}ƒl[ƒWƒƒ“ƒg. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć52‰ń“ú–{’_“šŠw‰ďŠwpW‰ď (2016/9/29), V‰Ą•l.


(’ˇŔ‰p–ž)

[Šw‰ďEŒ¤‹†‰ď“™]

723874. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “நáŠQ‚ĆƒXƒgƒŒƒX‚ĚŠÖ˜AŤ‚̉𖞁|Inositol trisphosphate receptor type 1KOƒ}ƒEƒX‚Ě嗋Œ`‘ԁ|. ’ˇŔ‰p–ž1, Ö“Ą—Yˆę˜Y, ŒäŽqŽÄŽ•F (1V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{’ŽŠoˆăŠw‰ďEŠwpu‰‰‰ď (2016/10/21), ˇ‰Ş.

723875. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “நáŠQ‚ĆƒXƒgƒŒƒX‚ĚŠÖ˜AŤ‚̉𖞁|Inositol trisphosphate receptor type 1KOƒ}ƒEƒX (8T—î) ‚Ě’ŽŠo‹@”\|. ’ˇŔ‰p–ž1, Ö“Ą—Yˆę˜Y, ’†ě‹M”V2, —Ž‡@“Ö2, “ż‘Œú“ń, ŒäŽqŽÄŽ•F (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć75‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ďEŠwpu‰‰‰ď (2016/10/27), ‘ĺă.

723876. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “நáŠQ‚ĆƒXƒgƒŒƒX‚ĚŠÖ˜AŤ‚̉𖞁|Inositol trisphosphate receptor stype1KOƒ}ƒEƒX‚Ě’ŽŠo‹@”\|. ’ˇŔ‰p–ž1, Ö“Ą—Yˆę˜Y, ’†ě‹M”V2, —Ž‡@“Ö2, “ż‘Œú“ń, ŒäŽqŽÄŽ•F (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć75‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2016/10/27), ‘ĺă.

731180. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “நŤ‚ß‚Ü‚˘‚ĚŒ´ˆö‚ĆŽĄ—Ă. ’ˇŔ‰p–ž (V˘‹Iˆă—ÁEć’[ˆă—Ă): “Œ‹ž“sŽ¨•@ˆôA‰Čˆă‰ďŠwpu‰‰‰ďEuK‰ď “ú–{ę–ĺˆă‹@\Ef—Ă—Ěˆć•Ę (Ž¨•@ˆôA‰Č—Ěˆć) uK (2017/1/28), “Œ‹ž.

731181. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂ˇ‚éHydration Therapy (…•ŞŰŽć—Ă–@)|ƒXƒgƒŒƒX‚Ć‚ĚŠÖ˜AŤ|. ’ˇŔ‰p–ž (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć15‰ńă_‚ß‚Ü‚˘E“ď’ŽŒ¤‹†‰ď (2017/2/25), ‘ĺă.


(“c’†@Œ‰)

[Šwp˜_•ś]

522130. [uŔ]y“ÁW: ’źŽ‹‰ş–D‡E•Ť‡‚ĚƒeƒNƒjƒbƒN: H•v‚ĆƒRƒczMartinŽčp‚̏Á‰ťŠÇ•Ť‡. “c’†@Œ‰ (V˘‹Iˆă—ÁEć’[ˆă—Ă): ŹŽ™ŠO‰Č 2016/6; 48 (6): 597-600.

522131. [uŔ]y“ÁW: ŹŽ™ŠO‰Č ƒfƒBƒx[ƒg‘ÎŒˆ (“úí‚ć‚­‚݂鎞Šł)z”^ᇌ`ŹŤ’Ž‚‰Š‚ɑ΂ˇ‚éinterval appendectomy: Ž{s‚ľ‚Č‚˘. “c’†@Œ‰1, •“cŒ›Žq2, ŽR–{—T‹P, ’Ç–ŘGé (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ŹŽ™ŠO‰Č 2017/2; 49 (2): 163-7.

[’˜@‘]

620184. [Šwp‘ (•Ş’SŽˇ•M)]y•W€ŹŽ™ŠO‰ČŠw (‘ć7”Ĺ)z‘ć20Í • •ÇEä`‚¨‚ć‚Ń‘lŒa•”@ä`‘Ńƒwƒ‹ƒjƒA, • •Ç”j—ô, ä`ƒwƒ‹ƒjƒA, ä`’°ŠÇˆâŽc, —‘‰Š’°ŠÇˆâŽc, ”A–ŒŠÇˆâŽc, ć“VŤ• •Ç‹ŘŒ`Ź•s‘S (prune bellyÇŒóŒQ), Body stalk anomaly, p.274-81. “c’†@Œ‰ (V˘‹Iˆă—ÁEć’[ˆă—Ă), ŠÄC: ‚ź‰p•v, •ŸŕVł—m, •Ň: ă–ě@Ž , m”öł‹L, ‰œŽRGb, ˆăŠw‘‰@, “Œ‹ž, 2017/2”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713159. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Complications related to the bile duct and the pancreatic duct after the operation of the congenital duodenal obstruction. Tanaka K1, Takeda N2, Kakihara T2, Watanabe M2: The 24th Congress of the Asian association of Pediatric Surgeons (2016/5/24), Fukuoka. (“c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č):

722264. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘”rŸ•oˆâŽcÇ, ”ĺ”AśB“´ˆŮíÇ’ˇŠúŒo‰ß—á‚É‚¨‚Ż‚é–â‘č“_. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć32‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2016/10/29), é‹Ę.

723877. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) VśŽ™‚É‚¨‚Ż‚銎‘S•Ş—ŁŽŽƒXƒgƒ}‘˘Ýp‚̐Ľ”ń. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć53‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠwpW‰ď (2016/5/25), •Ÿ‰Ş.

723878. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —LÇóä`’°ŠÇˆâŽcÇ‚ĚŒŸ“˘. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć30‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2016/7/1), ĺ‘ä.

723879. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) oś‘Of’f‚ł‚ę‚˝•›tůN–EŤŽîᎂ̎Ą—Ă•űj. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, –]ŒŽƒŽq3, ‹ŕˆä—Y“ń3 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č, 3ŽY‰Č): ‘ć52‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2016/7/18) •xŽR

723880. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) VśŽ™Šú‚É‹šo‹ž‰ş‚É“Eo‚ľ‚˝”x—tŠO”x•Ş‰ćÇ‚Ě1—á. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć29‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2016/12/10), ‰Ą•l.

733435. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ć“VŤH“š•Â˝Ç‚Ć‘ĺ“Ž–Ź‹|‚̍ś‰E. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć36‰ń“ú–{ŹŽ™“ŕŽ‹‹žŠO‰ČEŽčpŽč‹ZŒ¤‹†‰ď (2016/10/27), ‚ł‚˘‚˝‚Ü.


(‹g“cˆęŹ)

[Šwp˜_•ś]

521013. [‰đŕ (‘ć21‰ńPKD‚̉ďu‰‰‰ď)]yƒgƒ‹ƒoƒvƒ^ƒ“ (ƒTƒ€ƒXƒJŇ) ‚É‚ć‚鎥—Ă‚ĚŒťózŽż‹^‰ž“š. •“Ą@’q, ‘ştˆę, ‹g“cˆęŹ1,2 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): –k“lŻ 2016/9; 33: 14-24.

540011. [‚ť‚Ě‘ź (Ŕ’k‰ď)] Ŕ’k‰ď: ADPkD‚̍ŐVŽĄ—Ă‚ĚŒťó. –î”öł—S, ’|“ŕN—Y1, ŹŠâ•ś•F, ‹g“cˆęŹ2, ’J’ĂŒ\‰î (1t‘Ÿ“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): “úŒoƒƒfƒBƒJƒ‹Online 2016/12; p.1-4.

[’˜@‘]

620106. [Šwp‘ (•Ş’SŽˇ•M)]yt‚Ć“§Íf—ĂŽwj2016 (t‚Ć“§Í2016”N80ŠŞ‘Š§†)z‘ć18Í tˆÚA@4. ‹‘â”˝‰ž, p.692-5. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713120. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Long period follow-up of renal function of living renal donor. Yoshida K1,2, Ishii D1, Takeuchi Y3, Noguchi F4, Ikeda M1, Tanaka M4, Iriki R, Wakai H: 26th INTERNATIONAL CONGRESS OF THE TRANSPLANTATION SOCIETY (2016/8/20), Hong Kong. (‹g“cˆęŹ1,2, Îˆä‘ĺ•ă1, ’|“ŕN—Y3, –ěŒű•ś”T4, ’r“cŹ]1, “c’†”üŽ÷4: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3t‘Ÿ“ŕ, 4ŠĹŒě•”)

722152. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ĄŒă‚Ě“W–]‚Ɖۑč. Žáˆä—zŠó, ˆ˘•”“Ţ’Ă”ü, –Ř‘şŠG”ü, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 362.

722153. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yƒ[ƒNƒVƒ‡ƒbƒv3@“ú–{‚Ě“§Íˆă—Ă‚Ě—Ao: ”­“W“ră‘‚ɉ—‚Ż‚鎝‘ą‰Â”\‚Č“§Í—Ă–@‚đl‚Ś‚ézƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚éJapanese Assistance Council of establishing Dialysis Specialists system in Cambodia (JAC-DSC) ‚Ě‹OŐ|ĄŒă‚Ě“W–]‚Ɖۑč. Žáˆä—zŠó, ˆ˘•”“Ţ’Ă”ü, –Ř‘şŠG”ü, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă.

722155. [Šw‰ď (‘S‘)] (‘ŸŠí‰Ą’f“Iƒ[ƒNƒVƒ‡ƒbƒv) –Ɖuƒ‚ƒjƒ^ƒŠƒ“ƒO‚ĚŒťó‚Ɖۑč. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/10/1), `‹ć, ˆÚA 2016; 51 (‘‰ď—ŐŽž): 205.

722156. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ”ĺ”AŠí‰Čˆă‚Ě“§Íˆă—Ă‚É‚¨‚Ż‚é–đŠ„. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć81‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2016/10/9), ÂX.

722165. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) –k—˘‘ĺŠw‚É‚¨‚Ż‚étˆÚA—Տ°ŒoĎ‚ĚŒŸ“˘. ‹g“cˆęŹ1,2, ‹e’nO”ü, “c‘q’q”V (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/15), _ŒË.

722166. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) “ú–{‚̐t‘ă‘Öˆă—Ă‚ĚŒťó‚Ɖۑč (over view). ‹g“cˆęŹ1,2, –ěŒű•ś”T3, Îˆä‘ĺ•ă2, ’r“cŹ]2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3ŠĹŒě•”): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË.

723624. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’ˇŠú—Ż’uŒ^ƒJƒe[ƒeƒ‹‚đ—p‚˘‚˝Ý‘‰t“§Í—Ă–@‚ɂ‚˘‚Ä. ˆ˘•”“Ţ’Ă”ü, ‰Í‘ş”ŽŽq, –Ř‘şŠG”ü, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/10), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 722.

723627. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰h—{Žm‚Ě‘śÝ‚ľ‚Č‚˘ƒJƒ“ƒ{ƒWƒA‚ł̐t‘Ÿ•a‰h—{Žw“ą•ű–@Šm—§‚ÉŒü‚Ż‚˝Žć‚č‘g‚Ý. –k“‡KŽ}, “c‘ş’qŽq, ’ˇŔrG, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2, ěźGŽ÷ (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 790.

723628. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚Ĺ‚ĚW’†ƒZƒ~ƒi[ŠJĂ‚đŒoŒą‚ľ‚Ä. –Ř‘şŠG”ü, ˆ˘•”“Ţ’Ă”ü, ŠÚ–ě—Y‹M, ŽR’†—˘‰Ŕ, “n糗FŽq, Žáˆä—zŠó, Ź‹v•ŰŒŞˆę1, ‹g“cˆęŹ2,3, •ş“Ą@“§, ěźGŽ÷, ě‘ş–ž•v (1ˆă—ÉqśŠw•”, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3”ĺ”AŠí): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 791.


(‰Á“Ą—˘ŠG)

[Šwp˜_•ś]

522132. [uŔ]y“ÁW: •ę‘́E‘ŮŽ™‘hś: •Ş•ŘŽž‚Ě‹}•Ď‚É‚Ç‚¤‘Ήž‚ˇ‚é‚Šz[‘ŮŽ™‹~‹}] ’´‹Ů‹}’鉤ŘŠJ (ƒOƒŒ[ƒhA) ‚ւ̑Ήž: –ƒŒ‰Č‚Ě—§ę‚Š‚ç. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ŽüŽYŠúˆăŠw 2016/4; 46 (4): 433-6.

[Šw‰ďEŒ¤‹†‰ď“™]

722265. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€1: ‘˝—l‰ť‚ˇ‚é•Ş•Řƒj[ƒY‚ւ̑Ήžz–ł’É•Ş•Ř. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć57‰ń•ęŤ‰qśŠw‰ď‘‰ďEŠwpW‰ď (2016/10/14), “Œ‹ž.

722266. [Šw‰ď (‘S‘)] (ƒŠƒtƒŒƒbƒVƒƒ[ƒR[ƒX)yƒŠƒtƒŒƒbƒVƒƒ[ƒR[ƒX (17)z’鉤ŘŠJ‚̏pŒă’Á’É‚đŒŠ’ź‚ľ‚Ă݂悤! ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{—Տ°–ƒŒŠw‰ď‘ć36‰ń‘ĺ‰ď (2016/11/5), ‚’m.

722267. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€2: Ž€íŠú’鉤ŘŠJpzŽ€íŠú’鉤ŘŠJp‚ĚŠT—v‚Ć–â‘č“_. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć120‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďŠwpW‰ď (2016/11/26), “Œ‹ž.

732112. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)y•ę‘Ě•ŰŒě–@Žw’čˆăŽtŒ¤C‰ďzˆă—ĂˆŔ‘S: ”DŽY•w‚Ě‹~‹}ˆ’u. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć132‰ńŠÖ“Œ˜A‡“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpW‰ď (2016/10/15), “Œ‹ž.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-722002. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™)y“O’ꓢ˜_2zŽY‰ČDIC‚̐헪“IŠÇ—: ŽY‰ČŠë‹@“IoŒŒ‚Ö‚Ě–ƒŒ‰Č“Ií—Ş. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć119‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďŠwpW‰ď (2015/11/28), “Œ‹ž.

H27-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ”DŽY•w‚Ě‹~‹}ˆ’u. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): _“ŢěŒ§•ę‘Ě•ŰŒě–@Žw’čˆăŽtŒ¤C‰ď (2015/10/31), ‘Š–ÍŒ´.

H27-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ”DŽY•wICU‚É‚ŕŽQ‰Á‚ľ‚悤. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć4‰ń–ƒŒ‰Čˆă‚Ě‚˝‚ß‚ĚŽY‰Č–ƒŒƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹ƒZƒ~ƒi[ (2016/3/5), “Œ‹ž.


‰Ą’f“Iˆă—Ă—ĚˆćŠJ”­•”–ĺ

(˛X–ŘŽĄˆę˜Y)

[Šwp˜_•ś]

110295. [Œ´’˜] Survey of the management of chemotherapy-induced peripheral neuropathy in Japan: Japanese Society of Medical Oncology. Hirayama Y, Sasaki J1, Dosaka-Akita H, Ishitani K: ESMO Open 2016/5; 1 (3): e000053. (˛X–ŘŽĄˆę˜Y1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)


(VˆäłN)

[Šwp˜_•ś]

522133. [uŔ]y“ÁW: Vlƒi[ƒX‚Ě‚˝‚ß‚ĚpŒăŠłŽŇ‚ĚŒÄ‹zƒPƒA@5•ŞŠÔ‚Ĺƒ`ƒFƒbƒN‚Ĺ‚Ť‚éƒ|ƒCƒ“ƒgƒm[ƒgzTheme 2 pŒă‹}ŤŠú‚̐lHŒÄ‹zŠíÝ’č. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŒÄ‹zŠíƒPƒA 2016/6; 14: 12-3.

522134. [uŔ]y“ÁW: Vlƒi[ƒX‚Ě‚˝‚ß‚ĚpŒăŠłŽŇ‚ĚŒÄ‹zƒPƒA@5•ŞŠÔ‚Ĺƒ`ƒFƒbƒN‚Ĺ‚Ť‚éƒ|ƒCƒ“ƒgƒm[ƒgzTheme 3 pŒăŠłŽŇ‚ĚNPPV‚ĆƒnƒCƒtƒ[ƒZƒ‰ƒs[. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŒÄ‹zŠíƒPƒA 2016/6; 14: 14-5.

[Šw‰ďEŒ¤‹†‰ď“™]

722268. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –ƒŒ‰Čˆă‚ĚŽčpŽşŠOŠˆ“Ž, Rapid Response System‚É‚¨‚Ż‚é–ƒŒ‰ČˆăEW’†ŽĄ—Ăˆă‚Ě–đŠ„. VˆäłN1, ‘ĺ’Ë’q‹v2, ‹g–ě˜a‹v2, ˆÉ“Ą‘s•˝2, ŹâN°2, •Šâ­”V2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć63‰ńŠwpW‰ď (2016/5/27), •Ÿ‰Ş.

722269. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Respiratory Support Team‚đ‚ŕ‚Ć‚É‚ľ‚˝Rapid Response System“ą“ü‚ĚˆÓ‹`‚ĆŒř‰Ę. VˆäłN1, XˆŔŒbŽŔ, Ź’r•üF, ‘ĺ’JŽĆ, —é–Ř—D‘ž˜Y2, źŕV‹`”V2, ‘ĺ’Ë’q‹v2, ‹g–ě˜a‹v2, ˆÉ“Ą‘s•˝2, ŹâN°2, •Šâ­”V2, ˛“ĄŽ•F2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ): ‘ć38‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwpW‰ď (2016/7/16-17), –źŒĂ‰Ž.

722270. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ‚ć‚­‚í‚Š‚éƒZƒ~ƒi[40, Ą‚ł‚畡‚Ż‚Č‚˘!@ŒÄ‹z‚ĚƒtƒBƒWƒJƒ‹ƒAƒZƒXƒƒ“ƒg. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć38‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwpW‰ď (2016/7/16), –źŒĂ‰Ž.

722271. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Respiratory Support Team‚đ‚ŕ‚Ć‚É‚ľ‚˝Rapid Response System“ą“ü‚ĚˆÓ‹`‚ĆŒř‰Ę. VˆäłN1, XˆŔŒbŽŔ2, Ź’r•üF3, ‘ĺ’JŽ–ç2, —é–Ř—D‘ž˜Y4, źŕV‹`”V4, ‘ĺ’Ë’q‹v4, ‹g–ě˜a‹v4, ˆÉ“Ą‘s•˝4, ŹâN°4, •Šâ­”V4, ˛“ĄŽ•F4 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ŠĹŒě•”, 3–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[, 4–ƒŒ): ‘ć38‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwpW‰ď (2016/07/16), –źŒĂ‰Ž.

723881. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Rapid Response System“ą“ü5”N‚Ě–â‘č“_‚ƍĄŒă`ŒŔ’č‘̐§‚ĆíŽž‘̐§‚Ě”äŠr`. VˆäłN1, XˆŔŒbŽŔ2, Ź’r•üF3, ‘ĺ’JŽ–ç2, žŇź‹v”üŽq2, ‘ĺ’Ë’q‹v4, ŠÖ“cş•F4, źŕV‹`”V4, ŒË“c‰ë–ç4, •Šâ­”V4 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ŠĹŒě•”, 3–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[, 4–ƒŒ): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11), ŽD–y.

723882. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Rapid Response System‹N“ŽÇ—á‚Š‚猊‚˝SIRS‚ĆSepsis-3f’f. VˆäłN1, Ź’r•üF2, XˆŔŒbŽŔ3, ‘ĺ’JŽ–ç3, žŇź‹v”üŽq3, ‘ĺ’Ë’q‹v4, ‹g–ě˜a‹v4, “c’†ˆęś4, źŕV‹`”V4, •Šâ­”V4 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[, 3ŠĹŒě•”, 4–ƒŒ): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11), ŽD–y.

723883. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@ICU‚É‚¨‚Ż‚é[čň•””^á‡, cŠu”^ᇊłŽŇ8Ç—á‚ĚŒŸ“˘. —é–Ř—D‘ž˜Y1, VˆäłN2, ‚‹´@—É, źŕV‹`”V1, ‘ĺ’Ë’q‹v1, ‹g–ě˜a‹v1, ˆÉ“Ą‘s•˝1, ŹâN°1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11), ŽD–y.

732113. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)uICU‚É‚¨‚Ż‚é“dŽqƒJƒ‹ƒe‚ĚŽg‚˘ŸŽč‚Í‚Ç‚¤‚Š?v“ˆę‚ľ‚˝W’†ŽĄ—ĂŒn•”–ĺƒVƒXƒeƒ€“ą“ü‚Ě—˜“_‚ĆŽg‚˘ŸŽč. VˆäłN1, _œä’m“š2, ˆŔ“Ą@Žő3, ™›Ž@Šw3, XˆŔŒbŽŔ4, “ŕ“ĄˆŸŽ÷, ’J@Kˆę, ‘“cł˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2‹~–˝, 3ŹŽ™, 4ŠĹŒě•”): ‘ć25‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/8/20), “Œ‹ž.

732114. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) uŠłŽŇ‚̐śŠˆ‹óŠÔ‚Ć‚ľ‚Ä‚ĚICU‚މü‘P‚ˇ‚ׂŤ“_v“–‰@GICU‚ÍŠłŽŇ‚ĚŽ‹“_‚É—§‚Á‚˝—Ă—{ŠÂ‹Ť, śŠˆ‹óŠÔ‚Ć‚Č‚Á‚˝‚Š? VˆäłN1, ‹g–ě˜a‹v2, XˆŔŒbŽŔ3, ‘ĺ’JŽ–ç3, žŇź‹v”üŽq3, Ź’r•üF4, “ŕ“ĄˆŸŽ÷, Ö“Ąk•˝, ‰Ąa@Žq, ‘“cł˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ, 3ŠĹŒě•”, 4–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[): ‘ć25‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/8/20), “Œ‹ž.

732115. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) Rapid Response System‚Ć‚Í?”wŒi, Šî–{, “ą“ü. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘Ť—˜Ô\Žš•a‰@ˆă—ĂˆŔ‘Su‰‰‰ď (2016/12/2), ‘Ť—˜.

732116. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éRapid Response System. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć1‰ń_“ސěRapid Response SystemŒ¤‹†‰ď (2016/11/22), _“ސě.

732117. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) lHŒÄ‹zŠí‚Š‚ç‚Ě—Ł’EPAD‚ĆŒ‹‚т‚Ż‚é‚É‚Í. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć4‰ń_“ސě’ÁĂEŒÄ‹zƒTƒ|[ƒgƒtƒH[ƒ‰ƒ€ (2016/12/10), ‰Ą•l.

732118. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Sepsis-3, SSCG 2016‚ĆRapid Response System. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć2‰ń_“ސěRapid Response SystemŒ¤‹†‰ď (2017/3/14), _“ސě.

732119. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) –k—˘‘ĺŠw•a‰@GICU‚É‚¨‚Ż‚érTM‚Ć”sŒŒÇ. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆŽ‰ťŹƒƒfƒBƒJƒ‹Œ¤C‰ď (2017/3/22), Œú–Ř.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-522012. [uŔ]y“ÁW: ‘ĺ—ʏoŒŒ‚Ě•a‘Ԑś—‚Ć—AŒŒí—ށzŠOŤ‘ĺ—ʏoŒŒ: •a‘Ô‚Ć‘Îô. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Thrombosis Medicine 2016/3; 6 (1): 33-9.

[Šw‰ďEŒ¤‹†‰ď“™]

H24-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçƒZƒ~ƒi[) tˆÚA‚Ě–ƒŒŠÇ—. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć28‰ńtˆÚAEŒŒŠÇŠO‰ČŒ¤‹†‰ď (2012/7/6), ” Ş, ƒvƒƒOƒ‰ƒ€E´˜^W 2012; p. 58.

H24-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) RST‚Š‚çŽn‚Ü‚Á‚˝“–‰@‚ĚRapid Response Team (RRT). VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć26‰ń“Ţ—Ç–ƒŒW’†ŽĄ—ĂƒZƒ~ƒi[ (2012/9/28), “Ţ—Ç.

H24-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Rapid Response Team (RRT)‚Š‚ç‚Ý‚˝Oncological Emergencies‚Ě–â‘č“_. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă):u‚Ş‚ń‹~‹}v‚ÉŠÖ‚ˇ‚éę–ĺ‰ĆŒŸ“˘‰ď (2013/3/10), ‘—§‚Ş‚ńƒZƒ“ƒ^[.

H25-722001. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) đŒ‚Ş‘ľ‚Ś‚ǝŠw—Ă–@Žm‚͏W’†ŽĄ—ĂŽş‚É‚¨‚Ż‚闝Šw—Ă–@Ž{s‚ž‚Ż‚Ĺ‚Č‚­, RRT‚Ěˆęˆő‚Ć‚ŕ‚Č‚č“ž‚é. Ź’r•üF1, VˆäłN2, XˆŔŒbŽŔ3, •ž•”@4, •Šâ­”V5, ˆîŠ_‘דl4, ŽR“c—R—˘, ˆÉ“Ą‘s•˝, –kŒ´F—Y4 (1–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ŠĹŒě•”, 4‹~–˝, 5–ƒŒ): ‘ć41‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2014/2/27-3/1), ‹ž“s, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2014; 21: 55.

H25-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) yŠÄCzlHŒÄ‹z‚Š‚ç‚Ě—Ł’E‚ĆRST. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ƒRƒ”ƒBƒfƒBƒGƒ“EƒŒƒXƒsƒ‰ƒgƒŠ\ƒPƒAƒZƒ~ƒi[ (2013/5/11), “Œ‹ž.

H25-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘˝EŽí˜AŒgEƒ`[ƒ€ƒAƒvƒ[ƒ`‚É‚ć‚éŒÄ‹zƒPƒA`“–‰@‚É‚¨‚Ż‚éŒÄ‹zŠÇ—‚ɂ‚˘‚ā`. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Ă“ěŒÄ‹zŠÇ—ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2013/7/26), Œú–Ř.

H25-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Rapid Response System‚Ć‚Í? VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŽŠŽĄˆă‰Č‘ĺŠw‚ł‚˘‚˝‚܈ă—ĂƒZƒ“ƒ^[ˆă—ĂˆŔ‘SuK‰ď (2013/9/5), ‘ĺ‹{.

H25-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒ`[ƒ€‚ĹƒAƒvƒ[ƒ`‚ˇ‚éW’†ŽĄ—ĂŽş‚É‚¨‚Ż‚é‚š‚ń–Ď‘Îô. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć1‰ń_“ސě’ÁĂEŒÄ‹zƒtƒH[ƒ‰ƒ€ 2013 (2013/9/21), ‰Ą•l.

H26-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‰ď’ˇ“Á•ĘŠé‰ć) ŽáŽčˆăŽt‚ɖ𗧂ŽŔíuŔuŒÄ‹zŠÇ—‚ĚƒXƒ^ƒ“ƒ_[ƒh‚Š‚çvlHŒÄ‹z–@: ’Bl‚Ş‘E‚ß‚élHŒÄ‹zƒ‚[ƒh. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć54‰ń“ú–{ŒÄ‹zŠíŠw‰ďŠwpu‰‰‰ď (2014/4/27), ‘ĺă, ‘ć54‰ń“ú–{ŒÄ‹zŠíŠw‰ďŠwpu‰‰‰ďƒvƒƒOƒ‰ƒ€, 2014; p.66.

H26-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) lHŒÄ‹zŠłŽŇ‚Ě’ÁĂ. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Hospira Webinar (2014/9/19), “Œ‹ž.

H27-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “–‰@‚ĚRST, –{–M‚̏Ť—ˆ. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‰Ą•lƒoƒCƒ^ƒ‹ƒTƒCƒ“ƒZƒ~ƒi[ (2015/7/11), ‰Ą•l.


(Ź—ѐ´“T)

[Šwp˜_•ś]

110071. [Œ´’˜] Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis. Naganuma M, Aoyama N, Suzuki Y, Nishino H, Kobayashi K1,2, Hirai F, Watanabe K, Hibi T3,4: J Crohns Colitis 2016/7; 10 (7): 828-36. (Ź—ѐ´“T1,2, “ú”ä‹I•ś3,4: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@)

110075. [Œ´’˜] Surveillance for dysplasia in patients with ulcerative colitis: Discrepancy between guidelines and practice. Shinozaki M, Kobayashi K1,2, Kunisaki R, Hisamatsu T, Naganuma M, Takahashi KI, Iwao Y, Suzuki Y, Watanabe M, Itabashi M, Torii A, Takazoe M, Sugita A: Dig Endosc 2017/7; 29 (5): 584-93. (Ź—ѐ´“T1,2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ)

110082. [Œ´’˜] Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H, Kunisaki R, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Ohtsuka K, Murakami K, Kobayashi K1,2, Iwao Y, Nagahori M, Iizuka B, Hata K, Igarashi M, Hirata I, Kudo SE, Matsumoto T, Ueno F, Watanabe G, Ikegami M, Ito Y, Oba K, Inoue E, Tomotsugu N, Takebayashi T, Sugihara K, Suzuki Y, Watanabe M, Hibi T3,4: Gastroenterology 2016/12; 151 (6): 1122-30. (Ź—ѐ´“T1,2, “ú”ä‹I•ś3,4: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@)

110086. [Œ´’˜] Colonoscopy Withdrawal Time and Adenoma Detection Rate: A Japanese Multicenter Analysis. Kawamura T, Oda Y, Kobayashi K1,2, Matsuda K, Kida M2, Tanaka K, Kawahara Y, Yokota I, Koizumi W2, Yasuda K, Tajiri H: Journal of Gastroenterology and Hepatology Research 2017/2; 6 (1): 2273-8. (Ź—ѐ´“T1,2, –Ř“cŒőL2, Źň˜aŽO˜Y2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ)

522025. [uŔ]y“ÁW: ‘ĺ’°Žîᇁ|E‚˘ă‚°‚Š‚琸–§f’f‚܂ŁzŠe˜_ [ƒRƒ‰ƒ€]E‘ŠúŠŕ‚̐[’B“xf’f|EUS. Ź—ѐ´“T1,2, âV“Ą—FĆ2, ź–{ˆçG2, ěŠÝ‰Á“Ţ2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Á‰ťŠí“ŕŽ‹‹ž 2016/9; 28 (9): 1489-95.

522029. [uŔ]yŽĺ‘čI: ‘ĺ’°Šŕf’f‚ĚĹ‘OüzIII. ’´‰š”g“ŕŽ‹‹ž|3D-EUS‚đŠÜ‚ß‚Ä. Ź—ѐ´“T1,2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2016/11; 69 (10): 463-70.

522032. [uŔ]y“ÁW: ’°‰Š‚Ü‚é‚í‚Š‚čzŠe˜_@[‰ŠÇŤ’°ŽžŠł (IBDˆČŠO)]E”ń“ÁˆŮŤ‘˝”­ŤŹ’°’×ᇏÇ. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Á‰ťŠí“ŕŽ‹‹ž 2017/1; 29 (1): 60-4.

[’˜@‘]

620027. [Šwp‘ (•Ş’SŽˇ•M)]yƒNƒ[ƒ“•a‚̐f—ĂƒKƒCƒh ‘ć2”Łz‘ć11Í ŽĐ‰ďŽx‰‡, p.112-7. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), •Ň: NPO–@l“ú–{‰ŠÇŤ’°ŽžŠł‹Ś‰ď (CCFJ), •śŒő“°, “Œ‹ž, 2016/10”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722014. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘ĺ’°ŒŸ¸modality‚̍ŐVî•ń: ’´‰š”g“ŕŽ‹‹ž|3D-EUS‚đŠÜ‚ß‚Ä. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): “ú–{‘ĺ’°ăč–ĺ•aŠw‰ď‘ć25‰ń‹łˆçƒZƒ~ƒi[ (2016/5/22), “Œ‹ž.

722022. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“6: ‘ĺ’°“ŕŽ‹‹žŒŸf‚̐¸“xŠÇ—z‘ĺ’°“ŕŽ‹‹ž”˛‹ŽŽžŠÔ‚Í–{–M‚É‚¨‚˘‚Ä‚ŕQuality indicator‚ɂȂ肤‚é‚Š? ‰Í‘ş‘ě“ń1, Ź—ѐ´“T2, ”ö“c@‹ą3 (1‹ž“s‘ć“ńÔ\Žš•a‰@, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3”ö“cˆÝ’°“ŕ‰Č): JDDW2016 (2016/11/3), _ŒË, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2016/9; 113: A521.

722028. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate`5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š`. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć13‰ń“ú–{Á‰ťŠÇŠw‰ď‘‰ďŠwpW‰ď (2017/2/18), –źŒĂ‰Ž.

731008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate|5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ŠâŽčŒ§ƒŠƒAƒ‹ƒ_ů”­”„‹L”Ou‰‰‰ď (2017/2/15), ˇ‰Ş.

731009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate|5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ƒŠƒAƒ‹ƒ_”­”„‹L”Ou‰‰‰ď in “Ţ—Ç (2017/3/2), “Ţ—Ç.

731010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚Ěupdate|5-ASAťÜ‚Ě–{—ˆ‚Ě—Í‚đ‚˘‚Š‚Ɉř‚Ťo‚ˇ‚Š Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ƒŠƒAƒ‹ƒ_ů”­”„‹L”Ou‰‰‰ď (2017/3/14), Œú–Ř.

732018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘ĺ’°Žîᇂ̐f’f‚É‚¨‚Ż‚郂ƒ_ƒŠƒeƒB[‚đl‚Ś‚é.‘ĺ’°Žîᇂ̐f’f‚É‚¨‚Ż‚éEUS‚Ě–đŠ„. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć16‰ń‘ĺ’°‰ć‘œƒAƒJƒfƒ~[ (CIA) (2017/1/14), “Œ‹ž.


(‚ŽR—zŽq)

[Šw‰ďEŒ¤‹†‰ď“™]

733436. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒCƒ€ƒmƒNƒƒ}ƒg–@‚É‚ć‚éGBS”D•wŒ’f‚ĚŽŔ—p‰ť‚ÉŒü‚Ż‚˝•]‰ż. ‚ŽR—zŽq1, źˆäGm2, ‘ĺěŒ´—TŽ÷3, ˜a“c’B•F4, ’†‘şłŽ÷5, “ŕŽRŸ•ś6, ˆŔ’B@÷7, “ń–{–öL7, ‰Ô–؏G–ž2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–k—˘ś–˝Œ¤‹†Š, 3–ňÜ•”, 4äPŒ´•aEŠ´ő“ŕ, 5ˆă—ÉqśŠw•”, 6ŽŠO, 7—ŐŒŸ•”): ‘ć63‰ń“ú–{Š´őÇŠw‰ď“Œ“ú–{Žx•”‘‰ď (2016/10/26-28), VŠƒ.


(ÂŽR’ź‘P)

[Šwp˜_•ś]

540067. [‚ť‚Ě‘ź (Editorial Comment)] ”’ě˜_•ś‚ɑ΂ˇ‚éEditorial Comment|‹}ŤS‹Ř‰Š‚̕lj^“Ž’ቺ‚É‚Í“ń‚‚̋@˜‚ލl‚Ś‚ç‚ę‚é. ÂŽR’ź‘P (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): S‘Ÿ 2017/3; 49 (3): 283.

[Šw‰ďEŒ¤‹†‰ď“™]

713160. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Clinical characteristics of patients on hemodaialysis with peripheral arterial disease. Aoyama N1, Matuzawa R2: European atherosclerosis society (EAS 2016) (2016/6/1), Innsbruck, Austria. (ÂŽR’ź‘P1, ź‘ň—Ç‘ž2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ƒŠƒnƒrƒŠ•”)

H27”N“xˆČ‘O•Ş

[’˜@‘]

H27-620005. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ą‚Ş’m‚č‚˝‚˘@‹}ŤS•s‘S‚Ě‹~‹}EW’†ŽĄ—ĂŠÇ—z3Í ‰Šú‹~‹}ŽĄ—Á@1. ‰Šú‘Ήž, ƒNƒŠƒjƒJƒ‹ƒVƒiƒŠƒI, p.167-84. ÂŽR’ź‘P1, źˆäŠîŒp2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2zŠÂŠí“ŕ), •Ň’˜: ˛“ĄKl, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/3”­s.


(•˝“cŒő”Ž)

[Šw‰ďEŒ¤‹†‰ď“™]


723884. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ă’°ŠÔ–Œ“Ž–Ź‹ˇó‚đ•š”­‚ˇ‚é• •”‘ĺ“Ž–ŹáŽ‚ĚŽĄ—Âɂ‚˘‚Ä. •˝“cŒő”Ž1, “c‘şK•ä2, ”ü“‡—˜ş2, ‘ĺ‹v•Ű”Ž˘2, ‹{“c—L—Œb2, “y“c—E‘ž2, —с@GŒ›2, ź‘ă‘ě–ç2, “üŕV—F•ă2, Ź—ŃŒ’‰î2, ™–{Wˆę2, •ó—ˆ“N–ç2, –k‘ş@—Ľ2, ’šˆäWŽO3, ‹{’n@ŠÓ2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2S‘ŸŒŒŠÇŠO, 3ˆă—ĂˆŔ‘SŠw‹łˆç): ‘ć57‰ń“ú–{–ŹŠÇŠw‰ď‘‰ď (2016/10/14), “Ţ—Ç. –ŹŠÇŠw 2016/10; 56 (suppl): 66.


(‰Ź–ě”üŒbŽq)

[Šwp˜_•ś]

110296. [Œ´’˜] Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Yamasaki R , Matsushita T, Fukazawa T, Yokoyama K, Fujihara K, Ogino M1, Yokota T, Miyamoto K, Niino M, Nomura K, Tomioka R, Tanaka M, Kawachi I, Ohashi T, Kaida K, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Murai H, Kira J: Mult Scler 2016/9: 22 (10): 1337-48. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

[’˜@‘]

620185. [Šwp‘ (•Ş’SŽˇ•M)]y_ŒoÇŒóáŠQŠwz‘ćIIÍ _ŒoŽžŠł‚ĚŽĄ—Ă‚Ć—Šw—Ă–@@5. ‰^“Žƒjƒ…[ƒƒ“•a@A. •a‘Ô‚ĆŽĄ—Ă, p.238-48. ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •Ň: “ŕŽR@–ő, LŁ—˛ˆę2 (2_Œo“ŕ), •śŒő“°, “Œ‹ž, 2016/5”­s.

620186. [Šwp‘ (•Ş’SŽˇ•M)]yŠÉ˜aƒPƒAƒŒƒWƒfƒ“ƒgƒ}ƒjƒ…ƒAƒ‹z‘ć4Í ”ń‚Ş‚ń‚ĚŠÉ˜aƒPƒA@5. _Œo“ď•a‚ĚŠÉ˜aƒPƒA, p.333-40. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ŠÄC: X“c’B–ç, –ŘŕV‹`”V, •Ň: ź’q@O, ź–{’ő‹v, X@‰ë‹I, ŽRŒű@’, ˆăŠw‘‰@, “Œ‹ž, 2016/7”­s.


ˆăŠw•”‹łˆçŒn‹ZpEˆő

Œ`‘ÔŒn

[Šwp˜_•ś]

110001. [Œ´’˜] In vivo 3D analysis of systemic effects after local heavy-ion beam irradiation in an animal model. Nagata K, Hashimoto C, Watanabe-Asaka T, Itoh K, Yasuda T, Ohta K, Oonishi H, Igarashi K, Suzuki M, Funayama T, Kobayashi Y, Nishimaki T1, Katsumura T2, Oota H2, Ogawa M2, Oga A, Ikemoto K, Itoh H, Kutsuna N, Oda S, Mitani H: Sci Rep 2016/6; 6: 28691. (ź–Šr”V1, Ÿ‘şŒ[Žj2, ‘ž“c”ŽŽ÷2, ŹěŒł”V2: 1Œ`‘ÔŒn, 2‰đ–U)

110003. [Œ´’˜] Transgenic medaka that overexpress growth hormone have a skin color that does not indicate the activation or inhibition of somatolactin-ƒż signal. Komine R, Nishimaki T1, Kimura T, Oota H2, Naruse K, Homma N1, Fukamachi S: Gene 2016/6; 584 (1): 38-46. (ź–Šr”V1, ‘ž“c”ŽŽ÷2: 1Œ`‘ÔŒn, 2‰đ–U)

[Šw‰ďEŒ¤‹†‰ď“™]

723063. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Sox4/ƒŔ-ƒJƒeƒjƒ“/p300/SlugŒn‚͏ă”çŠÔ—t“]Šˇ/‚Ş‚ńŠ˛×–E‰ť‚đ‰î‚ľ‚ÄŽq‹{Šŕ“÷Žî‚Ě“÷ŽîŹ•ŞŒ`Ź‚ÉŠÖ—^‚ˇ‚é. ‹´‘ş”ü‹I1, ‚‹´”Ž”V2, ˆäă‹vŽq2, ŽOŽ}@M2 (1Œ`‘ÔŒn, 2•a—): ‘ć105‰ń“ú–{•a—Šw‰ď‘‰ď (2016/5/14), ĺ‘ä.

723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ň’Ĺ•ĎˆŮ‘Ěƒƒ_ƒJ‚ɑ΂ˇ‚é‚wüƒ}ƒCƒNƒCT‚Ć˜A‘ąŘ•Đ–@‚É‚ć‚éƒAƒvƒ[ƒ`|Ú×‚ČŒ`‘Ô‰đÍ‚đ–ÚŽw‚ľ‚ā|. źę r”V1, “ŕ“cŒ’‘ž˜Y, –ؐX‹`—˛, Ÿ‘şŒ[Žj, ‘ĺŠŃ—TŽq, ”ö“cł“ń, Ź‰ęŒú“ż, ‚‘ŠťŽm, ‘ž“c”ŽŽ÷2, ŹěŒł”V2 (1Œ`‘ÔŒn, 2‰đ–U): ‘ć122‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2017/3/28-30), ’ˇč.


ś•¨•¨—Œn

[Šw‰ďEŒ¤‹†‰ď“™]

723101. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚đ‰î‚ˇ‚é_Œo“`’B‚͉^“Žî•ń‚Ě“`’B‚Ɖ^“Ž‚Ě”­Œť‚É•s‰ÂŒ‡‚Ĺ‚ ‚é. ů‰Şr–M, ˛“Ą’ŠŽq (‘ĺ‹v•Ű’ŠŽq)1, ’mŒŠ‘”ü, ’†”ö‘G, ‘ĺ‹v•Ű’ź2, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ”něŒb—œŽq, ˛“ĄrĆ2, “ĄŕVM‹`, ‰ĄŽR•ő‰î, “ě•”@“Ä (1ś•¨•¨—Œn, 2ŽŔ“Ž): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/11/30), ‰Ą•l.

723102. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚đ‰î‚ˇ‚é_Œo“`’B‚͉^“Žî•ń‚Ě“`’B‚Ɖ^“Ž‚Ě”­Œť‚É•s‰ÂŒ‡‚Ĺ‚ ‚é. ů‰Şr–M, ˛“Ą’ŠŽq (‘ĺ‹v•Ű’ŠŽq)1, ’mŒŠ‘”ü, ‘ĺ‹v•Ű’ź2, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ’†”ö‘G, ˛“ĄrĆ2, “ĄŕVM‹`, “ě•”@“Ä (1ś•¨•¨—Œn, 2ŽŔ“Ž): ‘ć94‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2017/3/29), •lź.

733013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) D1/D2ƒh[ƒpƒ~ƒ“Žó—e‘ĚƒRƒ“ƒfƒBƒVƒ‡ƒiƒ‹”­Œťƒ}ƒEƒX‚É‚ć‚é‰^“Ž§Œä‹@\‚̉đ–ž. ů‰Şr–M, ˛“Ą’ŠŽq (‘ĺ‹v•Ű’ŠŽq)1, ’mŒŠ‘”ü, ‘ĺ‹v•Ű’ź2, ˆ˘•”@Šw, ě‘ş–źŽq, ’†”ö‘G, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ˛“ĄrĆ2, “ĄŕVM‹`, č‘şŒšŽi, “ě•”@“Ä (1ś•¨•¨—Œn, 2ŽŔ“Ž): •˝Ź28”N“xuć’[ƒ‚ƒfƒ‹“Ž•¨Žx‰‡ƒvƒ‰ƒbƒgƒtƒH[ƒ€vŹ‰Ę”­•\‰ď (2017/2/7), Ž ‰ę.


•a‘ԁEf—ĂŒn

[Šw‰ďEŒ¤‹†‰ď“™]

723027. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) GorlinÇŒóŒQŠłŽŇ—R—ˆ iPS×–E‚đ—p‚˘‚˝‘‰čŽí‚̍쐻. ’r–{@—D, –L“c‰ëŽm, “ߐ{“š˘, ‰Ł—m”ü1, ’ˇ”ö˜a‰E2, ‚ŽR‹g‰i2, ‹TŽRFŽO2, ”~ŕV–žO, ‹{‰şr”V2 (1•a‘ԁEf—ĂŒn, 2•ŞŽqˆâ“`): ‘ć39‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď (2016/11/30), _“ސě.


Œ’NŠÇ—ƒZƒ“ƒ^[

[Šwp˜_•ś]

110297. [Œ´’˜] Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications Study. Tanaka S1, Tanaka S1, Iimuro S1, Ishibashi S1, Yamashita H1, Moriya T1,2, Katayama S1, Akanuma Y1, Ohashi Y1, Yamada N1, Araki A1, Ito H1, Sone H1 (1Japan Diabetes Complications Study Group): J Diabetes Complications 2016/7; 30 (5): 790-7. (Žç‰Ž’B”ü1,2: 2Œ’NŠÇ—ƒZ)

110298. [Œ´’˜] Type 2 diabetic patients with diabetic retinopathy and concomitant microalbuminuria showed typical diabetic glomerulosclerosis and progressive renal dysfunction. Moriya T1, Matsubara M1, Kishihara E1, Yoshida Y1, Ouchi M: J Diabetes Complications 2016/8; 30 (6): 1111-6. (Žç‰Ž’B”ü1, źŒ´‚Ü‚Ç‚Š1, ŠÝŒ´ŠG—œŽq1, ‹g“c—F‹I1: 1Œ’NŠÇ—ƒZ)

110299. [Œ´’˜] Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study. Moriya T1, Tanaka S, Sone H, Ishibashi S, Matsunaga S, Ohashi Y, Akanuma Y, Haneda M, Katayama S: J Diabetes Complications 2017/2; 31 (2) :473-8. (Žç‰Ž’B”ü1: 1Œ’NŠÇ—ƒZ)

120046. [Œ´’˜] “d‹C‚Ż‚˘‚ę‚ń—Ă–@ƒNƒŠƒjƒJƒ‹ƒpƒX‰ü’č‚ĚŽć‚č‘g‚݁|‚ć‚čˆŔ‘S‚Ĺ“KŘ‚ČŽ{s‚đ–ÚŽw‚ľ‚ā|. ‰ş‘ş—TŒŠŽq1, ŕVŽRŒb”g2, ‰ÄŽR@‘ě1, ‹{’nLŒá3, ŒË“c‰ë–ç4, ŽRŒű–žŽq5, “c‘ş‘ń–˛5, ŠÖX‘쉛5, ´@„Žm5, —é–؁@‘ń5, –{‘˝—]3, ‘ĺÎ@’q3, ‹{‰Ş@“™3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Œ’NŠÇ—ƒZ, 3¸_, 4–ƒŒ, 5“Œ•a‰@ŠĹŒě•”): ¸_‰ČŽĄ—ĂŠw 2017/2; 32 (2): 265-70.

120047. [Œ´’˜] ƒJƒbƒvƒ‹ƒZƒ‰ƒs[‚ĚƒvƒƒZƒXŒ¤‹†|‰‰ń–ʐڂł̎Q‰ÁŽŇ‚Ě‘ĚŒą‚ÉŠÖ‚ˇ‚éŽŔŘ“IŒ¤‹†|. ‘ĺ’Ź’m‹v1, ‘吟^”ü2, ‘ĺ’ˁ@Ä3, “c•‚ ‚Ś‚Š4 (1Œ’NŠÇ—ƒZ, 2‘吳‘ĺŠwS—ŽĐ‰ďŠw•”—Տ°S—Šw‰Č, 3•‘ –쎙“śŠw‰€, 4’}”g‘ĺŠwlŠÔŒn): ‰Ć‘°S—ŠwŒ¤‹† 2017/3; 30 (2): 85-100.

210002. [€Œ´’˜] Short Note: Low Levels of Serum 1,5-Anhydroglucitol during Pregnancy Compared to Blood Glucose Measured by Continuous Glucose Monitoring. Moriya T1, Kishihara E1, Matsubara M1, Mori H, Okada Y, Koga M: Ann Clin Lab Sci 2016; 46 (2): 227-8. (Žç‰Ž’B”ü1, ŠÝŒ´ŠG—œŽq1, źŒ´‚Ü‚Ç‚Š1: 1Œ’NŠÇ—ƒZ)

220015. [€Œ´’˜] Šwś‘Š’kIŒ‹ŽžƒAƒ“ƒP[ƒg‚Š‚ç’T‚éŠwś‘Š’k‚ĚƒvƒƒZƒX‚ĆŒř‰Ę. ŽR“c—TŽq1, Î’ˏš•Ű1, ‘ĺ’Ź’m‹v1, ‰ÍŒ´‹v”üŽq1, “c’†‚ ‚ä‚Ý1, ŽRčˆť”T1, ŕVŽRŒb”g1, ‹g“c—F‹I1, źŒ´‚Ü‚Ç‚Š1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): CAMPUS HEALTH 2016/7; 53 (1): 396-8.

522135. [uŔ]y“ÁW: “œ”A•aŤtÇ‚̍Ž•ž‚đ–ÚŽw‚ľ‚ā`up to date`z“œ”A•aŤtÇ‚Ě•a—: łíƒAƒ‹ƒuƒ~ƒ“”AŠú‚Ĺ‚ŕ’ˆÓ‚Ş•K—v. źŒ´‚Ü‚Ç‚Š1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): Pharma Medica 2016/6; 34 (6): 25-9.

522136. [uŔ]y“ÁW: ƒpƒ‹ƒX”g“d‹C‚Ż‚˘‚ę‚ń—Ă–@‚͐ł‚ľ‚­s‚í‚ę‚Ä‚˘‚é‚Šzu“d‹C‚Ż‚˘‚ę‚ń—Ă–@ (ECT) „§Ž–€‰ü’ů”Łv‚É‘Ľ‚č•W€‰ť‚ƉŽ‹‰ť‚đ’Ç‹‚ľ‚˝ƒpƒX‰ü’ů. ŕVŽRŒb”g1,‰ş‘ş—TŒŠŽq2, ‰ÄŽR@‘ě2, –{‘˝—Œb3, “‡–ě•ü–ç3, ‹{’nLŒá3, ‘ĺÎ@’q3, –ě‘ş”ü‹I4, ŠÖX‘쉛4, “c‘ş‘ń–˛4, —é–ؐ­@4, ´@„Žm4, ŽRŒű–žŽq4, ŒË“c‰ë–ç5, ’|˜Q–Ż]5, ‹{‰Ş@“™3 (1Œ’NŠÇ—ƒZ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3¸_, 4“Œ•a‰@ŠĹŒě•”, 5–ƒŒ): ¸_‰ČŽĄ—ĂŠw 2016/12; 31 (12): 1529-35.

522137. [uŔ]y“œ”A•aŤtÇ‚ĚŒťó‚Ɛi“W‘jŽ~‘΍ô|śŠˆKŠľ‚̏Cł‚Ć–ň•¨—Ă–@z“œ”A•aŤtÇ‚Ě•a—Šw“I“Á’Ľ@t‘gD‚Í‚Ç‚ą‚܂Őt‹@”\—\Œă‚ĆŠÖ˜A‚ˇ‚é‚Š. Žç‰Ž’B”ü1, źŒ´‚Ü‚Ç‚Š1, ‹g“c—F‹I1, ‰HŽRŒdˆČ1, ‘ĺ“ŕŠîŽi (1Œ’NŠÇ—ƒZ): ƒJƒŒƒ“ƒgƒeƒ‰ƒs[ 2017/1; 35 (1): 30-5.

[Šw‰ďEŒ¤‹†‰ď“™]

713161. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Type 2 diabetic patients with diabetic retinopathy (DR) had typical diabetic glomerulosclerosis and showed progressive renal dysfunction after patients had microalbuminuria. Moriya T1, Matsubara M1, Kishihara E1, Yoshida Y1, Ouchi M2: American Diabetes Association 76th Scientific Sessions (2016/6/11), New Orleans, USA. (Žç‰Ž’B”ü1, źŒ´‚Ü‚Ç‚Š1, ŠÝŒ´ŠG—œŽq1, ‹g“c—F‹I1, ‘ĺ“ŕŠîŽi2: 1Œ’NŠÇ—ƒZ, 2ŕՋŚˆă‰Č‘ĺŠwˆăŠw•”)

721018. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Renal histological parameters indicating renal functional decline in patients with type 2 diabetes. Žç‰Ž’B”ü (Œ’NŠÇ—ƒZ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/21), ‹ž“s.

722272. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) “d‹C‚Ż‚˘‚ę‚ń—Ă–@ƒNƒŠƒjƒJƒ‹ƒpƒX‰ü’ů`‚ł‚ç‚Č‚éŒř‰Ę‚ĆˆŔ‘S‚Ě‚˝‚ß‚É. ŕVŽRŒb”g1, ‰ş‘ş—TŒŠŽq, –{‘˝—], ‰ÄŽR@‘ě, ‹{’nLŒá2, ‘ĺÎ@’q2, ŕVŽR@“§2, “c‘ş‘ń–˛3, ŠÖX‘쉛3, ´@„Žm3, —é–؁@‘ń3, ŽRŒű–žŽq3, ŒË“c‰ë–ç4, ‹{‰Ş@“™2 (1Œ’NŠÇ—ƒZ, 2¸_, 3“Œ•a‰@ŠĹŒě•”, 4–ƒŒ): ‘ć112‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2016/6/2), ç—t.

723885. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) łí`”÷—ĘƒAƒ‹ƒuƒ~ƒ“”AŠú2Œ^“œ”A•a‚Ěƒ_ƒpƒOƒŠƒtƒƒWƒ““Š—^‰ş‚É‚¨‚Ż‚鎅‹…‘Ěŕh‰ß’l‚Ć”A“œ. źŒ´‚Ü‚Ç‚Š1, ŠÝŒ´ŠG—œŽq1, Žľ—˘áÁ‹`2, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19), ‹ž“s, “œ”A•a 2016; 59 (Suppl 1): S-141.

723886. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŒ´1, 5AG‚Í“œ”A•a‡•š”DP—á‚ĚŒŒ“œƒRƒ“ƒgƒ[ƒ‹ó‘Ԃ𔽉f‚ľ‚Č‚˘. ŠÝŒ´ŠG—œŽq1, źŒ´‚Ü‚Ç‚Š1, Žľ—˘áÁ‹`2, ŒĂ‰ęłŽj3, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 3ěźŽs—§ěź•a‰@): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a 2016; 59 (Suppl 1): S-313.

723887. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “œ”A•a–Ô–ŒÇ‚đ—L‚ˇ‚é2Œ^“œ”A•a‚Í“TŒ^“It‘gDáŠQƒpƒ^[ƒ“‚đŽŚ‚ľ, ‚ł‚ç‚É”÷—ĘƒAƒ‹ƒuƒ~ƒ“”A‚đ‡•š‚ˇ‚é‚Ɛt‹@”\‚Ş’á‰ş‚ˇ‚é Žç‰Ž’B”ü1, źŒ´‚Ü‚Ç‚Š1, ŠÝŒ´ŠG—œŽq1, ‹g“c—F‹I1, ‘ĺ“ŕŠîŽi2 (1Œ’NŠÇ—ƒZ, 2ŕՋŚˆă‰Č‘ĺŠwˆăŠw•”): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/20), ‹ž“s, “œ”A•a 2016/5; 59 (Suppl 1): S-316.

723888. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Šwś‘Š’k‚É‚¨‚Ż‚éŽç”é‚Ć˜AŒg‚đl‚Ś‚é|˜AŒg‚ĆŽç”é‚ÉŠÖ‚ˇ‚é‰Ű‘č‚đ“ŕ•ď‚ˇ‚é3—á‚Ě•ń‚đ’Ę‚ľ‚ā|. ŽR“c—TŽq1, Î’ˏš•Ű1, ‘ĺ’Ź’m‹v1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): “ú–{Šwś‘Š’kŠw‰ď‘ć34‰ń‘ĺ‰ď (2016/5/22), “Œ‹ž, “ú–{Šwś‘Š’kŠw‰ď‘ć34‰ń‘ĺ‰ď”­•\˜_•śW 2016/4; p.51.

723889. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”­’BáŠQŠwś‚ĚŽx‰‡‚É‚¨‚˘‚Đś‚ś‚é˜AŒg‚ĚˆÓ–Ą|Ž–—á‚Ěƒƒ^•ŞÍ‚É‚ć‚鎿“IŒŸ“˘|. ‘ĺ’Ź’m‹v1, “c‘ş—Fˆę2, ŽR“c—TŽq1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ, 2–žŻ‘ĺŠw‘‡Œ’NƒZƒ“ƒ^[Šwś‘Š’kŽş): “ú–{Šwś‘Š’kŠw‰ď‘ć34‰ń‘ĺ‰ď (2016/5/22), “Œ‹ž, “ú–{Šwś‘Š’kŠw‰ď‘ć34‰ń‘ĺ‰ď”­•\˜_•śW 2016/4; p.59.

723890. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw‘Š–ÍŒ´ƒLƒƒƒ“ƒpƒX‹Ö‰ŒŠˆ“Ž‚É‚ć‚é‹łEˆő‚ĚˆÓŽŻ•Ď‰ť. źŒ´‚Ü‚Ç‚Š1, ‰HŽRŒdˆČ2, ŕVŽRŒb”g1, ‹g“c—F‹I1, Žç‰Ž’B”ü1, ‘ş“c—Ď–¤1, a’J’qŒb1, ěă”ü’q‘ă1, ´…@–F1, ŽR“c—TŽq1, ź“‡^—R1, ‚‹´–ž‹`3,4, Šâ‘şłŽk4,5, –k—˘‰p˜Y4,6 (1Œ’NŠÇ—ƒZ, 2ŒŒ‰t“ŕ, 3ŠC—mś–˝‰ČŠw•”, 4–k—˘‘ĺŠw‹Ö‰Œƒ[ƒLƒ“ƒOƒOƒ‹[ƒv, 5”ĺ”AŠí, 6ˆă—ÉqśŠw•”): ‘ć54‰ń‘S‘‘ĺŠw•ŰŒ’ŠÇ—Œ¤‹†W‰ď (2016/10/5), ‘ĺă, ‘ć54‰ń‘S‘‘ĺŠw•ŰŒ’ŠÇ—Œ¤‹†W‰ďƒvƒƒOƒ‰ƒ€ 2016; 54: 80.

723891. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é‹łEˆőBŒ^ŠĚ‰ŠƒƒNƒ`ƒ“‚̐ڎíƒXƒPƒWƒ…[ƒ‹‚ÉŠÖ‚ˇ‚錟“˘. ‹g“c—F‹I1, źŒ´‚Ü‚Ç‚Š1, ‰HŽRŒdˆČ2, ŕVŽRŒb”g1, Žç‰Ž’B”ü1, Žč“‡‰h—Žq1, a’J’qŒb1, ‘ş“c—Ď–¤1, ěă”ü’q‘ă1, ´…@–F1 (1Œ’NŠÇ—ƒZ, 2ŒŒ‰t“ŕ): ‘ć54‰ń‘S‘‘ĺŠw•ŰŒ’ŠÇ—Œ¤‹†W‰ď (2016/10/5), ‘ĺă, ‘ć54‰ń‘S‘‘ĺŠw•ŰŒ’ŠÇ—Œ¤‹†W‰ď 2016; 55: 83.

723892. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺŠwƒz[ƒ€ƒy[ƒWŒfÚî•ń‚Š‚ç’T‚éŠwś‘Š’k‹@ŠÖ‚É‚¨‚Ż‚éƒOƒ‹[ƒvƒvƒƒOƒ‰ƒ€‚Ě“Á’Ľ. Î’ˏš•Ű1, ŽR“c—TŽq1, ‘ĺ’Ź’m‹v1, ‰ÍŒ´‹v”üŽq1, “c’†‚ ‚ä‚Ý1, ŽRčˆť”T1, âˆä´1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): ‘ć54‰ń‘S‘‘ĺŠw•ŰŒ’ŠÇ—Œ¤‹†W‰ď (2016/10/6), ‘ĺă, CAMPUS HEALTH 2016/3; 54 (1): 437-9.

723893. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹łEˆő˜AŒg‚đŒ_‹@‚É—ˆ’k‚ˇ‚é”ńŽĺ‘Ě“I—ˆ’kŠwś‚ɑ΂ˇ‚éƒJƒEƒ“ƒZƒ‰[‚Ě—‰đ‚ƑΉž. ‘ĺ’Ź’m‹v1, ŽR“c—TŽq1, Î’ˏš•Ű1, ‰ÍŒ´‹v”üŽq1, “c’†‚ ‚ä‚Ý1, ŽRčˆť”T1, âˆä´1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): ‘ć54‰ń‘S‘‘ĺŠw•ŰŒ’ŠÇ—Œ¤‹†W‰ď (2016/10/6), ‘ĺă, CAMPUS HEALTH 2016/3; 54 (1): 422-4.

723894. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŒÂl‚Í‚˘‚Š‚É•ś‰ť‚đŽć‚荾‚݃p[ƒ\ƒiƒŠƒeƒB‚đŒ`Ź‚ľ‚Ä‚˘‚­‚Ě‚Š`ˆęŽ–—á‚đ’Ę‚ľ‚Ä‚ĚlŽ@`. ŽR“c—TŽq1, Î’ˏš•Ű1, ‘ĺ’Ź’m‹v1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): “ú–{‹łˆçS—Šw‰ď‘ć58‰ń‘‰ď (2016/10/9), ě, “ú–{‹łˆçS—Šw‰ď‘ć58‰ń‘‰ď”­•\˜_•śW 2017/2; p.577.

723895. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –k—˘‘ĺŠw‘Š–ÍŒ´ƒLƒƒƒ“ƒpƒX•~’n“ŕ‘S–Ę‹Ö‰Œ‰ť‚Ě‘OŒă‚É‚¨‚Ż‚éÝĐ‹łEˆő‚Ě‹i‰Œ—Ś ‚̐„ˆÚ. źŒ´‚Ü‚Ç‚Š1, Žç‰Ž’B”ü1 (1Œ’NŠÇ—ƒZ): ‘ć10‰ń“ú–{‹Ö‰ŒŠw‰ďŠwp‘‰ď (2016/10/29), “ú–{‹´.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-220001. [€Œ´’˜] –k—˘‘ĺŠw‘Š–ÍŒ´ƒLƒƒƒ“ƒpƒX•~’n“ŕ‘S–Ę‹Ö‰Œ‰ť‚ĚŽć‚č‘g‚Ý. źŒ´‚Ü‚Ç‚Š1, ŠÝŒ´ŠG—œŽq1, ŕVŽR Œb”g1, ‹g“c—F‹I1, Žç‰Ž’B”ü1, 傖ź—Ď–¤1, ’z–ě’qŒb1, ěă”ü’q‘ă1, ´…@–F1, ŽR“c—TŽq1, ź“‡^—R1, ‚‹´–ž‹`2, ˛“Ą”Vr2, –k—˘‰p˜Y2 (1Œ’NŠÇ—ƒZ, 2–k—˘‘ĺŠw‹Ö‰Œƒ[ƒLƒ“ƒOƒOƒ‹[ƒv): CAMPUS HEALTH 2016/3; 53 (1): 176-8.


–k—˘‘ĺŠw•a‰@

ŠĹŒě•”

[Šwp˜_•ś]

120048. [Œ´’˜] ‰ťŠw—Ă–@‚đŽó‚Ż‚Ä‚˘‚éisäX‚Ş‚ńŠłŽŇ‚Ě—Ă—{śŠˆ‚É‚¨‚Ż‚é‘ĚŒą|Žčp“K‰ž‚É‚Č‚ç‚Č‚Š‚Á‚˝ŠłŽŇ‚đ‘ÎŰ‚Ć‚ľ‚ā|. çř“”ü“oŽq (ŠĹŒě•”): –k—˘ŠĹŒěŠwŽ 2016/6;@18 (1): 9-20.

120049. [Œ´’˜] ŹŽ™Šú‚ɐś‘ĚŠĚˆÚA‚đŽó‚Ż‚˝ŠłŽŇ‚Ě‘ĚŒą|—Ă—{śŠˆ‚ɂ‚˘‚Ä‚ĚŒę‚č|. ź“ŕ‰ŔŽq1, Ź“‡‚Đ‚ĹŽq2 (1ŠĹŒě•”, 2‘ĺŠw‰@ŠĹŒěŠwŒ¤‹†‰Č): “ú–{ŹŽ™ŠĹŒěŠw‰ďŽ@2016/7; 25 (2): 1-7.

522138. [uŔ]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘ΉžzƒJƒM‚Í–đŠ„•Ş’S‚ĆƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“! XˆŔŒbŽŔ (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 12-3.

522139. [uŔ]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘Ήžz(2) ‚ˇ‚Ž‚É“Ž‚Ż‚é! ƒŠ[ƒ_[‚Ěƒ|ƒCƒ“ƒg. ‹Ë–{çŒb”ü (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 20-3.

522140. [uŔ]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘Ήžz(3) ‚ˇ‚Ž‚É“Ž‚Ż‚é! ’źÚ‰î•‚Ěƒ|ƒCƒ“ƒg. dM@—ş (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 24-8.

522141. [uŔ]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘Ήžz(4) ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹L˜^Eƒ^ƒCƒ€ƒL[ƒp[‚Ěƒ|ƒCƒ“ƒg. ’J@Kˆę (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 30-3.

522142. [uŔ]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘Ήžz(5) ‚ˇ‚Ž‚É“Ž‚Ż‚é! ŠO‰ń‚č‚Ěƒ|ƒCƒ“ƒg. ‹Ë–{çŒb”ü (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 36-7.

522143. [uŔ]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘Ήžz(6) ŽŸ‚ŕu‚ˇ‚Ž‚É“Ž‚Ż‚é!v‚˝‚߂̐U‚č•Ô‚č‚Ěƒ|ƒCƒ“ƒg. XˆŔŒbŽŔ (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 38-41.

522144. [uŔ]y˜AÚ: Happy! ƒ‰ƒCƒt•ƒ[ƒN‘ć4‰ńz‚Ć‚ŕ‚ɏ΂˘, ‚Ć‚ŕ‚É‹ƒ‚Ť, ‚Ć‚ŕ‚É•ŕ‚Ţ. HappyIƒ‰ƒCƒt&ƒ[ƒN. ‰Ąaˆç”ü (ŠĹŒě•”): BRAIN NURSING 2016/4; 32 (4): 313.

522145. [uŔ]y‚â‚é‹C‚ƐŹ’ˇ‚đ‘Ł‚ˇ@‹ł‚Ś‚郏ƒU‚đg‚ɂ‚Ż‚éz<‹ł‚Ś‚郏ƒU‚đg‚ɂ‚Ż‚é 2> lŢ‚Ě‘˝—lŤ‚đdŽ‹@‘gD•ś‰ť‚đ‹łˆç‚É‚Ç‚¤ś‚Š‚ˇ‚Š. •Ę•{çŒb (ŠĹŒě•”): Nursing BUSINESS 2016/5; 10 (5): 384-7.

522146. [uŔ]y‚â‚é‹C‚ƐŹ’ˇ‚đ‘Ł‚ˇ@‹ł‚Ś‚郏ƒU‚đg‚ɂ‚Ż‚éz<‚p•‚`>u‹ł‚Ś‚év‚Ě”Y‚Ý‚É“š‚Ś‚Ü‚ˇ! ˆÉ“Ąœ¨Žq1, ěč‚‚܎q2, •Ę•{çŒb3 (1ŠÖź“d—Í•a‰@, 2“Œ‹žˆă‰ČŽ•‰Č‘ĺŠwˆăŠw•”•‘Ž•a‰@, 3ŠĹŒě•”): Nursing BUSINESS 2016/5; 10 (5): 392-5.

522147. [uŔ]y“ÁW: ŒÂX‚Ě‹­‚Ý‚đŠˆ‚Š‚ľ‚Ä, –đŠ„‚É‰ž‚ś‚˝Ź‰Ę‚đ’BŹ‚ˇ‚é@ƒRƒ“ƒsƒeƒ“ƒV[‚đŠî”Ő‚É‚ľ‚˝ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[‚ĚŠJ”­@–k—˘‘ĺŠw•a‰@E“Œ•a‰@‚ĚŽć‚č‘g‚݁zĄ–k—˘‘ĺŠw•a‰@E“Œ•a‰@ŠĹŒě•”‚É‚¨‚Ż‚éuƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[v‚ĚŠJ”­‚Ć—”O. •Ę•{çŒb (ŠĹŒě•”): ŠĹŒěŠÇ— 2016/9; 26 (9): 771-7.

522148. [uŔ]y“ÁW: ŒÂX‚Ě‹­‚Ý‚đŠˆ‚Š‚ľ‚Ä, –đŠ„‚É‰ž‚ś‚˝Ź‰Ę‚đ’BŹ‚ˇ‚é@ƒRƒ“ƒsƒeƒ“ƒV[‚đŠî”Ő‚É‚ľ‚˝ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[‚ĚŠJ”­@–k—˘‘ĺŠw•a‰@E“Œ•a‰@‚ĚŽć‚č‘g‚݁zĄƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[ver.2ŠJ”­‚ÉŒü‚Ż‚˝‘gD‰ť‚ĆƒvƒƒZƒX. ’JŒű—zŽq1, •Ę•{çŒb1 (1ŠĹŒě•”): ŠĹŒěŠÇ— 2016/9; 26 (9): 778-83.

522149. [uŔ]y“ÁW: ŒÂX‚Ě‹­‚Ý‚đŠˆ‚Š‚ľ‚Ä, –đŠ„‚É‰ž‚ś‚˝Ź‰Ę‚đ’BŹ‚ˇ‚é@ƒRƒ“ƒsƒeƒ“ƒV[‚đŠî”Ő‚É‚ľ‚˝ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[‚ĚŠJ”­@–k—˘‘ĺŠw•a‰@E“Œ•a‰@‚ĚŽć‚č‘g‚݁zĄEˆć•Ę‚ĚƒRƒ“ƒsƒeƒ“ƒV[ŠJ”­ƒvƒƒZƒX@uŹ‰ĘÓ”Cv‚ƁuƒLƒƒƒŠƒAƒpƒXv‚ĚŽ‹“_‚đdŽ‹‚ľ‚˝Žć‚č‘g‚Ý. Ź‰z–ž”ü1, ‹ß“Ą‚Ü‚ä‚Ý1, ă–ě”ü•ä1, ‘吟‚Đ‚Ć‚Ý1 (1ŠĹŒě•”): ŠĹŒěŠÇ—@2016/9; 26 (9): 784-96.

522150. [uŔ]y“ÁW: ŒÂX‚Ě‹­‚Ý‚đŠˆ‚Š‚ľ‚Ä, –đŠ„‚É‰ž‚ś‚˝Ź‰Ę‚đ’BŹ‚ˇ‚é@ƒRƒ“ƒsƒeƒ“ƒV[‚đŠî”Ő‚É‚ľ‚˝ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[‚ĚŠJ”­@–k—˘‘ĺŠw•a‰@E“Œ•a‰@‚ĚŽć‚č‘g‚݁zĄƒIƒ“ƒ‰ƒCƒ“ă‚Ěeƒ|[ƒgƒtƒHƒŠƒI‚ɍ\’z‚ľ‚˝ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[ver.2•]‰żƒVƒXƒeƒ€. ´…›’“ (ŠĹŒě•”): ŠĹŒěŠÇ— 2016/9; 26 (9): 797-805.

522151. [uŔ]y“ÁW: ŒÂX‚Ě‹­‚Ý‚đŠˆ‚Š‚ľ‚Ä, –đŠ„‚É‰ž‚ś‚˝Ź‰Ę‚đ’BŹ‚ˇ‚é@ƒRƒ“ƒsƒeƒ“ƒV[‚đŠî”Ő‚É‚ľ‚˝ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[‚ĚŠJ”­@–k—˘‘ĺŠw•a‰@E“Œ•a‰@‚ĚŽć‚č‘g‚݁zĄƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[ver.2‚ĚŒř‰Ę“I‰^—p‚ÉŒü‚Ż‚˝‹łˆç“IŽx‰‡@Žĺ”C‚đŽ˛‚É˜‚Ś‚˝‘gD‘S‘̂ւ̐Z“§‚ÉŒü‚Ż‚˝Žć‚č‘g‚Ý. ‹g“cG”ü (ŠĹŒě•”): ŠĹŒěŠÇ— 2016/9; 26 (9): 808-12.

522152. [uŔ]y“ÁW: Žt’ˇ‚É‚Č‚č‚˝‚­‚Č‚˘v‚Ć‚ÍŒž‚í‚š‚Č‚˘! ƒ}ƒlƒWƒƒ“ƒg‚Ş–Ę”’‚­‚Č‚é ŽŸ˘‘ă‚ĚŠÇ—EˆçŹƒƒ\ƒbƒhz[ŽŸ˘‘ăƒŠ[ƒ_[‚Ěˆç‚Ä•űE“ą‚Ť•ű (2)] ƒXƒ^ƒbƒt‚̔敞‚ސi‚ŢŒťę‚đ‰üŠv@ŽŸ˘‘ăƒŠ[ƒ_[‚̉肪ˆç‚Ü‚ę‚é‚Ü‚Ĺ. ŒÜ“Ą—zŽq (ŠĹŒě•”): Nursing BUSINESS 2016/10; 10 (10): 872-4.

522153. [uŔ]y“ÁW: ‚Ş‚ńƒTƒoƒCƒo[‚Ö‚ĚŽx‰‡`Ą‚Ĺ‚Ť‚éƒTƒ|[ƒg/ƒPƒA‚Ƃ́`z‚Ş‚ńƒTƒoƒCƒo[ƒVƒbƒv‚ĆƒPƒA. ‹ß“Ą‚Ü‚ä‚Ý (ŠĹŒě•”): ‚Ş‚ńŠĹŒě 2016/11; 21 (7): 671-4.

540068. [(‚ť‚Ě‘ź (•ŇW)]y“ÁW: ‚ˇ‚Ž‚É“Ž‚Ż‚é! ‹}•Ď‘ΉžzXˆŔŒbŽŔ (ŠĹŒě•”): Expert Nurse 2016/4; 32 (5): 10-41.

[’˜@‘]

620187. [Šwp‘ (•Ş’SŽˇ•M)]yuŠĹŒě•K—v“xvŽć‚č‘g‚ÝŽ–—áW (ŠĹŒě2016”N11ŒŽ—ŐŽž‘Š§†)z‘ć2Í Žć‚č‘g‚݁EŠˆ—pŽ–—á@2-2. ŠĹŒě•K—v“x‚̐łŠm‚Č•]‰ż‚đ–Ú“I‚Ć‚ľ‚˝ƒf[ƒ^ŠÇ—‘̐§‚ĚŽŔŰ, p.38-47. ‹g“cG”ü1 (1ŠĹŒě•”), •Ň: “c’†˛Žq2 (2‰Ą•l‘n‰p‘ĺŠwŠĹŒěŠw•”), “ú–{ŠĹŒě‹Ś‰ďo”ʼnď, “Œ‹ž, 2016/11”­s.

620188. [Šwp‘ (•Ş’SŽˇ•M)]y‚Ş‚ń‘ĚŒąŽŇ‚Ć‚Ě‘Î˜b‚Š‚çŽn‚Ü‚éA˜JŽx‰‡z5Í ‚Ş‚ń‚Ě‹Ç–Ę‚˛‚Ć‚ĚŽx‰‡‚Ěƒ|ƒCƒ“ƒg@I. ‚Ş‚ńƒTƒoƒCƒo[ƒVƒbƒv‚ƏA˜JŽx‰‡, p.70-80. ‹ß“Ą‚Ü‚ä‚Ý1 (1ŠĹŒě•”), •Ň: Ź”—•x”üŒb2, ´…“ޏ”ü3 (2‰Ą•lŽs—§Žs–Ż•a‰@, 3_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[), “ú–{ŠĹŒě‹Ś‰ďo”ʼnď, “Œ‹ž, 2017/2/”­s.

620189. [Šwp‘ (•Ş’SŽˇ•M)]y‚Ş‚ńŠĹŒěƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€“ú–{”Ĺ (Žčp—Ă–@E–ň•¨—Ă–@E•úŽËü—Ă–@EŠÉ˜aƒPƒA)z‘ć2Í ŠÉ˜aƒPƒA‚É‚¨‚Ż‚éƒg[ƒ^ƒ‹ƒyƒCƒ“‚ĚƒAƒZƒXƒƒ“ƒg@1. 4‚‚̎‹“_‚Ĺ‚Ý‚éƒg[ƒ^ƒ‹ƒyƒCƒ“@D. ŽĐ‰ď“I‹ę’É‚ĚƒAƒZƒXƒƒ“ƒg, p.326-8. çř“”ü“oŽq1,2 (1ŠĹŒě•”), •Ň: “Ą“c˛˜a2, r”ö°œ¨2, —Yź’qŒb”ü2, ŹŕVŒjŽq2, Œă“ĄŽu•Ű2, ˛“Ą‚Ü‚ä‚Ý2, çř“”ü“oŽq1,2, “c’†‹žŽq2 (2ˆę”ĘŽĐ’c–@l“ú–{‚Ş‚ńŠĹŒěŠw‰ď‹łˆçEŒ¤‹†Šˆ“ŽˆĎˆő‰ďƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv), ˆăŠw‘‰@, “Œ‹ž, 2017/2”­s.

620190. [Šwp‘ (•Ş’SŽˇ•M)]y‚Ş‚ńŠĹŒěƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€“ú–{”Ĺ (Žčp—Ă–@E–ň•¨—Ă–@E•úŽËü—Ă–@EŠÉ˜aƒPƒA)z‘ć3Í ‚Ş‚ńŠłŽŇ‚Ěƒg[ƒ^ƒ‹ƒyƒCƒ“‚đŠÉ˜a‚ˇ‚é“úíśŠˆ‚ĚŽx‰‡@2. ƒg[ƒ^ƒ‹ƒyƒCƒ“‚đŠÉ˜a‚ˇ‚éƒPƒA@C. ŽĐ‰ď“I‹ę’ɂɑΏˆ‚ˇ‚é‚˝‚ß‚ĚŽx‰‡, p.338-9. çř“”ü“oŽq1,2 (1ŠĹŒě•”), •Ň: “Ą“c˛˜a2, r”ö°œ¨2, —Yź’qŒb”ü2, ŹŕVŒjŽq2, Œă“ĄŽu•Ű2, ˛“Ą‚Ü‚ä‚Ý2, çř“”ü“oŽq1,2, “c’†‹žŽq2 (2ˆę”ĘŽĐ’c–@l“ú–{‚Ş‚ńŠĹŒěŠw‰ď‹łˆçEŒ¤‹†Šˆ“ŽˆĎˆő‰ďƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv), ˆăŠw‘‰@, “Œ‹ž, 2017/2”­s.

621001. [Šwp‘ (•ŇW)]y‚Ş‚ńŠĹŒěƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€“ú–{”Ĺ (Žčp—Ă–@E–ň•¨—Ă–@E•úŽËü—Ă–@EŠÉ˜aƒPƒA)z•Ň: “Ą“c˛˜a1, r”ö°œ¨1, —Yź’qŒb”ü1, ŹŕVŒjŽq1, Œă“ĄŽu•Ű1, ˛“Ą‚Ü‚ä‚Ý1, çř“”ü“oŽq1,2, “c’†‹žŽq1 (1ˆę”ĘŽĐ’c–@l“ú–{‚Ş‚ńŠĹŒěŠw‰ď‹łˆçEŒ¤‹†Šˆ“ŽˆĎˆő‰ďƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv, 2ŠĹŒě•”), ˆăŠw‘‰@, “Œ‹ž, 2017/2”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722273. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘˝EŽíƒRƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“‚É‚ć‚é‰@“ŕCKDŽx‰‡‘̐§. –ěŒű•ś”T1, ’r“cŹ]2, Îˆä‘ĺ•ă2, ‹g“cˆęŹ2,3 (1ŠĹŒě•”, 2”ĺ”AŠí, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “§Í‰ďŽ 2016; 49 (Suppl 1): 347.

722274. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹ę’É‚ĚƒXƒNƒŠ[ƒjƒ“ƒO‚ĚŽŔŰ@‘ĺŠw•a‰@‚É‚¨‚Ż‚é‹ę’É‚ĚƒXƒNƒŠ[ƒjƒ“ƒO‚ĚŽć‚č‘g‚Ý. ‹ß“Ą‚Ü‚ä‚Ý1, Šâ–{ƒŽq1, Ž™‹Ę”ü—R‹I1 (1ŠĹŒě•”): ‘ć21‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2016/6/17), ‹ž“s, Palliative Care Research 2016/6; 11: S160.

722275. [Šw‰ď (‘S‘)] (ƒi[ƒVƒ“ƒOƒvƒƒOƒ‰ƒ€) ‘ĺŠw•a‰@‚ĚŠĹŒě‹łˆç‚Ć—Ő°ŠĹŒěŽt‚ĚˆçŹ. ŹâŒŚŽq (ŠĹŒě•”): ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2016/11/6), ‹ž“s, ‘ć70‰ń“ú–{—Տ°Šá‰ČŠw‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/10; p.151.

722276. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) RTC‚ŞŠÖ‚í‚éÄ—Ă–@‘I‘đ‚Ɛt•s‘SŠĹŒě˜AŒg`Ä—Ă–@‘I‘đ‚̏ę–Ę‚Š‚ç`. –ěŒű•ś”T1, ’r“cŹ]2, Îˆä‘ĺ•ă2, ‹g“cˆęŹ3 (1ŠĹŒě•”, 2”ĺ”AŠí, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË, ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.132.

722277. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ”r”AŽŠ—§Žx‰‡‚ÉŒü‚Ż‚˝ƒtƒ[‚̍쐬. ´‹{”ü‰r (ŠĹŒě•”): ‘ć34‰ń“ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘‰ď (2017/2/17), –źŒĂ‰Ž, “ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŽ 2017/1; 33 (1): 95.

722278. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŽčpŽşƒŠƒlƒ“‚Ě’P‰ńŽg—p‚ĆƒŠƒ†[ƒX‚đŒŸ“˘‚ˇ‚é`ƒŠƒ†[ƒX‚Š‚çƒfƒBƒXƒ|‚ւ̐؂č‘Ö‚Ś‚đŒoŒą‚ľ‚ā`. ‚é—R”üŽq1,2, ˛X–ŘŒ°Žq1,2, Â–ö˛’qŽq1,2, ‘ĺěŒ´—TŽ÷1,3, “ń–{–öL1,4, [–xMŽq1,2, ˜a“c’B•F1,5, ‚ŽR—zŽq1,6 (1Š´őŠÇ—Žş, 2ŠĹŒě•”, 3–ňÜ•”, 4—Տ°ŒŸ¸•”, 5äPŒ´•aEŠ´ő“ŕ, 6V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć32‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďEŠwpW‰ď (2017/2/25), •şŒÉ, “ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; 32: 218.

723896. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) š‹‰ş‚ɑ΂ˇ‚éƒl[ƒUƒ‹ƒnƒCƒtƒ[‘•’…‚̉e‹ż‚ÉŠÖ‚ˇ‚錟“˘. Î‘q@ˆ¤1, ŠŽR˜a”ü1, •Đ‰Ş—Sˆę2, _œä’m“š2, ó—˜@–ő2 (1ŠĹŒě•”, 2‹~–˝): ‘ć19‰ń“ú–{—Տ°‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/5/12), •Ÿ“‡, “ú–{—Տ°‹~‹}ˆăŠw‰ďŽGŽ 2016/4; 19 (2): 376.

723897. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠłŽŇ‚́wĹ‘Px‚đl‚Ś‚˝‹~‹}—Ěˆć‚̏I––Šú‚É‚¨‚Ż‚éŠĹŒě‰î“ü`gŒł•s–žÇ—á‚đU‚č•Ô‚Á‚ā`. ă‘ş—RŽ—1, Î‘q@ˆ¤1, ŠŽR˜a”ü1, ‚‹´@Œb1 (1ŠĹŒě•”): ‘ć19‰ń“ú–{—Տ°‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/5/14), •Ÿ“‡, “ú–{—Տ°‹~‹}ˆăŠw‰ďŽGŽ 2016/4; 19 (2): 415.

723898. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”ń–ƒŒ‰Čˆă‚É‚ć‚é“ŕŽ‹‹žŒŸ¸EŽĄ—Ă‚Ě’ÁĂp‘OŠłŽŇ•]‰ż‚ĚŽć‚č‘g‚Ý. ŠÝ–Ř‚ ‚ä‚Ý1, ‹{ŕVŽu˜N2, ÎŒËŒŞŽŸ2, “c糁@‘2,3, ‘OŕV”ü“ŢŽq1, ŽOŽ}Ž–1, Šâˆä’m‹v2, Ąň@O2, –Ř“cŒőL2, Źň˜aŽO˜Y2, •Šâ­”V4, ź“cO”ü4, źŕV‹`”V4 (1ŠĹŒě•”, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 4–ƒŒ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2016/5/12-14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 839.

723899. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) HD“ą“üŠú‚ĚƒXƒPƒWƒ…[ƒ‹•\Šˆ—p‚É‚ć‚銳ŽŇ‘¤•]‰ż‚ĆŽŔ‘Hó‹ľ. •Ÿ“‡˜a‘ă1, ‰ĄŽR—˜1, ’†“‡éş1, “c粍KŽŔ1, š ‹g’qŽq1, Ź–ě@–r1, ˛–ě@—˛2 (1ŠĹŒě•”, 2t‘Ÿ“ŕ): ‘ć61‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2016/6/11), ‘ĺă, “ú–{“§ÍˆăŠw‰ďŽGŽ 2016/5; 49 (Suppl 1): 830.

723900. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚­‚ŕ–Œ‰şƒ|[ƒg‚É‚ć‚éáu’Ƀ}ƒlƒWƒƒ“ƒg‚đs‚Á‚˝ŠłŽŇ‚Ě—Ă—{Žx‰‡‚É‚¨‚Ż‚é‰Ű‘č. Šâ–{ƒŽq1, ‹ß“Ą‚Ü‚ä‚Ý1, Ž™‹Ę”ü—R‹I1 (1ŠĹŒě•”): ‘ć21‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2016/6/17), ‹ž“s, Palliative Care Research 2016/6; 11 (Suppl): S357.

723901. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ĺŠw•a‰@‚É‚¨‚Ż‚é‚Ş‚ńŠłŽŇ‚Ě‹ę’ɃXƒNƒŠ[ƒjƒ“ƒO‚Ě•ŞÍ (‘ć1•ń)|‹ę’Éó‹ľ‚ĆŽĄ—ĂŽžŠú‚Ě“Á’Ľ|. Ž™‹Ę”ü—R‹I1, Šâ–{ƒŽq1, ‹ß“Ą‚Ü‚ä‚Ý1 (1ŠĹŒě•”): ‘ć21‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2016/6/18), ‹ž“s, Palliative Care Research 2016/6; 11 (Suppl): S317.

723902. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ĺŠw•a‰@‚É‚¨‚Ż‚é‚Ş‚ńŠłŽŇu‹ę’ɃXƒNƒŠ[ƒjƒ“ƒOv‚Ě•ŞÍ (‘ć2•ń)|ƒXƒNƒŠ[ƒjƒ“ƒO‚ĚŒ‹‰Ę‚ƑΉžó‹ľ‚ĚŠÖ˜A|. ‹ß“Ą‚Ü‚ä‚Ý1, Šâ–{ƒŽq1, Ž™‹Ę”ü—R‹I1 (1ŠĹŒě•”): ‘ć21‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2016/6/18), ‹ž“s, Palliative Care Research 2016/6; 11 (Suppl): S316.

723903. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠO—ˆŠĹŒěŽt‚ލs‚Á‚Ä‚˘‚é“d˜b‘Š’k‚ĚŒoŒą’m‚đ‰ÂŽ‹‰ť‚ˇ‚é. ‰vŽR“Ţ•äŽq1, ŒK–źŽő”üv, ź–{@ˆ˛1, ‘ĺ–ěKŽq1, ‹g“c—R”üŽq1, ŽRé—Ż”üŽq1, ˆä‘ş—[•P1, X“c—zŽ}1, ŒĂŻ´”ü1, ˛“Ą^‹IŽq1 (1ŠĹŒě•”): ‘ć66‰ń“ú–{•a‰@Šw‰ď (2016/6/24), ŠâŽč, ‘ć66‰ń“ú–{•a‰@Šw‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/6; p.328.

723904. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹~‹}•a“ŒÄ‹zƒPƒAƒ`[ƒ€Šˆ“Ž‚É‚ć‚éV‘˛ŠĹŒěŽt‚ĚƒŠƒAƒŠƒeƒBƒVƒ‡ƒbƒNŒyŒ¸‚Ö‚ĚŒř‰Ę. ŹŽR–ž—˘1, XˆŔŒbŽŔ1, Žu‘şŒhŽq1, ‘şă@ˆ˛1, –ź“nŽR‰Ŕ‹I1, ŠŽR˜a”ü1 (1ŠĹŒě•”): ‘ć38‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ď (2016/7/16), ˆ¤’m.

723905. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –ŤŽžŠł‚đ‚ŕ‚żAŠwE•œŠw‚đ‚ˇ‚éŽq‚Ç‚ŕ‚Ć‚ť‚̉Ƒ°‚̍˘‚č‚â•sˆŔ‹y‚Ń–]‚ŢŽx‰‡‚ÉŠÖ‚ˇ‚é•śŒŁŒ¤‹†|Šw“śŠú’†ŠúˆČ~‚ĚŽq‚Ç‚ŕ‚ƉƑ°‚Ö‚ĚŽx‰‡‚ÉĹ“_‚𓖂Ăā|. –Ř‘ş‚ä‚ÝŽq (ŠĹŒě•”): “ú–{ŹŽ™ŠĹŒěŠw‰ď‘ć26‰ńŠwpW‰ď (2016/7/23), ‘ĺă, “ú–{ŹŽ™ŠĹŒěŠw‰ď‘ć26‰ńŠwpW‰ďu‰‰W 2016/6; p.40.

723906. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒvƒŒƒpƒŒ[ƒVƒ‡ƒ“‚đ˘“ď‚É‚ˇ‚é—vˆö|•śŒŁŒŸ“˘‚đ’Ę‚ľ‚ā|. ‰““Ą@F1, “ŕ“Ą–΍K1 (1ŠĹŒě•”): “ú–{ŹŽ™ŠĹŒěŠw‰ď‘ć26‰ńŠwpW‰ď (2016/7/24), ‘ĺ•Ş, “ú–{ŹŽ™ŠĹŒěŠw‰ď‘ć26‰ńŠwpW‰ďu‰‰W 2016/6; p.143.

723907. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) d“xSgáŠQŽ™ (ŽŇ) ‚ĚˆŔ‘S‚Č‹CŠÇƒJƒjƒ…[ƒŒŠÇ—‚Ö‚ĚŽć‚č‘g‚݁|ƒJƒjƒ…[ƒŒ•ŰŽƒoƒ“ƒh‚Ě—LŒřŤ|. ź“ŕ‰ŔŽq1, ˆÉ“Ą‚Ý‚¸‚Ů1 (1ŠĹŒě•”): “ú–{ŹŽ™ŠĹŒěŠw‰ď‘ć26‰ńŠwpW‰ď (2016/7/24), ‘ĺ•Ş, “ú–{ŹŽ™ŠĹŒěŠw‰ď‘ć26‰ńŠwpW‰ďu‰‰W 2016/6; p.277.

723908. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŻŽíœ‚ÉŒW‚éf—Ă•ńV‰ü’č‚É”ş‚¤Ž{ÝŠÔŒ_–ń‚Ě’÷Œ‹ó‹ľ. Š}Œ´‚Ý‚Ç‚č1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, ‘ĺ’JŒö‹M3, ‚‘ŠťŽm2 (1ŠĹŒě•”, 2ŽŠO, 3œƒoƒ“ƒN): ‘ć15‰ń“ú–{‘gDˆÚAŠw‰ď‘‰ďEŠwpW‰ď (2016/8/27), •xŽR, “ú–{‘gDˆÚAŠw‰ďŽGŽ 2016/8; 15 (1): 30.

723909. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •˝Ź28”N“xf—Ă•ńV‰ü’č‚É‚ć‚é–k—˘‘ĺŠw•a‰@œƒoƒ“ƒN‚ĚŽűŽxƒoƒ‰ƒ“ƒX’˛¸. ‘ĺ’JŒö‹M1, ˆäă@Œş2, “ŕ“cŒ’‘ž˜Y2, Š}Œ´‚Ý‚Ç‚č3, ‚‘ŠťŽm2 (1œƒoƒ“ƒN, 2ŽŠO, 3ŠĹŒě•”): ‘ć15‰ń“ú–{‘gDˆÚAŠw‰ď‘‰ďEŠwpW‰ď (2016/8/27), •xŽR, “ú–{‘gDˆÚAŠw‰ďŽGŽ 2016/8; 15 (1): 29.

723910. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) A•a‰@‚É‚¨‚Ż‚éĐŠQŠĹŒěŒ¤C‚ĚŽć‚č‘g‚Ý. ’J@Kˆę1, Ž…’؁@Œb1, ůŒ´Š°”V1, ŹŽR–ž—˘1, ˜a’m—ÉŽq1, ŠŽR˜a”ü1 (1ŠĹŒě•”): “ú–{ĐŠQŠĹŒěŠw‰ď‘ć18‰ń”NŽŸ‘ĺ‰ď (2016/8/27), ‹v—Ż•Ä, “ú–{ĐŠQŠĹŒěŠw‰ďŽ 2016/8; 18 (1): 135.

723911. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ĐŠQŠĹŒě‚đZ“§‚ł‚š‚éŽć‚č‘g‚݁`DMAT‘ŕˆő‚É‚ć‚éĐŠQ‘΍ôƒ`[ƒ€ˆő‚ĚˆçŹ`. ŹŽR–ž—˘1, ůŒ´Š°”V1, ˜a’m—ÉŽq1, ă‘ş—RŽ—1, ’J@Kˆę1, ŠŽR˜a”ü1 (1ŠĹŒě•”): “ú–{ĐŠQŠĹŒěŠw‰ď‘ć18‰ń”NŽŸ‘ĺ‰ď (2016/8/27), ‹v—Ż•Ä, “ú–{ĐŠQŠĹŒěŠw‰ďŽ 2016/8; 18 (1): 136.

723912. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) VlŠĹŒěEˆő‚ĚƒtƒBƒWƒJƒ‹ƒAƒZƒXƒƒ“ƒgŒ¤C‚Ě‹łˆçŒř‰Ę`W‡Œ¤C‚đ6ƒ–ŒŽŒp‘ą‚ľ‚ā`. –x]çŒbŽq1, ’JŒű—zŽq1, “ŒŠC—Ń‚ż‚Ś‚Ý1, —ä–{ŒN]1, áÁ–ě“oŠěŽq1, XˆŔŒbŽŔ1, ‘ĺ’JŽ–ç1, ꎓĄk•˝1, “ŕ“ĄˆŸŽ÷1, ’†ŽR‰hƒ2, ’––”ŽŽq1 (1ŠĹŒě•”, 2ŠĹŒěŠw•”): ‘ć47‰ń“ú–{ŠĹŒěŠw‰ď|ŠĹŒě‹łˆç|ŠwpW‰ď (2016/8/5), Ž ‰ę, ‘ć47‰ń“ú–{ŠĹŒěŠw‰ď|ŠĹŒě‹łˆç|ŠwpW‰ď´˜^W 2016/7; p.205.

723913. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”]_ŒoŠO‰Č•a“‚É‚¨‚Ż‚é•@•”‚Ěˆă—ĂŠÖ˜A‹@Šíˆł”—‘n‚Ě”­śó‹ľ‚Ɖۑč. V“ż—T”ü1, źŒ´N”ü1, ‘ž“c—L”ÜŽq1 (1ŠĹŒě•”): ‘ć18‰ń“ú–{ĺńጊw‰ďŠwpW‰ď (2016/9/2), ‰Ą•l, “ú–{ĺńጊw‰ďŽ 2016/8; 18 (3): 309.

723914. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Œz’Ĺ‘•‹ď‚É‚ć‚éˆă—ĂŠÖ˜A‹@Šíˆł”—‘n‚Ě”­śŽ–—ጟ“˘‚ƍĄŒă‚̉ۑč. Źě—œŽŃ1, ŒŠŒ´@–Ň1, “cŒű^‹M1, ŒŃ“cŤŽk1, źŒ´N”ü1 (1ŠĹŒě•”): ‘ć18‰ń“ú–{ĺńጊw‰ďŠwpW‰ď (2016/9/2), ‰Ą•l, “ú–{ĺńጊw‰ďŽ 2016/8; 18 (3): 307.

723915. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŕŽ‹‹žŒŸ¸•”–ĺ‚É‚¨‚Ż‚錟¸‘Ň‚żŽžŠÔ‚ĚŒťó‚Ć‘Ň‚żŽžŠÔ’Zk‚ÉŒü‚Ż‚Ä‚ĚŽć‚č‘g‚Ý. ŽOŽ}Ž–1, Îěˆť”T1 (1ŠĹŒě•”): ‘ć47‰ń“ú–{ŠĹŒěŠw‰ď-ŠĹŒěŠÇ—-ŠwpW‰ď (2016/9/28), Îě, ‘ć47‰ń“ú–{ŠĹŒěŠw‰ď-ŠĹŒěŠÇ—-ŠwpW‰ď´˜^W 2016/9; p.547.

723916. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) RTC–đŠ„‚Ě‘˝—l‰ť‚Ɖۑč`”F’萧“x‚Š‚ç5”N, Žw“ąŠÇ——żŽZ’čŒă‚ĚˆÚAŠO—ˆ‚ĚŒťó. –ěŒű•ś”T1, ’r“cŹ]2, ˆä‘ş—[•P1, rě–@Žq1, Îˆä‘ĺ•ă2, ‹g“cˆęŹ3 (1ŠĹŒě•”, 2”ĺ”AŠí‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/10/1), “Œ‹ž, ˆÚA 2016/9; 51 (‘‰ď—ŐŽž): 337.

723917. [Šw‰ď (‘S‘)] ƒ|ƒXƒ^[) “–‰@ěč•a‹}ŤŠúƒNƒŠƒjƒJƒ‹ƒpƒX‚É‚¨‚Ż‚é‰^—p•]‰ż‚ƍĄŒă‚Ě‰Ű‘čŒŸ“˘. Î‰ş‰ë”ü1, ź“ŕ‰ŔŽq1, •űš•˝2, Ž–ě@Žő2, ]”gŒËF•ă2, îŒ´‹`l3, ŽR—œ‰€ś4, “cč—R‰Ŕ4, ’r“cKŽq1, rˆäN•v4, Îˆäł_2 (1ŠĹŒě•”, 2ŹŽ™, 3ŠC˜V–ź‘‡•a‰@ŹŽ™‰Č, 4f—Ïî•ńŠÇ—Žş) ‘ć36‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď (2016/10/1), _“ސě, ‘ć36‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď´˜^ 2016/9; p.114.

723918. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒiƒuƒpƒNƒŠƒ^ƒLƒZƒ‹‚É‚ć‚é’܏áŠQ‚ɑ΂ˇ‚é—â‹p–@‚Ě—\–hŒř‰Ę. ”Ş–öçt1, ˛X–Ř“O2, ŠO“‡ŠG—1, ćѓc—˘“Ţ1, ŒĂ•˝Œb”üŽq1, ˆÉ“Ą‚Ś‚čŽq1, ”ԏ ÍŽq1, ˛X–ŘŽőŽq3, ›Œ´[L3, ˛X–ŘŽĄˆę˜Y4 (1ŠĹŒě•”, 2Á‰ťŠí“ŕ, 3–ňÜ•”, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/20), _“ސě, “ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď´˜^W (ƒAƒvƒŠ´˜^) 2016/10; 54: WS3-6.

723919. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) H“š‚Ş‚ńŽüpŠúƒTƒ|[ƒgƒ`[ƒ€‰î“ü‚É‚ć‚é—Տ°“IŒř‰Ę`pŒăÝ‰@“ú”’Zk‚ĚŠĎ“_‚Š‚ç`. ’ˇ’Jě“ŢŽq1, X’JGŒő2, ˛“Ą‚Ý‚ł‚đ, ‹e’rŘ•äŽq, [‘ň˛ŒbŽq, ´–ě—R”y3, ‰Ş•”‘•c, _•Ű•‘Ľ4, ŒŠˆä“c˜ał4, •˝’ËŒö–¤5, ‚‹´N‰î, ‰Ş“c—SŽq, ‰iˆä”ü’qŽq, ŽR‰şŒpŽj2, “n粏š•F2 (1ŠĹŒě•”, 2ŠO‰Č, 3Ž¨•@ˆôAE“ŞčňŠO, 4ƒŠƒnƒrƒŠ•”, 5–ňÜ•”): ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2016/10/22), ‰Ą•l, ‘ć54‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď´˜^W 2016/10; p.71.

723920. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘Šú—Ł°‚É‚ć‚é•sˆŔ‚Ě‹Nˆö‚Ć—Ł°ƒvƒƒOƒ‰ƒ€‚ĚŒŸ“˘. ŒŠŒ´@–Ň1, ’Ö”ü’q”Ž1, •ÄŽR‰ÄŽŔ (1ŠĹŒě•”): ‘ć18‰ń“ú–{‹~‹}ŠĹŒěŠw‰ďŠwpW‰ď (2016/10/30), ç—t, “ú–{‹~‹}ŠĹŒěŠw‰ďŽGŽ 2016/10; 18 (3): 276.

723921. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒhƒNƒ^[ƒJ[ŠĹŒěŽt‚ĚŠĹŒěŽŔ‘H‚Š‚ç‚Ý‚Ś‚˝ĄŒă‚̉ۑč. ‰şˆä–ƒ‹IŽq1, Î‘q@ˆ¤1, ŠŽR˜a”ü1, žŇź‹v”üŽq1 (1ŠĹŒě•”): ‘ć18‰ń“ú–{‹~‹}ŠĹŒěŠw‰ďŠwpW‰ď (2016/10/30), ç—t, “ú–{‹~‹}ŠĹŒěŠw‰ďŽGŽ 2016/10; 18 (3): 288.

723922. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –ŤS•s‘S‚đ‚Š‚Š‚Ś‚鍂—îŽŇ‚Ě“ü‘މ@‚đŒJ‚č•Ô‚ˇ‰ß’ö‚É‚¨‚Ż‚é‘ĚŒą. 傖ź—R‰Á—˘1, Â–Ř—”ü1 (1ŠĹŒě•”): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwp‘‰ď (2016/10/7), ŽD–y.

723923. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˆę”Ę•a“‚É‚¨‚Ż‚éT––Šú‚Ş‚ńŠłŽŇ‚ĚƒPƒA‚ɑ΂ˇ‚鍢“‚ĚŒťó`ŠĹŽć‚č‚ĚŒoŒą‚Ě—L–ł‚ÉĹ“_‚đ‚ ‚Ä‚Ä`. “c’†Œ’‘ž˜Y1, ’†“‡éş1, ‰ĄŽR—˜1, •B“c—LŠóŽq1 (1ŠĹŒě•”): ‘ć47‰ń“ú–{ŠĹŒěŠw‰ď|–ŤŠúŠĹŒě|ŠwpW‰ď (2016/11/11), ’šŽć, ‘ć47‰ń“ú–{ŠĹŒěŠw‰ď|–ŤŠúŠĹŒě|ŠwpW‰ď´˜^W 2016/10; p.285.

723924. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éHIV/AIDSŠłŽŇ‚ĚŽüˆÍ‚Ö‚Ě’mŽx‰‡‚ĚŒŸ“˘. ‰Á“Ą@Î1, ꎓĄ‘Žq1, źŽRW‘ă1, ‘O“cŒiŽq2, ˜a“c’B•F3, ‚ŽR—zŽq4 (1ŠĹŒě•”, 2ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 3äPŒ´•aEŠ´ő“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć30‰ń“ú–{ƒGƒCƒYŠw‰ďŠwpW‰ďE‘‰ď (2016/11/25), Ž­Ž™“‡,“ú–{ƒGƒCƒYŠw‰ďŽ 2016/11; 18 (4): 499.

723925. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éHIV/AIDSf—Ă‚Ěƒ`[ƒ€—͂Ɖۑč. źŽRW‘ă1, ꎓĄ‘Žq1, ‰Á“Ą@Î1, ‘O“cŒiŽq2, —F“c‹g‘Ľ3, ź–{Œ\—S3, “c’†”Ž”V4, ˜a“c’B•F5, ‚ŽR—zŽq6 (1ŠĹŒě•”, 2ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 3–ňÜ•”, 4“Œ–M‘ĺŠw–ňŠw•”, 5äPŒ´•aEŠ´ő“ŕ, 6V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć30‰ń“ú–{ƒGƒCƒYŠw‰ďŠwpW‰ďE‘‰ď (2016/11/25), Ž­Ž™“‡, “ú–{ƒGƒCƒYŠw‰ďŽ 2016/11; 18 (4): 463.

723926. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •Ş•ŘŽş‚É‚¨‚Ż‚éŽYŒăoŒŒƒJ[ƒg“ą“üŒř‰Ę‚ĚŒŸ“˘|ˆă—ĂŽŇ‚ĚƒAƒ“ƒP[ƒg’˛¸‚ć‚č|. ŹŽRˆ¤”ü1, “ü]‹ĹŽq1, ×ěKŠó2, ‰Á“Ą—˘ŠG3, ‰œ•xr”V2 (1ŠĹŒě•”, 2–ƒŒ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć120‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďŠwpW‰ď (2016/11/26), “Œ‹ž, ‘ć120‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/11; p.68.

723927. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘‡•a‰@‚É‚¨‚Ż‚é–\—Í–hŽ~‘΍ô‚Ö‚ĚŽć‚č‘g‚݁`ŠĹŒěŽt‚đ‘ÎŰ‚Ć‚ľ‚˝Œ¤C‚ĚŒř‰Ę`. “c‹v•Ű”üç‘ă1, ˆŔ]‘ĺŽu2, “c‘ş‘ń–˛2, ”’ˆä‹łŽq1 (1ŠĹŒě•”, 2“Œ•a‰@ŠĹŒě•”): ‘ć29‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ďŠwp‘‰ď (2016/11/26), “Œ‹ž, ‘ć29‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ďŠwp‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/11; p.188.

723928. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) t•s‘SŠĹŒěŽt‚Ş‹‚ß‚éCKDƒg[ƒ^ƒ‹ƒPƒA`Œđ—ŹW‰ď‚Š‚ç‚Ě“WŠJ`. –ěŒű•ś”T1, ŽRăFŽq2, ‰Í–ě@Œb3, •Ÿ‰Ş”üŠó4, ’†‘şMŽq5, ŹâŽu•Ű6 (1ŠĹŒě•”, 2‘Žq‹L”O•a‰@, 3“Ţ—ÇŒ§—§ˆă‘ĺ•‘Ž•a‰@, 4ƒPƒAEƒ†ƒjƒeƒBƒOƒ‹[ƒv, 5‰Ą•lŽs‘ćˆę•a‰@, 6ă’q‘ĺŠw): ‘ć19‰ń“ú–{t•s‘SŠĹŒěŠw‰ďŠwpW‰ďE‘‰ď (2016/11/27), ‘ĺă, ‘ć19‰ń“ú–{t•s‘SŠĹŒěŠw‰ďŠwpW‰ď´˜^W 2016; p.126.

723929. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘B‚Ş‚ń‚ɑ΂ˇ‚éHDRŽĄ—Ă’†‚ĚŠłŽŇ‚ĚƒAƒvƒŠƒP[ƒ^[j‚Ş”˛‚Ż‚é—vˆö‚ÉŠÖ‚ˇ‚錤‹†. ˆŔ“cˆę”V1, ‰Í“c‘˝‰Á1, Šâ–{ƒŽq1, HŽR”üš1, ‹v•ÄŒb]1, ‘şŽR’m”ü1, ç•Űˆť”ü1, •zě–­Žq1, ˛“ĄˆĐ•ś2, ÎŽR”ŽžŠ3, Žń“Ąéş4, Ž›č„Žj4 (1ŠĹŒě•”, 2”ĺ”AŠí, 3•úŽËü (Žîá‡), 4•úŽËü•”): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/27), ‹ž“s.

723930. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹~‹}”Ŕ‘—‚ł‚ę‚˝ŠłŽŇ‰Ć‘°‚Ě‘ŸŠí’ń‹ŸˆÓŽvŒˆ’čŽx‰‡‚Ě‚ ‚č•ű‚ɂ‚˘‚Ä‚ĚŒŸ“˘`ŠłŽŇ‰Ć‘°‚É”z•z‚ł‚ę‚˝’˛¸•[‚Ě•ŞÍ`. ’Ö”ü’q”Ž1, ‰şŽi‰fˆę2, ‰|“c‚ß‚Ž‚Ý2, ˆŔ•”‘Žq2, ‚‹´@Œb1 (1ŠĹŒě•”, 2ş˜a‘ĺŠw‘ĺŠw‰@): ‘ć36‰ń“ú–{ŠĹŒě‰ČŠwŠw‰ďŠwpW‰ď (2016/12/11), “Œ‹ž, “ú–{ŠĹŒě‰ČŠwŠw‰ďŠwpW‰ďu‰‰W 2016/11; 36: 463.

723931. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‰@“ŕˆă—ĂƒƒfƒBƒG[ƒVƒ‡ƒ“Œ¤C‚ĚŒř‰Ę‚Ɖۑč. ě’JOŽq (ˆă—ĂŽx‰‡•”): “ú–{ˆă—ĂƒRƒ“ƒtƒŠƒNƒgEƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć6‰ńŠwp‘ĺ‰ď (2017/1/21), “Œ‹ž, ‘ć6‰ńˆă—ĂƒRƒ“ƒtƒŠƒNƒgEƒ}ƒlƒWƒƒ“ƒgŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/12; p.47.

723932. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚é‘˝EŽí‚É‚ć‚銳ŽŇŽx‰‡ŒŸ“˘‰ď‚ɂ‚˘‚Ä. ě’JOŽq (ˆă—ĂŽx‰‡•”): “ú–{ˆă—ĂƒRƒ“ƒtƒŠƒNƒgEƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć6‰ńŠwp‘ĺ‰ď (2017/1/21), “Œ‹ž, ‘ć6‰ńˆă—ĂƒRƒ“ƒtƒŠƒNƒgEƒ}ƒlƒWƒƒ“ƒgŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/12; p.52.

723933. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŽĄŒąƒf[ƒ^‚Ě‹L˜^ƒvƒƒZƒXŠÇ—‚ĚŽć‚č‘g‚݁|‹L˜^ƒvƒƒZƒXŠm”FƒŠƒXƒg‚̍쐬‚Ɖ^—p‚đŽŽ‚Ý‚Ä|. ’ƒ–ŘŒhŽq1, Œ˘’Ë’qŽq1, ‚‘ş‰ë”ü1, –ěŒűŒbŽq1, Ź‘ň@Šw1, ‰““Ą@—m2, ‰Ą“cœÄˆę2, ŠÖŞ’q”ü2, ‰Ş–{Œb”üŽq2, í“cˆ¤Žq2, ŽR–{–žŽq2, –F“c@v2, –ě‘şĄ“úŽq1, ŒF’J—YŽĄ2 (1ŠĹŒě•”, 2—Տ°ŽŽŒąƒZ): “ú–{—Տ°ŽŽŒąŠw‰ď‘ć8‰ńŠwpW‰ď‘‰ď (2017/1/27), ‘ĺă, “ú–{—Տ°ŽŽŒąŠw‰ď‘ć8‰ńŠwpW‰ď‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/1; p.69.

723934. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ĐŠQˆă—Ă‚ĚŒ´‘ĽuCSCATTTv‚ɉˆ‚Á‚˝ƒfƒuƒŠ[ƒtƒBƒ“ƒO‚ĚŽć‚č‘g‚Ý. ˆÉ“Œ—RN1, ă‘ş—RŽ—1, ŠŽR˜a”ü1, Žs–Ń—Y‘ĺ1, Ž…’؁@Œb1, ŒN“ˆ@“Œ1, ŽRŒű“ě”ü1, ˜a’m—ÉŽq1 (1ŠĹŒě•”): ‘ć22‰ń“ú–{W’cĐŠQˆăŠw‰ď‘‰ďEŠwpW‰ď (2017/2/15), –źŒĂ‰Ž, “ú–{W’cĐŠQˆăŠw‰ďŽ 2017/2; 21 (3): 550.

723935. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˆă—ĂŒn‘ĺŠwś‚ɑ΂ˇ‚éĐŠQˆă—ĂŠî‘b‹łˆç‚ĚŒř‰Ę. ŠŽR˜a”ü (ŠĹŒě•”): ‘ć22‰ń“ú–{W’cĐŠQˆăŠw‰ď‘‰ďEŠwpW‰ď (2017/2/15), –źŒĂ‰Ž, “ú–{W’cĐŠQˆăŠw‰ďŽ 2017/2; 21 (3): 546.

723936. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚đ’Ę‚ľ‚ÄŒŠ‚Ś‚˝, ƒhƒi[‰Ć‘°‚Ö‚ĚŠĹŒě. ă‘ş—RŽ—1, ŽR–{@Œ›1, ‰Á“Ą‚Đ‚Š‚č1, ě–k•‘ˆß1, ––‹g‚‚Ž‚Ý1, ’Ö”ü’q”Ž1, ŠŽR˜a”ü1, ‚‹´@Œb1 (1ŠĹŒě•”): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/15), _ŒË, ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.276.

723937. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žó‚Ż“ü‚ę•a‰@“ŕ‚ō쐬‚ˇ‚鏝•aŽŇˆę——•\‚ɑ΂ˇ‚éˆęlŽ@. ŠŽR˜a”ü1, ˜a’m—ÉŽq1, ’J@Kˆę1 (1ŠĹŒě•”): ‘ć22‰ń“ú–{W’cĐŠQˆăŠw‰ď‘‰ďEŠwpW‰ď (2017/2/15), –źŒĂ‰Ž, “ú–{W’cĐŠQˆăŠw‰ďŽ 2017/2; 21 (3): 615.

723938. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘˝”•aŽŇŽó‚Ż“ü‚ę‘Ήž‚É‚¨‚Ż‚é‘˝EŽí˜AŒg. ˜a’m—ÉŽq1, ’J@Kˆę1, ŠŽR˜a”ü1 (1ŠĹŒě•”): ‘ć22‰ń“ú–{W’cĐŠQˆăŠw‰ď‘‰ďEŠwpW‰ď (2017/2/15), –źŒĂ‰Ž, “ú–{W’cĐŠQˆăŠw‰ďŽ 2017/2; 21 (3): 427.

723939. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŹŽ™”]Ž€‰ş‘ŸŠí’ń‹ŸŒP—ű‚ĚŒř‰Ę. ‚‹´@Œb1, ’ҁ@•üŽq1, ěă‘ĺ•ă1, ˆŔ“Ą@Žő2, rě–@Žq1, ‹g“cˆęŹ3 (1ŠĹŒě•”, 2ŹŽ™, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/16), _ŒË, ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.277.

723940. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “§ÍŠĹŒěŽt‚É‚ć‚éŒŁtˆÚA“o˜^Žx‰‡. ”ŞŒŽń“ú‰Ŕ‘ă, —Ž‡—˘“Ţ, ‚‹´_—Y, –ěŒű•ś”T1, Îˆä‘ĺ•ă2, ‹g“cˆęŹ2,3, ‚‹´—Tˆę˜Y (1ŠĹŒě•”, 2”ĺ”AŠí, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË.

723941. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒXƒg[ƒ}‘˘ÝŠłŽŇ‚̑މ@Žž‹‘îƒT[ƒrƒX“ą“ü‚ÉŠÖ‚ˇ‚éŒťó‚ƍĄŒă‚̉ۑč. “n•ÓšD1, —F‰i—T”ü1, –kžŠ‚ß‚Ž‚Ý1, •Űâ‘‹I1, źŒ´N”ü2 (1ŠĹŒě•”, 2–k—˘‘ĺŠwŠĹŒěŠw•”): ‘ć34‰ń“ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘‰ď (2017/2/18), –źŒĂ‰Ž, “ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŽ 2017/1; 33 (1): 210.

723942. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹~‹}ICU‚É‚¨‚Ż‚é“ü‰@Žž‚̑ϐŤ‹Ű•Ű‹ŰŽŇ‚Ě”wŒi‚ĚŒŸ“˘. ’†–ě—R‹IŽq1, ‹AŽRˆęŽu1, Ž…’؁@Œb1 (1ŠĹŒě•”): ‘ć32‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďEŠwpW‰ď (2017/2/25), •şŒÉ, “ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; 32: 485.

723943. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‰ťŠw—Ă–@‚đŽó‚Ż‚Ä‚˘‚é‚Ş‚ńŠłŽŇ‚ޏA˜J‚ĚŒp‘ą‚đ‰Â”\‚É‚ľ‚Ä‚˘‚é—vˆö. ”Ş–Ř—Ú”ü1, ”ԏ ÍŽq1, Ź‘ň@1, ˛X–Ř–čˆę˜Y2 (1ŠĹŒě•”, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć31‰ń“ú–{‚Ş‚ńŠĹŒěŠw‰ďŠwpW‰ď (2017/2/4), ‚’m, “ú–{‚Ş‚ńŠĹŒěŠw‰ďŽ 2017/1; 31: 212.

723944. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “]“|“]—ŽƒAƒZƒXƒƒ“ƒgƒXƒRƒA•\‚Ě—L—pŤ‚Ć“]“|“]—Ž”­ś—vˆö`ŠĹŒěŽt‚Ě—§ę‚Š‚ç`. ˆÉ“Ą—R从q1, •˝“c—z1, ‚”ö^‹I1 (1ŠĹŒě•”): ‘ć31‰ń“ú–{‚Ş‚ńŠĹŒěŠw‰ďŠwpW‰ď (2017/2/4), ‚’m, “ú–{‚Ş‚ńŠĹŒěŠw‰ďŽ 2017/1; 31: 194.

723945. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’ʉ@ŽĄ—ĂŽş‚É‚¨‚Ż‚é‚Ş‚ńŠłŽŇŽw“ąŠÇ——ż2ŽZ’č‚ĚŒťó•ŞÍ`ŠO—ˆ‰ťŠw—Ă–@‚đŽó‚Ż‚銳ŽŇ‚Ě‹ę”Y‚ÉĹ“_‚𓖂Ăā`. Ź‘ň@1, ˛“Ą‹vŽq1, ”Ş–öçt1, ’–ˆäÍŽq1 (1ŠĹŒě•”): ‘ć31‰ń“ú–{‚Ş‚ńŠĹŒěŠw‰ďŠwpW‰ď (2017/2/5), ‚’m, “ú–{‚Ş‚ńŠĹŒěŠw‰ďŽ 2017/1; 31: 264.

723946. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ICUŠĹŒěŽt‚É‚ć‚éS‘ŸŒŒŠÇŠO‰Čp‘O‚ĚŽĺŠĎ“I‚š‚ń–Ď—\‘ރXƒP[ƒ‹‚͏pŒă‚Ě‚š‚ń–Ď”­ś—\‘Ş‚É—L—p‚Ĺ‚ ‚é. ‹{“‡@Œd (ŠĹŒě•”): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2017/2; 24: 91.

723947. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒl[ƒUƒ‹ƒnƒCƒtƒ[‘•’…‚É‚ć‚éš‹‰ş‚ւ̉e‹ż‚ÉŠÖ‚ˇ‚錟“˘. Î‘q@ˆ¤1, ‘“cł˜a1, ˜a’m—ÉŽq1, •Đ‰Ş—Sˆę2, _œä’m“š2, ó—˜@–ő2 (1ŠĹŒě•”, 2‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2017/2; 24 (Suppl): 92.

723948. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’ŽË‚ÉŠÖ‚ˇ‚éƒCƒ“ƒVƒfƒ“ƒg‚É‚¨‚Ż‚éŠm”F•s‘Ť‚Ě”wŒă—vˆö‚ĚŒŸ“˘. ’ˇâ—Y‘ž1, ’ˇ“ŕ—mˆę1, —ŹÎ“Žq1, Ą@ŽuD1, ŠÖ–îq•˝1, “y‰ŽŽu•Ű1, ‰şˆä–ƒ‹IŽq1, ‘“cł˜a1 (1ŠĹŒě•”): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2017/2; 24 (Suppl): 173.

723949. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) AƒZƒ“ƒ^[ƒOƒŠ[ƒtƒPƒAƒJƒ“ƒtƒ@ƒŒƒ“ƒX“ą“üŒă‚ĚŠłŽŇE‰Ć‘°‚ւ̉î“üó‹ľ‚ƍĄŒă‚̉ۑč. ŽR–{@Œ›1, ’J@Kˆę1, ‘“cł˜a1, ‚‹´@Œb1, ŒN“ˆ@“Œ1, ŽR“ŕ—BŒő1, •Đ‰Ş—Sˆę2 (1ŠĹŒě•”, 2‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2017/2; 24 (Suppl): 173.

723950. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹}•Ď‘ΉžŽ–—á‚Ě•ŞÍ‚Š‚ç‚Ý‚Ś‚é, ‹}•ĎŽ–—ጸ­‚ÉŒq‚°‚é‚˝‚߂̉ۑč. ‹Ë–{çŒb”ü1, XˆŔŒbŽŔ1, •ž•”@2 (1ŠĹŒě•”, 2‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2017/2; 24 (Suppl): 153.

723951. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒuƒŠ[ƒtƒBƒ“ƒOEƒfƒuƒŠ[ƒtƒBƒ“ƒOŽŔ‘H‚É‚ć‚éŠĹŒěƒ`[ƒ€‚Ö‚ĚŒř‰Ę. Źł]—˘“Ţ1, •äĎŘ•ä1, Î‰şˆçś2, …ă‚˘‚Ă‚Ý1 (1ŠĹŒě•”, 2ŠĹŒěŠw•”): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/11), ŽD–y, “ú–{W’†ŽĄ—ĂˆăŠw‰ďŽGŽ 2017/2; 24 (Suppl): 163.

723952. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠĹŒěŽt‚Š‚ç‚ĚRRS—vż‚ĚŒťó’˛¸‚ƍĄŒă‚̉ۑč. XˆŔŒbŽŔ1, ‘ĺ’JŽ–ç1, Ź’r•üF2, žŇź‹v”üŽq1, ‘ĺ’Ë’q‹v3, ‹g–ě˜a‹v3, “c’†ˆęś3, źŕV‹`”V3, •Šâ­”V3, VˆäłN4 (1ŠĹŒě•”, 2–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[, 3–ƒŒ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11), ŽD–y.

723953. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) SCU‚É‚¨‚Ż‚鑁Šú‘މ@Žx‰‡‚Ě—L—pŤ`‘Šú–Ę’k’˛Ž‚Ƒމ@Žx‰‡ƒpƒ“ƒtƒŒƒbƒg“ą“ü‚É‚ć‚éÝ‰@“ú”‚̕ωť`. –öŕVŒ’‘ž˜Y1, •˝“‡—DŽq1, m–Ř’ŹŽq1, ‰Ąaˆç”ü1, ’†‘şŽěŒb2, –k‘ş‰p“ń3, ˆ˘‹v’Ă“ń•v3, źŽR˜a—˜3 (1ŠĹŒě•”, 2ˆă—ĂŽx‰‡•”, 3_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď (2017/3/18), ‘ĺă, ‘ć42‰ń“ú–{”]‘˛’†Šw‰ďŠwpW‰ď´˜^W 2017; p.385.

731182. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚Ş‚ńŠłŽŇ‚ƉƑ°‚ĚˆÓŽvŒˆ’č‚đŽx‚Ś‚é. ‹ß“Ą‚Ü‚ä‚Ý (ŠĹŒě•”): ‘ć43‰ń‹žŽ ŠÉ˜aƒPƒAŒ¤‹†‰ď (2016/6/25), ‹ž“s.

731183. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) –k—˘ŠĹŒěŒ¤‹†‰ď‚É‚¨‚Ż‚é‰ß‹Ž15”NŠÔ‚ĚŒ¤‹†‚Ě“ŽŒü. ŽOŽ}Ž–1, Âů|Gş1, ŽR–{‰Ŕ“1, ŹŽR–ž—˘1, ˜a’m—ÉŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.19-22.

732120. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘Šú‚Š‚çŠĹŽć‚č‚Ü‚Ĺ‚ĚŠÉ˜aƒPƒA`‚Ş‚ń‚ŕ”ń‚Ş‚ń‚ŕ‚Č‚­OCNS‚ĚŠˆ“Ž`ƒnƒu‹@”\‚Ć‚ľ‚Ä‚ĚŠÉ˜aƒPƒAŠĹŒěŠO—ˆ‚𒆐S‚É. ‹ß“Ą‚Ü‚ä‚Ý (ŠĹŒě•”): ‘ć22‰ń‘ĺŠw•a‰@‚ĚŠÉ˜aƒPƒA‚đl‚Ś‚é‰ďŒ¤‹†‰ď (2016/9/17), _“ސě, ‘ĺŠw•a‰@‚ĚŠÉ˜aƒPƒA‚đl‚Ś‚é‰ďŽ‘‰ďEŒ¤‹†‰ď‹L˜^† 2016/12; 22: 29-32.

732121. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆă—ĂŒťę‚É•K—v‚Ć‚ł‚ę‚é”F’mÇƒPƒAuˆă—ĂŒťę‚Ĺ‚ĚŠ‹“Ąv. ꎓĄk•˝ (ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.24.

732122. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒV[ƒhp’†ŠĹŒě`‚“x”ě–žŠłŽŇ‚Ěˆę—á`. ”Ń“c@ˆ˛ (ŠĹŒě•”): ‘ć\ŽO‰ń‘O—§‘BŠŕ–§••ŹüŒš‰i‹v‘}“üŽĄ—ĂŒ¤‹†‰ď (2017/1/22), “Œ‹ž, ‘ć13‰ń‘O—§‘BŠŕ–§••ŹüŒš‰i‹v‘}“üŽĄ—ĂŒ¤‹†‰ď|´˜^EƒL[ƒXƒ‰ƒCƒhW| 2017/1; p.28.

733437. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”ń–ƒŒ‰Čˆă‚É‚ć‚é“ŕŽ‹‹žŒŸ¸EŽĄ—Ă‚Ě’ÁĂp‘OŠłŽŇ•]‰ż‚ĚŽć‚č‘g‚Ý. ŠÝ–Ř‚ ‚ä‚Ý1, ‹{ŕVŽu˜N2, ÎŒËŒŞŽŸ2, “c糁@‘3, ‘OŕV”ü“ŢŽq1, ŽOŽ}Ž–1, Šâˆä’m‹v2, Ąň@O2, –Ř“cŒőL2, Źň˜aŽO˜Y2, •Šâ­”V4, ź“cO”ü4, źŕV‹`”V4 (1ŠĹŒě•”, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 4–ƒŒ): ‘ć91‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď/•’uŒ¤‹†‰ď (2016/5/14), “Œ‹ž, Gastroenterological Endoscopy 2016/4; 58 (Suppl 1): 839.

733438. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) loss of variability‚đ‹^‚Á‚˝ŽY•w‚Ě•Ş•Ř—U”­ŠÇ—`‘ŮŽ™S””gŒ`‚Ě•Ş—Ţ‚Ĺl‚Ś‚˝•ŽYŽt‚̉‡•‚ÉĹ“_‚𓖂Ăā`. ˆä–{–ƒˆßŽq (ŠĹŒě•”): ‘ć47‰ń“ú–{•Ş•ŘŠÄŽ‹Œ¤‹†‰ď (2016/6/11), “Œ‹ž.

733439. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰)uŽčpŽşŠĹŒě‚đŒę‚éęv‚đ’ń‹Ÿ‚ˇ‚é‚˝‚߂Ɋ‹Ť–Ę‚ĹH•v‚ľ‚˝‚ą‚Ć. Žu‰ę•ü‘ă1, ˜a“cĘ‰Ř1, ‰ŽŠÚ”ü1 (1ŠĹŒě•”): ‘ć27‰ń“ú–{ŽčpŠĹŒěŠw‰ďŠÖ“ŒbM‰z’n‹ć (2016/6/18), _“ސě, ‘ć27‰ń“ú–{ŽčpŠĹŒěŠw‰ďŠÖ“ŒbM‰z’n‹ćW˜^ 2016/6; p.21.

733440. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒf[ƒ^‚̉Ž‹‰ť‚ƐŹ’ˇ‚ˇ‚éŠĹŒě`“Á’Ľ‚ ‚é•a“ƒŒƒCƒAƒEƒg‚đŠˆ‚Š‚ľ‚ā`. ŒÜ“Ą—zŽq (ŠĹŒě•”): ‘ć4‰ńƒPƒAŠÂ‹Ť‰ü‘PƒtƒH[ƒ‰ƒ€ (2016/8/19), _“ސě.

733441. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‹~‹}—Ěˆć‚É‚¨‚Ż‚éŠÉ˜aƒPƒA‚ĆƒOƒŠ[ƒtƒPƒA. ‚‹´@Œb (ŠĹŒě•”): ‘ć22‰ń‘ĺŠw•a‰@‚ĚŠÉ˜aƒPƒA‚đl‚Ś‚é‰ďŒ¤‹†‰ď (2016/9/17), _“ސě, ‘ĺŠw•a‰@‚ĚŠÉ˜aƒPƒA‚đl‚Ś‚é‰ďŽ‘‰ďEŒ¤‹†‰ď‹L˜^† 2016/12; 22: 20-2.

733442. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‹łˆçŒoŒą–L‚Š‚Čƒ[ƒe[ƒVƒ‡ƒ“ŠĹŒěŽt‚Ć“ŕŽ‹‹žŒoŒą–L‚Š‚ČŠĹŒěŽt‚É‚ć‚é‹łˆçŒv‰ć‚̍쐬. ‚‹´ˆŸ‹IŽq1, ‘OŕV”ü“ŢŽq1, ŽOŽ}Ž–1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.35.

733443. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‹~‹}ŠO—ˆ‚É‚¨‚Ż‚é—ˆ‰@ŽžS”x’âŽ~ŠłŽŇ‚̉Ƒ°Žx‰‡`ƒAƒMƒ…ƒ‰ƒ‰&ƒƒYƒBƒbƒN‚ĚŠë‹@—˜_‚đ—p‚˘‚ā`. “Ą‰Ş—Ú—ž1, ’ˇ–ě—F‹IŽq1, ŠŽR˜a”ü1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.38.

733444. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠO—ˆŠĹŒěŽt‚É‚ć‚éŠO—ˆ‘ҍ‡Žşƒ‰ƒEƒ“ƒh‚ĚŽć‚č‘g‚݁`ŠłŽŇ‚Ş‘Š’k‚Ĺ‚Ť‚郉ƒEƒ“ƒh‚ց`. “c•Ó—Œb1, ‘ě‚ľ‚¸‚Š1, ˛“Ą^‹IŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.40.

733445. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŹŽ™Ý‘ŒČ’ŽË“ą“ü‚É‚¨‚Ż‚éˆÓŽvŒˆ’čŽx‰‡`ŠO—ˆ“ą“ü‚ľ‚˝2Ž–—á‚Š‚ç‚Ý‚Ś‚˝‚ą‚Ɓ`. ‚âŽq1, ‘ĺ’ˁ@1, â–{”~Žq1, ꎓĄ‘Žq1, •űš•˝2, ]”gŒËF•ă2, –Ř‘şƒl2, Îˆäł_2 (1ŠĹŒě•”, 2ŹŽ™): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.41.

733446. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œľ‚ľ‚˘ŒťŽŔ‚É’ź–Ę‚ľŹ—‚ˇ‚éI––Šú“Şčň•”‚Ş‚ńŠłŽŇ‚Ć‚Ěƒp[ƒgƒi[ƒVƒbƒv`ƒ}[ƒKƒŒƒbƒgEƒjƒ…[ƒ}ƒ“—˜_‚ĚŽŔ‘H‚đ’Ę‚ľ‚Ä‚ĚŠw‚с`. ŒĂŕV‰Ŕ“Ţ1, –]ŒŽ”ü•ä1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.42.

733447. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‚Ş‚ńŠĹŒěę–ĺŠĹŒěŽt‚́u‚Ş‚ńŠłŽŇŽw“ąŠÇ——żv‚ĚŽZ’čó‹ľ‚ƍĄŒă‚̉ۑč`ŠO—ˆŠ‘Ž‚Ş‚ńŠĹŒěę–ĺŠĹŒěŽt‚ĚŽŔ‘HE’˛Ž–đŠ„‚ĚŠˆ“Ž•]‰ż`. ŒK–źŽő”ü1, ˛“Ą^‹IŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.43.

733448. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Á‰ťŠíŠŕŠłŽŇ‚̉Ƒ°ŠÖŒW‚̍č\’z‚Ö‚ĚŠĹŒě‰î“ü`ŠĹŽć‚č‚ÉŒü‚Ż‚Ä‚ĚŠĹŒěŽt‚ĚŠÖ‚í‚č‚đU‚č•Ô‚é`. Ŕ“c‰Á“ŢŽq1, ŒK–źŽő”ü1, ˛“Ą^‹IŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.44.

733449. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŒŔ‚ç‚ę‚˝ŽžŠÔ‚Ě’†‚ʼnƑ°‚ĚăJ‚đ[‚ß‚Č‚Ş‚çĹŠú‚đŒ}‚Ś‚é‚Ć‚˘‚¤‚ą‚Ɓ`ˆâ‚ł‚ę‚˝‰Ć‘°‚ĚŽx‚Ś‚É‚Č‚éŠĹŒě‚Ƃ́`. —é–ؐ°“Ţ1, ç–ؗǓމ›1, “‰€@”E1, ŒË“c@”Ł2 (1ŠĹŒě•”, 2ŠĹŒěŠw•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.46.

733450. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”ĺ”AŠí‰ČI––Šú‚Ş‚ńŠłŽŇ‚Ć‚ť‚̉Ƒ°‚đŽx‚Ś‚éŠĹŒě`“n•ÓŽŽ‰Ć‘°ƒAƒZƒXƒƒ“ƒg^Žx‰‡ƒ‚ƒfƒ‹‚đŽg—p‚ľ‚˝ŠÖ‚í‚č`. Ź•ô‚Č‚Ź‚ł1, ‰Í“c‘˝‰Á1, ř‹ŒŠ‹IŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.47.

733451. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) A•a“‚É‚¨‚Ż‚éƒJƒ“ƒtƒ@ƒŒƒ“ƒX“ŕ—e‚Ě•]‰ż‚ƍĄŒă‚̉ۑč. ™–{—T”ü1, Š’ŽRŸ1, “c糍NŠo1, ‘君Ź”ü1, “n糐çt1, ‰Í“c‘˝‰Á1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.49.

733452. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œ’íŽŇ‚Ěƒl[ƒUƒ‹ƒnƒCƒtƒ[‘•’…‚É‚ć‚éŒëš‹ƒŠƒXƒN‚ĚŒŸ“˘. Î‘q@ˆ¤1, ‹{ř“—FŒb1, “’–{@“ľ2, ´‰Ć—R”üŽq3, —é–Ř—§r2, ‘“cł˜a1 (1ŠĹŒě•”, 2Ž¨•@ˆôAE“ŞčňŠO, 3‰h—{•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.50.

733453. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) —}§ƒvƒƒgƒRƒ‹‚ĚŒř‰Ę‚ƍĄŒă‚̉ۑč`ŠłŽŇ‚Ě—}§‚ɂ‚˘‚čl‚Ś‚é‚ą‚Ć‚Ě‘ĺŘ‚ł`. —é–Ř’B•F1, ’ˇ“c‘P‹I1, ]ě˜aŠě1, ‰şˆä–ƒ‹IŽq1, ’J@Kˆę1, ‘“cł˜a1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.51.

733454. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠĹŒě•â˛‚Ě‹Ś“­‚đŽx‰‡‚ˇ‚éŽć‚č‘g‚݁`ŠĹŒě•â˛‚ĚƒGƒ“ƒpƒƒƒ“ƒg‚ˇ‚éEę‚Ă‚­‚č`. ś’J”ü•ä1, ꎓĄ‘Žq1, ˛“Ą^‹IŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.52.

733456. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŽŠ‘î‘މ@‚đ‹­‚­Šó–]‚ˇ‚é”F’mÇŠłŽŇ‰Ć‘°‚Ö‚ĚŠÖ‚í‚č`“n•ÓŽŽ‰Ć‘°ƒAƒZƒXƒƒ“ƒgƒ‚ƒfƒ‹‚đ—p‚˘‚đމ@Žx‰‡‚ɂ‚˘‚čl‚Ś‚é`. Ź—Ń—R‹G1, ‰iˆäD1, “n•”‡Žq1, ‘ĺ’ˁ@1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.53.

733457. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œ’Ns“Ž‚Ş‚Ĺ‚Ť‚Č‚˘ŠłŽŇ‚ւ̉Ƒ°ŠĹŒě‚đŠˆ—p‚ľ‚˝ŠÖ‚í‚č|“n•ÓŽŽ‰Ć‘°ƒAƒZƒXƒƒ“ƒg/Žx‰‡ƒ‚ƒfƒ‹‚đŠˆ—p‚ľ‚ā|. “n糁@•ŕ1, ‰iˆäD1, “n•”‡Žq1, ‚ŒŠ‹IŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.54.

733458. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠłŽŇ‚ĚŒž—t‚Ě— ‚É‚ ‚é‘z‚˘‚ÉŠń‚č“Y‚¤’ljÁ‘ĚŒą”\—Í‚đˆř‚Ťo‚ˇŽŔKŽw“ą|‹}ŤŠúŠĹŒěŠwŽŔK‚É‚¨‚Ż‚éŽŔKŽw“ą‚đ’Ę‚ľ‚ā|. ’Ë–{“l”ü1, ”’’š—FŠî1, ’ˇŕV—˘1, ŒË“c@”Ł2 (1ŠĹŒě•”, 2ŠĹŒěŠw•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.55.

733459. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 20•Ş‚ōs‚¤ƒAƒNƒVƒ‡ƒ“ƒJ[ƒh‚đ—p‚˘‚˝–hĐ”đ“ďŒP—ű. ŽRŒű“ě”ü1, ˜a’m—ÉŽq1, ŒN“ˆ@“Œ1, ŠŽR˜a”ü1, ă‘ş—RŽ—1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.58.

733460. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠłŽŇ‚̉ż’lŠĎ‚đƒ`[ƒ€‚Ĺ‹¤—L‚ľ‚˝‚ą‚Ć‚Ĺ, ‚ť‚̐l‚ç‚ľ‚˘ŽĄ—Ă‚Ş‚Ĺ‚Ť‚˝Ž–—á`”F’čŠĹŒěŽt‚Ć‚ľ‚Ä‚ĚŠĹŒěŽŔ‘H•ń`. •Đ‰–@K1, ě’[–[ŠG1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.61.

733461. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ˆŔ‘S‚Č“ŕŽ‹‹žŽĄ—Ă‚Ě’ń‹Ÿ‚Ě‚˝‚ß‚Ě’ÁĂ‘OŠłŽŇ•]‰ż‚Əî•ń‹¤—L‚Ö‚ĚŽć‚č‘g‚Ý. ŠÝ–Ř‚ ‚ä‚Ý1, ŽOŽ}Ž–1, ‘OŕV”ü“ŢŽq1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.63.

733462. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚é•â•lHS‘ŸÇ—á‚ĚŒŸ“˘. ’†“‡ßŽq1, ă–ě”ü•ä1, Â–Ř—”ü1, —ŃˆŸŠóŽq1, ‰Ąa@Žq1, ŽR–{‰Ŕ“1, –k‘ş@—Ľ2, ‹{’n@ŠÓ2, Îˆär•ă3, ’|“ŕˆę˜Y4 (11ŠĹŒě•”, 2S‘ŸŒŒŠÇŠO, 3zŠÂŠí“ŕ, 4‹~–˝): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.64.

733463. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) VlŠĹŒěEˆő‚ĚƒtƒBƒWƒJƒ‹ƒAƒZƒXƒƒ“ƒgŒ¤C‚Ě‹łˆçŒř‰Ę`W‡Œ¤C‚đ6ƒJŒŽŠÔŒp‘ą‚ľ‚ā`. –x]çŒbŽq1, ’JŒű—zŽq1, “ŒŠC—Ń‚ż‚Ś‚Ý1, áÁ–ě“oŠěŽq1, XˆŔŒbŽŔ1, ‘ĺ’JŽ–ç1, ꎓĄk•˝1, “ŕ“ĄˆŸŽ÷1, —ä–{ŒN]1, ’†ŽR‰hƒ2, ’––”ŽŽq3 (1ŠĹŒě•”, 2ŠĹŒěŠw•”, 3Ďś‰ď‰Ą•l“Œ•”•a‰@): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.65.

733464. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ş‚đ‚Š‚Ż‡‚Ś‚éEę‚đ–ÚŽw‚ľ‚ā`ƒnƒCƒ^ƒbƒ`‚Š‚çŽn‚Ü‚éˆę“ú`. ”Ń‘–ƒŽq1, ŒĂ‰ę“TŽq1, •˝—Ń“Ţ•c1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.66.

733465. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‹Ć–ąŽ—‚Š‚猊‚Ś‚˝ŠjˆăŠwŠĹŒěŽt‚Ě–đŠ„‚Ć‰Ű‘č. ‘şŽR—F”ü1, ě’[–[ŠG1 (1ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.68.

733466. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) dÇSgáŠQŽ™(ŽŇ)‚ĚˆŔ‘S‚Č‹CŠÇƒJƒjƒ…[ƒŒŠÇ—‚Ö‚ĚŽć‚č‘g‚Ý. ˆÉ“Ą‚Ý‚¸‚Ů1, ź“ŕ‰ŔŽq1, ‘ĺŒ´‘ěĆ2, ˛“Ą^‹IŽq1 (1ŠĹŒě•”, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.69.

733467. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ˆË‘śó‘Ԃ̉Ƒ°‚Ö‚ĚŽx‰‡EŠÖŒW\’z‚ɂ‚˘‚ā`“n•ÓŽŽ‰Ć‘°ƒAƒZƒXƒƒ“ƒg/Žx‰‡ƒ‚ƒfƒ‹‚đ—p‚˘‚ā`. ˆä“‡”ü‰Ä1, …‹´ŒbŽq1, ř‹ŒŠ‹IŽq2 (1“Œ•a‰@ŠĹŒě•”, 2ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.70.

733468. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ěč•a‹}ŤŠúƒNƒŠƒjƒJƒ‹ƒpƒX‚É‚¨‚Ż‚é‰^—p•]‰ż‚ƍĄŒă‚Ě‰Ű‘čŒŸ“˘. Î‰ş‰ë”ü1, ź“ŕ‰ŔŽq1, •űš•˝2, Ž–ě@Žő2, ]”gŒËF•ă2, îŒ´‹`l3, ŽR—œ‰€ś4, “cč—R‰Ŕ4, ’r“cKŽq1, rˆäN•v4, Îˆäł_2 (1ŠĹŒě•”, 2ŹŽ™, 3ŠC˜V–ź‘‡•a‰@ŹŽ™‰Č, 4f—Ïî•ńŠÇ—Žş): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.72.

733469. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) d“xSgáŠQ‚đŽ‚Á‚˝ŹŽ™‚̉Ƒ°‚Ć‚Ěƒp[ƒgƒi[ƒVƒbƒv‚̍\’z. {ě’qŹ (ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.73.

733470. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ŹŽ™Ý‘îŽx‰‡ŠĹŒěŠO—ˆ‚𗧂żă‚°‚ā`”­’B’iŠK•Ę‚É‚Ý‚˝ˆę”NŠÔ‚ĚŽŔŽ{ó‹ľ‚ĆˆęlŽ@`. ‹Ę–Ř—z‘ă1, â–{”~Žq1, ‘ĺ’ˁ@1, âV“Ą‘Žq1, •űš•˝2 (1ŠĹŒě•”, 2ŹŽ™): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.74.

733471. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) —v‹‚â‹ęî‚Ş‘˝‚˘•ƒe‚Ö‚ĚŠÖ‚í‚č‚Š‚猊‚Ś‚˝‚ŕ‚Ě“n•ÓŽŽ‰Ć‘°ƒAƒZƒXƒƒ“ƒgƒ‚ƒfƒ‹^Žx‰‡ƒ‚ƒfƒ‹‚đ—p‚˘‚Ä. “V–ě“ށXŽq (ŠĹŒě•”): _“ŢěŒ§ŠĹŒě‹Ś‰ď‘Š–ÍŒ´Žx•”ŠĹŒěŒ¤‹†”­•\‰ď (2017/1/26), _“ސě, •˝Ź28”N“xŠĹŒěŒ¤‹†”­•\‰ďW˜^W 2017/1; p.57.

733472. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) A•a‰@‚É‚¨‚Ż‚é•v—§‰ď‚˘oŽY‚ĚŽć‚č‘g‚݂Ɖۑč. ˆÉ“Œ–­ŠóŽq1, ˆŔź@ˆť1, ŹŽRˆ¤”ü1, ‹{â—ÇŽq1, •˝—Ń‘•c1, “ü]‹ĹŽq1 (1ŠĹŒě•”): ‘ć30‰ń_“ސě•ęŤ‰qśŠw‰ďŠwpW‰ď (2017/2/4), _“ސě, _“ސě•ęŤ‰qśŠw‰ďŽ 2017/2; 20 (1): 80.

733473. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) A•a‰@‚É‚¨‚Ż‚éMFICU‚ĚŽŔ‘Ô‚ĆMFICUŠĹŒě‚ĚŒŸ“˘. ’ˇ’J—zŒb1, ’ˇ“ě‹LŽuŽq1, “ü]‹ĹŽq1 (1ŠĹŒě•”): ‘ć30‰ń_“ސě•ęŤ‰qśŠw‰ďŠwpW‰ď (2017/2/4), _“ސě, _“ސě•ęŤ‰qśŠw‰ďŽ 2017/2; 20 (1): 81.

733474. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’nˆć‚Ö‚ĚŒp‘ąŽx‰‡‚Ě—v”Ű‚đŒˆ’č‚ˇ‚é‚˝‚ß‚ĚƒVƒXƒeƒ€\’z‚ĚŒŸ“˘`‘ć1•ńE’nˆć‚Ö‚ĚŒp‘ąŽx‰‡‚đ•K—v‚Ć‚ľ‚˝”DŽYĺń•w‚ĚŒťó’˛¸`. ŹěŠě”üŽq1, Žá‹ˇťŽq1, ’ˇ“ě‹LŽuŽq1, “ü]‹ĹŽq1 (1ŠĹŒě•”): ‘ć30‰ń_“ސě•ęŤ‰qśŠw‰ďŠwpW‰ď (2017/2/4), _“ސě, _“ސě•ęŤ‰qśŠw‰ďŽ 2017/2; 20 (1): 78.

733475. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ¸_ŽžŠł‡•š”D•w‚Ě”DP’†‚Š‚ç‚ĚŒp‘ąŽx‰‡`’nˆć˜AŒg‚Š‚ç‚Ó‚č•Ô‚é`. r–؏~Žq1, “n•Ó—mŽq1, “c‹v•Ű”üç‘ă1, ř‹ŒŠ‹IŽq1 (1ŠĹŒě•”): ‘ć30‰ń_“ސě•ęŤ‰qśŠw‰ďŠwpW‰ď (2017/2/4), _“ސě, _“ސě•ęŤ‰qśŠw‰ďŽ 2017/2; 20 (1): 78.

733476. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‹~‹}ŠO—ˆ‚É‚¨‚Ż‚éˆâ‘°‚Ö‚ĚƒPƒA‚Ě‚ ‚č•ű`ŽŠŽ€ˆâ‘°‘Š’k‘‹Œű‚Ö‚ĚĐ‰îƒpƒ“ƒtƒŒƒbƒg”z•z‚ĚŽć‚č‘g‚Ý‚đ’Ę‚ľ‚ā`. ’ˇ–ě—F‹IŽq1, ‚‹´@Œb1, ŠŽR˜a”ü1 (1ŠĹŒě•”): ‘ć67‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŠwpW‰ď/‘ć54‰ń‹~‹}‘ŕˆőŠwpŒ¤‹†‰ď (2017/2/4), “Č–Ř, “ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŽGŽ 2017/2; 38 (1): 122.

733477. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “§ÍŠłŽŇ‚̔畆ó‘Ԃɍ‡‚í‚š‚˝“§Í‰ń˜H‚ĚŒĹ’č‚ÉŠÖ‚ˇ‚éŽŔ‘H‚Ć•]‰ż. Ź‘q—Ú”ü1, š ‹g’qŽq1, ’ˇ‰Ş@‰~1 (1ŠĹŒě•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), _“ސě, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď´˜^W 2017/2; p.P3-1.

733478. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) V•a‰@ˆÚ“]‚É”ş‚¤ƒi[ƒXƒR[ƒ‹‘‰Á‚ɑ΂ˇ‚é‹Ć–ą‰ü‘P‚ĚŽć‚č‘g‚Ý. ‚‹´—L”ÜŽq1, ‰Ąaˆç”ü1 (1ŠĹŒě•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), _“ސě, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď´˜^W 2017/2; p.P3-3.

733479. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ˆçŹ‚đ–Ú“I‚Ć‚ľ‚˝Š÷ă‹łˆçƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚Ě“ą“ü. ŒN“ˆ@“Œ1, ’J@Kˆę1, ‘“cł˜a1, ŒŃ“cŤŽk1, “y‰ŽŽu•Ű1 (1ŠĹŒě•”): ‘ć25‰ń“ú–{”MŠw‰ďŠÖ“Œ’n•ű‰ď (2017/2/11), “Œ‹ž.

733480. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “ü‰@‘O–Ę’k‚ÉŠÖ‚ˇ‚éŽŔ‘H•ń. m–Ř’ŹŽq1, â‰ş’qŽěŽq1, —é–Ř”üŽ}Žq1, “c粁@‘2, Ź–ě‘ňŽ 3 (1ŠĹŒě•”, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ˆă—ĂŽx‰‡•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), _“ސě, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď´˜^W 2017/2; p.05-2.

733481. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’´‹}ŤŠú•a‰@‚É‚¨‚Ż‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“ŠĹŒěŽt‚Ě–đŠ„‚ÉŠÖ‚ˇ‚éŽŔ‘Ô’˛¸. ‘ѐě@ˆ¤1, ꎓĄŒ\Žq1, ‰Í–ě^—1 (1ŠĹŒě•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), _“ސě, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď´˜^W 2017/2; p.05-5.

733482. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “ŕŽ‹‹žŒŸ¸•”–ĺ‚É‚¨‚Ż‚éƒuƒŠ[ƒtƒBƒ“ƒO‚đ—p‚˘‚˝î•ń‹¤—L‚Ö‚ĚŽć‚č‘g‚Ý. ŠÝ–Ř‚ ‚ä‚Ý1, ŽOŽ}Ž–1, ‰Ą“c—FŠó1, ‘OŕV”ü“ŢŽq1 (1ŠĹŒě•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), _“ސě, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď´˜^W 2017/2; p.06-2.


—Տ°ŒŸ¸•”

[Šwp˜_•ś]

110300. [Œ´’˜] Basic study of the new static stabilometry in the sitting position. Obata S1, Ujihashi Y1, Munekata S1, Ochiai A2, Naganuma H3, Kanoh Y4: Kitasato Med J2016/9; 46 (2): 146-55. (Ź”Ś@i1, ‰FŽĄ‹´‘PŸ1, “•űLˆę1, —Ž‡@“Ö2, ’ˇŔ‰p–ž3, Žë–ě—Lě4: 1—ŐŒŸ•”, 2Ž¨•@ˆôAE“ŞčňŠO, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 4—ŐŒŸŠw)

120050. [Œ´’˜] Moraxella catarrhalis‚ĚŒŸoó‹ľ‚Ć–ňÜŠ´ŽóŤ‚̐„ˆÚ. “ń–{–öL1-3, ˜a“c’B•F2, ˆŔ’B @÷3,4, “Ą‘ş—T”ü4, “•űLˆę4, Žë–ě—Lě5, ‚ŽR—zŽq6 (1Š´őŠÇ—Žş, 2äPŒ´•aEŠ´ő“ŕ, 3–k—˘ś–˝‰ČŠwŒ¤‹†Š, 4—ŐŒŸ•”, 5—ŐŒŸŠw, 6V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆăŠwŒŸ¸ 2016; 65 (3): 268-74.

120051. [Œ´’˜] –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŒÄ‹zŠí—R—ˆStreptococcus pneumoniae‚ĚŒŸoó‹ľ‚Ć–ňÜŠ´ŽóŤ‚̐„ˆÚ. “ń–{–öL1, ‚ŽR—zŽq2, ˜a“c’B•F3, ’†‘şłŽ÷4, ’†čM•F1, ˛“ĄŠ°ś5, ‘ĺěŒ´—TŽ÷5, ‚é—R”üŽq5, Â–ö˛’mŽq5, “Ą–Ř‚­‚ÉŽq5, Žë–ě—Lě6 (1—ŐŒŸ•”, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4ˆă—ÉqśŠw•”, 5Š´őŠÇ—Žş, 6—ŐŒŸŠw): –k—˘ˆăŠw 2016/6; 46 (1): 25-33.

120052. [Œ´’˜] ƒ‰ƒeƒbƒNƒX–Ɖu”ä‘÷–@‚đŒ´—‚Ć‚ľ‚˝uƒmƒ‹ƒfƒBƒAEƒCƒ“ƒXƒŠƒ“ŽŽ–ňv‚đ—p‚˘‚˝ŒŒ’†ƒCƒ“ƒXƒŠƒ“”Z“x‘Ş’č‚ĚŠî‘b“IŒŸ“˘. “y•M’qť1, ŽRŒű‚Đ‚Ć‚Ý1, ŽÂŒ´—ş‘ž1, ŹŽRhŽq1, “Ą‘ş‘Ps1, ’†čLŽq1, “ŕ“cˆęO1, ‘ĺ’JTˆę2, Žë–ě—Lě3 (1—ŐŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ŐŒŸŠw): JJCLA 2016; 41 (5): 708-13.

120053. [Œ´’˜] –łü‚k‚`‚m“‹ÚS“dŒv‚đ—˜—p‚ľ‚˝S“d}ŠÇ—ƒVƒXƒeƒ€‚̍\’z‚¨‚ć‚ŃŒř‰Ę‚ɂ‚˘‚Ä. Ź–ěŽRŽuD1, Ź–ěŕV—T–ç1, ’†ź‹vK1, ‰FŽĄ‹´‘PŸ1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): _“ŢěŒ§—Տ°ŒŸ¸‹ZŽt‰ďŽGŽ•Ęű 2016; 51 (168): 32-8.

120054. [Œ´’˜] ‰@“ੴő‘΍ô‚đ–Ú“I‚Ć‚ľ‚˝’´‰š”gƒ[ƒŠ[‚̉qśŠÇ—‚ÉŠÖ‚ˇ‚錤‹†. •˝“cçL1, ŽRŒű“oŠóŽq1, ꠓcŠě”V1, ’†ź‹vK1, ‰FŽĄ‹´‘PŸ1, “Ą–Ř‚­‚ÉŽq2, •˝“c‘×—Ç2, Žë–ě—Lě3 (1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3—ŐŒŸŠw): ’´‰š”gŒŸ¸‹Zp 2016/10; 41 (5): 485-91.

310036. [Ç—á•ń] A very rare case of primary meningococcal arthritis in an adult male. Nihonyanagi S1, Sunakawa K2, Cui L3, Masaki T4, Wada T5, Hoshiyama T6, Nakamura M7, Takayama Y8, Kanoh Y9, Ogawa A6, Shichiri M4, Hanaki H3: Clin Case Rep 2015/2; 3 (2): 76-80. (“ń–{–öL1, ťěŒc‰î2, ›Á@—´ŸŞ3, ł–ŘŽkl4, ˜a“c’B•F5, ŻŽR—˛”V6, ’†‘şłŽ÷7, ‚ŽR—zŽq8, Žë–ě—Lě9, ŹěŒ°Žj6, Žľ—˘áÁ‹`4, ‰Ô–؏G–ž3: 1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3–k—˘ś–˝‰ČŠwŒ¤‹†ŠRŠ´őÇ–ňŒ¤‹†ƒZƒ“ƒ^[, 4“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 5äPŒ´•aEŠ´ő“ŕ, 6‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 7ˆă—ÉqśŠw•”, 8V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 9—ŐŒŸŠw)

521035. [‰đŕ]yTechnical Notez’P‹É”玿ŽhŒƒMEP‚ĚƒŠƒtƒ@ƒŒƒ“ƒX“d‹É‚̐ݒu‚ɂ‚˘‚ā|p’†ƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚Ż‚épitfall|. Ź–ěŕV—T–ç1, ˛“ĄŸl2, ‹{“‡—Ç‹P2, ŒG•”rG2 (1—ŐŒŸ•”, 2”]ŠO): ”]_ŒoŠO‰Č‘Ź•ń 2016/4; 26 (4): 392-8.

522154. [uŔ]y’´‰š”gŒŸ¸‚É‚¨‚Ż‚éŒv‘Ş•ű–@E•]‰ż–@‚́g—Ž‚Ć‚ľŒŠhz4. ‘ŮŽ™ƒGƒR[Œv‘ŞŽž‚ĚƒsƒbƒgƒtƒH[ƒ‹. “Ąˆä@Ž  (—ŐŒŸ•”): MEDICAL TECNOLOGY 2017/3; 45 (3): 271-6.

[’˜@‘]

620191. [Šwp‘ (•Ş’SŽˇ•M)]yJAMT‹Zp‹ł–{ƒVƒŠ[ƒY@’´‰š”gŒŸ¸Ç—áWz4Í œ”Սo’´‰š”gŒŸ¸@4.1 —Ťœ”Սo, p.206-11. ‰FŽĄ‹´‘PŸ (—ŐŒŸ•”), ŠÄC: ˆę”ĘŽĐ’c–@l“ú–{—Տ°‰qśŒŸ¸‹ZŽt‰ď, ‚ś‚Ů‚¤, “Œ‹ž, 2016/8”­s.

620192. [Šwp‘ (•Ş’SŽˇ•M)]yJAMT‹Zp‹ł–{ƒVƒŠ[ƒY@’´‰š”gŒŸ¸Ç—áWz5Í ‘Ě•\’´‰š”gŒŸ¸@5.1 bó‘B, p.222-9. ’†ź‹vK (—ŐŒŸ•”), ŠÄC: ˆę”ĘŽĐ’c–@l“ú–{—Տ°‰qśŒŸ¸‹ZŽt‰ď, ‚ś‚Ů‚¤, “Œ‹ž, 2016/8”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713162. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Evoked potentials may predict of functional outcome in a case of acute necrotizing encephalopathy Clinical utility of evoked potentials to predict of functional outcome in a ase of acute necrotizing encephalopathy. Onozawa Y1, Obata S1, Munekata S1, Nonoda Y2, Iwasaki T2, Iizuka T3, Kanoh Y4: The 32nd World Congress of Biomedical Laboratory Science (2016/9/3), Kobe, Japan, IFBLS2016 Abstract Book 2016/8/1; p.53. (Ź–ěŕV—T–ç1, Ź”Ś@i1, “•űLˆę1, –ěX“c–L2, Šâčr”V2, ”Ń’Ë‚_3, Žë–ě—Lě4: 1—ŐŒŸ•”, 2ŹŽ™, 3_Œo“ŕ, 4—ŐŒŸŠw)

713163. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Evaluation of the improved Dimention-TAC assay for the determination of tacrolimus concentrations in whole blood. Tsukushi T1, Katsumata M1, Yamaguchi H1, Nakazaki H1, Uchida K1, Munakata S1, Kanoh Y2: The 32nd World Congress of Biomedical Laboratory Science (2016/9/2), Kobe, Japan, IFBLS2016 Abstract Book 2016/8/1; p.94. (“y•M’qť1, Ÿ–””ü”g1, ŽRŒű‚Đ‚Ć‚Ý1, ’†čLŽq1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2: 1—ŐŒŸ•”, 2—ŐŒŸŠw)

713164. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Evaluation of the L-FABP assay using a latex turbidimetric immunoassay and stability of urinary L-FABP. Iiduka T, Tsukushi T1, Yamaguchi H1, Nakazaki H1, Uchida K1, Munekata S1, Kanoh Y2: The 32nd World Congress of Biomedical Laboratory Science (2016/9/3), Kobe, Japan, IFBLS2016 Abstract Book 2016/8/1; p.94. (“y•M’qť1, ŽRŒű‚Đ‚Ć‚Ý1, ’†čLŽq1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2: 1—ŐŒŸ•”, 2—ŐŒŸŠw)

723954. [Šw‰ď (‘S‘)] ƒ|ƒXƒ^[) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚é—AŒŒŒăŠ´őÇŒŸ¸‚ĚŽć‚č‘g‚Ý‚ĆŽŔŽ{ó‹ľ‚ɂ‚˘‚Ä. “c•”—T“ń1, Ź–{”ü“Ţ1, •—ŠÔ‚ ‚Ť‚Ý1, ‚–ě”g—Ż”ü1, ł–ŘˆÇ“Ţ1, ‘ĺ’JTˆę3 (1—AŒŒ•”, 2—ŐŒŸ•”, 3—AŒŒE×–EˆÚA): ‘ć64‰ń“ú–{—AŒŒE×–EŽĄ—ĂŠw‰ď‘‰ď (2016/4/29), ‹ž“s, “ú–{—AŒŒ×–EŽĄ—ĂŠw‰ďŽ 2016/4; 62 (2): 391.

723955. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒpƒ‹ƒXƒhƒvƒ‰–@‚É‚ć‚é“ŕŒz“Ž–ŹŒŒ—ŹŒv‘Ş‚ĚƒTƒ“ƒvƒ‹ƒ|ƒCƒ“ƒg‚ĚŒŸ“˘. â–{D1, “Ąˆä@Ž 1, ’†ź‹vK1, ꠓcŠě”V1, ‰FŽĄ‹´‘PŸ1 (1—ŐŒŸ•”): ‘ć41‰ń“ú–{’´‰š”gŒŸ¸Šw‰ďŠwpW‰ď (2016/6/11), ĺ‘ä, ’´‰š”gŒŸ¸‹Zp 2016/6; 41: S124.

723956. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é’´‰š”g‰ć‘œ—ň‰ť‚Ě•]‰ż‚ɂ‚˘‚ā`XVŒv‰ć‚Ö‚Ě’ńŒž`. ‰FŽĄ‹´‘PŸ1, –îŒű’ź‘ĺ2, Žá—Ń—Ç—Y2, “•űLˆę1, Žë–ě—Lě3 (1—ŐŒŸ•”, 2Ž––ą•”Ž‘Ţ‰Ű, 3—ŐŒŸŠw): ‘ć41‰ń“ú–{’´‰š”gŒŸ¸Šw‰ďŠwpW‰ď (2016/6/11), ĺ‘ä, ’´‰š”gŒŸ¸‹Zp 2016/6; 41: S216.

723957. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆâ“`Ťƒp[ƒLƒ“ƒ\ƒ“•aŠłŽŇ—R—ˆiPS×–E‚É‚¨‚Ż‚éƒQƒmƒ€•ŇWiPS×–E‚ĚŽ÷—§. ‘ž“c‰x˜N1,2, ‘]ŞŠxŽj2, ‘ĺ“ú•ű—F—1, ‰LŽ”‰pŽ÷3, ‹vź’mŽq4, –kě‹GŽq4, Îě@[2, ‹î–ě@”Ł2, ă“c‘׌Č3,5,6, Ź”Ś•ś–í1, ‰Ş–ě‰h”V2 (1ˆă—ÉqśŠw•”, 2Œcœä‹`m‘ĺŠwEˆăŠw•”Eś—Šw, 3—‰ťŠwŒ¤‹†ŠEś–˝ƒVƒXƒeƒ€Œ¤‹†ƒZƒ“ƒ^[E‡Źś•¨ŠwŒ¤‹†ƒOƒ‹[ƒv, 4—ŐŒŸ•”, 5“Œ‹ž‘ĺŠw‘ĺŠw‰@EˆăŠwŒ¤‹†EƒVƒXƒeƒ€ƒY–ň—Šw, 6“ú–{‰ČŠw‹ZpU‹ť‹@\CREST): ‘ć39‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2016/7/20-2), ‰Ą•l.

723958. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ĂŒĹĽü—nŒnƒ}[ƒJ[‚Ě•Ď“Ž‚ÉŠî‚Ă‚­DIC‚Ě•aŒ^•Ş—Ţ‚ÉŠÖ‚ˇ‚錟“˘. ăŒ´—R‰Ŕ—1, ’†ź@ŒO1, ˆ˘•”—L1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): ‘ć17‰ń“ú–{ŒŸ¸ŒŒ‰tŠw‰ďŠwpW‰ď (2016/8/7) •Ÿ‰Ş, “ú–{ŒŸ¸ŒŒ‰tŠw‰ďŽGŽ 2016/7; 17 (ŠwpW‰ď†): S198.

723959. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚ĚENGŒŸ¸‚É‚¨‚Ż‚éŠJŠá”ń’Ž‹ŠĎŽ@‰ş‚Ĺ‚ĚŠáUŒŸoó‹ľ‚ɂ‚˘‚Ä. Ź”Ś@i1, Ź–ě‘ň—T–ç1, —é–؏~Žq2, ‰Í“‡]”ü2, ‰FŽĄ‹´‘PŸ1, “•űLˆę1, Žë–ě—Lě3 (1—ŐŒŸ•”, 2“Œ•a‰@—ŐŒŸ•”, 3—ŐŒŸŠw): ‘ć63‰ń“ú–{—Տ°ŒŸ¸ˆăŠw‰ďŠwpW‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 68.

723960. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) HK-2×–E‚É‚¨‚˘‚č‚ƒOƒ‹ƒR[ƒX‚¨‚ć‚ŃƒAƒ‹ƒuƒ~ƒ“•‰‰×‚ރ~ƒgƒRƒ“ƒhƒŠƒA‹@”\‚đ’ቺ‚ł‚š’†ŤŽ‰–b’~Ď‚đ—U”­‚ˇ‚é. ˆä–{–ž”ü1, ˆ˘•”@“Ä2, •čËŽj1, ŒÜ\—’‘ĺŽm2, Ź”Ś@i3, —é–؉p–ž4, ‰Ąęł“T1, Žsě‘¸•ś1, ’|’†P•v5, •Đ‹Ë^l1, Îˆä’źm1 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3—ŐŒŸ•”, 4–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@, 5‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽR‰¤•a‰@t‘Ÿ“ŕ‰Č): ‘ć63‰ń“ú–{—Տ°ŒŸ¸ˆăŠw‰ďŠwpW‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 86.

723961. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ßˆĘ”A×ŠÇă”ç×–E‚É‚¨‚˘‚č‚ŒŒ“œ‚É‚ć‚éŽ_‰ťƒXƒgƒŒƒX‚Ě˜´i‚Ímegalin”­Œť‚đă¸‚ł‚š‚é. •čËŽj1, ŒÜ\—’‘žŽm2, ˆä–{–ž”ü1, ˆ˘•”@“Ä2, “y•M’qť3, Ź”Ś@i3, ‰Ąęł“T1, Žsě‘¸•ś1, ’|’†P•v4, •Đ‹Ë^l1, Îˆä’źm1 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3—ŐŒŸ•”, 4‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽR‰¤•a‰@t‘Ÿ“ŕ‰Č): ‘ć63‰ń“ú–{—Տ°ŒŸ¸ˆăŠw‰ďŠwpW‰ď (2016/9/3-4), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 86.

723962. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ƉuŒŒ´ŒŸ¸‚É‚¨‚Ż‚éƒn[ƒ‚ƒiƒCƒ[[ƒVƒ‡ƒ“‚̉”\Ť‚ɂ‚˘‚ā|‘ć1•ń|“ú—Ő‹Z¸“xŠÇ—Ž–‹Ć‚ʼnߋŽ5”NŠÔ‚Ƀv[ƒ‹ŒŒ´‚đ—p‚˘‚˝ƒ[ƒJ[ƒT[ƒxƒC‚ĚŒ‹‰Ę‚Š‚ç. ‰Í–ě@‹v1, –؉şŒhˆę˜Y2, “y•M’qť3, ź“cmŽĄ4, Ö“Ą@“Ä5, ‰Ş“c@Œ’6, ź‰Y–ž•F7, Šâă‚Ý‚ä‚Ť8 (1“V—‚ć‚ë‚Ă‘Š’kŠ•a‰@, 2’šŽćÔ\Žš•a‰@, 3—ŐŒŸ•”, 4LSIƒƒfƒBƒGƒ“ƒX‹ž“sŽs—§•a‰@, 5ŠâŽčˆă‰Č‘ĺŠw•‘Ž•a‰@, 6‰ŞŽR‘ĺŠw•a‰@, 7‘—§•a‰@‹@\‹ăBˆă—ĂƒZƒ“ƒ^[, 8ŠŮ—ŃŒúś•a‰@): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 56.

723963. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MSBOS“ą“ü‚É‚ć‚é—AŒŒ—pŒŒ‰tťÜ“KłŽg—p‚Ö‚ĚŽć‚č‘g‚Ý‚ĆŒř‰ĘŒŸŘ. ł–ŘˆÇ“Ţ1, “c•”—T“ń1, Ź–{”ü“Ţ1, ŽR•Ó°”ü1, ř‹–ě”g—Ż”ü1, •—ŠÔ‚ ‚Ť‚Ý1, “ŕ“cˆęO1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 80.

723964. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ŮŽ™ƒGƒR[‚É‚ć‚Á‚Ä“Á’Ľ“I‚ČƒGƒR[‘œ‚đ’ć‚ľ‚˝‘”rŸ•oˆâŽcÇ‚Ě2Ç—á‚ɂ‚˘‚Ä. ‰FŽĄ‹´‘PŸ1, ’†ź‹vK1, “Ąˆä@Ž 1, —é–ؐ­Žq1, H“Ą—ß—Ç1, •˝“cçL1, “•űLˆę1, Žë–ě—Lě2 (1—Տ°ŒŸ¸•”, 2—ŐŒŸŠw): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 266.

723965. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”~“ĹTPR‘Ě‚Ě”ń“ÁˆŮ”˝‰ž‚đŒ_‹@‚É”­ŒŠ‚ľ‚˝‘ć1ŽŽ–ň‚ĚŒoŽž“IpHă¸‚¨‚ć‚Ń‘Ş’č’l‚ւ̉e‹ż. ŽRŒű‚Đ‚Ć‚Ý1, “y•M’qť1, “Ą‘ş‘Ps1, ’†čLŽq1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/4), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 56.

723966. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽŽ–ň•Ű—âŒÉ“ŕ‚É‚¨‚Ż‚é‹ó‹CƒRƒ“ƒ^ƒ~‚ރAƒ“ƒ‚ƒjƒA‘Ş’čŽŽ–ň‚É—^‚Ś‚é‰e‹ż|3ŽŽ–ň‚Ě”äŠrŒŸ“˘|. ŽÂŒ´—ş‘ž1, “y•M’qť1, ŹŽRhŽq1, ’†čLŽq1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/4), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 63.

723967. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒrƒŠƒ‹ƒrƒ“•Ş‰ć‘Ş’č–@‚Ě•Ş—Ţ‚Ć”˝‰ž“ÁˆŮŤ‚ÉŠÖ‚ˇ‚é”FŽŻ’˛¸ ŠÖ“ŒbM’n‹ć—Տ°‰ťŠwŒŸ¸Œ¤‹†”Ç •˝Ź27”N“x‹¤“ŻŒŸ“˘ ‚ť‚Ě1. “Ą‘ş‘Ps1, ––‹g–ΗY2, “c‘şŸK3, ŠÖŒű”ü4, ŽO–Ř—˛ŽĄ5, ŽO––‚‰›6 (1‘ĺŠw•a‰@—Տ°ŒŸ¸•”, 2ç—tŒ§‚Ş‚ńƒZƒ“ƒ^[, 3“ߐ{Ô\Žš•a‰@, 4‘O‹´Ô\Žš•a‰@, 5ŕՋŚˆă‰Č‘ĺŠw‰z’J•a‰@, 6‘D‹´Žs—§ˆă—ĂƒZƒ“ƒ^[): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/4), _ŒË, ˆăŠwŒŸ¸ 2016/7; 63 (•Ęű): 63.

723968. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽŽ–ň•Ű—âŒÉ‚É‚¨‚Ż‚é‹ó‹CƒRƒ“ƒ^ƒ~‚ރAƒ“ƒ‚ƒjƒA‘Ş’čŽŽ–ň‚É—^‚Ś‚é‰e‹ż|3ŽŽ–ň‚Ě”äŠrŒŸ“˘|. ŽÂŒ´—ş‘ž1, “y•M’qť1, ŹŽRhŽq1, ’†čLŽq1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/4), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 63.

723969. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ĚŒŒˆ—‘Ź“x‚ɉe‹ż‚ˇ‚éˆöŽq‚ĚŒŸ“˘. •˝ˆä@˝1, “ŕ“c‘ĺ‹M1, ”Ş–Řˆę•v1, “ŕ“cˆęO1, “•űLˆę1, ‘ĺ’JTˆę2, Žë–ě—Lě3 (1—ŐŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ŐŒŸŠw): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/4), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 84.

723970. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘SŽŠ“Ž‰ťŠw”­Œőy‘f–Ɖu‘Ş’čƒVƒXƒeƒ€uƒ‹ƒ~ƒpƒ‹ƒXL2400v‚ĚŠî‘b“IŤ”\•]‰ż. ŹŽRhŽq1, “y•M’qť1, ‰Ş“c—R‹I1, “Ą‘ş‘Ps1, ’†čLŽq1, “ŕ“cˆęO1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): “ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ď‘ć48‰ń‘ĺ‰ď (2016/9/22-4), ‰Ą•l, “ú–{—Տ°ŒŸ¸ŽŠ“Ž‰ťŠw‰ď‰ďŽ 2016; 41 (4): 521.

723971. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) MEPƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚Ż‚é‰A‹ÉŽhŒƒ‚ĚˆÓ‹`. Ź–ěŕV—T–ç1, ˛“ĄŸl2, –Ń—˜’m—ĺ1, ‰Ÿ“cD”ü1, ‹{â˜aO2, ’h@@[2, ŽR–{‘ĺ•ă2, •“c”Ž‹I2, ŹňŠ°”V2, ŒG•”rG2 (1—ŐŒŸ•”, 2”]ŠO): ‘ć46‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć53‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2016/10/28), •Ÿ“‡, —Տ°_Œoś—Šw 2016/10; 44 (5): 404.

723972. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒrƒŠƒ‹ƒrƒ“•Ş‰ć‘Ş’č–@‚Ě•Ş—Ţ‚Ć”˝‰ž“ÁˆŮŤ‚ÉŠÖ‚ˇ‚é”FŽŻ’˛¸. “Ą‘ş‘Ps1, ––‹g–ΗY2, ŽO‰Y–F“T1, ŸÍŒ´@”Ž3, ‘ĺŕV@i4 (1‘ĺŠw•a‰@—Տ°ŒŸ¸•”, 2ç—tŒ§‚Ş‚ńƒZƒ“ƒ^[, 3ç—t‰ČŠw‘ĺŠw, 4‘Űˆă—Ă•ŸŽƒ‘ĺŠw): ‘ć56‰ń“ú–{—Տ°‰ťŠw‰ď (2016/12/2), ŒF–{, —Տ°‰ťŠw 2016/10; 44 (Suppl 1): 127.

723973. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) tÇ”­Ç‘O‚Ě“œ”A•aƒ‰ƒbƒg‚É‚¨‚Ż‚éƒI[ƒgƒtƒ@ƒW[‚É‚ć‚ét‹@”\•ŰŒě‚ɂ‚˘‚Ä. Žs‰Ş‹§–r1, ˆ˘•”@“Ä1, ŒÜ\—’‘ĺŽm1, ˆä–{–ž”ü2, •čËŽj2, “y•M’qť3, Ź”Ś@i3, —é–؉p–ž4, ’|’†P•v5, •Đ‹Ë^l2, Žsě‘¸•ś2, Îˆä’źm2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3—ŐŒŸ•”, 4–k—˘‘ĺŠw•ŰŒŻ‰qśę–ĺŠw‰@, 5‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽR‰¤•a‰@t‘Ÿ“ŕ‰Č): ‘ć56‰ń“ú–{—Տ°‰ťŠw‰ď (2016/12/3), ŒF–{, —Տ°‰ťŠw 2016; 45: 207.

732123. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‹Ů‹}Žž‚É”ő‚Ś‚ā`’´‰š”g‚ĚƒpƒjƒbƒNŠŒŠ‚đl‚Ś‚é`. ‰FŽĄ‹´‘PŸ1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): ‘ć65‰ń_“ŢěŒ§ˆăŠwŒŸ¸Šw‰ď (2016/11/13), ‰Ą•l, ‘ć65‰ń_“ސěˆăŠwŒŸ¸Šw‰ďƒvƒƒOƒ‰ƒ€´˜^W 2016/11; p.22.

733483. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) lHŠÖßŠ´őÇ‚É‚¨‚Ż‚é×‹Űˆâ“`ŽqŒŸ¸‚̐v‘ŹƒVƒXƒeƒ€‚ĚŽć‚č‘g‚Ý. ŸNˆäŒc‘˘1, ’†čM•F1, ˆŔ’B@ŒŞ1, Š}ˆäˆÇŽq1, “•űLˆę1, “ń–{–öL2, Žë–ě—Lě3, ÔŻ@“§4, “ŕŽRŸ•ś5, •ôŠÝ—mŽŸ˜Y5, ’r“cM‰î5, mˆäŒŠ‰pŽ÷6, ˜aŽRsł7 (1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3—ŐŒŸŠw, 4‘‡f—Ă, 5ŽŠO, 6•xŽR‘ĺŠw•t‘Ž•a‰@ŒŸ¸•”ˆâ“`ŽqEćiˆă—ĂŽx‰‡•”–ĺ, 7–k—˘‘ĺ’˃oƒCƒIƒƒfƒBƒJƒ‹ƒAƒbƒZƒCŒ¤‹†Š): ‘ć1‰ń_“ŢěœEŠÖßŠ´őÇƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/6/17), V‰Ą•l, ‘ć1‰ń_“ŢěœEŠÖßŠ´őÇƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒvƒƒOƒ‰ƒ€ 2016/6; p.1.

733484. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”÷ś•¨Š”•Ű‘ś‹@ŠÖ (ƒoƒNƒeƒŠƒAƒoƒ“ƒN) Ý—§‚ÉŒü‚Ż‚˝ŽYŠw‹Ś“ŻŽ–‹Ć‚Ć‚ľ‚Ă̐V‚˝‚ČŽć‚č‘g‚Ý. ŽRŒű“oŠóŽq (—ŐŒŸ•”): ‘ć27‰ń_“ŢěŒ§—Տ°ŒŸ¸ˆăŠw‰ď‘ĺ‰ď (2016/6/18), _“ސě, ‘ć27‰ń_“ŢěŒ§—Տ°ŒŸ¸ˆăŠw‰ď‘ĺ‰ďƒvƒƒOƒ‰ƒ€ 2016/6; p.1.

733485. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) p’†lHŠÖßŠ´őÇ‚É‚¨‚Ż‚é×‹Űˆâ“`ŽqŒŸ¸‚̐v‘ŹƒVƒXƒeƒ€‚ĚŽć‚č‘g‚Ý. –kě‹GŽq1, ŸNˆäŒc‘˘1, ’†čM•F1, ˆŔ’B@ŒŞ1, Š}ˆäˆÇŽq1, “•űLˆę1, “ń–{–öL2, Žë–ě—Lě3, ÔŻ@“§4, “ŕŽRŸ•ś5, •ôŠÝ—mŽŸ˜Y5, ’r“cM‰î5, mˆäŒŠ‰pŽ÷6, ˜aŽRsł7 (1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3—ŐŒŸŠw, 4‘‡f—Ă, 5ŽŠO, 6•xŽR‘ĺŠw•t‘Ž•a‰@ŒŸ¸•”ˆâ“`ŽqEćiˆă—ĂŽx‰‡•”–ĺ, 7–k—˘‘ĺ’˃oƒCƒIƒƒfƒBƒJƒ‹ƒAƒbƒZƒCŒ¤‹†Š): ‘ć6‰ń–k—˘‘ĺŠw4•a‰@—Տ°ŒŸ¸•”ŠwpW‰ď (2016/7/2), “Œ‹ž, ‘ć6‰ń–k—˘‘ĺŠw4•a‰@—Տ°ŒŸ¸•”ŠwpW‰ďƒvƒƒOƒ‰ƒ€ 2016/7; p.5.

733486. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Տ°ŒŸ¸‚É‚¨‚Ż‚錟¸ƒT[ƒrƒX‚¨‚ć‚ŃŽż“IŒüă‚Ö‚ĚŽć‚č‘g‚Ý. ŽO‰Y–F“T (—ŐŒŸ•”): ‘ć6‰ń–k—˘‘ĺŠwŽl•a‰@—Տ°ŒŸ¸•”ŠwpW‰ď (2016/7/2), “Œ‹ž, ‘ć6‰ń–k—˘‘ĺŠwŽl•a‰@—Տ°ŒŸ¸•”ŠwpW‰ď´˜^W 2016/7; p.11.

733487. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) LEBER•a‚É‚¨‚Ż‚éƒ~ƒgƒRƒ“ƒhƒŠƒADNA‰đÍ`ƒnƒvƒƒ^ƒCƒvŒˆ’č‚ĚŽć‚č‘g‚݁`. ź‰ş‹G1, ˆŔ–{—´”n1, ’†čM•F1, ŸNˆäŒc‘˘1, “ŕ“cˆęO1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď(‘ć53‰ń) (2016/10/29), ŽR—œ, •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď (‘ć53‰ń) ƒvƒƒOƒ‰ƒ€u‰‰´˜^W 2016/10; p.112.

733488. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •”•Ş‹ĂW‚Ü‚˝‚̓Iƒ‚ƒeEƒEƒ‰•sˆę’v‚É‚ć‚čŒŒ‰tŒ^”ť’č‚É‹ę—ś‚ľ‚˝3Ç—á. —L”n˜a“Ţ1,2, “c•”—T“ń1,2, ŠâŘ•śŽq2, ŽR•Ó°”ü1,2, ‚–ě”g—Ż”ü1,2, •—ŠÔ‚ ‚Ť‚Ý1,2, Ź–{”ü“Ţ1,2, “ŕ“cˆęO1,2 (1—ŐŒŸ•”, 2—AŒŒ•”): •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď (‘ć53‰ń) (2016/10/29-30), ŽR—œ, •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď (‘ć53‰ń) ƒvƒƒOƒ‰ƒ€u‰‰´˜^W 2016/10; p.115.

733489. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) dÇ‹Ř–ł—͏ǂɂ¨‚Ż‚é‘QŒ¸Œ¸­‚ĆŠááىş‚‚ĚŠÖ˜AŤ‚ɂ‚˘‚Ä. –Ń—˜’m—ĺ1, Ź–ěŕV—T–ç1, ‰Ÿ“cD”ü, Ź”Ś@i1, ‰FŽĄ‹´‘PŸ1, “•űLˆę1 (1—ŐŒŸ•”): •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď(‘ć53‰ń) (2016/10/29), ŽR—œ, •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď(‘ć53‰ń) ƒvƒƒOƒ‰ƒ€u‰‰´˜^W 2016/10; p.128.

733490. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Mycobacterium tuberculosis‚đŒŸo‚ľ‚˝‰óŽ€Ť‹Ř–Œ‰Š‚Ě1—á. ŹŠŃ’q˘1, “ń–{–öL2, ˆŔ’B@÷1, “ŕ“c–F]1, ’†čM•F1, “•űLˆę1, Žë–ě—Lě3 (1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3—ŐŒŸŠw): •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď (‘ć53‰ń) (2016/10/29-30), ŽR—œ, •˝Ź28”N“x“ú—Ő‹ZŠÖbMEŽń“sŒ—Žx•”ˆăŠwŒŸ¸Šw‰ď(‘ć53‰ń) ƒvƒƒOƒ‰ƒ€u‰‰´˜^W 2016/10; p.145.

733491. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒŒ‰t”|—{ŒŸ¸‚Ĺ“ŻŽž‚ÉSalmonella Typhi‚ĆSalmonella Paratyphi A‚đŒŸo‚ľ‚˝ˆę—á. ˆŔ’B@÷1, ŹŠŃ’q˘1, “ń–{–öL2, ˜a“c’B•F3, ‚ŽR—zŽq4 (1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3äPŒ´•aEŠ´ő“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć86‰ń“ú–{Š´őÇŠw‰ďź“ú–{’n•ű‰ďŠwpW‰ď/‘ć59‰ń“ú–{Š´őÇŠw‰ď’†“ú–{’n•ű‰ďŠwpW‰ď/‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ďź“ú–{Žx•”‘‰ď (2016/11/26), ‰Ť“ę, ‘ć86‰ń“ú–{Š´őÇŠw‰ďź“ú–{’n•ű‰ďŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; p.435.

733492. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —Տ°ŒŸ¸•”‚É‚¨‚Ż‚é•iŽżŠÇ—‚¨‚ć‚Ń•a‰@Žű‰v‚Ö‚ĚvŒŁ‚ÉŠÖ‚ˇ‚éŽć‚č‘g‚݂ɂ‚˘‚Ä. “Ą‘ş‘Ps (—ŐŒŸ•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), ‰Ą•l, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.20.

733493. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é’´‰š”gŒŸ¸‚ĹŒŸo‚ľ‚˝“ŕ‰Č—Ěˆć‚ĚDVT‚Ě”­ŒŠó‹ľ. ‰FŽĄ‹´‘PŸ1, ’†ź‹vK1, “Ąˆä@Ž 1, —é–ؐ­Žq1, H“Ą—ß—Ç1, •˝“cçL1, “•űLˆę1, Žë–ě—Lě2 (1—ŐŒŸ•”, 2—ŐŒŸŠw): JSSŠÖ“ŒbM‰z‘ć35‰ńŠwpW‰ď (2017/3/5), ‘ĺ‹{, ’´‰š”gŒŸ¸‹Zp 2017/6; 42 (3): 353.

733494. [Šw‰ď (’n•űŠw‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ć“VŤSŽžŠł‚̐SƒGƒR[`”­ś‚Š‚琏l‚܂Ł`‘ćV•” ŹŽ™. ꠓcŠě”V (—ŐŒŸ•”): JSSŠÖ“ŒbM‰z‘ć35‰ńŠwpW‰ď (2017/3/5), ‘ĺ‹{, ’´‰š”gŒŸ¸‹Zp 2017/6; 42 (3): 356-7.

H27”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H27-120004. [Œ´’˜] ’†•_ŒoŒnŠ´őÇ‚É‚¨‚Ż‚éMultiplex PCR–@‚ĆPCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚đ—p‚˘‚˝v‘Źˆâ“`ŽqŒŸ¸‚Ě—Ő°“I•]‰ż. ŸNˆäŒc‘˘1, “ń–{–öL1,2, ’†čM•F1, ‹vź’mŽq1, “•űLˆę1, ˜aŽRsł3, Žë–ě—Lě4 (1—ŐŒŸ•”, 2Š´őŠÇ—Žş, 3–k—˘‘ĺ’˃oƒCƒIƒƒfƒBƒJƒ‹ƒAƒbƒZƒCŒ¤‹†Š, 4—ŐŒŸŠw): ˆăŠwŒŸ¸ 2016/3; 65 (2): 159-65.


•úŽËü•”

[Šwp˜_•ś]

110301. [Œ´’˜] Influence of the Magnetic Field Strength on Image Contrast in Gd-EOB-DTPA-enhanced MR Imaging: Comparison between 1.5T and 3.0T. Hata H1, Inoue Y2, Nakajima A1, Komi S1, Miyatake H1: Magn Reson Med Sci 2017; 16 (2): 109-14. Published Online: 2016/4/28. (`@”Ž•ś1, ˆäă—D‰î2, ’†“ˆ@—•1, ŹŒŠł‘ž˜Y1, ‹{•”ä˜CŽ÷1: 1•úŽËü•”, 2•úŽËü (‰ć‘œ))

110302. [Œ´’˜] Cardiovascular magnetic resonance evaluation of left ventricular peak filling rate using steady-state free precession and phase contrast sequences. Komi S1, Inoue Y2, Hata H1, Nakajima A1, Miyatake H1: Springerplus 2016/7; 5 (1): 1163. (ŹŒŠł‘ž˜Y1, ˆäă—D‰î2, `@”Ž•ś1, ’†“ˆ@—•1, ‹{•”ä˜CŽ÷1: 1•úŽËü•”, 2•úŽËü (‰ć‘œ))

110303. [Œ´’˜] The functional activity and effective connectivity of pulvinar are modulated by individual differences in threat-related attentional bias. Hakamata Y, Sato E, Komi S1, Moriguchi Y, Izawa S, Murayama N2, Hanakawa T, Inoue Y3, Tagaya H2: Sci Rep 2016/10; 6: 34777. (ŹŒŠł‘ž˜Y1, ‘şŽRŒ›’j2, ˆäă—D‰î3, “cƒ–’J_–M2: 1•úŽËü•”, 2ˆă—ÉqśŠw•”, 3•úŽËü (‰ć‘œ))

[Šw‰ďEŒ¤‹†‰ď“™]

713165. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Comparison of respiratory navigator-gating techniques in two-dimensional spoiled gradient-recalled echo sequence. Hata H1, Inoue Y2, Nakajima A1, Omi S1, Abe Y1, Matsunaga K2, Miyatake H1: ISMRM - 2016 Annual Meeting & Exhibition (2016/5/7-13), Singapore, ISMRM 24th Annual Meeting and Exhibition Program 2016; p.1855. (`@”Ž•ś1, ˆäă—D‰î2, ’†“ˆ@—•1, ŹŒŠł‘ž˜Y1, ˆ˘•”@–L1, ź‰iŒh“ń2, ‹{•”ä˜CŽ÷1: 1•úŽËü•”, 2•úŽËü (‰ć‘œ))

713166. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Basic verification of respiratory-gated intensity modulated radiation therapy using a real-tome tumor-tracking radiotherapy system. Noda S1, Watanabe Y2, Shuto N1, Akimoto Y2, Fukumitsu M2, Eguchi S2, Ishiyama H3, Hayakawa K3: 22nd International Conference on Medical Physics (2016/12/10), Thai, The Journal of the International Organization for Medical Physics 2016/12; 4 (2): 396. (–ě“c–Η˜1, “n粗S‰î2, Žń“Ąéş1, H–{—Rˆß2, •ŸŒőŠ˛–ç2, ]Œű@V2, ÎŽR”ŽžŠ3, ‘ě˜ad3: 1•úŽËü•”, 2ˆă—ÉqśŠw•”, 3•úŽËü (Žîá‡))

722279. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) Imaging techniques in MR angiography of the body ‘ĚŠ˛•”MR angiography‚ĚŽB‘œ‹Zp. `@”Ž•ś (•úŽËü•”): ‘ć44‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2016/9/11), ‘ĺ‹{, ‘ć44‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďu‰‰´˜^W 2016/9; 36 (Suppl): 121.

723974. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) CT‰ć‘œÄ\ŹƒAƒ‹ƒSƒŠƒYƒ€‚Ěˆá‚˘‚É‚ć‚镨—“ÁŤ‚Ě”äŠr•]‰ż. ‘ě’ź“š1, ”ˇ@G“T1, ‰iŒ´˜aŒ›1, ˛“Ą@˝1, •ŕV–ő”V1, ˆäă—D‰î2 (1•úŽËü•”, 2•úŽËü (‰ć‘œ)): ‘ć72‰ń“ú–{•úŽËü‹ZpŠw‰ď‘‰ďŠwp‘ĺ‰ď (2016/4/16), ‰Ą•l, ‘ć72‰ń“ú–{•úŽËü‹ZpŠw‰ďŠwpW‰ď (—\eW) 2016/2; 72 (2): 356-7.

723975. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹…Œ`óƒAƒNƒŠƒ‹‹zŽű‘ĚƒgƒŒ[ƒTƒuƒ‹Ge-68/Ga-68“_óüŒš‚đ—p‚˘‚˝—Տ°—pPET‘•’uZł. ŹŽRăĎi1, ˆŔ“Ą@—Ä2, ŠOŽR@w2, ’ˇ’Jě’q”V2, ‹{•”ä˜CŽ÷3, ‹e’r@Œh3, ˆäă—D‰î4, ‰äČ@Œd5, D“cŒ\ˆę6, ˛“Ą@‘×7, ŽR“c’—T8 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3•úŽËü•”, 4•úŽËü (‰ć‘œ), 5“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[Œ¤‹†Š, 6–kŠC“š‰ČŠw‘ĺŠw, 7ŽY‹Ć‹Zp‘‡Œ¤‹†Š, 8“Œ‹ž”_‹Ć‘ĺŠw): ‘ć111‰ń“ú–{ˆăŠw•¨—Šw‰ďŠwp‘ĺ‰ď (2016/4/16), ‰Ą•l.

723976. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Comparison of respiratory navigator-gating techniques in 2D SPGR imaging of the liver 2DSPGR–@‚É‚¨‚Ż‚鉥Šu–Œ“ŻŠú‹Zp‚Ě”äŠr. `@”Ž•ś1, ˆäă—D‰î2, ’†“ˆ@—•1, ŹŒŠł‘ž˜Y1, ˆ˘•”@–L1, ź‰iŒh“ń2, ‹{•”ä˜CŽ÷1 (1•úŽËü•”, 2•úŽËü (‰ć‘œ)): ‘ć44‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2016/9/10), ‘ĺ‹{, ‘ć44‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďu‰‰´˜^W 2016/9; 36 (Suppl): 281.

723977. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 2D SPGR–@‚É‚¨‚Ż‚鉥Šu–Œ“ŻŠú‹Zp‚Ě”äŠr. `@”Ž•ś1, ˆäă—D‰î2, ’†“ˆ@—•1, ŹŒŠł‘ž˜Y1, ˆ˘•”@–L1, ź‰iŒh“ń2, ‹{•”ä˜CŽ÷1 (1•úŽËü•”, 2•úŽËü (‰ć‘œ)): ‘ć44‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2016/9/11), ‘ĺ‹{, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ 2016/9; 36 (suppl): 281.

723978. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Exposure IndexŽZo•ű–@‚Ş‹y‚Ú‚ˇ‰e‹ż. ŠÖ@ŤŽu1, –ö“c@’q2, ‰H“c‰ë_3, ‰Ş–{Œ[Œö1, Ą‰Ôml2 (1•úŽËü•”, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•úŽËü•”, 3–k—˘Œ¤‹†Š•a‰@•úŽËü•”): ‘ć44‰ń“ú–{•úŽËü‹ZpŠw‰ďH‹GŠwp‘ĺ‰ď (2016/10/14), ‘ĺ‹{, ‘ć44‰ń“ú–{•úŽËü‹ZpŠw‰ďH‹GŠwp‘ĺ‰ď—\eW 2016; p.41.

723979. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒtƒNƒƒ~ƒbƒNƒtƒBƒ‹ƒ€‚đŽg—p‚ľ‚˝‚ü—Ę—ŚŹüŒšŽĄ—Â̐ü—Ę•Ş•zŒŸŘ. Ž›ř“„Žj1, “n粗S‰î2, —с@“N•˝2, –ě“c–Η˜1, Îă@–Ť1, ˆî“c—´Ži1, Žń“Ąéş1, ÎŽR”ŽžŠ3, ‘ě˜ad3 (1•úŽËü•”, 2ˆă—ÉqśŠw•”, 3•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/25), ‹ž“s, “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď•ń•śW 2016/11; p.309.

723980. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Tomotherapy‚đ—p‚˘‚˝‘O—§‘BŠŕ’čˆĘ•úŽËüŽĄ—Ă‚É‚¨‚Ż‚éorgan motion‚̐ü—Ę•Ş•z‚ւ̉e‹ż. –ě“c–Η˜1, Ž›ř“„Žj1, Îă@–Ť1, Žń“Ąéş1, “n粗S‰î2, ˆî“c—´Ži1, ŽR–{˜ał1, ÎŽR”ŽžŠ3, ‘ě˜ad3 (1•úŽËü•”, 2ˆă—ÉqśŠw•”, 3•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď (2016/11/26), ‹ž“s, “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ńŠwp‘ĺ‰ď•ń•śW 2016/11; p.320.

732124. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒXƒgzEI‚Ě–â‘č“_. ŠÖ@ŤŽu (•úŽËü•”): ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ď (2017/1/29), ‰F“s‹{.

733495. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 111In•WŽŻťÜ‚ĚŽB‘œđŒ‚ĚŠî‘b“IŒŸ“˘. ˆ˘•”@–L1, ’†“ˆ@—•1, ‹{•”ä˜CŽ÷1, ‹e’r@Œh1, ˆäă—D‰î2 (1•úŽËü•”, 2•úŽËü (‰ć‘œ)): ‘ć85‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/7/9), “Œ‹ž, ŠjˆăŠw 2016; 53 (1): 542-3.

733496. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒh[ƒYƒLƒƒƒŠƒuƒŒ[ƒ^‚đ—p‚˘‚˝•úŽË”\‘Ş’č‚ɑ΂ˇ‚é—eŠí‚̉e‹ż: ‘˝ŠjŽí‚Ĺ‚ĚŒŸ“˘. ˆ˘•”@–L1, ‹{•”ä˜CŽ÷1, “n糓Ďj1, ‹e’r@Œh1, ˆäă—D‰î2 (1•úŽËü•”, 2•úŽËü (‰ć‘œ)): ‘ć86‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2017/1/28), “Œ‹ž, ŠjˆăŠw 2017; 54 (1): 539.

733497. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Q‘äâ‘΍Ŕ•W‚đ—p‚˘‚˝ƒZƒbƒgƒAƒbƒv•ű–@‚Ě—L—pŤ‚ĚŒŸ“˘. ŽR–{˜ał1, Îă@–Ť1, –ě“c–Η˜1, Ž›ř“„Žj1, ‹{•”ä˜CŽ÷1, Žń“Ąéş1, ‘ě˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ď (2017/1/28), ‰F“s‹{, ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ďƒvƒƒOƒ‰ƒ€´˜^W 2017/1; p.90.

733498. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹š•”ƒGƒlƒ‹ƒM[ƒTƒuƒgƒ‰ƒNƒVƒ‡ƒ“‚É‚¨‚Ż‚鎊“KŠÇ“dˆł‚ĚŒŸ“˘. ŽR‰ş—ş—C1, ŠÖ@ŤŽu1, ‰Ş–{Œ[Œö1 (1•úŽËü•”): ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ď (2017/1/28), ‰F“s‹{, ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ďƒvƒƒOƒ‰ƒ€´˜^W 2017/1; p.83.

733499. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ˆŮ‚Č‚éƒ[ƒJ[‚ĚFPD (Flat Panel Detector) ‚đ—p‚˘‚˝•¨—“ÁŤ‚Ě”ä. ‰Ş–{Œ[Œö1, ŠÖ@ŤŽu1, ŽR›˝‰ëŽj1 (1•úŽËü•”): ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ď (2017/1/28), ‰F“s‹{, ‘ć63‰ńŠÖ“ŒŽx•”Œ¤‹†”­•\‘ĺ‰ďƒvƒƒOƒ‰ƒ€´˜^W 2017/1; p.60.

733500. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) XüCTŒŸ¸‚É‚¨‚Ż‚é•úŽËü—ĘŠÇ—‚ĚŽć‚č‘g‚݂ɂ‚˘‚Ä. ‰iŒ´˜aŒ›1, ‘ě’ź“š1, ”ˇ@G“T1, `@”Ž•ś1, —é–Ř’ź“ń1, ˆäă—D‰î2 (1•úŽËü•”, 2•úŽËü (‰ć‘œ)): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), ‰Ą•l.


–ňÜ•”

[Šwp˜_•ś]

110304. [Œ´’˜] MicroRNA expression in the vildagliptin-treated two- and three-dimensional HepG2 cells. Yamashita Y, Asakura M, Mitsugi R, Fujii H, Nagai K, Atsuda K1, Itoh T, Fujiwara R: Drug Metab Pharmacokinet 2016/6; 31 (3): 201-9. (Œú“cKˆę˜Y1: 1–ňÜ•”)

110305. [Œ´’˜] Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor. Nojima H, Kanou K, Terashi G, Takeda-Shitaka M, Inoue G, Atsuda K1, Itoh C, Iguchi C, Matsubara H1: BMC Struct Biol 2016/8; 16: 11. doi: 10.1186/s12900-016-0062-8. (Œú“cKˆę˜Y1, źŒ´@”Ł1: 1–ňÜ•”)

110306. [Œ´’˜] Vildagliptin and its metabolite M20.7 induce the expression of S100A8 and S100A9 in human hepatoma HepG2 and leukemia HL-60 cells. Asakura M, Karaki F, Fujii H, Atsuda K1, Itoh T, Fujiwara R: Sci Rep 2016/10; 6: 35633. doi: 10.1038/srep35633. (Œú“cKˆę˜Y1: 1–ňÜ•”)

110307. [Œ´’˜] Optimal dosage of cefmetazole for intraoperative antimicrobial prophylaxis in patients undergoing surgery for colorectal cancer. Tomizawa A1, Nakamura T2, Komatsu T1, Inano H1, Kondo R1, Watanabe M2, Atsuda K1: J Pharm Health Care Sci 2017/1; 3: 1. Published online 2017 Jan 7. doi: 10.1186/s40780-016-0071-6. (•yŕV@~1, ’†‘ş—˛r2, Źź•q˛1, ˆî–ě@Š°1, ‹ß“Ą—Ż”üŽq1, “n粏š•F2, Œú“cKˆę˜Y1: 1–ňÜ•”, 2ŠO‰Č)

110308. [Œ´’˜] Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo. Asakura M, Fukami T, Nakajima M, Fujii H, Atsuda K1, Itoh T, Fujiwara R: Drug Metab Dispos 2017/2; 45 (2): 237-45. (Œú“cKˆę˜Y1: 1–ňÜ•”)

120055. [Œ´’˜] ƒƒ^ƒAƒiƒŠƒVƒX‚ĚŽč–@‚đ—p‚˘‚˝Linezolid‚ĚŒŒ’†”Z“xŠÇ—‚ÉŠÖ‚ˇ‚錟“˘. Źź•q˛1, •˝’ËŒöŒČ1, ŁŒË—Ç‹ł1, ‘ĺěŒ´—TŽ÷1, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”): TDMŒ¤‹† 2017/2; 34 (1): 8-12.

120056. [Œ´’˜] ƒƒXƒoƒXƒ^ƒ`ƒ“‚Ćƒ}ƒOƒlƒVƒEƒ€ŠÜ—LťÜ‚Ě•š—p‚Ş low-density lipoprotein cholesterol (LDL-C) ‚É—^‚Ś‚é‰e‹ż. ‘qŽ—L1, •“c_Ž÷1, Źź•q˛2, ”ö’šŸ–ç1, Œú“cKˆę˜Y1,2 (1–ňŠw•”, 2–ňÜ•”): “ú–{•a‰@–ňÜŽt‰ďŽGŽ 2016/10: 52 (10): 1298-300.

540069. [‚ť‚Ě‘ź] ˆă—Ă‹@ŠíCRCŒ¤C‚đŽóu‚ľ‚Ä. í“cˆ¤Žq (–ňÜ•”): “ú–{•a‰@–ňÜŽt‰ďŽGŽ 2017/3: 53 (3): 332-3.

[’˜@‘]

620193. [Šwp‘ (’P’˜EŠÄCE•ŇW)]y•a‹C‚Ć–ň•¨—Ă–@ ¸_ŽžŠł^_ŒoE‹ŘŽžŠłzŒú“cKˆę˜Y1 (1–ňÜ•”), ŠÄC: ¤ř“@žÄE•ŽR­ˆę1, ‹¤•Ň: ’|“ŕ—T‹I, •˝ŽR•Ži1, ƒI[ƒ€ŽĐ, “Œ‹ž, 2016/11”­s.

620194. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚ĚŽĄ—ĂŽwj 2017”N”Łz11. ‘ăŽÓŽžŠł, p.691, p.695, p.708. Œú“cKˆę˜Y (–ňÜ•”), ‘•ŇW: •ŸˆäŽŸ–î, ‚–؁@˝, ŹŽşˆęŹ, ˆăŠw‘‰@, “Œ‹ž, 2017/1”­s.

620195. [Šwp‘ (•Ş’SŽˇ•M)]yPocket Drugs 2017zŠŕ@65. RˆŤŤŽîᇖň (‘ăŽÓhR–ň), p.541-55. ‰Ş–{Œb”üŽq1, Źň˜aŽO˜Y2 (1–ňÜ•”, 2Á‰ťŠí“ŕ), ŠÄC: •ŸˆäŽŸ–î: •Ň: ŹźNG, “n糗TŽi, ˆăŠw‘‰@, “Œ‹ž, 2017/1”­s.

620196. [Šwp‘ (’P’˜)]y•a‹C‚Ć–ň•¨—Ă–@ Á‰ťŠíŽžŠłzŒú“cKˆę˜Y (–ňÜ•”), ŠÄC: ˆÉ“Œ–ž•F, ‘O“c’čH, ‹¤•Ň: ŽRŒłrŒ›, ƒI[ƒ€ŽĐ, “Œ‹ž, 2017/3”­s.

620197. [Šwp‘ (•Ş’SŽˇ•MEŠÄCE•ŇW)]yŒťę‚Ĺ–đ‚ž‚Â! ˆăŠwE–ňŠw—pŒęƒCƒ“ƒfƒbƒNƒXz•Ň’˜: ‹g”ö@—˛, Œú“cKˆę˜Y1, ˛X–Ř’‰“ż (1–ňÜ•”), ŠÄC: źŕVŒ’Ži, •Ň: Ź‰€K‹P, •˝ŽR•Ži1, ‚ś‚Ů‚¤, “Œ‹ž, 2017/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713167. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Basic research of amitriptyline oral rinse in healthy volunteers: analgesic effect in patients with oral mucositis pain due to chemotherapy. Sasaki H1, Kokubun H1, Eguchi T1, Atsuta K1,2: Multinational Association of Supportive Care in Cancer 2016 (2016/6/23), Adelaide, Australia, Support Care Cancer 2016; 24: S124. (˛X–ŘŽőŽq1, ‘•ŞG–ç1, ]Œű’qŽq1, Œú“cKˆę˜Y1,2: 1–ňÜ•”, 2–ňŠw•”)

713168. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Evaluation of use of dipeptidyl peptidase-4 inhibitors in an academic teaching hospital in Japan. Iwasawa M1, Atsuta K1,2: 2016”N (‘ć51‰ń) ASHPƒ~ƒbƒhƒCƒ„[—Տ°–ňŠw‰ď‹c (2016/12/6), LasVegas, USA. (ŠâŕV^‹IŽq1, Œú“cKˆę˜Y1,2: 1–ňŠw•”, 2–ňÜ•”)

713169. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Low-dose colchicine inhibited leukocyte activation induced free fatty acid in humans. Maeda M1-3, Mutoh A, Yasu T, Kumagai Y2, Ueda S: The 81st Annual Scientific Meeting of the Japanese Circulation Society (JCS2017) (2016/3/19), Kanazawa, Japan, ‘ć81‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď´˜^ 2017/2; p.444. (‘O“cŽŔ‰Ô1-3, ŒF’J—YŽĄ2: 1–ňÜ•”, 2—Տ°ŽŽŒąƒZ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

723981. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –ňŠw•”‚Ć•a‰@E–ň‹Ç‚Ć‚Ě˜AŒg‚É‚ć‚é—Տ°Œ¤‹†‚ĚŽŔ‘H`ƒ`[ƒ€ˆă—Єi‚ÉŒü‚Ż‚˝ƒAƒJƒfƒ~ƒA‚Ě–đŠ„`u‘˝Ž{Ý‹¤“ŻŒ¤‹†‚É‚¨‚Ż‚é–ňŠw•”‚Ě–đŠ„v. ‰H’šł_ (–ňÜ•”): ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď (2016/09/18), ‹ž“s, ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď—vŽ| 2016/6; p.50.

723982. [Šw‰ď (‘S‘)] (‘ć“ń‰ńŠwśŽĺĂƒVƒ“ƒ|ƒWƒEƒ€) 2Œ^“œ”A•aŽĄ—Ă–ňƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚ĚŽĺ‘ăŽÓy‘f‚̉đ–ž. ’Š‘q[r1, “ĄŒ´—şˆę1, [ŒŠ’BŠî3, ’†“‡”ü‹I3, “ĄˆäG–ž1, Œú“cKˆę˜Y1,2, ˆÉ“Ą’q•v1 (1–ňŠw•”, 2–ňÜ•”, 3‹ŕ‘ň‘ĺŠw–ňŠw•”): “ú–{–ň•¨“Ž‘ÔŠw‰ď‘ć31‰ń”N‰ď (2016/10/13), ź–{.

723983. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “œ”A•aŠłŽŇ‚Ě–ŻŠÔ—Ă–@ (Œ’NH•i‚đŠÜ‚Ţ) ‚ĚŽŔ‘ԁ|20”N‘O‚Ć‚Ě”äŠrŒŸ“˘|. Œüˆäˆę1, ‹ŕX@W3, •˝’Ë—D‰Á2, ”ö’šŸ–ç1, Œú“cKˆę˜Y1,2 (1–ňŠw•”, 2–ňÜ•”, 3‚Š‚Č‚ŕ‚č“ŕ‰Č): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/05/19), ‹ž“s.

723984. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) DPP-4‘jŠQ–ňƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚É‚ć‚鉊ÇŠÖ˜Aƒ^ƒ“ƒpƒNS100A8/A9‚Ě”­Œť—U“ą. ’Š‘q[r1, “ĄŒ´—şˆę1, “ĄˆäG–ž1, ˆÉ“Ą’q•v1, Œú“cKˆę˜Y1,2 (1–ňŠw•”, 2–ňÜ•”): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/05/20), ‹ž“s.

723985. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘źƒIƒsƒIƒCƒh‚Š‚çƒ^ƒyƒ“ƒ^ƒh[ƒ‹‚Ö‚ĚƒIƒsƒIƒCƒhƒXƒCƒbƒ`ƒ“ƒO‚É‚ć‚éŒř‰Ę‚¨‚ć‚Ń—LŠQ”˝‰ž. –{ŠÔ‰ëŽm1,2, ‘•ŞG–ç1, ‹ŕˆäş•ś3, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć10‰ń“ú–{ŠÉ˜aˆă—Ă–ňŠw‰ď”N‰ď (2016/6/4), •lź,.

723986. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‚Ş‚ńŤáu’ÉŠłŽŇ‚ɑ΂ľ‚ă^ƒyƒ“ƒ^ƒh[ƒ‹‚đ‚—p—ĘŽg—p‚ľ‚˝1—á. •˝’ËŒöŒČ1, –{ŠÔ‰ëŽm1, ‘•ŞG–ç1, —с@Œol2, ‹ŕˆäş•ś3, Œú“cKˆę˜Y1,4 (1–ňÜ•”, 2–ƒŒ, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4–ňŠw•”): ‘ć10‰ń“ú–{ŠÉ˜aˆă—Ă–ňŠw‰ď”N‰ď (2016/6/5), •lź.

723987. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘˘ŒŒŠíŽîᇊłŽŇ‚É‚¨‚Ż‚éƒoƒ“ƒRƒ}ƒCƒVƒ“ƒNƒŠƒAƒ‰ƒ“ƒX‚ɉe‹ż‚đ‹y‚Ú‚ˇˆöŽq‚ĚŒŸ“˘. ŁŒË—Ç‹ł1, Ź—яšG1, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”): ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď (2016/6/11), _ŒË, ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ď—vŽ| 2016/6; p.198.

723988. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒCƒgƒ‰ƒRƒiƒ][ƒ‹ŒŒ’†”Z“x‘Ş’č‚ĚˆÓ‹`. X@Ę‰Ä1, Źź•q˛1, ŁŒË—Ç‹ł1, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”): ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď (2016/09/18), ‹ž“s, ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď—vŽ|W 2016/9; p.74.

723989. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) dÇŠłŽŇ‚ɑ΂ˇ‚éƒOƒ‹ƒ^ƒ~ƒ““Š—^‚Ş—\Œă‚É—^‚Ś‚é‰e‹ż‚ɂ‚˘‚Ä‚ĚŒŸ“˘. _@ˆę–˛1, ’|‰ş‚ł‚¨‚č1, Œü”ü”T—˘1, •yŕV@~1, ’†‘ş@—D1, Ź—яšG1, ‹ß“Ą—Ż”üŽq1, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”): ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď (2016/09/18), ‹ž“s, ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď—vŽ|W 2016/9; p.144.

723990. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”ĺ”AŠí‰Č‚É‚¨‚Ż‚é‚Ş‚ń‰ťŠw—Ă–@‚Ě–ň•¨ŽĄ—ĂŠÇ— (PBPM) “ą“ü‚Ö‚ĚŽć‚č‘g‚Ý. ˆî–ě@Š°1, ŽR–{—IŽ÷1, Ź—яšG1, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”): ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď (2016/09/19), ‹ž“s, ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď—vŽ|W 2016/9; p.153.

723991. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) DPP-4‘jŠQ–ňƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚Ě“KłŽg—p‚ÉŒü‚Ż‚˝–ň•¨“Ž‘ÔŒ¤‹†. ’Š‘q[r1, “ĄŒ´—şˆę1, ˆÉ“Ą’q•v1, Œú“cKˆę˜Y1,2 (1–ňŠw•”, 2–ňÜ•”): ‘ć5‰ń“ú–{‚­‚ˇ‚č‚Ć“œ”A•aŠw‰ďŠwpW‰ď (2016/10/29), _ŒË, ‘ć5‰ń“ú–{‚­‚ˇ‚č‚Ć“œ”A•aŠw‰ďŠwpW‰ď´˜^W 2016/1; p.123.

723992. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹~‹}ICU“üŽşŠłŽŇ‚É‚¨‚Ż‚錌’†ˆŸ‰””Z“x‚ĆŠ´őŤ‡•šÇ‚ĚŠÖ˜AŤ. •yŕV@~1, _œä’m“š2, •Đ‰Ş—Sˆę2, ó—˜@–ő2 (1–ňÜ•”, 2‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y.

723993. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 2Œ^“œ”A•a“ü‰@ŠłŽŇ‚É‚¨‚Ż‚éDPP-4‘jŠQ–ň‚Ě“KłŽg—p•]‰ż. ‰Ź–ě—D‹G1, ŠâŕV^‹IŽq1, —F“c–žŽq2, ’Ł@@’2, â‘q’qŽq2, ‹ß“Ą—Ż”üŽq2, Œú“cKˆę˜Y1,2 (1–ňŠw•”, 2–ňÜ•”): ‘ć137‰ń“ú–{–ňŠw‰ď”N‰ď (2017/3/26), ĺ‘ä, ‘ć137‰ń“ú–{–ňŠw‰ď”N‰ď—vŽ| 2017/3; p.162.

733501. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) Œă”­ˆă–ň•i‚É‚¨‚Ż‚锟ů•ŞŠ„‚Ě—eˆŐŤ‚ÉŠÖ‚ˇ‚錤‹†. t“úˆäŒö”ü1, _Ž‡ˆ¤—Ú1, •˝ŽR•Ži1, Œú“cKˆę˜Y1,2 (1–ňŠw•”, 2–ňÜ•”): ‘ć15‰ń‚Š‚Č‚Ş‚í–ňÜŽtŠwp‘ĺ‰ď (2017/1/17), ‰Ą•l, ‘ć15‰ń‚Š‚Č‚Ş‚í–ňÜŽtŠwp‘ĺ‰ď´˜^ 2017/1; p.53.

733502. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŠČˆŐŒœ‘÷–@“ą“ü‚ÉŒü‚Ż‚˝Žć‚č‘g‚݁`ŹŽ™—Ěˆć`. ꎓĄ‹M—m1, ‹{â—Dl1, Źź•q˛1, ×ˆäËś1, “c‘ş˜aŒh1, â‘q’qŽq1, Œú“cKˆę˜Y1,2 (1–ňÜ•”, 2–ňŠw•”): “ú–{•a‰@–ňÜŽt‰ďŠÖ“ŒƒuƒƒbƒN‘ć46‰ńŠwp‘ĺ‰ď (2016/8/27), ç—t, “ú–{•a‰@–ňÜŽt‰ďŠÖ“ŒƒuƒƒbƒN‘ć46‰ńŠwp‘ĺ‰ď´˜^ 2016/8; p.199.


ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•”

[Šwp˜_•ś]

110309. [Œ´’˜] Complementary Role of Arm Circumference to Body Mass Index in Risk Stratification in Heart Failure. Kamiya K1, Masuda T2, Matsue Y, Inomata T3, Hamazaki N1, Matsuzawa R1, Tanaka S4, Nozaki K1, Maekawa E3, Noda C3, Yamaoka-Tojo M2, Matsunaga A2, Izumi T3, Ako J3: JACC Heart Fail 2016/4; 4 (4): 265-73. (_’JŒ’‘ž˜Y1, ‘“c@‘ě2, ’––”FŒł3, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í4, –ěčN•˝1, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq2, ź‰i“Ä•F2, ˜aň@“O3, ˆ˘ŒĂĆ3: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110310. [Œ´’˜] Low-intensity resistance training with blood flow restriction improves vascular endothelial function and peripheral blood circulation in healthy elderly people. Shimizu R, Hotta K, Yamamoto S, Matsumoto T, Kamiya K1, Kato M, Hamazaki N1, Kamekawa D, Akiyama A, Kamada Y2, Tanaka S2, Masuda T3: Eur J Appl Physiol 2016/4; 116 (4): 749-57. (_’JŒ’‘ž˜Y1, ŕ_čL–ž1, Š™“c—TŽŔ2, “c’†L–í2, ‘“c@‘ě3: 1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

110311. [Œ´’˜] Evaluating the effectiveness of exercise training on elderly patients who require haemodialysis: study protocol for a systematic review and meta-analysis. Matsuzawa R1, Hoshi K2, Yoneki K3, Matsunaga A: BMJ open 2016/6; 6 (6): e010990. (ź‘ň—Ç‘ž1, Ż@‰Ŕ–F2, •Ä–؁@Œc3, ź‰i“Ä•F4: 1ƒŠƒnƒrƒŠ•”, 2‰qś, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ˆă—ÉqśŠw•”)

110312. [Œ´’˜] Low ankle brachial index is associated with the magnitude of impaired walking endurance in patients with heart failure. Tanaka S1, Kamiya K2, Masuda T3, Hamazaki N2, Matsuzawa R2, Nozaki K2, Maekawa E4, Noda C4, Yamaoka-Tojo M3, Matsunaga A3, Ako J4: Int J Cardiol 2016/12; 224: 400-5. (“c’†L–í1, _’JŒ’‘ž˜Y2, ‘“c@‘ě3, ŕ_čL–ž2, ź‘ň—Ç‘ž2, –ěčN•˝2, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq3, ź‰i“Ä•F3, ˆ˘ŒĂĆ4: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ƒŠƒnƒrƒŠ•”, 3ˆă—ÉqśŠw•”, 4zŠÂŠí“ŕ)

110313. [Œ´’˜] Prognostic Usefulness of Arm and Calf Circumference in Patients ł65 Years of Age With Cardiovascular Disease. Kamiya K1, Masuda T2, Matsue Y, Hamazaki N1, Matsuzawa R1, Tanaka S3, Nozaki K1, Maekawa E4, Noda C4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Am J Cardiol 2017/1; 119 (2): 186-191. (_’JŒ’‘ž˜Y1, ‘“c@‘ě2, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í3, –ěčN•˝1, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ź‰i“Ä•F2, ˆ˘ŒĂĆ4: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ)

110314. [Œ´’˜] A Single Session of Neuromuscular Electrical Stimulation Enhances Vascular Endothelial Function and Peripheral Blood Circulation in Patients With Acute Myocardial Infarction. Tanaka S1, Masuda T2, Kamiya K3, Hamazaki N3, Akiyama A, Kamada Y1, Maekawa E4, Noda C4, Yamaoka-Tojo M2, Ako J4: Int Heart J 2016/12; 57 (6): 676-81. (“c’†L–í1, ‘“c@‘ě2, _’JŒ’‘ž˜Y3, ŕ_čL–ž3, Š™“c—TŽŔ1, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ƒŠƒnƒrƒŠ•”, 4zŠÂŠí“ŕ)

110315. [Œ´’˜] Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease. Tanaka S1, Kamiya K2, Hamazaki N2, Matsuzawa R2, Nozaki K2, Maekawa E3, Noda C3, Yamaoka-Tojo M4, Matsunaga A4, Masuda T4, Ako J3: J Am Med Dir Assoc 2017/2; 18 (2): 176-81. (“c’†L–í1, _’JŒ’‘ž˜Y2, ŕ_čL–ž2, ź‘ň—Ç‘ž2, –ěčN•˝2, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ƒŠƒnƒrƒŠ•”, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”)

522155. [uŔ]y“ÁW2: St˜AŠÖ‚ĚŽw•W‚đl‚Ś‚ézŒŒ‰t“§ÍŠłŽŇ‚ɑ΂ˇ‚é‰^“Ž—Ă–@EŽw“ą‚ĚŽć‚č‘g‚Ý. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”): S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ 2016/6; 22 (1): 39-43.

522156. [uŔ]yƒtƒbƒgƒPƒA‚É‚¨‚Ż‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“: ŽžŠł•ĘŽć‚č‘g‚Ý (‘ć4‰ń)zg‘Ť•a•Ď—\–hhgŽg‚Ś‚é‹r‚đ‚˘‚Š‚ÉŽç‚é‚Šh. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”): “ú–{ƒtƒbƒgƒPƒAŠw‰ďŽGŽ 2016/12; 14 (4): 144-8.

522157. [uŔ]y“ÁW: ƒTƒ‹ƒRƒyƒjƒA‚ĆƒtƒŒƒCƒ‹|ĹV’mŒŠ‚Š‚çl‚Ś‚é‚ť‚̍‚—îŽĐ‰ď‚É‚¨‚Ż‚éˆÓ‹`|z8. S•s‘S‚ĆƒTƒ‹ƒRƒyƒjƒA. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): Geriatric Medicine 2017/1; 55 (1): 61-4.

522158. [uŔ]y“ú–{zŠÂŠíŠw‰ď, “ú–{ƒTƒ‹ƒRƒyƒjƒAEƒtƒŒƒCƒ‹Œ¤‹†‰ď@ƒWƒ‡ƒCƒ“ƒgƒVƒ“ƒ|ƒWƒEƒ€: zŠÂŠíŽžŠł‚ĆƒTƒ‹ƒRƒyƒjƒA‚đl‚Ś‚éz2. ‚—îzŠÂŠíŽžŠłŠłŽŇ‚É‚¨‚Ż‚éƒTƒ‹ƒRƒyƒjƒAŽw•W‚ƐS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): Therapeutic Research 2016/9; 37 (9): 836-7.

522159. [uŔ]y—Šw—Ă–@ƒgƒsƒbƒNƒX: ƒVƒŠ[ƒYu“ŕ•”áŠQ‚ɑ΂ˇ‚é‰^“Ž—Ă–@‚ĚĹ‘Oüvz–ŤS•s‘S‚ɑ΂ˇ‚é‰^“Ž—Ă–@‚ĚĹ‘Oü. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): —Šw—Ă–@Šw 2016/9; 43 (4): 342-8.

522160. [uŔ]y“ÁW: ŽdŽ–‚Ě—Ź‹V ‹Ć–ą•Ę‚ÉŒŠ‚ég‚ą‚ę‚Ş‚¤‚ż‚̐S•s‘Sƒ`[ƒ€hz3-1. S•s‘S‹}ŤŠúƒŠƒn@“Œ‚̐ş‚𕡂­. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): zŠÂŠíƒi[ƒVƒ“ƒO 2016/9; 6 (9): 55-63.

[’˜@‘]

620198. [Šwp‘ (•Ş’SŽˇ•M)]yŽŔ‘HEBM S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“@ƒGƒrƒfƒ“ƒXf—ĂƒMƒƒƒbƒv‚Ć‚ť‚̑Ήžz‘ćIIÍ —Տ°ŽŔ‘H‚É‚¨‚Ż‚鏔–â‘č‚ւ̑Ήž–@@2 ƒŠƒXƒN‘w•Ę‰ť‚ĹˆŔ‘SŠÇ—‚͏\•Ş‚ŠH, p.88-98. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”), •Ň: ź”ö‘P”ü, ă“ˆŒ’ŽĄ, •śŒő“°, “Œ‹ž, 2016/5”­s.

620199. [Šwp‘ (•Ş’SŽˇ•M)]yŽŔ‘HEBM S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“@ƒGƒrƒfƒ“ƒXf—ĂƒMƒƒƒbƒv‚Ć‚ť‚̑Ήžz‘ćIIIÍ@S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ““ďaÇ—á‚̍U—Ş–@@8 ŒŒ‰t“§Í’†‚̐SŽžŠłŠłŽŇ|‚˘‚Â, ‚ǂ̂悤‚ɉî“ü‚ˇ‚é‚Š|, p.286-95. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”), •Ň: ź”ö‘P”ü, ă“ˆŒ’ŽĄ, •śŒő“°, “Œ‹ž, 2016/5”­s.

620200. [Šwp‘ (•Ş’SŽˇ•M)]y‚˘‚Ü‚ł‚çu‚Ż‚Č‚˘I CKDŠłŽŇ@‰h—{E‰^“Ž—Ă–@‚̍l‚Ś•ű, ‚â‚č•ű@Q&Az…Ł ‰^“Ž”\—Í‚Ě•]‰ż@Q2. CKDŠłŽŇ‚Ĺ‚Í‹Ř—Í‚Í‚Ç‚¤‚â‚Á‚Ä•]‰ż‚ˇ‚ę‚΂悢‚Ĺ‚ˇ‚Š?, p.123-6. ź‘ň—Ç‘ž1, ź‰i“Ä•F2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”), •Ň’˜: ‰Á“Ą–ž•F, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713170. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Gait speed provides prognostic capability comparable to 6-min walk test in elderly patients with cardiovascular disease. Kamiya K1, Masuda2, Matsue Y3, Hamazaki N1, Matsuzawa R1, Tanaka S4, Nozaki N1, Maekawa E5, Matsunaga A2, Ako J5: Heart Failure 2016 (2016/5/21-4), Florence, Italy. (_’JŒ’‘ž˜Y1, ‘“c@‘ě2, ––‰i—SĆ3, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í4, –ěčN•˝1, ‘OěŒb”ü5, ź‰i“Ä•F2, ˆ˘ŒĂĆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‹T“c‘‡•a‰@zŠÂŠí“ŕ‰Č, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 5zŠÂŠí“ŕ)

713171. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Mid-upper arm circumference is a better predictor of mortality than calf circumference in patients with heart failure. Kamiya K1, Masuda2, Matsue Y3, Hamazaki N1, Matsuzawa R1, Tanaka S4, Nozaki N1, Maekawa E5, Matsunaga A2, Ako J5: Heart Failure 2016 (2016/5/21-4), Florence, Italy. (_’JŒ’‘ž˜Y1, ‘“c@‘ě2, ––‰i—SĆ3, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í4, –ěčN•˝1, ‘OěŒb”ü5, ź‰i“Ä•F2, ˆ˘ŒĂĆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‹T“c‘‡•a‰@zŠÂŠí“ŕ‰Č, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 5zŠÂŠí“ŕ)

713172. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure. Hamazaki N1, Masuda T2, Kamiya K1, Matsuzawa R1, Nozaki K1, Tanaka S3, Yabu K3, Nakamura T3, Tabata M4, Maekawa E5, Noda C5, Tojo M2, Ako J5: ESC Congress 2016 (2016/8/27-31), Roma, Italy. (ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, ĺM@•c3, ’†‘şŠxŽj3, “c”¨@–Ť4, ‘OěŒb”ü5, –ě“cçt5, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–L‹´‘n‘˘‘ĺŠw, 5zŠÂŠí“ŕ)

713173. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Respiratory Muscle Weakness is an Independent Determinant for Decresaed Parasympathetic Activity in Patients with Chronic Heart Failure. Hamazaki N1, Masuda T2, Kamiya K1, Matsuzawa R1, Nozaki K1, Tanaka S3, Kamada Y3, Yabu K3, Nakamura T3, Tabata M4, Maekawa E5, Noda C5, Tojo M2, Ako J5: AHA 2016 (2016/11/12-6), New Orleans, USA. (ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, Š™“c—TŽŔ3, ĺM@•c3, ’†‘şŠxŽj3, “c”¨@–Ť4, ‘OěŒb”ü5, –ě“cçt5, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–L‹´‘n‘˘‘ĺŠw, 5zŠÂŠí“ŕ)

713174. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Supervised Aerobic Exercise after Hospital Discharge Improves Pulmonary and Respiratory Muscle Function in Patients with Chronic Heart Failure. Hamazaki N1, Masuda T2, Kamiya K1, Matsuzawa R1, Nozaki K1, Tanaka S3, Kamada Y3, Yabu K3, Nakamura T3, Tabata M4, Maekawa E5, Noda C5, Tojo M2, Ako J5: AHA 2016 (2016/11/12-6), New Orleans, USA. (ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, Š™“c—TŽŔ3, ĺM@•c3, ’†‘şŠxŽj3, “c”¨@–Ť4, ‘OěŒb”ü5, –ě“cçt5, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4–L‹´‘n‘˘‘ĺŠw, 5zŠÂŠí“ŕ)

713175. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Detecting the minimum recommendation of physical activity level in hemodialysis patients: a 7-year retrospective cohort study. Matsuzawa R1, Shimoda T2, Mamorita N3, Yoneki K2, Harada M2, Watanabe T2, Matsumoto M2, Yoshida A4, Takeuchi Y5, Matsunaga A3: ASN KIDNEY WEEK 2016 (2016/11/15-20), Chicago, USA. (ź‘ň—Ç‘ž1, ‰ş“c—˛‘ĺ2, Žç“cŒ›’3, •Ä–؁@Œc2, Œ´“cˆ¤‰i2, “n粍F–ž2, ź–{”ü2, ‹g“c‚ ‚‚ľ4, ’|“ŕN—Y5, ź‰i“Ä•F3: 1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”, 4‚ł‚Ş‚ÝzŠÂŠíƒNƒŠƒjƒbƒN, 5t‘Ÿ“ŕ)

722280. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) —\–h—Šw—Ă–@‚ĹÄ”­‚ÉŽ•Ž~‚ß‚Ş‚Š‚Ż‚ç‚ę‚é‚Š?`SŒŒŠÇŽžŠłŠłŽŇ‚É‚¨‚Ż‚éÄ”­—\–h‚Ɖۑč`. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): ‘ć51‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2016/5/27-9), ŽD–y.

722281. [Šw‰ď (‘S‘)] (•ń‰ď) V‚˝‚ȍœŠi‹Ř“d‹CŽhŒƒ–@‚͐S•s‘S‚Ĺ“ü‰@‚ľ‚˝ŒăŠú‚—îŽŇ‚̉^“Ž‹@”\’ቺ‚đ—\–h‚ˇ‚é. “c’†L–í (‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć52‰ń“ú–{zŠÂŠí•a—\–hŠw‰ďŠwpW‰ď (2016/6/17-8), é‹Ę.

722282. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) •W€ƒPƒA‚Ć‚ľ‚Ä‚Ě‘ŠúƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ć‘˝EŽí˜AŒg`—Šw—Ă–@Žm‚Ě—§ę‚Š‚ç`. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): ‘ć38‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwpW‰ď (2016/7/16), –źŒĂ‰Ž.

722283. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) d•ĄáŠQ‚đ—L‚ˇ‚銳ŽŇ‚ɑ΂ˇ‚éS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“|—Šw—Ă–@Žm‚Ě–đŠ„|. ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, ‰Í–ě^—1, ŒÜ\—’ˆŸŠóŽq1, Šâ‘ş‹M”ü1, ‘OěŒb”ü4, ź‰i“Ä•F2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

722284. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒCƒ“ƒ^[ƒoƒ‹ƒgƒŒ[ƒjƒ“ƒO`‚‹­“xƒCƒ“ƒ^[ƒoƒ‹‚Š‚çƒtƒŒƒCƒ‹‚ւ̑Ήž‚܂Ł`. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

722285. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Sarcopenia and Cardiovascuar Disease. Kamiya K1: The 2nd Asian Conference for Frailty and Sarcopenia (2016/11/4-5), –źŒĂ‰Ž. (_’JŒ’‘ž˜Y1: 1ƒŠƒnƒrƒŠ•”)

722286. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‚—ÍŠłŽŇ‚ɑ΂ˇ‚é‰^“Žˆ•ű‚ĚŽŔŰ. ź‘ň—Ç‘ž1, •Ä–؁@Œc2, Œ´“cˆ¤‰i2, “n粍F–ž2, ‰ş“c—˛‘ĺ2, ź–{”ü2, ‰ÍŒ´Ž‰ë3, ź‰i“Ä•F4 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ś—, 4ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2017/2/18-9), ˆďé.

722287. [Šw‰ď (‘S‘)] (ƒWƒ‡ƒCƒ“ƒgƒVƒ“ƒ|ƒWƒEƒ€) “§ÍŠłŽŇ‚ĚPADi“W—\–h‚Ě‚˝‚ß‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ź‘ň—Ç‘ž1, Œ´“cˆ¤‰i2, •Ä–؁@Œc2, “n粍F–ž2, ‰ş“c—˛‘ĺ2, ź–{”ü2, ‰ÍŒ´Ž‰ë3, ź‰i“Ä•F4 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ś—, 4ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2017/2/18-9), ˆďé.

722288. [Šw‰ď (‘S‘)] (ƒWƒ‡ƒCƒ“ƒgƒVƒ“ƒ|ƒWƒEƒ€) ƒtƒŒƒCƒ‹‚đ‡•š‚ľ‚˝SŽžŠłŠłŽŇ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): ‘ć7‰ń“ú–{t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2017/2/18-9), ’}”g.

722289. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ICU‚Ĺ‚Ě“d‹CŽhŒƒ—Ă–@‚Ě“K‰ž‚Ć‹ÖŠő‚ɂ‚˘‚Ä. _’JŒ’‘ž˜Y (ƒŠƒnƒrƒŠ•”): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11, ŽD–y.

723994. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) d“Ş•”ŠOŠłŽŇ‚ɑ΂ˇ‚é‹~–˝‹~‹}ICU‚Ĺ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚¨‚Ż‚éŒř‰Ę‚ĆˆŔ‘SŤ. ‹{č“š‹P1, •Đ‰Ş—Sˆę2, ŒŠˆä“c˜ał1, ‹ŕŽqŠěœ¨1, _œä’m“š2, •ž•”@2, ŹňŠ°”V2, –Ř‘ş‰ë•F3, ó—˜@–ő2 (1ƒŠƒnƒrƒŠ•”, 2‹~–˝, 3ˆă—ÉqśŠw•”): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11, –kŠC“š.

723995. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]‘˛’†ƒPƒAƒ†ƒjƒbƒgŠJÝ‚Ş‹}ŤŠú”]‘˛’†‚Ö‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‰î“ü‚Ć“]‹@ŽžADL‚É‹y‚Ú‚ˇ‰e‹ż. źŠŰƒ‰Ŕ1, ‰“Œ´‚Ü‚č‚Ś1, Œy•”“ÖŽq1, •Ó“y–ź—˛1, •Ÿ“c—Ď–ç2, ‹ß“Ą—łŽj3, ŒG•”rG3, ˆ˘‹v’Ă“ń•v4, źŽR˜a—˜4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3”]ŠO, 4_Œo“ŕ): ‘ć41‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2016/4/14-6), ŽD–y.

723996. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’nˆćÝZ—Ť’†‚—îŽŇ‚É‚¨‚Ż‚é•ŕsŽž‚ĚŽp¨‚ÉŠÖ‚ˇ‚é‰Á—î•Ď‰ť|Žp¨Œv‘ރAƒvƒŠƒP[ƒVƒ‡ƒ“‚đ—p‚˘‚˝3”NŠÔ‚̒ǐՒ˛¸Œ‹‰Ę|. …–ěŒö•ă1, ŽÄ@Šě’2, ăo’źl2, ˛“Ąt•F2, —é–Ř—Ç˜a1, ‘ĺ‹v•Ű‰ël3, —Lă’źĆ2, ’ß“c—z˜a2, ’|“ŕş”Ž4, •Ÿ“c—Ď–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ˆă—Ïî•ń‹łˆç): ‘ć51‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2016/5/27-9), ŽD–y.

723997. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ü‰@Šú‚—îS•s‘SŠłŽŇ‚É‚¨‚Ż‚é‘މ@Œă‚ĚŽč’i“I“úíśŠˆŠˆ“Ž”\—Í‚đ§ŒŔ‚ˇ‚éˆöŽq‚ĚŒŸ“˘. –ěčN•˝1, _’JŒ’‘ž˜Y1, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í2, ‘OěŒb”ü3, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): ‘ć51‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2016/5/27-9), ŽD–y.

723998. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ŤŠÖß‹@ŠB“I•sˆŔ’萍‚ɑ΂ˇ‚é‹žŽ‹‰ş‘O‹—äCčՑсEćůäCčՑэȚp‚Ĺ•Đ‹r—§ˆĘŽždS“Ž—h‚މü‘P‚ľ‚˝1—á. ‘q’Ř—ş‘ž1, “n粗T”V2, “ŒŽR—玥3, “cŒ´’ź—T4, –ĺ‘q˜aŹ4, …–ěŒö•ă1, ‹{é‚ľ‚Ů1, ‚‘ŠťŽm3, •Ÿ“c—Ď–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3ŽŠO, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć51‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2016/5/27-9), ŽD–y.

723999. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŹ—Í, •ŕs‘Ź“x‚¨‚ć‚яă˜rŽüˆÍ’ˇ‚É‚ć‚éƒTƒ‹ƒRƒyƒjƒA‚Ě’č‹`‚͍‚—îSŒŒŠÇŽžŠłŠłŽŇ‚̐ś–˝—\Œă—\‘Ş‚É—L—p‚Ĺ‚ ‚é. _’JŒ’‘ž˜Y1, ‘“c@‘ě2, ––ŽŸ—SĆ, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í3, –ěčN•˝1, ‰Í–ě^—1, ŒÜ\—’ˆŸŠóŽq1, Šâ‘ş‹M”ü1, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ź‰i“Ä•F2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): ‘ć52‰ń“ú–{zŠÂŠí•a—\–hŠw‰ďŠwpW‰ď (2016/6/17), é‹Ę.

7231000. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—îS•s‘SŠłŽŇ‚É‚¨‚Ż‚é’ቺ‚ľ‚˝‰^“Ž‹@”\‚̉ü‘P‚đ‘jŠQ‚ˇ‚éˆöŽq‚ĚŒŸ“˘. “c’†L–í1, ‘“c@‘ě2, _’JŒ’‘ž˜Y3, ŕ_čL–ž3, ź‘ň—Ç‘ž3, –ěčN•˝3, Š™“c—TŽŔ1, ÂŽRW‘ĺ1, ’†‘şŠxŽj1, ĺM@•c1, ‘OěŒb”ü4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ƒŠƒnƒrƒŠ•”, 4zŠÂŠí“ŕ): ‘ć52‰ń“ú–{zŠÂŠí•a—\–hŠw‰ďŠwpW‰ď (2016/6/17-8), é‹Ę.

7231001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“šŠŕŽüpŠúƒTƒ|[ƒgƒ`[ƒ€‚É‚¨‚Ż‚ép‘OŒÄ‹zƒŠƒnƒrƒŠ‚ĚˆÓ‹`. ŒŠˆä“c˜ał1, X’JGŒő2, _•Ű•‘Ľ1, ’ˇ’Jě“ŢŽq3, ‰Ş“c—SŽq3, ‹e’rŘ•äŽq4, ŽR‰şŒpŽj2, “n粏š•F2 (1ƒŠƒnƒrƒŠ•”, 2ŠO‰Č, 3ŠĹŒě•”, 4‰h—{•”): ‘ć70‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2016/7/4-6), “Œ‹ž.

7231002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—îS•s‘SŠłŽŇ‚ĚŽŠŒČŠÇ—‚̉‡•. Šâ‘ş‹M”ü1, ‰Í–ě^—1, ŒÜ\—’ˆŸŠóŽq1, _’JŒ’‘ž˜Y1, ŕ_čL–ž1, ź‘ň—Ç‘ž1, –ěčN•˝1, –ě“cçt2, ‘OěŒb”ü2, ‘“c@‘ě3, ˆ˘ŒĂĆ2 (1ƒŠƒnƒrƒŠ•”, 2zŠÂŠí“ŕ, 3ˆă—ÉqśŠw•”): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/16), “Œ‹ž.

7231003. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –ŤS•s‘SŠłŽŇ‚É‚¨‚Ż‚鎊—Ľ_ŒoŠˆ“Ž‚Ě•s‹Ďt‚͐S–[×“Ž‚̍‡•š‚ÉŠÖ‚í‚炸‰^“Ž‘Ď—e”\‚đ’ቺ‚ˇ‚é. –ěčN•˝1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í3, ‰Í–ě^—1, ŒÜ\—’ˆŸŠóŽq1, Šâ‘ş‹M”ü1, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

7231004. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Dead-space ventilation ratio as a determinant for exercise intolerance in chronic heart failure. ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, Šâ‘ş‹M”ü1, ‰Í–ě^—1, ŒÜ\—’ˆŸŠóŽq1, HŽRˆťŽq3, ĺM@•c3, ’†‘şŠxŽj3, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•” , 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

7231005. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) t‹@”\’ቺ‚Í‹•ŒŒŤSŽžŠłŠłŽŇ‚É‚¨‚Ż‚é‰^“Ž‘Ď—e”\‚̉ü‘P‚¨‚ć‚ѐg‘ĚŠˆ“Ž—ʂ̐„§’l’BŹ‚đ‘jŠQ‚ˇ‚é. ź‘ň—Ç‘ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ŕ_čL–ž1, –ěčN•˝1, “c’†L–í3, ‰Í–ě^—1, ŒÜ\—’ˆŸŠóŽq1, Šâ‘ş‹M”ü1, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

7231006. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‚—îS•s‘SŠłŽŇ‚̑މ@Žž•ŕs”\—Í‚Í“ü‰@‘Šú‚Ě•ŕs‘Ź“x‚ć‚čShort Physical Performance Battery‚Ĺ—\‘Ş‚ł‚ę‚é. “c’†L–í1, ‘“c@‘ě2, _’JŒ’‘ž˜Y3, ŕ_čL–ž3, ź‘ň—Ç‘ž3, –ěčN•˝3, Šâ‘ş‹M”ü3, ‰Í–ě^—3, ŒÜ\—’ˆŸŠóŽq3, Š™“c—TŽŔ1, ÂŽRW‘ĺ1, ’†‘şŠxŽj1, ĺM@•c1, ‘OěŒb”ü4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ƒŠƒnƒrƒŠ•”, 4zŠÂŠí“ŕ): ‘ć22‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2016/7/17), “Œ‹ž.

7231007. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é“ű‚Ş‚ńpŒăŠłŽŇ‚ĚAxillary Web Syndrome‚ɑ΂ˇ‚é’´‰š”gŽĄ—Ă. _•Ű•‘Ľ1, ’|“ੰl1, •Ÿ“c—Ď–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”): ‘ć50‰ń“ú–{ě‹Ć—Ă–@Šw‰ď (2016/9/9-11), ŽD–y.

7231008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) A Conventional and Novel Screening Tool for Frailty Predicting a Poor Prognosis in Patients with Heart Failure (S•s‘SŠłŽŇ‚É‚¨‚Ż‚éV‚˝‚ČƒtƒŒƒCƒ‹Žw•W‚Ɛś–˝—\Œă‚Ć‚ĚŠÖŒW). ź‘ň—Ç‘ž1, _’JŒ’‘ž˜Y1, “c’†L–í2, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2016/10/7-9), –kŠC“š.

7231009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Low Ankle Brachial Index is Associated With the Magnitude of Impaired Walking Endurance in Patients With Heart Failure. “c’†L–í1, _’JŒ’‘ž˜Y2, ź‘ň—Ç‘ž2, –ě“cçt3, ‘OěŒb”ü3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ƒŠƒnƒrƒŠ•”, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): ‘ć20‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2016/10/7-9), –kŠC“š.

7231010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘J‰„‚ˇ‚é–ł‹C”x‚̉ü‘P‚ɉ^“Ž—Ă–@‚ŞŒř‰Ę“I‚Ĺ‚ ‚Á‚˝ŹlŒ^Pompe•a‚Ě1—á. Ź—ŃŽĺŒŁ1, ‰ĄŽR”ü˛Žq2, ă“cN‹v3, –ě‘ş—DŽq1, ‹ŕŽq’‰O3, ”~Œ´@ŽŔ3, •Ÿ“c—Ď–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3ŹŽ™): ‘ć49‰ń“ú–{ŹŽ™ŒÄ‹zŠíŠw‰ď (2016/10/28-9), •xŽR.

7231011. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹šŠs‰^“Ž§ŒŔ‚Ě‚ ‚éƒżƒWƒXƒgƒƒOƒŠƒJƒmƒpƒ`[Ž™‚Ö‚ĚNPPV, MI-E“ą“üŒă‚ĚŒo‰ß`ŒÄ‹z—Šw—Ă–@‚É‚¨‚Ż‚é‘ĺŠw•a‰@‚Ć—ĂˆçŽ{Ý‚Ě˜AŒg`. –ě‘ş—DŽq1, ‰ĄŽR”ü˛Žq2, ă“cN‹v3, Ź—ŃŽĺŒŁ1, ‹ŕŽq’‰O3, –ěX“c–L3, ”~Œ´@ŽŔ3, •Ÿ“c—Ď–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3ŹŽ™): ‘ć49‰ń“ú–{ŹŽ™ŒÄ‹zŠíŠw‰ď (2016/10/28-9), •xŽR.

7231012. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠÄŽ‹Œ^‰^“Ž—Ă–@‚͍‚—‰t“§ÍŠłŽŇ‚̉^“Ž‘Ď—e”\‚đ‰ü‘P‚ˇ‚é‚Š|–łěˆ×‰ť”äŠrŽŽŒą‚Ěƒƒ^ƒAƒiƒŠƒVƒX|. ź‘ň—Ç‘ž1, Ż@‰Ŕ–F2, •Ä–؁@Œc3, Œ´“cˆ¤‰i3, “n粍F–ž3, ‰ş“c—˛‘ĺ3, ź–{”ü3, ‰ÍŒ´Ž‰ë4, ź‰i“Ä•F5 (1ƒŠƒnƒrƒŠ•”, 2‰qś, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ś—, 5ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2017/2/18-9), ˆďé.

7231013. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) CT’f‘w‰ć‘œ‚É‚ć‚éICU“üŽşŠłŽŇ‚̐ҒŒ‹N—§‹Ř‚Č‚ç‚Ń‚É‘ĺ˜‹Ř‚Ě‹Ř’f–ĘĎ‘Ş’č‚Š‚ç“ž‚ç‚ę‚˝”sŒŒÇŠłŽŇ‚ĚŒXŒü. Ź’r•üF1, ŒŠˆä“c˜ał2, ŹâN°3, •Šâ­”V3, VˆäłN4 (1–k—˘‘ĺŠw•a‰@‹~–˝‹~‹}ƒZƒ“ƒ^[, 2ƒŠƒnƒrƒŠ•”, 3–ƒŒ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9-11), ŽD–y.

7231014. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇ“Ş•”ŠOŠłŽŇ‚ɑ΂ˇ‚é‹~–˝‹~‹}ICU‚Ĺ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚¨‚Ż‚éŒř‰Ę‚ĆˆŔ‘SŤ. ‹{č“š‹P1, •Đ‰Ş—Sˆę2, •ž•”@2, ŹňŠ°”V2, ó—˜@–ő2 (1ƒŠƒnƒrƒŠ•”, 2‹~–˝): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y.

7231015. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}ŤŠú”]‘˛’†ŠłŽŇ‚É‚¨‚Ż‚é“ü‰@Œă1T‚Ě•a“•ŕsŽŠ—§‰Â”Ű‚Ě—\‘Ş. źŠŰƒ‰Ŕ1, ě’[—ÇŽĄ1, ‰“Œ´‚Ü‚č‚Ś1, “š–”“Ţ’Ă”ü1, źˆäˆŸš”ü1, •Ÿ“c—Ď–ç2, ‹ß“Ą—łŽj3, ˆ˘‹v’Ă“ń•v4, źŽR˜a—˜4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3”]ŠO, 4_Œo“ŕ): ‘ć42‰ń“ú–{”]‘˛’†Šw‰ď‘‰ď (2017/3/16-19), ‘ĺă

731184. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŒ‰t“§ÍŠłŽŇ‚É‚¨‚Ż‚éƒtƒŒƒCƒ‹‚đˆÓŽŻ‚ľ‚˝ŽžŠłŠÇ—. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”): ‘ć91‰ń_“ސětŒ¤‹†‰ď (2016/5/14), _“ސě.

731185. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŒ‰t“§ÍŠłŽŇ‚É‚¨‚Ż‚éƒtƒŒƒCƒ‹‚ĆŽžŠłŠÇ—. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”): ‘ć8‰ń‰Ą•l“§Í‡•šÇŽĄ—Íu‰‰‰ď (2016/9/14), _“ސě.

731186. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŒ‰t“§ÍŠłŽŇ‚É‚¨‚Ż‚éƒtƒŒƒCƒ‹‚ĆŽžŠłŠÇ—. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”): ‘ć20‰ńNAGASAKIt‚̉ď (2016/9/29), ’ˇč.

732125. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “§ÍŠłŽŇ‚É‚¨‚Ż‚éADLŠÇ—‚Ć––˝“Ž–ŹŽžŠł. ź‘ň—Ç‘ž (ƒŠƒnƒrƒŠ•”): ‘ć11‰ń‘Š–ÍŒ´ƒtƒbƒgƒPƒAƒZƒ~ƒi[ (2016/6/28), _“ސě.

732126. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “ŕ•”áŠQ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“`Ž„‚Č‚ç‚ą‚¤‚ˇ‚é`. ŕ_čL–ž (ƒŠƒnƒrƒŠ•”): ‘ć19‰ńě‹Ć—Ă–@’nˆć˜AŒg‰ď (2017/2/7), ‘Š–ÍŒ´.

732127. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) tˆÚA‚Ɛt‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ź‘ň—Ç‘ž1, ‹g“cˆęŹ2, Îˆä‘ĺ•ă3, ’|“ŕN—Y4, –ěŒű•ś”T5 (1ƒŠƒnƒrƒŠ•”, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3”ĺ”AŠí, 4t‘Ÿ“ŕ‰ČŠw, 5ŠĹŒě•”): ‘ć32‰ń_“ސěEtˆÚA‚đ•×‹­‚ˇ‚é‰ď (2017/3/4), _“ސě.

733503. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”F’mÇ‚É”][Ç‚đ‡•š‚ľ, Ý‘î•œ‹A‚É“ďa‚ľ‚˝47Î’jŤÇ—á. ł–Řꢎq1, •Ÿ“c—Ď–ç2, á–{—R”ü1, “ú”ä—mŽq1, ’†ŕVr”V1, ˆä“‡‘ĺ•ă3, źŽR˜a—˜3 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3_Œo“ŕ): ‘ć64‰ń“ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆăŠw‰ďŠÖ“Œ’n•ű‰ď (2016/10/1), VŠƒ.

733504. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒŒ‰t“§ÍŠłŽŇ‚ŞŠm•Ű‚ˇ‚é‚ׂŤg‘ĚŠˆ“Ž—Ę‚Ě–Ú•W’l‚Ć‚Í. ź‘ň—Ç‘ž1, ‰ş“c—˛‘ĺ2, •Ä–؁@Œc2, Œ´“cˆ¤‰i2, “n粍F–ž2, ź–{”ü2, ‹g“c@ŕˆ3, ź‰i“Ä•F4 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‚ł‚Ş‚ÝzŠÂŠíƒNƒŠƒjƒbƒN, 4ˆă—ÉqśŠwŽY): ‘ć7‰ń“§Í‰^“Ž—Ă–@Œ¤‹†‰ď (2017/2/5), •Ÿ‰Ş.

733505. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) •Đ‹r—§‚żƒeƒXƒg‚͍‚—îSŒŒŠÇŽžŠłŠłŽŇ‚̐g‘Ě‹@”\’ቺ‚𔝕ʂłŤ‚é‚Š|”N‘ă•Ę‚̉đÍ|. ź‘ň—Ç‘ž1, _’JŒ’‘ž˜Y1, ŕ_čL–ž1, –ěčN•˝1, “c’†L–í2, ŒÜ\—’ˆŸŠóŽq1, ’†‘ş“ŢŽq1, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): JACR“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), é‹Ę.

733506. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒTƒ‹ƒRƒyƒjƒA‚ĚŠČˆŐƒXƒNƒŠ[ƒjƒ“ƒOŽw•W‚Ĺ‚ ‚éSARC-F‚ÍŒăŠú‚—îSŒŒŠÇŽžŠłŠłŽŇ‚̉^“Ž‹@”\’ቺ‚𔝕ʂˇ‚é. “c’†L–í1, _’JŒ’‘ž˜Y2, ŕ_čL–ž2, ź‘ň—Ç‘ž2, –ěčN•˝2, ŒÜ\—’ˆŸŠóŽq2, ’†‘ş“ŢŽq2, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ƒŠƒnƒrƒŠ•”, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): JACR“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), é‹Ę.

733507. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‘ŤŠÖßă˜rŒŒˆł”ä’á’l‚͍‚—îS•s‘SŠłŽŇ‚̉^“Ž‘Ď—e”\‚đ’ቺ‚ˇ‚é‹­—Í‚Č‹K’čˆöŽq‚Ĺ‚ ‚é. “c’†L–í1, _’JŒ’‘ž˜Y2, ŕ_čL–ž2, ź‘ň—Ç‘ž2, –ěčN•˝2, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ƒŠƒnƒrƒŠ•”, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): JACR“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), é‹Ę.

733508. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”ń“´’˛—ĽS•s‘SŠłŽŇ‚ɑ΂ˇ‚é“ľE‚Ě‘ÎŒő”˝‰ž‚đ—p‚˘‚˝V‚˝‚ČŽŠ—Ľ_ŒoŠˆ“ŽŽw•W‚Ě—L—pŤ. –ěčN•˝1, _’JŒ’‘ž˜Y1, ŕ_čL–ž1, ź‘ň—Ç‘ž1, “c’†L–í2, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): JACR“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), é‹Ę.

733509. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “ü‰@ŠúS•s‘SŠłŽŇ‚ɑ΂ˇ‚éŒÄ‹z‹ŘƒgƒŒ[ƒjƒ“ƒO‚ĚˆŔ‘SŤ‚ĆŒř‰Ę. ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): “ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25), ‘ĺ‹{.

733510. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹}ŤS•s‘SŠłŽŇ‚É‚¨‚Ż‚é‰^“Ž—Ă–@‚ĚŒř‰Ę”ť’čŽw•W‚ĚŒŸ“˘. _’JŒ’‘ž˜Y1, ŕ_čL–ž2, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í2, ‘OěŒb”ü3, –ě“cçt3, “ŒžŠ”ü“ŢŽq4, ź‰i“Ä•F4, ‘“c@‘ě4, ˆ˘ŒĂĆ3 (1ƒŠƒnƒrƒŠ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3zŠÂŠí“ŕ, 4ˆă—ÉqśŠw•”): “ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď ‘ć1‰ńŠÖ“ŒbM‰zŽx•”’n•ű‰ď (2017/2/25) ‘ĺ‹{.

733511. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒr[ƒYƒ^ƒCƒv‚̉îŒě—pƒ~ƒgƒ“‚đŽčŽwŠŽ‘S‹ü‹ČˆĘ‚Ĺ‘•’…‚ľ‚˝Žž‚Ě•žŠQ’˛¸. _•Ű•‘Ľ1, ’|“ੰl1, ‰“Œ´‚Ü‚č‚Ś1, —é–Ř•ü‘ă1, “š–”“Ţ’Ă”ü1, źˆäˆŸš”ü1, ‹{č“š‹P1, —é–Ř‘ń^1, •Ÿ“c—Ď–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), _“ސě.

H27”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H27-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) New hand-made finger protection device for allodynia. Jimbo T1, Tanabe R, Kumazawa K2, Fukuda M3 (_•Ű•‘Ľ1, ŒFŕVŒ›ˆę2, •Ÿ“c—Ď–ç: 1ƒŠƒnƒrƒŠ•”, 2‹~–˝, 3ˆă—ÉqśŠw•”): 6th Asia Pacific Occupational Therapy congress (2015/9/14-8), Rotorua, New zealand.

H27-723025. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Respiratory Muscle Weakness Elicits Inefficient Ventilation Resulting in the Deterioration of Exercise Intolerance in Patients with Chronic Heart Failure. ŕ_čL–ž1, ‘“c@‘ě2, _’JŒ’‘ž˜Y1, ź‘ň—Ç‘ž1, –ěčN•˝1, “c’†L–í3, HŽRˆťŽq3, ÂŽRW‘ĺ3, ĺM@•c3, ’†‘şŠxŽj3, ‘OěŒb”ü4, –ě“cçt4, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18-20), ĺ‘ä.


‰h—{•”

[Šwp˜_•ś]

120057. [Œ´’˜] ƒ`[ƒ€‚ō\’z‚ľ‚˝tˆÚAƒŒƒVƒsƒGƒ“ƒg‚Ö‚Ě’čŠú“I‰h—{Žw“ą‚ĚŒř‰Ę. ‹g“c•üŽq1, –ěŒű•ś”T2, ˛“ĄĆŽq1, ’r“cŹ]3, ’|“ŕN—Y4, Îˆä‘ĺ•ă3, ‹g“cˆęŹ5 (1‰h—{•”, 2ŠĹŒě•”, 3”ĺ”AŠí, 4t‘Ÿ“ŕ, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{—Տ°tˆÚAŠw‰ďŽGŽ 2016/12; 4 (2): 243 -6.

522161. [uŔ]y“ÁW: ƒŠƒnƒrƒŠE‰^“Ž—Ă–@‚đŠˆ—p‚ľ‚˝‚—ît•s‘SŠłŽŇ‚̉h—{ŠÇ—z2-5. ‚—ît•s‘SE“§ÍŠłŽŇ‚ւ̉h—{Žw“ą‚ĚŽŔŰ@(5) ‹}ŤŠú‚Š‚ç‰ń•œ‚ľ‚˝¸_ŽžŠł‚đ—L‚ˇ‚鍂—ÍŠłŽŇ. ‹g“c•üŽq (‰h—{•”): —Տ°“§Í 2016/11; 32 (12): 73E1528-78E1534.

540070. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)] tˆÚAƒŒƒVƒsƒGƒ“ƒg‚ɑ΂ˇ‚éH•¨ŰŽć•p“x’˛¸FFQg‚đ—p‚˘‚˝HŽ–ŰŽć—ʁEŠˆ“Ž—Ę‚Ě’˛¸. ‹g“c•üŽq1, –ěŒű•ś”T2, ˛“ĄĆŽq1, ’r“cŹ]3, ’|“ŕN—Y4, Îˆä‘ĺ•ă3, ‹g“cˆęŹ5 (1‰h—{•”, 2ŠĹŒě•”, 3”ĺ”AŠí, 4t‘Ÿ“ŕ, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): –k—˘‘ĺŠw•a‰@E“Œ•a‰@ EˆőŒ¤‹†•ń‘ 2016/7.

[Šw‰ďEŒ¤‹†‰ď“™]

713176. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The Multidisciplinary Individual Team approach for efficacious hemodialysis initiation for patients with Diabetic nephropathy. Hitomi M1, Sato T1, Kawakami Y1, Shibata S1, Moriya T2: 76th Scientific Sessions American Diabetes Association (2016/6/10-14), New Orleans, USA, Diabetes 2016/6; 65 (Suppl 1): A59. (lŒŠ–ƒ”üŽq1, ˛“ĄĆŽq1, ěă—IŽq1, ŽÄ“c‘D1, Žç‰Ž’B”ü2: 1‰h—{•”, 2Œ’NŠÇ—ƒZ)

7231016. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)u“œ”A•aƒJƒ“ƒoƒZ[ƒVƒ‡ƒ“Eƒ}ƒbƒvTMv‚đ—p‚˘‚˝—Ă—{Žw“ą‚Ě—L—pŤ. ěă—IŽq1, lŒŠ–ƒ”üŽq1, ˛“ĄĆŽq1, Î–{–]”ü, ´…@—y, –öŕV^ŽŔ2, ŠÝŒ´ŠG—œŽq2, ‹g–쉑”ü3, —с@“N”Í2, ‚–ěK˜H2, Žľ—˘áÁ‹`2 (1‰h—{•”, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2016/5/19), ‹ž“s, “œ”A•a, 2016; 59: S262.

7231017. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘˝EŽí‰î“ü‚Í“œ”A•aŤtÇ (tÇ) ŠłŽŇ‚Ě“§Í“ą“üŽž‚ɗǍD‚ČŒř‰Ę‚đ‚ŕ‚˝‚炡‚Š. lŒŠ–ƒ”üŽq1, ˛“ĄĆŽq1, ěă—IŽq1, ŽÄ“c‘D1, ‘ĺŠŃŒbŽq2, â–{”~Žq2, ŽO‰Y–F“T3, Ÿ˜C”ü4, Žç‰Ž’B”ü5 (1‰h—{•”, 2ŠĹŒě•”, 3—ŐŒŸ•”, 4–ňÜ•”, 5Œ’NŠÇ—ƒZ): ‘ć59‰ń“ú–{“œ”A•aŠw‰ď (2016/5/20), ‹ž“s, “œ”A•a 2016; 58 (supplement 1): s-291.

7231018. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tˆÚAƒŒƒVƒsƒGƒ“ƒg‚ɑ΂ˇ‚éH•¨ŰŽć•p“x’˛¸‚đ—p‚˘‚˝HŽ–ŰŽć—ʁEŠˆ“Ž—Ę‚Ě’˛¸. ‹g“c•üŽq1, –ěŒű•ś”T2, ˛“ĄĆŽq1, ’r“cŹ]3, ’|“ŕN—Y4, Îˆä‘ĺ•ă3, ‹g“cˆęŹ5 (1‰h—{•”, 2ŠĹŒě•”, 3”ĺ”AŠí, 4t‘Ÿ“ŕ, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2016/10/1), V‚—Ö, ‘ć52‰ń“ú–{ˆÚAŠw‰ď‘‰ď—ŐŽž† 2016/9; 5: 341.

7231019. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) tˆÚAƒŒƒVƒsƒGƒ“ƒg‚É‚¨‚Ż‚éˆÚAt‹@”\•Ę‚̐HŽ–—Ă–@‚ĚŽŔŽ{ó‹ľ. ‹g“c•üŽq1, Îˆä‘ĺ•ă2, –ěŒű•ś”T3, ˛“ĄĆŽq1, ’r“cŹ]2, ‹g“cˆęŹ4 (1‰h—{•”, 2”ĺ”AŠí, 3ŠĹŒě•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć20‰ń“ú–{•a‘Ô‰h—{Šw‰ď”NŽŸŠwpW‰ď (2017/1/15), ‹ž“s, ‘ć20‰ń“ú–{•a‘Ô‰h—{Šw‰ď”NŽŸŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/1; 20 (Suppl 2017): S-170.

7231020. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) tˆÚAŒă“œ”A•a‚Ě‘Ěd‚ƐHŽ–ŠÇ—‚Ě–â‘č“_`”ě–ž“x•Ę‚ĚŒŸ“˘`. ‹g“c•üŽq1, Îˆä‘ĺ•ă2, –ěŒű•ś”T3, —с@“N”Í4, ě‘ş•ä2, ˛“ĄĆŽq1, ’r“cŹ]2, ‹g“cˆęŹ5 (1‰h—{•”, 2”ĺ”AŠí, 3ŠĹŒě•”, 4“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ď (2017/2/17), _ŒË, ‘ć50‰ń“ú–{—Տ°tˆÚAŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.298.

7231021. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) H“šŠŕŽüpŠúƒTƒ|[ƒgƒ`[ƒ€ (SPEC) ‚É‚¨‚Ż‚épŒă‰h—{ŠÇ—‚̉ۑč. ‹e’r“Ţ•äŽq1, [‘ň˛ŒbŽq1, X’JGŒő2 (1‰h—{•”, 2ŠO‰Č): ‘ć32‰ń“ú–{Ă–ŹŒo’°‰h—{Šw‰ďŠwpW‰ď (2017/2/23), ‰ŞŽR, ‘ć32‰ń“ú–{Ă–ŹŒo’°‰h—{Šw‰ďŠwpW‰ďƒvƒƒOƒ‰ƒ€W 2017/1; 32 (Suppl 2017): 97.

7231022. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’ˇŠúŠÔICU“ü‰@‚Ć‚Č‚Á‚˝dÇ‹~‹}ŠłŽŇ‚É‚¨‚Ż‚é–Ú•W“Š—^ƒGƒlƒ‹ƒM[‚ÉŠÖ‚ˇ‚錟“˘. ’†‰Ž—˘š1, ˛“ĄĆŽq1, ‰““ĄŹŽq1, [‘ň˛ŒbŽq1, ˜a’m—ÉŽq2, ’†‘ş@—D3, _@ˆę–˛3, _œä’m“š4, •Đ‰Ş—Sˆę4 (1‰h—{•”, 2ŠĹŒě•”, 3–ňÜ•”, 4‹~–˝): ‘ć32‰ń“ú–{Ă–ŹŒo’°‰h—{Šw‰ďŠwpW‰ď (2017/2/24), ‰ŞŽR, ‘ć32‰ń“ú–{Ă–ŹŒo’°‰h—{Šw‰ďŠwpW‰ďƒvƒƒOƒ‰ƒ€W 2017/1; 108: P-0834.

733512. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) tˆÚAƒŒƒVƒsƒGƒ“ƒg‚Ö“ü‰@’†‚Š‚çŠO—ˆ‚Ü‚ĹŒp‘ą‚ľ‚˝ŠÇ—‰h—{Žm‰î“ü‚ĚŽć‚č‘g‚Ý. ‹g“c•üŽq1, –ěŒű•ś”T2, ˛“ĄĆŽq1, ’r“cŹ]3, Îˆä‘ĺ•ă3, ‹g“cˆęŹ4 (1‰h—{•”, 2ŠĹŒě•”, 3”ĺ”AŠí, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć27‰ń_“ސěˆÚAˆăŠw‰ď (2016/6/4), “Œ‹ž.

733513. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˝EŽí‰î“ü‚Í“œ”A•aŤtÇ (tÇ) ŠłŽŇ‚Ě“§Í“ą“üŽž‚ɗǍD‚ČŒř‰Ę‚đ‚ŕ‚˝‚炡‚Š. lŒŠ–ƒ”üŽq1, ˛“ĄĆŽq1, ‘ĺŠŃŒbŽq2, â–{”~Žq2, ŽO‰Y–F“T3, “y•M’qš3, Ÿ˜C”ü4, Žç‰Ž’B”ü5 (1‰h—{•”, 2ŠĹŒě•”, 3—ŐŒŸ•”, 4–ňÜ•”, 5Œ’NŠÇ—ƒZ): ‘ć10‰ń“ú–{CKDƒ`[ƒ€ˆă—ĂŒ¤‹†‰ď (2016/10/22), “Œ‹ž.

733514. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) _ŒoŤHŽv•sUÇ‚ŞŒ´ˆö‚Ě’áŒŒ“œ‚ĆˆÓŽŻáŠQ‚đ’ć‚ľ‚˝2Ç—á. [‘ň˛ŒbŽq1, ’†‰Ž—˘š1, ‰““ĄŹŽq1, •Đ‰Ş—Sˆę2, _œä’m“š2, Vˆä‹v–Ť2, ‰Ô“‡@Ž‘2, ˆîŠ_‘דl2, •x‘ň@~3, ˜a’m—ÉŽq4, ˛“ĄĆŽq1, ó—˜@–ő2 (1‰h—{•”, 2‹~–˝, 3–ňÜ•”, 4ŠĹŒě•”): ‘ć3‰ń_“ސě‹}ŤŠú‰h—{ŠÇ—Œ¤‹†‰ď (2017/11/26), ‰Ą•l.

733515. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˝EŽí‰î“ü‚Í“œ”A•aŤtÇ (tÇ) ŠłŽŇ‚Ě“§Í“ą“üŽž‚ɗǍD‚ČŒř‰Ę‚đ‚ŕ‚˝‚炡‚Š. lŒŠ–ƒ”üŽq1, ˛“ĄĆŽq1, ‘ĺŠŃŒbŽq2, â–{”~Žq2, ŽO‰Y–F“T3, “y•M’qš3, Ÿ˜C”ü4, Žç‰Ž’B”ü5 (1‰h—{•”, 2ŠĹŒě•”, 3—ŐŒŸ•”, 4–ňÜ•”, 5Œ’NŠÇ—ƒZ): ‘ć28‰ń“ú–{“œ”A•aŤtÇŒ¤‹†‰ď (2016/12/3), “Œ‹ž.


•a‰@•a—•”

[Šwp˜_•ś]

120058. [Œ´’˜] ×–EŠ”‚đ—p‚˘‚˝–Ɖu‘gD‰ťŠwőFƒ}ƒ‹ƒ`ƒvƒ‹ƒRƒ“ƒgƒ[ƒ‹ŽŽ—ż‚̍쐻‚Ć•W€‰ť‚ĚŠî‘b“IŒŸ“˘. ŽR‰ş˜a–ç1, ˛“Ą—Yˆę2, ‹vę@Ž÷1, ‹g“c˛“yŽq1, ‰ĄŕVłŽu1, ‘ş‰_–FŽ÷3 (1•a—•”, 2ˆă—ÉqśŠw•”, 3•a—): _“ŢěŒ§—Տ°ŒŸ¸‹ZŽt‰ďŽGŽ 2017/2; 51 (168): 44-53.

[Šw‰ďEŒ¤‹†‰ď“™]

712032. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Molecular Target Therapy of Lung Cancer: the Usefulness of Conventional Cytological Samples in Gene Mutation Analyses. Machida D1, Jiang SX2, Yoshida T2, Kuba T1, Yamashita K1, Saegusa M2, Satoh Y3, Murakumo Y2: The 19th International Congress of Cytology (2016/5/29), Yokohama, Japan, http://www.myschedule.jp/cytologyjapan2016/search/detail_session/id:17. (’Ź“c‘ĺ•ă1, Ó@˘ˆŽ2, ‹g“c@Œ÷2, ‹vę@Ž÷1, ŽR‰ş˜a–ç1, ŽOŽ}@M2, ˛“Ą”Vr3, ‘ş‰_–FŽ÷2: 1•a—•”, 2•a—, 3ŒÄ‹zŠíŠO)

722290. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ĹVŒÄ‹zŠí×–EfŠÓ•Ęf’f‘‚Ü‚Ć‚ß: ŒÄ‹zŠí×–Ef‚É‚¨‚Ż‚é–Ɖu×–E‰ťŠw. Š`ŔœA–M1, •ž•”@Šw2, ’Ź“c‘ĺ•ă1, ŽR‰ş˜a–ç1, ‰€“c@‘ĺ3, ’†“‡—TN3, ˛“Ą”Vr3, ‹g“c@Œ÷4, ŽOŽ}@M4, ‘ş‰_–FŽ÷4 (1•a—•”, 2ˆă—ÉqśŠw•”, 3ŒÄ‹zŠíŠO, 4•a—): ‘ć57‰ń“ú–{—Տ°×–EŠw‰ď‘‰ďtŠú‘ĺ‰ď (2016/5/28), ‰Ą•l.

7231023. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”xŠŕ‚̉tó‰ťŒŁ‘Ě×–Ef‚É‚¨‚Ż‚éEGFRˆâ“`Žq‰đÍ‚ւ̉e‹ż‚ɂ‚˘‚Ä. ’Ź“c‘ĺ•ă1, ‹g“c@Œ÷2, ‹vę@Ž÷1, ŽR‰ş˜a–ç1, Ó@˘ˆŽ2, ˛“Ą”Vr3, ŽOŽ}@M2, ‘ş‰_–FŽ÷2 (1•a—•”, 2•a—, 3ŒÄ‹zŠíŠO): ‘ć57‰ń“ú–{—Տ°×–EŠw‰ď‘‰ďtŠú‘ĺ‰ď/‘ć19‰ń‘Ű×–EŠw‰ď‹c (2016/5/29), ‰Ą•l, “ú–{—Տ°×–EŠw‰ďŽGŽ 2016/4; 55 (•Ęű): 167.

7231024. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˆă—ĂŽ–ŒĚ–hŽ~‘΍ô‚É—ŻˆÓ‚ľ‚˝’…Fƒzƒ‹ƒ}ƒŠƒ“‚Ě’ńˆÄ. ŽR‰ş˜a–ç1, ‹vę@Ž÷1, ’Ź“c‘ĺ•ă1, âŒű@”E1, ‹g“c@Œ÷2, ‘ş‰_–FŽ÷2 (1•a—•”, 2•a—): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 65.

7231025. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) p’†v‘Źf’f‚Ě—‘z‚Ö‚Ě’§í. ‰ĄŽR‚˘‚ł‚Ý1, ”\¨•x˛Žq1, ŠÚ—Ń–­Žq1, ’Ź“c‘ĺ•ă1, ‹vę@Ž÷1, ŽR‰ş˜a–ç1, ‘ş‰_–FŽ÷2 (1•a—•”, 2•a—): ‘ć65‰ń“ú–{ˆăŠwŒŸ¸Šw‰ď (2016/9/3), _ŒË, ˆăŠwŒŸ¸ 2016/7; 65 (•Ęű): 67.


ME•”

[Šwp˜_•ś]

220016. [€Œ´’˜]y‹Zp•ńzňHˆă‰ČH‹ĆŽĐťlH”xHPO-21FHP‚Ě—Ő°Žg—p•]‰ż. ‘哇O”V1, “ŒžŠŒ\ˆę1, ŒĂ•˝@‘1, •“cÍ”1, —L”n@Ži1, ŠC˜VŞ’q‘ă1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ĚŠOzŠÂ‹Zp 2016/12; 43 (4): 383-8.

220017. [€Œ´’˜]y•ńz’PŽ…Œa2_‚Ěƒ}ƒCƒNƒƒtƒ@ƒCƒo[ƒNƒƒX‚É‚ć‚éƒEƒCƒ‹ƒX‚ɑ΂ˇ‚鐴@Ť”\‚ÉŠÖ‚ˇ‚錟“˘. “ŒžŠŒ\ˆę1, “ĄˆäłŽŔ1, –쓇NO2, ˛‰ş‹´L”J3, ’†‘ş‹ąŽq1, ˛“Ą@“ě1, ‹{’n@ŠÓ4 (1ME•”, 2–k—˘ŠÂ‹Ť‰ČŠwƒZƒ“ƒ^[ƒEƒCƒ‹ƒX•”, 3“ŒƒŒEƒƒfƒBƒJƒ‹Š”ŽŽ‰ďŽĐ, 4S‘ŸŒŒŠÇŠO): ˆă—Ă‹@ŠíŠw 2017/2; 87 (1): 40-6.

320032. [Ç—á•ń] śŽş‘ĺ“Ž–Źƒgƒ“ƒlƒ‹ŠłŽŇ‚Ö‚ĚŽčp‚ĚŒoŒą. ‘哇O”V1, “ŒžŠŒ\ˆę1, ŒĂ•˝@‘1, –؉şt“Ţ1, •“cÍ”1, —L”n@Ži1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ĚŠOzŠÂ‹Zp 2016/6; 43 (2): 89-94.

522162. [uŔ]y‘ć1“ÁW: —Տ°HŠw‹ZŽm‚Ě–éŠÔE‹x“úf—Âւ̑Ήžz5. “üE1”N–Ú‚Ě—Ő°HŠw‹ZŽm‚ŞŒę‚鏉‚ß‚Ä‚Ě–é‹Î. ŒKŒ´ŽŃˆß1, ‰eŽR‘”ü1 (1ME•”): ClinicalEngineering 2016/6; 27 (7): 565-7.

522163. [uŔ]y“ÁWŠÖ˜A‹LŽ–zŽŔ‘Ô’˛¸‚Š‚ç‚í‚Š‚éƒAƒ‰[ƒ€‚Ě”­śó‹ľ|‚ą‚ń‚Ȃɖ‚Á‚Ä‚˘‚é|. ’†‘ş‹ąŽq (ME•”): ClinicalEngineering 2016/11; 27 (12): 971-4.

522164. [uŔ]y“ÁW1: ś‘̏î•ńƒ‚ƒjƒ^ƒAƒ‰[ƒ€‚Ƃ̐ł‚ľ‚˘•t‚Ť‡‚˘•űz—Տ°HŠw‹ZŽm‚Ş‚Ý‚éƒAƒ‰[ƒ€‚Ě–â‘č“_‚Ć‘Îô@…@W’†ŽĄ—ĂŽşEŽčpŽş. “ŒžŠŒ\ˆę1, –؉şt“Ţ1, —§–ě@‘1 (1ME•”): ClinicalEngineering 2016/11; 27 (12): 975-81.

522165. [uŔ]y“ÁW1: ś‘̏î•ńƒ‚ƒjƒ^ƒAƒ‰[ƒ€‚Ƃ̐ł‚ľ‚˘•t‚Ť‡‚˘•űzMACT (monitor alarm control team) ‚É‚¨‚Ż‚é—Տ°HŠw‹ZŽm‚Ě–đŠ„. “ĄˆäłŽŔ (ME•”): ClinicalEngineering 2016/11; 27 (12): 994-9.

[’˜@‘]

620201. [Šwp‘ (•Ş’SŽˇ•M)yCE—Տ°ŽŔKƒ‹[ƒgƒ}ƒbƒvz2Í —Տ°ŽŔKŽŔ‹Z•Ň@4. ‚ť‚Ě‘ź‚ĚŽžŠł@3. Á‰ťŠíE”ĺ”AŠíŽžŠł@“ŕŽ‹‹ž (“d‹CƒƒXEƒŒ[ƒU[“™‚đŠÜ‚Ţ), p.300-7. —§–ě@‘1, “ŒžŠŒ\ˆę1 (1ME•”), •Ň: “ú”ä’JM, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/9”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722291. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ECMOƒfƒoƒCƒX‚É‚¨‚Ż‚鉓Sƒ|ƒ“ƒvˆł—Í“ÁŤ‚ĚŒŸ“˘. –؉şt“Ţ1, “c‘ş”üš‹I1, ’†‘ş‹ąŽq1, ˛“Ą‚ł‚â‚Š1, “ŒžŠŒ\ˆę1 (1ME•”): ‘ć42‰ń“ú–{‘ĚŠOzŠÂ‹ZpˆăŠw‰ď‘ĺ‰ď (2016/10/22), “Œ‹ž, ‘ĚŠOzŠÂ‹Zp 2016/9; 43 (3): 259.

722292. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ˆă—ĂˆŔ‘SŠˆ“Ž‚Ş‚ŕ‚˝‚炡ˆă—Ă‚ĚŽż‚ĆŠłŽŇ–ž‘Ť“xŒüă‚Ö‚ĚvŒŁ|Œo‰c‰ü‘P‚É‚Â‚Č‚Ş‚é‚Š|ˆă—Ă‹@ŠíŠÇ—‚É‚¨‚Ż‚éˆă—ĂˆŔ‘SŠˆ“Ž. “ŒžŠŒ\ˆę1, “ĄˆäłŽŔ1, –؉şt“Ţ1, “c‘ş”üš‹I1, ’†‘ş‹ąŽq1, ˛“Ą‚ł‚â‚Š1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y.

722293. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éECMOŠÇ—‚ĚŽw•W. “ŒžŠŒ\ˆę1, “ĄˆäłŽŔ1, –؉şt“Ţ1, “c‘ş”üš‹I1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/10), ŽD–y.

7231026. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒ^ƒbƒ`ƒpƒlƒ‹‰tťƒfƒBƒXƒvƒŒƒC‚ɑ΂ˇ‚éR‹Ű‰tť•ŰŒěƒtƒBƒ‹ƒ€‚É‚ć‚é‰e‹ż‚ĚŒŸ“˘. ‘‘ŹTŒá1, “ŒžŠŒ\ˆę1, “ĄˆäłŽŔ1, ‹ß“ĄˆŸ—R”ü1, ň@•üL1, —§–ě@‘1, “c‘ş”üš‹I1, ˛“Ą‚ł‚â‚Š1, ”’ˆä“ÖŽj1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/14), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 184.

7231027. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒ}ƒCƒNƒƒtƒ@ƒCƒo[‘fŢƒNƒŠ[ƒjƒ“ƒOƒNƒƒXƒgƒŒƒV[‚Ɗ‹Ťœ‹ŰEôňÜƒ‹ƒrƒXƒ^‚Ě•š—pŽg—p‚É‚ć‚錟“˘. ˛“Ą@“ě1, “ŒžŠŒ\ˆę1, “ĄˆäłŽŔ1, ‘‘ŹTŒá1, ˜a“c‰ŘŸ1, ‰z…ŒłŽ÷1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/14), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 198.

7231028. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ATP‚Ó‚ŤŽć‚čŒŸ¸‚đ—p‚˘‚˝lHS”xŒă‚̐lHS”x‘•’u‰˜ő“x‚ĆŠ´ő‘΍ô‚ĚŒř‰Ę. ŠC˜VŞ’q‘ă1, ‘哇O”V1, ’ˇ‘ş–Αž1, —L”n@Ži1, ˛“Ą‚ł‚â‚Š1, “ŒžŠŒ\ˆę1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/14), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 199.

7231029. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŽčpŽş‹Ć–ą‚É‚¨‚Ż‚郉ƒEƒ“ƒh“_ŒŸ‚ĚŒř‰Ę‚ÉŠÖ‚ˇ‚錟“˘. —§–ě@‘1, “ŒžŠŒ\ˆę1, ŒĂ•˝@‘1, ‹{“cW—˛1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/14), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 241.

7231030. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žčp—p“ŕŽ‹‹ž‘•’u‚Ě‹@Ží“ˆę‚¨‚ć‚щ^—p•ĎX‚É‚ć‚éŒoĎŒř‰Ę‚ÉŠÖ‚ˇ‚錟“˘. ŒĂ•˝@‘1, —§–ě@‘1, ‹{“cW—˛1, “ĄˆäłŽŔ1, –؉şt“Ţ1, •“cÍ”1, ‘‘ŹTŒá1, ‘哇O”V1, “ŒžŠŒ\ˆę1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/15), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 241.

7231031. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •úŽËü–hŒěˆß‚ĚŠ´őŠÇ—‚Ě•K—vŤ. •“cÍ”1, “ŒžŠŒ\ˆę1, ˛“Ą@“ě1, ˜a“c‰ŘŸ1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/15), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 313.

7231032. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “_ŒŸƒ}ƒjƒ…ƒAƒ‹‚Ě“Ž‰ć‰ť‚Ć‚ť‚̉^—p‚ɂ‚˘‚Ä. –؉şt“Ţ1, “ŒžŠŒ\ˆę1, “c‘ş”üš‹I1, ’†‘ş‹ąŽq1, —L”n@Ži1, ˛“Ą‚ł‚â‚Š1, ˛“Ą—R1, ň@•üL1, ‚‹´@Œő1, ŒKŒ´ŽŃˆß1 (1ME•”): ‘ć26‰ń“ú–{—Տ°HŠw‰ď‹y‚Ń•˝Ź28”N“xŒö‰vŽĐ’c–@l“ú–{—Տ°HŠw‹ZŽm‰ď‘‰ď (2016/5/15), ‹ž“s, “ú–{—Տ°HŠw‹ZŽm‰ď‰ďŽ 2016/4; 57: 321.

7231033. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŹŽ™ŠJSp‚É‚¨‚Ż‚é‘gDŽ_‘f–O˜a“x‚É‚ć‚éŽ_‰ťáŠQ•]‰ż‚ÉŠÖ‚ˇ‚錟“˘. ŒĂ•˝@‘1, ™–{Wˆę2, —с@GŒ›2, ’šˆäWŽO3, –k‘ş@—Ľ2, •ó—ˆ“N–ç2, •˝“cŒő”Ž4, ”ü“‡—˜ş2, “üŕV—F•ă2, ź‘ă‘ě–ç2, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO, 3ˆă—ĂˆŔ‘SŠw‹łˆç, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć69‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2016/9/29), ‰ŞŽR. “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2016/9; suppl: p.104.

7231034. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ňHˆă‰ČH‹ĆŽĐťlH”xHPO-21-FHP‚Ě—Ő°Žg—p•]‰ż. ‘哇O”V1, “ŒžŠŒ\ˆę1, ŒĂ•˝@‘1, •“cÍ”1, ’ˇ‘ş–Αž1, —L”n@Ži1, ŠC˜VŞ’q‘ă1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ć42‰ń“ú–{‘ĚŠOzŠÂ‹ZpˆăŠw‰ď‘ĺ‰ď (2016/10/22), “Œ‹ž, ‘ĚŠOzŠÂ‹Zp 2016/9; 43 (3): 293.

7231035. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) VśŽ™‘ĺ“Ž–Ź‹ŒC•œ’†‚ĚŽ_‘f‹Ÿ‹‹ó‹ľ‚Ć‘gDŽ_‘f–O˜a“x, pŒă‚Ě‘gDáŠQ‚ÉŠÖ‚ˇ‚錟“˘. ŒĂ•˝@‘1, •“cÍ”1, —L”n@Ži1, ŠC˜VŞ’q‘ă1, “ŒžŠŒ\ˆę1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ć42‰ń“ú–{‘ĚŠOzŠÂ‹ZpˆăŠw‰ď‘ĺ‰ď (2016/10/22), “Œ‹ž, ‘ĚŠOzŠÂ‹Zp 2016/9; 43 (3): 298.

7231036. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹlŠJSp‚É‚¨‚Ż‚é‘gDŽ_‘f–O˜a“x‚ƐlHS”xŠÖ˜A‹}ŤtáŠQ‚Ć‚ĚŠÖ˜AŤ. ŒĂ•˝@‘1, –k‘ş@—Ľ2, Ź—ŃŒ’‰î2, ’šˆäW‘˘3, •ó—ˆ“N–ç2, ™–{Wˆę2, “üŕV—F•ă2, —с@GŒ›2, •˝“cŒő”Ž4, ”ü“‡—˜ş2, ‘ĺ‹v•Ű”Ž˘2, ź‘ă‘ě–ç2, “y“c—E‘ž2, ‹{“c—L—œ¨2, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO, 3ˆă—ĂˆŔ‘SŠw‹łˆç, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2017/2/27), “Œ‹ž. ‘ć47‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď´˜^W 2017/2; p.121.

7231037. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒnƒCƒtƒ[ƒZƒ‰ƒs[‚ł̉Á‰ˇ‰ÁŽźŠíě“Ž‚ɂ‚˘‚Ä‚ĚŽŔŒą“IŒŸ“˘. ˛“Ą‚ł‚â‚Š1, –؉şt“Ţ1, “c‘ş”üš‹I1, ’†‘ş‹ąŽq1, “ŒžŠŒ\ˆę1 (1ME•”): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y.

7231038. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) lHŒÄ‹zŠí‚đ—p‚˘‚˝lH”xŽŠ“ŽƒKƒXƒtƒ‰ƒbƒVƒ…‘•’u‚ĚŒŸ“˘. “ŒžŠŒ\ˆę1, “ĄˆäłŽŔ1, –؉şt“Ţ1, “c‘ş”üš‹I1, ’†‘ş‹ąŽq1, ˛“Ą‚ł‚â‚Š1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ć44‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2017/3/9), ŽD–y.

732128. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ˆă—ĂˆŔ‘SŠˆ“Ž‚Ş‚ŕ‚˝‚炡ˆă—Ă‚ĚŽż‚ĆŠłŽŇ–ž‘Ť“xŒüă‚Ö‚ĚvŒŁ|Œo‰c‰ü‘P‚É‚Â‚Č‚Ş‚é‚Š|ˆă—Ă‹@ŠíŠÇ—‚É‚¨‚Ż‚éˆă—ĂˆŔ‘SŠˆ“Ž. “ŒžŠŒ\ˆę (ME•”): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), ‰Ą•l, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.21.

733516. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) MACT (monitor alarm control team) ‚É‚¨‚Ż‚é—Տ°HŠw‹ZŽm‚Ě–đŠ„. “ĄˆäłŽŔ1, “ŒžŠŒ\ˆę1, –؉şt“Ţ1, Ź—ŃˆŸ—R”ü1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ď (2017/3/4), ‰Ą•l, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ď‘ć16‰ń_“ސěŽx•”ŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p.44.


—Տ°ŽŽŒąƒZƒ“ƒ^[


ˆă—Ă‚ĚŽżEˆŔ‘S„iŽş

[Šw‰ďEŒ¤‹†‰ď“™]

7231039. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆă—ĂŽ–ŒĚ’˛¸§“x‚̉^—pŽx‰‡‚Ě‚˝‚ß‚Ě‘SŽ€–Sî•ńŽűW‚ĚŽŽ‚Ý. rˆä—L”ü1, ’ˇ“‡‹Žj, “y‰ŽŽu•Ű1, ‘•ŞG–ç2, ‘ĺă—R‹IŽq3, Źň–ƒ”ü3, rˆäN•v3, ˛“Ą•˜Y4, ó—˜@–ő5 (1ˆă—Ă‚ĚŽżEˆŔ‘S„iŽş, 2–ňÜ•”, 3f—Ïî•ńŠÇ—Žş, 4ŠO‰Č, 5‹~–˝): ‘ć11‰ńˆă—Ă‚ĚŽżEˆŔ‘SŠw‰ďŠwpW‰ď(2016/11/19), “Œ‹ž.


Š´őŠÇ—Žş

[Šwp˜_•ś]

120050. [Œ´’˜] Moraxella catarrhalis‚ĚŒŸoó‹ľ‚Ć–ňÜŠ´ŽóŤ‚̐„ˆÚ. “ń–{–öL1-3, ˜a“c’B•F2, ˆŔ’B @÷3,4, “Ą‘ş—T”ü4, “•űLˆę4, Žë–ě—Lě5, ‚ŽR—zŽq6 (1Š´őŠÇ—Žş, 2äPŒ´•aEŠ´ő“ŕ, 3–k—˘ś–˝‰ČŠwŒ¤‹†Š, 4—ŐŒŸ•”, 5—ŐŒŸŠw, 6V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆăŠwŒŸ¸ 2016; 65 (3): 268-74.

120051. [Œ´’˜] –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŒÄ‹zŠí—R—ˆStreptococcus pneumoniae‚ĚŒŸoó‹ľ‚Ć–ňÜŠ´ŽóŤ‚̐„ˆÚ. “ń–{–öL1, ‚ŽR—zŽq2, ˜a“c’B•F3, ’†‘şłŽ÷4, ’†čM•F1, ˛“ĄŠ°ś5, ‘ĺěŒ´—TŽ÷5, ‚é—R”üŽq5, Â–ö˛’mŽq5, “Ą–Ř‚­‚ÉŽq5, Žë–ě—Lě6 (1—ŐŒŸ•”, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4ˆă—ÉqśŠw•”, 5Š´őŠÇ—Žş, 6—ŐŒŸŠw): –k—˘ˆăŠw 2016/6; 46 (1): 25-33.

[Šw‰ďEŒ¤‹†‰ď“™]

722294. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yôňEÁ“ŁE–Ĺ‹Ű: ƒfƒBƒXƒ{ť•i‚ɂ‚˘‚ÄŒŠ’ź‚ť‚¤zŽčpŽşƒŠƒlƒ“‚Ě’P‰ńŽg—p‚ĆƒŠƒŠ[ƒX‚đŒŸ“˘‚ˇ‚é|ƒŠƒ†[ƒX‚Š‚çƒfƒBƒXƒ|‚ւ̐؂č‘Ö‚Ś‚đŒoŒą‚ľ‚ā|. ‚é—R”üŽq1, ˛X–ŘŒ°Žq1, Â–ö˛’qŽq1, ‘ĺěŒ´—TŽ÷1, “ń–{–öL1, [–xMŽq1, ˜a“c’B•F1, ‚ŽR—zŽq2 (1Š´őŠÇ—Žş, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{ŠÂ‹ŤŠ´őŠw‰ď (2017/2/25), _ŒË, “ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p. 218.

7231040. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŽčŽw‰qśŠĎŽ@ƒAƒvƒŠ‚đ—p‚˘‚˝’źÚŠĎŽ@–@‚Ě‹łˆçŒř‰Ę‚ÉŠÖ‚ˇ‚錟“˘. ‘ĺěŒ´—TŽ÷1,2, ’†–ě—R‹IŽq3, Â–ö˛’qŽq1, “ń–{–öL1, ‚é—R”üŽq1, ˜a“c’B•F1,4, ‚ŽR—zŽq1,5 (1Š´őŠÇ—Žş, 2–ňÜ•”, 3ŠĹŒě•”, 4äPŒ´•aEŠ´ő“ŕ, 5V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć32‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ď (2017/2/25), _ŒË, “ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2017/2; p. 289.

733517. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒJƒ“ƒWƒ_‹ŰŒŒÇŽĄ—Ă‚É‚¨‚Ż‚éAntimicrobial Stewardship Team‰î“üŒř‰Ę‚ĚŒŸ“˘. ‘ĺěŒ´—TŽ÷1,2, “ń–{–öL1, ˜a“c’B•F1,3, ‚ŽR—zŽq1,4, Œú“cKˆę˜Y2 (1Š´őŠÇ—Žş, 2–ňÜ•”, 3äPŒ´•aEŠ´ő“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć64‰ń“ú–{‰ťŠw—Ă–@Šw‰ďź“ú–{Žx•”‘‰ď/‘ć59‰ń“ú–{Š´őÇŠw‰ď’†“ú–{’n•ű‰ďŠwpW‰ď/‘ć86‰ń“ú–{Š´őÇŠw‰ďź“ú–{’n•ű‰ďŠwpW‰ď (2016/11/26), ‰Ť“ę, “ú–{‰ťŠw—Ă–@Šw‰ďŽGŽ 2017/3; 65 (2): 240.


f—Ïî•ńŠÇ—Žş

[Šw‰ďEŒ¤‹†‰ď“™]

722295. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) f—Ïî•ń‚đ‚ß‚Ž‚é–@“I–â‘čf—Ïî•ń‚Ě’ń‹Ÿ‚ÉŠÖ‚í‚é–@“I–â‘č. Ž™‹ĘˆŔŽi, –k–ě•śŤ, rˆäN•v1, ‘ĺ‹v•Ű´Žq (1f—Ïî•ńŠÇ—Žş): ‘ć42‰ń“ú–{f—Ïî•ńŠÇ—Šw‰ďŠwp‘ĺ‰ď (2016/10/13), “Œ‹ž.

722296. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) •a‰@ˆă—Ă‚ĚŽż‚ÉŽ‘‚ˇ‚é‘މ@Žž—v–ń‚ĚŒŸ“˘. ‚‹´’ˇ—T,‘ĺˆä—˜•v, rˆäN•v1, ––‰i—T”V (1f—Ïî•ńŠÇ—Žş): ‘ć36‰ńˆă—Ïî•ńŠw˜A‡‘ĺ‰ď/‘ć17‰ń“ú–{ˆă—Ïî•ńŠw‰ďŠwp‘ĺ‰ď (2016/11/23), ‰Ą•l.

722297. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆă—Ă‹@ŠÖ‚É‚¨‚Ż‚鏑—ޏî•ń‚ĚŠÇ—‚Ć•W€‰ť’ńˆÄ, f—Ïî•ńŠÇ—Žm‚Š‚ç‚Ý‚˝ˆă—Ă•ś‘‚ĚƒXƒLƒƒƒjƒ“ƒO‚̉ۑč. rˆäN•v (f—Ïî•ńŠÇ—Žş): ‘ć36‰ńˆă—Ïî•ńŠw˜A‡‘ĺ‰ď/‘ć17‰ń“ú–{ˆă—Ïî•ńŠw‰ďŠwp‘ĺ‰ď (2016/11/24), ‰Ą•l.

7231041. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆă—ĂŽ–ŒĚ’˛¸§“x‚̉^—pŽx‰‡‚Ě‚˝‚ß‚Ě‘SŽ€–Sî•ńŽűW‚ĚŽŽ‚Ý. ‘ĺă—R‹IŽq1, rˆäN•v1, Źň–ƒ”ü1, ˛“Ą•˜Y2, rˆä—L”ü, ó—˜@–ő3 (1f—Ïî•ńŠÇ—Žş, 2ŠO‰Č, 3‹~–˝): ‘ć42‰ń“ú–{f—Ïî•ńŠÇ—Šw‰ďŠwp‘ĺ‰ď (2016/10/14), “Œ‹ž.

7231042. [Šw‰ď(‘S‘)] (ˆę”ʍu‰‰) “dŽqƒJƒ‹ƒe‚đŠˆ—p‚ľ‚˝¸_•ŰŒ’‹y‚ѐ¸_áŠQŽŇ•ŸŽƒ‚ÉŠÖ‚ˇ‚é–@—Ľ‚ÉŠî‚Ă‚­‹L˜^“_ŒŸ‚ĚŽč–@‚ĚŒŸ“˘. ŹŽRƒAƒ„, rˆäN•v1, ”Ń’Ë‚_2, ‹{‰Ş@“™3 (1f—Ïî•ńŠÇ—Žş, 2_Œo“ŕ, 3¸_): ‘ć42‰ń“ú–{f—Ïî•ńŠÇ—Šw‰ďŠwp‘ĺ‰ď (2016/10/14), “Œ‹ž.

7231043. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆă—ĂŽ–ŒĚ’˛¸§“x‚̉^—pŽx‰‡‚Ě‚˝‚ß‚Ě‘SŽ€–Sî•ńŽűW‚ĚŽŽ‚Ý. rˆä—L”ü1, ’ˇ“‡‹Žj, “y‰ŽŽu•Ű1, ‘•ŞG–ç2, ‘ĺă—R‹IŽq3, Źň–ƒ”ü3, rˆäN•v3, ˛“Ą•˜Y4, ó—˜@–ő5 (1ˆă—Ă‚ĚŽżEˆŔ‘S„iŽş, 2–ňÜ•”, 3f—Ïî•ńŠÇ—Žş, 4ŠO‰Č, 5‹~–˝): ‘ć11‰ńˆă—Ă‚ĚŽżEˆŔ‘SŠw‰ďŠwpW‰ď(2016/11/19), “Œ‹ž.

733518. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •a‰@‚É‚¨‚Ż‚éf—Ïî•ńŠÇ—Žm‚É‹‚ß‚ç‚ę‚é–đŠ„‚ĆÓ”C. rˆäN•v (f—Ïî•ńŠÇ—Žş): ‘ć1‰ńŠâŽčŒ§f—Ïî•ńŠÇ—Œ¤‹†‰ď (2016/12/03), ŠâŽč.

733519. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒCƒ“ƒtƒH[ƒ€ƒhEƒRƒ“ƒZƒ“ƒg‚ÉŠÖ‚ľ‚Ĉă—Ă‹@ŠÖ‚É‹‚ß‚ç‚ę‚˝‘Ήž. rˆäN•v (f—Ïî•ńŠÇ—Žş): ŠâŽčˆă‰Č‘ĺŠw•‘Ž•a‰@ˆă—ĂˆŔ‘Su‰‰‰ď (2016/12/21), ŠâŽč.

733520. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) f—Ïî•ń‚ĚŠˆ—p‚Ö‚Ě‚˘‚´‚Č‚˘. rˆäN•v (f—Ïî•ńŠÇ—Žş): ‘ć148‰ń–kŠC“šf—Ïî•ńŠÇ—Œ¤‹†‰ďŠwpW‰ď (2017/03/11), ŽD–y.


–k—˘‘ĺŠw“Œ•a‰@

“Œ•a‰@ŠĹŒě•”

[’˜@‘]

620202. [Šwp‘ (•Ş’SŽˇ•M)]yƒ`[ƒ€ˆă—Âɂ‚Ȃ°‚é!@IBDf—ĂƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒgz‘ć4Í IBD‚Ě“ŕ‰ČŽĄ—Á@B “ŕ‰ČŽĄ—Ă‚ĚŽŔŰ@7) RTNF-ƒżR‘̐ťÜ@…BƒAƒ_ƒŠƒ€ƒ}ƒu”牺’ŽËŽw“ą, p.169-71. ‘ć5Í IBD‚̐HŽ–E‰h—{—Ă–@@5) ŒoŠÇ‰h—{—Ă–@, p.198-200. ‘ëŕVD1 (1“Œ•a‰@ŠĹŒě•”), ŠÄC: “ú”ä‹I”V2,3, •Ň: ‰ĄŽR@ŒO4, ꎓĄ‰rŽq, VˆäŸ‘ĺ, ´…‘׊x, ‘O–{“Ä’j, ‚’Ă“TF, “ŕ–ě@Šî, ‘č—ćŽq (2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4Á‰ťŠí“ŕ), —r“yŽĐ, “Œ‹ž, 2016/11”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

7231044. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ý‘îEŠÉ˜aŽx‰‡ƒZƒ“ƒ^[ŠJÝŒă8ƒ–ŒŽ‚ĚŽŔ‘Ô•ń. ŒşŠC‘׎q1, –Ń’Ë—R”üŽq1 (1“Œ•a‰@ŠĹŒě•”): ‘ć21‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2016/6/17-18), ‹ž“s, ‘ć21‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďƒvƒƒOƒ‰ƒ€´˜^W 2016/6; p.S517.

7231045. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •ŰŒ’Žw“ąŽŔŽ{ŽŇˆçŹ‚Ö‚ĚŽć‚č‘g‚݁`ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹łˆç‚ĚŠˆ—p`. ‘Oě‰ŔŽq1, V•á’mŒb1, ŽO“cŒÜŒŽŽq1, “ü]‡Žq1, …Œű@e1, ŹňŽüŽq2, Ź™—Œb3, ’|ŕVŽO‘ăŽq2, ‘şă‰ë”ü3, Ź—ѐ´“T4 (1“Œ•a‰@ŠĹŒě•”, 2Á‰ťŠí“ŕ, 3zŠÂŠí“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć57‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ď (2016/7/28-29), ź–{, ‘ć57‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016/7/1; 31 (2): 249.

7231046. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ŰŒ’Žw“ąŽŔŽ{ŽŇˆçŹ‚Ö‚ĚŽć‚č‘g‚݁|ƒ`ƒFƒbƒNƒŠƒXƒg‚̍쐬‚ĆŠˆ—p|. ‘Oě‰ŔŽq1, …Œű@e1, “ü]‡Žq1, ŽO“cŒÜŒŽŽq1, V•á’mŒb1, ŹňŽüŽq2, Ź™—Œb3, ’|ŕVŽO‘ăŽq2, ‘şă‰ë”ü3, Ź—ѐ´“T2,4 (1“Œ•a‰@ŠĹŒě•”, 2Á‰ťŠí“ŕ, 3zŠÂŠí“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć57‰ń“ú–{lŠÔƒhƒbƒNŠw‰ďŠwp‘ĺ‰ď (2016/7/29), ’ˇ–ě, lŠÔƒhƒbƒN 2016/7; 31 (2): 353.

7231047. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ`ƒSƒ`ƒ““\•tÜ‚É‚ć‚萜‚ś‚é“K—p•”ˆĘ”˝‰ž‚Ć•ŰŽźÜ‚ĚŠÖŒW. –ě“c—ÁŽq1, ‰Ô“‡—ĽŽq2, ŠIŕV“ށX1, âV“Ą^Žě1, Ž›“‡–ƒ”ü1, ‚‹´—R”ü1, ˜a‰Ć•‚Šó1, ‰iˆä^‹MŽq2, ´…˜aŒh2, ´…’G2, ě˜Q@•ś2, •x‰i“Ţ•Ű”ü2, š“ߏrŽ÷3, źŽR˜a—˜2 (1“Œ•a‰@ŠĹŒě•”, 2_Œo“ŕ, 3“Œ•a‰@ƒŠƒnƒrƒŠ•”): ‘ć10‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2016/10/7), ‹ž“s, ƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒXƒvƒƒOƒ‰ƒ€E´˜^W 2016/10; 10: 94.

7231048. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘˝EŽí‚Ć˜AŒg‚ľ‚˝ECTƒ†ƒjƒbƒgŠJÝ‚ĆƒpƒX‰ü’ů‚ÉŒü‚Ż‚˝Žć‚č‘g‚Ý. “c‘ş‘ń–˛1, ‰ş‘ş—TŒŠŽq2, ŕVŽRŒb”g3, ŒË“c‰ë–ç4, –ě‘ş”ü‹I1, ŠÖX‘쉛1, —é–ؐ­@1, ´@„Žm1, •“c‚ż‚Š]5, ‹{‰Ş@“™6 (1“Œ•a‰@ŠĹŒě•”, 2ˆă—ĂŒnŒ¤‹†‰Č, 3Œ’NŠÇ—ƒZ, 4–ƒŒ, 5–ňÜ•”, 6¸_): ‘ć17‰ń“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ďŠwpW‰ď (2016/11/26), ‹ŕ‘ň, ‘ć17‰ń“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ďŠwpW‰ď´˜^W 2016/10/25; 18 (4): 530.

7231049. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŽófŽŇ‚̏ó‘Ô‚É“K‚ľ‚˝ƒsƒƒŠ‹ŰŒŸ¸ŽŔŽ{‚Ö‚ĚŽć‚č‘g‚݁`‘˝EŽí˜AŒgE‹Ś“­‚É‚¨‚Ż‚éŠĹŒěŽt‚Ě–đŠ„`. ˜@ŒŠ—çŽq1, V•á’mŒb1, ŽO“cŒÜŒŽŽq1, ‰œ‰iGŽq1, Ź—ѐ´“T2, ’|ŕVŽO‘ăŽq3, —é–؁@—C4 (1“Œ•a‰@ŠĹŒě•”, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3Á‰ťŠí“ŕ, 4“Œ•a‰@Ž––ą•”): “ú–{‘‡Œ’fˆăŠw‰ď‘ć45‰ń‘ĺ‰ď (2017/1/27-28), ç—t, “ú–{‘‡Œ’fˆăŠw‰ď‘ć45‰ń‘ĺ‰ď—\e† 2017/1/1; 44 (1): 305.

733521. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠJ•úŽŽ‹CŠÇ“ŕ‹zˆř‚ĚŽč‡“ˆę`Š´őŠÇ—ƒxƒXƒgƒvƒ‰ƒNƒeƒBƒX‚đŠˆ—p‚ľ‚ā`. ŒË“cŽŔŠó (“Œ•a‰@ŠĹŒě•”): “ú–{Š´őŠÇ—ƒxƒXƒgƒvƒ‰ƒNƒeƒBƒXgSaizenhŒ¤‹†‰ď‘ć11‰ńƒZƒ~ƒi[ (2016/5/28), ‘ĺă, ƒxƒXƒgƒvƒ‰ƒNƒeƒBƒXusaizenvŒ¤‹†‰ď‘ć11‰ńƒZƒ~ƒi[Ž‘—żW 2016; p.67.

733522. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‘މ@Žx‰‡‚É‚ć‚č‚ť‚̐l‚ç‚ľ‚˘śŠˆ‚ŞŽŔŒť‚ľ‚˝Ž–—á`Ý‘îŠÉ˜aŽx‰‡ƒZƒ“ƒ^[•a“ŠĹŒěŽt‚Ě–đŠ„‚đl‚Ś‚é`. ‘ëŕVD (“Œ•a‰@ŠĹŒě•”): ‘ć18‰ń_“ŢěŒ§ŠĹŒěŠw‰ď (2016/12/3), _“ސě, ‘ć18‰ń_“ސěŠĹŒěŠw‰ďW˜^ 2016/12; p.39-41.

733523. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ¸_‰Č‹}ŤŠú•a“‚É‚¨‚Ż‚éƒp[ƒgƒi[ƒVƒbƒv`‚ć‚č—Ç‚˘ŠĹŒěŽŔ‘H‚đ’ń‹Ÿ‚ˇ‚é‚˝‚ß‚Ě‘ŠŒÝ•âŠŽ`. ’†‘ş^Ži1, ŒFâ^—R”ü1, —é–ؐ­@1, ‹g‘ş”ü’qŽq1, •ő@@•ŕ1 (1“Œ•a‰@ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.59.

733524. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) –Ď‘z‚𔺂¤‚¤‚•aŠłŽŇ‚Ě—‰đ‚ƐM—ŠŠÖŒW\’z‚ĚƒvƒƒZƒX‚ɂ‚˘‚ā`ƒgƒ‰ƒxƒ‹ƒr[‚Ě—˜_‚đ—p‚˘‚ā`. •Ä“cç—˘1, ŒFâ^—R”ü1, —é–ؐ­@1 (1“Œ•a‰@ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.60.

733525. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ˆË‘śó‘Ԃ̉Ƒ°‚Ö‚ĚŽx‰‡EŠÖŒW\’z‚ɂ‚˘‚ā|“n•ÓŽŽ‰Ć‘°ƒAƒZƒXƒƒ“ƒg^Žx‰‡ƒ‚ƒfƒ‹‚đ—p‚˘‚ā|. ˆä“‡”ü‰Ä1, …‹´ŒbŽq1, ‚ŒŠ‹IŽq1 (1“Œ•a‰@ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.70.

733526. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”F’mÇ‚É“Á—L‚Č—Ď—“I‰Ű‘č‚ĆˆÓŽvŒˆ’čŽx‰‡. ‘ëŕVD (“Œ•a‰@ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.26.

733527. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰)u‚ť‚̐l‚ç‚ľ‚łv‚đŽx‚Ś‚éŠĹŒě|I––Šú‚Ş‚ńŠłŽŇ‚Ć‚ĚŠÖ‚í‚č‚đ’Ę‚ľ‚ÄŠw‚ń‚ž‚ą‚Ɓ|. ź–{Œb—œŽq1, ‰Ş@‘˝Œb1 (1“Œ•a‰@ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.45.

733528. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) I––ŠúŠłŽŇ‚ĚˆÓŽvŒˆ’č‚đŽx‚Ś‚˝ŠĹŒě|Ž„‚ĚŠĹŒěŠĎ‚̕ωť‚đ’H‚Á‚ā|. Œ´@šŽq1, ‰Ş@‘˝Œb1 (1“Œ•a‰@ŠĹŒě•”): ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ď (2016/12/17), _“ސě, ‘ć16‰ń–k—˘ŠĹŒěŒ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^ 2016/11; p.48.

733529. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) Œř‰Ę“I‚Č•ž–ňŽŠŒČŠÇ—‚É‚Ţ‚Ż‚˝ƒAƒZƒXƒƒ“ƒgƒV[ƒg‚ĚŒŸ“˘. ‘O“c^ś1, ’†ě“Ţ•ä”ü1, …‹´ŒbŽq1 (1“Œ•a‰@ŠĹŒě•”): ‰ń•œŠúƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a“‹Ś‰ď‘ć29‰ńŒ¤‹†‘ĺ‰ďinL“‡ (2017/2/11), L“‡.


“Œ•a‰@—Տ°ŒŸ¸•”

[Šw‰ďEŒ¤‹†‰ď“™]

733530. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŠłŽŇƒT[ƒrƒX‚Ć‚ľ‚ÄŒŸ¸Œř—Ś‰ť‚ĚŽć‚č‘g‚݁`S‘Ÿ“ńŽŸ—\–hƒZƒ“ƒ^[‚Ć‚ĚŠÖ‚í‚č‚ɂ‚˘‚ā`. ‹{‰ş‰ŔŽq1, ‘ŽR–ƒ‹LŽq1, ÎěˆŸŠóŽq1, ‹{–{D1, Ź—ѓށXŠG1, ‘ĺ’Ë‚ß‚Ž‚Ý1, ‰Í“‡]”ü1, —é–؏~Žq1, “•űLˆę2, Žë–ě—Lě3 (1“Œ•a‰@—ŐŒŸ•”, 2—ŐŒŸ•”, 3—ŐŒŸŠw): ‘ć6‰ń–k—˘‘ĺŠw4•a‰@—Տ°ŒŸ¸•”ŠwpW‰ď (2016/7/2), “Œ‹ž.

733531. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw“Œ•a‰@‚É‚¨‚Ż‚é_ŒoŽ¨‰Č‹łˆç“ü‰@‚ĚŒťó‚ɂ‚˘‚Ä. ‘şŽR^‹|1, ‰Í“‡]”ü1, —é–؏~Žq1, “•űLˆę2, Žë–ě—Lě3, ’ˇŔ‰p–ž4 (1“Œ•a‰@—ŐŒŸ•”, 2—ŐŒŸ•”, 3—ŐŒŸŠw, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć6‰ń–k—˘‘ĺŠw4•a‰@—Տ°ŒŸ¸•”ŠwpW‰ď (2016/7/2), “Œ‹ž.


“Œ•a‰@–ňÜ•”

[Šwp˜_•ś]

110316. [Œ´’˜] Relation of %T>MIC of piperacillin to the clinical outcome in the treatment of Gram-negative bacterial infections. Okuma R1, Hamada Y, Kohara H1, Hirayama T1, Kumamoto Y2, Kuroyama M1: The Japanese Journal of Antibiotics 2017/8; 70 (4): 187-200. (‘ĺŒG—Ç‘ž1, •l“cKG, ŹŒ´”ü]1, •˝ŽR•Ži1, ŒGŒł—Y‰î2, •ŽR­ˆę1: 1“Œ•a‰@–ňÜ•”, 2ŠO‰Č)

[’˜@‘]

620203. [Šwp‘ (•Ş’SŽˇ•M)]y‘ąXˆá‚˘‚Ş•Ş‚Š‚é! “ŻŽíE“ŻŒř–ňz5Í ŠO—pR^‹Ű–ň, p.57-68. ‘ş–Ř—Dˆę, ‰œ“c^O, –kŒ´—˛Žu, •ĐŽRÎ–ç, •ŽR­ˆę1, ŠŰŽRCŽĄ, ěăƒˆę, ’†“‡–­Œb, ‘ĺ’J“š‹P, áÁ•”—y, ŽÂč@‘, ‹´“c@‹œ, ‰œŽR@´ (1“Œ•a‰@–ňÜ•”), •Ň: •ŽR­ˆę1, ‘ĺ’J“š‹P, “ě]“°, “Œ‹ž, 2016/9”­s.

620204. [Šwp‘ (•Ş’SŽˇ•M)]yƒ}ƒCƒXƒ^[‚Š‚çŠw‚Ԕ畆‰ČŽĄ—Ă–ň‚Ě•ž–ňŽw“ąpz‘ć1Í –ň•¨—Ă–@‚ĚŠî‘b’mŽŻ@uR^‹Ű–ňvQ2. ŒoŒűR^‹Ű–ň‚Ě•ž–ňŽw“ąƒ|ƒCƒ“ƒg‚ɂ‚˘‚Ä‹ł‚Ś‚Ä‚­‚ž‚ł‚˘, p.96-8. Žć—S‰î1, •ŽR­ˆę1, ‘ź (1“Œ•a‰@–ňÜ•”), •Ň: ‘ĺ’J“š‹P, ‹{’n—ÇŽ÷, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, “Œ‹ž, 2016/11”­s.

620205. [Šwp‘ (•Ş’SŽˇ•M)]yŽĄ—Ă–ňƒnƒ“ƒhƒuƒbƒN2017@–ňÜ‘I‘đ‚Əˆ•ű‚Ěƒ|ƒCƒ“ƒgz“ŻŒř–ň”äŠr•\, p.24-6, 60, 86, 111, 143, 160, 201, 318, 371-4, 463-4, 487, 529-30, 632, 656, 691, 774, 808, 822, 926-7, 1118, 1133, 1166-7, 1219, 1271. •˝ŽR•Ži1, ”ň“c—[‹I1, ě–ěçq1, •ŽR­ˆę1, ‘ź (1“Œ•a‰@–ňÜ•”), ŠÄC: ‚‹vŽj–›, •Ň: –x@ł“ń, ›–ěŒ’‘ž˜Y, –ĺ˜e@F, ŠŁ@ŒŤˆę, —с@š—m, ‚ś‚Ů‚¤, “Œ‹ž, 2017/1”­s.

620206. [Šwp‘ (•Ş’SŽˇ•M)]yŽĄ—Ă–ňƒnƒ“ƒhƒuƒbƒN2017@–ňÜ‘I‘đ‚Əˆ•ű‚Ěƒ|ƒCƒ“ƒgz•t˜^ R‹Ű–ň“K‰ž‹ŰŽíˆę——, •t1-15. •˝ŽR•Ži1, ”ň“c—[‹I1, ě–ěçq1, •ŽR­ˆę1, ‘ź (1“Œ•a‰@–ňÜ•”), ŠÄC: ‚‹vŽj–›, •Ň: –x@ł“ń, ›–ěŒ’‘ž˜Y, –ĺ˜e@F, ŠŁ@ŒŤˆę, —с@š—m, ‚ś‚Ů‚¤, “Œ‹ž, 2017/1”­s.

620207. [Šwp‘ (•Ş’SŽˇ•M)]y•a‹C‚Ć‚­‚ˇ‚č2017@Šî‘b‚ĆŽŔ‘HExpert's Guide (–ň‹Ç2017”N‘Š§ 68 (4))zB. ’†•ŒnŽžŠł@•s–°, •s–°Ç@ŽĄ—Ă–ň‚Ě–ň—‚Ć–ňŠwŠÇ—ă‚Ě’ˆÓ“_, p.667-77. •“c‚ż‚Š]1, •ŽR­ˆę1, ‘ź (1“Œ•a‰@–ňÜ•”), “ěŽR“°, “Œ‹ž, 2017/3”­s.

621002. [Šwp‘ (ŠÄCE•ŇW)]y•a‹C‚Ć–ň•¨—Ă–@ ¸_ŽžŠł^_ŒoE‹ŘŽžŠłzŒú“cKˆę˜Y1 (1–ňÜ•”), ŠÄC: ¤ř“@žÄE•ŽR­ˆę2, ‹¤•Ň: ’|“ŕ—T‹I, •˝ŽR•Ži2 (2“Œ•a‰@–ňÜ•”), ƒI[ƒ€ŽĐ, “Œ‹ž, 2016/11”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

7231050. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œü¸_–ň‘˝Ü“Š—^‚ĚŒ¸ŽZ‹K’čŠY“–ŠłŽŇ‚É‚¨‚Ż‚é’ǐՏˆ•ű’˛¸. ”ň“c—[‹I1,2, •“c‚ż‚Š]1, ‹ß“ĄĂ1, Ä“Ą”ü—é1, •˝ŽR•Ži1,2, ‹{’nLŒá3, ‹{‰Ş@“™3, •ŽR­ˆę1,2 (1“Œ•a‰@–ňÜ•”, 2–ňŠw•”, 3¸_): ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ď (2016/7/9), ‰Ą•l, ‘ć16‰ń“ú–{ŠO—ˆ¸_ˆă—ĂŠw‰ďu‰‰—vŽ|W 2016/7; p.102.

7231051. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ¸_‰Č—Ěˆć‚É‚¨‚Ż‚é–ňŠw“IŠÇ—‚Ě•W€‰ť‚ÉŒü‚Ż‚˝ŽŽ‚Ý. ‹ß“ĄĂ1, •“c‚ż‚Š]1, ”ň“c—[‹I1,2, ě–ěçq1,2, •˝ŽR•Ži1,2, •ŽR­ˆę1,2 (1“Œ•a‰@–ňÜ•”, 2–ňŠw•”): ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď (2016/9/18), ‹ž“s, ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ďƒvƒƒOƒ‰ƒ€W 2016/9; p.118.

7231052. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒŠƒ‹ƒ][ƒ‹‚É‚ć‚éŠĚ‹@”\áŠQ‚̏dÇ“x‚ÉŠÖ‚ˇ‚éŽŔ‘Ô’˛¸. ě–ěçq1,2, ˆéč—F—2, •˝ŽR•Ži1,2, źŽR˜a—˜3, •ŽR­ˆę1,2 (1“Œ•a‰@–ňÜ•”, 2–ňŠw•”, 3_Œo“ŕ): ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď (2016/9/18), ‹ž“s, ‘ć26‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ďƒvƒƒOƒ‰ƒ€W 2016/9; p.135.

7231053. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒOƒ[ƒoƒ‹lŢˆçŹ‚đ–ÚŽw‚ľ‚˝–ňŠwś‘o•űŒü‘ŰŒđ—Ź. ěăŽOD1, —LŠCGl1, ‹{č’qŽq1, •ŽR­ˆę1,2, źŒ´@”Ł1, Ź‹{ŽR‹MŽq1, Źě@‰q1, Œú“cKˆę˜Y1,3, ˆÉ“Ą’q•v1, ‹gŽR—F“ń1 (1–ňŠw•”, 2“Œ•a‰@–ňÜ•”, 3–ňÜ•”): ‘ć49‰ń“ú–{–ňÜŽt‰ďŠwp‘ĺ‰ď (2016/10/9), –źŒĂ‰Ž, ‘ć49‰ń“ú–{–ňÜŽt‰ďŠwp‘ĺ‰ď—vŽ|W 2016/10; p.580.

733532. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‚¨–ň‚Ěˆů‚Ý•ű`Šî–{•Ň`. ‹ß“ĄĂ (“Œ•a‰@–ňÜ•”): ƒfƒCƒPƒAS—‹łˆçƒvƒƒOƒ‰ƒ€ (2016/6/11), ‘Š–ÍŒ´.

733533. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ƒŠƒ‹ƒ][ƒ‹•ž—pŠłŽŇ‚É‚¨‚Ż‚éŠĚ‹@”\áŠQ‚ÉŠÖ‚ˇ‚錤‹†. ˆéř“—F—1, ě–ěçq1,2, •˝ŽR•Ži1,2, źŽR˜a—˜3, •ŽR­ˆę1,2 (1“Œ•a‰@–ňÜ•”, 2–ňŠw•”, 3¸_): “ú–{•a‰@–ňÜŽt‰ďŠÖ“ŒƒuƒƒbƒN‘ć46‰ńŠwp‘ĺ‰ď (2016/8/27), ç—t, “ú–{•a‰@–ňÜŽt‰ďŠÖ“ŒƒuƒƒbƒN‘ć46‰ńŠwp‘ĺ‰ďu‰‰—vŽ|W 2016/8; p.224.

733534. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ¸__Œo‰Č“ü‰@ŠłŽŇÇ—á‚É‚¨‚Ż‚é–ň•¨—Ă–@“Kł‰ť‚ÉŒü‚Ż‚˝Œü¸_–ň‚̏ˆ•űŽŔ‘Ô’˛¸. ’†“ˆ—ş•ă1, ”ň“c—[‹I1,2, •˝ŽR•Ži1,2, ‹{‰Ş@“™3, •ŽR­ˆę1,2 (1–ňŠw•”, 2“Œ•a‰@–ňÜ•”, 3¸_): “ú–{•a‰@–ňÜŽt‰ďŠÖ“ŒƒuƒƒbƒN‘ć46‰ńŠwp‘ĺ‰ď (2016/8/27), ç—t, “ú–{•a‰@–ňÜŽt‰ďŠÖ“ŒƒuƒƒbƒN‘ć46‰ńŠwp‘ĺ‰ďu‰‰—vŽ|W 2016/8; p.292.

733535. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ¸_‰Č‚É‚¨‚Ż‚é–ň•¨—Ă–@ (•ž–ňŽw“ąESST‚Č‚Ç). •“c‚ż‚Š] (“Œ•a‰@–ňÜ•”): ¸_ŠĹŒěƒI[ƒvƒ“ƒZƒ~ƒi[ (2016/9/3), ‘Š–ÍŒ´.

733536. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “‡Ž¸’˛Ç‚Ě‚¨–ň‚ɂ‚˘‚ā`ˆŔS‚ľ‚Ä‚¨–ň‚Ƃ‚Ť‚ ‚¤‚˝‚߂Ɂ`. ”ň“c—[‹I (“Œ•a‰@–ňÜ•”): •˝Ź28”N“x‰Ć‘°‹łŽş (2016/9/8), “Ą‘ň.

733537. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ƒŠƒ‹ƒ][ƒ‹‚É‚ć‚éŠĚ‹@”\áŠQ‚ÉŠÖ‚ˇ‚錤‹†. ě–ěçq1, •˝ŽR•Ži1, ”ň“c—[‹I1, •ŽR­ˆę1 (1–ňŠw•”): ‘ć37‰ń”’‹ŕƒVƒ“ƒ|ƒWƒEƒ€ (2016/12/20), “Œ‹ž, ‘ć37‰ń”’‹ŕƒVƒ“ƒ|ƒWƒEƒ€u‰‰—vŽ|W 2016/12; p.49.

733538. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) –ŤŠú•a‰@‚É‚¨‚Ż‚é•a“–ňÜŽt‚É‚ć‚é–ňŠw“I‰î“ü‚Ěˆă—ĂŒoĎŒř‰Ę‚ÉŠÖ‚ˇ‚錤‹†. —é–ŘŒh‘ž1, “ě@’mš2, ě–ěçq1,2, •ŽR­ˆę1,2 (1“Œ•a‰@–ňÜ•”, 2–ňŠw•”): ‘ć15‰ń‚Š‚Č‚Ş‚í–ňÜŽtŠwp‘ĺ‰ď (2017/1/15), ‰Ą•l, ‘ć15‰ń‚Š‚Č‚Ş‚í–ňÜŽtŠwp‘ĺ‰ďu‰‰—vŽ|W 2017/1; p.116.